Citrus Sinensis ID: 007239

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-
Protein Sequence
MLLLVVQFFMLSIFTDANPLDIACSNTSYAPNSPFESSLKLLLESIATNTSQGFYNLSIGDDPNRVFGRALCRGDVNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKFLVMVYAGQYAEKWNNQWKSVSNPARFIEVLTYLMTNLSIEASSDPAMFAVGEVKFPKRKTIYGLVQCTRDINSRDCNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSLFYNASTRIALTYPTSTDEKRSQRGLLHELAGPISVSLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFPVGRTIVLAEQPSTKDPSVCHDLTVSTLSPR
Secondary Structure (PSIPRED)
cHHHHHHHHHHHHccccccccccccccccccccHHHHHHHHHHHHHHHHccccccccccccccccEEEEEEccccccHHHHHHHHHHHHHHHHHcccccccEEEEcccEEEEEcccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEEEcccccccEEEEEEccccccHHHHHHHHHHHHHHccccccccEEEEEEEEEEEEEEEEEHHccccccccccccccccccccccccccccccccEEccccccccccccccccccHHHHHHHHccccccccccccccccccEEEcccccEEEEEEccccccHHHHHHHHHHHHHHHccccccccEEcccccccEEEEEEEEcccccccEEEEccccccccccHHHHHHHHHHHHHHHHHcccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccHHEEEEEEEccccccccccccccccHHHHHHHccccccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHcccccccccccccccccccccccccccccccccccccEEEEccccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHccccccccccccccccccccHHHHHHHHHHHHcccccccccccccccccccEEEEEEEEcccccHHHHHHHHHHHHHHHHHHcccccEEEEEEccEEEEEccccHcccccccccEEEEcccccccccHHHHHHHHHHHHHHHHHHHHcccccccccccccccccEEEEEEEEcccccHHHHHHHHHHHHHHcHHHcccccccEEEEccEEEEEEEEccccccccccccccccccccccccEEEEEEEccccccccccccccccccccEccHHHHHHHHHcccHHccccccccccEEccEcccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHEEcccccEEEEEEEcccccccEEEEcHHHHHHccHHHHHHHHHHHHHHHHHHHHccHccEEcccccHHHEEEcccccEEEccccccEEEccHHHHccccEEEEEcccccHHHHHcccEcEcccHEHEEEEEEEEEEccccccccccccHHHHHHHHHHHHHcccccEEccHHHcccccHHHHHHHHHHHHHEccccccccccHHHEEEEEcccccEcccccccEEEEEcccccccccccccccccccEEEEEcccc
Coil and Loop (DISEMBL)
MLLLVVQFFMLSiftdanpldiacsntsyapnspfeSSLKLLLESIATNtsqgfynlsigddpnrvfgralcrgdvnrtvCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKFLVMVYAGQYAEKWNNqwksvsnpaRFIEVLTYLMTNLsieassdpamfavgevkfpkrktiYGLVQctrdinsrdcndcltGALGDLKACcgareagiivnencnLRFQLSLFYNASTrialtyptstdekrsqrgllhelagpisvsltqegdlvsseelpFVHLAVIKAatdgfsdsnklgqggfgtvykgvlpngkeVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYelmpnrsldcfifdserrlQLNWNTCYNIIGGISKGLLYLHEDSRLKIIhrdlkpsnvlldKDMVAKISDFGMARIFCEnqktantrrvvgtygymapeyaMEGLFSVKSDVFSFGVIVLEIISgkrnsgfyltGHAQTLLAYVWQLWKegkemefvdpllmksssipqVVRCIHIGLlcvqedpavrptMSNVVALLGSesialseprqppfpvgrtivlaeqpstkdpsvchdltvstlspr
Flexible Loop (DISEMBL)
MLLLVVQFFMLSIFTDANPLDIACSNTSYAPNSPFESSLKLLLESIATNTSQGFynlsigddpnRVFGRALCRGDVNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKFLVMVYAGQYAEKWNNQWKSVSNPARFIEVLTYLMTNLSIEASSDPAMFAVGEVKFPKRKTIYGLVQCTRDINSRDCNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSLFYNASTRIALTYPTSTDEKRSQRGLLHELAGPISVSLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHrdlkpsnvllDKDMVAKISDFGMARIfcenqktantrrvVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESialseprqppFPVGRTIVLaeqpstkdpsvchdltvstlspr
Low Complexity Region (SEG)
MLLLVVQFFMLSIFTDANPLDIACSNTSYAPNSPFESSLKLLLESIATNTSQGFYNLSIGDDPNRVFGRALCRGDVNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKFLVMVYAGQYAEKWNNQWKSVSNPARFIEVLTYLMTNLSIEASSDPAMFAVGEVKFPKRKTIYGLVQCTRDINSRDCNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSLFYNASTRIALTYPTSTDEKRSQRGLLHELAGPISVSLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFPVGRTIVLAEQPSTKDPSVCHDLTVSTLSPR
Disordered region (IsUnstruct)
*LLLVVQFFMLSIFTDANPLDIACSNTSYAPNSPFESSLKLLLESIATNTSQGFYNLSIGDDPNRVFGRALCRGDVNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKFLVMVYAGQYAEKWNNQWKSVSNPARFIEVLTYLMTNLSIEASSDPAMFAVGEVKFPKRKTIYGLVQCTRDINSRDCNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSLFYNASTRIALTYP************LHELAGPISVSLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG*********************************************
Disordered Region (DISOPRED)
MLLLVVQFFMLSIFTDANPLDIACSNTSYAPNSPFESSLKLLLESIATNTSQGFYNLSIGDDPNRVFGRALCRGDVNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKFLVMVYAGQYAEKWNNQWKSVSNPARFIEVLTYLMTNLSIEASSDPAMFAVGEVKFPKRKTIYGLVQCTRDINSRDCNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSLFYNASTR*************************ISV**********SEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPF**********************LTVSTLSPR
Disordered Region (DISEMBL)
MLLLVVQFFMLSIFTDANPLDIACSNTSYAPNSPFESSLKLLLESIATNTSQGFYNLSIGDDPNRVFGRALCRGDVNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKFLVMVYAGQYAEKWNNQWKSVSNPARFIEVLTYLMTNLSIEASSDPAMFAVGEVKFPKRKTIYGLVQCTRDINSRDCNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSLFYNASTRIALTYP*********RGLLHELAGPISVSLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFPVGRTIVLAEQPSTKDPSVCHDL********
Disordered Region (DISPRO)
MLLLVVQFFMLSIFTDANPLDIACSNTSYAPNSPFESSLKLLLESIATNTSQGFYNLSIGDDPNRVFGRALCRGDVNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKFLVMVYAGQYAEKWNNQWKSVSNPARFIEVLTYLMTNLSIEASSDPAMFAVGEVKFPKRKTIYGLVQCTRDINSRDCNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSLFYNAS****************QRGLLHELAGPI********DLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFPVGRT****************DLTVSTL***
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLLLVVQFFMLSIFTDANPLDIACSNTSYAPNSPFESSLKLLLESIATNTSQGFYNLSIGDDPNRVFGRALCRGDVNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKFLVMVYAGQYAEKWNNQWKSVSNPARFIEVLTYLMTNLSIEASSDPAMFAVGEVKFPKRKTIYGLVQCTRDINSRDCNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSLFYNASTRIALTYPTSTDEKRSQRGLLHELAGPISVSLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFPVGRTIVLAEQPSTKDPSVCHDLTVSTLSPR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	611	2.2.26 [Sep-21-2011]
O65468	676	Cysteine-rich receptor-li	yes	no	0.965	0.872	0.435	1e-142
Q8W4G6	627	Cysteine-rich receptor-li	no	no	0.908	0.885	0.427	1e-137
Q9M0X5	675	Cysteine-rich receptor-li	no	no	0.988	0.894	0.407	1e-137
Q8L7G3	659	Cysteine-rich receptor-li	no	no	0.954	0.884	0.425	1e-132
Q9C5S9	674	Cysteine-rich receptor-li	no	no	0.959	0.869	0.411	1e-131
Q9LDQ3	669	Putative cysteine-rich re	no	no	0.980	0.895	0.387	1e-129
O65476	662	Putative cysteine-rich re	no	no	0.937	0.865	0.424	1e-128
Q9C5S8	659	Cysteine-rich receptor-li	no	no	0.952	0.883	0.414	1e-128
Q9T0J1	665	Cysteine-rich receptor-li	no	no	0.916	0.842	0.418	1e-126
Q9ZP16	667	Cysteine-rich receptor-li	no	no	0.965	0.884	0.402	1e-126

>sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2

 Score =  505 bits (1300), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 281/645 (43%), Positives = 389/645 (60%), Gaps = 55/645 (8%)

Query: 18  NP--LDIACSN-TSYAPNSPFESSLKLLLESIATNT---SQGFYNLSIGDDPNRVFGRAL 71
           NP  L+  C N T+Y+ NS + ++LK LL S A+     S GF N+  G  P+RV G  L
Sbjct: 36  NPFYLNHDCPNRTTYSSNSTYSTNLKTLLSSFASRNASYSTGFQNIRAGQTPDRVTGLFL 95

Query: 72  CRGDVNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKFLVMV-YAGQYAEK 130
           CRGD++  VC NC+  + +E L  C    EA+ +YE C ++YS++ FL  V Y G+   +
Sbjct: 96  CRGDLSPEVCSNCVAFSVNESLTRCPNQREAVFYYEECILRYSHKNFLSTVTYEGELIMR 155

Query: 131 WNNQWKSVSNPA-RFIEVLTYLMTNLSIEASSDPAMFAVGEVKFPKRKTIYGLVQCTRDI 189
             N   S+ N   +FI+++   M   + EA++    F+  + +    +T+YGLVQCT D+
Sbjct: 156 NPNNISSIQNQRDQFIDLVQSNMNQAANEAANSSRKFSTIKTELTSLQTLYGLVQCTPDL 215

Query: 190 NSRDCNDCLTGALGDLKAC--CGAREAGIIVNENCNLRFQLSLFYNAS------------ 235
             +DC  CLT ++  +      GAR+       +CN R++L  FYN +            
Sbjct: 216 ARQDCFSCLTSSINRMMPLFRIGARQFW----PSCNSRYELYAFYNETAIGTPSPPPLFP 271

Query: 236 -TRIALTYPT-----------STDEKRSQRGLLHELAGPI-----------SVSLTQEGD 272
            +   LT P+                     L   L G             + S ++ GD
Sbjct: 272 GSTPPLTSPSIPGKSGNSTVLVVAIVVLAVLLFIALVGYCFLAQRTKKTFDTASASEVGD 331

Query: 273 LVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGL 332
            +++ +   +    I+ AT+ F++SNK+G+GGFG VYKG   NGKEVAVKRLS+ S QG 
Sbjct: 332 DMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQGE 391

Query: 333 EEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNT 392
            EFK E++++AKLQHRNLVRL+G  ++GEE++L+YE MPN+SLDC +FD  ++ QL+W  
Sbjct: 392 AEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQTQLDWMQ 451

Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN 452
            YNIIGGI++G+LYLH+DSRL IIHRDLK SN+LLD D+  KI+DFGMARIF  +Q   N
Sbjct: 452 RYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQDN 511

Query: 453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW 512
           T R+VGTYGYMAPEYAM G FS+KSDV+SFGV+VLEIISG++NS F  +  AQ LL + W
Sbjct: 512 TSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDGAQDLLTHTW 571

Query: 513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIAL 572
           +LW     ++ VDPL+  +    +VVRCIHIGLLCVQEDPA RPT+S V  +L S ++ L
Sbjct: 572 RLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFMMLTSNTVTL 631

Query: 573 SEPRQPPF-----PVGRTIVLAEQPSTKD-PSVCHDLTVSTLSPR 611
             PRQP F     PV       +  +TK  P+   D  ++ L PR
Sbjct: 632 PVPRQPGFFIQSSPVKDPTDSDQSTTTKSTPASIDDELITDLYPR 676

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2

 Score =  488 bits (1257), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 256/599 (42%), Positives = 370/599 (61%), Gaps = 44/599 (7%)

Query: 24  CSNTS-YAPNSPFESSLKLLLESIAT---NTSQGFYNLSIGDDPNRVFGRALCRGDVNRT 79
           C NT+ Y+ NSP+ ++L+ LL S++    + S GF +   G  P+RV G  LCRGDV+  
Sbjct: 31  CPNTTTYSRNSPYLTNLRTLLSSLSAPNASYSTGFQSARAGQAPDRVTGLFLCRGDVSPA 90

Query: 80  VCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKFL-VMVYAGQYAEKWNNQWKSV 138
           VC+NC+  + ++ L  C +  +++ +Y+ C ++YS +  L  + Y G +     N     
Sbjct: 91  VCRNCVAFSINDTLVQCPSERKSVFYYDECMLRYSDQNILSTLAYDGAWIRMNGNISIDQ 150

Query: 139 SNPARFIEVLTYLMTNLSIEASSDPAMFAVGEVKFPKRKTIYGLVQCTRDINSRDCNDCL 198
           +   RF + ++  M   +++A+S P  F   +  +   +T+YGLVQCT D+  +DC  CL
Sbjct: 151 NQMNRFKDFVSSTMNQAAVKAASSPRKFYTVKATWTALQTLYGLVQCTPDLTRQDCFSCL 210

Query: 199 TGALGDLKACCGAREAGIIVNENCNLRFQLSLFYNAST--------------RIALTYPT 244
             ++   K     +  G  +  +CN R++L  FYN +T                 +T P+
Sbjct: 211 ESSI---KLMPLYKTGGRTLYSSCNSRYELFAFYNETTVRTQQAPPPLPPSSTPLVTSPS 267

Query: 245 STDEKRSQRGLLHELAGPISVSL---------------------TQEGDLVSSEELPFVH 283
              +  +   L+  +   I V+                        +GD +++E L   +
Sbjct: 268 LPGKSWNSNVLVVAIVLTILVAALLLIAGYCFAKRVKNSSDNAPAFDGDDITTESLQLDY 327

Query: 284 LAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIA 343
             +I+AAT+ FS++NK+GQGGFG VYKG   NG EVAVKRLS+ S QG  EFKNE++++A
Sbjct: 328 -RMIRAATNKFSENNKIGQGGFGEVYKGTFSNGTEVAVKRLSKSSGQGDTEFKNEVVVVA 386

Query: 344 KLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKG 403
           KLQHRNLVRL+G  I G E++L+YE MPN+SLD F+FD  ++ QL+W   Y +IGGI++G
Sbjct: 387 KLQHRNLVRLLGFSIGGGERILVYEYMPNKSLDYFLFDPAKQNQLDWTRRYKVIGGIARG 446

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           +LYLH+DSRL IIHRDLK SN+LLD DM  K++DFG+ARIF  +Q   NT R+VGT+GYM
Sbjct: 447 ILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGLARIFGMDQTQENTSRIVGTFGYM 506

Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF 523
           APEYA+ G FSVKSDV+SFGV+VLEIISGK+N+ FY T  A  L+ + W+LW  G  ++ 
Sbjct: 507 APEYAIHGQFSVKSDVYSFGVLVLEIISGKKNNSFYETDGAHDLVTHAWRLWSNGTALDL 566

Query: 524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFPV 582
           VDP+++ +    +VVRCIHI LLCVQEDPA RP +S +  +L S ++ L  P QP FPV
Sbjct: 567 VDPIIIDNCQKSEVVRCIHICLLCVQEDPAERPILSTIFMMLTSNTVTLPVPLQPGFPV 625

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1

 Score =  488 bits (1257), Expect = e-137,   Method: Compositional matrix adjust.
 Identities = 266/652 (40%), Positives = 394/652 (60%), Gaps = 48/652 (7%)

Query: 3   LLVVQFFML--SIFTDANPLDIACSNTS-YAPNSPFESSLKLLLESIAT-NTSQG--FYN 56
           L  V  FM+  ++ +D   L   C NT+ Y+ NS + ++L+ +L S+++ N +    F N
Sbjct: 11  LFSVFLFMILKTVTSDPTYLYHICPNTTTYSRNSSYLTNLRTVLSSLSSPNAAYASLFDN 70

Query: 57  LSIGD--DPNRVFGRALCRGDVNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYS 114
            + G+  D NRV+G  LCRGDV+  +C++C+  A +E L+ C   + A+IWY+ C ++YS
Sbjct: 71  AAAGEENDSNRVYGVFLCRGDVSAEICRDCVAFAANETLQRCPREKVAVIWYDECMVRYS 130

Query: 115 YRKFLVMVYAGQYAEKWNNQWKSVSNPARFIEVLTYLMTNLSIEASSDPAMFAVGEVKFP 174
            +  +  +         N Q  + +  +RF E L  L+ +++++A+     FA  +  F 
Sbjct: 131 NQSIVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAALSSRKFATEKANFT 190

Query: 175 KRKTIYGLVQCTRDINSRDCNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSLFYNA 234
             +TIY LVQCT D+ ++DC  CL   +  L  CC     G ++  +C+ R++L  FYN 
Sbjct: 191 VFQTIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPFYNE 250

Query: 235 S--------------TRIALTYPTSTDEKRSQRGLLHELAGPISVSLT------------ 268
           +              T   L  P+   + ++   ++  +A P+SV +             
Sbjct: 251 TIAAAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARR 310

Query: 269 ------------QEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNG 316
                        E  + S+E L F   + I+AAT+ FS+SNKLG GGFG VYKG L  G
Sbjct: 311 RNNKLSAETEDLDEDGITSTETLQF-QFSAIEAATNKFSESNKLGHGGFGEVYKGQLITG 369

Query: 317 KEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLD 376
           + VA+KRLS+ S QG EEFKNE+ ++AKLQHRNL +L+G  ++GEEK+L+YE +PN+SLD
Sbjct: 370 ETVAIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLD 429

Query: 377 CFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKIS 436
            F+FD+E+R  L+W   Y II GI++G+LYLH DSRL IIHRDLK SN+LLD DM  KIS
Sbjct: 430 YFLFDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKIS 489

Query: 437 DFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNS 496
           DFGMARIF  +Q  ANT+R+VGTYGYM+PEYA+ G +SVKSDV+SFGV+VLE+I+GK+NS
Sbjct: 490 DFGMARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNS 549

Query: 497 GFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRP 556
            FY       L+ YVW+LW E   +E VD  +  +    +V+RCIHI LLCVQED + RP
Sbjct: 550 SFYEEDGLGDLVTYVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERP 609

Query: 557 TMSNVVALLGSESIALSEPRQPPFPVGRTIVLAEQPSTKDPSVCHDLTVSTL 608
           +M +++ ++ S ++ L  P++  F + RT+  +  P +   +  H  T  +L
Sbjct: 610 SMDDILVMMNSFTVTLPIPKRSGFLL-RTMKDSRDPRSGGSASDHSATSKSL 660

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8L7G3|CRK7_ARATH Cysteine-rich receptor-like protein kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=2 SV=1

 Score =  473 bits (1217), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 269/632 (42%), Positives = 383/632 (60%), Gaps = 49/632 (7%)

Query: 24  CSN-TSYAPNSPFESSLKLLLESIATNT---SQGFYNLSIGDDPNRVFGRALCRGDVNRT 79
           C N T+Y+ NS + ++LK LL S+++     S GF N ++G   +RV G  LCRGDV+  
Sbjct: 33  CPNATTYSSNSTYLTNLKTLLSSLSSRNASYSTGFQNATVGQALDRVTGLFLCRGDVSPE 92

Query: 80  VCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKFL--VMVYAGQYAEKWNNQWKS 137
           VC+NC+  A +     C    EA+ +YE C ++YS++  L   +   G++  +  N    
Sbjct: 93  VCRNCVTFAVNNTFSRCPNQREAVFYYEECILRYSHKNILSTAITNEGEFILRNPNHISP 152

Query: 138 VSNP-ARFIEVLTYLMTNLSIEASSDPAMFAVGEVKFPKRKTIYGLVQCTRDINSRDCND 196
           + N   +F  ++   M  ++IEA+ +P  F+  + +    +T YGLVQCT D++ ++C +
Sbjct: 153 IQNQINQFTNLVLSNMNQIAIEAADNPRKFSTIKTELTALQTFYGLVQCTPDLSRQNCMN 212

Query: 197 CLTGALGDLK-ACCGAREAGIIVNENCNLRFQLSLFYNAS---TRIALTYPTSTDEKRSQ 252
           CLT ++  +  +  GAR+       +CN R++L  FYN +   T      P ++     +
Sbjct: 213 CLTSSINRMPFSRIGARQFW----PSCNSRYELYDFYNETAIGTPPPPLPPLASPSLSDK 268

Query: 253 RG----------------LLHELAGPI-----------SVSLTQEGDLVSSEELPFVHLA 285
            G                +L  +AG             +     E D  + E L   + A
Sbjct: 269 SGNSNVVVVAVVVPIIVAVLIFIAGYCFFAKRAKKTYGTTPALDEDDKTTIESLQLDYRA 328

Query: 286 VIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL 345
            I+AAT+ FS++NK+G+GGFG VYKG   NG EVAVKRLS+ S QG  EFKNE++++A L
Sbjct: 329 -IQAATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSEQGDTEFKNEVVVVANL 387

Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H+NLVR++G  IE EE++L+YE + N+SLD F+FD  ++ QL W   Y+IIGGI++G+L
Sbjct: 388 RHKNLVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLYWTQRYHIIGGIARGIL 447

Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH+DSRL IIHRDLK SN+LLD DM  KI+DFGMARIF  +Q   NT R+VGTYGYM+P
Sbjct: 448 YLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQTQQNTSRIVGTYGYMSP 507

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           EYAM G FS+KSDV+SFGV+VLEIISG++N+ F  T  AQ L+ + W+LW+ G  ++ VD
Sbjct: 508 EYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQDLVTHAWRLWRNGTALDLVD 567

Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFPVGR- 584
           P +  S    +VVRC HIGLLCVQEDP  RP MS +  +L S ++AL  P+QP F V   
Sbjct: 568 PFIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISVMLTSNTMALPAPQQPGFFVRSR 627

Query: 585 --TIVLAEQPSTKDPSVC---HDLTVSTLSPR 611
             T  L    ST + SV     D ++S L PR
Sbjct: 628 PGTNRLDSDQSTTNKSVTVSIDDKSMSDLDPR 659

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1

 Score =  468 bits (1205), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 268/651 (41%), Positives = 388/651 (59%), Gaps = 65/651 (9%)

Query: 20  LDIACSNTS-YAPNSPFESSLKLLLESIA---TNTSQGFYNLSIGDDPNRVFGRALCRGD 75
           L+  C NT+ Y+ NS + ++L+ LL S++    + S GF N + G  P+RV G  LCRGD
Sbjct: 30  LNHYCPNTTTYSSNSTYSTNLRTLLSSLSSRNASYSTGFQNATAGKAPDRVTGLFLCRGD 89

Query: 76  VNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKFLVMVYAGQYAEKWNNQW 135
           V+  VC+NC+  + ++ L  C    EA+ +YE C ++YS++  L      +  E   +  
Sbjct: 90  VSPEVCRNCVAFSVNQTLNLCPKVREAVFYYEQCILRYSHKNILSTAITNE-GEFILSNT 148

Query: 136 KSVSNPARFIEVLTYLMTNLSIEASSDPA-----MFAVGEVKFPKRKTIYGLVQCTRDIN 190
            ++S   + I+  T  +++   EA+   A     ++ V   +    + +YGL+QCT D+ 
Sbjct: 149 NTISPNQKQIDGFTSFVSSTMSEAAGKAANSSRKLYTV-NTELTAYQNLYGLLQCTPDLT 207

Query: 191 SRDCNDCLTGALGDLK-ACCGAREAGIIVNENCNLRFQLSLFYNAST------------- 236
             DC  CL  ++  +  +  GAR    +   +C  R++L  FYN S              
Sbjct: 208 RADCLSCLQSSINGMALSRIGAR----LYWPSCTARYELYPFYNESAIETPPLPPPPPPP 263

Query: 237 ----RIALTYPTSTDEKRSQRG---------------LLHELAGPI-----------SVS 266
                +  T P S+     + G               L   L G             + S
Sbjct: 264 PPRESLVSTPPISSSSLPGKSGNSTVLVVAVVVLAVLLFIALVGYCFLAKKKKKTFDTAS 323

Query: 267 LTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSR 326
            ++ GD +++ +   +    I+ AT+ F++SNK+G+GGFG VYKG   NGKEVAVKRLS+
Sbjct: 324 ASEVGDDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSK 383

Query: 327 KSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL 386
            S QG  EFK E++++AKLQHRNLVRL+G  ++GEE++L+YE MPN+SLDC +FD  +++
Sbjct: 384 NSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQI 443

Query: 387 QLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE 446
           QL+W   YNIIGGI++G+LYLH+DSRL IIHRDLK SN+LLD D+  KI+DFGMARIF  
Sbjct: 444 QLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGL 503

Query: 447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQT 506
           +Q   NT R+VGTYGYMAPEYAM G FS+KSDV+SFGV+VLEIISG++NS F  +  AQ 
Sbjct: 504 DQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFGESDGAQD 563

Query: 507 LLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG 566
           LL + W+LW   K ++ VDPL+ ++    +VVRCIHIGLLCVQEDPA RP +S V  +L 
Sbjct: 564 LLTHAWRLWTNKKALDLVDPLIAENCQNSEVVRCIHIGLLCVQEDPAKRPAISTVFMMLT 623

Query: 567 SESIALSEPRQPPFPVG----RTIVLAEQPSTKD--PSVCHDLTVSTLSPR 611
           S ++ L  PRQP F +     +  + ++Q +T    P+   D +++ L PR
Sbjct: 624 SNTVTLPVPRQPGFFIQCRAVKDPLDSDQSTTTKSFPASIDDESITDLYPR 674

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3

 Score =  461 bits (1186), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 257/664 (38%), Positives = 380/664 (57%), Gaps = 65/664 (9%)

Query: 8   FFMLSIFTDANPLDIACSNTSYAPNSPFESSLKLLLESIATNTS--QGFYNLSIGDDPNR 65
           F +  I  D+      C +  + PNS ++ + + +L ++++N +   GF+N   G  PNR
Sbjct: 11  FLIFLISLDSVTAQEICFSGFFKPNSTYDLNRRQILSTLSSNVTSHNGFFNSKFGQAPNR 70

Query: 66  VFGRALCRGDVNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKF---LVM- 121
           VF   +C        C +C++ A  +I ++C    +A  W + C ++YS   F   LVM 
Sbjct: 71  VFINGMCIPGTKPETCSDCIKGASDKISESCPNKTDAYTWPDCCMVRYSNVSFSGSLVME 130

Query: 122 -----VYAGQYAEKWNNQ------WKSVSNPARFIEVLTYLMTNLSIEASSDPAMFAVGE 170
                 + G   +   N       W+ +      +  +T    + S  +S     FA   
Sbjct: 131 PSETLYHTGDIEDTGTNLTVFDRIWEEL-----MLRTITAASLSSSNGSSFGQKYFAAEV 185

Query: 171 VKFPKRKTIYGLVQCTRDINSRDCNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSL 230
                 +T+Y ++QCT D++S+DC  CL  ++GD ++CC  ++ G ++  +C +R+ L  
Sbjct: 186 ASLTTFQTMYAMMQCTPDVSSKDCEFCLKTSVGDYESCCRGKQGGAVIRPSCFVRWDLYP 245

Query: 231 FYNA---------------STRIALTYPTSTDEKRSQ-RGLLHELAGPISVSLT------ 268
           +  A                  ++L  P  +D   +  +G++  +  PI V L       
Sbjct: 246 YAGAFENVTFPPPPPQSLPQPPVSLIPPPVSDRANTTIKGIIVAIVVPIIVILVSLVVLL 305

Query: 269 ---------QEGDLVSSEELPFVH-----LAVIKAATDGFSDSNKLGQGGFGTVYKGVLP 314
                    +  ++ +++E+   H        I+AATD FSDSN +G+GGFG VY+G L 
Sbjct: 306 VVCRRKKSYKTTEVQATDEITTTHSLQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLS 365

Query: 315 NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRS 374
           +G EVAVKRLS+ S QG EEFKNE +L++KLQH+NLVRL+G  +EGEEK+L+YE +PN+S
Sbjct: 366 SGPEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKS 425

Query: 375 LDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAK 434
           LD F+FD  ++ +L+W   YNIIGGI++G+LYLH+DSRL IIHRDLK SN+LLD DM  K
Sbjct: 426 LDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPK 485

Query: 435 ISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKR 494
           I+DFGMARIF  +Q  ANTRR+ GT+GYM+PEYAM G FS+KSDV+SFGV+VLEIISGK+
Sbjct: 486 IADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKK 545

Query: 495 NSGFY-LTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPA 553
           NS FY +      L+ + W+LW+ G  +E VDP + +S    +  RCIHI LLCVQEDPA
Sbjct: 546 NSSFYNIDDSGSNLVTHAWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQEDPA 605

Query: 554 VRPTMSNVVALLGSESIALSEPRQPPFPV-GRT-----IVLAEQPSTKDPSVCHDLTVST 607
            RP +  ++ +L S +  L  PR P F + GR      +   E  S   P   +D +++ 
Sbjct: 606 DRPLLPAIIMMLTSSTTTLHVPRAPGFCLSGRDLEQDGVEYTESTSRSIPGSINDASITE 665

Query: 608 LSPR 611
             PR
Sbjct: 666 FYPR 669

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65476|CRK16_ARATH Putative cysteine-rich receptor-like protein kinase 16 OS=Arabidopsis thaliana GN=CRK16 PE=3 SV=2

 Score =  459 bits (1181), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 263/619 (42%), Positives = 360/619 (58%), Gaps = 46/619 (7%)

Query: 2   LLLVVQFFMLSIFTDANPLDIACSNTS-YAPNSPFESSLKLLLESIATNTSQ--GFYNLS 58
           LL +  FF++S    +      C  T  + PN  ++ +  LLL S+A+N S   GFYN S
Sbjct: 10  LLPIFCFFLVSFSISSAQ---KCGKTGLFKPNDKYDINRHLLLSSLASNVSARGGFYNAS 66

Query: 59  IGDDPNRVFGRALCRGDVNRTVCQNCLENARHEILKNCKTAEEAIIWYEL-----CQIQY 113
           IG  P+R++    C       +C  C+++A   ++K C    EA+ W        C I+Y
Sbjct: 67  IGQGPDRLYASGTCIQGSEPELCSACIDSAFIRVIKKCHNQTEALDWSSFNEEYPCMIRY 126

Query: 114 SYRKFLVMVYAGQYAEKWNNQWKSVSNPARFIEVLTYLMTNLSIEA--SSDPAMFAVGEV 171
           S R F  ++    + + +N     V N   F +    LM  +  +A  S +P  +  G  
Sbjct: 127 SNRSFFGLLEMTPFFKNYNATDFQV-NLTEFYQKWEALMLGVIADAISSPNPKFYGAGTG 185

Query: 172 KFPKRKTIYGLVQCTRDINSRDCNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSLF 231
           K    +T+Y  V C++DI+  +C+ CL G + + K  C  +  G   + +C +R+ L  F
Sbjct: 186 KI-GIQTVYAFVLCSKDISPWNCSRCLRGNVDNYKLSCSGKPRGHSFSPSCYMRWDLYQF 244

Query: 232 YN-ASTRIALTYPTS-------TDE-----KRSQRGLLHELAGPISVSL----------- 267
           Y     R + T P         +D+      R+  G+   LA  I+V L           
Sbjct: 245 YGFIEYRASPTLPREKGRISELSDDGGKISTRNILGITVALAFFITVLLVLGYALSRRRK 304

Query: 268 -----TQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVK 322
                  E D+ +S  L F     I+AAT+ F  SNKLG GGFG V+KG  PNG EVAVK
Sbjct: 305 AYQEFATENDITTSGSLQF-DFKAIEAATNNFQKSNKLGHGGFGEVFKGTFPNGTEVAVK 363

Query: 323 RLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDS 382
           RLS+ S QG EEFKNE++L+AKLQHRNLVRL+G  +EGEEK+L+YE MPN+SLD F+FD 
Sbjct: 364 RLSKISGQGEEEFKNEVLLVAKLQHRNLVRLLGFSVEGEEKILVYEYMPNKSLDYFLFDH 423

Query: 383 ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR 442
            RR QL+W T YNII G+++G+LYLH+DSRL IIHRDLK  N+LLD DM  KI+DFG+AR
Sbjct: 424 RRRGQLDWRTRYNIIRGVTRGILYLHQDSRLTIIHRDLKAGNILLDVDMNPKIADFGVAR 483

Query: 443 IFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFY-LT 501
            F  +Q  A T RVVGT+GYM PEY   G FS+KSDV+SFGV++LEII GK++S F+ + 
Sbjct: 484 NFRVDQTEATTGRVVGTFGYMPPEYVANGQFSMKSDVYSFGVLILEIIVGKKSSSFHEID 543

Query: 502 GHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
           G    L+ YVW+LW     +E VDP + +S    +V+RCIHI LLCVQE+PA RPTMS V
Sbjct: 544 GSVGNLVTYVWRLWNNESFLELVDPAMGESYDKDEVIRCIHISLLCVQENPADRPTMSTV 603

Query: 562 VALLGSESIALSEPRQPPF 580
             +L +  + L  P+ P F
Sbjct: 604 FQMLTNTFLTLPVPQLPGF 622

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9C5S8|CRK5_ARATH Cysteine-rich receptor-like protein kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1

 Score =  457 bits (1177), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 261/630 (41%), Positives = 369/630 (58%), Gaps = 48/630 (7%)

Query: 24  CSNTSYAPNSPFESSLKLLLESIATNT---SQGFYNLSIGDDPNRVFGRALCRGDVNRTV 80
           C+N   + NS + S+L+ LL S+++N    S G ++L+ G + + VFG  LC+GD++   
Sbjct: 36  CTN-RISRNSIYFSNLQTLLTSLSSNNAYFSLGSHSLTKGQNSDMVFGLYLCKGDLSPES 94

Query: 81  CQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKFLVMVYAGQYAEKWNNQWKSVSN 140
           C+ C+  A  +    C   +E +I Y+ C + YS R   +          WN Q  +   
Sbjct: 95  CRECVIFAAKDTRSRCPGGKEFLIQYDECMLGYSDRNIFMDTVTTTTIITWNTQKVTADQ 154

Query: 141 PARFIEVLTYLMTNLSIEAS-SDPAMFAVGEVKFPKRKTIYGLVQCTRDINSRDCNDCLT 199
             RF + +  LM   + EA+ S    FAV +  F   +++Y  VQC  D+ S DC  CL 
Sbjct: 155 SDRFNDAVLSLMKKSAEEAANSTSKKFAVKKSDFSSSQSLYASVQCIPDLTSEDCVMCLQ 214

Query: 200 GALGDLKACCGAREAGIIVNENCNLRFQLSLFYNASTRIAL----------------TYP 243
            ++ +L      +  G  +  +CN R+++  FY  +    +                ++P
Sbjct: 215 QSIKELYF---NKVGGRFLVPSCNSRYEVYPFYKETIEGTVLPPPVSAPPLPLVSTPSFP 271

Query: 244 TSTDEKRSQRGLLHELAGPISVSLT-------------------QEGDLVSSEELPFVHL 284
               +  +   +   +   ISV +                    +E D+ ++  L F   
Sbjct: 272 PGKGKNSTVIIIAIVVPVAISVLICVAVFSFHASKRAKKTYDTPEEDDITTAGSLQF-DF 330

Query: 285 AVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAK 344
            VI+AATD FS  NKLGQGGFG VYKG LPNG +VAVKRLS+ S QG +EFKNE++++AK
Sbjct: 331 KVIEAATDKFSMCNKLGQGGFGQVYKGTLPNGVQVAVKRLSKTSGQGEKEFKNEVVVVAK 390

Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           LQHRNLV+L+G  +E EEK+L+YE + N+SLD F+FDS  + QL+W T Y IIGGI++G+
Sbjct: 391 LQHRNLVKLLGFCLEREEKILVYEFVSNKSLDYFLFDSRMQSQLDWTTRYKIIGGIARGI 450

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
           LYLH+DSRL IIHRDLK  N+LLD DM  K++DFGMARIF  +Q  A+TRRVVGTYGYM+
Sbjct: 451 LYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFEIDQTEAHTRRVVGTYGYMS 510

Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFY-LTGHAQTLLAYVWQLWKEGKEMEF 523
           PEYAM G FS+KSDV+SFGV+VLEIISG++NS  Y +      L+ Y W+LW +G  ++ 
Sbjct: 511 PEYAMYGQFSMKSDVYSFGVLVLEIISGRKNSSLYQMDASFGNLVTYTWRLWSDGSPLDL 570

Query: 524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFPVG 583
           VD     S    +++RCIHI LLCVQED   RPTMS +V +L + SIAL+ P QPP    
Sbjct: 571 VDSSFRDSYQRNEIIRCIHIALLCVQEDTENRPTMSAIVQMLTTSSIALAVP-QPPGFFF 629

Query: 584 RTIVLAEQPSTKDPSVC--HDLTVSTLSPR 611
           R+      PS    S+C     +++ L+PR
Sbjct: 630 RSNHEQAGPSMDKSSLCSIDAASITILAPR 659

Involved in multiple distinct defense responses. May function as a disease resistance (R) protein.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9T0J1|CRK26_ARATH Cysteine-rich receptor-like protein kinase 26 OS=Arabidopsis thaliana GN=CRK26 PE=2 SV=1

 Score =  454 bits (1168), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 255/610 (41%), Positives = 361/610 (59%), Gaps = 50/610 (8%)

Query: 19  PLDIACSNTS--YAPNSPFESSLKLLLESIAT--NTSQGFYNLSIGDDPNRVFGRALCRG 74
           PL+  CSN +  +  N+P+  +L  L+ S+++      GFYN+S+GD   +V   + CRG
Sbjct: 26  PLNQICSNVTGNFTVNTPYAVNLDRLISSLSSLRRNVNGFYNISVGDSDEKVNSISQCRG 85

Query: 75  DVNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKFLVMVYAGQYAEKWNNQ 134
           DV   VC NC+  A   ++  C   +EAIIWY+ C  +YS R     +    +      +
Sbjct: 86  DVKLEVCINCIAMAGKRLVTLCPVQKEAIIWYDKCTFRYSNRTIFNRLEISPHTSITGTR 145

Query: 135 WKSVSNPARFIEVLTYLMTNLSIEAS---SDPAMFAVGEVKFPKRKTIYGLVQCTRDINS 191
                +   + + L  L+  L   AS        F VGE   P  +T++GLVQCT DI+ 
Sbjct: 146 -NFTGDRDSWEKSLRGLLEGLKNRASVIGRSKKNFVVGETSGPSFQTLFGLVQCTPDISE 204

Query: 192 RDCNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSLFYN-ASTRIALTYPTS----- 245
            DC+ CL+  +  + +CC  +    +++ +C L +    FY+   T    + P +     
Sbjct: 205 EDCSYCLSQGIAKIPSCCDMKMGSYVMSPSCMLAYAPWRFYDPVDTDDPSSVPATPSRPP 264

Query: 246 TDEKRS------QRGLLHELA-GPISVSLT-------------------------QEGDL 273
            +E RS       RG+   L     SV++                           E + 
Sbjct: 265 KNETRSVTQGDKNRGVPKALIFASASVAIVVLFIVLLVVFLKLRRKENIRNSENKHENEN 324

Query: 274 VSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLE 333
           +S++ + F   +V++ AT  FS  NKLG+GGFG VYKGVL +G+++AVKRLS+ + QG  
Sbjct: 325 ISTDSMKF-DFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKIAVKRLSKNAQQGET 383

Query: 334 EFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTC 393
           EFKNE +L+AKLQHRNLV+L+G  IEG E+LL+YE +P+ SLD FIFD  +  +L W   
Sbjct: 384 EFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFDPIQGNELEWEIR 443

Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN- 452
           Y IIGG+++GLLYLH+DSRL+IIHRDLK SN+LLD++M  KI+DFGMAR+F  +  T   
Sbjct: 444 YKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLFDIDHTTQRY 503

Query: 453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW 512
           T R+VGT+GYMAPEY M G FS K+DV+SFGV+VLEIISGK+NSGF        L+++ W
Sbjct: 504 TNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEIISGKKNSGFSSEDSMGDLISFAW 563

Query: 513 QLWKEGKEMEFVDPLLMKSSSIPQ--VVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESI 570
           + WKEG  +  VD +LM  SS     ++RCI+IGLLCVQE  A RP+M++VV +L   +I
Sbjct: 564 RNWKEGVALNLVDKILMTMSSYSSNMIMRCINIGLLCVQEKVAERPSMASVVLMLDGHTI 623

Query: 571 ALSEPRQPPF 580
           ALSEP +P F
Sbjct: 624 ALSEPSKPAF 633

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9ZP16|CRK11_ARATH Cysteine-rich receptor-like protein kinase 11 OS=Arabidopsis thaliana GN=CRK11 PE=2 SV=2

 Score =  452 bits (1164), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 264/656 (40%), Positives = 365/656 (55%), Gaps = 66/656 (10%)

Query: 2   LLLVVQFFMLSIFTDANPLDIACSNT--SYAPNSPFESSLKLLLESIATNTSQG---FYN 56
           L  V+ FF +S F  A+     C+    ++ PN  ++ + +L+L S+ +N +     +YN
Sbjct: 6   LFSVLCFFFIS-FGVASVSAQTCTTDKGTFRPNGTYDVNRRLILSSLPSNVTDQDGLYYN 64

Query: 57  LSIGDDPNRVFGRALCRGDVNRTVCQNCLENARHEILKNCKTAEEAIIWY---ELCQIQY 113
            SIG  PNRV+   +C        C +C++      LKNC    EA  W     LC ++Y
Sbjct: 65  GSIGQQPNRVYAIGMCIPGSTSEDCSDCIKKESEFFLKNCPNQTEAYSWPGEPTLCYVRY 124

Query: 114 SYRKFLVMVYAGQYAEKW-NNQWKSVSNPARFIEVLTYLM--------TNLSIEASSDPA 164
           S   F     A      W  N     SN   F ++   LM        T  S  +SSD  
Sbjct: 125 SNTSF--SGSADLNPRNWLTNTGDLDSNLTEFTKIWEGLMGRMISAASTAKSTPSSSDNH 182

Query: 165 MFAVGEVKFPKRKTIYGLVQCTRDINSRDCNDCLTGALGDLKACCGAREAGIIVNENCNL 224
             A   V  P    IY L+QCT D++S DC +CL  +  D ++CC  +  G+++  +C L
Sbjct: 183 YSADSAVLTPLLN-IYALMQCTPDLSSGDCENCLRQSAIDYQSCCSQKRGGVVMRPSCFL 241

Query: 225 RFQLSLFYNASTRIALTY------------------PTSTDEKRSQRGLLHELAGPISVS 266
           R+ L  + NA   + +                    PT+ D K    G++  +  P  ++
Sbjct: 242 RWDLYTYSNAFDNLTVASPPPEPPVTVPQPAGDQDNPTNNDSKGISAGVVVAITVPTVIA 301

Query: 267 L----------------------TQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGG 304
           +                        E D+ +++ L +     I+AAT+ FS SNKLG+GG
Sbjct: 302 ILILLVLGFVLFRRRKSYQRTKTESESDISTTDSLVY-DFKTIEAATNKFSTSNKLGEGG 360

Query: 305 FGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL 364
           FG VYKG L NG +VAVKRLS+KS QG  EF+NE +L+ KLQHRNLVRL+G  +E EE++
Sbjct: 361 FGAVYKGKLSNGTDVAVKRLSKKSGQGTREFRNEAVLVTKLQHRNLVRLLGFCLEREEQI 420

Query: 365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSN 424
           LIYE + N+SLD F+FD E++ QL+W   Y IIGGI++G+LYLH+DSRLKIIHRDLK SN
Sbjct: 421 LIYEFVHNKSLDYFLFDPEKQSQLDWTRRYKIIGGIARGILYLHQDSRLKIIHRDLKASN 480

Query: 425 VLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGV 484
           +LLD DM  KI+DFG+A IF   Q   NT R+ GTY YM+PEYAM G +S+KSD++SFGV
Sbjct: 481 ILLDADMNPKIADFGLATIFGVEQTQGNTNRIAGTYAYMSPEYAMHGQYSMKSDIYSFGV 540

Query: 485 IVLEIISGKRNSGFYL---TGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCI 541
           +VLEIISGK+NSG Y    T  A  L+ Y  +LW+    +E VDP   ++    +V RCI
Sbjct: 541 LVLEIISGKKNSGVYQMDETSTAGNLVTYASRLWRNKSPLELVDPTFGRNYQSNEVTRCI 600

Query: 542 HIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPP-FPVGRTIVLAEQPSTKD 596
           HI LLCVQE+P  RP +S ++ +L S +I L  PR P  FP  R + L  + S  D
Sbjct: 601 HIALLCVQENPEDRPMLSTIILMLTSNTITLPVPRLPGFFPRSRQLKLVSEGSESD 656

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	611
255555025	663	Serine/threonine-protein kinase PBS1, pu	0.991	0.914	0.623	0.0
302144056	687	unnamed protein product [Vitis vinifera]	0.967	0.860	0.611	0.0
359483315	624	PREDICTED: cysteine-rich receptor-like p	0.949	0.929	0.619	0.0
224076415	659	predicted protein [Populus trichocarpa]	0.991	0.919	0.574	0.0
357480737	644	Cysteine-rich receptor-like protein kina	0.970	0.920	0.586	0.0
224113931	623	predicted protein [Populus trichocarpa]	0.939	0.921	0.566	0.0
359483376	578	PREDICTED: cysteine-rich receptor-like p	0.849	0.897	0.609	0.0
224076491	627	predicted protein [Populus trichocarpa]	0.944	0.920	0.534	0.0
359475757	565	PREDICTED: LOW QUALITY PROTEIN: cysteine	0.869	0.939	0.548	1e-175
359496581	666	PREDICTED: cysteine-rich receptor-like p	0.990	0.908	0.431	1e-151

>gi|255555025|ref|XP_002518550.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis] gi|223542395|gb|EEF43937.1| Serine/threonine-protein kinase PBS1, putative [Ricinus communis]

 Score =  773 bits (1997), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 400/642 (62%), Positives = 477/642 (74%), Gaps = 36/642 (5%)

Query: 1   MLLLVVQFFMLSIFTDANPLDIACSNTS----YAPNSPFESSLKLLLESIATNTS-QGFY 55
           ML LVV   +LS    ANPL   CS+ +    Y  NSPFE++LKLL +++ + T   GFY
Sbjct: 9   MLFLVVPILILSNSVAANPLFTDCSHGTTAENYTLNSPFENNLKLLFQNLTSMTPLTGFY 68

Query: 56  NLSIGDDPNRVFGRALCRGDVNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSY 115
           N SIG+ P+RV G+ALCRGD++ T C+ C+ENA  E++K CK+ ++AIIWYE CQ++YS 
Sbjct: 69  NTSIGESPDRVHGQALCRGDIHATACRTCIENAVQELVKICKS-KDAIIWYESCQVRYSL 127

Query: 116 RKFLVM-VYAGQYAEKWNNQWKSVSNPARFIEVLTYLMTNLSIEASSDPA--MFAVGEVK 172
           R F  M VY G+Y + W  Q K +SNP  F +VL YL+ N+S +A+  P+  MFA GEVK
Sbjct: 128 RMFFSMQVYTGKYVD-WETQKKMISNPVHFYDVLKYLLNNISNKAAFSPSEKMFATGEVK 186

Query: 173 FPKRKTIYGLVQCTRDINSRDCNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSLFY 232
           + ++ TIYGLVQCTRDI   DC  CL  A GDL+ CC +R+ GIIV+ NCN+R++L  FY
Sbjct: 187 YSQKDTIYGLVQCTRDIKGDDCRSCLDQAFGDLRGCCYSRQGGIIVSRNCNVRYELYSFY 246

Query: 233 NASTRIALTYPTSTDEKRSQRGLLHELAGPISV-----------------------SLTQ 269
           N S+R  LTYPT   +K     +   L  P  V                       S+T 
Sbjct: 247 N-SSRNLLTYPTPNGDKWKAWMIALALCIPTVVIAVLIGSCIFFHCRKGGQEEEGMSMTG 305

Query: 270 EGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW 329
             DLVSSE L F+ L  I+AATD FS SNKLGQG FGTV+KG LP+GKE+AVKRLSRKSW
Sbjct: 306 ANDLVSSEGLIFLDLTTIRAATDNFSYSNKLGQGSFGTVFKGALPDGKEIAVKRLSRKSW 365

Query: 330 QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLN 389
           QGLEEFKNEIILIAKLQHRNLVRL+GCGIEGEEKLL+YE MPN+SLD FIFDSERR QL+
Sbjct: 366 QGLEEFKNEIILIAKLQHRNLVRLLGCGIEGEEKLLVYEFMPNKSLDLFIFDSERRKQLD 425

Query: 390 WNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK 449
           W TCYNII GI+KGLLYLHEDSRLKIIHRDLKPSNVLLD +MVAKISDFGMARIF E+Q 
Sbjct: 426 WKTCYNIICGIAKGLLYLHEDSRLKIIHRDLKPSNVLLDNEMVAKISDFGMARIFGEDQH 485

Query: 450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLA 509
           TANTRRVVGTYGYM+PEYAMEGLFSVKSDVFSFGV++LEIISGK+N+GFY+T  A TLL 
Sbjct: 486 TANTRRVVGTYGYMSPEYAMEGLFSVKSDVFSFGVMMLEIISGKKNNGFYITELAPTLLV 545

Query: 510 YVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES 569
           YVWQL  EGKE+EF+DPLL++   I +VVRCIHIGLLCVQEDP  RPTMS+VV LLGSE 
Sbjct: 546 YVWQLRNEGKELEFIDPLLIEKVPIAEVVRCIHIGLLCVQEDPEDRPTMSSVVLLLGSEP 605

Query: 570 IALSEPRQPPFPVGRTIVLAEQPSTKDPSVCHDLTVSTLSPR 611
            AL EP+QP F VGR   + ++PST  PSV + +  S + PR
Sbjct: 606 NALPEPKQPAFSVGRMFSI-DRPSTTVPSV-NQIIDSIILPR 645

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302144056|emb|CBI23161.3| unnamed protein product [Vitis vinifera]

 Score =  761 bits (1965), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 386/631 (61%), Positives = 466/631 (73%), Gaps = 40/631 (6%)

Query: 17  ANPLDIACSNTS--YAPNSPFESSLKLLLESIATNTSQGFYNL-SIGDDPNRVFGRALCR 73
           A P+   C + +  Y  NS FE++LK LL+S+ +NT    +N+ S+G D NRV GRALCR
Sbjct: 61  AQPMYTFCDSGTGNYTSNSSFENNLKHLLQSLPSNTYLTCFNITSMGIDANRVSGRALCR 120

Query: 74  GDVNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKFLVM-VYAGQYAEKWN 132
           GDV   VC  CLENA  EI+K CK+ +EAIIWYELCQ+ YSYR    M  Y G+Y   WN
Sbjct: 121 GDVTDKVCWICLENASREIMKECKS-QEAIIWYELCQVHYSYRILSGMDAYTGKYP-LWN 178

Query: 133 NQWKSVSNPARFIEVLTYLMTNLSIEASSDPA--MFAVGEVKFPKRKTIYGLVQCTRDIN 190
           NQ K+VS+P  F EVL  LM NL+I+A+  P+  MF   +VKF +  TIYGLVQCTRD+ 
Sbjct: 179 NQEKNVSDPLSFYEVLNDLMRNLTIKAAQGPSKLMFGTDQVKFSRSDTIYGLVQCTRDLT 238

Query: 191 SRDCNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSLFYNASTR----------IAL 240
              C  CL+ ALGDLKACC  R  G I + +CN+R+ L+ FY+  +           + +
Sbjct: 239 VDSCRKCLSSALGDLKACCYGRGGGTIFSRSCNMRYGLTRFYDTPSVKGEWKTWMIVLVI 298

Query: 241 TYPT--------------------STDEKRSQRGLLHELAGPISVSLTQEGDLVSSEELP 280
             PT                      DE++SQR LLH LA P + ++TQE +L+SS+ELP
Sbjct: 299 CVPTFAAAVLVGSCVLYYRGRTGTQNDEEKSQRALLHNLATPTAAAITQEFNLLSSQELP 358

Query: 281 FVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEII 340
           F+ LA I+AAT+ FS+SNKLG GGFGTVYKGVLPNGKE+AVKRLS+KSWQG+EEFKNEII
Sbjct: 359 FMELATIRAATNDFSESNKLGHGGFGTVYKGVLPNGKEIAVKRLSKKSWQGIEEFKNEII 418

Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           LIAKLQHRNLVRL+GCG EG+EKLLIYE MPN+SLD FIFD+++R QLNW  C+NII GI
Sbjct: 419 LIAKLQHRNLVRLLGCGTEGQEKLLIYEFMPNKSLDIFIFDADKRQQLNWEICHNIIDGI 478

Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
           ++GLLYLHEDSRLKIIHRDLKP+NVLL+ DMVAKISDFGMARIF ENQ  ANTRR+VGTY
Sbjct: 479 ARGLLYLHEDSRLKIIHRDLKPNNVLLNHDMVAKISDFGMARIFGENQNAANTRRIVGTY 538

Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE 520
           GYMAPEYAMEG+FS+KSDVFSFGVI+LEIISGKRNSGF+LTGHA TL AY W+LW EGK 
Sbjct: 539 GYMAPEYAMEGMFSMKSDVFSFGVILLEIISGKRNSGFHLTGHAHTLPAYAWKLWNEGKG 598

Query: 521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPF 580
           +EFV PLL +S     V+RCIHIGLLCVQE+PA R TMS+VV LL S+S+AL EP+QPPF
Sbjct: 599 LEFVHPLLTESCPTEVVLRCIHIGLLCVQENPADRLTMSSVVVLLESKSMALPEPKQPPF 658

Query: 581 PVGRTIVLAEQPSTKDPSVCHDLTVSTLSPR 611
            VG  I   + P+T  P   ++L VS+  PR
Sbjct: 659 SVGIAIQFNQSPTT--PLSVNELAVSSFLPR 687

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483315|ref|XP_002265625.2| PREDICTED: cysteine-rich receptor-like protein kinase 25-like [Vitis vinifera]

 Score =  758 bits (1958), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 383/618 (61%), Positives = 461/618 (74%), Gaps = 38/618 (6%)

Query: 28  SYAPNSPFESSLKLLLESIATNTSQGFYNL-SIGDDPNRVFGRALCRGDVNRTVCQNCLE 86
           +Y  NS FE++LK LL+S+ +NT    +N+ S+G D NRV GRALCRGDV   VC  CLE
Sbjct: 11  NYTSNSSFENNLKHLLQSLPSNTYLTCFNITSMGIDANRVSGRALCRGDVTDKVCWICLE 70

Query: 87  NARHEILKNCKTAEEAIIWYELCQIQYSYRKFLVM-VYAGQYAEKWNNQWKSVSNPARFI 145
           NA  EI+K CK+ +EAIIWYELCQ+ YSYR    M  Y G+Y   WNNQ K+VS+P  F 
Sbjct: 71  NASREIMKECKS-QEAIIWYELCQVHYSYRILSGMDAYTGKYP-LWNNQEKNVSDPLSFY 128

Query: 146 EVLTYLMTNLSIEASSDPA--MFAVGEVKFPKRKTIYGLVQCTRDINSRDCNDCLTGALG 203
           EVL  LM NL+I+A+  P+  MF   +VKF +  TIYGLVQCTRD+    C  CL+ ALG
Sbjct: 129 EVLNDLMRNLTIKAAQGPSKLMFGTDQVKFSRSDTIYGLVQCTRDLTVDSCRKCLSSALG 188

Query: 204 DLKACCGAREAGIIVNENCNLRFQLSLFYNASTR----------IALTYPT--------- 244
           DLKACC  R  G I + +CN+R+ L+ FY+  +           + +  PT         
Sbjct: 189 DLKACCYGRGGGTIFSRSCNMRYGLTRFYDTPSVKGEWKTWMIVLVICVPTFAAAVLVGS 248

Query: 245 -----------STDEKRSQRGLLHELAGPISVSLTQEGDLVSSEELPFVHLAVIKAATDG 293
                        DE++SQR LLH LA P + ++TQE +L+SS+ELPF+ LA I+AAT+ 
Sbjct: 249 CVLYYRGRTGTQNDEEKSQRALLHNLATPTAAAITQEFNLLSSQELPFMELATIRAATND 308

Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           FS+SNKLG GGFGTVYKGVLPNGKE+AVKRLS+KSWQG+EEFKNEIILIAKLQHRNLVRL
Sbjct: 309 FSESNKLGHGGFGTVYKGVLPNGKEIAVKRLSKKSWQGIEEFKNEIILIAKLQHRNLVRL 368

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
           +GCG EG+EKLLIYE MPN+SLD FIFD+++R QLNW  C+NII GI++GLLYLHEDSRL
Sbjct: 369 LGCGTEGQEKLLIYEFMPNKSLDIFIFDADKRQQLNWEICHNIIDGIARGLLYLHEDSRL 428

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF 473
           KIIHRDLKP+NVLL+ DMVAKISDFGMARIF ENQ  ANTRR+VGTYGYMAPEYAMEG+F
Sbjct: 429 KIIHRDLKPNNVLLNHDMVAKISDFGMARIFGENQNAANTRRIVGTYGYMAPEYAMEGMF 488

Query: 474 SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSS 533
           S+KSDVFSFGVI+LEIISGKRNSGF+LTGHA TL AY W+LW EGK +EFV PLL +S  
Sbjct: 489 SMKSDVFSFGVILLEIISGKRNSGFHLTGHAHTLPAYAWKLWNEGKGLEFVHPLLTESCP 548

Query: 534 IPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFPVGRTIVLAEQPS 593
              V+RCIHIGLLCVQE+PA R TMS+VV LL S+S+AL EP+QPPF VG  I   + P+
Sbjct: 549 TEVVLRCIHIGLLCVQENPADRLTMSSVVVLLESKSMALPEPKQPPFSVGIAIQFNQSPT 608

Query: 594 TKDPSVCHDLTVSTLSPR 611
           T  P   ++L VS+  PR
Sbjct: 609 T--PLSVNELAVSSFLPR 624

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224076415|ref|XP_002304939.1| predicted protein [Populus trichocarpa] gi|222847903|gb|EEE85450.1| predicted protein [Populus trichocarpa]

 Score =  733 bits (1891), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/656 (57%), Positives = 470/656 (71%), Gaps = 50/656 (7%)

Query: 1   MLLLVVQFFMLSIFTDANPLDIACSNTSYAP---NSPFESSLKLLLESIATNTSQGFYN- 56
           M  L++   ML     A+PL   CS T Y      SPF  ++K++LE++ + TS   YN 
Sbjct: 9   MCFLIILLSMLFALVLADPLFTTCSTTEYGNYDLKSPFGKNVKIVLETLPSITSSTGYNS 68

Query: 57  LSIGDDPNRVFGRALCRGDVNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYR 116
            +IG+ P++V G+ALCRGDV  + CQ CL +A  ++LK+C++ +EAIIWYE CQI YS++
Sbjct: 69  TAIGEFPDKVTGKALCRGDVTSSACQTCLRDASQKLLKDCES-KEAIIWYERCQIHYSFQ 127

Query: 117 KFLVM-VYAGQYAEKWNNQWKSVSNPARFIEVLTYLMTNLSIEASSDPA--MFAVGEVKF 173
             + + VYAG+Y +  ++  KSVS+P  F + + +LM NLS EA+ + +  MF  GE+KF
Sbjct: 128 NIISLDVYAGKYPDMESHN-KSVSDPVHFYDNVRFLMDNLSNEAALNRSKLMFETGEIKF 186

Query: 174 PKRKTIYGLVQCTRDINSRDCNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSLFYN 233
            + +TIYGLVQCTRDI   +C  CL+ AL DLK CC +++ GIIV+ NCN+RF+L  +YN
Sbjct: 187 SRNETIYGLVQCTRDIREDECQKCLSSALIDLKGCCSSKQGGIIVSSNCNVRFELYKYYN 246

Query: 234 ASTRIALTYPT--------------------------------------STDEKRSQRGL 255
            S+ + +T+PT                                        D +RS   L
Sbjct: 247 TSSHL-ITFPTPKGRSNWKMVAIIVFIPTMVLTIVIGSSIFCLRRKRRRQRDMERSHLTL 305

Query: 256 LHELAGPISVSLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPN 315
           L E A PI  + T+EG LVSSE+LPF+ L  I+AATD FSD NKLGQGGFG VYKGVL N
Sbjct: 306 LKESASPIGFTTTEEGQLVSSEDLPFMDLNTIRAATDNFSDPNKLGQGGFGNVYKGVLTN 365

Query: 316 GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSL 375
            KE+AVKRLS KSWQGLEEFKNE +LI KLQHRNLVRL+GCG+EGEEKLLIYE MPN+SL
Sbjct: 366 VKEIAVKRLSIKSWQGLEEFKNEFMLIEKLQHRNLVRLLGCGMEGEEKLLIYEFMPNKSL 425

Query: 376 DCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKI 435
           D FIFD+ERR QL+W T YNII GI++GLLYLHEDSRL+IIHRDLKPSNVLLD +MVAKI
Sbjct: 426 DIFIFDAERRAQLDWETYYNIISGIARGLLYLHEDSRLRIIHRDLKPSNVLLDHEMVAKI 485

Query: 436 SDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRN 495
           SDFGMARIF ENQ  ANTRRVVGT+GYMAPEYAMEG+FSVKSDVFSFGVI+LEIISGKR+
Sbjct: 486 SDFGMARIFGENQNKANTRRVVGTFGYMAPEYAMEGIFSVKSDVFSFGVILLEIISGKRS 545

Query: 496 SGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVR 555
           SGFYLT H QTLLAY W+LW EGK MEF DPLL++ S    ++RC+HIGLLCVQ+DPA R
Sbjct: 546 SGFYLTEHGQTLLAYAWRLWIEGKAMEFADPLLVERSPAEGILRCMHIGLLCVQKDPADR 605

Query: 556 PTMSNVVALLGSESIALSEPRQPPFPVGRTIVLAEQPSTKDPSVCHDLTVSTLSPR 611
           PTMS V   L S+ IAL + +QP F + + IV A++ S+ D SV + +TVS+  PR
Sbjct: 606 PTMSFVDLALASDPIALPQSQQPAFSLVK-IVPADKSSSTDRSV-NQMTVSSFLPR 659

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357480737|ref|XP_003610654.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355511989|gb|AES93612.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula]

 Score =  731 bits (1887), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/629 (58%), Positives = 469/629 (74%), Gaps = 36/629 (5%)

Query: 15  TDANPLDIACSNTS--YAPNSPFESSLKLLLESIATNTSQG----FYNLSIGDDPNRVFG 68
           TD   +D  C +    Y  N+ F  +LKLL+E++++N +      F N SIG   ++V+G
Sbjct: 20  TDHLIIDTYCPDNFPFYTSNTSFHKNLKLLMETLSSNIAASNTSYFNNTSIGQGLDKVYG 79

Query: 69  RALCRGDV-NRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKFLV-MVYAGQ 126
           +ALCRGD+ N TVC+ C+E A  +++  CK+ E+A++WYELCQ++YS++ F    VY G+
Sbjct: 80  QALCRGDITNSTVCKECIEKASKDLMNRCKS-EDAMVWYELCQVRYSFQMFFSDAVYTGK 138

Query: 127 YAEKWNNQWKSVSNPARFIEVLTYLMTNLSIEASSDPA--MFAVGEVKF-PKRKTIYGLV 183
           Y  K N+  K VS+P  F +VLTYLM NLS EA+ +PA  MFA  E++F  K++ IYGLV
Sbjct: 139 YP-KQNDLEKRVSDPTSFQQVLTYLMNNLSNEAAFNPAKNMFATAEIEFSAKKERIYGLV 197

Query: 184 QCTRDINSRDCNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSLFYNASTRIAL-TY 242
           +CT+D++  DC  CL+ A+ +L ACC  RE GIIV+ NCN+RF L  F+NAS+  +L  +
Sbjct: 198 ECTKDVSETDCGSCLSSAVTELNACCSYREGGIIVSRNCNVRFDLFQFFNASSAASLLIF 257

Query: 243 PTST------------------DEKRSQRGLLHELAGPISVSLTQEGDLVSSEELPFVHL 284
           PTS                   DE+RS+R L  EL+ P +V++TQEG+L+SS++L F+ L
Sbjct: 258 PTSKVLIGLCTACRRQKNDRDKDEERSERMLFQELSSPKNVAITQEGELISSDQLLFMTL 317

Query: 285 AVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAK 344
           A IKA TD FS++NKLGQGGFG VYKGVLP+G E+AVKRLS+KSWQG+EEFKNEIILIAK
Sbjct: 318 ATIKAGTDDFSNTNKLGQGGFGAVYKGVLPDGNEIAVKRLSKKSWQGIEEFKNEIILIAK 377

Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           LQH+NLV+L+GC +EGEEK+L+YE M NRSLD FIFD  +R +L+W TCY IIGGI++GL
Sbjct: 378 LQHKNLVKLLGCVLEGEEKILVYEFMSNRSLDQFIFDPNKRPKLDWKTCYGIIGGIARGL 437

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
           LYLHE+SRLKIIHRDLKP+NVLLD ++VAKISDFGMAR+F ENQ TANT+RVVGT+GYMA
Sbjct: 438 LYLHEESRLKIIHRDLKPNNVLLDHELVAKISDFGMARMFSENQNTANTKRVVGTHGYMA 497

Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV 524
           PEYAMEGLFSVKSDVFSFGVI+LEIISGKRN GFYLT  A TLLAY W+LW EGK +EF 
Sbjct: 498 PEYAMEGLFSVKSDVFSFGVIMLEIISGKRNGGFYLTELAPTLLAYAWKLWNEGKGLEFA 557

Query: 525 DPLLMKS--SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFPV 582
           DP+L++S      +V+RCIHIGLLCVQEDP  RPTMSNVV LLGSES+ L +PRQP F  
Sbjct: 558 DPILLESCLDYESEVLRCIHIGLLCVQEDPQHRPTMSNVVVLLGSESMVLPQPRQPAFSS 617

Query: 583 GRTIVLAEQPSTKDPSVCHDLTVSTLSPR 611
           G+ I +   PS       +D   S +SPR
Sbjct: 618 GKMIRV--DPSASTNCSLNDSIWSNISPR 644

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224113931|ref|XP_002316617.1| predicted protein [Populus trichocarpa] gi|222859682|gb|EEE97229.1| predicted protein [Populus trichocarpa]

 Score =  668 bits (1724), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 343/606 (56%), Positives = 432/606 (71%), Gaps = 32/606 (5%)

Query: 1   MLLLVVQFFMLSIFT--DANPLDIACSNT-SYAPNSPFESSLKLLLESIATNTS-QGFYN 56
           M L ++ F +LS  T  D +     C+N  +Y  NS FE++LK++L+ + + TS  GF  
Sbjct: 10  MFLFIMPFTVLSTQTGPDVHLKTFCCNNALNYTRNSAFENNLKIVLKRLPSITSLTGFNY 69

Query: 57  LSIGDDPNRVFGRALCRGDVNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYR 116
              G+   +V+G+ALCRGDVN + C+ C+E A  +I  +C +  EAIIWYELCQ+ YS++
Sbjct: 70  TFFGEASAKVYGQALCRGDVNSSACRTCVEKASKQIFNDCISRGEAIIWYELCQVHYSFQ 129

Query: 117 KFLVM-VYAGQYAEKWNNQWKSVSNPARFIEVLTYLMTNLSIEASSDP-AMFAVGEVKFP 174
               + VYAG+Y ++ +++ KS S+   F++   YLMTNLS EA+ +P  MFA G++ F 
Sbjct: 130 NMTSLSVYAGKYLDR-DSKEKSESDQVHFLKFSKYLMTNLSNEAAFNPFNMFATGKINFS 188

Query: 175 KRKTIYGLVQCTRDINSRDCNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSLFYNA 234
           + KTI+  VQCTRDI   +C  CL  A+ DL+ CC +R+ G++++ NCN+RF+L  FYN 
Sbjct: 189 RSKTIFAHVQCTRDIRPHECLKCLKSAITDLEGCCSSRKGGMVLSRNCNVRFELYQFYNV 248

Query: 235 STRIALTYPTSTDEK-RSQRGLLHELAGPISVSLTQEGDLV--------------SSEEL 279
           S    L+ PTS   K ++ R +   +  PI+V     G  +              SS++ 
Sbjct: 249 SKH--LSSPTSRGRKWKAGRKVACVVFIPITVLAIVIGSCIVFLRHKRRKERGNASSDQQ 306

Query: 280 PFVH--------LAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQG 331
            FV           V + AT+ FSDSNKLGQ GFG VYKGVL +GKE+AVKRLSR SWQG
Sbjct: 307 CFVFSIGMECFSFGVFRPATENFSDSNKLGQAGFGAVYKGVLTDGKEIAVKRLSRNSWQG 366

Query: 332 LEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWN 391
           L EFKNEIILIAKLQHRNLV+L+GCGIEGEEKLLIYE MPN+SLD FIFD ERR QL+W 
Sbjct: 367 LAEFKNEIILIAKLQHRNLVKLLGCGIEGEEKLLIYEFMPNKSLDVFIFDEERREQLDWE 426

Query: 392 TCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA 451
           TCYNII GI++GLLYLHEDSRL+IIHRDLK SNVLLD +M A+ISDFGMARIF ENQ  A
Sbjct: 427 TCYNIISGIARGLLYLHEDSRLRIIHRDLKTSNVLLDHEMTARISDFGMARIFGENQNNA 486

Query: 452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYV 511
           NT+RVVGT+GYMAPEYAMEGLFSVKSDVFSFGV++LEI+ GKR+SGFYLT H QTLL Y 
Sbjct: 487 NTKRVVGTFGYMAPEYAMEGLFSVKSDVFSFGVMLLEILCGKRSSGFYLTQHGQTLLTYA 546

Query: 512 WQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIA 571
           W+LW EG+EMEF DPLLM  S   ++V C+HIGLLCVQEDPA RPTMS VV  LGSE +A
Sbjct: 547 WRLWNEGREMEFADPLLMGRSLAIEIVTCMHIGLLCVQEDPADRPTMSFVVLALGSEPVA 606

Query: 572 LSEPRQ 577
           L  P++
Sbjct: 607 LPLPKK 612

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483376|ref|XP_002265688.2| PREDICTED: cysteine-rich receptor-like protein kinase 15-like [Vitis vinifera]

 Score =  647 bits (1670), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 328/538 (60%), Positives = 395/538 (73%), Gaps = 19/538 (3%)

Query: 17  ANPLDIACSNTSYAPNSPFESSLKLLLESIATNTS-QGFYNLSIGDDPNRVFGRALCRGD 75
           A+PL    SN +Y PNSPFE++LK LL+S+++NT   GF + S+G + N+V GRALCRGD
Sbjct: 27  ADPLGKVRSNKTYTPNSPFENNLKGLLQSLSSNTHLTGFNSASVGSNTNQVHGRALCRGD 86

Query: 76  VNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKFLVMVYAGQYAEKWNNQW 135
           V    C+NC+ENA  EI+K CK+ EEAIIWYE CQ+QYSY+ F VMVY G+Y +  N+Q 
Sbjct: 87  VAAQDCKNCVENASQEIMKVCKS-EEAIIWYEFCQVQYSYQMFSVMVYTGKYPDS-NSQK 144

Query: 136 KSVSNPARFIEVLTYLMTNLSIEASSDPA--MFAVGEVKFPKRKTIYGLVQCTRDINSRD 193
           K+VS+P  F      LM NL+ +A+ D A  MFAVGE K  +  TIYGLVQCTRD     
Sbjct: 145 KNVSDPGHFYSFQKDLMGNLTNDAAFDHAKLMFAVGETKLSRNLTIYGLVQCTRDQPGGF 204

Query: 194 CNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSLFYNASTR-----------IALTY 242
           C++CL  A GDL  CC   E G I+  +CN+RF++  FY   T            + +  
Sbjct: 205 CSNCLMSAFGDLSGCCKTHEGGTIL-RSCNMRFEVHRFYTVPTVNAGEWKMWMLVLVICI 263

Query: 243 PTSTDEKRSQRGLLHELA--GPISVSLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKL 300
           P           +L+     G  +V++ QEG L+  +ELPF+  A +KAATD  SDSNKL
Sbjct: 264 PIFAPAVLIGSCILYRRGRKGTQNVAMIQEGSLLGPQELPFMDFATVKAATDNISDSNKL 323

Query: 301 GQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG 360
           GQGGFGTV+KGVLPNG E+AVKRLSRKSWQG EE KNEIILIAKLQHRNLVR +GCGIEG
Sbjct: 324 GQGGFGTVFKGVLPNGNEIAVKRLSRKSWQGAEEVKNEIILIAKLQHRNLVRFLGCGIEG 383

Query: 361 EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDL 420
           +EKLL YE MPN+SLD FIFD ++ LQ NW T +NII GI++GLLYL+EDSRLKIIHRDL
Sbjct: 384 DEKLLRYEFMPNKSLDIFIFDEDKELQFNWETRHNIINGIARGLLYLYEDSRLKIIHRDL 443

Query: 421 KPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVF 480
           KP+NVLLD DMVAKISDFGMARIFCE Q  ANTRR+VGTYGY+APEYAMEG+FSVKSD F
Sbjct: 444 KPNNVLLDHDMVAKISDFGMARIFCEKQNAANTRRIVGTYGYIAPEYAMEGIFSVKSDAF 503

Query: 481 SFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVV 538
           SFGVI+LEIISGKRNSGFYLT  A TLLAY W+LW EGKE+EFVD LL +S    +++
Sbjct: 504 SFGVILLEIISGKRNSGFYLTQLAPTLLAYAWRLWNEGKELEFVDSLLTESCPAEEIL 561

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224076491|ref|XP_002304951.1| predicted protein [Populus trichocarpa] gi|222847915|gb|EEE85462.1| predicted protein [Populus trichocarpa]

 Score =  641 bits (1653), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 331/619 (53%), Positives = 417/619 (67%), Gaps = 42/619 (6%)

Query: 3   LLVVQFFMLSIFT----DANPLDIACSN-TSYAPNSPFE----SSLKLLLESIATNTSQG 53
           ++++    L+I T    DAN L   C N T+   NS +       L  L  +   N + G
Sbjct: 8   VILLSLLTLAIITLAQEDANYLYHNCQNATTSTINSTYRVNLNLLLSSLASNATLNNTIG 67

Query: 54  FYNLSIGDDPNRVFGRALCRGDVNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQY 113
           FYN S G   ++V+G  +CRGD++ +VCQNC+  A  +I++ C     +I++Y+ C ++Y
Sbjct: 68  FYNTSFGQSTDQVYGLFICRGDLSNSVCQNCVTFATEDIVQRCPIGIASIVYYDACILRY 127

Query: 114 SYRKFLVMVYAGQYAEKWNNQWKSVSNPARFIEVLTYLMTNLSIEASSDP---AMFAVGE 170
           S R     V         N Q    + P RF  ++     +L+  A+S P     FAV +
Sbjct: 128 SNRNIFSKVDQSPGFSLLNTQ-NITTEPQRFNNLVGATANDLATRAASAPPGAKKFAVNK 186

Query: 171 VKFPKRKTIYGLVQCTRDINSRDCNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSL 230
             F   + IY L QCT D++S DCN CL+ A+  L  CC ++  G ++  +C + ++++ 
Sbjct: 187 TSFNAFQNIYSLAQCTPDLSSSDCNRCLSAAIAGLPNCCSSKIGGRVLFPSCYIHYEITE 246

Query: 231 FYNASTR----------IALTYPTSTD------------EKRSQR-------GLLHELAG 261
           FYNA+            +A+  P +                R  R        LL ELA 
Sbjct: 247 FYNATAIKKGGVPTVLIMAIVIPIAVSIALFSMCFCFLRRARKTRDYVPENDALLQELAC 306

Query: 262 PISVSLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAV 321
           P  V++T EG LVSSE+LPF+ L  I+ ATD FSDSNKLGQGGFGTVYKGVLP+GKE+AV
Sbjct: 307 PRGVTMTDEGQLVSSEDLPFMDLTTIREATDNFSDSNKLGQGGFGTVYKGVLPDGKEIAV 366

Query: 322 KRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFD 381
           KRLSRKSWQGLEEFKNE+ +IAKLQHRNLVRL+GCG+EG+EKLLIYE M N+SLD FIFD
Sbjct: 367 KRLSRKSWQGLEEFKNEVKVIAKLQHRNLVRLLGCGMEGDEKLLIYEFMHNKSLDIFIFD 426

Query: 382 SERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA 441
           +ERR  L+W TCYNI GGI++GLLYLHEDSRL+IIHRDLKPSNVLLD +MVAKISDFGMA
Sbjct: 427 AERRALLDWETCYNIAGGIARGLLYLHEDSRLRIIHRDLKPSNVLLDHEMVAKISDFGMA 486

Query: 442 RIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLT 501
           RIFCENQ  ANTRRVVGT+GYMAPEYAM GLFSVKSDVFSFGVI+LEI SG+R+SGFYL+
Sbjct: 487 RIFCENQNKANTRRVVGTFGYMAPEYAMGGLFSVKSDVFSFGVILLEITSGQRSSGFYLS 546

Query: 502 GHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
            H QTLLAY W+LW EG+E+E VDP LM  S    +VRC+H+GLLCVQEDP+ RPTMS V
Sbjct: 547 EHGQTLLAYTWRLWNEGREIELVDPSLMDRSQTEGIVRCMHVGLLCVQEDPSDRPTMSFV 606

Query: 562 VALLGSESIALSEPRQPPF 580
           V  LGS+ IAL +P+QP F
Sbjct: 607 VLALGSDPIALPQPKQPAF 625

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359475757|ref|XP_003631750.1| PREDICTED: LOW QUALITY PROTEIN: cysteine-rich receptor-like protein kinase 15-like [Vitis vinifera]

 Score =  621 bits (1601), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 328/598 (54%), Positives = 401/598 (67%), Gaps = 67/598 (11%)

Query: 17  ANPLDIACSNTSYAPNSPFESSLKLLLESIATNTS-QGFYNLSIGDDPNRVFGRALCRGD 75
            +PLD  CSN +Y PNSPFE++LK LL S+++NT+  GF + S+G + N+V GRALCRGD
Sbjct: 32  GDPLDKVCSNKTYTPNSPFENNLKGLLRSLSSNTNLTGFNSTSVGSNINQVHGRALCRGD 91

Query: 76  VNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKFLVMVYAGQYAEKWNNQW 135
           V    C+NC+ENA  EI+K CK+ EEAI WYE CQ+QYSY+ F V VY G+Y +  N+Q 
Sbjct: 92  VAAKDCENCVENASQEIMKVCKS-EEAITWYEFCQVQYSYQMFSVKVYTGKYPDS-NSQK 149

Query: 136 KSVSNPARFIEVLTYLMTNLSIEASSDPA--MFAVGEVKFPKRKTIYGLVQCTRDINSRD 193
           K VS+P  F  V   LM NL+ +A+ D A  MFAVGE K  +  TIYGLVQ +RD     
Sbjct: 150 KYVSDPGHFYSVFKDLMGNLTNDAAFDHAKLMFAVGETKLLRNLTIYGLVQXSRDQPGGF 209

Query: 194 CNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSLFYNASTRIALTYPTSTDEKRSQR 253
           C++CL  A GDL  CC   E G I++ +CN+RF++  FY          PT  DE++SQ 
Sbjct: 210 CSNCLMSAFGDLSGCCKTHEGGTILSRSCNMRFEVYRFYKV--------PTVHDEEKSQH 261

Query: 254 GLLHELAGPISVSLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVL 313
            LLHELA P +V++ QEG L+  +ELPF+ LA +KAATD F  SNKLGQGGFGTV+KGVL
Sbjct: 262 TLLHELAIPTTVAMIQEGSLLGPQELPFMDLATVKAATDNFLYSNKLGQGGFGTVFKGVL 321

Query: 314 PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNR 373
           PNG  +AVKRLSRKSWQG EEFKNEIILIAKLQ R LVRL+GCGI G+EKLLIYE MPN+
Sbjct: 322 PNGIXIAVKRLSRKSWQGAEEFKNEIILIAKLQDRKLVRLLGCGIGGDEKLLIYEFMPNK 381

Query: 374 SLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVA 433
           SLD FIFD E+  QLNW T +NII GI+ GLLYL EDSRLKIIHRDLKP+NVLLD DMV 
Sbjct: 382 SLDIFIFDEEKGSQLNWETRHNIIHGIAGGLLYLREDSRLKIIHRDLKPNNVLLDHDMV- 440

Query: 434 KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
                                                              ++LEIISGK
Sbjct: 441 ---------------------------------------------------LLLEIISGK 449

Query: 494 RNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPA 553
            NSGFYLT  A TLLAY W L  EG E+E VD LL +S    +++RC+HIGLLCVQEDP 
Sbjct: 450 XNSGFYLTQLAPTLLAYAWWLXNEGNELELVDSLLTESCPAEEILRCVHIGLLCVQEDPT 509

Query: 554 VRPTMSNVVALLGSESIALSEPRQPPFPVGRTIVLAEQPSTKDPSVCHDLTVSTLSPR 611
            RPT+S+VV L+ S+S++L EP+QP F VGR +   + PS+ +PS  H LTVS +SPR
Sbjct: 510 DRPTISSVVVLVESKSVSLPEPKQPAFSVGRGVQFDQSPSS-NPSTNH-LTVSGISPR 565

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359496581|ref|XP_002270035.2| PREDICTED: cysteine-rich receptor-like protein kinase 10-like [Vitis vinifera]

 Score =  541 bits (1395), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 285/661 (43%), Positives = 408/661 (61%), Gaps = 56/661 (8%)

Query: 4   LVVQFFMLSIFTDANP-----LDIACSNTSYAPNSPFESSLKLLLESIATNTS----QGF 54
           +V+ FF+ S+    +P           N++Y PNS ++SSL +LL S++++ +    + F
Sbjct: 9   IVLLFFLSSLIIHGSPKPTLLYSFCTENSNYVPNSTYQSSLNVLLTSLSSDATILNGRKF 68

Query: 55  YNLSIGDDPNRVFGRALCRGDVNRTVCQNCLENARHEILKNCKTAEEAIIWYELCQIQYS 114
           +N + G  P+ V+G  LCRGDV   VCQ+C++ A  EIL  C   +EA+ WY+ C ++YS
Sbjct: 69  HNTTAGQAPDMVYGLYLCRGDVTDAVCQDCVQTASQEILTKCPNRKEALSWYDQCMLRYS 128

Query: 115 YRKFLVMVYAGQYAEKWNNQWKSVSNPARFIEVLTYLMTNLSIEA---SSDPAMFAVGEV 171
            R    ++         N+    + +P RF +++   M  L  +A   SS+  MF  GE 
Sbjct: 129 NRSIFSIMEERPMLTMSNSL--DMDDPDRFDQIVNKTMVGLIEKATHNSSERDMFETGEA 186

Query: 172 KFPKRKTIYGLVQCTRDINSRDCNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSLF 231
            F     IYGLVQCT D++  +C+ CL      +  CC  ++   I+  +CN R++L  F
Sbjct: 187 NFNASTKIYGLVQCTPDLSGSNCSTCLENIFSRITNCCLGKQGARILVPSCNFRYELYPF 246

Query: 232 YN--------ASTRIALTYPTSTDEKRSQRGLLHELAGPISVSLT--------------- 268
           Y         A     L+  +   +K +   LL  +  P++VS+                
Sbjct: 247 YGDLAAATPPAPAPSPLSLLSPPGKKGNSSQLLIAIIVPVAVSVVIFSILCYCFICRKAK 306

Query: 269 ----------QEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKE 318
                      E D+ + + L F     ++AAT+ FSD NK+G+GGFG VYKG L +GKE
Sbjct: 307 KKYSSTEEEKVENDITTVQSLQF-DFGTLEAATNNFSDDNKIGEGGFGDVYKGTLSSGKE 365

Query: 319 VAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCF 378
           +A+KRLSR S QG  EFKNE++L+AKLQHRNLVRL+G  +EGEEK+L+YE +PN+SLDCF
Sbjct: 366 IAIKRLSRSSAQGAVEFKNEVVLVAKLQHRNLVRLLGFCLEGEEKILVYEYVPNKSLDCF 425

Query: 379 IFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDF 438
           +FD +++ QL+W+  Y IIGGI++G+LYLHEDS+LK+IHRDLK SNVLLD DM  KISDF
Sbjct: 426 LFDPDKQGQLDWSRRYKIIGGIARGILYLHEDSQLKVIHRDLKASNVLLDGDMNPKISDF 485

Query: 439 GMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGF 498
           GMARIF  +Q   +T+RVVGTYGYM+PEYAM G FS KSDV+SFGV+VLEIISGK+ S F
Sbjct: 486 GMARIFGGDQTRGSTKRVVGTYGYMSPEYAMRGHFSAKSDVYSFGVLVLEIISGKKISHF 545

Query: 499 YLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTM 558
           Y +   + LL Y W+LW++G  +E +DP++  S +  +V+RCIH+GLLCVQEDP  RP+M
Sbjct: 546 YESDQTEDLLGYAWKLWRDGTPLELMDPIMRDSYARNEVIRCIHMGLLCVQEDPDDRPSM 605

Query: 559 SNVVALLGSESIALSEPRQPPFPVGRTI-------VLAEQPSTKD-PSVCHDLTVSTLSP 610
           ++VV +L S S+ L  P+QP F +G            ++Q ++K  P   ++ ++S L P
Sbjct: 606 ASVVLMLSSYSVTLPLPQQPAFFIGSGTQSGFPIKAESDQSTSKSTPWSVNETSISELYP 665

Query: 611 R 611
           R
Sbjct: 666 R 666

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	611
TAIR|locus:2121651	676	CRK8 "cysteine-rich RLK (RECEP	0.569	0.514	0.548	2.5e-134
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.554	0.502	0.535	1.6e-128
TAIR|locus:2121636	659	CRK7 "cysteine-rich RLK (RECEP	0.558	0.517	0.551	2.4e-127
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.500	0.457	0.599	2.1e-126
TAIR|locus:2123111	669	CRK34 "cysteine-rich RLK (RECE	0.554	0.506	0.541	5.1e-123
TAIR|locus:2141201	679	CRK29 "cysteine-rich RLK (RECE	0.587	0.528	0.524	1.7e-122
TAIR|locus:2077147	676	CRK4 "cysteine-rich RLK (RECEP	0.563	0.508	0.548	3.5e-122
TAIR|locus:2141762	665	CRK26 "cysteine-rich RLK (RECE	0.507	0.466	0.563	7.4e-122
TAIR|locus:2121626	830	CRK23 "cysteine-rich RLK (RECE	0.569	0.419	0.532	5.1e-121
TAIR|locus:2121686	645	CRK19 "cysteine-rich RLK (RECE	0.561	0.531	0.541	3.6e-120

TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 985 (351.8 bits), Expect = 2.5e-134, Sum P(2) = 2.5e-134
 Identities = 194/354 (54%), Positives = 255/354 (72%)

Query:   264 SVSLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKR 323
             + S ++ GD +++ +   +    I+ AT+ F++SNK+G+GGFG VYKG   NGKEVAVKR
Sbjct:   323 TASASEVGDDMATADSLQLDYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKR 382

Query:   324 LSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSE 383
             LS+ S QG  EFK E++++AKLQHRNLVRL+G  ++GEE++L+YE MPN+SLDC +FD  
Sbjct:   383 LSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPT 442

Query:   384 RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI 443
             ++ QL+W   YNIIGGI++G+LYLH+DSRL IIHRDLK SN+LLD D+  KI+DFGMARI
Sbjct:   443 KQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARI 502

Query:   444 FCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGH 503
             F  +Q   NT R+VGTYGYMAPEYAM G FS+KSDV+SFGV+VLEIISG++NS F  +  
Sbjct:   503 FGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESDG 562

Query:   504 AQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA 563
             AQ LL + W+LW     ++ VDPL+  +    +VVRCIHIGLLCVQEDPA RPT+S V  
Sbjct:   563 AQDLLTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVFM 622

Query:   564 LLGSESIALSEPRQPPF-----PVGRTIVLAEQPSTKD-PSVCHDLTVSTLSPR 611
             +L S ++ L  PRQP F     PV       +  +TK  P+   D  ++ L PR
Sbjct:   623 MLTSNTVTLPVPRQPGFFIQSSPVKDPTDSDQSTTTKSTPASIDDELITDLYPR 676

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 934 (333.8 bits), Expect = 1.6e-128, Sum P(2) = 1.6e-128
 Identities = 183/342 (53%), Positives = 248/342 (72%)

Query:   267 LTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSR 326
             L ++G + S+E L F   + I+AAT+ FS+SNKLG GGFG VYKG L  G+ VA+KRLS+
Sbjct:   322 LDEDG-ITSTETLQF-QFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQ 379

Query:   327 KSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL 386
              S QG EEFKNE+ ++AKLQHRNL +L+G  ++GEEK+L+YE +PN+SLD F+FD+E+R 
Sbjct:   380 GSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRR 439

Query:   387 QLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE 446
              L+W   Y II GI++G+LYLH DSRL IIHRDLK SN+LLD DM  KISDFGMARIF  
Sbjct:   440 VLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGV 499

Query:   447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQT 506
             +Q  ANT+R+VGTYGYM+PEYA+ G +SVKSDV+SFGV+VLE+I+GK+NS FY       
Sbjct:   500 DQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLGD 559

Query:   507 LLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG 566
             L+ YVW+LW E   +E VD  +  +    +V+RCIHI LLCVQED + RP+M +++ ++ 
Sbjct:   560 LVTYVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDDILVMMN 619

Query:   567 SESIALSEPRQPPFPVGRTIVLAEQPSTKDPSVCHDLTVSTL 608
             S ++ L  P++  F + RT+  +  P +   +  H  T  +L
Sbjct:   620 SFTVTLPIPKRSGFLL-RTMKDSRDPRSGGSASDHSATSKSL 660

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2121636 CRK7 "cysteine-rich RLK (RECEPTOR-like protein kinase) 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 948 (338.8 bits), Expect = 2.4e-127, Sum P(2) = 2.4e-127
 Identities = 192/348 (55%), Positives = 249/348 (71%)

Query:   270 EGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW 329
             E D  + E L   + A I+AAT+ FS++NK+G+GGFG VYKG   NG EVAVKRLS+ S 
Sbjct:   313 EDDKTTIESLQLDYRA-IQAATNDFSENNKIGRGGFGDVYKGTFSNGTEVAVKRLSKTSE 371

Query:   330 QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLN 389
             QG  EFKNE++++A L+H+NLVR++G  IE EE++L+YE + N+SLD F+FD  ++ QL 
Sbjct:   372 QGDTEFKNEVVVVANLRHKNLVRILGFSIEREERILVYEYVENKSLDNFLFDPAKKGQLY 431

Query:   390 WNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK 449
             W   Y+IIGGI++G+LYLH+DSRL IIHRDLK SN+LLD DM  KI+DFGMARIF  +Q 
Sbjct:   432 WTQRYHIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGMDQT 491

Query:   450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLA 509
               NT R+VGTYGYM+PEYAM G FS+KSDV+SFGV+VLEIISG++N+ F  T  AQ L+ 
Sbjct:   492 QQNTSRIVGTYGYMSPEYAMRGQFSMKSDVYSFGVLVLEIISGRKNNSFIETDDAQDLVT 551

Query:   510 YVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES 569
             + W+LW+ G  ++ VDP +  S    +VVRC HIGLLCVQEDP  RP MS +  +L S +
Sbjct:   552 HAWRLWRNGTALDLVDPFIADSCRKSEVVRCTHIGLLCVQEDPVKRPAMSTISVMLTSNT 611

Query:   570 IALSEPRQPPFPV-GR--TIVLAEQPSTKDPSVC---HDLTVSTLSPR 611
             +AL  P+QP F V  R  T  L    ST + SV     D ++S L PR
Sbjct:   612 MALPAPQQPGFFVRSRPGTNRLDSDQSTTNKSVTVSIDDKSMSDLDPR 659

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 987 (352.5 bits), Expect = 2.1e-126, Sum P(2) = 2.1e-126
 Identities = 184/307 (59%), Positives = 239/307 (77%)

Query:   272 DLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQG 331
             D+ +++ L   +   I+ ATD F +SNK+GQGGFG VYKG L +G EVAVKRLS+ S QG
Sbjct:   327 DITTADSLQLDY-RTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQG 385

Query:   332 LEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWN 391
               EFKNE++L+AKLQHRNLVRL+G  ++GEE++L+YE +PN+SLD F+FD  ++ QL+W 
Sbjct:   386 EVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWT 445

Query:   392 TCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA 451
               Y IIGG+++G+LYLH+DSRL IIHRDLK SN+LLD DM  KI+DFGMARIF  +Q   
Sbjct:   446 RRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEE 505

Query:   452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYV 511
             NT R+VGTYGYM+PEYAM G +S+KSDV+SFGV+VLEIISGK+NS FY T  A  L++Y 
Sbjct:   506 NTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYA 565

Query:   512 WQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIA 571
             W LW  G+ +E VDP ++++    +VVRC+HIGLLCVQEDPA RPT+S +V +L S ++ 
Sbjct:   566 WGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVT 625

Query:   572 LSEPRQP 578
             L  PRQP
Sbjct:   626 LPVPRQP 632

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)]

 Score = 961 (343.3 bits), Expect = 5.1e-123, Sum P(2) = 5.1e-123
 Identities = 188/347 (54%), Positives = 247/347 (71%)

Query:   272 DLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQG 331
             ++ ++  L F     I+AATD FSDSN +G+GGFG VY+G L +G EVAVKRLS+ S QG
Sbjct:   324 EITTTHSLQF-SFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQG 382

Query:   332 LEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWN 391
              EEFKNE +L++KLQH+NLVRL+G  +EGEEK+L+YE +PN+SLD F+FD  ++ +L+W 
Sbjct:   383 AEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWT 442

Query:   392 TCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA 451
               YNIIGGI++G+LYLH+DSRL IIHRDLK SN+LLD DM  KI+DFGMARIF  +Q  A
Sbjct:   443 RRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQA 502

Query:   452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFY-LTGHAQTLLAY 510
             NTRR+ GT+GYM+PEYAM G FS+KSDV+SFGV+VLEIISGK+NS FY +      L+ +
Sbjct:   503 NTRRIAGTFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSGSNLVTH 562

Query:   511 VWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESI 570
              W+LW+ G  +E VDP + +S    +  RCIHI LLCVQEDPA RP +  ++ +L S + 
Sbjct:   563 AWRLWRNGSPLELVDPTIGESYQSSEATRCIHIALLCVQEDPADRPLLPAIIMMLTSSTT 622

Query:   571 ALSEPRQPPFPV-GRT-----IVLAEQPSTKDPSVCHDLTVSTLSPR 611
              L  PR P F + GR      +   E  S   P   +D +++   PR
Sbjct:   623 TLHVPRAPGFCLSGRDLEQDGVEYTESTSRSIPGSINDASITEFYPR 669

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 951 (339.8 bits), Expect = 1.7e-122, Sum P(2) = 1.7e-122
 Identities = 195/372 (52%), Positives = 263/372 (70%)

Query:   249 KRSQRGLLHELAG--PISVSLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFG 306
             ++++ G  +++ G  P+S S+ ++ +  ++E L  VH   +K ATD FS  N+LG+GGFG
Sbjct:   312 RKNKSGYKNKVLGKSPLSGSIAED-EFSNTESL-LVHFETLKTATDNFSSENELGRGGFG 369

Query:   307 TVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI 366
             +VYKGV P G+E+AVKRLS  S QG  EFKNEI+L+AKLQHRNLVRL+G  I+GEE+LL+
Sbjct:   370 SVYKGVFPQGQEIAVKRLSGNSGQGDNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLV 429

Query:   367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVL 426
             YE + N SLD FIFD+E+R  L+W   Y +IGGI++GLLYLHEDSR +IIHRDLK SN+L
Sbjct:   430 YEFIKNASLDQFIFDTEKRQLLDWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNIL 489

Query:   427 LDKDMVAKISDFGMARIFCENQKTAN--TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGV 484
             LD++M  KI+DFG+A++F   Q   +  T R+ GTYGYMAPEYAM G FSVK+DVFSFGV
Sbjct:   490 LDQEMNPKIADFGLAKLFDSGQTMTHRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFGV 549

Query:   485 IVLEIISGKRNSGFYLTGH--AQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIH 542
             +V+EII+GKRN+     G   A+ LL++VW+ W+E   +  +DP L   S   +++RCIH
Sbjct:   550 LVIEIITGKRNNNGGSNGDEDAEDLLSWVWRSWREDTILSVIDPSLTAGSR-NEILRCIH 608

Query:   543 IGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFPVGRTIVLAEQPSTKDPSV--- 599
             IGLLCVQE  A RPTM+ V  +L S S  L  P +P F V  ++V+    S+    +   
Sbjct:   609 IGLLCVQESAATRPTMATVSLMLNSYSFTLPTPLRPAF-VLESVVIPSNVSSSTEGLQMS 667

Query:   600 CHDLTVSTLSPR 611
              +D+TVS  SPR
Sbjct:   668 SNDVTVSEFSPR 679

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 950 (339.5 bits), Expect = 3.5e-122, Sum P(2) = 3.5e-122
 Identities = 194/354 (54%), Positives = 255/354 (72%)

Query:   267 LTQEGD-LVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLS 325
             LT+E D + ++  L F   A I+AAT+ F ++NKLGQGGFG VYKG+ P+G +VAVKRLS
Sbjct:   324 LTEESDDITTAGSLQFDFKA-IEAATNKFCETNKLGQGGFGEVYKGIFPSGVQVAVKRLS 382

Query:   326 RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERR 385
             + S QG  EF NE+I++AKLQHRNLVRL+G  +E +E++L+YE +PN+SLD FIFDS  +
Sbjct:   383 KTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERDERILVYEFVPNKSLDYFIFDSTMQ 442

Query:   386 LQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC 445
               L+W   Y IIGGI++G+LYLH+DSRL IIHRDLK  N+LL  DM AKI+DFGMARIF 
Sbjct:   443 SLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMARIFG 502

Query:   446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFY-LTG-H 503
              +Q  ANTRR+VGTYGYM+PEYAM G FS+KSDV+SFGV+VLEIISGK+NS  Y + G  
Sbjct:   503 MDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVYQMDGTS 562

Query:   504 AQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA 563
             A  L+ Y W+LW  G  +E VDP    +  I +V RCIHI LLCVQE+   RPTMS +V 
Sbjct:   563 AGNLVTYTWRLWSNGSPLELVDPSFRDNYRINEVSRCIHIALLCVQEEAEDRPTMSAIVQ 622

Query:   564 LLGSESIALSEPRQPPF----PVGRTIVLAEQPSTKDPSVCH--DLTVSTLSPR 611
             +L + SIAL+ P++P F         + L ++ S    ++C   D +++ ++PR
Sbjct:   623 MLTTSSIALAVPQRPGFFFRSSKHEQVGLVDRLSINTSALCSVDDASITNVTPR 676

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0012501 "programmed cell death" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IEP

TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)]

 Score = 906 (324.0 bits), Expect = 7.4e-122, Sum P(2) = 7.4e-122
 Identities = 177/314 (56%), Positives = 234/314 (74%)

Query:   270 EGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW 329
             E + +S++ + F   +V++ AT  FS  NKLG+GGFG VYKGVL +G+++AVKRLS+ + 
Sbjct:   321 ENENISTDSMKF-DFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKIAVKRLSKNAQ 379

Query:   330 QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLN 389
             QG  EFKNE +L+AKLQHRNLV+L+G  IEG E+LL+YE +P+ SLD FIFD  +  +L 
Sbjct:   380 QGETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFDPIQGNELE 439

Query:   390 WNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK 449
             W   Y IIGG+++GLLYLH+DSRL+IIHRDLK SN+LLD++M  KI+DFGMAR+F  +  
Sbjct:   440 WEIRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLFDIDHT 499

Query:   450 TAN-TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLL 508
             T   T R+VGT+GYMAPEY M G FS K+DV+SFGV+VLEIISGK+NSGF        L+
Sbjct:   500 TQRYTNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEIISGKKNSGFSSEDSMGDLI 559

Query:   509 AYVWQLWKEGKEMEFVDPLLMKSSSIPQ--VVRCIHIGLLCVQEDPAVRPTMSNVVALLG 566
             ++ W+ WKEG  +  VD +LM  SS     ++RCI+IGLLCVQE  A RP+M++VV +L 
Sbjct:   560 SFAWRNWKEGVALNLVDKILMTMSSYSSNMIMRCINIGLLCVQEKVAERPSMASVVLMLD 619

Query:   567 SESIALSEPRQPPF 580
               +IALSEP +P F
Sbjct:   620 GHTIALSEPSKPAF 633

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)]

 Score = 943 (337.0 bits), Expect = 5.1e-121, Sum P(2) = 5.1e-121
 Identities = 189/355 (53%), Positives = 251/355 (70%)

Query:   263 ISVSLTQEGDLVSSE-ELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAV 321
             ++  L + GD +++   L F   A++ AAT+ F   NKLGQGGFG VYKG  P+G +VAV
Sbjct:   477 VTEPLAENGDSITTAGSLQFDFKAIV-AATNNFLPINKLGQGGFGEVYKGTFPSGVQVAV 535

Query:   322 KRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFD 381
             KRLS+ S QG  EF+NE++++AKLQHRNLVRL+G  +EGEEK+L+YE + N+SLD F+FD
Sbjct:   536 KRLSKTSGQGEREFENEVVVVAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLDYFLFD 595

Query:   382 SERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA 441
             +  + QL+W   Y IIGGI++G+LYLH+DSRL IIHRDLK  N+LLD DM  K++DFGMA
Sbjct:   596 TTMKRQLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMA 655

Query:   442 RIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFY-L 500
             RIF  +Q  ANTRRVVGTYGYMAPEYAM G FS+KSDV+SFGV+V EIISG +NS  Y +
Sbjct:   656 RIFGMDQTEANTRRVVGTYGYMAPEYAMYGQFSMKSDVYSFGVLVFEIISGMKNSSLYQM 715

Query:   501 TGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSN 560
                   L+ Y W+LW  G +++ VDP    +     + RCIHI LLCVQED   RP MS 
Sbjct:   716 DDSVSNLVTYTWRLWSNGSQLDLVDPSFGDNYQTHDITRCIHIALLCVQEDVDDRPNMSA 775

Query:   561 VVALLGSESIALSEPRQPPFPV-GRTIVLAEQPSTKDP-SVCH--DLTVSTLSPR 611
             +V +L + SI L+ P+QP F   GR   + E  S+ D  ++C   D ++++++PR
Sbjct:   776 IVQMLTTSSIVLAVPKQPGFFFRGRHEQVGEVGSSVDRLALCSIDDASITSVAPR 830

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

TAIR|locus:2121686 CRK19 "cysteine-rich RLK (RECEPTOR-like protein kinase) 19" [Arabidopsis thaliana (taxid:3702)]

 Score = 934 (333.8 bits), Expect = 3.6e-120, Sum P(2) = 3.6e-120
 Identities = 189/349 (54%), Positives = 249/349 (71%)

Query:   267 LTQEG-DLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLS 325
             + ++G D+ ++  L F   A I+AAT+ F   NKLGQGGFG VYKG L +G +VAVKRLS
Sbjct:   299 VAEDGNDITTAGSLQFDFKA-IEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLS 357

Query:   326 RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERR 385
             + S QG +EF+NE++++AKLQHRNLV+L+G  +EGEEK+L+YE +PN+SLD F+FDS  +
Sbjct:   358 KTSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMK 417

Query:   386 LQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC 445
             ++L+W   Y IIGGI++G+LYLH+DSRL IIHRDLK  N+LLD DM  KI+DFGMARIF 
Sbjct:   418 MKLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFG 477

Query:   446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFY-LTGHA 504
              +Q  A TRRVVGTYGYM+PEYAM G FS+KSDV+SFGV+VLEIISG +NS  Y +    
Sbjct:   478 MDQTEAMTRRVVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESV 537

Query:   505 QTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL 564
               L+ Y W+LW  G   E VDP    +    ++ RCIHI LLCVQED   RPTMS++V +
Sbjct:   538 GNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSSIVQM 597

Query:   565 LGSESIALSEPRQPPFPVGRTIVLAEQPSTKDPSVCH--DLTVSTLSPR 611
             L +  IAL+EPR P F   R+      PS    + C   + +++ ++PR
Sbjct:   598 LTTSLIALAEPRPPGF-FFRSKQEQAGPSIDSSTHCSVDEASITRVTPR 645

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O65468	CRK8_ARATH	2, ., 7, ., 1, 1, ., -	0.4356	0.9656	0.8727	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.10.2	LOW CONFIDENCE prediction!
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	611
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-55
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-55
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-54
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-50
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-48
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-48
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-46
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-43
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-39
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-37
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-34
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-32
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-32
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-32
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-31
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-30
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-30
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-30
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-30
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-30
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-30
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-29
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-29
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-28
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-28
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-28
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-28
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-27
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-27
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-27
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-26
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-26
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-26
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-26
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-26
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-25
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-25
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-25
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	9e-25
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	1e-24
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-24
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-24
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-24
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-24
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-23
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-23
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-23
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-23
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-23
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-23
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-22
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-22
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-22
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-22
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-22
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-21
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-21
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-21
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-21
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-21
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-21
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-21
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-21
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-21
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-21
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	9e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-20
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-20
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-20
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-20
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-20
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-20
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-20
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-20
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-20
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-19
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-19
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-19
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-19
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-19
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-19
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-19
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-19
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-19
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-19
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-19
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	9e-19
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-18
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-18
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-18
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	4e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	4e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-18
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-18
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-18
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-18
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-18
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-18
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-17
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-17
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-17
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-17
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	5e-17
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-17
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-17
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-17
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-16
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-16
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-16
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-16
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-16
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	8e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-15
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-15
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-15
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-15
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	7e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	9e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-14
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-14
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-14
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-14
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	5e-14
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-14
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-14
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-13
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-13
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-13
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-13
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-13
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	7e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	8e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	9e-13
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-12
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-12
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-12
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-12
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	8e-12
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	8e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	4e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-11
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-10
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-10
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-10
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	6e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	7e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-08
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-08
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	7e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	8e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	6e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	9e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	5e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.002
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.003
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  188 bits (479), Expect = 2e-55
 Identities = 91/275 (33%), Positives = 140/275 (50%), Gaps = 31/275 (11%)

Query: 299 KLGQGGFGTVYKGVL-----PNGKEVAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           KLG+G FG VYKG L         EVAVK L    S Q +EEF  E  ++ KL H N+V+
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
           L+G   E E   ++ E M    L  ++   + R +L+ +   +    I++G+ YL     
Sbjct: 66  LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCENQKTANTRRVVGTYGYMAPEYAMEG 471
              IHRDL   N L+ +++V KISDFG++R ++ ++       ++     +MAPE   EG
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEG 178

Query: 472 LFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK 530
            F+ KSDV+SFGV++ EI + G++    Y     + +L Y+    K G  +        +
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQ---PYPGMSNEEVLEYL----KNGYRLP-------Q 224

Query: 531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
             + P  +    + L C  EDP  RPT S +V +L
Sbjct: 225 PPNCPPELY--DLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  187 bits (478), Expect = 3e-55
 Identities = 92/275 (33%), Positives = 140/275 (50%), Gaps = 30/275 (10%)

Query: 299 KLGQGGFGTVYKGVL-----PNGKEVAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           KLG+G FG VYKG L         EVAVK L    S Q +EEF  E  ++ KL H N+V+
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
           L+G   E E  +++ E MP   L  ++  +  +  L+ +   +    I++G+ YL     
Sbjct: 66  LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLE---S 121

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCENQKTANTRRVVGTYGYMAPEYAMEG 471
              IHRDL   N L+ +++V KISDFG++R ++ ++       ++     +MAPE   EG
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEG 179

Query: 472 LFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK 530
            F+ KSDV+SFGV++ EI + G+     Y       +L Y+    K+G  +        K
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEE---PYPGMSNAEVLEYL----KKGYRLP-------K 225

Query: 531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
             + P  +  +   L C  EDP  RPT S +V +L
Sbjct: 226 PPNCPPELYKLM--LQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  184 bits (469), Expect = 2e-54
 Identities = 75/194 (38%), Positives = 108/194 (55%), Gaps = 11/194 (5%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+GGFGTVY       GK+VA+K + ++     LEE   EI ++ KL H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +     L+ E     SL   +   E   +L+ +    I+  I +GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115

Query: 418 RDLKPSNVLLDKD-MVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE-YAMEGLFSV 475
           RDLKP N+LLD D    K++DFG++++   ++    T   VGT  YMAPE    +G +S 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI--VGTPAYMAPEVLLGKGYYSE 173

Query: 476 KSDVFSFGVIVLEI 489
           KSD++S GVI+ E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  173 bits (440), Expect = 8e-50
 Identities = 90/281 (32%), Positives = 136/281 (48%), Gaps = 33/281 (11%)

Query: 298 NKLGQGGFGTVYKGVL----PNGKEVAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLVR 352
            KLG+G FG VYKG L        EVAVK L    S +  ++F  E  ++ KL H N+VR
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFI------FDSERRLQLNWNTCYNIIGGISKGLLY 406
           L+G   E E   L+ E M    L  ++      F S  +  L+     +    I+KG+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCENQKTANTRRVVGTYGYMAP 465
           L      K +HRDL   N L+ +D+V KISDFG++R ++ ++     T   +    +MAP
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGF-YLTGHAQTLLAYVWQLWKEGKEMEFV 524
           E   +G+F+ KSDV+SFGV++ EI +        Y     + +L Y+    ++G  +   
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT---LGATPYPGLSNEEVLEYL----RKGYRLPK- 228

Query: 525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
            P       + +++        C Q DP  RPT S +V  L
Sbjct: 229 -PEYC-PDELYELMLS------CWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  170 bits (432), Expect = 1e-48
 Identities = 78/200 (39%), Positives = 109/200 (54%), Gaps = 14/200 (7%)

Query: 299 KLGQGGFGTVYKGVLPN-GKEVAVKRL---SRKSWQGLEEFKNEIILIAKLQHRNLVRLV 354
           KLG G FGTVYK      GK VAVK L   S KS +  +  + EI ++ +L H N+VRL+
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK-DQTARREIRILRRLSHPNIVRLI 64

Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
               + +   L+ E      L  ++    R   L+ +    I   I +GL YLH      
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS---NG 118

Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE-YAMEGLF 473
           IIHRDLKP N+LLD++ V KI+DFG+A+   ++  +  T   VGT  YMAPE       +
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGY 176

Query: 474 SVKSDVFSFGVIVLEIISGK 493
             K DV+S GVI+ E+++GK
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  168 bits (427), Expect = 6e-48
 Identities = 69/202 (34%), Positives = 102/202 (50%), Gaps = 11/202 (5%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLV 351
           +    KLG+G FG VY       GK VA+K +  +K  +  E    EI ++ KL+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           RL     + ++  L+ E      L   +     RL  +    +  +  I   L YLH   
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDL-FDLLKKRGRLSEDE-ARF-YLRQILSALEYLHS-- 115

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
              I+HRDLKP N+LLD+D   K++DFG+AR     +K       VGT  YMAPE  +  
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEYMAPEVLLGK 171

Query: 472 LFSVKSDVFSFGVIVLEIISGK 493
            +    D++S GVI+ E+++GK
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  163 bits (416), Expect = 3e-46
 Identities = 90/276 (32%), Positives = 134/276 (48%), Gaps = 32/276 (11%)

Query: 299 KLGQGGFGTVYKGVL-----PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
           KLG+G FG VYKG L         +VAVK L    S +  EEF  E  ++ KL H N+VR
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
           L+G   +GE   ++ E MP   L  F+     +L L       +   I+KG+ YL     
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLES--- 120

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCEN--QKTANTRRVVGTYGYMAPEYAM 469
              +HRDL   N L+ +++V KISDFG++R I+ ++  +K    +  +    +MAPE   
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPI---KWMAPESLK 177

Query: 470 EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
           +G F+ KSDV+SFGV++ EI +       Y     + +L  +    ++G  +    P   
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQP--YPGMSNEEVLELL----EDGYRLPR--PENC 229

Query: 530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
                P  +    + L C   DP  RPT S +V  L
Sbjct: 230 -----PDELY--ELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  156 bits (397), Expect = 1e-43
 Identities = 80/273 (29%), Positives = 124/273 (45%), Gaps = 41/273 (15%)

Query: 298 NKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHRNLVRLV 354
             LG+G FG+VY  +    G+ +AVK   LS  S + LE  + EI +++ LQH N+VR  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 355 GCGIEGEEK-LLIY-ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
           G   + E+  L I+ E +   SL   +   ++  +L           I +GL YLH    
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLPEPVIRKYTRQILEGLAYLH---S 119

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
             I+HRD+K +N+L+D D V K++DFG A+   + +    T  V GT  +MAPE      
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 473 FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK-- 530
           +   +D++S G  V+E+ +GK                  W       E+      L K  
Sbjct: 180 YGRAADIWSLGCTVIEMATGKP----------------PWS------ELGNPMAALYKIG 217

Query: 531 -SSSIPQVVRCIHIGLL-----CVQEDPAVRPT 557
            S   P++   +          C++ DP  RPT
Sbjct: 218 SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  143 bits (364), Expect = 4e-39
 Identities = 68/201 (33%), Positives = 106/201 (52%), Gaps = 9/201 (4%)

Query: 294 FSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           F    K+G+GGFG VYK      GKEVA+K +  +S +  E+  NEI ++ K +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
             G  ++ +E  ++ E     SL   +  + + L  +      +   + KGL YLH    
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY--VCKELLKGLEYLHS--- 116

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
             IIHRD+K +N+LL  D   K+ DFG++     + K  NT   VGT  +MAPE      
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLS-AQLSDTKARNTM--VGTPYWMAPEVINGKP 173

Query: 473 FSVKSDVFSFGVIVLEIISGK 493
           +  K+D++S G+  +E+  GK
Sbjct: 174 YDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  138 bits (350), Expect = 3e-37
 Identities = 69/201 (34%), Positives = 106/201 (52%), Gaps = 13/201 (6%)

Query: 297 SNKLGQGGFGTVYKGV-LPNGKEVAVKRLS--RKSWQGLEEFKNEIILIAKLQHRNLVRL 353
            + +G+G FG VYKG+ L  G  VA+K++S  +   + L+    EI L+  L+H N+V+ 
Sbjct: 5   GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
           +G     +   +I E   N SL   I           +     +  + +GL YLHE    
Sbjct: 65  IGSIETSDSLYIILEYAENGSLRQIIKKFGP---FPESLVAVYVYQVLQGLAYLHEQ--- 118

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE-YAMEGL 472
            +IHRD+K +N+L  KD V K++DFG+A    +  K   +  VVGT  +MAPE   M G 
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGTPYWMAPEVIEMSGA 176

Query: 473 FSVKSDVFSFGVIVLEIISGK 493
            S  SD++S G  V+E+++G 
Sbjct: 177 -STASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  131 bits (332), Expect = 1e-34
 Identities = 67/198 (33%), Positives = 113/198 (57%), Gaps = 6/198 (3%)

Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           F+   KLG G FG V++G+  N   VA+K L        ++F+ E+  + +L+H++L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
                 GE   +I ELM   SL  F+   E +  L   +  ++   +++G+ YL E    
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQ--- 123

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF 473
             IHRDL   N+L+ +D+V K++DFG+AR+  E+   ++ +++   Y + APE A  G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181

Query: 474 SVKSDVFSFGVIVLEIIS 491
           S KSDV+SFG+++ E+ +
Sbjct: 182 STKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  127 bits (319), Expect = 5e-32
 Identities = 84/285 (29%), Positives = 133/285 (46%), Gaps = 25/285 (8%)

Query: 293 GFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQH-R 348
            +    KLG+G FG VY       K VA+K L++K     + +E F  EI ++A L H  
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 349 NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
           N+V+L     +     L+ E +   SL+  +    R+  L+ +    I+  I   L YLH
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 409 EDSRLKIIHRDLKPSNVLLDKD-MVAKISDFGMARIFCENQKTANTRR----VVGTYGYM 463
                 IIHRD+KP N+LLD+D  V K+ DFG+A++  +   T++        VGT GYM
Sbjct: 119 S---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175

Query: 464 APEYAMEGLF---SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE 520
           APE  +       S  SD++S G+ + E+++G     F          +   Q  K   E
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL--PPFEGE----KNSSATSQTLKIILE 229

Query: 521 MEFVDPLLMKSSSIPQVVRCIHIGLL--CVQEDPAVRPTMSNVVA 563
           +         S S P+++      LL   + +DP  R + S+ ++
Sbjct: 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  123 bits (312), Expect = 8e-32
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 23/208 (11%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKR--LSRKSWQGLEEFKNEIILIAKLQHRNLVRLV 354
            ++G+G FG VY      +GK   +K   LS  S +  E+  NE+ ++ KL H N+++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLN--------WNTCYNIIGGISKGLLY 406
               E  +  ++ E      L   I   +++ +           +    +       L Y
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKI---KKQKKEGKPFPEEQILDWFVQL----CLALKY 118

Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH     KI+HRD+KP N+ L  + + K+ DFG++++       A T  VVGT  Y++PE
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGTPYYLSPE 173

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGKR 494
                 ++ KSD++S G ++ E+ + K 
Sbjct: 174 LCQNKPYNYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  123 bits (311), Expect = 9e-32
 Identities = 68/196 (34%), Positives = 105/196 (53%), Gaps = 12/196 (6%)

Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLG G FG V+ G      +VAVK L +      E F  E  ++ KL+H  LV+L     
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
           E E   ++ E M   SL  F+   E + +L      ++   I++G+ YL        IHR
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEGMAYLE---SRNYIHR 127

Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAMEGLFSV 475
           DL   N+L+ +++V KI+DFG+AR+  +++ TA      G      + APE A  G F++
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLIEDDEYTARE----GAKFPIKWTAPEAANYGRFTI 183

Query: 476 KSDVFSFGVIVLEIIS 491
           KSDV+SFG+++ EI++
Sbjct: 184 KSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  122 bits (308), Expect = 5e-31
 Identities = 64/205 (31%), Positives = 104/205 (50%), Gaps = 19/205 (9%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           + +  K+G+G  G VYK      GKEVA+K++  +  Q  E   NEI+++   +H N+V 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVD 79

Query: 353 LVGCGIEGEEKLLIYELMPNRSL-----DCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
                + G+E  ++ E M   SL       F+  +E ++         +   + +GL YL
Sbjct: 80  YYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-------VCREVLQGLEYL 132

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H      +IHRD+K  N+LL KD   K++DFG A    + +   N+  VVGT  +MAPE 
Sbjct: 133 H---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEV 187

Query: 468 AMEGLFSVKSDVFSFGVIVLEIISG 492
                +  K D++S G++ +E+  G
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  120 bits (303), Expect = 1e-30
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 17/201 (8%)

Query: 299 KLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGC 356
            LGQG  G VYK    P GK  A+K++      +  ++   E+  +   +   +V+  G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS----KGLLYLHEDSR 412
             +  E  ++ E M   SL   +     +          ++  I+    KGL YLH  ++
Sbjct: 68  FYKEGEISIVLEYMDGGSLADLL-----KKVGKIPE--PVLAYIARQILKGLDYLH--TK 118

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
             IIHRD+KPSN+L++     KI+DFG++++             VGT  YM+PE      
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVL--ENTLDQCNTFVGTVTYMSPERIQGES 176

Query: 473 FSVKSDVFSFGVIVLEIISGK 493
           +S  +D++S G+ +LE   GK
Sbjct: 177 YSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  120 bits (302), Expect = 1e-30
 Identities = 81/266 (30%), Positives = 123/266 (46%), Gaps = 35/266 (13%)

Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLG G FG V++G+  N   VAVK L   +    ++F  E  ++ KL+H  L++L     
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ ELM   SL  ++     R  L      ++   ++ G+ YL   +    IHR
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127

Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAMEGLFSV 475
           DL   NVL+ ++ + K++DFG+AR+  E+   A      G      + APE A+   FS+
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNRFSI 183

Query: 476 KSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIP 535
           KSDV+SFG+++ EI++  R     +T         V Q   +G  M             P
Sbjct: 184 KSDVWSFGILLTEIVTYGRMPYPGMTNAE------VLQQVDQGYRM-------------P 224

Query: 536 QVVRC----IHIGLLCVQEDPAVRPT 557
               C      I L C +EDP  RPT
Sbjct: 225 CPPGCPKELYDIMLDCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  119 bits (302), Expect = 2e-30
 Identities = 71/231 (30%), Positives = 102/231 (44%), Gaps = 38/231 (16%)

Query: 300 LGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL------QHRNLVR 352
           +G+G F TV         KE A+K L ++  Q ++E K + + I K        H  +++
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66

Query: 353 LVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           L     + EE L  + E  PN  L  +I    +   L+          I   L YLH   
Sbjct: 67  LYYT-FQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYLH--- 119

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ------------------KTANT 453
              IIHRDLKP N+LLDKDM  KI+DFG A++   N                        
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179

Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK---RNSGFYLT 501
              VGT  Y++PE   E      SD+++ G I+ ++++GK   R S  YLT
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT 230

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  119 bits (300), Expect = 4e-30
 Identities = 85/281 (30%), Positives = 135/281 (48%), Gaps = 49/281 (17%)

Query: 300 LGQGGFGTVYKGV-LPNGK----EVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRL 353
           LG G FGTVYKGV +P G+     VA+K L  ++  +  +E  +E  ++A + H ++VRL
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ----LNWNTCYNIIGGISKGLLYLHE 409
           +G  +   +  LI +LMP   L  ++ + +  +     LNW         I+KG+ YL E
Sbjct: 75  LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV------QIAKGMSYL-E 126

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC--ENQKTANTRRVVGTYGYMAPEY 467
           + RL  +HRDL   NVL+      KI+DFG+A++    E +  A   +V     +MA E 
Sbjct: 127 EKRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV--PIKWMALES 182

Query: 468 AMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP 526
            +  +++ KSDV+S+GV V E+++ G +               Y      EG     +  
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAK--------------PY------EGIPAVEIPD 222

Query: 527 LLMKSSSIPQVVRCI----HIGLLCVQEDPAVRPTMSNVVA 563
           LL K   +PQ   C      + + C   D   RPT   ++ 
Sbjct: 223 LLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  118 bits (297), Expect = 6e-30
 Identities = 68/203 (33%), Positives = 102/203 (50%), Gaps = 25/203 (12%)

Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE 359
           +G+G FG V  G    G++VAVK L   S    + F  E  ++  L+H NLV+L+G  ++
Sbjct: 14  IGKGEFGDVMLGDY-RGQKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 360 GEEKLLIYELMPNRSLDCFIFDSER-------RLQLNWNTCYNIIGGISKGLLYLHEDSR 412
           G    ++ E M   SL  ++    R       +L    + C        +G+ YL E   
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVC--------EGMEYLEEK-- 121

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
              +HRDL   NVL+ +D+VAK+SDFG+A+   + Q +           + APE   E  
Sbjct: 122 -NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL-----PVKWTAPEALREKK 175

Query: 473 FSVKSDVFSFGVIVLEIISGKRN 495
           FS KSDV+SFG+++ EI S  R 
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRV 198

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  119 bits (299), Expect = 7e-30
 Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 16/205 (7%)

Query: 297 SNKLGQGGFGTVYKGVLPN-----GKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNL 350
             +LG+G FG V            G++VAVK L+     Q   +F+ EI ++  L H N+
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 351 VRLVGC--GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
           V+  G      G    LI E +P+ SL  ++     R Q+N          I KG+ YL 
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126

Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK--TANTRRVVGTYGYMAPE 466
                + IHRDL   N+L++ + + KISDFG+A++  E++             + Y APE
Sbjct: 127 S---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIIS 491
                 FS  SDV+SFGV + E+ +
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  117 bits (295), Expect = 1e-29
 Identities = 82/268 (30%), Positives = 137/268 (51%), Gaps = 37/268 (13%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLS-----RKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           LG G FG+VY+G+ L +G   AVK +S     +   + +++ + EI L++KLQH N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 354 VGCGIEGEEKLLIY-ELMPNRSLDCFI--FDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +G   E E+ L I+ EL+P  SL   +  + S     +   T       I  GL YLH+ 
Sbjct: 68  LGTERE-EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYT-----RQILLGLEYLHDR 121

Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM- 469
                +HRD+K +N+L+D + V K++DFGMA+   E    +  +   G+  +MAPE    
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF---SFAKSFKGSPYWMAPEVIAQ 175

Query: 470 EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
           +G + + +D++S G  VLE+ +GK              +A V+++ +  +     D L  
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGK------PPWSQLEGVAAVFKIGRSKELPPIPDHLSD 229

Query: 530 KSSSIPQVVRCIHIGLLCVQEDPAVRPT 557
           ++             L C+Q DP++RPT
Sbjct: 230 EAKDFI---------LKCLQRDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  116 bits (292), Expect = 3e-29
 Identities = 61/207 (29%), Positives = 104/207 (50%), Gaps = 32/207 (15%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           KLG+G +G+VYK +    G+ VA+K +  +    L+E   EI ++ +     +V+  G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 358 IEGEEKLLIYE---------LMP--NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLY 406
            +  +  ++ E         +M   N++L       E  +       Y  +    KGL Y
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIMKITNKTLT------EEEIAA---ILYQTL----KGLEY 114

Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH     K IHRD+K  N+LL+++  AK++DFG++    +     NT  V+GT  +MAPE
Sbjct: 115 LH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPE 169

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGK 493
              E  ++ K+D++S G+  +E+  GK
Sbjct: 170 VIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  114 bits (286), Expect = 2e-28
 Identities = 69/196 (35%), Positives = 108/196 (55%), Gaps = 7/196 (3%)

Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLG G FG V+ G      +VA+K L + S    E F  E  L+ +LQH  LVRL    +
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAV-V 70

Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   +I E M N SL  F+  +   ++L  N   ++   I++G+ ++    R   IHR
Sbjct: 71  TQEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHR 126

Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+ + +  KI+DFG+AR+  +N+ TA          + APE    G F++KSD
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF-PIKWTAPEAINYGTFTIKSD 185

Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ EI++  R
Sbjct: 186 VWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  114 bits (287), Expect = 3e-28
 Identities = 75/208 (36%), Positives = 112/208 (53%), Gaps = 30/208 (14%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFK----NEIILIAKLQHRNLVRL 353
           KLG+G +G VYK      G+ VA+K++  +     E        EI L+ +L+H N+V+L
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 354 --VGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
             V   I  E KL L++E   +  L  ++   +R   L+ N   +I+  + +GL Y H  
Sbjct: 64  LDV---IHTERKLYLVFEYC-DMDLKKYL--DKRPGPLSPNLIKSIMYQLLRGLAYCH-- 115

Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAME 470
           S  +I+HRDLKP N+L+++D V K++DFG+AR F    +T  T  VV T  Y APE    
Sbjct: 116 SH-RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-YTHEVV-TLWYRAPEI--- 169

Query: 471 GLFSVKS-----DVFSFGVIVLEIISGK 493
            L   K      D++S G I  E+I+GK
Sbjct: 170 -LLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  113 bits (284), Expect = 4e-28
 Identities = 83/277 (29%), Positives = 132/277 (47%), Gaps = 37/277 (13%)

Query: 300 LGQGGFGTVYKGVL--PNGKE--VAVKRL----SRKSWQGLEEFKNEIILIAKLQHRNLV 351
           +G G FG V +G L  P  KE  VA+K L    S K      +F  E  ++ +  H N++
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL---DFLTEASIMGQFDHPNII 68

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           RL G   +    ++I E M N SLD F+   E   +        ++ GI+ G+ YL   S
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---S 123

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
            +  +HRDL   N+L++ ++V K+SDFG++R   +++ T  T+       + APE     
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183

Query: 472 LFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL--L 528
            F+  SDV+SFG+++ E++S G+R    Y     Q ++  V   ++    M+    L  L
Sbjct: 184 KFTSASDVWSFGIVMWEVMSYGERP---YWDMSNQDVIKAVEDGYRLPPPMDCPSALYQL 240

Query: 529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
           M                 C Q+D   RPT S +V+ L
Sbjct: 241 MLD---------------CWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  113 bits (285), Expect = 5e-28
 Identities = 79/288 (27%), Positives = 128/288 (44%), Gaps = 44/288 (15%)

Query: 300 LGQGGFGTVYKGVLPNGKE------VAVKRLSRKSWQGLEE-FKNEIILIAKLQHRNLVR 352
           LG+G FG V+ G   + +       VAVK L   +     + F+ E  L+   QH N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-----------QLNWNTCYNIIGGIS 401
             G   EG+  ++++E M +  L+ F+                  +L  +    I   I+
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-- 459
            G++YL   +    +HRDL   N L+  D+V KI DFGM+R    +  T +  RV G   
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----DVYTTDYYRVGGHTM 185

Query: 460 --YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKE 517
               +M PE  M   F+ +SDV+SFGV++ EI +  +   + L+         V +   +
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------VIECITQ 239

Query: 518 GKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
           G+       LL +  + P  V    I L C + DP  R  + ++   L
Sbjct: 240 GR-------LLQRPRTCPSEVY--DIMLGCWKRDPQQRINIKDIHERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 8e-28
 Identities = 67/202 (33%), Positives = 96/202 (47%), Gaps = 20/202 (9%)

Query: 300 LGQGGFGTVY----KGVLPNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVR 352
           LG+G FG V     K     GK  A+K L +K     + +E    E  +++++ H  +V+
Sbjct: 1   LGKGSFGKVLLVRKKD---TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57

Query: 353 LVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           L     + EEKL L+ E  P   L       E R        Y     I   L YLH   
Sbjct: 58  LH-YAFQTEEKLYLVLEYAPGGELF-SHLSKEGRFSEERARFY--AAEIVLALEYLH--- 110

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
            L II+RDLKP N+LLD D   K++DFG+A+         NT    GT  Y+APE  +  
Sbjct: 111 SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLLGK 168

Query: 472 LFSVKSDVFSFGVIVLEIISGK 493
            +    D +S GV++ E+++GK
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  111 bits (279), Expect = 1e-27
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 13/198 (6%)

Query: 297 SNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
             ++G G FG V+ G     ++VA+K + R+     E+F  E  ++ KL H  LV+L G 
Sbjct: 9   VQEIGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
             E     L++E M +  L  ++    +R + +  T   +   + +G+ YL   +   +I
Sbjct: 68  CTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122

Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAMEGLF 473
           HRDL   N L+ ++ V K+SDFGM R   ++Q T++T    GT     + +PE      +
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST----GTKFPVKWSSPEVFSFSKY 178

Query: 474 SVKSDVFSFGVIVLEIIS 491
           S KSDV+SFGV++ E+ S
Sbjct: 179 SSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  110 bits (278), Expect = 2e-27
 Identities = 76/204 (37%), Positives = 106/204 (51%), Gaps = 21/204 (10%)

Query: 298 NKLGQGGFGTVYKGV--LPNGKE--VAVKRLSR-KSWQGLEEFKNEIILIAKLQHRNLVR 352
            +LG G FG+V KGV  + +GKE  VAVK L +     G +EF  E  ++A+L H  +VR
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 353 LVG-CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           L+G C  +GE  +L+ EL P   L  ++     R ++  +    +   ++ G+ YL    
Sbjct: 61  LIGVC--KGEPLMLVMELAPLGPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESK- 114

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARI--FCENQKTANT--RRVVGTYGYMAPEY 467
               +HRDL   NVLL     AKISDFGM+R      +   A T  R  +  Y   APE 
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY---APEC 169

Query: 468 AMEGLFSVKSDVFSFGVIVLEIIS 491
              G FS KSDV+S+GV + E  S
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  110 bits (278), Expect = 3e-27
 Identities = 75/293 (25%), Positives = 126/293 (43%), Gaps = 58/293 (19%)

Query: 300 LGQGGFGTVYKGVLPN------GKEVAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVR 352
           LGQG FG VY+G+            VA+K ++   S +   EF NE  ++ +    ++VR
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 353 LVGCGIEGEEKLLIYELM-------------PNRSLDCFIFDSERRLQLNWNTCYNIIGG 399
           L+G    G+  L++ ELM             P    +          +        +   
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPG-LGPPTLQKF-----IQMAAE 127

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I+ G+ YL      K +HRDL   N ++ +D+  KI DFGM R   E        + +  
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-------GKRNSGFYLTGHAQTLLAYVW 512
             +MAPE   +G+F+ KSDV+SFGV++ E+ +       G  N         + +L +V 
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---------EEVLKFV- 234

Query: 513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
               +G  ++          + P   + + +  +C Q +P +RPT   +V+ L
Sbjct: 235 ---IDGGHLD-------LPENCPD--KLLELMRMCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 2e-26
 Identities = 78/289 (26%), Positives = 123/289 (42%), Gaps = 66/289 (22%)

Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE 359
           LG G FG V+ G      +VA+K + R+     ++F  E  ++ KL H NLV+L G   +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 360 GEEKLLIYELMPNRSLDCFIFDSERRLQLNW--NTCYNIIGGISKGLLYLHEDSRLKIIH 417
                ++ E M N  L  ++ + + +L   W  + C ++     + + YL  +     IH
Sbjct: 71  QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDV----CEAMEYLESNG---FIH 123

Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAMEGLFS 474
           RDL   N L+ +D V K+SDFG+AR   ++Q T++     GT     +  PE      FS
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFS 179

Query: 475 VKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSI 534
            KSDV+SFGV+                         +W+++ EGK      P    S+S 
Sbjct: 180 SKSDVWSFGVL-------------------------MWEVFSEGKM-----PYERFSNS- 208

Query: 535 PQVVRCIHIGL-----------------LCVQEDPAVRPTMSNVVALLG 566
            +VV  +  G                   C  E P  RP    +++ L 
Sbjct: 209 -EVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  108 bits (270), Expect = 3e-26
 Identities = 68/196 (34%), Positives = 108/196 (55%), Gaps = 7/196 (3%)

Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLG G FG V+ G      +VAVK L +      E F  E  ++ KL+H  LV+L    +
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAV-V 70

Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M   SL  F+ D E R  L      ++   ++ G+ Y+    R+  IHR
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126

Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+   +V KI+DFG+AR+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ E+++  R
Sbjct: 186 VWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  108 bits (271), Expect = 3e-26
 Identities = 67/210 (31%), Positives = 105/210 (50%), Gaps = 22/210 (10%)

Query: 297 SNKLGQGGFGTVYKGV-LPNGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
            NK+G G FG VY  V L  G+ +AVK  R+     + ++E  +E+ ++  L+H NLV+ 
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFI----FDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
            G  +  E+  +  E     +L+  +       E  +++     Y +   + +GL YLH 
Sbjct: 65  YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRV-----YTL--QLLEGLAYLHS 117

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR--RVVGTYGYMAPEY 467
                I+HRD+KP+N+ LD + V K+ DFG A     N  T       + GT  YMAPE 
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 468 AMEGLFSVK---SDVFSFGVIVLEIISGKR 494
              G        +D++S G +VLE+ +GKR
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  107 bits (269), Expect = 6e-26
 Identities = 82/290 (28%), Positives = 122/290 (42%), Gaps = 46/290 (15%)

Query: 298 NKLGQGGFGTVYKGVL------PNGKEVAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNL 350
             LG G FG VY+G+           +VAVK L    S Q   +F  E ++++K  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDS----ERRLQLNWNTCYNIIGGISKGLLY 406
           VRL+G   E   + ++ ELM    L  F+ ++    ER   L           ++KG  Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 407 LHEDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           L E+     IHRD+   N LL       VAKI+DFGMAR            R +    +M
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188

Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIIS-------GKRNSGFYLTGHAQTLLAYVWQLWK 516
            PE  ++G+F+ K+DV+SFGV++ EI S       G+ N               V +   
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-------------VMEFVT 235

Query: 517 EGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG 566
            G  ++            P       I   C Q  P  RP  + ++  + 
Sbjct: 236 GGGRLD-------PPKGCP--GPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  106 bits (267), Expect = 6e-26
 Identities = 66/203 (32%), Positives = 107/203 (52%), Gaps = 9/203 (4%)

Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKEV-AVKR--LSRKSWQGLEEFKNEIILIAKLQHRNL 350
           F   NK+G+G FG V+K V    K V A+K+  LS+ + +  EE  +E  ++AKL    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +R     ++  +  ++ E   N  L   +   +R   L  +  +     I  GL +LH  
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAME 470
              KI+HRD+K  N+ LD     KI D G+A++  +N   ANT  +VGT  Y++PE   +
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCED 175

Query: 471 GLFSVKSDVFSFGVIVLEIISGK 493
             ++ KSDV++ GV++ E  +GK
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  106 bits (267), Expect = 7e-26
 Identities = 79/281 (28%), Positives = 133/281 (47%), Gaps = 33/281 (11%)

Query: 291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKR------LSRKSWQGLEEFKNEIILIA 343
              F    K+G+G F  VYK + L +G+ VA+K+      +  K+ Q   +   EI L+ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57

Query: 344 KLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFI--FDSERRLQLNWNTCYNIIGGIS 401
           +L H N+++ +   IE  E  ++ EL     L   I  F  ++RL +   T +     + 
Sbjct: 58  QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTIWKYFVQLC 116

Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG 461
             L ++H     +I+HRD+KP+NV +    V K+ D G+ R F    KT     +VGT  
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPY 171

Query: 462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM 521
           YM+PE   E  ++ KSD++S G ++ E+ + +  S FY           ++ L K+ ++ 
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQ--SPFYGDK------MNLYSLCKKIEKC 223

Query: 522 EFVD-PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
           ++   P    S  +  +V        C+  DP  RP +S V
Sbjct: 224 DYPPLPADHYSEELRDLVS------RCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  106 bits (265), Expect = 1e-25
 Identities = 69/194 (35%), Positives = 104/194 (53%), Gaps = 8/194 (4%)

Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLG G FG V+ G   N  +VAVK L   +   ++ F  E  L+  LQH  LVRL     
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 359 EGEEKLLIYELMPNRSL-DCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
           + E   +I E M   SL D    D   ++ L      +    I++G+ Y+    R   IH
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQIAEGMAYIE---RKNYIH 126

Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKS 477
           RDL+ +NVL+ + ++ KI+DFG+AR+  +N+ TA          + APE    G F++KS
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKS 185

Query: 478 DVFSFGVIVLEIIS 491
           DV+SFG+++ EI++
Sbjct: 186 DVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 1e-25
 Identities = 64/195 (32%), Positives = 101/195 (51%), Gaps = 6/195 (3%)

Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRNLVRLVGCG 357
           K+G+G FG VYKGVL    EVAVK         L  +F  E  ++ +  H N+V+L+G  
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
           ++ +   ++ EL+P  SL  F+   + RL +       +    + G+ YL  +S+   IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK--KLLQMSLDAAAGMEYL--ESK-NCIH 116

Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKS 477
           RDL   N L+ ++ V KISDFGM+R       T +         + APE    G ++ +S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176

Query: 478 DVFSFGVIVLEIISG 492
           DV+S+G+++ E  S 
Sbjct: 177 DVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  106 bits (266), Expect = 2e-25
 Identities = 64/202 (31%), Positives = 104/202 (51%), Gaps = 19/202 (9%)

Query: 299 KLGQGGFGTVYK-GVLPNGKEVAVKRL-SRKSWQGL-EEFKNEIILIAKLQHRNLVRLVG 355
           ++G+G  G V+K      G+ VA+K++  R+   G+  +   EI  +   QH  +V+L+ 
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
               G   +L+ E MP   L   + D ER L       Y  +  + KG+ Y+H      I
Sbjct: 67  VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRM--LLKGVAYMHA---NGI 120

Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSV 475
           +HRDLKP+N+L+  D V KI+DFG+AR+F E +    + + V T  Y APE     L+  
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPEL----LYGA 175

Query: 476 KS-----DVFSFGVIVLEIISG 492
           +      D+++ G I  E+++G
Sbjct: 176 RKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  105 bits (264), Expect = 3e-25
 Identities = 65/213 (30%), Positives = 109/213 (51%), Gaps = 25/213 (11%)

Query: 300 LGQGGFGTVYKG--VLPNGKE----VAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
           LG+G FG VYKG    PN +     VA+K L      +  +EF+ E  L++ LQH N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIF-------------DSERRLQLNWNTCYNIIGG 399
           L+G   + +   +++E + +  L  F+              D   +  L+ +   +I   
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCENQKTANTRRVVG 458
           I+ G+ YL   S    +HRDL   N L+ + +  KISDFG++R I+  +     ++ ++ 
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
              +M PE  + G F+ +SD++SFGV++ EI S
Sbjct: 190 VR-WMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 3e-25
 Identities = 64/208 (30%), Positives = 102/208 (49%), Gaps = 25/208 (12%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEF----KNEIILIAKLQHRNLVR 352
            ++G+G +G VYK      G+ VA+K++  +     E F      EI L+ KL+H N+VR
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 353 LVGCGIEGEEK--LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK----GLLY 406
           L        +    +++E M +  L   +   E +      T   I     K    GL Y
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKF-----TESQI-KCYMKQLLEGLQY 115

Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH +    I+HRD+K SN+L++ D V K++DFG+AR + +      T RV+ T  Y  PE
Sbjct: 116 LHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPE 171

Query: 467 YAM-EGLFSVKSDVFSFGVIVLEIISGK 493
             +    +  + D++S G I+ E+  GK
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  103 bits (259), Expect = 9e-25
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 11/210 (5%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           LG+G +G VY    L     +A+K +  +  + ++    EI L + L+HRN+V+ +G   
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
           E     +  E +P  SL   +      L+ N  T       I +GL YLH+    +I+HR
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHR 132

Query: 419 DLKPSNVLLDK-DMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL--FSV 475
           D+K  NVL++    V KISDFG ++          T    GT  YMAPE   +G   +  
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET--FTGTLQYMAPEVIDKGPRGYGA 190

Query: 476 KSDVFSFGVIVLEIISGKRNSGFYLTGHAQ 505
            +D++S G  ++E+ +GK    F   G  Q
Sbjct: 191 PADIWSLGCTIVEMATGK--PPFIELGEPQ 218

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 97.9 bits (244), Expect = 1e-24
 Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 4/98 (4%)

Query: 25  SNTSYAPNSPFESSLKLLLESIATNTS----QGFYNLSIGDDPNRVFGRALCRGDVNRTV 80
           S      NS FES+L  LL S+++N +    +GF   + G  P+ V+G A CRGD++ + 
Sbjct: 9   SGNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGDLSASD 68

Query: 81  CQNCLENARHEILKNCKTAEEAIIWYELCQIQYSYRKF 118
           C++CL  A  E+ + C   +   IWY+ C ++Y    F
Sbjct: 69  CRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  102 bits (257), Expect = 2e-24
 Identities = 82/278 (29%), Positives = 122/278 (43%), Gaps = 35/278 (12%)

Query: 299 KLGQGGFGTVYKG--VLPNGK--EVAVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRL 353
           KLG G FG V +G      GK   VAVK L        +++F  E  ++  L H NL+RL
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 354 VGCGIEGEEKLLIYELMPNRSL-DCFIFDSERRLQLN--WNTCYNIIGGISKGLLYLHED 410
            G  +     + + EL P  SL D    D+     ++   +    I    + G+ YL   
Sbjct: 62  YGVVLTHPLMM-VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLESK 116

Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ---KTANTRRVVGTYGYMAPEY 467
              + IHRDL   N+LL  D   KI DFG+ R   +N+         +V   + + APE 
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPES 171

Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL 527
                FS  SDV+ FGV + E+ +        L+G +Q L      + KEG+ +E     
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-SQILKK----IDKEGERLE----- 221

Query: 528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
             +  + PQ     ++ L C   +PA RPT + +   L
Sbjct: 222 --RPEACPQ--DIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  103 bits (257), Expect = 2e-24
 Identities = 85/284 (29%), Positives = 135/284 (47%), Gaps = 53/284 (18%)

Query: 300 LGQGGFGTVYKG----VLPNGKE---VAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLV 351
           LG G FG VY+G    +L  G     VAVK L + +  Q  +EF  E  L++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ------LNWNTCYNIIGGISKGLL 405
           +L+G  +  E + +I ELM    L  ++ D+  R++      L      +I   ++KG +
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDA--RVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 406 YLHEDSRLKIIHRDLKPSNVLL-----DKDMVAKISDFGMARIFCEN-------QKTANT 453
           YL    ++  IHRDL   N L+     D D V KI DFG+AR   ++       +     
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
           R       +MAPE  ++G F+ +SDV+SFGV++ EI++  +    Y   + Q +L +V  
Sbjct: 178 R-------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP--YPALNNQEVLQHV-- 226

Query: 514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT 557
               G  ++       K  + P  +    +   C  +DP+ RPT
Sbjct: 227 --TAGGRLQ-------KPENCPDKIY--QLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  102 bits (256), Expect = 2e-24
 Identities = 76/268 (28%), Positives = 134/268 (50%), Gaps = 28/268 (10%)

Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L ++    +EEF  E  ++ +++H NLV+L+G 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+  +N      +   IS  + YL + +    I
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQE-VNAVVLLYMATQISSAMEYLEKKN---FI 126

Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAMEGLF 473
           HRDL   N L+ ++ + K++DFG++R+   +  TA+     G      + APE      F
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA----GAKFPIKWTAPESLAYNKF 182

Query: 474 SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSS 533
           S+KSDV++FGV++ EI +      + ++ +    L+ V++L ++G  ME           
Sbjct: 183 SIKSDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKGYRME------RPEGC 230

Query: 534 IPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
            P+V   +     C Q +P+ RP+ + +
Sbjct: 231 PPKVYELMR---ACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  101 bits (252), Expect = 5e-24
 Identities = 65/196 (33%), Positives = 107/196 (54%), Gaps = 7/196 (3%)

Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G       VA+K L +      E F  E  ++ KL+H  LV+L    +
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 70

Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M   SL  F+   E    L      ++   I+ G+ Y+    R+  +HR
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126

Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+ +++V K++DFG+AR+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ E+ +  R
Sbjct: 186 VWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  101 bits (252), Expect = 5e-24
 Identities = 66/196 (33%), Positives = 109/196 (55%), Gaps = 7/196 (3%)

Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G      +VA+K L +      E F  E  ++ KL+H  LV L    +
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV-V 70

Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M   SL  F+ + + +  L      ++   I+ G+ Y+    R+  IHR
Sbjct: 71  SEEPIYIVTEFMGKGSLLDFLKEGDGK-YLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126

Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+  ++V KI+DFG+AR+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ E+++  R
Sbjct: 186 VWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  100 bits (251), Expect = 1e-23
 Identities = 63/202 (31%), Positives = 109/202 (53%), Gaps = 10/202 (4%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQ-GLEEFKNEIILIAKLQHRNLVRLVG 355
             +G G    VY  + LPN ++VA+KR+  +  Q  ++E + E+  +++  H N+V+   
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66

Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
             + G+E  L+   +   SL   +  S  R  L+      ++  + KGL YLH + +   
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ--- 123

Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCEN-QKTANTRR-VVGTYGYMAPEYAMEGL- 472
           IHRD+K  N+LL +D   KI+DFG++    +   +T   R+  VGT  +MAPE  ME + 
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQVH 182

Query: 473 -FSVKSDVFSFGVIVLEIISGK 493
            +  K+D++SFG+  +E+ +G 
Sbjct: 183 GYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  100 bits (250), Expect = 1e-23
 Identities = 81/281 (28%), Positives = 143/281 (50%), Gaps = 44/281 (15%)

Query: 300 LGQGGFGTVYKGVL--PNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V++G+L  P  KEVAV   + K   + +  ++F +E  ++ +  H N++RL 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   + +  ++I E M N +LD ++ D +        + Y ++G   GI+ G+ YL   S
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEF-----SSYQLVGMLRGIAAGMKYL---S 124

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG------YMAP 465
            +  +HRDL   N+L++ ++  K+SDFG++R+  ++ +   T     T G      + AP
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYT-----TSGGKIPIRWTAP 179

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E      F+  SDV+SFG+++ E++S      + ++ H       V +   +G    F  
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE------VMKAINDG----FRL 229

Query: 526 PLLMK-SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
           P  M   S++ Q++      L C Q+D A RP   ++V LL
Sbjct: 230 PAPMDCPSAVYQLM------LQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  100 bits (251), Expect = 1e-23
 Identities = 79/291 (27%), Positives = 136/291 (46%), Gaps = 50/291 (17%)

Query: 300 LGQGGFGTVYK----GVLPNGKE--VAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
           +GQG FG V++    G+LP      VAVK L  + S     +F+ E  L+A+  H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFD-------------------SERRLQLNWNTC 393
           L+G    G+   L++E M    L+ F+                         L L+    
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCENQKTAN 452
             I   ++ G+ YL E    K +HRDL   N L+ ++MV KI+DFG++R I+  +   A+
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW 512
               +    +M PE      ++ +SDV+++GV++ EI S      +Y   H + ++ YV 
Sbjct: 190 ENDAIPIR-WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP-YYGMAHEE-VIYYV- 245

Query: 513 QLWKEGKEMEFVD--PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
              ++G  +   D  PL      +  ++R      LC  + P+ RP+ +++
Sbjct: 246 ---RDGNVLSCPDNCPL-----ELYNLMR------LCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  100 bits (250), Expect = 2e-23
 Identities = 66/207 (31%), Positives = 101/207 (48%), Gaps = 16/207 (7%)

Query: 292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHR-- 348
           D      +LG G  G V K +  P GK +AVK +  +     E  + +I+    + H+  
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCN 57

Query: 349 --NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLY 406
              +V   G      +  +  E M   SLD  +   E + ++       I   + KGL Y
Sbjct: 58  SPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTY 115

Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LHE    KIIHRD+KPSN+L++     K+ DFG++     +   A T   VGT  YMAPE
Sbjct: 116 LHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--LAKT--FVGTSSYMAPE 169

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGK 493
                 +SVKSD++S G+ ++E+ +G+
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  100 bits (250), Expect = 2e-23
 Identities = 84/286 (29%), Positives = 132/286 (46%), Gaps = 49/286 (17%)

Query: 300 LGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLV 354
           LG+G FG+V    Y  +  N G+ VAVK+L   + + L +F+ EI ++  LQH N+V+  
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 355 G-CGIEGEEKL-LIYELMPNRSLDCFI------FDSERRLQLNWNTCYNIIGGISKGLLY 406
           G C   G   L L+ E +P  SL  ++       D  + L      C        KG+ Y
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQIC--------KGMEY 123

Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG---TYGYM 463
           L      + +HRDL   N+L++ +   KI DFG+ ++  ++ K     R  G    + Y 
Sbjct: 124 L---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-KEYYKVREPGESPIFWY- 178

Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSG-----FYLTGHAQTLLAYVWQLWKE 517
           APE   E  FSV SDV+SFGV++ E+ +   ++         + G+ +     V+ L + 
Sbjct: 179 APESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE- 237

Query: 518 GKEMEFVDPLLMKSSSIPQVVRC---IH-IGLLCVQEDPAVRPTMS 559
                    LL  +  +P    C   I+ I   C   DP+ RP+ S
Sbjct: 238 ---------LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFS 274

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 99.7 bits (248), Expect = 3e-23
 Identities = 82/286 (28%), Positives = 134/286 (46%), Gaps = 38/286 (13%)

Query: 299 KLGQGGFGTVY----KGVLPNGKE--VAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           +LG+G FG V+      +LP   +  VAVK L   S    ++F+ E  L+  LQH+++VR
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 353 LVGCGIEGEEKLLIYELMP----NRSL-----DCFIFDSERRL---QLNWNTCYNIIGGI 400
             G   EG   L+++E M     NR L     D  I      +   QL       I   I
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCENQKTANTRRVVGT 459
           + G++YL   + L  +HRDL   N L+ + +V KI DFGM+R I+  +      R ++  
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK 519
             +M PE  +   F+ +SD++SFGV++ EI +  +   + L+           +   +G+
Sbjct: 189 R-WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI------ECITQGR 241

Query: 520 EMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
           E+E       +  + P  V  I  G  C Q +P  R  + ++ + L
Sbjct: 242 ELE-------RPRTCPPEVYAIMQG--CWQREPQQRMVIKDIHSRL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =   99 bits (250), Expect = 3e-23
 Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 23/207 (11%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN-----EIILIAKLQHRNLV 351
            KLG+G +  VYK      G+ VA+K++     +  ++  N     EI L+ +L+H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            L+          L++E M    L+  I D    L       Y  +    +GL YLH   
Sbjct: 66  GLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSY--MLMTLRGLEYLH--- 119

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
              I+HRDLKP+N+L+  D V K++DFG+AR F  +     T +VV T  Y APE     
Sbjct: 120 SNWILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRKMTHQVV-TRWYRAPEL---- 173

Query: 472 LFSVKS-----DVFSFGVIVLEIISGK 493
           LF  +      D++S G I  E++   
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 99.3 bits (247), Expect = 3e-23
 Identities = 82/292 (28%), Positives = 138/292 (47%), Gaps = 36/292 (12%)

Query: 288 KAATDGFSDSNKLGQGGFGTVY----KGVLPNGKE--VAVKRLSRK-SWQGLEEFKNEII 340
           + A +  + S +LGQG FG VY    KGV+ +  E  VA+K ++   S +   EF NE  
Sbjct: 2   EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61

Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLN-------WNTC 393
           ++ +    ++VRL+G   +G+  L+I ELM    L  ++      ++ N           
Sbjct: 62  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKM 121

Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT 453
             + G I+ G+ YL+ +   K +HRDL   N ++ +D   KI DFGM R   E       
Sbjct: 122 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 178

Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
            + +    +M+PE   +G+F+  SDV+SFGV++ EI                TL    +Q
Sbjct: 179 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQ 223

Query: 514 LWKEGKEMEFV--DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA 563
                + + FV    LL K  + P ++    +  +C Q +P +RP+   +++
Sbjct: 224 GMSNEQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 98.9 bits (247), Expect = 4e-23
 Identities = 74/285 (25%), Positives = 119/285 (41%), Gaps = 60/285 (21%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVK-----RLSRKSWQGLEEFKNEIILIAKLQHRNLV 351
             +G+G FGTV K     +GK +  K      ++ K  Q L    +E+ ++ +L+H N+V
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQL---VSEVNILRELKHPNIV 62

Query: 352 RLVGCGIEGEEKLLIYELM-----------------PNRSLD-CFIFDSERRLQLNWNTC 393
           R     I       +Y +M                   + ++  FI+    +L L    C
Sbjct: 63  RYYD-RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYEC 121

Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT 453
           +N              D    ++HRDLKP+N+ LD +   K+ DFG+A+I   +   A T
Sbjct: 122 HN------------RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT 169

Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
              VGT  YM+PE      +  KSD++S G ++ E+ +      F      Q  LA    
Sbjct: 170 --YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS--PPFTARNQLQ--LA---S 220

Query: 514 LWKEGKEMEFVDPL-LMKSSSIPQVVRCIHIGLLCVQEDPAVRPT 557
             KEGK       +    SS + +V++        +  DP  RP+
Sbjct: 221 KIKEGK----FRRIPYRYSSELNEVIK------SMLNVDPDKRPS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 98.6 bits (245), Expect = 4e-23
 Identities = 76/268 (28%), Positives = 127/268 (47%), Gaps = 24/268 (8%)

Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLG G FG V+        +VAVK +   S   +E F  E  ++  LQH  LV+L    +
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV-V 70

Query: 359 EGEEKLLIYELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
             E   +I E M   SL  F+   E  +  L      +    I++G+ ++ + +    IH
Sbjct: 71  TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRN---YIH 125

Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKS 477
           RDL+ +N+L+   +V KI+DFG+AR+  +N+ TA          + APE    G F++KS
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKS 184

Query: 478 DVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQV 537
           DV+SFG++++EI++  R        +       V +  + G  M        +  + P+ 
Sbjct: 185 DVWSFGILLMEIVTYGR------IPYPGMSNPEVIRALERGYRMP-------RPENCPE- 230

Query: 538 VRCIHIGLLCVQEDPAVRPTMSNVVALL 565
               +I + C +  P  RPT   + ++L
Sbjct: 231 -ELYNIMMRCWKNRPEERPTFEYIQSVL 257

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 98.5 bits (246), Expect = 7e-23
 Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 23/208 (11%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAK-------L 345
           F+    +G+G FG VYK +     + VA+K +       LEE ++EI  I +        
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID------LEEAEDEIEDIQQEIQFLSQC 56

Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +   + +  G  ++G +  +I E     S      D  +  +L+      I+  +  GL 
Sbjct: 57  RSPYITKYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLE 112

Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLHE+     IHRD+K +N+LL ++   K++DFG++          NT   VGT  +MAP
Sbjct: 113 YLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAP 167

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           E   +  +  K+D++S G+  +E+  G+
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 96.6 bits (240), Expect = 2e-22
 Identities = 65/196 (33%), Positives = 104/196 (53%), Gaps = 13/196 (6%)

Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
            +G+G FG V +G    G++VAVK +  K     + F  E  ++ KL H+NLVRL+G  I
Sbjct: 13  IIGEGEFGAVLQGEY-TGQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGV-I 68

Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
                 ++ ELM   +L  F+  +  R  ++          +++G+ YL      K++HR
Sbjct: 69  LHNGLYIVMELMSKGNLVNFL-RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHR 124

Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL   N+L+ +D VAK+SDFG+AR+        +  ++     + APE      FS KSD
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL--PVKWTAPEALKHKKFSSKSD 179

Query: 479 VFSFGVIVLEIISGKR 494
           V+S+GV++ E+ S  R
Sbjct: 180 VWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 96.4 bits (240), Expect = 3e-22
 Identities = 65/205 (31%), Positives = 101/205 (49%), Gaps = 21/205 (10%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRL--------SRKSWQGLEEFKNEIILIAKLQHRNL 350
           LGQG FG VY    +  G+E+AVK++        ++K    LE    EI L+  LQH  +
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALE---CEIQLLKNLQHERI 66

Query: 351 VRLVGCGIEGEEKLLIY-ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
           V+  GC +  +E L I+ E MP  S+   +   +    L           I +G+ YLH 
Sbjct: 67  VQYYGC-LRDDETLSIFMEYMPGGSVKDQL---KAYGALTETVTRKYTRQILEGVEYLHS 122

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA-RIFCENQKTANTRRVVGTYGYMAPEYA 468
           +    I+HRD+K +N+L D     K+ DFG + R+          + V GT  +M+PE  
Sbjct: 123 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179

Query: 469 MEGLFSVKSDVFSFGVIVLEIISGK 493
               +  K+DV+S G  V+E+++ K
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 96.0 bits (239), Expect = 3e-22
 Identities = 76/280 (27%), Positives = 130/280 (46%), Gaps = 51/280 (18%)

Query: 300 LGQGGFG--TVYK----GVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           LG+G FG  T+Y+      L   KEV + RLS K      +  NEI++++ LQH N++  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEK---ERRDALNEIVILSLLQHPNIIAY 64

Query: 354 VGCGIEGEEKLLI----------YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKG 403
               ++ +  LLI          Y+ +  +     +F+ E    + W   + I+  +S  
Sbjct: 65  YNHFMD-DNTLLIEMEYANGGTLYDKIVRQ--KGQLFEEE---MVLW-YLFQIVSAVS-- 115

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             Y+H+     I+HRD+K  N+ L K  + K+ DFG+++I     + +    VVGT  YM
Sbjct: 116 --YIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYM 168

Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF 523
           +PE      ++ KSD+++ G ++ E+++ KR      T  A   L  V ++ +       
Sbjct: 169 SPELCQGVKYNFKSDIWALGCVLYELLTLKR------TFDATNPLNLVVKIVQGNYTPV- 221

Query: 524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA 563
           V      SS +  +V         +Q+DP  RPT   V+ 
Sbjct: 222 VSVY---SSELISLVHS------LLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 96.4 bits (240), Expect = 4e-22
 Identities = 66/200 (33%), Positives = 95/200 (47%), Gaps = 15/200 (7%)

Query: 300 LGQGGFGTVYK-GVLPNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVG 355
           LG+GGFG V    V   GK  A K+L +K     +G +   NE  ++ K+  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFD-SERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
              E ++ L L+  LM    L   I++  E          Y     I  GL +LH   + 
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYA--AQIICGLEHLH---QR 114

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF 473
           +I++RDLKP NVLLD     +ISD G+A      +K        GT GYMAPE     ++
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQGEVY 171

Query: 474 SVKSDVFSFGVIVLEIISGK 493
               D F+ G  + E+I+G+
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 95.7 bits (238), Expect = 5e-22
 Identities = 66/208 (31%), Positives = 109/208 (52%), Gaps = 20/208 (9%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKR--LSRKSWQG-------LEEFKNEIILIAKLQHRN 349
           +G G FG+VY G+   +G+ +AVK+  L   S          L+    EI L+ +LQH N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
           +V+ +G  ++ +   +  E +P  S+   +               N +  I KGL YLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLH- 123

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN--QKTANTRR--VVGTYGYMAP 465
            +R  IIHRD+K +N+L+D     KISDFG+++    N      N  R  + G+  +MAP
Sbjct: 124 -NR-GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           E   +  ++ K+D++S G +V+E+++GK
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 96.7 bits (240), Expect = 5e-22
 Identities = 69/202 (34%), Positives = 114/202 (56%), Gaps = 20/202 (9%)

Query: 300 LGQGGFGTVYKGV-LPNGKEV----AVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRL 353
           LG G FGTVYKG+ +P G+ V    A+K L+  +  +   EF +E +++A + H +LVRL
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSE----RRLQLNWNTCYNIIGGISKGLLYLHE 409
           +G  +    +L + +LMP+  L  ++ + +     +L LNW  C  I    +KG++YL E
Sbjct: 75  LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW--CVQI----AKGMMYLEE 127

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               +++HRDL   NVL+      KI+DFG+AR+   ++K  N         +MA E   
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 470 EGLFSVKSDVFSFGVIVLEIIS 491
              F+ +SDV+S+GV + E+++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 96.2 bits (239), Expect = 6e-22
 Identities = 79/285 (27%), Positives = 128/285 (44%), Gaps = 40/285 (14%)

Query: 299 KLGQGGFGTVYKGVLPN------GKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLV 351
           +LGQG FG VY+G   +         VAVK ++   S +   EF NE  ++      ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIF----DSER---RLQLNWNTCYNIIGGISKGL 404
           RL+G   +G+  L++ ELM +  L  ++     ++E    R          +   I+ G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            YL+     K +HRDL   N ++  D   KI DFGM R   E        + +    +MA
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV 524
           PE   +G+F+  SD++SFGV++ EI                +L    +Q     + ++FV
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFV 234

Query: 525 DPLLMKSSSIPQVVRC---IH-IGLLCVQEDPAVRPTMSNVVALL 565
               M    + Q   C   +  +  +C Q +P +RPT   +V LL
Sbjct: 235 ----MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 94.7 bits (235), Expect = 9e-22
 Identities = 80/263 (30%), Positives = 122/263 (46%), Gaps = 28/263 (10%)

Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE 359
           +G+G FG V  G    G +VAVK +  K+    + F  E  ++ +L+H NLV+L+G  +E
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 360 GEEKLLIY-ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
            +  L I  E M   SL  ++  S  R  L  +        + + + YL  ++    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126

Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL   NVL+ +D VAK+SDFG+ +     Q T           + APE   E  FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEALREKKFSTKSD 181

Query: 479 VFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVV 538
           V+SFG+++ EI S      F    + +  L  V    ++G +M+  D         P VV
Sbjct: 182 VWSFGILLWEIYS------FGRVPYPRIPLKDVVPRVEKGYKMDAPD-------GCPPVV 228

Query: 539 RCIHIGLLCVQEDPAVRPTMSNV 561
               +   C   D A RP+   +
Sbjct: 229 --YDVMKQCWHLDAATRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 86/292 (29%), Positives = 137/292 (46%), Gaps = 55/292 (18%)

Query: 300 LGQGGFGTVYKGV---LPNGKE---VAVKRL-SRKSWQGLEEFKNEIILIAKL-QHRNLV 351
           LG+G FG V K     L N  E   VAVK L    + + L +  +E+ ++  + +H+N++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERR---LQLNWNTCYNIIGGIS------- 401
            L+G   +     ++ E   + +L  F+    RR      + +        ++       
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRA--RRPPGEYASPDDPRPPEETLTQKDLVSF 137

Query: 402 -----KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCEN--QKTANT 453
                +G+ +L   S+ K IHRDL   NVL+ +D V KI+DFG+AR I   +  +KT N 
Sbjct: 138 AYQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194

Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
           R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G     +  V +
Sbjct: 195 RLPV---KWMAPEALFDRVYTHQSDVWSFGVLLWEI--------FTLGGSPYPGIP-VEE 242

Query: 514 LW---KEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           L+   KEG  ME       K  +  Q +   H+   C  E P+ RPT   +V
Sbjct: 243 LFKLLKEGYRME-------KPQNCTQEL--YHLMRDCWHEVPSQRPTFKQLV 285

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 95.0 bits (236), Expect = 1e-21
 Identities = 87/285 (30%), Positives = 123/285 (43%), Gaps = 33/285 (11%)

Query: 300 LGQGGFGTV--YKGVLPN---GKEVAVKRLSRKSWQGLEE-FKNEIILIAKLQHRNLVRL 353
           LG+G FG V  Y     N   G+ VAVK L R+  Q     +K EI ++  L H N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 354 VGCGIEGEEK--LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            GC  E   K   LI E +P  SL     D   + +LN          I +G+ YLH   
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSL----RDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ- 126

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
               IHRDL   NVLLD D + KI DFG+A+   E  +    R    +   + A E   E
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184

Query: 471 GLFSVKSDVFSFGVIVLEIIS------GKRNSGFYLTGHAQTLLAYV--WQLWKEGKEME 522
             FS  SDV+SFGV + E+++              + G  Q  +  V   +L + G    
Sbjct: 185 NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR-- 242

Query: 523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS 567
                L    + PQ V    +   C + +   RPT  +++ +L  
Sbjct: 243 -----LPCPKNCPQEVY--ILMKNCWETEAKFRPTFRSLIPILKE 280

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 60/200 (30%), Positives = 102/200 (51%), Gaps = 14/200 (7%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN--EIILIAKLQHRNLVRLVG 355
           K+G+G +G VYK      G+ VA+K++  +            EI L+ +L H N+++L+ 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
                 +  L++E M     D +    +R+  L  +   + +  + +GL + H      I
Sbjct: 66  VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGI 119

Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE--YAMEGLF 473
           +HRDLKP N+L++ + V K++DFG+AR F    +   T  VV T  Y APE     +G +
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY-THYVV-TRWYRAPELLLGDKG-Y 176

Query: 474 SVKSDVFSFGVIVLEIISGK 493
           S   D++S G I  E++S +
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 64/205 (31%), Positives = 106/205 (51%), Gaps = 11/205 (5%)

Query: 293 GFSDSNKLGQGGFGTVYK-GVLPNGKEVAVKR--LSRKSWQGLEEFKNEIILIAKLQHRN 349
            F    KLG+G +G+VYK   L + +  A+K   L   S +  E+  NEI ++A + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSER-RLQLNWNTCYNIIGGISKGLLYLH 408
           ++      ++G +  ++ E  P   L   I   ++ R  +     + I   + +GL  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
           E    KI+HRDLK +N+LL  + + KI D G++++  +N   A T   +GT  YMAPE  
Sbjct: 121 E---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKT--QIGTPHYMAPEVW 173

Query: 469 MEGLFSVKSDVFSFGVIVLEIISGK 493
               +S KSD++S G ++ E+ +  
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 60/198 (30%), Positives = 93/198 (46%), Gaps = 13/198 (6%)

Query: 301 GQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQGLEEFKN---EIILIAKLQHRNLVRLVGC 356
           G+G FG V      + K++ A+K ++++        +N   E  ++ +L H  LV L   
Sbjct: 9   GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYS 68

Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
             + E   L+ +L+    L    +   ++++ +       I  I   L YLH      II
Sbjct: 69  FQDEENMYLVVDLLLGGDLR---YHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GII 122

Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+     I+DF +A     +  T +T    GT GYMAPE      +SV 
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST---SGTPGYMAPEVLCRQGYSVA 179

Query: 477 SDVFSFGVIVLEIISGKR 494
            D +S GV   E + GKR
Sbjct: 180 VDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 94.0 bits (233), Expect = 3e-21
 Identities = 78/297 (26%), Positives = 145/297 (48%), Gaps = 44/297 (14%)

Query: 299 KLGQGGFGTVY----KGVLPNGKE--VAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           +LG+G FG V+      + P   +  VAVK L   S    ++F  E  L+  LQH ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFI----------FDSERRLQLNWNTCYNIIGGISK 402
             G  +EG+  ++++E M +  L+ F+           +  R  +L  +   +I   I+ 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG---- 458
           G++YL   +    +HRDL   N L+ ++++ KI DFGM+R    +  + +  RV G    
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRVGGHTML 184

Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG 518
              +M PE  M   F+ +SDV+S GV++ EI +  +   + L+ +       V +   +G
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIECITQG 238

Query: 519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEP 575
           +       +L +  + P+ V  + +G  C Q +P +R  +  + +LL  +++A + P
Sbjct: 239 R-------VLQRPRTCPKEVYDLMLG--CWQREPHMRLNIKEIHSLL--QNLAKASP 284

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 93.8 bits (233), Expect = 3e-21
 Identities = 76/278 (27%), Positives = 136/278 (48%), Gaps = 36/278 (12%)

Query: 300 LGQGGFGTVYKGVL--PNGKE--VAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V +G L  P  +E  VA+K L S  + +   +F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   +    ++I E M N +LD F+     R      T   ++G   GI+ G+ YL E  
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFL-----RQNDGQFTVIQLVGMLRGIAAGMKYLSE-- 124

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG---TYGYMAPEYA 468
            +  +HRDL   N+L++ ++V K+SDFG++R   ++         +G      + APE  
Sbjct: 125 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183

Query: 469 MEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL 527
               F+  SDV+S+G+++ E++S G+R    Y     Q ++  + Q ++       + P 
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERP---YWDMSNQDVINAIEQDYR-------LPPP 233

Query: 528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
           +   +++ Q++      L C Q+D   RP    +V+ L
Sbjct: 234 MDCPTALHQLM------LDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 58/217 (26%), Positives = 106/217 (48%), Gaps = 17/217 (7%)

Query: 283 HLAVIKAATD---GFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRKSWQGLEEFKNE 338
            L ++    D      +  K+G+G  G V        G++VAVK++  +  Q  E   NE
Sbjct: 7   ALQLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNE 66

Query: 339 IILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG 398
           ++++   QH N+V +    + G+E  ++ E +   +L     D     ++N      +  
Sbjct: 67  VVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCL 122

Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE--NQKTANTRRV 456
            + K L +LH      +IHRD+K  ++LL  D   K+SDFG    FC   +++    + +
Sbjct: 123 AVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSL 175

Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           VGT  +MAPE      +  + D++S G++V+E++ G+
Sbjct: 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 93.7 bits (233), Expect = 3e-21
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 18/207 (8%)

Query: 300 LGQGGFGTVYKGVL--PNGK--EVAVK--RLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           LG+G FG+V +G L   +G   +VAVK  +L   ++  +EEF +E   +    H N+++L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 354 VGCGIEGEEK------LLIYELMPNRSLDCFIFDS---ERRLQLNWNTCYNIIGGISKGL 404
           +G   E          ++I   M +  L  F+  S       +L   T    +  I+ G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            YL   S    IHRDL   N +L +DM   ++DFG+++           R       ++A
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183

Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIIS 491
            E   + +++ KSDV++FGV + EI +
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 94.5 bits (236), Expect = 3e-21
 Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 61/226 (26%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---------EIILIAKLQHRN 349
           +G G +G V   V    G++VA+K++S         F +         EI L+  L+H N
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF----------------IFDSERRLQL---NW 390
           ++ L              +++   S + F                +  S + L      +
Sbjct: 61  IIGL-------------LDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQY 107

Query: 391 NTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT 450
              Y I+    +GL YLH      +IHRDLKPSN+L++ +   KI DFG+AR    ++  
Sbjct: 108 FL-YQIL----RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159

Query: 451 AN--TRRVVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
               T  VV T  Y APE  +    ++   D++S G I  E+++ K
Sbjct: 160 KGFLTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 93.3 bits (232), Expect = 4e-21
 Identities = 69/199 (34%), Positives = 109/199 (54%), Gaps = 11/199 (5%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFK-NEIILIAKLQHRNLVRLVGC 356
           KLG+G + TVYKG     G+ VA+K +   + +G       EI L+ +L+H N+VRL   
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66

Query: 357 GIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
            I  E KL L++E M    L  ++     R  L+ NT  +    + KG+ + HE+   ++
Sbjct: 67  -IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121

Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG-LFS 474
           +HRDLKP N+L++K    K++DFG+AR F     T +   V  T  Y AP+  +    +S
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLGSRTYS 179

Query: 475 VKSDVFSFGVIVLEIISGK 493
              D++S G I+ E+I+G+
Sbjct: 180 TSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 92.1 bits (229), Expect = 9e-21
 Identities = 73/284 (25%), Positives = 119/284 (41%), Gaps = 39/284 (13%)

Query: 300 LGQGGFGTVYKGVLPNGKE------VAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           LG+G FG V+       +E      V VK L   K      EF+ E+ +  KL H+N+VR
Sbjct: 13  LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ------LNWNTCYNIIGGISKGLLY 406
           L+G   E E   +I E      L  F+  ++ + +      L+      +   I+ G+ +
Sbjct: 73  LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132

Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           L   S  + +HRDL   N L+      K+S   +++    N +    R  +    ++APE
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKD-VYNSEYYKLRNALIPLRWLAPE 188

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP 526
              E  FS KSDV+SFGV++ E+ +             Q  L +         + E ++ 
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT-------------QGELPF-----YGLSDEEVLNR 230

Query: 527 LLMKSSSIPQVVRC----IHIGLLCVQEDPAVRPTMSNVVALLG 566
           L      +P    C      +   C   +P  RP+ S +V+ LG
Sbjct: 231 LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 91.9 bits (228), Expect = 1e-20
 Identities = 62/210 (29%), Positives = 111/210 (52%), Gaps = 28/210 (13%)

Query: 300 LGQGGFGTVYKGVL--PNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G L  P  +E+ V   + K   + +   +F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   + +  +++ E M N SLD F+   + +      T   ++G   GI+ G+ YL   S
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQF-----TVIQLVGMLRGIASGMKYL---S 123

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG------YMAP 465
            +  +HRDL   N+L++ ++V K+SDFG++R+  ++ + A T     T G      + AP
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT-----TRGGKIPIRWTAP 178

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS-GKR 494
           E      F+  SDV+S+G+++ E++S G+R
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMSYGER 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 92.3 bits (229), Expect = 1e-20
 Identities = 65/199 (32%), Positives = 104/199 (52%), Gaps = 14/199 (7%)

Query: 300 LGQGGFGTVYKGV-LPNGKE----VAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           LG G FGTV+KG+ +P G      VA+K +  R   Q  +E  + ++ +  L H  +VRL
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 354 VG-CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
           +G C   G    L+ +L P  SL   +   + R  L+     N    I+KG+ YL E   
Sbjct: 75  LGIC--PGASLQLVTQLSPLGSLLDHV--RQHRDSLDPQRLLNWCVQIAKGMYYLEEH-- 128

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
            +++HR+L   N+LL  D + +I+DFG+A +   + K            +MA E  + G 
Sbjct: 129 -RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187

Query: 473 FSVKSDVFSFGVIVLEIIS 491
           ++ +SDV+S+GV V E++S
Sbjct: 188 YTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 91.9 bits (228), Expect = 1e-20
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 22/209 (10%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRL---------SRKSWQGLEEFKNEIILIAKLQHR 348
             LG+G +GTVY G+   G+ +AVK++         + K ++ L+E   E+ L+  L+H 
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQE---EVDLLKSLKHV 62

Query: 349 NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
           N+V+ +G  ++     +  E +P  S+   +    R   L           I  G+ YLH
Sbjct: 63  NIVQYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLH 119

Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC----ENQKTANTRRVVGTYGYMA 464
            +    ++HRD+K +NV+L  + + K+ DFG AR           +   + + GT  +MA
Sbjct: 120 NNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMA 176

Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           PE   E  +  KSD++S G  V E+ +GK
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 92.8 bits (231), Expect = 1e-20
 Identities = 58/216 (26%), Positives = 108/216 (50%), Gaps = 27/216 (12%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFK----NEIILIAKLQHRNLVRL 353
           KLG+G FG VYK   +  G+ VA+K++   + +  + F      EI ++ KL+H N+V L
Sbjct: 15  KLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPL 72

Query: 354 VGCGIE-----GEEKLLIYELMPNRSLD-CFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           +   +E       ++  +Y + P    D   + ++   ++L  +     +  + +G+ YL
Sbjct: 73  IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPS-VKLTESQIKCYMLQLLEGINYL 131

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT------ANTRR---VVG 458
           HE+    I+HRD+K +N+L+D   + KI+DFG+AR +              TR+   +V 
Sbjct: 132 HEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV 188

Query: 459 TYGYMAPEYAM-EGLFSVKSDVFSFGVIVLEIISGK 493
           T  Y  PE  + E  ++   D++  G +  E+ + +
Sbjct: 189 TRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 91.6 bits (227), Expect = 1e-20
 Identities = 78/277 (28%), Positives = 132/277 (47%), Gaps = 25/277 (9%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLS---RKSWQGLEEFKNEIILIAKLQHRN 349
           F    K+G+G F  VY+   L +G  VA+K++        +   +   EI L+ +L H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFI--FDSERRLQLNWNTCYNIIGGISKGLLYL 407
           +++     IE  E  ++ EL     L   I  F  ++RL +   T +     +   L ++
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTVWKYFVQLCSALEHM 122

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H  SR +++HRD+KP+NV +    V K+ D G+ R F  + KT     +VGT  YM+PE 
Sbjct: 123 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPER 177

Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL 527
             E  ++ KSD++S G ++ E+ +    S FY  G    L +         K++E  D  
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAA--LQSPFY--GDKMNLYSLC-------KKIEQCDYP 226

Query: 528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL 564
            + S    + +R   +  +C+  DP  RP ++ V  +
Sbjct: 227 PLPSDHYSEELR--QLVNMCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 92.0 bits (228), Expect = 1e-20
 Identities = 63/202 (31%), Positives = 106/202 (52%), Gaps = 11/202 (5%)

Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLV 351
           F+   ++G+G FG VYKG+    KEV A+K +   ++   +E+ + EI ++++     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           R  G  ++G +  +I E +   S      D  +   L       I+  I KGL YLH + 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSER 121

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
           +   IHRD+K +NVLL +    K++DFG+A    + Q   NT   VGT  +MAPE   + 
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176

Query: 472 LFSVKSDVFSFGVIVLEIISGK 493
            +  K+D++S G+  +E+  G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 91.5 bits (227), Expect = 1e-20
 Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 18/201 (8%)

Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           +LG G FG V  G      +VA+K +   S    +EF  E  ++ KL H  LV+L G   
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLN--WNTCYNIIGGISKGLLYLHEDSRLKII 416
           +     ++ E M N  L  ++ +  +R Q +     C ++     +G+ YL      + I
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDV----CEGMAYLESK---QFI 122

Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAMEGLF 473
           HRDL   N L+D     K+SDFG++R   +++ T++    VG+     +  PE  +   F
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLLYSKF 178

Query: 474 SVKSDVFSFGVIVLEIIS-GK 493
           S KSDV++FGV++ E+ S GK
Sbjct: 179 SSKSDVWAFGVLMWEVYSLGK 199

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 91.4 bits (227), Expect = 1e-20
 Identities = 80/279 (28%), Positives = 131/279 (46%), Gaps = 42/279 (15%)

Query: 300 LGQGGFGTVYKGVL--PNGKEV--AVKRLSR-KSWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG VY G L   +G+++  AVK L+R    + +E+F  E I++    H N++ L+
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 355 GCGIEGE-EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHED 410
           G  +  E   L++   M +  L  FI            T  ++IG    ++KG+ YL   
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHN-----PTVKDLIGFGLQVAKGMEYLASK 117

Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAPEYA 468
              K +HRDL   N +LD+    K++DFG+AR   + +     N         +MA E  
Sbjct: 118 ---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESL 174

Query: 469 MEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM---EFV- 524
               F+ KSDV+SFGV++ E+++  R +  Y    +  +  Y+ Q    G+ +   E+  
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELMT--RGAPPYPDVDSFDITVYLLQ----GRRLLQPEYCP 228

Query: 525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA 563
           DPL               + L C    P +RPT S +V+
Sbjct: 229 DPLY-------------EVMLSCWHPKPEMRPTFSELVS 254

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 18/210 (8%)

Query: 292 DGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQGLE-EFKNEIILIAKLQHRN 349
           +   + ++LG+G  G+V K  L N   + A+K ++      L+ +   E+ +    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 350 LVRLVGCGIEGEEKLL--IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG----GISKG 403
           +V+  G  ++     +    E     SLD      ++  +        ++G     + KG
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY---KKVKKRGGRIGEKVLGKIAESVLKG 117

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           L YLH     KIIHRD+KPSN+LL +    K+ DFG++     +   A T    GT  YM
Sbjct: 118 LSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGT--FTGTSFYM 170

Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           APE      +S+ SDV+S G+ +LE+   +
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 91.4 bits (227), Expect = 2e-20
 Identities = 63/218 (28%), Positives = 108/218 (49%), Gaps = 39/218 (17%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVK----------RLSRKSWQGLEEFKNEIILIAKLQHR 348
           +G+G +G VY  + +  G+ +AVK          R   +    ++  ++EI  +  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 349 NLVRLVGCGIEGEEKLLIY-ELMPNRSLDCFI-----FDSERRLQLNWNTCYNIIGGISK 402
           N+V+ +G     EE L I+ E +P  S+   +     F+ +                   
Sbjct: 69  NIVQYLGFE-TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLE-------- 119

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR----IFCENQKTANTRRVVG 458
           GL YLH      I+HRDLK  N+L+D D + KISDFG+++    I+ +N +  + +   G
Sbjct: 120 GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIY-DNDQNMSMQ---G 172

Query: 459 TYGYMAPE--YAMEGLFSVKSDVFSFGVIVLEIISGKR 494
           +  +MAPE  ++    +S K D++S G +VLE+ +G+R
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 91.9 bits (228), Expect = 2e-20
 Identities = 58/198 (29%), Positives = 104/198 (52%), Gaps = 14/198 (7%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           K+GQG  GTVY  + +  G+EVA+K+++ +     E   NEI+++ + +H N+V  +   
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
           + G+E  ++ E +   SL     D      ++      +     + L +LH +   ++IH
Sbjct: 86  LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 138

Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPEYAMEGLFSV 475
           RD+K  N+LL  D   K++DFG    FC       ++R  +VGT  +MAPE      +  
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 194

Query: 476 KSDVFSFGVIVLEIISGK 493
           K D++S G++ +E++ G+
Sbjct: 195 KVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 91.2 bits (226), Expect = 3e-20
 Identities = 78/290 (26%), Positives = 136/290 (46%), Gaps = 45/290 (15%)

Query: 299 KLGQGGFGTVY----KGVLPNGKE--VAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           +LG+G FG V+      + P   +  VAVK L   +    ++F+ E  L+  LQH ++V+
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCF----------IFDSERRL---QLNWNTCYNIIGG 399
             G   +G+  ++++E M +  L+ F          + D + R    +L  +   +I   
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG- 458
           I+ G++YL   +    +HRDL   N L+  +++ KI DFGM+R    +  + +  RV G 
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGH 184

Query: 459 ---TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLW 515
                 +M PE  M   F+ +SDV+SFGVI+ EI +  +   F L+         V +  
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN------TEVIECI 238

Query: 516 KEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
            +G+ +E       +    P+ V  I +G  C Q +P  R  +  +  +L
Sbjct: 239 TQGRVLE-------RPRVCPKEVYDIMLG--CWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 91.1 bits (227), Expect = 3e-20
 Identities = 81/283 (28%), Positives = 129/283 (45%), Gaps = 39/283 (13%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRK--SWQGLEEFKN--EIILIAKLQ-HRNLVR 352
           +LG G FG+VY       G+ VA+K++ +K  SW   EE  N  E+  + KL  H N+V+
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW---EECMNLREVKSLRKLNEHPNIVK 62

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
           L     E +E   ++E M   +L   + D + +   + +   +II  I +GL ++H   +
Sbjct: 63  LKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKP-FSESVIRSIIYQILQGLAHIH---K 117

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCENQKTANTRRVVGTYGYMAPEYAME- 470
               HRDLKP N+L+    V KI+DFG+AR I      T      V T  Y APE  +  
Sbjct: 118 HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTD----YVSTRWYRAPEILLRS 173

Query: 471 GLFSVKSDVFSFGVIVLEIISGK-----RNS--GFYLTGHAQTLLAYVWQLWKEGKE--- 520
             +S   D+++ G I+ E+ + +      +     Y       L     Q W EG +   
Sbjct: 174 TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKI--CSVLGTPTKQDWPEGYKLAS 231

Query: 521 -MEFVDPLLMKSSSIPQVV-----RCIHIGLLCVQEDPAVRPT 557
            + F  P     +S+ Q++       I +    ++ DP  RPT
Sbjct: 232 KLGFRFP-QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT 273

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 65/207 (31%), Positives = 112/207 (54%), Gaps = 19/207 (9%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLS-RKSWQGLEEFK-NEIILIAKLQ---H 347
           + +  ++G+G +GTVYK   L  G+ VA+K++    S +G+      EI L+ +L+   H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 348 RNLVRL----VGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
            N+VRL     G   + E KL L++E + ++ L  ++     +  L   T  +++  + +
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLR 118

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           G+ +LH     +I+HRDLKP N+L+  D   KI+DFG+ARI+       +   VV T  Y
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS---VVVTLWY 172

Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEI 489
            APE  ++  ++   D++S G I  E+
Sbjct: 173 RAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 90.8 bits (225), Expect = 4e-20
 Identities = 77/290 (26%), Positives = 126/290 (43%), Gaps = 46/290 (15%)

Query: 300 LGQGGFGTVYKGV------LPNGKEVAVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVR 352
           LG+G FG V K              VAVK L   +    L +  +E  L+ ++ H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSER------RLQLNWNTCYNIIGG------- 399
           L G   +    LLI E     SL  F+ +S +          N N+ Y            
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 400 --------ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA 451
                   IS+G+ YL E   +K++HRDL   NVL+ +    KISDFG++R   E     
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYV 511
              +      +MA E   + +++ +SDV+SFGV++ EI++   N   Y     + L    
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP--YPGIAPERL---- 238

Query: 512 WQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
           + L K G  ME  +     S  +  ++        C +++P  RPT +++
Sbjct: 239 FNLLKTGYRMERPENC---SEEMYNLML------TCWKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 90.2 bits (224), Expect = 4e-20
 Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 23/201 (11%)

Query: 300 LGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           LG G FG VYK      G   A K +  +S + LE+F  EI ++++ +H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYE-AY 71

Query: 359 EGEEKLLIY-ELMPNRSLDCFIFDSERRL---QLNWNTCYNIIGGISKGLLYLHEDSRLK 414
             E KL I  E     +LD  + + ER L   Q+ +  C  ++    + L +LH     K
Sbjct: 72  FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-VCRQML----EALNFLHSH---K 123

Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-VGTYGYMAPEYAMEGLF 473
           +IHRDLK  N+LL  D   K++DFG++    +N+ T   R   +GT  +MAPE      F
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVS---AKNKSTLQKRDTFIGTPYWMAPEVVACETF 180

Query: 474 S-----VKSDVFSFGVIVLEI 489
                  K+D++S G+ ++E+
Sbjct: 181 KDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 89.1 bits (221), Expect = 7e-20
 Identities = 74/285 (25%), Positives = 123/285 (43%), Gaps = 56/285 (19%)

Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           +LG G FG V+ G      +VA+K +  +     E+F  E  ++ KL H  LV+L G   
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
           + +   ++ E M N  L  ++   +R+ +L+ +   ++   + +G+ YL  +S    IHR
Sbjct: 70  QQKPLYIVTEFMENGCLLNYL--RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL   N L+    V K+SDFGM R   +++ T+++        +  PE      +S KSD
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF-PVKWSPPEVFNFSKYSSKSD 183

Query: 479 VFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVV 538
           V+SFGV+                         +W+++ EGK M F      +  S  +VV
Sbjct: 184 VWSFGVL-------------------------MWEVFTEGK-MPF------EKKSNYEVV 211

Query: 539 RCIHIG-----------------LLCVQEDPAVRPTMSNVVALLG 566
             I  G                   C  E P  RPT + ++  + 
Sbjct: 212 EMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 38/217 (17%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGC- 356
           +G+G +G VYK      G+ VA+K +        EE K E  ++ K   H N+    G  
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNHPNIATFYGAF 72

Query: 357 -----GIEGEEKLLIYEL--------MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKG 403
                    ++  L+ EL        +             +RL+  W   Y I+    +G
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK-----GKRLKEEW-IAY-ILRETLRG 125

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYG 461
           L YLHE+   K+IHRD+K  N+LL K+   K+ DFG++        +   RR   +GT  
Sbjct: 126 LAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA----QLDSTLGRRNTFIGTPY 178

Query: 462 YMAPE-----YAMEGLFSVKSDVFSFGVIVLEIISGK 493
           +MAPE        +  +  +SDV+S G+  +E+  GK
Sbjct: 179 WMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 89.7 bits (222), Expect = 1e-19
 Identities = 58/198 (29%), Positives = 102/198 (51%), Gaps = 14/198 (7%)

Query: 299 KLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           K+G+G  G V       +G++VAVK +  +  Q  E   NE++++   QH+N+V +    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
           + GEE  ++ E +   +L     D   + +LN      +   + + L YLH      +IH
Sbjct: 88  LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCE--NQKTANTRRVVGTYGYMAPEYAMEGLFSV 475
           RD+K  ++LL  D   K+SDFG    FC   ++     + +VGT  +MAPE      +  
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT 196

Query: 476 KSDVFSFGVIVLEIISGK 493
           + D++S G++V+E++ G+
Sbjct: 197 EVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 90.3 bits (224), Expect = 1e-19
 Identities = 79/302 (26%), Positives = 128/302 (42%), Gaps = 35/302 (11%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLE-EFKNEIILIAKLQHRNLVRLVG 355
           N++G G  GTVYK +  P G+  A+K +       +  +   EI ++  + H N+V+   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
                 E  ++ E M   SL+      E+ L    +    I+ GI+    YLH   R  I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA---DVARQILSGIA----YLH---RRHI 189

Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSV 475
           +HRD+KPSN+L++     KI+DFG++RI  +     N+   VGT  YM+PE     L   
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS--VGTIAYMSPERINTDLNHG 247

Query: 476 K-----SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK 530
                  D++S GV +LE   G+   G    G   +L+  +              P    
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC----------MSQPPEAP 297

Query: 531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFPVGRTIVLAE 590
           +++  +    I     C+Q +PA R +    + LL    I  ++P Q         +L  
Sbjct: 298 ATASREFRHFIS---CCLQREPAKRWS---AMQLLQHPFILRAQPGQGQGGPNLHQLLPP 351

Query: 591 QP 592
             
Sbjct: 352 PR 353

Length = 353

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 89.1 bits (221), Expect = 2e-19
 Identities = 64/203 (31%), Positives = 102/203 (50%), Gaps = 19/203 (9%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           F+D  ++G G FG VY    +   + VA+K++S    Q  E++++   E+  + +L+H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
            +   GC +      L+ E     + D  I +  ++  L       I  G  +GL YLH 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKK-PLQEVEIAAICHGALQGLAYLHS 133

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE--Y 467
               + IHRD+K  N+LL +    K++DFG A +       AN+   VGT  +MAPE   
Sbjct: 134 ---HERIHRDIKAGNILLTEPGTVKLADFGSASLVS----PANS--FVGTPYWMAPEVIL 184

Query: 468 AM-EGLFSVKSDVFSFGVIVLEI 489
           AM EG +  K DV+S G+  +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 88.2 bits (218), Expect = 2e-19
 Identities = 75/274 (27%), Positives = 132/274 (48%), Gaps = 25/274 (9%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLS---RKSWQGLEEFKNEIILIAKLQHRN 349
           F    K+G+G F  VY+   L + K VA+K++        +  ++   EI L+ +L H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFI--FDSERRLQLNWNTCYNIIGGISKGLLYL 407
           +++ +   IE  E  ++ EL     L   I  F  ++RL +   T +     +   + ++
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL-IPERTVWKYFVQLCSAVEHM 122

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H  SR +++HRD+KP+NV +    V K+ D G+ R F  + KT     +VGT  YM+PE 
Sbjct: 123 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPER 177

Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL 527
             E  ++ KSD++S G ++ E+ +    S FY  G    L +         +++E  D  
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAA--LQSPFY--GDKMNLFSLC-------QKIEQCDYP 226

Query: 528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
            + +    + +R   +  +C+  DP  RP +  V
Sbjct: 227 PLPTEHYSEKLR--ELVSMCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 87.6 bits (217), Expect = 3e-19
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 17/202 (8%)

Query: 300 LGQGGFGTVYKGVLPNG------KEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +G+G FG V+             K++ V+++++      +   NE  ++  L H N++  
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
               +E +  +++ E  P  +L  +I      L L+ +T   I+    + LL LH     
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDT---ILHFFVQILLALHHVHTK 120

Query: 414 KIIHRDLKPSNVLLDK-DMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
            I+HRDLK  N+LLDK  MV KI DFG+++I     K A T  VVGT  Y++PE      
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-AYT--VVGTPCYISPELCEGKP 177

Query: 473 FSVKSDVFSFGVIVLEIISGKR 494
           ++ KSD+++ G ++ E+ S KR
Sbjct: 178 YNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 36/213 (16%)

Query: 300 LGQGGFGTVY---KGVLPNGKEVAVKRLSRKSWQG---LEEFKNEIILIAKLQHRNLVRL 353
           + +G +G V+   K     G   A+K + +        +++   E  ++++ Q   +V+L
Sbjct: 1   ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 354 VGCGIEGEEKL-LIYELMPN-------RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
                +G++ L L+ E +P         ++     D  R            I  I   L 
Sbjct: 59  Y-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR----------IYIAEIVLALE 107

Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ------KTANTRRVVGT 459
           YLH      IIHRDLKP N+L+D +   K++DFG++++    +           +R+VGT
Sbjct: 108 YLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
             Y+APE  +    S   D +S G I+ E + G
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 88.2 bits (218), Expect = 3e-19
 Identities = 65/198 (32%), Positives = 102/198 (51%), Gaps = 15/198 (7%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           +LG G FG VYK      G   A K +  KS + LE++  EI ++A   H  +V+L+G  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
               +  ++ E  P  ++D  + + +R L         I   + + L YLH    +KIIH
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLT--EPQIQVICRQMLEALQYLHS---MKIIH 133

Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR-RVVGTYGYMAPEYAM-----EG 471
           RDLK  NVLL  D   K++DFG++    +N KT   R   +GT  +MAPE  M     + 
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS---AKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190

Query: 472 LFSVKSDVFSFGVIVLEI 489
            +  K+D++S G+ ++E+
Sbjct: 191 PYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 62/214 (28%), Positives = 110/214 (51%), Gaps = 18/214 (8%)

Query: 293 GFSDSNKLGQGGFGTVYKGVLPN---GKEVAVKRL--SRKSWQGLEEFK-NEIILIAKLQ 346
            +     +G+G +G VYK    N   GKE A+K+    ++ + G+ +    EI L+ +L+
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 347 HRNLVRLVGCGIEGEEKL--LIYELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKG 403
           H N+V LV   +E  +K   L+++   +       F  + +R+ +  +   +++  I  G
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLL----DKDMVAKISDFGMARIFCENQKT-ANTRRVVG 458
           + YLH +    ++HRDLKP+N+L+     +  V KI D G+AR+F    K  A+   VV 
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177

Query: 459 TYGYMAPEYAMEGLFSVKS-DVFSFGVIVLEIIS 491
           T  Y APE  +      K+ D+++ G I  E+++
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 87.8 bits (217), Expect = 4e-19
 Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 14/198 (7%)

Query: 299 KLGQGGFGTV-YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           K+G+G  G V    V  +GK VAVK++  +  Q  E   NE++++   QH N+V +    
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
           + G+E  ++ E +   +L     D     ++N      +   + K L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139

Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCE--NQKTANTRRVVGTYGYMAPEYAMEGLFSV 475
           RD+K  ++LL  D   K+SDFG    FC   +++    + +VGT  +MAPE      +  
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGP 195

Query: 476 KSDVFSFGVIVLEIISGK 493
           + D++S G++V+E++ G+
Sbjct: 196 EVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 88.1 bits (218), Expect = 5e-19
 Identities = 65/206 (31%), Positives = 112/206 (54%), Gaps = 16/206 (7%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKE----VAVKRLSR-KSWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++    VA+K L    S +  +E  +E  ++A + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNW--NTCYNIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP   L  ++ + +  +   +  N C  I    +KG+ 
Sbjct: 69  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----AKGMN 123

Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL E+ RL  +HRDL   NVL+      KI+DFG+A++   ++K  +         +MA 
Sbjct: 124 YL-EERRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 86.8 bits (215), Expect = 5e-19
 Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 19/204 (9%)

Query: 300 LGQGGFGTVYKGVLPNG-------KEVAVKRLS-----RKSWQGLEEFKNEIILIAK-LQ 346
           LG G FG VYK    N        KE+ V   +     R+  + + +  +E+ +I + L+
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 347 HRNLVRLVGCGIEGEEKLLIYELMPNRSL-DCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           H N+VR     +E +   ++ +L+    L + F    E++ +      +NI   +   L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH++ R  I+HRDL P+N++L +D    I+DFG+A+   + Q  +    VVGT  Y  P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVVGTILYSCP 182

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEI 489
           E      +  K+DV++FG I+ ++
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 87.0 bits (215), Expect = 7e-19
 Identities = 65/217 (29%), Positives = 111/217 (51%), Gaps = 31/217 (14%)

Query: 299 KLGQGGFGTVYKGVL------PNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRNLV 351
           +LG+  FG VYKG L         + VA+K L  K+   L EEFK+E ++ ++LQH N+V
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIF-----------DSERRLQ--LNWNTCYNIIG 398
            L+G   + +   +I+    +  L  F+            D ++ ++  L      +I+ 
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG 458
            I+ G+ +L   S   ++H+DL   NVL+   +  KISD G+ R        A+  +++G
Sbjct: 132 QIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR----EVYAADYYKLMG 184

Query: 459 T----YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
                  +M+PE  M G FS+ SD++S+GV++ E+ S
Sbjct: 185 NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 86.7 bits (215), Expect = 7e-19
 Identities = 55/202 (27%), Positives = 106/202 (52%), Gaps = 21/202 (10%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG-LEEFKNEIILIAKLQH---RNLVRLV 354
           +G+G +G VY+G  +P G+ VA+K ++  +    + + + E+ L+++L+     N+ +  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFD---SERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           G  ++G    +I E     S+   +     +E+ + +       II  +   L Y+H+  
Sbjct: 69  GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALKYIHKVG 121

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
              +IHRD+K +N+L+      K+ DFG+A +   NQ ++     VGT  +MAPE   EG
Sbjct: 122 ---VIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 472 -LFSVKSDVFSFGVIVLEIISG 492
             +  K+D++S G+ + E+ +G
Sbjct: 177 KYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 86.7 bits (215), Expect = 7e-19
 Identities = 68/211 (32%), Positives = 105/211 (49%), Gaps = 24/211 (11%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFK------NEIILIAKLQ 346
           ++   K+G+G +G VYKG     G+ VA+K++  +S    EE         EI L+ +LQ
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES----EEEGVPSTAIREISLLKELQ 57

Query: 347 HRNLVRLVGCGIEGEEKLLIYELMP---NRSLDCFIFDSERRLQLNWNTCYNIIGGISKG 403
           H N+V L    ++     LI+E +     + LD          +L  +  Y I+ GI   
Sbjct: 58  HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI--- 114

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
            L+ H     +++HRDLKP N+L+D   V K++DFG+AR F    +   T  VV T  Y 
Sbjct: 115 -LFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-VYTHEVV-TLWYR 168

Query: 464 APEYAMEG-LFSVKSDVFSFGVIVLEIISGK 493
           APE  +    +S   D++S G I  E+ + K
Sbjct: 169 APEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 86.6 bits (215), Expect = 9e-19
 Identities = 70/212 (33%), Positives = 111/212 (52%), Gaps = 26/212 (12%)

Query: 296 DSNKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEE--FKNEIILIAKLQH-RNLV 351
           D  ++G+G FGTV K +    G  +AVKR+ R +    E+     ++ ++ +      +V
Sbjct: 8   DLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQKRLLMDLDVVMRSSDCPYIV 66

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGIS----KGLL 405
           +  G      +  +  ELM + SLD F     + +     +     I+G I+    K L 
Sbjct: 67  KFYGALFREGDCWICMELM-DISLDKFY----KYVYEVLKSVIPEEILGKIAVATVKALN 121

Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL E+  LKIIHRD+KPSN+LLD++   K+ DFG++    ++   A TR   G   YMAP
Sbjct: 122 YLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS--IAKTRD-AGCRPYMAP 176

Query: 466 E----YAMEGLFSVKSDVFSFGVIVLEIISGK 493
           E     A +G + V+SDV+S G+ + E+ +GK
Sbjct: 177 ERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 86.7 bits (214), Expect = 1e-18
 Identities = 59/206 (28%), Positives = 110/206 (53%), Gaps = 20/206 (9%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           ++   K+GQG  GTV+  + +  G+EVA+K+++ +     E   NEI+++ +L++ N+V 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDS---ERRLQLNWNTCYNIIGGISKGLLYLHE 409
            +   + G+E  ++ E +   SL   + ++   E ++      C        + L +LH 
Sbjct: 81  FLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-------QALEFLHA 133

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPEY 467
           +   ++IHRD+K  NVLL  D   K++DFG    FC       ++R  +VGT  +MAPE 
Sbjct: 134 N---QVIHRDIKSDNVLLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTPYWMAPEV 186

Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGK 493
                +  K D++S G++ +E++ G+
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 56/205 (27%), Positives = 103/205 (50%), Gaps = 14/205 (6%)

Query: 292 DGFSDSNKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNL 350
           +      K+G+G  G V      + GK+VAVK++  +  Q  E   NE++++    H N+
Sbjct: 22  EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENV 81

Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           V +    + G+E  ++ E +   +L   +  +    +     C +++    + L YLH  
Sbjct: 82  VDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVL----RALSYLHNQ 137

Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE--NQKTANTRRVVGTYGYMAPEYA 468
               +IHRD+K  ++LL  D   K+SDFG    FC   +++    + +VGT  +MAPE  
Sbjct: 138 G---VIHRDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKSLVGTPYWMAPEVI 190

Query: 469 MEGLFSVKSDVFSFGVIVLEIISGK 493
               +  + D++S G++V+E+I G+
Sbjct: 191 SRLPYGTEVDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 23/204 (11%)

Query: 300 LGQGGFGTV------YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           LG+GGFG V        G +   K++  KRL +KS + +   + EI     L+  N   +
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEI-----LEKVNSPFI 55

Query: 354 VGCGIEGEEKL---LIYELMPNRSLDCFIFD-SERRLQLNWNTCYNIIGGISKGLLYLHE 409
           V      E K    L+  LM    L   I++  ER L++     Y+    I+ G+L+LH 
Sbjct: 56  VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYS--AQITCGILHLHS 113

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
              + I++RD+KP NVLLD     ++SD G+A    E +      +  GT GYMAPE   
Sbjct: 114 ---MDIVYRDMKPENVLLDDQGNCRLSDLGLA---VELKDGKTITQRAGTNGYMAPEILK 167

Query: 470 EGLFSVKSDVFSFGVIVLEIISGK 493
           E  +S   D F+ G  + E+++G+
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 86.3 bits (213), Expect = 1e-18
 Identities = 72/269 (26%), Positives = 127/269 (47%), Gaps = 33/269 (12%)

Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLV 351
           F+   ++G+G FG V+KG+    ++V A+K +   ++   +E+ + EI ++++     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +  G  ++G +  +I E +   S      D  R    +      ++  I KGL YLH + 
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSE- 120

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
             K IHRD+K +NVLL +    K++DFG+A    + Q   NT   VGT  +MAPE   + 
Sbjct: 121 --KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 176

Query: 472 LFSVKSDVFSFGVIVLEIISGK-RNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK 530
            +  K+D++S G+  +E+  G+  NS      H   +L  +          +   P L  
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPPNSDM----HPMRVLFLI---------PKNNPPTLTG 223

Query: 531 --SSSIPQVVRCIHIGLLCVQEDPAVRPT 557
             S    + +        C+ +DP+ RPT
Sbjct: 224 EFSKPFKEFIDA------CLNKDPSFRPT 246

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 86.3 bits (213), Expect = 1e-18
 Identities = 58/206 (28%), Positives = 109/206 (52%), Gaps = 20/206 (9%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           ++   K+GQG  GTVY  + +  G+EVA+K+++ +     E   NEI+++ + ++ N+V 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDS---ERRLQLNWNTCYNIIGGISKGLLYLHE 409
            +   + G+E  ++ E +   SL   + ++   E ++      C        + L +LH 
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------QALDFLHS 133

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPEY 467
           +   ++IHRD+K  N+LL  D   K++DFG    FC       ++R  +VGT  +MAPE 
Sbjct: 134 N---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTPYWMAPEV 186

Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGK 493
                +  K D++S G++ +E++ G+
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 69/224 (30%), Positives = 105/224 (46%), Gaps = 39/224 (17%)

Query: 299 KLGQGGFGTVY------------KGVLPNGKE-----VAVKRLSRK--SWQGLEEFKNEI 339
           KLG+G FG V+            K    N        VAVK L R   S    E+F  E+
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNAREDFLKEV 70

Query: 340 ILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFI--------FDSERRLQLNWN 391
            ++++L   N+ RL+G         +I E M N  L+ F+          +     L+++
Sbjct: 71  KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130

Query: 392 TCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA 451
           T   +   I+ G+ YL     L  +HRDL   N L+ K+   KI+DFGM+R    N  ++
Sbjct: 131 TLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSR----NLYSS 183

Query: 452 NTRRVVGT----YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
           +  RV G       +MA E  + G F+ KSDV++FGV + EI++
Sbjct: 184 DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 85.9 bits (212), Expect = 2e-18
 Identities = 58/206 (28%), Positives = 109/206 (52%), Gaps = 20/206 (9%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           ++   K+GQG  GTVY  + +  G+EVA+++++ +     E   NEI+++ + ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDS---ERRLQLNWNTCYNIIGGISKGLLYLHE 409
            +   + G+E  ++ E +   SL   + ++   E ++      C        + L +LH 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------QALEFLHS 134

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPEY 467
           +   ++IHRD+K  N+LL  D   K++DFG    FC       ++R  +VGT  +MAPE 
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTPYWMAPEV 187

Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGK 493
                +  K D++S G++ +E+I G+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 70/269 (26%), Positives = 118/269 (43%), Gaps = 32/269 (11%)

Query: 299 KLGQGGFGTV----------YKGVLPNGKE-----VAVKRL-SRKSWQGLEEFKNEIILI 342
           KLG+G FG V          + G      +     VAVK L +  +     +F  EI ++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 343 AKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNI------ 396
           ++L++ N++RL+G  +  +   +I E M N  L+ F+  S+R ++  +    NI      
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL--SQREIESTFTHANNIPSVSIA 129

Query: 397 -----IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA 451
                   I+ G+ YL   + L  +HRDL   N L+      KI+DFGM+R         
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186

Query: 452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYV 511
              R V    +MA E  + G F+  SDV++FGV + E+ +  +   + L    Q +    
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTG 246

Query: 512 WQLWKEGKEMEFVDPLLMKSSSIPQVVRC 540
                +G+++      L  S     ++RC
Sbjct: 247 EFFRNQGRQIYLSQTPLCPSPVFKLMMRC 275

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 79.4 bits (196), Expect = 4e-18
 Identities = 33/101 (32%), Positives = 51/101 (50%), Gaps = 2/101 (1%)

Query: 132 NNQWKSVSNPARFIEVLTYLMTNL-SIEASSDPAMFAVGEVKFPKRKTIYGLVQCTRDIN 190
           N      +  + F   L  L+++L S  ASS    FA G        T+YGL QC  D++
Sbjct: 7   NTSGNYTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAA-PDTVYGLAQCRGDLS 65

Query: 191 SRDCNDCLTGALGDLKACCGAREAGIIVNENCNLRFQLSLF 231
           + DC  CL  A+ +L+ CC  ++ G I  ++C LR++   F
Sbjct: 66  ASDCRSCLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 84.3 bits (208), Expect = 4e-18
 Identities = 58/193 (30%), Positives = 101/193 (52%), Gaps = 7/193 (3%)

Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLE-EFKNEIILIAKLQHRNLVRLVGCGI 358
           LG+G FG V+KG L +   VAVK       Q L+ +F +E  ++ +  H N+V+L+G   
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
           + +   ++ EL+P      F+   +  L+      + +    + G+ YL   +    IHR
Sbjct: 63  QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL--DAAAGMAYLESKN---CIHR 117

Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL   N L+ ++ V KISDFGM+R   +   +++  + +    + APE    G +S +SD
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSSESD 176

Query: 479 VFSFGVIVLEIIS 491
           V+S+G+++ E  S
Sbjct: 177 VWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 84.2 bits (208), Expect = 4e-18
 Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 26/207 (12%)

Query: 299 KLGQGGFGTVY--KGVLPNGKEVAVKR--LSRKSWQGLEEFKNEIILIAKLQHRNLVRLV 354
           K+G+G FG +Y  K    + +   +K   L++   +  E  K E+IL+AK++H N+V   
Sbjct: 7   KIGEGSFGKIYLAKAKSDS-EHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 355 GCGIEGEEKLLIY-------ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
               +   +L I        +LM   +    +  SE ++ L+W         IS GL ++
Sbjct: 66  A-SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI-LSWFV------QISLGLKHI 117

Query: 408 HEDSRLKIIHRDLKPSNVLLDKD-MVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           H+    KI+HRD+K  N+ L K+ MVAK+ DFG+AR    N         VGT  Y++PE
Sbjct: 118 HDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPYYLSPE 172

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGK 493
                 ++ K+D++S G ++ E+ + K
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 84.5 bits (209), Expect = 5e-18
 Identities = 65/206 (31%), Positives = 111/206 (53%), Gaps = 15/206 (7%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVK--RLSRKSWQGLEEFK-NEIILIAKLQHRN 349
           F    K+G+G +G VYK      G+ VA+K  RL  ++ +G+      EI L+ +L H N
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPN 60

Query: 350 LVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
           +V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL + H
Sbjct: 61  IVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCH 117

Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
                +++HRDLKP N+L++ +   K++DFG+AR F    +T  T  VV T  Y APE  
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEIL 172

Query: 469 M-EGLFSVKSDVFSFGVIVLEIISGK 493
           +    +S   D++S G I  E+++ +
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 84.1 bits (208), Expect = 5e-18
 Identities = 67/201 (33%), Positives = 99/201 (49%), Gaps = 14/201 (6%)

Query: 300 LGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVG 355
           LG+GGFG V    +   GK  A K+L++K     +G E    E  ++AK+  R +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59

Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIF--DSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
              + +  L L+  +M    L   I+  D E         C+     I  GL +LH+   
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF-YTAQIISGLEHLHQR-- 116

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
            +II+RDLKP NVLLD D   +ISD G+A    + Q  + T+   GT G+MAPE      
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYAGTPGFMAPELLQGEE 173

Query: 473 FSVKSDVFSFGVIVLEIISGK 493
           +    D F+ GV + E+I+ +
Sbjct: 174 YDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 83.9 bits (207), Expect = 7e-18
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 43/277 (15%)

Query: 300 LGQGGFGTVYKGV-LPNGKE----VAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRL 353
           LG G FGTVYKG+ +P+G+     VA+K L    S +  +E  +E  ++A +    + RL
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ----LNWNTCYNIIGGISKGLLYLHE 409
           +G  +    +L + +LMP   L  ++ +++ R+     LNW  C  I    +KG+ YL E
Sbjct: 75  LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW--CVQI----AKGMSYLEE 127

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
              ++++HRDL   NVL+      KI+DFG+AR+   ++   +         +MA E  +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 470 EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
              F+ +SDV+S+GV V E+++      F    +             +G     +  LL 
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMT------FGAKPY-------------DGIPAREIPDLLE 225

Query: 530 KSSSIPQVVRCI----HIGLLCVQEDPAVRPTMSNVV 562
           K   +PQ   C      I + C   D   RP    +V
Sbjct: 226 KGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 262

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 7e-18
 Identities = 67/207 (32%), Positives = 108/207 (52%), Gaps = 27/207 (13%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN--------EIILIAKLQHRN 349
           K+G+G +G VYK      G+ VA+K++       LE            EI L+ +L H N
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIR------LETEDEGVPSTAIREISLLKELNHPN 59

Query: 350 LVRLVGCGIEGEEKL-LIYELMPNRSLDCFIF-DSERRLQLNWNTCYNIIGGISKGLLYL 407
           +VRL+   +  E KL L++E +    LD   + DS     L+     + +  + +G+ Y 
Sbjct: 60  IVRLLDV-VHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYC 115

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H  S  +++HRDLKP N+L+D++   K++DFG+AR F    +T  T  VV T  Y APE 
Sbjct: 116 H--SH-RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEI 170

Query: 468 AMEG-LFSVKSDVFSFGVIVLEIISGK 493
            +    +S   D++S G I  E+++ +
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 83.9 bits (207), Expect = 8e-18
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 27/204 (13%)

Query: 299 KLGQGGFGTVYKGVLPNGKEV----AVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +LG G FG VYK      KE     A K +  KS + LE++  EI ++A   H N+V+L+
Sbjct: 12  ELGDGAFGKVYKA---QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 68

Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRL---QLNWNTCYNIIGGISKGLLYLHEDS 411
                     ++ E     ++D  + + ER L   Q+    C   +    + L YLHE+ 
Sbjct: 69  DAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRV-VCKQTL----EALNYLHEN- 122

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR-RVVGTYGYMAPEYAM- 469
             KIIHRDLK  N+L   D   K++DFG++    +N +T   R   +GT  +MAPE  M 
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVS---AKNTRTIQRRDSFIGTPYWMAPEVVMC 177

Query: 470 ----EGLFSVKSDVFSFGVIVLEI 489
               +  +  K+DV+S G+ ++E+
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 71/225 (31%), Positives = 109/225 (48%), Gaps = 48/225 (21%)

Query: 292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFK----NEIILIAKLQ 346
           D +   N++ +G +G VY+      G+ VA+K+L  K  +  E F      EI ++ KLQ
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKL--KMEKEKEGFPITSLREINILLKLQ 62

Query: 347 HRNLVRL----VGCG----------IEGEEKLLIYELMPNRSLDCFIFDSERR---LQLN 389
           H N+V +    VG            +E + K L+ E M    L      SE +   LQL 
Sbjct: 63  HPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLM-ETMKQPFL-----QSEVKCLMLQL- 115

Query: 390 WNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK 449
                  + G++    +LH++    I+HRDLK SN+LL+   + KI DFG+AR +    K
Sbjct: 116 -------LSGVA----HLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161

Query: 450 TANTRRVVGTYGYMAPEYAM-EGLFSVKSDVFSFGVIVLEIISGK 493
              T+ VV T  Y APE  +    +S   D++S G I  E+++ K
Sbjct: 162 PY-TQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 83.3 bits (206), Expect = 3e-17
 Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 37/225 (16%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN--------------EIILI 342
             LG+G +G V K      GK VA+K++                           E+ ++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 343 AKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
            +++H N++ LV   +EG+   L+ ++M +      + D + RL  +   C  I+  I  
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIMASDLKK--VVDRKIRLTESQVKC--ILLQILN 130

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF--------CENQKTANTR 454
           GL  LH+      +HRDL P+N+ ++   + KI+DFG+AR +            +T   R
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 455 R-----VVGTYGYMAPEYAM-EGLFSVKSDVFSFGVIVLEIISGK 493
                 VV T  Y APE  M    +    D++S G I  E+++GK
Sbjct: 188 EEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 77/259 (29%), Positives = 119/259 (45%), Gaps = 35/259 (13%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           FSD  ++G G FG VY    + N + VA+K++S    Q  E++++   E+  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
            ++  GC +      L+ E     + D        +  L       +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
            +   +IHRD+K  N+LL +  + K+ DFG A I       A     VGT  +MAPE  +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANXFVGTPYWMAPEVIL 184

Query: 470 ---EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ---------LWKE 517
              EG +  K DV+S G+  +E+   +R    +   +A + L ++ Q          W E
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL--AERKPPLF-NMNAMSALYHIAQNESPALQSGHWSE 241

Query: 518 GKEMEFVDPLLMKSSSIPQ 536
                FVD  L K   IPQ
Sbjct: 242 YFR-NFVDSCLQK---IPQ 256

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 82.4 bits (204), Expect = 4e-17
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 31/207 (14%)

Query: 276 SEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRL---SRKSWQG 331
             E PF            +    K+GQG FG V+K       + VA+K++   + K    
Sbjct: 2   QYEFPFCD------EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK---- 51

Query: 332 LEEFK----NEIILIAKLQHRNLVRLVG-CGIEGEE----KLLIYELMPNRSLDCFIFDS 382
            E F      EI ++  L+H N+V L+  C  +       K   Y +      D     S
Sbjct: 52  -EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLS 110

Query: 383 ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR 442
            + ++   +    ++  +  GL Y+H   R KI+HRD+K +N+L+ KD + K++DFG+AR
Sbjct: 111 NKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167

Query: 443 IFCENQKTANTR---RVVGTYGYMAPE 466
            F  ++ +   R   RVV T  Y  PE
Sbjct: 168 AFSLSKNSKPNRYTNRVV-TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 23/201 (11%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
            ++G G +G VYK   +  G+ VA+K +  +     E  + EI ++ + +H N+V   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERR----LQLNWNTCYNIIGGISKGLLYLHEDSR 412
            +  ++  ++ E     SL   I+   R     LQ+ +     +     KGL YLHE   
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQ-DIYQVTRGPLSELQIAYVCRETL-----KGLAYLHE--- 119

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGM-ARIFCENQKTANTRR-VVGTYGYMAPEYA-- 468
              IHRD+K +N+LL +D   K++DFG+ A++      T   R+  +GT  +MAPE A  
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLT----ATIAKRKSFIGTPYWMAPEVAAV 175

Query: 469 -MEGLFSVKSDVFSFGVIVLE 488
             +G +  K D+++ G+  +E
Sbjct: 176 ERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 81.2 bits (200), Expect = 4e-17
 Identities = 73/209 (34%), Positives = 104/209 (49%), Gaps = 33/209 (15%)

Query: 299 KLGQGGFGTVYKGVL---PNGKEVAVKRLSRKSWQGLEEFKNEIILIAK----LQHRNLV 351
           +LG G FGTV KG+     + K VAVK L  K+       K+E++  A     L +  +V
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKIL--KNDNNDPALKDELLREANVMQQLDNPYIV 59

Query: 352 RLVG-CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWN-TCYNI---IGGISKGLLY 406
           R++G C  E E  +L+ EL     L+ F       LQ N + T  NI   +  +S G+ Y
Sbjct: 60  RMIGIC--EAESWMLVMELAELGPLNKF-------LQKNKHVTEKNITELVHQVSMGMKY 110

Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           L E +    +HRDL   NVLL     AKISDFG+++    ++   N  +      +    
Sbjct: 111 LEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---NYYKAKTHGKWPVKW 164

Query: 467 YAMEGL----FSVKSDVFSFGVIVLEIIS 491
           YA E +    FS KSDV+SFGV++ E  S
Sbjct: 165 YAPECMNYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 81.1 bits (200), Expect = 5e-17
 Identities = 60/199 (30%), Positives = 103/199 (51%), Gaps = 13/199 (6%)

Query: 299 KLGQGGFGTVYKGVLPNGK---EVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRNLVRLV 354
           +LG G FG V KGV    K   +VA+K L  ++ + + +E   E  ++ +L +  +VR++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           G   E E  +L+ E+     L+ F+  S ++ ++  +    ++  +S G+ YL   +   
Sbjct: 62  GV-CEAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115

Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY--GYMAPEYAMEGL 472
            +HRDL   NVLL     AKISDFG+++    +  +    R  G +   + APE      
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADD-SYYKARSAGKWPLKWYAPECINFRK 174

Query: 473 FSVKSDVFSFGVIVLEIIS 491
           FS +SDV+S+G+ + E  S
Sbjct: 175 FSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 81.3 bits (201), Expect = 5e-17
 Identities = 62/201 (30%), Positives = 106/201 (52%), Gaps = 14/201 (6%)

Query: 299 KLGQGGFGTVYKGVLPNGKE-VAVKRLSRKSW-QGLEEFK-NEIILIAKLQHRNLVRLVG 355
           K+G+G +GTV+K       E VA+KR+      +G+      EI L+ +L+H+N+VRL  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
             +  ++KL L++E   ++ L  + FDS     ++     + +  + KGL + H      
Sbjct: 67  V-LHSDKKLTLVFEYC-DQDLKKY-FDSCNG-DIDPEIVKSFMFQLLKGLAFCHSH---N 119

Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG-LF 473
           ++HRDLKP N+L++K+   K++DFG+AR F    +  +   V  T  Y  P+      L+
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLY 177

Query: 474 SVKSDVFSFGVIVLEIISGKR 494
           S   D++S G I  E+ +  R
Sbjct: 178 STSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 81.4 bits (201), Expect = 6e-17
 Identities = 83/294 (28%), Positives = 121/294 (41%), Gaps = 60/294 (20%)

Query: 300 LGQGGFGTVYKGVLPN-GKE-----VAVKRLSRKSWQGLEE-FKNEIILIAKL-QHRNLV 351
           LG G FG V +       K      VAVK L   +     E   +E+ +++ L  H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFD------SERRLQLNWNTCYNIIGGISKGLL 405
            L+G    G   L+I E        C   D       +R   L      +    ++KG+ 
Sbjct: 103 NLLGACTIGGPILVITEY-------CCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMA 155

Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCENQKTA--NTRRVVGTYGY 462
           +L   +    IHRDL   NVLL    + KI DFG+AR I  ++      N R  V    +
Sbjct: 156 FLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV---KW 209

Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKR-------NSGFYLTGHAQTLLAYVWQL 514
           MAPE     +++ +SDV+S+G+++ EI S G         +S FY             +L
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY-------------KL 256

Query: 515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE 568
            KEG  M        +    P  +  I     C   DP  RPT   +V L+G +
Sbjct: 257 IKEGYRMA-------QPEHAPAEIYDIMKT--CWDADPLKRPTFKQIVQLIGKQ 301

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 80.9 bits (199), Expect = 7e-17
 Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 11/202 (5%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLV 351
           F+   K+G+G FG V+KG+     K VA+K +   ++   +E+ + EI ++++     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +  G  ++  +  +I E +   S      D      L+      I+  I KGL YLH + 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
           +   IHRD+K +NVLL +    K++DFG+A    + Q   N    VGT  +MAPE   + 
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFVGTPFWMAPEVIKQS 176

Query: 472 LFSVKSDVFSFGVIVLEIISGK 493
            +  K+D++S G+  +E+  G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 80.4 bits (199), Expect = 7e-17
 Identities = 57/199 (28%), Positives = 90/199 (45%), Gaps = 15/199 (7%)

Query: 300 LGQGGFGTVYK-GVLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVG 355
           LG GGFG V    V    +  A+K + ++        E   +E  ++ +  H  +V+L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKGLLYLHEDSRLK 414
                ++K  IY LM    L   ++   R     +  T    I  +     YLH      
Sbjct: 61  ---TFKDKKYIYMLM-EYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLH---NRG 113

Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
           II+RDLKP N+LLD +   K+ DFG A+     QKT       GT  Y+APE  +   + 
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKGYD 170

Query: 475 VKSDVFSFGVIVLEIISGK 493
              D +S G+++ E+++G+
Sbjct: 171 FSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 80.8 bits (200), Expect = 9e-17
 Identities = 60/204 (29%), Positives = 104/204 (50%), Gaps = 24/204 (11%)

Query: 298 NKLGQGGFGTVYKG-VLPNGKEVAVKRLSRKSWQGLEEFKN--EIILIAKLQ-HRNLVRL 353
            K+G+G F  V K      GK  A+K + +K ++ LE+  N  EI  + +L  H N++RL
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63

Query: 354 VGCGIEGEEK--LLIYELMPNRSLDCFIFD--SERRLQLNWNTCYNIIGGISKGLLYLHE 409
           +    + +     L++ELM     D  +++    R+  L      + +  + K L ++H 
Sbjct: 64  IEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH- 117

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCENQKTANTRRVVGTYGYMAPEYA 468
             R  I HRD+KP N+L+  D++ K++DFG  R I+ +   T      + T  Y APE  
Sbjct: 118 --RNGIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTE----YISTRWYRAPECL 170

Query: 469 M-EGLFSVKSDVFSFGVIVLEIIS 491
           + +G +  K D+++ G +  EI+S
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 79/285 (27%), Positives = 127/285 (44%), Gaps = 54/285 (18%)

Query: 300 LGQGGFGTVYKGVL--PNGKE--VAVKRL----SRKSWQGLEEFKNEIILIAKLQHRNLV 351
           LG G FG + +G L  P+ +E  VA+  L    S K  +G   F  E + + +  H N+V
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG---FLAEALTLGQFDHSNIV 69

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           RL G    G   +++ E M N +LD F+   E   QL       ++ G++ G+ YL E  
Sbjct: 70  RLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSE-- 125

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFG------MARIFCENQKTANTRRVVGTYGYMAP 465
            +  +H+ L    VL++ D+V KIS F          I+     T + +  V    + AP
Sbjct: 126 -MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY----TTMSGKSPVL---WAAP 177

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV 524
           E      FS  SDV+SFG+++ E++S G+R   ++       + A          E  F 
Sbjct: 178 EAIQYHHFSSASDVWSFGIVMWEVMSYGERP--YWDMSGQDVIKAV---------EDGF- 225

Query: 525 DPLLMKSSSIPQVVRC---IHIGLL-CVQEDPAVRPTMSNVVALL 565
                    +P    C   +H  +L C Q++   RP  S + ++L
Sbjct: 226 --------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 81.6 bits (202), Expect = 1e-16
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 25/205 (12%)

Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLSRKSWQGLEEFKN---EIILIAKLQHRNLVRLVG 355
           +G G +G V           VA+K+LSR  +Q     K    E+ L+  + H N++ L+ 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSR-PFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81

Query: 356 C-----GIEG-EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
                  +E  ++  L+  LM    L+  +    +  +L+ +    ++  I +GL Y+H 
Sbjct: 82  VFTPASSLEDFQDVYLVTHLM-GADLNNIV----KCQKLSDDHIQFLVYQILRGLKYIHS 136

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
                IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      V T  Y APE  +
Sbjct: 137 AG---IIHRDLKPSNIAVNEDCELKILDFGLARH-TDDEMTG----YVATRWYRAPEIML 188

Query: 470 EGLFSVKS-DVFSFGVIVLEIISGK 493
             +   ++ D++S G I+ E+++GK
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 83.7 bits (207), Expect = 1e-16
 Identities = 70/286 (24%), Positives = 129/286 (45%), Gaps = 21/286 (7%)

Query: 287 IKAATDGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL 345
           I        + N + +G  G  YKG  + NG +  VK +       +    +EI  + KL
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEI--NDVNSIPS--SEIADMGKL 740

Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           QH N+V+L+G     +   LI+E +  ++L      SE    L+W     I  GI+K L 
Sbjct: 741 QHPNIVKLIGLCRSEKGAYLIHEYIEGKNL------SEVLRNLSWERRRKIAIGIAKALR 794

Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           +LH      ++  +L P  +++D      +    +  + C + K         +  Y+AP
Sbjct: 795 FLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKC------FISSAYVAP 847

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E       + KSD++ FG+I++E+++GK  +      H  +++ +    + +     ++D
Sbjct: 848 ETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH-GSIVEWARYCYSDCHLDMWID 906

Query: 526 PLLMKSSSIPQ--VVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES 569
           P +    S+ Q  +V  +++ L C   DP  RP  ++V+  L S S
Sbjct: 907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952

Length = 968

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 20/170 (11%)

Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN 452
              I   + +GL YL+   R  I+HRD+KPSN+L++     K+ DFG++     +   A+
Sbjct: 105 LGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IAD 160

Query: 453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK-----RNSGFYLTGHAQTL 507
           T   VGT  YM+PE    G ++VKSDV+S G+ ++E+  GK      N           +
Sbjct: 161 T--FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI 218

Query: 508 LAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT 557
           L  + Q+ +E        P  + SS  P+ +R       C+ +DP  RPT
Sbjct: 219 LDLLQQIVQE-------PPPRLPSSDFPEDLR--DFVDACLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 80.5 bits (198), Expect = 2e-16
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 19/207 (9%)

Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           F+D  ++G G FG VY        EV A+K++S    Q  E++++   E+  + +++H N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
            +   GC +      L+ E     + D        +  L       I  G  +GL YLH 
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
            +   +IHRD+K  N+LL +    K++DFG A I       AN+   VGT  +MAPE  +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI----ASPANS--FVGTPYWMAPEVIL 194

Query: 470 ---EGLFSVKSDVFSFGVIVLEIISGK 493
              EG +  K DV+S G+  +E+   K
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERK 221

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 57/198 (28%), Positives = 95/198 (47%), Gaps = 12/198 (6%)

Query: 299 KLGQGGFGTVYKGV--LPNGKE--VAVKRLSRKSWQGL-EEFKNEIILIAKLQHRNLVRL 353
            +G+G FG VY+GV   P  ++  VAVK     +   + E+F  E  ++ +  H ++V+L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
           +G  I      ++ EL P   L  ++  ++  L L     Y     +S  L YL      
Sbjct: 73  IGV-ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILY--SYQLSTALAYLES---K 126

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF 473
           + +HRD+   NVL+      K+ DFG++R + E++      +      +MAPE      F
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESINFRRF 185

Query: 474 SVKSDVFSFGVIVLEIIS 491
           +  SDV+ FGV + EI+ 
Sbjct: 186 TSASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 24/208 (11%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLS----RKSWQG--LEEFKNEIILIAKLQHRNLVR 352
           LG G F + Y+   +  G  +AVK+++      S Q   +E  + EI L+A+L H +++R
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFD----SERRLQLNWNTCYNIIGGISKGLLYLH 408
           ++G   E     L  E M   S+   +       E           N    + +GL YLH
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE-------AVIINYTEQLLRGLSYLH 120

Query: 409 EDSRLKIIHRDLKPSNVLLDKD-MVAKISDFGMA-RIFCENQKTANTR-RVVGTYGYMAP 465
           E+   +IIHRD+K +N+L+D      +I+DFG A R+  +       + +++GT  +MAP
Sbjct: 121 EN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           E      +    DV+S G +++E+ + K
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 64/221 (28%), Positives = 104/221 (47%), Gaps = 33/221 (14%)

Query: 299 KLGQGGFGTVY----KGVLPNGKE-------------VAVKRL-SRKSWQGLEEFKNEII 340
           KLG+G FG V+    +G+     +             VAVK L    +     +F  EI 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ----------LNW 390
           ++++L+  N++RL+   I  +   +I E M N  L+ F+  S    Q          +++
Sbjct: 72  IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFL--SRHEPQEAAEKADVVTISY 129

Query: 391 NTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT 450
           +T   +   I+ G+ YL   S L  +HRDL   N L+ K+   KI+DFGM+R        
Sbjct: 130 STLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186

Query: 451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
               R V    +M+ E  + G F+  SDV++FGV + EI++
Sbjct: 187 RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 80.0 bits (197), Expect = 3e-16
 Identities = 88/307 (28%), Positives = 146/307 (47%), Gaps = 59/307 (19%)

Query: 300 LGQGGFGTVYK----GVLPNGKE----VAVKRLS-RKSWQGLEEFKNEIILIAKL-QHRN 349
           LG+G FG V +    G+  +  +    VAVK L    + + L +  +E+ L+  + +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFI-----------FDSER--RLQLNWNTCYNI 396
           ++ L+G   +     +I E     +L  F+           FD  +    QL++    + 
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE---NQKTANT 453
              +++G+ YL  +SR + IHRDL   NVL+ +D V KI+DFG+AR   +    +KT+N 
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAY--V 511
           R  V    +MAPE   + +++ +SDV+SFG+++ EI        F L G     +    +
Sbjct: 197 RLPV---KWMAPEALFDRVYTHQSDVWSFGILMWEI--------FTLGGSPYPGIPVEEL 245

Query: 512 WQLWKEGKEMEFVDPLLMKSSSIPQVVRCIH--IGLL--CVQEDPAVRPTMSNVVALLGS 567
           ++L +EG  M+       K S+      C H    L+  C    P  RPT   +V  L  
Sbjct: 246 FKLLREGHRMD-------KPSN------CTHELYMLMRECWHAVPTQRPTFKQLVEALDK 292

Query: 568 ESIALSE 574
              A+SE
Sbjct: 293 VLAAVSE 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 25/214 (11%)

Query: 299 KLGQGGFGTVYKG--VLP---NGKEVAVKRLSR-KSWQGLEEFKNEIILIAKLQHRNLVR 352
           +LG+  FG +YKG   LP   + + VA+K L    + Q   EF+ E  L+A+L H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIF--------------DSERRLQLNWNTCYNIIG 398
           L+G   + +   +++E +    L  F+               D   +  L+     +I  
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCENQKTANTRRVV 457
            I+ G+ YL   S    +H+DL   N+L+ + +  KISD G++R I+  +      + ++
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188

Query: 458 GTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
               +M PE  M G FS  SD++SFGV++ EI S
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 79.9 bits (197), Expect = 3e-16
 Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 36/217 (16%)

Query: 291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---------EII 340
           T+ + D   +G G FG V        G+ VA+K++       ++ F           E+ 
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAKRTYRELK 61

Query: 341 LIAKLQHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRL--QLNWNTCYNII 397
           L+  L+H N++ L    I   E +  + EL+     D     + R L  Q      Y I+
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELL---GTDLHRLLTSRPLEKQFIQYFLYQIL 118

Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVV 457
               +GL Y+H      ++HRDLKPSN+L++++   KI DFG+ARI  + Q T      V
Sbjct: 119 ----RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-QDPQMTG----YV 166

Query: 458 GTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
            T  Y APE  +    + V+ D++S G I  E++ GK
Sbjct: 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 70/223 (31%), Positives = 109/223 (48%), Gaps = 56/223 (25%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNL------VR 352
           LG+G +G V K   +P G  +AVKR+ R +    E            Q R L      +R
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRI-RATVNSQE------------QKRLLMDLDISMR 55

Query: 353 LVGC--------GIEGEEKLLIY-ELMPNRSLDCF---IFDSERRLQLNWNTCYNIIGGI 400
            V C         +  E  + I  E+M + SLD F   ++D    +        +I+G I
Sbjct: 56  SVDCPYTVTFYGALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIP------EDILGKI 108

Query: 401 S----KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN-QKTANTRR 455
           +    K L YLH   +L +IHRD+KPSNVL++++   K+ DFG++    ++  KT +   
Sbjct: 109 AVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID--- 163

Query: 456 VVGTYGYMAPE-----YAMEGLFSVKSDVFSFGVIVLEIISGK 493
             G   YMAPE        +G + VKSDV+S G+ ++E+ +G+
Sbjct: 164 -AGCKPYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 78.9 bits (194), Expect = 6e-16
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 19/207 (9%)

Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKE-VAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           F   +++G G FG VY     +  E VAVK++S    Q  E++++   E+  + +L+H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
            +   GC ++     L+ E     + D        +  L       I  G  +GL YLH 
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
            +   +IHRD+K  N+LL +    K++DFG A         AN+   VGT  +MAPE  +
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANS--FVGTPYWMAPEVIL 190

Query: 470 ---EGLFSVKSDVFSFGVIVLEIISGK 493
              EG +  K DV+S G+  +E+   K
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIELAERK 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 77.7 bits (191), Expect = 8e-16
 Identities = 66/202 (32%), Positives = 107/202 (52%), Gaps = 16/202 (7%)

Query: 300 LGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRL 353
           LG+G FG V    Y     N G++VAVK L  +S    + + K EI ++  L H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 354 VG-CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            G C  +G   + LI E +P+ SL  ++  ++ ++ L     Y +   I KG+ YL   S
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYL--GS 127

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK--TANTRRVVGTYGYMAPEYAM 469
           R + +HRDL   NVL++ +   KI DFG+ +    +++  T         + Y APE  +
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLI 185

Query: 470 EGLFSVKSDVFSFGVIVLEIIS 491
           +  F + SDV+SFGV + E+++
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 88/298 (29%), Positives = 121/298 (40%), Gaps = 59/298 (19%)

Query: 300 LGQGGFGTVYK-GVLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVG 355
           LG+GGFG V    V   GK  A K+L +K     +G     NE  ++ K+  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66

Query: 356 CGIEGEEKL-LIYELMPNRSLDCFI-------FDSERRLQLNWNTCYNIIGGISKGLLYL 407
              E ++ L L+  LM    L   I       FD ER +                GL  L
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC--------GLEDL 118

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H   R +I++RDLKP N+LLD     +ISD G+A    E +     R  VGT GYMAPE 
Sbjct: 119 H---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEV 172

Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL 527
                ++   D +  G ++ E+I GK  S F              +  KE  + E V+  
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGK--SPF--------------RQRKEKVKREEVERR 216

Query: 528 LMK-----SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPF 580
           + +     S    +  R I   LL   +DP  R         LG       E +  PF
Sbjct: 217 VKEDQEEYSEKFSEAARSICRQLLT--KDPGFR---------LGCRGEGAEEVKAHPF 263

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 17/200 (8%)

Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFK-NEII-------LIAKLQHRNL 350
           +LG+G FGTVY  ++ + K VA +RL       + E   NE +       L++KL H  +
Sbjct: 7   RLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64

Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ-LNWNTCYNIIGGISKGLLYLHE 409
           V+     +E +   +I E    R LDC + + +   + L+ N        +  G+ Y+H+
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               +I+HRDLK  N+ L  +++ KI DFG++R+   +   A T    GT  YM+PE   
Sbjct: 125 R---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEALK 178

Query: 470 EGLFSVKSDVFSFGVIVLEI 489
              +  KSD++S G I+ E+
Sbjct: 179 HQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 77.1 bits (190), Expect = 3e-15
 Identities = 69/215 (32%), Positives = 100/215 (46%), Gaps = 45/215 (20%)

Query: 300 LGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGLEEFKN---------EIILIAKLQH 347
           +G G  G V   Y  V   G+ VA+K+LSR        F+N         E++L+  + H
Sbjct: 24  IGSGAQGIVCAAYDTVT--GQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNH 74

Query: 348 RNLVRLVGCGI------EGEEKLLIYELMPNRSLDCFI---FDSERRLQLNWNTCYNIIG 398
           +N++ L+          E ++  L+ ELM + +L   I    D ER   L     Y ++ 
Sbjct: 75  KNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMDLDHERMSYL----LYQMLC 129

Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG 458
           GI     +LH      IIHRDLKPSN+++  D   KI DFG+AR          T  VV 
Sbjct: 130 GIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVT 180

Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
            Y Y APE  +   +    D++S G I+ E+I G 
Sbjct: 181 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 33/210 (15%)

Query: 300 LGQGGFGTVYKG-VLPNGKEVAVKRLSRKSWQGLEEFKNEIIL----IAKLQHR--NLVR 352
           +G G  G VYK      G  +AVK++ R   +  EE K   IL    +    H    +V+
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKR--ILMDLDVVLKSHDCPYIVK 78

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTC-YNIIGGIS----KGLLYL 407
             G  I   +  +  ELM      C     ++ L+        +I+G ++    K L YL
Sbjct: 79  CYGYFITDSDVFICMELMST----CL----DKLLKRIQGPIPEDILGKMTVAIVKALHYL 130

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
            E     +IHRD+KPSN+LLD     K+ DFG++    +++  A TR   G   YMAPE 
Sbjct: 131 KEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK--AKTRS-AGCAAYMAPER 185

Query: 468 ----AMEGLFSVKSDVFSFGVIVLEIISGK 493
                    + +++DV+S G+ ++E+ +G+
Sbjct: 186 IDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 75.7 bits (186), Expect = 4e-15
 Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 26/217 (11%)

Query: 294 FSDSNKLGQGGFGTVYKGVLP----NGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQH 347
           F+    LG+G FG+V +  L     + ++VAVK L     S   +EEF  E   + +  H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 348 RNLVRLVGCGIEGEEK------LLIYELMPNRSLDCFIFDS---ERRLQLNWNTCYNIIG 398
            N+++L+G  +    K      ++I   M +  L  F+  S   E    L   T    + 
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120

Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCEN---QKTANTR 454
            I+ G+ YL   S    IHRDL   N +L+++M   ++DFG+++ I+  +   Q  A+  
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 455 RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
            V     ++A E   + +++  SDV++FGV + EI++
Sbjct: 178 PV----KWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 75.5 bits (185), Expect = 4e-15
 Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 24/221 (10%)

Query: 300 LGQGGFGTVYKGVLPNGK---EVAVK--RLSRKSWQGLEEFKNEIILIAKLQHRNLVRLV 354
           LG+G FG+V +G L       +VAVK  +++  +   +E+F +E + + +  H N++RL+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 355 GCGIEGEEK------LLIYELMPNRSLDCFIFDS---ERRLQLNWNTCYNIIGGISKGLL 405
           G  ++  E       ++I   M +  L  F+  S   +    L        +  I+ G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL   S    IHRDL   N +L+++M   ++DFG+++           R       ++A 
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS-------GKRNSGFY 499
           E   + +++ KSDV+SFGV + EI +       G  NS  Y
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 67/211 (31%), Positives = 96/211 (45%), Gaps = 25/211 (11%)

Query: 294 FSDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRN 349
           F     LG+GGFG V    V   GK  A K+L +K     +G     NE  ++ K+  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFI-------FDSERRLQLNWNTCYNIIGGISK 402
           +V L       +   L+  LM    L   I       F+  R +      C         
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICC-------- 113

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           GL  LH++   +I++RDLKP N+LLD     +ISD G+A    E Q T   R  VGT GY
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGR--VGTVGY 167

Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           MAPE      ++   D ++ G ++ E+I+G+
Sbjct: 168 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 75.1 bits (184), Expect = 5e-15
 Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 17/204 (8%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRL-----SRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           LGQG FG VY    +  G+E+A K++     S ++ + +   + EI L+  LQH  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 354 VGCGIE-GEEKLLIY-ELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKGLLYLHED 410
            GC  +  E+ L I+ E MP  S+     D  +    L  +        I +G+ YLH +
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125

Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMA-RIFCENQKTANTRRVVGTYGYMAPEYAM 469
               I+HRD+K +N+L D     K+ DFG + R+          R V GT  +M+PE   
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 470 EGLFSVKSDVFSFGVIVLEIISGK 493
              +  K+DV+S G  V+E+++ K
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 75.3 bits (185), Expect = 6e-15
 Identities = 60/200 (30%), Positives = 93/200 (46%), Gaps = 24/200 (12%)

Query: 300 LGQGGFGTVYKG-VLPNGKEVAVKRLSRKSWQGLE-EFKNEIILIAKLQHRNLVRLVGCG 357
           LG G  GTVYK   L   + +AVK +       L+ +  +E+ ++ K     ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS----KGLLYLHEDSRL 413
                  +  E M   SLD +                +++G I+    KGL YL     L
Sbjct: 69  FVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS---L 114

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF 473
           KI+HRD+KPSN+L++     K+ DFG++     +   A T   VGT  YMAPE      +
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKT--YVGTNAYMAPERISGEQY 170

Query: 474 SVKSDVFSFGVIVLEIISGK 493
            + SDV+S G+  +E+  G+
Sbjct: 171 GIHSDVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 75.0 bits (185), Expect = 7e-15
 Identities = 56/203 (27%), Positives = 90/203 (44%), Gaps = 21/203 (10%)

Query: 299 KLGQGGFGTVYKG-VLPNGKEVAVKRLSRKSWQGLEEFKN----EIILIAKLQHRNLVRL 353
            +G+G +G V K      G+ VA+K+   K  +  E+ K     E+ ++ +L+H N+V L
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLRHENIVNL 65

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
                      L++E +    L+           L  +   + I  + + + Y H     
Sbjct: 66  KEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCH---SH 119

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE----YAM 469
            IIHRD+KP N+L+ +  V K+ DFG AR       +  T  V  T  Y APE       
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTN 178

Query: 470 EGLFSVKSDVFSFGVIVLEIISG 492
            G   V  DV++ G I+ E++ G
Sbjct: 179 YG-KPV--DVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 75.5 bits (186), Expect = 7e-15
 Identities = 40/103 (38%), Positives = 65/103 (63%), Gaps = 10/103 (9%)

Query: 395 NIIGGIS----KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT 450
           NI+G IS    +GL YL E  + KI+HRD+KPSN+L++     K+ DFG++    ++   
Sbjct: 99  NILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 154

Query: 451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           AN+   VGT  YM+PE      ++V+SD++S G+ ++E+  G+
Sbjct: 155 ANS--FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 75.2 bits (185), Expect = 7e-15
 Identities = 69/212 (32%), Positives = 109/212 (51%), Gaps = 22/212 (10%)

Query: 292 DGFSDSNKLGQGGFGTVYKGVLPNGKE-VAVK--RLSRKSWQGLEEFKNEIILIAKLQHR 348
           D +    K+G+G +G VYK       E +A+K  RL ++          EI L+ ++QH 
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 349 NLVRLVGCGIEGEEKL-LIYELMP---NRSLD-CFIFDSERRLQLNWNTCYNIIGGISKG 403
           N+VRL    +  E++L L++E +     + +D    F    RL   +   Y I+ GI+  
Sbjct: 62  NIVRLQDV-VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTY--LYQILRGIA-- 116

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGY 462
             Y H     +++HRDLKP N+L+D+   A K++DFG+AR F    +T  T  VV T  Y
Sbjct: 117 --YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF-THEVV-TLWY 169

Query: 463 MAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
            APE  +    +S   D++S G I  E+++ K
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 74.9 bits (184), Expect = 8e-15
 Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 30/212 (14%)

Query: 298 NKLGQGGFGTVYKGVL--PNGKEVAVK--RLSRKSWQGLEEFK-NEIILIAKLQHR---- 348
           ++LG+G +G+VYK VL  P G  +A+K  RL       L+E K N+II+   + H+    
Sbjct: 7   DELGKGNYGSVYK-VLHRPTGVTMAMKEIRLE------LDESKFNQIIMELDILHKAVSP 59

Query: 349 NLVRLVGC-GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
            +V   G   IEG   + + E M   SLD           +  +    I   + KGL +L
Sbjct: 60  YIVDFYGAFFIEGAVYMCM-EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
            E+    IIHRD+KP+NVL++ +   K+ DFG++     +    N    +G   YMAPE 
Sbjct: 119 KEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN----IGCQSYMAPER 172

Query: 468 ------AMEGLFSVKSDVFSFGVIVLEIISGK 493
                      ++V+SDV+S G+ +LE+  G+
Sbjct: 173 IKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 74.3 bits (182), Expect = 9e-15
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 11/197 (5%)

Query: 299 KLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLE-EFKNEIILIAKLQHRNLVRLVGC 356
           ++G+G FG V+ G L  +   VAVK         L+ +F  E  ++ +  H N+VRL+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
             + +   ++ EL+       F+     RL++       ++   + G+ YL        I
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVK--ELIQMVENAAAGMEYLESKH---CI 116

Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCEN--QKTANTRRVVGTYGYMAPEYAMEGLFS 474
           HRDL   N L+ +  V KISDFGM+R   +     T   +++     + APE    G +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174

Query: 475 VKSDVFSFGVIVLEIIS 491
            +SDV+SFG+++ E  S
Sbjct: 175 SESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 64/211 (30%), Positives = 93/211 (44%), Gaps = 25/211 (11%)

Query: 294 FSDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRN 349
           F     LG+GGFG V    V   GK  A KRL +K     +G     NE  ++ K+  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFI-------FDSERRLQLNWNTCYNIIGGISK 402
           +V L       +   L+  +M    L   I       F+ ER L                
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILC-------- 113

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           GL  LH ++    ++RDLKP N+LLD     +ISD G+A    E +   + R  VGT GY
Sbjct: 114 GLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGY 167

Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           MAPE      +++  D +  G ++ E+I G+
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 21/206 (10%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRL-----SRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           LGQG FG VY       G+E+AVK++     S ++ + +   + EI L+  L H  +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 354 VGCGIEGEEKLL--IYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKGLLYLHED 410
            GC  +  E+ L    E MP  S    I D  +    L  N        I +G+ YLH +
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125

Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR---IFCENQKTANTRRVVGTYGYMAPEY 467
               I+HRD+K +N+L D     K+ DFG ++     C +      + V GT  +M+PE 
Sbjct: 126 ---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS--GTGMKSVTGTPYWMSPEV 180

Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGK 493
                +  K+D++S G  V+E+++ K
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 75.3 bits (185), Expect = 1e-14
 Identities = 60/201 (29%), Positives = 100/201 (49%), Gaps = 18/201 (8%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHRNLVRLVG- 355
           +G G +G+V   +    G++VA+K+LSR  +S    +    E+ L+  +QH N++ L+  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 356 --CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
               + G+E    Y +MP    D           L+ +    ++  +  GL Y+H     
Sbjct: 83  FTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG-- 137

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF 473
            IIHRDLKP N+ +++D   KI DFG+AR        A     V T  Y APE  +  + 
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILNWMH 191

Query: 474 SVKS-DVFSFGVIVLEIISGK 493
             ++ D++S G I+ E+++GK
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 17/204 (8%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRL-----SRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           LG+G FG VY       G+E+AVK++     S+++ + +   + EI L+  L+H  +V+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 354 VGCGIEGEEKLL--IYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKGLLYLHED 410
            GC  + EEK L    E MP  S    I D  +    L  N        I +G+ YLH +
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125

Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMA-RIFCENQKTANTRRVVGTYGYMAPEYAM 469
               I+HRD+K +N+L D     K+ DFG + RI          + V GT  +M+PE   
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVIS 182

Query: 470 EGLFSVKSDVFSFGVIVLEIISGK 493
              +  K+DV+S    V+E+++ K
Sbjct: 183 GEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 75.6 bits (186), Expect = 1e-14
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 43/216 (19%)

Query: 300 LGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRNLVRLVG 355
           +G G FG V+    P +GK VA+K++    +Q L   K    E+ ++   +H N++  + 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMP-NVFQNLVSCKRVFRELKMLCFFKHDNVLSAL- 65

Query: 356 CGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYNIIGG-------------- 399
                       +++    +D F  I+     +Q +    + II                
Sbjct: 66  ------------DILQPPHIDPFEEIYVVTELMQSD---LHKIIVSPQPLSSDHVKVFLY 110

Query: 400 -ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG 458
            I +GL YLH      I+HRD+KP N+L++ + V KI DFG+AR+   ++    T+ VV 
Sbjct: 111 QILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVT 167

Query: 459 TYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
            Y Y APE  M    ++   D++S G I  E++  +
Sbjct: 168 QY-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 55/201 (27%), Positives = 91/201 (45%), Gaps = 21/201 (10%)

Query: 299 KLGQGGFGTVYKGVLPNGKE-VAVKRLSRKSWQGLEEFK---NEIILIAKLQHRNLVRLV 354
           ++GQGG+G V+     +  E VA+KR+ +     L E +    E  ++   +   LV+L+
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67

Query: 355 GCGIEGEEKLLIYELMPN---RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
               + E   L  E +P    R+L      +   L  +    Y     +++    +    
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLLN----NLGVLSEDHARFY-----MAEMFEAVDALH 118

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
            L  IHRDLKP N L+D     K++DFG+++        AN+  VVG+  YMAPE     
Sbjct: 119 ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANS--VVGSPDYMAPEVLRGK 173

Query: 472 LFSVKSDVFSFGVIVLEIISG 492
            +    D +S G ++ E + G
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 74.1 bits (183), Expect = 1e-14
 Identities = 65/208 (31%), Positives = 94/208 (45%), Gaps = 37/208 (17%)

Query: 300 LGQGGFGTV----YKGVLPNGKEVAVKRLSR----KSWQGLEEFKNEIILIAKLQHRNLV 351
           LG G FG V    +K    +GK  A+K LS+    K  Q +E   NE  ++  ++H  LV
Sbjct: 9   LGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIRHPFLV 64

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCF-IFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
            L G   +     L+ E +P   L  F       R        Y     +   L YLH  
Sbjct: 65  NLYGSFQDDSNLYLVMEYVPGGEL--FSHLRKSGRFPEPVARFY--AAQVVLALEYLH-- 118

Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE---- 466
             L I++RDLKP N+LLD D   KI+DFG A+       T     + GT  Y+APE    
Sbjct: 119 -SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT-----LCGTPEYLAPEIILS 172

Query: 467 --YAMEGLFSVKSDVFSFGVIVLEIISG 492
             Y      +V  D ++ G+++ E+++G
Sbjct: 173 KGYGK----AV--DWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 66/206 (32%), Positives = 94/206 (45%), Gaps = 27/206 (13%)

Query: 300 LGQGGFGTVYK-GVLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVG 355
           LG+GGFG V    V   GK  A K+L +K     +G     NE  ++ K+  R +V L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66

Query: 356 CGIEGEEKL-LIYELMPNRSLDCFI-------FDSERRLQLNWNTCYNIIGGISKGLLYL 407
              E ++ L L+  +M    L   I       FD +R +      C         GL  L
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCC--------GLEDL 118

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
               R +I++RDLKP N+LLD     +ISD G+A    E +     R  VGT GYMAPE 
Sbjct: 119 Q---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEV 172

Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGK 493
                ++   D +  G ++ E+I G+
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 23/216 (10%)

Query: 292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKR-LSRKSWQGLEEFK-NEIILIAKLQHR 348
           D +    K+G+G +G VYK      GK VA+K+       +G+      EI L+  L   
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 349 N-LVRLVGCGIEGEEKL------LIYELMPNRSLDCFIFDSERRLQ---LNWNTCYNIIG 398
             +VRL+      EEK       L++E + +  L  F+ DS  R     L   T  + + 
Sbjct: 61  IYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFM-DSNGRGPGRPLPAKTIKSFMY 117

Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD-MVAKISDFGMARIFCENQKTANTRRVV 457
            + KG+ + H   +  ++HRDLKP N+L+DK   + KI+D G+ R F    K + T  +V
Sbjct: 118 QLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK-SYTHEIV 173

Query: 458 GTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISG 492
            T  Y APE  +    +S   D++S G I  E+   
Sbjct: 174 -TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 73.3 bits (180), Expect = 5e-14
 Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 46/228 (20%)

Query: 294 FSDSNKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           + D   LG G  G V+  V  +  K VAVK++     Q ++    EI +I +L H N+V+
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 353 L--------------VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNT------ 392
           +              VG   E     ++ E M          +++    L          
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM----------ETDLANVLEQGPLSEEHA 116

Query: 393 ---CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD-KDMVAKISDFGMARIFCEN- 447
               Y ++    +GL Y+H  +   ++HRDLKP+NV ++ +D+V KI DFG+ARI   + 
Sbjct: 117 RLFMYQLL----RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHY 169

Query: 448 -QKTANTRRVVGTYGYMAPEYAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             K   +  +V  + Y +P   +      K+ D+++ G I  E+++GK
Sbjct: 170 SHKGYLSEGLVTKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 6e-14
 Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 23/212 (10%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLS--RKSWQGLEEFKNEIILIAKLQHRNL 350
           + + + +G+G +G V      P G +VA+K++S            + EI ++ + +H N+
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHENI 65

Query: 351 VRLVGCGIEG-----EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           + ++            +  ++ ELM     D +     + L  N +  Y  +  I +GL 
Sbjct: 66  IGILDIIRPPSFESFNDVYIVQELMET---DLYKLIKTQHLS-NDHIQY-FLYQILRGLK 120

Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV---VGTYGY 462
           Y+H  +   ++HRDLKPSN+LL+ +   KI DFG+ARI        +T  +   V T  Y
Sbjct: 121 YIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD--HTGFLTEYVATRWY 175

Query: 463 MAPEYAMEGLFSVKS-DVFSFGVIVLEIISGK 493
            APE  +      K+ D++S G I+ E++S +
Sbjct: 176 RAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 73.5 bits (180), Expect = 6e-14
 Identities = 71/208 (34%), Positives = 102/208 (49%), Gaps = 33/208 (15%)

Query: 300 LGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRNLVRL 353
           +G G  G V   +  VL  G  VAVK+LSR  +Q     K    E++L+  + H+N++ L
Sbjct: 29  IGSGAQGIVCAAFDTVL--GINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVNHKNIISL 85

Query: 354 VGCGI------EGEEKLLIYELMPNRSLDCFI---FDSERRLQLNWNTCYNIIGGISKGL 404
           +          E ++  L+ ELM + +L   I    D ER   L     Y ++ GI    
Sbjct: 86  LNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSYL----LYQMLCGIK--- 137

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            +LH      IIHRDLKPSN+++  D   KI DFG+AR  C N     T  VV  Y Y A
Sbjct: 138 -HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTRY-YRA 190

Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           PE  +   +    D++S G I+ E++ G
Sbjct: 191 PEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 72.3 bits (177), Expect = 8e-14
 Identities = 62/229 (27%), Positives = 107/229 (46%), Gaps = 41/229 (17%)

Query: 299 KLGQGGFGTVYKGVLPNGKE-----------------VAVKRL-SRKSWQGLEEFKNEII 340
           KLG+G FG V+   + N ++                 VAVK L    +     +F  E+ 
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ------------- 387
           ++++L+  N++RL+G  ++ +   +I E M N  L+ F+  S   L              
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL--SSHHLDDKEENGNDAVPPA 129

Query: 388 -----LNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR 442
                +++++  ++   I+ G+ YL   S L  +HRDL   N L+ +++  KI+DFGM+R
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186

Query: 443 IFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
                       R V    +MA E  + G F+  SDV++FGV + EI+ 
Sbjct: 187 NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 72.2 bits (178), Expect = 1e-13
 Identities = 67/230 (29%), Positives = 102/230 (44%), Gaps = 66/230 (28%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---------EIILIAKL-Q 346
            KLG+G +G V+K +     + VA+K++        + F+N         EI+ + +L  
Sbjct: 13  QKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELGD 65

Query: 347 HRNLVRLVGCGIEGEEKLLIY---ELM---------PNRSLD---CFIFDSERRLQLNWN 391
           H N+V+L+   I+ E    IY   E M          N   D    +I            
Sbjct: 66  HPNIVKLLNV-IKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIM----------- 113

Query: 392 TCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA 451
             Y ++    K L Y+H  S   +IHRDLKPSN+LL+ D   K++DFG+AR   E ++  
Sbjct: 114 --YQLL----KALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164

Query: 452 NTRRV---VGTYGYMAPEYAMEGLFSVKS-----DVFSFGVIVLEIISGK 493
               +   V T  Y APE     L          D++S G I+ E++ GK
Sbjct: 165 ENPVLTDYVATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 36/95 (37%), Positives = 51/95 (53%), Gaps = 7/95 (7%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN-TRRVVG 458
           I  GL +LHE     II+RDLK  NVLLD +   KI+DFGM +   E       T    G
Sbjct: 105 IVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCG 158

Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           T  Y+APE      +    D ++ GV++ E+++G+
Sbjct: 159 TPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 58/210 (27%), Positives = 104/210 (49%), Gaps = 33/210 (15%)

Query: 299 KLGQGGFGTVYKGVL----PNGKEVAVKRL--SRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           K+G+G FG   K +L     +GK+  +K +  S+ S +  EE + E+ +++ ++H N+V+
Sbjct: 7   KIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ 63

Query: 353 LVGCGIEGEEKLLIYELMPN-RSLDCF--------IFDSERRLQLNWNTCYNIIGGISKG 403
                   EE   +Y +M      D +        +   E ++ L+W         I   
Sbjct: 64  YQE---SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI-LDWFV------QICLA 113

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           L ++H+    KI+HRD+K  N+ L KD   K+ DFG+AR+   N      R  +GT  Y+
Sbjct: 114 LKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL--NSTVELARTCIGTPYYL 168

Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           +PE      ++ KSD+++ G ++ E+ + K
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 22/210 (10%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLS-RKSWQGLE-EFKNEIILIAKLQHRNL 350
           F   N++G+G +G VY+     +G+ VA+K++       G+      EI L+  L+H N+
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 351 VRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
           V L  V  G   +   L+ E    + L   + +       +   C  ++  + +GL YLH
Sbjct: 69  VELKEVVVGKHLDSIFLVMEYC-EQDLASLLDNMPTPFSESQVKC--LMLQLLRGLQYLH 125

Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
           E+    IIHRDLK SN+LL      KI+DFG+AR +        T +VV T  Y APE  
Sbjct: 126 ENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TLWYRAPEL- 179

Query: 469 MEGLFSVKS-----DVFSFGVIVLEIISGK 493
              L    +     D+++ G I+ E+++ K
Sbjct: 180 ---LLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 19/199 (9%)

Query: 302 QGGFGTVY--KGVLPNGKEVAVKRLSRKSWQGLEEFKN----EIILIAKLQHRNLVRLVG 355
           +G FG+VY  K     G   A+K L +       +  N      I++ + +   + +L  
Sbjct: 6   KGAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYY 64

Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
                +   L+ E +        I  +   L  +W   Y  I  +  G+  LH+     I
Sbjct: 65  SFQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQY--IAEVVLGVEDLHQRG---I 118

Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSV 475
           IHRD+KP N+L+D+    K++DFG++R   EN      ++ VGT  Y+APE  +      
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN------KKFVGTPDYLAPETILGVGDDK 172

Query: 476 KSDVFSFGVIVLEIISGKR 494
            SD +S G ++ E + G  
Sbjct: 173 MSDWWSLGCVIFEFLFGYP 191

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 73/251 (29%), Positives = 120/251 (47%), Gaps = 42/251 (16%)

Query: 300 LGQGGFGTVYKGVL-------PNG-KEVAVKRL-SRKSWQGLEEFKNEIILIAKL-QHRN 349
           LG+G FG V            PN   +VAVK L S  + + L +  +E+ ++  + +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLD-------------CFIFDSERRLQLNWNTCYNI 396
           ++ L+G   +     +I E     +L              C+        QL++    + 
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE---NQKTANT 453
              +++G+ YL   +  K IHRDL   NVL+ +D V KI+DFG+AR        +KT N 
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--HAQTLLAYV 511
           R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +    +  +
Sbjct: 203 RLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEI--------FTLGGSPYPGVPVEEL 251

Query: 512 WQLWKEGKEME 522
           ++L KEG  M+
Sbjct: 252 FKLLKEGHRMD 262

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 66/207 (31%), Positives = 111/207 (53%), Gaps = 21/207 (10%)

Query: 299 KLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQ-GLE-EFKNEIILIAKLQ---HRNLVR 352
           ++G G +GTVYK   P+ G  VA+K +  ++ + GL      E+ L+ +L+   H N+VR
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 353 LVG-CG---IEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           L+  C     + E K+ L++E + ++ L  ++ D      L   T  +++    +GL +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H +    I+HRDLKP N+L+      K++DFG+ARI+ C+   T     VV T  Y APE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP----VVVTLWYRAPE 177

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGK 493
             ++  ++   D++S G I  E+   K
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 73.3 bits (180), Expect = 2e-13
 Identities = 56/196 (28%), Positives = 87/196 (44%), Gaps = 28/196 (14%)

Query: 316 GKEVAVKRLSRKSWQGLEE---FKNEIILIAKLQHRNLVRLVGCGIEGEEKLL-IYELMP 371
           G EVA+K L   + +   +   F+ E  L A+L H N+V L+  G      L  ++E +P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 372 NRSLDCFIFDSERRLQ----LNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL 427
            R+L          L     L       ++  +   L   H      I+HRDLKP N+++
Sbjct: 63  GRTL-------REVLAADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMV 112

Query: 428 ---DKDMVAKISDFGM------ARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
                   AK+ DFG+       R       T  T  V+GT  Y APE       +  SD
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTT-EVLGTPTYCAPEQLRGEPVTPNSD 171

Query: 479 VFSFGVIVLEIISGKR 494
           ++++G+I LE ++G+R
Sbjct: 172 LYAWGLIFLECLTGQR 187

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 30/212 (14%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKS------WQGLEEFKNEIILIAKLQHRNLV 351
            +G G +G V   +   +GK+VA+K++           + L E K    ++   +H N++
Sbjct: 12  NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELK----ILRHFKHDNII 67

Query: 352 R----LVGCGIEGEEKLLIYELMPNRSLDCF-IFDSERRLQLNWNTCYNIIGGISKGLLY 406
                L   G + ++  ++ +LM +   D   I  S++ L    +  Y  +  + +GL Y
Sbjct: 68  AIRDILRPPGADFKDVYVVMDLMES---DLHHIIHSDQPLTEE-HIRY-FLYQLLRGLKY 122

Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT--RRVVGTYGYMA 464
           +H      +IHRDLKPSN+L+++D   +I DFGMAR    +           V T  Y A
Sbjct: 123 IHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179

Query: 465 PE--YAMEGLFSVKSDVFSFGVIVLEIISGKR 494
           PE   ++   ++   D++S G I  E++ G+R
Sbjct: 180 PELLLSLPE-YTTAIDMWSVGCIFAEML-GRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 71.1 bits (174), Expect = 3e-13
 Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 29/215 (13%)

Query: 292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGL--EEFKNEIILIAKLQHR 348
           D + D  ++G G +GTV   +    G +VA+K+L R     L  +    E+ L+  ++H 
Sbjct: 15  DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74

Query: 349 NLVRLVGCGIEGEEKLL----IYELMPNRSLDCFIFD-----SERRLQLNWNTCYNIIGG 399
           N++ L+      +  L      Y +MP    D          SE R+Q      Y ++  
Sbjct: 75  NVIGLLDV-FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF---LVYQML-- 128

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
             KGL Y+H      IIHRDLKP N+ +++D   KI DFG+AR     Q  +     V T
Sbjct: 129 --KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVT 178

Query: 460 YGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
             Y APE  +  + ++   D++S G I+ E+++GK
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 57/176 (32%), Positives = 87/176 (49%), Gaps = 23/176 (13%)

Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN 452
           CY+    +++G+ +L   SR K IHRDL   N+LL ++ V KI DFG+AR   ++     
Sbjct: 178 CYSF--QVARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 232

Query: 453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS--GKRNSGFYLTGHAQTLLAY 510
                    +MAPE   + +++ +SDV+SFGV++ EI S       G  +          
Sbjct: 233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------- 285

Query: 511 VWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG 566
             Q  K+G  M   +      ++ P++ R   I L C Q DP  RPT S +V +LG
Sbjct: 286 FCQRLKDGTRMRAPE------NATPEIYR---IMLACWQGDPKERPTFSALVEILG 332

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 70.6 bits (173), Expect = 3e-13
 Identities = 61/200 (30%), Positives = 108/200 (54%), Gaps = 16/200 (8%)

Query: 300 LGQGGFGTVY--KGVLP--NGKEVAVKRLSRKSWQGLEEF--KNEIILIAKLQHRNLVRL 353
           LGQG FG V+  + +     G+  A+K L + + +  +    K E  ++A++ H  +V+L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 354 VGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
                + E KL LI + +  R  D F   S+  +    +  +  +  ++  L +LH    
Sbjct: 64  -HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKF-YLAELALALDHLH---S 116

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
           L II+RDLKP N+LLD++   K++DFG+++   +++K A +    GT  YMAPE      
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRRG 174

Query: 473 FSVKSDVFSFGVIVLEIISG 492
            +  +D +SFGV++ E+++G
Sbjct: 175 HTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 26/209 (12%)

Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGCGI 358
           +G G +G VYKG      ++A  ++   +    EE K EI ++ K   HRN+    G  I
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 359 E------GEEKLLIYELMPNRSLDCFIFDSE-RRLQLNW--NTCYNIIGGISKGLLYLHE 409
           +       ++  L+ E     S+   I +++   L+  W    C  I+    +GL +LH+
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL----RGLSHLHQ 129

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-VGTYGYMAPEYA 468
               K+IHRD+K  NVLL ++   K+ DFG++    +  +T   R   +GT  +MAPE  
Sbjct: 130 H---KVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTVGRRNTFIGTPYWMAPEVI 183

Query: 469 M-----EGLFSVKSDVFSFGVIVLEIISG 492
                 +  +  KSD++S G+  +E+  G
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 70.2 bits (172), Expect = 4e-13
 Identities = 39/94 (41%), Positives = 55/94 (58%), Gaps = 5/94 (5%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I  GL +LH+     II+RDLK  NVLLDKD   KI+DFGM +     +  A+T    GT
Sbjct: 105 IICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGT 159

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y+APE      ++   D +SFGV++ E++ G+
Sbjct: 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 70.4 bits (172), Expect = 4e-13
 Identities = 80/295 (27%), Positives = 132/295 (44%), Gaps = 59/295 (20%)

Query: 300 LGQGGFGTVY--------KGVLPNGKEVAVKRLSRKSW-QGLEEFKNEIILIAKL-QHRN 349
           LG+G FG V         K        VAVK L   +  + L +  +E+ ++  + +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFI-----------FDSER--RLQLNWNTCYNI 396
           ++ L+G   +     ++ E     +L  ++           FD+ +    QL +    + 
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE---NQKTANT 453
              +++G+ YL   +  K IHRDL   NVL+ +D V KI+DFG+AR        +KT N 
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--HAQTLLAYV 511
           R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +    +  +
Sbjct: 197 RLPV---KWMAPEALFDRVYTHQSDVWSFGVLLWEI--------FTLGGSPYPGIPVEEL 245

Query: 512 WQLWKEGKEMEFVDPLLMKSSSIPQVVRCIH----IGLLCVQEDPAVRPTMSNVV 562
           ++L KEG  M+             +   C H    I   C    P+ RPT   +V
Sbjct: 246 FKLLKEGHRMD-------------KPANCTHELYMIMRECWHAVPSQRPTFKQLV 287

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 69.3 bits (169), Expect = 7e-13
 Identities = 71/259 (27%), Positives = 121/259 (46%), Gaps = 42/259 (16%)

Query: 292 DGFSDSNKLGQGGFGTVY--------KGVLPNGKEVAVKRLSRKSWQ-GLEEFKNEIILI 342
           D  +    LG+G FG V         K        VAVK L   + +  L +  +E+ ++
Sbjct: 15  DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74

Query: 343 AKL-QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFI-----------FDSER--RLQL 388
             + +H+N++ L+G   +     +I E     +L  ++           +D  R    Q+
Sbjct: 75  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134

Query: 389 NWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE-- 446
            +    +    +++G+ YL   +  K IHRDL   NVL+ ++ V KI+DFG+AR      
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191

Query: 447 -NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--H 503
             +KT N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +
Sbjct: 192 YYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSPY 240

Query: 504 AQTLLAYVWQLWKEGKEME 522
               +  +++L KEG  M+
Sbjct: 241 PGIPVEELFKLLKEGHRMD 259

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 68.9 bits (168), Expect = 8e-13
 Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 26/205 (12%)

Query: 300 LGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           +G+GGFG VY     + GK  A+K L +K    ++  + E +    L  R ++ LV  G 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKR---IKMKQGETL---ALNERIMLSLVSTGD 55

Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNII----------GGISKGLLYLH 408
                 + Y       L CFI D      L+++   + +            I  GL ++H
Sbjct: 56  CPFIVCMTYAFHTPDKL-CFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH 114

Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
             +R  +++RDLKP+N+LLD+    +ISD G+A  F + +  A+    VGT+GYMAPE  
Sbjct: 115 --NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVL 167

Query: 469 MEGL-FSVKSDVFSFGVIVLEIISG 492
            +G  +   +D FS G ++ +++ G
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 68.5 bits (167), Expect = 8e-13
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 32/209 (15%)

Query: 300 LGQGGFGTV----YKGVLPNGKEVAVKRL-----SRKSWQGLEEFKNEIILIAKLQHRNL 350
           +G+G +G V    ++    +GK+  +K+L     SR+  +  E+   E  L+++L+H N+
Sbjct: 8   VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQ---EAQLLSQLKHPNI 61

Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ------LNWNTCYNIIGGISKGL 404
           V       EGE+ LL Y +M      C   D   +L+      L  N        I+  L
Sbjct: 62  VAYRE-SWEGEDGLL-YIVMGF----CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            YLHE     I+HRDLK  NV L +  + K+ D G+AR+       A+T  ++GT  YM+
Sbjct: 116 QYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMS 170

Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           PE      ++ KSDV++ G  V E+ + K
Sbjct: 171 PELFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 68.9 bits (168), Expect = 9e-13
 Identities = 61/207 (29%), Positives = 108/207 (52%), Gaps = 20/207 (9%)

Query: 299 KLGQGGFGTVYKGV-LPNG-KEVAVKRLS-RKSWQG--LEEFKNEIIL--IAKLQHRNLV 351
           ++G+G +G V+K   L NG + VA+KR+  +   +G  L   +   +L  +   +H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 352 RLVG-CGI---EGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLY 406
           RL   C +   + E KL L++E + ++ L  ++ D      +   T  +++  + +GL +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH     +++HRDLKP N+L+      K++DFG+ARI+           VV T  Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGK 493
             ++  ++   D++S G I  E+   K
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 34/211 (16%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---------EIILIAKLQHRN 349
           +G+G +G V         ++VA+K+++         F N         EI L+  L H N
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65

Query: 350 LVRLVGCGIEGEEK------LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKG 403
           ++ +    +    +       ++YELM +  L   I  S+    L+ + C   +  + +G
Sbjct: 66  VIAIKDI-MPPPHREAFNDVYIVYELM-DTDLHQIIRSSQ---TLSDDHCQYFLYQLLRG 120

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           L Y+H  +   ++HRDLKPSN+LL+ +   KI DFG+AR   E      T  VV T  Y 
Sbjct: 121 LKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM-TEYVV-TRWYR 175

Query: 464 APEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           APE  +    ++   DV+S G I  E++  K
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 31/216 (14%)

Query: 292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQH 347
           + + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H
Sbjct: 17  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 75

Query: 348 RNLVRLVGCGI------EGEEKLLIYELMP---NRSLDCFIFDSERRLQLNWNTCYNIIG 398
            N++ L+          E  +  L+  LM    N  + C         +L  +    +I 
Sbjct: 76  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--------QKLTDDHVQFLIY 127

Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG 458
            I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      V 
Sbjct: 128 QILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVA 179

Query: 459 TYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 56/177 (31%), Positives = 85/177 (48%), Gaps = 23/177 (12%)

Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN 452
           CY+    ++KG+ +L   SR K IHRDL   N+LL ++ V KI DFG+AR   ++     
Sbjct: 183 CYSF--QVAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 237

Query: 453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS--GKRNSGFYLTGHAQTLLAY 510
                    +MAPE   + +++++SDV+SFGV++ EI S       G  +       L  
Sbjct: 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-- 295

Query: 511 VWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS 567
                KEG  M   D     +  + Q +      L C   +P+ RPT S +V  LG+
Sbjct: 296 -----KEGTRMRAPD---YTTPEMYQTM------LDCWHGEPSQRPTFSELVEHLGN 338

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 62/214 (28%), Positives = 110/214 (51%), Gaps = 32/214 (14%)

Query: 300 LGQGGFGTVYKG-VLPNG--KEVAVKRLSRKSWQG-LEEFKNEIILIAKL-QHRNLVRLV 354
           +G+G FG V K  +  +G   + A+KR+   + +    +F  E+ ++ KL  H N++ L+
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 355 G-CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ--------------LNWNTCYNIIGG 399
           G C   G   L I E  P+ +L  F+  S R L+              L+     +    
Sbjct: 75  GACEHRGYLYLAI-EYAPHGNLLDFLRKS-RVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           +++G+ YL   S+ + IHRDL   N+L+ ++ VAKI+DFG++R      +    ++ +G 
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGR 184

Query: 460 YG--YMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
               +MA E     +++  SDV+S+GV++ EI+S
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 54/177 (30%), Positives = 83/177 (46%), Gaps = 39/177 (22%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK---TANTRRV 456
           +++G+ +L   +    IHRD+   NVLL    VAKI DFG+AR    +       N R  
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP 277

Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKR-------NSGFYLTGHAQTLL 508
           V    +MAPE   + +++V+SDV+S+G+++ EI S GK        NS FY         
Sbjct: 278 V---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY--------- 325

Query: 509 AYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
               ++ K G +M   D    +  SI +         +C   +P  RPT S +  L+
Sbjct: 326 ----KMVKRGYQMSRPDFAPPEIYSIMK---------MCWNLEPTERPTFSQISQLI 369

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 15/200 (7%)

Query: 299 KLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFK--NEIILIAKLQHRNLVRLVG 355
           KLG+G + TVYKG+   NG+ VA+K +S K+ +G+  F    E  L+  L+H N+V L  
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHD 70

Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
             I  +E L  ++E M     D   +  +    L+       +  + +GL Y+H      
Sbjct: 71  I-IHTKETLTFVFEYM---HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQH 123

Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL-F 473
           I+HRDLKP N+L+      K++DFG+AR      +T ++  V  T  Y  P+  +    +
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDY 181

Query: 474 SVKSDVFSFGVIVLEIISGK 493
           S   D++  G I +E++ G+
Sbjct: 182 SSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 68.2 bits (166), Expect = 3e-12
 Identities = 63/208 (30%), Positives = 100/208 (48%), Gaps = 31/208 (14%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRNLVRLV- 354
           +G G +G+V         ++VAVK+LSR  +Q L   +    E+ L+  ++H N++ L+ 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSR-PFQSLIHARRTYRELRLLKHMKHENVIGLLD 81

Query: 355 -----GCGIEGEEKLLIYELMP---NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLY 406
                       E  L+  LM    N  + C    S+  +Q        +I  + +GL Y
Sbjct: 82  VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKL-SDEHVQF-------LIYQLLRGLKY 133

Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           +H      IIHRDLKPSNV +++D   +I DFG+AR     Q        V T  Y APE
Sbjct: 134 IHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPE 185

Query: 467 YAMEGL-FSVKSDVFSFGVIVLEIISGK 493
             +  + ++   D++S G I+ E++ GK
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 61/214 (28%), Positives = 102/214 (47%), Gaps = 32/214 (14%)

Query: 300 LGQGGFGTVYKGVLP---NGKEVAVKRLSR-KSWQGLEEFKNEIILIAKL-QHRNLVRLV 354
           +G+G FG V + ++         A+K L    S     +F  E+ ++ KL  H N++ L+
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 355 G-CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ--------------LNWNTCYNIIGG 399
           G C   G   + I E  P  +L  F+  S R L+              L           
Sbjct: 70  GACENRGYLYIAI-EYAPYGNLLDFLRKS-RVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           ++ G+ YL E    + IHRDL   NVL+ +++ +KI+DFG++R      +    ++ +G 
Sbjct: 128 VATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGR 179

Query: 460 YG--YMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
               +MA E     +++ KSDV+SFGV++ EI+S
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 67.8 bits (165), Expect = 3e-12
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 25/211 (11%)

Query: 292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHR-- 348
           D F   ++LG G  G V+K    P+G  +A K +  +    +   +N+II   ++ H   
Sbjct: 5   DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAI---RNQIIRELQVLHECN 61

Query: 349 --NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS----K 402
              +V   G      E  +  E M   SLD  +  + R  +        I+G +S    K
Sbjct: 62  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGKVSIAVIK 114

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           GL YL E  + KI+HRD+KPSN+L++     K+ DFG++    ++   AN+   VGT  Y
Sbjct: 115 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS--FVGTRSY 168

Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           M+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 63/220 (28%), Positives = 94/220 (42%), Gaps = 44/220 (20%)

Query: 299 KLGQGGFGTV----YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-------- 346
           +LGQG +G V              VA+K+++         F  +I+    L+        
Sbjct: 7   ELGQGAYGIVCSARNAETSEEET-VAIKKITNV-------FSKKILAKRALRELKLLRHF 58

Query: 347 --HRNLVRLVGCGI---EGEEKLLIY-ELMPNRSLDC---FIFDSERRLQLNWNTCYN-I 396
             H+N+  L    I       +L +Y ELM     +     I  S + L    +  +   
Sbjct: 59  RGHKNITCLYDMDIVFPGNFNELYLYEELM-----EADLHQIIRSGQPLT---DAHFQSF 110

Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK--TANTR 454
           I  I  GL Y+H  +   ++HRDLKP N+L++ D   KI DFG+AR F EN         
Sbjct: 111 IYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMT 167

Query: 455 RVVGTYGYMAPEYAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             V T  Y APE  +      K+ DV+S G I+ E++  K
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 25/222 (11%)

Query: 288 KAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFK----NEIILI 342
           K   D F    ++G+G +G VYK      G+ VA+K++   + +  E F      EI ++
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKIL 60

Query: 343 AKLQHRNLVRLVGCGIEGEEKL----------LIYELMPNRSLDCFIFDSERRLQLNWNT 392
            +L HRN+V L     + ++ L          L++E M +   D         +  + + 
Sbjct: 61  RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH---DLMGLLESGLVHFSEDH 117

Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN 452
             + +  + +GL Y H+ + L   HRD+K SN+LL+     K++DFG+AR++   +    
Sbjct: 118 IKSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174

Query: 453 TRRVVGTYGYMAPEYAM-EGLFSVKSDVFSFGVIVLEIISGK 493
           T +V+ T  Y  PE  + E  +    DV+S G I+ E+ + K
Sbjct: 175 TNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 67.5 bits (165), Expect = 4e-12
 Identities = 37/94 (39%), Positives = 54/94 (57%), Gaps = 5/94 (5%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I+ GL +LH      II+RDLK  NV+LD +   KI+DFGM +      KT  TR   GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGT 164

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y+APE      +    D ++FGV++ E+++G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 62/211 (29%), Positives = 103/211 (48%), Gaps = 38/211 (18%)

Query: 300 LGQGGFGTVYKGVLPN-GKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVG 355
           +G+GGFG VY     + GK  A+K L +K     QG     NE I+++ +   +   +V 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV- 60

Query: 356 C---GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNII----------GGISK 402
           C        +KL             FI D      L+++   + +            I  
Sbjct: 61  CMSYAFHTPDKL------------SFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIIL 108

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           GL ++H  +R  +++RDLKP+N+LLD+    +ISD G+A  F + +  A+    VGT+GY
Sbjct: 109 GLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGY 161

Query: 463 MAPEYAMEGL-FSVKSDVFSFGVIVLEIISG 492
           MAPE   +G+ +   +D FS G ++ +++ G
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 66.8 bits (163), Expect = 5e-12
 Identities = 37/93 (39%), Positives = 55/93 (59%), Gaps = 5/93 (5%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I+  L++LH+     II+RDLK  NVLLD +   K++DFGM +    N KT +T    GT
Sbjct: 105 ITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST--FCGT 159

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
             Y+APE   E L+    D ++ GV++ E++ G
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 23/210 (10%)

Query: 292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHR--- 348
           D F   ++LG G  G V K        +  ++L     +     +N+II   ++ H    
Sbjct: 5   DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNS 62

Query: 349 -NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS----KG 403
             +V   G      E  +  E M   SLD  + +++R  +        I+G +S    +G
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-------EILGKVSIAVLRG 115

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           L YL E  + +I+HRD+KPSN+L++     K+ DFG++    ++   AN+   VGT  YM
Sbjct: 116 LAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANS--FVGTRSYM 169

Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           +PE      +SV+SD++S G+ ++E+  G+
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 67.2 bits (164), Expect = 5e-12
 Identities = 53/169 (31%), Positives = 81/169 (47%), Gaps = 21/169 (12%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           +++G+ +L   SR K IHRDL   N+LL ++ V KI DFG+AR   ++            
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS--GKRNSGFYLTGHAQTLLAYVWQLWKE 517
             +MAPE   + +++ +SDV+SFGV++ EI S       G  +       L       KE
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL-------KE 291

Query: 518 GKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG 566
           G  M   +       + P++     I L C   +P  RPT S +V +LG
Sbjct: 292 GTRMRAPE------YATPEIYS---IMLDCWHNNPEDRPTFSELVEILG 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 66.6 bits (162), Expect = 6e-12
 Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 31/209 (14%)

Query: 298 NKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLE-EFKNEIILIAKLQHRNLVRLVG 355
           +KLG+G + TVYKG        VA+K +  +  +G       E+ L+  L+H N+V L  
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---------GISKGLL 405
             I  E+ L L++E +            ++ L+   + C N I           + +GL 
Sbjct: 72  I-IHTEKSLTLVFEYL------------DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLN 118

Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H   R K++HRDLKP N+L+++    K++DFG+AR      KT +   V  T  Y  P
Sbjct: 119 YCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPP 173

Query: 466 EYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           +  +    +S + D++  G I  E+ +G+
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 6e-12
 Identities = 33/116 (28%), Positives = 50/116 (43%), Gaps = 27/116 (23%)

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA---------------------- 441
           +L L    +L  IHRD+KP N+L+D D   K++DFG+                       
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170

Query: 442 -----RIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
                R     Q+       VGT  Y+APE      + ++ D +S GVI+ E++ G
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 66.2 bits (161), Expect = 8e-12
 Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 29/208 (13%)

Query: 298 NKLGQGGFGTVYKGVLPNGKE-VAVKRLSRKSWQGLE-EFKNEIILIAKLQHRNLVRLVG 355
            KLG+G + TV+KG     +  VA+K +  +  +G       E+ L+  L+H N+V L  
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---------GISKGLLY 406
                +   L++E +            ++ L+   + C NI+           I +GL Y
Sbjct: 72  IVHTDKSLTLVFEYL------------DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119

Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
            H   R K++HRDLKP N+L+++    K++DFG+AR      KT +   V  T  Y  P+
Sbjct: 120 CH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPD 174

Query: 467 YAM-EGLFSVKSDVFSFGVIVLEIISGK 493
             +    +S + D++  G I  E+ SG+
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 66.2 bits (162), Expect = 8e-12
 Identities = 52/213 (24%), Positives = 84/213 (39%), Gaps = 36/213 (16%)

Query: 300 LGQGGFGTVYKGVLPNGKEVAVKR--LSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
                   + K   P    VAVK+  L   S + L+  + EII   +LQH N++  V   
Sbjct: 10  FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--------NIIGGISKGLLYLHE 409
           I   E  ++  LM         + S   L L  +            I+  +   L Y+H 
Sbjct: 69  IVDSELYVVSPLMA--------YGSCEDL-LKTHFPEGLPELAIAFILKDVLNALDYIH- 118

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG-------- 461
                 IHR +K S++LL  D    +S     R      K    +RVV  +         
Sbjct: 119 --SKGFIHRSVKASHILLSGDGKVVLSGL---RYSVSMIKHGKRQRVVHDFPKSSVKNLP 173

Query: 462 YMAPEYAMEGL--FSVKSDVFSFGVIVLEIISG 492
           +++PE   + L  ++ KSD++S G+   E+ +G
Sbjct: 174 WLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 38/154 (24%), Positives = 74/154 (48%), Gaps = 9/154 (5%)

Query: 338 EIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNII 397
           E +L+  + H +++R+    + G    ++   +P+ S D + + ++R   L  +    I 
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVV 457
             I +GL YLH     +IIHRD+K  N+ ++      I D G A+             + 
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF---PVVAPAFLGLA 217

Query: 458 GTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
           GT    APE      ++ K+D++S G+++ E+++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 24/204 (11%)

Query: 299 KLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFK-------NEIILIAKLQHRNL 350
            +G+G +G V K      G+ VA+K+         E+ K        EI ++ +L+H NL
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLES-----EDDKMVKKIAMREIRMLKQLRHENL 62

Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ-LNWNTCYNIIGGISKGLLYLHE 409
           V L+      +   L++E + +  LD    D E+    L+ +     +  I +G+ + H 
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCHS 118

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
            +   IIHRD+KP N+L+ +  V K+ DFG AR      +       V T  Y APE  +
Sbjct: 119 HN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD--YVATRWYRAPELLV 173

Query: 470 -EGLFSVKSDVFSFGVIVLEIISG 492
            +  +    D+++ G +V E+++G
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 67.1 bits (164), Expect = 1e-11
 Identities = 58/226 (25%), Positives = 98/226 (43%), Gaps = 41/226 (18%)

Query: 299 KLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKN----EIILIAKLQHRNLVRL 353
            +G+GG G VY    P   + VA+K++ R+        K     E  + A L H  +V +
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 354 VGCGIEGEEKLLIYELMPN------RSL-----DCFIFDSERRLQLNWNTCYNIIGGISK 402
                +G+    +Y  MP       +SL            E   + +     +I   I  
Sbjct: 68  YSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK------TANTR-- 454
            + Y+H  S+  ++HRDLKP N+LL       I D+G A IF + ++        + R  
Sbjct: 125 TIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAA-IFKKLEEEDLLDIDVDERNI 180

Query: 455 ---------RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
                    ++VGT  YMAPE  +    S  +D+++ GVI+ ++++
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 61/225 (27%), Positives = 107/225 (47%), Gaps = 22/225 (9%)

Query: 282 VHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIIL 341
           + L+ ++     F     +G G +G VYKG      ++A  ++   +    EE K EI +
Sbjct: 6   IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM 65

Query: 342 IAKL-QHRNLVRLVGCGIE------GEEKLLIYELMPNRSLDCFIFDSE-RRLQLNWNTC 393
           + K   HRN+    G  I+       ++  L+ E     S+   + +++   L+ +W   
Sbjct: 66  LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW-IA 124

Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT 453
           Y I   I +GL +LH     K+IHRD+K  NVLL ++   K+ DFG++    +  +T   
Sbjct: 125 Y-ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRTVGR 177

Query: 454 RRV-VGTYGYMAPEYAM-----EGLFSVKSDVFSFGVIVLEIISG 492
           R   +GT  +MAPE        +  +  +SD++S G+  +E+  G
Sbjct: 178 RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 36/93 (38%), Positives = 55/93 (59%), Gaps = 9/93 (9%)

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR--IFCENQKTANTRRVVGTY 460
           GL +LH      II+RDLK  NV+LD+D   KI+DFGM +  +F +N+ +       GT 
Sbjct: 108 GLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST----FCGTP 160

Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
            Y+APE      ++   D +SFGV++ E++ G+
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 11/204 (5%)

Query: 292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLE-EFKNEIILIAKLQHRN 349
           D +    KLG+G + TVYKG    NGK VA+K +  +  +G       E  L+  L+H N
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
           +V L       E   L++E +     D   +  +    L+       +  + +GL Y+H+
Sbjct: 65  IVLLHDIIHTKETLTLVFEYV---HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
                I+HRDLKP N+L+      K++DFG+AR       T +   V  T  Y  P+  +
Sbjct: 122 RY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--TLWYRPPDVLL 176

Query: 470 EGL-FSVKSDVFSFGVIVLEIISG 492
               +S   D++  G I +E+I G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 63/211 (29%), Positives = 101/211 (47%), Gaps = 25/211 (11%)

Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  VL   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           N++ L+          E ++  L+ ELM + +L C +   E   +      Y ++ GI  
Sbjct: 77  NIISLLNVFTPQKSLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK- 133

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
              +LH      IIHRDLKPSN+++  D   KI DFG+AR          T  VV  Y Y
Sbjct: 134 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY-Y 184

Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
            APE  +   +    D++S G I+ E++  K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 38/208 (18%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           ++G G +G VYK   +  G+  A+K +  +  +     + EII++   +H N+V   G  
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75

Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS------------KGLL 405
           +   +KL I          C  F     LQ      Y++ G +S            +GL 
Sbjct: 76  LR-RDKLWI----------CMEFCGGGSLQ----DIYHVTGPLSESQIAYVSRETLQGLY 120

Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGM-ARIFCENQKTANTRRVVGTYGYMA 464
           YLH   +   +HRD+K +N+LL  +   K++DFG+ A+I       A  +  +GT  +MA
Sbjct: 121 YLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQI---TATIAKRKSFIGTPYWMA 174

Query: 465 PEYAM---EGLFSVKSDVFSFGVIVLEI 489
           PE A    +G ++   D+++ G+  +E+
Sbjct: 175 PEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 32/208 (15%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN-------EIILIAKLQHRNL 350
           K+G+G +G V+K      G+ VA+K+         E+          EI ++ +L+H NL
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPNL 62

Query: 351 VRLVGCGIE---GEEKL-LIYELMPNRSLDCFIFDSERRLQ-LNWNTCYNIIGGISKGLL 405
           V L    IE    + KL L++E   +  L+    + E+  + +  +    II    + + 
Sbjct: 63  VNL----IEVFRRKRKLHLVFEYCDHTVLN----ELEKNPRGVPEHLIKKIIWQTLQAVN 114

Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           + H   +   IHRD+KP N+L+ K    K+ DFG ARI        +    V T  Y AP
Sbjct: 115 FCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARIL--TGPGDDYTDYVATRWYRAP 169

Query: 466 EYAMEGL-FSVKSDVFSFGVIVLEIISG 492
           E  +    +    DV++ G +  E+++G
Sbjct: 170 ELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 63.9 bits (155), Expect = 6e-11
 Identities = 69/220 (31%), Positives = 104/220 (47%), Gaps = 43/220 (19%)

Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQH 347
           + +   +G G  G V   Y  +L   + VA+K+LSR  +Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 82

Query: 348 RNLVRLVGCGI------EGEEKLLIYELMPNRSLDCFI---FDSERRLQLNWNTCYNIIG 398
           +N++ L+          E ++  ++ ELM + +L   I    D ER   L     Y ++ 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYL----LYQMLC 137

Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR---- 454
           GI     +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T     
Sbjct: 138 GIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMT 183

Query: 455 -RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             VV  Y Y APE  +   +    D++S G I+ E+I G 
Sbjct: 184 PYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 63.5 bits (154), Expect = 7e-11
 Identities = 57/210 (27%), Positives = 106/210 (50%), Gaps = 19/210 (9%)

Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFK-NEIILIAKLQHRNLVRLVGCG 357
           K+G+G +G VYK    +GK+     L +    G+      EI L+ +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 358 IEGEEK--LLIYELMPNRSLDCFIFD-----SERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +   ++   L+++   +       F      +++ +QL  +   +++  I  G+ YLH +
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127

Query: 411 SRLKIIHRDLKPSNVLL-----DKDMVAKISDFGMARIFCENQKT-ANTRRVVGTYGYMA 464
               ++HRDLKP+N+L+     ++  V KI+D G AR+F    K  A+   VV T+ Y A
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRV-KIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 465 PEYAMEGLFSVKS-DVFSFGVIVLEIISGK 493
           PE  +      K+ D+++ G I  E+++ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 55/202 (27%), Positives = 94/202 (46%), Gaps = 20/202 (9%)

Query: 300 LGQGGFGT--VYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           +G+G FG   + + V  + K    +    KS   +E+ + E +L+AK++H N+V      
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE-S 66

Query: 358 IEGEEKL-LIYELMPNRSLDCFIFDSERRL-----QLNWNTCYNIIGGISKGLLYLHEDS 411
            E +  L ++ E      L   I     +L      L W         +  G+ ++HE  
Sbjct: 67  FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV------QMCLGVQHIHEK- 119

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
             +++HRD+K  N+ L ++   K+ DFG AR+       A T   VGT  Y+ PE     
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENM 175

Query: 472 LFSVKSDVFSFGVIVLEIISGK 493
            ++ KSD++S G I+ E+ + K
Sbjct: 176 PYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 54/197 (27%), Positives = 95/197 (48%), Gaps = 16/197 (8%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           ++G G +G VYK   L  G+  AVK +  +        + EI ++ + +H N+V   G  
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75

Query: 358 IEGEEKLLIYELMPNRSL-DCF-IFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
           +  E+  +  E     SL D + +      LQ+ +  C   +    +GL YLH   ++  
Sbjct: 76  LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY-VCRETL----QGLAYLHSKGKM-- 128

Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM---EGL 472
            HRD+K +N+LL  +   K++DFG+A         A  +  +GT  +MAPE A     G 
Sbjct: 129 -HRDIKGANILLTDNGDVKLADFGVAAKI--TATIAKRKSFIGTPYWMAPEVAAVEKNGG 185

Query: 473 FSVKSDVFSFGVIVLEI 489
           ++   D+++ G+  +E+
Sbjct: 186 YNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 59/199 (29%), Positives = 101/199 (50%), Gaps = 15/199 (7%)

Query: 299 KLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFK--NEIILIAKLQHRNLVRLVG 355
           KLG+G + TVYKG     G+ VA+K +  +  +G   F    E  L+  L+H N+V L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP-FTAIREASLLKDLKHANIVTLHD 70

Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
             I  ++ L L++E + +  L  ++ D    L ++    +  +  + +GL Y H   + +
Sbjct: 71  I-IHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLF--LFQLLRGLAYCH---QRR 123

Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL-F 473
           ++HRDLKP N+L+ +    K++DFG+AR      KT +   V  T  Y  P+  +    +
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVLLGSTEY 181

Query: 474 SVKSDVFSFGVIVLEIISG 492
           S   D++  G I  E+ +G
Sbjct: 182 STSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 63/202 (31%), Positives = 91/202 (45%), Gaps = 19/202 (9%)

Query: 300 LGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAK------LQHRNLVR 352
           LG+G FG V+   L    +  A+K L +     L +   E  ++ K       +H  L  
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVV--LMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
           L  C  + +E L       N     F   S  +  L   T Y     I  GL +LH    
Sbjct: 61  LY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFY--AAEIICGLQFLHSKG- 116

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ-KTANTRRVVGTYGYMAPEYAMEG 471
             I++RDLK  N+LLD D   KI+DFGM +   EN    A T    GT  Y+APE  +  
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPDYIAPEILLGQ 171

Query: 472 LFSVKSDVFSFGVIVLEIISGK 493
            ++   D +SFGV++ E++ G+
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 55/215 (25%), Positives = 106/215 (49%), Gaps = 21/215 (9%)

Query: 292 DGFSDSNKLGQGGFGTVYKGVL-----PNGKEVAVKRLSRKSWQ-GLEEFKNEIILIAKL 345
           D  + S+ L +G FG ++ G+L        +EV VK +   + +  +     E  L+  L
Sbjct: 6   DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65

Query: 346 QHRNLVRLVGCGIEGEEK-LLIYELMPNRSL-----DCFIFDSERRLQLNWNTCYNIIGG 399
            H+N++ ++   IE  E   ++Y  M   +L      C + ++     L+     ++   
Sbjct: 66  SHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ 125

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCENQKTA--NTRRV 456
           I+ G+ YLH   +  +IH+D+   N ++D+++  KI+D  ++R +F  +      N  R 
Sbjct: 126 IACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRP 182

Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
           V    +MA E  +   +S  SDV+SFGV++ E+++
Sbjct: 183 VK---WMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 57/210 (27%), Positives = 105/210 (50%), Gaps = 19/210 (9%)

Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFK-NEIILIAKLQHRNLVRLVGCG 357
           K+G+G +G VYK    +GK+     L +    G+      EI L+ +L+H N++ L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 358 IEGEEK--LLIYELMPNRSLDCFIFD-----SERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +   ++   L+++   +       F      +++ +QL      +++  I  G+ YLH +
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127

Query: 411 SRLKIIHRDLKPSNVLL-----DKDMVAKISDFGMARIFCENQKT-ANTRRVVGTYGYMA 464
               ++HRDLKP+N+L+     ++  V KI+D G AR+F    K  A+   VV T+ Y A
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRV-KIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 465 PEYAMEGLFSVKS-DVFSFGVIVLEIISGK 493
           PE  +      K+ D+++ G I  E+++ +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 31/209 (14%)

Query: 298 NKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLE-EFKNEIILIAKLQHRNLVRLVG 355
           +KLG+G + TV+KG        VA+K +  +  +G       E+ L+  L+H N+V L  
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---------GISKGLL 405
             I  E  L L++E +          DS+ +  L+   C N++           + +GL 
Sbjct: 71  I-IHTERCLTLVFEYL----------DSDLKQYLD--NCGNLMSMHNVKIFMFQLLRGLS 117

Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H   + KI+HRDLKP N+L+++    K++DFG+AR      KT +   V  T  Y  P
Sbjct: 118 YCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPP 172

Query: 466 EYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           +  +    +S   D++  G I+ E+ +G+
Sbjct: 173 DVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 35/99 (35%), Positives = 54/99 (54%), Gaps = 8/99 (8%)

Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRR 455
           I  I   L +LH+   L II+RD+K  N+LLD +    ++DFG+++ F  E ++ A +  
Sbjct: 111 IAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-- 165

Query: 456 VVGTYGYMAPEYAM--EGLFSVKSDVFSFGVIVLEIISG 492
             GT  YMAPE      G      D +S GV+  E+++G
Sbjct: 166 FCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 32/214 (14%)

Query: 300 LGQGGFGTVYKGVLPNG---KEVAVKRLSR-KSWQGLEEFKNEIILIAKL-QHRNLVRLV 354
           +G+G FG V K  +       + A+KR+    S     +F  E+ ++ KL  H N++ L+
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 355 G-CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ--------------LNWNTCYNIIGG 399
           G C   G   L I E  P+ +L  F+  S R L+              L+     +    
Sbjct: 63  GACEHRGYLYLAI-EYAPHGNLLDFLRKS-RVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           +++G+ YL +    + IHRDL   N+L+ ++ VAKI+DFG++R      +    ++ +G 
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGR 172

Query: 460 YG--YMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
               +MA E     +++  SDV+S+GV++ EI+S
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 63.0 bits (153), Expect = 2e-10
 Identities = 32/91 (35%), Positives = 53/91 (58%)

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           LL +H      +IHRD+K +N+LL  + + K+ DFG ++++         R   GT  Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISGKR 494
           APE      +S K+D+FS GV++ E+++ KR
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKR 243

Length = 496

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 62.2 bits (151), Expect = 3e-10
 Identities = 53/183 (28%), Positives = 78/183 (42%), Gaps = 51/183 (27%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK---TANTRRV 456
           ++KG+ +L   +    IHRDL   N+LL    + KI DFG+AR    +       N R  
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKR-------NSGFYLTGHAQTLL 508
           V    +MAPE     +++ +SDV+S+G+++ EI S G         +S FY         
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY--------- 327

Query: 509 AYVWQLWKEGKEM---EFVDPLL---MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
               ++ KEG  M   E     +   MKS               C   DP  RPT   +V
Sbjct: 328 ----KMIKEGYRMLSPECAPSEMYDIMKS---------------CWDADPLKRPTFKQIV 368

Query: 563 ALL 565
            L+
Sbjct: 369 QLI 371

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 7/95 (7%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ-KTANTRRVVG 458
           IS GL +LH      II+RDLK  NV+LD +   KI+DFGM +   E+      TR   G
Sbjct: 110 ISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCG 163

Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           T  Y+APE      +    D +++GV++ E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 37/222 (16%)

Query: 300 LGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEI----ILIAKLQHRNLVRLV 354
           +G+G FG V       +GK  AVK L +K+    +E K+ +    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 355 GCGIEGEEKL-----------LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKG 403
               +  +KL           L + L   RS        E R +            I+  
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRERSF------PEPRARF-------YAAEIASA 108

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           L YLH    L II+RDLKP N+LLD      ++DFG+ +   E+ KT +T    GT  Y+
Sbjct: 109 LGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST--FCGTPEYL 163

Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQ 505
           APE   +  +    D +  G ++ E++ G     FY    A+
Sbjct: 164 APEVLRKQPYDRTVDWWCLGAVLYEMLYGL--PPFYSRDTAE 203

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 55/199 (27%), Positives = 92/199 (46%), Gaps = 14/199 (7%)

Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLSRKSWQGLEEFKN----EIILIAKLQHRNLVRLV 354
           +G+G +G V K      KE VA+K+   K  +  EE K     E+ ++  L+  N+V L 
Sbjct: 9   VGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLKQENIVELK 66

Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
                  +  L++E +    L+      E    +      + I  + K + + H++    
Sbjct: 67  EAFRRRGKLYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYIYQLIKAIHWCHKN---D 120

Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
           I+HRD+KP N+L+  + V K+ DFG AR   E    AN    V T  Y +PE  +   + 
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYG 179

Query: 475 VKSDVFSFGVIVLEIISGK 493
              D++S G I+ E+  G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 60.6 bits (147), Expect = 6e-10
 Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 5/94 (5%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           ++  L++LH   R  +I+RDLK  N+LLD +   K++DFGM +    N  T  T    GT
Sbjct: 105 VTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTT--FCGT 159

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y+APE   E  +    D ++ GV++ E+++G+
Sbjct: 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 63/220 (28%), Positives = 101/220 (45%), Gaps = 29/220 (13%)

Query: 291 TDGFSDSNKLGQGGFGTVYKGVL--PNGKEVAVKRLSRKSWQGLEEFKNEI-----ILIA 343
           +D +     +G+G +G V+K VL   NG + AVK L       + +   EI     IL A
Sbjct: 17  SDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDP-----IHDIDEEIEAEYNILKA 70

Query: 344 KLQHRNLVRLVGC-----GIEGEEKLLIYELMPNRSL-DCFIFDSERRLQLNWNTCYNII 397
              H N+V+  G         G++  L+ EL    S+ D      +R  ++       I+
Sbjct: 71  LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYIL 130

Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVV 457
                GL +LH +   K IHRD+K +N+LL  +   K+ DFG++      +   NT   V
Sbjct: 131 HEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--V 185

Query: 458 GTYGYMAPEY-----AMEGLFSVKSDVFSFGVIVLEIISG 492
           GT  +MAPE       ++  +  + DV+S G+  +E+  G
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 60.5 bits (147), Expect = 6e-10
 Identities = 62/207 (29%), Positives = 91/207 (43%), Gaps = 30/207 (14%)

Query: 300 LGQGGFGTV----YKGVLPNGKEVAVKRLSRK---SWQGLEEFKNE--IILIA-KLQHRN 349
           LG+G FG V    YK     G+  A+K L +    +   +E    E  I   A   +H  
Sbjct: 7   LGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFD---SERRLQLNWNTCYNIIGGISKGLLY 406
           LV L  C    +    + E      L   I     SE R    +  C      +  GL Y
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVF-YAAC------VVLGLQY 116

Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN-TRRVVGTYGYMAP 465
           LHE+   KI++RDLK  N+LLD +   KI+DFG+ +   E     + T    GT  ++AP
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEFLAP 170

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E   E  ++   D +  GV++ E++ G
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 37/95 (38%), Positives = 54/95 (56%), Gaps = 7/95 (7%)

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
           L +H   ++  +HRD+KP NVL+D+    K++DFG A     N K  N++  VGT  Y+A
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN-KMVNSKLPVGTPDYIA 171

Query: 465 PEY--AMEG----LFSVKSDVFSFGVIVLEIISGK 493
           PE    M G     + V+ D +S GVI  E+I G+
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 51/206 (24%), Positives = 93/206 (45%), Gaps = 15/206 (7%)

Query: 292 DGFSDSNKLGQGGFGTVYKGVLPNGKE-VAVKRLSRK---SWQGLEEFKNEIILIAKLQH 347
           D       +G G FG V+       +   A+K ++       +  +   NE  ++ ++ H
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60

Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
             ++RL     +     ++ E +P   L  ++ +S R    + +T       I   L YL
Sbjct: 61  PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYL 117

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H     +I++RDLKP N+LLDK+   K++DFG A+   +   T     + GT  Y+APE 
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-----LCGTPEYLAPEV 169

Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGK 493
                 +   D ++ G+++ E++ G 
Sbjct: 170 IQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 16/210 (7%)

Query: 288 KAATDGFSDSNKLGQGGFGTVYKGVLPNGK--EVAVKRLSRKS---WQGLEEFKNEIILI 342
           K   + F+    LG G FG V      N     VA+KR  +      + ++   +E  ++
Sbjct: 26  KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKIL 85

Query: 343 AKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
             + H   V L G   +     L+ E +       F F    +   N   C+      ++
Sbjct: 86  NYINHPFCVNLYGSFKDESYLYLVLEFVIGGEF--FTFLRRNKRFPNDVGCFYA----AQ 139

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
            +L       L I++RDLKP N+LLDKD   K++DFG A++         T  + GT  Y
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEY 194

Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           +APE  +       +D ++ G+ + EI+ G
Sbjct: 195 IAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 36/95 (37%), Positives = 54/95 (56%), Gaps = 7/95 (7%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ-KTANTRRVVG 458
           I+ GL +LH      II+RDLK  NV+LD +   KI+DFGM +   EN      T+   G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCG 163

Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           T  Y+APE      +    D ++FGV++ E+++G+
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 3/92 (3%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           +++G+ +L   +    +HRDL   NVLL +  + KI DFG+AR    +    +       
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
             +MAPE   + L++  SDV+S+G+++ EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 37/97 (38%), Positives = 54/97 (55%), Gaps = 8/97 (8%)

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           L +LH+     I++RDLKP N+LLD      + DFG+++    + KT NT    GT  Y+
Sbjct: 109 LEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYL 163

Query: 464 APEYAM-EGLFSVKSDVFSFGVIVLEIISGKRNSGFY 499
           APE  + E  ++   D +S GV+V E+  G   S FY
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGW--SPFY 198

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 19/215 (8%)

Query: 291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHR 348
           TD +     +G+G +G VYK     +G   AVK L   S    EE + E  ++  L  H 
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHP 79

Query: 349 NLVRLVGC-----GIEGEEKLLIYELMPNRSLDCFIFDSERRLQ-LNWNTCYNIIGGISK 402
           N+V+  G       + G +  L+ EL    S+   +       Q L+      I+ G   
Sbjct: 80  NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           GL +LH +   +IIHRD+K +N+LL  +   K+ DFG++      +   NT   VGT  +
Sbjct: 140 GLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 194

Query: 463 MAPEY-----AMEGLFSVKSDVFSFGVIVLEIISG 492
           MAPE        +  +  + DV+S G+  +E+  G
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 32/87 (36%), Positives = 45/87 (51%), Gaps = 8/87 (9%)

Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH      II+RDLKP N+LLD     K++DFG A+     +    T  + GT  Y+AP
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEYLAP 184

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E           D ++ GV++ E I+G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 49/142 (34%), Positives = 78/142 (54%), Gaps = 18/142 (12%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-VG 458
           IS  L +LHE     II+RDLK  NVLLD +   K++D+GM +   E  +  +T     G
Sbjct: 105 ISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCG 158

Query: 459 TYGYMAPEY--AMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHA----QTLLAYVW 512
           T  Y+APE     +  FSV  D ++ GV++ E+++G+  S F + G +    Q    Y++
Sbjct: 159 TPNYIAPEILRGEDYGFSV--DWWALGVLMFEMMAGR--SPFDIVGMSDNPDQNTEDYLF 214

Query: 513 QLWKEGKEMEFVDPLLMKSSSI 534
           Q+  E K++     L +K+SS+
Sbjct: 215 QVILE-KQIRIPRSLSVKASSV 235

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 58.3 bits (141), Expect = 4e-09
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 20/203 (9%)

Query: 300 LGQGGFGTVYKGVL----PNGKEVAVKRLSR----KSWQGLEEFKNEIILIAKLQHRNLV 351
           LG+GG+G V++         GK  A+K L +    ++ +     K E  ++  ++H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            L+     G +  LI E +    L  F+      + +    C+  +  IS  L +LH   
Sbjct: 64  DLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACF-YLSEISLALEHLH--- 117

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN--QKTANTRRVVGTYGYMAPEYAM 469
           +  II+RDLKP N+LLD     K++DFG+    C+    +   T    GT  YMAPE  M
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGL----CKESIHEGTVTHTFCGTIEYMAPEILM 173

Query: 470 EGLFSVKSDVFSFGVIVLEIISG 492
                   D +S G ++ ++++G
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 57.9 bits (140), Expect = 6e-09
 Identities = 36/97 (37%), Positives = 50/97 (51%), Gaps = 10/97 (10%)

Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI-FCENQKTANTRRVVGTY 460
           + L Y+H  +   + HRDLKP N+L + D   KI DFG+AR+ F +          V T 
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 461 GYMAPEYAMEGLFSVKS----DVFSFGVIVLEIISGK 493
            Y APE    G F  K     D++S G I  E+++GK
Sbjct: 171 WYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 34/218 (15%)

Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVV 457
           G I   L +LH   +L I++RD+K  N+LLD +    ++DFG+++ F   +K   T    
Sbjct: 112 GEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK-ERTYSFC 167

Query: 458 GTYGYMAPEYAM-EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWK 516
           GT  YMAPE    +G      D +S G+++ E+++G   S F L G   T          
Sbjct: 168 GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGA--SPFTLEGERNT---------- 215

Query: 517 EGKEMEFVDPLLMKSSSIPQVVRCIHIGLL--CVQEDPAVRPTMSNVVALLGSESIALSE 574
              + E    +L      P  +      LL   +++DP  R         LG+     SE
Sbjct: 216 ---QSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKR---------LGAGPQGASE 263

Query: 575 PRQPPFPVGRTIV-LAEQ--PSTKDPSVCHDLTVSTLS 609
            ++ PF  G     LA +       PS+ ++L V   +
Sbjct: 264 IKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFA 301

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 57.8 bits (140), Expect = 7e-09
 Identities = 36/129 (27%), Positives = 56/129 (43%), Gaps = 36/129 (27%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGM------------ARIFCEN 447
           I++ +L +    +L  IHRD+KP N+LLD     K+SDFG+             RI    
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166

Query: 448 QKTANT-------------------RRV-----VGTYGYMAPEYAMEGLFSVKSDVFSFG 483
             +                      RR      VGT  Y+APE  ++  ++ + D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226

Query: 484 VIVLEIISG 492
           VI+ E++ G
Sbjct: 227 VIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 57.4 bits (138), Expect = 7e-09
 Identities = 46/140 (32%), Positives = 75/140 (53%), Gaps = 14/140 (10%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN-TRRVVG 458
           IS  L YLHE     II+RDLK  NVLLD +   K++D+GM +   E  +  + T    G
Sbjct: 105 ISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCG 158

Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHA----QTLLAYVWQL 514
           T  Y+APE      +    D ++ GV++ E+++G+  S F + G +    Q    Y++Q+
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR--SPFDIVGSSDNPDQNTEDYLFQV 216

Query: 515 WKEGKEMEFVDPLLMKSSSI 534
             E K++     L +K++S+
Sbjct: 217 ILE-KQIRIPRSLSVKAASV 235

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 56.8 bits (137), Expect = 7e-09
 Identities = 52/214 (24%), Positives = 86/214 (40%), Gaps = 34/214 (15%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVA---VKRL-SRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +++G G FG V  G    G   A   VK L +  +      F  E+    +L H N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFI--------FDSERRLQLNWNTCYNIIGGISKGLL 405
           +G  IE    LL+ E  P   L  ++          +++ +         +   ++ GLL
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR------MACEVASGLL 114

Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC---ENQKTANTRRVVGTYGY 462
           +LH   +   IH DL   N  L  D+  KI D+G+A       E+         V    +
Sbjct: 115 WLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAV-PLRW 168

Query: 463 MAPEYAME---GLFSVK----SDVFSFGVIVLEI 489
           +APE        L        S+++S GV + E+
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 13/198 (6%)

Query: 300 LGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEI----ILIAKLQHRNLVRLV 354
           +G+G FG V       +G   AVK L +K+    +E  + +    +L+  L+H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61

Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
               +  EKL       N     F    ER         Y     ++  + YLH    L 
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFY--AAEVASAIGYLHS---LN 116

Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
           II+RDLKP N+LLD      ++DFG+ +   E ++T +T    GT  Y+APE   +  + 
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST--FCGTPEYLAPEVLRKEPYD 174

Query: 475 VKSDVFSFGVIVLEIISG 492
              D +  G ++ E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 45/164 (27%), Positives = 75/164 (45%), Gaps = 14/164 (8%)

Query: 338 EIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNII 397
           EI ++  + HR ++ L+        K  +  +MP    D F +  +R   L       I 
Sbjct: 136 EIDILKTISHRAIINLIHAY---RWKSTVCMVMPKYKCDLFTY-VDRSGPLPLEQAITIQ 191

Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVV 457
             + + L YLH      IIHRD+K  N+ LD+   A + DFG A   C+     +T +  
Sbjct: 192 RRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA---CKLDAHPDTPQCY 245

Query: 458 GTYGYM---APEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGF 498
           G  G +   +PE      +  K+D++S G+++ E +S K  + F
Sbjct: 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE-MSVKNVTLF 288

Length = 392

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 9/96 (9%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT--ANTRRVV 457
           I   L YLH      +++RDLK  N++LDKD   KI+DFG+    C+   +  A  +   
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGL----CKEGISDGATMKTFC 156

Query: 458 GTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           GT  Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 5/94 (5%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I   L YLH     KI++RDLK  N++LDKD   KI+DFG+ +    +  T  T    GT
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGT 158

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 33/98 (33%), Positives = 54/98 (55%), Gaps = 6/98 (6%)

Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
            G I   L +LH   +L II+RD+K  N+LLD +    ++DFG+++ F E++        
Sbjct: 111 SGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE-VERAYSF 166

Query: 457 VGTYGYMAPEYAM--EGLFSVKSDVFSFGVIVLEIISG 492
            GT  YMAP+     +G      D +S GV++ E+++G
Sbjct: 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 4/94 (4%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I   L YLH  S   +++RDLK  N++LDKD   KI+DFG+ +   ++  T  T    GT
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGT 159

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 56.7 bits (136), Expect = 3e-08
 Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 56/236 (23%)

Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKN-----EIILIAKLQHRNLVRL 353
           K+G G FG V+  ++ + +          S++GL+E +      E+ ++ +L+H+N+VR 
Sbjct: 20  KIGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK----------- 402
           +   +    + L Y LM      C   D  R +Q     CY + G I +           
Sbjct: 78  IDRFLNKANQKL-YILMEF----CDAGDLSRNIQ----KCYKMFGKIEEHAIVDITRQLL 128

Query: 403 -GLLYLHE----DSRLKIIHRDLKPSNVLLDKDM-----------------VAKISDFGM 440
             L Y H      +  +++HRDLKP N+ L   +                 +AKI DFG+
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188

Query: 441 AR-IFCENQKTANTRRVVGTYGYMAPEYAMEGLFSV--KSDVFSFGVIVLEIISGK 493
           ++ I  E+         VGT  Y +PE  +    S   KSD+++ G I+ E+ SGK
Sbjct: 189 SKNIGIESM----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 55.8 bits (134), Expect = 3e-08
 Identities = 56/243 (23%), Positives = 108/243 (44%), Gaps = 49/243 (20%)

Query: 275 SSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLE 333
             +E   +   + ++    +   N +G G FG VY+ + +   ++VA+K++ +       
Sbjct: 49  DEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----- 103

Query: 334 EFKN-EIILIAKLQHRNLVRL-----VGCGIEGEEKL---LIYELMP------------- 371
           ++KN E++++  L H N++ L       C  + E+ +   ++ E +P             
Sbjct: 104 QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARN 163

Query: 372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD-KD 430
           N +L  F+         ++  C        + L Y+H      I HRDLKP N+L+D   
Sbjct: 164 NHALPLFLVK-----LYSYQLC--------RALAYIHSKF---ICHRDLKPQNLLIDPNT 207

Query: 431 MVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEI 489
              K+ DFG A+     Q++ +    + +  Y APE  +    ++   D++S G I+ E+
Sbjct: 208 HTLKLCDFGSAKNLLAGQRSVS---YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264

Query: 490 ISG 492
           I G
Sbjct: 265 ILG 267

Length = 440

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 5/94 (5%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I   L YLH      +++RD+K  N++LDKD   KI+DFG+ +    +  T  T    GT
Sbjct: 104 IVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGT 158

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 54.6 bits (131), Expect = 6e-08
 Identities = 57/198 (28%), Positives = 86/198 (43%), Gaps = 13/198 (6%)

Query: 300 LGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEI----ILIAKLQHRNLVRLV 354
           +G+G FG V       +GK  AVK L +K     +E K+ +    +L+  ++H  LV L 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61

Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
               +  EKL       N     F    ER         Y     I+  L YLH    + 
Sbjct: 62  HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFY--AAEIASALGYLHS---IN 116

Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
           I++RDLKP N+LLD      ++DFG+ +       T  T    GT  Y+APE   +  + 
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT--FCGTPEYLAPEVIRKQPYD 174

Query: 475 VKSDVFSFGVIVLEIISG 492
              D +  G ++ E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 54.7 bits (131), Expect = 6e-08
 Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 5/94 (5%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I   L +LHE     II+RDLK  NVLLD D   K++D+GM +       T +T    GT
Sbjct: 105 ICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST--FCGT 159

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y+APE      +    D ++ GV++ E+++G+
Sbjct: 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 55.1 bits (132), Expect = 6e-08
 Identities = 48/188 (25%), Positives = 90/188 (47%), Gaps = 24/188 (12%)

Query: 314 PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE---LM 370
           P  + +  KR+ +   +   + +NEI+ + +L H N++++        E++L  E    M
Sbjct: 190 PKCERLIAKRV-KAGSRAAIQLENEILALGRLNHENILKI--------EEILRSEANTYM 240

Query: 371 PNRSLD----CFIFDSERRLQ---LNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPS 423
             +  D     F++D     +   L   T   I+  +   + Y+H+    K+IHRD+K  
Sbjct: 241 ITQKYDFDLYSFMYDEAFDWKDRPLLKQT-RAIMKQLLCAVEYIHDK---KLIHRDIKLE 296

Query: 424 NVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFG 483
           N+ L+ D    + DFG A  F E ++ A     VGT    +PE      +   +D++S G
Sbjct: 297 NIFLNCDGKIVLGDFGTAMPF-EKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCG 355

Query: 484 VIVLEIIS 491
           +I+L+++S
Sbjct: 356 LILLDMLS 363

Length = 501

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 54.6 bits (131), Expect = 6e-08
 Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           ++ G+ +L   +    +HRDL   NVL+ +  + KI DFG+AR    +    +       
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
             +MAPE     L++  SDV+SFG+++ EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 54.2 bits (130), Expect = 7e-08
 Identities = 37/112 (33%), Positives = 61/112 (54%), Gaps = 8/112 (7%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I++ +L +H   +L  +HRD+KP NVLLD +   +++DFG   +      T  +   VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC-LKMNQDGTVQSSVAVGT 166

Query: 460 YGYMAPEY--AME---GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQT 506
             Y++PE   AME   G +  + D +S GV + E++ G+  + FY     +T
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVET 216

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 55.0 bits (132), Expect = 7e-08
 Identities = 30/91 (32%), Positives = 51/91 (56%)

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           +L L E    K++HRDLK +N+ L    + K+ DFG ++ + ++          GT  Y+
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238

Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISGKR 494
           APE      +S K+D++S GVI+ E+++  R
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLTLHR 269

Length = 478

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 54.2 bits (130), Expect = 8e-08
 Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 5/89 (5%)

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           L  LH+     +I+RDLKP N+LLD      + DFG+ ++  ++    NT    GT  Y+
Sbjct: 106 LENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT--FCGTPEYL 160

Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+++G
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 5/93 (5%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I+  L YLH    L I++RDLKP N+LLD      ++DFG+ +   E+  T +T    GT
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST--FCGT 159

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
             Y+APE   +  +    D +  G ++ E++ G
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 37/113 (32%), Positives = 63/113 (55%), Gaps = 10/113 (8%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA-RIFCENQKTANTRRVVG 458
           +++ +L +    +L  +HRD+KP NVLLDK+   +++DFG   R+  +   T  +   VG
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVAVG 165

Query: 459 TYGYMAPEY--AME---GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQT 506
           T  Y++PE   AME   G +  + D +S GV + E++ G+  + FY     +T
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAESLVET 216

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 18/205 (8%)

Query: 299 KLGQGGFGTVYKGVLPNG---KEVAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLVRLV 354
           ++G G FG V  G + +G    +V VK L    S Q   +F  E      LQH NL++ +
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQL---NWNTCYNIIGGISKGLLYLHEDS 411
           G   E    LL+ E  P   L  ++  S R+ +L   +  T   +   I+ GLL+LH+++
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYL-RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAME- 470
               IH DL   N LL  D+  KI D+G++    +        ++     ++APE   E 
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177

Query: 471 --GLFSV----KSDVFSFGVIVLEI 489
              L  V    +S+V+S GV + E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.4 bits (125), Expect = 3e-07
 Identities = 60/261 (22%), Positives = 117/261 (44%), Gaps = 27/261 (10%)

Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEE-----FKNEIILIAKLQHRNLVRLV 354
           +G+G FG V    L N  +V   ++  K W+ L+      F+ E  ++    ++ +  L 
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNK-WEMLKRAETACFREERDVLVNGDNQWITTLH 67

Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
               +     L+ +      L   +   E RL  +    Y     +++ ++ +    +L 
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY-----LAEMVIAIDSVHQLH 122

Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY--AME-- 470
            +HRD+KP N+L+D +   +++DFG      E+  T  +   VGT  Y++PE   AME  
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGTPDYISPEILQAMEDG 181

Query: 471 -GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
            G +  + D +S GV + E++ G+  + FY    A++L+    ++    +  +F   +  
Sbjct: 182 KGKYGPECDWWSLGVCMYEMLYGE--TPFY----AESLVETYGKIMNHKERFQFPAQVTD 235

Query: 530 KSSSIPQVVRCIHIGLLCVQE 550
            S     ++R     L+C +E
Sbjct: 236 VSEDAKDLIR----RLICSRE 252

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 51.2 bits (122), Expect = 8e-07
 Identities = 36/126 (28%), Positives = 57/126 (45%), Gaps = 33/126 (26%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA-------- 451
           I++ +L +    +L  IHRD+KP N+LLD     K+SDFG+     +  +T         
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166

Query: 452 ----------NTRR---------------VVGTYGYMAPEYAMEGLFSVKSDVFSFGVIV 486
                     N++R                VGT  Y+APE  M+  ++   D +S GVI+
Sbjct: 167 PPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 487 LEIISG 492
            E++ G
Sbjct: 227 YEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 33/213 (15%)

Query: 300 LGQGGFGTVYKGVLPN---------GKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           LGQG F  +YKGVL           G+EV+V      S       F     L+++L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
           LV+L G  +  +E +++ E +    LD F+   +  + L+W    ++   ++  L YL +
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119

Query: 410 DSRLKIIHRDLKPSNVLLDKD-------MVAKISDFGMARIFCENQKTANTRRV-VGTYG 461
               K++H ++   N+L+ +           K+SD G+         T  +R   V    
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI-------TVLSREERVERIP 169

Query: 462 YMAPEYAMEGLFSVKS--DVFSFGVIVLEIISG 492
           ++APE    G  S+    D +SFG  +LEI S 
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 41/149 (27%), Positives = 70/149 (46%), Gaps = 15/149 (10%)

Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           C  + ++ L ++ E MP   L   +  S   +   W   Y      ++ +L L     + 
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYT-----AEVVLALDAIHSMG 162

Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY----AME 470
           +IHRD+KP N+LLDK    K++DFG   +  +          VGT  Y++PE       +
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVRCDTAVGTPDYISPEVLKSQGGD 221

Query: 471 GLFSVKSDVFSFGVIVLEIISGKRNSGFY 499
           G +  + D +S GV + E++ G  ++ FY
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVG--DTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 33/102 (32%), Positives = 52/102 (50%), Gaps = 16/102 (15%)

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT--------ANTR- 454
           L YLH      I+HRDLKP N+L+      K++DFG+++I   +  T         +TR 
Sbjct: 114 LEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 455 ----RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
               +V GT  Y+APE  +   +    D ++ G+I+ E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 31/126 (24%), Positives = 49/126 (38%), Gaps = 45/126 (35%)

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF---------------CENQKTANTRR- 455
           +L  IHRD+KP N+L+D+    K+SDFG++  F                 N+   + R  
Sbjct: 119 KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178

Query: 456 -----------------------------VVGTYGYMAPEYAMEGLFSVKSDVFSFGVIV 486
                                         VGT  Y+APE  ++  +  + D +S G I+
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238

Query: 487 LEIISG 492
            E + G
Sbjct: 239 FECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 36/126 (28%), Positives = 57/126 (45%), Gaps = 33/126 (26%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA-------- 451
           I++ +L +    +L  IHRD+KP N+LLD     K+SDFG+     +  +T         
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS 166

Query: 452 ----------NTRR---------------VVGTYGYMAPEYAMEGLFSVKSDVFSFGVIV 486
                     N++R                VGT  Y+APE  M+  ++   D +S GVI+
Sbjct: 167 LPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIM 226

Query: 487 LEIISG 492
            E++ G
Sbjct: 227 YEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 31/123 (25%), Positives = 53/123 (43%), Gaps = 41/123 (33%)

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGM---------ARIFCENQ-------------- 448
           ++  IHRD+KP N+L+D+D   K++DFG+         ++ + +                
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178

Query: 449 -------KTANTRRV-----------VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEII 490
                  K    RR            VGT  Y+APE  +   ++   D +S GVI+ E++
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238

Query: 491 SGK 493
            G+
Sbjct: 239 VGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 49.4 bits (118), Expect = 3e-06
 Identities = 35/121 (28%), Positives = 60/121 (49%), Gaps = 13/121 (10%)

Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMA-RIFCENQKTANTRRVVGTYGYMAPEYAM----E 470
           IHRD+KP N+LLDK    K++DFG   ++        +T   VGT  Y++PE       +
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT--AVGTPDYISPEVLKSQGGD 221

Query: 471 GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK 530
           G +  + D +S GV + E++ G  ++ FY    A +L+    ++      + F D + + 
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVG--DTPFY----ADSLVGTYSKIMDHKNSLTFPDDIEIS 275

Query: 531 S 531
            
Sbjct: 276 K 276

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 47.9 bits (114), Expect = 6e-06
 Identities = 51/211 (24%), Positives = 93/211 (44%), Gaps = 30/211 (14%)

Query: 300 LGQGGFGTVYKGVLPNGK--------EVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLV 351
           LGQG F  ++KG+             EV +K L +      E F     ++++L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLY-LHED 410
              G  + G+E +++ E +   SLD ++  ++  + ++W         ++K L + LH  
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKL------EVAKQLAWALHFL 116

Query: 411 SRLKIIHRDLKPSNVLLDKDMVA--------KISDFGMARIFCENQKTANTRRVVGTYGY 462
               + H ++   NVLL ++           K+SD G++       K     R+     +
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP--KEILLERI----PW 170

Query: 463 MAPEYAMEGL-FSVKSDVFSFGVIVLEIISG 492
           + PE        S+ +D +SFG  + EI SG
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 48.4 bits (115), Expect = 6e-06
 Identities = 45/198 (22%), Positives = 87/198 (43%), Gaps = 31/198 (15%)

Query: 314 PNGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP 371
           P G  V V+   L   + + L+  +NE++L    +H N++        G    +I   M 
Sbjct: 23  PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82

Query: 372 NRSLDCFIFDSERRLQLNW-------NTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSN 424
                   + S   L   +           NI+ G  +GL YLH++     IHR++K S+
Sbjct: 83  --------YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASH 131

Query: 425 VLLDKDMVAKISDFGMARIFCENQKTANTRRV-------VGTYGYMAPEYAMEGL--FSV 475
           +L+  D +  +S  G++ ++   +     + V            +++PE   + L  ++V
Sbjct: 132 ILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNV 189

Query: 476 KSDVFSFGVIVLEIISGK 493
           KSD++S G+   E+ +G+
Sbjct: 190 KSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.1 bits (114), Expect = 9e-06
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 13/94 (13%)

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR---VVGTYGYMAPEY-- 467
           +  IHRD+KP N+LLDK    K++DFG     C         R    VGT  Y++PE   
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGT----CMKMNKEGMVRCDTAVGTPDYISPEVLK 216

Query: 468 --AMEGLFSVKSDVFSFGVIVLEIISGKRNSGFY 499
               +G +  + D +S GV + E++ G  ++ FY
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVG--DTPFY 248

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 44/179 (24%), Positives = 70/179 (39%), Gaps = 36/179 (20%)

Query: 292 DGFSDSNKLGQGGFGTVYKGVLPN-----GKEVAVKRLSRKSWQGLEEFKNEIIL----- 341
           D F    KLG+G FG VYK  L N       +  +K+     +  +E + NE +      
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKA--TEYGAVEIWMNERVRRACPN 189

Query: 342 -IAKLQHRNLVRLVGCG---------IEGEEKLLIYELMPNR----SLDCFIFDSERRLQ 387
             A   +  L  +              EGE  L   +LM ++    +++ ++    + L 
Sbjct: 190 SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTL--ADLMQSKEFPYNVEPYLLGKVQDLP 247

Query: 388 LNWNTCYNIIGGISKGLLY----LHEDSRLKIIHRDLKPSNVLLD-KDMVAKISDFGMA 441
                   II  I + +L+    LH      I+HRD+KP N++        KI D G A
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303

Length = 566

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 45/196 (22%), Positives = 90/196 (45%), Gaps = 22/196 (11%)

Query: 308 VYKGVLPNGKEVAVKRL---SRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL 364
           +YKG+  N KEV ++      +     ++  +NEI  + ++   N++++ G  I+  + L
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 365 ----LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDL 420
               LI E      L   + D E+   L++ T  ++     KGL  L+        +++L
Sbjct: 95  PRLSLILEYCTRGYLREVL-DKEK--DLSFKTKLDMAIDCCKGLYNLY--KYTNKPYKNL 149

Query: 421 KPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS---VKS 477
              + L+ ++   KI   G+     E   ++   + V    Y + +  +  +FS   +K 
Sbjct: 150 TSVSFLVTENYKLKIICHGL-----EKILSSPPFKNVNFMVYFSYKM-LNDIFSEYTIKD 203

Query: 478 DVFSFGVIVLEIISGK 493
           D++S GV++ EI +GK
Sbjct: 204 DIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 32/127 (25%), Positives = 53/127 (41%), Gaps = 45/127 (35%)

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF--------------------------- 444
           ++  IHRD+KP N+L+D+D   K++DFG+   F                           
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 445 ------CENQKTANTRR------------VVGTYGYMAPEYAMEGLFSVKSDVFSFGVIV 486
                 C ++     RR            +VGT  Y+APE  +   ++   D +S GVI+
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238

Query: 487 LEIISGK 493
            E++ G+
Sbjct: 239 YEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 45.4 bits (107), Expect = 6e-05
 Identities = 39/165 (23%), Positives = 71/165 (43%), Gaps = 17/165 (10%)

Query: 338 EIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTC--YN 395
           E  ++  + H ++++L G     +   LI   +P    D + + + +R   N   C    
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKR---NIAICDILA 186

Query: 396 IIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR 455
           I   + + + YLHE+    IIHRD+K  N+ ++      + DFG A   C        + 
Sbjct: 187 IERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA---CFPVDINANKY 240

Query: 456 V--VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGF 498
               GT    APE      +    D++S G+++ E+ +   +S F
Sbjct: 241 YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH-DSLF 284

Length = 391

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 44.5 bits (105), Expect = 9e-05
 Identities = 53/218 (24%), Positives = 91/218 (41%), Gaps = 45/218 (20%)

Query: 299 KLGQGGFGTVYKGVL---PNGKEVAVKRLSRKSWQGLEEFKNEIILIAK----LQHRNLV 351
           ++G G FG V    +        V VK L  K+    +E +NE +        LQH N++
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKEL--KANASSKE-QNEFLQQGDPYRILQHPNIL 58

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFI------FDSERRLQLNWNTCYNIIGGISKGLL 405
           + +G  +E    LL++E      L  ++        + + L L    C      I+ G+ 
Sbjct: 59  QCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACE-----IAAGVT 113

Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA-------RIFCENQKTANTRRVVG 458
           ++H   +   +H DL   N  L  D+  K+ D+G+         I  E+ K    R    
Sbjct: 114 HMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR---- 166

Query: 459 TYGYMAPEYAME---GLFSVK----SDVFSFGVIVLEI 489
              ++APE   E   GL + +    S+V++ GV + E+
Sbjct: 167 ---WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 44.1 bits (105), Expect = 1e-04
 Identities = 30/107 (28%), Positives = 49/107 (45%), Gaps = 10/107 (9%)

Query: 388 LNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV-AKISDFGMARIFCE 446
           L+      II  + + L  LH   +  IIH D+K  NVL D+      + D+G+ +I   
Sbjct: 106 LSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI--I 160

Query: 447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
              +       GT  Y +PE      + V  D ++ GV+  E+++GK
Sbjct: 161 GTPSCYD----GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 44.5 bits (105), Expect = 2e-04
 Identities = 19/40 (47%), Positives = 28/40 (70%), Gaps = 3/40 (7%)

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI 443
           L YLH   R  IIHRDLKP N+L+  +   K++DFG++++
Sbjct: 117 LDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 33/127 (25%), Positives = 54/127 (42%), Gaps = 45/127 (35%)

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF--CEN----QKTANTRR---------- 455
           ++  IHRD+KP N+L+D D   K++DFG+   F    N    QK ++ R+          
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178

Query: 456 -----------------------------VVGTYGYMAPEYAMEGLFSVKSDVFSFGVIV 486
                                        +VGT  Y+APE  +   ++   D +S GVI+
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238

Query: 487 LEIISGK 493
            E++ G+
Sbjct: 239 FEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 42.8 bits (100), Expect = 5e-04
 Identities = 24/55 (43%), Positives = 32/55 (58%), Gaps = 7/55 (12%)

Query: 395 NIIGGISK----GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC 445
           N+I G+ +    GL  LH   R+ I+HRD+KP N+L+  D   KI DFG A   C
Sbjct: 309 NVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360

Length = 507

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 40.0 bits (94), Expect = 0.002
 Identities = 31/119 (26%), Positives = 51/119 (42%), Gaps = 34/119 (28%)

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGM-------------ARIFCENQK 449
            L YLH    L I++RDLKP N+LL +     +SDF +             A      + 
Sbjct: 115 ALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171

Query: 450 --------------TANTRRVVGTYGYMAPEY-AMEG-LFSVKSDVFSFGVIVLEIISG 492
                         +  +   VGT  Y+APE  + +G   +V  D ++ G+++ E++ G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV--DWWTLGILLYEMLYG 228

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 39.5 bits (92), Expect = 0.003
 Identities = 47/200 (23%), Positives = 86/200 (43%), Gaps = 37/200 (18%)

Query: 314 PNGKEVAVKRLSRKSWQGLEEFKNEIIL-------IAKL-QHRNLVRLVGCGIEGEEKLL 365
           P G+ V V+R++      LE   NE++        ++KL  H N+V      I   E  +
Sbjct: 23  PTGEYVTVRRIN------LEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 76

Query: 366 IYELM---PNRSLDCFIF-DSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLK 421
           +   M     + L C  F D    L + +     I+ G+ K L Y+H    +  +HR +K
Sbjct: 77  VTSFMAYGSAKDLICTHFMDGMSELAIAY-----ILQGVLKALDYIHH---MGYVHRSVK 128

Query: 422 PSNVLLDKDMVAKISDFGMARIFC-----ENQKTANT--RRVVGTYGYMAPEYAMEGL-- 472
            S++L+  D   K+   G+          +  +  +   +  V    +++PE   + L  
Sbjct: 129 ASHILISVD--GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQG 186

Query: 473 FSVKSDVFSFGVIVLEIISG 492
           +  KSD++S G+   E+ +G
Sbjct: 187 YDAKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 39.6 bits (92), Expect = 0.004
 Identities = 30/114 (26%), Positives = 51/114 (44%), Gaps = 23/114 (20%)

Query: 396 IIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVA----------------KISDFG 439
           II      L Y H  + L ++H DLKP N+L++                     +I D G
Sbjct: 236 IIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG 293

Query: 440 MARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
                C +++ + T  +V T  Y +PE  +   +   +D++S G I+ E+ +GK
Sbjct: 294 G----CCDERHSRT-AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	611
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.98
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.98
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.98
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.98
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.98
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.91
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.89
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.89
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.88
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.87
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.87
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.86
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.85
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.84
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.84
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.81
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.8
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
PRK10345	210	hypothetical protein; Provisional	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.77
smart00090	237	RIO RIO-like kinase.	99.75
PRK14879	211	serine/threonine protein kinase; Provisional	99.74
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.72
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.72
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.72
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.71
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.71
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.62
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.61
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.6
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.48
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.38
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.36
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.35
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.34
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.26
KOG1243	690	consensus Protein kinase [General function predict	99.24
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.17
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.16
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.16
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.1
KOG3087	229	consensus Serine/threonine protein kinase [General	99.05
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.99
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.96
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.92
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.91
COG4248	637	Uncharacterized protein with protein kinase and he	98.7
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.69
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.62
PRK09902	216	hypothetical protein; Provisional	98.55
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.48
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.48
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.47
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.38
PF01636	239	APH: Phosphotransferase enzyme family This family	98.34
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.3
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.28
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.26
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.08
PLN02876	822	acyl-CoA dehydrogenase	98.03
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.02
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.99
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.94
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.91
PRK10593	297	hypothetical protein; Provisional	97.84
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.84
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.79
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.76
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.71
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.53
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.51
PRK05231	319	homoserine kinase; Provisional	97.5
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.5
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.48
PF11883	48	DUF3403: Domain of unknown function (DUF3403); Int	97.43
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.25
PLN02236	344	choline kinase	97.24
KOG2270	520	consensus Serine/threonine protein kinase involved	97.12
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.08
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.91
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.85
PRK12396	409	5-methylribose kinase; Reviewed	96.76
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.73
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.51
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.5
PLN02756	418	S-methyl-5-thioribose kinase	96.42
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.11
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.07
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.9
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.31
PRK11768	325	serine/threonine protein kinase; Provisional	95.18
PRK06148	1013	hypothetical protein; Provisional	95.11
COG2334	331	Putative homoserine kinase type II (protein kinase	95.11
PTZ00384	383	choline kinase; Provisional	95.04

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-52  Score=433.06  Aligned_cols=287  Identities=45%  Similarity=0.724  Sum_probs=254.0

Q ss_pred             CCCccCHHHHHHhhCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeE
Q 007239          278 ELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG  357 (611)
Q Consensus       278 ~~~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~  357 (611)
                      ....+.+.++..+|++|...+.||+|+||.||+|..++|+.||||++.....+...+|.+|+.++.+++|||+|+++|+|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45558999999999999999999999999999999999999999988766543144599999999999999999999999


Q ss_pred             eeCC-eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEe
Q 007239          358 IEGE-EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKIS  436 (611)
Q Consensus       358 ~~~~-~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~  436 (611)
                      .+.+ +.+||||||++|+|.++|+..... .++|..+++|+.++|+||+|||......|||||||++|||+|++++.||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9998 599999999999999999765444 78999999999999999999999876789999999999999999999999


Q ss_pred             ccccceecccCCCccccccc-cccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHH
Q 007239          437 DFGMARIFCENQKTANTRRV-VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLW  515 (611)
Q Consensus       437 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~  515 (611)
                      |||+|+........  .... .||.+|+|||++..+..+.|+|||||||+|+||++|+++.+.........+..|.+..+
T Consensus       220 DFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             CccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999654331111  1112 89999999999999999999999999999999999999887666566667999999999


Q ss_pred             hcCccccccccccC-CCCCH-HHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          516 KEGKEMEFVDPLLM-KSSSI-PQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       516 ~~~~~~~~~d~~l~-~~~~~-~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      .++...+++|+.+. ..+.. .++.++..++.+|++.+|++||+|.+|+++|+.
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~  351 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG  351 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence            99999999999987 55554 688889999999999999999999999999954

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-47  Score=398.09  Aligned_cols=247  Identities=26%  Similarity=0.387  Sum_probs=209.6

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ..|+..+.||+|||+.+|.++. ..|+.||+|++.+.   +....+.+.+||+|.+.|+|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5799999999999999999996 88999999999864   3345678999999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      |+|++++|..++   ++++.+++.+++.++.||+.||.|||+++   |||||||..|+|+++++++||+|||||..+..+
T Consensus        98 ELC~~~sL~el~---Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELL---KRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHH---HhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            999999999998   57788999999999999999999999996   999999999999999999999999999988644


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                      ...  ..+++|||.|+|||++.....+..+||||+|||||.||.|++||....       +......++...-      .
T Consensus       172 ~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-------vkety~~Ik~~~Y------~  236 (592)
T KOG0575|consen  172 GER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-------VKETYNKIKLNEY------S  236 (592)
T ss_pred             ccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-------HHHHHHHHHhcCc------c
Confidence            333  335899999999999999999999999999999999999999984221       1111111222111      1


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      +.    .....+..+||..+|+.||.+|||+++|+.
T Consensus       237 ~P----~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  237 MP----SHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             cc----cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            11    122234568899999999999999999995

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-47  Score=379.81  Aligned_cols=254  Identities=26%  Similarity=0.373  Sum_probs=204.9

Q ss_pred             HhhCCCCcccccCccCceEEEEEE-cCCCcEEEEEEecccChhh-------HHHHHHHHHHHHhcCCCCeeeEEEeEeeC
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG-------LEEFKNEIILIAKLQHRNLVRLVGCGIEG  360 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~  360 (611)
                      ...+.|.+.+.||+|+||.|-+|. .++|+.||||++.+.....       .....+|++||++|+|||||+++++|...
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            356789999999999999999999 4689999999997643221       23357999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC---CCEEEec
Q 007239          361 EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD---MVAKISD  437 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~---~~~kl~D  437 (611)
                      +..|+||||++||.|.+++.   ..+.+.+.....++.|++.|+.|||++|   |+||||||+|||++.+   ..+||+|
T Consensus       249 ds~YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             CceEEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence            99999999999999999984   4556888888999999999999999998   9999999999999766   6899999


Q ss_pred             cccceecccCCCccccccccccCCCCCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH
Q 007239          438 FGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL---FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL  514 (611)
Q Consensus       438 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~  514 (611)
                      ||+|+..++   ...+++.+|||.|.|||++.++.   +..|+|+||+||+||-+|+|.+||.....+.  .+.+    .
T Consensus       323 FGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~e----Q  393 (475)
T KOG0615|consen  323 FGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKE----Q  393 (475)
T ss_pred             cchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHH----H
Confidence            999998653   34567899999999999998764   3348899999999999999999986544332  1111    1


Q ss_pred             HhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       515 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      +..+....  .+    ..-..-..+.++|+.+||+.||++|||+.|+++
T Consensus       394 I~~G~y~f--~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  394 ILKGRYAF--GP----LQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HhcCcccc--cC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            22222111  00    011122346779999999999999999999986

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-46  Score=367.71  Aligned_cols=199  Identities=35%  Similarity=0.572  Sum_probs=180.7

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ...+|.+.++||+|+||+||+|++ +++..||||.+.+.  ..+..+.+..|+++|+.++|||||++++++..++.++||
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            346899999999999999999995 46899999999876  556677889999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC------CCEEEecccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD------MVAKISDFGM  440 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~------~~~kl~DFGl  440 (611)
                      ||||+||+|.++|   .+++.+++..++.++.||+.||++||+++   ||||||||.||||+..      -.+||+|||+
T Consensus        88 MEyC~gGDLs~yi---~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   88 MEYCNGGDLSDYI---RRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EEeCCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            9999999999999   45567999999999999999999999996   9999999999999764      4689999999


Q ss_pred             ceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007239          441 ARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSG  497 (611)
Q Consensus       441 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~  497 (611)
                      |+.+.+..   ...+.+|+|-|||||++..++|+.|+|+||+|+++|+|++|+.||.
T Consensus       162 AR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~  215 (429)
T KOG0595|consen  162 ARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD  215 (429)
T ss_pred             hhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence            99876433   3446899999999999999999999999999999999999999974

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-46  Score=365.37  Aligned_cols=251  Identities=29%  Similarity=0.364  Sum_probs=206.9

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC-eEEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE-EKLLIYE  368 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~lv~E  368 (611)
                      .+.+.++.||+|..|+|||++++ +++.+|+|.+... .....+++.+|++++++.+||+||.+|+.|.... .+.++||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            35667789999999999999965 6888999999543 3445678999999999999999999999999998 4999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      ||++|+|++++.   ..+.+++..+-+|+.+|++||.|||+..  +||||||||+||||+..|++||+|||.++.+... 
T Consensus       159 YMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  159 YMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             hcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            999999999984   3467999999999999999999999632  5999999999999999999999999999876544 


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CCchhhHHHHHHHHHhcCcccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYL--TGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~--~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                         ....++||..|||||.+.+..|+.++||||||++++|+.+|+-|+....  ......++..+    -.+...+    
T Consensus       233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I----v~~ppP~----  301 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI----VDEPPPR----  301 (364)
T ss_pred             ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH----hcCCCCC----
Confidence               3456899999999999999999999999999999999999999876531  12222333322    1111111    


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       +...   ....++.+++..||++||.+||++.|+++
T Consensus       302 -lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  302 -LPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             -CCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             1111   23356789999999999999999999886

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-45  Score=378.16  Aligned_cols=255  Identities=31%  Similarity=0.475  Sum_probs=207.7

Q ss_pred             CCcccccCccCceEEEEEEcCCCcEEEEEEecccChh--hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC-eEEEEEEec
Q 007239          294 FSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQ--GLEEFKNEIILIAKLQHRNLVRLVGCGIEGE-EKLLIYELM  370 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~lv~E~~  370 (611)
                      +.+.+.||+|+||+||+|.+.....||+|++......  ..+.|.+|+.+|.+++|||||+++|++.+.. ...+||||+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            4445669999999999999965555999999765322  2568999999999999999999999999888 799999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC-CEEEeccccceecccCCC
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQK  449 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGla~~~~~~~~  449 (611)
                      ++|+|.++++.. ....+++..+++|+.+|++||.|||+++.  ||||||||+||||+.++ ++||+|||+++...... 
T Consensus       123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            999999999764 46779999999999999999999999852  99999999999999998 99999999998754332 


Q ss_pred             ccccccccccCCCCCccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          450 TANTRRVVGTYGYMAPEYAM--EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~--~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                       .......||+.|||||++.  ...|+.|+||||||++||||+||+.||.....      .+........+....+..  
T Consensus       199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~------~~~~~~v~~~~~Rp~~p~--  269 (362)
T KOG0192|consen  199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP------VQVASAVVVGGLRPPIPK--  269 (362)
T ss_pred             -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhcCCCCCCCc--
Confidence             2233368999999999999  66999999999999999999999999854332      122222222333222211  


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                             .....+..++.+||+.||+.||++.+++.+|+..
T Consensus       270 -------~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  270 -------ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             -------cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence                   1334567888899999999999999999999754

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=363.11  Aligned_cols=242  Identities=26%  Similarity=0.337  Sum_probs=200.9

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++++.||+|+||+|+.++. ++++-+|+|++++...   ...+...+|..||.+++||+||+++..|++.+.+|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            47899999999999999999995 5688899999987633   3456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      +||+.||.|...|   ++.+.+++..++-++.+|+.||.|||+++   ||||||||+|||+|.+|+++|+|||+++....
T Consensus       104 ld~~~GGeLf~hL---~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHL---QREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHH---HhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            9999999999888   55677999999999999999999999997   99999999999999999999999999986543


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ...  .+.+++||+.|||||++.+..|+..+|+||||+++|||++|.+||.....      ..+. +.+..++..     
T Consensus       178 ~~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~-~~I~~~k~~-----  243 (357)
T KOG0598|consen  178 DGD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMY-DKILKGKLP-----  243 (357)
T ss_pred             CCC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHH-HHHhcCcCC-----
Confidence            332  34458999999999999999999999999999999999999999853221      1111 112222210     


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCC
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRP  556 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP  556 (611)
                          ..+.-...+..+++...|+.||++|-
T Consensus       244 ----~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  244 ----LPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ----CCCccCCHHHHHHHHHHhccCHHHhc
Confidence                01111223466888899999999996

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5e-46  Score=351.63  Aligned_cols=259  Identities=27%  Similarity=0.403  Sum_probs=209.6

Q ss_pred             CCCCcccccCccCceEEEEEE-cCCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEE-eEeeCCe-EEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVG-CGIEGEE-KLLI  366 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~-~~~~~~~-~~lv  366 (611)
                      .+|.++++||+|.||+|||+. ..+|..+|.|.+.-.  +.+....+..|+.+|++|+|||||+.++ -|.++.. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            468899999999999999999 568999999988633  3345667889999999999999999998 4444444 8999


Q ss_pred             EEecCCCChhhHhhh-chhhccCCHHHHHHHHHHHHHHHHHHhhcC-CCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          367 YELMPNRSLDCFIFD-SERRLQLNWNTCYNIIGGISKGLLYLHEDS-RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~-~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      |||+.+|+|..++.. ++.+..+++..+|+++.|+++||.++|++- +.-|+||||||.||+|+.+|.+||+|||+++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999976 345667999999999999999999999842 234999999999999999999999999999987


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      .....  .....+|||.||+||.+.+.+|+.|+||||+||++|||..-++||...      ++.+ +.+.+..+....+.
T Consensus       179 ~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~-L~~KI~qgd~~~~p  249 (375)
T KOG0591|consen  179 SSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLS-LCKKIEQGDYPPLP  249 (375)
T ss_pred             cchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHH-HHHHHHcCCCCCCc
Confidence            54433  234589999999999999999999999999999999999999998432      2332 22334444332221


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      +        .-...++..|+..|+..||+.||+...+++.+.+
T Consensus       250 ~--------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  250 D--------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             H--------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            1        2234567788889999999999997766666654

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-44  Score=368.25  Aligned_cols=254  Identities=32%  Similarity=0.460  Sum_probs=208.3

Q ss_pred             CCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      .++..+.||+|-||+||.|.++...+||+|.++... ...+.|.+|+++|++|+|+|||++++++..++.++||||||+.
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~  285 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence            355678999999999999999888899999998764 3457788999999999999999999999998999999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      |+|.++|.. ..+..+...+.+.++.|||+||+||+++.   +|||||...||||+++..+||+|||||+...++.....
T Consensus       286 GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~  361 (468)
T KOG0197|consen  286 GSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS  361 (468)
T ss_pred             CcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence            999999965 34567899999999999999999999985   99999999999999999999999999996554444332


Q ss_pred             cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCC
Q 007239          453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKS  531 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  531 (611)
                      . ...-...|.|||.+..+.|+.|||||||||+||||+| |+.|++....   .+++    +.+..|..         -+
T Consensus       362 ~-~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn---~ev~----~~le~GyR---------lp  424 (468)
T KOG0197|consen  362 E-GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN---EEVL----ELLERGYR---------LP  424 (468)
T ss_pred             C-CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH---HHHH----HHHhccCc---------CC
Confidence            2 2234567999999999999999999999999999998 6666543221   1222    22233322         11


Q ss_pred             CCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          532 SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       532 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      .+.....++.+|+..||+.+|++|||.+.+...|+..
T Consensus       425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence            2233445677899999999999999999999988753

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=355.81  Aligned_cols=272  Identities=26%  Similarity=0.351  Sum_probs=217.4

Q ss_pred             HHhhCCCCcccccCccCceEEEEEE-cCCCcEEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCe
Q 007239          288 KAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       288 ~~~~~~y~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~  362 (611)
                      +...++|.+++.||+|+|++|++++ ...+++||||++.++-   ....+.+..|-.+|.+| .||.|++|+..|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            3456789999999999999999999 4579999999987652   22345678899999999 69999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      +|+|+||+++|+|.++|   .+.+.+++..++.++.||+.||+|||+.|   ||||||||+|||||++|++||+|||.|+
T Consensus       149 LYFvLe~A~nGdll~~i---~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLI---KKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             eEEEEEecCCCcHHHHH---HHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence            99999999999999999   45577999999999999999999999997   9999999999999999999999999999


Q ss_pred             ecccCCCc-----------cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHH
Q 007239          443 IFCENQKT-----------ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYV  511 (611)
Q Consensus       443 ~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~  511 (611)
                      .+......           .....++||..|.+||++..+..+..+|+|+|||+||+|+.|++||...   .+..+.+.+
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~---NeyliFqkI  299 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA---NEYLIFQKI  299 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc---cHHHHHHHH
Confidence            88554322           1124589999999999999999999999999999999999999998421   222222222


Q ss_pred             HHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHh--cCC----CCCCCCCCCCCCcc
Q 007239          512 WQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL--GSE----SIALSEPRQPPFPV  582 (611)
Q Consensus       512 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L--~~~----~~~l~~~~~p~~~~  582 (611)
                      ..          ++-.+....    .....+|+...|..||.+|+|.++|-+..  +..    -+...+|..-||..
T Consensus       300 ~~----------l~y~fp~~f----p~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~py~p  362 (604)
T KOG0592|consen  300 QA----------LDYEFPEGF----PEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQPYKP  362 (604)
T ss_pred             HH----------hcccCCCCC----CHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCcccCCCC
Confidence            11          111111111    13455888899999999999999988754  322    24455555555543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.3e-43  Score=333.79  Aligned_cols=264  Identities=21%  Similarity=0.284  Sum_probs=204.4

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ++|+.+.++|+|+||+|||++++ +|+.||||++.....  .-.+-..+|+++|++|+|+|+|.++++|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            46888999999999999999964 699999999865432  234556899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |++..-|+++-.   -...++.+.+.+++.|+++|+.|+|++.   +|||||||+||||+.+|.+||||||+|+.+....
T Consensus        82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            999988777642   2334889999999999999999999985   9999999999999999999999999999876322


Q ss_pred             CccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHH--------HHHHhcCc
Q 007239          449 KTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYV--------WQLWKEGK  519 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~~  519 (611)
                        ..-+..+.|.+|.|||.+.+ .+|+..+|||++||++.||++|.+-|+...+.++-.++...        .+.+..+.
T Consensus       156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence              12234678999999999987 78999999999999999999999988766555443333221        12222211


Q ss_pred             -cccccccccCCCCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          520 -EMEFVDPLLMKSSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       520 -~~~~~d~~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       ...+.-+......+.     ....-+++++..||+.||++|++-++++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence             111111111110000     01113579999999999999999999863

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-42  Score=349.70  Aligned_cols=264  Identities=25%  Similarity=0.360  Sum_probs=204.6

Q ss_pred             hhCCCCcccccCccCceEEEEEE-cCCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC--CeEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG--EEKL  364 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~  364 (611)
                      -.+.|+.+++||+|.||.||+++ ..+|+.||+|+++...  ........+||.||++|+||||++|.+...+.  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            34678889999999999999999 4689999999987654  44556678999999999999999999998876  7899


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      ||+|||++ +|.-++.  .....+++.++..++.||+.||+|+|++|   |+|||||.+|||||.+|.+||+|||||+++
T Consensus       195 lVFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence            99999998 5666653  23456999999999999999999999997   999999999999999999999999999988


Q ss_pred             ccCCCccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc---
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE---  520 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~---  520 (611)
                      ........ +..+-|..|.|||.+.+. .|+.++|+||.||||.||+.|++.+......   ..++.+.++......   
T Consensus       269 ~~~~~~~~-T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv---eQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  269 TPSGSAPY-TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV---EQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             cCCCCccc-ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH---HHHHHHHHHhCCCChhcc
Confidence            65554333 345679999999998874 6999999999999999999999887543332   233333333221111   


Q ss_pred             c-------cccccccCCCCCHHH-----HHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          521 M-------EFVDPLLMKSSSIPQ-----VVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       521 ~-------~~~d~~l~~~~~~~~-----~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .       ..+.+...-.....+     ....++|+..+|..||++|.|+.++++
T Consensus       345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1       111111110111111     124578888999999999999999875

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-42  Score=325.53  Aligned_cols=237  Identities=26%  Similarity=0.319  Sum_probs=198.3

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|+..+.||.|+||.|.+++. .+|..+|+|++.+...   +..+...+|..+|+.+.||+++++++.+.+...+++|
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            46899999999999999999995 4688899999987643   3456678899999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||++||.|..++   .+.+++++..++.++.||+.||+|||+.+   |++|||||+|||+|.+|.+||+|||+|+....
T Consensus       123 meyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  123 MEYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             EeccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            9999999999999   55567999999999999999999999986   99999999999999999999999999997633


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                           .+-+.+|||.|+|||+++.+.++.++|+|+|||++|||+.|.+||....+   ..+.    +.+-+++.      
T Consensus       197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY----~KI~~~~v------  258 (355)
T KOG0616|consen  197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIY----EKILEGKV------  258 (355)
T ss_pred             -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHH----HHHHhCcc------
Confidence                 24468999999999999999999999999999999999999999854333   1111    22222221      


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCC
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVR  555 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~R  555 (611)
                          ..+.-....+.+|+...|+.|-.+|
T Consensus       259 ----~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 ----KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ----cCCcccCHHHHHHHHHHHhhhhHhh
Confidence                0111122345677888889888888

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-42  Score=354.71  Aligned_cols=250  Identities=27%  Similarity=0.422  Sum_probs=211.9

Q ss_pred             hCCCCcccccCccCceEEEEEE-cCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      ...|....+||+|+.|.||.+. ..+++.||||++........+-+.+|+.+|+..+|+|||++++.|...+++|+||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            4578888999999999999999 467889999999888777778899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      |+||+|.+.+.    .-.+++.++..|+++++.||+|||.+|   |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus       352 m~ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  352 MEGGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             cCCCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            99999999873    234899999999999999999999997   99999999999999999999999999998866554


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                        .....+|||.|||||++....|++|+||||||++++||+-|++||-..      .-+..++.....+.. ++-.    
T Consensus       425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE------~PlrAlyLIa~ng~P-~lk~----  491 (550)
T KOG0578|consen  425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE------NPLRALYLIATNGTP-KLKN----  491 (550)
T ss_pred             --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC------ChHHHHHHHhhcCCC-CcCC----
Confidence              334579999999999999999999999999999999999999997331      122223333333322 1111    


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                         .......+.+++.+||+.|+++||++.|+|+
T Consensus       492 ---~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  492 ---PEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             ---ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence               1222345679999999999999999999986

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=354.68  Aligned_cols=250  Identities=25%  Similarity=0.365  Sum_probs=205.2

Q ss_pred             HhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc----Ch-hhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCC
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK----SW-QGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGE  361 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~  361 (611)
                      ...++|.+++.||+|+||+|+.+.. .+++.||+|++.+.    .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3457899999999999999999984 57899999977654    22 23556778999999999 999999999999999


Q ss_pred             eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC-CCEEEecccc
Q 007239          362 EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD-MVAKISDFGM  440 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~-~~~kl~DFGl  440 (611)
                      ..++||||+.||.|.+++.+   .+++.+..+..+++||+.|++|+|++|   |+||||||+|||++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            99999999999999999943   567899999999999999999999997   9999999999999999 9999999999


Q ss_pred             ceecccCCCccccccccccCCCCCccccccCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC
Q 007239          441 ARIFCENQKTANTRRVVGTYGYMAPEYAMEGL-FS-VKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG  518 (611)
Q Consensus       441 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  518 (611)
                      +....  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||..      .+....... +..+
T Consensus       168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d------~~~~~l~~k-i~~~  238 (370)
T KOG0583|consen  168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD------SNVPNLYRK-IRKG  238 (370)
T ss_pred             ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC------ccHHHHHHH-HhcC
Confidence            99763  2223345679999999999999877 85 789999999999999999999854      111111111 2222


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 007239          519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV  562 (611)
Q Consensus       519 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  562 (611)
                      ...  +...+    .   ..++.+|+.+||+.||.+|+++.+|+
T Consensus       239 ~~~--~p~~~----~---S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  239 EFK--IPSYL----L---SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             Ccc--CCCCc----C---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            110  00001    0   34677899999999999999999999

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-41  Score=337.73  Aligned_cols=262  Identities=25%  Similarity=0.380  Sum_probs=208.9

Q ss_pred             hCCCCcccccCccCceEEEEEE-cCCCcEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQ-GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .+.|++...||.|..++||+|+ .+.++.||||++.-+... ..+.+.+|+..++.++||||++.+..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            3679999999999999999999 567899999999765433 36889999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      ||.+||+.+++...-.. .+++..+..|++++++||.|||.+|   .||||||+.||||+.+|.|||+|||....+....
T Consensus       105 fMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            99999999999764433 3899999999999999999999998   9999999999999999999999999886553322


Q ss_pred             C-cc-ccccccccCCCCCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          449 K-TA-NTRRVVGTYGYMAPEYAME--GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       449 ~-~~-~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      . .. ..+.++||+.|||||++..  ..|+.|+||||||++..||.+|..||....+-.  -|+    ..+.+ ......
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk--vLl----~tLqn-~pp~~~  253 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK--VLL----LTLQN-DPPTLL  253 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH--HHH----HHhcC-CCCCcc
Confidence            1 11 2256799999999999654  469999999999999999999999986544311  111    11111 111111


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      -..+..+........+.+++..||+.||++|||+++++.
T Consensus       254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            112222222223336678899999999999999999875

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=340.85  Aligned_cols=256  Identities=29%  Similarity=0.413  Sum_probs=202.6

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC--eEEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE--EKLLIYE  368 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~--~~~lv~E  368 (611)
                      .++...+.||+|+||.||++... +|+..|||.+...+....+.+.+|+.+|.+++|||||+.+|.....+  .++++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            45778899999999999999964 58999999987654334677999999999999999999999755444  6899999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC-CCCEEEeccccceeccc-
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK-DMVAKISDFGMARIFCE-  446 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGla~~~~~-  446 (611)
                      |+++|+|.+++.....  .+++..+.++.+||++||.|||++|   ||||||||+||||+. ++.+||+|||+++.... 
T Consensus        97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999999954332  6999999999999999999999997   999999999999999 79999999999987653 


Q ss_pred             CCCccccccccccCCCCCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ...........||+.|||||++..+. ...++|||||||++.||+||++||...     ..................   
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~~~P~---  243 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGREDSLPE---  243 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccCCCCC---
Confidence            12222334578999999999999643 345999999999999999999998543     111122222222221111   


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                        +    +.....+..+++..|++.||++|||++++++.--
T Consensus       244 --i----p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  244 --I----PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             --C----CcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence              1    1112235668999999999999999999998653

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.6e-41  Score=346.15  Aligned_cols=275  Identities=21%  Similarity=0.247  Sum_probs=212.9

Q ss_pred             HHhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChh---hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeE
Q 007239          288 KAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQ---GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       288 ~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  363 (611)
                      +...++|++++.||+|+||.||+++. ++|..+|+|++++....   ..+.++.|-.+|....+|+||+++..|.+.+.+
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            33568999999999999999999995 57999999999876433   456678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ||||||++||++..+|   .+.+.|+++.++.++.+++.|+.-||+.|   +|||||||+|+|||..|++||+||||+.-
T Consensus       217 YLiMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence            9999999999999999   56678999999999999999999999997   99999999999999999999999999964


Q ss_pred             cccC----------------------CCc-----cc------------------cccccccCCCCCccccccCCCCchhh
Q 007239          444 FCEN----------------------QKT-----AN------------------TRRVVGTYGYMAPEYAMEGLFSVKSD  478 (611)
Q Consensus       444 ~~~~----------------------~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~~~k~D  478 (611)
                      +...                      ...     ..                  ....+|||.|||||++.+..|+..+|
T Consensus       291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD  370 (550)
T KOG0605|consen  291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD  370 (550)
T ss_pred             hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence            3210                      000     00                  11358999999999999999999999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCC-
Q 007239          479 VFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT-  557 (611)
Q Consensus       479 vwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-  557 (611)
                      +|||||||||||.|.+||....+......+......+.             .+.......+..+||.+||. ||++|.- 
T Consensus       371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-------------fP~~~~~s~eA~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-------------FPEEVDLSDEAKDLITRLLC-DPENRLGS  436 (550)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-------------CCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence            99999999999999999865444322211111111111             11111112456688889888 9999976 


Q ss_pred             --HHHHHHH--hcCCCCCCCCCCCCCCcc
Q 007239          558 --MSNVVAL--LGSESIALSEPRQPPFPV  582 (611)
Q Consensus       558 --~~evl~~--L~~~~~~l~~~~~p~~~~  582 (611)
                        ++||-+.  +....++.-.-..|||..
T Consensus       437 ~G~~EIK~HPfF~~v~W~~l~~~~apfvP  465 (550)
T KOG0605|consen  437 KGAEEIKKHPFFKGVDWDHLREMPAPFVP  465 (550)
T ss_pred             ccHHHHhcCCccccCCcchhhcCCCCCCC
Confidence              4454432  244455444444466654

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.9e-41  Score=318.67  Aligned_cols=262  Identities=26%  Similarity=0.342  Sum_probs=208.2

Q ss_pred             CCCCcccccCccCceEEEEEE-cCCCcEEEEEEecccChh--hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQ--GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ++|...++||+|.||.||+|+ ..+|+.||||+++.....  -.....+|++.|+.++|+||+.++++|...+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            468888999999999999999 468999999999865433  13457899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      ||+. +|+..+.++  ...++..++..++.++++||+|||++.   |+||||||.|+||+++|.+||+|||+|+.+....
T Consensus        82 fm~t-dLe~vIkd~--~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDK--NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             eccc-cHHHHhccc--ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9975 888888653  456889999999999999999999996   9999999999999999999999999999987655


Q ss_pred             CccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                      .....  .+-|..|.|||.+.+ ..|+..+||||.||++.||+-|.+-+....+   .+.+..+.+.+......++.+-.
T Consensus       156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD---idQL~~If~~LGTP~~~~WP~~~  230 (318)
T KOG0659|consen  156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD---IDQLSKIFRALGTPTPDQWPEMT  230 (318)
T ss_pred             ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch---HHHHHHHHHHcCCCCcccCcccc
Confidence            44332  267899999999987 5699999999999999999999876643333   33444444444333322222211


Q ss_pred             cC---------CC-----CCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          528 LM---------KS-----SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       528 l~---------~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      -.         ..     .-.......++|+..|+..||.+|++++|++++
T Consensus       231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            00         00     111123356899999999999999999999874

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-42  Score=347.66  Aligned_cols=263  Identities=26%  Similarity=0.364  Sum_probs=206.6

Q ss_pred             hhCCCCcccccCccCceEEEEEE-cCCCcEEEEEEecccChhhHHH--HHHHHHHHHhcC-CCCeeeEEEeEeeCC-eEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEE--FKNEIILIAKLQ-HRNLVRLVGCGIEGE-EKL  364 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~--~~~E~~il~~l~-h~niv~l~~~~~~~~-~~~  364 (611)
                      ..++|.+.++||.|.||.||+|+ ...|+.||||+++++-.. +++  -.+|++-|++|+ ||||+++.+++.+.+ .++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            45789999999999999999999 457889999998765432 333  367999999999 999999999999888 999


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +|||||+. +|.+++.+.  +..+++..++.|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+|||+|+.+
T Consensus        87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence            99999976 788888654  678999999999999999999999998   999999999999999999999999999976


Q ss_pred             ccCCCccccccccccCCCCCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAM-EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      .....   -+..+.|.+|+|||++. .+.|+.+.|+|++|||++||.+-++-|+.....++   +-.+.+.+......++
T Consensus       161 ~SkpP---YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq---i~KIc~VLGtP~~~~~  234 (538)
T KOG0661|consen  161 RSKPP---YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ---IYKICEVLGTPDKDSW  234 (538)
T ss_pred             ccCCC---cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH---HHHHHHHhCCCccccc
Confidence            43322   23468899999999875 57899999999999999999999988754443332   2222222222111111


Q ss_pred             cc-----ccc------CCCCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHHHh
Q 007239          524 VD-----PLL------MKSSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVALL  565 (611)
Q Consensus       524 ~d-----~~l------~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  565 (611)
                      ..     ..+      ....+.     ....++++++..||..||++|||+.+.++.-
T Consensus       235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            11     000      011111     1345778999999999999999999999864

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=9.3e-41  Score=349.24  Aligned_cols=259  Identities=28%  Similarity=0.422  Sum_probs=202.2

Q ss_pred             hCCCCcccccCccCceEEEEEEc------CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeC-C
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL------PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEG-E  361 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~-~  361 (611)
                      .++|++.++||+|+||.||+|.+      .+++.||+|++.... ......+.+|+.+++.+ +||||+++++.+... .
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46899999999999999999973      235679999987543 23456789999999999 899999999987754 4


Q ss_pred             eEEEEEEecCCCChhhHhhhchh---------------------------------------------------------
Q 007239          362 EKLLIYELMPNRSLDCFIFDSER---------------------------------------------------------  384 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~---------------------------------------------------------  384 (611)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            57899999999999998854211                                                         


Q ss_pred             --hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccccccccccCCC
Q 007239          385 --RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY  462 (611)
Q Consensus       385 --~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  462 (611)
                        ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence              134788899999999999999999986   999999999999999999999999999865433222222234567889


Q ss_pred             CCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHH
Q 007239          463 MAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCI  541 (611)
Q Consensus       463 ~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  541 (611)
                      +|||++.+..++.++||||||+++|||++ |..||......  ..    .......+.....         +......+.
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~----~~~~~~~~~~~~~---------~~~~~~~l~  307 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EE----FCQRLKDGTRMRA---------PENATPEIY  307 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HH----HHHHHhcCCCCCC---------CCCCCHHHH
Confidence            99999999999999999999999999997 99887543221  11    1122222221111         011223577


Q ss_pred             HHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          542 HIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       542 ~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      +|+.+||+.||++|||+.+|+++|+.
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~  333 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGD  333 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHH
Confidence            89999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.4e-40  Score=337.66  Aligned_cols=265  Identities=26%  Similarity=0.389  Sum_probs=203.5

Q ss_pred             hCCCCcccccCccCceEEEEEEcCC-----------------CcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeee
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPN-----------------GKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVR  352 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~  352 (611)
                      .++|++.++||+|+||.||++.+.+                 +..||+|.+.... ......+.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3578999999999999999998532                 3369999987643 334567899999999999999999


Q ss_pred             EEEeEeeCCeEEEEEEecCCCChhhHhhhch----------------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceE
Q 007239          353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSE----------------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII  416 (611)
Q Consensus       353 l~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~----------------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~ii  416 (611)
                      +++++.+.+..++||||+++++|.+++....                ....+++..+++++.||+.||.|||+.+   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999999885321                1134688899999999999999999986   99


Q ss_pred             ecCCCCCcEEecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCC--C
Q 007239          417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK--R  494 (611)
Q Consensus       417 HrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~--~  494 (611)
                      ||||||+|||++.++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||+++.  .
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            99999999999999999999999998654333222233445688999999999999999999999999999999754  4


Q ss_pred             CCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          495 NSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       495 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      |+....   ...........+..........      .+......+.+|+.+||+.||++|||+.+|++.|++
T Consensus       241 p~~~~~---~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         241 PYGELT---DEQVIENAGEFFRDQGRQVYLF------RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCCcCC---HHHHHHHHHHHhhhcccccccc------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            543221   2222222222222211111000      011122457799999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-41  Score=346.18  Aligned_cols=274  Identities=27%  Similarity=0.419  Sum_probs=214.2

Q ss_pred             HhhCCCCcccccCccCceEEEEEEcCCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ...+.+.++..||+|.||+||+|.|.  ..||||++...  ..+..+.|++|+.++++-+|.||+-++|++...+. .||
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi  465 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII  465 (678)
T ss_pred             cCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence            33456778899999999999999984  36999999865  34467889999999999999999999999988777 999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      +.+|+|.+|+.+++..+  ..++..+.++|++||++||.|||.++   |||||||..||++.++++|||+|||++..-..
T Consensus       466 TqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~  540 (678)
T KOG0193|consen  466 TQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR  540 (678)
T ss_pred             ehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeee
Confidence            99999999999997544  45899999999999999999999985   99999999999999999999999999976443


Q ss_pred             CCCccccccccccCCCCCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAME---GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      -..........|...|||||+++.   .+|++.+||||||+++|||++|..|+.....+.      .+   |.-+.-.-.
T Consensus       541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq------Ii---fmVGrG~l~  611 (678)
T KOG0193|consen  541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ------II---FMVGRGYLM  611 (678)
T ss_pred             eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh------eE---EEecccccC
Confidence            333333444567888999999974   469999999999999999999999986222111      11   111111111


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCCCCCCCCCC-CCCcc
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQ-PPFPV  582 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~~~~-p~~~~  582 (611)
                      .|.....   .....++.+|+..||..++++||+..+|+.+|+..--.+|...+ |.+|.
T Consensus       612 pd~s~~~---s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S~P~  668 (678)
T KOG0193|consen  612 PDLSKIR---SNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSASEPV  668 (678)
T ss_pred             ccchhhh---ccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcCccc
Confidence            1111111   12233566888899999999999999999988876555655555 55553

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=4.4e-41  Score=343.91  Aligned_cols=266  Identities=26%  Similarity=0.384  Sum_probs=217.2

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+.  ..++.+.+.+|++|++.++||||+.++++|+...++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888999999999999999954 6788999998764  34457789999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+.| +|..++   ...+.++++.+..++.+++.||.|||+.+   |+|||+||.|||++..|.+|++|||+|+....+.
T Consensus        82 ~a~g-~L~~il---~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTIL---EQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHH---HhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9988 999998   44566999999999999999999999986   9999999999999999999999999999875533


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                        .....+.|||-|||||.+.+++|+..+|+||+||++|||.+|++||.      ...+.+.+.....+..         
T Consensus       155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~------a~si~~Lv~~I~~d~v---------  217 (808)
T KOG0597|consen  155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY------ARSITQLVKSILKDPV---------  217 (808)
T ss_pred             --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch------HHHHHHHHHHHhcCCC---------
Confidence              33456899999999999999999999999999999999999999973      1122222222222211         


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH--hcCCCCCCCCCCCCCCccc
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL--LGSESIALSEPRQPPFPVG  583 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~~~~l~~~~~p~~~~~  583 (611)
                        .++......++.++...|++||..|.|..+++..  +.+.......|.+|++-.+
T Consensus       218 --~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~sp  272 (808)
T KOG0597|consen  218 --KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSP  272 (808)
T ss_pred             --CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCc
Confidence              1122344567788889999999999999999863  3444344555566665543

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-41  Score=332.49  Aligned_cols=250  Identities=21%  Similarity=0.342  Sum_probs=210.6

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      ...+|++.+.||+|.||+|-++.. ..|+.||||.+++..   .++.-.+.+|++|+..|+||||+.+|.+|++.+.++|
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi  130 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI  130 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence            346899999999999999999994 789999999998754   3456678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||..+|.|.+++   .+++.+++.+++.+++||..|+.|+|+++   ++|||||.+|||+|.++++||+|||++..+.
T Consensus       131 vMEYaS~GeLYDYi---Ser~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  131 VMEYASGGELYDYI---SERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EEEecCCccHHHHH---HHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence            99999999999999   56677999999999999999999999986   9999999999999999999999999998875


Q ss_pred             cCCCccccccccccCCCCCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLF-SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ...   ..++++|+|-|.+||++.+.+| ++.+|-|||||+||.|+.|..||+..+   .   ...+ +.+..+...+  
T Consensus       205 ~~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---h---k~lv-rQIs~GaYrE--  272 (668)
T KOG0611|consen  205 DKK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---H---KRLV-RQISRGAYRE--  272 (668)
T ss_pred             ccc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---H---HHHH-HHhhcccccC--
Confidence            443   2446899999999999999998 578999999999999999999985332   1   1112 2223332211  


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                               .+......-||.|||..||++|.|+.+|...+.
T Consensus       273 ---------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  273 ---------PETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             ---------CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence                     111223446888999999999999999998773

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-41  Score=350.42  Aligned_cols=249  Identities=26%  Similarity=0.352  Sum_probs=207.6

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ..-|++++.||+|+-|.|-+|++ .+|+..|||++.+..   ......+.+|+.||+.+.|||++++|+++++..++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            34588899999999999999995 589999999997652   12245678999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      .||+++|.|.+++   .+++.+.+.++.+++.||+.|+.|+|..+   |+||||||+|+|||..+++||+|||||..-.+
T Consensus        91 lEyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~  164 (786)
T KOG0588|consen   91 LEYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP  164 (786)
T ss_pred             EEecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence            9999999999998   56778999999999999999999999875   99999999999999999999999999986433


Q ss_pred             CCCccccccccccCCCCCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLF-SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                         .....+.||+|.|.+||++.+.+| +.++||||.|||||.||+|+.||+   ++....++..+    ..|... +  
T Consensus       165 ---gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd---DdNir~LLlKV----~~G~f~-M--  231 (786)
T KOG0588|consen  165 ---GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD---DDNIRVLLLKV----QRGVFE-M--  231 (786)
T ss_pred             ---CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC---CccHHHHHHHH----HcCccc-C--
Confidence               233456799999999999999998 468999999999999999999985   33333333333    222210 0  


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHh
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL  565 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  565 (611)
                             +.....++.+|+.+||..||++|.|++||++.-
T Consensus       232 -------Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  232 -------PSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             -------CCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence                   111123577999999999999999999999854

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=348.81  Aligned_cols=243  Identities=25%  Similarity=0.302  Sum_probs=202.7

Q ss_pred             HHhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCe
Q 007239          288 KAATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEE  362 (611)
Q Consensus       288 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~  362 (611)
                      ....++|.+++.||+|.||+|+++..+ +++.+|||++++..   ..+.+..+.|..|+.... ||.+++++.+|...++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            345689999999999999999999964 67889999998764   345777889999998886 9999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      +++||||+.||++..+    .....+++..+..++..|+.||.|||+++   |||||||.+|||+|.+|++||+||||++
T Consensus       444 l~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence            9999999999994333    34467999999999999999999999997   9999999999999999999999999998


Q ss_pred             ecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          443 IFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       443 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      .--.  ....+.+++|||.|||||++.+..|+.++|+|||||+|||||.|+.||...+.   +                +
T Consensus       517 e~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE---e----------------e  575 (694)
T KOG0694|consen  517 EGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE---E----------------E  575 (694)
T ss_pred             ccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH---H----------------H
Confidence            5321  22345679999999999999999999999999999999999999999753222   1                2


Q ss_pred             ccccccCC--CCCHHHHHHHHHHhhccccCCCCCCCCH
Q 007239          523 FVDPLLMK--SSSIPQVVRCIHIGLLCVQEDPAVRPTM  558 (611)
Q Consensus       523 ~~d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~  558 (611)
                      +.|..+..  .++.-...+.+.|+.++|..||++|--+
T Consensus       576 ~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  576 VFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            22222222  2233344567889999999999999876

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=332.78  Aligned_cols=274  Identities=24%  Similarity=0.318  Sum_probs=207.8

Q ss_pred             HHhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh--------------hhHHHHHHHHHHHHhcCCCCeee
Q 007239          288 KAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW--------------QGLEEFKNEIILIAKLQHRNLVR  352 (611)
Q Consensus       288 ~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~E~~il~~l~h~niv~  352 (611)
                      ....++|++.+.||+|.||.|-+++. .+++.||||++.+...              ..++...+||.||+++.|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            34568999999999999999999995 4788999999975422              12567899999999999999999


Q ss_pred             EEEeEeeC--CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC
Q 007239          353 LVGCGIEG--EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD  430 (611)
Q Consensus       353 l~~~~~~~--~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~  430 (611)
                      |+++..+.  +.+|||+|||..|.+...-   .....+++.++++++++++.||+|||.+|   ||||||||+|+||+++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence            99998754  5789999999998874432   22233899999999999999999999997   9999999999999999


Q ss_pred             CCEEEeccccceecccCCC---ccccccccccCCCCCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 007239          431 MVAKISDFGMARIFCENQK---TANTRRVVGTYGYMAPEYAMEGL----FSVKSDVFSFGVIVLEIISGKRNSGFYLTGH  503 (611)
Q Consensus       431 ~~~kl~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DvwSlGvll~elltG~~p~~~~~~~~  503 (611)
                      |++||+|||.+..+.....   .......+|||.|+|||.+.++.    .+.+.||||+||+||.|+.|+.||-.   +.
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~---~~  323 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD---DF  323 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc---ch
Confidence            9999999999987733211   11223468999999999998743    35689999999999999999999721   11


Q ss_pred             hhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC-CCCCCCCCCCCCCcc
Q 007239          504 AQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS-ESIALSEPRQPPFPV  582 (611)
Q Consensus       504 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~-~~~~l~~~~~p~~~~  582 (611)
                      ...+.    ..+.+        ..+.-+...+....+.+|+.+||++||+.|.++.+|.....- ....-+.+..|....
T Consensus       324 ~~~l~----~KIvn--------~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~~~s~~~~c~  391 (576)
T KOG0585|consen  324 ELELF----DKIVN--------DPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSPQSSEPSSCS  391 (576)
T ss_pred             HHHHH----HHHhc--------CcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCCccCCcccce
Confidence            11111    11111        112222222344567799999999999999999999877642 222334444444443

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-41  Score=337.02  Aligned_cols=248  Identities=24%  Similarity=0.366  Sum_probs=204.6

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      ..|+..+.||+|.||.||+|.+ ..++.||+|++..+. ...++.+.+|+.+|..++++||.+.|+.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            4577779999999999999995 578889999998653 34578899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +.||++.+.+   +....+++..+.-++++++.||.|||.++   .+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus        93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            9999999998   34444588888889999999999999996   99999999999999999999999999987755443


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                      .  ..+++|||.|||||++....|+.|+||||||++.+||.+|.+|+....+                ....-++-..-.
T Consensus       167 r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP----------------mrvlflIpk~~P  228 (467)
T KOG0201|consen  167 R--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP----------------MRVLFLIPKSAP  228 (467)
T ss_pred             c--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc----------------ceEEEeccCCCC
Confidence            3  3678999999999999988999999999999999999999999743222                111111111111


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ...+......+.+++..||+.||++||++.+++.
T Consensus       229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            1111223344678999999999999999998875

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.8e-39  Score=333.71  Aligned_cols=199  Identities=27%  Similarity=0.366  Sum_probs=175.3

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999964 68889999987542 3345679999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+++  +|+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            9999999999843   345899999999999999999999863  49999999999999999999999999997653322


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGF  498 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~  498 (611)
                          .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~  204 (331)
T cd06649         159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence                2345799999999999999999999999999999999999999853

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-40  Score=307.62  Aligned_cols=250  Identities=25%  Similarity=0.325  Sum_probs=207.2

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      ..++|++++.||+|.||.||.|+. +++-.||+|++.+...   +...++.+|++|-..|+||||+++|++|.+....||
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            457899999999999999999995 5677899999876532   235678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ++||..+|+|...|+. .+...+++.....++.|+|.||.|+|.+.   ||||||||+|+|++.++.+||+|||.+..-.
T Consensus       100 ilEya~~gel~k~L~~-~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQE-GRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEEecCCchHHHHHHh-cccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            9999999999999864 24466899999999999999999999985   9999999999999999999999999997643


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                          .....+.+||..|.+||+..+..++.++|+|++|++.||++.|.+||....   .......+    ...   ++.+
T Consensus       176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI----~k~---~~~~  241 (281)
T KOG0580|consen  176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRI----RKV---DLKF  241 (281)
T ss_pred             ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHH----HHc---cccC
Confidence                223446899999999999999999999999999999999999999985332   11111111    111   1111


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      +       ........++|..|+..+|.+|.+..|++..
T Consensus       242 p-------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  242 P-------STISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             C-------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            1       1112346799999999999999999999864

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-40  Score=341.51  Aligned_cols=253  Identities=21%  Similarity=0.297  Sum_probs=203.0

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++.+.||+|+||.||++++. +++.||+|++.+..   ......+.+|+.++..++||||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46899999999999999999965 68899999997542   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLN---NLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999983   3456899999999999999999999986   99999999999999999999999999986533 


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ......+.. +...     +...
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~---~~~~~~i~~-~~~~-----~~~~  220 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP---NETWENLKY-WKET-----LQRP  220 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH---HHHHHHHHh-cccc-----ccCC
Confidence                22346799999999999999999999999999999999999999853322   111111111 1100     0000


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ...........++.+++.+||+.+|++||+++++++.
T Consensus       221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0000011223456788999999999999999999975

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=9.6e-41  Score=359.92  Aligned_cols=260  Identities=29%  Similarity=0.444  Sum_probs=213.4

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKSWQ-GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  362 (611)
                      ...+.+..+.||+|.||+||+|+..      +...||||.++..... ...+|++|++++..|+|||||+++|+|.+++.
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            3456777899999999999999842      3456999999876544 78899999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhch-------h----hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC
Q 007239          363 KLLIYELMPNRSLDCFIFDSE-------R----RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM  431 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~-------~----~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~  431 (611)
                      +++|+|||..|+|.+||.-..       .    ..+++..+.+.|+.|||.||+||-++.   +|||||...|+||.++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence            999999999999999985311       1    334889999999999999999999885   99999999999999999


Q ss_pred             CEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHH
Q 007239          432 VAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAY  510 (611)
Q Consensus       432 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~  510 (611)
                      .|||+||||++..-..+.........-...|||||.+..++|+.+||||||||+|||+++ |+.|+.....       +.
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-------~E  713 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-------QE  713 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-------HH
Confidence            999999999987644443333323344678999999999999999999999999999998 7888643322       12


Q ss_pred             HHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          511 VWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       511 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      +.+.++.+...+         .+.....++..|+..||+.+|++||+++||-.+|++-
T Consensus       714 VIe~i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  714 VIECIRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             HHHHHHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence            333444554322         2334456788999999999999999999999999753

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.9e-39  Score=343.91  Aligned_cols=259  Identities=28%  Similarity=0.415  Sum_probs=203.2

Q ss_pred             hCCCCcccccCccCceEEEEEEc------CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL------PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~  362 (611)
                      .++|++.+.||+|+||.||++.+      .++..||+|+++... ....+.+.+|+.+++.+ +||||+++++++.....
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45799999999999999999973      245689999987543 33456788999999999 79999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchh----------------------------------------------------------
Q 007239          363 KLLIYELMPNRSLDCFIFDSER----------------------------------------------------------  384 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~----------------------------------------------------------  384 (611)
                      .++||||+++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999988854211                                                          


Q ss_pred             --------------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          385 --------------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       385 --------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                                    ...+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          124788999999999999999999986   999999999999999999999999999866433222


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                      .......++..|+|||++.+..++.++||||||+++|||++ |..||......  ..    ..+.+..+....  .+   
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~----~~~~~~~~~~~~--~~---  339 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SK----FYKMIKEGYRML--SP---  339 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HH----HHHHHHhCccCC--CC---
Confidence            22222345678999999999999999999999999999998 77776432211  11    122222221111  00   


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                          .....++.+|+.+||+.||++||++.+|+++|+.
T Consensus       340 ----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         340 ----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                0112357799999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.6e-39  Score=328.70  Aligned_cols=245  Identities=19%  Similarity=0.301  Sum_probs=196.5

Q ss_pred             cccCccCceEEEEEEcCCCcEEEEEEecccChhh---HHHHHHHHHHHHhcCCCCeeeEEEeEee----CCeEEEEEEec
Q 007239          298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQG---LEEFKNEIILIAKLQHRNLVRLVGCGIE----GEEKLLIYELM  370 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~lv~E~~  370 (611)
                      ..||+|+++.||+|.+ +|+.||+|+++......   .+.+.+|+.++++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999998 68899999987653322   5678899999999999999999999876    35789999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++|+|.+++..   ...+++.....++.|++.||.|||+..  +++||||||+|||+++++.+||+|||+++......  
T Consensus       105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            99999999843   346899999999999999999999852  38899999999999999999999999998653321  


Q ss_pred             cccccccccCCCCCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          451 ANTRRVVGTYGYMAPEYAME--GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                         ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||....   ...+...+   ...+....     +
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~---~~~~~~~i---~~~~~~~~-----~  243 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT---TKEIYDLI---INKNNSLK-----L  243 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC---HHHHHHHH---HhcCCCCC-----C
Confidence               13468899999999976  689999999999999999999999985332   11222211   11111111     1


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                          +......+.+++.+||+.||++|||++|+++.|+..
T Consensus       244 ----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        244 ----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             ----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence                112234577899999999999999999999999753

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.6e-39  Score=344.22  Aligned_cols=259  Identities=29%  Similarity=0.430  Sum_probs=202.8

Q ss_pred             hCCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~  362 (611)
                      .++|++.+.||+|+||.||++++.      +++.||+|+++... ....+.+.+|+.+++.+ +|+||+++++.+.....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            457999999999999999998842      34579999997543 33456788999999999 89999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchh----------------------------------------------------------
Q 007239          363 KLLIYELMPNRSLDCFIFDSER----------------------------------------------------------  384 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~----------------------------------------------------------  384 (611)
                      .++||||+++|+|.+++.....                                                          
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            9999999999999998853211                                                          


Q ss_pred             ---------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcccccc
Q 007239          385 ---------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR  455 (611)
Q Consensus       385 ---------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  455 (611)
                               ...+++..+++++.||++||.|||+++   |+||||||+|||+++++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                     124788899999999999999999987   99999999999999999999999999986543322212222


Q ss_pred             ccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCH
Q 007239          456 VVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSI  534 (611)
Q Consensus       456 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  534 (611)
                      ..+++.|+|||++.+..++.++||||||+++|||++ |+.||.......  .    .......+....     ...    
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~----~~~~~~~~~~~~-----~~~----  338 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K----FYKMVKRGYQMS-----RPD----  338 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H----HHHHHHcccCcc-----CCC----
Confidence            345678999999999999999999999999999997 999875432211  1    111122211100     000    


Q ss_pred             HHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          535 PQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       535 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ....++.+++.+||+.||++||++.+|+++|+.
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            112456788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.5e-39  Score=326.68  Aligned_cols=251  Identities=27%  Similarity=0.345  Sum_probs=199.6

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .|+..+.||+|+||.||++.. .+++.||+|.+.....   .....+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            377889999999999999995 5789999999875432   233467899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++++|..++... ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            99999998877532 2345899999999999999999999987   9999999999999999999999999998753322


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                      .   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ............        
T Consensus       157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~--------  222 (285)
T cd05631         157 T---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVKEDQE--------  222 (285)
T ss_pred             e---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhhcccc--------
Confidence            1   22357999999999999999999999999999999999999998643322111   111111111110        


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPT-----MSNVVA  563 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  563 (611)
                        .........+.+|+.+||+.||++||+     ++++++
T Consensus       223 --~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         223 --EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             --cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence              011112235678999999999999997     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2e-39  Score=330.99  Aligned_cols=265  Identities=21%  Similarity=0.250  Sum_probs=200.6

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ++|++.+.||+|+||.||++++. +++.||+|++....  ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47999999999999999999965 67889999987542  2335678899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |++++.+..+.   .....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~---~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLE---EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            99998776554   22346899999999999999999999986   9999999999999999999999999998764322


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHH--------HHHHHhc-Cc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAY--------VWQLWKE-GK  519 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~--------~~~~~~~-~~  519 (611)
                      .. ......|++.|+|||++.+..++.++|||||||++|||++|+.||......+.......        .+..+.. ..
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         155 NA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             cc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            21 22245789999999999998999999999999999999999999854322111000000        0000000 00


Q ss_pred             cccccccccCCCCC------HHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          520 EMEFVDPLLMKSSS------IPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       520 ~~~~~d~~l~~~~~------~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ......+.......      ......+.+|+.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000011100000      011235789999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=319.80  Aligned_cols=266  Identities=26%  Similarity=0.344  Sum_probs=204.7

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEec--ccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee-----CCeE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLS--RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE-----GEEK  363 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-----~~~~  363 (611)
                      ..|...+.||+|++|.|..++. .+|+.||||++.  -......++..+|+++|+.++|+||+.+++++..     -..+
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            4566678999999999999995 578999999987  3455567888999999999999999999999865     4578


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      |+|+|+| +.+|...+   .....++..++..++.||++||.|+|+.+   |+||||||+|+|++.+..+||+|||+|+.
T Consensus       102 YiV~elM-etDL~~ii---k~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen  102 YLVFELM-ETDLHQII---KSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             EEehhHH-hhHHHHHH---HcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence            9999999 55888887   34445999999999999999999999985   99999999999999999999999999998


Q ss_pred             cccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHH--------HH
Q 007239          444 FCENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW--------QL  514 (611)
Q Consensus       444 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~--------~~  514 (611)
                      ..........+..+-|..|.|||++.. ..|+.+.||||+||++.||++|++-|...+..++..+...+.        ..
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence            754433334456788999999998754 679999999999999999999999887665544433332211        11


Q ss_pred             HhcCccccccccccC-CCCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          515 WKEGKEMEFVDPLLM-KSSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       515 ~~~~~~~~~~d~~l~-~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      +........+...-. ...+.     ......++|+.+||..||.+|+|++|.++.
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            111111111110000 00010     111245789999999999999999999874

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.8e-39  Score=311.07  Aligned_cols=279  Identities=23%  Similarity=0.277  Sum_probs=207.0

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChh--hHHHHHHHHHHHHhcCCCCeeeEEEeEee--CCeEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQ--GLEEFKNEIILIAKLQHRNLVRLVGCGIE--GEEKL  364 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~  364 (611)
                      ..+.|+.+++|++|+||.||+|++ ++++.||+|+++.+...  ..-.-.+||.+|.+.+|||||.+-.+...  -+.+|
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy  153 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY  153 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence            346799999999999999999996 47889999999765322  12345789999999999999999998764  35799


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +|||||++ +|..++....  .++...++..++.|+++|++|||++.   |+|||||++|+|++..|.+||+|||+|+.+
T Consensus       154 ~VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  154 IVMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             eeHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhh
Confidence            99999987 6777774322  56889999999999999999999997   999999999999999999999999999988


Q ss_pred             ccCCCccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      +....  ..+..+-|..|.|||.+.+. .|+..+|+||+|||+.||+++++-|......+   .+..+.+.........+
T Consensus       228 gsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d---Ql~~If~llGtPte~iw  302 (419)
T KOG0663|consen  228 GSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID---QLDKIFKLLGTPSEAIW  302 (419)
T ss_pred             cCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH---HHHHHHHHhCCCccccC
Confidence            66532  23456789999999998875 58999999999999999999998775444333   33333333322221111


Q ss_pred             cc--------cccCCCCCHH----------HHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCCCCCCCCCCCCCc
Q 007239          524 VD--------PLLMKSSSIP----------QVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFP  581 (611)
Q Consensus       524 ~d--------~~l~~~~~~~----------~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~~~~p~~~  581 (611)
                      ..        ..-....+..          ....-.+|+..+|..||++|.|++|.|+.  .-..+.|.|.-|.|+
T Consensus       303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h--~~F~e~P~p~~P~~~  376 (419)
T KOG0663|consen  303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH--EYFRETPLPIDPSMF  376 (419)
T ss_pred             CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc--cccccCCCCCChhhc
Confidence            10        0000001100          11233578888999999999999998762  223334444444443

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6e-39  Score=327.86  Aligned_cols=262  Identities=21%  Similarity=0.289  Sum_probs=198.1

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.++||+|+||.||++... +++.||+|+++... ......+.+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            357999999999999999999954 68899999987543 2234567899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++ +|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          84 YLDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             CCCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            9986 887777432  235788999999999999999999986   9999999999999999999999999997643222


Q ss_pred             CccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC--------c
Q 007239          449 KTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG--------K  519 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--------~  519 (611)
                      .  ......|++.|+|||++.+ ..++.++||||+|+++|+|++|++||......   .......+.....        .
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07871         158 K--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK---EELHLIFRLLGTPTEETWPGIT  232 (288)
T ss_pred             c--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCChHHhhccc
Confidence            1  1223568999999998875 56899999999999999999999997543221   1122221111110        0


Q ss_pred             cc----cccccccCCCC----CHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          520 EM----EFVDPLLMKSS----SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       520 ~~----~~~d~~l~~~~----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..    ....+......    ......++++|+.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00    00000000000    0011235679999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-39  Score=330.26  Aligned_cols=245  Identities=22%  Similarity=0.263  Sum_probs=199.4

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47899999999999999999964 68899999986532   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLR---NSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            9999999999884   3456899999999999999999999987   999999999999999999999999999865322


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                           .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....   ...+...    ...+.. +     
T Consensus       155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---~~~~~~~----i~~~~~-~-----  216 (291)
T cd05612         155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN---PFGIYEK----ILAGKL-E-----  216 (291)
T ss_pred             -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH----HHhCCc-C-----
Confidence                 223579999999999999899999999999999999999999975322   1111111    111111 0     


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCC-----HHHHHHH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPT-----MSNVVAL  564 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~  564 (611)
                      +..    .....+.+++.+||+.||.+||+     ++++++.
T Consensus       217 ~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         217 FPR----HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CCc----cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            111    11235678999999999999995     8887754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.8e-39  Score=326.20  Aligned_cols=257  Identities=28%  Similarity=0.466  Sum_probs=205.4

Q ss_pred             CCCCcccccCccCceEEEEEEcCC------CcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPN------GKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  364 (611)
                      ++|++.+.||+|+||.||+|....      ...|++|.+.... ......+.+|+.++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            478899999999999999998532      2579999987543 334567899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhHhhhchh-------------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC
Q 007239          365 LIYELMPNRSLDCFIFDSER-------------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM  431 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~  431 (611)
                      ++|||+++++|.+++.....             ...+++..++.++.||+.||.|||+++   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999998854211             145888999999999999999999986   99999999999999999


Q ss_pred             CEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHH
Q 007239          432 VAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAY  510 (611)
Q Consensus       432 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~  510 (611)
                      .+||+|||+++...............+++.|+|||++.++.++.++||||||+++|||++ |..||.....   ..+.  
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~~--  236 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEVI--  236 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHH--
Confidence            999999999986543332222334467889999999999999999999999999999998 9888743221   1121  


Q ss_pred             HHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          511 VWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       511 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                        ..+..+....         .+.....++.+|+.+||+.||++||++.+|++.|++
T Consensus       237 --~~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 --EMIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             --HHHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence              2222222111         112223567789999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.4e-39  Score=349.64  Aligned_cols=252  Identities=21%  Similarity=0.247  Sum_probs=204.1

Q ss_pred             CCCcccccCccCceEEEEEEcC-C-CcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-N-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      .|.+.+.||+|+||.||++... + ++.|++|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4899999999999999999853 3 6789999876665555667889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhc-hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          371 PNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       371 ~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      ++++|.+++.+. .....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999887542 23456899999999999999999999986   99999999999999999999999999987654333


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||....   ...+.   .... .+....     . 
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~---~~~~~---~~~~-~~~~~~-----~-  291 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS---QREIM---QQVL-YGKYDP-----F-  291 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHH---HHHH-hCCCCC-----C-
Confidence            223345679999999999999999999999999999999999999974321   11111   1111 111111     0 


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                         +......+.+++..||+.||++||++++++.
T Consensus       292 ---~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        292 ---PCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ---CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence               1112235778999999999999999999874

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=6.7e-39  Score=325.58  Aligned_cols=257  Identities=28%  Similarity=0.443  Sum_probs=205.1

Q ss_pred             hCCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKSWQ-GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  363 (611)
                      .++|.+.+.||+|+||.||+|...      +++.||+|.++..... ..+.+.+|+++++.++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            356888999999999999999853      2478999998765433 457899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhHhhhch-----------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCC
Q 007239          364 LLIYELMPNRSLDCFIFDSE-----------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV  432 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~  432 (611)
                      ++||||+++++|.+++....           ....+++..+..++.||+.+|.|||+++   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            99999999999999985421           2345789999999999999999999986   999999999999999999


Q ss_pred             EEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHH
Q 007239          433 AKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYV  511 (611)
Q Consensus       433 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~  511 (611)
                      +||+|||+++...............+++.|+|||++.++.++.++||||||+++|||++ |+.||.....   ...... 
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~-  236 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIEC-  236 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHH-
Confidence            99999999976533322222223456788999999999999999999999999999998 9988643221   112211 


Q ss_pred             HHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          512 WQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       512 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                         ...+.....         .......+.+++..||+.||++||++.||+++|+
T Consensus       237 ---~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 ---ITQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             ---HHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence               122221111         1112245678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.6e-38  Score=328.13  Aligned_cols=199  Identities=28%  Similarity=0.382  Sum_probs=174.3

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.++||+|+||.||++.+. ++..+|+|++... .......+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            468999999999999999999965 6788999988754 23345678999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++++|.+++.   ....+++..+..++.||+.||.|||+..  +++||||||+|||++.++.+||+|||++..+....
T Consensus        84 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  158 (333)
T cd06650          84 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (333)
T ss_pred             cCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence            999999999984   3346889999999999999999999753  49999999999999999999999999997653221


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGF  498 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~  498 (611)
                          .....|++.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus       159 ----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             ----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence                2235789999999999998999999999999999999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.7e-39  Score=336.83  Aligned_cols=246  Identities=22%  Similarity=0.272  Sum_probs=200.0

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++.+.||+|+||.||++++. +++.||+|++....   ....+.+.+|+.++++++||||+++++.+...+..++|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            367999999999999999999964 68899999987542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        97 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         97 LEFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EcCCCCChHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            99999999998884   3456889999999999999999999986   99999999999999999999999999986533


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ..     ....||+.|+|||++.+..++.++|||||||++|||++|+.||....   .....    +....+.. .    
T Consensus       171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~----~~i~~~~~-~----  233 (329)
T PTZ00263        171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT---PFRIY----EKILAGRL-K----  233 (329)
T ss_pred             Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC---HHHHH----HHHhcCCc-C----
Confidence            22     23579999999999999999999999999999999999999974321   11111    11222211 0    


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCC-----HHHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT-----MSNVVAL  564 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~~  564 (611)
                       +...    ...++.+|+..||+.||++||+     +++++..
T Consensus       234 -~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        234 -FPNW----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             -CCCC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence             0011    1234678999999999999996     6776643

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-38  Score=335.94  Aligned_cols=259  Identities=17%  Similarity=0.203  Sum_probs=195.4

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      ..+|++.+.||+|+||.||++.. .+++.||+|...      ...+.+|+.++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            46799999999999999999995 578899999753      23567899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +. ++|..++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       165 ~~-~~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-  236 (391)
T PHA03212        165 YK-TDLYCYLA---AKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-  236 (391)
T ss_pred             CC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence            86 57777763   3345899999999999999999999986   9999999999999999999999999997542221 


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC----chhhHHHHHHHHHhcCc------
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG----HAQTLLAYVWQLWKEGK------  519 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~----~~~~l~~~~~~~~~~~~------  519 (611)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+......    .....+..+........      
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            11223467999999999999999999999999999999999999875322211    11111111111110000      


Q ss_pred             ----ccccc---------ccccCCC--CCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          520 ----EMEFV---------DPLLMKS--SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       520 ----~~~~~---------d~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                          ..+.+         .+.....  .......++.+|+.+||+.||++|||++|+++
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                00000         0000000  00112346789999999999999999999985

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=7e-39  Score=332.89  Aligned_cols=241  Identities=22%  Similarity=0.246  Sum_probs=194.5

Q ss_pred             cccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCC
Q 007239          298 NKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNR  373 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~  373 (611)
                      +.||+|+||.||+++. .+|+.||+|++++..   ......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999995 578899999987542   233456788999999999999999999999999999999999999


Q ss_pred             ChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcccc
Q 007239          374 SLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT  453 (611)
Q Consensus       374 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  453 (611)
                      +|.+++.   ....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~  152 (323)
T cd05571          81 ELFFHLS---RERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence            9988884   3456899999999999999999999987   9999999999999999999999999987532211  122


Q ss_pred             ccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCC
Q 007239          454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSS  533 (611)
Q Consensus       454 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  533 (611)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||....   ...+...+    ..+..      .+    +
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~~----~~~~~------~~----p  215 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELI----LMEEI------RF----P  215 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC---HHHHHHHH----HcCCC------CC----C
Confidence            34679999999999999999999999999999999999999974321   11111111    11111      01    1


Q ss_pred             HHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 007239          534 IPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVA  563 (611)
Q Consensus       534 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  563 (611)
                      .....++.+++.+||+.||++||     ++.++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            11234567899999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.9e-38  Score=324.23  Aligned_cols=263  Identities=25%  Similarity=0.315  Sum_probs=196.9

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.+.||+|+||.||++... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            478999999999999999999964 688999999875432 223467889999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++ +|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        84 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVHT-DLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCCc-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            9964 66666532  2345889999999999999999999997   9999999999999999999999999997543222


Q ss_pred             CccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc-----
Q 007239          449 KTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME-----  522 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-----  522 (611)
                      .  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....  ...................     
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         158 H--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             c--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchh
Confidence            1  1223568999999998865 4588999999999999999999999864322  1112222211111110000     


Q ss_pred             ---cccc-ccC--CCCCHH-------HHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          523 ---FVDP-LLM--KSSSIP-------QVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       523 ---~~d~-~l~--~~~~~~-------~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                         ..++ ...  ......       ....+.+|+..||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence               0000 000  000000       1134668999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.4e-38  Score=329.62  Aligned_cols=262  Identities=24%  Similarity=0.347  Sum_probs=194.8

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC-----CeEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG-----EEKL  364 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~~~  364 (611)
                      +|++.+.||+|+||.||+|+. .+++.||+|++...  .......+.+|+.++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            588899999999999999995 47899999998643  223445788999999999999999999987543     3579


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +||||+. ++|.+++.   ....+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999996 57888773   3346899999999999999999999987   999999999999999999999999999865


Q ss_pred             ccCCCc-cccccccccCCCCCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH-------
Q 007239          445 CENQKT-ANTRRVVGTYGYMAPEYAME--GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL-------  514 (611)
Q Consensus       445 ~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~-------  514 (611)
                      ...... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.......   ....+...       
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~  230 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH---QLDLITDLLGTPSPE  230 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH---HHHHHHHHhCCCCHH
Confidence            322211 11234579999999999876  678999999999999999999999985432211   11111110       


Q ss_pred             ----HhcCccccccccccCC-CCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          515 ----WKEGKEMEFVDPLLMK-SSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       515 ----~~~~~~~~~~d~~l~~-~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                          +......+.+...... ....     .....+.+++.+||+.||++|||++|+++.
T Consensus       231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                0000000000000000 0000     012346789999999999999999999963

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.4e-39  Score=321.44  Aligned_cols=256  Identities=30%  Similarity=0.480  Sum_probs=209.1

Q ss_pred             hhCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      ...+|++.++||+|+||.||+|.+.+++.+++|.+..........+.+|+.+++.++|+||+++++++...+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            34578999999999999999999877899999999877665677899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++.+. ....+++..++.++.||+.||.|||+++   ++|+||||+||++++++.+||+|||++........
T Consensus        84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            9999999998653 2346899999999999999999999987   99999999999999999999999999986543222


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                      .  .....++..|+|||.+..+.++.++||||||+++|+|++ |+.|+....   .......+    ..+...       
T Consensus       160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~~----~~~~~~-------  223 (261)
T cd05148         160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQI----TAGYRM-------  223 (261)
T ss_pred             c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHH----HhCCcC-------
Confidence            1  113346778999999999999999999999999999998 788874322   11122211    111110       


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                        ..+......+.+++.+||+.||++|||+.++++.|++
T Consensus       224 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         224 --PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence              0111222456799999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.1e-38  Score=322.05  Aligned_cols=254  Identities=26%  Similarity=0.369  Sum_probs=200.9

Q ss_pred             CCCCcccccCccCceEEEEEEcC----CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP----NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ++|++.+.||+|+||.||+|.++    .+..||+|.++... ......+.+|+.++++++||||+++++++...+..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            56899999999999999999853    35689999987653 23356789999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++...  ...+++..++.++.||+.||.|||+++   ++||||||+|||++.++.+|++|||.+.....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            9999999999988542  246899999999999999999999986   99999999999999999999999998765322


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ... .......++..|+|||.+.++.++.++||||||+++|||++ |+.||.....   ..+...    ...+....   
T Consensus       160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~~~~~~----~~~~~~~~---  228 (266)
T cd05064         160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QDVIKA----VEDGFRLP---  228 (266)
T ss_pred             cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHH----HHCCCCCC---
Confidence            111 11112345678999999999999999999999999999775 9988743221   111111    12221110   


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                        .    +......+.+++..||+.+|++||++++|++.|++
T Consensus       229 --~----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         229 --A----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             --C----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence              0    11122456789999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.2e-38  Score=320.46  Aligned_cols=255  Identities=30%  Similarity=0.448  Sum_probs=205.9

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      .++|++.++||+|+||.||+|...+++.|++|.+.... ...+.+.+|+.+++.++|+||+++++.+...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            36799999999999999999998788889999987543 23578899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++++|.+++... ....+++..++.++.||+.||+|||+.+   ++||||||+||+++.++.+||+|||++.........
T Consensus        84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            999999988542 2346888999999999999999999986   999999999999999999999999999876433221


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                       ......++..|+|||++..+.++.++||||||+++|+|++ |+.||....   .......+    ......    +.  
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~~~----~~~~~~----~~--  225 (261)
T cd05072         160 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS---NSDVMSAL----QRGYRM----PR--  225 (261)
T ss_pred             -ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC---HHHHHHHH----HcCCCC----CC--
Confidence             1222346778999999999999999999999999999998 888874321   11222211    111110    00  


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                         .......+.+++.+||+.+|++||++++++++|+.
T Consensus       226 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         226 ---MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ---CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               01122457789999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.6e-38  Score=338.28  Aligned_cols=261  Identities=25%  Similarity=0.378  Sum_probs=205.1

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCC
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGE  361 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~  361 (611)
                      ..++|.++++||+|+||.||+|++.      .+..||+|++.... ....+.+.+|+++++++. ||||+++++++.+..
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3578999999999999999999842      23479999997543 233567899999999996 999999999999999


Q ss_pred             eEEEEEEecCCCChhhHhhhchh---------------------------------------------------------
Q 007239          362 EKLLIYELMPNRSLDCFIFDSER---------------------------------------------------------  384 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~---------------------------------------------------------  384 (611)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            99999999999999988854211                                                         


Q ss_pred             ------------------------------------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec
Q 007239          385 ------------------------------------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD  428 (611)
Q Consensus       385 ------------------------------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~  428 (611)
                                                          ...+++..+..++.||++||.|||+.+   |+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence                                                124788889999999999999999986   99999999999999


Q ss_pred             CCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhH
Q 007239          429 KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTL  507 (611)
Q Consensus       429 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l  507 (611)
                      .++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..|+......  .  
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~--  347 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--S--  347 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--H--
Confidence            999999999999987644332222333467788999999999999999999999999999997 88887432211  1  


Q ss_pred             HHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          508 LAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       508 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                        ........+....     .    .......+.+++.+||+.+|++||++.+|+++|...
T Consensus       348 --~~~~~~~~~~~~~-----~----~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         348 --TFYNKIKSGYRMA-----K----PDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             --HHHHHHhcCCCCC-----C----CccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence              1111122221111     0    111234577899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.5e-38  Score=318.89  Aligned_cols=252  Identities=27%  Similarity=0.410  Sum_probs=201.8

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      ++|++.+.||+|+||.||++.++++..+|+|.+.... ...+.+.+|+.++++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            4688899999999999999998888889999886443 234678899999999999999999999999999999999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +++|.+++...  ...+++..+..++.|++.||.|||+++   ++||||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence            99999988532  235899999999999999999999986   999999999999999999999999999865332221 


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.|+....   .......+    ..+...  ..+.   
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~---~~~~~~~i----~~~~~~--~~~~---  224 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS---NYEVVEMI----SRGFRL--YRPK---  224 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH----HCCCCC--CCCC---
Confidence            1112345668999999998889999999999999999999 888864221   11222222    111110  1111   


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                          .....+.+++.+||+.+|++||++.++++.|+
T Consensus       225 ----~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         225 ----LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ----CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                11235779999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.4e-38  Score=323.03  Aligned_cols=259  Identities=27%  Similarity=0.465  Sum_probs=202.1

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  362 (611)
                      ..++|++.+.||+|+||.||+|.+.      .++.||+|++.... .....++.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4578999999999999999998742      35679999886432 3345678899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchh-------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEE
Q 007239          363 KLLIYELMPNRSLDCFIFDSER-------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKI  435 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl  435 (611)
                      .++||||+++++|.+++.....       ...+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence            9999999999999998854221       234678889999999999999999986   999999999999999999999


Q ss_pred             eccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHH
Q 007239          436 SDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQL  514 (611)
Q Consensus       436 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~  514 (611)
                      +|||+++...............+++.|+|||++.++.++.++||||||+++|||++ |..|+....   .....    ..
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~---~~~~~----~~  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS---NEQVL----RF  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHH----HH
Confidence            99999976533222111122355788999999999999999999999999999999 677764321   11111    11


Q ss_pred             HhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       515 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ...+.....         +......+.+++.+||+.||++|||+.|+++.|++
T Consensus       234 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         234 VMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHcCCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            122211111         01112357789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.5e-38  Score=322.67  Aligned_cols=258  Identities=27%  Similarity=0.423  Sum_probs=207.9

Q ss_pred             CCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      ++|.+.+.||+|+||.||++...      ++..+++|.+........+.+.+|+.++++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            46888999999999999999842      345689999877666666789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhch-------------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCC
Q 007239          366 IYELMPNRSLDCFIFDSE-------------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV  432 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~  432 (611)
                      ||||+++++|.+++....             ....+++..++.++.||+.||.|||+++   ++||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999985422             1245899999999999999999999987   999999999999999999


Q ss_pred             EEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHH
Q 007239          433 AKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYV  511 (611)
Q Consensus       433 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~  511 (611)
                      +||+|||++................++..|+|||++.+..++.++||||||+++|||++ |+.|+.....   ..    .
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~----~  234 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TE----V  234 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HH----H
Confidence            99999999976543332222233457788999999999999999999999999999998 8888643221   11    1


Q ss_pred             HHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          512 WQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       512 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ++.+..+...+..         ......+.+++.+||+.+|++||++++|+++|...
T Consensus       235 ~~~~~~~~~~~~~---------~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         235 IECITQGRVLERP---------RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             HHHHhCCCCCCCC---------ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            2222232222111         11224577999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.2e-38  Score=331.22  Aligned_cols=249  Identities=27%  Similarity=0.379  Sum_probs=194.4

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|+..++||+|+||.||++++ .+++.||+|++..... .....+.+|+++++.++|+||+++++++...+..++|||
T Consensus        73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            35677889999999999999995 4689999999865432 335678999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++++|....       ...+..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++.+....
T Consensus       153 ~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        153 FMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             cCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            99999985432       3466778899999999999999986   9999999999999999999999999998764322


Q ss_pred             CccccccccccCCCCCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAME-----GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      .  ......||..|+|||++..     ...+.++|||||||++|||++|+.||..........+....    ......  
T Consensus       223 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~----~~~~~~--  294 (353)
T PLN00034        223 D--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI----CMSQPP--  294 (353)
T ss_pred             c--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH----hccCCC--
Confidence            1  1234579999999998743     23456899999999999999999998633222211111111    011000  


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                             ........++.+|+.+||+.||++||++.|+++.
T Consensus       295 -------~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        295 -------EAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -------CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                   0011223457789999999999999999999974

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-38  Score=318.49  Aligned_cols=255  Identities=29%  Similarity=0.427  Sum_probs=204.5

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      .++|++.+.||+|++|.||++.+.+++.||+|.++... ...+.+.+|+.++++++||||+++++++...+..+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            46789999999999999999998778889999987554 23567899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++........
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999985432 345899999999999999999999987   999999999999999999999999999876532211


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                       .......+..|+|||++.+..++.++||||||+++|||++ |+.|+....   ...+..    ........        
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~----~~~~~~~~--------  223 (261)
T cd05068         160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT---NAEVLQ----QVDQGYRM--------  223 (261)
T ss_pred             -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC---HHHHHH----HHHcCCCC--------
Confidence             1111223457999999999999999999999999999999 888874221   111111    11111110        


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                       .........+.+++.+||+.+|++||++.++++.|+.
T Consensus       224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence             0011123457789999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.2e-38  Score=323.63  Aligned_cols=259  Identities=27%  Similarity=0.440  Sum_probs=206.0

Q ss_pred             hCCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  364 (611)
                      .++|.+.+.||+|+||.||++...      ++..+++|.+........+.+.+|+.++++++||||+++++++......+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            357899999999999999999841      34568999987766566778999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhHhhhch----------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEE
Q 007239          365 LIYELMPNRSLDCFIFDSE----------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAK  434 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~k  434 (611)
                      +||||+++++|.+++....          +...+++..++.++.||+.+|.|||+++   ++||||||+||++++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999999885321          2235899999999999999999999987   99999999999999999999


Q ss_pred             EeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHH
Q 007239          435 ISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQ  513 (611)
Q Consensus       435 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~  513 (611)
                      |+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |+.|+.....   ....    .
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~~----~  233 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVI----E  233 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHH----H
Confidence            999999986533322222223446788999999999999999999999999999998 8888643221   1111    1


Q ss_pred             HHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       514 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ....+.....     ..    .....+.+++.+||+.||.+|||+.+|++.|+..
T Consensus       234 ~i~~~~~~~~-----~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~  279 (288)
T cd05093         234 CITQGRVLQR-----PR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL  279 (288)
T ss_pred             HHHcCCcCCC-----CC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            1222221111     11    1123578999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-39  Score=330.38  Aligned_cols=241  Identities=19%  Similarity=0.230  Sum_probs=192.0

Q ss_pred             cCccCceEEEEEEcC-CCcEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCCh
Q 007239          300 LGQGGFGTVYKGVLP-NGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSL  375 (611)
Q Consensus       300 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~sL  375 (611)
                      ||+|+||.||++... +++.||+|++.+.   .......+.+|+.++++++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999964 6889999998753   233456788899999999999999999999999999999999999999


Q ss_pred             hhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcccccc
Q 007239          376 DCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR  455 (611)
Q Consensus       376 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  455 (611)
                      .+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~  152 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT  152 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence            988843   456899999999999999999999986   9999999999999999999999999997542222  12334


Q ss_pred             ccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHH
Q 007239          456 VVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIP  535 (611)
Q Consensus       456 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  535 (611)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||....   .   ......... ... .     +    +..
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~---~---~~~~~~~~~-~~~-~-----~----~~~  215 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN---V---NEMYRKILQ-EPL-R-----F----PDG  215 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC---H---HHHHHHHHc-CCC-C-----C----CCc
Confidence            679999999999999999999999999999999999999974321   1   111111111 110 0     1    111


Q ss_pred             HHHHHHHHhhccccCCCCCCCCHHHHHHHh
Q 007239          536 QVVRCIHIGLLCVQEDPAVRPTMSNVVALL  565 (611)
Q Consensus       536 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L  565 (611)
                      ....+.+++..||+.||++||+..++.+.|
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            223567889999999999998654444444

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.3e-38  Score=322.43  Aligned_cols=257  Identities=28%  Similarity=0.432  Sum_probs=203.0

Q ss_pred             CCCCcccccCccCceEEEEEEc-----CCCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-----PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      ++|++.+.||+|+||.||+|.+     ..++.+++|.+... ..+....+.+|+.++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            5688899999999999999984     24578999998753 33445678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhch--------------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC
Q 007239          366 IYELMPNRSLDCFIFDSE--------------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM  431 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~--------------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~  431 (611)
                      ||||+++++|.+++....              ....+++.++..++.||+.||.|||+++   ++||||||+|||++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            999999999999885321              1234788999999999999999999987   99999999999999999


Q ss_pred             CEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHH
Q 007239          432 VAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAY  510 (611)
Q Consensus       432 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~  510 (611)
                      .+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++ |..||....   ...+...
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~---~~~~~~~  238 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---NQEVIEM  238 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH
Confidence            999999999986543332222233456778999999998889999999999999999998 888864321   1112221


Q ss_pred             HHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          511 VWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       511 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      +    .......     .    ......++.+++.+||+.||++||++.+|+++|..
T Consensus       239 ~----~~~~~~~-----~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         239 V----RKRQLLP-----C----SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             H----HcCCcCC-----C----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1    1111111     1    11112456788999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.8e-38  Score=328.32  Aligned_cols=241  Identities=22%  Similarity=0.255  Sum_probs=193.1

Q ss_pred             cccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCC
Q 007239          298 NKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNR  373 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~  373 (611)
                      +.||+|+||.||++.. .+|+.||+|+++...   ......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999995 478999999987542   234556788999999999999999999999999999999999999


Q ss_pred             ChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcccc
Q 007239          374 SLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT  453 (611)
Q Consensus       374 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  453 (611)
                      +|..++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~  152 (323)
T cd05595          81 ELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM  152 (323)
T ss_pred             cHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence            9988873   3346899999999999999999999986   9999999999999999999999999987532221  122


Q ss_pred             ccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCC
Q 007239          454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSS  533 (611)
Q Consensus       454 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  533 (611)
                      ....||+.|+|||++.++.++.++|||||||++|||++|+.||.....   ..+...+   .. ...      .+..   
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~~---~~-~~~------~~p~---  216 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELI---LM-EEI------RFPR---  216 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHH---hc-CCC------CCCC---
Confidence            345799999999999999999999999999999999999999743221   1111111   11 110      0111   


Q ss_pred             HHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 007239          534 IPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVA  563 (611)
Q Consensus       534 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  563 (611)
                       .....+.+++.+||+.||++||     ++.++++
T Consensus       217 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         217 -TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             -CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence             1123566889999999999998     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-38  Score=318.91  Aligned_cols=255  Identities=29%  Similarity=0.449  Sum_probs=203.4

Q ss_pred             CCCCcccccCccCceEEEEEEcCC----CcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPN----GKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ++|++.+.||+|+||.||+|.+..    ...|++|.++... ......+.+|+.++++++||||+++++.+...+..+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            578999999999999999999642    3579999987543 33456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||+++.+..
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            9999999999998542  236899999999999999999999986   99999999999999999999999999987752


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ...........+++.|+|||.+.+..++.++||||||+++|+|++ |..|+....   ...+.    .....+....   
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~---~~~~~----~~~~~~~~~~---  228 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS---NQDVI----KAVEDGYRLP---  228 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC---HHHHH----HHHHcCCCCC---
Confidence            222222222345678999999999999999999999999999998 888864221   11111    1122211110   


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                            ........+.+++.+||+.+|++||++++|+++|..
T Consensus       229 ------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         229 ------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             ------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                  011123457799999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.4e-38  Score=314.65  Aligned_cols=248  Identities=27%  Similarity=0.376  Sum_probs=194.8

Q ss_pred             cccCccCceEEEEEEc-CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCCh
Q 007239          298 NKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSL  375 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~sL  375 (611)
                      +.||+|+||.||++++ .+++.+|+|.+.... .+....+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4699999999999996 478899999876542 34456799999999999999999999999999999999999999999


Q ss_pred             hhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcccccc
Q 007239          376 DCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR  455 (611)
Q Consensus       376 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  455 (611)
                      .+++...  ...+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++..............
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            9988432  345889999999999999999999987   99999999999999999999999999876433221111111


Q ss_pred             ccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCH
Q 007239          456 VVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSI  534 (611)
Q Consensus       456 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  534 (611)
                      ..++..|+|||.+.++.++.++||||||+++|||++ |..|+.....   .....    ........         ....
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---~~~~~----~~~~~~~~---------~~~~  219 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---QQTRE----AIEQGVRL---------PCPE  219 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---HHHHH----HHHcCCCC---------CCcc
Confidence            223457999999999999999999999999999998 7777642211   11111    11111110         0111


Q ss_pred             HHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          535 PQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       535 ~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                      ....++.+++.+||+.+|++||++.+|+++|.
T Consensus       220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            12346778999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.8e-38  Score=329.01  Aligned_cols=242  Identities=22%  Similarity=0.243  Sum_probs=194.5

Q ss_pred             cccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCC
Q 007239          298 NKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNR  373 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~  373 (611)
                      +.||+|+||.||++.. .+++.||+|++.+..   ......+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999995 468999999997542   234567888999999999999999999999999999999999999


Q ss_pred             ChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcccc
Q 007239          374 SLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT  453 (611)
Q Consensus       374 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  453 (611)
                      +|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  ...
T Consensus        81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~  152 (328)
T cd05593          81 ELFFHLS---RERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM  152 (328)
T ss_pred             CHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence            9988874   3346899999999999999999999986   9999999999999999999999999987532221  122


Q ss_pred             ccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCC
Q 007239          454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSS  533 (611)
Q Consensus       454 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  533 (611)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.....   ..+...    ......      .+..   
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~~~~----~~~~~~------~~p~---  216 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFEL----ILMEDI------KFPR---  216 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---HHHHHH----hccCCc------cCCC---
Confidence            346799999999999999999999999999999999999999743211   111111    111110      1111   


Q ss_pred             HHHHHHHHHHhhccccCCCCCCC-----CHHHHHHH
Q 007239          534 IPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVAL  564 (611)
Q Consensus       534 ~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  564 (611)
                       ....++.+++.+||+.||++||     ++.++++.
T Consensus       217 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         217 -TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             -CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence             1223567899999999999997     88988864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-37  Score=318.41  Aligned_cols=264  Identities=24%  Similarity=0.360  Sum_probs=201.2

Q ss_pred             hCCCCcccccCccCceEEEEEEcCC---------------CcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPN---------------GKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLV  354 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~  354 (611)
                      .++|++.+.||+|+||.||+++...               ...||+|.++.. .....+.+.+|++++++++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3589999999999999999987532               234899998764 333456789999999999999999999


Q ss_pred             EeEeeCCeEEEEEEecCCCChhhHhhhchh---------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcE
Q 007239          355 GCGIEGEEKLLIYELMPNRSLDCFIFDSER---------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNV  425 (611)
Q Consensus       355 ~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~---------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NI  425 (611)
                      +++......++||||+++++|.+++.....         ...+++..++.++.||+.||.|||+.+   ++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            999999999999999999999998854221         124688899999999999999999986   99999999999


Q ss_pred             EecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhC--CCCCCCCCCCc
Q 007239          426 LLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG--KRNSGFYLTGH  503 (611)
Q Consensus       426 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG--~~p~~~~~~~~  503 (611)
                      +++.++.+||+|||++................++..|+|||++.++.++.++||||||+++|+|+++  ..|+.....  
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--  238 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--  238 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh--
Confidence            9999999999999999765433222222234557789999999999999999999999999999984  445432211  


Q ss_pred             hhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          504 AQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       504 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                       ........+.+..........  .    .......+.+|+.+||+.||++||++++|++.|.
T Consensus       239 -~~~~~~~~~~~~~~~~~~~~~--~----~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         239 -EQVIENTGEFFRNQGRQIYLS--Q----TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             -HHHHHHHHHhhhhccccccCC--C----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence             222222222222111111100  0    0111246789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-38  Score=313.73  Aligned_cols=273  Identities=23%  Similarity=0.244  Sum_probs=219.9

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChh---hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQ---GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++++.||.|.-|+||++... ++..+|+|++.+....   ...+...|-+||+.++||.++.+|..|+.++..+++
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            356888999999999999999965 4688999999876443   345667799999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      ||||+||+|..+++. +....+++..++.++.+|+-||+|||-.|   ||+|||||+||||-++|++.|+||.|+.....
T Consensus       156 meyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             EecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            999999999988754 45567999999999999999999999987   99999999999999999999999998864311


Q ss_pred             ---------------------------------CCC---------------------ccccccccccCCCCCccccccCC
Q 007239          447 ---------------------------------NQK---------------------TANTRRVVGTYGYMAPEYAMEGL  472 (611)
Q Consensus       447 ---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~  472 (611)
                                                       ...                     ......++||-.|+|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             000                     01123478999999999999999


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCC
Q 007239          473 FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDP  552 (611)
Q Consensus       473 ~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP  552 (611)
                      .+.++|+|+|||++||||.|..||.....  .+.+...+             ...+.-.........+.+||...|.+||
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~--~~Tl~NIv-------------~~~l~Fp~~~~vs~~akDLIr~LLvKdP  376 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNN--KETLRNIV-------------GQPLKFPEEPEVSSAAKDLIRKLLVKDP  376 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCc--hhhHHHHh-------------cCCCcCCCCCcchhHHHHHHHHHhccCh
Confidence            99999999999999999999999754332  22233222             1111111112334567899999999999


Q ss_pred             CCCCC----HHHHHH--HhcCCCCCCCCCCCCCCcc
Q 007239          553 AVRPT----MSNVVA--LLGSESIALSEPRQPPFPV  582 (611)
Q Consensus       553 ~~RPt----~~evl~--~L~~~~~~l~~~~~p~~~~  582 (611)
                      ++|..    +.||-+  .++..+|.|-.-..||+..
T Consensus       377 ~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP  412 (459)
T KOG0610|consen  377 SKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIP  412 (459)
T ss_pred             hhhhccccchHHhhcCccccCCChhheeccCCCcCC
Confidence            99998    777765  4577888888888888854

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.9e-38  Score=326.81  Aligned_cols=248  Identities=23%  Similarity=0.316  Sum_probs=195.6

Q ss_pred             cccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      +.||+|+||.||++.. .+++.||+|++++..   ....+.+.+|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999995 468899999997542   23456688899999998 699999999999999999999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      ++|.+++.   ....+++..++.++.||+.||.|||+++   ++||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~  152 (329)
T cd05588          81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT  152 (329)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence            99988873   3356999999999999999999999987   9999999999999999999999999987432111  12


Q ss_pred             cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc--hhhHHHHHHHHHhcCccccccccccCC
Q 007239          453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGH--AQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ......+..+........      +..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~p~  226 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------IPR  226 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------CCC
Confidence            234679999999999999999999999999999999999999986432211  112222233322222110      111


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCC------HHHHHH
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPT------MSNVVA  563 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt------~~evl~  563 (611)
                      .    ...++.+++.+||+.||++||+      ++++++
T Consensus       227 ~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         227 S----LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             C----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            1    1235678999999999999997      667764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.2e-38  Score=334.58  Aligned_cols=253  Identities=21%  Similarity=0.294  Sum_probs=195.0

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .|++.+.||+|+||+||+++. .+++.||+|++.+..   ......+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            588899999999999999995 568899999997543   2345678999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++|+|.+++.   +...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++++||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999999884   3346889999999999999999999986   9999999999999999999999999986432100


Q ss_pred             C---------------------------------------------ccccccccccCCCCCccccccCCCCchhhHHHHH
Q 007239          449 K---------------------------------------------TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFG  483 (611)
Q Consensus       449 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG  483 (611)
                      .                                             .......+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                             0001235799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhc--cccCCCCCCCCHHHH
Q 007239          484 VIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLL--CVQEDPAVRPTMSNV  561 (611)
Q Consensus       484 vll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~--cl~~dP~~RPt~~ev  561 (611)
                      |++|||++|+.||.......   ...   ..........+       ........++.+++.+  |+..+|..||+++++
T Consensus       236 ~il~elltG~~Pf~~~~~~~---~~~---~i~~~~~~~~~-------~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTE---TQL---KVINWENTLHI-------PPQVKLSPEAVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHH---HHH---HHHccccccCC-------CCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence            99999999999985432211   111   11110100000       0001112345566655  566677779999999


Q ss_pred             HHH
Q 007239          562 VAL  564 (611)
Q Consensus       562 l~~  564 (611)
                      ++.
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            874

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-39  Score=298.06  Aligned_cols=262  Identities=24%  Similarity=0.255  Sum_probs=210.0

Q ss_pred             hCCCCcccccCccCceEEEEEE-cCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC-----CeEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG-----EEKL  364 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~~~  364 (611)
                      .++|++.++||+|||+-||.++ ..+++.||+|++.-.+.++.+..++|++..++++|||+++++++...+     ...|
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y   99 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY   99 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence            4689999999999999999999 568889999999888788889999999999999999999999876544     3589


Q ss_pred             EEEEecCCCChhhHhhhchhhc-cCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          365 LIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~-~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      |+++|...|+|.+.+.....++ .+++.+++.|+.+|++||++||+.. .+++||||||.|||+.+.+.++|.|||.+..
T Consensus       100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen  100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence            9999999999999886644433 7999999999999999999999985 4799999999999999999999999999976


Q ss_pred             cccCCCccc-------cccccccCCCCCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHH
Q 007239          444 FCENQKTAN-------TRRVVGTYGYMAPEYAM---EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ  513 (611)
Q Consensus       444 ~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~  513 (611)
                      ..-......       ...-.-|..|.|||.+.   +...++++|||||||+||+|+.|..||+....            
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~------------  246 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ------------  246 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh------------
Confidence            422111110       11124678899999875   45678999999999999999999999853221            


Q ss_pred             HHhcCccc-cccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          514 LWKEGKEM-EFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       514 ~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                        ..+... -+....+.-+......+.+.+++.+|||.||.+||++.+++..+..
T Consensus       247 --~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  247 --QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             --cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence              111111 1222222222233356678899999999999999999999998864

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-38  Score=333.79  Aligned_cols=253  Identities=22%  Similarity=0.294  Sum_probs=197.8

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++.+.||+|+||.||+++. .+++.||+|++....   ......+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4789999999999999999996 468899999997542   233456788999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            99999999998843   346899999999999999999999987   999999999999999999999999999765322


Q ss_pred             CCcc------------------------------------ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh
Q 007239          448 QKTA------------------------------------NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS  491 (611)
Q Consensus       448 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt  491 (611)
                      ....                                    .....+||+.|+|||++....++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1100                                    0112469999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCC---HHHHHHH
Q 007239          492 GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT---MSNVVAL  564 (611)
Q Consensus       492 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~  564 (611)
                      |..||.....   .....   ..........+.     .  .......+.+++.+|+. +|.+|++   +.++++.
T Consensus       235 G~~Pf~~~~~---~~~~~---~i~~~~~~~~~~-----~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         235 GYPPFCSDNP---QETYR---KIINWKETLQFP-----D--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCCH---HHHHH---HHHcCCCccCCC-----C--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            9999853221   11111   111111100100     0  01112345677888886 9999998   8888763

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-38  Score=315.87  Aligned_cols=252  Identities=27%  Similarity=0.409  Sum_probs=200.7

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      .+|++.+.||+|+||.||++.+++++.+++|++..... ..+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            35888999999999999999987777899999865432 34578889999999999999999999999999999999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +++|.+++....  ..+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||+++.........
T Consensus        83 ~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          83 NGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            999999885422  36899999999999999999999987   9999999999999999999999999998654322111


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                       .....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+.....   .....    .........        
T Consensus       158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~----~~~~~~~~~--------  221 (256)
T cd05059         158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVE----SVSAGYRLY--------  221 (256)
T ss_pred             -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHH----HHHcCCcCC--------
Confidence             111234457999999999999999999999999999999 7888753322   11111    111111100        


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                       .+.....++.+++.+||+.+|++|||+.++++.|.
T Consensus       222 -~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         222 -RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence             01112346779999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.6e-38  Score=345.73  Aligned_cols=257  Identities=21%  Similarity=0.253  Sum_probs=204.4

Q ss_pred             HhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC----
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE----  361 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----  361 (611)
                      ...++|.+.+.||+|+||+||+++. .+++.||+|++...  .......+.+|+.++..++|+|++++++.+....    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3457999999999999999999985 57899999998654  3344567889999999999999999988765432    


Q ss_pred             ----eEEEEEEecCCCChhhHhhhch-hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEe
Q 007239          362 ----EKLLIYELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKIS  436 (611)
Q Consensus       362 ----~~~lv~E~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~  436 (611)
                          .+++||||+++|+|.+++.... ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence                3689999999999999885432 2346899999999999999999999986   9999999999999999999999


Q ss_pred             ccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHh
Q 007239          437 DFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWK  516 (611)
Q Consensus       437 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~  516 (611)
                      |||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||....      ....... ..
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~~-~~  258 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMHK-TL  258 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHHH-Hh
Confidence            9999987654333333345689999999999999999999999999999999999999974321      1111111 11


Q ss_pred             cCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          517 EGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       517 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      .+....     +    +.....++.+++..||+.||++||++.++++.
T Consensus       259 ~~~~~~-----~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        259 AGRYDP-----L----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             cCCCCC-----C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            111111     1    11122457789999999999999999999864

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.7e-38  Score=316.29  Aligned_cols=252  Identities=26%  Similarity=0.389  Sum_probs=201.6

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      ++|++.+.||+|+||.||++.+.++..+|+|.+.... ...+.+.+|+.++++++||||+++++++......++||||+.
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4688899999999999999998777789999987543 234678999999999999999999999998889999999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +++|.+++....  ..+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            999999885422  36899999999999999999999987   999999999999999999999999999865432211 


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                      ......++..|++||++.+..++.++||||||+++|+|++ |+.|+.....   .....    ....+.....       
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~----~~~~~~~~~~-------  222 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVE----KVSQGLRLYR-------  222 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHH----HHhcCCCCCC-------
Confidence            1112345678999999998889999999999999999998 8888743221   11111    1111111100       


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                        .......+.+++.+||+.+|.+||++.++++.|+
T Consensus       223 --~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         223 --PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             --CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence              0112346778999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=342.13  Aligned_cols=255  Identities=24%  Similarity=0.263  Sum_probs=208.2

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCC-cEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEE-eEee------CC
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNG-KEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVG-CGIE------GE  361 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~-~~~~------~~  361 (611)
                      ..++++.+.|.+|||+.||.+.+..+ .+||+|++-..+....+.+++|+.+|++|+ |+|||.+++ ....      .-
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            35678889999999999999997655 999999988778888899999999999998 999999999 3221      23


Q ss_pred             eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccc
Q 007239          362 EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA  441 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  441 (611)
                      +.+|.||||.||.|-+++....... |++.++++|+.++++|+.+||... .+|||||||-+||||+.+++.||||||.|
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccccc
Confidence            6789999999999999996654444 999999999999999999999884 78999999999999999999999999999


Q ss_pred             eecccCCCccc-------cccccccCCCCCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHH
Q 007239          442 RIFCENQKTAN-------TRRVVGTYGYMAPEYA---MEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYV  511 (611)
Q Consensus       442 ~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~  511 (611)
                      ...........       .-...-|+.|+|||++   .+..+++|+|||+|||+||-|+....||+..            
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s------------  261 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES------------  261 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC------------
Confidence            75432221111       1123579999999987   4678999999999999999999999998522            


Q ss_pred             HHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          512 WQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       512 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                             -...+++....-+...+...++.+||..||+.||++||++-+|+..+-
T Consensus       262 -------g~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  262 -------GKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             -------cceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence                   112233333333333456678889999999999999999999998873

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-38  Score=327.02  Aligned_cols=253  Identities=23%  Similarity=0.291  Sum_probs=209.4

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe-EEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE-KLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-~~lv  366 (611)
                      .++|..++.+|+|+||.++..+.+ +++.+++|.+.....  .......+|+.++++++|||||.+.+.|.+++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            367899999999999999999854 677899999875432  233467899999999999999999999999988 9999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |+|++||++.+.|...+ ...++++++.+|+.||+.|+.|||++.   |+|||||+.|||++.++.|||+|||+|+....
T Consensus        83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            99999999999986533 577999999999999999999999774   99999999999999999999999999998865


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ..  ......+|||.||.||++.+.+|+.|+|||||||++|||++-+++|...+   -..+...+.+   ..     .  
T Consensus       159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~---m~~Li~ki~~---~~-----~--  223 (426)
T KOG0589|consen  159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN---MSELILKINR---GL-----Y--  223 (426)
T ss_pred             ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc---hHHHHHHHhh---cc-----C--
Confidence            54  23345799999999999999999999999999999999999999874322   2222222211   11     1  


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHh
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL  565 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  565 (611)
                         ...+.....++..++..||+.+|+.||++.+++.+-
T Consensus       224 ---~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P  259 (426)
T KOG0589|consen  224 ---SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP  259 (426)
T ss_pred             ---CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence               122334445677888899999999999999999763

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.6e-38  Score=328.56  Aligned_cols=259  Identities=27%  Similarity=0.420  Sum_probs=202.4

Q ss_pred             hCCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEee-CC
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIE-GE  361 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~-~~  361 (611)
                      .++|++.+.||+|+||.||+|+..      +++.||+|+++... ....+.+.+|+.++.++ +|+||+++++++.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357999999999999999999732      35789999987542 23456788899999999 79999999998764 45


Q ss_pred             eEEEEEEecCCCChhhHhhhchh---------------------------------------------------------
Q 007239          362 EKLLIYELMPNRSLDCFIFDSER---------------------------------------------------------  384 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~---------------------------------------------------------  384 (611)
                      ..+++|||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            68899999999999988853211                                                         


Q ss_pred             -hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccccccccccCCCC
Q 007239          385 -RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM  463 (611)
Q Consensus       385 -~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~  463 (611)
                       ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             236899999999999999999999986   9999999999999999999999999998764433222233345678899


Q ss_pred             CccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHH
Q 007239          464 APEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIH  542 (611)
Q Consensus       464 aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  542 (611)
                      |||++.+..++.++|||||||++|||++ |..||......+  .    .......+.....         +.....++.+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~----~~~~~~~~~~~~~---------~~~~~~~~~~  307 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--E----FCRRLKEGTRMRA---------PEYATPEIYS  307 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--H----HHHHHhccCCCCC---------CccCCHHHHH
Confidence            9999999999999999999999999998 988875322111  1    1122222211110         1112245778


Q ss_pred             HhhccccCCCCCCCCHHHHHHHhcC
Q 007239          543 IGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       543 li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ++.+||+.+|++||++.||+++|..
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~  332 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGD  332 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHH
Confidence            9999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.5e-38  Score=331.53  Aligned_cols=200  Identities=25%  Similarity=0.354  Sum_probs=174.0

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++.+.||+|+||+||++.. .+++.||+|++.+..   ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4789999999999999999985 468899999997542   233456888999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++|+|.+++.   +...+++..+..++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            9999999999984   3456899999999999999999999986   999999999999999999999999999754321


Q ss_pred             CCc---------------------------------cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 007239          448 QKT---------------------------------ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKR  494 (611)
Q Consensus       448 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~  494 (611)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123579999999999999999999999999999999999999


Q ss_pred             CCC
Q 007239          495 NSG  497 (611)
Q Consensus       495 p~~  497 (611)
                      ||.
T Consensus       235 Pf~  237 (363)
T cd05628         235 PFC  237 (363)
T ss_pred             CCC
Confidence            985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.1e-38  Score=327.11  Aligned_cols=252  Identities=23%  Similarity=0.279  Sum_probs=197.4

Q ss_pred             CCCcccccCccCceEEEEEEc----CCCcEEEEEEecccC----hhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL----PNGKEVAVKRLSRKS----WQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~  363 (611)
                      +|++.+.||+|+||.||+++.    .+++.||+|++.+..    ....+.+.+|+.+++.++ ||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            488899999999999999885    357899999986532    233456788999999995 99999999999999999


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ++||||+++++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLY---QRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999998884   3456899999999999999999999987   99999999999999999999999999986


Q ss_pred             cccCCCccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          444 FCENQKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       444 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      +...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..........   .+.......    
T Consensus       155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~~~~----  226 (332)
T cd05614         155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSRRILKC----  226 (332)
T ss_pred             ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHHHHHhcC----
Confidence            5332221 22346799999999998865 47889999999999999999999985433222111   111111111    


Q ss_pred             ccccccCCCCCHHHHHHHHHHhhccccCCCCCCC-----CHHHHHHH
Q 007239          523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVAL  564 (611)
Q Consensus       523 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  564 (611)
                        ++.+..    .....+.+++.+||+.||++||     +++++++.
T Consensus       227 --~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         227 --DPPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             --CCCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence              111111    1123466889999999999999     67777653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-38  Score=331.89  Aligned_cols=246  Identities=26%  Similarity=0.300  Sum_probs=199.5

Q ss_pred             hCCCCcccccCccCceEEEEEEcCC--CcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPN--GKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      .++|++.+.||+|+||.||+|.+..  +..||+|++....   ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            4679999999999999999998543  3689999986532   2345678899999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       109 v~Ey~~~g~L~~~i~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLR---RNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999884   3456899999999999999999999987   9999999999999999999999999998653


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ..     .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   .....    +....+.. .   
T Consensus       183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~~~~~----~~i~~~~~-~---  246 (340)
T PTZ00426        183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE---PLLIY----QKILEGII-Y---  246 (340)
T ss_pred             CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC---HHHHH----HHHhcCCC-C---
Confidence            21     224679999999999999889999999999999999999999985321   11111    11112111 0   


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCC-----CHHHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVAL  564 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  564 (611)
                        ....    ....+.+++.+||+.||++|+     +++++++.
T Consensus       247 --~p~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        247 --FPKF----LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --CCCC----CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence              0111    123466889999999999995     88888765

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9.2e-39  Score=321.38  Aligned_cols=250  Identities=34%  Similarity=0.526  Sum_probs=192.7

Q ss_pred             cccccCccCceEEEEEEcC-----CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          296 DSNKLGQGGFGTVYKGVLP-----NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       296 ~~~~lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +.+.||.|.||.||+|.+.     .+..|+||.++.. ..+..+.+.+|++++++++||||+++++++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4578999999999999965     3567999999654 334478899999999999999999999999988889999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++|+|.+++... ....+++..++.|+.||++||.|||+++   ++|+||+++||+++.++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999553 2356899999999999999999999986   99999999999999999999999999987633322


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                      ........+...|+|||.+....++.++||||||+++|||++ |+.|+...   ....+..    .+..+......    
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~~~----~~~~~~~~~~~----  227 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEIIE----KLKQGQRLPIP----  227 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHHHH----HHHTTEETTSB----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccc----cccccccceec----
Confidence            222233456788999999999999999999999999999999 66775322   2222222    22233221111    


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHh
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL  565 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  565 (611)
                           .....++.+++..||..+|++||++.++++.|
T Consensus       228 -----~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  228 -----DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -----TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -----cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                 11123567899999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.2e-38  Score=330.22  Aligned_cols=252  Identities=21%  Similarity=0.274  Sum_probs=199.1

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++.+.||+|+||+||++.. .+++.||+|+++....   +....+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4789999999999999999995 4788999999975422   34566889999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999998532  246899999999999999999999986   999999999999999999999999999876433


Q ss_pred             CCccccccccccCCCCCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAM------EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM  521 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  521 (611)
                      ... ......||+.|+|||++.      ...++.++||||||+++|||++|+.||.....   ...   ...........
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~---~~~i~~~~~~~  228 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS---AKT---YNNIMNFQRFL  228 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH---HHH---HHHHHcCCCcc
Confidence            222 223357999999999986      45678999999999999999999999743221   111   11111111111


Q ss_pred             cccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          522 EFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       522 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .+.       ........+.+|+..||+ +|++||++.++++
T Consensus       229 ~~~-------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         229 KFP-------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CCC-------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            110       011122346678888998 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=333.24  Aligned_cols=253  Identities=23%  Similarity=0.321  Sum_probs=202.1

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++.+.||+|+||.||++... +++.||+|++....   ......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47899999999999999999964 78999999987542   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIR---KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            99999999999853   356899999999999999999999986   999999999999999999999999999866433


Q ss_pred             C---------------------------CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 007239          448 Q---------------------------KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYL  500 (611)
Q Consensus       448 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~  500 (611)
                      .                           .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0112234579999999999999999999999999999999999999975332


Q ss_pred             CCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCC-HHHHHHH
Q 007239          501 TGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT-MSNVVAL  564 (611)
Q Consensus       501 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~  564 (611)
                      .   .....   ........  +.   +  .........+.+++..||+ +|++||+ ++++++.
T Consensus       235 ~---~~~~~---~i~~~~~~--~~---~--p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 L---QETYN---KIINWKES--LR---F--PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             H---HHHHH---HHhccCCc--cc---C--CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            1   11111   11110000  00   0  0001123456788889997 9999999 9999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.7e-37  Score=317.22  Aligned_cols=261  Identities=23%  Similarity=0.338  Sum_probs=193.0

Q ss_pred             CCCCcccccCccCceEEEEEEc-C-CCcEEEEEEecccCh--hhHHHHHHHHHHHHhc---CCCCeeeEEEeEe-----e
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-P-NGKEVAVKRLSRKSW--QGLEEFKNEIILIAKL---QHRNLVRLVGCGI-----E  359 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~h~niv~l~~~~~-----~  359 (611)
                      ++|++.+.||+|+||.||+++. . +++.||+|+++....  .....+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            4789999999999999999985 3 467899998865422  2234566788777766   6999999999875     2


Q ss_pred             CCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccc
Q 007239          360 GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFG  439 (611)
Q Consensus       360 ~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  439 (611)
                      ....++||||++ ++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            456899999997 5788877432 2345899999999999999999999986   9999999999999999999999999


Q ss_pred             cceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCc
Q 007239          440 MARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK  519 (611)
Q Consensus       440 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  519 (611)
                      +++.....   .......||+.|+|||.+.+..++.++||||||+++|||++|++||.....   ......+........
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~---~~~~~~i~~~~~~~~  229 (290)
T cd07862         156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD---VDQLGKILDVIGLPG  229 (290)
T ss_pred             ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH---HHHHHHHHHHhCCCC
Confidence            99865433   122345789999999999999999999999999999999999999754322   112222211111000


Q ss_pred             cccc------cccccC--CCCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          520 EMEF------VDPLLM--KSSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       520 ~~~~------~d~~l~--~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..++      ....+.  .....     .....+.+++.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0000      000000  00001     11234568999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=3.2e-38  Score=326.97  Aligned_cols=255  Identities=27%  Similarity=0.430  Sum_probs=200.2

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCc----EEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGK----EVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      .+|++.+.||+|+||.||+|++. +++    .||+|+++... .....++.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            56999999999999999999853 333    48999987543 34456789999999999999999999998764 5789


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ++||+++|+|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999988543  235889999999999999999999986   9999999999999999999999999998765


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ............++..|+|||++.+..++.++||||||+++|||++ |+.|+....   ...+    ......+....  
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~---~~~~----~~~~~~~~~~~--  231 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP---ASEI----SSILEKGERLP--  231 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC---HHHH----HHHHhCCCCCC--
Confidence            4333222222345678999999999999999999999999999998 888874321   1111    11112211100  


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      .       ......++.+++..||+.+|++||++.+++..|...
T Consensus       232 ~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         232 Q-------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             C-------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            0       011123567899999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.8e-38  Score=308.68  Aligned_cols=265  Identities=26%  Similarity=0.351  Sum_probs=204.0

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChh--hHHHHHHHHHHHHhcCCCC-eeeEEEeEeeCC-----
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQ--GLEEFKNEIILIAKLQHRN-LVRLVGCGIEGE-----  361 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~n-iv~l~~~~~~~~-----  361 (611)
                      ...|...++||+|+||+||+|+. .+|+.||+|+++....+  ......+|+.+|++|+|+| |+++++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            34577778899999999999994 57899999999865432  2345689999999999999 999999998877     


Q ss_pred             -eEEEEEEecCCCChhhHhhhchhh-ccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccc
Q 007239          362 -EKLLIYELMPNRSLDCFIFDSERR-LQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFG  439 (611)
Q Consensus       362 -~~~lv~E~~~~~sL~~~l~~~~~~-~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  439 (611)
                       .+++|+||++. +|..++...... ..++...+..++.||++||+|||+++   |+||||||.||||+++|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence             88999999965 788887443221 34677889999999999999999997   9999999999999999999999999


Q ss_pred             cceecccCCCccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC
Q 007239          440 MARIFCENQKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG  518 (611)
Q Consensus       440 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  518 (611)
                      +|+.+.-+...  ....++|..|.|||++.+. .|+...||||+||++.||+++++-|....+   .+.+..+.+.....
T Consensus       166 lAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP  240 (323)
T KOG0594|consen  166 LARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTP  240 (323)
T ss_pred             hHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCC
Confidence            99976543332  2235789999999999886 699999999999999999998877644333   44444555444333


Q ss_pred             cccccc--------ccccCCCC-CHHH-------HHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          519 KEMEFV--------DPLLMKSS-SIPQ-------VVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       519 ~~~~~~--------d~~l~~~~-~~~~-------~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ....+.        +....... ....       ..+..+++.+||+.+|.+|.|+..++++
T Consensus       241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            222111        11111111 0111       1256789999999999999999999985

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1e-37  Score=325.02  Aligned_cols=243  Identities=24%  Similarity=0.323  Sum_probs=191.4

Q ss_pred             cccCccCceEEEEEEcC-CCcEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK---SWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      +.||+|+||.||++... +++.||+|++++.   .......+.+|+.++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999954 6789999999754   223455678899988877 799999999999999999999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      ++|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~  152 (329)
T cd05618          81 GDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--T  152 (329)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--c
Confidence            99988773   3356899999999999999999999986   99999999999999999999999999875322111  2


Q ss_pred             cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC--chhhHHHHHHHHHhcCccccccccccCC
Q 007239          453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--HAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||......  .......+.++....... .     +..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~-----~p~  226 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R-----IPR  226 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-C-----CCC
Confidence            23467999999999999999999999999999999999999998532211  111222233332222211 1     111


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCH
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTM  558 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~  558 (611)
                          .....+.+++.+||+.||++||+.
T Consensus       227 ----~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         227 ----SLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             ----CCCHHHHHHHHHHhcCCHHHcCCC
Confidence                122356789999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-38  Score=331.99  Aligned_cols=253  Identities=22%  Similarity=0.273  Sum_probs=195.8

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++.+.||+|+||.||++.. .+++.||+|++.+..   ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4789999999999999999985 578899999986532   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999998843   356889999999999999999999987   999999999999999999999999999643211


Q ss_pred             CCc------------c---------------------------------ccccccccCCCCCccccccCCCCchhhHHHH
Q 007239          448 QKT------------A---------------------------------NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSF  482 (611)
Q Consensus       448 ~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSl  482 (611)
                      ...            .                                 .....+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000            0                                 0012469999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCC---CCHH
Q 007239          483 GVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVR---PTMS  559 (611)
Q Consensus       483 Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~  559 (611)
                      ||++|||++|+.||.....   ......+   ........+     ...  .....++.+++..||+ +|.+|   +++.
T Consensus       235 Gvil~elltG~~Pf~~~~~---~~~~~~i---~~~~~~~~~-----p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~  300 (377)
T cd05629         235 GAIMFECLIGWPPFCSENS---HETYRKI---INWRETLYF-----PDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAH  300 (377)
T ss_pred             chhhhhhhcCCCCCCCCCH---HHHHHHH---HccCCccCC-----CCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence            9999999999999853221   1111111   110110111     010  0112346688888997 66665   5999


Q ss_pred             HHHHH
Q 007239          560 NVVAL  564 (611)
Q Consensus       560 evl~~  564 (611)
                      ++++.
T Consensus       301 ~~l~h  305 (377)
T cd05629         301 EIKSH  305 (377)
T ss_pred             HHhcC
Confidence            88875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.7e-38  Score=320.10  Aligned_cols=257  Identities=27%  Similarity=0.409  Sum_probs=202.3

Q ss_pred             CCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  364 (611)
                      .+|++.+.||+|+||.||+|.+.      .++.||+|+++.... ...+.+.+|+.++..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            35778899999999999999853      246799999875432 23467889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhHhhhc-------------hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC
Q 007239          365 LIYELMPNRSLDCFIFDS-------------ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM  431 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~  431 (611)
                      +++||+.+++|.+++...             .....+++..+..++.|++.||.|||+++   ++||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            999999999999988421             11235788899999999999999999987   99999999999999999


Q ss_pred             CEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHH
Q 007239          432 VAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAY  510 (611)
Q Consensus       432 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~  510 (611)
                      .+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..|+....   ...+.  
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~--  236 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDVI--  236 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC---HHHHH--
Confidence            999999999886543332222333456789999999998999999999999999999998 777764321   11122  


Q ss_pred             HHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          511 VWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       511 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                        .....+.....         .......+.+++..||+.+|++||++.+|++.|+.
T Consensus       237 --~~i~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 --EMIRNRQVLPC---------PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             --HHHHcCCcCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence              22222221111         11223446789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.4e-38  Score=315.70  Aligned_cols=254  Identities=29%  Similarity=0.438  Sum_probs=203.2

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      .+|.+.+.||+|+||.||++.+. .++.|++|++.... .....+.+|+.+++.++|+||+++++++......+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45888899999999999999964 58889999987543 34567899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++++|.+++... ....+++..++.++.|++++|.|||+.+   ++||||||+||++++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            999999988542 2345899999999999999999999986   999999999999999999999999999876433221


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                      . .....++..|+|||.+.+..++.++||||||+++|||++ |..|+....   ...    .++........+     . 
T Consensus       161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~---~~~----~~~~~~~~~~~~-----~-  226 (263)
T cd05052         161 A-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID---LSQ----VYELLEKGYRME-----R-  226 (263)
T ss_pred             c-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHH----HHHHHHCCCCCC-----C-
Confidence            1 112234678999999999999999999999999999998 888864321   111    122222211111     1 


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                         +......+.+++.+||+.+|++||++.+++++|+.
T Consensus       227 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         227 ---PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             ---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence               11122457789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-39  Score=300.03  Aligned_cols=251  Identities=26%  Similarity=0.351  Sum_probs=201.4

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      .+.|++.+.||+|.|+.|+++.. .+|+++|+|++...  +..+.+.+.+|+.|-+.|+||||+++++.+.+....|+|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            46788889999999999999985 57999999987533  3346778999999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC---CCCEEEeccccceec
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK---DMVAKISDFGMARIF  444 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFGla~~~  444 (611)
                      |+|.|+.|-.-|   ..+..+++..+...++||+++|.|+|.++   |||||+||+|+++-.   .--+||+|||+|..+
T Consensus        90 e~m~G~dl~~eI---V~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDI---VAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            999999996655   33456788889999999999999999996   999999999999953   346999999999987


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      .....   ....+|||+|||||++...+|+..+|||+-||+||-||.|.+||..   +++..+.+.+    +.+...  +
T Consensus       164 ~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~~~~rlye~I----~~g~yd--~  231 (355)
T KOG0033|consen  164 NDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYEQI----KAGAYD--Y  231 (355)
T ss_pred             CCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHH----hccccC--C
Confidence            63332   3356899999999999999999999999999999999999999742   2333444433    222210  0


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ++....    ....+..+|+.+||..||++|.|+.|.+.
T Consensus       232 ~~~~w~----~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  232 PSPEWD----TVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CCcccC----cCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            110001    11134568899999999999999998774

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.2e-37  Score=310.18  Aligned_cols=259  Identities=24%  Similarity=0.369  Sum_probs=206.3

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++.+.||+|+||.||+++. .+++.||+|.+...   .......+.+|+.+++.++||||+++++.+...+..++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5799999999999999999995 47899999987642   2334557889999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhch-hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          368 ELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      ||+++++|.+++.... ....+++..+..++.||+.||.|||+++   ++|+||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999998875422 2345789999999999999999999986   99999999999999999999999999987643


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ...  ......|++.|+|||.+.+..++.++|+||||+++|||++|+.|+..... .   ..... ..........    
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~---~~~~~-~~~~~~~~~~----  227 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-N---LFSLC-QKIEQCDYPP----  227 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-c---HHHHH-HHHhcCCCCC----
Confidence            321  12235688999999999988899999999999999999999999742211 1   11111 1111111100    


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                       .   ........+.+++.+||+.+|++||++.+|++.|+..
T Consensus       228 -~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         228 -L---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             -C---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence             0   1112234577899999999999999999999999754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=331.61  Aligned_cols=259  Identities=32%  Similarity=0.441  Sum_probs=202.1

Q ss_pred             CCCcccccCccCceEEEEEEcC--CC---cEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP--NG---KEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~--~~---~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  364 (611)
                      +-.+.++||+|+||+||+|.+.  ++   ..||+|..+..   ..+.+.+|.+|++++++++|||||++||+......++
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            4455689999999999999953  22   23899988752   3566789999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +|||+|.||+|.++|.....  .++..+...++.+.+.||+|||++.   +|||||-..|+|++.++.+||+|||+++.-
T Consensus       238 ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCC
Confidence            99999999999999954332  5899999999999999999999986   999999999999999999999999998753


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      ..  .........-...|+|||.+..+.|+.++|||||||++||+++ |..|+.....   ..+..++   ...+.....
T Consensus       313 ~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~---~~v~~kI---~~~~~r~~~  384 (474)
T KOG0194|consen  313 SQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN---YEVKAKI---VKNGYRMPI  384 (474)
T ss_pred             cc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH---HHHHHHH---HhcCccCCC
Confidence            21  1111111234578999999999999999999999999999998 7777643221   1122211   122222111


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCCCCCC
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALS  573 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~  573 (611)
                               +......+..++..||..+|++||+|.++.+.|........
T Consensus       385 ---------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  385 ---------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             ---------CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence                     11223345567779999999999999999999976544333

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.4e-38  Score=324.81  Aligned_cols=241  Identities=26%  Similarity=0.324  Sum_probs=192.8

Q ss_pred             cccCccCceEEEEEEc----CCCcEEEEEEecccC----hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          298 NKLGQGGFGTVYKGVL----PNGKEVAVKRLSRKS----WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +.||+|+||.||+++.    ..++.||+|++....    ......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999985    357889999987532    22345678899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++.   +...+.+..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLE---REGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999998883   3456788899999999999999999986   99999999999999999999999999975432221


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                        ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....   .   ..... ...+.. .     +.
T Consensus       156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~---~---~~~~~-~~~~~~-~-----~~  220 (323)
T cd05584         156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR---K---KTIDK-ILKGKL-N-----LP  220 (323)
T ss_pred             --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH---H---HHHHH-HHcCCC-C-----CC
Confidence              22345799999999999998899999999999999999999999753221   1   11111 111111 0     11


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVA  563 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  563 (611)
                      .    .....+.+++.+||+.+|++||     +++++++
T Consensus       221 ~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         221 P----YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             C----CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            1    1123567899999999999999     7888776

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4e-37  Score=315.31  Aligned_cols=264  Identities=26%  Similarity=0.376  Sum_probs=205.3

Q ss_pred             hCCCCcccccCccCceEEEEEEcCC-----------------CcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeee
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPN-----------------GKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVR  352 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~  352 (611)
                      .++|++.+.||+|+||.||++....                 +..||+|++.... ....+.+.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4679999999999999999988532                 2458999987553 345678899999999999999999


Q ss_pred             EEEeEeeCCeEEEEEEecCCCChhhHhhhch--------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCc
Q 007239          353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSE--------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSN  424 (611)
Q Consensus       353 l~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~--------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~N  424 (611)
                      +++++..+...+++|||+++++|.+++....        ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999985432        1126899999999999999999999986   9999999999


Q ss_pred             EEecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCC
Q 007239          425 VLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS--GKRNSGFYLTG  502 (611)
Q Consensus       425 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt--G~~p~~~~~~~  502 (611)
                      |+++.++.++|+|||+++...............+++.|+|||++..+.++.++||||||+++|||++  |..|+...   
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~---  237 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL---  237 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc---
Confidence            9999999999999999986543332222334567789999999998899999999999999999998  55554322   


Q ss_pred             chhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          503 HAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       503 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                      ............+..........      .......++.+++.+||+.||++|||+.||++.|+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         238 TDQQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ChHHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            12222232222222211111111      01112246789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.4e-37  Score=322.06  Aligned_cols=241  Identities=26%  Similarity=0.299  Sum_probs=188.9

Q ss_pred             cccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      +.||+|+||.||++.. .+++.||+|+++...   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999996 467889999987542   22344556677777654 799999999999999999999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~  152 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence            999888843   346899999999999999999999986   9999999999999999999999999998643222  22


Q ss_pred             cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCC
Q 007239          453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSS  532 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  532 (611)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+..   . +....      +.+..  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~---~-i~~~~------~~~~~--  217 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFD---S-ILNDR------PHFPR--  217 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHH---H-HHcCC------CCCCC--
Confidence            2346799999999999999999999999999999999999999853221   11111   1 11110      01111  


Q ss_pred             CHHHHHHHHHHhhccccCCCCCCCCHH-HHHH
Q 007239          533 SIPQVVRCIHIGLLCVQEDPAVRPTMS-NVVA  563 (611)
Q Consensus       533 ~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~  563 (611)
                        ....++.+++..||+.||++||++. ++++
T Consensus       218 --~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         218 --WISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             --CCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence              1123466888999999999999875 4543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.6e-37  Score=312.41  Aligned_cols=251  Identities=24%  Similarity=0.344  Sum_probs=198.9

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      ++|++.+.||+|+||.||+++. .+++.||+|++... .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            4678889999999999999995 57889999998654 333456789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|..+.       .+++..+..++.||+.||.|||+.+   |+|+||||+|||++.++.+||+|||++....... 
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-  149 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-  149 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence            9999986542       4678888999999999999999987   9999999999999999999999999998653322 


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                         .....|+..|+|||++.+..++.++||||||+++|+|++|+.||................+.........     +.
T Consensus       150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~  221 (279)
T cd06619         150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV-----LP  221 (279)
T ss_pred             ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC-----CC
Confidence               2235789999999999999999999999999999999999999854332221111111111111111111     10


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      .   .....++.+++.+||+.+|++||+++|+++.
T Consensus       222 ~---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 V---GQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             C---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            1   1122356789999999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=9.5e-38  Score=318.06  Aligned_cols=262  Identities=27%  Similarity=0.401  Sum_probs=200.3

Q ss_pred             CCCCcccccCccCceEEEEEEc-----CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee--CCeEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-----PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE--GEEKL  364 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~  364 (611)
                      ++|++.+.||+|+||.||++..     .+++.|++|.+........+.+.+|+++++.++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            5788999999999999999974     2578899999987766667789999999999999999999997653  34689


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +||||+++++|.+++...  ...+++..++.++.||+.||.|||+++   ++||||||+||++++++.+||+|||+++..
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999998532  345899999999999999999999986   999999999999999999999999999876


Q ss_pred             ccCCCccc-cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCch---------hhHHHHHHHH
Q 007239          445 CENQKTAN-TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHA---------QTLLAYVWQL  514 (611)
Q Consensus       445 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~---------~~l~~~~~~~  514 (611)
                      ........ .....++..|+|||++.+..++.++||||||+++|||++|..++........         ..........
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            43322111 1112234569999999999999999999999999999998766422111000         0000011111


Q ss_pred             HhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       515 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ......         .........++.+++.+||+.+|++|||+.||+++|+.
T Consensus       239 ~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         239 LKNNGR---------LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             HhcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            111100         00111122457799999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=9.6e-38  Score=324.54  Aligned_cols=241  Identities=25%  Similarity=0.279  Sum_probs=192.6

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCC-CeeeEEEeEeeCCeEEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHR-NLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~-niv~l~~~~~~~~~~~lv~  367 (611)
                      +|++.+.||+|+||.||+|+.. +++.||+|++.+..   ....+.+..|..++..++|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5888999999999999999964 57889999987542   23456778899999999865 5888999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQ---QVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999998883   3456899999999999999999999986   999999999999999999999999998753221


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                      .  .......||+.|+|||++.+..++.++||||||+++|||++|+.||....   ...+...+    .....      .
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i----~~~~~------~  219 (324)
T cd05587         155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQSI----MEHNV------S  219 (324)
T ss_pred             C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHH----HcCCC------C
Confidence            1  12334679999999999999999999999999999999999999975322   11222211    11110      0


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTM  558 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  558 (611)
                      ...    ....++.+++.+||+.||++|++.
T Consensus       220 ~~~----~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         220 YPK----SLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCC----CCCHHHHHHHHHHhhcCHHHcCCC
Confidence            111    122356789999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-38  Score=350.18  Aligned_cols=259  Identities=31%  Similarity=0.490  Sum_probs=207.1

Q ss_pred             hCCCCcccccCccCceEEEEEEcC--CCc----EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP--NGK----EVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  363 (611)
                      .+..+..+.||+|.||+||.|...  +|.    .||+|.+++. +.+....|.+|..+|++++|||||+++|++.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            345677889999999999999953  333    4899988765 556788999999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhHhhhch----hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccc
Q 007239          364 LLIYELMPNRSLDCFIFDSE----RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFG  439 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  439 (611)
                      +|++|||++|+|..+|.+..    +...++...++.++.+||+|+.||+++.   +|||||...|+||++...+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999996531    2456899999999999999999999986   9999999999999999999999999


Q ss_pred             cceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcC
Q 007239          440 MARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEG  518 (611)
Q Consensus       440 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~  518 (611)
                      ||+.+...+.........-...|||||.+..+.|+.|+|||||||+|||++| |..|++...   ...+...+   ...+
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~---n~~v~~~~---~~gg  921 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS---NFEVLLDV---LEGG  921 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc---hHHHHHHH---HhCC
Confidence            9995544333322222233467999999999999999999999999999998 667764322   12222211   2223


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       519 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      .        |  ..+......+.+++..||+.+|++||++..+++.+...
T Consensus       922 R--------L--~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  922 R--------L--DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             c--------c--CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence            1        1  11233445677999999999999999999999988653

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.7e-37  Score=323.00  Aligned_cols=243  Identities=24%  Similarity=0.307  Sum_probs=192.9

Q ss_pred             cccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      +.||+|+||.||++.. .+++.||+|++++..   ....+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999995 467899999997642   23456688999999888 599999999999999999999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      ++|..++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~  152 (327)
T cd05617          81 GDLMFHMQ---RQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT  152 (327)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence            99988873   3346899999999999999999999987   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCC
Q 007239          453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSS  532 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  532 (611)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||................+....... .     +..  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~-----~p~--  224 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-R-----IPR--  224 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-C-----CCC--
Confidence            23467999999999999999999999999999999999999998643332222222333333322211 0     111  


Q ss_pred             CHHHHHHHHHHhhccccCCCCCCCCH
Q 007239          533 SIPQVVRCIHIGLLCVQEDPAVRPTM  558 (611)
Q Consensus       533 ~~~~~~~l~~li~~cl~~dP~~RPt~  558 (611)
                        ....++.+++.+||+.||++||++
T Consensus       225 --~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         225 --FLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             --CCCHHHHHHHHHHhccCHHHcCCC
Confidence              112346688999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-37  Score=316.87  Aligned_cols=266  Identities=28%  Similarity=0.372  Sum_probs=198.9

Q ss_pred             CCcccccCccCceEEEEEEc-----CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC--CeEEE
Q 007239          294 FSDSNKLGQGGFGTVYKGVL-----PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG--EEKLL  365 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~l  365 (611)
                      |++.+.||+|+||+||++..     .+++.||+|.++... ......+.+|+.++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            48899999999999988652     357789999987653 23456788999999999999999999987653  45799


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      +|||+++++|.+++..    ..+++..++.++.|++.||.|||+++   ++||||||+|||+++++.+||+|||+++...
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999998843    35899999999999999999999986   9999999999999999999999999998764


Q ss_pred             cCCCccc-cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          446 ENQKTAN-TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       446 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++|..|+....... .................+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhh
Confidence            3322111 112245667999999998899999999999999999999998864332110 01110000000000111111


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      +.......+.....++.+++..||+.+|++|||+++|+++|+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~  280 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE  280 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence            1111111112223467789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-39  Score=328.63  Aligned_cols=239  Identities=27%  Similarity=0.418  Sum_probs=194.6

Q ss_pred             ccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCChh
Q 007239          297 SNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLD  376 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~sL~  376 (611)
                      ++-||.|+.|.||+|++. ++.||||+++.-.       ..+|+-|++|+||||+.+.|+|....-++||||||..|-|.
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~  200 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY  200 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence            457999999999999984 6789999875322       35788899999999999999999999999999999999999


Q ss_pred             hHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccccccc
Q 007239          377 CFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV  456 (611)
Q Consensus       377 ~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  456 (611)
                      .+|   +....+.......|..+||.||.|||.+.   |||||||.-||||..+..|||+|||-++...+.   ...-.+
T Consensus       201 ~VL---ka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF  271 (904)
T KOG4721|consen  201 EVL---KAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF  271 (904)
T ss_pred             HHH---hccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence            999   45566888999999999999999999985   999999999999999999999999999866433   122247


Q ss_pred             cccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHH
Q 007239          457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ  536 (611)
Q Consensus       457 ~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  536 (611)
                      +||..|||||++.+.+.++|+|||||||||||||||.-|+..-+.      ...+|..  ..+...+       .-+...
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds------sAIIwGV--GsNsL~L-------pvPstc  336 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS------SAIIWGV--GSNSLHL-------PVPSTC  336 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch------heeEEec--cCCcccc-------cCcccC
Confidence            999999999999999999999999999999999999999632211      1112211  1111111       112223


Q ss_pred             HHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          537 VVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       537 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ...+.-|+.+||+..|.+||++++++..|.=
T Consensus       337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             chHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            3445667888999999999999999999963

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.9e-38  Score=297.49  Aligned_cols=254  Identities=28%  Similarity=0.398  Sum_probs=203.2

Q ss_pred             HHhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC----h----hhHHHHHHHHHHHHhcC-CCCeeeEEEeE
Q 007239          288 KAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS----W----QGLEEFKNEIILIAKLQ-HRNLVRLVGCG  357 (611)
Q Consensus       288 ~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~----~----~~~~~~~~E~~il~~l~-h~niv~l~~~~  357 (611)
                      +.--.+|...+.||.|..++|-++.. .+|+++|+|++....    .    .-.+.-.+|+.||+++. ||+|+++.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            34456788889999999999999885 578899999885321    1    12445678999999986 99999999999


Q ss_pred             eeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEec
Q 007239          358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISD  437 (611)
Q Consensus       358 ~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~D  437 (611)
                      +.+...++|+|.|+.|.|.+++   .....+++++.++|++|+.+|++|||.+.   ||||||||+|||++++.++||+|
T Consensus        93 es~sF~FlVFdl~prGELFDyL---ts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYL---TSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHh---hhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence            9999999999999999999999   55677999999999999999999999884   99999999999999999999999


Q ss_pred             cccceecccCCCccccccccccCCCCCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHH
Q 007239          438 FGMARIFCENQKTANTRRVVGTYGYMAPEYAM------EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYV  511 (611)
Q Consensus       438 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~  511 (611)
                      ||+++.+.++..   ....+|||+|+|||.+.      ...|+..+|+|+.||+||.|+.|.+||-       .......
T Consensus       167 FGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw-------HRkQmlM  236 (411)
T KOG0599|consen  167 FGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW-------HRKQMLM  236 (411)
T ss_pred             cceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh-------HHHHHHH
Confidence            999998755443   34579999999999885      2358889999999999999999999972       1111122


Q ss_pred             HHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          512 WQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       512 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .+.+.+|+.. +-.+..     .+......+|+.+||+.||.+|.|.+|+++
T Consensus       237 LR~ImeGkyq-F~speW-----adis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  237 LRMIMEGKYQ-FRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHHHhcccc-cCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            2334444321 111111     011224568999999999999999999986

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.6e-38  Score=333.84  Aligned_cols=200  Identities=25%  Similarity=0.355  Sum_probs=172.0

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .|++.+.||+|+||.||+++. .+++.||+|++.+..   ......+.+|+.++++++||||+++++.+.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588999999999999999995 468889999987542   2335678899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999998843   346889999999999999999999986   9999999999999999999999999975431100


Q ss_pred             ---------------------------------------------CccccccccccCCCCCccccccCCCCchhhHHHHH
Q 007239          449 ---------------------------------------------KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFG  483 (611)
Q Consensus       449 ---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlG  483 (611)
                                                                   ........+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                         00001235799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCC
Q 007239          484 VIVLEIISGKRNSGF  498 (611)
Q Consensus       484 vll~elltG~~p~~~  498 (611)
                      |++|||++|++||..
T Consensus       236 vil~elltG~~Pf~~  250 (382)
T cd05625         236 VILYEMLVGQPPFLA  250 (382)
T ss_pred             HHHHHHHhCCCCCCC
Confidence            999999999999853

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.2e-37  Score=316.75  Aligned_cols=256  Identities=29%  Similarity=0.426  Sum_probs=202.5

Q ss_pred             CCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      ++|...++||+|+||.||++...      ++..+++|.+........+.+.+|+++++.++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            56888999999999999999732      356789998877666667789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchh------------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCE
Q 007239          366 IYELMPNRSLDCFIFDSER------------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVA  433 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~  433 (611)
                      +|||+++++|.+++.....            ...+++..++.++.||+.||.|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999998854221            134789999999999999999999986   9999999999999999999


Q ss_pred             EEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHH
Q 007239          434 KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVW  512 (611)
Q Consensus       434 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~  512 (611)
                      ||+|||++................+++.|+|||++.+..++.++||||||+++|||++ |++||....   .......  
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~~--  236 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS---NTEAIEC--  236 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC---HHHHHHH--
Confidence            9999999976543222122223345788999999999999999999999999999998 888863221   1111111  


Q ss_pred             HHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       513 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                        ...+....     ...    .....+.+++.+||+.||++||++.+|++.|+
T Consensus       237 --~~~~~~~~-----~~~----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         237 --ITQGRELE-----RPR----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             --HHcCccCC-----CCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence              11111110     001    11234668999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2.3e-37  Score=312.20  Aligned_cols=255  Identities=23%  Similarity=0.335  Sum_probs=201.3

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++.+...+..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35799999999999999999995 57889999999766545566788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++.   ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..+.....
T Consensus        88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          88 CGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            99999999884   3346899999999999999999999986   99999999999999999999999999987633221


Q ss_pred             ccccccccccCCCCCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          450 TANTRRVVGTYGYMAPEYAM---EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                        ......|++.|+|||.+.   ...++.++||||||+++|||++|+.|+....+...  ..    . +...   .+..+
T Consensus       162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--~~----~-~~~~---~~~~~  229 (267)
T cd06646         162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--LF----L-MSKS---NFQPP  229 (267)
T ss_pred             --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--he----e-eecC---CCCCC
Confidence              122356889999999884   34578899999999999999999998732211100  00    0 0000   00001


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHh
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL  565 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  565 (611)
                      ....  .......+.+++.+||+.+|++||+++++++.|
T Consensus       230 ~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 KLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1111  111234677899999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.4e-37  Score=314.44  Aligned_cols=255  Identities=24%  Similarity=0.420  Sum_probs=196.8

Q ss_pred             CCcccccCccCceEEEEEEcCC-Cc--EEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC------Ce
Q 007239          294 FSDSNKLGQGGFGTVYKGVLPN-GK--EVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG------EE  362 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~~  362 (611)
                      |.+.+.||+|+||.||+|.+.. ++  .+|+|.++..  .....+.+.+|+.+++.++|+||+++++.+...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4567899999999999999653 33  5899988653  334567889999999999999999999976432      24


Q ss_pred             EEEEEEecCCCChhhHhhhc---hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccc
Q 007239          363 KLLIYELMPNRSLDCFIFDS---ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFG  439 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~---~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  439 (611)
                      .+++|||+++++|.+++...   .....+++..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            68999999999998887432   12345889999999999999999999986   9999999999999999999999999


Q ss_pred             cceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcC
Q 007239          440 MARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEG  518 (611)
Q Consensus       440 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~  518 (611)
                      +++...............+++.|++||++.+..++.++||||||+++|||++ |+.||...   ....+    +.....+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~~~~----~~~~~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV---ENSEI----YDYLRQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC---CHHHH----HHHHHcC
Confidence            9987643322111223356778999999999999999999999999999999 77776432   11122    2222222


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       519 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      .....         .......+.+++.+||+.||++|||+.++++.|+.
T Consensus       231 ~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         231 NRLKQ---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             CCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            21111         01122346799999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1e-37  Score=324.37  Aligned_cols=244  Identities=24%  Similarity=0.294  Sum_probs=192.0

Q ss_pred             CCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHH---HhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILI---AKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il---~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      |++.+.||+|+||.||++.+ .+++.||+|++++..   ....+.+.+|+.++   +.++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            67889999999999999995 468999999997542   22345667776665   456799999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|...+.    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            99999999987763    245899999999999999999999986   99999999999999999999999999875322


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ..  .......|++.|+|||++.+..++.++|||||||++|||++|+.||.....   ..+...    +..+..      
T Consensus       154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---~~~~~~----i~~~~~------  218 (324)
T cd05589         154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---EEVFDS----IVNDEV------  218 (324)
T ss_pred             CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---HHHHHH----HHhCCC------
Confidence            11  122346799999999999999999999999999999999999999753221   111111    111111      


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVA  563 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  563 (611)
                      ....    .....+.+++.+||+.||++||     ++.++++
T Consensus       219 ~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 RYPR----FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CCCC----CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            0111    1123467899999999999999     4666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4e-38  Score=334.30  Aligned_cols=253  Identities=21%  Similarity=0.281  Sum_probs=194.4

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      .+|++.+.||+|+||.||+++. .+++.||+|++.+..   ......+.+|+.++++++||||+++++.+.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3689999999999999999995 468899999986532   223456889999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            99999999999843   456889999999999999999999987   999999999999999999999999998533100


Q ss_pred             C-----------------------------------------CccccccccccCCCCCccccccCCCCchhhHHHHHHHH
Q 007239          448 Q-----------------------------------------KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIV  486 (611)
Q Consensus       448 ~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll  486 (611)
                      .                                         .........||+.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0                                         00011235799999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCC---CHHHHHH
Q 007239          487 LEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRP---TMSNVVA  563 (611)
Q Consensus       487 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP---t~~evl~  563 (611)
                      |||++|+.||.......   ....+ ..+..  ...+  +     ........+.+++.+|+ .+|.+|+   ++.++++
T Consensus       235 yell~G~~Pf~~~~~~~---~~~~i-~~~~~--~~~~--~-----~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         235 YEMLVGQPPFLADTPAE---TQLKV-INWET--TLHI--P-----SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             eehhhCCCCCCCCCHHH---HHHHH-hccCc--cccC--C-----CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            99999999985432211   11111 00100  0000  0     00111223456666655 5999999   8888876


Q ss_pred             H
Q 007239          564 L  564 (611)
Q Consensus       564 ~  564 (611)
                      .
T Consensus       301 h  301 (376)
T cd05598         301 H  301 (376)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.9e-37  Score=310.98  Aligned_cols=252  Identities=30%  Similarity=0.447  Sum_probs=199.9

Q ss_pred             CCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHH--HHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          294 FSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLE--EFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      |++.+.||+|+||+||++... +++.+|+|++.........  ...+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            677899999999999999965 5678999999877544332  3456999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++++|.+++.   ....+++..++.++.||++||.+||+.+   ++|+||||+||+++.++.++|+|||.+....  ...
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--ccc
Confidence            9999999984   4567899999999999999999999986   9999999999999999999999999998641  112


Q ss_pred             cccccccccCCCCCccccc-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          451 ANTRRVVGTYGYMAPEYAM-EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                      .......+++.|+|||++. +..++.++||||+|+++|+|++|..|+........   .....+.......    .....
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~---~~~~~~~~~~~~~----~~~~~  225 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ---LEIIEKILKRPLP----SSSQQ  225 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH---HHHHHHHHHTHHH----HHTTS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhh---hhhhhhccccccc----ccccc
Confidence            2333467899999999998 78899999999999999999999999764411111   1111111110000    00000


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                         .......+.+++..||+.||++||++.++++
T Consensus       226 ---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  226 ---SREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             ---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ---cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0001156789999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-37  Score=313.74  Aligned_cols=255  Identities=26%  Similarity=0.450  Sum_probs=199.4

Q ss_pred             CCcccccCccCceEEEEEEcC-C---CcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe-----
Q 007239          294 FSDSNKLGQGGFGTVYKGVLP-N---GKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE-----  362 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~-~---~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-----  362 (611)
                      |++.+.||+|+||.||+|... +   +..||+|+++..  .....+.+.+|+.+++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            577899999999999999853 2   367999998754  23345688999999999999999999998766554     


Q ss_pred             -EEEEEEecCCCChhhHhhhch---hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecc
Q 007239          363 -KLLIYELMPNRSLDCFIFDSE---RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDF  438 (611)
Q Consensus       363 -~~lv~E~~~~~sL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  438 (611)
                       .+++|||+++++|..++....   ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             799999999999998885432   2346899999999999999999999986   999999999999999999999999


Q ss_pred             ccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhc
Q 007239          439 GMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKE  517 (611)
Q Consensus       439 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  517 (611)
                      |+++...............++..|+|||++....++.++||||||+++|||++ |..|+....   ...+....    ..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~---~~~~~~~~----~~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE---NHEIYDYL----RH  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----Hc
Confidence            99987643332222222345678999999988899999999999999999999 777764321   12222222    11


Q ss_pred             CccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          518 GKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       518 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      +.....         +.....++.+++.+||+.||++||++.||++.|+.
T Consensus       231 ~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         231 GNRLKQ---------PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             CCCCCC---------CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            111111         11223467889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=6e-38  Score=326.18  Aligned_cols=242  Identities=21%  Similarity=0.246  Sum_probs=193.4

Q ss_pred             cccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCC
Q 007239          298 NKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNR  373 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~  373 (611)
                      +.||+|+||.||++.. .+++.||+|++.+..   ......+.+|+++++.++||||+++++.+...+..++||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999995 478899999997542   233566788999999999999999999999999999999999999


Q ss_pred             ChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhh-cCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          374 SLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE-DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       374 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      +|..++.   ....+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~  152 (325)
T cd05594          81 ELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--T  152 (325)
T ss_pred             cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--c
Confidence            9988873   33468999999999999999999997 55   99999999999999999999999999875422211  2


Q ss_pred             cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCC
Q 007239          453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSS  532 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  532 (611)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ..+...+    .....      .+..  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~~i----~~~~~------~~p~--  217 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELI----LMEEI------RFPR--  217 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHHHHH----hcCCC------CCCC--
Confidence            2345799999999999999999999999999999999999999743221   1111111    11110      0111  


Q ss_pred             CHHHHHHHHHHhhccccCCCCCCC-----CHHHHHHH
Q 007239          533 SIPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVAL  564 (611)
Q Consensus       533 ~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  564 (611)
                        ....++.+++.+||+.||++|+     ++.++++.
T Consensus       218 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         218 --TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             --CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence              1123567889999999999996     89998854

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3e-37  Score=321.79  Aligned_cols=253  Identities=26%  Similarity=0.340  Sum_probs=208.1

Q ss_pred             HhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChh---hHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeE
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQ---GLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~  363 (611)
                      ...+.|++.+.||+|.||.||+++.+ +|+.+|+|.+.+....   ..+.+.+|+.+|+++. ||||+.+++.|++....
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            34578999999999999999999965 5999999999876443   3568999999999999 99999999999999999


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC----CCCEEEeccc
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK----DMVAKISDFG  439 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~----~~~~kl~DFG  439 (611)
                      ++|||++.||.|.+.+...    .+++..+..++.||+.++.|||+.|   |+||||||+|+|+..    ++.+|++|||
T Consensus       112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            9999999999999998554    3999999999999999999999987   999999999999953    3579999999


Q ss_pred             cceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCc
Q 007239          440 MARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK  519 (611)
Q Consensus       440 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  519 (611)
                      ++.....   .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.......  ...     ....+.
T Consensus       185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~--~~~-----~i~~~~  254 (382)
T KOG0032|consen  185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE--IFL-----AILRGD  254 (382)
T ss_pred             CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH--HHH-----HHHcCC
Confidence            9998755   334556899999999999999999999999999999999999999974332211  111     122222


Q ss_pred             cccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          520 EMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       520 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      . ++.++.     -......+.+++..||..||.+|+|+.++++.
T Consensus       255 ~-~f~~~~-----w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  255 F-DFTSEP-----WDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             C-CCCCCC-----ccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            2 111111     11123456689999999999999999999983

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.2e-37  Score=316.27  Aligned_cols=257  Identities=30%  Similarity=0.476  Sum_probs=200.3

Q ss_pred             hCCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  363 (611)
                      .++|.+.+.||+|++|.||++.+.      .+..|++|.+.... ......+.+|+.+++.++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            467999999999999999999964      35678999886443 33345689999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhHhhhchh----hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC---CEEEe
Q 007239          364 LLIYELMPNRSLDCFIFDSER----RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM---VAKIS  436 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~---~~kl~  436 (611)
                      ++||||+++++|.+++.....    ...+++..+..++.||+.||.|||+++   ++||||||+||+++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999998854321    135899999999999999999999986   99999999999998655   59999


Q ss_pred             ccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHH
Q 007239          437 DFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLW  515 (611)
Q Consensus       437 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  515 (611)
                      |||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||.....   ..+...    .
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~~~----~  234 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVMEF----V  234 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH----H
Confidence            9999986633222111222334568999999999999999999999999999997 8888743221   122211    1


Q ss_pred             hcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          516 KEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       516 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                      .......         .+......+.+++.+||+.+|++||++.+|++.|+
T Consensus       235 ~~~~~~~---------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 TGGGRLD---------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            1111111         01112245678999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.7e-37  Score=311.51  Aligned_cols=246  Identities=29%  Similarity=0.390  Sum_probs=193.9

Q ss_pred             ccCccCceEEEEEEc---CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCC
Q 007239          299 KLGQGGFGTVYKGVL---PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNR  373 (611)
Q Consensus       299 ~lg~G~fg~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~  373 (611)
                      +||+|+||.||+|.+   .+++.+|+|+++...  ....+.+.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            699999999999974   357889999986543  234567899999999999999999999875 45678999999999


Q ss_pred             ChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc-
Q 007239          374 SLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN-  452 (611)
Q Consensus       374 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-  452 (611)
                      +|.+++.   ....+++..+..++.|++.||.|||+++   ++||||||.||+++.++.+||+|||+++.......... 
T Consensus        81 ~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQ---KNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            9999884   3346899999999999999999999986   99999999999999999999999999987643322111 


Q ss_pred             cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCC
Q 007239          453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKS  531 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  531 (611)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.||.....   ..+..    ....+....     .   
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~----~i~~~~~~~-----~---  219 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQ----MIESGERME-----C---  219 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHHCCCCCC-----C---
Confidence            112234678999999988889999999999999999998 8988753221   11222    122221111     1   


Q ss_pred             CCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          532 SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       532 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                       +.....++.+++.+||+.||++||++++|++.|.+
T Consensus       220 -~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         220 -PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             -CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence             11123457799999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.1e-37  Score=328.99  Aligned_cols=263  Identities=20%  Similarity=0.226  Sum_probs=200.8

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC---CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP---NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ...+|++.+.||+|+||.||++...   .+++|++|.+....     ...+|+.++++++||||+++++++......+++
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            3467999999999999999999742   46789999886432     346899999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      ||++. ++|.+++   .....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       165 ~e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        165 MPKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             ehhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            99986 5777777   34456899999999999999999999987   99999999999999999999999999987654


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc----
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME----  522 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~----  522 (611)
                      ...........||+.|+|||++....++.++|||||||++|||++|+.||...........+..+.+........-    
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            4333333456899999999999999999999999999999999999999854433222222222211111110000    


Q ss_pred             ---c------cccccCCCCCH-------HHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          523 ---F------VDPLLMKSSSI-------PQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       523 ---~------~d~~l~~~~~~-------~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                         +      +..........       ....++.+++.+||+.||++|||+.|++..
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence               0      00000000000       112356788999999999999999999974

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-37  Score=312.18  Aligned_cols=258  Identities=27%  Similarity=0.467  Sum_probs=204.7

Q ss_pred             hCCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  363 (611)
                      .++|++.+.||+|+||.||++...      .+..|++|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            467899999999999999999853      24679999986543 33456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhHhhhchh-------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEe
Q 007239          364 LLIYELMPNRSLDCFIFDSER-------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKIS  436 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~  436 (611)
                      ++||||+++++|.+++.....       ...+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            999999999999999854221       234788999999999999999999986   9999999999999999999999


Q ss_pred             ccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHH
Q 007239          437 DFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLW  515 (611)
Q Consensus       437 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  515 (611)
                      |||+++...............++..|+|||.+.++.++.++||||||+++|||++ |+.|+....   .....    +..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~---~~~~~----~~~  234 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS---NEEVL----KFV  234 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC---HHHHH----HHH
Confidence            9999986544332222233457889999999998899999999999999999998 888864221   11121    122


Q ss_pred             hcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          516 KEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       516 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ..+.....     ..    ....++.+++.+||+.+|++|||+.++++.|++
T Consensus       235 ~~~~~~~~-----~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         235 IDGGHLDL-----PE----NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             hcCCCCCC-----CC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            22211111     11    113467799999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.3e-37  Score=313.25  Aligned_cols=264  Identities=26%  Similarity=0.392  Sum_probs=201.2

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-----------------CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeee
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-----------------NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVR  352 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~  352 (611)
                      .++|++.+.||+|+||.||++.+.                 ++..+|+|++.... ......+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            357999999999999999998532                 23468999987543 334568899999999999999999


Q ss_pred             EEEeEeeCCeEEEEEEecCCCChhhHhhhchh--------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCc
Q 007239          353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSER--------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSN  424 (611)
Q Consensus       353 l~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~N  424 (611)
                      +++++...+..++||||+++++|.+++.....        ...+++..++.++.||+.||.|||+.+   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            99999999999999999999999998854221        134778899999999999999999986   9999999999


Q ss_pred             EEecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCC
Q 007239          425 VLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS--GKRNSGFYLTG  502 (611)
Q Consensus       425 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt--G~~p~~~~~~~  502 (611)
                      ||++.++.++|+|||+++.+.............+++.|++||....+.++.++||||||+++|||++  |..|+..... 
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-  239 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-
Confidence            9999999999999999986543322222223345678999999988899999999999999999998  5566532211 


Q ss_pred             chhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          503 HAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       503 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                        ..........+......... +   .  +......+.+++.+||+.||++||++.+|++.|+
T Consensus       240 --~~~~~~~~~~~~~~~~~~~~-~---~--~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         240 --EQVIENTGEFFRDQGRQVYL-P---K--PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             --HHHHHHHHHHHhhccccccC-C---C--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence              11222121212111111100 0   0  1112245778999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.3e-37  Score=318.24  Aligned_cols=256  Identities=29%  Similarity=0.419  Sum_probs=201.7

Q ss_pred             CCCcccccCccCceEEEEEEcC------CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      +|++.+.||+|+||.||+|+..      ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4788899999999999999852      23568888887543 3345678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhch---------------------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCc
Q 007239          366 IYELMPNRSLDCFIFDSE---------------------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSN  424 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~N  424 (611)
                      +|||+.+++|.+++....                     ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999999874321                     1235789999999999999999999986   9999999999


Q ss_pred             EEecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 007239          425 VLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGH  503 (611)
Q Consensus       425 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~  503 (611)
                      ||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+....   
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---  234 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA---  234 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC---
Confidence            9999999999999999986533322222223456778999999988889999999999999999998 888874321   


Q ss_pred             hhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          504 AQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       504 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      .+.    ++..........     .    ......++.+++.+||+.+|++||++.++++.|++
T Consensus       235 ~~~----~~~~~~~~~~~~-----~----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~  285 (290)
T cd05045         235 PER----LFNLLKTGYRME-----R----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK  285 (290)
T ss_pred             HHH----HHHHHhCCCCCC-----C----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            222    222222221111     0    11122457789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.7e-37  Score=327.41  Aligned_cols=261  Identities=24%  Similarity=0.322  Sum_probs=196.7

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC-----eEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE-----EKL  364 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-----~~~  364 (611)
                      +|++.+.||+|+||.||++.. .+++.||+|++...  ......++.+|+.+++.++||||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999995 47899999998653  2234567889999999999999999999988776     789


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +||||+.+ +|...+.   ....+++..+..++.||+.||.|||+++   ++||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~~-~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQS-DLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeecccc-CHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            99999974 6766663   3456899999999999999999999987   999999999999999999999999999865


Q ss_pred             ccCCCccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc-
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME-  522 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~-  522 (611)
                      ...... ......+++.|+|||++.+. .++.++|||||||++|||++|+.||......   .....+..........+ 
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~g~~~~~~~  229 (372)
T cd07853         154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI---QQLDLITDLLGTPSLEAM  229 (372)
T ss_pred             ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHcCCCCHHHH
Confidence            332221 22234688999999998874 4799999999999999999999998543321   11111111111000000 


Q ss_pred             ----------ccccccCC-------CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          523 ----------FVDPLLMK-------SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       523 ----------~~d~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                                +.......       ........++.+|+.+||+.||++|||+.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                      00000000       0001113457789999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=8.7e-38  Score=324.23  Aligned_cols=236  Identities=25%  Similarity=0.333  Sum_probs=188.8

Q ss_pred             cccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      +.||+|+||.||+++.+ +++.||+|++.+..   ....+.+.+|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999964 68899999987542   23455677888888876 699999999999999999999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      ++|.+++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~---~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~  152 (320)
T cd05590          81 GDLMFHIQ---KSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT  152 (320)
T ss_pred             chHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence            99998874   3346899999999999999999999986   9999999999999999999999999987542221  12


Q ss_pred             cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCC
Q 007239          453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSS  532 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  532 (611)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||....   ...+..    .+..+...      ..   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~----~i~~~~~~------~~---  216 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFE----AILNDEVV------YP---  216 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHH----HHhcCCCC------CC---
Confidence            234679999999999999999999999999999999999999985322   111111    11111110      00   


Q ss_pred             CHHHHHHHHHHhhccccCCCCCCCCH
Q 007239          533 SIPQVVRCIHIGLLCVQEDPAVRPTM  558 (611)
Q Consensus       533 ~~~~~~~l~~li~~cl~~dP~~RPt~  558 (611)
                       .....++.+++.+||+.||++||++
T Consensus       217 -~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 -TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             -CCCCHHHHHHHHHHcccCHHHCCCC
Confidence             1112356789999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=8.8e-38  Score=324.38  Aligned_cols=242  Identities=23%  Similarity=0.295  Sum_probs=192.7

Q ss_pred             cccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      +.||+|+||.||+|+.. +++.||+|++.+..   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999964 57899999987542   23445677899998876 799999999999999999999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      ++|...+.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++........  .
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~  152 (321)
T cd05591          81 GDLMFQIQ---RSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--T  152 (321)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc--c
Confidence            99988874   3346899999999999999999999987   99999999999999999999999999975432221  2


Q ss_pred             cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCC
Q 007239          453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSS  532 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  532 (611)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||....   ...+...    +.....   ..+      
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~---~~~~~~~----i~~~~~---~~p------  216 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFES----ILHDDV---LYP------  216 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC---HHHHHHH----HHcCCC---CCC------
Confidence            234579999999999999999999999999999999999999985332   1112211    111110   000      


Q ss_pred             CHHHHHHHHHHhhccccCCCCCCC-------CHHHHHHH
Q 007239          533 SIPQVVRCIHIGLLCVQEDPAVRP-------TMSNVVAL  564 (611)
Q Consensus       533 ~~~~~~~l~~li~~cl~~dP~~RP-------t~~evl~~  564 (611)
                       .....++.+++..||+.||++||       ++.++++.
T Consensus       217 -~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         217 -VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             -CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence             01123567889999999999999       77777754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=8.6e-38  Score=325.02  Aligned_cols=243  Identities=22%  Similarity=0.248  Sum_probs=189.5

Q ss_pred             cccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHH-HHHhcCCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEII-LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      +.||+|+||+||+++. .+|+.+|+|++.+..   ......+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999995 478999999987542   223345555654 56789999999999999999999999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      ++|..++.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~  152 (325)
T cd05604          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DT  152 (325)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CC
Confidence            99988873   3456899999999999999999999987   9999999999999999999999999987532211  12


Q ss_pred             cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCC
Q 007239          453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSS  532 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  532 (611)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   ...+   ..... ....      .+..  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~---~~~~~-~~~~------~~~~--  217 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD---VAEM---YDNIL-HKPL------VLRP--  217 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC---HHHH---HHHHH-cCCc------cCCC--
Confidence            234679999999999999999999999999999999999999974321   1111   11111 1111      0111  


Q ss_pred             CHHHHHHHHHHhhccccCCCCCCCCHHHHHHHh
Q 007239          533 SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL  565 (611)
Q Consensus       533 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  565 (611)
                        .....+.+++..||+.+|.+||++.+.++.+
T Consensus       218 --~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i  248 (325)
T cd05604         218 --GASLTAWSILEELLEKDRQRRLGAKEDFLEI  248 (325)
T ss_pred             --CCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence              1223466888999999999999987544443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=4.1e-37  Score=310.23  Aligned_cols=258  Identities=25%  Similarity=0.380  Sum_probs=205.6

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++.+.||+|+||.||++.. .+++.+++|.+...   .......+.+|+.+++.++||||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            5788999999999999999995 57899999987643   2234467889999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhc-hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          368 ELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       368 E~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      ||+++++|.+++... .....+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999988542 22456899999999999999999999986   99999999999999999999999999876543


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ...  ......|+..|+|||++.+..++.++||||||+++|+|++|..|+......    ..... +......     .+
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~~~-----~~  226 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLC-KKIEQCD-----YP  226 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHh-hhhhcCC-----CC
Confidence            322  122356889999999999989999999999999999999999997422111    11111 1111111     01


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      .+.   .......+.+++.+||+.+|++|||+.+|++++.+
T Consensus       227 ~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         227 PLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             CCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence            111   11233457789999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.2e-37  Score=311.17  Aligned_cols=253  Identities=30%  Similarity=0.478  Sum_probs=201.3

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      ++|++.++||+|+||.||++...++..+++|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS   83 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence            57899999999999999999988888899999876543 3467899999999999999999999875 456899999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++..+.......
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            99999988542 2345899999999999999999999986   9999999999999999999999999998764332211


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                       .....++..|+|||++.+..++.++||||||+++|+|++ |+.||....   .......    +..+...         
T Consensus       160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~---~~~~~~~----~~~~~~~---------  222 (260)
T cd05070         160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN---NREVLEQ----VERGYRM---------  222 (260)
T ss_pred             -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH----HHcCCCC---------
Confidence             112345678999999998899999999999999999999 888874321   1111111    1111110         


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ..+......+.+++.+||+.+|++|||+.++++.|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            0111223457799999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.4e-37  Score=314.53  Aligned_cols=254  Identities=29%  Similarity=0.443  Sum_probs=198.9

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCc----EEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGK----EVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      ++|++.+.||+|+||+||+|++. +++    ++++|.+.... .....++..|+.+++++.||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            57888999999999999999963 444    47778775432 233467788899999999999999999875 456789


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ++||+++++|.+++...  ...+++..+..++.||+.||.|||+++   ++||||||+||++++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            99999999999998532  346899999999999999999999986   9999999999999999999999999998764


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ............++..|+|||++.++.++.++||||||+++|||++ |+.|+.....   ..+.    ..+..+....  
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~----~~~~~~~~~~--  231 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---HEVP----DLLEKGERLA--  231 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHH----HHHHCCCcCC--
Confidence            4333223334567789999999999999999999999999999998 8888743221   1111    1122222111  


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      .+.       .....+.+++.+||+.||++|||+.|+++.|..
T Consensus       232 ~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~  267 (279)
T cd05111         232 QPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTR  267 (279)
T ss_pred             CCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            111       012346678889999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.8e-37  Score=326.67  Aligned_cols=254  Identities=20%  Similarity=0.241  Sum_probs=199.3

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      ..++|++.+.||+|+||.||+++. .+++.||+|++.+..   ......+.+|+.+++.++||||+++++++.+....++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            346899999999999999999995 468899999986532   2234557889999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+++|+|.+++..    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999988742    34788899999999999999999986   9999999999999999999999999998654


Q ss_pred             cCCCccccccccccCCCCCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEG----LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM  521 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  521 (611)
                      .... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.....   ...   ...........
T Consensus       194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~---~~~i~~~~~~~  266 (370)
T cd05596         194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL---VGT---YSKIMDHKNSL  266 (370)
T ss_pred             CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH---HHH---HHHHHcCCCcC
Confidence            3221 122345799999999998653    478999999999999999999999853221   111   11111111111


Q ss_pred             cccccccCCCCCHHHHHHHHHHhhccccCCCCC--CCCHHHHHHH
Q 007239          522 EFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAV--RPTMSNVVAL  564 (611)
Q Consensus       522 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~  564 (611)
                      .+.     .  .......+.+++..||+.+|++  ||+++++++.
T Consensus       267 ~~~-----~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         267 TFP-----D--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCC-----C--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            111     1  1112245678899999999988  9999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.3e-36  Score=306.39  Aligned_cols=258  Identities=25%  Similarity=0.381  Sum_probs=206.9

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++.+.||+|+||.||+|... +|+.+++|.++..   .....+.+.+|++++++++|+|++++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            67999999999999999999965 7899999988642   2233567899999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhc-hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          368 ELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       368 E~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      ||+++++|..++... .....+++.+++.++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999888542 22455899999999999999999999987   99999999999999999999999999886543


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ...  ......|++.|+|||++.+..++.++||||||+++|+|++|+.|+.....    .+.... ..+..+......  
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~-~~~~~~~~~~~~--  229 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLC-KKIEKCDYPPLP--  229 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHH-hhhhcCCCCCCC--
Confidence            221  12235688999999999988999999999999999999999998742221    111111 111111111100  


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                            .......+.+++.+||+.+|++||++.+|+++|+.
T Consensus       230 ------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~  264 (267)
T cd08224         230 ------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE  264 (267)
T ss_pred             ------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence                  11223456789999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.3e-37  Score=321.49  Aligned_cols=241  Identities=24%  Similarity=0.268  Sum_probs=192.4

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~  367 (611)
                      +|++.+.||+|+||.||+++.. +++.||+|++.+..   ......+..|..++..+. |++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5888999999999999999964 67899999987542   223445677888888774 899999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+.+.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQ---QVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999988873   3356899999999999999999999987   999999999999999999999999999754322


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||....   ...+...+    .....      .
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~---~~~~~~~i----~~~~~------~  219 (323)
T cd05616         155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED---EDELFQSI----MEHNV------A  219 (323)
T ss_pred             C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC---HHHHHHHH----HhCCC------C
Confidence            2  12234679999999999999999999999999999999999999985322   12222211    11111      0


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTM  558 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  558 (611)
                      .    +.....++.+++.+||+.+|++|++.
T Consensus       220 ~----p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         220 Y----PKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             C----CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence            1    11122456789999999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.2e-37  Score=323.55  Aligned_cols=237  Identities=24%  Similarity=0.264  Sum_probs=186.5

Q ss_pred             cccCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHHHHH-HHHhcCCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKNEII-LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      +.||+|+||+||+++. .+|+.||+|++.+...   .....+.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4699999999999996 4789999999875421   22344555554 56789999999999999999999999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      ++|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (323)
T cd05575          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KT  152 (323)
T ss_pred             CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cc
Confidence            99988884   3456899999999999999999999987   9999999999999999999999999987532221  12


Q ss_pred             cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCC
Q 007239          453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSS  532 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  532 (611)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   ...+.   .. ......      .+..  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~---~~~~~---~~-i~~~~~------~~~~--  217 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---TAEMY---DN-ILNKPL------RLKP--  217 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC---HHHHH---HH-HHcCCC------CCCC--
Confidence            334679999999999999999999999999999999999999974321   11111   11 111111      0111  


Q ss_pred             CHHHHHHHHHHhhccccCCCCCCCCHH
Q 007239          533 SIPQVVRCIHIGLLCVQEDPAVRPTMS  559 (611)
Q Consensus       533 ~~~~~~~l~~li~~cl~~dP~~RPt~~  559 (611)
                        .....+.+++.+||+.||++||++.
T Consensus       218 --~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         218 --NISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             --CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence              1134567899999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.2e-36  Score=304.44  Aligned_cols=250  Identities=26%  Similarity=0.356  Sum_probs=203.3

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +|++.+.||+|++|.||++... +++.|++|.+...  .......+.+|+.+++.++||||+++++.+.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4778899999999999999964 6889999998643  334567789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++... ....+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+.....
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999988543 2356899999999999999999999986   99999999999999999999999999987644322


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                      .  .....|++.|+|||++.++.++.++|+||||+++|+|++|+.|+....   ......    ....+....     + 
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~----~~~~~~~~~-----~-  221 (256)
T cd08529         157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALIL----KIIRGVFPP-----V-  221 (256)
T ss_pred             h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHH----HHHcCCCCC-----C-
Confidence            1  223568899999999999999999999999999999999999975332   111111    111111111     1 


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                         .......+.+++.+||+.+|++||++.++++.
T Consensus       222 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         222 ---SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ---ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence               11223457789999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=3.4e-37  Score=309.76  Aligned_cols=254  Identities=30%  Similarity=0.463  Sum_probs=203.2

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      .++|++.++||+|+||.||++..++++.||+|.+..... ..+.+.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            467899999999999999999988889999999875543 3567899999999999999999999864 56789999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      .+++|.+++... ....+++.++..++.|++.+|+|||+.+   ++||||||+||+++.++.++|+|||++.........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05067          83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence            999999987543 2346899999999999999999999986   999999999999999999999999999876422211


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                       ......++..|+|||++....++.++||||||+++|||++ |+.||.....   ..+...    ...+....     . 
T Consensus       159 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~----~~~~~~~~-----~-  224 (260)
T cd05067         159 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQN----LERGYRMP-----R-  224 (260)
T ss_pred             -cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHH----HHcCCCCC-----C-
Confidence             1122346778999999998999999999999999999998 9988753221   111111    11111111     0 


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                         ......++.+++.+||+.+|++||+++++++.|+.
T Consensus       225 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 ---PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence               11122457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=305.47  Aligned_cols=252  Identities=25%  Similarity=0.364  Sum_probs=200.6

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-----hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-----WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      ++|.+.+.||+|++|.||++.. .+++++++|.+....     ......+.+|+.++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5789999999999999999995 468999999886432     1234578899999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      |+||+++++|.+++.   ....+++..+..++.|++.||.|||+.+   ++||||||+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLK---AYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999998884   3346889999999999999999999986   9999999999999999999999999998654


Q ss_pred             cCCCccc-cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          446 ENQKTAN-TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       446 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ....... .....|+..|+|||++.+..++.++||||||+++|||++|+.||.....      .....+........   
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~---  226 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA------MAAIFKIATQPTNP---  226 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch------HHHHHHHhccCCCC---
Confidence            3221111 1235688899999999998899999999999999999999999742211      11111111111111   


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                        .+    +......+.+++..||+.+|++|||+.++++.
T Consensus       227 --~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         227 --QL----PSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --CC----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence              11    11122356789999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2e-37  Score=334.69  Aligned_cols=261  Identities=22%  Similarity=0.322  Sum_probs=191.7

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC--------
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG--------  360 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--------  360 (611)
                      ..++|++.+.||+|+||.||+|+. .+++.||+|++....    ....+|+.+++.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            456899999999999999999996 468899999886432    2345799999999999999999876432        


Q ss_pred             CeEEEEEEecCCCChhhHhhh-chhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC-CEEEecc
Q 007239          361 EEKLLIYELMPNRSLDCFIFD-SERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDF  438 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~-~~kl~DF  438 (611)
                      ..+++||||+++ +|.+++.. ......+++..++.++.||+.||.|||+++   |+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            246789999986 56565533 223456899999999999999999999987   99999999999999665 7999999


Q ss_pred             ccceecccCCCccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhc
Q 007239          439 GMARIFCENQKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKE  517 (611)
Q Consensus       439 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  517 (611)
                      |+++.+.....   .....||+.|+|||++.+. .++.++|||||||++|||++|.+||.....  ...+.. +.+.+..
T Consensus       216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~--~~~~~~-i~~~~~~  289 (440)
T PTZ00036        216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS--VDQLVR-IIQVLGT  289 (440)
T ss_pred             ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHH-HHHHhCC
Confidence            99986643322   2235789999999988764 689999999999999999999999753221  111211 2111111


Q ss_pred             Ccc----------ccccccccC-----CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          518 GKE----------MEFVDPLLM-----KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       518 ~~~----------~~~~d~~l~-----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ...          .++.-+...     ...+.....++++|+.+||+.||.+|||+.|+++.
T Consensus       290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            100          000000000     00011122467899999999999999999998843

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.4e-37  Score=312.11  Aligned_cols=246  Identities=28%  Similarity=0.334  Sum_probs=193.9

Q ss_pred             cCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCCh
Q 007239          300 LGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSL  375 (611)
Q Consensus       300 lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~sL  375 (611)
                      ||+|+||+||++.. .+++.||+|.+.....   ...+.+..|+.+++.++|+||+++++++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999995 4788999999875422   2345678899999999999999999999999999999999999999


Q ss_pred             hhHhhhc-hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccccc
Q 007239          376 DCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR  454 (611)
Q Consensus       376 ~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  454 (611)
                      ...+... .....+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++..+.....  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            8877542 23456899999999999999999999986   99999999999999999999999999986644332  123


Q ss_pred             cccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCH
Q 007239          455 RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSI  534 (611)
Q Consensus       455 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  534 (611)
                      ...||+.|+|||++.+..++.++||||||+++|||++|+.||........  . ...........        .  ....
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~-~~~~~~~~~~~--------~--~~~~  222 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--N-KELKQRILNDS--------V--TYPD  222 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--H-HHHHHhhcccC--------C--CCcc
Confidence            45799999999999999999999999999999999999999854322111  0 11111010000        0  0111


Q ss_pred             HHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 007239          535 PQVVRCIHIGLLCVQEDPAVRP-----TMSNVVA  563 (611)
Q Consensus       535 ~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  563 (611)
                      .....+.+++..||+.||++||     +++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            1234567899999999999999     6677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1e-37  Score=319.21  Aligned_cols=259  Identities=28%  Similarity=0.415  Sum_probs=204.3

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC------CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCC
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGE  361 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~  361 (611)
                      ..++|++.+.||+|+||.||++.+.      ....+++|.+... ..+....+.+|+.+++++ +|+||+++++++...+
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            3467899999999999999999853      2367999998754 233456788999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCChhhHhhhc-------------hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec
Q 007239          362 EKLLIYELMPNRSLDCFIFDS-------------ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD  428 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~  428 (611)
                      ..+++|||+++++|..++...             .....+++..++.++.||+.||.|||+.+   |+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence            999999999999999998532             22356899999999999999999999986   99999999999999


Q ss_pred             CCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhH
Q 007239          429 KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTL  507 (611)
Q Consensus       429 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l  507 (611)
                      .++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..|+.....   ..+
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~  243 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV---EEL  243 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH---HHH
Confidence            999999999999987644332222222345678999999999999999999999999999997 8887642211   111


Q ss_pred             HHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          508 LAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       508 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                          .+....+....         .+......+.+|+.+||+.||++|||+.|+++.|++
T Consensus       244 ----~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~  290 (293)
T cd05053         244 ----FKLLKEGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR  290 (293)
T ss_pred             ----HHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence                12222221111         111223457799999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-37  Score=313.59  Aligned_cols=252  Identities=29%  Similarity=0.350  Sum_probs=199.5

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .|++.+.||+|+||.||++.. .+++.||+|++.....   .....+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            478889999999999999995 4688999999875432   223457889999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++++|.+++... ....+++..+..++.||+.||.|||+.+   ++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999998887532 2345899999999999999999999986   9999999999999999999999999998653222


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                      .   .....|++.|+|||++.+..++.++||||+|+++|||++|+.||......   .....+........         
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~---~~~~~~~~~~~~~~---------  221 (285)
T cd05605         157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK---VKREEVERRVKEDQ---------  221 (285)
T ss_pred             c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh---hHHHHHHHHhhhcc---------
Confidence            1   12347899999999999999999999999999999999999998532211   11111111111111         


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCC-----CHHHHHHH
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVAL  564 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  564 (611)
                       ..........+.+|+..||+.||++||     +++++++.
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         222 -EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             -cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence             011112234567899999999999999     78888654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.8e-37  Score=310.96  Aligned_cols=253  Identities=28%  Similarity=0.445  Sum_probs=200.7

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      ++|++.++||+|+||.||+|.+.++..|++|+++.... ..+.+.+|+++++.++||||+++++.+. ....++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~   83 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS   83 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence            56999999999999999999987777899999875432 3467899999999999999999999874 456799999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +++|.+++... ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.+...... 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-  158 (262)
T cd05071          84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-  158 (262)
T ss_pred             CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence            99999998542 2345789999999999999999999986   999999999999999999999999999866433221 


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                      ......++..|+|||+..++.++.++||||||+++|||++ |+.|+....   ...+..    ....+...         
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~---~~~~~~----~~~~~~~~---------  222 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLD----QVERGYRM---------  222 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---hHHHHH----HHhcCCCC---------
Confidence            1122346778999999999999999999999999999999 777764221   111111    11111100         


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      .........+.+++.+|++.+|++||++.++++.|+.
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            0112233467799999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=9.1e-37  Score=314.87  Aligned_cols=262  Identities=25%  Similarity=0.310  Sum_probs=200.5

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      ++|++.+.||+|+||.||++.+. ++..+++|.+... ......++.+|++++++++||||+++++.+..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46899999999999999999954 6788999988754 233456788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++..   ...+++..+..++.||++||.|||++.  +++|+||||+|||++.++.+||+|||++....... 
T Consensus        81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence            999999999843   356899999999999999999999742  49999999999999999999999999987543221 


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc--------
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM--------  521 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~--------  521 (611)
                         .....|++.|+|||.+.+..++.++||||||+++|+|++|+.|+......   ................        
T Consensus       155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---ELEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh---hHHHhhcCccccccccCCcccccC
Confidence               22357899999999998888999999999999999999999997432211   1111110000000000        


Q ss_pred             ------------cccccccCC----CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHh
Q 007239          522 ------------EFVDPLLMK----SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL  565 (611)
Q Consensus       522 ------------~~~d~~l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  565 (611)
                                  +..+.....    ........++.+++.+||+.+|++||++.+|++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                        000000000    00001223577999999999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-36  Score=304.31  Aligned_cols=250  Identities=34%  Similarity=0.493  Sum_probs=202.1

Q ss_pred             cccCccCceEEEEEEcCC----CcEEEEEEecccChhh-HHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVLPN----GKEVAVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      +.||+|+||.||++....    +..+++|.+....... .+.+.+|+.+++.++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999999653    7889999997654333 67899999999999999999999999999999999999999


Q ss_pred             CChhhHhhhchh------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          373 RSLDCFIFDSER------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       373 ~sL~~~l~~~~~------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      ++|.+++.....      ...+++..++.++.||+.||.|||+++   ++|+||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999865321      367899999999999999999999986   99999999999999999999999999987654


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ...........+++.|+|||.+....++.++||||||+++|+|++ |..|+....   ...+.    +....+.....  
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~----~~~~~~~~~~~--  228 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS---NEEVL----EYLRKGYRLPK--  228 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC---HHHHH----HHHHcCCCCCC--
Confidence            432222334567889999999998899999999999999999999 588875431   11122    22222111110  


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                             +.....++.+++.+||+.+|++||++.++++.|+
T Consensus       229 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         229 -------PEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -------CccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                   1111346778999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.6e-37  Score=317.91  Aligned_cols=242  Identities=26%  Similarity=0.280  Sum_probs=193.4

Q ss_pred             cccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      +.||+|+||.||++.+. +++.||+|++++..   ....+.+.+|..+++.+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999964 57899999997542   23456678899999888 699999999999999999999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      ++|..++.   +...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~  152 (318)
T cd05570          81 GDLMFHIQ---RSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--T  152 (318)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--c
Confidence            99988874   3346899999999999999999999986   99999999999999999999999999875322211  2


Q ss_pred             cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCC
Q 007239          453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSS  532 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  532 (611)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||....   ...+..    .......      ....  
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~~~~----~i~~~~~------~~~~--  217 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDELFQ----SILEDEV------RYPR--  217 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHHHHH----HHHcCCC------CCCC--
Confidence            234579999999999999999999999999999999999999985322   111111    1111111      0111  


Q ss_pred             CHHHHHHHHHHhhccccCCCCCCCCH-----HHHHHH
Q 007239          533 SIPQVVRCIHIGLLCVQEDPAVRPTM-----SNVVAL  564 (611)
Q Consensus       533 ~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~~  564 (611)
                        .....+.+|+.+||+.||++||++     .++++.
T Consensus       218 --~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         218 --WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             --cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence              112356789999999999999999     887753

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.3e-37  Score=316.39  Aligned_cols=259  Identities=29%  Similarity=0.419  Sum_probs=203.6

Q ss_pred             hhCCCCcccccCccCceEEEEEEc------CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCC
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL------PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGE  361 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~  361 (611)
                      ..++|.+.+.||+|+||.||++..      ..+..+|+|+++... ....+.+.+|+.+++++ +||||+++++.+...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            346799999999999999999973      134579999987543 33456789999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccc
Q 007239          362 EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA  441 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  441 (611)
                      ..+++|||+.+++|.+++.... ...+++.++..++.||+.||.|||+++   ++|+||||+|||++.++.+||+|||++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence            9999999999999999885422 234899999999999999999999986   999999999999999999999999999


Q ss_pred             eecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcc
Q 007239          442 RIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKE  520 (611)
Q Consensus       442 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~  520 (611)
                      +...............+++.|+|||.+.++.++.++||||||+++|||++ |+.|+......  ...    ......+..
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~----~~~~~~~~~  262 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKF----YKLIKEGYR  262 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHH----HHHHHcCCc
Confidence            86643322222223456788999999999999999999999999999998 88886432211  111    111111111


Q ss_pred             ccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       521 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ..     .    ......++.+++.+||+.+|++||++.++++.|.+
T Consensus       263 ~~-----~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         263 MA-----Q----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             CC-----C----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence            00     0    01112357789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.4e-37  Score=318.30  Aligned_cols=241  Identities=25%  Similarity=0.310  Sum_probs=190.4

Q ss_pred             cccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHh-cCCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAK-LQHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~-l~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      +.||+|+||+||+|... +++.||+|+++...   ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999964 57899999987542   2234556778888876 4899999999999999999999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      ++|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05619          81 GDLMFHIQ---SCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK  152 (316)
T ss_pred             CcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence            99998884   3346899999999999999999999987   9999999999999999999999999987532221  12


Q ss_pred             cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCC
Q 007239          453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSS  532 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  532 (611)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   ...+...    .....      +....  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~----i~~~~------~~~~~--  217 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD---EEELFQS----IRMDN------PCYPR--  217 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC---HHHHHHH----HHhCC------CCCCc--
Confidence            234579999999999999999999999999999999999999975322   1112111    11111      11111  


Q ss_pred             CHHHHHHHHHHhhccccCCCCCCCCHH-HHHH
Q 007239          533 SIPQVVRCIHIGLLCVQEDPAVRPTMS-NVVA  563 (611)
Q Consensus       533 ~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~  563 (611)
                        ....++.+++.+||+.||++||++. ++.+
T Consensus       218 --~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         218 --WLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             --cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence              1123567899999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.2e-37  Score=325.11  Aligned_cols=254  Identities=20%  Similarity=0.244  Sum_probs=197.3

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      ..++|++.+.||+|+||.||++... +++.+|+|++.+.   .......+.+|+.+++.++||||+++++++.++...++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            4578999999999999999999964 6888999998643   22234567899999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+++|+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         121 VMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            9999999999998842    34788999999999999999999986   9999999999999999999999999998764


Q ss_pred             cCCCccccccccccCCCCCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEG----LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM  521 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  521 (611)
                      .... .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.....      ..............
T Consensus       194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~  266 (370)
T cd05621         194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMDHKNSL  266 (370)
T ss_pred             cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCccc
Confidence            3221 122346799999999998754    378899999999999999999999853221      11111111111111


Q ss_pred             cccccccCCCCCHHHHHHHHHHhhccccCCCCC--CCCHHHHHHH
Q 007239          522 EFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAV--RPTMSNVVAL  564 (611)
Q Consensus       522 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~  564 (611)
                      .+.       ........+.+++..||+.++.+  ||++.|+++.
T Consensus       267 ~~p-------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         267 NFP-------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCC-------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            110       11111234567788888866544  8999999886

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-37  Score=306.67  Aligned_cols=248  Identities=29%  Similarity=0.404  Sum_probs=197.3

Q ss_pred             cccCccCceEEEEEEcCCCcEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCChh
Q 007239          298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQ-GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLD  376 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~sL~  376 (611)
                      ++||+|+||.||++.+.+++.|++|++...... ....+.+|+.++++++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999999766999999998765433 5678999999999999999999999999999999999999999999


Q ss_pred             hHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccccccc
Q 007239          377 CFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV  456 (611)
Q Consensus       377 ~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  456 (611)
                      +++...  ...+++..+..++.+++.+|.|||+++   ++||||||+||+++.++.+||+|||++...............
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            988442  235789999999999999999999986   999999999999999999999999999865422222121223


Q ss_pred             cccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHH
Q 007239          457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIP  535 (611)
Q Consensus       457 ~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  535 (611)
                      .++..|+|||.+.++.++.++||||||+++|||++ |..|+......   ....    ........         ..+..
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~~----~~~~~~~~---------~~~~~  219 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRE----RIESGYRM---------PAPQL  219 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHHH----HHhcCCCC---------CCCcc
Confidence            34667999999998899999999999999999999 77776433211   1111    11111100         01111


Q ss_pred             HHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          536 QVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       536 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                      ...++.+++.+||+.+|++||++.||++.|.
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            2346789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.8e-37  Score=318.83  Aligned_cols=261  Identities=24%  Similarity=0.317  Sum_probs=196.7

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      ++|.+.+.||+|+||.||+++.. +++.||+|.++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57999999999999999999964 678899999875432 2334678899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++ +|..++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            986 777666432  345789999999999999999999987   99999999999999999999999999976433221


Q ss_pred             ccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc--------
Q 007239          450 TANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE--------  520 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--------  520 (611)
                        ......+++.|+|||++.+ ..++.++||||||+++|+|++|++||......+   ........+.....        
T Consensus       160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07872         160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED---ELHLIFRLLGTPTEETWPGISS  234 (309)
T ss_pred             --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHhhhcc
Confidence              1223468899999998865 468999999999999999999999985433221   11111111111000        


Q ss_pred             -ccccccccCCC-------CCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          521 -MEFVDPLLMKS-------SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       521 -~~~~d~~l~~~-------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       .+..+......       .......++.+++.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence             00000000000       00011235678999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.4e-37  Score=318.51  Aligned_cols=259  Identities=26%  Similarity=0.393  Sum_probs=203.6

Q ss_pred             hhCCCCcccccCccCceEEEEEEc--------CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEee
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL--------PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIE  359 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~  359 (611)
                      ..++|.+.+.||+|+||.||+++.        .++..|++|.+.... ......+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            356789999999999999999973        124579999887542 34457789999999999 79999999999999


Q ss_pred             CCeEEEEEEecCCCChhhHhhhchh-------------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEE
Q 007239          360 GEEKLLIYELMPNRSLDCFIFDSER-------------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVL  426 (611)
Q Consensus       360 ~~~~~lv~E~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIl  426 (611)
                      ....++||||+++++|.+++.....             ...+++..+..++.||+.||.|||+++   ++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence            9999999999999999999864321             235788899999999999999999987   999999999999


Q ss_pred             ecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchh
Q 007239          427 LDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQ  505 (611)
Q Consensus       427 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~  505 (611)
                      ++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..|+....   ..
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~  246 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VE  246 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---HH
Confidence            99999999999999987644332222223456778999999999899999999999999999998 677753221   11


Q ss_pred             hHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          506 TLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       506 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      .    ..+....+.....         .......+.+++.+||+.+|++||++.+|++.|..
T Consensus       247 ~----~~~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~  295 (304)
T cd05101         247 E----LFKLLKEGHRMDK---------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR  295 (304)
T ss_pred             H----HHHHHHcCCcCCC---------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence            1    1122222211110         11123457789999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.4e-37  Score=322.51  Aligned_cols=260  Identities=25%  Similarity=0.311  Sum_probs=195.5

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC-----
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE-----  361 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-----  361 (611)
                      ..++|++.+.||+|+||.||++.. .+|+.||+|++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            468899999999999999999996 46889999998653  2334567889999999999999999999886543     


Q ss_pred             -eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccc
Q 007239          362 -EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGM  440 (611)
Q Consensus       362 -~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  440 (611)
                       ..++||||++++ |...+.     ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             579999999864 444442     24788899999999999999999987   99999999999999999999999999


Q ss_pred             ceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHH-------
Q 007239          441 ARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ-------  513 (611)
Q Consensus       441 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~-------  513 (611)
                      ++......   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......   ......+       
T Consensus       170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~~  243 (359)
T cd07876         170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID---QWNKVIEQLGTPSA  243 (359)
T ss_pred             ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCcH
Confidence            97543221   2233578999999999999999999999999999999999999986432211   1110000       


Q ss_pred             ------------HHhcCcc------ccccccccCC---CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          514 ------------LWKEGKE------MEFVDPLLMK---SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       514 ------------~~~~~~~------~~~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                                  .......      .+........   .........+.+|+.+||+.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                        0000000      0000000000   0001112356789999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.1e-36  Score=309.28  Aligned_cols=250  Identities=25%  Similarity=0.296  Sum_probs=194.5

Q ss_pred             cCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCCh
Q 007239          300 LGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSL  375 (611)
Q Consensus       300 lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~sL  375 (611)
                      ||+|+||.||++.. .+|+.||+|.+.....   .....+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999995 4689999999864322   1234456799999999999999999999999999999999999999


Q ss_pred             hhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcccccc
Q 007239          376 DCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR  455 (611)
Q Consensus       376 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  455 (611)
                      .+++... ....+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.++|+|||++........   ...
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~  153 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ  153 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence            8887542 2345889999999999999999999986   99999999999999999999999999986643221   223


Q ss_pred             ccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHH
Q 007239          456 VVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIP  535 (611)
Q Consensus       456 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  535 (611)
                      ..|++.|+|||++.+..++.++|||||||++|||++|+.||........  .......... ...    ...  .   ..
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~-~~~----~~~--~---~~  221 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLE-DEV----KFE--H---QN  221 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhc-ccc----ccc--c---cc
Confidence            5689999999999998999999999999999999999999754322111  1111111111 110    000  0   01


Q ss_pred             HHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          536 QVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       536 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ...++.+++..||+.||++||++.|+++.+..+
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h  254 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKNDDPRKH  254 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchhhhhcC
Confidence            123467899999999999999998877655544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.1e-37  Score=317.27  Aligned_cols=258  Identities=28%  Similarity=0.392  Sum_probs=201.5

Q ss_pred             hCCCCcccccCccCceEEEEEEcC--------CCcEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeC
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP--------NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEG  360 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~  360 (611)
                      .++|.+.+.||+|+||.||++...        ....+|+|.+.... ......+.+|+.+++++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            467999999999999999999742        23569999987542 34456788999999999 799999999999999


Q ss_pred             CeEEEEEEecCCCChhhHhhhchh-------------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe
Q 007239          361 EEKLLIYELMPNRSLDCFIFDSER-------------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL  427 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll  427 (611)
                      ...++||||+++++|.+++.....             ...+++.++++++.||+.||+|||+.+   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999854321             134889999999999999999999986   9999999999999


Q ss_pred             cCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhh
Q 007239          428 DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQT  506 (611)
Q Consensus       428 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~  506 (611)
                      +.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.|+....   ...
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~---~~~  250 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---VEE  250 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC---HHH
Confidence            9999999999999976543221111112234568999999999999999999999999999998 777764221   111


Q ss_pred             HHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          507 LLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       507 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      +..    ....+...+.         +.....++.+++..||+.+|++||++.+|++.|..
T Consensus       251 ~~~----~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~  298 (307)
T cd05098         251 LFK----LLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  298 (307)
T ss_pred             HHH----HHHcCCCCCC---------CCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence            111    1122211110         11122456789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.8e-37  Score=315.51  Aligned_cols=260  Identities=28%  Similarity=0.463  Sum_probs=201.7

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  362 (611)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            3578999999999999999999743      24579999886443 2334567899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchh-------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEE
Q 007239          363 KLLIYELMPNRSLDCFIFDSER-------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKI  435 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl  435 (611)
                      .++||||+++++|.+++.....       ...+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999854221       234567788999999999999999986   999999999999999999999


Q ss_pred             eccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHH
Q 007239          436 SDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQL  514 (611)
Q Consensus       436 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~  514 (611)
                      +|||+++...............++..|+|||.+.++.++.++||||||+++|||++ |..|+....   .......    
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~---~~~~~~~----  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS---NEQVLKF----  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH----
Confidence            99999986533222212222345678999999999999999999999999999998 677764221   1112211    


Q ss_pred             HhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       515 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ...+.....         .......+.+++.+||+.+|++|||+.++++.|.+.
T Consensus       234 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         234 VMDGGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHcCCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            111111110         011124677999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.1e-37  Score=313.55  Aligned_cols=259  Identities=25%  Similarity=0.373  Sum_probs=204.7

Q ss_pred             hCCCCcccccCccCceEEEEEEcCC-----CcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee-CCeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPN-----GKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE-GEEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~  363 (611)
                      .++|.+.+.||+|+||.||+|.+.+     +..|++|++... .....+.+.+|+.+++.++|+||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4689999999999999999999754     678999988654 33446778999999999999999999998765 5678


Q ss_pred             EEEEEecCCCChhhHhhhchhh-----ccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecc
Q 007239          364 LLIYELMPNRSLDCFIFDSERR-----LQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDF  438 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~-----~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  438 (611)
                      ++++||+++++|.+++......     ..+++..++.++.||+.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999988543222     46899999999999999999999986   999999999999999999999999


Q ss_pred             ccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhc
Q 007239          439 GMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKE  517 (611)
Q Consensus       439 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  517 (611)
                      |+++.+.............++..|+|||++.+..++.++||||||+++|||++ |+.|+...   ....+..    ....
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~---~~~~~~~----~~~~  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI---DPFEMAA----YLKD  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC---CHHHHHH----HHHc
Confidence            99986644332222223356778999999998889999999999999999999 99887432   1122221    1222


Q ss_pred             CccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          518 GKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       518 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      +....  .       ......++.+++.+||+.+|++|||+.+|++.|+..
T Consensus       235 ~~~~~--~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         235 GYRLA--Q-------PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             CCCCC--C-------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            21100  0       011123577899999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1e-36  Score=312.72  Aligned_cols=251  Identities=24%  Similarity=0.370  Sum_probs=203.2

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ...+|++.+.||+|+||.||+++. .+++.|++|.+........+.+.+|+.+++.+.|+||+++++.+......++|||
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            346899999999999999999995 5788999999987665666788999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++++|.+++..    ..+++.++..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        98 ~~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654          98 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             ccCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            9999999998732    34789999999999999999999987   9999999999999999999999999987653322


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                      ..  .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||.....  ...+.    ....... .     .+
T Consensus       171 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~--~~~~~----~~~~~~~-~-----~~  236 (296)
T cd06654         171 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LRALY----LIATNGT-P-----EL  236 (296)
T ss_pred             cc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH--HHhHH----HHhcCCC-C-----CC
Confidence            11  1234688999999999988899999999999999999999999743221  11111    1111111 0     01


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..  .......+.+++.+||+.+|++||++.++++
T Consensus       237 ~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         237 QN--PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CC--ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            00  1112245678999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.8e-38  Score=310.19  Aligned_cols=258  Identities=25%  Similarity=0.330  Sum_probs=195.3

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC-----eEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE-----EKLLI  366 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-----~~~lv  366 (611)
                      .|...+.+|.|+||.||+|+. .++++||||+...+..    .-.+|+++|+++.|||||+++.+|....     ...+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            577789999999999999995 4578999999876543    2257999999999999999999886432     23579


Q ss_pred             EEecCCCChhhHhhhc-hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC-CCEEEeccccceec
Q 007239          367 YELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD-MVAKISDFGMARIF  444 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~-~~~kl~DFGla~~~  444 (611)
                      ||||+. +|.+.+... ..+..++...+.-+..||++||.|||+.+   |+||||||.|+|+|.+ |.+||+|||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999987 677776431 23456888888999999999999999986   9999999999999976 99999999999988


Q ss_pred             ccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc--
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM--  521 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~--  521 (611)
                      ..+...   ....-|..|+|||.+.+ ..|+.+.||||.||++.||+-|++-|......+   .+..+.+.+......  
T Consensus       177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d---QL~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD---QLVEIIKVLGTPTREDI  250 (364)
T ss_pred             ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH---HHHHHHHHhCCCCHHHH
Confidence            655443   23566889999999887 569999999999999999999998876533322   222232222222111  


Q ss_pred             --------cccccccCCC-----CCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          522 --------EFVDPLLMKS-----SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       522 --------~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                              +...+.+...     .......+.++|+.++|+.+|.+|.++.|++..
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence                    1112222211     112233467899999999999999999988753

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.8e-38  Score=325.90  Aligned_cols=238  Identities=24%  Similarity=0.292  Sum_probs=190.3

Q ss_pred             cccCccCceEEEEEEc----CCCcEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          298 NKLGQGGFGTVYKGVL----PNGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      +.||+|+||.||++..    .+|+.||+|++.....  .....+.+|++++++++||||+++++.+...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999874    3678999999975432  234567889999999999999999999999999999999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +++|.+++.   +...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  .
T Consensus        82 ~~~L~~~l~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~  153 (318)
T cd05582          82 GGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K  153 (318)
T ss_pred             CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence            999998883   3456899999999999999999999986   9999999999999999999999999997653321  1


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKS  531 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  531 (611)
                      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....   ......   ... .... .     +.. 
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~---~~~~~~---~i~-~~~~-~-----~p~-  219 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD---RKETMT---MIL-KAKL-G-----MPQ-  219 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC---HHHHHH---HHH-cCCC-C-----CCC-
Confidence            2234679999999999998889999999999999999999999975322   111111   111 1111 0     111 


Q ss_pred             CCHHHHHHHHHHhhccccCCCCCCCCHHH
Q 007239          532 SSIPQVVRCIHIGLLCVQEDPAVRPTMSN  560 (611)
Q Consensus       532 ~~~~~~~~l~~li~~cl~~dP~~RPt~~e  560 (611)
                         .....+.+++.+||+.||++||++.+
T Consensus       220 ---~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         220 ---FLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             ---CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence               11234668889999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1e-36  Score=307.92  Aligned_cols=254  Identities=26%  Similarity=0.383  Sum_probs=191.8

Q ss_pred             cccCccCceEEEEEEcC---CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCC
Q 007239          298 NKLGQGGFGTVYKGVLP---NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNR  373 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~  373 (611)
                      +.||+|+||.||+|.+.   .+..+++|.++... ......+.+|+.++++++||||+++++++.+....++||||++++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            46999999999999853   34579999887543 233457889999999999999999999999999999999999999


Q ss_pred             ChhhHhhhchh--hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          374 SLDCFIFDSER--RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       374 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +|.+++.....  ....++..+..++.|++.||.|||+.+   ++|+||||+||+++.++++||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999854322  234677788899999999999999986   9999999999999999999999999997543332222


Q ss_pred             ccccccccCCCCCccccccC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          452 NTRRVVGTYGYMAPEYAMEG-------LFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~-------~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      ......|+..|+|||++...       .++.++||||||+++|||++ |+.||.....   .......    ..+.....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~~~~~----~~~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD---EQVLTYT----VREQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHH----hhcccCCC
Confidence            22335678889999988642       35789999999999999996 9988754322   1111111    11112222


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                      .++.+...    ....+.+++..|+ .+|++|||++||+..|+
T Consensus       231 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            22222211    1224567788898 58999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-36  Score=327.51  Aligned_cols=194  Identities=23%  Similarity=0.305  Sum_probs=166.8

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      ..+|.+.+.||+|+||.||++.+. .++.||+|...      ...+.+|+.++++++|+||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            458999999999999999999965 57889999643      23457899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +. ++|..++..  ....+++.+++.|+.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.......
T Consensus       242 ~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            96 577777643  2346899999999999999999999987   99999999999999999999999999987643322


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNS  496 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~  496 (611)
                      ........||+.|+|||++.+..++.++|||||||+||||++|..++
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            22223467999999999999999999999999999999999988654

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.6e-36  Score=305.95  Aligned_cols=253  Identities=23%  Similarity=0.360  Sum_probs=200.8

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      .++|++.+.||+|+||.||++.. .+++.|++|.++.........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            35788899999999999999995 46889999998766555566788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++.   ....+++.+++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++....... 
T Consensus        88 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-  160 (267)
T cd06645          88 CGGGSLQDIYH---VTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-  160 (267)
T ss_pred             cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence            99999999883   3456899999999999999999999986   9999999999999999999999999997654322 


Q ss_pred             ccccccccccCCCCCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          450 TANTRRVVGTYGYMAPEYAM---EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                       .......|++.|+|||++.   .+.++.++|||||||++|+|++|+.|+......  ..+    ..........    +
T Consensus       161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~--~~~----~~~~~~~~~~----~  229 (267)
T cd06645         161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--RAL----FLMTKSNFQP----P  229 (267)
T ss_pred             -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch--hhH----HhhhccCCCC----C
Confidence             1223457899999999874   456889999999999999999999986432211  111    1111111110    1


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .....  ......+.+++.+||+.+|++||++++|++
T Consensus       230 ~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         230 KLKDK--MKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ccccc--CCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            11110  011234678999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-37  Score=307.13  Aligned_cols=250  Identities=31%  Similarity=0.448  Sum_probs=203.2

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      .++|++.+.||.|+||.||++... |+.|++|.+..... ..+++.+|+.+++.++|+||+++++++......++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            357889999999999999999874 78899999976654 5678999999999999999999999999899999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+++....... 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            9999999885422 236899999999999999999999987   99999999999999999999999999986532221 


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                          ...++..|+|||++..+.++.++||||||+++|||++ |..|+....   ...+...+    ..+.....      
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~----~~~~~~~~------  220 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPHV----EKGYRMEA------  220 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHH----hcCCCCCC------
Confidence                2234567999999998899999999999999999997 888864321   22222211    11111110      


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                         .......+.+++.+||+.+|++||++++++++|++
T Consensus       221 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         221 ---PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ---ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence               11122457789999999999999999999999974

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.7e-37  Score=319.73  Aligned_cols=237  Identities=23%  Similarity=0.270  Sum_probs=185.5

Q ss_pred             cccCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHHHH-HHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKNEI-ILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~-~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      +.||+|+||.||+++. .+++.||+|++.+...   .....+.+|. .+++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999996 4688999999875422   2233455555 467889999999999999999999999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      ++|...+.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~  152 (321)
T cd05603          81 GELFFHLQ---RERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET  152 (321)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence            99988773   3456888999999999999999999986   9999999999999999999999999987532221  12


Q ss_pred             cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCC
Q 007239          453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSS  532 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  532 (611)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   ...+..   . +.....      .+    
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~---~-i~~~~~------~~----  215 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---VSQMYD---N-ILHKPL------QL----  215 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC---HHHHHH---H-HhcCCC------CC----
Confidence            234679999999999999999999999999999999999999974321   111111   1 111110      01    


Q ss_pred             CHHHHHHHHHHhhccccCCCCCCCCHH
Q 007239          533 SIPQVVRCIHIGLLCVQEDPAVRPTMS  559 (611)
Q Consensus       533 ~~~~~~~l~~li~~cl~~dP~~RPt~~  559 (611)
                      +......+.+++.+||+.+|++||+..
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         216 PGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            111223567899999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.9e-37  Score=318.05  Aligned_cols=240  Identities=27%  Similarity=0.310  Sum_probs=189.9

Q ss_pred             cccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      +.||+|+||.||++++. +|+.||+|++++..   ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999964 68899999987542   22345667788888754 799999999999999999999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      ++|..++..   ...+++..+..++.||++||+|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~  152 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence            999888743   356899999999999999999999986   9999999999999999999999999987432211  12


Q ss_pred             cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCC
Q 007239          453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSS  532 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  532 (611)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||....   ...+..    ......      +.+..  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~---~~~~~~----~~~~~~------~~~~~--  217 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD---EDELFE----SIRVDT------PHYPR--  217 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHH----HHHhCC------CCCCC--
Confidence            234679999999999999999999999999999999999999984322   111211    111111      11111  


Q ss_pred             CHHHHHHHHHHhhccccCCCCCCCCHH-HHH
Q 007239          533 SIPQVVRCIHIGLLCVQEDPAVRPTMS-NVV  562 (611)
Q Consensus       533 ~~~~~~~l~~li~~cl~~dP~~RPt~~-evl  562 (611)
                        ....++.+++..||+.||++||++. +++
T Consensus       218 --~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         218 --WITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             --CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence              1123567889999999999999985 555

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8.4e-37  Score=307.03  Aligned_cols=253  Identities=30%  Similarity=0.460  Sum_probs=200.2

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      ++|++.+.||+|++|.||++.+..+..+++|.+.... ...+.+.+|+.+++.++|+|++++++++. ....+++|||+.
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            5688999999999999999998777789999886543 23467889999999999999999999875 456889999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +++|.+++... ....+++..+..++.||+.||.|||+.+   ++|+||||+||++++++.++|+|||++......... 
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-  158 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-  158 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc-
Confidence            99999988542 2335789999999999999999999986   999999999999999999999999999876433221 


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+....   ......    ....+....        
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~----~~~~~~~~~--------  223 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV---NREVLE----QVERGYRMP--------  223 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHH----HHHcCCCCC--------
Confidence            1122346778999999998999999999999999999999 888864321   111111    111111100        


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                       ........+.+++.+||+.||++||++++|++.|+.
T Consensus       224 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 -CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             011123457789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-36  Score=315.85  Aligned_cols=200  Identities=23%  Similarity=0.321  Sum_probs=171.9

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++.+.||+|+||.||+++. .+++.||+|++.+.   .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4799999999999999999995 46889999998753   2233456889999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999998843  2345889999999999999999999987   999999999999999999999999999765432


Q ss_pred             CCccccccccccCCCCCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007239          448 QKTANTRRVVGTYGYMAPEYAME-----GLFSVKSDVFSFGVIVLEIISGKRNSG  497 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvll~elltG~~p~~  497 (611)
                      ... ......||+.|+|||++..     +.++.++|||||||++|||++|+.||.
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~  209 (331)
T cd05597         156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY  209 (331)
T ss_pred             CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence            221 1223469999999999863     457889999999999999999999974

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.6e-37  Score=315.36  Aligned_cols=255  Identities=26%  Similarity=0.374  Sum_probs=197.4

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCc--EEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGK--EVAVKRLSRK-SWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ++|++.+.||+|+||.||+|+.. ++.  .+++|.++.. .....+.+.+|+.++.++ +||||+++++++......+++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            57899999999999999999864 333  4788887642 334456789999999999 699999999999999999999


Q ss_pred             EEecCCCChhhHhhhch-------------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCE
Q 007239          367 YELMPNRSLDCFIFDSE-------------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVA  433 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~  433 (611)
                      |||+++++|.+++....             ....+++..++.++.||+.||+|||+++   ++||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999985422             1135889999999999999999999986   9999999999999999999


Q ss_pred             EEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHH
Q 007239          434 KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVW  512 (611)
Q Consensus       434 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~  512 (611)
                      ||+|||++.......   .......+..|+|||++....++.++||||||+++|||++ |+.||.....   ..+..   
T Consensus       159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~~~---  229 (297)
T cd05089         159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AELYE---  229 (297)
T ss_pred             EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH---
Confidence            999999986422111   1111223457999999998899999999999999999997 9888743221   11111   


Q ss_pred             HHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       513 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                       ....+....     .    +......+.+|+.+||+.+|.+||+++++++.|...
T Consensus       230 -~~~~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  275 (297)
T cd05089         230 -KLPQGYRME-----K----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM  275 (297)
T ss_pred             -HHhcCCCCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             111111100     0    111223567899999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.2e-37  Score=326.62  Aligned_cols=201  Identities=25%  Similarity=0.359  Sum_probs=173.8

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++.+.||+|+||.||++.. .+++.||+|++....   ......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4688999999999999999995 468899999987532   234567888999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++.   +...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            9999999999884   3456899999999999999999999987   999999999999999999999999998754321


Q ss_pred             CCc---------------------------------cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 007239          448 QKT---------------------------------ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKR  494 (611)
Q Consensus       448 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~  494 (611)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            100                                 00113579999999999999999999999999999999999999


Q ss_pred             CCCC
Q 007239          495 NSGF  498 (611)
Q Consensus       495 p~~~  498 (611)
                      ||..
T Consensus       235 Pf~~  238 (360)
T cd05627         235 PFCS  238 (360)
T ss_pred             CCCC
Confidence            9853

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.4e-37  Score=309.13  Aligned_cols=255  Identities=27%  Similarity=0.482  Sum_probs=201.3

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CC---cEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NG---KEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ++|+..+.||+|+||.||+++.. ++   ..+++|.+... .....+.+.+|+.++++++|||++++++++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            46888899999999999999964 33   36999998755 234456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++.....
T Consensus        85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence            9999999999988542  346899999999999999999999986   99999999999999999999999999986643


Q ss_pred             CCCcccc-ccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          447 NQKTANT-RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       447 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ....... .....++.|+|||++....++.++||||||+++|||++ |+.|+.....   ..+.    ..+..+...   
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~----~~i~~~~~~---  229 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVM----KAINDGFRL---  229 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHH----HHHhcCCCC---
Confidence            2221111 11223457999999998899999999999999999997 9998743221   1111    112221110   


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                            .........+.+++.+||+.+|++||++.+|++.|.+
T Consensus       230 ------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         230 ------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             ------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                  0111123457799999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.8e-37  Score=311.06  Aligned_cols=255  Identities=26%  Similarity=0.444  Sum_probs=199.8

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CC---cEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NG---KEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ..|++.+.||+|+||.||+|.+. ++   ..|++|.+... .......+.+|+.+++.++||||+++++++..+...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            35788999999999999999964 23   36999998754 344567899999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++...  ...+++.+++.++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++.....
T Consensus        84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            9999999999988542  346899999999999999999999987   99999999999999999999999999876543


Q ss_pred             CCCcccccc-cc--ccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          447 NQKTANTRR-VV--GTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       447 ~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      ......... ..  .+..|+|||++.+..++.++||||||+++|||++ |+.|+....   .......+    ...... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~---~~~~~~~i----~~~~~~-  230 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---NQDVINAI----EQDYRL-  230 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC---HHHHHHHH----HcCCcC-
Confidence            322111111 11  2357999999999999999999999999999886 988874322   11122211    111100 


Q ss_pred             ccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       523 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                              .........+.+++..||+.+|++||++++|+.+|++
T Consensus       231 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         231 --------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             --------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence                    0011122356789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.1e-36  Score=304.00  Aligned_cols=247  Identities=27%  Similarity=0.373  Sum_probs=196.6

Q ss_pred             cccCccCceEEEEEEcCCCcEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCChh
Q 007239          298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLD  376 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~sL~  376 (611)
                      +.||+|+||.||+|...+++.+|+|.+..... .....+.+|+.+++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            46999999999999987889999999876543 33456889999999999999999999999999999999999999999


Q ss_pred             hHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccccccc
Q 007239          377 CFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV  456 (611)
Q Consensus       377 ~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  456 (611)
                      +++...  ...+++..++.++.|++.+|.|||+++   ++||||||+||+++.++.+||+|||++......... .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~  154 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLK  154 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCC
Confidence            987432  345789999999999999999999986   999999999999999999999999999754332211 11122


Q ss_pred             cccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHH
Q 007239          457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIP  535 (611)
Q Consensus       457 ~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  535 (611)
                      .+++.|+|||++..+.++.++||||||+++|+|++ |..||.....   ....    .....+....         ....
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~---~~~~----~~~~~~~~~~---------~~~~  218 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN---QQAR----EQVEKGYRMS---------CPQK  218 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH---HHHH----HHHHcCCCCC---------CCCC
Confidence            44677999999999999999999999999999998 8888743211   1111    1111211111         0111


Q ss_pred             HHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          536 QVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       536 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                      ....+.+++.+||+.+|++||++.++++.|.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            2346778999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.3e-36  Score=318.38  Aligned_cols=193  Identities=23%  Similarity=0.357  Sum_probs=164.4

Q ss_pred             HhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ....+|++.+.||+|+||.||++... +++.||+|+....      ....|+.++++++||||+++++++......++||
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            34568999999999999999999964 5778999975433      2356999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      |++.+ +|..++..  ....+++..++.|+.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       137 e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        137 PHYSS-DLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EccCC-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            99964 77776643  3356899999999999999999999986   999999999999999999999999999753221


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNS  496 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~  496 (611)
                         .......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus       211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence               1222457999999999999999999999999999999999866553

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.3e-37  Score=307.32  Aligned_cols=255  Identities=31%  Similarity=0.473  Sum_probs=204.3

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      .++|++.+.||+|+||.||++..++++.+++|.+.... ...+.+.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            46899999999999999999998778889999987544 33567899999999999999999999999889999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++++|.+++.... ...+++..+..++.||+.||.|||+++   ++|+||||+||+++.++.+||+|||++..+......
T Consensus        84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            9999999985422 245899999999999999999999986   999999999999999999999999999876432211


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                       ......++..|+|||.+.+..++.++||||||+++|+|++ |+.|+...   .........    ..+....     . 
T Consensus       160 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~---~~~~~~~~~----~~~~~~~-----~-  225 (261)
T cd05034         160 -AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM---TNREVLEQV----ERGYRMP-----R-  225 (261)
T ss_pred             -hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHH----HcCCCCC-----C-
Confidence             1112234568999999998899999999999999999998 88887422   111122211    1111000     0 


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                         +.....++.+++.+||+.+|++||+++++++.|+.
T Consensus       226 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         226 ---PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence               01112457789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.8e-37  Score=312.06  Aligned_cols=258  Identities=26%  Similarity=0.436  Sum_probs=202.4

Q ss_pred             hCCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  363 (611)
                      .++|++.+.||+|+||.||++..+      +++.||+|++.... ......+.+|+.++++++||||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467999999999999999999853      46789999987543 33456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhHhhhch-------------------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCc
Q 007239          364 LLIYELMPNRSLDCFIFDSE-------------------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSN  424 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~-------------------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~N  424 (611)
                      ++||||+++++|.+++....                   ....+++..++.++.||+.||.|||+++   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999985321                   1234788899999999999999999986   9999999999


Q ss_pred             EEecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 007239          425 VLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGH  503 (611)
Q Consensus       425 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~  503 (611)
                      |+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..|+...   .
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~---~  237 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM---A  237 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---C
Confidence            9999999999999999876533222111222345677999999998999999999999999999997 77775321   1


Q ss_pred             hhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          504 AQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       504 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      .....    .....+.....         ......++.+++.+||+.+|++|||+.|+++.|+.
T Consensus       238 ~~~~~----~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         238 HEEVI----YYVRDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHHHH----HHHhcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            11111    12222221110         11123467789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.1e-37  Score=322.08  Aligned_cols=243  Identities=22%  Similarity=0.255  Sum_probs=187.9

Q ss_pred             cccCccCceEEEEEEcC-CCcEEEEEEecccCh---hhHHHHHHHH-HHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW---QGLEEFKNEI-ILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~-~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      +.||+|+||+||+++.. +++.||+|++.+...   .....+..|. .+++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999964 678899999875421   2223344444 457889999999999999999999999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      ++|.+++..   ...+.+..+..++.||++||.|||+.+   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~  152 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT  152 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence            999988843   345788899999999999999999987   9999999999999999999999999997542222  12


Q ss_pred             cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCC
Q 007239          453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSS  532 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  532 (611)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   ......   .... ... .     +..  
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~---~i~~-~~~-~-----~~~--  217 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYD---NILN-KPL-Q-----LKP--  217 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC---HHHHHH---HHHh-CCc-C-----CCC--
Confidence            334679999999999999999999999999999999999999974321   111111   1111 111 0     001  


Q ss_pred             CHHHHHHHHHHhhccccCCCCCCCCHHHHHHHh
Q 007239          533 SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL  565 (611)
Q Consensus       533 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  565 (611)
                        .....+.+++..||+.||.+||++.+.+..+
T Consensus       218 --~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i  248 (325)
T cd05602         218 --NITNSARHLLEGLLQKDRTKRLGAKDDFMEI  248 (325)
T ss_pred             --CCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence              1123467888999999999999987544443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=8.9e-37  Score=324.85  Aligned_cols=259  Identities=25%  Similarity=0.397  Sum_probs=202.2

Q ss_pred             hCCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEE  362 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~  362 (611)
                      .++|.+.++||+|+||.||++++.      .++.||+|+++... ......+.+|+.++.++. ||||+++++.+...+.
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            356888999999999999999853      34679999997543 233457889999999998 9999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchh----------------------------------------------------------
Q 007239          363 KLLIYELMPNRSLDCFIFDSER----------------------------------------------------------  384 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~----------------------------------------------------------  384 (611)
                      .++||||+++|+|.+++.....                                                          
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            9999999999999998854211                                                          


Q ss_pred             -------------------------------------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe
Q 007239          385 -------------------------------------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL  427 (611)
Q Consensus       385 -------------------------------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll  427 (611)
                                                           ...+++..++.++.||+.||.|||+.+   ++||||||+|||+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl  272 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI  272 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence                                                 123677888999999999999999986   9999999999999


Q ss_pred             cCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhh
Q 007239          428 DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQT  506 (611)
Q Consensus       428 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~  506 (611)
                      ++++.+||+|||+++...............+++.|+|||.+....++.++||||||+++|||++ |+.|+......  ..
T Consensus       273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~--~~  350 (401)
T cd05107         273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN--EQ  350 (401)
T ss_pred             eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch--HH
Confidence            9999999999999986543322222223467889999999999899999999999999999998 88886432211  11


Q ss_pred             HHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          507 LLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       507 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                          .......+....     .    +......+.+|+..||+.+|++||++++|++.|+.
T Consensus       351 ----~~~~~~~~~~~~-----~----p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         351 ----FYNAIKRGYRMA-----K----PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             ----HHHHHHcCCCCC-----C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                111122221110     0    11112456788899999999999999999999974

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.8e-36  Score=305.27  Aligned_cols=240  Identities=20%  Similarity=0.338  Sum_probs=188.0

Q ss_pred             cccCccCceEEEEEEcCC-------------CcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE
Q 007239          298 NKLGQGGFGTVYKGVLPN-------------GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  364 (611)
                      +.||+|+||.||+|++..             ..++++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2358899887665555667889999999999999999999999999999


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCC-------EEEec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV-------AKISD  437 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~-------~kl~D  437 (611)
                      +||||+++++|+.++..  ....+++..++.++.||++||+|||+++   |+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999888743  2345899999999999999999999986   999999999999987664       89999


Q ss_pred             cccceecccCCCccccccccccCCCCCccccc-cCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCCCchhhHHHHHHHHH
Q 007239          438 FGMARIFCENQKTANTRRVVGTYGYMAPEYAM-EGLFSVKSDVFSFGVIVLEII-SGKRNSGFYLTGHAQTLLAYVWQLW  515 (611)
Q Consensus       438 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~k~DvwSlGvll~ell-tG~~p~~~~~~~~~~~l~~~~~~~~  515 (611)
                      ||++......      ....++..|+|||.+. ...++.++||||||+++|||+ .|..|+.......       .....
T Consensus       156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~  222 (262)
T cd05077         156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------KERFY  222 (262)
T ss_pred             CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------HHHHH
Confidence            9998754221      2246788999999887 466899999999999999998 5777753221110       11111


Q ss_pred             hcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          516 KEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       516 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                      ... . ..         ..+...++.+|+.+||+.||++||++.+|++.|+
T Consensus       223 ~~~-~-~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 EGQ-C-ML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             hcC-c-cC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            111 0 00         1112345778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.4e-36  Score=314.70  Aligned_cols=197  Identities=27%  Similarity=0.442  Sum_probs=160.3

Q ss_pred             ccccCccCceEEEEEEcC---CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee--CCeEEEEEEecC
Q 007239          297 SNKLGQGGFGTVYKGVLP---NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE--GEEKLLIYELMP  371 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~lv~E~~~  371 (611)
                      +++||+|+||+||+|+..   +++.+|+|.+.....  ...+.+|+.++++++||||+++++.+..  ....+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999853   567899999865432  3457889999999999999999998854  456899999987


Q ss_pred             CCChhhHhhhc------hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe----cCCCCEEEeccccc
Q 007239          372 NRSLDCFIFDS------ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL----DKDMVAKISDFGMA  441 (611)
Q Consensus       372 ~~sL~~~l~~~------~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll----~~~~~~kl~DFGla  441 (611)
                      + +|.+++...      .....+++..+..++.||+.||.|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            5 676665321      12235889999999999999999999987   9999999999999    45678999999999


Q ss_pred             eecccCCCc-cccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 007239          442 RIFCENQKT-ANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFY  499 (611)
Q Consensus       442 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~  499 (611)
                      +.+...... .......||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            876433221 12234678999999999877 45899999999999999999999998543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.4e-36  Score=321.34  Aligned_cols=257  Identities=20%  Similarity=0.236  Sum_probs=198.3

Q ss_pred             HHhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeE
Q 007239          288 KAATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       288 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  363 (611)
                      ....++|++.+.||+|+||.||++... +++.+|+|++.+..   ......+.+|+.+++.++||||+++++.+.+....
T Consensus        39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (371)
T cd05622          39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  118 (371)
T ss_pred             CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            334579999999999999999999964 68889999986432   22345678899999999999999999999999999


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ++||||+++++|.+++..    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       119 ~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~  191 (371)
T cd05622         119 YMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (371)
T ss_pred             EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence            999999999999998842    34788899999999999999999987   99999999999999999999999999987


Q ss_pred             cccCCCccccccccccCCCCCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCc
Q 007239          444 FCENQKTANTRRVVGTYGYMAPEYAMEG----LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK  519 (611)
Q Consensus       444 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  519 (611)
                      ...... .......||+.|+|||++...    .++.++|||||||++|||++|+.||.....      ............
T Consensus       192 ~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~  264 (371)
T cd05622         192 MNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNHKN  264 (371)
T ss_pred             cCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCC
Confidence            643221 122346799999999998754    378999999999999999999999853211      111111111111


Q ss_pred             cccccccccCCCCCHHHHHHHHHHhhccccCCCCC--CCCHHHHHHHh
Q 007239          520 EMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAV--RPTMSNVVALL  565 (611)
Q Consensus       520 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~L  565 (611)
                      ...+.+       .......+.+++..||+.++.+  ||+++++++..
T Consensus       265 ~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         265 SLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             cccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            111111       1112234568888899854443  78999998864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=9.1e-37  Score=305.71  Aligned_cols=252  Identities=28%  Similarity=0.445  Sum_probs=201.0

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      .+|++.+.||+|+||.||++.+.+++.+++|.+..... ..+.+.+|++++++++|||++++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46888899999999999999987788999999875432 34678999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +++|.+++...  ...+++..++.++.|++.+|.|||+.+   ++|+||||+||+++.++.+||+|||++..........
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            99999888432  245789999999999999999999986   9999999999999999999999999998654332111


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                       .....++..|+|||++.++.++.++||||||+++|||++ |..|+....   ...+..    ....+.  ....+..  
T Consensus       158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~~----~~~~~~--~~~~~~~--  225 (256)
T cd05112         158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS---NSEVVE----TINAGF--RLYKPRL--  225 (256)
T ss_pred             -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC---HHHHHH----HHhCCC--CCCCCCC--
Confidence             112235678999999998999999999999999999998 888864221   111111    111111  1111111  


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                           ....+.+|+.+||+.+|++||++.+++++|.
T Consensus       226 -----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         226 -----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             -----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                 1245778999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=8.1e-37  Score=310.46  Aligned_cols=256  Identities=27%  Similarity=0.420  Sum_probs=200.1

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCc----EEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGK----EVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  364 (611)
                      .++|++.+.||+|+||.||+|.+ .+++    +||+|++.... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            35788999999999999999985 3444    48999987543 3345678899999999999999999998875 4578


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +++||+++|+|.+++...  ...+++..++.++.||+.||.|||+++   ++||||||+|||+++++.+||+|||+++..
T Consensus        85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            999999999999988542  345899999999999999999999986   999999999999999999999999999876


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      .............+++.|+|||.+.+..++.++||||||+++|||++ |..|+....   ...+..    .+..+.....
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~----~~~~~~~~~~  232 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP---AREIPD----LLEKGERLPQ  232 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHH----HHHCCCcCCC
Confidence            43332222222345678999999999999999999999999999998 888864322   111221    1222211110


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                               ......++.+++..||+.||++||++.++++.|...
T Consensus       233 ---------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         233 ---------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             ---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                     111223567899999999999999999999998654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.4e-36  Score=341.61  Aligned_cols=259  Identities=21%  Similarity=0.282  Sum_probs=199.9

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++.++||+|+||.||+|++. +++.||+|++....   ....+++.+|+.++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999964 68999999987532   223567899999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhch--------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccc
Q 007239          368 ELMPNRSLDCFIFDSE--------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFG  439 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~--------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  439 (611)
                      ||++|++|.+++....        ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999885321        1234567788999999999999999986   9999999999999999999999999


Q ss_pred             cceecccCCC----------------ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 007239          440 MARIFCENQK----------------TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGH  503 (611)
Q Consensus       440 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~  503 (611)
                      +++.......                ........||+.|+|||++.+..++.++|||||||++|||++|+.||...... 
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR-  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence            9987621110                00112357999999999999999999999999999999999999997532211 


Q ss_pred             hhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCC-CHHHHHHHhcC
Q 007239          504 AQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRP-TMSNVVALLGS  567 (611)
Q Consensus       504 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~  567 (611)
                        .+.   ..    ...   .++... .........+.+++.+||+.||++|| +++++++.|..
T Consensus       238 --ki~---~~----~~i---~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        238 --KIS---YR----DVI---LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             --hhh---hh----hhc---cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              000   00    000   000000 00011223466889999999999996 66777776643

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.3e-36  Score=301.80  Aligned_cols=249  Identities=31%  Similarity=0.450  Sum_probs=198.3

Q ss_pred             cccCccCceEEEEEEcCC--Cc--EEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVLPN--GK--EVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~--~~--~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      +.||+|++|.||++.+.+  ++  .||+|.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999643  33  689999987765 567789999999999999999999999888 889999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc-
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA-  451 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~-  451 (611)
                      ++|.+++.+... ..+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+++.+....... 
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999865332 46899999999999999999999986   9999999999999999999999999998764422211 


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.|+...   ....+.....   .......  .     
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~~~~~~~~~~---~~~~~~~--~-----  222 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL---SGSQILKKID---KEGERLE--R-----  222 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHH---hcCCcCC--C-----
Confidence            1123457789999999999999999999999999999998 99987422   1111222111   1111000  0     


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                        +......+.+++.+||+.+|++||++.+|++.|.
T Consensus       223 --~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         223 --PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             --CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence              1112245778999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3e-36  Score=301.86  Aligned_cols=250  Identities=21%  Similarity=0.280  Sum_probs=201.3

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      +|++.+.||+|+||.||++... +++.+++|.++.. .....+.+.+|+.+++.++|+||+++++.+......+++|||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788999999999999999954 6889999998643 3345677889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++++|.+++... ....+++..++.++.||+.||.|||+++   ++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            999998887432 2345789999999999999999999986   99999999999999999999999999986643222 


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                       ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||....   ..   ...... ..+....+     . 
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~---~~---~~~~~~-~~~~~~~~-----~-  221 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS---WK---NLILKV-CQGSYKPL-----P-  221 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC---HH---HHHHHH-hcCCCCCC-----C-
Confidence             1224578999999999998889999999999999999999999974321   11   111111 11211111     1 


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                         ......+.+++.+||+.||++||++.+++..
T Consensus       222 ---~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         222 ---SHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ---cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence               1122346789999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1e-36  Score=319.36  Aligned_cols=259  Identities=27%  Similarity=0.421  Sum_probs=199.7

Q ss_pred             hCCCCcccccCccCceEEEEEEc------CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeC-C
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL------PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEG-E  361 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~-~  361 (611)
                      .++|++.+.||+|+||.||+|++      .+++.||||+++... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46899999999999999999973      356789999997543 23456788999999999 689999999987654 5


Q ss_pred             eEEEEEEecCCCChhhHhhhchh---------------------------------------------------------
Q 007239          362 EKLLIYELMPNRSLDCFIFDSER---------------------------------------------------------  384 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~---------------------------------------------------------  384 (611)
                      ..+++|||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999998853210                                                         


Q ss_pred             -------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcccccccc
Q 007239          385 -------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVV  457 (611)
Q Consensus       385 -------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  457 (611)
                             ...+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   124688889999999999999999987   9999999999999999999999999998653332222222334


Q ss_pred             ccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHH
Q 007239          458 GTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ  536 (611)
Q Consensus       458 gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  536 (611)
                      +++.|+|||.+.+..++.++||||||+++|+|++ |..|+......  ..    .......+.....  +   ..    .
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~----~~~~~~~~~~~~~--~---~~----~  307 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EE----FCRRLKEGTRMRA--P---DY----T  307 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HH----HHHHHhccCCCCC--C---CC----C
Confidence            6678999999999999999999999999999997 88887432211  11    1111222221111  0   00    1


Q ss_pred             HHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          537 VVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       537 ~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ..++.+++..||+.+|++||++.+|++.|+.
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~  338 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  338 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            1356788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9.5e-37  Score=316.86  Aligned_cols=241  Identities=24%  Similarity=0.287  Sum_probs=191.9

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~  367 (611)
                      +|+..+.||+|+||.||++.. .+++.||+|++.+..   ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            477889999999999999995 468899999987542   233456788999998886 577888999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++.   ....+++.++..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQ---QVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999998883   3356899999999999999999999987   999999999999999999999999998754222


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                      .  .......||+.|+|||++.+..++.++||||||+++|||++|+.||....   ...+...+    ..... .     
T Consensus       155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i----~~~~~-~-----  219 (323)
T cd05615         155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED---EDELFQSI----MEHNV-S-----  219 (323)
T ss_pred             C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHH----HhCCC-C-----
Confidence            1  12234579999999999999999999999999999999999999975322   11222211    11111 0     


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTM  558 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  558 (611)
                      .    +.....++.+++.+||+.+|++|++.
T Consensus       220 ~----p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         220 Y----PKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             C----CccCCHHHHHHHHHHcccCHhhCCCC
Confidence            0    11112356788999999999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=318.01  Aligned_cols=269  Identities=25%  Similarity=0.376  Sum_probs=216.4

Q ss_pred             HHHhhCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhh-HHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          287 IKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       287 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      .+...+...+.++||+|.||+|.++....+.+||+|+++...... ...|..|+++|.+|+||||++++++|..++.+++
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence            344567788999999999999999998788999999999876554 4889999999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      |+|||++|+|..++..++... +.-....+|+.||+.||+||.+-   ++|||||.+.|+|++.++++||+|||+++-+-
T Consensus       613 I~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence            999999999999996653322 45566778999999999999976   69999999999999999999999999999765


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS--GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt--G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      ..+......+.+-...|||||.+.-++++.++|||+||++|||+++  ..+|++...+   +..++..-..+..+.....
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~~~~  765 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGRQVV  765 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCccee
Confidence            5555555556677889999999999999999999999999999875  5667532221   2222222233333222221


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      +      ..+.-...++.+++++||..+.++||+.+++...|...
T Consensus       766 l------~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  766 L------SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             c------cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            1      11222345677999999999999999999999988754

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.5e-36  Score=305.97  Aligned_cols=251  Identities=25%  Similarity=0.376  Sum_probs=200.5

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      +.|++.++||+|+||.||+|... +++.+++|.+........+.+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            67999999999999999999964 58899999998777677788999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++++|..++...  ...+++..+..++.||+.+|.|||+.+   ++||||||+||+++.++.+||+|||++.......  
T Consensus        92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--  164 (292)
T cd06644          92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--  164 (292)
T ss_pred             CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence            999998877432  345899999999999999999999986   9999999999999999999999999987543221  


Q ss_pred             cccccccccCCCCCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          451 ANTRRVVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      .......+++.|+|||++.     ...++.++|||||||++|||++|+.|+.....      .....+. ......... 
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~-~~~~~~~~~-  236 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKI-AKSEPPTLS-  236 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHH-hcCCCccCC-
Confidence            1123456889999999885     34578899999999999999999998743221      1111111 111111100 


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                          .  ......++.+++.+||+.+|++||+++++++
T Consensus       237 ----~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         237 ----Q--PSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ----C--CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                0  1112235678999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.4e-36  Score=305.15  Aligned_cols=248  Identities=25%  Similarity=0.384  Sum_probs=193.0

Q ss_pred             ccCccCceEEEEEEcC---CCcEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCC
Q 007239          299 KLGQGGFGTVYKGVLP---NGKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRS  374 (611)
Q Consensus       299 ~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~s  374 (611)
                      .||+|+||.||+|++.   .+..||+|++..... ...+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999853   355799999876532 33567899999999999999999999875 457899999999999


Q ss_pred             hhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc-c
Q 007239          375 LDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN-T  453 (611)
Q Consensus       375 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-~  453 (611)
                      |.+++..  ....+++..+++++.||+.||.|||+++   ++||||||+||+++.++.+||+|||++........... .
T Consensus        81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9998843  2346899999999999999999999987   99999999999999999999999999986543322111 1


Q ss_pred             ccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCC
Q 007239          454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSS  532 (611)
Q Consensus       454 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  532 (611)
                      ....+++.|+|||.+....++.++||||||+++|||++ |+.|+.....   ....    .....+....         .
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~----~~~~~~~~~~---------~  219 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG---PEVM----SFIEQGKRLD---------C  219 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH---HHHH----HHHHCCCCCC---------C
Confidence            11233578999999988889999999999999999996 9988743221   1111    1222221111         1


Q ss_pred             CHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          533 SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       533 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      +.....++.+++..||+.+|++||++.+|.+.|...
T Consensus       220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            111234567899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.7e-36  Score=302.02  Aligned_cols=250  Identities=26%  Similarity=0.393  Sum_probs=202.5

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      .++|++.+.||+|+||.||++.+. +++.+++|.+.....  .+.+.+|+.++++++||||+++++.+......++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            367999999999999999999975 478999999876533  67899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++..  ....+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            999999998843  2356899999999999999999999986   99999999999999999999999999987643321


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                        ......|+..|+|||++.+..++.++||||||+++|+|++|+.|+........  ..     ......     ...+.
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~--~~-----~~~~~~-----~~~~~  220 (256)
T cd06612         155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA--IF-----MIPNKP-----PPTLS  220 (256)
T ss_pred             --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh--hh-----hhccCC-----CCCCC
Confidence              22235688999999999999999999999999999999999999754322110  00     000000     00110


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .  +......+.+++.+||+.||++|||+++|++
T Consensus       221 ~--~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 D--PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             c--hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            0  1112245778999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.1e-36  Score=313.04  Aligned_cols=258  Identities=27%  Similarity=0.394  Sum_probs=201.4

Q ss_pred             CCCCcccccCccCceEEEEEEcC--------CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCC
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP--------NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGE  361 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~  361 (611)
                      ++|.+.+.||+|+||.||++...        ....+|+|+++.. .......+.+|+.+++++ +||||+++++++....
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            57889999999999999999741        2456899988754 234466788999999999 5999999999999999


Q ss_pred             eEEEEEEecCCCChhhHhhhch-------------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec
Q 007239          362 EKLLIYELMPNRSLDCFIFDSE-------------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD  428 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~  428 (611)
                      ..+++|||+++++|.+++....             ....+++..+..++.||+.||.|||+++   ++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence            9999999999999999985432             1245889999999999999999999987   99999999999999


Q ss_pred             CCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhH
Q 007239          429 KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTL  507 (611)
Q Consensus       429 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l  507 (611)
                      .++.+||+|||+++...............++..|+|||++.++.++.++||||||+++|||++ |..|+....   ...+
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~---~~~~  245 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP---VEEL  245 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC---HHHH
Confidence            999999999999986543222111112234567999999999999999999999999999999 787763221   1222


Q ss_pred             HHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          508 LAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       508 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ...    ...+...+.         ......++.+++.+||+.+|++||++.++++.|...
T Consensus       246 ~~~----~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         246 FKL----LREGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             HHH----HHcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            221    122211111         111223567899999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3e-36  Score=307.57  Aligned_cols=260  Identities=25%  Similarity=0.339  Sum_probs=191.7

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh--hhHHHHHHHHHHHHhc---CCCCeeeEEEeEee-----CC
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW--QGLEEFKNEIILIAKL---QHRNLVRLVGCGIE-----GE  361 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~h~niv~l~~~~~~-----~~  361 (611)
                      +|++.+.||+|+||+||++... +++.||+|.++....  .....+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5888999999999999999964 688999999875321  1223456777777766   69999999998764     34


Q ss_pred             eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccc
Q 007239          362 EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA  441 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  441 (611)
                      ..+++|||+.+ +|..++... ....+++..+..++.||+.||.|||+++   ++||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57999999985 777776432 2245899999999999999999999987   999999999999999999999999999


Q ss_pred             eecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc
Q 007239          442 RIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM  521 (611)
Q Consensus       442 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  521 (611)
                      +.......   .....||+.|+|||++.+..++.++|||||||++|+|++|++||.....   ......+..........
T Consensus       156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~---~~~~~~~~~~~~~~~~~  229 (288)
T cd07863         156 RIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE---ADQLGKIFDLIGLPPED  229 (288)
T ss_pred             ccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH---HHHHHHHHHHhCCCChh
Confidence            86543221   2235689999999999999999999999999999999999998743322   11222222211111000


Q ss_pred             cc------cccccCC-------CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          522 EF------VDPLLMK-------SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       522 ~~------~d~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ++      .......       .........+.+++.+||+.||++|||+.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00      0000000       000112235679999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.4e-36  Score=308.95  Aligned_cols=251  Identities=25%  Similarity=0.380  Sum_probs=202.8

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ..++|++.+.||+|+||.||+++. .+++.||+|.+........+.+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            347899999999999999999995 5789999999976655556778999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++++|.+++..    ..+++..+..++.|++.+|.|||+.+   ++||||||+|||++.++.++|+|||++.......
T Consensus        97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          97 YLAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            9999999998732    35788999999999999999999986   9999999999999999999999999998654332


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                      ..  .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||........  +.    .....+ .     +.+
T Consensus       170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~~----~~~~~~-~-----~~~  235 (297)
T cd06656         170 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LY----LIATNG-T-----PEL  235 (297)
T ss_pred             cC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--ee----eeccCC-C-----CCC
Confidence            21  2235688999999999999999999999999999999999999743222110  00    000000 0     000


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..  .......+.+++.+||+.+|++||+++++++
T Consensus       236 ~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         236 QN--PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CC--ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00  1112234568899999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.2e-36  Score=307.98  Aligned_cols=262  Identities=25%  Similarity=0.331  Sum_probs=196.0

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +|++.+.||+|++|.||+|+.. +++.|++|+++...  ....+.+.+|+.+++.++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788999999999999999964 68899999986442  22346788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      ++ ++|.+++........+++..++.++.||+.||.|||+++   ++|+||||+||+++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            98 578777754344456899999999999999999999986   99999999999999999999999999976533221


Q ss_pred             ccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC--------cc
Q 007239          450 TANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG--------KE  520 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--------~~  520 (611)
                        ......+++.|+|||++.+. .++.++||||||+++|+|++|+.|+......  ..+.... +.+...        ..
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~  231 (285)
T cd07861         157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI--DQLFRIF-RILGTPTEDVWPGVTS  231 (285)
T ss_pred             --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHH-HHhCCCChhhhhcchh
Confidence              11223678899999988754 5789999999999999999999987532211  1111100 000000        00


Q ss_pred             cc----ccccccCC---CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          521 ME----FVDPLLMK---SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       521 ~~----~~d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..    ........   ........++.+++.+||+.||++|||+.+|++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00    00000000   000012235678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-37  Score=310.82  Aligned_cols=247  Identities=25%  Similarity=0.343  Sum_probs=207.2

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhh--HHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQG--LEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ..-|.+.+.||+|-|++|-++++ =+|++||||++.+.....  ...+.+|+.-|+.++|||||++|++......+|||.
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            45688889999999999999984 389999999998765443  457899999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec-CCCCEEEeccccceeccc
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD-KDMVAKISDFGMARIFCE  446 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~-~~~~~kl~DFGla~~~~~  446 (611)
                      |+=++|+|.++|...+.  .+.++.+.+++.||+.|+.|+|+-.   +|||||||+||.+. +-|-+||+|||++..|.+
T Consensus        97 ELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            99999999999976554  4899999999999999999999875   99999999999875 568999999999988765


Q ss_pred             CCCccccccccccCCCCCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFS-VKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      +..   ..+.+|+..|.|||++.+..|+ +++||||||||||-|++|++||....+.+.  +.                 
T Consensus       172 G~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET--LT-----------------  229 (864)
T KOG4717|consen  172 GKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET--LT-----------------  229 (864)
T ss_pred             cch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh--hh-----------------
Confidence            543   3457999999999999999886 579999999999999999999854333222  11                 


Q ss_pred             cccCCCC--CHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          526 PLLMKSS--SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       526 ~~l~~~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ..+.-.+  +.....+|.+||..||+.||++|.+.+||+.-
T Consensus       230 mImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  230 MIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             hhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            1111222  23345689999999999999999999999863

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.1e-36  Score=306.16  Aligned_cols=262  Identities=26%  Similarity=0.399  Sum_probs=201.1

Q ss_pred             CCCCcccccCccCceEEEEEEc-----CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC--CeE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-----PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG--EEK  363 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~  363 (611)
                      +-|++.+.||+|+||.||++..     .+++.|++|.++... ......+.+|+.+++.++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3578899999999999999973     357889999987553 34456799999999999999999999988775  568


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ++||||+++++|.+++...  ...+++..+..++.||+.+|.|||+++   ++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            9999999999999988432  235899999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCCCc-cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------CchhhHHHHHHHH
Q 007239          444 FCENQKT-ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLT--------GHAQTLLAYVWQL  514 (611)
Q Consensus       444 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~--------~~~~~l~~~~~~~  514 (611)
                      +...... .......++..|+|||++.+..++.++||||||+++|||++++.|......        ...+.........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6433221 112234567789999999988999999999999999999998765321110        0001111111111


Q ss_pred             HhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       515 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ...+....         .......++.+|+.+||+.+|++||++.++++.|+.
T Consensus       239 ~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         239 LEEGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHcCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            12211111         011123467899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.7e-36  Score=303.03  Aligned_cols=254  Identities=25%  Similarity=0.341  Sum_probs=188.1

Q ss_pred             cccCccCceEEEEEEcC---CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCC
Q 007239          298 NKLGQGGFGTVYKGVLP---NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNR  373 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~  373 (611)
                      +.||+|+||.||+|...   ....+++|.+.... ......+.+|+.+++.++|+||+++++.+......++||||++++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            36999999999999743   34568888876443 233567889999999999999999999999999999999999999


Q ss_pred             ChhhHhhhchh--hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          374 SLDCFIFDSER--RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       374 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +|.+++.....  ....++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999865322  233567888999999999999999986   9999999999999999999999999987543222111


Q ss_pred             ccccccccCCCCCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          452 NTRRVVGTYGYMAPEYAME-------GLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      ......+++.|+|||++..       ..++.++||||||+++|||++ |..|+.....   ...   ........ ...+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~---~~~~~~~~-~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD---EQV---LKQVVREQ-DIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH---HHH---HHHHhhcc-CccC
Confidence            1223456778999998743       356889999999999999999 6777643211   111   11112221 1222


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                      ..+.+...    ....+.+++..|+ .||++|||+++|+++|+
T Consensus       231 ~~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            22222211    1233456677787 59999999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-36  Score=306.19  Aligned_cols=254  Identities=28%  Similarity=0.438  Sum_probs=203.0

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      .++|++.++||+|+||.||++.+.++..+++|.+.... ...+.+.+|+.+++.++|+||+++++.+.. ...+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            46899999999999999999997777889999887543 345678999999999999999999999877 7789999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++++|.+++... ....+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+......
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  158 (260)
T cd05073          83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence            999999998542 2345788999999999999999999986   999999999999999999999999999866432221


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                       ......++..|+|||++..+.++.++|+||||+++|+|++ |+.|+....   ...+..    ....+.....      
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~---~~~~~~----~~~~~~~~~~------  224 (260)
T cd05073         159 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIR----ALERGYRMPR------  224 (260)
T ss_pred             -cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC---HHHHHH----HHhCCCCCCC------
Confidence             1222345678999999998899999999999999999998 888874321   111111    1122211110      


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                         .......+.+++.+||+.+|++||++.+++++|+.
T Consensus       225 ---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         225 ---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ---cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               11122457789999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.4e-36  Score=312.35  Aligned_cols=262  Identities=22%  Similarity=0.295  Sum_probs=197.0

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.+.||+|+||.||++... +++.||+|.+.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            367999999999999999999964 68899999987543 2234567889999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++ +|..++...  ...+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++.......
T Consensus        85 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          85 YLDK-DLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             cccc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            9974 787777432  345889999999999999999999986   9999999999999999999999999997643222


Q ss_pred             CccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC---cccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG---KEMEFV  524 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~~  524 (611)
                      .  ......+++.|+|||++.+. .++.++||||||+++|||++|++||......   .....+.......   .+..+.
T Consensus       159 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         159 K--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE---EQLHFIFRILGTPTEETWPGIL  233 (301)
T ss_pred             C--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCChhhchhhh
Confidence            1  11234578999999988654 5788999999999999999999998543221   1121111111100   000000


Q ss_pred             ------c---cccCCC----CCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          525 ------D---PLLMKS----SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       525 ------d---~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                            .   +.....    ........+.+|+.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                  0   000000    00011235678999999999999999999987

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.8e-36  Score=307.37  Aligned_cols=256  Identities=27%  Similarity=0.363  Sum_probs=203.6

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      ++|++.+.||+|+||+||++.. ++++.||+|++.... ....+.+.+|+++++.++||||+++++.+......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            5788999999999999999995 468889999876543 33457889999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++.   ..+.+++..+..++.+++.+|.|||+..  +++||||||+||+++.++.++|+|||++....... 
T Consensus        85 ~~~~~L~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          85 MDCGSLDRIYK---KGGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             CCCCCHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            99999998873   3356899999999999999999999742  49999999999999999999999999987542221 


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC-----chhhHHHHHHHHHhcCcccccc
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG-----HAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~-----~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                         .....|+..|+|||++.++.++.++||||||+++|+|++|+.||......     ....+........... .    
T Consensus       159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~----  230 (284)
T cd06620         159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-P----  230 (284)
T ss_pred             ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-C----
Confidence               22457899999999998889999999999999999999999998644332     1111222222211111 0    


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHh
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL  565 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  565 (611)
                       +.+.   .......+.+++.+||+.||++|||+.|++++.
T Consensus       231 -~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         231 -PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             -CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence             0010   011234577899999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.7e-36  Score=306.83  Aligned_cols=250  Identities=28%  Similarity=0.358  Sum_probs=197.1

Q ss_pred             CCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      |+..+.||+|+||.||++.+ .+++.||+|.+.....   .....+.+|+.++++++|++++++++.+...+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            67788999999999999995 4688999999865422   2235578899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++........
T Consensus        82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            9999999888442 2345899999999999999999999986   99999999999999999999999999976532221


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                         .....|++.|+|||++.+..++.++||||||+++|+|++|+.||.............   .......      ....
T Consensus       158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~---~~~~~~~------~~~~  225 (285)
T cd05630         158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE---RLVKEVQ------EEYS  225 (285)
T ss_pred             ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH---hhhhhhh------hhcC
Confidence               123478999999999999999999999999999999999999985432211111111   1111000      0011


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPT-----MSNVVA  563 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  563 (611)
                      .    .....+.+|+..||+.||++|||     ++|+++
T Consensus       226 ~----~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         226 E----KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             c----cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            1    11234668889999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.4e-36  Score=303.33  Aligned_cols=251  Identities=26%  Similarity=0.408  Sum_probs=199.1

Q ss_pred             CCCcccccCccCceEEEEEEcCCCcEEEEEEecccC------hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKS------WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      +|+..+.||+|+||.||+|...+++.+|+|.+....      ......+.+|+.+++.++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            478899999999999999998889999999886432      12345688999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++..   ...+++..+..++.||+.+|.|||+.+   ++|+||||+||++++++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            999999999999843   345889999999999999999999986   99999999999999999999999999876532


Q ss_pred             CCC----ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          447 NQK----TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       447 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      ...    ........|+..|+|||++.+..++.++||||||+++|+|++|+.||......  ..... .  .......  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~-~--~~~~~~~--  227 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL--AAMFY-I--GAHRGLM--  227 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH--HHHHH-h--hhccCCC--
Confidence            111    11122356899999999999988999999999999999999999997532111  11100 0  0000111  


Q ss_pred             ccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       523 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                         +.+..    .....+.+++.+||+.+|++||++.++++
T Consensus       228 ---~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         228 ---PRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ---CCCCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               11111    12345678999999999999999999885

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.2e-36  Score=307.15  Aligned_cols=255  Identities=27%  Similarity=0.449  Sum_probs=200.7

Q ss_pred             CCCCcccccCccCceEEEEEEcC-C---CcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-N---GKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .+|++.+.||+|+||.||+|.+. +   +..+++|.++... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            57889999999999999999853 2   3369999887543 33456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++...  ...+++.+++.++.||+.||.|||+.+   ++||||||+|||++.++.++|+|||++..+..
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999998532  245899999999999999999999986   99999999999999999999999999987643


Q ss_pred             CCCccc-cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          447 NQKTAN-TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       447 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ...... .....++..|+|||++.++.++.++||||||+++|||++ |+.|+.....   ......    ...+...   
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~~~----~~~~~~~---  228 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVIKA----IEEGYRL---  228 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHHHH----HhCCCcC---
Confidence            322111 111233567999999999899999999999999999886 9988743221   111111    1111110   


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                            .........+.+++.+||+.+|++||++.++++.|..
T Consensus       229 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         229 ------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             ------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence                  0011122456789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-36  Score=301.08  Aligned_cols=254  Identities=25%  Similarity=0.368  Sum_probs=204.3

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      .++|++.+.||+|+||.||++.. .+++.+++|.+........+.+.+|+.++++++||||+++++.+......+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            36799999999999999999996 46788999999876656678899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++...  ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++..+.....
T Consensus        82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  156 (262)
T cd06613          82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA  156 (262)
T ss_pred             CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence            9999999987432  256899999999999999999999986   99999999999999999999999999976543221


Q ss_pred             ccccccccccCCCCCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          450 TANTRRVVGTYGYMAPEYAMEG---LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                        ......++..|+|||.+...   .++.++||||||+++|+|++|+.|+.....  ......    .....    +...
T Consensus       157 --~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~--~~~~~~----~~~~~----~~~~  224 (262)
T cd06613         157 --KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP--MRALFL----ISKSN----FPPP  224 (262)
T ss_pred             --ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHH----HHhcc----CCCc
Confidence              12235788899999998776   889999999999999999999999743221  111111    11110    0001


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .+.  .......++.+++.+||+.+|++|||+++|+.
T Consensus       225 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         225 KLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            111  11223456789999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.3e-36  Score=314.30  Aligned_cols=258  Identities=27%  Similarity=0.390  Sum_probs=201.5

Q ss_pred             CCCCcccccCccCceEEEEEEcC--------CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCC
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP--------NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGE  361 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~  361 (611)
                      .+|++.+.||+|+||.||++...        .+..||+|.+... .....+.+.+|+++++++ +||||+++++++...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            46899999999999999999742        1236899988754 234467889999999999 7999999999999999


Q ss_pred             eEEEEEEecCCCChhhHhhhch-------------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec
Q 007239          362 EKLLIYELMPNRSLDCFIFDSE-------------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD  428 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~  428 (611)
                      ..+++|||+++++|.+++....             ....+++..+..++.||+.||.|||+++   ++||||||+|||++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence            9999999999999999985421             2235788999999999999999999987   99999999999999


Q ss_pred             CCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhH
Q 007239          429 KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTL  507 (611)
Q Consensus       429 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l  507 (611)
                      .++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..|+....   ...+
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~  245 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---VEEL  245 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC---HHHH
Confidence            999999999999986543322222222344567999999999999999999999999999998 777764221   1111


Q ss_pred             HHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          508 LAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       508 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      .    .....+.....         ......++.+++.+||+.+|++||++.|+++.|...
T Consensus       246 ~----~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~  293 (334)
T cd05100         246 F----KLLKEGHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV  293 (334)
T ss_pred             H----HHHHcCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            1    11222111111         111223577899999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.3e-36  Score=313.03  Aligned_cols=255  Identities=28%  Similarity=0.459  Sum_probs=198.2

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCc----EEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGK----EVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  364 (611)
                      .++|+..+.||+|+||.||++.+. +++    .+|+|.+..... .....+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            357888999999999999999853 444    578898865432 3345788999999999999999999988654 567


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +++||+++|+|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++.+
T Consensus        85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            999999999999988532  235889999999999999999999986   999999999999999999999999999876


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      .............++..|+|||++.+..++.++||||||+++|||++ |+.|+....   .....    .....+.... 
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~~~~~----~~~~~~~~~~-  231 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---TREIP----DLLEKGERLP-  231 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHH----HHHHCCCCCC-
Confidence            43332222223456778999999999999999999999999999997 888874321   11111    1122221110 


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                       .       .......+.+++..||..+|++||+++++++.|..
T Consensus       232 -~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~  267 (303)
T cd05110         232 -Q-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR  267 (303)
T ss_pred             -C-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence             0       01112356788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.4e-36  Score=305.27  Aligned_cols=263  Identities=27%  Similarity=0.413  Sum_probs=203.8

Q ss_pred             CCCCcccccCccCceEEEEEEcC-----CCcEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEeEee--CCeE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-----NGKEVAVKRLSRKSWQ-GLEEFKNEIILIAKLQHRNLVRLVGCGIE--GEEK  363 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~  363 (611)
                      +.|++.+.||+|+||.||++.+.     +++.+|+|.+...... ..+.+.+|+++++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46788899999999999999853     3678999999766543 46789999999999999999999999877  5678


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      +++|||+++++|.+++....  ..+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            99999999999999985432  35899999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCCCcc-ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchh--------hHHHHHHHH
Q 007239          444 FCENQKTA-NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQ--------TLLAYVWQL  514 (611)
Q Consensus       444 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~--------~l~~~~~~~  514 (611)
                      ........ ......++..|++||.+.+..++.++||||||+++|||++|+.|+.........        .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            65322211 111234456799999999889999999999999999999999886432211100        011111111


Q ss_pred             HhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       515 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      .......         ........++.+++.+||+.+|++|||+.||+++|...
T Consensus       239 ~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKEGERL---------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHcCCcC---------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111110         00111224677999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-36  Score=306.07  Aligned_cols=248  Identities=25%  Similarity=0.378  Sum_probs=201.9

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      ++|++.+.||.|++|.||++++. +++.|++|.+.... ......+.+|+.+++.++|+||+++++.+.+....++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888999999999999999964 68899999987553 34456788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++..    ..+++..++.++.||+.+|.|||+++   ++|+||+|+||++++++.++|+|||+++.......
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            999999998843    26899999999999999999999986   99999999999999999999999999987654321


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                        ......|++.|+|||++.+..++.++||||||+++|+|++|+.|+.....   .....    ........     .+.
T Consensus       154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~~~~----~~~~~~~~-----~~~  219 (274)
T cd06609         154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---MRVLF----LIPKNNPP-----SLE  219 (274)
T ss_pred             --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---HHHHH----HhhhcCCC-----CCc
Confidence              22345788999999999998899999999999999999999999753321   11111    11111111     111


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..   .....+.+++..||+.+|++|||++++++
T Consensus       220 ~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         220 GN---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             cc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            11   02235678999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2e-36  Score=318.65  Aligned_cols=262  Identities=24%  Similarity=0.277  Sum_probs=196.0

Q ss_pred             HhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC-----
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG-----  360 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----  360 (611)
                      ...++|++.+.||+|+||.||++.. ..++.||+|++...  .......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            3567999999999999999999995 46889999998754  223456788999999999999999999988643     


Q ss_pred             -CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccc
Q 007239          361 -EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFG  439 (611)
Q Consensus       361 -~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  439 (611)
                       ...++||||+++ +|...+.     ..+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence             357999999976 4555442     24788999999999999999999987   9999999999999999999999999


Q ss_pred             cceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHH-------
Q 007239          440 MARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW-------  512 (611)
Q Consensus       440 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~-------  512 (611)
                      +++......   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......  .....+.       
T Consensus       165 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~  239 (355)
T cd07874         165 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCP  239 (355)
T ss_pred             ccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCH
Confidence            998643221   2234578999999999999999999999999999999999999985332111  0100000       


Q ss_pred             -----------HHHhcC-cccccc------ccccC--CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          513 -----------QLWKEG-KEMEFV------DPLLM--KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       513 -----------~~~~~~-~~~~~~------d~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                                 ...... ......      +....  ..........+.+|+.+||+.||++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                       000000 000000      00000  00011123456799999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=8.5e-37  Score=314.36  Aligned_cols=255  Identities=26%  Similarity=0.398  Sum_probs=197.7

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCc--EEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGK--EVAVKRLSRK-SWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~l  365 (611)
                      .++|++.+.||+|+||.||+|.+. ++.  .+++|.+... .......+.+|+.++.++ +||||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357899999999999999999964 454  4577776543 233456788999999999 89999999999999999999


Q ss_pred             EEEecCCCChhhHhhhch-------------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCC
Q 007239          366 IYELMPNRSLDCFIFDSE-------------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV  432 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~  432 (611)
                      ||||+++++|.+++....             ....+++..++.++.||+.||.|||+.+   ++||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            999999999999985432             1235889999999999999999999986   999999999999999999


Q ss_pred             EEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHH
Q 007239          433 AKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYV  511 (611)
Q Consensus       433 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~  511 (611)
                      +||+|||++......   .......++..|+|||++.+..++.++||||||+++|||++ |..||.....   ...... 
T Consensus       163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~~-  235 (303)
T cd05088         163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEK-  235 (303)
T ss_pred             EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh---HHHHHH-
Confidence            999999998642111   11111234667999999988889999999999999999998 8988742221   111111 


Q ss_pred             HHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          512 WQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       512 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                         ...+...+         ........+.+|+.+||+.+|++||+++++++.|..
T Consensus       236 ---~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~  279 (303)
T cd05088         236 ---LPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  279 (303)
T ss_pred             ---HhcCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence               11111000         011112356789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.5e-36  Score=307.07  Aligned_cols=253  Identities=26%  Similarity=0.380  Sum_probs=197.3

Q ss_pred             HhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeC------
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEG------  360 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~------  360 (611)
                      .+.+.|++.+.||+|+||.||+|.+ .+++.||+|++.... .....+.+|+.+++++ +|+||+++++.+...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            3567789999999999999999995 468889999987543 3446788999999998 699999999998753      


Q ss_pred             CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccc
Q 007239          361 EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGM  440 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  440 (611)
                      ...+++|||+++++|.+++... ....+++..+..++.||+.||.|||+++   |+|+||||+||++++++.+||+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            4689999999999999988542 2346889999999999999999999986   99999999999999999999999999


Q ss_pred             ceecccCCCccccccccccCCCCCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHH
Q 007239          441 ARIFCENQKTANTRRVVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLW  515 (611)
Q Consensus       441 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~  515 (611)
                      +........  ......|++.|+|||++.     ...++.++|||||||++|||++|+.|+......   .  . .....
T Consensus       158 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~---~--~-~~~~~  229 (272)
T cd06637         158 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---R--A-LFLIP  229 (272)
T ss_pred             ceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH---H--H-HHHHh
Confidence            986533221  223467899999999986     345888999999999999999999997432211   1  0 11111


Q ss_pred             hcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          516 KEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       516 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .. ..     +....   ......+.+|+.+||+.+|.+|||+.++++
T Consensus       230 ~~-~~-----~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         230 RN-PA-----PRLKS---KKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             cC-CC-----CCCCC---CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            11 11     11111   111235678999999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=8.1e-36  Score=303.58  Aligned_cols=250  Identities=25%  Similarity=0.359  Sum_probs=198.4

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      .|++.+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++.+......++||||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            3678889999999999999965 577889999877666667789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +++|..++..  ....+++..+..++.||++||.|||+.+   ++||||||+||+++.++.+||+|||++........  
T Consensus        86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--  158 (282)
T cd06643          86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--  158 (282)
T ss_pred             CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc--
Confidence            9999887743  2346899999999999999999999987   99999999999999999999999999976532221  


Q ss_pred             ccccccccCCCCCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          452 NTRRVVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ......|++.|+|||++.     +..++.++|||||||++|||++|++|+.....  .. .   ...... ........+
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~-~---~~~~~~-~~~~~~~~~  231 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--MR-V---LLKIAK-SEPPTLAQP  231 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--HH-H---HHHHhh-cCCCCCCCc
Confidence            122356899999999884     45578899999999999999999998743221  11 1   111111 111111000


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                             .....++.+++.+||+.||++||++.++++
T Consensus       232 -------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         232 -------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             -------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   111245678999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3e-36  Score=318.43  Aligned_cols=260  Identities=23%  Similarity=0.273  Sum_probs=195.5

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC------
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG------  360 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------  360 (611)
                      ..++|++.+.||+|+||.||+++. ..++.||+|++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            457899999999999999999995 46888999998753  233456788999999999999999999987543      


Q ss_pred             CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccc
Q 007239          361 EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGM  440 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  440 (611)
                      ...++||||+++ +|...+.     ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            357999999976 5655552     24788899999999999999999986   99999999999999999999999999


Q ss_pred             ceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHh----
Q 007239          441 ARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWK----  516 (611)
Q Consensus       441 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~----  516 (611)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......   .....+.....    
T Consensus       173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~~  246 (364)
T cd07875         173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLGTPCP  246 (364)
T ss_pred             ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCCCH
Confidence            98653221   223457899999999999999999999999999999999999998543221   11111111000    


Q ss_pred             ---------------cC-ccc-----cccccccC---CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          517 ---------------EG-KEM-----EFVDPLLM---KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       517 ---------------~~-~~~-----~~~d~~l~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                                     .. ...     +.....+.   .........++.+++.+||+.||++|||+.++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                           00 000     00000000   00011112356799999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.1e-36  Score=302.61  Aligned_cols=255  Identities=27%  Similarity=0.400  Sum_probs=198.6

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++.+.....||+|+||.||+|.+ .+++.|++|.+........+.+.+|+.+++.++|+||+++++++...+..++|+|
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence            455666667999999999999995 4678899999887766667789999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC-CCCEEEeccccceecccC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK-DMVAKISDFGMARIFCEN  447 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGla~~~~~~  447 (611)
                      |+++++|.+++.........++..+..++.||+.||.|||+++   |+||||||+||+++. ++.+||+|||++......
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  162 (268)
T cd06624          86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI  162 (268)
T ss_pred             cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccC
Confidence            9999999999854322222378888999999999999999986   999999999999976 679999999999765432


Q ss_pred             CCccccccccccCCCCCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGL--FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ..  ......|++.|+|||++....  ++.++||||||+++|+|++|+.|+........   .  .+.......     .
T Consensus       163 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~--~~~~~~~~~-----~  230 (268)
T cd06624         163 NP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---A--MFKVGMFKI-----H  230 (268)
T ss_pred             CC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---h--Hhhhhhhcc-----C
Confidence            22  122346889999999987644  78899999999999999999999743221110   0  111000000     0


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      +.+    +.....++.+++.+||+.+|++|||+.++++
T Consensus       231 ~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         231 PEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             CCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            011    1112245678899999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.9e-36  Score=305.89  Aligned_cols=250  Identities=27%  Similarity=0.339  Sum_probs=196.2

Q ss_pred             CCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      |+..+.||+|+||+||++.+ .+++.+|+|.+.....   .....+.+|+.+++.++|+|++++++.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            67788999999999999995 4688999999865432   2234578899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++........
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            9999998887542 2346899999999999999999999987   99999999999999999999999999976532211


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                         .....|+..|+|||++.+..++.++|+||||+++|+|++|+.||......   .....+........  .    ...
T Consensus       158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~---~~~~~~~~~~~~~~--~----~~~  225 (285)
T cd05632         158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEK---VKREEVDRRVLETE--E----VYS  225 (285)
T ss_pred             ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhhhccc--c----ccC
Confidence               12347899999999999999999999999999999999999997532211   11111111111111  0    011


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPT-----MSNVVA  563 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  563 (611)
                      .    .....+.+|+..||+.||++||+     +.+++.
T Consensus       226 ~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         226 A----KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             c----cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            1    11234568888999999999999     666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.4e-36  Score=304.58  Aligned_cols=249  Identities=28%  Similarity=0.458  Sum_probs=198.3

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh---------hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---------QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  362 (611)
                      +|.+.+.||+|++|.||+|.. .+++.+++|.+.....         +..+.+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            477889999999999999996 4678999998865322         123568899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .++||||+++++|.+++.   ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~---~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLN---NYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHH---hccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999983   3356889999999999999999999986   9999999999999999999999999998


Q ss_pred             ecccCCCc----cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC
Q 007239          443 IFCENQKT----ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG  518 (611)
Q Consensus       443 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  518 (611)
                      ........    .......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.....      ....... ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~-~~~  227 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ------LQAIFKI-GEN  227 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH------HHHHHHH-hcc
Confidence            76432111    111234688999999999998999999999999999999999999753211      1111111 111


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       519 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                           ..+.+.    ......+.+++.+||+.+|++||++.+|++
T Consensus       228 -----~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 -----ASPEIP----SNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -----CCCcCC----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                 111111    122345678899999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-36  Score=302.51  Aligned_cols=248  Identities=33%  Similarity=0.480  Sum_probs=194.7

Q ss_pred             cccCccCceEEEEEEcC--C--CcEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVLP--N--GKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      ++||+|+||.||+|++.  +  +..+++|.+..... ...+.+.+|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999842  2  36899999876543 34567899999999999999999999875 4568999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      ++|.+++..   ...+++..+..++.|++.+|.|||+.+   ++|+||||+|||++.++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKK---RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            999999853   236899999999999999999999986   99999999999999999999999999987643332111


Q ss_pred             -cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          453 -TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       453 -~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                       .....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+....   ...+...+    .......        
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~---~~~~~~~~----~~~~~~~--------  218 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK---GAEVIAML----ESGERLP--------  218 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC---HHHHHHHH----HcCCcCC--------
Confidence             111223567999999999999999999999999999998 898875332   12222222    1211111        


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                       ........+.+++.+||+.+|++||++.+|++.|...
T Consensus       219 -~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 -RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence             0111124567899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.3e-36  Score=329.65  Aligned_cols=263  Identities=19%  Similarity=0.223  Sum_probs=190.4

Q ss_pred             HHhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCC------CeeeEEEeEeeC
Q 007239          288 KAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHR------NLVRLVGCGIEG  360 (611)
Q Consensus       288 ~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~------niv~l~~~~~~~  360 (611)
                      ....++|++.++||+|+||+||++++ ..++.||||+++... .....+..|+.+++.++|.      +++++++++...
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~  203 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE  203 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence            34568899999999999999999996 467889999986432 2234556788888777654      588898888754


Q ss_pred             -CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhc-CCCceEecCCCCCcEEecCCC-------
Q 007239          361 -EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED-SRLKIIHRDLKPSNVLLDKDM-------  431 (611)
Q Consensus       361 -~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDikp~NIll~~~~-------  431 (611)
                       ...++|||++ +++|.+++.   +...+++..+..++.||+.||.|||++ +   ||||||||+|||++.++       
T Consensus       204 ~~~~~iv~~~~-g~~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        204 TGHMCIVMPKY-GPCLLDWIM---KHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             CceEEEEEecc-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence             5788999987 667777773   335689999999999999999999974 5   99999999999998765       


Q ss_pred             ---------CEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 007239          432 ---------VAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG  502 (611)
Q Consensus       432 ---------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~  502 (611)
                               .+||+|||++.....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             ccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                     499999998864211     123468999999999999999999999999999999999999998643322


Q ss_pred             chhhHHHHHH----HHHhcC----ccccccc------cccC--------CCCCH---HHHHHHHHHhhccccCCCCCCCC
Q 007239          503 HAQTLLAYVW----QLWKEG----KEMEFVD------PLLM--------KSSSI---PQVVRCIHIGLLCVQEDPAVRPT  557 (611)
Q Consensus       503 ~~~~l~~~~~----~~~~~~----~~~~~~d------~~l~--------~~~~~---~~~~~l~~li~~cl~~dP~~RPt  557 (611)
                      +...+.....    ..|...    ...++.+      +...        .....   .....+++|+.+||+.||++|||
T Consensus       352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            1111111100    000000    0000000      0000        00000   01234679999999999999999


Q ss_pred             HHHHHH
Q 007239          558 MSNVVA  563 (611)
Q Consensus       558 ~~evl~  563 (611)
                      ++|+++
T Consensus       432 a~e~L~  437 (467)
T PTZ00284        432 ARQMTT  437 (467)
T ss_pred             HHHHhc
Confidence            999996

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.7e-36  Score=305.00  Aligned_cols=239  Identities=21%  Similarity=0.322  Sum_probs=186.3

Q ss_pred             ccCccCceEEEEEEcCC-------------------------CcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeE
Q 007239          299 KLGQGGFGTVYKGVLPN-------------------------GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL  353 (611)
Q Consensus       299 ~lg~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l  353 (611)
                      .||+|+||.||+|.+..                         ...|++|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997411                         13588998876555555678899999999999999999


Q ss_pred             EEeEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC--
Q 007239          354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM--  431 (611)
Q Consensus       354 ~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~--  431 (611)
                      ++++......++||||+++++|..++..  ....+++..+..++.||++||.|||+++   |+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999988843  2346889999999999999999999986   99999999999997644  


Q ss_pred             -----CEEEeccccceecccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCCCch
Q 007239          432 -----VAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEII-SGKRNSGFYLTGHA  504 (611)
Q Consensus       432 -----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~ell-tG~~p~~~~~~~~~  504 (611)
                           .+|++|||++......      ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+....... 
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-  229 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-  229 (274)
T ss_pred             cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH-
Confidence                 3899999988643221      12357888999998875 56899999999999999995 6888874332211 


Q ss_pred             hhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          505 QTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       505 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                        ....    .....       .+..    +....+.+++.+||+.+|++||++.+|++.|+
T Consensus       230 --~~~~----~~~~~-------~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 --KERF----YEKKH-------RLPE----PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             --HHHH----HHhcc-------CCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence              1111    11100       0001    11135778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.3e-36  Score=306.63  Aligned_cols=261  Identities=22%  Similarity=0.298  Sum_probs=198.5

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ++|++.+.||+|+||.||++++. +++.||+|++....  ....+.+.+|+.+++.++|||++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            47889999999999999999965 68899999886442  2233567899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |++++.|..++.   ....+++..++.++.||+.+|.|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            999998887763   3345899999999999999999999986   9999999999999999999999999998764432


Q ss_pred             CccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhc----------
Q 007239          449 KTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKE----------  517 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----------  517 (611)
                      .  ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......+.   ..........          
T Consensus       155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07847         155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ---LYLIRKTLGDLIPRHQQIFS  229 (286)
T ss_pred             c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChHHhhhcc
Confidence            2  1223467889999999876 5578999999999999999999999854332111   1111111100          


Q ss_pred             -Ccc-ccccccccCCCCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          518 -GKE-MEFVDPLLMKSSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       518 -~~~-~~~~d~~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       ... .....+........     .....+.+++.+||+.+|++||++.|++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence             000 00000000000000     11245679999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.4e-36  Score=308.02  Aligned_cols=250  Identities=25%  Similarity=0.384  Sum_probs=202.2

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      ..+|++.+.||.|++|.||+++. .+++.|++|.+........+.+.+|+.+++.++|||++++++.+...+..++|+||
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            35699999999999999999995 57899999998766555667889999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|..++..    ..+++.++..++.|++.+|.|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~  170 (296)
T cd06655          98 LAGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS  170 (296)
T ss_pred             cCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence            999999988732    35899999999999999999999987   99999999999999999999999999876543322


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                      .  .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||........  + .   ...... ...     +.
T Consensus       171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~--~-~---~~~~~~-~~~-----~~  236 (296)
T cd06655         171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--L-Y---LIATNG-TPE-----LQ  236 (296)
T ss_pred             c--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--H-H---HHHhcC-Ccc-----cC
Confidence            1  2234688999999999998899999999999999999999999743322111  1 1   111111 100     10


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..  ......+.+++.+||+.+|++||++.+++.
T Consensus       237 ~~--~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         237 NP--EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             Cc--ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            11  111234668889999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.9e-36  Score=311.05  Aligned_cols=255  Identities=18%  Similarity=0.217  Sum_probs=195.4

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++.+.||+|+||.||+++.. +++.||+|++.+..   ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999964 67889999986532   223455788999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++|+|.+++...  ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999998532  346889999999999999999999986   999999999999999999999999999866433


Q ss_pred             CCccccccccccCCCCCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAME-----GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      ... ......||+.|+|||++.+     +.++.++||||||+++|||++|+.||.....      ...............
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~  228 (331)
T cd05624         156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEERFQ  228 (331)
T ss_pred             Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCccc
Confidence            221 1223579999999999875     5678899999999999999999999743221      111111111111111


Q ss_pred             ccccccCCCCCHHHHHHHHHHhhccccCCCCC--CCCHHHHHHH
Q 007239          523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAV--RPTMSNVVAL  564 (611)
Q Consensus       523 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~  564 (611)
                      + ....     .....++.+++.+||+.++++  |++++++++.
T Consensus       229 ~-p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         229 F-PSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             C-CCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            1 0100     111245667888888866544  4688888754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.4e-36  Score=302.84  Aligned_cols=248  Identities=28%  Similarity=0.392  Sum_probs=196.9

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEe-eCCeEEEEEEec
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI-EGEEKLLIYELM  370 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~-~~~~~~lv~E~~  370 (611)
                      ++|++.+.||+|+||.||++... ++.+++|.++...  ..+.+.+|+.++++++|+|++++++++. .....+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            47889999999999999999874 7789999986543  3467899999999999999999999754 456789999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++++|.+++... ....+++..++.++.||+.+|.|||+++   ++||||||+||+++.++.+||+|||+++......  
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999999988542 2235889999999999999999999986   9999999999999999999999999987543222  


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                         ....++..|+|||++.+..++.++||||||+++|||++ |+.|+...   ....+...    ...+....     ..
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~---~~~~~~~~----~~~~~~~~-----~~  221 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPR----VEKGYKMD-----AP  221 (256)
T ss_pred             ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC---CHHHHHHH----HhcCCCCC-----CC
Confidence               12345678999999999899999999999999999997 88886422   11111111    11111111     11


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                          ......+.+++.+||+.+|++|||+.++++.|..
T Consensus       222 ----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         222 ----DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             ----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence                1122456789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.8e-36  Score=305.93  Aligned_cols=250  Identities=32%  Similarity=0.493  Sum_probs=196.0

Q ss_pred             cccCccCceEEEEEEcCC-------CcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          298 NKLGQGGFGTVYKGVLPN-------GKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +.||+|+||.||+|.+.+       ++.+++|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            469999999999998532       2578999876543 23466789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhch----hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC-----CEEEecccc
Q 007239          370 MPNRSLDCFIFDSE----RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-----VAKISDFGM  440 (611)
Q Consensus       370 ~~~~sL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~-----~~kl~DFGl  440 (611)
                      +++++|.+++....    ....+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999986432    2234788999999999999999999986   99999999999999877     899999999


Q ss_pred             ceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCc
Q 007239          441 ARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGK  519 (611)
Q Consensus       441 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  519 (611)
                      ++...............++..|+|||++.++.++.++||||||+++|||++ |+.|+....   .......+    ..+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~---~~~~~~~~----~~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN---NQEVLQHV----TAGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC---HHHHHHHH----hcCC
Confidence            986543332222223456788999999999999999999999999999998 998874321   11111111    1111


Q ss_pred             cccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          520 EMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       520 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                      ...         ........+.+++.+||+.+|++||++.+|++.|+
T Consensus       231 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 RLQ---------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ccC---------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            100         01112345678999999999999999999999986

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.5e-36  Score=301.92  Aligned_cols=254  Identities=25%  Similarity=0.386  Sum_probs=199.9

Q ss_pred             CCCcccccCccCceEEEEEEcCC--CcEEEEEEeccc----------ChhhHHHHHHHHHHHHh-cCCCCeeeEEEeEee
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLPN--GKEVAVKRLSRK----------SWQGLEEFKNEIILIAK-LQHRNLVRLVGCGIE  359 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~il~~-l~h~niv~l~~~~~~  359 (611)
                      +|++.+.||+|+||.||++.+..  ++.+++|.+...          ......++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999654  678999987532          22334567789988875 789999999999999


Q ss_pred             CCeEEEEEEecCCCChhhHhhhc-hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecc
Q 007239          360 GEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDF  438 (611)
Q Consensus       360 ~~~~~lv~E~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  438 (611)
                      .+..+++|||+++++|.+++... .....+++..++.++.|++.+|.|||+..  +++|+||||+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999887442 23456899999999999999999999632  4999999999999999999999999


Q ss_pred             ccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC
Q 007239          439 GMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG  518 (611)
Q Consensus       439 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  518 (611)
                      |++.......   ......|+..|++||++.++.++.++||||||+++|+|++|+.|+.....   .....   . ....
T Consensus       159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---~~~~~---~-~~~~  228 (269)
T cd08528         159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLAT---K-IVEA  228 (269)
T ss_pred             cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---HHHHH---H-Hhhc
Confidence            9998754332   22345789999999999998899999999999999999999998742211   11111   1 1111


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       519 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                      ....    ...    ......+.+++.+||+.||++||++.||.++|.
T Consensus       229 ~~~~----~~~----~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 VYEP----LPE----GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cCCc----CCc----ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            1111    000    011245778999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5e-36  Score=305.70  Aligned_cols=253  Identities=25%  Similarity=0.377  Sum_probs=199.5

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      ++|++.+.||+|+||.||++.+. +++.||+|.++.. .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46889999999999999999965 7899999988754 333456789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|..++........+++..+..++.||+.+|.|||++.  +++|+||||+||+++.++.+||+|||++..+.... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            999999888854333346899999999999999999999742  49999999999999999999999999997653221 


Q ss_pred             ccccccccccCCCCCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          450 TANTRRVVGTYGYMAPEYAMEG------LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~------~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                         .....|++.|+|||.+.+.      .++.++|||||||++|+|++|+.||.....   ......... ...+.... 
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~-~~~~~~~~-  229 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY---ANIFAQLSA-IVDGDPPT-  229 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch---hhHHHHHHH-HhhcCCCC-
Confidence               2234688899999998654      358899999999999999999999743221   111111111 11111111 


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                          +    ......++.+++.+||+.+|++||++.++++
T Consensus       230 ----~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         230 ----L----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ----C----CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                1    1123345678999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.9e-36  Score=300.40  Aligned_cols=251  Identities=24%  Similarity=0.327  Sum_probs=203.0

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +|+..+.||+|+||.||.+.. .+++.+++|.+...  .......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            588899999999999999884 46889999987654  334566789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++.... ...+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999885432 356899999999999999999999986   99999999999999999999999999987644332


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                        ......|++.|+|||++.+..++.++||||||+++|||++|..|+....   .   ....... ..+.....      
T Consensus       157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~---~---~~~~~~~-~~~~~~~~------  221 (256)
T cd08221         157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN---P---LNLVVKI-VQGNYTPV------  221 (256)
T ss_pred             --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC---H---HHHHHHH-HcCCCCCC------
Confidence              2234578999999999988889999999999999999999999874321   1   1111111 11211111      


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHh
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL  565 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  565 (611)
                         ......++.+++.+||+.+|++||++.++++.+
T Consensus       222 ---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         222 ---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ---ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence               111234577899999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.7e-36  Score=300.51  Aligned_cols=257  Identities=27%  Similarity=0.431  Sum_probs=204.5

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      ++|++.+.||.|+||+||++.. .++..+++|++.... ......+.+|+++++.++|+|++++++.+...+..++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            4789999999999999999995 467889999986543 33567899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++........+++..+..++.||+.||.|||+.+   ++|+||||+||++++++.+||+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999854333356899999999999999999999986   99999999999999999999999999987654332


Q ss_pred             cc--ccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          450 TA--NTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       450 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ..  ......|+..|+|||++... .++.++|+||||+++|+|++|+.|+......      ....+......      +
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~~~~~------~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM------KVLMLTLQNDP------P  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh------hhHHHHhcCCC------C
Confidence            21  22345789999999998877 7899999999999999999999997533221      11111111110      0


Q ss_pred             ccCCCC-CHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          527 LLMKSS-SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       527 ~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .+.... .......+.+++..||+.||++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            111100 0122345678999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-36  Score=303.65  Aligned_cols=253  Identities=24%  Similarity=0.347  Sum_probs=202.0

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      .++|++.+.||+|+||.||++.+. +++.+++|.+........+.+.+|++++++++||||+++++.+......++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            367999999999999999999964 6889999999877666677899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++...  ...+++..+..++.|++.+|.|||+.+   |+|+||||+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            9999999988432  245899999999999999999999987   99999999999999999999999999875432221


Q ss_pred             ccccccccccCCCCCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          450 TANTRRVVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                        ......|++.|+|||.+.     ...++.++||||||+++|+|++|+.|+.....   ...   ... +..+....  
T Consensus       159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~---~~~---~~~-~~~~~~~~--  227 (280)
T cd06611         159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---MRV---LLK-ILKSEPPT--  227 (280)
T ss_pred             --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH---HHH---HHH-HhcCCCCC--
Confidence              223457899999999875     34577899999999999999999999753221   111   111 11111111  


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                         +..  +......+.+++..||+.+|++||++.++++.
T Consensus       228 ---~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         228 ---LDQ--PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ---cCC--cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence               100  11112356788999999999999999999763

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.5e-35  Score=296.86  Aligned_cols=250  Identities=23%  Similarity=0.332  Sum_probs=199.5

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEee-CCeEEEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIE-GEEKLLIYE  368 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~~lv~E  368 (611)
                      +|++.+.||+|++|.||++... +++.+++|++....  ....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5889999999999999999954 57889999986542  2345678899999999999999999988764 446799999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++++|.+++... ....+++.+++.++.|++.+|.+||+.+   ++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999888542 2345899999999999999999999986   9999999999999999999999999998764322


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                      .  ......|++.|+|||++.+..++.++||||||+++|+|++|+.|+....      ......... .+....     +
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~------~~~~~~~~~-~~~~~~-----~  222 (257)
T cd08223         157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD------MNSLVYRII-EGKLPP-----M  222 (257)
T ss_pred             C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHH-hcCCCC-----C
Confidence            1  2234578999999999999999999999999999999999999874321      111111111 121111     1


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                          .......+.+++.+||+.+|++||++.++++.
T Consensus       223 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         223 ----PKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ----ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                11223457799999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3.2e-36  Score=305.16  Aligned_cols=256  Identities=27%  Similarity=0.367  Sum_probs=201.6

Q ss_pred             CCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKSWQ-GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  364 (611)
                      ++|++.+.||+|+||.||+++.+      +.+.+++|.+...... ..+.+.+|+.++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            57889999999999999999953      2457999988765433 4578999999999999999999999999989999


Q ss_pred             EEEEecCCCChhhHhhhchhh------ccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecc
Q 007239          365 LIYELMPNRSLDCFIFDSERR------LQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDF  438 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  438 (611)
                      +||||+++++|.+++......      ..+++..+..++.||+.+|.|||+.+   |+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998543321      25899999999999999999999986   999999999999999999999999


Q ss_pred             ccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhc
Q 007239          439 GMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKE  517 (611)
Q Consensus       439 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  517 (611)
                      |++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.....   ....    .....
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~----~~~~~  233 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVL----NRLQA  233 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHH----HHHHc
Confidence            9987542221 112223456778999999988889999999999999999998 6777632211   1111    11221


Q ss_pred             CccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          518 GKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       518 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                      +.... .       ........+.+++.+||+.+|++||++.+++..|+
T Consensus       234 ~~~~~-~-------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 GKLEL-P-------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCcCC-C-------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            21110 0       01112245778999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.3e-36  Score=301.11  Aligned_cols=238  Identities=24%  Similarity=0.425  Sum_probs=187.6

Q ss_pred             cccCccCceEEEEEEcCCCc-----------EEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          298 NKLGQGGFGTVYKGVLPNGK-----------EVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      +.||+|+||.||+|.+.+..           .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999975322           5788877655433 6788999999999999999999999887 778999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC-------CEEEeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-------VAKISDFG  439 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~-------~~kl~DFG  439 (611)
                      |||+++++|.+++....  ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999985432  26899999999999999999999986   99999999999999887       79999999


Q ss_pred             cceecccCCCccccccccccCCCCCccccccC--CCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCchhhHHHHHHHHHh
Q 007239          440 MARIFCENQKTANTRRVVGTYGYMAPEYAMEG--LFSVKSDVFSFGVIVLEIISG-KRNSGFYLTGHAQTLLAYVWQLWK  516 (611)
Q Consensus       440 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~  516 (611)
                      ++.....      .....++..|+|||++...  .++.++||||||+++|||++| ..|+.......   ..    ..+.
T Consensus       154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~----~~~~  220 (259)
T cd05037         154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KE----RFYQ  220 (259)
T ss_pred             ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HH----HHHh
Confidence            9986533      1224567889999999876  789999999999999999995 55553322111   01    1111


Q ss_pred             cCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          517 EGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       517 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                      ....       .    ..+....+.+++..||+.+|++|||+.+|++.|+
T Consensus       221 ~~~~-------~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQHR-------L----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cCCC-------C----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1100       0    0111156778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.1e-36  Score=309.72  Aligned_cols=197  Identities=28%  Similarity=0.445  Sum_probs=159.7

Q ss_pred             ccccCccCceEEEEEEcC---CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee--CCeEEEEEEecC
Q 007239          297 SNKLGQGGFGTVYKGVLP---NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE--GEEKLLIYELMP  371 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~lv~E~~~  371 (611)
                      ..+||+|+||.||+|+..   +++.||+|.+.....  ...+.+|+.++++++||||+++++++..  ....++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            468999999999999954   457899999875432  3467889999999999999999998853  567899999987


Q ss_pred             CCChhhHhhhc------hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe----cCCCCEEEeccccc
Q 007239          372 NRSLDCFIFDS------ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL----DKDMVAKISDFGMA  441 (611)
Q Consensus       372 ~~sL~~~l~~~------~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll----~~~~~~kl~DFGla  441 (611)
                      + +|.+++...      .....+++..++.++.||+.||.|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            6 565555321      12335889999999999999999999987   9999999999999    56679999999999


Q ss_pred             eecccCCCc-cccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 007239          442 RIFCENQKT-ANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFY  499 (611)
Q Consensus       442 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~  499 (611)
                      +.+...... .......||+.|+|||++.+ ..++.++||||||+++|||++|++||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            876443221 12234578999999999876 45899999999999999999999998543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.3e-35  Score=299.97  Aligned_cols=254  Identities=22%  Similarity=0.326  Sum_probs=188.4

Q ss_pred             cccCccCceEEEEEEcCCC---cEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCC
Q 007239          298 NKLGQGGFGTVYKGVLPNG---KEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNR  373 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~  373 (611)
                      +.||+|+||.||++...++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999985333   346677766443 345678999999999999999999999999999999999999999


Q ss_pred             ChhhHhhhchh-hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          374 SLDCFIFDSER-RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       374 sL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      +|.+++..... ....++..+..++.||++||.|||+.+   ++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999864322 234677788899999999999999986   99999999999999999999999999864322211112


Q ss_pred             cccccccCCCCCcccccc-------CCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          453 TRRVVGTYGYMAPEYAME-------GLFSVKSDVFSFGVIVLEIISG-KRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwSlGvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      .....|+..|+|||++..       ..++.++||||||+++|||+++ ..|+...   ........   .+.+ ....+.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~---~~~~~~~~---~~~~-~~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL---SDREVLNH---VIKD-QQVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC---CHHHHHHH---HHhh-cccccC
Confidence            224568899999998753       2457899999999999999975 5565321   11112221   1222 222333


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                      ++.+....    ..++.+++..|| .+|++||++++|++.|.
T Consensus       231 ~~~~~~~~----~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLELPY----SERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCCCC----cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            33332222    234567777898 67999999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-36  Score=304.85  Aligned_cols=240  Identities=23%  Similarity=0.387  Sum_probs=188.3

Q ss_pred             cccCccCceEEEEEEcCC--------CcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          298 NKLGQGGFGTVYKGVLPN--------GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +.||+|+||.||+|....        ..++++|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998532        234888888765555567889999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCC--------EEEeccccc
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV--------AKISDFGMA  441 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~--------~kl~DFGla  441 (611)
                      +++++|..++...  ...+++..+..++.||+.||.|||+++   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999998543  235889999999999999999999986   999999999999987765        699999988


Q ss_pred             eecccCCCccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCchhhHHHHHHHHHhcCc
Q 007239          442 RIFCENQKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGK-RNSGFYLTGHAQTLLAYVWQLWKEGK  519 (611)
Q Consensus       442 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~  519 (611)
                      .....      .....+++.|+|||++.+. .++.++||||||+++|||++|. .|+....   ......    ..... 
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~---~~~~~~----~~~~~-  221 (258)
T cd05078         156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD---SQKKLQ----FYEDR-  221 (258)
T ss_pred             cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc---HHHHHH----HHHcc-
Confidence            65422      1235688899999999874 5799999999999999999995 4432111   111111    11110 


Q ss_pred             cccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          520 EMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       520 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                       .     .+    +.....++.+++..||+.||++|||++++++.|+
T Consensus       222 -~-----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 -H-----QL----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -c-----cC----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             0     01    1112245778999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-36  Score=303.46  Aligned_cols=248  Identities=27%  Similarity=0.413  Sum_probs=191.9

Q ss_pred             cccCccCceEEEEEEcC-CCc--EEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVLP-NGK--EVAVKRLSRK-SWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      +.||+|+||.||+|.+. ++.  .+++|.++.. .....+.+.+|++++.++ +||||+++++++......+++|||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            36899999999999964 344  4688888743 234456788999999999 799999999999999999999999999


Q ss_pred             CChhhHhhhch-------------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccc
Q 007239          373 RSLDCFIFDSE-------------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFG  439 (611)
Q Consensus       373 ~sL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  439 (611)
                      ++|.+++....             ....+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999985422             1234789999999999999999999986   9999999999999999999999999


Q ss_pred             cceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcC
Q 007239          440 MARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEG  518 (611)
Q Consensus       440 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~  518 (611)
                      ++......   ........+..|+|||++....++.++||||||+++|||++ |+.||....   ......    ....+
T Consensus       158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~---~~~~~~----~~~~~  227 (270)
T cd05047         158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYE----KLPQG  227 (270)
T ss_pred             Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC---HHHHHH----HHhCC
Confidence            98632111   11111234567999999988899999999999999999997 888874321   111111    11111


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       519 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ...+     .    .......+.+++.+||+.+|.+|||+.+++..|+.
T Consensus       228 ~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~  267 (270)
T cd05047         228 YRLE-----K----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  267 (270)
T ss_pred             CCCC-----C----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence            1111     0    11122356799999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-35  Score=297.37  Aligned_cols=247  Identities=30%  Similarity=0.463  Sum_probs=199.5

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC-----hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS-----WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      +|+..+.||+|++|.||+|+.. +++.|++|.+....     .+..+.+.+|+.+++.++|+||+++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4778899999999999999975 78999999886543     23456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++..   ...+++..+..++.||+.+|.|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999998843   345889999999999999999999986   99999999999999999999999999987543


Q ss_pred             CCCccccccccccCCCCCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ..   ......|++.|++||.+.... ++.++|+||||+++|+|++|+.||.....      ....+..........   
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~---  222 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELPP---  222 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhcccCCC---
Confidence            32   223456899999999988776 89999999999999999999999754321      111111111111111   


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                        +    +......+.+++.+||+.+|++||++.++++
T Consensus       223 --~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         223 --I----PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             --c----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence              1    1112245678999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.1e-35  Score=301.80  Aligned_cols=248  Identities=25%  Similarity=0.396  Sum_probs=201.4

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      ..|+..+.||+|+||.||+|.+. +++.||+|.+.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            45778899999999999999964 68899999987543 34567789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++..    ..+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999999988732    35888999999999999999999986   99999999999999999999999999987643321


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                        ......++..|+|||++.+..++.++|+||||+++|||++|+.|+......   ....    ......         .
T Consensus       157 --~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~---~~~~----~~~~~~---------~  218 (277)
T cd06640         157 --KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM---RVLF----LIPKNN---------P  218 (277)
T ss_pred             --ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH---hHhh----hhhcCC---------C
Confidence              122346888999999999889999999999999999999999987432211   1110    000110         1


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ..........+.+++..||+.+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            11122334567799999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.6e-36  Score=306.38  Aligned_cols=248  Identities=27%  Similarity=0.427  Sum_probs=199.3

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +.|+..+.||+|+||.||+|.+ .+++.||+|.+.... ....+.+.+|+.++++++||||+++++.+......++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            3467778999999999999995 467889999987543 34456789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++.    ...+++..+..++.||++||.|||+++   ++|+||+|+||++++++.++|+|||++..+.....
T Consensus        84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            99999988873    245889999999999999999999986   99999999999999999999999999976543221


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                        ......|+..|+|||++.+..++.++||||||+++|||++|+.|+.......   ...    ....+.     .+.+ 
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~----~~~~~~-----~~~~-  221 (277)
T cd06642         157 --KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLF----LIPKNS-----PPTL-  221 (277)
T ss_pred             --hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHh----hhhcCC-----CCCC-
Confidence              1223468899999999999899999999999999999999999864222111   110    011111     1111 


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                         .......+.+++.+||+.+|++||++.+|++.
T Consensus       222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         222 ---EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             ---CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence               11223457789999999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1e-35  Score=300.15  Aligned_cols=253  Identities=25%  Similarity=0.402  Sum_probs=200.3

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC------hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS------WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      +|+..+.||+|++|.||++.. .+++.+|+|.+....      ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            478889999999999999995 578999999986432      1235678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC-CEEEeccccceec
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIF  444 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGla~~~  444 (611)
                      ||||+++++|.+++.   +...+++..+..++.||+.||.|||+++   ++|+||||+||+++.++ .+||+|||++...
T Consensus        81 v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLS---KYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999884   3346889999999999999999999986   99999999999998776 5999999999876


Q ss_pred             ccCCCc--cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          445 CENQKT--ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       445 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      ......  .......|+..|+|||++.+..++.++||||+|+++|+|++|+.|+........   .....+......   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~---  228 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH---LALIFKIASATT---  228 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch---HHHHHHHhccCC---
Confidence            433211  112235688999999999888899999999999999999999999753322111   111111111110   


Q ss_pred             ccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       523 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                            ....+.....++.+++.+||+.+|++||++.+++.
T Consensus       229 ------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         229 ------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             ------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                  01111223346778999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-37  Score=317.85  Aligned_cols=240  Identities=23%  Similarity=0.279  Sum_probs=184.8

Q ss_pred             cCccCceEEEEEEcC-CCcEEEEEEecccCh---hhHHHHHHHHHHHHhc---CCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          300 LGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW---QGLEEFKNEIILIAKL---QHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       300 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l---~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      ||+|+||+||+++.. +++.||+|++.+...   .....+..|..++..+   .||||+++++.+......++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999954 689999999865322   2233455677777665   699999999999999999999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      ++|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......  ..
T Consensus        81 g~L~~~l~---~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~  152 (330)
T cd05586          81 GELFWHLQ---KEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT  152 (330)
T ss_pred             ChHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence            99988874   3456899999999999999999999986   9999999999999999999999999997542222  12


Q ss_pred             cccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCC
Q 007239          453 TRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKS  531 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  531 (611)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||....   ...    ..+.+..+.. .+.     ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~---~~~----~~~~i~~~~~-~~~-----~~  219 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED---TQQ----MYRNIAFGKV-RFP-----KN  219 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC---HHH----HHHHHHcCCC-CCC-----Cc
Confidence            2346799999999998765 47999999999999999999999974321   111    1111221111 111     10


Q ss_pred             CCHHHHHHHHHHhhccccCCCCCCCC----HHHHHH
Q 007239          532 SSIPQVVRCIHIGLLCVQEDPAVRPT----MSNVVA  563 (611)
Q Consensus       532 ~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~  563 (611)
                         .....+.+++.+||+.||++||+    +.++++
T Consensus       220 ---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         220 ---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence               11234668899999999999984    555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-36  Score=308.41  Aligned_cols=253  Identities=23%  Similarity=0.250  Sum_probs=199.8

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChh---hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQ---GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++.+.||+|++|.||++... +++.+|+|.+......   ....+.+|+++++.++||||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            46889999999999999999964 5899999998765322   4567889999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+.+++|.+++.. .....+++..+..++.||+.+|.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQR-QPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHh-CCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            99999999998753 22356899999999999999999999986   999999999999999999999999998754322


Q ss_pred             CCc---------------------------cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 007239          448 QKT---------------------------ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYL  500 (611)
Q Consensus       448 ~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~  500 (611)
                      ...                           .......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                           01123468999999999999899999999999999999999999975322


Q ss_pred             CCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCC----HHHHHH
Q 007239          501 TGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT----MSNVVA  563 (611)
Q Consensus       501 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~evl~  563 (611)
                      ..  ..    .........         ...........+.+++.+||+.+|++||+    +++++.
T Consensus       237 ~~--~~----~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RD--ET----FSNILKKEV---------TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hH--HH----HHHHhcCCc---------cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            11  11    111111110         00001113346779999999999999999    666655

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.9e-35  Score=295.82  Aligned_cols=251  Identities=34%  Similarity=0.528  Sum_probs=199.6

Q ss_pred             CCcccccCccCceEEEEEEcCC-----CcEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          294 FSDSNKLGQGGFGTVYKGVLPN-----GKEVAVKRLSRKSWQ-GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      |++.+.||.|+||.||++.+..     +..||+|.+...... ..+.+.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4577899999999999999643     378999999765433 5678999999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++..... ..+++..++.++.||+.+|.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999999854222 22899999999999999999999986   999999999999999999999999999876544


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ...... ...+++.|+|||.+.+..++.++||||+|+++|+|++ |+.|+...   ....+...    .........   
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~---~~~~~~~~----~~~~~~~~~---  225 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM---SNEEVLEY----LKKGYRLPK---  225 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHH----HhcCCCCCC---
Confidence            222211 2347789999999988889999999999999999998 67775431   11122221    111111110   


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHh
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL  565 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  565 (611)
                            ......++.+++.+||+.+|++|||+.++++.|
T Consensus       226 ------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      226 ------PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                  011234577899999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.5e-35  Score=299.87  Aligned_cols=255  Identities=25%  Similarity=0.390  Sum_probs=198.0

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh----------hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW----------QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE  361 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~  361 (611)
                      +|.+.+.||+|+||.||+|.. .+++.+|+|.++....          ...+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            477889999999999999985 4688999998753211          12356788999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccc
Q 007239          362 EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA  441 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  441 (611)
                      ..++||||+++++|.+++..   ...+++..+..++.||+.+|.|||+++   ++||||||+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRT---YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            99999999999999998843   356899999999999999999999986   999999999999999999999999999


Q ss_pred             eecccCCCccccccccccCCCCCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCc
Q 007239          442 RIFCENQKTANTRRVVGTYGYMAPEYAMEGL--FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK  519 (611)
Q Consensus       442 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  519 (611)
                      +...............|+..|+|||.+....  ++.++|+||||+++|+|++|..|+.....      ............
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~~  229 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA------IAAMFKLGNKRS  229 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch------HHHHHHhhcccc
Confidence            7653322222223456889999999987654  78999999999999999999999742111      111111111111


Q ss_pred             cccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          520 EMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       520 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ...+.+     .........+.+++..||+.+|++||++.+|++.
T Consensus       230 ~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         230 APPIPP-----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CCcCCc-----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            111111     1111123467789999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=9.5e-36  Score=310.60  Aligned_cols=255  Identities=18%  Similarity=0.224  Sum_probs=193.9

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++.++||+|+||.||+++.+ +++.+|+|++.+..   ......+.+|+.++..++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47899999999999999999964 57889999986432   223445788999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++|+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999999998532  345899999999999999999999986   999999999999999999999999999765332


Q ss_pred             CCccccccccccCCCCCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      .. .......||+.|+|||++.     .+.++.++|||||||++|||++|+.||....      ................
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~------~~~~~~~i~~~~~~~~  228 (332)
T cd05623         156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES------LVETYGKIMNHKERFQ  228 (332)
T ss_pred             Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC------HHHHHHHHhCCCcccc
Confidence            21 1222357999999999986     3468899999999999999999999974321      1111111111111111


Q ss_pred             ccccccCCCCCHHHHHHHHHHhhccccCCCCC--CCCHHHHHHH
Q 007239          523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAV--RPTMSNVVAL  564 (611)
Q Consensus       523 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~  564 (611)
                      +...      .......+.+++.+||..++++  |++++++++.
T Consensus       229 ~p~~------~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 FPAQ------VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCCc------cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            1000      0111234567777777654444  6899988865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-36  Score=308.14  Aligned_cols=267  Identities=24%  Similarity=0.340  Sum_probs=197.2

Q ss_pred             CCCcccccCccCceEEEEEEcC---CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC--CeEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP---NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG--EEKL  364 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~  364 (611)
                      +|++.+.||+|+||.||+|...   +++.||+|.+....   ......+.+|+.+++.++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999964   47899999998632   33346778899999999999999999999988  8899


Q ss_pred             EEEEecCCCChhhHhhhch--hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC----CCCEEEecc
Q 007239          365 LIYELMPNRSLDCFIFDSE--RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK----DMVAKISDF  438 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~----~~~~kl~DF  438 (611)
                      +||||+++ +|.+++....  ....+++..++.++.||+.||.|||+.+   ++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999986 5655553322  2236899999999999999999999986   999999999999999    999999999


Q ss_pred             ccceecccCCC-ccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCch------hhHHHH
Q 007239          439 GMARIFCENQK-TANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHA------QTLLAY  510 (611)
Q Consensus       439 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~------~~l~~~  510 (611)
                      |++........ ........+++.|+|||++.+. .++.++||||||+++|+|++|++|+........      ......
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987643322 1222345788999999988764 578999999999999999999999864433220      001111


Q ss_pred             HHHHHhcC------------ccccccccccCCCCC---H--------HHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          511 VWQLWKEG------------KEMEFVDPLLMKSSS---I--------PQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       511 ~~~~~~~~------------~~~~~~d~~l~~~~~---~--------~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      +...+...            ......+........   .        ....++.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11111100            000000000000000   0        12235789999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2e-36  Score=308.40  Aligned_cols=261  Identities=23%  Similarity=0.318  Sum_probs=198.0

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ++|++.+.||+|+||.||++.++ +++.||+|++.....  ...+.+.+|+++++.++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46889999999999999999975 588999998765322  234568899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++++|..+...   ...+++..+..++.||+.+|.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            9999999877632   334899999999999999999999986   9999999999999999999999999998654332


Q ss_pred             CccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhc----------
Q 007239          449 KTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKE----------  517 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----------  517 (611)
                      .  ......++..|+|||++.+ ..++.++||||||+++|||++|++|+.....   .............          
T Consensus       155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07846         155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD---IDQLYHIIKCLGNLIPRHQEIFQ  229 (286)
T ss_pred             c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHHHhCCCchhhHHHhc
Confidence            2  1223568899999999875 4578899999999999999999988753221   1111111110000          


Q ss_pred             -Ccc-ccccccccCCCC-----CHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          518 -GKE-MEFVDPLLMKSS-----SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       518 -~~~-~~~~d~~l~~~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       ... .....+......     .......+.+++.+||+.+|++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             000 000000000000     0112345789999999999999999999886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-36  Score=306.18  Aligned_cols=262  Identities=22%  Similarity=0.300  Sum_probs=200.1

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ++|++.+.||+|+||.||++.+. +++.|++|+++...  ....+.+.+|+++++.++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36889999999999999999965 68899999886532  2335778999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |++++.+..++.   +...+++..++.++.||+.||.|||+++   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999877766552   3345899999999999999999999986   9999999999999999999999999998764433


Q ss_pred             CccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhc----------
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKE----------  517 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----------  517 (611)
                      . .......++..|+|||++.+. .++.++||||||+++|+|++|++|+......+   ........+..          
T Consensus       155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (288)
T cd07833         155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID---QLYLIQKCLGPLPPSHQELFS  230 (288)
T ss_pred             c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHHhhhcc
Confidence            2 122335788999999999888 88999999999999999999999875332211   11111110000          


Q ss_pred             -Cc-c--cccccccc----CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          518 -GK-E--MEFVDPLL----MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       518 -~~-~--~~~~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       .. .  .+..+...    ..........++.+++..||+.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence             00 0  00000000    00011111356789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2e-35  Score=307.55  Aligned_cols=199  Identities=21%  Similarity=0.262  Sum_probs=165.0

Q ss_pred             cccccCcc--CceEEEEEEc-CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          296 DSNKLGQG--GFGTVYKGVL-PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       296 ~~~~lg~G--~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      +.++||+|  +|++||++.. .+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  7899999995 578999999987542  233456788999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++++|.+++.... ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.++++||+...........
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999885422 234899999999999999999999986   999999999999999999999999865433211110


Q ss_pred             c-----ccccccccCCCCCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 007239          451 A-----NTRRVVGTYGYMAPEYAME--GLFSVKSDVFSFGVIVLEIISGKRNSGF  498 (611)
Q Consensus       451 ~-----~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvll~elltG~~p~~~  498 (611)
                      .     ......++..|+|||++.+  ..++.++|||||||++|||++|+.||..
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence            0     1122356778999999876  4589999999999999999999999853

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.6e-35  Score=297.82  Aligned_cols=249  Identities=27%  Similarity=0.408  Sum_probs=189.6

Q ss_pred             cccCccCceEEEEEEcC----CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEe-eCCeEEEEEEecC
Q 007239          298 NKLGQGGFGTVYKGVLP----NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGI-EGEEKLLIYELMP  371 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~-~~~~~~lv~E~~~  371 (611)
                      +.||+|+||.||+|.+.    .+..+|+|++... .....+.+.+|+.+++.++||||+++++++. .+...+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999853    2457999988543 3345678889999999999999999999765 4556899999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc-
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT-  450 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~-  450 (611)
                      +++|.+++...  ...+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+++........ 
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999998532  234677888899999999999999986   999999999999999999999999999755322111 


Q ss_pred             -cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          451 -ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKR-NSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       451 -~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~-p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                       .......+++.|+|||++.+..++.++||||||+++|||++|+. |+..   .....+...+   ......      ..
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~---~~~~~~~~~~---~~~~~~------~~  223 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD---VDSFDITVYL---LQGRRL------LQ  223 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHHHH---hcCCCC------CC
Confidence             11123356778999999998899999999999999999999654 4421   1222222221   111110      00


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ..    .....+.+++..||+.+|++||++.+|++.|++
T Consensus       224 ~~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~  258 (262)
T cd05058         224 PE----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ  258 (262)
T ss_pred             CC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            00    112357789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1e-35  Score=335.73  Aligned_cols=256  Identities=22%  Similarity=0.316  Sum_probs=197.4

Q ss_pred             HhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee--CCeE
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE--GEEK  363 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~  363 (611)
                      ...++|++.+.||+|+||+||++... .++.+|+|.+...  .......+.+|+.+++.|+||||++++++|..  ...+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34578999999999999999999964 5778999988653  22345678999999999999999999998854  3568


Q ss_pred             EEEEEecCCCChhhHhhhch-hhccCCHHHHHHHHHHHHHHHHHHhhcCC----CceEecCCCCCcEEecC---------
Q 007239          364 LLIYELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYLHEDSR----LKIIHRDLKPSNVLLDK---------  429 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~----~~iiHrDikp~NIll~~---------  429 (611)
                      +|||||+++++|.++|.... ....+++..++.|+.||+.||.|||+.+.    .+||||||||+||||+.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            99999999999999885422 23569999999999999999999998531    24999999999999964         


Q ss_pred             --------CCCEEEeccccceecccCCCccccccccccCCCCCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 007239          430 --------DMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAME--GLFSVKSDVFSFGVIVLEIISGKRNSGFY  499 (611)
Q Consensus       430 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvll~elltG~~p~~~~  499 (611)
                              .+.+||+|||++..+.....   .....||+.|+|||++.+  ..++.++|||||||+||||++|+.||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                    33589999999986533221   234579999999999864  45889999999999999999999998532


Q ss_pred             CCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          500 LTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       500 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .  ....+.    ..+......     .+ .    ....++.+|+..||+.+|++||++.+++.
T Consensus       247 ~--~~~qli----~~lk~~p~l-----pi-~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 N--NFSQLI----SELKRGPDL-----PI-K----GKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             C--cHHHHH----HHHhcCCCC-----Cc-C----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            2  111111    111111110     00 0    11245778999999999999999999983

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.6e-35  Score=301.89  Aligned_cols=258  Identities=24%  Similarity=0.338  Sum_probs=198.3

Q ss_pred             HHHhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEe-----e
Q 007239          287 IKAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGCGI-----E  359 (611)
Q Consensus       287 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~-----~  359 (611)
                      +....++|++.+.||+|+||.||++.. .+++.+++|++.... .....+.+|+.+++.+ +||||+++++++.     .
T Consensus        13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            345678999999999999999999995 467899999886533 2235678899999999 6999999999874     3


Q ss_pred             CCeEEEEEEecCCCChhhHhhhc-hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecc
Q 007239          360 GEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDF  438 (611)
Q Consensus       360 ~~~~~lv~E~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  438 (611)
                      +...++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+||
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~df  168 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDF  168 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccC
Confidence            45689999999999999887532 23356889999999999999999999986   999999999999999999999999


Q ss_pred             ccceecccCCCccccccccccCCCCCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHH
Q 007239          439 GMARIFCENQKTANTRRVVGTYGYMAPEYAME-----GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ  513 (611)
Q Consensus       439 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~  513 (611)
                      |+++.......  ......|++.|+|||++..     ..++.++|||||||++|||++|+.|+......  .    ....
T Consensus       169 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~--~----~~~~  240 (286)
T cd06638         169 GVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM--R----ALFK  240 (286)
T ss_pred             CceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh--H----HHhh
Confidence            99986543221  1223468999999998753     45788999999999999999999997432211  0    0000


Q ss_pred             HHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       514 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                       ..........++.       ....++.+++.+||+.||++|||+.||++.
T Consensus       241 -~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         241 -IPRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             -ccccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence             0111111111110       112357789999999999999999999974

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.3e-35  Score=299.36  Aligned_cols=250  Identities=26%  Similarity=0.388  Sum_probs=192.8

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-----hhhHHHHHHHHHHHHhcCCCCeeeEEEeEee--CCeE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-----WQGLEEFKNEIILIAKLQHRNLVRLVGCGIE--GEEK  363 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~  363 (611)
                      .+|+..+.||+|+||.||++.. .+++.|++|++....     .+....+.+|+.+++.++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            3688999999999999999996 468899999886432     2335678899999999999999999998875  3577


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ++++||+++++|.+++..   ...+++...+.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999998843   345889999999999999999999886   99999999999999999999999999976


Q ss_pred             cccCCC-ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          444 FCENQK-TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       444 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      ...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||.....      ............   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~------~~~~~~~~~~~~---  226 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA------MAAIFKIATQPT---  226 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch------HHHHHHHhcCCC---
Confidence            532211 1112235688999999999988899999999999999999999999753211      111111111111   


Q ss_pred             ccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       523 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                        .+.+    +......+.+++ .||..+|++||+++||++
T Consensus       227 --~~~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 --NPQL----PSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             --CCCC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence              1111    111122334555 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-36  Score=309.34  Aligned_cols=254  Identities=26%  Similarity=0.415  Sum_probs=200.2

Q ss_pred             hhCCCCcccccCccCceEEEEEEcCCCcEEEEEEec--ccChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLS--RKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv  366 (611)
                      ....|+++++||+||.+.||++...+.+.||+|++.  ..+.+....|.+|+..|.+|+ |.+|++++++-..++.+|+|
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            446799999999999999999998888889998764  345566788999999999997 99999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||= ..+|..+|..... ....| .++.+..|++.++.++|++|   |||.||||.|+|+- .|.+||+|||+|..+..
T Consensus       439 mE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQP  511 (677)
T ss_pred             eecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence            9984 4588888854322 22223 77889999999999999997   99999999999984 57999999999999887


Q ss_pred             CCCccccccccccCCCCCccccccC-----------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHH
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEG-----------LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLW  515 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~  515 (611)
                      +.........+||+.||+||.+...           +.+.++||||+||+||+|+-|++||+...     +....+....
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~aKl~aI~  586 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQIAKLHAIT  586 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHHHHHHhhc
Confidence            7777777778999999999988532           25678999999999999999999985221     1111111111


Q ss_pred             hcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          516 KEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       516 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..+...++  +.      .+...++++++..||+.||++||++.|+|+
T Consensus       587 ~P~~~Ief--p~------~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  587 DPNHEIEF--PD------IPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             CCCccccc--cC------CCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            11111111  11      111123889999999999999999999986

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.3e-36  Score=304.43  Aligned_cols=255  Identities=29%  Similarity=0.446  Sum_probs=200.7

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCc----EEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGK----EVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      .+|++.+.||+|+||.||+|.++ +|+    .+++|.+.... ......+.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            57889999999999999999953 333    58999887654 3345678999999999999999999999887 78899


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+++++|.+++...  ...+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||+++...
T Consensus        86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999988542  335899999999999999999999986   9999999999999999999999999998764


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ............++..|+|||.+....++.++||||||+++|||++ |+.|+....   ...+..    ....+...  .
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~----~~~~~~~~--~  231 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP---AVEIPD----LLEKGERL--P  231 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC---HHHHHH----HHhCCCCC--C
Confidence            3322222112234568999999988899999999999999999998 999875332   112221    11211110  0


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      .+       ......+.+++..||..+|++||++.++++.|.+.
T Consensus       232 ~~-------~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         232 QP-------PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             CC-------CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            00       11123567888999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-35  Score=311.47  Aligned_cols=259  Identities=25%  Similarity=0.321  Sum_probs=194.0

Q ss_pred             HhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC-----
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG-----  360 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----  360 (611)
                      ...++|.+.+.||+|+||.||++.. .+++.||+|++....  ......+.+|+.+++.++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3457899999999999999999995 568899999987542  22345678899999999999999999987543     


Q ss_pred             -CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccc
Q 007239          361 -EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFG  439 (611)
Q Consensus       361 -~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  439 (611)
                       ...++++|++ +++|..++.    ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence             3568999987 678877763    245899999999999999999999987   9999999999999999999999999


Q ss_pred             cceecccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC
Q 007239          440 MARIFCENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG  518 (611)
Q Consensus       440 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  518 (611)
                      +++.....     .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.....   ............. 
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~-  234 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY---IDQLKRIMEVVGT-  234 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHhCC-
Confidence            99865322     223578999999999877 5689999999999999999999999753221   1111111110000 


Q ss_pred             cccccccc-----------ccCCCC--CH-----HHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          519 KEMEFVDP-----------LLMKSS--SI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       519 ~~~~~~d~-----------~l~~~~--~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ...+....           .+....  ..     .....+.+|+.+||+.||++|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000           000000  00     011235789999999999999999999953

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.1e-35  Score=295.58  Aligned_cols=252  Identities=27%  Similarity=0.336  Sum_probs=206.0

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      ++|++.+.||+|++|.||+++.. +++.|++|++..... .....+.+|+.++..++|+|++++++++......++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999999965 589999999876643 4467899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhh-cCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE-DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      +++++|.+++..   ...+++..++.++.||+++|.|||+ .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            999999999843   3668999999999999999999999 86   9999999999999999999999999998764333


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                      ..  .....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+..........+...+    ......     .+
T Consensus       155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~----~~~~~~-----~~  223 (264)
T cd06623         155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI----CDGPPP-----SL  223 (264)
T ss_pred             Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH----hcCCCC-----CC
Confidence            22  12456889999999999999999999999999999999999997544322222222211    111111     11


Q ss_pred             CCCCCHH-HHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          529 MKSSSIP-QVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       529 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                          ... ....+.+++..||+.+|++||++.++++.
T Consensus       224 ----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         224 ----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                111 23467789999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.7e-35  Score=350.97  Aligned_cols=264  Identities=24%  Similarity=0.445  Sum_probs=212.7

Q ss_pred             HHHhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          287 IKAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       287 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      .+.....|...+.||+|+||.||+|+. .+++.||+|++......    ..+|++++++++||||+++++++.+.+..++
T Consensus       685 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l  760 (968)
T PLN00113        685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYL  760 (968)
T ss_pred             HHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence            344556788889999999999999996 57899999998654322    2356889999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+++++|.+++.      .++|.++.+++.||++||+|||.....+|+||||||+||+++.++..++. ||......
T Consensus       761 v~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~  833 (968)
T PLN00113        761 IHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC  833 (968)
T ss_pred             EEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc
Confidence            999999999999983      38999999999999999999996544569999999999999999888875 66554321


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ..      ....||+.|+|||++.+..++.|+|||||||++|||++|+.|+..... ....+..+............++|
T Consensus       834 ~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  906 (968)
T PLN00113        834 TD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWID  906 (968)
T ss_pred             cC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeC
Confidence            11      123688999999999999999999999999999999999999843322 23345555554444445555666


Q ss_pred             cccCCC--CCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          526 PLLMKS--SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       526 ~~l~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      +.+...  ....+..++.+++.+||+.||++||+|+||+++|+..
T Consensus       907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA  951 (968)
T ss_pred             ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence            665432  3445667888999999999999999999999999754

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=327.17  Aligned_cols=254  Identities=27%  Similarity=0.430  Sum_probs=208.3

Q ss_pred             CCCcccccCccCceEEEEEEcC-C---CcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-N---GKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ..++.+.||.|.||+|++|+++ .   ...||||.++... .+....|..|+.||-+++||||++|.|+....+...||.
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT  709 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT  709 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence            4667889999999999999964 2   2459999998654 345678999999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      |||++|+|+.||..+.  +++.+.++.-++++|+.||.||-+.+   +|||||...||||+.+...|++|||+++.+.++
T Consensus       710 EyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd  784 (996)
T KOG0196|consen  710 EYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  784 (996)
T ss_pred             hhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccC
Confidence            9999999999996544  56999999999999999999999875   999999999999999999999999999977544


Q ss_pred             CCcccc-ccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          448 QKTANT-RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       448 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      .....+ ..-.-...|.|||.+...+++.++||||||++|||.++ |.+|+-...   .++.+.             -++
T Consensus       785 ~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS---NQdVIk-------------aIe  848 (996)
T KOG0196|consen  785 PEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---NQDVIK-------------AIE  848 (996)
T ss_pred             CCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc---hHHHHH-------------HHH
Confidence            422111 11122467999999999999999999999999999776 888863221   112222             222


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ....-+.++.....|.+|++.|||+|-.+||.+.+|+..|.+
T Consensus       849 ~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk  890 (996)
T KOG0196|consen  849 QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK  890 (996)
T ss_pred             hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence            223334566677788999999999999999999999999964

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3e-35  Score=299.57  Aligned_cols=262  Identities=25%  Similarity=0.331  Sum_probs=199.8

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +|++.+.||+|++|.||++.+ .+|+.|++|++....  ......+.+|+.++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            588899999999999999996 468899999987654  23356789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      + +++|.+++....  ..+++.+++.++.||+++|.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999998885432  56899999999999999999999986   99999999999999999999999999987644322


Q ss_pred             ccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc--------
Q 007239          450 TANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE--------  520 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--------  520 (611)
                       .......|+..|+|||++.+. .++.++||||+|+++|||++|++++.....   ......+.........        
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND---IEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH---HHHHHHHHHHcCCCChHHHhhccC
Confidence             112234689999999998754 468999999999999999999777643221   1122222221111100        


Q ss_pred             ccccccc---cCCCCC-----HHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          521 MEFVDPL---LMKSSS-----IPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       521 ~~~~d~~---l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      .......   ......     ......+.+++.+||+.+|++||+++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000000   000000     0112567799999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=8.5e-36  Score=298.69  Aligned_cols=249  Identities=22%  Similarity=0.341  Sum_probs=200.5

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +|++.+.||+|+||.||++.. .+++.|++|.+...  ......++.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            588899999999999999995 46889999998643  233456789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +.+++|.+++... ....+++.+++.++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            9999998887432 2235789999999999999999999986   99999999999999999999999999986543322


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                      .  .....|++.|+|||++.++.++.++|+||||+++|+|++|+.|+....   ..   ....... .+....       
T Consensus       157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~---~~---~~~~~~~-~~~~~~-------  220 (256)
T cd08218         157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN---MK---NLVLKII-RGSYPP-------  220 (256)
T ss_pred             h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC---HH---HHHHHHh-cCCCCC-------
Confidence            1  223468899999999999999999999999999999999999874221   11   1111111 111111       


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                        .......++.+++.+||+.+|++||++.+|++
T Consensus       221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         221 --VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             --CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              11122345778999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.9e-35  Score=303.17  Aligned_cols=261  Identities=25%  Similarity=0.321  Sum_probs=197.8

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChh-----hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQ-----GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      +|++.+.||+|++|.||+|... +++.|++|.+......     ....+.+|+++++.++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999964 6899999998755322     234577899999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+ +++|..++....  ..+++..++.++.||++||.|||+++   ++|+||||+||+++.++.+||+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 889999884422  36899999999999999999999987   99999999999999999999999999987644


Q ss_pred             CCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC-------
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG-------  518 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-------  518 (611)
                      ....  .....+++.|+|||.+.+ ..++.++||||||+++|||++|.+++.....   ..............       
T Consensus       155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  229 (298)
T cd07841         155 PNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD---IDQLGKIFEALGTPTEENWPG  229 (298)
T ss_pred             CCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc---HHHHHHHHHHcCCCchhhhhh
Confidence            3221  122356788999998865 4678999999999999999999777643221   11111111111000       


Q ss_pred             --ccccccccccCCCCC-----HHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          519 --KEMEFVDPLLMKSSS-----IPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       519 --~~~~~~d~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                        ..............+     ......+.+++.+||+.+|++|||+.||++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence              000000000001111     1123467899999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.8e-35  Score=298.19  Aligned_cols=250  Identities=25%  Similarity=0.373  Sum_probs=194.8

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC--CeE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK-----SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG--EEK  363 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~  363 (611)
                      ++|++.+.||+|+||.||++.. .+++.|++|.+...     .....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4789999999999999999996 46889999987532     123356788999999999999999999988763  467


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      +++|||+++++|.+++.   +...+++..+..++.|++.+|.|||+++   ++|+||||+||+++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLK---SYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            89999999999999884   3345788999999999999999999986   99999999999999999999999999986


Q ss_pred             cccCCCc-cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          444 FCENQKT-ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       444 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      ....... .......|+..|+|||.+.+..++.++||||||+++|||++|+.|+.....     ... ..+......   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~-~~~~~~~~~---  226 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----MAA-IFKIATQPT---  226 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-----HHH-HHHHhcCCC---
Confidence            5322111 122335688999999999888899999999999999999999999743211     111 111111110   


Q ss_pred             ccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       523 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                        .+    ..+......+.+++..|+. +|++||++++|++
T Consensus       227 --~~----~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         227 --NP----VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             --CC----CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence              11    1122233456678888885 9999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.7e-35  Score=303.42  Aligned_cols=257  Identities=18%  Similarity=0.215  Sum_probs=200.8

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++.+.||+|+||.||++... .++.|++|.+....   ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46889999999999999999964 57899999987543   233567889999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++.   ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLK---NIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999984   3356899999999999999999999986   999999999999999999999999998742110


Q ss_pred             C-------------CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH
Q 007239          448 Q-------------KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL  514 (611)
Q Consensus       448 ~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~  514 (611)
                      .             .........|+..|+|||.+.+..++.++|+||||+++|||++|+.||....   ...+..    .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~---~~~~~~----~  227 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT---PEELFG----Q  227 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHH----H
Confidence            0             0001112467889999999998899999999999999999999999974221   111111    1


Q ss_pred             HhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       515 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ...+..   ..+....    .....+.+++.+||+.+|++||+..++.+.|+..
T Consensus       228 ~~~~~~---~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         228 VISDDI---EWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             HHhccc---CCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence            111111   0011000    1223467899999999999999988888877653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8.7e-36  Score=305.18  Aligned_cols=250  Identities=24%  Similarity=0.370  Sum_probs=199.3

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      +.|.....||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++.+...+..++||||+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            3445557799999999999995 468899999987666566678999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++++|.+++..    ..+++..+..++.||+.||.|||+++   ++||||||+||+++.++.+||+|||++........ 
T Consensus       102 ~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-  173 (292)
T cd06658         102 EGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-  173 (292)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence            99999988732    35889999999999999999999986   99999999999999999999999999876533221 


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                       ......|++.|+|||++.+..++.++||||||+++|||++|+.|+.....   ......    ....     ....+..
T Consensus       174 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~----~~~~-----~~~~~~~  240 (292)
T cd06658         174 -KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRR----IRDN-----LPPRVKD  240 (292)
T ss_pred             -cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH----HHhc-----CCCcccc
Confidence             12335689999999999988999999999999999999999999743221   111111    1111     1111111


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ..  .....+.+++..||+.||++|||++++++.
T Consensus       241 ~~--~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         241 SH--KVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cc--ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            11  122346688889999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=7.2e-36  Score=299.06  Aligned_cols=247  Identities=28%  Similarity=0.433  Sum_probs=196.4

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      ++|++.+.||+|+||.||++.. +++.+++|.++...  ..+.+.+|+.++++++|||++++++++... ..+++|||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            5689999999999999999875 67889999986543  346788999999999999999999998654 5799999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......   
T Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            99999998543 2345889999999999999999999986   9999999999999999999999999997543221   


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                        .....+..|+|||++.++.++.++|+||||+++|||++ |+.||....   ...+.    .....+...+.       
T Consensus       155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~---~~~~~----~~~~~~~~~~~-------  218 (254)
T cd05083         155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS---LKEVK----ECVEKGYRMEP-------  218 (254)
T ss_pred             --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC---HHHHH----HHHhCCCCCCC-------
Confidence              12234568999999998999999999999999999998 888864321   11111    11222111110       


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                        .......+.+++.+||+.+|++||++.++++.|..
T Consensus       219 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         219 --PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             --CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence              11122456789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.7e-35  Score=297.88  Aligned_cols=253  Identities=27%  Similarity=0.365  Sum_probs=202.4

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      ++|+..+.||+|++|.||++.+. +++.+++|++.... ......+.+|++++++++||||+++++.+......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            46888899999999999999965 68899999987653 34456789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhh-cCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE-DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      +++++|.+++....  ..+++..+..++.|++.+|.|||+ .+   ++|+||||+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999885422  568999999999999999999999 75   9999999999999999999999999987653222


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                      ..    ...++..|+|||++.+..++.++||||||+++|+|++|+.|+...... ............ ....     +.+
T Consensus       156 ~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~-~~~~-----~~~  224 (265)
T cd06605         156 AK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIV-NEPP-----PRL  224 (265)
T ss_pred             hh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHh-cCCC-----CCC
Confidence            11    257889999999999999999999999999999999999997543221 112222222211 1111     011


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ...   .....+.+++..||..||++|||+.+++.
T Consensus       225 ~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         225 PSG---KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             Chh---hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            110   12345678999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.3e-35  Score=292.23  Aligned_cols=251  Identities=28%  Similarity=0.423  Sum_probs=204.6

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC--CeEEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVGCGIEG--EEKLLIY  367 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lv~  367 (611)
                      +|+..+.||+|++|.||+|... +++.|++|++.....  ...+.+.+|+.++++++||||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999965 788999999876542  4567899999999999999999999999988  8899999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++..   ...+++..++.++.|++++|.|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKK---FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            99999999999843   237899999999999999999999986   999999999999999999999999999877554


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                      ..........++..|+|||.+.....+.++||||||+++|+|++|+.|+....     ......+..........     
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~-----  224 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKIGSSGEPPE-----  224 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhccccCCCcC-----
Confidence            43212234578899999999998889999999999999999999999985443     11222222111111111     


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                          .+......+.+++.+||+.+|++||++.+++.
T Consensus       225 ----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         225 ----IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ----CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                11111346778999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-36  Score=313.88  Aligned_cols=248  Identities=22%  Similarity=0.337  Sum_probs=210.8

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChh--hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQ--GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ....|.+.+.||+|.|++|..++. .++.+||||.+.+....  ....+.+|+++++.++|||||+++.+.+....+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            356799999999999999999995 57999999999876433  334588999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+.+|.+.+++.   +.+.+.+..+..++.|+.++++|||++.   |+|||||++||||+.++++||+|||++..+..
T Consensus       134 ~eya~~ge~~~yl~---~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLV---KHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEeccCchhHHHHH---hcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence            99999999999994   4455777899999999999999999996   99999999999999999999999999998864


Q ss_pred             CCCccccccccccCCCCCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLF-SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ..   ....++|++.|.|||++.+.+| ++.+|+||+|+++|.|+.|..||+                   .+...++-.
T Consensus       208 ~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD-------------------G~~lk~Lr~  265 (596)
T KOG0586|consen  208 GL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD-------------------GQNLKELRP  265 (596)
T ss_pred             cc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC-------------------Ccccccccc
Confidence            43   3346899999999999998876 578999999999999999999973                   233444444


Q ss_pred             cccCCCCCHHH--HHHHHHHhhccccCCCCCCCCHHHHHHHh
Q 007239          526 PLLMKSSSIPQ--VVRCIHIGLLCVQEDPAVRPTMSNVVALL  565 (611)
Q Consensus       526 ~~l~~~~~~~~--~~~l~~li~~cl~~dP~~RPt~~evl~~L  565 (611)
                      +.+.+.+..+.  ..+|-+++..+|-.+|.+|++++++..--
T Consensus       266 rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~  307 (596)
T KOG0586|consen  266 RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR  307 (596)
T ss_pred             hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence            44444444333  34678999999999999999999997644

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=315.05  Aligned_cols=246  Identities=29%  Similarity=0.430  Sum_probs=201.7

Q ss_pred             ccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCChhh
Q 007239          299 KLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDC  377 (611)
Q Consensus       299 ~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~sL~~  377 (611)
                      .||+|.||+||.|++. +...+|||.+..+.......+.+|+.+.++|+|.|||+.+|.+.+++..-|.||.++||+|..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            6999999999999965 455799999988777777889999999999999999999999999999999999999999999


Q ss_pred             HhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec-CCCCEEEeccccceecccCCCccccccc
Q 007239          378 FIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD-KDMVAKISDFGMARIFCENQKTANTRRV  456 (611)
Q Consensus       378 ~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~  456 (611)
                      ++...-....=++...-.+.+||++||.|||++.   |||||||-+||||+ -.|.+||+|||-++.+..  ....+.++
T Consensus       662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF  736 (1226)
T ss_pred             HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence            9854333222378888899999999999999985   99999999999996 578999999999987643  23345568


Q ss_pred             cccCCCCCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCH
Q 007239          457 VGTYGYMAPEYAMEGL--FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSI  534 (611)
Q Consensus       457 ~gt~~y~aPE~~~~~~--~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  534 (611)
                      -||..|||||++-.++  |+.++|||||||.+.||.||++||-......        ...++-|...      .-.+.+.
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq--------AAMFkVGmyK------vHP~iPe  802 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ--------AAMFKVGMYK------VHPPIPE  802 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh--------Hhhhhhccee------cCCCCcH
Confidence            8999999999998764  8999999999999999999999984332211        1112222211      1123344


Q ss_pred             HHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          535 PQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       535 ~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      +...++..++++|...+|.+||++.++++
T Consensus       803 elsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  803 ELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            55667889999999999999999999986

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-37  Score=294.42  Aligned_cols=251  Identities=22%  Similarity=0.244  Sum_probs=199.2

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChh---hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQ---GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      ..++|..++.||+|.||+|.+++. .+++.+|+|+++++-..   ....-..|-.+|+..+||.+..+...|...+.+++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            457899999999999999999994 57899999999876433   33445668899999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||..||.|...+   .+...+++...+.+-.+|+.||.|||+++   ||+||||.+|+|+|.+|++||+|||+.+.-.
T Consensus       246 VMeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  246 VMEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence            99999999998887   34556899999999999999999999985   9999999999999999999999999997421


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                        .....+++++|||.|+|||++....|+.++|+|.+||+||||++|+.||...+.+   .+.+.+    ...   ++- 
T Consensus       320 --~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kLFeLI----l~e---d~k-  386 (516)
T KOG0690|consen  320 --KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KLFELI----LME---DLK-  386 (516)
T ss_pred             --cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HHHHHH----Hhh---hcc-
Confidence              2223456799999999999999999999999999999999999999997533322   222211    111   110 


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCC--CHHHHHHHh
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRP--TMSNVVALL  565 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP--t~~evl~~L  565 (611)
                            .+.....+...|+...|..||.+|.  ..+++.+..
T Consensus       387 ------FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~  422 (516)
T KOG0690|consen  387 ------FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIM  422 (516)
T ss_pred             ------CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHH
Confidence                  1111112345677788999999995  344444433

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=5.4e-36  Score=315.29  Aligned_cols=196  Identities=28%  Similarity=0.373  Sum_probs=169.6

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcC-C-----CCeeeEEEeEeeCCeEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-H-----RNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h-----~niv~l~~~~~~~~~~~  364 (611)
                      -+|++.+.||+|.||.|-++.+ ++++.||||+++... ....+-..|+.+|..|+ |     -|+|+++++|...++++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            3899999999999999999995 579999999998664 34556678999999997 4     38999999999999999


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC--CCEEEeccccce
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD--MVAKISDFGMAR  442 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~--~~~kl~DFGla~  442 (611)
                      ||+|.++. +|.++|..+ +...++...++.++.||+.+|..||+.+   |||+||||+||||...  ..+||+|||.+.
T Consensus       265 iVfELL~~-NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  265 IVFELLST-NLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eeehhhhh-hHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence            99999854 899999664 3455999999999999999999999886   9999999999999644  379999999998


Q ss_pred             ecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 007239          443 IFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGF  498 (611)
Q Consensus       443 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~  498 (611)
                      .......     ..+-+..|+|||++.+.+|+.+.||||||||+.||++|.+-|..
T Consensus       340 ~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  340 FESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             ccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence            7533222     45678899999999999999999999999999999999776643

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1e-35  Score=302.92  Aligned_cols=261  Identities=24%  Similarity=0.320  Sum_probs=194.4

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +|++.+.||+|+||.||+++.. +|+.+++|++.....  .....+.+|+.++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999999964 688999999865321  2235678899999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++ +|.+++..  ....+++..++.++.||++||.|||+.+   ++||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            975 67666633  2345899999999999999999999986   99999999999999999999999999986543221


Q ss_pred             ccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc------cc
Q 007239          450 TANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE------ME  522 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~------~~  522 (611)
                      .  .....+++.|+|||++.+. .++.++||||||+++|+|++|+.|+....  ........+.........      .+
T Consensus       155 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         155 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             C--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC--CHHHHHHHHHHHhCCCChHHhHHhhh
Confidence            1  2234678899999998765 47899999999999999999998853221  111122211111110000      00


Q ss_pred             ccc----cccCCC-----CCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          523 FVD----PLLMKS-----SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       523 ~~d----~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..+    +.....     .......++.+++.+||+.||++|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            000    000000     00112245678999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.9e-35  Score=305.11  Aligned_cols=280  Identities=24%  Similarity=0.307  Sum_probs=201.4

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC--CeEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVGCGIEG--EEKLL  365 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~l  365 (611)
                      .++|++.+.||+|+||.||++.+ .+|+.||+|+++....  .....+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            46899999999999999999996 4689999999864422  1233567899999999999999999998755  56899


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+++ +|.+++...  ...+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999975 777776432  256899999999999999999999987   9999999999999999999999999998764


Q ss_pred             cCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC------
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG------  518 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------  518 (611)
                      .....  .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.....   ......+.......      
T Consensus       160 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~---~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07845         160 LPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE---IEQLDLIIQLLGTPNESIWP  234 (309)
T ss_pred             CccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCChhhch
Confidence            33211  122346788999999875 4578999999999999999999998753222   12222221111100      


Q ss_pred             -----ccccccccccCCCCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHHHh--cCCCCCCCCCCCCCCc
Q 007239          519 -----KEMEFVDPLLMKSSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVALL--GSESIALSEPRQPPFP  581 (611)
Q Consensus       519 -----~~~~~~d~~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~L--~~~~~~l~~~~~p~~~  581 (611)
                           ................     .....+.+++.+||+.||++|||++++++.-  ........+...|.||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~~~~~~  309 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEMMPTFP  309 (309)
T ss_pred             hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCcCCCCC
Confidence                 0000000000000000     0133567899999999999999999998643  2233333344444443

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.1e-35  Score=303.10  Aligned_cols=249  Identities=24%  Similarity=0.359  Sum_probs=198.8

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      .|.....||+|+||.||++.. .+++.|++|.+........+.+.+|+.+++.++||||+++++.+..++..++||||++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            345566899999999999995 4688999999876555556778999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +++|..++.    ...+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++..+.....  
T Consensus       102 ~~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--  172 (297)
T cd06659         102 GGALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--  172 (297)
T ss_pred             CCCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--
Confidence            999988763    245899999999999999999999986   99999999999999999999999999875533221  


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKS  531 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  531 (611)
                      ......|++.|+|||++.+..++.++||||||+++|||++|+.|+.....   ....   .. +.......     ....
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~---~~-~~~~~~~~-----~~~~  240 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAM---KR-LRDSPPPK-----LKNA  240 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHH---HH-HhccCCCC-----cccc
Confidence            12235789999999999988999999999999999999999999753221   1111   11 11111100     0000


Q ss_pred             CCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          532 SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       532 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                        ......+.+++..||+.+|++||+++++++.
T Consensus       241 --~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         241 --HKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             --CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence              0112346688899999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-35  Score=300.51  Aligned_cols=263  Identities=24%  Similarity=0.349  Sum_probs=196.8

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.+.||+|++|.||++... +++.|++|.+..... .....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            368999999999999999999965 688999999865432 223456789999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+.+ +|.+++...  ...+++..+..++.||++||.|||+.+   ++||||||+||+++.++.+||+|||+++......
T Consensus        84 ~~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  157 (291)
T cd07844          84 YLDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS  157 (291)
T ss_pred             cCCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence            9985 888877532  236889999999999999999999986   9999999999999999999999999987543221


Q ss_pred             CccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc----
Q 007239          449 KTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF----  523 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~----  523 (611)
                      ..  .....++..|+|||++.+ ..++.++||||+|+++|+|++|+.||.....  ........+..........+    
T Consensus       158 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         158 KT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             cc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhhhhh
Confidence            11  112356889999998875 4588999999999999999999999753321  11122222221111100000    


Q ss_pred             -----cc---cccCC------CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          524 -----VD---PLLMK------SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       524 -----~d---~~l~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                           ..   .....      .........+.+++..||+.+|++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                 00   00000      001111245678999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.9e-35  Score=300.85  Aligned_cols=244  Identities=26%  Similarity=0.310  Sum_probs=198.4

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++.+.||+|+||.||++.+. +++.+|+|.+....   ....+.+.+|++++++++||||+++++++......++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46889999999999999999964 68899999986542   234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            99999999998843   356899999999999999999999986   999999999999999999999999999875433


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                           .....|++.|+|||.+.+...+.++||||||+++|+|++|+.|+....   .....    +....+..      .
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~----~~~~~~~~------~  216 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIY----EKILEGKV------R  216 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHH----HHHhcCCc------c
Confidence                 223578999999999988889999999999999999999999975332   11111    11111111      0


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVA  563 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  563 (611)
                      +...    ....+.+++.+||+.||++||     +++|+++
T Consensus       217 ~~~~----~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         217 FPSF----FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             CCcc----CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            1111    124567899999999999999     6666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1e-35  Score=300.71  Aligned_cols=255  Identities=24%  Similarity=0.365  Sum_probs=199.5

Q ss_pred             hCCCCcccccCccCceEEEEEEcCC----CcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPN----GKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      .++|.+.+.||+|+||.||+|.+.+    ...|++|...... .+..+.+.+|+.++++++||||+++++++.+ +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3568889999999999999998533    2468999887654 4456789999999999999999999998865 55789


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||+++...
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence            99999999999998532  235899999999999999999999986   9999999999999999999999999998664


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ...... .....+++.|+|||.+....++.++||||||+++|||++ |+.||.....   ......    ...+....  
T Consensus       159 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~----~~~~~~~~--  228 (270)
T cd05056         159 DESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN---NDVIGR----IENGERLP--  228 (270)
T ss_pred             ccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHH----HHcCCcCC--
Confidence            332211 112334568999999988889999999999999999986 9988743321   111111    11221111  


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                         ...    .....+.+++.+|+..+|++|||+.++++.|...
T Consensus       229 ---~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         229 ---MPP----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             ---CCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               011    1123577899999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9.8e-36  Score=301.19  Aligned_cols=255  Identities=25%  Similarity=0.433  Sum_probs=197.7

Q ss_pred             CCcccccCccCceEEEEEEcC----CCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC------
Q 007239          294 FSDSNKLGQGGFGTVYKGVLP----NGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE------  361 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------  361 (611)
                      |++.+.||+|+||.||+|.+.    +++.||+|++...  .....+++.+|+.++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            677889999999999999853    4688999998754  3344677899999999999999999999876532      


Q ss_pred             eEEEEEEecCCCChhhHhhhc---hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecc
Q 007239          362 EKLLIYELMPNRSLDCFIFDS---ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDF  438 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~---~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  438 (611)
                      ..++++||+++++|..++...   .....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            247889999999998877432   12235788999999999999999999986   999999999999999999999999


Q ss_pred             ccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhc
Q 007239          439 GMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKE  517 (611)
Q Consensus       439 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  517 (611)
                      |+++...............+++.|++||.+....++.++||||||+++|||++ |++|+...   ....+....    ..
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~---~~~~~~~~~----~~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV---ENSEIYNYL----IK  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC---CHHHHHHHH----Hc
Confidence            99986643332222223456678999999999899999999999999999999 77776422   122222222    11


Q ss_pred             CccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          518 GKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       518 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ......         .......+.+++.+||+.+|++||++.++++.|++
T Consensus       231 ~~~~~~---------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         231 GNRLKQ---------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             CCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            111100         01122467789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.7e-35  Score=297.36  Aligned_cols=254  Identities=25%  Similarity=0.352  Sum_probs=200.7

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee--CCeEEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE--GEEKLLIY  367 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~lv~  367 (611)
                      +|++.+.||.|+||.||++.. .+++.+++|.+...  .....+++.+|+++++.++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            478899999999999999995 46788999998643  23445678899999999999999999997754  45679999


Q ss_pred             EecCCCChhhHhhhc-hhhccCCHHHHHHHHHHHHHHHHHHhhcC--CCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          368 ELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDS--RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       368 E~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~--~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      ||+++++|.+++... .....+++..++.++.||+.||.|||..+  ..+++|+||||+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999988542 22456899999999999999999999322  234999999999999999999999999999876


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ......  .....|++.|+|||++.+..++.++|+||||+++|+|++|+.|+....   ...+.    +....+...   
T Consensus       161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~----~~~~~~~~~---  228 (265)
T cd08217         161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLA----SKIKEGKFR---  228 (265)
T ss_pred             cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHH----HHHhcCCCC---
Confidence            443321  223578999999999999899999999999999999999999975432   11111    112222111   


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                            ..+.....++.+++.+||+.+|++||++.+|++.
T Consensus       229 ------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 ------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                  1111223467799999999999999999999873

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=312.85  Aligned_cols=246  Identities=29%  Similarity=0.418  Sum_probs=198.2

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecc---cChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSR---KSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ...|..++.||.|+||.||.+++ .+.+.||||+..-   .+.+.+..+..|+..|++++|||++.+.+||..+...|||
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV  104 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV  104 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence            34577889999999999999995 5788899999863   3445678899999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      ||||-| +-.|++-  ..++++.+.++..|..+.+.||.|||+.+   .||||||..|||+++.|.|||+|||.|....+
T Consensus       105 MEYClG-SAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P  178 (948)
T KOG0577|consen  105 MEYCLG-SASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP  178 (948)
T ss_pred             HHHHhc-cHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc
Confidence            999976 6666663  33467889999999999999999999986   99999999999999999999999999986533


Q ss_pred             CCCccccccccccCCCCCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAM---EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                            .+.++|||.|||||++.   .|.|+-|+||||||++..||...++|.-...  .-..+..     +..+.    
T Consensus       179 ------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN--AMSALYH-----IAQNe----  241 (948)
T KOG0577|consen  179 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYH-----IAQNE----  241 (948)
T ss_pred             ------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch--HHHHHHH-----HHhcC----
Confidence                  33589999999999986   5889999999999999999999998852111  1111111     11111    


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       .|.+.   +......+..++-.||+.-|++|||.++++.
T Consensus       242 -sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  242 -SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             -CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence             12222   2333445678888999999999999998765

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1e-34  Score=296.40  Aligned_cols=258  Identities=26%  Similarity=0.334  Sum_probs=201.1

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC--CeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRLVGCGIEG--EEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lv~  367 (611)
                      ++|+..++||.|++|.||++.. .+++.+|+|.+..... .....+.+|++++++++||||+++++++...  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            4688899999999999999996 4688899999875432 3456789999999999999999999988653  4689999


Q ss_pred             EecCCCChhhHhhhc-hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          368 ELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       368 E~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      ||+++++|.+++... .....+++..+..++.||+.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999998887532 23445889999999999999999999986   99999999999999999999999999875432


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC--chhhHHHHHHHHHhcCcccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--HAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ...    ....++..|+|||.+.+..++.++||||||+++|+|++|+.|+......  ....+..+    ........+.
T Consensus       158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~  229 (287)
T cd06621         158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSY----IVNMPNPELK  229 (287)
T ss_pred             ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHH----HhcCCchhhc
Confidence            221    2346788999999999999999999999999999999999998654321  11112111    1111111111


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      +. ..  ........+.+++.+||+.+|++|||+.||++
T Consensus       230 ~~-~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         230 DE-PG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             cC-CC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            11 10  01123346789999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4.1e-35  Score=299.81  Aligned_cols=264  Identities=25%  Similarity=0.327  Sum_probs=196.0

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQ-GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++++|++.+.||+|+||.||+|.. .+++.|++|++...... ....+.+|+.+++.++|+||+++++++......++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            357899999999999999999985 46889999998754322 2346788999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+. ++|..++..  ....+.+..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQ--HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9996 566665533  2245788889999999999999999986   999999999999999999999999999754322


Q ss_pred             CCccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCc-------
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK-------  519 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-------  519 (611)
                      ...  .....+++.|+|||++.+. .++.++||||||+++|+|++|+.||.....  ....+...|..+....       
T Consensus       157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07870         157 SQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWPGV  232 (291)
T ss_pred             CCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhhhh
Confidence            211  1234578999999998764 578899999999999999999999853322  1122222222111100       


Q ss_pred             ------cccccccccCCC-----CCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          520 ------EMEFVDPLLMKS-----SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       520 ------~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                            ..+.........     ........+.+++.+|++.||++|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         233 SKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                  000000000000     00111235668899999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2e-35  Score=295.68  Aligned_cols=248  Identities=27%  Similarity=0.388  Sum_probs=198.9

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +|+..+.||+|+||.||++.. .+++.+++|.+....  ......+.+|+.+++.++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            588899999999999999995 468889999987542  33467789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC-CCEEEeccccceecccCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD-MVAKISDFGMARIFCENQ  448 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~-~~~kl~DFGla~~~~~~~  448 (611)
                      +++++|.+++... ....+++..+..++.|++++|.|||+++   ++|+||||+||+++.+ +.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            9999999998542 2345899999999999999999999986   9999999999999865 468999999998764332


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                      .   .....|++.|+|||.+.+..++.++||||||+++|+|++|+.|+.....   .......    .......+.+   
T Consensus       157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~----~~~~~~~~~~---  223 (256)
T cd08220         157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKI----MSGTFAPISD---  223 (256)
T ss_pred             c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHHHH----HhcCCCCCCC---
Confidence            2   2235688999999999988899999999999999999999998743221   1111111    1111111111   


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                            .....+.+++.+||+.+|++|||++|+++
T Consensus       224 ------~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         224 ------RYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ------CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                  12335678999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.9e-35  Score=300.53  Aligned_cols=251  Identities=25%  Similarity=0.390  Sum_probs=202.5

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      .++|++.+.||+|+||.||++.. .+++.|++|.+........+.+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            46899999999999999999985 46788999998765555567789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++..    ..+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            999999998842    34789999999999999999999987   99999999999999999999999999876543322


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                        ......|++.|++||.+..+.++.++||||||+++|+|++|+.||........      .......+.      +...
T Consensus       171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~------~~~~~~~~~------~~~~  236 (293)
T cd06647         171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNGT------PELQ  236 (293)
T ss_pred             --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh------eeehhcCCC------CCCC
Confidence              12234688999999999988899999999999999999999999853322110      000011110      0000


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                        ........+.+++..||+.+|++||++++++..
T Consensus       237 --~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         237 --NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             --CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              011122356789999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.9e-35  Score=298.63  Aligned_cols=258  Identities=26%  Similarity=0.346  Sum_probs=199.5

Q ss_pred             HHHHhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeC---
Q 007239          286 VIKAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEG---  360 (611)
Q Consensus       286 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~---  360 (611)
                      .+..+.++|.+.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.+++++ +|||++++++++...   
T Consensus        16 ~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~   94 (291)
T cd06639          16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL   94 (291)
T ss_pred             cCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence            3445678899999999999999999996 568899999986543 2345678899999999 799999999998754   


Q ss_pred             --CeEEEEEEecCCCChhhHhhhc-hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEec
Q 007239          361 --EEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISD  437 (611)
Q Consensus       361 --~~~~lv~E~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~D  437 (611)
                        ...++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|
T Consensus        95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~d  171 (291)
T cd06639          95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVD  171 (291)
T ss_pred             CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEee
Confidence              3589999999999999887532 23356899999999999999999999986   99999999999999999999999


Q ss_pred             cccceecccCCCccccccccccCCCCCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHH
Q 007239          438 FGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG-----LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW  512 (611)
Q Consensus       438 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~  512 (611)
                      ||++.........  .....|+..|+|||++...     .++.++|||||||++|||++|+.|+.....  ...    ..
T Consensus       172 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~--~~~----~~  243 (291)
T cd06639         172 FGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKT----LF  243 (291)
T ss_pred             cccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH--HHH----HH
Confidence            9999865432221  1234688999999987644     368899999999999999999999743211  111    11


Q ss_pred             HHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       513 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      + +.......+.++       ......+.+++.+||+.+|++||++.|+++
T Consensus       244 ~-~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         244 K-IPRNPPPTLLHP-------EKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             H-HhcCCCCCCCcc-------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1 111111111111       112235779999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.2e-35  Score=297.56  Aligned_cols=247  Identities=27%  Similarity=0.413  Sum_probs=198.8

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      -|++.+.||+|+||.||+|.+ .+++.+|+|.+.... ......+.+|+.++++++||||+++++.+..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            477888999999999999985 468899999886443 334567889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++++|..++.    ...+++..+..++.|++.++.|||+.+   ++|+||||+||+++.++.++|+|||++........ 
T Consensus        85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence            9999998873    245899999999999999999999986   99999999999999999999999999976543221 


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                       ......|+..|+|||++.+..++.++|+||||+++|+|++|..|+.....   .....    .......     +.+. 
T Consensus       157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~----~~~~~~~-----~~~~-  222 (277)
T cd06641         157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLF----LIPKNNP-----PTLE-  222 (277)
T ss_pred             -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHH----HHhcCCC-----CCCC-
Confidence             12234688899999999988899999999999999999999998743211   11111    1111111     1111 


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                         ......+.+++.+||+.+|++||++.++++.
T Consensus       223 ---~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         223 ---GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ---cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence               1123456789999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=303.77  Aligned_cols=247  Identities=28%  Similarity=0.330  Sum_probs=201.5

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      ..+.|+.-+.||+|+||+|+-++. .+|+-+|.|++.++..   ++.....+|-.||.+++.+.||.+-..|+..+.+++
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            356789999999999999999994 5799999998865432   334456889999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      |+..|+||+|...|.+... ..+++..++.++.+|+.||++||+..   ||+||+||+|||+|+.|+++|+|.|+|..+.
T Consensus       263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence            9999999999998876443 56999999999999999999999986   9999999999999999999999999999887


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      +.+...   ..+||.+|||||++.++.|+...|+|||||+||||+.|+.||........                .+-+|
T Consensus       339 ~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----------------~eEvd  399 (591)
T KOG0986|consen  339 EGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----------------REEVD  399 (591)
T ss_pred             CCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh----------------HHHHH
Confidence            665443   23899999999999999999999999999999999999999742211110                01111


Q ss_pred             ccc---CCCCCHHHHHHHHHHhhccccCCCCCCCCHH
Q 007239          526 PLL---MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMS  559 (611)
Q Consensus       526 ~~l---~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  559 (611)
                      +..   ...++.....++.+|....|+.||++|..-+
T Consensus       400 rr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  400 RRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            111   1123334445566777788999999997544

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.2e-34  Score=291.38  Aligned_cols=252  Identities=29%  Similarity=0.474  Sum_probs=200.2

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +|.+.+.||+|+||.||++.. .+++.|++|.+.....  .....+.+|+.+++.++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            588899999999999999995 4788999999876544  3567899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999998843   345789999999999999999999987   99999999999999999999999999987644332


Q ss_pred             ccc--cccccccCCCCCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          450 TAN--TRRVVGTYGYMAPEYAMEGL---FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       450 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ...  .....+++.|+|||++....   ++.++||||||+++|+|++|+.||.....  ..   ....... .+..    
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~---~~~~~~~-~~~~----  224 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EF---QIMFHVG-AGHK----  224 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hH---HHHHHHh-cCCC----
Confidence            211  12356788999999998766   88999999999999999999999853321  11   1111101 1111    


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       +.+..  .......+.+++.+||+.+|++||++.+++.
T Consensus       225 -~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 -PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             -CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             01111  1111234568899999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.7e-35  Score=299.65  Aligned_cols=255  Identities=25%  Similarity=0.382  Sum_probs=197.2

Q ss_pred             HHHhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEee-----
Q 007239          287 IKAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIE-----  359 (611)
Q Consensus       287 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~-----  359 (611)
                      +....+.|++.+.||+|+||.||++.. .+++.+|+|++.... .....+..|+.+++++ +|+||+++++++..     
T Consensus        11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             hcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            334567899999999999999999996 468889999986543 3346688899999998 69999999999853     


Q ss_pred             -CCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecc
Q 007239          360 -GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDF  438 (611)
Q Consensus       360 -~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  438 (611)
                       ....+++|||+++++|.+++... ....+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.++|+||
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~df  165 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDF  165 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeC
Confidence             45789999999999999988542 2345788889999999999999999986   999999999999999999999999


Q ss_pred             ccceecccCCCccccccccccCCCCCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHH
Q 007239          439 GMARIFCENQKTANTRRVVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ  513 (611)
Q Consensus       439 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~  513 (611)
                      |++........  ......|++.|+|||.+.     ...++.++||||||+++|||++|+.||......  ..+.    .
T Consensus       166 g~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~--~~~~----~  237 (282)
T cd06636         166 GVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM--RALF----L  237 (282)
T ss_pred             cchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH--hhhh----h
Confidence            99876532221  123457899999999876     346788999999999999999999997432211  1010    0


Q ss_pred             HHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       514 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .... .     ...+.   .......+.+++..||+.||.+||++.|+++
T Consensus       238 ~~~~-~-----~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 IPRN-P-----PPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             HhhC-C-----CCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            0000 0     00010   0112245778999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-35  Score=297.00  Aligned_cols=247  Identities=25%  Similarity=0.418  Sum_probs=198.1

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcC---CCCeeeEEEeEeeCCeEEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQ---HRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~lv~  367 (611)
                      .|++.+.||+|+||.||+|.+ .+++.+++|.+... .....+.+.+|+.++++++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            578889999999999999995 57889999998754 3344567889999999997   999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++..    ..+++..++.++.||+.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999988732    36899999999999999999999987   999999999999999999999999999876543


Q ss_pred             CCccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ..  ......|+..|+|||.+.++ .++.++||||||+++|+|++|+.|+.......      ... ......     .+
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~~-~~~~~~-----~~  220 (277)
T cd06917         155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AMM-LIPKSK-----PP  220 (277)
T ss_pred             cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hhh-ccccCC-----CC
Confidence            32  22335789999999988754 46899999999999999999999985322111      010 001110     01


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .+...   ....++.+++.+||+.||++||++.+++.
T Consensus       221 ~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         221 RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            11111   12345778999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-35  Score=296.20  Aligned_cols=254  Identities=26%  Similarity=0.360  Sum_probs=199.1

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCC------
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGE------  361 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~------  361 (611)
                      .+++|++.+.||+|++|.||++... +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4689999999999999999999964 678899999876543 346789999999999 6999999999987644      


Q ss_pred             eEEEEEEecCCCChhhHhhhch-hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccc
Q 007239          362 EKLLIYELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGM  440 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  440 (611)
                      ..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            4899999999999998885422 2456899999999999999999999986   99999999999999999999999999


Q ss_pred             ceecccCCCccccccccccCCCCCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHH
Q 007239          441 ARIFCENQKTANTRRVVGTYGYMAPEYAME-----GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLW  515 (611)
Q Consensus       441 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~  515 (611)
                      +........  ......|++.|+|||++..     ..++.++||||||+++|+|++|+.|+.....  ...+.    + .
T Consensus       160 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~----~-~  230 (275)
T cd06608         160 SAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--MRALF----K-I  230 (275)
T ss_pred             ceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--HHHHH----H-h
Confidence            976533221  1223568999999998753     3467899999999999999999999742211  11111    1 1


Q ss_pred             hcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          516 KEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       516 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ......     .+..  .......+.+++.+||..||++|||+.++++
T Consensus       231 ~~~~~~-----~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 PRNPPP-----TLKS--PENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hccCCC-----CCCc--hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            111111     1111  1112346779999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.1e-35  Score=298.85  Aligned_cols=261  Identities=25%  Similarity=0.313  Sum_probs=196.5

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC--CeEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVGCGIEG--EEKLLI  366 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lv  366 (611)
                      ++|++.+.||+|+||.||+|.+. +++.+++|.++....  .....+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57899999999999999999965 688899999875432  2234567899999999999999999998877  889999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++ +|.+++...  ...+++..++.++.||+.||.|||+++   ++|+||||+||+++.++.+||+|||++..+..
T Consensus        85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            999985 888877432  235899999999999999999999987   99999999999999999999999999987654


Q ss_pred             CCCccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH-----------
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL-----------  514 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~-----------  514 (611)
                      ....  .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||......   .....+...           
T Consensus       159 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~  233 (293)
T cd07843         159 PLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI---DQLNKIFKLLGTPTEKIWPG  233 (293)
T ss_pred             Cccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHhCCCchHHHHH
Confidence            3221  2234678899999988764 4689999999999999999999997543321   111111111           


Q ss_pred             Hhc------CccccccccccCCCCCHH-HHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          515 WKE------GKEMEFVDPLLMKSSSIP-QVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       515 ~~~------~~~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      +..      ..........+....+.. ....+.+++..||+.+|++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         234 FSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            100      000000000111111111 2344678999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=315.99  Aligned_cols=252  Identities=29%  Similarity=0.389  Sum_probs=203.7

Q ss_pred             CCCcccccCccCceEEEEEEcC--CCc--EEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP--NGK--EVAVKRLSRKSWQ-GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      +.+..++||+|.||+|++|.|.  +|+  .||||.++..... ..+.|.+|+.+|.+|+|+|++++||+..+ ....+||
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~  189 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF  189 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence            3456689999999999999985  354  4899999876544 67889999999999999999999999887 7788999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      |+++.|+|.+.|.+ ..+..|-...+..++.|||.||.||.+++   +|||||...|+|+-....|||+||||.+.++.+
T Consensus       190 ELaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hhcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            99999999999976 45667888999999999999999999996   999999999999999999999999999988765


Q ss_pred             CCccccc-cccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          448 QKTANTR-RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       448 ~~~~~~~-~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      .....+. ...-.+.|+|||.+....|+.++|||+|||+||||++ |..||-.   .....+++             .+|
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G---~~g~qIL~-------------~iD  329 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG---CRGIQILK-------------NID  329 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC---CCHHHHHH-------------hcc
Confidence            5443322 2334567999999999999999999999999999998 4566521   11222222             222


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHh
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL  565 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  565 (611)
                      ..-.-..+....+++.+++..||..+|++|||+..|.+.+
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            1111122345567788999999999999999999997443

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-35  Score=324.52  Aligned_cols=268  Identities=22%  Similarity=0.284  Sum_probs=187.3

Q ss_pred             HhhCCCCcccccCccCceEEEEEEcCC--CcEEEEE------------------EecccChhhHHHHHHHHHHHHhcCCC
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVLPN--GKEVAVK------------------RLSRKSWQGLEEFKNEIILIAKLQHR  348 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~il~~l~h~  348 (611)
                      ...++|++.++||+|+||+||++..+.  +...+.|                  .+. ........+.+|+.++++++||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence            345789999999999999999987431  2222222                  111 1112345688999999999999


Q ss_pred             CeeeEEEeEeeCCeEEEEEEecCCCChhhHhhhchh--hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEE
Q 007239          349 NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSER--RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVL  426 (611)
Q Consensus       349 niv~l~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIl  426 (611)
                      ||+++++++...+..++|+|++.+ +|..++.....  ........+..++.||+.||.|||+++   |+||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence            999999999999999999999865 56565543211  122345677889999999999999986   999999999999


Q ss_pred             ecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCCCchh
Q 007239          427 LDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRN-SGFYLTGHAQ  505 (611)
Q Consensus       427 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p-~~~~~~~~~~  505 (611)
                      ++.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.+ +.........
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             ECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            999999999999999876433221 22246799999999999999999999999999999999998754 3322222222


Q ss_pred             hHHHHHHHHHhcCccccccc----------cc-cC-CCCCHH-------HHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          506 TLLAYVWQLWKEGKEMEFVD----------PL-LM-KSSSIP-------QVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       506 ~l~~~~~~~~~~~~~~~~~d----------~~-l~-~~~~~~-------~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      .+...+. .+.. ...++.+          .. +. .....+       ...++.+++.+||+.||++|||+.|+++.
T Consensus       379 ~~~~~~~-~~~~-~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        379 QLLKIID-SLSV-CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHH-hccc-ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            2222111 1000 0000000          00 00 000000       11245677889999999999999999863

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.8e-34  Score=287.23  Aligned_cols=249  Identities=29%  Similarity=0.445  Sum_probs=202.7

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      +|+..+.||+|++|.||++... +++.+++|++..........+.+|+.++++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999999965 688999999987665566789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +++|.+++....  ..+++..+..++.|++++|.+||+.+   ++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999999884422  46899999999999999999999986   99999999999999999999999999987644332  


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKS  531 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  531 (611)
                       .....|+..|++||++.+..++.++||||||+++|+|++|+.|+......      ..... ............     
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~~~~~-----  220 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFK-IATNGPPGLRNP-----  220 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHH-HHhcCCCCcCcc-----
Confidence             23457899999999999888999999999999999999999987432211      11111 111111111111     


Q ss_pred             CCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          532 SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       532 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                        ......+.+++.+||+.||++|||+.++++
T Consensus       221 --~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         221 --EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             --cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              101245778999999999999999999986

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5.6e-35  Score=297.43  Aligned_cols=262  Identities=27%  Similarity=0.367  Sum_probs=197.8

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      +|++.++||.|++|.||+|+.. +|+.||+|.++.... ...+.+.+|+.++++++||||+++++.+...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999999964 688999999875532 23466788999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++ +|.+++........+++..+..++.||++||.|||+.+   ++||||||+||++++++.++|+|||++.........
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            86 78777755444456899999999999999999999986   999999999999999999999999999765332211


Q ss_pred             cccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCc--------cc
Q 007239          451 ANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK--------EM  521 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--------~~  521 (611)
                        .....+++.|++||++.+. .++.++||||||+++|+|++|+.|+......   ..............        ..
T Consensus       157 --~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07836         157 --FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE---DQLLKIFRIMGTPTESTWPGISQL  231 (284)
T ss_pred             --cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCCChhhHHHHhcC
Confidence              1224578899999988664 5788999999999999999999987543221   11111111110000        00


Q ss_pred             cccccccCCC-------CCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          522 EFVDPLLMKS-------SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       522 ~~~d~~l~~~-------~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..+.......       ........+.+++.+||+.||++||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0000000000       00011235678999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1e-34  Score=305.41  Aligned_cols=260  Identities=25%  Similarity=0.298  Sum_probs=196.4

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC------
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG------  360 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------  360 (611)
                      ..++|++.+.||+|+||.||++.. .+++.||+|++...  .......+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999995 47899999998643  233456778899999999999999999987643      


Q ss_pred             CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccc
Q 007239          361 EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGM  440 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  440 (611)
                      ...++||||+.+ +|.+.+..     .+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            357999999975 77666632     2888999999999999999999986   99999999999999999999999999


Q ss_pred             ceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHH-------
Q 007239          441 ARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ-------  513 (611)
Q Consensus       441 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~-------  513 (611)
                      ++.......   .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+...   ....+..       
T Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~  238 (353)
T cd07850         165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID---QWNKIIEQLGTPSD  238 (353)
T ss_pred             ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence            986543221   223468899999999999999999999999999999999999975332111   1111100       


Q ss_pred             -----------HHhc-Cc------cccccccccC----CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          514 -----------LWKE-GK------EMEFVDPLLM----KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       514 -----------~~~~-~~------~~~~~d~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                                 .+.. ..      ..+.....+.    ..........+.+++.+||+.||++|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                       0000 00      0001111100    00011223456799999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.7e-35  Score=295.48  Aligned_cols=247  Identities=26%  Similarity=0.313  Sum_probs=199.8

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      +|++.+.||.|+||.||++... +++.|++|.+.+..   ....+.+.+|++++++++||||+++++.+.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5888999999999999999965 68899999987543   2346788999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++++|.+++..   ...+++..+..++.||+++|.|||+.+   ++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            9999999998843   357899999999999999999999986   9999999999999999999999999998654332


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                         ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+.........    ......... . .    . 
T Consensus       155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~-~-~----~-  220 (258)
T cd05578         155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD----QIRAKQETA-D-V----L-  220 (258)
T ss_pred             ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH----HHHHHhccc-c-c----c-
Confidence               122356888999999999888999999999999999999999997544332111    111111110 0 0    0 


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCH--HHHH
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTM--SNVV  562 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl  562 (611)
                         .+......+.+++.+||+.||++||+.  +|++
T Consensus       221 ---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         221 ---YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ---CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence               111122567789999999999999999  5544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-37  Score=292.97  Aligned_cols=248  Identities=25%  Similarity=0.386  Sum_probs=203.8

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      +-|.++.+||+|+||.||++.++ .|+.+|||.+....  +..++..|+.|+++...|++|+.|+.+.....+|+|||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            44778899999999999999965 69999999987654  4678899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ..|+..+++.  .+++++.++++..+++.-+.||+|||.-   +-||||||..|||++.+|+.||+|||.|..+.+.-  
T Consensus       111 GAGSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--  183 (502)
T KOG0574|consen  111 GAGSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--  183 (502)
T ss_pred             CCCcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH--
Confidence            9999999984  4667899999999999999999999986   48999999999999999999999999997654322  


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                      ...++..|||-|||||++..-.|+.++||||||+...||..|++|+...-+                ....-++-..-..
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP----------------MRAIFMIPT~PPP  247 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP----------------MRAIFMIPTKPPP  247 (502)
T ss_pred             HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc----------------cceeEeccCCCCC
Confidence            223468999999999999999999999999999999999999999742111                0000001101111


Q ss_pred             CC--CHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          531 SS--SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       531 ~~--~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ..  +..-..++-+++..||-.+|++|-|+.++++.
T Consensus       248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            11  12223456789999999999999999888763

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-35  Score=308.39  Aligned_cols=267  Identities=23%  Similarity=0.317  Sum_probs=196.9

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC-----CeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG-----EEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~~  363 (611)
                      .++|++.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            47899999999999999999995 478999999986432 23456688899999999999999999876544     357


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ++|+||+.+ +|...+.    ...+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999975 6666652    245899999999999999999999987   99999999999999999999999999986


Q ss_pred             cccCCCcc-ccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc
Q 007239          444 FCENQKTA-NTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM  521 (611)
Q Consensus       444 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  521 (611)
                      ........ ......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.....   .................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~---~~~~~~~~~~~~~~~~~  232 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY---LHQLNLILGVLGTPSQE  232 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHcCCCCHH
Confidence            54322211 1223578999999998755 5689999999999999999999998743221   11111111111110000


Q ss_pred             c---ccc-------cccCC--CCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHHH--hcCC
Q 007239          522 E---FVD-------PLLMK--SSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVAL--LGSE  568 (611)
Q Consensus       522 ~---~~d-------~~l~~--~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~  568 (611)
                      .   ..+       .....  ....     ....++.+++.+||+.+|++|||+.++++.  |...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            0   000       00000  0000     112457799999999999999999999986  5443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.9e-35  Score=299.05  Aligned_cols=263  Identities=27%  Similarity=0.339  Sum_probs=193.7

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh--hhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCe-----
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEE-----  362 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~-----  362 (611)
                      ++|++.+.||+|+||.||++.+. +++.||+|++.....  .....+.+|+.+++.+. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46899999999999999999964 688999998765432  23456888999999995 6999999999887665     


Q ss_pred             EEEEEEecCCCChhhHhhhchh--hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC-CCCEEEeccc
Q 007239          363 KLLIYELMPNRSLDCFIFDSER--RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK-DMVAKISDFG  439 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFG  439 (611)
                      .++||||+++ +|.+++.....  ...+++..++.++.||++||.|||+++   ++||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999986 78777754222  346899999999999999999999986   999999999999998 8899999999


Q ss_pred             cceecccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC
Q 007239          440 MARIFCENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG  518 (611)
Q Consensus       440 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  518 (611)
                      ++..+......  .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.....  ...+.. +...+...
T Consensus       157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~~~~-~~~~~~~~  231 (295)
T cd07837         157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE--LQQLLH-IFKLLGTP  231 (295)
T ss_pred             cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHH-HHHHhCCC
Confidence            99865332211  112356889999998865 4578999999999999999999998753221  111111 11111111


Q ss_pred             cccccc------c----cccC----CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          519 KEMEFV------D----PLLM----KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       519 ~~~~~~------d----~~l~----~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ....+.      +    +...    .........++.+++.+||+.||++||++.|++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000000      0    0000    0000112345778999999999999999999885

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.1e-34  Score=293.86  Aligned_cols=248  Identities=25%  Similarity=0.370  Sum_probs=199.2

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      .|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            355567999999999999995 4688999999876555556778999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +++|.+++..    ..+++..+..++.||+.+|.|||+++   ++||||||+||+++.++.++|+|||++........  
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--  170 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--  170 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence            9999998743    45899999999999999999999987   99999999999999999999999998875533221  


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKS  531 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  531 (611)
                      ......|++.|+|||.+.+..++.++||||||+++|+|++|+.|+....   .......    ......     +.+...
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~---~~~~~~~----~~~~~~-----~~~~~~  238 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP---PLQAMKR----IRDNLP-----PKLKNL  238 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC---HHHHHHH----HHhcCC-----CCCccc
Confidence            1223568999999999998889999999999999999999999974321   1111111    111111     111111


Q ss_pred             CCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          532 SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       532 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                        ......+.+++.+||+.+|++||++.++++
T Consensus       239 --~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         239 --HKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             --ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence              112245779999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.3e-36  Score=311.36  Aligned_cols=246  Identities=26%  Similarity=0.373  Sum_probs=193.4

Q ss_pred             CCcccccCccCceEEEEEEcC-CCcEEEEEEecc----cChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe--EEEE
Q 007239          294 FSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSR----KSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE--KLLI  366 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~----~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~--~~lv  366 (611)
                      .+....||+|+|-+||+|.+. +|-+||--.++.    .+....++|..|+.+|+.|+||||+++++.+.+...  +.+|
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            345678999999999999964 576776443321    234556899999999999999999999999987655  7899


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC-CCCEEEeccccceecc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK-DMVAKISDFGMARIFC  445 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGla~~~~  445 (611)
                      +|.+..|+|..++   .+.+.++...+..|++||++||.|||++. ++|||||||.+||||+. .|.|||+|+|||....
T Consensus       122 TEL~TSGtLr~Y~---kk~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  122 TELFTSGTLREYR---KKHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             eecccCCcHHHHH---HHhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            9999999999998   45566899999999999999999999984 79999999999999985 5899999999998764


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ....    +..+|||.|||||+.. ..|++.+||||||+.|+||+|+..|+..  -.....+...+....+......+- 
T Consensus       198 ~s~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE--C~n~AQIYKKV~SGiKP~sl~kV~-  269 (632)
T KOG0584|consen  198 KSHA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE--CTNPAQIYKKVTSGIKPAALSKVK-  269 (632)
T ss_pred             cccc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh--hCCHHHHHHHHHcCCCHHHhhccC-
Confidence            4332    3479999999999876 7899999999999999999999998632  122222222222211111111111 


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                                 ..++.+||..||.. .++|||+.|+|.
T Consensus       270 -----------dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  270 -----------DPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             -----------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                       12456788899999 999999999986

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.8e-35  Score=297.17  Aligned_cols=252  Identities=25%  Similarity=0.358  Sum_probs=191.9

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC-hhhHHHHHHHHHH-HHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS-WQGLEEFKNEIIL-IAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~i-l~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ++|++.+.||+|+||.||++++. +|+.||+|+++... ......+..|+.+ ++.++||||+++++++..+...+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46889999999999999999964 68999999987542 2233455566665 666789999999999999999999999


Q ss_pred             ecCCCChhhHhhhc-hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          369 LMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       369 ~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      |++ ++|.+++... .....+++..++.++.||+.||.|||++.  +++||||||+||+++.++.+||+|||++..+...
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            997 5777776432 23356899999999999999999999861  3999999999999999999999999999865332


Q ss_pred             CCccccccccccCCCCCcccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAME----GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      .   ......|+..|+|||.+.+    ..++.++|+||||+++|+|++|+.|+..... ...    ....... +....+
T Consensus       158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~----~~~~~~~-~~~~~~  228 (283)
T cd06617         158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-PFQ----QLKQVVE-EPSPQL  228 (283)
T ss_pred             c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-CHH----HHHHHHh-cCCCCC
Confidence            1   1123468899999998864    4568899999999999999999999743221 111    1111111 111111


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ...        ....++.+++..||+.+|++||++.++++
T Consensus       229 ~~~--------~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         229 PAE--------KFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             Ccc--------ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            100        11245778999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=6.8e-35  Score=296.90  Aligned_cols=260  Identities=24%  Similarity=0.332  Sum_probs=194.8

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +|++.+.||+|++|.||+++.. +++.|++|++....  ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4888999999999999999964 68899999886442  22345788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +. ++|..++... ....+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 5787777432 2356899999999999999999999986   99999999999999999999999999876533221


Q ss_pred             ccccccccccCCCCCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCc---------
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK---------  519 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---------  519 (611)
                      .  .....+++.|+|||++.+.. ++.++||||||+++|||++|+.||.....  ...+.... +......         
T Consensus       156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~-~~~~~~~~~~~~~~~~  230 (284)
T cd07860         156 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFRIF-RTLGTPDEVVWPGVTS  230 (284)
T ss_pred             c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHH-HHhCCCChhhhhhhhH
Confidence            1  12235788999999887654 68899999999999999999998753221  11111111 1100000         


Q ss_pred             -------cccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          520 -------EMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       520 -------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                             ........+.. .......++.+++.+||+.||++|||+++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         231 LPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                   00000000000 00011234668999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.4e-34  Score=302.46  Aligned_cols=264  Identities=26%  Similarity=0.336  Sum_probs=196.7

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc--ChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeC--CeE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK--SWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEG--EEK  363 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~--~~~  363 (611)
                      ..++|++.+.||+|+||.||+|.+. +++.+++|++...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4578999999999999999999965 6888999988542  223445678899999999 999999999987643  468


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ++||||+++ +|..++..    ..+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        85 ~lv~e~~~~-~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYMET-DLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEeccccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            999999975 88777732    26889999999999999999999986   99999999999999999999999999986


Q ss_pred             cccCCCc---cccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHH----
Q 007239          444 FCENQKT---ANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLW----  515 (611)
Q Consensus       444 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~----  515 (611)
                      .......   .......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||.......   .........    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~---~~~~~~~~~~~~~  233 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN---QLEKIIEVIGPPS  233 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCC
Confidence            6433221   12234578999999998765 457889999999999999999999975432211   111111110    


Q ss_pred             -------hcCccccccccccCCC-CC-----HHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          516 -------KEGKEMEFVDPLLMKS-SS-----IPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       516 -------~~~~~~~~~d~~l~~~-~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                             ......++++...... ..     .....++.+++.+||+.+|++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                   0000011111000000 00     0023467899999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.6e-34  Score=294.67  Aligned_cols=254  Identities=27%  Similarity=0.390  Sum_probs=203.7

Q ss_pred             HhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ...+.|+..+.||+|++|.||++.++ +++.+++|++..... ..+.+.+|+++++.++|+|++++++.+......++++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            34577899999999999999999975 688999999976544 4667889999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++....  ..+++..+..++.||+.+|.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            9999999999985422  37999999999999999999999986   999999999999999999999999998755332


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                      ..  ......+++.|++||++.+..++.++||||||+++|+|++|+.|+......   ....   . +.........   
T Consensus       170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~~~---~-~~~~~~~~~~---  237 (286)
T cd06614         170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RALF---L-ITTKGIPPLK---  237 (286)
T ss_pred             hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHHH---H-HHhcCCCCCc---
Confidence            21  122346788999999999888999999999999999999999997432211   1111   1 1111111100   


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                        .  .......+.+++.+||+.+|.+||++.++++.
T Consensus       238 --~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         238 --N--PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             --c--hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence              0  01122457789999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-35  Score=295.69  Aligned_cols=260  Identities=24%  Similarity=0.338  Sum_probs=196.6

Q ss_pred             CCcccccCccCceEEEEEEcC-CCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC--CeEEEEEE
Q 007239          294 FSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG--EEKLLIYE  368 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lv~E  368 (611)
                      |++.+.||+|++|.||++++. +++.+++|++....  ......+.+|+.+++.++|+|++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            677899999999999999965 58899999998653  33346688999999999999999999999888  89999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++ +|..++...  ...+++..++.++.||++||.|||+.+   ++|+||||+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9985 787777432  246899999999999999999999986   9999999999999999999999999998764433


Q ss_pred             CccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc----
Q 007239          449 KTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF----  523 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~----  523 (611)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.....   ......+...........+    
T Consensus       155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE---LEQLEKIFELCGSPTDENWPGVS  230 (287)
T ss_pred             cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCchhhccccc
Confidence            21 1223456888999998765 4578999999999999999999998753332   1112222111111100000    


Q ss_pred             -------------cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          524 -------------VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       524 -------------~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                                   ....+...........+.+++.+||+.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                         0000000000001346789999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.9e-34  Score=295.98  Aligned_cols=247  Identities=27%  Similarity=0.392  Sum_probs=194.0

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .+.|.+.+.||+|+||.||++... +++.|++|.+....   .+....+.+|+.+++.++||||+++++++......++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            456899999999999999999964 68899999886432   23446788999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+.+ ++.+++..  ....+++..+..++.||+.+|.|||+.+   ++||||+|+||+++.++.+||+|||++.....
T Consensus        94 ~e~~~g-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~  167 (307)
T cd06607          94 MEYCLG-SASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP  167 (307)
T ss_pred             HHhhCC-CHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence            999975 56555532  2345899999999999999999999986   99999999999999999999999999876432


Q ss_pred             CCCccccccccccCCCCCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAM---EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      .      ....|++.|+|||++.   .+.++.++||||||+++|||++|+.|+.....   ..   ....... ...   
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~---~~---~~~~~~~-~~~---  231 (307)
T cd06607         168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MS---ALYHIAQ-NDS---  231 (307)
T ss_pred             C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH---HH---HHHHHhc-CCC---
Confidence            2      2346888999999874   45688999999999999999999998632211   11   1111111 100   


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                        +.+.   .......+.+++.+||+.+|++||++.+|+..
T Consensus       232 --~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 --PTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             --CCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence              0010   11123457899999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=310.36  Aligned_cols=252  Identities=24%  Similarity=0.351  Sum_probs=202.2

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCc-EEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGK-EVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      .+.|.++..||.|+||.||+++.++.. --|.|++...+.+..+.+.-|+.||....||+||++++.|.-.+.++++.||
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            356778889999999999999976433 4577888888888899999999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      |.||..+.++..-  ...+.+.++..+++|++.||.|||++   +|||||||..|||++-+|.++|+|||.+....  ..
T Consensus       111 C~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t  183 (1187)
T KOG0579|consen  111 CGGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--ST  183 (1187)
T ss_pred             cCCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch--hH
Confidence            9999999888543  34689999999999999999999998   49999999999999999999999999986432  12


Q ss_pred             ccccccccccCCCCCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          450 TANTRRVVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ......++|||.|||||+..     ..+|+.++||||||+.|.||..+.+|-....       ...+.-.+.......++
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln-------pMRVllKiaKSePPTLl  256 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN-------PMRVLLKIAKSEPPTLL  256 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc-------hHHHHHHHhhcCCCccc
Confidence            22344689999999999874     5689999999999999999999998842111       11111111122221222


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .+       ......+.+++..||..||+.||++.++++
T Consensus       257 qP-------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  257 QP-------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             Cc-------chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            11       122345678999999999999999999876

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.6e-35  Score=300.19  Aligned_cols=265  Identities=22%  Similarity=0.330  Sum_probs=193.7

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC-----
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE-----  361 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-----  361 (611)
                      ..++|++.++||+|+||.||++... +++.||+|.+....  ......+.+|+.++++++||||+++++++...+     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3467999999999999999999964 68899999886432  222345678999999999999999999887654     


Q ss_pred             ---eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecc
Q 007239          362 ---EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDF  438 (611)
Q Consensus       362 ---~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  438 (611)
                         ..++||||+.+ +|.+.+..  ....+++.+++.++.||+.||.|||+++   ++|+||||+||+++.++.+||+||
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence               45999999975 67666632  2346899999999999999999999986   999999999999999999999999


Q ss_pred             ccceecccCCCc--cccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHH
Q 007239          439 GMARIFCENQKT--ANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLW  515 (611)
Q Consensus       439 Gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~  515 (611)
                      |++..+......  .......++..|+|||++.+. .++.++||||||+++|||++|+.|+......   .....+....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~---~~~~~~~~~~  240 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ---HQLTLISQLC  240 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHh
Confidence            999866432221  112234678899999988764 4788999999999999999999887543322   2222222211


Q ss_pred             hcCc--------cccccccc-cCCCC---------CHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          516 KEGK--------EMEFVDPL-LMKSS---------SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       516 ~~~~--------~~~~~d~~-l~~~~---------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ....        .....+.. .....         .......+.+++.+||+.||++|||++++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         241 GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            1000        00000000 00000         0001234568999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.7e-34  Score=289.18  Aligned_cols=250  Identities=25%  Similarity=0.378  Sum_probs=198.8

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +|++.+.||+|+||.||++... +|..+++|.+....  ....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5788999999999999999964 68889999986542  23456788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC-CEEEeccccceecccCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQ  448 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGla~~~~~~~  448 (611)
                      +++++|.+++... ....+++..+..++.||+.+|.|||+.+   ++|+||||+||++++++ .+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999988542 2235799999999999999999999986   99999999999999886 46999999998664332


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                      ..  .....|++.|+|||++....++.++|+||||+++|||++|+.|+....      ......+... +..    .+. 
T Consensus       157 ~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~-~~~----~~~-  222 (257)
T cd08225         157 EL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQ-GYF----API-  222 (257)
T ss_pred             cc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhc-ccC----CCC-
Confidence            21  223468999999999988889999999999999999999999974221      1112222111 111    110 


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                          .......+.+++.+||+.+|++|||+.++++.
T Consensus       223 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         223 ----SPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ----CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                11122357789999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-34  Score=294.77  Aligned_cols=260  Identities=24%  Similarity=0.340  Sum_probs=194.1

Q ss_pred             CCcccccCccCceEEEEEEc-CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      |++.+.||.|++|.||++.+ .+|+.|++|++....  ....+.+.+|+.+++.++|||++++++++.+....+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            67789999999999999996 478999999987543  223456889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      + ++|.+++.... ...+++..++.++.||+++|.|||+++   ++||||+|+||+++.++.++|+|||++.........
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 58888874322 236899999999999999999999986   999999999999999999999999999765332211


Q ss_pred             cccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCc---------c
Q 007239          451 ANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK---------E  520 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---------~  520 (611)
                        .....+++.|+|||++.+. .++.++||||||+++|+|++|+.||......  ..+.. +.+......         .
T Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFR-IFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-HHHHhCCCChHHhhhhhhc
Confidence              1123568899999988764 5789999999999999999999987533221  11111 111000000         0


Q ss_pred             cccccccc------CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          521 MEFVDPLL------MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       521 ~~~~d~~l------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .+......      ...........+.+++.+||+.+|++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00000000      00001111245778999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.9e-34  Score=294.38  Aligned_cols=256  Identities=29%  Similarity=0.416  Sum_probs=194.6

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ++|...+.||+|+||.||++.. .+++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            3566778999999999999995 468999999987543 234567889999999996 9999999999999999999999


Q ss_pred             ecCCCChhhHhhh--chhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          369 LMPNRSLDCFIFD--SERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       369 ~~~~~sL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |+.. ++.++...  ......+++..+..++.|++.||+|||+..  +++||||||+||+++.++.+||+|||+++.+..
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            9875 55443211  122356899999999999999999999752  499999999999999999999999999976533


Q ss_pred             CCCccccccccccCCCCCccccccC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEG---LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      ...   .....|++.|+|||++...   .++.++||||||+++|+|++|+.||....     .......+... +..   
T Consensus       161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~-~~~---  228 (288)
T cd06616         161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVK-GDP---  228 (288)
T ss_pred             CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcC-CCC---
Confidence            221   1234688999999998776   68999999999999999999999975332     11111111111 111   


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                        +.+..........++.+|+.+||+.+|++|||+++|++.
T Consensus       229 --~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         229 --PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             --CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              111111112233467899999999999999999999873

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.7e-34  Score=293.39  Aligned_cols=257  Identities=23%  Similarity=0.303  Sum_probs=190.7

Q ss_pred             CCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeC--CeEEEEEE
Q 007239          294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEG--EEKLLIYE  368 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~--~~~~lv~E  368 (611)
                      |++.+.||+|+||.||++.. .+++.||+|+++... ........+|+.++.++. |+|++++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            67789999999999999995 468899999987542 122234457888999886 99999999999887  88999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++ +|.+++..  ....+++..++.++.||+.||.|||+.+   ++||||||+||+++. +.+||+|||+++......
T Consensus        81 ~~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMDM-NLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCCc-cHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            9975 67666643  2346899999999999999999999986   999999999999999 999999999998654322


Q ss_pred             CccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHH-----------HHh
Q 007239          449 KTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ-----------LWK  516 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~-----------~~~  516 (611)
                      .   .....+++.|+|||++.. +.++.++|||||||++|||++|+.||......   ........           ...
T Consensus       154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  227 (282)
T cd07831         154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKKFR  227 (282)
T ss_pred             C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHhhc
Confidence            2   123467899999997654 56788999999999999999999988543221   11111111           111


Q ss_pred             cCccccccccccCCC----CCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          517 EGKEMEFVDPLLMKS----SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       517 ~~~~~~~~d~~l~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .........+.....    ........+.+++.+||+.+|++||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            111111100000000    00122456789999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.7e-34  Score=287.94  Aligned_cols=242  Identities=23%  Similarity=0.308  Sum_probs=193.6

Q ss_pred             cCccCceEEEEEEcC-CCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCCh
Q 007239          300 LGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSL  375 (611)
Q Consensus       300 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~sL  375 (611)
                      ||.|++|.||+++.. +++.+++|++.+...   ...+.+.+|+.+++.++||||+++++.+.++...+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999964 588999999875432   3456789999999999999999999999999999999999999999


Q ss_pred             hhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcccccc
Q 007239          376 DCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR  455 (611)
Q Consensus       376 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  455 (611)
                      .+++..   ...+++..+..++.||+.||.|||+++   ++|+||||+||+++.++.++|+|||++.......   ....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            999843   345899999999999999999999986   9999999999999999999999999998764432   1223


Q ss_pred             ccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHH
Q 007239          456 VVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIP  535 (611)
Q Consensus       456 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  535 (611)
                      ..|++.|++||.+....++.++|+||||+++|+|++|+.|+.....+. ......+   .......         ..+..
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~---~~~~~~~---------~~~~~  218 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIYNDI---LKGNGKL---------EFPNY  218 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHHHHH---hccCCCC---------CCCcc
Confidence            578999999999988889999999999999999999999985443211 1111111   1001100         01111


Q ss_pred             HHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 007239          536 QVVRCIHIGLLCVQEDPAVRPT-----MSNVVA  563 (611)
Q Consensus       536 ~~~~l~~li~~cl~~dP~~RPt-----~~evl~  563 (611)
                      ...++.+++..||+.+|++||+     +.|+++
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            1346789999999999999999     666665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=5.7e-34  Score=292.01  Aligned_cols=256  Identities=19%  Similarity=0.210  Sum_probs=182.5

Q ss_pred             hCCCCcccccCccCceEEEEEEcCC----CcEEEEEEecccChhh-H----------HHHHHHHHHHHhcCCCCeeeEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPN----GKEVAVKRLSRKSWQG-L----------EEFKNEIILIAKLQHRNLVRLVG  355 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~-~----------~~~~~E~~il~~l~h~niv~l~~  355 (611)
                      .++|++.+.||+|+||.||+|.+.+    +..+++|+........ .          .....+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4689999999999999999999643    4456666543222111 0          11223344556678999999998


Q ss_pred             eEeeCC----eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC
Q 007239          356 CGIEGE----EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM  431 (611)
Q Consensus       356 ~~~~~~----~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~  431 (611)
                      ++....    ..++++|++.. ++.+.+.   .....++..+..++.||++||.|||+++   |+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            765543    34677777644 4545442   2233578888999999999999999986   99999999999999999


Q ss_pred             CEEEeccccceecccCCCc-----cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhh
Q 007239          432 VAKISDFGMARIFCENQKT-----ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQT  506 (611)
Q Consensus       432 ~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~  506 (611)
                      .++|+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~--~  241 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG--N  241 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch--H
Confidence            9999999999876432211     11223579999999999999999999999999999999999999985442211  1


Q ss_pred             HHHHH----HHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          507 LLAYV----WQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       507 l~~~~----~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                      +....    ......+..        ....   ....+.+++..|++.+|++||++.++++.|+
T Consensus       242 ~~~~~~~~~~~~~~~~~~--------~~~~---~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        242 LIHAAKCDFIKRLHEGKI--------KIKN---ANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHHhHHHHHHHhhhhhh--------ccCC---CCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            11111    111111111        0011   1245678888999999999999999999874

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=5.5e-34  Score=289.85  Aligned_cols=242  Identities=26%  Similarity=0.298  Sum_probs=185.5

Q ss_pred             ccCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHHHHHHHHh---cCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          299 KLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAK---LQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       299 ~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~---l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      .||+|+||.||++.. .+++.+|+|.+.+...   .....+.+|..+++.   ..||||+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999996 4688999998865422   122334455544443   469999999999999999999999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +++|.+++.   ....+++..+..++.||+.||.|||+.+   ++||||||+|||+++++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~---~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLS---QHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            999998874   3356899999999999999999999987   9999999999999999999999999997553221   


Q ss_pred             ccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          452 NTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                       .....|++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||..........    .......      ....+  
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~~------~~~~~--  218 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------VNVEL--  218 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhhc------CCcCC--
Confidence             123468999999998864 568999999999999999999999985433322211    1111100      01111  


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCC-----CHHHHHHH
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVAL  564 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  564 (611)
                        +.....++.+++..||+.||++||     ++.++++.
T Consensus       219 --~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         219 --PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             --ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence              111234567889999999999999     59988874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-34  Score=283.88  Aligned_cols=247  Identities=30%  Similarity=0.439  Sum_probs=201.4

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +|++.+.||+|++|.||++... +++.|++|.+.....  ...+.+.+|++++++++|+|++++++++.+....+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788899999999999999864 678999999876643  4567899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++..   ...+++..++.++.|++.+|.|||+.+   ++||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            999999998843   356899999999999999999999986   99999999999999999999999999987654332


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                      .  .....++..|+|||.+.+..++.++||||+|+++|+|++|+.|+.....      ....+.... ....     .+.
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~------~~~~~~~~~-~~~~-----~~~  220 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP------MAALFRIVQ-DDHP-----PLP  220 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-cCCC-----CCC
Confidence            2  2235688999999999888889999999999999999999998743221      111111111 1110     111


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                          ......+.+++.+||+.+|++||++.+++.
T Consensus       221 ----~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         221 ----EGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ----CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                111245678999999999999999999984

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7e-34  Score=284.18  Aligned_cols=250  Identities=22%  Similarity=0.356  Sum_probs=203.3

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +|++.+.||+|+||.||++... +++.+++|++.....  .....+.+|+++++.++|||++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788899999999999999964 688999999876533  4567789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhch-hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          370 MPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       370 ~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      +++++|.+++.... ....+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999885421 1366899999999999999999999986   9999999999999999999999999998764433


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                        .......|++.|+|||.+....++.++|+||+|+++++|++|+.|+....   ..   ..... ........     +
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~---~~~~~-~~~~~~~~-----~  223 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LL---ELALK-ILKGQYPP-----I  223 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HH---HHHHH-HhcCCCCC-----C
Confidence              12234578999999999999899999999999999999999999874322   11   11111 11111111     1


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                          +......+.+++.+||+.+|++||++.++++
T Consensus       224 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         224 ----PSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ----CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                1122245678999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.1e-34  Score=302.84  Aligned_cols=265  Identities=22%  Similarity=0.325  Sum_probs=197.5

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEee----CCeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIE----GEEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~  363 (611)
                      .++|++.+.||+|+||.||++.. .+++.|++|++....  ......+.+|+.+++.++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            37899999999999999999995 468999999987542  2345677889999999999999999988753    3568


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ++||||+. ++|.+++.   ....+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999996 57888773   3345899999999999999999999986   99999999999999999999999999986


Q ss_pred             cccCCCcc--ccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHh----
Q 007239          444 FCENQKTA--NTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWK----  516 (611)
Q Consensus       444 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~----  516 (611)
                      ........  ......|+..|+|||++.+ ..++.++||||||+++|||++|+.||.......   ....+.....    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~---~~~~~~~~~g~~~~  233 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH---QLKLILSVLGSPSE  233 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH---HHHHHHHHhCCChh
Confidence            54332211  1123578999999998865 468899999999999999999999984332211   1111111000    


Q ss_pred             -------cCcccccccccc-CCCCC-----HHHHHHHHHHhhccccCCCCCCCCHHHHHHHh
Q 007239          517 -------EGKEMEFVDPLL-MKSSS-----IPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL  565 (611)
Q Consensus       517 -------~~~~~~~~d~~l-~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  565 (611)
                             .....+..+..- .....     .....++.+++.+||+.+|++||++++++..-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence                   000000000000 00000     11234678999999999999999999998743

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.5e-34  Score=293.27  Aligned_cols=245  Identities=25%  Similarity=0.369  Sum_probs=196.0

Q ss_pred             cccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCC
Q 007239          296 DSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRS  374 (611)
Q Consensus       296 ~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~s  374 (611)
                      ...+||+|+||.||++.. .+++.||+|++........+.+.+|+.+++.++|+|++++++.+...+..++||||+++++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            346899999999999986 4788999999876555566779999999999999999999999999999999999999999


Q ss_pred             hhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccccc
Q 007239          375 LDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR  454 (611)
Q Consensus       375 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  454 (611)
                      |.+++..    ..+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.++|+|||++........  ...
T Consensus       104 L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~  174 (292)
T cd06657         104 LTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRK  174 (292)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--ccc
Confidence            9887632    35789999999999999999999987   99999999999999999999999999876533221  122


Q ss_pred             cccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCH
Q 007239          455 RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSI  534 (611)
Q Consensus       455 ~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~  534 (611)
                      ...|++.|+|||++.+..++.++|+||+|+++|+|++|+.|+.....   ......+    .....     ..+...  .
T Consensus       175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~----~~~~~-----~~~~~~--~  240 (292)
T cd06657         175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMI----RDNLP-----PKLKNL--H  240 (292)
T ss_pred             ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH----HhhCC-----cccCCc--c
Confidence            35688999999999888899999999999999999999999743211   1111111    11110     011000  0


Q ss_pred             HHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          535 PQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       535 ~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .....+.+++.+||+.+|.+||++.++++
T Consensus       241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         241 KVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             cCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            11234668889999999999999999887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.3e-34  Score=289.62  Aligned_cols=248  Identities=27%  Similarity=0.373  Sum_probs=201.8

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +|++.++||+|++|.||++.. .+++.+++|.+....  ......+.+|+.+++.++|+||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            478899999999999999985 478899999987542  33456778999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhch-hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          370 MPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       370 ~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      +++++|..++.+.. ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999885422 2356899999999999999999999987   999999999999999999999999999876443 


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                         ......|++.|++||.+.+..++.++|+||||+++|+|++|+.|+.....   ..+..    ....+....      
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~----~~~~~~~~~------  220 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRY----KVQRGKYPP------  220 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHH----HHhcCCCCC------
Confidence               12234688999999999999999999999999999999999999743321   11111    111221111      


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                         .......++.+++..||+.+|++||++.++++
T Consensus       221 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         221 ---IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ---CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence               11123356789999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.1e-35  Score=303.88  Aligned_cols=262  Identities=25%  Similarity=0.342  Sum_probs=196.3

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC-----Ce
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG-----EE  362 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~  362 (611)
                      .++|.+.+.||+|+||.||+++. .+++.||+|.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            46799999999999999999995 46899999998653  223345678899999999999999999987644     35


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .++||||+. ++|.+++.   ....+++..+..++.||+.||.|||+++   ++||||||+||+++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 57877773   3356899999999999999999999986   9999999999999999999999999998


Q ss_pred             ecccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC---
Q 007239          443 IFCENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG---  518 (611)
Q Consensus       443 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---  518 (611)
                      ......  .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||.....   ..............   
T Consensus       157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~  231 (337)
T cd07858         157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY---VHQLKLITELLGSPSEE  231 (337)
T ss_pred             ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh---HHHHHHHHHHhCCCChH
Confidence            653322  11223467889999998865 4688999999999999999999999854321   11111111111110   


Q ss_pred             --------ccccccccccCC-CC-----CHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          519 --------KEMEFVDPLLMK-SS-----SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       519 --------~~~~~~d~~l~~-~~-----~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                              ...+.+...... ..     ......++.+++.+||+.+|++|||++++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                    000000000000 00     01123457799999999999999999999976

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5e-34  Score=289.68  Aligned_cols=244  Identities=27%  Similarity=0.326  Sum_probs=190.3

Q ss_pred             cCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCCh
Q 007239          300 LGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSL  375 (611)
Q Consensus       300 lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~sL  375 (611)
                      ||+|+||+||++.. .+|+.+++|.+....   ......+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999985 468899999986532   22344567899999999999999999999999999999999999999


Q ss_pred             hhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcccccc
Q 007239          376 DCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR  455 (611)
Q Consensus       376 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  455 (611)
                      .+++..... ..+++..+..++.|++.+|.|||+.+   ++||||+|+||+++.++.+||+|||++.......   ....
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~  153 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKG  153 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cccc
Confidence            988854322 36899999999999999999999987   9999999999999999999999999987653321   1223


Q ss_pred             ccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHH
Q 007239          456 VVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIP  535 (611)
Q Consensus       456 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  535 (611)
                      ..++..|+|||++.++.++.++||||||+++|+|++|+.||..........   .+..    .....  ....    +..
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~----~~~~~--~~~~----~~~  220 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELKR----RTLEM--AVEY----PDK  220 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHHh----ccccc--cccC----Ccc
Confidence            467889999999988889999999999999999999999985433211111   1110    00000  0001    111


Q ss_pred             HHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 007239          536 QVVRCIHIGLLCVQEDPAVRP-----TMSNVVA  563 (611)
Q Consensus       536 ~~~~l~~li~~cl~~dP~~RP-----t~~evl~  563 (611)
                      ....+.+++..||+.+|++||     ++.++++
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            234567899999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.4e-34  Score=296.90  Aligned_cols=248  Identities=27%  Similarity=0.390  Sum_probs=194.4

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      +.|+..+.||+|+||.||++++ .+++.+++|++....   .+....+.+|+++++.++|||++++++++..+...++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            4478889999999999999995 468899999986432   233457889999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+.+ +|.+.+..  ....+++..+..++.||+.||.|||+.+   ++||||+|+||+++.++.+||+|||++......
T Consensus       105 e~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         105 EYCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             eCCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            99975 66666532  2345899999999999999999999987   999999999999999999999999998754321


Q ss_pred             CCccccccccccCCCCCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAM---EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                            ....|++.|+|||++.   .+.++.++||||||+++|||++|+.|+....   .....   ........ ..  
T Consensus       179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~---~~~~~---~~~~~~~~-~~--  243 (317)
T cd06635         179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSAL---YHIAQNES-PT--  243 (317)
T ss_pred             ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc---HHHHH---HHHHhccC-CC--
Confidence                  2346889999999874   4678899999999999999999999864321   11111   11111111 00  


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                         ..   .......+.+++.+||+.+|++||++.+|++.+-
T Consensus       244 ---~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~  279 (317)
T cd06635         244 ---LQ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF  279 (317)
T ss_pred             ---CC---CccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence               00   1112234678999999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=292.83  Aligned_cols=259  Identities=25%  Similarity=0.330  Sum_probs=197.5

Q ss_pred             CCcccccCccCceEEEEEEcC-CCcEEEEEEecccChh--hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          294 FSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQ--GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      |++.+.||+|++|.||++... +++.+++|.+......  ....+.+|+.+++.++|+||+++++++......++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567889999999999999964 6888999998755322  4567889999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++ +|..++...  ...+++..++.++.||+.+|.|||+.+   ++|+||||+||+++.++.+||+|||.+........ 
T Consensus        81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-  153 (283)
T cd05118          81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-  153 (283)
T ss_pred             CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence            86 777776432  256899999999999999999999986   99999999999999999999999999987654431 


Q ss_pred             cccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCc---cccccc-
Q 007239          451 ANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK---EMEFVD-  525 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~---~~~~~d-  525 (611)
                       ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......   ..............   ...+.+ 
T Consensus       154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI---DQLFKIFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCchHhcccchhh
Confidence             11224678899999998876 7899999999999999999999887533321   11111111111100   000000 


Q ss_pred             ----------cccC--CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          526 ----------PLLM--KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       526 ----------~~l~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                                ....  .........++.+++..||+.||.+||++++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                      0000  0001112356789999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.4e-34  Score=291.43  Aligned_cols=261  Identities=25%  Similarity=0.332  Sum_probs=193.6

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ++|++.+.||+|++|.||+|.+. +++.|++|++.....  ...+.+.+|++++++++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57899999999999999999964 688999999865422  234578899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC-CCCEEEeccccceecccC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK-DMVAKISDFGMARIFCEN  447 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGla~~~~~~  447 (611)
                      |+++ +|.+++... ....+++..+..++.||+.||.|||+++   ++|+||||+||+++. ++.+||+|||++......
T Consensus        82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            9965 676666332 2234678888999999999999999986   999999999999985 567999999999765332


Q ss_pred             CCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc-
Q 007239          448 QKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD-  525 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d-  525 (611)
                      ..  ......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||.....  ...+.. ....+.... .+..+ 
T Consensus       157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~--~~~~~~-~~~~~~~~~-~~~~~~  230 (294)
T PLN00009        157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE--IDELFK-IFRILGTPN-EETWPG  230 (294)
T ss_pred             cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH-HHHHhCCCC-hhhccc
Confidence            11  1123467889999998876 4578999999999999999999998754322  111111 111111110 00000 


Q ss_pred             --------cccCC--C-----CCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          526 --------PLLMK--S-----SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       526 --------~~l~~--~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                              .....  .     .......++.+++.+||+.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    00000  0     00111234678999999999999999999996

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.2e-33  Score=285.50  Aligned_cols=247  Identities=21%  Similarity=0.255  Sum_probs=189.6

Q ss_pred             HHHhhCCCCccccc--CccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCe
Q 007239          287 IKAATDGFSDSNKL--GQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       287 ~~~~~~~y~~~~~l--g~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~  362 (611)
                      .....++|++.+.+  |+|+||.||++.. .+++.+++|.+........     |+.....+ +||||+++++.+...+.
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~   83 (267)
T PHA03390          9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKG   83 (267)
T ss_pred             HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence            34445678887777  9999999999995 4688899999865432211     23333323 69999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC-CEEEeccccc
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMA  441 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGla  441 (611)
                      .++||||+++++|.+++..   ...+++..+..++.||++||.|||+.+   ++||||||+||+++.++ .++|+|||++
T Consensus        84 ~~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~  157 (267)
T PHA03390         84 HVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC  157 (267)
T ss_pred             eEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence            9999999999999999843   337899999999999999999999987   99999999999999998 9999999998


Q ss_pred             eecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc
Q 007239          442 RIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM  521 (611)
Q Consensus       442 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  521 (611)
                      ......      ....|+..|+|||++.+..++.++||||||+++|+|++|+.|+....... .....+. ...  ....
T Consensus       158 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~-~~~--~~~~  227 (267)
T PHA03390        158 KIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLL-KRQ--QKKL  227 (267)
T ss_pred             eecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHH-Hhh--cccC
Confidence            765322      12468899999999999999999999999999999999999986332211 1111111 111  1000


Q ss_pred             cccccccCCCCCHHHHHHHHHHhhccccCCCCCCCC-HHHHHH
Q 007239          522 EFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT-MSNVVA  563 (611)
Q Consensus       522 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~  563 (611)
                      ...         ......+.+++..||+.+|.+||+ ++++++
T Consensus       228 ~~~---------~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        228 PFI---------KNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             Ccc---------cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            100         112345678899999999999996 688874

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.2e-34  Score=291.08  Aligned_cols=247  Identities=23%  Similarity=0.344  Sum_probs=196.5

Q ss_pred             cCccCceEEEEEEcC-CCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCCh
Q 007239          300 LGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSL  375 (611)
Q Consensus       300 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~sL  375 (611)
                      ||+|+||.||+++.. +++.+++|.+.....   ...+.+.+|+.++++++||||+++++.+......+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999975 589999999876543   3466789999999999999999999999999999999999999999


Q ss_pred             hhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC------
Q 007239          376 DCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK------  449 (611)
Q Consensus       376 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~------  449 (611)
                      .+++..   ...+++..+..++.||++||.|||+.+   ++|+||+|+||+++.++.++|+|||++........      
T Consensus        81 ~~~l~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLEN---VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            998843   336899999999999999999999987   99999999999999999999999999876533221      


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                      ........++..|++||.......+.++||||||+++|+|++|+.|+.....   ...   ... ...+... .      
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~---~~~-~~~~~~~-~------  220 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP---EEI---FQN-ILNGKIE-W------  220 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHH---HHH-HhcCCcC-C------
Confidence            1122345688899999999888899999999999999999999999753321   111   111 1111110 0      


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                       .........+.+++..||+.+|++|||+.++.+.|+.
T Consensus       221 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         221 -PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             -CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence             0000013456789999999999999999777777764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.8e-34  Score=296.06  Aligned_cols=264  Identities=23%  Similarity=0.319  Sum_probs=193.2

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChh--hHHHHHHHHHHHHhcCCCCeeeEEEeEeeC-------
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQ--GLEEFKNEIILIAKLQHRNLVRLVGCGIEG-------  360 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~-------  360 (611)
                      .++|++.++||+|+||.||++++. +++.+++|++......  ....+.+|+++++.++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999999964 6889999998654322  234578899999999999999999987543       


Q ss_pred             -CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccc
Q 007239          361 -EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFG  439 (611)
Q Consensus       361 -~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  439 (611)
                       ...++||||+.+ +|...+..  ....+++..+..++.||+++|.|||+++   ++|+||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence             346999999976 55555532  2346899999999999999999999987   9999999999999999999999999


Q ss_pred             cceecccCCCcc---------ccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHH
Q 007239          440 MARIFCENQKTA---------NTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLA  509 (611)
Q Consensus       440 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~  509 (611)
                      +++.........         ......|++.|+|||.+.+. .++.++||||||+++|||++|++||.....   .....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~---~~~~~  237 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD---IDQLH  237 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH---HHHHH
Confidence            998654322111         11234678889999987654 588999999999999999999998743222   12222


Q ss_pred             HHHHHHhcCcc---------cccccccc--CCCCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          510 YVWQLWKEGKE---------MEFVDPLL--MKSSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       510 ~~~~~~~~~~~---------~~~~d~~l--~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .++........         ....+...  ......     .....+.+++.+||+.||++|||+.|++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            22222111100         00000000  000000     11145779999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.1e-34  Score=294.74  Aligned_cols=264  Identities=23%  Similarity=0.303  Sum_probs=196.0

Q ss_pred             HhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC----
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE----  361 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----  361 (611)
                      ...++|++.+.||+|+||.||+|..+ +++.|++|+++...  ......+.+|+.+++.++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999964 68899999987542  223456788999999999999999999887654    


Q ss_pred             ------eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEE
Q 007239          362 ------EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKI  435 (611)
Q Consensus       362 ------~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl  435 (611)
                            ..++|+||+++ ++...+..  ....+++..++.++.||+.||.|||+.+   |+|+||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999987 56555532  2346899999999999999999999986   999999999999999999999


Q ss_pred             eccccceecccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH
Q 007239          436 SDFGMARIFCENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL  514 (611)
Q Consensus       436 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~  514 (611)
                      +|||++.......... .....++..|+|||.+.+ ..++.++||||||+++|||++|++|+....   .......+.+.
T Consensus       158 ~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~---~~~~~~~~~~~  233 (302)
T cd07864         158 ADFGLARLYNSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ---ELAQLELISRL  233 (302)
T ss_pred             CcccccccccCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHH
Confidence            9999998764333211 112346788999998865 457889999999999999999999875322   11222222222


Q ss_pred             HhcCccc---cc--------cc------cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          515 WKEGKEM---EF--------VD------PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       515 ~~~~~~~---~~--------~d------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .......   .+        .+      ....... ......+.+++.+||+.+|++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111100   00        00      0000000 011245779999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=305.02  Aligned_cols=255  Identities=28%  Similarity=0.432  Sum_probs=208.7

Q ss_pred             hhCCCCcccccCccCceEEEEEEcCC-CcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ...+..+..+||-|.||.||.|+|+. .-.||||.++.+. ...++|..|..+|+.++|||+|+++++|..+...|||.|
T Consensus       265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence            34456677899999999999999864 5679999987554 557899999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      ||..|+|.++|.+..+ ..++...++.++.||..||+||..+   ++|||||...|.||.++..+|++|||+++++..+.
T Consensus       344 fM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT  419 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT  419 (1157)
T ss_pred             cccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence            9999999999966443 4577788899999999999999988   59999999999999999999999999999886655


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                      ..... ...-...|.|||-+....++.|+|||+|||+||||.| |..|+...+       +..+..++..+-..+     
T Consensus       420 YTAHA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-------lSqVY~LLEkgyRM~-----  486 (1157)
T KOG4278|consen  420 YTAHA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYGLLEKGYRMD-----  486 (1157)
T ss_pred             eeccc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-------HHHHHHHHhcccccc-----
Confidence            44332 2233567999999999999999999999999999998 666653221       223344444443221     


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                          .+.....++.+|++.||+.+|.+||++.|+-+.|+
T Consensus       487 ----~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  487 ----GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             ----CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence                22334456788999999999999999999988774

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-34  Score=286.40  Aligned_cols=250  Identities=26%  Similarity=0.361  Sum_probs=195.2

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC--CeE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK-----SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG--EEK  363 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~  363 (611)
                      .+|++.+.||+|+||.||++.+ .+++.|++|.+...     ..+....+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4789999999999999999995 46889999987532     223456789999999999999999999998764  467


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ++++||+++++|.+++.   ....+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~---~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLK---AYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999998884   3345889999999999999999999987   99999999999999999999999999986


Q ss_pred             cccCCC-ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          444 FCENQK-TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       444 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      ...... ........|+..|+|||++.+..++.++||||||+++|+|++|+.||....  ..    ..+.+.......  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~----~~~~~~~~~~~~--  227 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE--AM----AAIFKIATQPTK--  227 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC--HH----HHHHHHHcCCCC--
Confidence            532111 111223568999999999998889999999999999999999999974321  11    111111111111  


Q ss_pred             ccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       523 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                         +.+    +......+.+++..||+ +|..||+..+++.
T Consensus       228 ---~~~----p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         228 ---PML----PDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ---CCC----CcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence               111    11222456788889999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-34  Score=285.16  Aligned_cols=245  Identities=22%  Similarity=0.250  Sum_probs=189.3

Q ss_pred             cccCccCceEEEEEEc-CCCcEEEEEEecccChh---hHHHHHHHHHHH-HhcCCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQ---GLEEFKNEIILI-AKLQHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~il-~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      +.||+|+||.||++.. .+++.||+|.+.+....   ....+..|..++ ...+|+|++++++.+...+..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5799999999999996 46889999998754322   223344555444 455899999999999999999999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      ++|.+++.   ....+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.....      
T Consensus        82 ~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------  149 (260)
T cd05611          82 GDCASLIK---TLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------  149 (260)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence            99999884   3346899999999999999999999986   99999999999999999999999999875432      


Q ss_pred             cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCC
Q 007239          453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSS  532 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  532 (611)
                      .....|++.|++||.+.+..++.++||||||+++|+|++|..|+.....   ...    +.....+...  .....    
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~----~~~~~~~~~~--~~~~~----  216 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAV----FDNILSRRIN--WPEEV----  216 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHH----HHHHHhcccC--CCCcc----
Confidence            2235688999999999888899999999999999999999999743221   111    1111111110  00000    


Q ss_pred             CHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          533 SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       533 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      .......+.+++.+||+.+|++||++.++.+.|+-
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            00122456789999999999999988877776653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.8e-33  Score=290.81  Aligned_cols=264  Identities=22%  Similarity=0.217  Sum_probs=193.1

Q ss_pred             CCcccccCccCceEEEEEEcCCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          294 FSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      +.+++.+|.|+++.|+++.. +++.||+|++...  .....+.+.+|+.+++.++|+||+++++++.+.+..+++|||++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA   82 (314)
T ss_pred             hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence            34455566666666666655 7899999998754  34456789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC--
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK--  449 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~--  449 (611)
                      +++|.+++.... ...+++..+..++.||+.||.|||+++   |+||||||+||+++.++.+||+|||.+........  
T Consensus        83 ~~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          83 YGSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             CCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            999999885432 235889999999999999999999986   99999999999999999999999999876532211  


Q ss_pred             ---ccccccccccCCCCCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHH----hcC--
Q 007239          450 ---TANTRRVVGTYGYMAPEYAME--GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLW----KEG--  518 (611)
Q Consensus       450 ---~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~----~~~--  518 (611)
                         ........++..|+|||++..  ..++.++||||||+++|||++|+.||.....  ...+........    ...  
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~  236 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA--TQMLLEKVRGTVPCLLDKSTY  236 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCccccccCch
Confidence               111223457788999999876  3588999999999999999999999753221  111111110000    000  


Q ss_pred             -----cccc----cccccc----CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          519 -----KEME----FVDPLL----MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       519 -----~~~~----~~d~~l----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                           ....    ..+...    ..........++.+++.+||+.||++|||++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                 0000    000000    001111223467789999999999999999999873

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.2e-33  Score=294.16  Aligned_cols=261  Identities=24%  Similarity=0.328  Sum_probs=191.1

Q ss_pred             cccCcc--CceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQG--GFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G--~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      ..||+|  +||+||++.+ .+|+.||+|++...  .....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456766  9999999996 47899999998753  233457889999999999999999999999999999999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      ++|.+++.... ...+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+|++||+.+...........
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99998885432 235889999999999999999999986   99999999999999999999999986543322111100


Q ss_pred             -----cccccccCCCCCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHH------------
Q 007239          453 -----TRRVVGTYGYMAPEYAMEG--LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ------------  513 (611)
Q Consensus       453 -----~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~------------  513 (611)
                           .....++..|+|||++.+.  .++.++||||||+++|||++|+.||......  ..+......            
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTFP  237 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCccccccc
Confidence                 1112345679999998764  4789999999999999999999997543211  111110000            


Q ss_pred             ----H-------H---------hcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          514 ----L-------W---------KEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       514 ----~-------~---------~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                          .       +         ..+......+..+...........+.+|+.+||+.||++|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                0       0         0000000111111111122344567899999999999999999999853

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-33  Score=294.47  Aligned_cols=278  Identities=25%  Similarity=0.320  Sum_probs=201.4

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC-----
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE-----  361 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-----  361 (611)
                      ..++|++.+.||+|+||.||+++. .+++.||+|++....  ......+.+|+.+++.++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            467899999999999999999994 578999999986432  223456889999999999999999999887553     


Q ss_pred             -eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccc
Q 007239          362 -EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGM  440 (611)
Q Consensus       362 -~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  440 (611)
                       ..++||||+ +++|.+++.    ...+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence             458999998 678887763    245899999999999999999999986   99999999999999999999999999


Q ss_pred             ceecccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHH--------
Q 007239          441 ARIFCENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYV--------  511 (611)
Q Consensus       441 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~--------  511 (611)
                      +......     .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||......  .......        
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~  237 (343)
T cd07880         165 ARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL--DQLMEIMKVTGTPSK  237 (343)
T ss_pred             ccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCCCCH
Confidence            9764322     123467899999999876 45889999999999999999999997532211  1111100        


Q ss_pred             --HHHHhcCccccccccc--cCC----CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH--HhcCCCCCCCCCCCCCCc
Q 007239          512 --WQLWKEGKEMEFVDPL--LMK----SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA--LLGSESIALSEPRQPPFP  581 (611)
Q Consensus       512 --~~~~~~~~~~~~~d~~--l~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~l~~~~~p~~~  581 (611)
                        +..+............  ...    .........+.+++.+||+.||++|||+.++++  .+........++..|+|.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~~~~~~~~~~~  317 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDPEDETEAPPYD  317 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCcccccCCCCcc
Confidence              0000000000000000  000    000011224678999999999999999999993  444433334444555554


Q ss_pred             c
Q 007239          582 V  582 (611)
Q Consensus       582 ~  582 (611)
                      .
T Consensus       318 ~  318 (343)
T cd07880         318 D  318 (343)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-35  Score=306.82  Aligned_cols=202  Identities=31%  Similarity=0.485  Sum_probs=175.6

Q ss_pred             CCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC------CeEEE
Q 007239          294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG------EEKLL  365 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~~~~l  365 (611)
                      +...+.||+|+||.||+|++ .+|+.||||.++... ....+...+|+++|++|+|+|||+++++-++.      ...++
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            55668899999999999995 579999999987643 34567788999999999999999999985543      35689


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec--CCC--CEEEeccccc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD--KDM--VAKISDFGMA  441 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~--~~~--~~kl~DFGla  441 (611)
                      |||||.+|+|...+.+.+....+++.+.+.++..+..||.|||+++   |+||||||.||++-  ++|  ..||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999988888888999999999999999999999986   99999999999993  333  5799999999


Q ss_pred             eecccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 007239          442 RIFCENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLT  501 (611)
Q Consensus       442 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~  501 (611)
                      +-+.++.   ....++||+.|++||+... +.|+..+|.|||||++|+..||..||-....
T Consensus       172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            9775544   4567899999999999984 8899999999999999999999999854443

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1e-34  Score=320.78  Aligned_cols=256  Identities=28%  Similarity=0.420  Sum_probs=190.2

Q ss_pred             HHhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee------
Q 007239          288 KAATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE------  359 (611)
Q Consensus       288 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~------  359 (611)
                      .....+|+.++.||+||||.|||++++ +|+.||||++... +......+.+|+..|++|+|||||+++..+.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            345678999999999999999999965 8999999998755 33445678899999999999999998721100      


Q ss_pred             --------------------------------------------------------------------------------
Q 007239          360 --------------------------------------------------------------------------------  359 (611)
Q Consensus       360 --------------------------------------------------------------------------------  359 (611)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------C--------CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHH
Q 007239          360 -------------------------G--------EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLY  406 (611)
Q Consensus       360 -------------------------~--------~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~y  406 (611)
                                               +        ..+||-||||+...|.+++.++.-.  -....+|+++++|++||.|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHH
Confidence                                     0        1247789999998888887432211  1477899999999999999


Q ss_pred             HhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc------c----------CCCccccccccccCCCCCcccccc
Q 007239          407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC------E----------NQKTANTRRVVGTYGYMAPEYAME  470 (611)
Q Consensus       407 LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~------~----------~~~~~~~~~~~gt~~y~aPE~~~~  470 (611)
                      +|++|   ||||||||.||++++++.|||+|||+|....      .          .......+..+||.-|+|||.+.+
T Consensus       713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            99998   9999999999999999999999999998721      0          011112345789999999999876


Q ss_pred             C---CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhcc
Q 007239          471 G---LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLC  547 (611)
Q Consensus       471 ~---~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~c  547 (611)
                      .   .|+.|+|+||||||++||+.   ||+...  +.    ..+...++.+.....  +.+    ..+....-..++.||
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ER----a~iL~~LR~g~iP~~--~~f----~~~~~~~e~slI~~L  854 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ER----ASILTNLRKGSIPEP--ADF----FDPEHPEEASLIRWL  854 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCchH--HH----HHHHHhcccCCCCCC--ccc----ccccchHHHHHHHHH
Confidence            4   49999999999999999985   332111  11    112222334433332  111    112222234788899


Q ss_pred             ccCCCCCCCCHHHHHH
Q 007239          548 VQEDPAVRPTMSNVVA  563 (611)
Q Consensus       548 l~~dP~~RPt~~evl~  563 (611)
                      ++.||.+|||+.|+|.
T Consensus       855 l~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  855 LSHDPSKRPTATELLN  870 (1351)
T ss_pred             hcCCCccCCCHHHHhh
Confidence            9999999999999985

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8.3e-34  Score=296.34  Aligned_cols=265  Identities=24%  Similarity=0.325  Sum_probs=196.2

Q ss_pred             hCCCC-cccccCccCceEEEEEEcC-CCcEEEEEEecccChhh--------------HHHHHHHHHHHHhcCCCCeeeEE
Q 007239          291 TDGFS-DSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQG--------------LEEFKNEIILIAKLQHRNLVRLV  354 (611)
Q Consensus       291 ~~~y~-~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~il~~l~h~niv~l~  354 (611)
                      .++|. +.+.||+|+||+||+++.. +++.||+|+++......              ...+.+|+++++.++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            34565 4577999999999999954 68999999986542211              12477899999999999999999


Q ss_pred             EeEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEE
Q 007239          355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAK  434 (611)
Q Consensus       355 ~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~k  434 (611)
                      +++...+..++||||+. ++|.+++.   ....+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+|
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~---~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVD---RKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence            99999999999999997 57888773   3456899999999999999999999987   99999999999999999999


Q ss_pred             EeccccceecccCCC------------ccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 007239          435 ISDFGMARIFCENQK------------TANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLT  501 (611)
Q Consensus       435 l~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~  501 (611)
                      |+|||++........            ........+++.|+|||++.+. .++.++||||||+++|||++|+.|+.....
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999987641110            1111223568889999998764 468999999999999999999999754332


Q ss_pred             CchhhHHHHHHHHHhcCcccccc-----------ccccCCC---CCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHh
Q 007239          502 GHAQTLLAYVWQLWKEGKEMEFV-----------DPLLMKS---SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL  565 (611)
Q Consensus       502 ~~~~~l~~~~~~~~~~~~~~~~~-----------d~~l~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  565 (611)
                         ......+...........+.           .......   .......++.+++..||+.+|++||++++++..-
T Consensus       240 ---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        240 ---IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             ---HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence               22222232222211111000           0000000   0001124577899999999999999999999743

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1e-33  Score=289.05  Aligned_cols=255  Identities=22%  Similarity=0.276  Sum_probs=198.6

Q ss_pred             CCCcccccCccCceEEEEEEc----CCCcEEEEEEecccC----hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL----PNGKEVAVKRLSRKS----WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~  363 (611)
                      +|++.+.||+|++|.||++..    .+++.||+|.++...    ....+.+.+|+.++.++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477889999999999999884    356889999987432    22345688999999999 499999999999999999


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ++||||+++++|.+++..   ...+++..+..++.|++++|.|||+.+   ++||||||+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999988743   345889999999999999999999986   99999999999999999999999999986


Q ss_pred             cccCCCccccccccccCCCCCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc
Q 007239          444 FCENQKTANTRRVVGTYGYMAPEYAMEGL--FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM  521 (611)
Q Consensus       444 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  521 (611)
                      +...... ......|+..|+|||.+.+..  .+.++||||||+++|||++|..|+........  ............   
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~---  228 (288)
T cd05583         155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKSK---  228 (288)
T ss_pred             ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHccC---
Confidence            5433221 122356899999999987665  78899999999999999999999753221111  111111111110   


Q ss_pred             cccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          522 EFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       522 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                          ...    +......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       229 ----~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         229 ----PPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ----CCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                001    11122346788999999999999999999888864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7.6e-34  Score=288.02  Aligned_cols=249  Identities=28%  Similarity=0.334  Sum_probs=199.9

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc---ChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv  366 (611)
                      ++|.+.+.||+|+||.||++... +++.|++|++...   .......+.+|++++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47899999999999999999964 7899999998753   2233467889999999999 99999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++.   +...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~---~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIR---KYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999884   3346999999999999999999999986   99999999999999999999999999987644


Q ss_pred             CCCc------------------cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHH
Q 007239          447 NQKT------------------ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLL  508 (611)
Q Consensus       447 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~  508 (611)
                      ....                  .......|+..|+|||.+....++.++||||||+++++|++|+.|+.....   ... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~-  230 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLT-  230 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHH-
Confidence            3321                  122335688999999999888899999999999999999999999753321   111 


Q ss_pred             HHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCH----HHHHH
Q 007239          509 AYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTM----SNVVA  563 (611)
Q Consensus       509 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~----~evl~  563 (611)
                        ..... ....          ..+......+.+++.+||+.+|++||++    +++++
T Consensus       231 --~~~~~-~~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         231 --FQKIL-KLEY----------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             --HHHHH-hcCC----------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence              11111 1000          0111113456789999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.4e-33  Score=288.31  Aligned_cols=251  Identities=23%  Similarity=0.268  Sum_probs=194.7

Q ss_pred             CCCcccccCccCceEEEEEEc----CCCcEEEEEEecccCh----hhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL----PNGKEVAVKRLSRKSW----QGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~  363 (611)
                      +|++.+.||+|+||.||++..    .+|+.||+|++.....    ...+.+.+|+.+++++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999985    3688999999875322    2346678899999999 599999999999999999


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ++||||+++++|.+++..   ...+++..+..++.||++||.|||+.+   ++||||||+|||++.++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999998843   346889999999999999999999986   99999999999999999999999999987


Q ss_pred             cccCCCccccccccccCCCCCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc
Q 007239          444 FCENQKTANTRRVVGTYGYMAPEYAMEG--LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM  521 (611)
Q Consensus       444 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  521 (611)
                      ....... ......|+..|+|||.+...  .++.++||||||+++|+|++|+.|+......  ...............  
T Consensus       155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~~--  229 (290)
T cd05613         155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSEP--  229 (290)
T ss_pred             ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccCC--
Confidence            5433221 22235689999999998753  4678999999999999999999997532221  111111111111110  


Q ss_pred             cccccccCCCCCHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 007239          522 EFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVA  563 (611)
Q Consensus       522 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  563 (611)
                           .    .+......+.+++..||+.+|++||     ++++++.
T Consensus       230 -----~----~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         230 -----P----YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -----C----CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                 0    1111223566889999999999997     6666665

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-34  Score=299.42  Aligned_cols=262  Identities=26%  Similarity=0.323  Sum_probs=199.3

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC-----eEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE-----EKL  364 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-----~~~  364 (611)
                      +|++.+.||+|++|.||+++.. +++.+++|++....  ....+.+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999964 58899999987643  344567899999999999999999999988765     789


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      ++|||+++ +|..++.   ....+++..++.++.||++||.|||+.+   |+||||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~~-~l~~~l~---~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELMET-DLHKVIK---SPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchhh-hHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            99999985 7877773   3347899999999999999999999987   999999999999999999999999999876


Q ss_pred             ccCCCc-cccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC----
Q 007239          445 CENQKT-ANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG----  518 (611)
Q Consensus       445 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----  518 (611)
                      ...... .......+++.|+|||++.+. .++.++||||||+++|+|++|+.||......   .....+.......    
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~  230 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI---DQLNLIVEVLGTPSEED  230 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHhcCCCChhH
Confidence            443210 112234678899999999887 7899999999999999999999997544321   1111111111000    


Q ss_pred             -------cccccccccc-CCCCC-----HHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          519 -------KEMEFVDPLL-MKSSS-----IPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       519 -------~~~~~~d~~l-~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                             .....+...- .....     ......+.+++.+||+.+|++||+++++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                   0000000000 00000     0123456789999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.4e-33  Score=284.96  Aligned_cols=241  Identities=26%  Similarity=0.300  Sum_probs=185.5

Q ss_pred             ccCccCceEEEEEEc-CCCcEEEEEEecccChh---hHHHHHHHHH---HHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          299 KLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQ---GLEEFKNEII---LIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       299 ~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~---il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      .||+|+||.||++.. .+++.||+|.+.+....   ....+.+|..   +++...||+|+++++.+...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999995 46889999998754321   1223344444   3444579999999999999999999999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +++|.+++.   ....+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.+||+|||++..+....   
T Consensus        81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            999998873   3456999999999999999999999986   9999999999999999999999999987553221   


Q ss_pred             ccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                       .....|+..|+|||.+.++ .++.++||||+|+++|+|++|+.||...........    .......      ...+..
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~------~~~~~~  220 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTLTM------AVELPD  220 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHHhhcc------CCCCCC
Confidence             2235789999999998754 689999999999999999999999854322221111    1111110      111111


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVA  563 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  563 (611)
                          ....++.+++.+||+.+|++||     ++.++++
T Consensus       221 ----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         221 ----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             ----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence                1134577888999999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=275.76  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=198.1

Q ss_pred             cccCccCceEEEEEE-cCCCcEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEEEEecCCCCh
Q 007239          298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLIYELMPNRSL  375 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~~sL  375 (611)
                      +.||+|+++.|--++ ..+|.+||||++.+.......+..+|++++.+.+ |+||++++++|+++...|||||-|.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            579999999999988 6789999999999887777889999999999998 99999999999999999999999999999


Q ss_pred             hhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC---CEEEeccccceecccCCC---
Q 007239          376 DCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM---VAKISDFGMARIFCENQK---  449 (611)
Q Consensus       376 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~---~~kl~DFGla~~~~~~~~---  449 (611)
                      ...|   .++.-+++.++.+++..|+.||.+||.+|   |.|||+||+|||-....   -+||+||.+..-......   
T Consensus       164 LshI---~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  164 LSHI---QKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             HHHH---HHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            9888   45567999999999999999999999998   99999999999997554   489999988865432211   


Q ss_pred             --ccccccccccCCCCCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCch--------hhHHHHHHHH
Q 007239          450 --TANTRRVVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHA--------QTLLAYVWQL  514 (611)
Q Consensus       450 --~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~--------~~l~~~~~~~  514 (611)
                        .....+.+|+..|||||+..     ...|+.+.|.||||||+|-||+|.+||-.....+-        ..=...+.+.
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes  317 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES  317 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence              11233568999999999763     34688999999999999999999999954333211        1111222222


Q ss_pred             HhcCccccccccccCCCCCHHH-HHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          515 WKEGKEMEFVDPLLMKSSSIPQ-VVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       515 ~~~~~~~~~~d~~l~~~~~~~~-~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      +.++.. ++.|..      ... ..+..+++...|..++.+|-++.+++.
T Consensus       318 IQEGkY-eFPdkd------WahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  318 IQEGKY-EFPDKD------WAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HhccCC-cCChhh------hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            333322 111110      111 123457888889999999999998886

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-34  Score=296.17  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=201.2

Q ss_pred             CCCCcccccCccCceEEEEEEcC---CCc--EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP---NGK--EVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~---~~~--~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      +.....+.||.|.||.||+|+..   .|+  .||||.-+.+ ..+..+.|.+|..++++++||||++++|++.+ ...||
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence            44556678999999999999942   344  4788887763 44567889999999999999999999999875 56799


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      |||.++-|.|..++..  ++..++......++.||+.+|.|||++   ++|||||...|||+....-+||+|||+++.+.
T Consensus       468 vmEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             EEecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            9999999999999964  345688899999999999999999998   49999999999999999999999999999886


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      .+.....+ ...-...|||||.+.-..++.++|||-|||.||||++ |..||..-.                +.+..-.+
T Consensus       543 d~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk----------------NsDVI~~i  605 (974)
T KOG4257|consen  543 DDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK----------------NSDVIGHI  605 (974)
T ss_pred             ccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc----------------ccceEEEe
Confidence            55544333 3344667999999999999999999999999999986 888874221                11222122


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                      ...-.-+.+......+..|+.+||..+|.+||...++...|+
T Consensus       606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS  647 (974)
T ss_pred             cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence            211112223344556778999999999999999999888774

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-33  Score=286.27  Aligned_cols=259  Identities=25%  Similarity=0.347  Sum_probs=193.0

Q ss_pred             CCcccccCccCceEEEEEEcC-CCcEEEEEEecccChh--hHHHHHHHHHHHHhc---CCCCeeeEEEeEeeCCe-----
Q 007239          294 FSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQ--GLEEFKNEIILIAKL---QHRNLVRLVGCGIEGEE-----  362 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l---~h~niv~l~~~~~~~~~-----  362 (611)
                      |++.+.||+|+||.||++++. +++.+|+|+++.....  ....+.+|+.+++++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            677899999999999999975 5899999998743221  234566788877766   59999999999988776     


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .+++|||+.+ +|.+++.... ...+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999975 7877774322 235899999999999999999999986   9999999999999999999999999998


Q ss_pred             ecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          443 IFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       443 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      ........   ....++..|+|||++.+..++.++||||||+++|||++|++|+.....   ......+...........
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  229 (287)
T cd07838         156 IYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE---ADQLDKIFDVIGLPSEEE  229 (287)
T ss_pred             eccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh---HHHHHHHHHHcCCCChHh
Confidence            76433221   223578899999999999999999999999999999999888753222   111111111111000000


Q ss_pred             c----------cccccCCCC---CHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          523 F----------VDPLLMKSS---SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       523 ~----------~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      +          .........   .......+.+++.+||+.||++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0          000000000   0112345678999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.5e-34  Score=275.60  Aligned_cols=272  Identities=25%  Similarity=0.338  Sum_probs=200.4

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC---C--CcEEEEEEecccChh-h-HHHHHHHHHHHHhcCCCCeeeEEEeEee-CC
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP---N--GKEVAVKRLSRKSWQ-G-LEEFKNEIILIAKLQHRNLVRLVGCGIE-GE  361 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~---~--~~~vavK~~~~~~~~-~-~~~~~~E~~il~~l~h~niv~l~~~~~~-~~  361 (611)
                      ....|+....||+|.+|.||+++-+   +  .+.+|+|+++..+.. + .....+|+.+++.++|||++.+..+|.. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            3467999999999999999999732   2  236899999765321 2 2456889999999999999999999887 78


Q ss_pred             eEEEEEEecCCCChhhHhhh--chhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC----CCEEE
Q 007239          362 EKLLIYELMPNRSLDCFIFD--SERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD----MVAKI  435 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~----~~~kl  435 (611)
                      ..++++||.+. +|..+|..  ..+...++...+..|+.||+.|+.|||++-   |+||||||.||||..+    |.+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence            89999999988 56566543  223457899999999999999999999986   9999999999999877    89999


Q ss_pred             eccccceecccCCCcc-ccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC------CchhhH
Q 007239          436 SDFGMARIFCENQKTA-NTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLT------GHAQTL  507 (611)
Q Consensus       436 ~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~------~~~~~l  507 (611)
                      +|||+++.+...-... .....+-|..|.|||.+.+ ..|+++.|||++||++.||++-++-|.....      .-..+.
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            9999999986654433 3445678999999999887 4699999999999999999998877632221      111223


Q ss_pred             HHHHHHHHhcCccccccccccC------------CCCC---HHHH--------HHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          508 LAYVWQLWKEGKEMEFVDPLLM------------KSSS---IPQV--------VRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       508 ~~~~~~~~~~~~~~~~~d~~l~------------~~~~---~~~~--------~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      +..+.+.+.......+.+-.--            ..+.   ....        ....+|+..+|+.||-+|.|+++.++.
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            3333333222222111110000            0000   0000        014678889999999999999999875


Q ss_pred             h
Q 007239          565 L  565 (611)
Q Consensus       565 L  565 (611)
                      -
T Consensus       338 ~  338 (438)
T KOG0666|consen  338 P  338 (438)
T ss_pred             c
Confidence            4

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.9e-33  Score=288.27  Aligned_cols=253  Identities=25%  Similarity=0.368  Sum_probs=192.5

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~  367 (611)
                      .++|++.+.||+|+||.||++.+. +++.||+|+++... ......+.+|+.++.+.. ||||+++++++......+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            467899999999999999999975 48899999987543 233455667777776665 999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+.+ .|..++...  ...+++..+..++.||+.||.|||+..  +|+||||+|+||++++++.+||+|||++..+...
T Consensus        94 e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          94 ELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             eccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            99865 666665332  236899999999999999999999741  3999999999999999999999999999765432


Q ss_pred             CCccccccccccCCCCCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGL----FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      ...   ....+++.|+|||++....    ++.++||||||+++|+|++|+.||......     ........... ... 
T Consensus       169 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~-  238 (296)
T cd06618         169 KAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-PPS-  238 (296)
T ss_pred             Ccc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-CCC-
Confidence            221   2235788999999987553    788999999999999999999997432111     11111111111 111 


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                          ...  ......++.+++.+||+.||++||+++++++.
T Consensus       239 ----~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         239 ----LPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             ----CCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                000  00123457789999999999999999999865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2e-33  Score=294.40  Aligned_cols=263  Identities=22%  Similarity=0.260  Sum_probs=192.4

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC---------
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG---------  360 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~---------  360 (611)
                      ..+|.+.+.||+|+||.||+|+. .+++.|++|++........+.+.+|++++++++||||+++++.+...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            36899999999999999999995 46889999998776666677889999999999999999999776543         


Q ss_pred             -----CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC-CCCEE
Q 007239          361 -----EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK-DMVAK  434 (611)
Q Consensus       361 -----~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~-~~~~k  434 (611)
                           ...++||||+++ +|.+++.    ...+++..++.++.||++||.|||+.+   ++||||||+||+++. ++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYMET-DLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeecccc-cHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 357899999974 7877763    235889999999999999999999986   999999999999974 56789


Q ss_pred             EeccccceecccCCCcc-ccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHH
Q 007239          435 ISDFGMARIFCENQKTA-NTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW  512 (611)
Q Consensus       435 l~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~  512 (611)
                      |+|||+++......... ......|+..|+|||.+.. ..++.++||||||+++|+|++|+.||.......  .......
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~~~~~~~  233 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE--QMQLILE  233 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence            99999998653221111 1122467889999998754 567889999999999999999999984332111  1111000


Q ss_pred             HH----------HhcCccccccccccCCCCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          513 QL----------WKEGKEMEFVDPLLMKSSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       513 ~~----------~~~~~~~~~~d~~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..          ..................+.     ....++.+++..||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            00          00000000000000000000     11245778999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-33  Score=287.21  Aligned_cols=260  Identities=27%  Similarity=0.338  Sum_probs=193.6

Q ss_pred             CCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh-hhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEEEEec
Q 007239          294 FSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      |++.+.||+|++|+||+|+.. +++.|++|++..... .......+|+..+++++ |+|++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            677899999999999999965 578899999865432 22234567999999999 999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                       +++|.+.+.... ...+++..+..++.|++.+|.|||+++   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             778887774322 246899999999999999999999986   99999999999999999999999999986543221 


Q ss_pred             cccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH--------HhcCc-c
Q 007239          451 ANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL--------WKEGK-E  520 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~--------~~~~~-~  520 (611)
                        .....++..|+|||++.. ..++.++|+||||++++||++|++|+........   .......        |.++. .
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07830         155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ---LYKICSVLGTPTKQDWPEGYKL  229 (283)
T ss_pred             --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH---HHHHHHhcCCCChhhhhhHhhh
Confidence              123468889999998754 4578999999999999999999988754322111   1110000        00000 0


Q ss_pred             ccccccccCCCC-------CHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          521 MEFVDPLLMKSS-------SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       521 ~~~~d~~l~~~~-------~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ....+..+....       .......+.+++.+||+.+|++|||++|++..
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000000000000       00112467899999999999999999999863

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.6e-33  Score=290.58  Aligned_cols=260  Identities=26%  Similarity=0.346  Sum_probs=194.6

Q ss_pred             HhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEee-CCeEE
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIE-GEEKL  364 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~~  364 (611)
                      ...++|++.+.||+|+||.||++.. .+++.||+|++.+..  ....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            3568899999999999999999995 478999999886432  2234678899999999999999999998865 56789


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +++||+ +++|..++.    ...+++..+..++.||++||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            999998 457877763    235788888999999999999999986   999999999999999999999999998754


Q ss_pred             ccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH---------
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL---------  514 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~---------  514 (611)
                      ...     .....+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......   .....+.+.         
T Consensus       159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~---~~~~~~~~~~~~~~~~~~  230 (328)
T cd07856         159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV---NQFSIITDLLGTPPDDVI  230 (328)
T ss_pred             CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCCCCHHHH
Confidence            221     123467889999998766 56899999999999999999999987543221   111111110         


Q ss_pred             --HhcCcccccccccc-CCCCCHH-----HHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          515 --WKEGKEMEFVDPLL-MKSSSIP-----QVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       515 --~~~~~~~~~~d~~l-~~~~~~~-----~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                        +......+++.... ....+..     ...++.+++.+||+.+|++||++++++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              00011111111100 0011111     12467799999999999999999998764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.5e-33  Score=285.96  Aligned_cols=245  Identities=26%  Similarity=0.380  Sum_probs=190.6

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      -|...++||+|+||+||+|+. .+++.|++|++....   ......+.+|+.+++.++|||++++++++.+....++|||
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            367778899999999999995 468899999986432   2334578899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+.+ ++.+++..  ....+++..+..++.||+.+|.|||+.+   ++|+||||+||+++.++.+||+|||++....   
T Consensus       102 ~~~~-~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~---  172 (313)
T cd06633         102 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS---  172 (313)
T ss_pred             cCCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC---
Confidence            9975 66666532  2345899999999999999999999987   9999999999999999999999999986422   


Q ss_pred             CccccccccccCCCCCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAM---EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                         ......|+..|+|||++.   .+.++.++||||||+++|+|++|+.|+.....   .   .......... ..... 
T Consensus       173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~---~---~~~~~~~~~~-~~~~~-  241 (313)
T cd06633         173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---M---SALYHIAQND-SPTLQ-  241 (313)
T ss_pred             ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---H---HHHHHHHhcC-CCCCC-
Confidence               122457889999999984   46688999999999999999999998643211   1   1111111111 11110 


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                         ..    .....+.+++.+||+.+|.+||++.++++.
T Consensus       242 ---~~----~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         242 ---SN----EWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ---cc----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               01    111346789999999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.4e-33  Score=288.21  Aligned_cols=247  Identities=29%  Similarity=0.404  Sum_probs=192.9

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      +.|...+.||+|+||.||+|+.. +++.+++|.+...   .......+.+|+++++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            45777889999999999999964 6788999988642   2234567889999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+. +++.+.+..  ....+++..+..++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9997 477666532  2345889999999999999999999986   999999999999999999999999998765322


Q ss_pred             CCccccccccccCCCCCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAM---EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                            ....|++.|+|||.+.   .+.++.++||||||+++|+|++|+.|+......  ..+.    . +..+..    
T Consensus       169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~----~-~~~~~~----  231 (308)
T cd06634         169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALY----H-IAQNES----  231 (308)
T ss_pred             ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHH----H-HhhcCC----
Confidence                  2346889999999874   356788999999999999999999986432111  0011    1 111111    


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHh
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL  565 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  565 (611)
                       +...   .......+.+++.+||+.+|++||++.++++..
T Consensus       232 -~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         232 -PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             -CCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence             0110   112234567899999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=284.84  Aligned_cols=241  Identities=25%  Similarity=0.293  Sum_probs=193.0

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh---hhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~l  365 (611)
                      ..+|.++..||+|+||+|.++..+ +.+.+|||++++.-.   .+.+--+.|-.+|.... -|.+++++.+|..-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            457999999999999999999865 466799999987532   23334466888887775 6789999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+.||+|-..|   ++-+.+.+..+..++.+|+-||-+||++|   ||+||||.+|||+|.+|++||+|||+.+.--
T Consensus       428 VMEyvnGGDLMyhi---QQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHI---QQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEEecCchhhhHH---HHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence            99999999997777   55667899999999999999999999998   9999999999999999999999999997422


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                        .....+++++|||.|+|||++...+|+..+|+||+||+||||+.|++||+..+   ...+.+.+    .+.+      
T Consensus       502 --~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD---E~elF~aI----~ehn------  566 (683)
T KOG0696|consen  502 --FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQAI----MEHN------  566 (683)
T ss_pred             --cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHH----HHcc------
Confidence              22334567899999999999999999999999999999999999999985432   22233222    2111      


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCC
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRP  556 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP  556 (611)
                          -.++.....+...+....|..+|.+|.
T Consensus       567 ----vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  567 ----VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ----CcCcccccHHHHHHHHHHhhcCCcccc
Confidence                122333334455666677888998884

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=315.40  Aligned_cols=275  Identities=22%  Similarity=0.244  Sum_probs=207.8

Q ss_pred             HHHhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe
Q 007239          287 IKAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       287 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  362 (611)
                      ++-..++|.+++.||+|+||.|..++. .+++.||+|++.+-   ......-|..|-.+|..-+.+.|++++..|.+...
T Consensus        70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~  149 (1317)
T KOG0612|consen   70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY  149 (1317)
T ss_pred             HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence            334468899999999999999999996 46888999999762   23345678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      +|+|||||+||+|..++.+   ...++++.++.++..|+-||.-||+-|   +|||||||+|||||..|++||+|||.+-
T Consensus       150 LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsCl  223 (1317)
T KOG0612|consen  150 LYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCL  223 (1317)
T ss_pred             eEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHH
Confidence            9999999999999999843   336899999999999999999999987   9999999999999999999999999998


Q ss_pred             ecccCCCccccccccccCCCCCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhc
Q 007239          443 IFCENQKTANTRRVVGTYGYMAPEYAME-----GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKE  517 (611)
Q Consensus       443 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  517 (611)
                      .+..+. .......+|||.|++||++..     +.|+..+|+||+||++|||+.|..||...      .++.---+....
T Consensus       224 km~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~KIm~h  296 (1317)
T KOG0612|consen  224 KMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGKIMNH  296 (1317)
T ss_pred             hcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHHHhch
Confidence            775433 334446799999999999862     67999999999999999999999998421      122111111111


Q ss_pred             CccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCC---HHHHHHH--hcCCCCCCCCCCCCCCcc
Q 007239          518 GKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT---MSNVVAL--LGSESIALSEPRQPPFPV  582 (611)
Q Consensus       518 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt---~~evl~~--L~~~~~~l~~~~~p~~~~  582 (611)
                      .....+.+.       .....+..+||...+ -+|+.|-.   ++++-..  +.+..|.--.-..|||..
T Consensus       297 k~~l~FP~~-------~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vP  358 (1317)
T KOG0612|consen  297 KESLSFPDE-------TDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVP  358 (1317)
T ss_pred             hhhcCCCcc-------cccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCC
Confidence            112222211       112233445554443 47888887   8887653  345555444444455543

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-33  Score=295.29  Aligned_cols=262  Identities=26%  Similarity=0.327  Sum_probs=194.7

Q ss_pred             HHHHhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC--
Q 007239          286 VIKAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG--  360 (611)
Q Consensus       286 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--  360 (611)
                      .+....++|.+.+.||+|+||.||++.. .+++.||+|++....  ....+.+.+|+.++++++||||+++++++...  
T Consensus        11 ~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~   90 (345)
T cd07877          11 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS   90 (345)
T ss_pred             HHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence            3455678999999999999999999985 578899999987532  23346688899999999999999999987643  


Q ss_pred             ----CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEe
Q 007239          361 ----EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKIS  436 (611)
Q Consensus       361 ----~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~  436 (611)
                          ...+++++++ +++|.+++.    ...+++..++.++.||++||.|||+.+   ++||||||+||+++.++.+||+
T Consensus        91 ~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~  162 (345)
T cd07877          91 LEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL  162 (345)
T ss_pred             ccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEe
Confidence                3467888876 678877763    235899999999999999999999987   9999999999999999999999


Q ss_pred             ccccceecccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHH
Q 007239          437 DFGMARIFCENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLW  515 (611)
Q Consensus       437 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~  515 (611)
                      |||+++.....     .....|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||......   .....+....
T Consensus       163 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~---~~~~~~~~~~  234 (345)
T cd07877         163 DFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI---DQLKLILRLV  234 (345)
T ss_pred             ccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHh
Confidence            99998754221     223568899999998866 56889999999999999999999987432211   1111111100


Q ss_pred             hcCcccccc---------------ccccCCCC---CHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          516 KEGKEMEFV---------------DPLLMKSS---SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       516 ~~~~~~~~~---------------d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      .. ....+.               ........   ......++.+++.+||+.||++||++.++++.
T Consensus       235 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         235 GT-PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CC-CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            00 000000               00000000   00112356799999999999999999998864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.8e-33  Score=289.86  Aligned_cols=261  Identities=24%  Similarity=0.333  Sum_probs=192.7

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC------C
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG------E  361 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~  361 (611)
                      .++|.+.+.||+|+||.||+|++ .+|+.||+|++....  ......+.+|+.+++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            47899999999999999999995 468999999986532  22345678999999999999999999988654      3


Q ss_pred             eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccc
Q 007239          362 EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA  441 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  441 (611)
                      ..++|+||+.. +|..++     ...+++..+..++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            46999999864 555443     235889999999999999999999986   999999999999999999999999998


Q ss_pred             eecccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHH-----
Q 007239          442 RIFCENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLW-----  515 (611)
Q Consensus       442 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~-----  515 (611)
                      +.....     .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||.....   ......++...     
T Consensus       165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~  236 (342)
T cd07879         165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGP  236 (342)
T ss_pred             cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCH
Confidence            754221     123467889999999876 4688999999999999999999999853321   11111111110     


Q ss_pred             ------hcCccccccc--cccCC-CCC---HHHHHHHHHHhhccccCCCCCCCCHHHHHHH--hcCC
Q 007239          516 ------KEGKEMEFVD--PLLMK-SSS---IPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL--LGSE  568 (611)
Q Consensus       516 ------~~~~~~~~~d--~~l~~-~~~---~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~  568 (611)
                            ..........  +.... ...   .....++.+++.+||+.||++||+++++++.  ++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence                  0000000000  00000 000   0112357799999999999999999999853  5543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-33  Score=283.58  Aligned_cols=259  Identities=29%  Similarity=0.359  Sum_probs=196.6

Q ss_pred             CCcccccCccCceEEEEEEcC-CCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          294 FSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      |+..+.||+|++|.||+++.. +++.+++|++....  ....+.+.+|+.+++.++|+|++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            567789999999999999965 58999999987653  233467789999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++ +|.+++....  ..+++..+..++.|++.+|.|||+.+   ++||||+|+||++++++.+||+|||++.........
T Consensus        81 ~~-~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          81 DM-DLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             Cc-CHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence            85 8988884322  46899999999999999999999987   999999999999999999999999999876433221


Q ss_pred             cccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc--------c
Q 007239          451 ANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE--------M  521 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--------~  521 (611)
                        .....++..|+|||.+.+. .++.++||||||+++|||++|++|+......   .....+.........        .
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07829         155 --YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI---DQLFKIFQILGTPTEESWPGVTKL  229 (282)
T ss_pred             --cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHHHhCCCcHHHHHhhccc
Confidence              1223567789999998776 7899999999999999999999887433211   111111111100000        0


Q ss_pred             cccccccCCC----C---CHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          522 EFVDPLLMKS----S---SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       522 ~~~d~~l~~~----~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ...+......    .   .......+.+++..||+.+|++||++++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0000000000    0   0011346789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.6e-33  Score=279.04  Aligned_cols=249  Identities=27%  Similarity=0.358  Sum_probs=193.0

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK-----SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      +|.+.+.||+|+||.||++++. .+..+++|.++..     .......+.+|+.+++.++||||+++++.+.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5888999999999999999864 3445556555431     122334577899999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhc-hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          367 YELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      |||+++++|.+++... .....+++..++.++.|++.||.|||+.+   ++|+||||+||+++. +.+||+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999888542 23456899999999999999999999986   999999999999975 569999999998764


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ....  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..|+....      ....... ...+...    
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~-~~~~~~~----  223 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLR-IVEGPTP----  223 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHH-HHcCCCC----
Confidence            3322  1223568899999999988888999999999999999999999874211      1111111 1111111    


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       .+    +.....++.+++.+||+.+|++||++.++++
T Consensus       224 -~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         224 -SL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -CC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence             11    1222346778999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.7e-33  Score=292.10  Aligned_cols=261  Identities=26%  Similarity=0.324  Sum_probs=189.6

Q ss_pred             CCCcccccCccCceEEEEEEcC-C--CcEEEEEEeccc--ChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeC----Ce
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-N--GKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEG----EE  362 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~----~~  362 (611)
                      +|++.+.||+|+||.||++... .  ++.||+|++...  .......+.+|+.++++++ ||||+++++.....    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788899999999999999954 3  778999998643  2223456788999999995 99999999875432    45


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .++++||+. ++|..++.   ....+++..++.++.||+.||.|||+++   ++||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            788899986 57887773   3456899999999999999999999987   9999999999999999999999999998


Q ss_pred             ecccCCCc--cccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHh---
Q 007239          443 IFCENQKT--ANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWK---  516 (611)
Q Consensus       443 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~---  516 (611)
                      .+......  .......|++.|+|||++.+ ..++.++||||||+++|+|++|+.||.....   ............   
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~  230 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY---VDQLNQILQVLGTPD  230 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH---HHHHHHHHHHhCCCC
Confidence            76432221  11234578999999998765 4689999999999999999999998754321   111111111000   


Q ss_pred             --------cCccccccccc-cCCCCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          517 --------EGKEMEFVDPL-LMKSSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       517 --------~~~~~~~~d~~-l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                              ........... .......     .....+.+++.+||+.||++|||+.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                    00000000000 0000000     01235678999999999999999999864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-33  Score=281.72  Aligned_cols=268  Identities=27%  Similarity=0.399  Sum_probs=204.1

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHh--cCCCCeeeEEEeEeeCC----eEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAK--LQHRNLVRLVGCGIEGE----EKL  364 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~h~niv~l~~~~~~~~----~~~  364 (611)
                      .+...+.+.||+|.||.||||.+. ++.||||++...   ....+.+|-.|.+.  ++|+||+++++.-....    +.+
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            345666789999999999999984 589999998644   45678888888775  57999999998765444    889


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhc------CCCceEecCCCCCcEEecCCCCEEEecc
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED------SRLKIIHRDLKPSNVLLDKDMVAKISDF  438 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------~~~~iiHrDikp~NIll~~~~~~kl~DF  438 (611)
                      ||+||.+.|+|.++|.    ...++|....+|+..+++||+|||+.      .++.|+|||||.+||||.+|++..|+||
T Consensus       285 LVt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             EEeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            9999999999999984    34689999999999999999999964      2457999999999999999999999999


Q ss_pred             ccceecccCCCccccccccccCCCCCccccccCC-CC-----chhhHHHHHHHHHHHHhCCCCCCCCCC-----------
Q 007239          439 GMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL-FS-----VKSDVFSFGVIVLEIISGKRNSGFYLT-----------  501 (611)
Q Consensus       439 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~k~DvwSlGvll~elltG~~p~~~~~~-----------  501 (611)
                      |+|.++............+||..|||||++.+.- +.     .+.||||+|.|||||++.-.-......           
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV  440 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence            9999998766666666689999999999987632 22     368999999999999986533210000           


Q ss_pred             CchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCCC
Q 007239          502 GHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESI  570 (611)
Q Consensus       502 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  570 (611)
                      +....+.+...-..++.....+.+.+...    ..+.-+.+.+..||..||+.|.|+.=|-+++.....
T Consensus       441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  441 GNHPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             cCCCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence            00111111111112333334444444332    334456688889999999999999999999986644

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-33  Score=292.65  Aligned_cols=258  Identities=26%  Similarity=0.362  Sum_probs=194.8

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe----
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE----  362 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~----  362 (611)
                      ..++|++.+.||+|++|.||+++.. +++.||+|++...  .....+.+.+|+.+++.++|||++++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4578999999999999999999964 6788999998643  22344667889999999999999999988766554    


Q ss_pred             --EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccc
Q 007239          363 --KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGM  440 (611)
Q Consensus       363 --~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  440 (611)
                        .++|+||+ +++|.+++..    ..+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 5688887732    46899999999999999999999986   99999999999999999999999999


Q ss_pred             ceecccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHh---
Q 007239          441 ARIFCENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWK---  516 (611)
Q Consensus       441 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~---  516 (611)
                      +......     .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.....   ......+.....   
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~~~~  236 (343)
T cd07851         165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH---IDQLKRIMNLVGTPD  236 (343)
T ss_pred             ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCCCC
Confidence            9865332     223467889999998865 3678999999999999999999999753322   111111111100   


Q ss_pred             --------cCccccccccccC-CCCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          517 --------EGKEMEFVDPLLM-KSSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       517 --------~~~~~~~~d~~l~-~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                              ......++..... .....     ....++.+++.+||+.+|++|||+.+|++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence                    0000000000000 00000     11346789999999999999999999976

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-32  Score=273.78  Aligned_cols=236  Identities=26%  Similarity=0.318  Sum_probs=190.8

Q ss_pred             cCccCceEEEEEEcC-CCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCCh
Q 007239          300 LGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSL  375 (611)
Q Consensus       300 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~sL  375 (611)
                      ||+|+||.||++... +++.+++|.+.....   ...+.+.+|+.+++.++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            799999999999964 588999999876532   2456789999999999999999999999999999999999999999


Q ss_pred             hhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcccccc
Q 007239          376 DCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR  455 (611)
Q Consensus       376 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  455 (611)
                      .+++..   ...+++..+..++.||+.+|.|||+.+   ++|+||||+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~  152 (250)
T cd05123          81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT  152 (250)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence            998843   336899999999999999999999986   9999999999999999999999999998764332  12234


Q ss_pred             ccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHH
Q 007239          456 VVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIP  535 (611)
Q Consensus       456 ~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  535 (611)
                      ..++..|++||...+...+.++|+||||+++|+|++|+.|+.....   ..+...+    .....      .+    +..
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~----~~~~~------~~----~~~  215 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKI----LKDPL------RF----PEF  215 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHH----hcCCC------CC----CCC
Confidence            5788999999999988899999999999999999999999743321   1111111    11100      01    111


Q ss_pred             HHHHHHHHhhccccCCCCCCCCHHH
Q 007239          536 QVVRCIHIGLLCVQEDPAVRPTMSN  560 (611)
Q Consensus       536 ~~~~l~~li~~cl~~dP~~RPt~~e  560 (611)
                      ....+.+++.+||+.||++||++.+
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCccc
Confidence            1345678999999999999999955

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-34  Score=296.87  Aligned_cols=239  Identities=25%  Similarity=0.311  Sum_probs=191.9

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ++.|.+...+|.|+|+.|-++.. .+++..++|++.+...    .-.+|+.++... +||||+++++.+.+..+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            57889999999999999999984 5788999999976622    235677666665 59999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe-cCCCCEEEeccccceecccC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL-DKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll-~~~~~~kl~DFGla~~~~~~  447 (611)
                      .+.++.+.+.+...   ..+. .++..|+.+|+.++.|||++|   +|||||||+|||+ +..++++|+|||.++.....
T Consensus       397 ~l~g~ell~ri~~~---~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSK---PEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHhc---chhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            99999887777432   2233 778889999999999999997   9999999999999 68999999999999865433


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                           ....+-|..|.|||++....|++++||||||++||+||+|+.|+.....+  ..+.    ..+..+..       
T Consensus       470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~----~~i~~~~~-------  531 (612)
T KOG0603|consen  470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIH----TRIQMPKF-------  531 (612)
T ss_pred             -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHH----HhhcCCcc-------
Confidence                 22346688999999999999999999999999999999999997544333  1111    11222221       


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                           +........+|+.+|||.||.+||+|.++..
T Consensus       532 -----s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  532 -----SECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             -----ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                 1222234568999999999999999999875

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=322.08  Aligned_cols=253  Identities=28%  Similarity=0.391  Sum_probs=198.4

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      +-++.-..+||.|.||.||.++. ++|+-.|+|.++...  ........+|..++..++|||+|+.+|+-...+..+|.|
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            44677788999999999999994 578889999876432  334567789999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      |||++|+|.+++.   ...-.++.....+..|++.|+.|||++|   ||||||||.||+++.+|.+|++|||.|..+..+
T Consensus      1314 EyC~~GsLa~ll~---~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLE---HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHhccCcHHHHHH---hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            9999999999983   3333566666778899999999999998   999999999999999999999999999987654


Q ss_pred             CC--ccccccccccCCCCCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          448 QK--TANTRRVVGTYGYMAPEYAMEGL---FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       448 ~~--~~~~~~~~gt~~y~aPE~~~~~~---~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      ..  ....+...||+-|||||++.+..   ..-+.||||+|||++||+||++||...+..-     + +.-+...+...+
T Consensus      1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~-----a-IMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW-----A-IMYHVAAGHKPQ 1461 (1509)
T ss_pred             hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh-----H-HHhHHhccCCCC
Confidence            32  22334578999999999997643   4568999999999999999999986443220     0 011111222111


Q ss_pred             ccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       523 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      +         +.....+=.+++.+||+.||++|=++.|+++.
T Consensus      1462 ~---------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 I---------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             C---------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            1         11122234588999999999999888887764

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-34  Score=270.62  Aligned_cols=270  Identities=23%  Similarity=0.247  Sum_probs=200.9

Q ss_pred             hhCCCCcc-cccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEee----CCe
Q 007239          290 ATDGFSDS-NKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIE----GEE  362 (611)
Q Consensus       290 ~~~~y~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~----~~~  362 (611)
                      .+++|++. ++||-|-.|.|-.+.. .+++++|+|++...     ...++|+++.-... |||||.++++|++    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            56677765 5799999999999985 47899999998533     34578998876665 9999999998764    456


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC---CCCEEEeccc
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK---DMVAKISDFG  439 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFG  439 (611)
                      +.+|||.|+||.|...+.+ .....+++.++..|+.||..|+.|||+.   +|.||||||+|+|...   |-.+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence            7899999999999998855 3345699999999999999999999987   5999999999999964   4579999999


Q ss_pred             cceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCc
Q 007239          440 MARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK  519 (611)
Q Consensus       440 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  519 (611)
                      +|+.-.   ......+.+-||.|.|||++...+|+...|+||+||+||-||+|.+||...-.   ..+.--....++.+.
T Consensus       210 FAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~gq  283 (400)
T KOG0604|consen  210 FAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTGQ  283 (400)
T ss_pred             cccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhccC
Confidence            998543   23344567889999999999999999999999999999999999999843221   111111111122221


Q ss_pred             cccccccccCCCCCHH-HHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCCCCCCCCCCCCCcc
Q 007239          520 EMEFVDPLLMKSSSIP-QVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFPV  582 (611)
Q Consensus       520 ~~~~~d~~l~~~~~~~-~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~~~~p~~~~  582 (611)
                      . ++.++      ... ..+...+++..+|..+|.+|.|+.+++..=. ..-.-..|+.|.+..
T Consensus       284 y-~FP~p------EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw-i~~~~~vp~tpl~t~  339 (400)
T KOG0604|consen  284 Y-EFPEP------EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW-INQYEAVPQTPLSTS  339 (400)
T ss_pred             c-cCCCh------hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch-hcccccCCCCCchhh
Confidence            1 11111      111 2234568999999999999999999986321 111233455555554

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=266.60  Aligned_cols=251  Identities=25%  Similarity=0.384  Sum_probs=195.1

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ++.+.+..||.|..|.||+.+. .+|..+|||...+. +.+..+++...+.++.+-+ +|.||+.+|+|..+...++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            4556678899999999999995 46888999998765 4456778888888877665 8999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      .|.. -++.++.  .-.+++++..+-++...++.||.||.++.  .|||||+||+|||+|+.|++||+|||++-++.+..
T Consensus       172 lMs~-C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  172 LMST-CAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHH-HHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            9843 3444443  23456888888899999999999999875  79999999999999999999999999998775544


Q ss_pred             CccccccccccCCCCCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAME---GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ...   ...|-+.|||||.+.-   ..|+.++||||||+.++||.||+.|+..-..  ....+..+..   +  ..    
T Consensus       247 Aht---rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t--dFe~ltkvln---~--eP----  312 (391)
T KOG0983|consen  247 AHT---RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT--DFEVLTKVLN---E--EP----  312 (391)
T ss_pred             ccc---cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc--cHHHHHHHHh---c--CC----
Confidence            332   3579999999999864   4689999999999999999999999753222  2222222211   1  11    


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      +.+....  .....+++++..||+.|+.+||...++++
T Consensus       313 P~L~~~~--gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  313 PLLPGHM--GFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CCCCccc--CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            2232221  13345678888999999999999999886

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.6e-32  Score=310.24  Aligned_cols=146  Identities=25%  Similarity=0.367  Sum_probs=131.2

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|.+.++||+|+||.||+|++. +++.||+|+++...   ......+.+|+.+++.++||||+++++++......++|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            468999999999999999999965 68899999987542   23346788999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      |||+.+++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999998843   345889999999999999999999986   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-34  Score=289.47  Aligned_cols=243  Identities=28%  Similarity=0.363  Sum_probs=193.7

Q ss_pred             ccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCC
Q 007239          297 SNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNR  373 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~  373 (611)
                      .+.||+|.||+||-|+. ++|+.||||++.+.  ..+...++++|+.||+++.||.||.+...|+..+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            47899999999999994 68999999999754  2344578999999999999999999999999999999999999776


Q ss_pred             ChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC---CCEEEeccccceecccCCCc
Q 007239          374 SLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD---MVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       374 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~---~~~kl~DFGla~~~~~~~~~  450 (611)
                      -|+-++.  ...+++++.....++.||+.||+|||.++   |+|.||||+|||+...   -.+||+|||+|+++++... 
T Consensus       649 MLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-  722 (888)
T KOG4236|consen  649 MLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-  722 (888)
T ss_pred             HHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh-
Confidence            6655443  44567999999999999999999999985   9999999999999643   4799999999999876553 


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                        .+..+|||.|+|||+++.+.|...-|+||+||++|.-|+|.-||....+...  .++..         .-++-+    
T Consensus       723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QIQNA---------aFMyPp----  785 (888)
T KOG4236|consen  723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QIQNA---------AFMYPP----  785 (888)
T ss_pred             --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH--Hhhcc---------ccccCC----
Confidence              3457999999999999999999999999999999999999988753322111  11110         001111    


Q ss_pred             CCCHHH-HHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          531 SSSIPQ-VVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       531 ~~~~~~-~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       .+..+ ....++||...||..-++|.+.+..+.
T Consensus       786 -~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  786 -NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             -CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence             11111 124567888888998899988876653

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-33  Score=267.51  Aligned_cols=249  Identities=22%  Similarity=0.307  Sum_probs=199.7

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~  364 (611)
                      ..++|.+++.||+|++++|-.+++ ++.+.+|+|+++++   ..++++..+.|-.+..+. +||.+|-++.+|..+..++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            357899999999999999999995 46788999999864   445567778888888776 4999999999999999999


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +|.||++||+|-..+   ++...++++.++.+..+|..+|.|||++|   ||+||||.+|+|+|..|++||+|+|+.+.-
T Consensus       328 fvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence            999999999986655   55567999999999999999999999998   999999999999999999999999999753


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-CchhhHHHHHHHHHhcCccccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLT-GHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~-~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      -.+  ...+.+++|||.|+|||++.+..|...+|+|+|||+|+||+.|+.||+.-.. ...++...++.+.+-+..+ + 
T Consensus       402 l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-r-  477 (593)
T KOG0695|consen  402 LGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-R-  477 (593)
T ss_pred             CCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-c-
Confidence            222  2234468999999999999999999999999999999999999999975432 2233444444444433222 1 


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCC
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRP  556 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP  556 (611)
                          +.+    ....+...++..-|.+||.+|.
T Consensus       478 ----ipr----slsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  478 ----IPR----SLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ----ccc----eeehhhHHHHHHhhcCCcHHhc
Confidence                111    1122334566678899999884

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-32  Score=271.52  Aligned_cols=272  Identities=24%  Similarity=0.341  Sum_probs=205.4

Q ss_pred             CHHHHHHhhCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHh--cCCCCeeeEEEeEeeC
Q 007239          283 HLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAK--LQHRNLVRLVGCGIEG  360 (611)
Q Consensus       283 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~h~niv~l~~~~~~~  360 (611)
                      ++.......++..+.+.||+|.||+||+|.| -|+.||||++...+.   ....+|.+|.+.  |+|+||+.+++.-..+
T Consensus       202 plLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~  277 (513)
T KOG2052|consen  202 PLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKD  277 (513)
T ss_pred             hhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccC
Confidence            3444556677889999999999999999999 488999999976543   345677777764  6899999999875443


Q ss_pred             ----CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhh-----cCCCceEecCCCCCcEEecCCC
Q 007239          361 ----EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE-----DSRLKIIHRDLKPSNVLLDKDM  431 (611)
Q Consensus       361 ----~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-----~~~~~iiHrDikp~NIll~~~~  431 (611)
                          ..++||.+|.++|||.|+|.    +..++.+..++++..+|.||+|||-     +|++.|.|||||..||||.+++
T Consensus       278 ~gs~TQLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~  353 (513)
T KOG2052|consen  278 NGSWTQLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  353 (513)
T ss_pred             CCceEEEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence                36899999999999999993    3568999999999999999999994     5778899999999999999999


Q ss_pred             CEEEeccccceecccCC--CccccccccccCCCCCccccccCC----C-C-chhhHHHHHHHHHHHHh----C------C
Q 007239          432 VAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAPEYAMEGL----F-S-VKSDVFSFGVIVLEIIS----G------K  493 (611)
Q Consensus       432 ~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~----~-~-~k~DvwSlGvll~ellt----G------~  493 (611)
                      ...|+|+|||.......  .....+..+||..|||||++.+.-    | + ..+||||||.++||+.-    |      +
T Consensus       354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~  433 (513)
T KOG2052|consen  354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ  433 (513)
T ss_pred             cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence            99999999998875542  222345578999999999986532    2 2 35899999999999974    2      2


Q ss_pred             CCCCCCCCCchhhHHHHHHHHHhcCccccccccccC-CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          494 RNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM-KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       494 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      .||...-+.++. ..     -.++.--.+.+.|.+. ...+.+.+..+.+|+..||..||.-|-|+-.+-..|.+.
T Consensus       434 ~Pyyd~Vp~DPs-~e-----eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  434 LPYYDVVPSDPS-FE-----EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             CCcccCCCCCCC-HH-----HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence            444322222221 00     0111112222333332 233556777888999999999999999998888877654

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=4.1e-32  Score=269.29  Aligned_cols=220  Identities=20%  Similarity=0.165  Sum_probs=174.0

Q ss_pred             cCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCChhhHhhh
Q 007239          303 GGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFD  381 (611)
Q Consensus       303 G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~sL~~~l~~  381 (611)
                      |.+|.||++++ .+++.+|+|+++...     .+.+|...+....||||+++++++...+..++||||+++++|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            88999999996 478899999997653     234455556666799999999999999999999999999999988843


Q ss_pred             chhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccccccccccCC
Q 007239          382 SERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG  461 (611)
Q Consensus       382 ~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  461 (611)
                         ...+++..+..++.|+++||.|||+.+   ++||||||+||+++.++.++++|||.+.......     ....++..
T Consensus        79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~  147 (237)
T cd05576          79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM  147 (237)
T ss_pred             ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence               345899999999999999999999987   9999999999999999999999999886543221     12356778


Q ss_pred             CCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHH
Q 007239          462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCI  541 (611)
Q Consensus       462 y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  541 (611)
                      |+|||.+.+..++.++||||+|+++|||++|+.|+......            ......     ..+..    .....+.
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------~~~~~~-----~~~~~----~~~~~~~  206 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------INTHTT-----LNIPE----WVSEEAR  206 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------cccccc-----cCCcc----cCCHHHH
Confidence            99999998888999999999999999999999775321110            000000     00111    1123567


Q ss_pred             HHhhccccCCCCCCCCHH
Q 007239          542 HIGLLCVQEDPAVRPTMS  559 (611)
Q Consensus       542 ~li~~cl~~dP~~RPt~~  559 (611)
                      +++.+||+.||++||++.
T Consensus       207 ~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         207 SLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHccCCHHHhcCCC
Confidence            899999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4e-33  Score=277.89  Aligned_cols=257  Identities=26%  Similarity=0.361  Sum_probs=197.3

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-hh------hHHHHHHHHHHHHhcCCCCeeeEEEeEe-eCC
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQ------GLEEFKNEIILIAKLQHRNLVRLVGCGI-EGE  361 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~------~~~~~~~E~~il~~l~h~niv~l~~~~~-~~~  361 (611)
                      .++|-++..||+|||++||++.+ ...+.||+|+-.... +.      -.+...+|..|.+.|.||.||++|++|. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            35788899999999999999994 567789999864321 11      1334678999999999999999999986 556


Q ss_pred             eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec---CCCCEEEecc
Q 007239          362 EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD---KDMVAKISDF  438 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~---~~~~~kl~DF  438 (611)
                      ..+-|.||++|.+|+.+|   .....+++.+++.|+.||+.||.||.+. ..+|||-||||.|||+.   .-|.+||+||
T Consensus       542 sFCTVLEYceGNDLDFYL---KQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYL---KQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             cceeeeeecCCCchhHHH---HhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence            778999999999999999   4556799999999999999999999988 47899999999999995   4578999999


Q ss_pred             ccceecccCCCcc-----ccccccccCCCCCccccccC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHH
Q 007239          439 GMARIFCENQKTA-----NTRRVVGTYGYMAPEYAMEG----LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLA  509 (611)
Q Consensus       439 Gla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~  509 (611)
                      |+++++..+....     .+....||.+|++||.+.-+    +++.|+||||+||++|..+-|+.||+....  .++++.
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdILq  695 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDILQ  695 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHHh
Confidence            9999986544332     24457899999999987644    478899999999999999999999875432  222222


Q ss_pred             HHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 007239          510 YVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV  562 (611)
Q Consensus       510 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  562 (611)
                             ++.+.....-....  ......+..++|.+||+..-++|....++.
T Consensus       696 -------eNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  696 -------ENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             -------hhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence                   22222211111111  111223456899999999999998766654

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.98  E-value=7.4e-34  Score=267.14  Aligned_cols=256  Identities=28%  Similarity=0.401  Sum_probs=196.4

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh-hhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW-QGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ++.+.+..||.|.||+|+|-.+ +.|+..|||+++.... .+..++..|.+...+- +.||||+++|....++..|+.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            3445567899999999999885 5799999999987654 4567788888766554 58999999999999999999999


Q ss_pred             ecCCCChhhHhhh--chhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          369 LMPNRSLDCFIFD--SERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       369 ~~~~~sL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      .|+- ||+.+-..  ..+...++++.+-.|..-..+||.||...  ++|||||+||+|||++..|.+||+|||++-.+.+
T Consensus       144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            9964 66554321  23455688888888888899999999986  4899999999999999999999999999876533


Q ss_pred             CCCccccccccccCCCCCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAME--GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ...   ...-.|-..|||||.+..  ..|+.++||||||++|||+.||+-|+..+..     +.+.+.+.. .+....+.
T Consensus       221 SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv-~gdpp~l~  291 (361)
T KOG1006|consen  221 SIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVV-IGDPPILL  291 (361)
T ss_pred             HHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHH-cCCCCeec
Confidence            222   223478889999999864  3589999999999999999999999765443     222222222 22222221


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                          ...........+..++..||-+|-.+||...++..
T Consensus       292 ----~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  292 ----FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             ----CcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence                11222344567788999999999999999999875

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=7.2e-32  Score=289.85  Aligned_cols=258  Identities=24%  Similarity=0.362  Sum_probs=206.5

Q ss_pred             HHHHHhhCCCCcccccCccCceEEEEEE-cCCCcEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEee---
Q 007239          285 AVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIE---  359 (611)
Q Consensus       285 ~~~~~~~~~y~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~---  359 (611)
                      ..+...++-|++.+.||.|.+|.||+++ .++++..|+|+...... ..+++..|..||+.+. |||++.++++|..   
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            3344556789999999999999999999 56788999999876543 3467788999999885 9999999999863   


Q ss_pred             --CCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEec
Q 007239          360 --GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISD  437 (611)
Q Consensus       360 --~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~D  437 (611)
                        ++.+|||||||.+||..|++..-. ...+.|..+..|++.+++|+.|||...   ++|||||-.|||++.++.|||.|
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvD  166 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVD  166 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEee
Confidence              568999999999999999997644 677999999999999999999999885   99999999999999999999999


Q ss_pred             cccceecccCCCccccccccccCCCCCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHH
Q 007239          438 FGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG-----LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW  512 (611)
Q Consensus       438 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~  512 (611)
                      ||.+..+..  ......+.+|||.|||||++.-.     .|+..+|+||||++..||--|.+|+...-+         ..
T Consensus       167 FGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP---------mr  235 (953)
T KOG0587|consen  167 FGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP---------MR  235 (953)
T ss_pred             eeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch---------hh
Confidence            999987533  33345568999999999998643     477789999999999999999999632111         00


Q ss_pred             HHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       513 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .++.   +....-+.+  ..+..-..++.++|..||..|.++||++.++++
T Consensus       236 aLF~---IpRNPPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  236 ALFL---IPRNPPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             hhcc---CCCCCCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            0110   111111122  223455667889999999999999999998875

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=9.2e-33  Score=293.30  Aligned_cols=253  Identities=30%  Similarity=0.441  Sum_probs=205.4

Q ss_pred             CCcccccCccCceEEEEEEc-CCCc----EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          294 FSDSNKLGQGGFGTVYKGVL-PNGK----EVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      .+..++||+|+||+||+|.| ++|+    +||+|++... ..+...++..|+-+|.+++|||++++++++.... +.||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            45578999999999999995 4444    6899988654 4455788999999999999999999999987665 88999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      +||+.|.|.+++..  .+..+..+..+.|..||++||.|||++.   ++||||-..||||.+-.++||.|||+++....+
T Consensus       777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999864  4556888999999999999999999985   999999999999999999999999999988666


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ..........-.+.|||-|.+....|+.++|||||||.+||++| |..|+......+       +..+++.+..      
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-------I~dlle~geR------  918 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-------IPDLLEKGER------  918 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-------hhHHHhcccc------
Confidence            55544444445667999999999999999999999999999997 777865443322       2222333322      


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                       |  +.+.-...++..++..||..|++.||+++++...+++.
T Consensus       919 -L--sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  919 -L--SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             -C--CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence             1  12233445677888999999999999999999988654

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.98  E-value=8.9e-32  Score=239.20  Aligned_cols=261  Identities=24%  Similarity=0.343  Sum_probs=191.8

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChh--hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQ--GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +|.-.++||+|.+|+||+++. .+++.||+|+++.....  -.....+|+-+|+.++|+|||+++++...++.+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            466678999999999999994 56888999998754322  245678999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      |.. .|..+..  .-.+.++.+.++.++.|+++||.+.|++.   +.|||+||.|+||+.+|++|++|||+++.++-...
T Consensus        83 cdq-dlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CDQ-DLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hhH-HHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            965 5655542  33467899999999999999999999984   99999999999999999999999999998765432


Q ss_pred             ccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc------
Q 007239          450 TANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME------  522 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~------  522 (611)
                      -..  ..+-|..|.+|.++.+. .|+...|+||-||++.||....+|.  +...+..+.+..+.+.........      
T Consensus       157 cys--aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl--fpg~dvddqlkrif~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  157 CYS--AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRIFRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             eee--ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC--CCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence            222  23568899999999875 4889999999999999999765553  122222222333332222221111      


Q ss_pred             ccccccCCCC----CHHHH-H----HHHHHhhccccCCCCCCCCHHHHHH
Q 007239          523 FVDPLLMKSS----SIPQV-V----RCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       523 ~~d~~l~~~~----~~~~~-~----~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      +.|...-..+    +..++ .    .=.+++...|.-+|..|.++++.++
T Consensus       233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            1111111111    11111 1    1146666778889999999998875

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=8.1e-34  Score=264.74  Aligned_cols=267  Identities=22%  Similarity=0.350  Sum_probs=191.5

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee--------C
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE--------G  360 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--------~  360 (611)
                      ..|+-..+||+|.||+||+++. ++|++||+|++.-+  .........+|+.+|..|.|+|++.++++|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            4566778999999999999995 46788999876432  21223445789999999999999999987753        3


Q ss_pred             CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccc
Q 007239          361 EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGM  440 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  440 (611)
                      ...|+||+++++ +|.-++.+  ....++..++.+++.++.+||.|+|...   |+|||+|+.|+||+.+|.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            458999999987 66666633  3356899999999999999999999874   99999999999999999999999999


Q ss_pred             ceecccCCCcc--ccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhc
Q 007239          441 ARIFCENQKTA--NTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKE  517 (611)
Q Consensus       441 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  517 (611)
                      ++.+.......  .-+..+-|..|++||.+.+ ..|+++.|||.-||+|.||++|.+-+.......+..++......+..
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            98875433222  2223456899999998876 56999999999999999999998765332222222222222111111


Q ss_pred             Cccccc-----cccc----cC-CCCC-HHH-H------HHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          518 GKEMEF-----VDPL----LM-KSSS-IPQ-V------VRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       518 ~~~~~~-----~d~~----l~-~~~~-~~~-~------~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ..+.+.     +...    +. +... .+. .      .+..+|+..+|..||.+|+++++++..
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            111111     1111    10 0000 000 0      135688889999999999999998853

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.5e-33  Score=282.73  Aligned_cols=249  Identities=22%  Similarity=0.288  Sum_probs=202.3

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCC-cEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNG-KEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~-~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ..+++....||-|+||.|-++..++. ..+|+|++++..   ....+.+..|-.||...+.|.||++|..|.+.+..|++
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            45677788899999999999886433 348999887653   33456788899999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      ||-|-||.|...+   ..++.++...+..++..+++|++|||+++   ||+|||||+|.+++.+|-+||.|||+|+.+..
T Consensus       499 mEaClGGElWTiL---rdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  499 MEACLGGELWTIL---RDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             HHhhcCchhhhhh---hhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            9999999999998   55677999999999999999999999997   99999999999999999999999999998765


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      +..   +-+++|||.|.|||++.++..+.++|.|+||+++|||++|++||...++-...+++-.-.      ...++   
T Consensus       573 g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi------d~i~~---  640 (732)
T KOG0614|consen  573 GRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI------DKIEF---  640 (732)
T ss_pred             CCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh------hhhhc---
Confidence            443   446899999999999999999999999999999999999999986655544333322111      11111   


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT-----MSNVVA  563 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  563 (611)
                            +..-.....+|+......+|.+|..     +.+|-.
T Consensus       641 ------Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk  676 (732)
T KOG0614|consen  641 ------PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK  676 (732)
T ss_pred             ------ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence                  1111234567888888999999975     555543

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.1e-31  Score=277.86  Aligned_cols=207  Identities=24%  Similarity=0.334  Sum_probs=176.0

Q ss_pred             hCCCCcccccCccCceEEEEEE-cCCCcEEEEEEecccChh---hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQ---GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ..-|..++.||-|+||+|-++. .++...||+|.+++.+.-   .....+.|-.||.....+.||+||..|.+++.+|+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            4568888999999999999998 455667999999876543   344578899999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||++||++-.+|   .+.+-+.++.++.++.++..|+++.|.-|   +|||||||+|||||.+|++||+||||+.-+.-
T Consensus       708 MdYIPGGDmMSLL---IrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLL---IRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             EeccCCccHHHHH---HHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence            9999999998888   45566899999999999999999999987   99999999999999999999999999864311


Q ss_pred             CCC--------c--------------------------------cccccccccCCCCCccccccCCCCchhhHHHHHHHH
Q 007239          447 NQK--------T--------------------------------ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIV  486 (611)
Q Consensus       447 ~~~--------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll  486 (611)
                      ...        .                                ......+||+.|+|||++....++...|+||.||||
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil  861 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL  861 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence            000        0                                001246899999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCCCc
Q 007239          487 LEIISGKRNSGFYLTGH  503 (611)
Q Consensus       487 ~elltG~~p~~~~~~~~  503 (611)
                      |||+.|+.||-...+..
T Consensus       862 ~em~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  862 YEMLVGQPPFLADTPGE  878 (1034)
T ss_pred             HHHhhCCCCccCCCCCc
Confidence            99999999985444433

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=8.5e-31  Score=258.73  Aligned_cols=238  Identities=29%  Similarity=0.350  Sum_probs=192.2

Q ss_pred             CceEEEEEEcC-CCcEEEEEEecccChhh-HHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCChhhHhhh
Q 007239          304 GFGTVYKGVLP-NGKEVAVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFD  381 (611)
Q Consensus       304 ~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~sL~~~l~~  381 (611)
                      +||.||++++. +++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999975 58999999998765444 67899999999999999999999999999999999999999999998843


Q ss_pred             chhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccccccccccCC
Q 007239          382 SERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG  461 (611)
Q Consensus       382 ~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  461 (611)
                      .   ..+++..++.++.++++++.|||+.+   ++|+||+|+||+++.++.++|+|||.+.......   ......++..
T Consensus        81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            2   23889999999999999999999986   9999999999999999999999999998765432   2234568899


Q ss_pred             CCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHH
Q 007239          462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCI  541 (611)
Q Consensus       462 y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  541 (611)
                      |++||.+....++.++|||+||+++++|++|..|+...  .....+..    ............       ......++.
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~--~~~~~~~~----~~~~~~~~~~~~-------~~~~~~~~~  218 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD--DQLLELFK----KIGKPKPPFPPP-------EWKISPEAK  218 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHH----HHhccCCCCccc-------cccCCHHHH
Confidence            99999999888999999999999999999999887432  11111111    112111110000       000224677


Q ss_pred             HHhhccccCCCCCCCCHHHHHH
Q 007239          542 HIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       542 ~li~~cl~~dP~~RPt~~evl~  563 (611)
                      +++.+||..+|++||++.++++
T Consensus       219 ~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      219 DLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHccCCchhccCHHHHhh
Confidence            8999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=2.3e-31  Score=293.85  Aligned_cols=259  Identities=22%  Similarity=0.252  Sum_probs=167.0

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-C----CcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEe------Ee
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-N----GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC------GI  358 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~------~~  358 (611)
                      ..++|.+.+.||+|+||.||+|++. +    ++.||+|++......  +...+|  .+....+.++..++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4578999999999999999999964 4    689999987643321  111111  1122222222222111      24


Q ss_pred             eCCeEEEEEEecCCCChhhHhhhchh-----------------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCC
Q 007239          359 EGEEKLLIYELMPNRSLDCFIFDSER-----------------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLK  421 (611)
Q Consensus       359 ~~~~~~lv~E~~~~~sL~~~l~~~~~-----------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDik  421 (611)
                      .....++||||+++++|.+++.....                 ........+..++.||+.||.|||+++   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            56688999999999999988854211                 011123446689999999999999986   9999999


Q ss_pred             CCcEEecC-CCCEEEeccccceecccCCCccccccccccCCCCCccccccC----------------------CCCchhh
Q 007239          422 PSNVLLDK-DMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG----------------------LFSVKSD  478 (611)
Q Consensus       422 p~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~k~D  478 (611)
                      |+|||++. ++.+||+|||+++.+..... .......|++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 58999999999986533222 223346889999999965322                      2345679


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc----ccccccc----CCCCC--HHHHHHHHHHhhccc
Q 007239          479 VFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM----EFVDPLL----MKSSS--IPQVVRCIHIGLLCV  548 (611)
Q Consensus       479 vwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~----~~~d~~l----~~~~~--~~~~~~l~~li~~cl  548 (611)
                      ||||||+||||+++..+.+       ..+..........+...    ..+.+..    .....  ........+|+.+||
T Consensus       362 VwSlGviL~el~~~~~~~~-------~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL  434 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSD-------SNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM  434 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCc-------hHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence            9999999999999765532       11111111111111000    0001100    00000  001113458999999


Q ss_pred             cCCCCCCCCHHHHHH
Q 007239          549 QEDPAVRPTMSNVVA  563 (611)
Q Consensus       549 ~~dP~~RPt~~evl~  563 (611)
                      +.||++|||+.++++
T Consensus       435 ~~dP~kR~ta~e~L~  449 (566)
T PLN03225        435 RFKGRQRISAKAALA  449 (566)
T ss_pred             cCCcccCCCHHHHhC
Confidence            999999999999997

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-31  Score=294.26  Aligned_cols=261  Identities=28%  Similarity=0.396  Sum_probs=204.5

Q ss_pred             HhhCCCCcccccCccCceEEEEEEcC----C----CcEEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCeeeEEEeEe
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVLP----N----GKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQ-HRNLVRLVGCGI  358 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~~----~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~niv~l~~~~~  358 (611)
                      ...++..+.+.||+|.||.|++|...    .    ...||||.++... ....+.+..|+++++.+. |+||+.+++++.
T Consensus       293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t  372 (609)
T KOG0200|consen  293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT  372 (609)
T ss_pred             echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence            33455567779999999999999832    1    3569999987543 345678999999999996 999999999999


Q ss_pred             eCCeEEEEEEecCCCChhhHhhhch-----h------h--ccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcE
Q 007239          359 EGEEKLLIYELMPNRSLDCFIFDSE-----R------R--LQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNV  425 (611)
Q Consensus       359 ~~~~~~lv~E~~~~~sL~~~l~~~~-----~------~--~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NI  425 (611)
                      .++..++|+||++.|+|..++....     .      .  ..++....+.++.||+.||+||++..   +|||||-..||
T Consensus       373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNV  449 (609)
T KOG0200|consen  373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNV  449 (609)
T ss_pred             cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhE
Confidence            9999999999999999999996543     0      0  23888999999999999999999985   99999999999


Q ss_pred             EecCCCCEEEeccccceecccCCCcccccccc--ccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCC
Q 007239          426 LLDKDMVAKISDFGMARIFCENQKTANTRRVV--GTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTG  502 (611)
Q Consensus       426 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~  502 (611)
                      |+.++..+||+|||+++........... .-.  -...|||||.+....|+.|+|||||||+||||+| |..|++...  
T Consensus       450 Li~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~--  526 (609)
T KOG0200|consen  450 LITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP--  526 (609)
T ss_pred             EecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--
Confidence            9999999999999999965433322211 112  2345999999999999999999999999999998 566653311  


Q ss_pred             chhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          503 HAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       503 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ....+    ++..+.|...+.         +.....++.+++..||+.+|++||+..++++.|..+
T Consensus       527 ~~~~l----~~~l~~G~r~~~---------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  527 PTEEL----LEFLKEGNRMEQ---------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             cHHHH----HHHHhcCCCCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            11222    334555554332         112234567899999999999999999999999873

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=1.3e-30  Score=280.94  Aligned_cols=261  Identities=20%  Similarity=0.276  Sum_probs=177.8

Q ss_pred             hCCCCcccccCccCceEEEEEEc-----------------CCCcEEEEEEecccChhhHHHH--------------HHHH
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-----------------PNGKEVAVKRLSRKSWQGLEEF--------------KNEI  339 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E~  339 (611)
                      .++|++.++||+|+||+||+|.+                 ..++.||||++........+.|              ..|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            46899999999999999999963                 2356799999875443322333              3467


Q ss_pred             HHHHhcCCCCe-----eeEEEeEee--------CCeEEEEEEecCCCChhhHhhhch---------------------hh
Q 007239          340 ILIAKLQHRNL-----VRLVGCGIE--------GEEKLLIYELMPNRSLDCFIFDSE---------------------RR  385 (611)
Q Consensus       340 ~il~~l~h~ni-----v~l~~~~~~--------~~~~~lv~E~~~~~sL~~~l~~~~---------------------~~  385 (611)
                      .++.+++|.++     +++++++..        .+..++||||+++++|.+++....                     ..
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777776654     566666543        356899999999999999885321                     11


Q ss_pred             ccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccccccccccCCCCCc
Q 007239          386 LQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP  465 (611)
Q Consensus       386 ~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP  465 (611)
                      ..+++..++.++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||++......... ......+|+.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeCh
Confidence            23467789999999999999999986   999999999999999999999999999765332211 11122457899999


Q ss_pred             cccccCC--------------------C--CchhhHHHHHHHHHHHHhCCC-CCCCCCCCch----hhHHHHHHHHHhcC
Q 007239          466 EYAMEGL--------------------F--SVKSDVFSFGVIVLEIISGKR-NSGFYLTGHA----QTLLAYVWQLWKEG  518 (611)
Q Consensus       466 E~~~~~~--------------------~--~~k~DvwSlGvll~elltG~~-p~~~~~~~~~----~~l~~~~~~~~~~~  518 (611)
                      |.+....                    +  ..+.||||+||++|+|++|.. |+........    .......|+.+...
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            9875432                    1  134799999999999999875 5421110000    00111122222221


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHhhccccCCC---CCCCCHHHHHH
Q 007239          519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDP---AVRPTMSNVVA  563 (611)
Q Consensus       519 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP---~~RPt~~evl~  563 (611)
                      ..    +-...    ........+|+..+|..+|   .+|+|++|+++
T Consensus       460 ~~----~~~~~----d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        460 KY----DFSLL----DRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             CC----Ccccc----cccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            11    10000    0112345688888998766   78999999985

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=5.1e-32  Score=267.30  Aligned_cols=261  Identities=21%  Similarity=0.269  Sum_probs=198.7

Q ss_pred             HhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCC--C----CeeeEEEeEeeCC
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQH--R----NLVRLVGCGIEGE  361 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h--~----niv~l~~~~~~~~  361 (611)
                      ...++|.+.+.+|+|.||.|-.+.+. .+..||+|+++.-. .-.+.-+-|+++|+++.+  |    -++.+.+||.-.+
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            44789999999999999999999854 47889999987443 223455679999999952  3    2788889999999


Q ss_pred             eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC------------
Q 007239          362 EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK------------  429 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~------------  429 (611)
                      +.++|+|.+ |-|+.+++.. ..-.+++..+++.+..||++++.+||+.+   ++|-||||+|||+.+            
T Consensus       165 hiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             ceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence            999999998 5588899854 34467899999999999999999999986   999999999999931            


Q ss_pred             --------CCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 007239          430 --------DMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLT  501 (611)
Q Consensus       430 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~  501 (611)
                              +-.++|+|||.|+.-.+..     ..++.|..|.|||++.+-.++.++||||+||||+||.+|..-|...+.
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen  314 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN  314 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence                    3358999999998754433     246889999999999999999999999999999999999987654442


Q ss_pred             CchhhHH--HHH--------------HHHHhcCccccccccccCC----------------CCCHHHHHHHHHHhhcccc
Q 007239          502 GHAQTLL--AYV--------------WQLWKEGKEMEFVDPLLMK----------------SSSIPQVVRCIHIGLLCVQ  549 (611)
Q Consensus       502 ~~~~~l~--~~~--------------~~~~~~~~~~~~~d~~l~~----------------~~~~~~~~~l~~li~~cl~  549 (611)
                        .+++.  +.+              .+.+..+ ..++-+....+                .....+..++++|+..||.
T Consensus       315 --~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~  391 (415)
T KOG0671|consen  315 --LEHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE  391 (415)
T ss_pred             --HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence              22221  111              1111111 11111110000                1123455678999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 007239          550 EDPAVRPTMSNVVA  563 (611)
Q Consensus       550 ~dP~~RPt~~evl~  563 (611)
                      .||.+|+|+.|++.
T Consensus       392 fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  392 FDPARRITLREALS  405 (415)
T ss_pred             cCccccccHHHHhc
Confidence            99999999999985

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.7e-32  Score=255.47  Aligned_cols=265  Identities=24%  Similarity=0.329  Sum_probs=193.4

Q ss_pred             CCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC-----CeEEE
Q 007239          294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG-----EEKLL  365 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~~~l  365 (611)
                      .+-.+.||-|+||+||.+.+ .+|+.|++|++..-  +....+++.+|+++|.-++|.|++..+++....     +++|+
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            44568899999999999996 47999999988643  233457889999999999999999988876543     35678


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      +.|.|.. +|+.+|   .....++.+.+.-++.||++||.|||+.+   |.||||||.|+|++.+..+||+|||+++...
T Consensus       135 ~TELmQS-DLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  135 LTELMQS-DLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHHh-hhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence            8888854 777777   44556888999999999999999999986   9999999999999999999999999999765


Q ss_pred             cCCCccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHH--------HHHHh
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYV--------WQLWK  516 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~  516 (611)
                      .++.. .++.-+-|..|.|||++++. .|+.++||||+||++.||+..+--|.-..+..+.+++...        .+..-
T Consensus       208 ~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  208 QRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             hhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence            44433 34445668899999999874 6999999999999999999877655332222222222111        11111


Q ss_pred             cCccccccccccC---------CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          517 EGKEMEFVDPLLM---------KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       517 ~~~~~~~~d~~l~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                      ++....++....+         -..+.....+..++...++..||++|.+..+.+..+-
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            1111111111111         1111122234457777899999999999999987663

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.3e-30  Score=240.34  Aligned_cols=258  Identities=20%  Similarity=0.299  Sum_probs=192.1

Q ss_pred             hhCCCCcccccCccCceEEEEEE-cCCCcEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeC--CeEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEG--EEKLL  365 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~--~~~~l  365 (611)
                      ..++|++.+++|+|.+++||.|+ ..++++++||++++-.   .+.+.+|++||+.|. ||||++++++..+.  ....|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            45789999999999999999999 4678899999997654   356789999999998 99999999998765  45689


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC-CCEEEeccccceec
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD-MVAKISDFGMARIF  444 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~-~~~kl~DFGla~~~  444 (611)
                      |+||+++.+...+-      ..++...+...+.+++.||.|+|+.|   |+|||+||.|++||.. -.++|+|+|+|.++
T Consensus       113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY  183 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY  183 (338)
T ss_pred             HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence            99999998876554      34777788999999999999999998   9999999999999865 57999999999988


Q ss_pred             ccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHH--------HH
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ--------LW  515 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~--------~~  515 (611)
                      ........   .+.+..|--||.+-. ..|+..-|+|||||++..|+..+.||-.. .+....++..+.-        ..
T Consensus       184 Hp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG-~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  184 HPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG-HDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             CCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCC-CCCHHHHHHHHHHhChHHHHHHH
Confidence            66554322   355677889998875 45788999999999999999999997322 2222222222110        00


Q ss_pred             hcC--cccccccc------------ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          516 KEG--KEMEFVDP------------LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       516 ~~~--~~~~~~d~------------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..-  ....-++.            .+..+...-...+.++++...|..|-++|||+.|...
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            000  00000111            1111111111235678888899999999999999874

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=236.65  Aligned_cols=205  Identities=29%  Similarity=0.391  Sum_probs=168.6

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      .+...-+..||+|++|.|-+-++ .+|+..|+|+++.. ..+..+++.+|+.+..+. .+|.+|.++|........++.|
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM  124 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM  124 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence            34555677899999999988884 58999999999754 345567788888876654 5999999999999999999999


Q ss_pred             EecCCCChhhHhhh-chhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          368 ELMPNRSLDCFIFD-SERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       368 E~~~~~sL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |.|.- ||+.+-.+ -.+.+.+++..+-+|+..+.+||.|||++  +.+||||+||+||||+.+|++|+||||.+-.+.+
T Consensus       125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            99954 77766433 24456789999999999999999999997  4899999999999999999999999999987644


Q ss_pred             CCCccccccccccCCCCCcccccc----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAME----GLFSVKSDVFSFGVIVLEIISGKRNSGFYLT  501 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~k~DvwSlGvll~elltG~~p~~~~~~  501 (611)
                      .-..   ....|-..|||||.+..    ..|+.|+||||||+.+.||.+++.|++.+..
T Consensus       202 SiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  202 SIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             hhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            3322   12467788999998853    4689999999999999999999999765443

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=6e-30  Score=252.22  Aligned_cols=266  Identities=22%  Similarity=0.331  Sum_probs=213.8

Q ss_pred             CHHHHHHhhCCCCcccccCccCceEEEEEEcC------CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEE
Q 007239          283 HLAVIKAATDGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVG  355 (611)
Q Consensus       283 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~  355 (611)
                      ...++.....+++....+-+|.||.||.|+|.      +.+.|.+|.++.. +......+..|.-++..+.|||+..+.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            34455566778999999999999999999764      2345777877644 4445678899999999999999999999


Q ss_pred             eEeeC-CeEEEEEEecCCCChhhHhh-----hchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC
Q 007239          356 CGIEG-EEKLLIYELMPNRSLDCFIF-----DSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK  429 (611)
Q Consensus       356 ~~~~~-~~~~lv~E~~~~~sL~~~l~-----~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~  429 (611)
                      +..++ ...++++.++.-|+|..|+.     +......++-.+...++.|++.|++|||+++   |||.||...|.+|++
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence            87654 56788999999999999997     4444556788889999999999999999997   999999999999999


Q ss_pred             CCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHH
Q 007239          430 DMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLL  508 (611)
Q Consensus       430 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~  508 (611)
                      ...+||+|-.+++.+-+.+.......-.....||+||.+.+..|+.++|||||||+||||+| |+.|+..-++   ....
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP---fEm~  508 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP---FEME  508 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH---HHHH
Confidence            99999999999998766666655444556678999999999999999999999999999987 7888654333   2333


Q ss_pred             HHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          509 AYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       509 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      .++    ++|..       +  ..+....-++..++.-||...|++||+.++++.-|+.
T Consensus       509 ~yl----kdGyR-------l--aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  509 HYL----KDGYR-------L--AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             HHH----hccce-------e--cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            333    23321       1  1133445578889999999999999999999998864

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=2e-30  Score=277.61  Aligned_cols=261  Identities=29%  Similarity=0.433  Sum_probs=192.9

Q ss_pred             CCcccccCccCceE-EEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          294 FSDSNKLGQGGFGT-VYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       294 y~~~~~lg~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      |.-.+.+|.|..|+ ||+|.. +|++||||++-...   .+...+|+..|+.-+ |||||++++.-.+....||..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            44456789999987 699998 68899999986443   345688999998875 9999999999899999999999996


Q ss_pred             CCChhhHhhhc-hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC---C--CCEEEeccccceecc
Q 007239          372 NRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK---D--MVAKISDFGMARIFC  445 (611)
Q Consensus       372 ~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~---~--~~~kl~DFGla~~~~  445 (611)
                      . +|.+++... .......-...+.++.|++.||+|||+-+   ||||||||.||||+.   +  ..++|+|||+++.+.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            5 899988542 11111121456788999999999999975   999999999999975   3  478999999999886


Q ss_pred             cCCCccc-cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          446 ENQKTAN-TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG-KRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       446 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      .+..... .....||-+|+|||++....-+.++||||+||++|+.++| +.||+.....+.        ...........
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~L~~  734 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYTLVH  734 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCccceee
Confidence            6554332 3456799999999999998888899999999999998886 789864332211        11111111111


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCCCCCCCCCCCCCcc
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFPV  582 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~~~~p~~~~  582 (611)
                      +.+       .++. +..+||.+|+..+|..||++.+|+.    +...+...++=.|..
T Consensus       735 L~~-------~~d~-eA~dLI~~ml~~dP~~RPsa~~VL~----HPlFW~~ekrL~Fl~  781 (903)
T KOG1027|consen  735 LEP-------LPDC-EAKDLISRMLNPDPQLRPSATDVLN----HPLFWDSEKRLSFLR  781 (903)
T ss_pred             ecc-------CchH-HHHHHHHHhcCCCcccCCCHHHHhC----CCccCChHHHHHHHH
Confidence            111       1111 5668999999999999999999984    333444444444443

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=2.5e-28  Score=234.98  Aligned_cols=211  Identities=37%  Similarity=0.591  Sum_probs=183.3

Q ss_pred             cCccCceEEEEEEcC-CCcEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCChhh
Q 007239          300 LGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQ-GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDC  377 (611)
Q Consensus       300 lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~sL~~  377 (611)
                      ||+|.+|.||++... +++++++|++...... ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999975 4899999999866533 35678999999999999999999999999999999999999999999


Q ss_pred             HhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC-CCCEEEeccccceecccCCCccccccc
Q 007239          378 FIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK-DMVAKISDFGMARIFCENQKTANTRRV  456 (611)
Q Consensus       378 ~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~  456 (611)
                      ++....  ..+++..++.++.++++++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            884321  45899999999999999999999986   999999999999999 89999999999987644321  12235


Q ss_pred             cccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHH
Q 007239          457 VGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIP  535 (611)
Q Consensus       457 ~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~  535 (611)
                      .+...|++||..... ..+.+.|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            678899999999887 788999999999999998                                              


Q ss_pred             HHHHHHHHhhccccCCCCCCCCHHHHHHHh
Q 007239          536 QVVRCIHIGLLCVQEDPAVRPTMSNVVALL  565 (611)
Q Consensus       536 ~~~~l~~li~~cl~~dP~~RPt~~evl~~L  565 (611)
                        ..+.+++..|++.+|++||++.++++.|
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence              4567888999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=7.2e-30  Score=262.57  Aligned_cols=196  Identities=26%  Similarity=0.392  Sum_probs=169.6

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChh--------hHHHHHHHHHHHHhcC---CCCeeeEEEeEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQ--------GLEEFKNEIILIAKLQ---HRNLVRLVGCGI  358 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~---h~niv~l~~~~~  358 (611)
                      ..+|...+.+|+|+||.|+.++++ +..+|++|.+.++..-        .......|++||..++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            456999999999999999999965 5678999998765321        1223566999999998   999999999999


Q ss_pred             eCCeEEEEEEec-CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEec
Q 007239          359 EGEEKLLIYELM-PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISD  437 (611)
Q Consensus       359 ~~~~~~lv~E~~-~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~D  437 (611)
                      +++..||+||-- ++.+|.++|   +.+..+++.++..|+.||+.|+++||++|   |||||||-+|+.++.+|-+||+|
T Consensus       640 ddd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence            999999999975 466888888   56677999999999999999999999998   99999999999999999999999


Q ss_pred             cccceecccCCCccccccccccCCCCCccccccCCC-CchhhHHHHHHHHHHHHhCCCCC
Q 007239          438 FGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF-SVKSDVFSFGVIVLEIISGKRNS  496 (611)
Q Consensus       438 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvll~elltG~~p~  496 (611)
                      ||.+.....+.    ...++||.+|.|||++.+.+| +..-|||++|++||.++-...|+
T Consensus       714 fgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  714 FGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             ccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            99997654333    445899999999999999887 45689999999999999888775

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-27  Score=240.95  Aligned_cols=131  Identities=31%  Similarity=0.402  Sum_probs=109.0

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcC-----C---CCeeeEEEeEee---
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-----H---RNLVRLVGCGIE---  359 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----h---~niv~l~~~~~~---  359 (611)
                      .+|.+.++||.|-|++||++.+ .+.+.||+|+.+... .-.+.-..||++|++++     |   ..||+|++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            6899999999999999999995 467789999987543 22455688999999985     3   359999999864   


Q ss_pred             -CCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe
Q 007239          360 -GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL  427 (611)
Q Consensus       360 -~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll  427 (611)
                       +.++++|+|++. ..|..+|....- ..++...+.+|++||+.||.|||.+.  +|||-||||+|||+
T Consensus       157 NG~HVCMVfEvLG-dnLLklI~~s~Y-rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVLG-DNLLKLIKYSNY-RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhhh-hHHHHHHHHhCC-CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence             568999999984 466677654333 45899999999999999999999986  79999999999999

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=2.7e-28  Score=235.72  Aligned_cols=260  Identities=26%  Similarity=0.280  Sum_probs=190.6

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC------Ce
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG------EE  362 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~~  362 (611)
                      .+|..++.+|.|.- .|-.+.+ -.++.||+|++...  ......+..+|..++..++|+||++++.+|.-.      .+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            56777888999988 4544443 26889999987543  334567788999999999999999999998644      35


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .|+|||+|.. +|...+.     ..++-+.+..|+.|++.|++|||+.|   |+||||||+||++..+..+||.|||+|+
T Consensus        96 ~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            6999999965 7777664     34778889999999999999999997   9999999999999999999999999998


Q ss_pred             ecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhH---------------
Q 007239          443 IFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTL---------------  507 (611)
Q Consensus       443 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l---------------  507 (611)
                      .-.   ........+.|..|.|||++.+..+.+.+||||+||++.||++|+--|...+..++...               
T Consensus       167 ~e~---~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q  243 (369)
T KOG0665|consen  167 TED---TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ  243 (369)
T ss_pred             ccC---cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence            532   22345567889999999999998899999999999999999999976643222111110               


Q ss_pred             -HHHHHHHHhcC------cccccc-ccccCC--CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          508 -LAYVWQLWKEG------KEMEFV-DPLLMK--SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       508 -~~~~~~~~~~~------~~~~~~-d~~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                       ...+.......      ...+.+ |.....  +.+........+++..||-.||++|.+++++|+.
T Consensus       244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence             00011111100      011111 111111  1111222334589999999999999999999874

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=3.8e-27  Score=230.32  Aligned_cols=197  Identities=34%  Similarity=0.478  Sum_probs=171.8

Q ss_pred             CCcccccCccCceEEEEEEcCC-CcEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          294 FSDSNKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQ-GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      |.+.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++.+......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            5677899999999999999754 889999999876544 67789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhchhhcc-CCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          372 NRSLDCFIFDSERRLQ-LNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~-l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      +++|.+++...   .. +++..++.++.++++++.+||+.+   ++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       81 GGDLFDYLRKK---GGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            99999988432   23 789999999999999999999986   999999999999999999999999999877544211


Q ss_pred             cccccccccCCCCCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 007239          451 ANTRRVVGTYGYMAPEYA-MEGLFSVKSDVFSFGVIVLEIISGKRNSG  497 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~-~~~~~~~k~DvwSlGvll~elltG~~p~~  497 (611)
                       ......++..|++||.+ ....++.++|||+||+++++|++|+.||.
T Consensus       155 -~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      155 -LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             -cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence             22345678899999998 66778889999999999999999999973

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=2.9e-29  Score=262.18  Aligned_cols=253  Identities=23%  Similarity=0.329  Sum_probs=202.2

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ..++|+...++|.|.+|.|||+++ .+++..|+|+++-.......-+.+|+.+++..+||||+.+++.+.....+++.||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            457899999999999999999995 5788999999998877778888999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+.+|+|.+.-   ...+.+++.++....++.++|+.|||+.|   -+|||||-.|||+++.|.+|++|||.+-.+... 
T Consensus        93 ycgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat-  165 (829)
T KOG0576|consen   93 YCGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT-  165 (829)
T ss_pred             ecCCCccccee---eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh-
Confidence            99999998875   45677999999999999999999999997   899999999999999999999999998765322 


Q ss_pred             CccccccccccCCCCCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYA---MEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                       ....+.++||+.|||||+.   +.+.|..++|||++|+...|+-.-++|.  ++--..+.+..     ...    ...+
T Consensus       166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl--fdlhpmr~l~L-----mTk----S~~q  233 (829)
T KOG0576|consen  166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL--FDLHPMRALFL-----MTK----SGFQ  233 (829)
T ss_pred             -hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc--cccchHHHHHH-----hhc----cCCC
Confidence             2234568999999999976   4677999999999999999997777663  11111111111     111    1111


Q ss_pred             -cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          526 -PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       526 -~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       +.++.....  ..-+-+++..+|-.+|++||+++.+|+
T Consensus       234 pp~lkDk~kw--s~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  234 PPTLKDKTKW--SEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCcccCCccc--hHHHHHHHHHHhcCCCccCCChhhhee
Confidence             122222211  223457888999999999999987664

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.95  E-value=1.2e-27  Score=239.70  Aligned_cols=201  Identities=26%  Similarity=0.417  Sum_probs=168.3

Q ss_pred             HHHhhCCCCcccccCccCceEEEEEEcC----CCcEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCC
Q 007239          287 IKAATDGFSDSNKLGQGGFGTVYKGVLP----NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGE  361 (611)
Q Consensus       287 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~  361 (611)
                      +....+.|...++||+|.|++||++.+.    ..+.||+|.+...+  ...++.+|+++|..+. +.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            4556788999999999999999999953    46789999986553  3467899999999997 999999999999999


Q ss_pred             eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC-CCCEEEecccc
Q 007239          362 EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK-DMVAKISDFGM  440 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGl  440 (611)
                      ...+|+||+++....++..      .++...+..+++.++.||.++|.+|   ||||||||+|+|.+. .+.-.|.|||+
T Consensus       109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            9999999999999888873      3678889999999999999999998   999999999999984 56789999999


Q ss_pred             ceecccCC-------------Cc-----------------------------cccccccccCCCCCccccccC-CCCchh
Q 007239          441 ARIFCENQ-------------KT-----------------------------ANTRRVVGTYGYMAPEYAMEG-LFSVKS  477 (611)
Q Consensus       441 a~~~~~~~-------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~k~  477 (611)
                      |.......             ..                             .......||+||.|||++... ..+.++
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            98211000             00                             001135799999999999864 468899


Q ss_pred             hHHHHHHHHHHHHhCCCCCCC
Q 007239          478 DVFSFGVIVLEIISGKRNSGF  498 (611)
Q Consensus       478 DvwSlGvll~elltG~~p~~~  498 (611)
                      ||||.||+++.+++++.||-.
T Consensus       260 Diws~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             ceeeccceeehhhcccccccc
Confidence            999999999999999999743

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.94  E-value=7.7e-28  Score=244.76  Aligned_cols=208  Identities=22%  Similarity=0.282  Sum_probs=174.2

Q ss_pred             cCHHHHHHhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCC------CCeeeEE
Q 007239          282 VHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQH------RNLVRLV  354 (611)
Q Consensus       282 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h------~niv~l~  354 (611)
                      +.+...+..-.+|.+....|+|-|++|-+|.+. -|..||||+|...... .+.=+.|++||++|+.      -++++++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            344445566788999999999999999999964 4779999999866433 2334679999999963      4799999


Q ss_pred             EeEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC-CCE
Q 007239          355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD-MVA  433 (611)
Q Consensus       355 ~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~-~~~  433 (611)
                      ..|...++++||+|-+. -+|.++|....+...|....+..++.|+.-||..|..-+   |+|.||||+||||++. ..+
T Consensus       501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iL  576 (752)
T KOG0670|consen  501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNIL  576 (752)
T ss_pred             HHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCccee
Confidence            99999999999999874 478888887777778999999999999999999999876   9999999999999865 568


Q ss_pred             EEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 007239          434 KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGF  498 (611)
Q Consensus       434 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~  498 (611)
                      ||||||.|....++....    ..-+..|.|||++.+-+|+...|+||+||.||||.||+--|+.
T Consensus       577 KLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG  637 (752)
T KOG0670|consen  577 KLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG  637 (752)
T ss_pred             eeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence            999999998776554322    2334569999999999999999999999999999999977643

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=1.6e-26  Score=267.59  Aligned_cols=196  Identities=17%  Similarity=0.267  Sum_probs=136.4

Q ss_pred             hcCC-CCeeeEEEeE-------eeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCce
Q 007239          344 KLQH-RNLVRLVGCG-------IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI  415 (611)
Q Consensus       344 ~l~h-~niv~l~~~~-------~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~i  415 (611)
                      .++| +||+++++.|       ...+..++++|++ +++|.+++...  ...+++.+++.++.||++||.|||+++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            3445 5777777766       2334567888987 55999998532  345899999999999999999999987   9


Q ss_pred             EecCCCCCcEEecC-------------------CCCEEEeccccceecccCCC--------------ccccccccccCCC
Q 007239          416 IHRDLKPSNVLLDK-------------------DMVAKISDFGMARIFCENQK--------------TANTRRVVGTYGY  462 (611)
Q Consensus       416 iHrDikp~NIll~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y  462 (611)
                      +||||||+||||+.                   ++.+|++|||+++.......              ........||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999965                   44566666666654211000              0001124688999


Q ss_pred             CCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHH
Q 007239          463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIH  542 (611)
Q Consensus       463 ~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  542 (611)
                      ||||++.+..++.++|||||||+||||++|.+|+...     ......    +...    .+.+.     ......+..+
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~-----~~~~~~----~~~~----~~~~~-----~~~~~~~~~~  243 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEK-----SRTMSS----LRHR----VLPPQ-----ILLNWPKEAS  243 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhH-----HHHHHH----HHHh----hcChh-----hhhcCHHHHH
Confidence            9999999999999999999999999999988774211     001110    1000    00110     0112234567


Q ss_pred             HhhccccCCCCCCCCHHHHHH
Q 007239          543 IGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       543 li~~cl~~dP~~RPt~~evl~  563 (611)
                      ++.+||+.+|.+||++.||++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhh
Confidence            888999999999999999986

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.3e-25  Score=210.47  Aligned_cols=250  Identities=17%  Similarity=0.303  Sum_probs=180.1

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEe-EeeCCeEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGC-GIEGEEKLLIY  367 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~-~~~~~~~~lv~  367 (611)
                      .+.|.+.+.||+|-||.+-++.++ +.+.+++|.+.... .....|.+|...--.|. |.||+..|+. |+..+..++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            468999999999999999999965 67789999887553 34678888988766665 8999988875 56677888999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec--CCCCEEEeccccceecc
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD--KDMVAKISDFGMARIFC  445 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~--~~~~~kl~DFGla~~~~  445 (611)
                      ||++.|+|..-+-    ...+.+....+++.|++.|+.|+|++   ++||||||.+||||-  +.-++||+|||+.+..+
T Consensus       102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence            9999999977662    24477888899999999999999998   599999999999994  33489999999987532


Q ss_pred             cCCCccccccccccCCCCCcccccc---C--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAME---G--LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE  520 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  520 (611)
                      .     ......-+..|.+||....   +  ...+.+|||.||+++|.+++|+.|+.. ........  +-|..|..+..
T Consensus       175 ~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y--~~~~~w~~rk~  246 (378)
T KOG1345|consen  175 T-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPY--WEWEQWLKRKN  246 (378)
T ss_pred             c-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchH--HHHHHHhcccC
Confidence            2     1223345678999997643   2  245779999999999999999999862 22222222  22334444443


Q ss_pred             ccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 007239          521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV  562 (611)
Q Consensus       521 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  562 (611)
                      ..+.+..  .    ....++..+..+-|..+|++|=-+.++-
T Consensus       247 ~~~P~~F--~----~fs~~a~r~Fkk~lt~~~~drcki~~~k  282 (378)
T KOG1345|consen  247 PALPKKF--N----PFSEKALRLFKKSLTPRFKDRCKIWTAK  282 (378)
T ss_pred             ccCchhh--c----ccCHHHHHHHHHhcCCcccccchhHHHH
Confidence            3222111  1    1112344455567788888884444433

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=2.9e-24  Score=202.65  Aligned_cols=164  Identities=20%  Similarity=0.196  Sum_probs=122.3

Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      |+|.+++..  ....+++.+++.++.||++||.|||+++         ||+|||++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            678888843  2345999999999999999999999874         999999999999999  99998653321    


Q ss_pred             cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCC
Q 007239          453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSS  532 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  532 (611)
                         ..||+.|+|||++.+..++.++|||||||++|||++|+.|+......  ......+.......   .   +.  ...
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~---~---~~--~~~  130 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPAD---D---PR--DRS  130 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccC---C---cc--ccc
Confidence               26899999999999999999999999999999999999997432211  11111111111110   0   00  000


Q ss_pred             CHHHH---HHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          533 SIPQV---VRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       533 ~~~~~---~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                      .....   .++.+++.+||+.+|++||++.++++.+.
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~  167 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCR  167 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence            11111   25889999999999999999999999874

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=4.9e-24  Score=220.79  Aligned_cols=166  Identities=22%  Similarity=0.233  Sum_probs=130.6

Q ss_pred             HhhCCCCcccccCccCceEEEEEEcC--CCcEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCCeee-EEEeEeeC
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVLP--NGKEVAVKRLSRK-----SWQGLEEFKNEIILIAKLQHRNLVR-LVGCGIEG  360 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~niv~-l~~~~~~~  360 (611)
                      ...++|.+.+.||+|+||+||+|.+.  +++.+|||++...     .......+.+|+++|++++|+|+++ +++.    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            34578999999999999999999864  5777899987533     1223566899999999999999985 4432    


Q ss_pred             CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCC-CCCcEEecCCCCEEEeccc
Q 007239          361 EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDL-KPSNVLLDKDMVAKISDFG  439 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDi-kp~NIll~~~~~~kl~DFG  439 (611)
                      +..++||||++|++|....    .   ..   ...++.|++++|.|||++|   |+|||| ||+|||++.++.+||+|||
T Consensus        91 ~~~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG  157 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ  157 (365)
T ss_pred             CCcEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence            4579999999999996321    1   11   1467889999999999987   999999 9999999999999999999


Q ss_pred             cceecccCCCccc------cccccccCCCCCccccccC
Q 007239          440 MARIFCENQKTAN------TRRVVGTYGYMAPEYAMEG  471 (611)
Q Consensus       440 la~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~  471 (611)
                      +++.+........      .....+++.|+|||++...
T Consensus       158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             cceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9997754321111      1356789999999998654

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.91  E-value=5.1e-23  Score=213.34  Aligned_cols=258  Identities=21%  Similarity=0.223  Sum_probs=191.0

Q ss_pred             CCCcccccCccCceEEEEEEcCCC--cEEEEEEecccChhhHHHHHHHHHHHHhcCC----CCeeeEEEeE-eeCCeEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLPNG--KEVAVKRLSRKSWQGLEEFKNEIILIAKLQH----RNLVRLVGCG-IEGEEKLL  365 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~il~~l~h----~niv~l~~~~-~~~~~~~l  365 (611)
                      +|++.++||+|+||.||++.....  ..+|+|............+..|..++..++.    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            899999999999999999996543  5789998766533333378889999999973    5899999998 47778899


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC-----CCEEEecccc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD-----MVAKISDFGM  440 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~-----~~~kl~DFGl  440 (611)
                      ||+.+ |.+|.++..... ...++...+..|+.|++.+|++||+.|   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99987 778988764433 567999999999999999999999998   9999999999999754     4699999999


Q ss_pred             ce--ecccCCC----ccc--cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHH
Q 007239          441 AR--IFCENQK----TAN--TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW  512 (611)
Q Consensus       441 a~--~~~~~~~----~~~--~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~  512 (611)
                      ++  .+.....    ...  .....||..|.++..+.+...+.+.|+||++.++.||+.|..|+........   ...+.
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~  250 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFE  250 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHHH
Confidence            99  4322221    111  1235699999999999999999999999999999999999999743332211   11111


Q ss_pred             HHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       513 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      +......    ...  .......+   +.++...+-..+..++|....+...|..
T Consensus       251 ~~~~~~~----~~~--~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~  296 (322)
T KOG1164|consen  251 KDPRKLL----TDR--FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKD  296 (322)
T ss_pred             HHhhhhc----ccc--ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHH
Confidence            1111111    111  11112223   3333334455899999999999988754

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.89  E-value=1.1e-21  Score=201.35  Aligned_cols=261  Identities=30%  Similarity=0.390  Sum_probs=196.9

Q ss_pred             CCcccccCccCceEEEEEEcCCCcEEEEEEecccChh---hHHHHHHHHHHHHhcCCC-CeeeEEEeEeeCCeEEEEEEe
Q 007239          294 FSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQ---GLEEFKNEIILIAKLQHR-NLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~-niv~l~~~~~~~~~~~lv~E~  369 (611)
                      |.+.+.||.|+|+.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++++.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677889999999999999976  78899998765332   367899999999999988 799999999777778999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC-CEEEeccccceecccCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQ  448 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGla~~~~~~~  448 (611)
                      +.++++.+++........+.......++.|++.++.|+|+.+   ++||||||+||+++..+ .++++|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966532211126889999999999999999999997   99999999999999988 79999999998665443


Q ss_pred             Ccc----ccccccccCCCCCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC-chhhHHHHHHHHHhcCcc
Q 007239          449 KTA----NTRRVVGTYGYMAPEYAME---GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG-HAQTLLAYVWQLWKEGKE  520 (611)
Q Consensus       449 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvll~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~  520 (611)
                      ...    ......|+..|++||.+.+   ..++...|+||+|++++++++|..|+...... ........+    .....
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~----~~~~~  232 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII----LELPT  232 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH----HhcCC
Confidence            322    2345789999999999987   57889999999999999999999995433321 011122222    21111


Q ss_pred             ccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       521 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      . .................+.+++..++..+|..|.+..+....
T Consensus       233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1 000000000001222355678888999999999999887764

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.89  E-value=2.3e-23  Score=178.64  Aligned_cols=96  Identities=39%  Similarity=0.780  Sum_probs=76.4

Q ss_pred             CCC---CCcc-CCCChhHHHHHHHHHHHHhcc-c---CCceeeeeCCCCCeEEEEEEcCCCCCccchHHHHHHHHHHHHH
Q 007239           23 ACS---NTSY-APNSPFESSLKLLLESIATNT-S---QGFYNLSIGDDPNRVFGRALCRGDVNRTVCQNCLENARHEILK   94 (611)
Q Consensus        23 ~C~---~~~~-~~~s~~~~nl~~l~~~l~~~~-~---~~f~~~~~g~~~~~vyg~~~C~~d~~~~~C~~C~~~a~~~~~~   94 (611)
                      .|+   +++| +++++|++||+.||+.|...+ .   .+|+++..|.++++|||++||++|+++.+|..||+.|+..+..
T Consensus         3 ~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~   82 (106)
T PF01657_consen    3 FCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANISS   82 (106)
T ss_dssp             -E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHH
T ss_pred             cCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHH
Confidence            788   3667 678889999999999999997 2   3799998899999999999999999999999999999999999


Q ss_pred             hCCCcceeeEEcCccEEEecCccc
Q 007239           95 NCKTAEEAIIWYELCQIQYSYRKF  118 (611)
Q Consensus        95 ~C~~~~~a~~~~~~C~~ry~~~~f  118 (611)
                      .|+.+++|+||++.|+|||++++|
T Consensus        83 ~C~~~~g~~v~~~~C~lRY~~~~F  106 (106)
T PF01657_consen   83 CCPGSRGGRVWYDSCFLRYENYPF  106 (106)
T ss_dssp             HTTSBSSEEEEESSEEEEEESS--
T ss_pred             hCCCCceEEEECCCEEEEEECCCC
Confidence            999999999999999999999998

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=1.6e-23  Score=230.79  Aligned_cols=254  Identities=22%  Similarity=0.246  Sum_probs=185.9

Q ss_pred             CcccccCccCceEEEEEEcC-CCcEEEEEEec----cc-Chh-hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          295 SDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLS----RK-SWQ-GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       295 ~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~----~~-~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ...+.+|.|++|.|+..... ..+..+.|..+    .. ... ....+..|+-+-..+.|||++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            56788999999977777632 33334444332    11 111 1222667888888899999988887777666666669


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++ +|..++   .+...+...++..++.|++.|+.|||+.|   |.|||||++|+++..+|.+||+|||.+..+..+
T Consensus       401 E~~~~-Dlf~~~---~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLV---MSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHH---hcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 998888   33356888999999999999999999998   999999999999999999999999999988655


Q ss_pred             CCc--cccccccccCCCCCccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          448 QKT--ANTRRVVGTYGYMAPEYAMEGLFSVK-SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       448 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k-~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ...  .....++|+..|+|||.+.+..|.+. .||||.|+++..|++|+.||......+.+.      ............
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~~~~~  547 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQRNIF  547 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hhhccccccccc
Confidence            544  44556889999999999999999875 899999999999999999975444333221      000000000000


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..  ..........+...++.+||+.+|.+|.|+++|++
T Consensus       548 ~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  548 EG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            00  00011122345678899999999999999999986

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=8.8e-22  Score=183.46  Aligned_cols=205  Identities=23%  Similarity=0.339  Sum_probs=170.3

Q ss_pred             hhCCCCcccccCccCceEEEEEE-cCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCC-CCeeeEEEeEeeCCeEEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQH-RNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~lv~  367 (611)
                      ...+|++.++||.|+||.+|.|. ..+|++||||+-+....  ..++.-|..+...|++ ..|..+..+..+...-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            35789999999999999999999 67899999998765432  3467889999999986 67777888888888889999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC---CCCEEEeccccceec
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK---DMVAKISDFGMARIF  444 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFGla~~~  444 (611)
                      |.+ |-+|+++..-..+  .++..+++-++-|++.-++|+|.++   +|||||||+|+|+.-   ...+.++|||+++.+
T Consensus        91 dLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence            998 7799888754443  4888999999999999999999986   999999999999963   357999999999987


Q ss_pred             ccCCCcc-----ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 007239          445 CENQKTA-----NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG  502 (611)
Q Consensus       445 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~  502 (611)
                      .+.....     ..+...||..|.+-..+.+...+.+.|+-|+|.+|..+.-|..||......
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~  227 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA  227 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence            5433221     234578999999998888888899999999999999999999998654443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.87  E-value=1.7e-21  Score=189.29  Aligned_cols=202  Identities=25%  Similarity=0.374  Sum_probs=171.5

Q ss_pred             CCCCcccccCccCceEEEEEE-cCCCcEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEEEEe
Q 007239          292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      -.|+++++||+|.||+++.|. +-+++.||||.-..++  ...++..|....+.|. .++|..++.+..++..-.||+|.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            369999999999999999999 4589999999865544  2357788999999886 79999999999998899999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC-----CCEEEeccccceec
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD-----MVAKISDFGMARIF  444 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~-----~~~kl~DFGla~~~  444 (611)
                      + |-||+|+..-.  ...++...+.-++.|++.-++|+|++.   +|+|||||+|+||...     ..+.|+|||+|+.+
T Consensus       106 L-GPSLEDLFD~C--gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  106 L-GPSLEDLFDLC--GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             h-CcCHHHHHHHh--cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            8 67888876322  345899999999999999999999996   9999999999999643     35899999999988


Q ss_pred             ccCCCcc-----ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 007239          445 CENQKTA-----NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLT  501 (611)
Q Consensus       445 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~  501 (611)
                      .+.....     ..+..-||..||+-..+.+.+.+.+.|+-|||-++++.|-|..||.....
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            6554433     23456899999999999999999999999999999999999999854443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.86  E-value=9.6e-22  Score=189.73  Aligned_cols=173  Identities=13%  Similarity=0.149  Sum_probs=135.3

Q ss_pred             HHhhCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhH---HH------HHHHHHHHHhcCCCCeeeEEEeEe
Q 007239          288 KAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGL---EE------FKNEIILIAKLQHRNLVRLVGCGI  358 (611)
Q Consensus       288 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~---~~------~~~E~~il~~l~h~niv~l~~~~~  358 (611)
                      +...++|+..+.||.|+||.||.... +++.+|+|.++.......   ..      +.+|+..+.+++|++|..+.+++.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            34578999999999999999999655 677899999975432222   22      678999999999999999988866


Q ss_pred             eC--------CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC
Q 007239          359 EG--------EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD  430 (611)
Q Consensus       359 ~~--------~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~  430 (611)
                      ..        ...+++|||++|.+|.++..       ++.    ....+|+.+|..+|+.|   ++||||||+||+++.+
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~  171 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN  171 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence            43        35789999999999977631       222    24568999999999997   9999999999999998


Q ss_pred             CCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHH
Q 007239          431 MVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEII  490 (611)
Q Consensus       431 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ell  490 (611)
                      | ++|+|||......+....              ..+.....+..++|+|+||+.+..+.
T Consensus       172 g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             C-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            8 999999988754222111              11445556778999999999877654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.86  E-value=2.5e-22  Score=189.90  Aligned_cols=246  Identities=19%  Similarity=0.297  Sum_probs=182.7

Q ss_pred             CCcccccCccCceEEEEEEcCCCcEEEEEEecccChh--hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          294 FSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQ--GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      ..+..+|.+...|+.|+|+|+ |..+++|++......  ....|..|.-.|+-+.||||+.+++.|.....+.++..||+
T Consensus       192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp  270 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence            445567889999999999995 556778887654322  23468889999999999999999999999999999999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEec-CCCCCcEEecCCCCEEEe--ccccceecccCC
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR-DLKPSNVLLDKDMVAKIS--DFGMARIFCENQ  448 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHr-Dikp~NIll~~~~~~kl~--DFGla~~~~~~~  448 (611)
                      .|+|...++.. ....++..++.+++..|++|+.|||+-.  +++-| -|....++||++.+.+|.  |--++       
T Consensus       271 ~gslynvlhe~-t~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfs-------  340 (448)
T KOG0195|consen  271 FGSLYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFS-------  340 (448)
T ss_pred             chHHHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceee-------
Confidence            99999999653 3345788899999999999999999975  44433 588899999999887774  32111       


Q ss_pred             CccccccccccCCCCCccccccCCCC---chhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFS---VKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~---~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                        .......-.|.||+||.++.++-+   .++|+|||.+++|||.|...||....+-+-.      .+..     .+-+.
T Consensus       341 --fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg------mkia-----leglr  407 (448)
T KOG0195|consen  341 --FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG------MKIA-----LEGLR  407 (448)
T ss_pred             --eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh------hhhh-----hcccc
Confidence              111122457899999999876643   4799999999999999999998654432211      0000     11111


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      .    ..+......+.+|+.-|+..||.+||....|+-.|++
T Consensus       408 v----~ippgis~hm~klm~icmnedpgkrpkfdmivpilek  445 (448)
T KOG0195|consen  408 V----HIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK  445 (448)
T ss_pred             c----cCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence            1    2222223345567777999999999999999998875

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=3e-21  Score=184.01  Aligned_cols=139  Identities=16%  Similarity=0.157  Sum_probs=108.4

Q ss_pred             ccccCccCceEEEEEEcCCCcEEEEEEecccChh--h-------H-----------------HHHHHHHHHHHhcCCCCe
Q 007239          297 SNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQ--G-------L-----------------EEFKNEIILIAKLQHRNL  350 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~E~~il~~l~h~ni  350 (611)
                      ...||+|+||.||+|...+|+.||+|+++.....  .       .                 ....+|++++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999878999999998754211  0       1                 122459999999988776


Q ss_pred             eeEEEeEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHH-hhcCCCceEecCCCCCcEEecC
Q 007239          351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL-HEDSRLKIIHRDLKPSNVLLDK  429 (611)
Q Consensus       351 v~l~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yL-H~~~~~~iiHrDikp~NIll~~  429 (611)
                      ........  ...++||||++++++...+.   ....+++..+..++.|++.+|.+| |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            43332211  23389999999987765432   234688999999999999999999 6876   99999999999998 


Q ss_pred             CCCEEEeccccceec
Q 007239          430 DMVAKISDFGMARIF  444 (611)
Q Consensus       430 ~~~~kl~DFGla~~~  444 (611)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.85  E-value=9e-22  Score=168.78  Aligned_cols=103  Identities=28%  Similarity=0.562  Sum_probs=76.7

Q ss_pred             ceecC-C-CCccCCChhHHHHHHHHHHHHHHHHhcCC-CccceeeeeccCCccceEEEEeeecCCCCCchhhHHHHHHhh
Q 007239          128 AEKWN-N-QWKSVSNPARFIEVLTYLMTNLSIEASSD-PAMFAVGEVKFPKRKTIYGLVQCTRDINSRDCNDCLTGALGD  204 (611)
Q Consensus       128 ~~~~~-~-~~~~~~~~~~f~~~~~~ll~~l~~~a~~~-~~~fa~~~~~~~~~~~~yglaqC~~dls~~~C~~CL~~a~~~  204 (611)
                      |+.|. + .++.+++++.|+.++..||..|+..|+.+ +.+|++++.+ .+.+++|||+||++||++.||..||..++..
T Consensus         1 ~~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~-~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~   79 (106)
T PF01657_consen    1 WHFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAG-SGPDTVYGLAQCRGDLSPSDCRACLADAVAN   79 (106)
T ss_dssp             ---E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE---ST---EEEEEEE-TTS-HHHHHHHHHHHHCC
T ss_pred             CCcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeecC-CCCCeEEEEEEcCCCCChhhhHHHHHHHHHH
Confidence            34563 2 23343455669999999999999998864 5789999874 4667999999999999999999999999999


Q ss_pred             hhhhcCCCcceEEEcccccceeeccee
Q 007239          205 LKACCGAREAGIIVNENCNLRFQLSLF  231 (611)
Q Consensus       205 ~~~~c~~~~~~~v~~~~C~lry~~~~f  231 (611)
                      ++.+|+.++||+|++++|+|||++++|
T Consensus        80 ~~~~C~~~~g~~v~~~~C~lRY~~~~F  106 (106)
T PF01657_consen   80 ISSCCPGSRGGRVWYDSCFLRYENYPF  106 (106)
T ss_dssp             HHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred             HHHhCCCCceEEEECCCEEEEEECCCC
Confidence            999999999999999999999999998

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.84  E-value=1.1e-21  Score=215.85  Aligned_cols=250  Identities=19%  Similarity=0.181  Sum_probs=180.9

Q ss_pred             CCCcccccCccCceEEEEEEcCCCcEEEEEEecccC-hhhH---HHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKS-WQGL---EEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~---~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ++...+.||.+.|=+|.++++++|. |++|++-+.. ....   .+...|++ ...++|||.+++..+....+..|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5777889999999999999998887 9999886554 2233   34444555 566789999999888777888899999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc-cC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC-EN  447 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~-~~  447 (611)
                      |+.+ +|.|.+   ..+..+...+.+.|+.||+.||..+|..|   |+|||||.+||||+.-..+.|+||..-+..- ..
T Consensus       102 yvkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            9877 677777   45566788888999999999999999987   9999999999999999999999998765431 22


Q ss_pred             CCcccccccccc----CCCCCccccccC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHH
Q 007239          448 QKTANTRRVVGT----YGYMAPEYAMEG----------L-FSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYV  511 (611)
Q Consensus       448 ~~~~~~~~~~gt----~~y~aPE~~~~~----------~-~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~  511 (611)
                      +.......+..|    ..|+|||.+...          . .+++.||||+||++.||++ |+++|.         +.+.+
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~---------LSQL~  245 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT---------LSQLL  245 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc---------HHHHH
Confidence            222222223333    359999977531          2 6789999999999999988 466653         11111


Q ss_pred             HHHHhcC-ccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          512 WQLWKEG-KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       512 ~~~~~~~-~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                       ..-..+ ...+.+-..+..       ..+..+++.|++.||++|.++++.|+.-...
T Consensus       246 -aYr~~~~~~~e~~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  246 -AYRSGNADDPEQLLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             -hHhccCccCHHHHHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence             111111 111111111111       1456889999999999999999999985443

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.84  E-value=3.3e-20  Score=177.32  Aligned_cols=140  Identities=16%  Similarity=0.187  Sum_probs=111.2

Q ss_pred             ccccCccCceEEEEEEcCCCcEEEEEEecccChh--------------------------hHHHHHHHHHHHHhcCCCCe
Q 007239          297 SNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQ--------------------------GLEEFKNEIILIAKLQHRNL  350 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~il~~l~h~ni  350 (611)
                      .+.||+|++|.||+|...+|+.||+|+++.....                          ....+.+|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5789999999999999778999999998754211                          01234679999999999987


Q ss_pred             eeEEEeEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhh-cCCCceEecCCCCCcEEecC
Q 007239          351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE-DSRLKIIHRDLKPSNVLLDK  429 (611)
Q Consensus       351 v~l~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDikp~NIll~~  429 (611)
                      .....+...  ..++||||++++++.....   ....++...+..++.|++.++.+||+ .|   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            544433322  2489999999886544321   22457788899999999999999999 76   99999999999999 


Q ss_pred             CCCEEEeccccceecc
Q 007239          430 DMVAKISDFGMARIFC  445 (611)
Q Consensus       430 ~~~~kl~DFGla~~~~  445 (611)
                      ++.++|+|||++....
T Consensus       153 ~~~~~liDFG~a~~~~  168 (190)
T cd05145         153 DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCCEEEEEcccceecC
Confidence            8999999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=2.8e-19  Score=168.94  Aligned_cols=184  Identities=16%  Similarity=0.130  Sum_probs=139.4

Q ss_pred             CcccccCccCceEEEEEEcCCCcEEEEEEecccChh----hHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEEEEe
Q 007239          295 SDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQ----GLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       295 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      .+...|++|+||+||.+.. .+.+++.+.+.....-    ....+.+|+++|++|+ |+++++++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3457899999999997665 6788888877654321    1225789999999996 5889999886    456999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCC-CCCcEEecCCCCEEEeccccceecccCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDL-KPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDi-kp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      +.|.+|...+..          ....++.|++++|.++|++|   |+|||| ||+|||++.++.++|+|||++.......
T Consensus        80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999998654311          11357889999999999997   999999 7999999999999999999998654332


Q ss_pred             Cc----c-------ccccccccCCCCCcccccc-CCCC-chhhHHHHHHHHHHHHhCCCCC
Q 007239          449 KT----A-------NTRRVVGTYGYMAPEYAME-GLFS-VKSDVFSFGVIVLEIISGKRNS  496 (611)
Q Consensus       449 ~~----~-------~~~~~~gt~~y~aPE~~~~-~~~~-~k~DvwSlGvll~elltG~~p~  496 (611)
                      ..    .       .......++.|+.|+...- ...+ ...++++.|..+|.++|++.+.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            11    0       0112346888899885432 1233 6789999999999999999774

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.81  E-value=9.1e-21  Score=199.60  Aligned_cols=233  Identities=23%  Similarity=0.259  Sum_probs=178.4

Q ss_pred             ccCccCceEEEEEEc----CCCcEEEEEEecccChh--hHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          299 KLGQGGFGTVYKGVL----PNGKEVAVKRLSRKSWQ--GLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       299 ~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      .+|+|.||.|+++..    +.|.-+++|.+.+....  .......|..++...+ ||.+++++..+..+...+++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998763    35677899988654321  1125567889999998 9999999999999999999999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +|.|...+.   ....+.+.........++-+++++|+.+   |+|||+|++||+++.+|++++.|||+.+..-....  
T Consensus        81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            999877763   3344677777888889999999999987   99999999999999999999999999987643332  


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKS  531 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  531 (611)
                          .+||..|||||++.  ......|.||||++++||++|..||..       +....+   .+.           .-.
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~I---l~~-----------~~~  205 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRI---LKA-----------ELE  205 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHH---hhh-----------ccC
Confidence                28999999999988  557789999999999999999999753       111111   110           011


Q ss_pred             CCHHHHHHHHHHhhccccCCCCCCCCH--HHHHHHhc
Q 007239          532 SSIPQVVRCIHIGLLCVQEDPAVRPTM--SNVVALLG  566 (611)
Q Consensus       532 ~~~~~~~~l~~li~~cl~~dP~~RPt~--~evl~~L~  566 (611)
                      .+........+++..++..+|.+|--.  ..+.+.++
T Consensus       206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~  242 (612)
T KOG0603|consen  206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ  242 (612)
T ss_pred             CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence            122333345577778888889888755  45555543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.80  E-value=3.9e-19  Score=199.85  Aligned_cols=198  Identities=21%  Similarity=0.237  Sum_probs=158.7

Q ss_pred             HHhhCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcC---CCCeeeEEEeEeeCCeEE
Q 007239          288 KAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ---HRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       288 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~  364 (611)
                      +...+.|.+.+.||+|+||.||+|...+|+.||+|+-++...-+   |.--.+++.+|+   -+.|..+...+.-.+.-+
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence            33456899999999999999999998789999999977654321   111223334444   244555555556667789


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec-------CCCCEEEec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD-------KDMVAKISD  437 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~-------~~~~~kl~D  437 (611)
                      ||+||.+.|+|.+++.   ..+.++|..+..++.|+++.+++||..+   |||+||||+|+||.       ..--++|+|
T Consensus       771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence            9999999999999994   5567999999999999999999999997   99999999999993       234699999


Q ss_pred             cccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 007239          438 FGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKR  494 (611)
Q Consensus       438 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~  494 (611)
                      ||.+--+..-......+..++|-.+--+|+..+..++..+|.|.|..+++-||.|+.
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            999965533222334556788999999999999999999999999999999999974

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=6.9e-19  Score=174.98  Aligned_cols=233  Identities=17%  Similarity=0.231  Sum_probs=146.9

Q ss_pred             CCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCC----------CCeeeEEEeE-
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQH----------RNLVRLVGCG-  357 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h----------~niv~l~~~~-  357 (611)
                      .+...+.||.|+++.||.+++. +++++|+|++....   ...++.+++|......+.+          -.++..++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3456788999999999999975 68999999875332   2346777777765555433          1222222221 


Q ss_pred             --------eeC---C-----eEEEEEEecCCCChhhHhhh---chh-hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEe
Q 007239          358 --------IEG---E-----EKLLIYELMPNRSLDCFIFD---SER-RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH  417 (611)
Q Consensus       358 --------~~~---~-----~~~lv~E~~~~~sL~~~l~~---~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiH  417 (611)
                              ...   .     ..+++|+-+ .++|.+++.-   ... ...+.......+..|+++.+++||+.|   ++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence                    111   1     236678777 4577776532   111 122334445667789999999999998   999


Q ss_pred             cCCCCCcEEecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccC--------CCCchhhHHHHHHHHHHH
Q 007239          418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG--------LFSVKSDVFSFGVIVLEI  489 (611)
Q Consensus       418 rDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~k~DvwSlGvll~el  489 (611)
                      +||||+|++++.+|.++|+||+.....+.....     ...+..|.+||.....        .++.+.|.|+||+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            999999999999999999999988765332211     2345789999976442        478899999999999999


Q ss_pred             HhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCC
Q 007239          490 ISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVR  555 (611)
Q Consensus       490 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R  555 (611)
                      ++|..|++..........                   .. .... +....+..||..+|+.||.+|
T Consensus       244 WC~~lPf~~~~~~~~~~~-------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW-------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG-------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccccc-------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999875543322111                   11 1112 334456689999999999988

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=1.8e-18  Score=166.48  Aligned_cols=137  Identities=21%  Similarity=0.302  Sum_probs=106.8

Q ss_pred             CcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhc-----CCCCeeeEEEeEeeCC---e-EEE
Q 007239          295 SDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-----QHRNLVRLVGCGIEGE---E-KLL  365 (611)
Q Consensus       295 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-----~h~niv~l~~~~~~~~---~-~~l  365 (611)
                      .-.+.||+|+||.||.  ++.....+||++........+.+.+|+.+++.+     .||||+++++++.++.   . ..+
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3457899999999996  443333479988765445567899999999999     5799999999998874   3 337


Q ss_pred             EEEe--cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHH-HHHhhcCCCceEecCCCCCcEEecC----CCCEEEecc
Q 007239          366 IYEL--MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL-LYLHEDSRLKIIHRDLKPSNVLLDK----DMVAKISDF  438 (611)
Q Consensus       366 v~E~--~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l-~yLH~~~~~~iiHrDikp~NIll~~----~~~~kl~DF  438 (611)
                      |+||  +.+++|.+++.+    ..+++.  ..++.|++.++ +|||+++   |+||||||+|||++.    ++.++|+||
T Consensus        83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            8999  557999999943    235554  35678888777 9999997   999999999999974    348999995


Q ss_pred             ccce
Q 007239          439 GMAR  442 (611)
Q Consensus       439 Gla~  442 (611)
                      +.+.
T Consensus       154 ~G~~  157 (210)
T PRK10345        154 IGES  157 (210)
T ss_pred             CCCc
Confidence            5443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.77  E-value=1.1e-18  Score=184.29  Aligned_cols=216  Identities=25%  Similarity=0.388  Sum_probs=161.6

Q ss_pred             HHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCC
Q 007239          342 IAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLK  421 (611)
Q Consensus       342 l~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDik  421 (611)
                      |+.+.|.|+.++++.+.++...+.|.+|+..|+|.+.+..  ....+++.....+++.|+.||.|||... . ..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeec
Confidence            4578899999999999999999999999999999999965  3456899999999999999999999874 2 2999999


Q ss_pred             CCcEEecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccC-------CCCchhhHHHHHHHHHHHHhCCC
Q 007239          422 PSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG-------LFSVKSDVFSFGVIVLEIISGKR  494 (611)
Q Consensus       422 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~k~DvwSlGvll~elltG~~  494 (611)
                      +.|.+++....+||+|||+.................-..-|.|||.+...       ..+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999999876431111111112234569999998763       14667999999999999999999


Q ss_pred             CCCCCCCCc-hhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          495 NSGFYLTGH-AQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       495 p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ||+...... ...+...+..     .....+.+.+....  +....++.++..||..+|++||++++|-..+...
T Consensus       157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            987643322 2233333222     11122223222111  2222678899999999999999999999888653

>smart00090 RIO RIO-like kinase

Probab=99.75  E-value=6.3e-18  Score=166.62  Aligned_cols=142  Identities=17%  Similarity=0.199  Sum_probs=111.5

Q ss_pred             CCCcccccCccCceEEEEEE--cCCCcEEEEEEecccChh------------------------hHHHHHHHHHHHHhcC
Q 007239          293 GFSDSNKLGQGGFGTVYKGV--LPNGKEVAVKRLSRKSWQ------------------------GLEEFKNEIILIAKLQ  346 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~il~~l~  346 (611)
                      .|.+.+.||+|++|.||+|+  ..+|+.||+|+++.....                        ....+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998  568999999998753210                        0123568999999998


Q ss_pred             CCC--eeeEEEeEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCc
Q 007239          347 HRN--LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSN  424 (611)
Q Consensus       347 h~n--iv~l~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~N  424 (611)
                      +..  +.++++.    ...++||||+++.+|.....   ....+....+..++.||+.+|.+||+++  +++||||||+|
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence            633  3444443    23589999999988866542   2234566677899999999999999984  49999999999


Q ss_pred             EEecCCCCEEEeccccceec
Q 007239          425 VLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       425 Ill~~~~~~kl~DFGla~~~  444 (611)
                      |+++ ++.++|+|||.+...
T Consensus       180 Ili~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEEE-CCCEEEEEChhhhcc
Confidence            9999 889999999998753

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=2.6e-17  Score=159.96  Aligned_cols=134  Identities=20%  Similarity=0.288  Sum_probs=112.7

Q ss_pred             cccCccCceEEEEEEcCCCcEEEEEEecccChh--------hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQ--------GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +.||+|++|.||+|.+ .|..+++|+.......        ....+.+|+.++..+.|+++.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999988 6778999986543211        124578899999999999987777777777888999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ++|++|.+++...      .. ....++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999887421      12 77889999999999999987   99999999999999 78999999999864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.72  E-value=6.1e-17  Score=155.84  Aligned_cols=138  Identities=20%  Similarity=0.176  Sum_probs=109.9

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChh----------------------hHHHHHHHHHHHHhcCCCC
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQ----------------------GLEEFKNEIILIAKLQHRN  349 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~il~~l~h~n  349 (611)
                      ..|.+.+.||+|+||.||++..++|+.||||++......                      ......+|+.++..+.|++
T Consensus        15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            348888999999999999999888999999987643210                      1123577899999998874


Q ss_pred             --eeeEEEeEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe
Q 007239          350 --LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL  427 (611)
Q Consensus       350 --iv~l~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll  427 (611)
                        +...++    ....++||||+++++|..+..         ......++.+|+.++.++|+.+   ++||||||+||++
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill  158 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILV  158 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEE
Confidence              444443    245589999999999876541         1345678899999999999986   9999999999999


Q ss_pred             cCCCCEEEeccccceecc
Q 007239          428 DKDMVAKISDFGMARIFC  445 (611)
Q Consensus       428 ~~~~~~kl~DFGla~~~~  445 (611)
                      ++++.++|+|||++..+.
T Consensus       159 ~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         159 DDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cCCCcEEEEECCccccCC
Confidence            999999999999997553

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.72  E-value=1.5e-18  Score=179.67  Aligned_cols=124  Identities=27%  Similarity=0.455  Sum_probs=108.9

Q ss_pred             eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccc
Q 007239          362 EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA  441 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  441 (611)
                      .+++.|+++.-.+|.++|.........++.....++.|++.++.|   ++   .+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999766666678889999999999999999   55   999999999999999999999999999


Q ss_pred             eecccCC----CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh
Q 007239          442 RIFCENQ----KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS  491 (611)
Q Consensus       442 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt  491 (611)
                      .......    .........||..||+||.+.+..|+.|+|||+||++|+||+.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            8664433    1223445789999999999999999999999999999999997

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.72  E-value=7.9e-17  Score=155.15  Aligned_cols=130  Identities=22%  Similarity=0.377  Sum_probs=105.7

Q ss_pred             ccCccCceEEEEEEcCCCcEEEEEEecccCh--------hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW--------QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       299 ~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      .||+|+||.||++.+ +++++++|.......        ....++.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999996 568899998654321        12356788999999999887655444555666779999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      +|++|.+++.....          .++.+++.+|.+||+.+   ++|+|++|+||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~~----------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND----------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH----------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999887633110          78999999999999987   99999999999999 89999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.71  E-value=7.4e-18  Score=185.90  Aligned_cols=217  Identities=20%  Similarity=0.270  Sum_probs=144.9

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ...+|..++.|..|++|.||..+++ ..+.+|+|+- +....    +++   ++.....|.+|                 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiN-kq~li----lRn---ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNLI----LRN---ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhccc-ccchh----hhc---cccccCCccee-----------------
Confidence            3468999999999999999999976 4667888542 22111    111   33333344443                 


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                          |+-...+   ...+.++.+        ++.+++|||+.|   |+|||+||+|.+|+.-|++|++|||+.+......
T Consensus       136 ----gDc~tll---k~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 ----GDCATLL---KNIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             ----chhhhhc---ccCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence                2222333   122233322        278899999997   9999999999999999999999999987532211


Q ss_pred             C-------------ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHH
Q 007239          449 K-------------TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLW  515 (611)
Q Consensus       449 ~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~  515 (611)
                      .             ....+..+|||.|+|||++....|+..+|+|++|+++||.+.|..||...   ..+.|...+..  
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd---tpeelfg~vis--  272 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD---TPEELFGQVIS--  272 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC---CHHHHHhhhhh--
Confidence            1             11234679999999999999999999999999999999999999997422   22333332221  


Q ss_pred             hcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          516 KEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       516 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ....+.|-         ......+..+++.+.|+.+|..|--....++
T Consensus       273 d~i~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e  311 (1205)
T KOG0606|consen  273 DDIEWPEE---------DEALPPEAQDLIEQLLRQNPLCRLGTGGALE  311 (1205)
T ss_pred             hhcccccc---------CcCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence            01111111         2222345667888899999999964434443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.71  E-value=1.4e-17  Score=165.65  Aligned_cols=198  Identities=21%  Similarity=0.263  Sum_probs=131.2

Q ss_pred             CCCCeeeEEEeEee---------------------------CCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHH
Q 007239          346 QHRNLVRLVGCGIE---------------------------GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG  398 (611)
Q Consensus       346 ~h~niv~l~~~~~~---------------------------~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~  398 (611)
                      +|||||++.+.|.+                           ...+|+||.-.+. +|..+++..    ..+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~----~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR----HRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC----CCchHHHHHHHH
Confidence            59999999887643                           3467889887755 788887542    245556677899


Q ss_pred             HHHHHHHHHhhcCCCceEecCCCCCcEEec--CCC--CEEEeccccceecccCC----CccccccccccCCCCCcccccc
Q 007239          399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLD--KDM--VAKISDFGMARIFCENQ----KTANTRRVVGTYGYMAPEYAME  470 (611)
Q Consensus       399 qi~~~l~yLH~~~~~~iiHrDikp~NIll~--~~~--~~kl~DFGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~  470 (611)
                      |+++|+.|||++|   |.|||+|.+||||.  +|+  .+.|+|||.+---....    ..+..-..-|.-.-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999998   99999999999994  333  57889999875321100    0001112346667899998865


Q ss_pred             CC------CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHh
Q 007239          471 GL------FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIG  544 (611)
Q Consensus       471 ~~------~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li  544 (611)
                      .+      --.|+|.|+.|.+.||+++...||.. ..+...+...     ..+...     +.+    +......+.+++
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~-rGem~L~~r~-----Yqe~qL-----Pal----p~~vpp~~rqlV  490 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK-RGEMLLDTRT-----YQESQL-----PAL----PSRVPPVARQLV  490 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccc-cchheechhh-----hhhhhC-----CCC----cccCChHHHHHH
Confidence            32      12489999999999999999999742 1111101111     111111     111    111122345788


Q ss_pred             hccccCCCCCCCCHHHHHHHhc
Q 007239          545 LLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       545 ~~cl~~dP~~RPt~~evl~~L~  566 (611)
                      ...|+.||.+|++..-....|+
T Consensus       491 ~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHhcCCccccCCccHHHhHHH
Confidence            8899999999998776665553

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.70  E-value=1.2e-16  Score=176.97  Aligned_cols=137  Identities=19%  Similarity=0.285  Sum_probs=110.9

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEe-ccc-C------hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRL-SRK-S------WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~-~~~-~------~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  362 (611)
                      ...|...+.||+|+||+||++.+.... +++|+. .+. .      ....+++.+|+++++.++|++++....+......
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            345577899999999999999875443 444432 211 1      1123568899999999999999887777777778


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .++||||+++++|.+++.           ....++.+++++|.+||+.+   ++||||||+|||+ .++.++|+|||+++
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            899999999999988873           34678999999999999987   9999999999999 67899999999997


Q ss_pred             e
Q 007239          443 I  443 (611)
Q Consensus       443 ~  443 (611)
                      .
T Consensus       476 ~  476 (535)
T PRK09605        476 Y  476 (535)
T ss_pred             c
Confidence            5

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.64  E-value=1.5e-15  Score=144.64  Aligned_cols=136  Identities=20%  Similarity=0.226  Sum_probs=98.8

Q ss_pred             ccccCccCceEEEEEEcCCCcEEEEEEecccChh--hHHH----------------------HHHHHHHHHhcCCCC--e
Q 007239          297 SNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQ--GLEE----------------------FKNEIILIAKLQHRN--L  350 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~il~~l~h~n--i  350 (611)
                      .+.||+|+||.||++...+++.||||++......  ....                      ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            5789999999999999878999999998653211  1111                      135666666665443  4


Q ss_pred             eeEEEeEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhh-cCCCceEecCCCCCcEEecC
Q 007239          351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE-DSRLKIIHRDLKPSNVLLDK  429 (611)
Q Consensus       351 v~l~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDikp~NIll~~  429 (611)
                      .+.+++    ...++||||++++.+.........   .. ..+..++.+++.++.++|. .+   |+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            444443    245899999999544321111000   11 5678899999999999998 75   99999999999999 


Q ss_pred             CCCEEEeccccceec
Q 007239          430 DMVAKISDFGMARIF  444 (611)
Q Consensus       430 ~~~~kl~DFGla~~~  444 (611)
                      ++.++|+|||.+...
T Consensus       150 ~~~~~liDfg~a~~~  164 (187)
T cd05119         150 DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CCcEEEEECcccccc
Confidence            899999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.62  E-value=4.2e-15  Score=135.41  Aligned_cols=135  Identities=20%  Similarity=0.231  Sum_probs=113.6

Q ss_pred             cccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCC--CCeeeEEEeEeeCCeEEEEEEecCCC
Q 007239          296 DSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQH--RNLVRLVGCGIEGEEKLLIYELMPNR  373 (611)
Q Consensus       296 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~~  373 (611)
                      +.+.||+|.++.||++...+ +.+++|.......  ...+.+|+.+++.++|  .++.+++......+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999754 7899999865543  4678899999999986  58999998888878899999999988


Q ss_pred             ChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          374 SLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       374 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      .+..+          +......++.++++++.+||......++|+|++|+||++++.+.++++|||.+..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77543          4455667889999999999986434599999999999999999999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=8.5e-17  Score=177.74  Aligned_cols=256  Identities=24%  Similarity=0.314  Sum_probs=188.6

Q ss_pred             CCCCcccccCccCceEEEEEEcC--CCcEEEEEEecccC--hhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP--NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv  366 (611)
                      ..|.+.+.||+|+|+.|-.....  ....+++|.+....  ....+....|..+-..+. |+|++.+++.....+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            45777788999999999887753  34456777665443  333455566888888887 99999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHh-hcCCCceEecCCCCCcEEecCCC-CEEEeccccceec
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH-EDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIF  444 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH-~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGla~~~  444 (611)
                      .||..++++.+.+... .....+...+-..+.|+..++.|+| ..+   +.|+||||+|.+++..+ .+++.|||+|..+
T Consensus       100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence            9999999998877321 1113555667788999999999999 776   99999999999999999 9999999999988


Q ss_pred             cc-CCCccccccccc-cCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc
Q 007239          445 CE-NQKTANTRRVVG-TYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM  521 (611)
Q Consensus       445 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  521 (611)
                      .. ..........+| ++.|+|||...+. ...+..|+||.|+++..+++|..|+......... ...     |.+... 
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~-----~~~~~~-  248 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSS-----WKSNKG-  248 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-cee-----eccccc-
Confidence            76 444445556788 9999999998884 4567899999999999999999997654433211 000     111110 


Q ss_pred             cccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          522 EFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       522 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       .........    ......++...++..+|..|.+.+++-.
T Consensus       249 -~~~~~~~~~----~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  249 -RFTQLPWNS----ISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             -ccccCcccc----CChhhhhcccccccCCchhccccccccc
Confidence             000001111    1123446667788899999999887753

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.60  E-value=9.7e-15  Score=144.29  Aligned_cols=134  Identities=22%  Similarity=0.279  Sum_probs=102.9

Q ss_pred             cccC-ccCceEEEEEEcCCCcEEEEEEecccC-------------hhhHHHHHHHHHHHHhcCCCCe--eeEEEeEeeCC
Q 007239          298 NKLG-QGGFGTVYKGVLPNGKEVAVKRLSRKS-------------WQGLEEFKNEIILIAKLQHRNL--VRLVGCGIEGE  361 (611)
Q Consensus       298 ~~lg-~G~fg~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~il~~l~h~ni--v~l~~~~~~~~  361 (611)
                      ..|| .|+.|+||++... ++.+++|++....             ......+.+|+.++.+|+|++|  ++.++......
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4677 7888888888774 7789999875321             1223567889999999998875  66666543322


Q ss_pred             ----eEEEEEEecCC-CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEe
Q 007239          362 ----EKLLIYELMPN-RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKIS  436 (611)
Q Consensus       362 ----~~~lv~E~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~  436 (611)
                          ..++|||++++ .+|.+++.+    ..++..    .+.+|+.+|.+||+.|   |+||||||+|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence                23599999997 688887732    234443    3678999999999997   9999999999999999999999


Q ss_pred             cccccee
Q 007239          437 DFGMARI  443 (611)
Q Consensus       437 DFGla~~  443 (611)
                      |||.+..
T Consensus       185 Dfg~~~~  191 (239)
T PRK01723        185 DFDRGEL  191 (239)
T ss_pred             ECCCccc
Confidence            9998875

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.48  E-value=3e-13  Score=145.10  Aligned_cols=144  Identities=23%  Similarity=0.252  Sum_probs=101.5

Q ss_pred             CCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhH----------------------------------------
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGL----------------------------------------  332 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------  332 (611)
                      .|. .+.||.|++|.||+|++++|++||||+.++...+..                                        
T Consensus       119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E  197 (437)
T TIGR01982       119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE  197 (437)
T ss_pred             hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence            344 368999999999999999999999999865421110                                        


Q ss_pred             HHHHHHHHHHHhcC----CCCeeeEEEeE-eeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHH-HHHH
Q 007239          333 EEFKNEIILIAKLQ----HRNLVRLVGCG-IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK-GLLY  406 (611)
Q Consensus       333 ~~~~~E~~il~~l~----h~niv~l~~~~-~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~-~l~y  406 (611)
                      -.|.+|...+.++.    |.+-+.+-.++ ......+|||||++|++|.++.....  ...+   ...++.++++ .+..
T Consensus       198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~--~~~~---~~~ia~~~~~~~l~q  272 (437)
T TIGR01982       198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE--AGLD---RKALAENLARSFLNQ  272 (437)
T ss_pred             HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh--cCCC---HHHHHHHHHHHHHHH
Confidence            02445666666553    33333333332 22345799999999999988763211  1122   3446666665 4678


Q ss_pred             HhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       407 LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      +|..|   ++|+|+||.||+++.++.++++|||++..+.
T Consensus       273 l~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       273 VLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            89886   9999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=1.2e-12  Score=128.09  Aligned_cols=203  Identities=20%  Similarity=0.229  Sum_probs=137.7

Q ss_pred             HHHHHhcCCCCeeeEEEeEeeC-----CeEEEEEEecCCCChhhHhhhch-hhccCCHHHHHHHHHHHHHHHHHHhhcCC
Q 007239          339 IILIAKLQHRNLVRLVGCGIEG-----EEKLLIYELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYLHEDSR  412 (611)
Q Consensus       339 ~~il~~l~h~niv~l~~~~~~~-----~~~~lv~E~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~  412 (611)
                      ...|-.+-|.||++++.++.+.     ....++.|||..|++..+|.+.. ....+......+|+.||+.||.|||+. .
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            3445556799999999887643     45789999999999999997633 345577778889999999999999997 4


Q ss_pred             CceEecCCCCCcEEecCCCCEEEeccccceecc--cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHH
Q 007239          413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC--ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEII  490 (611)
Q Consensus       413 ~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ell  490 (611)
                      +.|+|+++..+-|++..+|-+|+.--.-.....  ..........-.+-++|.+||+-.....+.++|||+||+..+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            789999999999999999999985211111000  000001111234678999999887777888999999999999998


Q ss_pred             hCCCCCCCC-CC-CchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          491 SGKRNSGFY-LT-GHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       491 tG~~p~~~~-~~-~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      -|.--.... .. ........ +        +.. +...+.           ..++..|++..|..||+|++++.
T Consensus       277 ilEiq~tnseS~~~~ee~ia~-~--------i~~-len~lq-----------r~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIAN-V--------IIG-LENGLQ-----------RGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             HheeccCCCcceeehhhhhhh-h--------eee-ccCccc-----------cCcCcccccCCCCCCcchhhhhc
Confidence            775321111 00 11111100 0        000 001111           14556799999999999998764

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.36  E-value=3.7e-12  Score=138.32  Aligned_cols=147  Identities=18%  Similarity=0.193  Sum_probs=98.5

Q ss_pred             hhCCCCcccccCccCceEEEEEEcCC-CcEEEEEEecccChhh----------------------------------HH-
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQG----------------------------------LE-  333 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~-  333 (611)
                      ....|+. +.||+|++|.||++++++ |++||||++++.-.+.                                  .+ 
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3456776 799999999999999876 9999999997542110                                  01 


Q ss_pred             -----HHHHHHHHHHhcC----CCCeeeEEEeEee-CCeEEEEEEecCCCChhhHhhhchh---hccCCHHHHHHHHHHH
Q 007239          334 -----EFKNEIILIAKLQ----HRNLVRLVGCGIE-GEEKLLIYELMPNRSLDCFIFDSER---RLQLNWNTCYNIIGGI  400 (611)
Q Consensus       334 -----~~~~E~~il~~l~----h~niv~l~~~~~~-~~~~~lv~E~~~~~sL~~~l~~~~~---~~~l~~~~~~~i~~qi  400 (611)
                           .+.+|...+.++.    +.+.+.+-.++.+ ....+|||||++|+.+.++..-...   ...+....+..++.||
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence                 1344555555553    4444444444433 4567899999999999775311111   1123333333444444


Q ss_pred             HHHHHHHhhcCCCceEecCCCCCcEEecCCC----CEEEeccccceecccC
Q 007239          401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM----VAKISDFGMARIFCEN  447 (611)
Q Consensus       401 ~~~l~yLH~~~~~~iiHrDikp~NIll~~~~----~~kl~DFGla~~~~~~  447 (611)
                             +..|   ++|+|+||.||+++.++    .++++|||++..+...
T Consensus       277 -------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        277 -------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             -------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                   3455   99999999999999888    9999999999877543

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=1.9e-12  Score=137.15  Aligned_cols=250  Identities=25%  Similarity=0.307  Sum_probs=177.9

Q ss_pred             hCCCCcccccCc--cCceEEEEEEc---CCCcEEEEEEecc--cChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCe
Q 007239          291 TDGFSDSNKLGQ--GGFGTVYKGVL---PNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEE  362 (611)
Q Consensus       291 ~~~y~~~~~lg~--G~fg~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~  362 (611)
                      ...|.+...+|.  |.+|.||.+..   .++..+|+|+-+.  ........-.+|+...+.+. |+|.++.+..++..+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            345778889999  99999999986   3577899997432  22233333456777777775 9999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHH----HHHHHhhcCCCceEecCCCCCcEEecCC-CCEEEec
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK----GLLYLHEDSRLKIIHRDLKPSNVLLDKD-MVAKISD  437 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~----~l~yLH~~~~~~iiHrDikp~NIll~~~-~~~kl~D  437 (611)
                      .++-.|++. .+|..+...  ....++...++..+.+...    ||.++|+..   ++|-|+||.||++..+ ...+++|
T Consensus       193 lfiqtE~~~-~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             ceeeecccc-chhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence            999999986 566555432  2233677778888888888    999999985   9999999999999999 8899999


Q ss_pred             cccceecccCCCcccc---ccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH
Q 007239          438 FGMARIFCENQKTANT---RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL  514 (611)
Q Consensus       438 FGla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~  514 (611)
                      ||+...+.........   .+..|...|++||.. .+.++.+.|+|++|.++.+-..|..........        .|..
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W~~  337 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS--------SWSQ  337 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC--------Cccc
Confidence            9999988766533322   234677889999955 567789999999999999988876543111000        1111


Q ss_pred             HhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       515 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .+...   +-+...     .....++...+.+|++.+|-.|++.+.+..
T Consensus       338 ~r~~~---ip~e~~-----~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  338 LRQGY---IPLEFC-----EGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ccccc---Cchhhh-----cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            11111   111111     111123334777899999999998877664

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.34  E-value=4.6e-12  Score=118.43  Aligned_cols=130  Identities=24%  Similarity=0.156  Sum_probs=97.2

Q ss_pred             ccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCee-eEEEeEeeCCeEEEEEEecCCCCh
Q 007239          297 SNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLV-RLVGCGIEGEEKLLIYELMPNRSL  375 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv-~l~~~~~~~~~~~lv~E~~~~~sL  375 (611)
                      .+.|+.|.++.||++... ++.+++|....... ....+.+|+.+++.+.+.+++ +++.+.  ....++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            357899999999999874 77899998765432 123467899999998765544 455443  3345899999999887


Q ss_pred             hhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcC--CCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          376 DCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS--RLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       376 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~--~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      ....        .   ....++.+++++|..||..+  ...++|+|++|.||+++ ++.++++|||.+.
T Consensus        79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            5420        0   11245678999999999875  22369999999999999 6789999999885

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.26  E-value=1.1e-10  Score=110.63  Aligned_cols=136  Identities=15%  Similarity=0.115  Sum_probs=98.9

Q ss_pred             ccccCccCceEEEEEEcCC-------CcEEEEEEecccCh----------------------hhHHHHH----HHHHHHH
Q 007239          297 SNKLGQGGFGTVYKGVLPN-------GKEVAVKRLSRKSW----------------------QGLEEFK----NEIILIA  343 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~~~----~E~~il~  343 (611)
                      ...||.|.-+.||.|...+       +..+|||+.+....                      .....+.    +|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999998543       57899998752100                      0122233    7999999


Q ss_pred             hcCC--CCeeeEEEeEeeCCeEEEEEEecCCCChhh-HhhhchhhccCCHHHHHHHHHHHHHHHHHH-hhcCCCceEecC
Q 007239          344 KLQH--RNLVRLVGCGIEGEEKLLIYELMPNRSLDC-FIFDSERRLQLNWNTCYNIIGGISKGLLYL-HEDSRLKIIHRD  419 (611)
Q Consensus       344 ~l~h--~niv~l~~~~~~~~~~~lv~E~~~~~sL~~-~l~~~~~~~~l~~~~~~~i~~qi~~~l~yL-H~~~~~~iiHrD  419 (611)
                      ++..  -++.+++++    ...+|||||+.+..+.. .+.    ...++......+..+++.+|..| |+.+   ++|+|
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD  150 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD  150 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            9874  355666654    56689999998754422 221    12345556677889999999999 7776   99999


Q ss_pred             CCCCcEEecCCCCEEEeccccceec
Q 007239          420 LKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       420 ikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      |++.|||++ ++.+.|+|||.+...
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeC
Confidence            999999997 468999999988754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.24  E-value=6.5e-11  Score=126.74  Aligned_cols=167  Identities=16%  Similarity=0.206  Sum_probs=127.9

Q ss_pred             cCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHH
Q 007239          313 LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNT  392 (611)
Q Consensus       313 ~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~  392 (611)
                      ..++.+|.|...+.......+...+-++.|+.++||||+++++.++.++..|||+|-+.  .|...+..      +....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence            45788888888876655555667888999999999999999999999999999999874  45555522      23556


Q ss_pred             HHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCC
Q 007239          393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL  472 (611)
Q Consensus       393 ~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  472 (611)
                      +..-+.||+.||.+||+++  +++|++|..+.|+|+..|+.||++|.++........  ..+...--..|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence            6678899999999999876  799999999999999999999999998865422221  111122233567777543322


Q ss_pred             CCchhhHHHHHHHHHHHHhCC
Q 007239          473 FSVKSDVFSFGVIVLEIISGK  493 (611)
Q Consensus       473 ~~~k~DvwSlGvll~elltG~  493 (611)
                        -..|.|.||++++|++.|.
T Consensus       182 --~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             --cchhhhhHHHHHHHHhCcc
Confidence              3469999999999999993

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.17  E-value=2.9e-11  Score=128.31  Aligned_cols=246  Identities=20%  Similarity=0.167  Sum_probs=172.9

Q ss_pred             hhCCCCcccccCccCceEEEEEEc--CCCcEEEEEEecccChhhHHH--HHHHHHHHHhcC-CCCeeeEEEeEeeCCeEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL--PNGKEVAVKRLSRKSWQGLEE--FKNEIILIAKLQ-HRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~il~~l~-h~niv~l~~~~~~~~~~~  364 (611)
                      ...+|..+..||.|.|+.|++...  .++..|++|.+.+.......+  -..|+.+...+. |.++++....+......+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            356788999999999999999874  367789999887654333222  245666666665 888888887777778888


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC-CCEEEecccccee
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD-MVAKISDFGMARI  443 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~-~~~kl~DFGla~~  443 (611)
                      +--||++++++...+   .-...++....+++..|++.++.++|+..   ++|+|+||+||++..+ +..++.|||....
T Consensus       343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence            999999999987665   33345788889999999999999999886   9999999999999886 7889999999864


Q ss_pred             cccCCCccccccccccCCCC--CccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc
Q 007239          444 FCENQKTANTRRVVGTYGYM--APEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM  521 (611)
Q Consensus       444 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  521 (611)
                      +......     ..+.-++.  +|+......+..+.|++|||.-+.+.++|..-......          |..++.+.  
T Consensus       417 ~~~~~~~-----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----------~~~i~~~~--  479 (524)
T KOG0601|consen  417 LAFSSGV-----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----------SLTIRSGD--  479 (524)
T ss_pred             cceeccc-----ccccccccccchhhccccccccccccccccccccccccCcccCccccc----------ceeeeccc--
Confidence            3211111     12223334  45555566788999999999999999998753211000          11111111  


Q ss_pred             cccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          522 EFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       522 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                            +......  ...+..+...++..++..||...++..+..
T Consensus       480 ------~p~~~~~--~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  480 ------TPNLPGL--KLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             ------ccCCCch--HHhhhhhhhhhcCCccccchhhhhhcccch
Confidence                  1111111  134445666688999999999888776543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.16  E-value=3e-10  Score=110.94  Aligned_cols=141  Identities=16%  Similarity=0.236  Sum_probs=108.0

Q ss_pred             cccCccCceEEEEEEcCCCcEEEEEEecccCh-hhHHHHHHHHHHHHhcCCC--CeeeEEEeEeeCC---eEEEEEEecC
Q 007239          298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHR--NLVRLVGCGIEGE---EKLLIYELMP  371 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~--niv~l~~~~~~~~---~~~lv~E~~~  371 (611)
                      +.|+.|..+.||++...+|+.+++|+...... .....+.+|+++++.+.+.  ++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999999986678999999765432 2355789999999999863  4566777765532   5689999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS----------------------------------------  411 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~----------------------------------------  411 (611)
                      |.++...+..    ..++..+...++.++++.|..||+..                                        
T Consensus        84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (223)
T cd05154          84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER  159 (223)
T ss_pred             CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence            9988765421    23566677777888888888887421                                        


Q ss_pred             -------------CCceEecCCCCCcEEecC--CCCEEEeccccce
Q 007239          412 -------------RLKIIHRDLKPSNVLLDK--DMVAKISDFGMAR  442 (611)
Q Consensus       412 -------------~~~iiHrDikp~NIll~~--~~~~kl~DFGla~  442 (611)
                                   ...++|+|+++.||+++.  ++.+.|+||+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                         235799999999999998  6678999999875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.16  E-value=4.8e-10  Score=102.66  Aligned_cols=131  Identities=20%  Similarity=0.310  Sum_probs=99.7

Q ss_pred             cccCccCceEEEEEEcCCCcEEEEEEecccChh--------hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQ--------GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      ..+.+|+-+.++.+.+. |.++++|.-.++...        ..++-.+|+.++.++.--.|.-.+=+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46789999999999873 445777754333211        134567899999999765554444455677788899999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ++|..|.+.+...          ...++..+-+-+.-||..|   |+|+||.++||++..++ +.++||||+..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999998888433          2456777778888899997   99999999999998765 99999999974

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.10  E-value=1.8e-09  Score=112.37  Aligned_cols=169  Identities=20%  Similarity=0.309  Sum_probs=131.3

Q ss_pred             ceEEEEEE-cCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEe----eCCeEEEEEEecCC-CChhhH
Q 007239          305 FGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI----EGEEKLLIYELMPN-RSLDCF  378 (611)
Q Consensus       305 fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~----~~~~~~lv~E~~~~-~sL~~~  378 (611)
                      -.+.||+. .-+|..|++|+++....+.......-+++++++.|+|+|++.++|.    .+..+++||+|.++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            35679988 4589999999996555454445566789999999999999999887    34578999999986 567666


Q ss_pred             hhhc------------hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          379 IFDS------------ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       379 l~~~------------~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      -+..            ......++..+|.++.||..||.++|+.|   +.-+-|.|.+|+++.+.+++|...|......+
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            5432            12334678899999999999999999997   88899999999999999999998888766543


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRN  495 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p  495 (611)
                      +...                -+..   -.+-|.=-||.+++.|.+|...
T Consensus       446 d~~~----------------~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPTE----------------PLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCc----------------chhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            3311                1111   2357888999999999999754

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.05  E-value=2.8e-09  Score=97.13  Aligned_cols=143  Identities=22%  Similarity=0.281  Sum_probs=104.7

Q ss_pred             cccccCccCceEEEEEEcCCCcEEEEEEecccCh--------hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          296 DSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW--------QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       296 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ....|-+|+-+.|+++.+ .|+..+||.-..+..        -...+..+|+.+|.++.--.|.-..-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            567888999999999998 577777775432211        12456788999999987545444444556667778999


Q ss_pred             EecCC-CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC---CEEEecccccee
Q 007239          368 ELMPN-RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM---VAKISDFGMARI  443 (611)
Q Consensus       368 E~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~---~~kl~DFGla~~  443 (611)
                      ||++| .++.++++........+ .....++..|-+.+.-||..+   |||+||..+||++..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99988 46777776533322222 223678888889999999987   99999999999997655   458999999864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.99  E-value=9.1e-11  Score=130.66  Aligned_cols=251  Identities=19%  Similarity=0.179  Sum_probs=168.6

Q ss_pred             HhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  364 (611)
                      ...+.+.+.+-+-+|.++.++...-. .|...+.|.....   .....+....+-.++-...||.+++...-+......+
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            35678888999999999999887743 3433333332211   1112233344444554556677776665566778889


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      |+++|..+++|...++..   +..+.+-++..+..+..+++|||..-   +.|+|++|.|+++..+++.++.|||.....
T Consensus       881 L~~~~~~~~~~~Skl~~~---~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNS---GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhhHHhccCCchhhhhcC---CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence            999999999998887442   34566667778888999999999863   899999999999999999999999844432


Q ss_pred             ccC--------C-------------C----c----cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 007239          445 CEN--------Q-------------K----T----ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRN  495 (611)
Q Consensus       445 ~~~--------~-------------~----~----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p  495 (611)
                      +.-        .             .    .    .......||+.|.+||...+......+|+|++|+.++|.++|.+|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            110        0             0    0    012246799999999999999999999999999999999999999


Q ss_pred             CCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHH
Q 007239          496 SGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMS  559 (611)
Q Consensus       496 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  559 (611)
                      |.-...   +...    +.+-.+.     -++..+  ......+..+++...+..+|.+|-.+.
T Consensus      1035 ~na~tp---q~~f----~ni~~~~-----~~~p~g--~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETP---QQIF----ENILNRD-----IPWPEG--PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCcch---hhhh----hccccCC-----CCCCCC--ccccChhhhhhhhhhhccCchhccCcc
Confidence            742221   1111    1111111     111111  111222344666677888888887766

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.96  E-value=9.3e-09  Score=97.09  Aligned_cols=125  Identities=26%  Similarity=0.317  Sum_probs=83.5

Q ss_pred             EEEEEEcCCCcEEEEEEecccCh--------------------------hhHHHHHHHHHHHHhcCCC--CeeeEEEeEe
Q 007239          307 TVYKGVLPNGKEVAVKRLSRKSW--------------------------QGLEEFKNEIILIAKLQHR--NLVRLVGCGI  358 (611)
Q Consensus       307 ~Vy~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~il~~l~h~--niv~l~~~~~  358 (611)
                      .||.|...+|.++|+|+.+....                          .......+|...|.++..-  ++.+++++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            48999988999999998753210                          0123467899999999866  45666655  


Q ss_pred             eCCeEEEEEEecC--CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHH-HhhcCCCceEecCCCCCcEEecCCCCEEE
Q 007239          359 EGEEKLLIYELMP--NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLY-LHEDSRLKIIHRDLKPSNVLLDKDMVAKI  435 (611)
Q Consensus       359 ~~~~~~lv~E~~~--~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~y-LH~~~~~~iiHrDikp~NIll~~~~~~kl  435 (611)
                        ...+|||||++  |..+..+. +..    ++......++.++++.+.. +|..|   |+|+||.+.|||++++ .+.|
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~-~~~----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLK-DVD----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHH-HCG----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHH-hcc----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence              24479999999  65554433 111    1234556778888886555 56776   9999999999999988 9999


Q ss_pred             eccccceec
Q 007239          436 SDFGMARIF  444 (611)
Q Consensus       436 ~DFGla~~~  444 (611)
                      +|||.+...
T Consensus       148 IDf~qav~~  156 (188)
T PF01163_consen  148 IDFGQAVDS  156 (188)
T ss_dssp             --GTTEEET
T ss_pred             EecCcceec
Confidence            999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.92  E-value=2e-08  Score=100.59  Aligned_cols=134  Identities=20%  Similarity=0.179  Sum_probs=96.4

Q ss_pred             ceEEEEEEcCCCcEEEEEEecccChhh-H----------HHHHHHHHHHHhcCCCCe--eeEEEeEee-----CCeEEEE
Q 007239          305 FGTVYKGVLPNGKEVAVKRLSRKSWQG-L----------EEFKNEIILIAKLQHRNL--VRLVGCGIE-----GEEKLLI  366 (611)
Q Consensus       305 fg~Vy~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~E~~il~~l~h~ni--v~l~~~~~~-----~~~~~lv  366 (611)
                      ...|.+..+ +|+.|.||+........ .          ..+.+|...+.+|..-+|  .+++.+.+.     ....+||
T Consensus        35 ~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV  113 (268)
T PRK15123         35 GRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII  113 (268)
T ss_pred             CceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence            334666655 67889999775433111 1          136789999988864443  334444432     2357899


Q ss_pred             EEecCCC-ChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC-------CCCEEEecc
Q 007239          367 YELMPNR-SLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK-------DMVAKISDF  438 (611)
Q Consensus       367 ~E~~~~~-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~-------~~~~kl~DF  438 (611)
                      +|++++. +|.+++.+.. ....+......++.+++..+.-||+.|   |+|+|++++|||++.       +..+.++||
T Consensus       114 te~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl  189 (268)
T PRK15123        114 TEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDL  189 (268)
T ss_pred             EeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEEC
Confidence            9999986 8888874321 234556677889999999999999997   999999999999975       468999999


Q ss_pred             cccee
Q 007239          439 GMARI  443 (611)
Q Consensus       439 Gla~~  443 (611)
                      +.++.
T Consensus       190 ~r~~~  194 (268)
T PRK15123        190 HRAQI  194 (268)
T ss_pred             Ccccc
Confidence            98853

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.91  E-value=1.1e-08  Score=99.28  Aligned_cols=134  Identities=20%  Similarity=0.215  Sum_probs=99.1

Q ss_pred             CCcccccCccCceEEEEEEcCCCcEEEEEEecccCh----------------------hhHHHHHHHHHHHHhcCCC--C
Q 007239          294 FSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW----------------------QGLEEFKNEIILIAKLQHR--N  349 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~il~~l~h~--n  349 (611)
                      ..++..||-|.-+.||.|..++|.++|||.-+....                      .......+|.++|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            556789999999999999999999999996432110                      0123457799999999865  6


Q ss_pred             eeeEEEeEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC
Q 007239          350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK  429 (611)
Q Consensus       350 iv~l~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~  429 (611)
                      +.+.+++    +...+||||++|..|...-        ++.+....++..|++-+.-+-..|   +||+|+.+-||++++
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            6666665    5668999999997775432        123334445555555555555555   999999999999999


Q ss_pred             CCCEEEeccccce
Q 007239          430 DMVAKISDFGMAR  442 (611)
Q Consensus       430 ~~~~kl~DFGla~  442 (611)
                      +|.+.++||--+.
T Consensus       238 dg~~~vIDwPQ~v  250 (304)
T COG0478         238 DGDIVVIDWPQAV  250 (304)
T ss_pred             CCCEEEEeCcccc
Confidence            9999999996554

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.70  E-value=2.3e-07  Score=94.58  Aligned_cols=193  Identities=15%  Similarity=0.177  Sum_probs=127.1

Q ss_pred             cccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEe------E-eeCCeEEEEE
Q 007239          296 DSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGC------G-IEGEEKLLIY  367 (611)
Q Consensus       296 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~------~-~~~~~~~lv~  367 (611)
                      .++.||+|+-+.+|-.-  +-+.-+.|+..........+.   +..|.+. .||-+-.-+.|      . .....+-++|
T Consensus        15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            46789999999998743  122346677765443322221   2223222 35543321111      1 1223366788


Q ss_pred             EecCCCCh-hhHhhh---chhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          368 ELMPNRSL-DCFIFD---SERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       368 E~~~~~sL-~~~l~~---~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      +.+.+..= ..+..-   .+.-...+|..+++.++.|+.+...||..|   .+-+|++++|+|+.+++.+.|.|-..-.+
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence            88776422 222211   223345789999999999999999999998   89999999999999999999998654443


Q ss_pred             cccCCCccccccccccCCCCCccccc-----cCCCCchhhHHHHHHHHHHHHhC-CCCCCCC
Q 007239          444 FCENQKTANTRRVVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVIVLEIISG-KRNSGFY  499 (611)
Q Consensus       444 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvll~elltG-~~p~~~~  499 (611)
                      ...   .....-.+|...|.+||.-.     +..-+...|.|.|||++++++.| +.|+...
T Consensus       167 ~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         167 NAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             ccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            211   11222357899999999765     23345679999999999999887 7887543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.69  E-value=1e-07  Score=103.27  Aligned_cols=143  Identities=17%  Similarity=0.224  Sum_probs=95.1

Q ss_pred             cccCccCceEEEEEEcCCCcEEEEEEecccChhh------------------------------HH----------HHHH
Q 007239          298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQG------------------------------LE----------EFKN  337 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~----------~~~~  337 (611)
                      +.|+.++-|.||+|++++|++||||+.++.-.+.                              .+          .+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6799999999999999999999999886542211                              00          1344


Q ss_pred             HHHHHHhcC-----CCCeeeEEEeE-eeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcC
Q 007239          338 EIILIAKLQ-----HRNLVRLVGCG-IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS  411 (611)
Q Consensus       338 E~~il~~l~-----h~niv~l~~~~-~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~  411 (611)
                      |...+.++.     .+++ ++=.++ .-....+|+|||++|..+.+...-..  ..++.+.+.....++.  +..+=..|
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f--~~q~~~dg  285 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAF--LRQLLRDG  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHH--HHHHHhcC
Confidence            666665553     2332 222333 33567799999999999988853222  2345333332222222  12222234


Q ss_pred             CCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       412 ~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                         ++|.|.+|.||+++.+|++.+.|||+...+.+..
T Consensus       286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~~  319 (517)
T COG0661         286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPKF  319 (517)
T ss_pred             ---ccccCCCccceEEecCCcEEEEcCcceecCCHHH
Confidence               9999999999999999999999999998765443

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.62  E-value=2.4e-07  Score=89.55  Aligned_cols=123  Identities=26%  Similarity=0.290  Sum_probs=89.9

Q ss_pred             CCcEEEEEEecccC-------hhhHHHHHHHHHHHHhcCCCC--eeeEEEeEeeC----CeEEEEEEecCCC-ChhhHhh
Q 007239          315 NGKEVAVKRLSRKS-------WQGLEEFKNEIILIAKLQHRN--LVRLVGCGIEG----EEKLLIYELMPNR-SLDCFIF  380 (611)
Q Consensus       315 ~~~~vavK~~~~~~-------~~~~~~~~~E~~il~~l~h~n--iv~l~~~~~~~----~~~~lv~E~~~~~-sL~~~l~  380 (611)
                      .++.+.+|.....-       .-......+|...+..|..-.  ..+.+.+....    ...++|+|++++. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            45666666543211       012346788999888886433  34555555442    2458999999984 7888884


Q ss_pred             hchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC---CEEEecccccee
Q 007239          381 DSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM---VAKISDFGMARI  443 (611)
Q Consensus       381 ~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~---~~kl~DFGla~~  443 (611)
                      +..   ..+......++.++++.+.-||+.|   |+|+|+++.|||++.++   .+.++||+-++.
T Consensus       111 ~~~---~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  111 QWE---QLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             hhc---ccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            322   2566677889999999999999997   99999999999999887   899999998765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.55  E-value=1e-06  Score=83.90  Aligned_cols=138  Identities=18%  Similarity=0.173  Sum_probs=101.5

Q ss_pred             cCccCceEEEEEEcCCCcEEEEEEeccc---C---hhhHHHHHHHHHHHHhcCCCC--eeeEEEeEe-e----CCeEEEE
Q 007239          300 LGQGGFGTVYKGVLPNGKEVAVKRLSRK---S---WQGLEEFKNEIILIAKLQHRN--LVRLVGCGI-E----GEEKLLI  366 (611)
Q Consensus       300 lg~G~fg~Vy~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~il~~l~h~n--iv~l~~~~~-~----~~~~~lv  366 (611)
                      -|+||.+-|++... +|+.+-+|+-...   +   +.+...|.+|+..|.+|..-+  +.++. ++. .    .-..+||
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            46789999999776 3457999976421   1   335678999999999997432  44444 222 1    1246899


Q ss_pred             EEecCC-CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCC--EEEecccccee
Q 007239          367 YELMPN-RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV--AKISDFGMARI  443 (611)
Q Consensus       367 ~E~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~--~kl~DFGla~~  443 (611)
                      +|-+++ .+|.+++.+. ...+.+......++.+|+..+.-||+.|   +.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997764 6888877432 2234567777899999999999999997   999999999999986677  99999976653

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.48  E-value=2.7e-08  Score=107.44  Aligned_cols=154  Identities=19%  Similarity=0.266  Sum_probs=100.4

Q ss_pred             HHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc-------ccccccccCCCCCccccc
Q 007239          397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA-------NTRRVVGTYGYMAPEYAM  469 (611)
Q Consensus       397 ~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~  469 (611)
                      +.+++.|+.|+|..-  .+||+.|.|++|.++.++..||+.|+.+.....+....       ..-...-...|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            445569999999875  79999999999999999999999999886543311111       000123445799999999


Q ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccc
Q 007239          470 EGLFSVKSDVFSFGVIVLEIISGKRN-SGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCV  548 (611)
Q Consensus       470 ~~~~~~k~DvwSlGvll~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl  548 (611)
                      +...+.++|+||+|+++|.+..|..+ +.........     ...        ...+..-...++.....++.+=+.+++
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-----~~~--------~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-----SFS--------RNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchh-----hhh--------hcccccccccccccCcHHHHHHHHHHh
Confidence            98889999999999999999955443 2211111100     000        000111111122223334555566789


Q ss_pred             cCCCCCCCCHHHHHHHh
Q 007239          549 QEDPAVRPTMSNVVALL  565 (611)
Q Consensus       549 ~~dP~~RPt~~evl~~L  565 (611)
                      ..++.-||++.++....
T Consensus       250 ~~~~~~rp~~~~l~~~~  266 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLSIP  266 (700)
T ss_pred             cCCcccCcchhhhhccc
Confidence            99999999887776543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.48  E-value=2.3e-06  Score=83.84  Aligned_cols=139  Identities=18%  Similarity=0.180  Sum_probs=85.8

Q ss_pred             cccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--eeeEEEeEeeCCeEEEEEEecCCCC-
Q 007239          298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN--LVRLVGCGIEGEEKLLIYELMPNRS-  374 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~~~~~~~~~~lv~E~~~~~s-  374 (611)
                      ..||+|..+.||+.   .+..+++|......  ......+|.++++.+..-.  +.+.+.+....+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999984   25568889876533  3355789999999987433  4667777777777889999999963 


Q ss_pred             hhhHhh--------------h------chhhccCCHHHHH-HHHHH----------HHH-HHHHHhh-cCCCceEecCCC
Q 007239          375 LDCFIF--------------D------SERRLQLNWNTCY-NIIGG----------ISK-GLLYLHE-DSRLKIIHRDLK  421 (611)
Q Consensus       375 L~~~l~--------------~------~~~~~~l~~~~~~-~i~~q----------i~~-~l~yLH~-~~~~~iiHrDik  421 (611)
                      +...+.              .      ............. .+..+          +.+ ...+|.. .....++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            221110              0      0000001111000 00000          001 1112211 123357899999


Q ss_pred             CCcEEecCCCCEEEeccccce
Q 007239          422 PSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       422 p~NIll~~~~~~kl~DFGla~  442 (611)
                      |.||++++++ +.|+||+.+.
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcC
Confidence            9999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.47  E-value=2.3e-06  Score=81.76  Aligned_cols=138  Identities=14%  Similarity=0.123  Sum_probs=92.9

Q ss_pred             HhhCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHH---------HHHHHHHHHhcCCC---CeeeEEEe
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEE---------FKNEIILIAKLQHR---NLVRLVGC  356 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~il~~l~h~---niv~l~~~  356 (611)
                      ....+|+..+.+-......|.+... +|+.+++|..+.........         ..+++..+..++..   ....++-.
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            3567888888888888888877666 57899999887654322222         23344444444322   22222222


Q ss_pred             -----EeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC
Q 007239          357 -----GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM  431 (611)
Q Consensus       357 -----~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~  431 (611)
                           +......+++|||++|..|.+...       ++.    .+...|.+.+.-||+.|   +.|+|.+|.|+++++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~  172 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG  172 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence                 222345578999999988866531       222    24456778899999998   99999999999998654


Q ss_pred             CEEEeccccce
Q 007239          432 VAKISDFGMAR  442 (611)
Q Consensus       432 ~~kl~DFGla~  442 (611)
                       ++++||+..+
T Consensus       173 -i~iID~~~k~  182 (229)
T PF06176_consen  173 -IRIIDTQGKR  182 (229)
T ss_pred             -EEEEECcccc
Confidence             9999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.38  E-value=3.7e-06  Score=81.20  Aligned_cols=152  Identities=16%  Similarity=0.168  Sum_probs=100.2

Q ss_pred             CHHHHHHhhCCCCccc---ccCccCceEEEEEEcCCCcEEEEEEecccChhh------------------------HHHH
Q 007239          283 HLAVIKAATDGFSDSN---KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQG------------------------LEEF  335 (611)
Q Consensus       283 ~~~~~~~~~~~y~~~~---~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------------------------~~~~  335 (611)
                      .+..+....++..+..   .|+.|.-+.||+|...++..+|+|+++......                        ....
T Consensus        36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~  115 (268)
T COG1718          36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA  115 (268)
T ss_pred             HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence            3444555555555544   456777888999998889999999986432211                        0112


Q ss_pred             HHHHHHHHhcCC--CCeeeEEEeEeeCCeEEEEEEecCCCCh-hhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCC
Q 007239          336 KNEIILIAKLQH--RNLVRLVGCGIEGEEKLLIYELMPNRSL-DCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR  412 (611)
Q Consensus       336 ~~E~~il~~l~h--~niv~l~~~~~~~~~~~lv~E~~~~~sL-~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~  412 (611)
                      ..|+..|+++..  =.+.+-+.+.    .-.|||||+....+ .-.|.    ...+...++..+..++++.+.-|-... 
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk----Dv~~e~~e~~~~~~~~v~~~~~l~~~a-  186 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK----DVPLELEEAEGLYEDVVEYMRRLYKEA-  186 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc----cCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence            457777777753  3344444442    34799999976421 11121    112233357777888888888887733 


Q ss_pred             CceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       413 ~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                       ++||+||..-|||+. ++.+.|+|||-|....
T Consensus       187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             -CcccccchhhheEEE-CCeEEEEECccccccC
Confidence             599999999999999 8899999999887543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.34  E-value=6e-06  Score=80.96  Aligned_cols=143  Identities=21%  Similarity=0.214  Sum_probs=85.0

Q ss_pred             ccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--eeeEEEeEe---eCCeEEEEEEecC
Q 007239          297 SNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN--LVRLVGCGI---EGEEKLLIYELMP  371 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~~~~---~~~~~~lv~E~~~  371 (611)
                      ++.|+.|..+.||+....+ +.+++|.....  .....+.+|..+++.+....  +.+++....   .....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3578999999999999876 69999997655  45567889999999886433  456665432   2335789999999


Q ss_pred             CCChhh----------------Hhhh---c-hhhccCCHHH---------HHH------------HHHHHHH-HHHHHhh
Q 007239          372 NRSLDC----------------FIFD---S-ERRLQLNWNT---------CYN------------IIGGISK-GLLYLHE  409 (611)
Q Consensus       372 ~~sL~~----------------~l~~---~-~~~~~l~~~~---------~~~------------i~~qi~~-~l~yLH~  409 (611)
                      +..+..                .+..   . .....+....         ...            ....+.+ .+..+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            998877                1100   0 0000000000         000            0111222 2333332


Q ss_pred             ----cCCCceEecCCCCCcEEec-CCCCEEEeccccce
Q 007239          410 ----DSRLKIIHRDLKPSNVLLD-KDMVAKISDFGMAR  442 (611)
Q Consensus       410 ----~~~~~iiHrDikp~NIll~-~~~~~kl~DFGla~  442 (611)
                          .....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                1234699999999999999 66667899998775

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.30  E-value=4.4e-06  Score=90.36  Aligned_cols=143  Identities=15%  Similarity=0.181  Sum_probs=92.9

Q ss_pred             ccccCccCceEEEEEEcCCCcEEEEEEecccChhh-------------------------------HH------HHHHHH
Q 007239          297 SNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQG-------------------------------LE------EFKNEI  339 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~E~  339 (611)
                      .+.||.-+.|.||+++.++|+.||||+-++.-.+.                               .+      .|.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            36799999999999999999999999876532110                               00      244455


Q ss_pred             HHHHhc----CCCC---eeeEEEeEe-eCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcC
Q 007239          340 ILIAKL----QHRN---LVRLVGCGI-EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS  411 (611)
Q Consensus       340 ~il~~l----~h~n---iv~l~~~~~-~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~  411 (611)
                      +...+.    .|-+   -|.+=.++. -....+|+||||+|..+.++-.  .....++...+..-+.+...-+-+-  .|
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~--i~~~gi~~~~i~~~l~~~~~~qIf~--~G  321 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA--IDKRGISPHDILNKLVEAYLEQIFK--TG  321 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH--HHHcCCCHHHHHHHHHHHHHHHHHh--cC
Confidence            544444    3545   122222222 2356799999999998887642  2233355554443333333222222  23


Q ss_pred             CCceEecCCCCCcEEecC----CCCEEEeccccceeccc
Q 007239          412 RLKIIHRDLKPSNVLLDK----DMVAKISDFGMARIFCE  446 (611)
Q Consensus       412 ~~~iiHrDikp~NIll~~----~~~~kl~DFGla~~~~~  446 (611)
                         ++|.|-+|.||++..    ++.+.+.|||+...+..
T Consensus       322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             ---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence               999999999999983    67899999999986544

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.28  E-value=9.1e-08  Score=102.18  Aligned_cols=192  Identities=19%  Similarity=0.141  Sum_probs=139.7

Q ss_pred             HHHhhCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCC-eeeEEEeEeeCCeEEE
Q 007239          287 IKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN-LVRLVGCGIEGEEKLL  365 (611)
Q Consensus       287 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~l~~~~~~~~~~~l  365 (611)
                      +++.+..+..-+.+++|+.++++|.+....+....+.+...     ....-++++|.+++||| .+..++-+..+...++
T Consensus       237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i  311 (829)
T KOG0576|consen  237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI  311 (829)
T ss_pred             ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence            34556667777889999999999988544444556655433     44566899999999999 6666666666778889


Q ss_pred             EEEecCCC-ChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          366 IYELMPNR-SLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       366 v~E~~~~~-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +++++.++ +-...+.  .....+..-+...+.+.-++++++||+..   -+|+|    ||+..+ +..|..||+....+
T Consensus       312 ~~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L  381 (829)
T KOG0576|consen  312 PMRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQL  381 (829)
T ss_pred             hhhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCccc
Confidence            99999877 2222111  11122334445566677788999999863   48888    777655 68899999998766


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNS  496 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~  496 (611)
                      ....   ..+...+++.++|||+.....+..+.|+|++|+--.+|--|-+|.
T Consensus       382 ~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  382 TRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             Cccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            4433   344578999999999999999999999999999877777777664

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.26  E-value=1.4e-05  Score=79.29  Aligned_cols=76  Identities=14%  Similarity=0.164  Sum_probs=55.1

Q ss_pred             ccCccCc-eEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEEEEecCCCChh
Q 007239          299 KLGQGGF-GTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLIYELMPNRSLD  376 (611)
Q Consensus       299 ~lg~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~~sL~  376 (611)
                      .|-.|.. ..||+...+ +.++++|+.....   ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3555555 788998764 4788999876543   345678999998885 444567777776666789999999998876


Q ss_pred             hH
Q 007239          377 CF  378 (611)
Q Consensus       377 ~~  378 (611)
                      ..
T Consensus        81 ~~   82 (244)
T cd05150          81 AL   82 (244)
T ss_pred             Hh
Confidence            43

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.08  E-value=2.5e-05  Score=71.53  Aligned_cols=129  Identities=22%  Similarity=0.256  Sum_probs=88.4

Q ss_pred             CcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeee-EEEeEeeCCeEEEEEEecCCC
Q 007239          295 SDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR-LVGCGIEGEEKLLIYELMPNR  373 (611)
Q Consensus       295 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~-l~~~~~~~~~~~lv~E~~~~~  373 (611)
                      ...+.|++|.+|.||+|.+. |.++|+|+-+.++  ....+..|+++|..++-.++.+ ++.+    +..++.|||++|.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhcCc
Confidence            34578999999999999995 4589999876554  3467889999999998766544 4444    2234559999998


Q ss_pred             ChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCC-CCcEEecCCCCEEEecccccee
Q 007239          374 SLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLK-PSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       374 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDik-p~NIll~~~~~~kl~DFGla~~  443 (611)
                      .|.+.-...      +.++    +..+++.-.-|...|   |-|+.|. |..++|-+++.+.|+||..|+.
T Consensus        98 ~L~~~~~~~------~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIGG------DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhcc------cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            886654211      2222    334445533444444   8898887 4444444555999999998873

>PLN02876 acyl-CoA dehydrogenase

Probab=98.03  E-value=6.1e-05  Score=88.00  Aligned_cols=79  Identities=15%  Similarity=0.267  Sum_probs=58.2

Q ss_pred             ccccCccCceEEEEEEcCCC---cEEEEEEecccC-hhhHHHHHHHHHHHHhcC-CCCe--eeEEEeEeeC---CeEEEE
Q 007239          297 SNKLGQGGFGTVYKGVLPNG---KEVAVKRLSRKS-WQGLEEFKNEIILIAKLQ-HRNL--VRLVGCGIEG---EEKLLI  366 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~ni--v~l~~~~~~~---~~~~lv  366 (611)
                      .+.|+.|.+..+|+....++   ..+++|+..... ......+.+|+.+++.+. |.++  .+++.++.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56789999999999886543   468888765432 223457889999999996 6664  7777776654   457899


Q ss_pred             EEecCCCCh
Q 007239          367 YELMPNRSL  375 (611)
Q Consensus       367 ~E~~~~~sL  375 (611)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998754

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.02  E-value=0.00012  Score=69.80  Aligned_cols=128  Identities=20%  Similarity=0.311  Sum_probs=90.5

Q ss_pred             ccccCccCceEEEEEEcCCCcEEEEEEecccC----------------hhhHHHHHHHHHHHHhcC------CCCeeeEE
Q 007239          297 SNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKS----------------WQGLEEFKNEIILIAKLQ------HRNLVRLV  354 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~il~~l~------h~niv~l~  354 (611)
                      ...||+|+.-.||.  +++.....||+.....                .....+..+|+.-...+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            45799999999987  5566678889887655                123456677777776666      78899999


Q ss_pred             EeEeeCCeEEEEEEecCC------CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec
Q 007239          355 GCGIEGEEKLLIYELMPN------RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD  428 (611)
Q Consensus       355 ~~~~~~~~~~lv~E~~~~------~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~  428 (611)
                      |+.+++...-+|+|.+.+      -+|.+++    ....++. .....+.++   ..||-+..   |+.+|++|.||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEEEE
Confidence            999999999999998753      3456665    2334555 444444444   44555553   99999999999995


Q ss_pred             CC--C--CEEEec
Q 007239          429 KD--M--VAKISD  437 (611)
Q Consensus       429 ~~--~--~~kl~D  437 (611)
                      ..  +  .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            32  2  577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.99  E-value=2.9e-05  Score=73.68  Aligned_cols=105  Identities=21%  Similarity=0.164  Sum_probs=83.0

Q ss_pred             HHHHHHHHhcCC-CCeeeEEEeEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCc
Q 007239          336 KNEIILIAKLQH-RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK  414 (611)
Q Consensus       336 ~~E~~il~~l~h-~niv~l~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~  414 (611)
                      .+|..+++.+++ +++.+++|.|-    .++|.||...+++...-..-..-...+|..+.+|+.++++.+.+|+......
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            468889999986 69999999984    3678999987766421000012234689999999999999999999864445


Q ss_pred             eEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          415 IIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       415 iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +...|++++|+-+++++++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999877543

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.94  E-value=8.2e-05  Score=73.48  Aligned_cols=73  Identities=15%  Similarity=0.270  Sum_probs=47.2

Q ss_pred             cccCccCce-EEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCC---CeeeEEEeEeeC---CeEEEEEEec
Q 007239          298 NKLGQGGFG-TVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHR---NLVRLVGCGIEG---EEKLLIYELM  370 (611)
Q Consensus       298 ~~lg~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~---niv~l~~~~~~~---~~~~lv~E~~  370 (611)
                      +.|+.|+.. .||+.    +..+++|..+...  ....+.+|.+++..+...   -+.++++.....   ...+++||++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            467877776 48875    3457788755422  345788999999888632   234444433322   2348899999


Q ss_pred             CCCChh
Q 007239          371 PNRSLD  376 (611)
Q Consensus       371 ~~~sL~  376 (611)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            997774

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.91  E-value=0.00012  Score=72.21  Aligned_cols=74  Identities=20%  Similarity=0.235  Sum_probs=49.8

Q ss_pred             cccCccCceEEEEEEcCC--CcEEEEEEecccChhhHHHHHHHHHHHHhcCCCC-eeeEEEeEeeCCeEEEEEEecCCCC
Q 007239          298 NKLGQGGFGTVYKGVLPN--GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN-LVRLVGCGIEGEEKLLIYELMPNRS  374 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~l~~~~~~~~~~~lv~E~~~~~s  374 (611)
                      +.|..|-...+|+....+  ++.|++|+....... .-...+|+.+++.+...+ ..+++....    -.++|||++|..
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~   78 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT   78 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence            567788889999988664  678999987643222 123357999999886433 344444332    248999999977


Q ss_pred             hh
Q 007239          375 LD  376 (611)
Q Consensus       375 L~  376 (611)
                      +.
T Consensus        79 l~   80 (235)
T cd05157          79 LE   80 (235)
T ss_pred             CC
Confidence            63

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.84  E-value=0.0003  Score=71.97  Aligned_cols=78  Identities=10%  Similarity=0.060  Sum_probs=57.4

Q ss_pred             CcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCC---CCeeeEEEeEee---CCeEEEEEE
Q 007239          295 SDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQH---RNLVRLVGCGIE---GEEKLLIYE  368 (611)
Q Consensus       295 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h---~niv~l~~~~~~---~~~~~lv~E  368 (611)
                      .-.+.||.|..+.||+....++ ++++|..+..  .....+.+|...|+.|..   -.+.++++++..   .+..++|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            3456799999999999876555 4777775431  123578899999998863   357788877654   356899999


Q ss_pred             ecCCCCh
Q 007239          369 LMPNRSL  375 (611)
Q Consensus       369 ~~~~~sL  375 (611)
                      ++++.++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.84  E-value=0.00017  Score=82.83  Aligned_cols=198  Identities=21%  Similarity=0.218  Sum_probs=135.6

Q ss_pred             HHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE----EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhh
Q 007239          334 EFKNEIILIAKLQHRNLVRLVGCGIEGEEKL----LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE  409 (611)
Q Consensus       334 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~----lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~  409 (611)
                      ...-|...+.++.|+|++.++.+..+....-    +..|++...++...+   .....++....+.+..++.+|+.|+|+
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHHHH
Confidence            3445777788889999999998876554333    345677777777666   445668899999999999999999998


Q ss_pred             cCCCceEecCCCCC---cEEecCCCCEEEe--ccccceecccCCCccccccccccCCCCCccccccCCCCch--hhHHHH
Q 007239          410 DSRLKIIHRDLKPS---NVLLDKDMVAKIS--DFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK--SDVFSF  482 (611)
Q Consensus       410 ~~~~~iiHrDikp~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k--~DvwSl  482 (611)
                      ..   ..|.-+..+   +--++..+.+.++  ||+..+.+.......   ...-+..+.+||......+..+  .|+|.+
T Consensus       305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCL  378 (1351)
T ss_pred             hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHH
Confidence            74   444444333   4445666777777  998887664433221   2344567888988877665554  799999


Q ss_pred             HHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 007239          483 GVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV  562 (611)
Q Consensus       483 Gvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  562 (611)
                      |.+...+..|..+.....                  ....+++....     .   ...+....|+..++++|++..+++
T Consensus       379 gll~~~~~~~~~i~~~~~------------------~~~~~l~~~~~-----~---~~~d~~~~~~~~~~~~Rl~~~~ll  432 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKSA------------------VPVSLLDVLST-----S---ELLDALPKCLDEDSEERLSALELL  432 (1351)
T ss_pred             HHHHhhhhhcCccccccc------------------chhhhhccccc-----h---hhhhhhhhhcchhhhhccchhhhh
Confidence            999999999876532110                  11111111110     0   344666789999999999999999


Q ss_pred             HHhc
Q 007239          563 ALLG  566 (611)
Q Consensus       563 ~~L~  566 (611)
                      ...-
T Consensus       433 ~~~f  436 (1351)
T KOG1035|consen  433 THPF  436 (1351)
T ss_pred             hchh
Confidence            8653

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.79  E-value=0.00015  Score=72.62  Aligned_cols=138  Identities=13%  Similarity=0.062  Sum_probs=78.9

Q ss_pred             ccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCe-eeEEEeEeeCCeEEEEEEecCCCChhh
Q 007239          299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNL-VRLVGCGIEGEEKLLIYELMPNRSLDC  377 (611)
Q Consensus       299 ~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~~sL~~  377 (611)
                      .+..|-.+.+|+... +++++++|..........-...+|..+++.+....+ .+++....    -++||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            356677888998874 567899997654322211135789999999874433 33443321    368999999977642


Q ss_pred             H----------h-------hhch-hhccCCHH-HHHHHHHHH---------HHHHHHHhhc-----CCCceEecCCCCCc
Q 007239          378 F----------I-------FDSE-RRLQLNWN-TCYNIIGGI---------SKGLLYLHED-----SRLKIIHRDLKPSN  424 (611)
Q Consensus       378 ~----------l-------~~~~-~~~~l~~~-~~~~i~~qi---------~~~l~yLH~~-----~~~~iiHrDikp~N  424 (611)
                      .          +       +... ....++.. .+..+..++         ...+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1          0       0000 01111111 111111111         1112222111     12358999999999


Q ss_pred             EEecCCCCEEEeccccce
Q 007239          425 VLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       425 Ill~~~~~~kl~DFGla~  442 (611)
                      |++++++ +.|+||+.+.
T Consensus       158 il~~~~~-~~lIDwE~a~  174 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYAS  174 (256)
T ss_pred             EEEeCCC-CEEEeccccC
Confidence            9999877 7899999885

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.76  E-value=0.00032  Score=66.47  Aligned_cols=125  Identities=25%  Similarity=0.351  Sum_probs=90.1

Q ss_pred             CCCCcccccCccCc-eEEEEEEcCCCcEEEEEEecc---cCh------------------hhHHHHHHHHHHHHhcC---
Q 007239          292 DGFSDSNKLGQGGF-GTVYKGVLPNGKEVAVKRLSR---KSW------------------QGLEEFKNEIILIAKLQ---  346 (611)
Q Consensus       292 ~~y~~~~~lg~G~f-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~il~~l~---  346 (611)
                      .+++.++.||.|.- |.||++.. +|+.+|+|+++.   ...                  ...+.|..|.....+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            68889999999999 99999998 577999999321   100                  11235778888777775   


Q ss_pred             CCCe--eeEEEeEeeC------------------CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHH
Q 007239          347 HRNL--VRLVGCGIEG------------------EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLY  406 (611)
Q Consensus       347 h~ni--v~l~~~~~~~------------------~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~y  406 (611)
                      +.++  ++++|+..-.                  ....||.||++...            .+..    +-+.+|.+-|.-
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence            4566  9999987322                  12357888776543            1222    235677788888


Q ss_pred             HhhcCCCceEecCCCCCcEEecCCCCEEEeccccc
Q 007239          407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA  441 (611)
Q Consensus       407 LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  441 (611)
                      +|..|   |+-+|+|+.|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99987   999999999987     4589999864

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.71  E-value=0.00027  Score=72.36  Aligned_cols=142  Identities=19%  Similarity=0.180  Sum_probs=85.7

Q ss_pred             ccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--eeeEEEe------EeeCCeEEEEEE
Q 007239          297 SNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN--LVRLVGC------GIEGEEKLLIYE  368 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~~------~~~~~~~~lv~E  368 (611)
                      .+.|..|....+|+....+ ..+++|+...   ...+.+..|+.++..+.+.+  +.+++..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4567788888999987644 4789998764   23456777888888886432  4444431      123456689999


Q ss_pred             ecCCCChhh----Hh----------hhchhh--------ccCCHHHHH----------HHHHHHHHHHHHHhh----cCC
Q 007239          369 LMPNRSLDC----FI----------FDSERR--------LQLNWNTCY----------NIIGGISKGLLYLHE----DSR  412 (611)
Q Consensus       369 ~~~~~sL~~----~l----------~~~~~~--------~~l~~~~~~----------~i~~qi~~~l~yLH~----~~~  412 (611)
                      |++|..+..    ..          +.....        ....|....          .....+...+.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999977532    10          000000        001111110          011122334444443    112


Q ss_pred             CceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          413 LKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       413 ~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      ..++|+|+.|.||++++++.+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            359999999999999998778999998875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.53  E-value=9.3e-05  Score=73.94  Aligned_cols=133  Identities=16%  Similarity=0.158  Sum_probs=92.7

Q ss_pred             CCcccccCccCceEEEEEEcCCCcEEEEEEecccC-----------------hhh-----HHHHHHHHHHHHhcC-CCC-
Q 007239          294 FSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKS-----------------WQG-----LEEFKNEIILIAKLQ-HRN-  349 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-----------------~~~-----~~~~~~E~~il~~l~-h~n-  349 (611)
                      +.+++.||-|.-+.||.+...+|++.++|.-+...                 ...     .-...+|...|+.|. |.. 
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            56789999999999999999999999999542110                 000     112356888888886 332 


Q ss_pred             eeeEEEeEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC
Q 007239          350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK  429 (611)
Q Consensus       350 iv~l~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~  429 (611)
                      +.+.+++    ...++|||++.+-.|...-.      ..+...   +...+..-+--|..+|   +||+|..-=||+|++
T Consensus       174 VPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  174 VPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCcccc----cceeeHHHhhcccceeeeee------cCChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEec
Confidence            3444443    56789999999987754421      122233   3334444455566776   999999999999999


Q ss_pred             CCCEEEeccccce
Q 007239          430 DMVAKISDFGMAR  442 (611)
Q Consensus       430 ~~~~kl~DFGla~  442 (611)
                      ++.++++||--..
T Consensus       238 d~~i~vIDFPQmv  250 (465)
T KOG2268|consen  238 DDKIVVIDFPQMV  250 (465)
T ss_pred             CCCEEEeechHhh
Confidence            9999999996443

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.51  E-value=0.00062  Score=69.93  Aligned_cols=74  Identities=30%  Similarity=0.439  Sum_probs=50.0

Q ss_pred             cccCccCceEEEEEEcCC-------CcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCe-eeEEEeEeeCCeEEEEEEe
Q 007239          298 NKLGQGGFGTVYKGVLPN-------GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNL-VRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lv~E~  369 (611)
                      +.|..|-...+|+....+       ++.+++|+..... .......+|.+++..+....+ .+++..+..    .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            456667778899988654       5789999976543 223456789999988864333 345555432    368999


Q ss_pred             cCCCChh
Q 007239          370 MPNRSLD  376 (611)
Q Consensus       370 ~~~~sL~  376 (611)
                      ++|..+.
T Consensus        79 i~G~~l~   85 (302)
T cd05156          79 IPSRTLT   85 (302)
T ss_pred             eCCCcCC
Confidence            9987764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.50  E-value=0.002  Score=66.70  Aligned_cols=141  Identities=19%  Similarity=0.241  Sum_probs=77.5

Q ss_pred             cccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--eeeEEE------eEeeCCeEEEEEEe
Q 007239          298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN--LVRLVG------CGIEGEEKLLIYEL  369 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~------~~~~~~~~~lv~E~  369 (611)
                      +.|+.|....+|+....+| .+++|+.....   .+.+..|..++..|...+  +.+.+.      +....+..++++||
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            4567777788999886555 68999876222   334455666666664222  233332      12234567899999


Q ss_pred             cCCCChhh-----------Hh---hhchhh--------ccC-CHHHHHH------------HHHH-HHHHHHHHhhc---
Q 007239          370 MPNRSLDC-----------FI---FDSERR--------LQL-NWNTCYN------------IIGG-ISKGLLYLHED---  410 (611)
Q Consensus       370 ~~~~sL~~-----------~l---~~~~~~--------~~l-~~~~~~~------------i~~q-i~~~l~yLH~~---  410 (611)
                      ++|..+..           .+   +.....        ..+ .|.....            .+.+ +...+..+...   
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            99975421           11   000000        001 1111111            1111 11122222211   


Q ss_pred             -CCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          411 -SRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       411 -~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                       -...++|+|++|.||+++.+...-|+||+.+.
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence             12359999999999999976656899999875

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.50  E-value=0.0012  Score=68.03  Aligned_cols=143  Identities=22%  Similarity=0.242  Sum_probs=82.4

Q ss_pred             ccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--eeeEEEe------EeeCCeEEEEEE
Q 007239          297 SNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN--LVRLVGC------GIEGEEKLLIYE  368 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~~------~~~~~~~~lv~E  368 (611)
                      .+.++.|....+|+....+| .+++|+.....  ..+.+..|.+++..|....  +.+++..      ....+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            45677777789999876444 68889875432  2345566778887775322  3344332      122456789999


Q ss_pred             ecCCCChhhH--------------hhhchhh------c---cCCHHHHH------------HHHHHHHHHHHHHhh----
Q 007239          369 LMPNRSLDCF--------------IFDSERR------L---QLNWNTCY------------NIIGGISKGLLYLHE----  409 (611)
Q Consensus       369 ~~~~~sL~~~--------------l~~~~~~------~---~l~~~~~~------------~i~~qi~~~l~yLH~----  409 (611)
                      |++|..+...              ++.....      .   .-.|....            .....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9998654210              0110000      0   01111100            001122334555532    


Q ss_pred             cCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       410 ~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .-...++|+|+++.||++++++.+.|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            112459999999999999998877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.48  E-value=0.0018  Score=68.55  Aligned_cols=75  Identities=17%  Similarity=0.194  Sum_probs=55.1

Q ss_pred             cccCccCceEEEEEEcCCC-cEEEEEEeccc------C-hhhHHHHHHHHHHHHhcC---CCCeeeEEEeEeeCCeEEEE
Q 007239          298 NKLGQGGFGTVYKGVLPNG-KEVAVKRLSRK------S-WQGLEEFKNEIILIAKLQ---HRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~lv  366 (611)
                      +.||.|.+..||++...+| +.++||.-.+.      . ....++...|.+.|+.+.   ...+.+++.+  +.+..++|
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV  109 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV  109 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence            5799999999999998776 58999985421      1 224567788888888864   2456777766  44567899


Q ss_pred             EEecCCCC
Q 007239          367 YELMPNRS  374 (611)
Q Consensus       367 ~E~~~~~s  374 (611)
                      |||+++..
T Consensus       110 ME~L~~~~  117 (401)
T PRK09550        110 MEDLSDHK  117 (401)
T ss_pred             EecCCCcc
Confidence            99998643

>PF11883 DUF3403: Domain of unknown function (DUF3403); InterPro: IPR021820 This functionally uncharacterised domain of around 50 amino acids is found in the C terminus of eukaryotic S-locus receptor kinase proteins

Probab=97.43  E-value=0.0001  Score=52.38  Aligned_cols=43  Identities=33%  Similarity=0.565  Sum_probs=33.7

Q ss_pred             CCCCCCCCCCCCCcccccccccCCCCC----CCCCccCCcccccccCC
Q 007239          568 ESIALSEPRQPPFPVGRTIVLAEQPST----KDPSVCHDLTVSTLSPR  611 (611)
Q Consensus       568 ~~~~l~~~~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~~r  611 (611)
                      ....||.|++|+|+..+......+++.    ...|. |++|+|.+++|
T Consensus         2 e~~~LP~PKqPgF~~~r~~~e~~sSss~~~~~~~Sv-NevTiT~l~~R   48 (48)
T PF11883_consen    2 ETATLPQPKQPGFFTGRSPSETDSSSSKQRDESCSV-NEVTITMLEAR   48 (48)
T ss_pred             CcccCCCCCCCCEEeEcCCCCcCCCcccccCCCCCe-eeEEEEeEecC
Confidence            457899999999999887643333332    46899 99999999998

; GO: 0004674 protein serine/threonine kinase activity

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.25  E-value=0.0033  Score=64.21  Aligned_cols=138  Identities=16%  Similarity=0.231  Sum_probs=81.3

Q ss_pred             ccccCccCceEEEEEEcCCCcEEEEEEec-ccChhhHHHHHHHHHHHHhcCC--CCeeeEEEeEeeCC--eEEEEEEecC
Q 007239          297 SNKLGQGGFGTVYKGVLPNGKEVAVKRLS-RKSWQGLEEFKNEIILIAKLQH--RNLVRLVGCGIEGE--EKLLIYELMP  371 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~il~~l~h--~niv~l~~~~~~~~--~~~lv~E~~~  371 (611)
                      .+.+..|..-.+|..... ++++++.+-. ...........+|..+++.+.-  --+.+.++.+.++.  ..+.||+|++
T Consensus        30 v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve  108 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE  108 (321)
T ss_pred             eeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence            344434444445555543 7888888221 1233345566788888887753  23344556665555  6799999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHH-HHHHHHH---------------------------------------------
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIG-GISKGLL---------------------------------------------  405 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~-qi~~~l~---------------------------------------------  405 (611)
                      |..+...+....    ..    .+++. .+++.|.                                             
T Consensus       109 Ge~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~  180 (321)
T COG3173         109 GEVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA  180 (321)
T ss_pred             ceeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence            853322211000    00    01111 3333333                                             


Q ss_pred             -----HHhhc-----CCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          406 -----YLHED-----SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       406 -----yLH~~-----~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                           +|+.+     +...++|+|+++.||+++.++.+-+.||+++..
T Consensus       181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                 33322     234699999999999999998899999999874

>PLN02236 choline kinase

Probab=97.24  E-value=0.0025  Score=66.66  Aligned_cols=141  Identities=20%  Similarity=0.260  Sum_probs=83.6

Q ss_pred             cccCccCceEEEEEEcCC-----CcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCee-eEEEeEeeCCeEEEEEEecC
Q 007239          298 NKLGQGGFGTVYKGVLPN-----GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLV-RLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv-~l~~~~~~~~~~~lv~E~~~  371 (611)
                      +.|-.|-...+|+..+.+     ++.|++|+........+++ .+|..+++.+..-++. ++++.+...    .|+||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence            355567788899987532     3679999886654333333 7799999988754443 455655332    5899998


Q ss_pred             CCChhhHh-----------------hhch---hhccCCHHHHHHHHHHH-----------------HHHHHHH----hh-
Q 007239          372 NRSLDCFI-----------------FDSE---RRLQLNWNTCYNIIGGI-----------------SKGLLYL----HE-  409 (611)
Q Consensus       372 ~~sL~~~l-----------------~~~~---~~~~l~~~~~~~i~~qi-----------------~~~l~yL----H~-  409 (611)
                      +.++...-                 +...   ......+.++.++..++                 ..-+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            87764210                 0000   00011123333333221                 1111122    21 


Q ss_pred             cCCCceEecCCCCCcEEecC-CCCEEEecccccee
Q 007239          410 DSRLKIIHRDLKPSNVLLDK-DMVAKISDFGMARI  443 (611)
Q Consensus       410 ~~~~~iiHrDikp~NIll~~-~~~~kl~DFGla~~  443 (611)
                      .....++|+|+++.|||+++ ++.+.++||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            22346899999999999986 46899999988863

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.12  E-value=0.0027  Score=64.86  Aligned_cols=140  Identities=16%  Similarity=0.168  Sum_probs=96.8

Q ss_pred             cccccCccCceEEEEEEcCCCcEEEEEEecccC-----hh----h-----------------HHHHHHHHHHHHhcCCCC
Q 007239          296 DSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKS-----WQ----G-----------------LEEFKNEIILIAKLQHRN  349 (611)
Q Consensus       296 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~-----~~----~-----------------~~~~~~E~~il~~l~h~n  349 (611)
                      +...|..|.-+.||.+...+|..+|||+++..-     .+    +                 .-....|+..|++|+...
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            345788999999999998899999999875210     00    0                 011245777888886544


Q ss_pred             eeeEEEeEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC
Q 007239          350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK  429 (611)
Q Consensus       350 iv~l~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~  429 (611)
                      |.-.--+..  ...+|||+|+.....   -....+...++...+..+-.|++.-|.-|-+..  ++||.||.--|+|+. 
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh-  299 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH-  299 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE-
Confidence            321111111  234799999864322   212223445777788888999999999998876  799999999999985 


Q ss_pred             CCCEEEecccccee
Q 007239          430 DMVAKISDFGMARI  443 (611)
Q Consensus       430 ~~~~kl~DFGla~~  443 (611)
                      +|.+.|+|.+-+..
T Consensus       300 dG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  300 DGKLYIIDVSQSVE  313 (520)
T ss_pred             CCEEEEEEcccccc
Confidence            57899999887654

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.08  E-value=0.006  Score=61.72  Aligned_cols=70  Identities=14%  Similarity=0.018  Sum_probs=40.8

Q ss_pred             cCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCC--CC-eeeEEEeEeeCCeEEEEEEecCCCCh
Q 007239          300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQH--RN-LVRLVGCGIEGEEKLLIYELMPNRSL  375 (611)
Q Consensus       300 lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h--~n-iv~l~~~~~~~~~~~lv~E~~~~~sL  375 (611)
                      .++|-...|+.....+|+.+++|.-+..  .....+.+|.++|+.+..  +- +.+++.  .  ..-.++|++++|..+
T Consensus        19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~~--~~~~~l~rE~~vL~~L~~~l~vpvP~~~~--~--~~~~~~y~~i~G~p~   91 (276)
T cd05152          19 NESGLDFQVVFAKDTDGVPWVLRIPRRP--DVSERAAAEKRVLALVRKHLPVQVPDWRV--H--TPELIAYPKLPGVPA   91 (276)
T ss_pred             cCCcceeEEEEEEcCCCCeEEEEecCCH--HHHHHHHHHHHHHHHHHhcCCCCCCceee--e--cCceEEEeccCCCcc
Confidence            3444445566655556889999987532  234567899999999863  21 122211  1  122456777766543

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.91  E-value=0.0097  Score=60.35  Aligned_cols=74  Identities=18%  Similarity=0.269  Sum_probs=48.8

Q ss_pred             cccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcC---CCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          296 DSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ---HRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       296 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      -.+.|+.|....+|+.. .+++.+.+|.-..   .....|..|.+-|+.|.   --.+.+++.+....+..+|||||++.
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            34678889999999977 5778899998762   22356788998888884   34577888888877788999999987


Q ss_pred             C
Q 007239          373 R  373 (611)
Q Consensus       373 ~  373 (611)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            6

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.85  E-value=0.001  Score=78.39  Aligned_cols=160  Identities=12%  Similarity=-0.044  Sum_probs=117.5

Q ss_pred             HHHHHHHHHhcCCCCeeeEEEeEee--CCeEEEEEEecCCCChhhHhhhc-hhhccCCHHHHHHHHHHHHHHHHHHhhcC
Q 007239          335 FKNEIILIAKLQHRNLVRLVGCGIE--GEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDS  411 (611)
Q Consensus       335 ~~~E~~il~~l~h~niv~l~~~~~~--~~~~~lv~E~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~  411 (611)
                      ...|...++...|+++.....-...  ..+.+..++|+.+|.+...|.+. ++...++..-+.....+......-+|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            3445556666789988876655443  34568899999999998888654 33344555545544444455555555442


Q ss_pred             --CCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHH
Q 007239          412 --RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEI  489 (611)
Q Consensus       412 --~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~el  489 (611)
                        ..-.+|+++|+-|.+|..+.++|+.++|+.++.  .......+...+++.|+.|+....-.++.++|+|..|+.+|++
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk--np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK--NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCccccccccccccc--CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence              234689999999999999999999999999842  2222334456788899999999999999999999999999999


Q ss_pred             HhCCCCC
Q 007239          490 ISGKRNS  496 (611)
Q Consensus       490 ltG~~p~  496 (611)
                      --|..++
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            8888764

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.76  E-value=0.0067  Score=63.68  Aligned_cols=74  Identities=11%  Similarity=0.100  Sum_probs=51.2

Q ss_pred             ccccCccCceEEEEEEcCC-CcEEEEEEecc------cChhhHHHHHHHHHHHHhcC--CC-CeeeEEEeEeeCCeEEEE
Q 007239          297 SNKLGQGGFGTVYKGVLPN-GKEVAVKRLSR------KSWQGLEEFKNEIILIAKLQ--HR-NLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~------~~~~~~~~~~~E~~il~~l~--h~-niv~l~~~~~~~~~~~lv  366 (611)
                      .+.||-|.-.-||++...+ ++.|+||.-.+      .-.-..++..-|.+.|+...  .| .+.+++.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            4578999999999999743 56799996431      11234567777888888764  34 45556554  55666788


Q ss_pred             EEecCC
Q 007239          367 YELMPN  372 (611)
Q Consensus       367 ~E~~~~  372 (611)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998854

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.73  E-value=0.017  Score=59.89  Aligned_cols=72  Identities=17%  Similarity=0.188  Sum_probs=49.2

Q ss_pred             ccCccCceEEEEEEcCCC-cEEEEEEeccc------C-hhhHHHHHHHHHHHHhcC--CC-CeeeEEEeEeeCCeEEEEE
Q 007239          299 KLGQGGFGTVYKGVLPNG-KEVAVKRLSRK------S-WQGLEEFKNEIILIAKLQ--HR-NLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       299 ~lg~G~fg~Vy~~~~~~~-~~vavK~~~~~------~-~~~~~~~~~E~~il~~l~--h~-niv~l~~~~~~~~~~~lv~  367 (611)
                      .||-|....||++..++| +.|+||.-.+.      + .-..++..-|...|+...  -| .+.+++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            589999999999997654 58999964321      1 233556667888887664  34 45555544  556667999


Q ss_pred             EecCC
Q 007239          368 ELMPN  372 (611)
Q Consensus       368 E~~~~  372 (611)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99864

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.51  E-value=0.019  Score=59.68  Aligned_cols=141  Identities=16%  Similarity=0.214  Sum_probs=80.3

Q ss_pred             cccCccCceEEEEEEcCC----CcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCe-eeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVLPN----GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNL-VRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      +.|..|-...+|+....+    +..|++|+........+ ...+|..+++.+..-++ .++++++. .+   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            345557778889887432    34799998765433222 23679999999975555 34555553 22   58999988


Q ss_pred             CChhhH-------h----------hhch-h--hccCCHHHHHHHHHHH----------------------HHHHHH---H
Q 007239          373 RSLDCF-------I----------FDSE-R--RLQLNWNTCYNIIGGI----------------------SKGLLY---L  407 (611)
Q Consensus       373 ~sL~~~-------l----------~~~~-~--~~~l~~~~~~~i~~qi----------------------~~~l~y---L  407 (611)
                      ..|..-       +          +... .  ...--+..+.++..++                      .+-+..   +
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            766321       1          0000 0  0011122222222221                      111111   1


Q ss_pred             h-hc-CCCceEecCCCCCcEEecC-CCCEEEecccccee
Q 007239          408 H-ED-SRLKIIHRDLKPSNVLLDK-DMVAKISDFGMARI  443 (611)
Q Consensus       408 H-~~-~~~~iiHrDikp~NIll~~-~~~~kl~DFGla~~  443 (611)
                      . .. ...-+.|.|+.+.|||+++ ++.++++||..|..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1 11 1234789999999999975 57899999998853

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.50  E-value=0.0081  Score=58.13  Aligned_cols=123  Identities=20%  Similarity=0.243  Sum_probs=61.1

Q ss_pred             CcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCe-eeEEEeEeeCCeEEEEEEecCCCChhhH-------h--------
Q 007239          316 GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNL-VRLVGCGIEGEEKLLIYELMPNRSLDCF-------I--------  379 (611)
Q Consensus       316 ~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~~sL~~~-------l--------  379 (611)
                      +++|++++..... ...-...+|..+++.+..-++ .++++.+.+    ..|+||+++..|..-       +        
T Consensus         2 ~~~~~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence            4678888887653 334456789999998875444 456665433    257799987765321       1        


Q ss_pred             --hhchh----hccCCHHHHHHH----------------------HHHHHHHHHHHhh----c-CCCceEecCCCCCcEE
Q 007239          380 --FDSER----RLQLNWNTCYNI----------------------IGGISKGLLYLHE----D-SRLKIIHRDLKPSNVL  426 (611)
Q Consensus       380 --~~~~~----~~~l~~~~~~~i----------------------~~qi~~~l~yLH~----~-~~~~iiHrDikp~NIl  426 (611)
                        +....    ...--+.....+                      +..+..-+..+.+    . ...-+.|.|+.+.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence              00000    000011222222                      0111112222211    1 1134789999999999


Q ss_pred             e-cCCCCEEEecccccee
Q 007239          427 L-DKDMVAKISDFGMARI  443 (611)
Q Consensus       427 l-~~~~~~kl~DFGla~~  443 (611)
                      + +.++.++++||..+..
T Consensus       157 ~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             ETSSSSCEEE--GTT-EE
T ss_pred             eccCCCeEEEecHHHHhh
Confidence            9 8899999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.42  E-value=0.044  Score=57.96  Aligned_cols=73  Identities=12%  Similarity=0.062  Sum_probs=50.3

Q ss_pred             ccccCccCceEEEEEEcCCCcEEEEEEeccc----Ch---hhHHHHHHHHHHHHhcC---CCCeeeEEEeEeeCCeEEEE
Q 007239          297 SNKLGQGGFGTVYKGVLPNGKEVAVKRLSRK----SW---QGLEEFKNEIILIAKLQ---HRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~----~~---~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~lv  366 (611)
                      .+.||.|....||+...+ ++.++||.-...    ..   -..++-..|...|+.+.   ...+.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            467899999999998864 557999976521    11   13444555677776654   246778887765  456788


Q ss_pred             EEecCC
Q 007239          367 YELMPN  372 (611)
Q Consensus       367 ~E~~~~  372 (611)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.11  E-value=0.061  Score=55.29  Aligned_cols=64  Identities=16%  Similarity=0.189  Sum_probs=39.9

Q ss_pred             EEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCC--CeeeEEEe------EeeCCeEEEEEEecCCCCh
Q 007239          307 TVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHR--NLVRLVGC------GIEGEEKLLIYELMPNRSL  375 (611)
Q Consensus       307 ~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~--niv~l~~~------~~~~~~~~lv~E~~~~~sL  375 (611)
                      .||+...++| .+++|+....    ...+..|..++..|...  .+.+++..      ...++..++++||++|..+
T Consensus        11 ~v~~v~t~~g-~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~   82 (313)
T TIGR02906        11 NVYKVETDSG-NKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC   82 (313)
T ss_pred             cEEEEEeCCC-CeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence            4888876444 6899987532    23455677777776533  23333322      2235678999999998665

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.07  E-value=0.03  Score=53.51  Aligned_cols=153  Identities=18%  Similarity=0.168  Sum_probs=93.0

Q ss_pred             cCceEEEEEEcCCCcEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCChhhHhhh
Q 007239          303 GGFGTVYKGVLPNGKEVAVKRLSRKSWQ-GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFD  381 (611)
Q Consensus       303 G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~sL~~~l~~  381 (611)
                      ++.++.-++..+- .+..+|++..-... ....|.++..+++++.  .|+++..-  +....-++.|+|.....      
T Consensus        73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            3445554444322 34667776654443 4556788999988875  56666632  34456688888744221      


Q ss_pred             chhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccccccccccCC
Q 007239          382 SERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG  461 (611)
Q Consensus       382 ~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  461 (611)
                            ..    ..++.-=+..|.-.|+. ....+|+|-.|+|||-|..|.+||.|-+..-.              .+..
T Consensus       142 ------~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~  196 (308)
T PF07387_consen  142 ------NF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVN  196 (308)
T ss_pred             ------ch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--------------heee
Confidence                  01    11111114678888954 24799999999999999999999999764421              0111


Q ss_pred             CCCccccccCCCCchhhHHHHHHHHHHHHhCCC
Q 007239          462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKR  494 (611)
Q Consensus       462 y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~  494 (611)
                      |.--|   ....+.++.+=+|=.-++++....+
T Consensus       197 ~vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~~  226 (308)
T PF07387_consen  197 MVNIE---YESLTQEAEVKVFVKSCLKLVEKQR  226 (308)
T ss_pred             EEeee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence            22211   2335667788777777777776543

The function of this family is unknown.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.90  E-value=0.12  Score=53.10  Aligned_cols=31  Identities=26%  Similarity=0.325  Sum_probs=27.9

Q ss_pred             CCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       412 ~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      +..++|+|+.++|||+++++.+.++||..+.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            3469999999999999999999999998875

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.31  E-value=0.26  Score=47.57  Aligned_cols=75  Identities=19%  Similarity=0.285  Sum_probs=52.4

Q ss_pred             cccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcC---CCCeeeEEEeEeeCCeEEEEEEecCCCC
Q 007239          298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ---HRNLVRLVGCGIEGEEKLLIYELMPNRS  374 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~lv~E~~~~~s  374 (611)
                      +.+.-|---+.|.... ...++.+|+-..   +....|..|+.-|..|.   .-.+.+++.+.....+.|+|+||++-+.
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~   97 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP   97 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence            3455555555555443 456788887533   23456778887777775   3457888888889999999999999877


Q ss_pred             hh
Q 007239          375 LD  376 (611)
Q Consensus       375 L~  376 (611)
                      ++
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            65

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.18  E-value=0.32  Score=50.42  Aligned_cols=72  Identities=14%  Similarity=0.087  Sum_probs=45.9

Q ss_pred             cCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--eeeEE---E--eEeeCCeEEEEEEecCCCCh
Q 007239          303 GGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN--LVRLV---G--CGIEGEEKLLIYELMPNRSL  375 (611)
Q Consensus       303 G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~---~--~~~~~~~~~lv~E~~~~~sL  375 (611)
                      +.-..||+....+++.+++|+.+... ....++..|...+..|....  ++...   +  ....++..+.++++++|...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            34567899888778889999876432 23456777888887775221  12211   1  12234567889999988653

>PRK06148 hypothetical protein; Provisional

Probab=95.11  E-value=0.28  Score=58.81  Aligned_cols=142  Identities=17%  Similarity=0.198  Sum_probs=78.8

Q ss_pred             cccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcC-------CCCeeeEEE-----eEee-CC--e
Q 007239          298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-------HRNLVRLVG-----CGIE-GE--E  362 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-------h~niv~l~~-----~~~~-~~--~  362 (611)
                      +.|+ |..-.+|+....+|+.+++|+.+...  ....+..|.+.|..|.       -|.+++..+     .... ++  .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            4454 34577888887788899999987643  2234445566666553       223333211     1111 12  4


Q ss_pred             EEEEEEecCCCChhhHh-----------------hh------c-hhhccCCHHH-----------------HHHHHHHHH
Q 007239          363 KLLIYELMPNRSLDCFI-----------------FD------S-ERRLQLNWNT-----------------CYNIIGGIS  401 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l-----------------~~------~-~~~~~l~~~~-----------------~~~i~~qi~  401 (611)
                      .+.+++|++|..+.+..                 +.      . .....+.|..                 .+.++.+++
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            57789999998775510                 00      0 0001122221                 122233333


Q ss_pred             HHHH-----HHhhcCCCceEecCCCCCcEEecCCC--CEE-Eecccccee
Q 007239          402 KGLL-----YLHEDSRLKIIHRDLKPSNVLLDKDM--VAK-ISDFGMARI  443 (611)
Q Consensus       402 ~~l~-----yLH~~~~~~iiHrDikp~NIll~~~~--~~k-l~DFGla~~  443 (611)
                      +...     .|.+ -+..+||+|+.+.|||++.++  ++. |+|||-+..
T Consensus       188 ~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        188 ARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            3222     1211 133599999999999999875  555 999998753

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.11  E-value=0.24  Score=51.28  Aligned_cols=139  Identities=23%  Similarity=0.282  Sum_probs=81.6

Q ss_pred             cCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCe---ee---EE----EeEeeCCeEEEEEEe
Q 007239          300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNL---VR---LV----GCGIEGEEKLLIYEL  369 (611)
Q Consensus       300 lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni---v~---l~----~~~~~~~~~~lv~E~  369 (611)
                      |.+ .-..+|+....+|+. ++|+.+..  ....++.-|...+..|.-..|   ++   +-    .........+-+++|
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~  109 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY  109 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence            444 456688888766665 89988765  345667778888888752221   11   11    111122367889999


Q ss_pred             cCCCChhh-Hh--------------hh---------chhhccCCHHH-------------HHHHHHHHHHHHHHHhhc--
Q 007239          370 MPNRSLDC-FI--------------FD---------SERRLQLNWNT-------------CYNIIGGISKGLLYLHED--  410 (611)
Q Consensus       370 ~~~~sL~~-~l--------------~~---------~~~~~~l~~~~-------------~~~i~~qi~~~l~yLH~~--  410 (611)
                      ++|..+.. .-              +.         ........|..             ......++...+..+.+.  
T Consensus       110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~  189 (331)
T COG2334         110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP  189 (331)
T ss_pred             cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence            99988872 10              00         00011223330             111223344444444431  


Q ss_pred             -----CCCceEecCCCCCcEEecCCCC-EEEeccccce
Q 007239          411 -----SRLKIIHRDLKPSNVLLDKDMV-AKISDFGMAR  442 (611)
Q Consensus       411 -----~~~~iiHrDikp~NIll~~~~~-~kl~DFGla~  442 (611)
                           ++..+||+|+.|.||+++.+.. +.++||+-+.
T Consensus       190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                 1122999999999999998875 8999999775

>PTZ00384 choline kinase; Provisional

Probab=95.04  E-value=0.18  Score=53.36  Aligned_cols=74  Identities=19%  Similarity=0.272  Sum_probs=46.0

Q ss_pred             cccCccCceEEEEEEcCCC--cE-----EEEEEecccChhhHHHHHHHHHHHHhcCCCCe-eeEEEeEeeCCeEEEEEEe
Q 007239          298 NKLGQGGFGTVYKGVLPNG--KE-----VAVKRLSRKSWQGLEEFKNEIILIAKLQHRNL-VRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lv~E~  369 (611)
                      +.|..|-...+|++...++  ..     |.++.........+ .-.+|+.+++.+...++ .++++.+..    ++|+||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence            4566688889999875432  22     33333222211122 23678999999986555 456666542    699999


Q ss_pred             cCCCChh
Q 007239          370 MPNRSLD  376 (611)
Q Consensus       370 ~~~~sL~  376 (611)
                      ++|..|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9998774

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	611
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-50
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-49
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-37
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-37
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-36
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-35
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-35
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-34
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-22
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-22
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-22
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-22
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-22
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-22
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-22
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-22
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-22
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-22
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-22
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-22
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-22
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-22
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-22
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		8e-22
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-21
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-21
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-21
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-21
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-21
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-21
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-21
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-21
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-21
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-21
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-21
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-21
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-21
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		6e-21
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-21
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		8e-21
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		9e-21
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		9e-21
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-20
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-20
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-20
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-20
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-20
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-20
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-20
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-20
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-20
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-20
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-20
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-20
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-20
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-20
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-20
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-20
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-20
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-20
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-20
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-20
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-20
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		8e-20
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-19
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-19
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-19
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-19
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-19
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-19
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-19
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-19
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-19
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-19
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-19
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-19
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-19
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-19
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-19
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-19
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-19
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-19
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		9e-19
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		9e-19
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-19
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		9e-19
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-19
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-19
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-19
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-18
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-18
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-18
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-18
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-18
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-18
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-18
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-18
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-18
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		7e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		7e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		7e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		8e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		8e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-18
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		9e-18
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-17
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		2e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-17
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-17
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-17
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-17
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-17
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-17
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-17
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-17
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-17
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-17
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-17
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-17
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-17
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-17
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		5e-17
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-17
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-17
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-17
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-17
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		5e-17
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-17
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-17
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-17
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-17
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-17
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-17
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		6e-17
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-17
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-17
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-17
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-17
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		9e-17
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		9e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-16
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-16
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-16
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-16
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-16
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-16
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-16
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-16
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-16
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-16
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		4e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-16
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-16
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-16
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-16
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		7e-16
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-16
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		8e-16
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		9e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-15
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-15
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-15
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-15
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		7e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		9e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		9e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		9e-15
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		9e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-14
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-14
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-14
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-14
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-14
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-14
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-14
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-14
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-14
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-14
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-14
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-14
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-14
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-14
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-14
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-14
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-14
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-14
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-14
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-13
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-13
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-13
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-13
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-13
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-13
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		6e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-13
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		8e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		9e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-12
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-12
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-12
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-12
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-12
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-12
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-12
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-12
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-12
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-12
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-12
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-12
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-12
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-12
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-12
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-12
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		5e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-12
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		6e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		6e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		6e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		7e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		7e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		7e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-12
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		7e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-12
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		7e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		8e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		8e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		8e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		8e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		8e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-12
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		8e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		9e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		9e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		9e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-12
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-12
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		9e-12
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-11
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-11
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-11
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-11
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-11
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-11
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-11
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-11
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-11
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-11
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-11
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-11
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-11
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-11
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-11
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-11
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		5e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-11
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-11
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		6e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-11
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-11
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-11
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		6e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		6e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		6e-11
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-11
3soa_A	444	Full-Length Human Camkii Length = 444		6e-11
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-11
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		6e-11
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		7e-11
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		7e-11
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-11
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		7e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-11
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-11
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-11
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		9e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		9e-11
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-10
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-10
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-10
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-10
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-10
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		7e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		8e-10
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		9e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-09
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-09
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-09
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-09
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-09
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-09
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		4e-09
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-09
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		5e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-09
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		8e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-09
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		3e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-08
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		5e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		6e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		6e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		6e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		6e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		6e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		6e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		6e-08
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		7e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		7e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		8e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		9e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		9e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		9e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-07
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		8e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		8e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		4e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-06

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  197 bits (502), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 128/313 (40%), Positives = 178/313 (56%), Gaps = 19/313 (6%)
Query: 274 VSSEELPFVHLAVIK--------AATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLS 325
           V +EE P VHL  +K         A+D FS+ N LG+GGFG VYKG L +G  VAVKRL 
Sbjct: 12  VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLK 71
Query: 326 RKSWQGLE-EFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSL-DCFIFDSE 383
            +  QG E +F+ E+ +I+   HRNL+RL G  +   E+LL+Y  M N S+  C     E
Sbjct: 72  EERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 131
Query: 384 RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI 443
            +  L+W     I  G ++GL YLH+    KIIHRD+K +N+LLD++  A + DFG+A++
Sbjct: 132 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 191
Query: 444 FCENQKTANTRRVV-GTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG 502
              + K  +    V GT G++APEY   G  S K+DVF +GV++LE+I+G+R   F L  
Sbjct: 192 M--DYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR--AFDLAR 247
Query: 503 HAQT----LLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTM 558
            A      LL +V  L KE K    VD  L  +    +V + I + LLC Q  P  RP M
Sbjct: 248 LANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM 307
Query: 559 SNVVALLGSESIA 571
           S VV +L  + +A
Sbjct: 308 SEVVRMLEGDGLA 320

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  193 bits (490), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 126/313 (40%), Positives = 176/313 (56%), Gaps = 19/313 (6%)
Query: 274 VSSEELPFVHLAVIK--------AATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLS 325
           V +EE P VHL  +K         A+D F + N LG+GGFG VYKG L +G  VAVKRL 
Sbjct: 4   VPAEEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLK 63
Query: 326 RKSWQGLE-EFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSL-DCFIFDSE 383
            +  QG E +F+ E+ +I+   HRNL+RL G  +   E+LL+Y  M N S+  C     E
Sbjct: 64  EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 123
Query: 384 RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI 443
            +  L+W     I  G ++GL YLH+    KIIHRD+K +N+LLD++  A + DFG+A++
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 444 FCENQKTANTRRVV-GTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG 502
              + K  +    V G  G++APEY   G  S K+DVF +GV++LE+I+G+R   F L  
Sbjct: 184 M--DYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR--AFDLAR 239
Query: 503 HAQ----TLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTM 558
            A      LL +V  L KE K    VD  L  +    +V + I + LLC Q  P  RP M
Sbjct: 240 LANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM 299
Query: 559 SNVVALLGSESIA 571
           S VV +L  + +A
Sbjct: 300 SEVVRMLEGDGLA 312

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  152 bits (383), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 90/216 (41%), Positives = 132/216 (61%), Gaps = 15/216 (6%)
Query: 287 IKAATDGFSD------SNKLGQGGFGTVYKGVLPNGKEVAVKRLSR----KSWQGLEEFK 336
           +K  T+ F +       NK+G+GGFG VYKG + N   VAVK+L+      + +  ++F 
Sbjct: 20  LKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFD 78
Query: 337 NEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNI 396
            EI ++AK QH NLV L+G   +G++  L+Y  MPN SL   +   +    L+W+    I
Sbjct: 79  QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKI 138
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
             G + G+ +LHE+     IHRD+K +N+LLD+   AKISDFG+AR   +  +T    R+
Sbjct: 139 AQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRI 195
Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           VGT  YMAPE A+ G  + KSD++SFGV++LEII+G
Sbjct: 196 VGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  152 bits (383), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 90/216 (41%), Positives = 132/216 (61%), Gaps = 15/216 (6%)
Query: 287 IKAATDGFSD------SNKLGQGGFGTVYKGVLPNGKEVAVKRLSR----KSWQGLEEFK 336
           +K  T+ F +       NK+G+GGFG VYKG + N   VAVK+L+      + +  ++F 
Sbjct: 20  LKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFD 78
Query: 337 NEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNI 396
            EI ++AK QH NLV L+G   +G++  L+Y  MPN SL   +   +    L+W+    I
Sbjct: 79  QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKI 138
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
             G + G+ +LHE+     IHRD+K +N+LLD+   AKISDFG+AR   +  +T    R+
Sbjct: 139 AQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRI 195
Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           VGT  YMAPE A+ G  + KSD++SFGV++LEII+G
Sbjct: 196 VGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  149 bits (377), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 89/216 (41%), Positives = 131/216 (60%), Gaps = 15/216 (6%)
Query: 287 IKAATDGFSD------SNKLGQGGFGTVYKGVLPNGKEVAVKRLSR----KSWQGLEEFK 336
           +K  T+ F +       NK+G+GGFG VYKG + N   VAVK+L+      + +  ++F 
Sbjct: 14  LKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFD 72
Query: 337 NEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNI 396
            EI ++AK QH NLV L+G   +G++  L+Y  MPN SL   +   +    L+W+    I
Sbjct: 73  QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKI 132
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
             G + G+ +LHE+     IHRD+K +N+LLD+   AKISDFG+AR   +  +     R+
Sbjct: 133 AQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRI 189
Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           VGT  YMAPE A+ G  + KSD++SFGV++LEII+G
Sbjct: 190 VGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG 224

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 103/295 (34%), Positives = 162/295 (54%), Gaps = 8/295 (2%)
Query: 273 LVSSEELPF----VHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKS 328
           L SS  +PF    V L  ++ AT+ F     +G G FG VYKGVL +G +VA+KR + +S
Sbjct: 16  LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES 75
Query: 329 WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSE-RRLQ 387
            QG+EEF+ EI  ++  +H +LV L+G   E  E +LIY+ M N +L   ++ S+   + 
Sbjct: 76  SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135
Query: 388 LNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN 447
           ++W     I  G ++GL YLH  +   IIHRD+K  N+LLD++ V KI+DFG+++   E 
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTL 507
            +T     V GT GY+ PEY ++G  + KSDV+SFGV++ E++  +      L      L
Sbjct: 193 DQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 508 LAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
             +  +    G+  + VDP L        + +     + C+      RP+M +V+
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  146 bits (368), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 103/295 (34%), Positives = 162/295 (54%), Gaps = 8/295 (2%)
Query: 273 LVSSEELPF----VHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKS 328
           L SS  +PF    V L  ++ AT+ F     +G G FG VYKGVL +G +VA+KR + +S
Sbjct: 16  LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES 75
Query: 329 WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSE-RRLQ 387
            QG+EEF+ EI  ++  +H +LV L+G   E  E +LIY+ M N +L   ++ S+   + 
Sbjct: 76  SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135
Query: 388 LNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN 447
           ++W     I  G ++GL YLH  +   IIHRD+K  N+LLD++ V KI+DFG+++   E 
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTL 507
            +T     V GT GY+ PEY ++G  + KSDV+SFGV++ E++  +      L      L
Sbjct: 193 GQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 508 LAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
             +  +    G+  + VDP L        + +     + C+      RP+M +V+
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  143 bits (360), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 87/216 (40%), Positives = 127/216 (58%), Gaps = 15/216 (6%)
Query: 287 IKAATDGFSD------SNKLGQGGFGTVYKGVLPNGKEVAVKRLSR----KSWQGLEEFK 336
           +K  T+ F +       NK G+GGFG VYKG + N   VAVK+L+      + +  ++F 
Sbjct: 11  LKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFD 69
Query: 337 NEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNI 396
            EI + AK QH NLV L+G   +G++  L+Y   PN SL   +   +    L+W+    I
Sbjct: 70  QEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKI 129
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
             G + G+ +LHE+     IHRD+K +N+LLD+   AKISDFG+AR   +  +     R+
Sbjct: 130 AQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRI 186
Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           VGT  Y APE A+ G  + KSD++SFGV++LEII+G
Sbjct: 187 VGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 115/217 (52%), Gaps = 17/217 (7%)
Query: 278 ELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKN 337
           E+P   L +IK          +LG G FG V+ G      +VA+K L   +    E F  
Sbjct: 5   EIPRESLQLIK----------RLGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLE 53
Query: 338 EIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNII 397
           E  ++ KL+H  LV+L    +  E   ++ E M   SL  F+ D E R  L      ++ 
Sbjct: 54  EAQIMKKLKHDKLVQLYAV-VSEEPIYIVTEYMNKGSLLDFLKDGEGR-ALKLPNLVDMA 111
Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVV 457
             ++ G+ Y+    R+  IHRDL+ +N+L+   ++ KI+DFG+AR+  +N+ TA  +   
Sbjct: 112 AQVAAGMAYIE---RMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTAR-QGAK 167
Query: 458 GTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKR 494
               + APE A+ G F++KSDV+SFG+++ E+++  R
Sbjct: 168 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 204

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 87/303 (28%), Positives = 149/303 (49%), Gaps = 30/303 (9%)
Query: 274 VSSEELPFVHLAVIKAATDG------FSDSN---KLGQGGFGTVYKGVLPNGKEVAVKRL 324
           +S  ++P       + A DG      + D N   K+G G FGTV++    +G +VAVK L
Sbjct: 10  MSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKIL 68
Query: 325 SRKSWQG--LEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDS 382
             + +    + EF  E+ ++ +L+H N+V  +G   +     ++ E +   SL   +  S
Sbjct: 69  MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS 128
Query: 383 ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR 442
             R QL+     ++   ++KG+ YLH +    I+HRDLK  N+L+DK    K+ DFG++R
Sbjct: 129 GAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSR 187
Query: 443 IFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG 502
           +  +      ++   GT  +MAPE   +   + KSDV+SFGVI+ E+ + ++  G     
Sbjct: 188 L--KASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL--N 243
Query: 503 HAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
            AQ + A  ++     K +E      +  +  PQV   I     C   +P  RP+ + ++
Sbjct: 244 PAQVVAAVGFKC----KRLE------IPRNLNPQVAAIIEG---CWTNEPWKRPSFATIM 290
Query: 563 ALL 565
            LL
Sbjct: 291 DLL 293

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/196 (34%), Positives = 109/196 (55%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           +LG G FG V+ G      +VAVK L + S    + F  E  L+ +LQH+ LVRL    +
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 83
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   +I E M N SL  F+  +   ++L  N   ++   I++G+ ++ E +    IHR
Sbjct: 84  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 139
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+   +  KI+DFG+AR+  +N+ TA          + APE    G F++KSD
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSD 198
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ EI++  R
Sbjct: 199 VWSFGILLTEIVTHGR 214

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  104 bits (259), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/196 (34%), Positives = 109/196 (55%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           +LG G FG V+ G      +VAVK L + S    + F  E  L+ +LQH+ LVRL    +
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 86
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   +I E M N SL  F+  +   ++L  N   ++   I++G+ ++ E +    IHR
Sbjct: 87  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 142
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+   +  KI+DFG+AR+  +N+ TA          + APE    G F++KSD
Sbjct: 143 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSD 201
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ EI++  R
Sbjct: 202 VWSFGILLTEIVTHGR 217

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/196 (34%), Positives = 109/196 (55%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           +LG G FG V+ G      +VAVK L + S    + F  E  L+ +LQH+ LVRL    +
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 85
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   +I E M N SL  F+  +   ++L  N   ++   I++G+ ++ E +    IHR
Sbjct: 86  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 141
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+   +  KI+DFG+AR+  +N+ TA          + APE    G F++KSD
Sbjct: 142 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSD 200
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ EI++  R
Sbjct: 201 VWSFGILLTEIVTHGR 216

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/196 (34%), Positives = 109/196 (55%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           +LG G FG V+ G      +VAVK L + S    + F  E  L+ +LQH+ LVRL    +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   +I E M N SL  F+  +   ++L  N   ++   I++G+ ++ E +    IHR
Sbjct: 78  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+   +  KI+DFG+AR+  +N+ TA          + APE    G F++KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSD 192
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ EI++  R
Sbjct: 193 VWSFGILLTEIVTHGR 208

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/196 (34%), Positives = 109/196 (55%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           +LG G FG V+ G      +VAVK L + S    + F  E  L+ +LQH+ LVRL    +
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 79
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   +I E M N SL  F+  +   ++L  N   ++   I++G+ ++ E +    IHR
Sbjct: 80  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 135
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+   +  KI+DFG+AR+  +N+ TA          + APE    G F++KSD
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSD 194
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ EI++  R
Sbjct: 195 VWSFGILLTEIVTHGR 210

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/196 (34%), Positives = 109/196 (55%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           +LG G FG V+ G      +VAVK L + S    + F  E  L+ +LQH+ LVRL    +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   +I E M N SL  F+  +   ++L  N   ++   I++G+ ++ E +    IHR
Sbjct: 78  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+   +  KI+DFG+AR+  +N+ TA          + APE    G F++KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSD 192
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ EI++  R
Sbjct: 193 VWSFGILLTEIVTHGR 208

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/196 (34%), Positives = 109/196 (55%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           +LG G FG V+ G      +VAVK L + S    + F  E  L+ +LQH+ LVRL    +
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 78
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   +I E M N SL  F+  +   ++L  N   ++   I++G+ ++ E +    IHR
Sbjct: 79  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 134
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+   +  KI+DFG+AR+  +N+ TA          + APE    G F++KSD
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPI-KWTAPEAINYGTFTIKSD 193
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ EI++  R
Sbjct: 194 VWSFGILLTEIVTHGR 209

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/196 (34%), Positives = 109/196 (55%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           +LG G FG V+ G      +VAVK L + S    + F  E  L+ +LQH+ LVRL    +
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 87
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   +I E M N SL  F+  +   ++L  N   ++   I++G+ ++ E +    IHR
Sbjct: 88  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 143
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+   +  KI+DFG+AR+  +N+ TA          + APE    G F++KSD
Sbjct: 144 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSD 202
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ EI++  R
Sbjct: 203 VWSFGILLTEIVTHGR 218

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/196 (34%), Positives = 109/196 (55%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           +LG G FG V+ G      +VAVK L + S    + F  E  L+ +LQH+ LVRL    +
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 82
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   +I E M N SL  F+  +   ++L  N   ++   I++G+ ++ E +    IHR
Sbjct: 83  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 138
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+   +  KI+DFG+AR+  +N+ TA          + APE    G F++KSD
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSD 197
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ EI++  R
Sbjct: 198 VWSFGILLTEIVTHGR 213

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/196 (34%), Positives = 109/196 (55%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           +LG G FG V+ G      +VAVK L + S    + F  E  L+ +LQH+ LVRL    +
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 83
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   +I E M N SL  F+  +   ++L  N   ++   I++G+ ++ E +    IHR
Sbjct: 84  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 139
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+   +  KI+DFG+AR+  +N+ TA          + APE    G F++KSD
Sbjct: 140 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSD 198
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ EI++  R
Sbjct: 199 VWSFGILLTEIVTHGR 214

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/196 (34%), Positives = 109/196 (55%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           +LG G FG V+ G      +VAVK L + S    + F  E  L+ +LQH+ LVRL    +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   +I E M N SL  F+  +   ++L  N   ++   I++G+ ++ E +    IHR
Sbjct: 78  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+   +  KI+DFG+AR+  +N+ TA          + APE    G F++KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSD 192
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ EI++  R
Sbjct: 193 VWSFGILLTEIVTHGR 208

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 68/196 (34%), Positives = 109/196 (55%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           +LG G FG V+ G      +VAVK L + S    + F  E  L+ +LQH+ LVRL    +
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 72
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   +I E M N SL  F+  +   ++L  N   ++   I++G+ ++ E +    IHR
Sbjct: 73  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 128
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+   +  KI+DFG+AR+  +N+ TA          + APE    G F++KSD
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSD 187
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ EI++  R
Sbjct: 188 VWSFGILLTEIVTHGR 203

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 86/303 (28%), Positives = 150/303 (49%), Gaps = 30/303 (9%)
Query: 274 VSSEELPFVHLAVIKAATDG------FSDSN---KLGQGGFGTVYKGVLPNGKEVAVKRL 324
           +S  ++P       + A DG      + D N   K+G G FGTV++    +G +VAVK L
Sbjct: 10  MSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKIL 68
Query: 325 SRKSWQG--LEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDS 382
             + +    + EF  E+ ++ +L+H N+V  +G   +     ++ E +   SL   +  S
Sbjct: 69  MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS 128
Query: 383 ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR 442
             R QL+     ++   ++KG+ YLH +    I+HR+LK  N+L+DK    K+ DFG++R
Sbjct: 129 GAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187
Query: 443 IFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG 502
           +  +     +++   GT  +MAPE   +   + KSDV+SFGVI+ E+ + ++  G     
Sbjct: 188 L--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL--N 243
Query: 503 HAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
            AQ + A  ++     K +E      +  +  PQV   I     C   +P  RP+ + ++
Sbjct: 244 PAQVVAAVGFKC----KRLE------IPRNLNPQVAAIIEG---CWTNEPWKRPSFATIM 290
Query: 563 ALL 565
            LL
Sbjct: 291 DLL 293

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 107/196 (54%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G       VA+K L +      E F  E  ++ KL+H  LV+L    +
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-V 331
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M   SL  F+   E    L      ++   I+ G+ Y+    R+  +HR
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+ +++V K++DFG+AR+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ E+ +  R
Sbjct: 447 VWSFGILLTELTTKGR 462

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 107/196 (54%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M   SL  F+   E    L      ++   I+ G+ Y+    R+  +HR
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+ +++V K++DFG+AR+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ E+ +  R
Sbjct: 364 VWSFGILLTELTTKGR 379

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 107/196 (54%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M   SL  F+   E    L      ++   I+ G+ Y+    R+  +HR
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+ +++V K++DFG+AR+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ E+ +  R
Sbjct: 364 VWSFGILLTELTTKGR 379

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 107/196 (54%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV+L    +
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 72
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M   SL  F+   E    L      ++   I+ G+ Y+    R+  +HR
Sbjct: 73  SEEPIXIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 128
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+ +++V K++DFG+AR+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTAR-QGAKFPIKWTAPEAALYGRFTIKSD 187
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ E+ +  R
Sbjct: 188 VWSFGILLTELTTKGR 203

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 107/196 (54%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M   SL  F+   E    L      ++   I+ G+ Y+    R+  +HR
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+ +++V K++DFG+AR+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTAR-QGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ E+ +  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 142/297 (47%), Gaps = 36/297 (12%)
Query: 288 KAATDGFSDSNKLGQGGFGTVY----KGVLPNGKE--VAVKRLSRK-SWQGLEEFKNEII 340
           + A +  + S +LGQG FG VY    KGV+ +  E  VA+K ++   S +   EF NE  
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 65
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLN-------WNTC 393
           ++ +    ++VRL+G   +G+  L+I ELM    L  ++      ++ N        +  
Sbjct: 66  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 125
Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT 453
             + G I+ G+ YL+ +   K +HRDL   N ++ +D   KI DFGM R   E       
Sbjct: 126 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG 182
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
            + +    +M+PE   +G+F+  SDV+SFGV++ EI                TL    +Q
Sbjct: 183 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQ 227
Query: 514 LWKEGKEMEFV--DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE 568
                + + FV    LL K  + P ++  + +  +C Q +P +RP+   +++ +  E
Sbjct: 228 GLSNEQVLRFVMEGGLLDKPDNCPDML--LELMRMCWQYNPKMRPSFLEIISSIKEE 282

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 107/196 (54%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV+L    +
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 71
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M   SL  F+   E    L      ++   I+ G+ Y+    R+  +HR
Sbjct: 72  SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 127
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+ +++V K++DFG+AR+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSD 186
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ E+ +  R
Sbjct: 187 VWSFGILLTELTTKGR 202

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 107/196 (54%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV+L    +
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 75
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M   SL  F+   E    L      ++   I+ G+ Y+    R+  +HR
Sbjct: 76  SEEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 131
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+ +++V K++DFG+AR+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSD 190
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ E+ +  R
Sbjct: 191 VWSFGILLTELTTKGR 206

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 107/196 (54%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV+L    +
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 248
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M   SL  F+   E    L      ++   I+ G+ Y+    R+  +HR
Sbjct: 249 SEEPIYIVGEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+ +++V K++DFG+AR+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ E+ +  R
Sbjct: 364 VWSFGILLTELTTKGR 379

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 109/196 (55%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           +LG G FG V+ G      +VAVK L + S    + F  E  L+ +LQH+ LVRL    +
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 73
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   +I E M N SL  F+  +   ++L  N   ++   I++G+ ++ E +    IHR
Sbjct: 74  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 129
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           +L+ +N+L+   +  KI+DFG+AR+  +N+ TA          + APE    G F++KSD
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI-KWTAPEAINYGTFTIKSD 188
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ EI++  R
Sbjct: 189 VWSFGILLTEIVTHGR 204

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 107/196 (54%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M   SL  F+   E    L      ++   I+ G+ Y+    R+  +HR
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+ +++V K++DFG+AR+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ E+ +  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 107/196 (54%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M   SL  F+   E    L      ++   I+ G+ Y+    R+  +HR
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+ +++V K++DFG+AR+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ E+ +  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 107/196 (54%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV+L    +
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 73
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M   SL  F+   E    L      ++   I+ G+ Y+    R+  +HR
Sbjct: 74  SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 129
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+ +++V K++DFG+AR+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ E+ +  R
Sbjct: 189 VWSFGILLTELTTKGR 204

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score =  101 bits (251), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 141/297 (47%), Gaps = 36/297 (12%)
Query: 288 KAATDGFSDSNKLGQGGFGTVY----KGVLPNGKE--VAVKRLSRK-SWQGLEEFKNEII 340
           + A +  + S +LGQG FG VY    KGV+ +  E  VA+K ++   S +   EF NE  
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLN-------WNTC 393
           ++ +    ++VRL+G   +G+  L+I ELM    L  ++      ++ N        +  
Sbjct: 75  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT 453
             + G I+ G+ YL+ +   K +HRDL   N ++ +D   KI DFGM R   E       
Sbjct: 135 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG 191
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
            + +    +M+PE   +G+F+  SDV+SFGV++ EI                TL    +Q
Sbjct: 192 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQ 236
Query: 514 LWKEGKEMEFV--DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE 568
                + + FV    LL K  + P ++    +  +C Q +P +RP+   +++ +  E
Sbjct: 237 GLSNEQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIISSIKEE 291

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 104/194 (53%), Gaps = 6/194 (3%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            +LG G FG V+ G   N  +VAVK L   +   ++ F  E  L+  LQH  LVRL    
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
              E   +I E M   SL  F+  S+   ++      +    I++G+ Y+    R   IH
Sbjct: 78  TREEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIH 133
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKS 477
           RDL+ +NVL+ + ++ KI+DFG+AR+  +N+ TA          + APE    G F++KS
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGCFTIKS 192
Query: 478 DVFSFGVIVLEIIS 491
           DV+SFG+++ EI++
Sbjct: 193 DVWSFGILLYEIVT 206

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 107/196 (54%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M   SL  F+   E    L      ++   I+ G+ Y+    R+  +HR
Sbjct: 83  SEEPIYIVCEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+ +++V K++DFG+AR+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ E+ +  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 105/194 (54%), Gaps = 6/194 (3%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            KLG G FG V+ G   N  +VAVK L   +   ++ F  E  L+  LQH  LVRL    
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            + E   +I E M   SL  F+  S+   ++      +    I++G+ Y+    R   IH
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIH 132
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKS 477
           RDL+ +NVL+ + ++ KI+DFG+AR+  +N+ TA          + APE    G F++KS
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGCFTIKS 191
Query: 478 DVFSFGVIVLEIIS 491
           +V+SFG+++ EI++
Sbjct: 192 NVWSFGILLYEIVT 205

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 107/196 (54%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV+L    +
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 79
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M   SL  F+   E    L      ++   I+ G+ Y+    R+  +HR
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+ +++V K++DFG+AR+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEWTAR-QGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ E+ +  R
Sbjct: 195 VWSFGILLTELTTKGR 210

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 107/196 (54%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G       VA+K L   +    E F  E  ++ K++H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLVQLYAV-V 82
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M   SL  F+   E    L      ++   I+ G+ Y+    R+  +HR
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+ +++V K++DFG+AR+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ E+ +  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 107/196 (54%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV+L    +
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 79
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M   SL  F+   E    L      ++   I+ G+ Y+    R+  +HR
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFL-KGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+ +++V K++DFG+AR+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ E+ +  R
Sbjct: 195 VWSFGILLTELTTKGR 210

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 82/282 (29%), Positives = 136/282 (48%), Gaps = 25/282 (8%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV+L    +
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGN-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 249
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M   SL  F+   E    L      ++   I+ G+ Y+    R+  +HR
Sbjct: 250 SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 305
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+ +++V K++DFG+ R+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSD 364
Query: 479 VFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVV 538
           V+SFG+++ E+ +  R    Y     + +L  V    + G  M             P+  
Sbjct: 365 VWSFGILLTELTTKGRVP--YPGMVNREVLDQV----ERGYRM----------PCPPECP 408
Query: 539 RCIH-IGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPP 579
             +H +   C ++DP  RPT   + A L  +    +EP+  P
Sbjct: 409 ESLHDLMCQCWRKDPEERPTFEYLQAFL-EDYFTSTEPQXQP 449

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 65/196 (33%), Positives = 106/196 (54%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M   SL  F+   E    L      ++   I+ G+ Y+    R+  +HR
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL  +N+L+ +++V K++DFG+AR+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ E+ +  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 141/297 (47%), Gaps = 36/297 (12%)
Query: 288 KAATDGFSDSNKLGQGGFGTVY----KGVLPNGKE--VAVKRLSRK-SWQGLEEFKNEII 340
           + A +  + S +LGQG FG VY    KGV+ +  E  VA+K ++   S +   EF NE  
Sbjct: 12  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 71
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLN-------WNTC 393
           ++ +    ++VRL+G   +G+  L+I ELM    L  ++      ++ N        +  
Sbjct: 72  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 131
Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT 453
             + G I+ G+ YL+ +   K +HRDL   N ++ +D   KI DFGM R   E       
Sbjct: 132 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 188
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
            + +    +M+PE   +G+F+  SDV+SFGV++ EI                TL    +Q
Sbjct: 189 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQ 233
Query: 514 LWKEGKEMEFV--DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE 568
                + + FV    LL K  + P ++    +  +C Q +P +RP+   +++ +  E
Sbjct: 234 GLSNEQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIISSIKEE 288

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 66/198 (33%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA--V 81
Query: 359 EGEEKLLIYELMPNRSLDCFI--FDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
             EE   IY +M   S  C +     E    L      ++   I+ G+ Y+    R+  +
Sbjct: 82  VSEEP--IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYV 136
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL+ +N+L+ +++V K++DFG+AR+  +N+ TA  +       + APE A+ G F++K
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIK 195
Query: 477 SDVFSFGVIVLEIISGKR 494
           SDV+SFG+++ E+ +  R
Sbjct: 196 SDVWSFGILLTELTTKGR 213

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 141/297 (47%), Gaps = 36/297 (12%)
Query: 288 KAATDGFSDSNKLGQGGFGTVY----KGVLPNGKE--VAVKRLSRK-SWQGLEEFKNEII 340
           + A +  + S +LGQG FG VY    KGV+ +  E  VA+K ++   S +   EF NE  
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLN-------WNTC 393
           ++ +    ++VRL+G   +G+  L+I ELM    L  ++      ++ N        +  
Sbjct: 74  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT 453
             + G I+ G+ YL+ +   K +HRDL   N ++ +D   KI DFGM R   E       
Sbjct: 134 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 190
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
            + +    +M+PE   +G+F+  SDV+SFGV++ EI                TL    +Q
Sbjct: 191 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQ 235
Query: 514 LWKEGKEMEFV--DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE 568
                + + FV    LL K  + P ++    +  +C Q +P +RP+   +++ +  E
Sbjct: 236 GLSNEQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIISSIKEE 290

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 141/297 (47%), Gaps = 36/297 (12%)
Query: 288 KAATDGFSDSNKLGQGGFGTVY----KGVLPNGKE--VAVKRLSRK-SWQGLEEFKNEII 340
           + A +  + S +LGQG FG VY    KGV+ +  E  VA+K ++   S +   EF NE  
Sbjct: 43  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 102
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLN-------WNTC 393
           ++ +    ++VRL+G   +G+  L+I ELM    L  ++      ++ N        +  
Sbjct: 103 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 162
Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT 453
             + G I+ G+ YL+ +   K +HRDL   N ++ +D   KI DFGM R   E       
Sbjct: 163 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 219
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
            + +    +M+PE   +G+F+  SDV+SFGV++ EI                TL    +Q
Sbjct: 220 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQ 264
Query: 514 LWKEGKEMEFV--DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE 568
                + + FV    LL K  + P ++    +  +C Q +P +RP+   +++ +  E
Sbjct: 265 GLSNEQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIISSIKEE 319

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 141/297 (47%), Gaps = 36/297 (12%)
Query: 288 KAATDGFSDSNKLGQGGFGTVY----KGVLPNGKE--VAVKRLSRK-SWQGLEEFKNEII 340
           + A +  + S +LGQG FG VY    KGV+ +  E  VA+K ++   S +   EF NE  
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLN-------WNTC 393
           ++ +    ++VRL+G   +G+  L+I ELM    L  ++      ++ N        +  
Sbjct: 75  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT 453
             + G I+ G+ YL+ +   K +HRDL   N ++ +D   KI DFGM R   E       
Sbjct: 135 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 191
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
            + +    +M+PE   +G+F+  SDV+SFGV++ EI                TL    +Q
Sbjct: 192 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQ 236
Query: 514 LWKEGKEMEFV--DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE 568
                + + FV    LL K  + P ++    +  +C Q +P +RP+   +++ +  E
Sbjct: 237 GLSNEQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIISSIKEE 291

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 141/297 (47%), Gaps = 36/297 (12%)
Query: 288 KAATDGFSDSNKLGQGGFGTVY----KGVLPNGKE--VAVKRLSRK-SWQGLEEFKNEII 340
           + A +  + S +LGQG FG VY    KGV+ +  E  VA+K ++   S +   EF NE  
Sbjct: 14  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 73
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLN-------WNTC 393
           ++ +    ++VRL+G   +G+  L+I ELM    L  ++      ++ N        +  
Sbjct: 74  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT 453
             + G I+ G+ YL+ +   K +HRDL   N ++ +D   KI DFGM R   E       
Sbjct: 134 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 190
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
            + +    +M+PE   +G+F+  SDV+SFGV++ EI                TL    +Q
Sbjct: 191 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQ 235
Query: 514 LWKEGKEMEFV--DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE 568
                + + FV    LL K  + P ++    +  +C Q +P +RP+   +++ +  E
Sbjct: 236 GLSNEQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIISSIKEE 290

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 142/295 (48%), Gaps = 32/295 (10%)
Query: 288 KAATDGFSDSNKLGQGGFGTVY----KGVLPNGKE--VAVKRLSRK-SWQGLEEFKNEII 340
           + A +  + S +LGQG FG VY    KGV+ +  E  VA+K ++   S +   EF NE  
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLN-------WNTC 393
           ++ +    ++VRL+G   +G+  L+I ELM    L  ++      ++ N        +  
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 140
Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT 453
             + G I+ G+ YL+ +   K +HRDL   N ++ +D   KI DFGM R   E       
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
            + +    +M+PE   +G+F+  SDV+SFGV++ EI +       Y     + +L +V  
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP--YQGLSNEQVLRFV-- 253
Query: 514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE 568
              EG        LL K  + P ++    +  +C Q +P +RP+   +++ +  E
Sbjct: 254 --MEGG-------LLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIISSIKEE 297

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 141/297 (47%), Gaps = 36/297 (12%)
Query: 288 KAATDGFSDSNKLGQGGFGTVY----KGVLPNGKE--VAVKRLSRK-SWQGLEEFKNEII 340
           + A +  + S +LGQG FG VY    KGV+ +  E  VA+K ++   S +   EF NE  
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLN-------WNTC 393
           ++ +    ++VRL+G   +G+  L+I ELM    L  ++      ++ N        +  
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT 453
             + G I+ G+ YL+ +   K +HRDL   N ++ +D   KI DFGM R   E       
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 184
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
            + +    +M+PE   +G+F+  SDV+SFGV++ EI                TL    +Q
Sbjct: 185 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQ 229
Query: 514 LWKEGKEMEFV--DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE 568
                + + FV    LL K  + P ++    +  +C Q +P +RP+   +++ +  E
Sbjct: 230 GLSNEQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIISSIKEE 284

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 64/196 (32%), Positives = 106/196 (54%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           KLGQG FG V+ G       VA+K L   +    E F  E  ++ KL+H  LV+L    +
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV-V 82
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   ++ E M    L  F+   E    L      ++   I+ G+ Y+    R+  +HR
Sbjct: 83  SEEPIYIVTEYMSKGCLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+ +++V K++DFG+AR+  +N+ TA  +       + APE A+ G F++KSD
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ E+ +  R
Sbjct: 198 VWSFGILLTELTTKGR 213

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 141/297 (47%), Gaps = 36/297 (12%)
Query: 288 KAATDGFSDSNKLGQGGFGTVY----KGVLPNGKE--VAVKRLSRK-SWQGLEEFKNEII 340
           + A +  + S +LGQG FG VY    KGV+ +  E  VA+K ++   S +   EF NE  
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLN-------WNTC 393
           ++ +    ++VRL+G   +G+  L+I ELM    L  ++      ++ N        +  
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT 453
             + G I+ G+ YL+ +   K +HRDL   N  + +D   KI DFGM R   E       
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKG 184
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
            + +    +M+PE   +G+F+  SDV+SFGV++ EI                TL    +Q
Sbjct: 185 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQ 229
Query: 514 LWKEGKEMEFV--DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE 568
                + + FV    LL K  + P ++  + +  +C Q +P +RP+   +++ +  E
Sbjct: 230 GLSNEQVLRFVMEGGLLDKPDNCPDML--LELMRMCWQYNPKMRPSFLEIISSIKEE 284

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 110/210 (52%), Gaps = 29/210 (13%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKS----WQGLEEFKNEIILIAKLQHRNLVRLVG 355
           +G GGFG VY+     G EVAVK           Q +E  + E  L A L+H N++ L G
Sbjct: 15  IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ----LNWNTCYNIIGGISKGLLYLHEDS 411
             ++     L+ E      L+  +  S +R+     +NW         I++G+ YLH+++
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAV------QIARGMNYLHDEA 125
Query: 412 RLKIIHRDLKPSNVLLDKDM--------VAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
            + IIHRDLK SN+L+ + +        + KI+DFG+AR +    K +      G Y +M
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS----AAGAYAWM 181
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           APE     +FS  SDV+S+GV++ E+++G+
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 300 LGQGGFGTVYKGVL------PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
           LG G FG VY+G +      P+  +VAVK L    S Q   +F  E ++I+KL H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL----QLNWNTCYNIIGGISKGLLYLH 408
            +G  ++   + ++ ELM    L  F+ ++  R      L      ++   I+ G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 409 EDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           E+     IHRD+   N LL       VAKI DFGMAR              +    +M P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  MEG+F+ K+D +SFGV++ EI S
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 140/297 (47%), Gaps = 36/297 (12%)
Query: 288 KAATDGFSDSNKLGQGGFGTVY----KGVLPNGKE--VAVKRLSRK-SWQGLEEFKNEII 340
           + A +  + S +LGQG FG VY    KGV+ +  E  VA+K ++   S +   EF NE  
Sbjct: 21  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLN-------WNTC 393
           ++ +    ++VRL+G   +G+  L+I ELM    L  ++      +  N        +  
Sbjct: 81  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT 453
             + G I+ G+ YL+ +   K +HRDL   N ++ +D   KI DFGM R   E       
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
            + +    +M+PE   +G+F+  SDV+SFGV++ EI                TL    +Q
Sbjct: 198 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQ 242
Query: 514 LWKEGKEMEFV--DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE 568
                + + FV    LL K  + P ++    +  +C Q +P +RP+   +++ +  E
Sbjct: 243 GLSNEQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIISSIKEE 297

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 300 LGQGGFGTVYKGVL------PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
           LG G FG VY+G +      P+  +VAVK L    S Q   +F  E ++I+KL H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL----QLNWNTCYNIIGGISKGLLYLH 408
            +G  ++   + ++ ELM    L  F+ ++  R      L      ++   I+ G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 409 EDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           E+     IHRD+   N LL       VAKI DFGMAR              +    +M P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  MEG+F+ K+D +SFGV++ EI S
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 140/297 (47%), Gaps = 36/297 (12%)
Query: 288 KAATDGFSDSNKLGQGGFGTVY----KGVLPNGKE--VAVKRLSRK-SWQGLEEFKNEII 340
           + A +  + S +LGQG FG VY    KGV+ +  E  VA+K ++   S +   EF NE  
Sbjct: 11  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 70
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLN-------WNTC 393
           ++ +    ++VRL+G   +G+  L+I ELM    L  ++      +  N        +  
Sbjct: 71  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 130
Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT 453
             + G I+ G+ YL+ +   K +HRDL   N ++ +D   KI DFGM R   E       
Sbjct: 131 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 187
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
            + +    +M+PE   +G+F+  SDV+SFGV++ EI                TL    +Q
Sbjct: 188 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI---------------ATLAEQPYQ 232
Query: 514 LWKEGKEMEFV--DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE 568
                + + FV    LL K  + P ++    +  +C Q +P +RP+   +++ +  E
Sbjct: 233 GLSNEQVLRFVMEGGLLDKPDNCPDML--FELMRMCWQYNPKMRPSFLEIISSIKEE 287

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 107/196 (54%), Gaps = 7/196 (3%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           +LG G  G V+ G      +VAVK L + S    + F  E  L+ +LQH+ LVRL    +
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
             E   +I E M N SL  F+  +   ++L  N   ++   I++G+ ++ E +    IHR
Sbjct: 78  TQEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL+ +N+L+   +  KI+DFG+AR+  + + TA          + APE    G F++KSD
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPI-KWTAPEAINYGTFTIKSD 192
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ EI++  R
Sbjct: 193 VWSFGILLTEIVTHGR 208

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 137/295 (46%), Gaps = 38/295 (12%)
Query: 299 KLGQGGFGTVY----KGVLPNGKE--VAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           +LG+G FG V+      +LP   +  VAVK L   S    ++F+ E  L+  LQH+++VR
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFI--FDSERRL----------QLNWNTCYNIIGGI 400
             G   EG   L+++E M +  L+ F+     + +L           L       +   +
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
           + G++YL   + L  +HRDL   N L+ + +V KI DFGM+R            R +   
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE 520
            +M PE  +   F+ +SDV+SFGV++ EI +  +   + L+               +G+E
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI------DCITQGRE 255
Query: 521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEP 575
           +E       +  + P  V  I  G  C Q +P  R ++ +V A L  +++A + P
Sbjct: 256 LE-------RPRACPPEVYAIMRG--CWQREPQQRHSIKDVHARL--QALAQAPP 299

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 137/295 (46%), Gaps = 38/295 (12%)
Query: 299 KLGQGGFGTVY----KGVLPNGKE--VAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           +LG+G FG V+      +LP   +  VAVK L   S    ++F+ E  L+  LQH+++VR
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFI--FDSERRL----------QLNWNTCYNIIGGI 400
             G   EG   L+++E M +  L+ F+     + +L           L       +   +
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
           + G++YL   + L  +HRDL   N L+ + +V KI DFGM+R            R +   
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE 520
            +M PE  +   F+ +SDV+SFGV++ EI +  +   + L+               +G+E
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI------DCITQGRE 249
Query: 521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEP 575
           +E       +  + P  V  I  G  C Q +P  R ++ +V A L  +++A + P
Sbjct: 250 LE-------RPRACPPEVYAIMRG--CWQREPQQRHSIKDVHARL--QALAQAPP 293

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 300 LGQGGFGTVYKGVL------PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
           LG G FG VY+G +      P+  +VAVK L    S Q   +F  E ++I+K  H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL----QLNWNTCYNIIGGISKGLLYLH 408
            +G  ++   + ++ ELM    L  F+ ++  R      L      ++   I+ G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 409 EDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           E+     IHRD+   N LL       VAKI DFGMAR              +    +M P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  MEG+F+ K+D +SFGV++ EI S
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 137/295 (46%), Gaps = 38/295 (12%)
Query: 299 KLGQGGFGTVY----KGVLPNGKE--VAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           +LG+G FG V+      +LP   +  VAVK L   S    ++F+ E  L+  LQH+++VR
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFI--FDSERRL----------QLNWNTCYNIIGGI 400
             G   EG   L+++E M +  L+ F+     + +L           L       +   +
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
           + G++YL   + L  +HRDL   N L+ + +V KI DFGM+R            R +   
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE 520
            +M PE  +   F+ +SDV+SFGV++ EI +  +   + L+               +G+E
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI------DCITQGRE 278
Query: 521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEP 575
           +E       +  + P  V  I  G  C Q +P  R ++ +V A L  +++A + P
Sbjct: 279 LE-------RPRACPPEVYAIMRG--CWQREPQQRHSIKDVHARL--QALAQAPP 322

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 300 LGQGGFGTVYKGVL------PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
           LG G FG VY+G +      P+  +VAVK L    S Q   +F  E ++I+K  H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL----QLNWNTCYNIIGGISKGLLYLH 408
            +G  ++   + ++ ELM    L  F+ ++  R      L      ++   I+ G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 409 EDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           E+     IHRD+   N LL       VAKI DFGMAR              +    +M P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  MEG+F+ K+D +SFGV++ EI S
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 300 LGQGGFGTVYKGVL------PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
           LG G FG VY+G +      P+  +VAVK L    S Q   +F  E ++I+K  H+N+VR
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL----QLNWNTCYNIIGGISKGLLYLH 408
            +G  ++   + ++ ELM    L  F+ ++  R      L      ++   I+ G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 409 EDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           E+     IHRD+   N LL       VAKI DFGMAR              +    +M P
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  MEG+F+ K+D +SFGV++ EI S
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 109/201 (54%), Gaps = 13/201 (6%)
Query: 298 NKLGQGGFGTVY--KGVLPNGKEVAVKRL---SRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           +KLG GG  TVY  +  + N K VA+K +    R+  + L+ F+ E+   ++L H+N+V 
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIK-VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
           ++    E +   L+ E +   +L  +I   E    L+ +T  N    I  G+ + H+   
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHD--- 129
Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
           ++I+HRD+KP N+L+D +   KI DFG+A+   E   T  T  V+GT  Y +PE A    
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEA 188
Query: 473 FSVKSDVFSFGVIVLEIISGK 493
               +D++S G+++ E++ G+
Sbjct: 189 TDECTDIYSIGIVLYEMLVGE 209

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 300 LGQGGFGTVYKGVL------PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
           LG G FG VY+G +      P+  +VAVK L    S Q   +F  E ++I+K  H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL----QLNWNTCYNIIGGISKGLLYLH 408
            +G  ++   + ++ ELM    L  F+ ++  R      L      ++   I+ G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 409 EDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           E+     IHRD+   N LL       VAKI DFGMAR              +    +M P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  MEG+F+ K+D +SFGV++ EI S
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 300 LGQGGFGTVYKGVL------PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
           LG G FG VY+G +      P+  +VAVK L    S Q   +F  E ++I+K  H+N+VR
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL----QLNWNTCYNIIGGISKGLLYLH 408
            +G  ++   + ++ ELM    L  F+ ++  R      L      ++   I+ G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 409 EDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           E+     IHRD+   N LL       VAKI DFGMAR              +    +M P
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  MEG+F+ K+D +SFGV++ EI S
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 300 LGQGGFGTVYKGVL------PNGKEVAVKRLSR-KSWQGLEEFKNEIILIAKLQHRNLVR 352
           LG G FG VY+G +      P+  +VAVK L    S Q   +F  E ++I+K  H+N+VR
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL----QLNWNTCYNIIGGISKGLLYLH 408
            +G  ++   + ++ ELM    L  F+ ++  R      L      ++   I+ G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 409 EDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           E+     IHRD+   N LL       VAKI DFGMAR              +    +M P
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  MEG+F+ K+D +SFGV++ EI S
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 300 LGQGGFGTVYKGVL------PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
           LG G FG VY+G +      P+  +VAVK L    S Q   +F  E ++I+K  H+N+VR
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL----QLNWNTCYNIIGGISKGLLYLH 408
            +G  ++   + ++ ELM    L  F+ ++  R      L      ++   I+ G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 409 EDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           E+     IHRD+   N LL       VAKI DFGMAR              +    +M P
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  MEG+F+ K+D +SFGV++ EI S
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 300 LGQGGFGTVYKGVL------PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
           LG G FG VY+G +      P+  +VAVK L    S Q   +F  E ++I+K  H+N+VR
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL----QLNWNTCYNIIGGISKGLLYLH 408
            +G  ++   + ++ ELM    L  F+ ++  R      L      ++   I+ G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 409 EDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           E+     IHRD+   N LL       VAKI DFGMAR              +    +M P
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  MEG+F+ K+D +SFGV++ EI S
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 300 LGQGGFGTVYKGVL------PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
           LG G FG VY+G +      P+  +VAVK L    S Q   +F  E ++I+K  H+N+VR
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL----QLNWNTCYNIIGGISKGLLYLH 408
            +G  ++   + ++ ELM    L  F+ ++  R      L      ++   I+ G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 409 EDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           E+     IHRD+   N LL       VAKI DFGMAR              +    +M P
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  MEG+F+ K+D +SFGV++ EI S
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 107/199 (53%), Gaps = 9/199 (4%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FGTVYKG       V +  ++  + Q L+ FKNE+ ++ K +H N++  +G  
Sbjct: 18  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +  +  ++ +     SL   +  SE + ++      +I    ++G+ YLH  S   IIH
Sbjct: 78  TK-PQLAIVTQWCEGSSLYHHLHASETKFEMK--KLIDIARQTARGMDYLHAKS---IIH 131
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM---EGLFS 474
           RDLK +N+ L +D   KI DFG+A +      +    ++ G+  +MAPE         +S
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 191
Query: 475 VKSDVFSFGVIVLEIISGK 493
            +SDV++FG+++ E+++G+
Sbjct: 192 FQSDVYAFGIVLYELMTGQ 210

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 116/211 (54%), Gaps = 22/211 (10%)
Query: 300 LGQGGFGTVYKGV-LPNGK----EVAVKRLSRKSWQGLE-EFKNEIILIAKLQHRNLVRL 353
           LG G FGTVYKG+ +P G+     VA+K L+  +      EF +E +++A + H +LVRL
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSE----RRLQLNWNTCYNIIGGISKGLLYLHE 409
           +G  +    +L + +LMP+  L  ++ + +     +L LNW  C  I    +KG++YL E
Sbjct: 106 LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNW--CVQI----AKGMMYLEE 158
Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               +++HRDL   NVL+      KI+DFG+AR+   ++K  N         +MA E   
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 470 EGLFSVKSDVFSFGVIVLEIIS--GKRNSGF 498
              F+ +SDV+S+GV + E+++  GK   G 
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 246

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 300 LGQGGFGTVYKGVL------PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
           LG G FG VY+G +      P+  +VAVK L    S Q   +F  E ++I+K  H+N+VR
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL----QLNWNTCYNIIGGISKGLLYLH 408
            +G  ++   + ++ ELM    L  F+ ++  R      L      ++   I+ G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 409 EDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           E+     IHRD+   N LL       VAKI DFGMAR              +    +M P
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  MEG+F+ K+D +SFGV++ EI S
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 300 LGQGGFGTVYKGVL------PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
           LG G FG VY+G +      P+  +VAVK L    S Q   +F  E ++I+K  H+N+VR
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL----QLNWNTCYNIIGGISKGLLYLH 408
            +G  ++   + ++ ELM    L  F+ ++  R      L      ++   I+ G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 409 EDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           E+     IHRD+   N LL       VAKI DFGMAR              +    +M P
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  MEG+F+ K+D +SFGV++ EI S
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 116/211 (54%), Gaps = 22/211 (10%)
Query: 300 LGQGGFGTVYKGV-LPNGK----EVAVKRLSRKSWQGLE-EFKNEIILIAKLQHRNLVRL 353
           LG G FGTVYKG+ +P G+     VA+K L+  +      EF +E +++A + H +LVRL
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSE----RRLQLNWNTCYNIIGGISKGLLYLHE 409
           +G  +    +L + +LMP+  L  ++ + +     +L LNW  C  I    +KG++YL E
Sbjct: 83  LGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNW--CVQI----AKGMMYLEE 135
Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               +++HRDL   NVL+      KI+DFG+AR+   ++K  N         +MA E   
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 470 EGLFSVKSDVFSFGVIVLEIIS--GKRNSGF 498
              F+ +SDV+S+GV + E+++  GK   G 
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 223

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 142/274 (51%), Gaps = 29/274 (10%)
Query: 300 LGQGGFGTVYKGVLP--NGKE---VAVKRLSRKSWQGLE-EFKNEIILIAKLQHRNLVRL 353
           +G G FG VYKG+L   +GK+   VA+K L     +    +F  E  ++ +  H N++RL
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
            G   + +  ++I E M N +LD F+   E+  + +      ++ GI+ G+ YL   + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYL---ANM 166
Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN-QKTANTRRVVGTYGYMAPEYAMEGL 472
             +HRDL   N+L++ ++V K+SDFG++R+  ++ + T  T        + APE      
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226
Query: 473 FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK-S 531
           F+  SDV+SFG+++ E+++      + L+ H       V +   +G    F  P  M   
Sbjct: 227 FTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDG----FRLPTPMDCP 276
Query: 532 SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
           S+I Q++      + C Q++ A RP  +++V++L
Sbjct: 277 SAIYQLM------MQCWQQERARRPKFADIVSIL 304

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 106/203 (52%), Gaps = 25/203 (12%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FG V+ G   N  +VA+K + R+     E+F  E  ++ KL H  LV+L G  
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 358 IEGEEKLLIYELMPNRSLDCFI------FDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +E     L++E M +  L  ++      F +E  L +  + C        +G+ YL E S
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC--------EGMAYLEEAS 123
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYA 468
              +IHRDL   N L+ ++ V K+SDFGM R   ++Q T++T    GT     + +PE  
Sbjct: 124 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVF 176
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               +S KSDV+SFGV++ E+ S
Sbjct: 177 SFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 300 LGQGGFGTVYKGVL------PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
           LG G FG VY+G +      P+  +VAVK L    S Q   +F  E ++I+K  H+N+VR
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL----QLNWNTCYNIIGGISKGLLYLH 408
            +G  ++   + ++ ELM    L  F+ ++  R      L      ++   I+ G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 409 EDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           E+     IHRD+   N LL       VAKI DFGMA+              +    +M P
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  MEG+F+ K+D +SFGV++ EI S
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 121/246 (49%), Gaps = 17/246 (6%)
Query: 249 KRSQRGLLHELAGPISVSLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTV 308
           K+   GL  +L+ P   S  Q+     + E+P   L + K          KLG G FG V
Sbjct: 155 KKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEK----------KLGAGQFGEV 204
Query: 309 YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE 368
           +        +VAVK +   S   +E F  E  ++  LQH  LV+L    +  E   +I E
Sbjct: 205 WMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITE 262
Query: 369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD 428
            M   SL  F+   E   Q       +    I++G+ ++ + +    IHRDL+ +N+L+ 
Sbjct: 263 FMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVS 318
Query: 429 KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLE 488
             +V KI+DFG+AR+  +N+ TA          + APE    G F++KSDV+SFG++++E
Sbjct: 319 ASLVCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSDVWSFGILLME 377
Query: 489 IISGKR 494
           I++  R
Sbjct: 378 IVTYGR 383

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 135/278 (48%), Gaps = 36/278 (12%)
Query: 300 LGQGGFGTVYKGVL--PNGKE--VAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V +G L  P  KE  VA+K L    + +   EF +E  ++ + +H N++RL 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G        +++ E M N +LD F+     RL     T   ++G   GI+ G+ YL E  
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFL-----RLNDGQFTVIQLVGMLRGIASGMRYLAE-- 136
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG---TYGYMAPEYA 468
            +  +HRDL   N+L++ ++V K+SDFG++R   EN         +G      + APE  
Sbjct: 137 -MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL 527
               F+  SD +S+G+++ E++S G+R    Y     Q ++  + Q ++       + P 
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMSFGERP---YWDMSNQDVINAIEQDYR-------LPPP 245
Query: 528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
               +S+ Q++      L C Q+D   RP    VV+ L
Sbjct: 246 PDCPTSLHQLM------LDCWQKDRNARPRFPQVVSAL 277

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 108/199 (54%), Gaps = 9/199 (4%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FGTVYKG       V +  ++  + Q L+ FKNE+ ++ K +H N++  +G  
Sbjct: 16  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +  +  ++ +     SL   +   E + ++      +I    ++G+ YLH  S   IIH
Sbjct: 76  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIH 129
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM---EGLFS 474
           RDLK +N+ L +D+  KI DFG+A +      +    ++ G+  +MAPE      +  +S
Sbjct: 130 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 189
Query: 475 VKSDVFSFGVIVLEIISGK 493
            +SDV++FG+++ E+++G+
Sbjct: 190 FQSDVYAFGIVLYELMTGQ 208

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 108/199 (54%), Gaps = 9/199 (4%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FGTVYKG       V +  ++  + Q L+ FKNE+ ++ K +H N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +  +  ++ +     SL   +   E + ++      +I    ++G+ YLH  S   IIH
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIH 127
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM---EGLFS 474
           RDLK +N+ L +D+  KI DFG+A +      +    ++ G+  +MAPE      +  +S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 475 VKSDVFSFGVIVLEIISGK 493
            +SDV++FG+++ E+++G+
Sbjct: 188 FQSDVYAFGIVLYELMTGQ 206

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 108/199 (54%), Gaps = 9/199 (4%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FGTVYKG       V +  ++  + Q L+ FKNE+ ++ K +H N++  +G  
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +  +  ++ +     SL   +   E + ++      +I    ++G+ YLH  S   IIH
Sbjct: 79  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIH 132
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM---EGLFS 474
           RDLK +N+ L +D+  KI DFG+A +      +    ++ G+  +MAPE      +  +S
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 475 VKSDVFSFGVIVLEIISGK 493
            +SDV++FG+++ E+++G+
Sbjct: 193 FQSDVYAFGIVLYELMTGQ 211

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 108/199 (54%), Gaps = 9/199 (4%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FGTVYKG       V +  ++  + Q L+ FKNE+ ++ K +H N++  +G  
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +  +  ++ +     SL   +   E + ++      +I    ++G+ YLH  S   IIH
Sbjct: 79  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIH 132
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM---EGLFS 474
           RDLK +N+ L +D+  KI DFG+A +      +    ++ G+  +MAPE      +  +S
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 192
Query: 475 VKSDVFSFGVIVLEIISGK 493
            +SDV++FG+++ E+++G+
Sbjct: 193 FQSDVYAFGIVLYELMTGQ 211

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 135/285 (47%), Gaps = 52/285 (18%)
Query: 300 LGQGGFGTVYKGVL--PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G  G V  G L  P  ++V V   + K+    +   +F +E  ++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G    G   +++ E M N SLD F+     R      T   ++G   G+  G+ YL   S
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL-----RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG------YMAP 465
            L  +HRDL   NVL+D ++V K+SDFG++R+  ++   A T     T G      + AP
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXT-----TTGGKIPIRWTAP 223
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV 524
           E      FS  SDV+SFGV++ E+++ G+R    Y     + +++ V + ++        
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP---YWNMTNRDVISSVEEGYR-------- 272
Query: 525 DPLLMKSSSIPQVVRCIH----IGLLCVQEDPAVRPTMSNVVALL 565
                    +P  + C H    + L C  +D A RP  S +V++L
Sbjct: 273 ---------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 107/199 (53%), Gaps = 9/199 (4%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FGTVYKG       V +  ++  + Q L+ FKNE+ ++ K +H N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
               +  ++ +     SL   +   E + ++      +I    ++G+ YLH  S   IIH
Sbjct: 74  T-APQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIH 127
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM---EGLFS 474
           RDLK +N+ L +D+  KI DFG+A +      +    ++ G+  +MAPE      +  +S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 475 VKSDVFSFGVIVLEIISGK 493
            +SDV++FG+++ E+++G+
Sbjct: 188 FQSDVYAFGIVLYELMTGQ 206

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 105/199 (52%), Gaps = 9/199 (4%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FGTVYKG       V +  ++  + Q L+ FKNE+ ++ K +H N++  +G  
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
               +  ++ +     SL   +  SE + ++      +I    ++G+ YLH  S   IIH
Sbjct: 90  T-APQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---IIH 143
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM---EGLFS 474
           RDLK +N+ L +D   KI DFG+A        +    ++ G+  +MAPE         +S
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 475 VKSDVFSFGVIVLEIISGK 493
            +SDV++FG+++ E+++G+
Sbjct: 204 FQSDVYAFGIVLYELMTGQ 222

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/213 (35%), Positives = 116/213 (54%), Gaps = 16/213 (7%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFK-NEIILIAKLQ 346
           +++  F    KLG G + TVYKG+    G  VA+K +   S +G       EI L+ +L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 347 HRNLVRLVGCGIEGEEKL-LIYELMPN---RSLDC-FIFDSERRLQLNWNTCYNIIGGIS 401
           H N+VRL    I  E KL L++E M N   + +D   + ++ R L+LN    +     + 
Sbjct: 62  HENIVRLYDV-IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQW--QLL 118
Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG 461
           +GL + HE+   KI+HRDLKP N+L++K    K+ DFG+AR F     T ++  V  T  
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV--TLW 173
Query: 462 YMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGK 493
           Y AP+  M    +S   D++S G I+ E+I+GK
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 140/276 (50%), Gaps = 34/276 (12%)
Query: 300 LGQGGFGTVYKG--VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G   LP+ KE++V   + K   + +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   + +  +++ E M N SLD F+   + +      T   ++G   GI+ G+ YL   S
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGMKYL---S 164
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
            +  +HRDL   N+L++ ++V K+SDFG+AR+  ++ + A T R       + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 471 GLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
             F+  SDV+S+G+++ E++S G+R    Y     Q ++  V     EG  +    P + 
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP---YWEMSNQDVIKAV----DEGYRLP---PPMD 274
Query: 530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
             +++ Q++      L C Q+D   RP    +V++L
Sbjct: 275 CPAALYQLM------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 106/199 (53%), Gaps = 9/199 (4%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FGTVYKG       V +  ++  + Q L+ FKNE+ ++ K +H N++  +G  
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +  +  ++ +     SL   +  SE + ++      +I    ++G+ YLH  S   IIH
Sbjct: 90  TK-PQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---IIH 143
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM---EGLFS 474
           RDLK +N+ L +D   KI DFG+A        +    ++ G+  +MAPE         +S
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 475 VKSDVFSFGVIVLEIISGK 493
            +SDV++FG+++ E+++G+
Sbjct: 204 FQSDVYAFGIVLYELMTGQ 222

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 108/199 (54%), Gaps = 9/199 (4%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FGTVYKG       V +  ++  + Q L+ FKNE+ ++ K +H N++  +G  
Sbjct: 41  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +  +  ++ +     SL   +   E + ++      +I    ++G+ YLH  S   IIH
Sbjct: 101 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIH 154
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM---EGLFS 474
           RDLK +N+ L +D+  KI DFG+A +      +    ++ G+  +MAPE      +  +S
Sbjct: 155 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 214
Query: 475 VKSDVFSFGVIVLEIISGK 493
            +SDV++FG+++ E+++G+
Sbjct: 215 FQSDVYAFGIVLYELMTGQ 233

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 135/285 (47%), Gaps = 52/285 (18%)
Query: 300 LGQGGFGTVYKGVL--PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G  G V  G L  P  ++V V   + K+    +   +F +E  ++ +  H N++RL 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G    G   +++ E M N SLD F+     R      T   ++G   G+  G+ YL   S
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL-----RTHDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG------YMAP 465
            L  +HRDL   NVL+D ++V K+SDFG++R+  ++   A T     T G      + AP
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIRWTAP 223
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV 524
           E      FS  SDV+SFGV++ E+++ G+R    Y     + +++ V + ++        
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGERP---YWNMTNRDVISSVEEGYR-------- 272
Query: 525 DPLLMKSSSIPQVVRCIH----IGLLCVQEDPAVRPTMSNVVALL 565
                    +P  + C H    + L C  +D A RP  S +V++L
Sbjct: 273 ---------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 105/203 (51%), Gaps = 25/203 (12%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FG V+ G   N  +VA+K + R+     E+F  E  ++ KL H  LV+L G  
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 358 IEGEEKLLIYELMPNRSLDCFI------FDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +E     L++E M +  L  ++      F +E  L +  + C        +G+ YL E  
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC--------EGMAYLEEAC 121
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYA 468
              +IHRDL   N L+ ++ V K+SDFGM R   ++Q T++T    GT     + +PE  
Sbjct: 122 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVF 174
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               +S KSDV+SFGV++ E+ S
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFS 197

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 135/278 (48%), Gaps = 36/278 (12%)
Query: 300 LGQGGFGTVYKGVL--PNGKE--VAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V +G L  P  KE  VA+K L    + +   EF +E  ++ + +H N++RL 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G        +++ E M N +LD F+     RL     T   ++G   GI+ G+ YL E  
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFL-----RLNDGQFTVIQLVGMLRGIASGMRYLAE-- 134
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG---TYGYMAPEYA 468
            +  +HRDL   N+L++ ++V K+SDFG++R   EN         +G      + APE  
Sbjct: 135 -MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL 527
               F+  SD +S+G+++ E++S G+R    Y     Q ++  + Q ++       + P 
Sbjct: 194 AFRKFTSASDAWSYGIVMWEVMSFGERP---YWDMSNQDVINAIEQDYR-------LPPP 243
Query: 528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
               +S+ Q++      L C Q+D   RP    VV+ L
Sbjct: 244 PDCPTSLHQLM------LDCWQKDRNARPRFPQVVSAL 275

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 105/203 (51%), Gaps = 25/203 (12%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FG V+ G   N  +VA+K + R+     E+F  E  ++ KL H  LV+L G  
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 358 IEGEEKLLIYELMPNRSLDCFI------FDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +E     L++E M +  L  ++      F +E  L +  + C        +G+ YL E  
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC--------EGMAYLEEAC 126
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYA 468
              +IHRDL   N L+ ++ V K+SDFGM R   ++Q T++T    GT     + +PE  
Sbjct: 127 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVF 179
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               +S KSDV+SFGV++ E+ S
Sbjct: 180 SFSRYSSKSDVWSFGVLMWEVFS 202

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 105/203 (51%), Gaps = 25/203 (12%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FG V+ G   N  +VA+K + R+     E+F  E  ++ KL H  LV+L G  
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 358 IEGEEKLLIYELMPNRSLDCFI------FDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +E     L++E M +  L  ++      F +E  L +  + C        +G+ YL E  
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC--------EGMAYLEEAC 123
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYA 468
              +IHRDL   N L+ ++ V K+SDFGM R   ++Q T++T    GT     + +PE  
Sbjct: 124 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVF 176
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               +S KSDV+SFGV++ E+ S
Sbjct: 177 SFSRYSSKSDVWSFGVLMWEVFS 199

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 108/199 (54%), Gaps = 9/199 (4%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FGTVYKG       V +  ++  + Q L+ FKNE+ ++ K +H N++  +G  
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +  +  ++ +     SL   +   E + ++      +I    ++G+ YLH  S   IIH
Sbjct: 102 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEMI--KLIDIARQTAQGMDYLHAKS---IIH 155
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM---EGLFS 474
           RDLK +N+ L +D+  KI DFG+A +      +    ++ G+  +MAPE      +  +S
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 215
Query: 475 VKSDVFSFGVIVLEIISGK 493
            +SDV++FG+++ E+++G+
Sbjct: 216 FQSDVYAFGIVLYELMTGQ 234

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 140/276 (50%), Gaps = 34/276 (12%)
Query: 300 LGQGGFGTVYKG--VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G   LP+ KE++V   + K   + +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   + +  +++ E M N SLD F+   + +      T   ++G   GI+ G+ YL   S
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGMKYL---S 164
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
            +  +HRDL   N+L++ ++V K+SDFG++R+  ++ + A T R       + +PE    
Sbjct: 165 DMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 471 GLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
             F+  SDV+S+G+++ E++S G+R    Y     Q ++  V     EG  +    P + 
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP---YWEMSNQDVIKAV----DEGYRLP---PPMD 274
Query: 530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
             +++ Q++      L C Q+D   RP    +V++L
Sbjct: 275 CPAALYQLM------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 143/297 (48%), Gaps = 44/297 (14%)
Query: 299 KLGQGGFGTVY----KGVLPNGKE--VAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           +LG+G FG V+      + P   +  VAVK L   S    ++F  E  L+  LQH ++V+
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 79
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFI----------FDSERRLQLNWNTCYNIIGGISK 402
             G  +EG+  ++++E M +  L+ F+           +     +L  +   +I   I+ 
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG---- 458
           G++YL   +    +HRDL   N L+ ++++ KI DFGM+R    +  + +  RV G    
Sbjct: 140 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYSTDYYRVGGHTML 192
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG 518
              +M PE  M   F+ +SDV+S GV++ EI +  +   + L+ +       V +   +G
Sbjct: 193 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIECITQG 246
Query: 519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEP 575
           +       +L +  + PQ V  + +G  C Q +P +R  +  +  LL  +++A + P
Sbjct: 247 R-------VLQRPRTCPQEVYELMLG--CWQREPHMRKNIKGIHTLL--QNLAKASP 292

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 103/197 (52%), Gaps = 7/197 (3%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            KLG G FG V+        +VAVK +   S   +E F  E  ++  LQH  LV+L    
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV- 78
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
           +  E   +I E M   SL  F+   E   Q       +    I++G+ ++ + +    IH
Sbjct: 79  VTKEPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRN---YIH 134
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKS 477
           RDL+ +N+L+   +V KI+DFG+AR+  +N+ TA          + APE    G F++KS
Sbjct: 135 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI-KWTAPEAINFGSFTIKS 193
Query: 478 DVFSFGVIVLEIISGKR 494
           DV+SFG++++EI++  R
Sbjct: 194 DVWSFGILLMEIVTYGR 210

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 140/276 (50%), Gaps = 34/276 (12%)
Query: 300 LGQGGFGTVYKG--VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G   LP+ KE++V   + K   + +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   + +  +++ E M N SLD F+   + +      T   ++G   GI+ G+ YL   S
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGMKYL---S 164
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
            +  +HRDL   N+L++ ++V K+SDFG++R+  ++ + A T R       + +PE    
Sbjct: 165 DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 471 GLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
             F+  SDV+S+G+++ E++S G+R    Y     Q ++  V     EG  +    P + 
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP---YWEMSNQDVIKAV----DEGYRLP---PPMD 274
Query: 530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
             +++ Q++      L C Q+D   RP    +V++L
Sbjct: 275 CPAALYQLM------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 134/299 (44%), Gaps = 43/299 (14%)
Query: 299 KLGQGGFGTVYKG----VLPNGKE--VAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLV 351
           +LGQG FG VY+G    ++    E  VAVK ++   S +   EF NE  ++      ++V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIF-------DSERRLQLNWNTCYNIIGGISKGL 404
           RL+G   +G+  L++ ELM +  L  ++        ++  R          +   I+ G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            YL+     K +HRDL   N ++  D   KI DFGM R   E        + +    +MA
Sbjct: 141 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 197
Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV 524
           PE   +G+F+  SD++SFGV++ EI S               L    +Q     + ++FV
Sbjct: 198 PESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLKFV 242
Query: 525 --DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFP 581
                L +  + P+  R   +  +C Q +P +RPT   +V LL  +         P FP
Sbjct: 243 MDGGYLDQPDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD-------LHPSFP 292

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 140/276 (50%), Gaps = 34/276 (12%)
Query: 300 LGQGGFGTVYKG--VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G   LP+ KE++V   + K   + +   +F  E  ++ +  H N++RL 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   + +  +++ E M N SLD F+   + +      T   ++G   GI+ G+ YL   S
Sbjct: 84  GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGMKYL---S 135
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
            +  +HRDL   N+L++ ++V K+SDFG++R+  ++ + A T R       + +PE    
Sbjct: 136 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 195
Query: 471 GLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
             F+  SDV+S+G+++ E++S G+R    Y     Q ++  V     EG  +    P + 
Sbjct: 196 RKFTSASDVWSYGIVLWEVMSYGERP---YWEMSNQDVIKAV----DEGYRLP---PPMD 245
Query: 530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
             +++ Q++      L C Q+D   RP    +V++L
Sbjct: 246 CPAALYQLM------LDCWQKDRNNRPKFEQIVSIL 275

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 140/276 (50%), Gaps = 34/276 (12%)
Query: 300 LGQGGFGTVYKG--VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G   LP+ KE++V   + K   + +   +F  E  ++ +  H N++RL 
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 110
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   + +  +++ E M N SLD F+   + +      T   ++G   GI+ G+ YL   S
Sbjct: 111 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGMKYL---S 162
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
            +  +HRDL   N+L++ ++V K+SDFG++R+  ++ + A T R       + +PE    
Sbjct: 163 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 222
Query: 471 GLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
             F+  SDV+S+G+++ E++S G+R    Y     Q ++  V     EG  +    P + 
Sbjct: 223 RKFTSASDVWSYGIVLWEVMSYGERP---YWEMSNQDVIKAV----DEGYRLP---PPMD 272
Query: 530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
             +++ Q++      L C Q+D   RP    +V++L
Sbjct: 273 CPAALYQLM------LDCWQKDRNNRPKFEQIVSIL 302

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 140/276 (50%), Gaps = 34/276 (12%)
Query: 300 LGQGGFGTVYKG--VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G   LP+ KE++V   + K   + +   +F  E  ++ +  H N++RL 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 83
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   + +  +++ E M N SLD F+   + +      T   ++G   GI+ G+ YL   S
Sbjct: 84  GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGMKYL---S 135
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
            +  +HRDL   N+L++ ++V K+SDFG++R+  ++ + A T R       + +PE    
Sbjct: 136 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 195
Query: 471 GLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
             F+  SDV+S+G+++ E++S G+R    Y     Q ++  V     EG  +    P + 
Sbjct: 196 RKFTSASDVWSYGIVLWEVMSYGERP---YWEMSNQDVIKAV----DEGYRLP---PPMD 245
Query: 530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
             +++ Q++      L C Q+D   RP    +V++L
Sbjct: 246 CPAALYQLM------LDCWQKDRNNRPKFEQIVSIL 275

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 140/276 (50%), Gaps = 34/276 (12%)
Query: 300 LGQGGFGTVYKG--VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G   LP+ KE++V   + K   + +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   + +  +++ E M N SLD F+   + +      T   ++G   GI+ G+ YL   S
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGMKYL---S 164
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
            +  +HRDL   N+L++ ++V K+SDFG++R+  ++ + A T R       + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 471 GLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
             F+  SDV+S+G+++ E++S G+R    Y     Q ++  V     EG  +    P + 
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP---YWEMSNQDVIKAV----DEGYRLP---PPMD 274
Query: 530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
             +++ Q++      L C Q+D   RP    +V++L
Sbjct: 275 CPAALYQLM------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 140/276 (50%), Gaps = 34/276 (12%)
Query: 300 LGQGGFGTVYKG--VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G   LP+ KE++V   + K   + +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   + +  +++ E M N SLD F+   + +      T   ++G   GI+ G+ YL   S
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGMKYL---S 164
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
            +  +HRDL   N+L++ ++V K+SDFG++R+  ++ + A T R       + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 471 GLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
             F+  SDV+S+G+++ E++S G+R    Y     Q ++  V     EG  +    P + 
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP---YWEMSNQDVIKAV----DEGYRLP---PPMD 274
Query: 530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
             +++ Q++      L C Q+D   RP    +V++L
Sbjct: 275 CPAALYQLM------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 140/276 (50%), Gaps = 34/276 (12%)
Query: 300 LGQGGFGTVYKG--VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G   LP+ KE++V   + K   + +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   + +  +++ E M N SLD F+   + +      T   ++G   GI+ G+ YL   S
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGMKYL---S 164
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
            +  +HRDL   N+L++ ++V K+SDFG++R+  ++ + A T R       + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 471 GLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
             F+  SDV+S+G+++ E++S G+R    Y     Q ++  V     EG  +    P + 
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP---YWEMSNQDVIKAV----DEGYRLP---PPMD 274
Query: 530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
             +++ Q++      L C Q+D   RP    +V++L
Sbjct: 275 CPAALYQLM------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 140/276 (50%), Gaps = 34/276 (12%)
Query: 300 LGQGGFGTVYKG--VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G   LP+ KE++V   + K   + +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   + +  +++ E M N SLD F+   + +      T   ++G   GI+ G+ YL   S
Sbjct: 113 GVVTKSKPVMIVTEXMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGMKYL---S 164
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
            +  +HRDL   N+L++ ++V K+SDFG++R+  ++ + A T R       + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 471 GLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
             F+  SDV+S+G+++ E++S G+R    Y     Q ++  V     EG  +    P + 
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP---YWEMSNQDVIKAV----DEGYRLP---PPMD 274
Query: 530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
             +++ Q++      L C Q+D   RP    +V++L
Sbjct: 275 CPAALYQLM------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 140/276 (50%), Gaps = 34/276 (12%)
Query: 300 LGQGGFGTVYKG--VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G   LP+ KE++V   + K   + +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   + +  +++ E M N SLD F+   + +      T   ++G   GI+ G+ YL   S
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGMKYL---S 164
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
            +  +HRDL   N+L++ ++V K+SDFG++R+  ++ + A T R       + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 471 GLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
             F+  SDV+S+G+++ E++S G+R    Y     Q ++  V     EG  +    P + 
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP---YWEMSNQDVIKAV----DEGYRLP---PPMD 274
Query: 530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
             +++ Q++      L C Q+D   RP    +V++L
Sbjct: 275 CPAALYQLM------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 130/283 (45%), Gaps = 36/283 (12%)
Query: 299 KLGQGGFGTVYKG----VLPNGKE--VAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLV 351
           +LGQG FG VY+G    ++    E  VAVK ++   S +   EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIF-------DSERRLQLNWNTCYNIIGGISKGL 404
           RL+G   +G+  L++ ELM +  L  ++        ++  R          +   I+ G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            YL+     K +HRDL   N ++  D   KI DFGM R   E        + +    +MA
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV 524
           PE   +G+F+  SD++SFGV++ EI S               L    +Q     + ++FV
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLKFV 245
Query: 525 --DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
                L +  + P+  R   +  +C Q +P +RPT   +V LL
Sbjct: 246 MDGGYLDQPDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 140/276 (50%), Gaps = 34/276 (12%)
Query: 300 LGQGGFGTVYKG--VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G   LP+ KE++V   + K   + +   +F  E  ++ +  H N++RL 
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 100
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   + +  +++ E M N SLD F+   + +      T   ++G   GI+ G+ YL   S
Sbjct: 101 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGMKYL---S 152
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
            +  +HRDL   N+L++ ++V K+SDFG++R+  ++ + A T R       + +PE    
Sbjct: 153 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 212
Query: 471 GLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
             F+  SDV+S+G+++ E++S G+R    Y     Q ++  V     EG  +    P + 
Sbjct: 213 RKFTSASDVWSYGIVLWEVMSYGERP---YWEMSNQDVIKAV----DEGYRLP---PPMD 262
Query: 530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
             +++ Q++      L C Q+D   RP    +V++L
Sbjct: 263 CPAALYQLM------LDCWQKDRNNRPKFEQIVSIL 292

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 131/286 (45%), Gaps = 36/286 (12%)
Query: 299 KLGQGGFGTVYKG----VLPNGKE--VAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLV 351
           +LGQG FG VY+G    ++    E  VAVK ++   S +   EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIF-------DSERRLQLNWNTCYNIIGGISKGL 404
           RL+G   +G+  L++ ELM +  L  ++        ++  R          +   I+ G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            YL+     K +HRDL   N ++  D   KI DFGM R   E        + +    +MA
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV 524
           PE   +G+F+  SD++SFGV++ EI S               L    +Q     + ++FV
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLKFV 245
Query: 525 --DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE 568
                L +  + P+  R   +  +C Q +P +RPT   +V LL  +
Sbjct: 246 MDGGYLDQPDNCPE--RVTDLMRMCWQFNPNMRPTFLEIVNLLKDD 289

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 139/276 (50%), Gaps = 34/276 (12%)
Query: 300 LGQGGFGTVYKG--VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G   LP+ KE++V   + K   + +   +F  E  ++ +  H N++RL 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   + +  +++ E M N SLD F+   + +      T   ++G   GI+ G+ YL   S
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF-----TVIQLVGMLRGIASGMKYL---S 164
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
            +  +HRDL   N+L++ ++V K+SDFG+ R+  ++ + A T R       + +PE    
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224
Query: 471 GLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
             F+  SDV+S+G+++ E++S G+R    Y     Q ++  V     EG  +    P + 
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERP---YWEMSNQDVIKAV----DEGYRLP---PPMD 274
Query: 530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
             +++ Q++      L C Q+D   RP    +V++L
Sbjct: 275 CPAALYQLM------LDCWQKDRNNRPKFEQIVSIL 304

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 104/198 (52%), Gaps = 14/198 (7%)
Query: 299 KLGQGGFGTV-YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           K+G+G  G V       +G++VAVK +  +  Q  E   NE++++   QH N+V +    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
           + GEE  ++ E +   +L     D   +++LN      +   + + L YLH      +IH
Sbjct: 112 LVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIH 164
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCE--NQKTANTRRVVGTYGYMAPEYAMEGLFSV 475
           RD+K  ++LL  D   K+SDFG    FC   ++     + +VGT  +MAPE     L++ 
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKXLVGTPYWMAPEVISRSLYAT 220
Query: 476 KSDVFSFGVIVLEIISGK 493
           + D++S G++V+E++ G+
Sbjct: 221 EVDIWSLGIMVIEMVDGE 238

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 299 KLGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +LG+G FG+V    Y  +  N G+ VAVK+L   + + L +F+ EI ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 354 VG-CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            G C   G   L LI E +P  SL  ++   + R  ++          I KG+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 134
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-VGTYGYMAPEYAME 470
             + IHRDL   N+L++ +   KI DFG+ ++  ++++    +        + APE   E
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 471 GLFSVKSDVFSFGVIVLEIIS 491
             FSV SDV+SFGV++ E+ +
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 299 KLGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +LG+G FG+V    Y  +  N G+ VAVK+L   + + L +F+ EI ++  LQH N+V+ 
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 354 VG-CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            G C   G   L LI E +P  SL  ++   + R  ++          I KG+ YL    
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 135
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-VGTYGYMAPEYAME 470
             + IHRDL   N+L++ +   KI DFG+ ++  ++++    +        + APE   E
Sbjct: 136 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 195
Query: 471 GLFSVKSDVFSFGVIVLEIIS 491
             FSV SDV+SFGV++ E+ +
Sbjct: 196 SKFSVASDVWSFGVVLYELFT 216

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 299 KLGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +LG+G FG+V    Y  +  N G+ VAVK+L   + + L +F+ EI ++  LQH N+V+ 
Sbjct: 48  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 354 VG-CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            G C   G   L LI E +P  SL  ++   + R  ++          I KG+ YL    
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 162
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-VGTYGYMAPEYAME 470
             + IHRDL   N+L++ +   KI DFG+ ++  ++++    +        + APE   E
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 222
Query: 471 GLFSVKSDVFSFGVIVLEIIS 491
             FSV SDV+SFGV++ E+ +
Sbjct: 223 SKFSVASDVWSFGVVLYELFT 243

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 299 KLGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +LG+G FG+V    Y  +  N G+ VAVK+L   + + L +F+ EI ++  LQH N+V+ 
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 354 VG-CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            G C   G   L LI E +P  SL  ++   + R  ++          I KG+ YL    
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 130
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-VGTYGYMAPEYAME 470
             + IHRDL   N+L++ +   KI DFG+ ++  ++++    +        + APE   E
Sbjct: 131 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 190
Query: 471 GLFSVKSDVFSFGVIVLEIIS 491
             FSV SDV+SFGV++ E+ +
Sbjct: 191 SKFSVASDVWSFGVVLYELFT 211

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 299 KLGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +LG+G FG+V    Y  +  N G+ VAVK+L   + + L +F+ EI ++  LQH N+V+ 
Sbjct: 15  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 74
Query: 354 VG-CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            G C   G   L LI E +P  SL  ++   + R  ++          I KG+ YL    
Sbjct: 75  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 129
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-VGTYGYMAPEYAME 470
             + IHRDL   N+L++ +   KI DFG+ ++  ++++    +        + APE   E
Sbjct: 130 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 189
Query: 471 GLFSVKSDVFSFGVIVLEIIS 491
             FSV SDV+SFGV++ E+ +
Sbjct: 190 SKFSVASDVWSFGVVLYELFT 210

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 107/199 (53%), Gaps = 9/199 (4%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FGTVYKG       V +  ++  + Q L+ FKNE+ ++ K +H N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +  +  ++ +     SL   +   E + ++      +I    ++G+ YLH  S   IIH
Sbjct: 74  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---IIH 127
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM---EGLFS 474
           RDLK +N+ L +D+  KI DFG+A        +    ++ G+  +MAPE      +  +S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187
Query: 475 VKSDVFSFGVIVLEIISGK 493
            +SDV++FG+++ E+++G+
Sbjct: 188 FQSDVYAFGIVLYELMTGQ 206

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 131/286 (45%), Gaps = 36/286 (12%)
Query: 299 KLGQGGFGTVYKG----VLPNGKE--VAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLV 351
           +LGQG FG VY+G    ++    E  VAVK ++   S +   EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIF-------DSERRLQLNWNTCYNIIGGISKGL 404
           RL+G   +G+  L++ ELM +  L  ++        ++  R          +   I+ G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            YL+     K +HRDL   N ++  D   KI DFGM R   E        + +    +MA
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV 524
           PE   +G+F+  SD++SFGV++ EI S               L    +Q     + ++FV
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLKFV 245
Query: 525 --DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE 568
                L +  + P+  R   +  +C Q +P +RPT   +V LL  +
Sbjct: 246 MDGGYLDQPDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 289

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 299 KLGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +LG+G FG+V    Y  +  N G+ VAVK+L   + + L +F+ EI ++  LQH N+V+ 
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 354 VG-CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            G C   G   L LI E +P  SL  ++   + R  ++          I KG+ YL    
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 136
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-VGTYGYMAPEYAME 470
             + IHRDL   N+L++ +   KI DFG+ ++  ++++    +        + APE   E
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 196
Query: 471 GLFSVKSDVFSFGVIVLEIIS 491
             FSV SDV+SFGV++ E+ +
Sbjct: 197 SKFSVASDVWSFGVVLYELFT 217

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 92.0 bits (227), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 299 KLGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +LG+G FG+V    Y  +  N G+ VAVK+L   + + L +F+ EI ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 354 VG-CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            G C   G   L LI E +P  SL  ++   + R  ++          I KG+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 131
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-VGTYGYMAPEYAME 470
             + IHRDL   N+L++ +   KI DFG+ ++  ++++    +        + APE   E
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 471 GLFSVKSDVFSFGVIVLEIIS 491
             FSV SDV+SFGV++ E+ +
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 13/201 (6%)
Query: 299 KLGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +LG+G FG+V    Y  +  N G+ VAVK+L   + + L +F+ EI ++  LQH N+V+ 
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 354 VG-CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            G C   G   L LI E +P  SL  ++   + R  ++          I KG+ YL    
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 138
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
             + IHRDL   N+L++ +   KI DFG+ ++  ++++    +    +   + APE   E
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 471 GLFSVKSDVFSFGVIVLEIIS 491
             FSV SDV+SFGV++ E+ +
Sbjct: 199 SKFSVASDVWSFGVVLYELFT 219

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/203 (33%), Positives = 104/203 (51%), Gaps = 25/203 (12%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FG V+ G   N  +VA+K + R+     E+F  E  ++ KL H  LV+L G  
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 358 IEGEEKLLIYELMPNRSLDCFI------FDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +E     L+ E M +  L  ++      F +E  L +  + C        +G+ YL E  
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC--------EGMAYLEEAC 124
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYA 468
              +IHRDL   N L+ ++ V K+SDFGM R   ++Q T++T    GT     + +PE  
Sbjct: 125 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVF 177
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               +S KSDV+SFGV++ E+ S
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFS 200

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ ++N      +   IS  + YL + +    I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNKFSIK 197
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +    L+ V++L ++   ME       +    P+
Sbjct: 198 SDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE 244
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 245 --KVYELMRACWQWNPSDRPSFAEI 267

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 299 KLGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +LG+G FG+V    Y  +  N G+ VAVK+L   + + L +F+ EI ++  LQH N+V+ 
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 354 VG-CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            G C   G   L LI E +P  SL  ++   + R  ++          I KG+ YL    
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 137
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-VGTYGYMAPEYAME 470
             + IHRDL   N+L++ +   KI DFG+ ++  ++++    +        + APE   E
Sbjct: 138 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 197
Query: 471 GLFSVKSDVFSFGVIVLEIIS 491
             FSV SDV+SFGV++ E+ +
Sbjct: 198 SKFSVASDVWSFGVVLYELFT 218

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 134/299 (44%), Gaps = 43/299 (14%)
Query: 299 KLGQGGFGTVYKG----VLPNGKE--VAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLV 351
           +LGQG FG VY+G    ++    E  VAVK ++   S +   EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIF-------DSERRLQLNWNTCYNIIGGISKGL 404
           RL+G   +G+  L++ ELM +  L  ++        ++  R          +   I+ G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            YL+     K +HRDL   N ++  D   KI DFGM R   E        + +    +MA
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMA 200
Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV 524
           PE   +G+F+  SD++SFGV++ EI S               L    +Q     + ++FV
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLKFV 245
Query: 525 --DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFP 581
                L +  + P+  R   +  +C Q +P +RPT   +V LL  +         P FP
Sbjct: 246 MDGGYLDQPDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD-------LHPSFP 295

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 104/203 (51%), Gaps = 25/203 (12%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FG V+ G   N  +VA+K +   S    ++F  E  ++ KL H  LV+L G  
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 358 IEGEEKLLIYELMPNRSLDCFI------FDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +E     L++E M +  L  ++      F +E  L +  + C        +G+ YL E  
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC--------EGMAYLEEAC 143
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYA 468
              +IHRDL   N L+ ++ V K+SDFGM R   ++Q T++T    GT     + +PE  
Sbjct: 144 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVF 196
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               +S KSDV+SFGV++ E+ S
Sbjct: 197 SFSRYSSKSDVWSFGVLMWEVFS 219

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ ++N      +   IS  + YL + +    I
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 197
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +    L+ V++L ++   ME       +    P+
Sbjct: 198 SDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE 244
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 245 --KVYELMRACWQWNPSDRPSFAEI 267

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 299 KLGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +LG+G FG+V    Y  +  N G+ VAVK+L   + + L +F+ EI ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 354 VG-CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            G C   G   L LI E +P  SL  ++   + R  ++          I KG+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 131
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-VGTYGYMAPEYAME 470
             + IHRDL   N+L++ +   KI DFG+ ++  ++++    +        + APE   E
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 471 GLFSVKSDVFSFGVIVLEIIS 491
             FSV SDV+SFGV++ E+ +
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 299 KLGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +LG+G FG+V    Y  +  N G+ VAVK+L   + + L +F+ EI ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 354 VG-CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            G C   G   L LI E +P  SL  ++   + R  ++          I KG+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 134
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-VGTYGYMAPEYAME 470
             + IHRDL   N+L++ +   KI DFG+ ++  ++++    +        + APE   E
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 471 GLFSVKSDVFSFGVIVLEIIS 491
             FSV SDV+SFGV++ E+ +
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/299 (27%), Positives = 134/299 (44%), Gaps = 43/299 (14%)
Query: 299 KLGQGGFGTVYKG----VLPNGKE--VAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLV 351
           +LGQG FG VY+G    ++    E  VAVK ++   S +   EF NE  ++      ++V
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIF-------DSERRLQLNWNTCYNIIGGISKGL 404
           RL+G   +G+  L++ ELM +  L  ++        ++  R          +   I+ G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            YL+     K +HRDL   N ++  D   KI DFGM R   E        + +    +MA
Sbjct: 143 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 199
Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV 524
           PE   +G+F+  SD++SFGV++ EI S               L    +Q     + ++FV
Sbjct: 200 PESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLKFV 244
Query: 525 --DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFP 581
                L +  + P+  R   +  +C Q +P +RPT   +V LL  +         P FP
Sbjct: 245 MDGGYLDQPDNCPE--RVTDLMRMCWQFNPKMRPTFLEIVNLLKDD-------LHPSFP 294

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 107/199 (53%), Gaps = 9/199 (4%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FGTVYKG       V +  ++  + Q L+ FKNE+ ++ K +H N++  +G  
Sbjct: 34  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +  +  ++ +     SL   +   E + ++      +I    ++G+ YLH  S   IIH
Sbjct: 94  TK-PQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---IIH 147
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM---EGLFS 474
           RDLK +N+ L +D+  KI DFG+A        +    ++ G+  +MAPE      +  +S
Sbjct: 148 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 207
Query: 475 VKSDVFSFGVIVLEIISGK 493
            +SDV++FG+++ E+++G+
Sbjct: 208 FQSDVYAFGIVLYELMTGQ 226

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ ++N      +   IS  + YL + +    I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 197
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +    L+ V++L ++   ME       +    P+
Sbjct: 198 SDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE 244
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 245 --KVYELMRACWQWNPSDRPSFAEI 267

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/275 (28%), Positives = 134/275 (48%), Gaps = 27/275 (9%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRL---SRKSWQGLEEFKNEIILIAKLQHRN 349
           F    K+G+G F  VY+   L +G  VA+K++        +   +   EI L+ +L H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFI--FDSERRLQLNWNTCYNIIGGISKGLLYL 407
           +++     IE  E  ++ EL     L   I  F  ++RL +   T +     +   L ++
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTVWKYFVQLCSALEHM 152
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H  SR +++HRD+KP+NV +    V K+ D G+ R F  + KT     +VGT  YM+PE 
Sbjct: 153 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYYMSPER 207
Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD-P 526
             E  ++ KSD++S G ++ E+ + +  S FY  G    L    + L K+ ++ ++   P
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQ--SPFY--GDKMNL----YSLCKKIEQCDYPPLP 259
Query: 527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
               S  + Q+V       +C+  DP  RP ++ V
Sbjct: 260 SDHYSEELRQLVN------MCINPDPEKRPDVTYV 288

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ ++N      +   IS  + YL + +    I
Sbjct: 82  CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---FI 137
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 196
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +    L+ V++L ++   ME       +    P+
Sbjct: 197 SDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE 243
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 244 --KVYELMRACWQWNPSDRPSFAEI 266

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ ++N      +   IS  + YL + +    I
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---FI 134
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNKFSIK 193
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +    L+ V++L ++   ME       +    P+
Sbjct: 194 SDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE 240
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 241 --KVYELMRACWQWNPSDRPSFAEI 263

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 13/201 (6%)
Query: 299 KLGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +LG+G FG+V    Y  +  N G+ VAVK+L   + + L +F+ EI ++  LQH N+V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 354 VG-CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            G C   G   L LI E +P  SL  ++   + R  ++          I KG+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 149
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
             + IHRDL   N+L++ +   KI DFG+ ++  ++++    +    +   + APE   E
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 471 GLFSVKSDVFSFGVIVLEIIS 491
             FSV SDV+SFGV++ E+ +
Sbjct: 210 SKFSVASDVWSFGVVLYELFT 230

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 13/201 (6%)
Query: 299 KLGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +LG+G FG+V    Y  +  N G+ VAVK+L   + + L +F+ EI ++  LQH N+V+ 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 354 VG-CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            G C   G   L LI E +P  SL  ++   + R  ++          I KG+ YL    
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 149
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
             + IHRDL   N+L++ +   KI DFG+ ++  ++++    +    +   + APE   E
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 471 GLFSVKSDVFSFGVIVLEIIS 491
             FSV SDV+SFGV++ E+ +
Sbjct: 210 SKFSVASDVWSFGVVLYELFT 230

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ ++N      +   IS  + YL + +    I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +    L+ V++L ++   ME       +    P+
Sbjct: 193 SDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE 239
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 240 --KVYELMRACWQWNPSDRPSFAEI 262

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 105/200 (52%), Gaps = 9/200 (4%)
Query: 297 SNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           S ++G G FGTVYKG       V + ++   + +  + F+NE+ ++ K +H N++  +G 
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            +  +   ++ +     SL   +   E + Q+      +I    ++G+ YLH  +   II
Sbjct: 101 -MTKDNLAIVTQWCEGSSLYKHLHVQETKFQMF--QLIDIARQTAQGMDYLHAKN---II 154
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM---EGLF 473
           HRD+K +N+ L + +  KI DFG+A +      +    +  G+  +MAPE         F
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF 214
Query: 474 SVKSDVFSFGVIVLEIISGK 493
           S +SDV+S+G+++ E+++G+
Sbjct: 215 SFQSDVYSYGIVLYELMTGE 234

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 107/199 (53%), Gaps = 9/199 (4%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FGTVYKG       V +  ++  + Q L+ FKNE+ ++ K +H N++  +G  
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +  +  ++ +     SL   +   E + ++      +I    ++G+ YLH  S   IIH
Sbjct: 102 TK-PQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---IIH 155
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM---EGLFS 474
           RDLK +N+ L +D+  KI DFG+A        +    ++ G+  +MAPE      +  +S
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 215
Query: 475 VKSDVFSFGVIVLEIISGK 493
            +SDV++FG+++ E+++G+
Sbjct: 216 FQSDVYAFGIVLYELMTGQ 234

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ ++N      +   IS  + YL + +    I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +    L+ V++L ++   ME       +    P+
Sbjct: 193 SDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE 239
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 240 --KVYELMRACWQWNPSDRPSFAEI 262

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ ++N      +   IS  + YL + +    I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 197
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +    L+ V++L ++   ME       +    P+
Sbjct: 198 SDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE 244
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 245 --KVYELMRACWQWNPSDRPSFAEI 267

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ ++N      +   IS  + YL + +    I
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---FI 135
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 194
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +    L+ V++L ++   ME       +    P+
Sbjct: 195 SDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE 241
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 242 --KVYELMRACWQWNPSDRPSFAEI 264

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 32  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ ++N      +   IS  + YL + +    I
Sbjct: 91  CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---FI 146
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 205
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +    L+ V++L ++   ME       +    P+
Sbjct: 206 SDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE 252
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 253 --KVYELMRACWQWNPSDRPSFAEI 275

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 299 KLGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +LG+G FG+V    Y  +  N G+ VAVK+L   + + L +F+ EI ++  LQH N+V+ 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 354 VG-CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            G C   G   L LI E +P  SL  ++     R  ++          I KG+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAER--IDHIKLLQYTSQICKGMEYL---G 134
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-VGTYGYMAPEYAME 470
             + IHRDL   N+L++ +   KI DFG+ ++  ++++    +        + APE   E
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 471 GLFSVKSDVFSFGVIVLEIIS 491
             FSV SDV+SFGV++ E+ +
Sbjct: 195 SKFSVASDVWSFGVVLYELFT 215

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 18/205 (8%)
Query: 300 LGQGGFGTVYKGVL--PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G L  P  +E+ V   + K+    +   +F +E  ++ +  H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   + +  ++I E M N SLD F+  ++ R      T   ++G   GI  G+ YL   S
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRF-----TVIQLVGMLRGIGSGMKYL---S 148
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
            +  +HRDL   N+L++ ++V K+SDFGM+R+  ++ + A T R       + APE    
Sbjct: 149 DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 208
Query: 471 GLFSVKSDVFSFGVIVLEIIS-GKR 494
             F+  SDV+S+G+++ E++S G+R
Sbjct: 209 RKFTSASDVWSYGIVMWEVMSYGER 233

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 299 KLGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +LG+G FG+V    Y  +  N G+ VAVK+L   + + L +F+ EI ++  LQH N+V+ 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 354 VG-CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            G C   G   L LI E +P  SL  ++   + R  ++          I KG+ YL    
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 131
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-VGTYGYMAPEYAME 470
             + IHRDL   N+L++ +   KI DFG+ ++  ++++    +        + APE   E
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 471 GLFSVKSDVFSFGVIVLEIIS 491
             FSV SDV+SFGV++ E+ +
Sbjct: 192 SKFSVASDVWSFGVVLYELFT 212

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ ++N      +   IS  + YL + +    I
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---FI 135
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 194
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +    L+ V++L ++   ME       +    P+
Sbjct: 195 SDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE 241
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 242 --KVYELMRACWQWNPSDRPSFAEI 264

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 18/205 (8%)
Query: 300 LGQGGFGTVYKGVL--PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G L  P  +E+ V   + K+    +   +F +E  ++ +  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   + +  ++I E M N SLD F+  ++ R      T   ++G   GI  G+ YL   S
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRF-----TVIQLVGMLRGIGSGMKYL---S 127
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
            +  +HRDL   N+L++ ++V K+SDFGM+R+  ++ + A T R       + APE    
Sbjct: 128 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 187
Query: 471 GLFSVKSDVFSFGVIVLEIIS-GKR 494
             F+  SDV+S+G+++ E++S G+R
Sbjct: 188 RKFTSASDVWSYGIVMWEVMSYGER 212

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 137/289 (47%), Gaps = 22/289 (7%)
Query: 274 VSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGL 332
           + +E L F  +   +      +  +KLG G +G VY GV       VAVK L   + + +
Sbjct: 14  LGTENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-V 72
Query: 333 EEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNT 392
           EEF  E  ++ +++H NLV+L+G         ++ E MP  +L  ++ +  R  ++    
Sbjct: 73  EEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNRE-EVTAVV 131
Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN 452
              +   IS  + YL + +    IHRDL   N L+ ++ V K++DFG++R+   +  TA+
Sbjct: 132 LLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAH 188
Query: 453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW 512
                    + APE      FS+KSDV++FGV++ EI +      + ++ +    L+ V+
Sbjct: 189 AGAKFPI-KWTAPESLAYNTFSIKSDVWAFGVLLWEIAT------YGMSPYPGIDLSQVY 241
Query: 513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
            L ++G  ME            P+V   +     C +  PA RP+ +  
Sbjct: 242 DLLEKGYRME------QPEGCPPKVYELMRA---CWKWSPADRPSFAET 281

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 110/205 (53%), Gaps = 18/205 (8%)
Query: 300 LGQGGFGTVYKGVL--PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G L  P  +E+ V   + K+    +   +F +E  ++ +  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   + +  ++I E M N SLD F+  ++ R      T   ++G   GI  G+ YL   S
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLRKNDGRF-----TVIQLVGMLRGIGSGMKYL---S 133
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
            +  +HRDL   N+L++ ++V K+SDFGM+R+  ++ + A T R       + APE    
Sbjct: 134 DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 193
Query: 471 GLFSVKSDVFSFGVIVLEIIS-GKR 494
             F+  SDV+S+G+++ E++S G+R
Sbjct: 194 RKFTSASDVWSYGIVMWEVMSYGER 218

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 133/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ ++N      +   IS  + YL + +    I
Sbjct: 79  CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---FI 134
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA          + APE      FS+K
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAYNKFSIK 193
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +    L+ V++L ++   ME       +    P+
Sbjct: 194 SDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE 240
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 241 --KVYELMRACWQWNPSDRPSFAEI 263

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 133/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ ++N      +   IS  + YL + +    I
Sbjct: 80  CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---FI 135
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA          + APE      FS+K
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI-KWTAPESLAYNKFSIK 194
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +    L+ V++L ++   ME       +    P+
Sbjct: 195 SDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE 241
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 242 --KVYELMRACWQWNPSDRPSFAEI 264

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 134/299 (44%), Gaps = 43/299 (14%)
Query: 299 KLGQGGFGTVYKG----VLPNGKE--VAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLV 351
           +LGQG FG VY+G    ++    E  VAVK ++   S +   EF NE  ++      ++V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIF-------DSERRLQLNWNTCYNIIGGISKGL 404
           RL+G   +G+  L++ ELM +  L  ++        ++  R          +   I+ G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            YL+     K +HR+L   N ++  D   KI DFGM R   E        + +    +MA
Sbjct: 145 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 201
Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV 524
           PE   +G+F+  SD++SFGV++ EI S               L    +Q     + ++FV
Sbjct: 202 PESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLKFV 246
Query: 525 --DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFP 581
                L +  + P+  R   +  +C Q +P +RPT   +V LL  +         P FP
Sbjct: 247 MDGGYLDQPDNCPE--RVTDLMRMCWQFNPNMRPTFLEIVNLLKDD-------LHPSFP 296

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 134/299 (44%), Gaps = 43/299 (14%)
Query: 299 KLGQGGFGTVYKG----VLPNGKE--VAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLV 351
           +LGQG FG VY+G    ++    E  VAVK ++   S +   EF NE  ++      ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIF-------DSERRLQLNWNTCYNIIGGISKGL 404
           RL+G   +G+  L++ ELM +  L  ++        ++  R          +   I+ G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            YL+     K +HR+L   N ++  D   KI DFGM R   E        + +    +MA
Sbjct: 144 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 200
Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV 524
           PE   +G+F+  SD++SFGV++ EI S               L    +Q     + ++FV
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLKFV 245
Query: 525 --DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFP 581
                L +  + P+  R   +  +C Q +P +RPT   +V LL  +         P FP
Sbjct: 246 MDGGYLDQPDNCPE--RVTDLMRMCWQFNPNMRPTFLEIVNLLKDD-------LHPSFP 295

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 111/205 (54%), Gaps = 18/205 (8%)
Query: 300 LGQGGFGTVYKG--VLPNGKE--VAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G   LP  +E  VA+K L    + +   +F  E  ++ +  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   + +  +++ E M N SLD F+  ++ +      T   ++G   GIS G+ YL   S
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFLKKNDGQF-----TVIQLVGMLRGISAGMKYL---S 141
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
            +  +HRDL   N+L++ ++V K+SDFG++R+  ++ + A T R       + APE    
Sbjct: 142 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 471 GLFSVKSDVFSFGVIVLEIIS-GKR 494
             F+  SDV+S+G+++ E++S G+R
Sbjct: 202 RKFTSASDVWSYGIVMWEVVSYGER 226

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 121/256 (47%), Gaps = 18/256 (7%)
Query: 243 PTSTDEKRSQRGLLHELAGPISVSLTQEGDLVSSEEL-PFVHLAVIKAATDGFSDSN-KL 300
           P      R + G+  +  GP S    +E   VS E+    + L V       + D+  K+
Sbjct: 102 PPPPARARQENGMPEKPPGPRSPQ--REPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKI 159
Query: 301 GQGGFGTV-YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE 359
           G+G  G V    V  +GK VAVK++  +  Q  E   NE++++   QH N+V +    + 
Sbjct: 160 GEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV 219
Query: 360 GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRD 419
           G+E  ++ E +   +L   +  +    ++N      +   + + L  LH      +IHRD
Sbjct: 220 GDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRD 272
Query: 420 LKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPEYAMEGLFSVKS 477
           +K  ++LL  D   K+SDFG    FC        RR  +VGT  +MAPE      +  + 
Sbjct: 273 IKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 328
Query: 478 DVFSFGVIVLEIISGK 493
           D++S G++V+E++ G+
Sbjct: 329 DIWSLGIMVIEMVDGE 344

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPNGK-EVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ ++N      +   IS  + YL + +    I
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---FI 379
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HR+L   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIK 438
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +    L+ V++L ++   ME       +    P+
Sbjct: 439 SDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE 485
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 486 --KVYELMRACWQWNPSDRPSFAEI 508

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ +++      +   IS  + YL + +    I
Sbjct: 83  CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---FI 138
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 197
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +    L+ V++L ++   ME       +    P+
Sbjct: 198 SDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE 244
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 245 --KVYELMRACWQWNPSDRPSFAEI 267

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 106/201 (52%), Gaps = 13/201 (6%)
Query: 299 KLGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +LG+G FG+V    Y  +  N G+ VAVK+L   + + L +F+ EI ++  LQH N+V+ 
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 354 VG-CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            G C   G   L LI E +P  SL  ++   + R  ++          I KG+ YL    
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYL---G 132
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-VGTYGYMAPEYAME 470
             + IHR+L   N+L++ +   KI DFG+ ++  ++++    +        + APE   E
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 192
Query: 471 GLFSVKSDVFSFGVIVLEIIS 491
             FSV SDV+SFGV++ E+ +
Sbjct: 193 SKFSVASDVWSFGVVLYELFT 213

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ +++      +   IS  + YL + +    I
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +    L+ V++L ++   ME       +    P+
Sbjct: 193 SDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE 239
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 240 --KVYELMRACWQWNPSDRPSFAEI 262

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ +++      +   IS  + YL + +    I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +    L+ V++L ++   ME       +    P+
Sbjct: 193 SDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE 239
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 240 --KVYELMRACWQWNPSDRPSFAEI 262

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ +++      +   IS  + YL + +    I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +    L+ V++L ++   ME       +    P+
Sbjct: 193 SDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE 239
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 240 --KVYELMRACWQWNPSDRPSFAEI 262

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ +++      +   IS  + YL + +    I
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---FI 133
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 192
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +    L+ V++L ++   ME       +    P+
Sbjct: 193 SDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE 239
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 240 --KVYELMRACWQWNPSDRPSFAEI 262

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 136/278 (48%), Gaps = 36/278 (12%)
Query: 300 LGQGGFGTVYKG--VLPNGKE--VAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G   LP  +E  VA+K L S  + +   +F +E  ++ +  H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   +    ++I E M N SLD F+  ++ +      T   ++G   GI+ G+ YL +  
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-----TVIQLVGMLRGIAAGMKYLAD-- 153
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG---TYGYMAPEYA 468
            +  +HRDL   N+L++ ++V K+SDFG++R   ++         +G      + APE  
Sbjct: 154 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 212
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL 527
               F+  SDV+S+G+++ E++S G+R    Y     Q ++  + Q ++       + P 
Sbjct: 213 QYRKFTSASDVWSYGIVMWEVMSYGERP---YWDMTNQDVINAIEQDYR-------LPPP 262
Query: 528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
           +   S++ Q++      L C Q+D   RP    +V  L
Sbjct: 263 MDCPSALHQLM------LDCWQKDRNHRPKFGQIVNTL 294

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/229 (33%), Positives = 121/229 (52%), Gaps = 17/229 (7%)
Query: 271 GDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLS 325
           G  ++S E P   L  I   T+ F     LG G FGTVYKG+ +P G++V    A+K L 
Sbjct: 1   GSHMASGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR 59
Query: 326 RK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSER 384
              S +  +E  +E  ++A + + ++ RL+G  +    +L I +LMP     C + D  R
Sbjct: 60  EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMP---FGCLL-DYVR 114
Query: 385 RLQLNWNTCY--NIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR 442
             + N  + Y  N    I+KG+ YL ED RL  +HRDL   NVL+      KI+DFG+A+
Sbjct: 115 EHKDNIGSQYLLNWCVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAK 171
Query: 443 IFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
           +    +K  +         +MA E  +  +++ +SDV+S+GV V E+++
Sbjct: 172 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 113/228 (49%), Gaps = 30/228 (13%)
Query: 297 SNKLGQGGFGTVYKG----VLPNGKE--VAVKRLSRKSWQGLEEFKNEIILIAKLQHRNL 350
             +LG+G FG V+      + P   +  VAVK L   +    ++F+ E  L+  LQH ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCF----------IFDSERRL---QLNWNTCYNII 397
           V+  G   +G+  ++++E M +  L+ F          + D + R    +L  +   +I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVV 457
             I+ G++YL   +    +HRDL   N L+  +++ KI DFGM+R    +  + +  RV 
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVG 192
Query: 458 G----TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLT 501
           G       +M PE  M   F+ +SDV+SFGVI+ EI +  +   F L+
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 240

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           ++   K+GQG  GTVY  + +  G+EVA+++++ +     E   NEI+++ + ++ N+V 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDS---ERRLQLNWNTCYNIIGGISKGLLYLHE 409
            +   + G+E  ++ E +   SL   + ++   E ++      C        + L +LH 
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------QALEFLHS 135
Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPEY 467
           +   ++IHRD+K  N+LL  D   K++DFG    FC       ++R  +VGT  +MAPE 
Sbjct: 136 N---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSXMVGTPYWMAPEV 188
Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGK 493
                +  K D++S G++ +E+I G+
Sbjct: 189 VTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 111/217 (51%), Gaps = 31/217 (14%)
Query: 299 KLGQGGFGTVYKGVL------PNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRNLV 351
           +LG+  FG VYKG L         + VA+K L  K+   L EEF++E +L A+LQH N+V
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 92
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIF-----------DSERRLQ--LNWNTCYNIIG 398
            L+G   + +   +I+    +  L  F+            D +R ++  L      +++ 
Sbjct: 93  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152
Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG 458
            I+ G+ YL   S   ++H+DL   NVL+   +  KISD G+ R        A+  +++G
Sbjct: 153 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKLLG 205
Query: 459 T----YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
                  +MAPE  M G FS+ SD++S+GV++ E+ S
Sbjct: 206 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           ++   K+GQG  GTVY  + +  G+EVA+++++ +     E   NEI+++ + ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDS---ERRLQLNWNTCYNIIGGISKGLLYLHE 409
            +   + G+E  ++ E +   SL   + ++   E ++      C        + L +LH 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------QALEFLHS 134
Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPEY 467
           +   ++IHRD+K  N+LL  D   K++DFG    FC       ++R  +VGT  +MAPE 
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSXMVGTPYWMAPEV 187
Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGK 493
                +  K D++S G++ +E+I G+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           ++   K+GQG  GTVY  + +  G+EVA+++++ +     E   NEI+++ + ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDS---ERRLQLNWNTCYNIIGGISKGLLYLHE 409
            +   + G+E  ++ E +   SL   + ++   E ++      C        + L +LH 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------QALEFLHS 134
Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPEY 467
           +   ++IHRD+K  N+LL  D   K++DFG    FC       ++R  +VGT  +MAPE 
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTPYWMAPEV 187
Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGK 493
                +  K D++S G++ +E+I G+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           ++   K+GQG  GTVY  + +  G+EVA+++++ +     E   NEI+++ + ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDS---ERRLQLNWNTCYNIIGGISKGLLYLHE 409
            +   + G+E  ++ E +   SL   + ++   E ++      C        + L +LH 
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------QALEFLHS 134
Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPEY 467
           +   ++IHRD+K  N+LL  D   K++DFG    FC       ++R  +VGT  +MAPE 
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSEMVGTPYWMAPEV 187
Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGK 493
                +  K D++S G++ +E+I G+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 139/282 (49%), Gaps = 38/282 (13%)
Query: 299 KLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQG-------LEEFKNEIILIAKLQHRNL 350
           ++G+GGFG V+KG L   K V A+K L     +G        +EF+ E+ +++ L H N+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           V+L   G+      ++ E +P   L   + D    ++  W+    ++  I+ G+ Y+ ++
Sbjct: 86  VKLY--GLMHNPPRMVMEFVPCGDLYHRLLDKAHPIK--WSVKLRLMLDIALGIEYM-QN 140
Query: 411 SRLKIIHRDLKPSNVLL-----DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
               I+HRDL+  N+ L     +  + AK++DFG+++     Q   +   ++G + +MAP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 466 EY--AMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF 523
           E   A E  ++ K+D +SF +I+  I++G+     Y  G     + ++  + +EG     
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEG----- 246
Query: 524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
           + P + +    P++   I    LC   DP  RP  S +V  L
Sbjct: 247 LRPTIPEDCP-PRLRNVIE---LCWSGDPKKRPHFSYIVKEL 284

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 133/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G FG VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ +++      +   IS  + YL + +    I
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---FI 131
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNKFSIK 190
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +     + V++L ++   ME       +    P+
Sbjct: 191 SDVWAFGVLLWEIAT------YGMSPYPGIDPSQVYELLEKDYRME-------RPEGCPE 237
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 238 --KVYELMRACWQWNPSDRPSFAEI 260

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/252 (30%), Positives = 116/252 (46%), Gaps = 18/252 (7%)
Query: 264 SVSLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVK 322
           S+  T+EGD  S        L       D   D   LG+G +G VY G  L N   +A+K
Sbjct: 1   SMRSTEEGDCESD-------LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIK 53
Query: 323 RLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDS 382
            +  +  +  +    EI L   L+H+N+V+ +G   E     +  E +P  SL   +   
Sbjct: 54  EIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSK 113
Query: 383 ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK-DMVAKISDFGMA 441
              L+ N  T       I +GL YLH++   +I+HRD+K  NVL++    V KISDFG +
Sbjct: 114 WGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTS 170
Query: 442 RIFCENQKTANTRRVVGTYGYMAPEYAMEGL--FSVKSDVFSFGVIVLEIISGKRNSGFY 499
           +          T    GT  YMAPE   +G   +   +D++S G  ++E+ +GK    FY
Sbjct: 171 KRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK--PPFY 226
Query: 500 LTGHAQTLLAYV 511
             G  Q  +  V
Sbjct: 227 ELGEPQAAMFKV 238

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 134/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPNGK-EVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ +++      +   IS  + YL + +    I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---FI 340
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HR+L   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI-KWTAPESLAYNKFSIK 399
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +    L+ V++L ++   ME       +    P+
Sbjct: 400 SDVWAFGVLLWEIAT------YGMSPYPGIDLSQVYELLEKDYRME-------RPEGCPE 446
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 447 --KVYELMRACWQWNPSDRPSFAEI 469

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 120/249 (48%), Gaps = 18/249 (7%)
Query: 250 RSQRGLLHELAGPISVSLTQEGDLVSSEEL-PFVHLAVIKAATDGFSDSN-KLGQGGFGT 307
           R + G+  +  GP S    +E   VS E+    + L V       + D+  K+G+G  G 
Sbjct: 32  RQENGMPEKPPGPRSPQ--REPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGI 89
Query: 308 V-YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI 366
           V    V  +GK VAVK++  +  Q  E   NE++++   QH N+V +    + G+E  ++
Sbjct: 90  VCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149
Query: 367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVL 426
            E +   +L   +  +    ++N      +   + + L  LH      +IHRD+K  ++L
Sbjct: 150 MEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSIL 202
Query: 427 LDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPEYAMEGLFSVKSDVFSFGV 484
           L  D   K+SDFG    FC        RR  +VGT  +MAPE      +  + D++S G+
Sbjct: 203 LTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGI 258
Query: 485 IVLEIISGK 493
           +V+E++ G+
Sbjct: 259 MVIEMVDGE 267

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/246 (29%), Positives = 117/246 (47%), Gaps = 27/246 (10%)
Query: 249 KRSQRGLLHELAGPISVSLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTV 308
           K+   GL  +L+ P   S  Q+     + E+P   L + K          KLG G FG V
Sbjct: 149 KKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEK----------KLGAGQFGEV 198
Query: 309 YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE 368
           +        +VAVK +   S   +E F  E  ++  LQH  LV+L    +  E   +I E
Sbjct: 199 WMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITE 256
Query: 369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD 428
            M   SL  F+   E   Q       +    I++G+ ++ + +    IHRDL+ +N+L+ 
Sbjct: 257 FMAKGSLLDFLKSDEGSKQ-PLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVS 312
Query: 429 KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLE 488
             +V KI+DFG+AR+  +               + APE    G F++KSDV+SFG++++E
Sbjct: 313 ASLVCKIADFGLARVGAKF-----------PIKWTAPEAINFGSFTIKSDVWSFGILLME 361
Query: 489 IISGKR 494
           I++  R
Sbjct: 362 IVTYGR 367

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 111/217 (51%), Gaps = 31/217 (14%)
Query: 299 KLGQGGFGTVYKGVL------PNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRNLV 351
           +LG+  FG VYKG L         + VA+K L  K+   L EEF++E +L A+LQH N+V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIF-----------DSERRLQ--LNWNTCYNIIG 398
            L+G   + +   +I+    +  L  F+            D +R ++  L      +++ 
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG 458
            I+ G+ YL   S   ++H+DL   NVL+   +  KISD G+ R        A+  +++G
Sbjct: 136 QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKLLG 188
Query: 459 T----YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
                  +MAPE  M G FS+ SD++S+GV++ E+ S
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 299 KLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           K+G+G  G V      + GK+VAVK++  +  Q  E   NE++++    H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
           + G+E  ++ E +   +L   +  +    +     C +++  +S    YLH      +IH
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALS----YLHNQG---VIH 164
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCE--NQKTANTRRVVGTYGYMAPEYAMEGLFSV 475
           RD+K  ++LL  D   K+SDFG    FC   +++    + +VGT  +MAPE      +  
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFG----FCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGT 220
Query: 476 KSDVFSFGVIVLEIISGK 493
           + D++S G++V+E+I G+
Sbjct: 221 EVDIWSLGIMVIEMIDGE 238

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 133/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ +++      +   IS  + YL + +    I
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---FI 131
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI-KWTAPESLAYNKFSIK 190
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +     + V++L ++   ME       +    P+
Sbjct: 191 SDVWAFGVLLWEIAT------YGMSPYPGIDPSQVYELLEKDYRME-------RPEGCPE 237
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 238 --KVYELMRACWQWNPSDRPSFAEI 260

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 138/282 (48%), Gaps = 38/282 (13%)
Query: 299 KLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQG-------LEEFKNEIILIAKLQHRNL 350
           ++G+GGFG V+KG L   K V A+K L     +G        +EF+ E+ +++ L H N+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           V+L   G+      ++ E +P   L   + D    ++  W+    ++  I+ G+ Y+ ++
Sbjct: 86  VKLY--GLMHNPPRMVMEFVPCGDLYHRLLDKAHPIK--WSVKLRLMLDIALGIEYM-QN 140
Query: 411 SRLKIIHRDLKPSNVLL-----DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
               I+HRDL+  N+ L     +  + AK++DFG ++     Q   +   ++G + +MAP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 466 EY--AMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF 523
           E   A E  ++ K+D +SF +I+  I++G+     Y  G     + ++  + +EG     
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEG----- 246
Query: 524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
           + P + +    P++   I    LC   DP  RP  S +V  L
Sbjct: 247 LRPTIPEDCP-PRLRNVIE---LCWSGDPKKRPHFSYIVKEL 284

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 299 KLGQGGFGTV-YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           K+G+G  G V    V  +GK VAVK++  +  Q  E   NE++++   QH N+V +    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
           + G+E  ++ E +   +L   +  +    ++N      +   + + L  LH      +IH
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIH 148
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPEYAMEGLFSV 475
           RD+K  ++LL  D   K+SDFG    FC        RR  +VGT  +MAPE      +  
Sbjct: 149 RDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 204
Query: 476 KSDVFSFGVIVLEIISGK 493
           + D++S G++V+E++ G+
Sbjct: 205 EVDIWSLGIMVIEMVDGE 222

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/228 (32%), Positives = 120/228 (52%), Gaps = 21/228 (9%)
Query: 274 VSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK- 327
           + S E P   L  I   T+ F     LG G FGTVYKG+ +P G++V    A+K L    
Sbjct: 5   IRSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 63
Query: 328 SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ 387
           S +  +E  +E  ++A + + ++ RL+G  +    +L I +LMP   L  ++ + +  + 
Sbjct: 64  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIG 122
Query: 388 ----LNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI 443
               LNW  C  I    +KG+ YL ED RL  +HRDL   NVL+      KI+DFG+A++
Sbjct: 123 SQYLLNW--CVQI----AKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKL 173
Query: 444 FCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
               +K  +         +MA E  +  +++ +SDV+S+GV V E+++
Sbjct: 174 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 299 KLGQGGFGTV-YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           K+G+G  G V    V  +GK VAVK++  +  Q  E   NE++++   QH N+V +    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
           + G+E  ++ E +   +L   +  +    ++N      +   + + L  LH      +IH
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIH 150
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPEYAMEGLFSV 475
           RD+K  ++LL  D   K+SDFG    FC        RR  +VGT  +MAPE      +  
Sbjct: 151 RDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 206
Query: 476 KSDVFSFGVIVLEIISGK 493
           + D++S G++V+E++ G+
Sbjct: 207 EVDIWSLGIMVIEMVDGE 224

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 112/208 (53%), Gaps = 20/208 (9%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ----LNWNTCYNIIGGISKG 403
            ++ RL+G  +    +L I +LMP   L  ++ + +  +     LNW  C  I    +KG
Sbjct: 78  PHVCRLLGICLTSTVQL-IMQLMPFGXLLDYVREHKDNIGSQYLLNW--CVQI----AKG 130
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           + YL ED RL  +HRDL   NVL+      KI+DFG+A++    +K  +         +M
Sbjct: 131 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIIS 491
           A E  +  +++ +SDV+S+GV V E+++
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 104/213 (48%), Gaps = 11/213 (5%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           LG+G +G VY G  L N   +A+K +  +  +  +    EI L   L+H+N+V+ +G   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
           E     +  E +P  SL   +      L+ N  T       I +GL YLH++   +I+HR
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 132
Query: 419 DLKPSNVLLDK-DMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL--FSV 475
           D+K  NVL++    V KISDFG ++          T    GT  YMAPE   +G   +  
Sbjct: 133 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRGYGK 190
Query: 476 KSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLL 508
            +D++S G  ++E+ +GK    FY  G  Q  +
Sbjct: 191 AADIWSLGCTIIEMATGK--PPFYELGEPQAAM 221

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 299 KLGQGGFGTV-YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           K+G+G  G V    V  +GK VAVK++  +  Q  E   NE++++   QH N+V +    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
           + G+E  ++ E +   +L   +  +    ++N      +   + + L  LH      +IH
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIH 139
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPEYAMEGLFSV 475
           RD+K  ++LL  D   K+SDFG    FC        RR  +VGT  +MAPE      +  
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 195
Query: 476 KSDVFSFGVIVLEIISGK 493
           + D++S G++V+E++ G+
Sbjct: 196 EVDIWSLGIMVIEMVDGE 213

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 299 KLGQGGFGTV-YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           K+G+G  G V    V  +GK VAVK++  +  Q  E   NE++++   QH N+V +    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
           + G+E  ++ E +   +L   +  +    ++N      +   + + L  LH      +IH
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIH 143
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPEYAMEGLFSV 475
           RD+K  ++LL  D   K+SDFG    FC        RR  +VGT  +MAPE      +  
Sbjct: 144 RDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGP 199
Query: 476 KSDVFSFGVIVLEIISGK 493
           + D++S G++V+E++ G+
Sbjct: 200 EVDIWSLGIMVIEMVDGE 217

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 101/212 (47%), Gaps = 31/212 (14%)
Query: 301 GQGGFGTVYKGVLPNGKEVAVKRL---SRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            +G FG V+K  L N   VAVK      ++SWQ     + EI     ++H NL++ +   
Sbjct: 24  ARGRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQS----EREIFSTPGMKHENLLQFIAAE 78
Query: 358 IEGE----EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED--- 410
             G     E  LI       SL  ++  +     + WN   ++   +S+GL YLHED   
Sbjct: 79  KRGSNLEVELWLITAFHDKGSLTDYLKGN----IITWNELCHVAETMSRGLSYLHEDVPW 134
Query: 411 -----SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
                 +  I HRD K  NVLL  D+ A ++DFG+A  F   +   +T   VGT  YMAP
Sbjct: 135 CRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAP 194
Query: 466 EYAMEGLFSVKSDVF------SFGVIVLEIIS 491
           E  +EG  + + D F      + G+++ E++S
Sbjct: 195 E-VLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP     C + D  R  + N  + Y  N    I+KG+ 
Sbjct: 81  PHVCRLLGICLTSTVQL-IMQLMP---FGCLL-DYVREHKDNIGSQYLLNWCVQIAKGMN 135
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL ED RL  +HRDL   NVL+      KI+DFG+A++    +K  +         +MA 
Sbjct: 136 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 193 ESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 105/211 (49%), Gaps = 30/211 (14%)
Query: 301 GQGGFGTVYKGVLPNGKEVAVKRL---SRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            +G FG V+K  L N + VAVK      ++SWQ     + E+  +  ++H N+++ +G  
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQN----EYEVYSLPGMKHENILQFIGAE 87
Query: 358 IEGE----EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED--- 410
             G     +  LI       SL  F+    +   ++WN   +I   +++GL YLHED   
Sbjct: 88  KRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPG 143
Query: 411 ----SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
                +  I HRD+K  NVLL  ++ A I+DFG+A  F   +   +T   VGT  YMAPE
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE 203
Query: 467 YAMEGLFSVKSDVF------SFGVIVLEIIS 491
             +EG  + + D F      + G+++ E+ S
Sbjct: 204 -VLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP     C + D  R  + N  + Y  N    I+KG+ 
Sbjct: 78  PHVCRLLGICLTSTVQL-IMQLMP---FGCLL-DYVREHKDNIGSQYLLNWCVQIAKGMN 132
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL ED RL  +HRDL   NVL+      KI+DFG+A++    +K  +         +MA 
Sbjct: 133 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 190 ESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 112/208 (53%), Gaps = 20/208 (9%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ----LNWNTCYNIIGGISKG 403
            ++ RL+G  +    +L I +LMP   L  ++ + +  +     LNW  C  I    +KG
Sbjct: 77  PHVCRLLGICLTSTVQL-ITQLMPFGXLLDYVREHKDNIGSQYLLNW--CVQI----AKG 129
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           + YL ED RL  +HRDL   NVL+      KI+DFG+A++    +K  +         +M
Sbjct: 130 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIIS 491
           A E  +  +++ +SDV+S+GV V E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP     C + D  R  + N  + Y  N    I+KG+ 
Sbjct: 77  PHVCRLLGICLTSTVQL-IMQLMP---FGCLL-DYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL ED RL  +HRDL   NVL+      KI+DFG+A++    +K  +         +MA 
Sbjct: 132 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP     C + D  R  + N  + Y  N    I+KG+ 
Sbjct: 80  PHVCRLLGICLTSTVQL-IMQLMP---FGCLL-DYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL ED RL  +HRDL   NVL+      KI+DFG+A++    +K  +         +MA 
Sbjct: 135 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP     C + D  R  + N  + Y  N    I+KG+ 
Sbjct: 87  PHVCRLLGICLTSTVQL-ITQLMP---FGCLL-DYVREHKDNIGSQYLLNWCVQIAKGMN 141
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL ED RL  +HRDL   NVL+      KI+DFG+A++    +K  +         +MA 
Sbjct: 142 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 198
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 199 ESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           FSD  ++G G FG VY    + N + VA+K++S    Q  E++++   E+  + KL+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
            ++  GC +      L+ E     + D        +  L       +  G  +GL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
            +   +IHRD+K  N+LL +  + K+ DFG A I       A     VGT  +MAPE  +
Sbjct: 173 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 223
Query: 470 ---EGLFSVKSDVFSFGVIVLEIISGK 493
              EG +  K DV+S G+  +E+   K
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERK 250

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP     C + D  R  + N  + Y  N    I+KG+ 
Sbjct: 79  PHVCRLLGICLTSTVQL-IMQLMP---FGCLL-DYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL ED RL  +HRDL   NVL+      KI+DFG+A++    +K  +         +MA 
Sbjct: 134 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP     C + D  R  + N  + Y  N    I+KG+ 
Sbjct: 77  PHVCRLLGICLTSTVQL-ITQLMP---FGCLL-DYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL ED RL  +HRDL   NVL+      KI+DFG+A++    +K  +         +MA 
Sbjct: 132 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP     C + D  R  + N  + Y  N    I+KG+ 
Sbjct: 80  PHVCRLLGICLTSTVQL-ITQLMP---FGCLL-DYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL ED RL  +HRDL   NVL+      KI+DFG+A++    +K  +         +MA 
Sbjct: 135 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 19/207 (9%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           FSD  ++G G FG VY    + N + VA+K++S    Q  E++++   E+  + KL+H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
            ++  GC +      L+ E     + D        +  L       +  G  +GL YLH 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
            +   +IHRD+K  N+LL +  + K+ DFG A I       A     VGT  +MAPE  +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVIL 184
Query: 470 ---EGLFSVKSDVFSFGVIVLEIISGK 493
              EG +  K DV+S G+  +E+   K
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERK 211

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP     C + D  R  + N  + Y  N    I+KG+ 
Sbjct: 80  PHVCRLLGICLTSTVQL-ITQLMP---FGCLL-DYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL ED RL  +HRDL   NVL+      KI+DFG+A++    +K  +         +MA 
Sbjct: 135 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP     C + D  R  + N  + Y  N    I+KG+ 
Sbjct: 71  PHVCRLLGICLTSTVQL-ITQLMP---FGCLL-DYVREHKDNIGSQYLLNWCVQIAKGMN 125
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL ED RL  +HRDL   NVL+      KI+DFG+A++    +K  +         +MA 
Sbjct: 126 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP     C + D  R  + N  + Y  N    I+KG+ 
Sbjct: 80  PHVCRLLGICLTSTVQL-ITQLMP---FGCLL-DYVREHKDNIGSQYLLNWCVQIAKGMN 134
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL ED RL  +HRDL   NVL+      KI+DFG+A++    +K  +         +MA 
Sbjct: 135 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 192 ESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP     C + D  R  + N  + Y  N    I+KG+ 
Sbjct: 79  PHVCRLLGICLTSTVQL-ITQLMP---FGCLL-DYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL ED RL  +HRDL   NVL+      KI+DFG+A++    +K  +         +MA 
Sbjct: 134 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP     C + D  R  + N  + Y  N    I+KG+ 
Sbjct: 102 PHVCRLLGICLTSTVQL-ITQLMP---FGCLL-DYVREHKDNIGSQYLLNWCVQIAKGMN 156
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL ED RL  +HRDL   NVL+      KI+DFG+A++    +K  +         +MA 
Sbjct: 157 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 213
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 214 ESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 109/206 (52%), Gaps = 20/206 (9%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           ++   K+GQG  GTVY  + +  G+EVA+++++ +     E   NEI+++ + ++ N+V 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDS---ERRLQLNWNTCYNIIGGISKGLLYLHE 409
            +   + G+E  ++ E +   SL   + ++   E ++      C        + L +LH 
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------QALEFLHS 135
Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPEY 467
           +   ++IHR++K  N+LL  D   K++DFG    FC       ++R  +VGT  +MAPE 
Sbjct: 136 N---QVIHRNIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTPYWMAPEV 188
Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGK 493
                +  K D++S G++ +E+I G+
Sbjct: 189 VTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 138/282 (48%), Gaps = 46/282 (16%)
Query: 300 LGQGGFGTVYKG--VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G   LP  ++VAV   + K   + +   +F  E  ++ +  H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G    G+  +++ E M N +LD F+   + +      T   ++G   GI+ G+ YL +  
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFLRKHDGQF-----TVIQLVGMLRGIAAGMRYLAD-- 163
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG------YMAP 465
            +  +HRDL   N+L++ ++V K+SDFG++R+  ++ +   T     T G      + AP
Sbjct: 164 -MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYT-----TTGGKIPVRWTAP 217
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV 524
           E      F+  SDV+S+G+++ E++S G+R    Y     Q ++  +    +EG  +   
Sbjct: 218 EAIQYRKFTSASDVWSYGIVMWEVMSYGERP---YWDMSNQDVIKAI----EEGYRL--- 267
Query: 525 DPLLMK-SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
            P  M   + + Q++      L C Q++ A RP    +V +L
Sbjct: 268 -PAPMDCPAGLHQLM------LDCWQKERAERPKFEQIVGIL 302

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 112/208 (53%), Gaps = 20/208 (9%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ----LNWNTCYNIIGGISKG 403
            ++ RL+G  +    +L I +LMP   L  ++ + +  +     LNW  C  I    +KG
Sbjct: 77  PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW--CVQI----AKG 129
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           + YL ED RL  +HRDL   NVL+      KI+DFG+A++    +K  +         +M
Sbjct: 130 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIIS 491
           A E  +  +++ +SDV+S+GV V E+++
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/237 (33%), Positives = 123/237 (51%), Gaps = 21/237 (8%)
Query: 267 LTQEGDLVS----SEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEV-- 319
           L QE +LV     S E P   L  I   T+ F     LG G FGTVYKG+ +P G++V  
Sbjct: 21  LLQERELVEPLTPSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKI 79
Query: 320 --AVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLD 376
             A+  L    S +  +E  +E  ++A + + ++ RL+G  +    +L I +LMP     
Sbjct: 80  PVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMP---FG 135
Query: 377 CFIFDSERRLQLNWNTCY--NIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAK 434
           C + D  R  + N  + Y  N    I+KG+ YL ED RL  +HRDL   NVL+      K
Sbjct: 136 CLL-DYVREHKDNIGSQYLLNWCVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVK 191
Query: 435 ISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
           I+DFG+A++    +K  +         +MA E  +  +++ +SDV+S+GV V E+++
Sbjct: 192 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/265 (26%), Positives = 133/265 (50%), Gaps = 22/265 (8%)
Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NLV+L+G 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++ +  R+ +++      +   IS  + YL + +    I
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN---FI 131
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+K
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI-KWTAPESLAYNKFSIK 190
Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV++FGV++ EI +      + ++ +     + V++L ++   ME       +    P+
Sbjct: 191 SDVWAFGVLLWEIAT------YGMSPYPGIDPSQVYELLEKDYRME-------RPEGCPE 237
Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNV 561
             +   +   C Q +P+ RP+ + +
Sbjct: 238 --KVYELMRACWQWNPSDRPSFAEI 260

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 10/210 (4%)
Query: 285 AVIKAATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIA 343
           ++ K   + F    KLG+G +G+VYK +    G+ VA+K++  +S   L+E   EI ++ 
Sbjct: 22  SLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQ 79
Query: 344 KLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKG 403
           +    ++V+  G   +  +  ++ E     S+   I    R   L  +    I+    KG
Sbjct: 80  QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKG 137
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           L YLH    ++ IHRD+K  N+LL+ +  AK++DFG+A    +     N   V+GT  +M
Sbjct: 138 LEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNX--VIGTPFWM 192
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           APE   E  ++  +D++S G+  +E+  GK
Sbjct: 193 APEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 135/278 (48%), Gaps = 36/278 (12%)
Query: 300 LGQGGFGTVYKG--VLPNGKE--VAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G FG V  G   LP  +E  VA+K L S  + +   +F +E  ++ +  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHEDS 411
           G   +    ++I E M N SLD F+  ++ +      T   ++G   GI+ G+ YL +  
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-----TVIQLVGMLRGIAAGMKYLAD-- 127
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG---TYGYMAPEYA 468
            +  +HR L   N+L++ ++V K+SDFG++R   ++         +G      + APE  
Sbjct: 128 -MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 186
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL 527
               F+  SDV+S+G+++ E++S G+R    Y     Q ++  + Q ++       + P 
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMSYGERP---YWDMTNQDVINAIEQDYR-------LPPP 236
Query: 528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
           +   S++ Q++      L C Q+D   RP    +V  L
Sbjct: 237 MDCPSALHQLM------LDCWQKDRNHRPKFGQIVNTL 268

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 138/282 (48%), Gaps = 38/282 (13%)
Query: 299 KLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQG-------LEEFKNEIILIAKLQHRNL 350
           ++G+GGFG V+KG L   K V A+K L     +G        +EF+ E+ +++ L H N+
Sbjct: 26  QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           V+L   G+      ++ E +P   L   + D    ++  W+    ++  I+ G+ Y+ ++
Sbjct: 86  VKLY--GLMHNPPRMVMEFVPCGDLYHRLLDKAHPIK--WSVKLRLMLDIALGIEYM-QN 140
Query: 411 SRLKIIHRDLKPSNVLL-----DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
               I+HRDL+  N+ L     +  + AK++DF +++     Q   +   ++G + +MAP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 466 EY--AMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF 523
           E   A E  ++ K+D +SF +I+  I++G+     Y  G     + ++  + +EG     
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEG----- 246
Query: 524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
           + P + +    P++   I    LC   DP  RP  S +V  L
Sbjct: 247 LRPTIPEDCP-PRLRNVIE---LCWSGDPKKRPHFSYIVKEL 284

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/226 (33%), Positives = 118/226 (52%), Gaps = 17/226 (7%)
Query: 274 VSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK- 327
           + S E P   L  I   T+ F     LG G FGTVYKG+ +P G++V    A+K L    
Sbjct: 5   IRSGEAPNQALLRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 63
Query: 328 SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ 387
           S +  +E  +E  ++A + + ++ RL+G  +    +L I +LMP     C + D  R  +
Sbjct: 64  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMP---FGCLL-DYVREHK 118
Query: 388 LNWNTCY--NIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC 445
            N  + Y  N    I+KG+ YL ED RL  +HRDL   NVL+      KI+DFG A++  
Sbjct: 119 DNIGSQYLLNWCVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLG 175
Query: 446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
             +K  +         +MA E  +  +++ +SDV+S+GV V E+++
Sbjct: 176 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 128/267 (47%), Gaps = 25/267 (9%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE 359
           +G+G FG V K      K+VA+K++  +S +  + F  E+  ++++ H N+V+L G  + 
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 73
Query: 360 GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRD 419
                L+ E     SL   +  +E           +     S+G+ YLH      +IHRD
Sbjct: 74  --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 131
Query: 420 LKPSNVLL-DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           LKP N+LL     V KI DFG A   C+ Q      +  G+  +MAPE      +S K D
Sbjct: 132 LKPPNLLLVAGGTVLKICDFGTA---CDIQTHMTNNK--GSAAWMAPEVFEGSNYSEKCD 186
Query: 479 VFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVV 538
           VFS+G+I+ E+I+ +R     + G A  ++  V              P L+K  ++P+ +
Sbjct: 187 VFSWGIILWEVIT-RRKPFDEIGGPAFRIMWAV---------HNGTRPPLIK--NLPKPI 234
Query: 539 RCIHIGLLCVQEDPAVRPTMSNVVALL 565
             +     C  +DP+ RP+M  +V ++
Sbjct: 235 ESLMT--RCWSKDPSQRPSMEEIVKIM 259

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 110/206 (53%), Gaps = 16/206 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP     C + D  R  + N  + Y  N    I+KG+ 
Sbjct: 81  PHVCRLLGICLTSTVQL-IMQLMP---FGCLL-DYVREHKDNIGSQYLLNWCVQIAKGMN 135
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL ED RL  +HRDL   NVL+      KI+DFG A++    +K  +         +MA 
Sbjct: 136 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 193 ESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 128/267 (47%), Gaps = 25/267 (9%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE 359
           +G+G FG V K      K+VA+K++  +S +  + F  E+  ++++ H N+V+L G  + 
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 360 GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRD 419
                L+ E     SL   +  +E           +     S+G+ YLH      +IHRD
Sbjct: 73  --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 420 LKPSNVLL-DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           LKP N+LL     V KI DFG A   C+ Q      +  G+  +MAPE      +S K D
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTA---CDIQTHMTNNK--GSAAWMAPEVFEGSNYSEKCD 185
Query: 479 VFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVV 538
           VFS+G+I+ E+I+ +R     + G A  ++  V              P L+K  ++P+ +
Sbjct: 186 VFSWGIILWEVIT-RRKPFDEIGGPAFRIMWAV---------HNGTRPPLIK--NLPKPI 233
Query: 539 RCIHIGLLCVQEDPAVRPTMSNVVALL 565
             +     C  +DP+ RP+M  +V ++
Sbjct: 234 ESLMT--RCWSKDPSQRPSMEEIVKIM 258

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 128/299 (42%), Gaps = 56/299 (18%)
Query: 300 LGQGGFGTVYKGVL----PNGKEVAVKRLSR-KSWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG VY G       N  + A+K LSR    Q +E F  E +L+  L H N++ L+
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 355 GCGI--EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
           G  +  EG   +L+   M +  L  FI   +R   +     + +   +++G+ YL E   
Sbjct: 89  GIMLPPEGLPHVLL-PYMCHGDLLQFIRSPQRNPTVKDLISFGL--QVARGMEYLAEQ-- 143
Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAPEYAME 470
            K +HRDL   N +LD+    K++DFG+AR   + +       R       + A E    
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 471 GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL--- 527
             F+ KSDV+SFGV++ E+++                        +       +DP    
Sbjct: 203 YRFTTKSDVWSFGVLLWELLT------------------------RGAPPYRHIDPFDLT 238
Query: 528 --LMKSSSIPQVVRC----IHIGLLCVQEDPAVRPTMSNVV--------ALLGSESIAL 572
             L +   +PQ   C      +   C + DPAVRPT   +V        ALLG   + L
Sbjct: 239 HFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQL 297

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 110/206 (53%), Gaps = 16/206 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP     C + D  R  + N  + Y  N    I+KG+ 
Sbjct: 79  PHVCRLLGICLTSTVQL-IMQLMP---FGCLL-DYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL ED RL  +HRDL   NVL+      KI+DFG A++    +K  +         +MA 
Sbjct: 134 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 106/211 (50%), Gaps = 11/211 (5%)
Query: 287 IKAATDGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRKSWQG---LEEFKNEIILI 342
           I    + F   N LG+G F  VY+   +  G EVA+K + +K+      ++  +NE+ + 
Sbjct: 6   IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIH 65
Query: 343 AKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
            +L+H +++ L     +     L+ E+  N  ++ ++    R    + N   + +  I  
Sbjct: 66  CQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL--KNRVKPFSENEARHFMHQIIT 123
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           G+LYLH      I+HRDL  SN+LL ++M  KI+DFG+A       +   T  + GT  Y
Sbjct: 124 GMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNY 178
Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           ++PE A      ++SDV+S G +   ++ G+
Sbjct: 179 ISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 110/206 (53%), Gaps = 16/206 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP     C + D  R  + N  + Y  N    I+KG+ 
Sbjct: 79  PHVCRLLGICLTSTVQL-IMQLMP---FGCLL-DYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL ED RL  +HRDL   NVL+      KI+DFG A++    +K  +         +MA 
Sbjct: 134 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 110/206 (53%), Gaps = 16/206 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP     C + D  R  + N  + Y  N    I+KG+ 
Sbjct: 77  PHVCRLLGICLTSTVQL-ITQLMP---FGCLL-DYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL ED RL  +HRDL   NVL+      KI+DFG A++    +K  +         +MA 
Sbjct: 132 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 110/206 (53%), Gaps = 16/206 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP     C + D  R  + N  + Y  N    I+KG+ 
Sbjct: 79  PHVCRLLGICLTSTVQL-ITQLMP---FGCLL-DYVREHKDNIGSQYLLNWCVQIAKGMN 133
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL ED RL  +HRDL   NVL+      KI+DFG A++    +K  +         +MA 
Sbjct: 134 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 191 ESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 299 KLGQGGFGTVYKGVLPN-GKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLV--RLV 354
           +LG GGFG V + +  + G++VA+K+  ++ S +  E +  EI ++ KL H N+V  R V
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 355 GCGIE----GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
             G++     +  LL  E      L  ++   E    L       ++  IS  L YLHE+
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140
Query: 411 SRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
              +IIHRDLKP N++L    + ++ KI D G A+   + +        VGT  Y+APE 
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE---FVGTLQYLAPEL 194
Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGKR 494
             +  ++V  D +SFG +  E I+G R
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 106/207 (51%), Gaps = 17/207 (8%)
Query: 299 KLGQGGFGTVYKGVLPN-GKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLV--RLV 354
           +LG GGFG V + +  + G++VA+K+  ++ S +  E +  EI ++ KL H N+V  R V
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 355 GCGIE----GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
             G++     +  LL  E      L  ++   E    L       ++  IS  L YLHE+
Sbjct: 82  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 141
Query: 411 SRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
              +IIHRDLKP N++L    + ++ KI D G A+   + +        VGT  Y+APE 
Sbjct: 142 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE---FVGTLQYLAPEL 195
Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGKR 494
             +  ++V  D +SFG +  E I+G R
Sbjct: 196 LEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     LG G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP     C + D  R  + N  + Y  N    I++G+ 
Sbjct: 74  PHVCRLLGICLTSTVQL-ITQLMP---FGCLL-DYVREHKDNIGSQYLLNWCVQIAEGMN 128
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL ED RL  +HRDL   NVL+      KI+DFG+A++    +K  +         +MA 
Sbjct: 129 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 185
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 186 ESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/226 (32%), Positives = 118/226 (52%), Gaps = 17/226 (7%)
Query: 274 VSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK- 327
           + S E P   L  I   T+ F     L  G FGTVYKG+ +P G++V    A+K L    
Sbjct: 5   IRSGEAPNQALLRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 63
Query: 328 SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ 387
           S +  +E  +E  ++A + + ++ RL+G  +    +L I +LMP     C + D  R  +
Sbjct: 64  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-IMQLMP---FGCLL-DYVREHK 118
Query: 388 LNWNTCY--NIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC 445
            N  + Y  N    I+KG+ YL ED RL  +HRDL   NVL+      KI+DFG+A++  
Sbjct: 119 DNIGSQYLLNWCVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLG 175
Query: 446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
             +K  +         +MA E  +  +++ +SDV+S+GV V E+++
Sbjct: 176 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/226 (32%), Positives = 118/226 (52%), Gaps = 17/226 (7%)
Query: 274 VSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK- 327
           + S E P   L  I   T+ F     L  G FGTVYKG+ +P G++V    A+K L    
Sbjct: 5   IRSGEAPNQALLRILKETE-FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 63
Query: 328 SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ 387
           S +  +E  +E  ++A + + ++ RL+G  +    +L I +LMP     C + D  R  +
Sbjct: 64  SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMP---FGCLL-DYVREHK 118
Query: 388 LNWNTCY--NIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC 445
            N  + Y  N    I+KG+ YL ED RL  +HRDL   NVL+      KI+DFG+A++  
Sbjct: 119 DNIGSQYLLNWCVQIAKGMNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLG 175
Query: 446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
             +K  +         +MA E  +  +++ +SDV+S+GV V E+++
Sbjct: 176 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 125/277 (45%), Gaps = 35/277 (12%)
Query: 300 LGQGGFGTVYKGVLPNGK----EVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           LG+G FG VY+GV  N K     VAVK   +  +    E+F +E +++  L H ++V+L+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           G  IE E   +I EL P   L  ++  ++  L++     Y++   I K + YL     + 
Sbjct: 76  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 129
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
            +HRD+   N+L+      K+ DFG++R + E++             +M+PE      F+
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESINFRRFT 188
Query: 475 VKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSI 534
             SDV+ F V + EI+S  +   F                W E K+   V  +L K   +
Sbjct: 189 TASDVWMFAVCMWEILSFGKQPFF----------------WLENKD---VIGVLEKGDRL 229
Query: 535 PQVVRC----IHIGLLCVQEDPAVRPTMSNVVALLGS 567
           P+   C      +   C   DP+ RP  + +V  L  
Sbjct: 230 PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 266

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 110/206 (53%), Gaps = 16/206 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQH 347
           F     L  G FGTVYKG+ +P G++V    A+K L    S +  +E  +E  ++A + +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLL 405
            ++ RL+G  +    +L I +LMP     C + D  R  + N  + Y  N    I+KG+ 
Sbjct: 77  PHVCRLLGICLTSTVQL-ITQLMP---FGCLL-DYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL ED RL  +HRDL   NVL+      KI+DFG+A++    +K  +         +MA 
Sbjct: 132 YL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS 491
           E  +  +++ +SDV+S+GV V E+++
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 108/203 (53%), Gaps = 19/203 (9%)
Query: 300 LGQGGFGTVYKGVL--PNGKEV--AVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG VY G L   +GK++  AVK L+R +  G + +F  E I++    H N++ L+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 355 GCGIEGE-EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHED 410
           G  +  E   L++   M +  L  FI     R + +  T  ++IG    ++KG+ YL   
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKYL--- 148
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA--NTRRVVGTYGYMAPEYA 468
           +  K +HRDL   N +LD+    K++DFG+AR   + +  +  N         +MA E  
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESL 208
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               F+ KSDV+SFGV++ E+++
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELMT 231

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 37/278 (13%)
Query: 300 LGQGGFGTVYKGVLPNGK----EVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           LG+G FG VY+GV  N K     VAVK   +  +    E+F +E +++  L H ++V+L+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           G  IE E   +I EL P   L  ++  ++  L++     Y++   I K + YL     + 
Sbjct: 92  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 145
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCENQKTANTRRVVGTYGYMAPEYAMEGLF 473
            +HRD+   N+L+      K+ DFG++R I  E+   A+  R+     +M+PE      F
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 203
Query: 474 SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSS 533
           +  SDV+ F V + EI+S  +   F                W E K+   V  +L K   
Sbjct: 204 TTASDVWMFAVCMWEILSFGKQPFF----------------WLENKD---VIGVLEKGDR 244
Query: 534 IPQVVRC----IHIGLLCVQEDPAVRPTMSNVVALLGS 567
           +P+   C      +   C   DP+ RP  + +V  L  
Sbjct: 245 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 282

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 128/278 (46%), Gaps = 37/278 (13%)
Query: 300 LGQGGFGTVYKGVLPNGK----EVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           LG+G FG VY+GV  N K     VAVK   +  +    E+F +E +++  L H ++V+L+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           G  IE E   +I EL P   L  ++  ++  L++     Y++   I K + YL     + 
Sbjct: 80  GI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL--QICKAMAYLES---IN 133
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCENQKTANTRRVVGTYGYMAPEYAMEGLF 473
            +HRD+   N+L+      K+ DFG++R I  E+   A+  R+     +M+PE      F
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRF 191
Query: 474 SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSS 533
           +  SDV+ F V + EI+S  +   F                W E K+   V  +L K   
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQPFF----------------WLENKD---VIGVLEKGDR 232
Query: 534 IPQVVRC----IHIGLLCVQEDPAVRPTMSNVVALLGS 567
           +P+   C      +   C   DP+ RP  + +V  L  
Sbjct: 233 LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD 270

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 300 LGQGGFGTVYKGVL--PNGKEV--AVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG VY G L   +GK++  AVK L+R +  G + +F  E I++    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 355 GCGIEGE-EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHED 410
           G  +  E   L++   M +  L  FI     R + +  T  ++IG    ++KG+ YL   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKYL--- 149
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAPEYA 468
           +  K +HRDL   N +LD+    K++DFG+AR   + +     N         +MA E  
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               F+ KSDV+SFGV++ E+++
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 21/201 (10%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAV----KRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +LG G FG VYK      KE +V    K +  KS + LE++  EI ++A   H N+V+L+
Sbjct: 44  ELGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
                     ++ E     ++D  + + ER   L  +    +       L YLH++   K
Sbjct: 101 DAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDN---K 155
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR-RVVGTYGYMAPEYAM---- 469
           IIHRDLK  N+L   D   K++DFG++    +N +T   R   +GT  +MAPE  M    
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVS---AKNTRTIQRRDSFIGTPYWMAPEVVMCETS 212
Query: 470 -EGLFSVKSDVFSFGVIVLEI 489
            +  +  K+DV+S G+ ++E+
Sbjct: 213 KDRPYDYKADVWSLGITLIEM 233

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 300 LGQGGFGTVYKGVL--PNGKEV--AVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG VY G L   +GK++  AVK L+R +  G + +F  E I++    H N++ L+
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 355 GCGIEGE-EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHED 410
           G  +  E   L++   M +  L  FI     R + +  T  ++IG    ++KG+ YL   
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKYL--- 168
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAPEYA 468
           +  K +HRDL   N +LD+    K++DFG+AR   + +     N         +MA E  
Sbjct: 169 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 228
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               F+ KSDV+SFGV++ E+++
Sbjct: 229 QTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 113/210 (53%), Gaps = 13/210 (6%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW-QGLEEFK-NEIILIAKL 345
           +   + +    K+G+G +G VYK     G+ VA+KR+   +  +G+      EI L+ +L
Sbjct: 17  QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 346 QHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
            H N+V L+   I  E  L L++E M  + L   + +++  LQ +    Y  +  + +G+
Sbjct: 77  HHPNIVSLIDV-IHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIY--LYQLLRGV 132
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            + H+    +I+HRDLKP N+L++ D   K++DFG+AR F    ++  T  VV T  Y A
Sbjct: 133 AHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-THEVV-TLWYRA 187
Query: 465 PEYAM-EGLFSVKSDVFSFGVIVLEIISGK 493
           P+  M    +S   D++S G I  E+I+GK
Sbjct: 188 PDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/199 (33%), Positives = 110/199 (55%), Gaps = 13/199 (6%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW-QGLEEFK-NEIILIAKLQHRNLVRLVGC 356
           K+G+G +G VYK     G+ VA+KR+   +  +G+      EI L+ +L H N+V L+  
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 357 GIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
            I  E  L L++E M  + L   + +++  LQ +    Y  +  + +G+ + H+    +I
Sbjct: 88  -IHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIY--LYQLLRGVAHCHQH---RI 140
Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM-EGLFS 474
           +HRDLKP N+L++ D   K++DFG+AR F    ++  T  VV T  Y AP+  M    +S
Sbjct: 141 LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-THEVV-TLWYRAPDVLMGSKKYS 198
Query: 475 VKSDVFSFGVIVLEIISGK 493
              D++S G I  E+I+GK
Sbjct: 199 TSVDIWSIGCIFAEMITGK 217

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 300 LGQGGFGTVYKGVL--PNGKEV--AVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG VY G L   +GK++  AVK L+R +  G + +F  E I++    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 355 GCGIEGE-EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHED 410
           G  +  E   L++   M +  L  FI     R + +  T  ++IG    ++KG+ YL   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKYL--- 149
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAPEYA 468
           +  K +HRDL   N +LD+    K++DFG+AR   + +     N         +MA E  
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               F+ KSDV+SFGV++ E+++
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 300 LGQGGFGTVYKGVL--PNGKEV--AVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG VY G L   +GK++  AVK L+R +  G + +F  E I++    H N++ L+
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 355 GCGIEGE-EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHED 410
           G  +  E   L++   M +  L  FI     R + +  T  ++IG    ++KG+ YL   
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKYL--- 144
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAPEYA 468
           +  K +HRDL   N +LD+    K++DFG+AR   + +     N         +MA E  
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               F+ KSDV+SFGV++ E+++
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 300 LGQGGFGTVYKGVL--PNGKEV--AVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG VY G L   +GK++  AVK L+R +  G + +F  E I++    H N++ L+
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 355 GCGIEGE-EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHED 410
           G  +  E   L++   M +  L  FI     R + +  T  ++IG    ++KG+ YL   
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKYL--- 141
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAPEYA 468
           +  K +HRDL   N +LD+    K++DFG+AR   + +     N         +MA E  
Sbjct: 142 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 201
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               F+ KSDV+SFGV++ E+++
Sbjct: 202 QTQKFTTKSDVWSFGVLLWELMT 224

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 300 LGQGGFGTVYKGVL--PNGKEV--AVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG VY G L   +GK++  AVK L+R +  G + +F  E I++    H N++ L+
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 355 GCGIEGE-EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHED 410
           G  +  E   L++   M +  L  FI     R + +  T  ++IG    ++KG+ YL   
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKYL--- 148
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAPEYA 468
           +  K +HRDL   N +LD+    K++DFG+AR   + +     N         +MA E  
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 208
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               F+ KSDV+SFGV++ E+++
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 300 LGQGGFGTVYKGVL--PNGKEV--AVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG VY G L   +GK++  AVK L+R +  G + +F  E I++    H N++ L+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 355 GCGIEGE-EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHED 410
           G  +  E   L++   M +  L  FI     R + +  T  ++IG    ++KG+ YL   
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKYL--- 147
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAPEYA 468
           +  K +HRDL   N +LD+    K++DFG+AR   + +     N         +MA E  
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 207
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               F+ KSDV+SFGV++ E+++
Sbjct: 208 QTQKFTTKSDVWSFGVLLWELMT 230

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 300 LGQGGFGTVYKGVL--PNGKEV--AVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG VY G L   +GK++  AVK L+R +  G + +F  E I++    H N++ L+
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 355 GCGIEGE-EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHED 410
           G  +  E   L++   M +  L  FI     R + +  T  ++IG    ++KG+ YL   
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKYL--- 167
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAPEYA 468
           +  K +HRDL   N +LD+    K++DFG+AR   + +     N         +MA E  
Sbjct: 168 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 227
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               F+ KSDV+SFGV++ E+++
Sbjct: 228 QTQKFTTKSDVWSFGVLLWELMT 250

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 300 LGQGGFGTVYKGVL--PNGKEV--AVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG VY G L   +GK++  AVK L+R +  G + +F  E I++    H N++ L+
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 355 GCGIEGE-EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHED 410
           G  +  E   L++   M +  L  FI     R + +  T  ++IG    ++KG+ YL   
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKYL--- 146
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAPEYA 468
           +  K +HRDL   N +LD+    K++DFG+AR   + +     N         +MA E  
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 206
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               F+ KSDV+SFGV++ E+++
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMT 229

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 84/271 (30%), Positives = 130/271 (47%), Gaps = 27/271 (9%)
Query: 280 PFVHLAVI--KAATDGF---SDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLE 333
           PF H  V   + A + F   S +  LG G FG V+K      G ++A K +  +  +  E
Sbjct: 72  PFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE 131
Query: 334 EFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTC 393
           E KNEI ++ +L H NL++L        + +L+ E +    L   I D    L    +T 
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT-ELDTI 190
Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVL-LDKDMVA-KISDFGMARIFCENQKTA 451
              +  I +G+ ++H+   + I+H DLKP N+L +++D    KI DFG+AR +   +K  
Sbjct: 191 L-FMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-- 244
Query: 452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTL---L 508
             +   GT  ++APE       S  +D++S GVI   ++SG   S F     A+TL   L
Sbjct: 245 -LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGL--SPFLGDNDAETLNNIL 301
Query: 509 AYVWQLWKE------GKEMEFVDPLLMKSSS 533
           A  W L  E       +  EF+  LL+K  S
Sbjct: 302 ACRWDLEDEEFQDISEEAKEFISKLLIKEKS 332

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 123/272 (45%), Gaps = 34/272 (12%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            +LG G FG V  G      +VAVK +   S    +EF  E   + KL H  LV+  G  
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLN--WNTCYNIIGGISKGLLYLHEDSRLKI 415
            +     ++ E + N  L  ++    + L+ +     CY++  G++   L  H+      
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA--FLESHQ-----F 125
Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAMEGL 472
           IHRDL   N L+D+D+  K+SDFGM R   ++Q  ++    VGT     + APE      
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS----VGTKFPVKWSAPEVFHYFK 181
Query: 473 FSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKS 531
           +S KSDV++FG+++ E+ S GK     Y        ++   +L++            + S
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPH----------LAS 231
Query: 532 SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA 563
            +I Q++        C  E P  RPT   +++
Sbjct: 232 DTIYQIMYS------CWHELPEKRPTFQQLLS 257

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 82/269 (30%), Positives = 128/269 (47%), Gaps = 25/269 (9%)
Query: 271 GDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTV----YKGVLPN-GKEVAVKRLS 325
           GD+VS E+ P   +               LG+G FG V    Y     N G++VAVK L 
Sbjct: 1   GDIVS-EKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK 59
Query: 326 RKSW-QGLEEFKNEIILIAKLQHRNLVRLVG-CGIEGEEKL-LIYELMPNRSLDCFIFDS 382
            +S    + + K EI ++  L H N+V+  G C  +G   + LI E +P+ SL  ++  +
Sbjct: 60  PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN 119
Query: 383 ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR 442
           + ++ L     Y +   I KG+ YL   SR + +HRDL   NVL++ +   KI DFG+ +
Sbjct: 120 KNKINLKQQLKYAV--QICKGMDYL--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTK 174
Query: 443 IFCENQK--TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEII----SGKRNS 496
               +++  T    R    + Y APE  M+  F + SDV+SFGV + E++    S     
Sbjct: 175 AIETDKEXXTVKDDRDSPVFWY-APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM 233
Query: 497 GFYLT----GHAQTLLAYVWQLWKEGKEM 521
             +L      H Q  +  +    KEGK +
Sbjct: 234 ALFLKMIGPTHGQMTVTRLVNTLKEGKRL 262

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 106/202 (52%), Gaps = 11/202 (5%)
Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLV 351
           F+  +++G+G FG VYKG+  + KEV A+K +   ++   +E+ + EI ++++     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           R  G  ++  +  +I E +   S      D  +   L       I+  I KGL YLH + 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSER 136
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
           +   IHRD+K +NVLL +    K++DFG+A    + Q   N    VGT  +MAPE   + 
Sbjct: 137 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQS 191
Query: 472 LFSVKSDVFSFGVIVLEIISGK 493
            +  K+D++S G+  +E+  G+
Sbjct: 192 AYDFKADIWSLGITAIELAKGE 213

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 26/276 (9%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            +LG G FG V  G      +VA+K +   S    +EF  E  ++  L H  LV+L G  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +     +I E M N  L  ++ +   R Q        +   + + + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLESK---QFLH 143
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAMEGLFS 474
           RDL   N L++   V K+SDFG++R   ++++T++    VG+     +  PE  M   FS
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSS----VGSKFPVRWSPPEVLMYSKFS 199
Query: 475 VKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSS 533
            KSD+++FGV++ EI S GK     +        +A   +L++         P L     
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---------PHLASEKV 250
Query: 534 IPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES 569
              +  C H       E P  +  +SN++ ++  ES
Sbjct: 251 YTIMYSCWHEK---ADERPTFKILLSNILDVMDEES 283

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 104/196 (53%), Gaps = 13/196 (6%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE 359
           +G+G FG V  G    G +VAVK +   +    + F  E  ++ +L+H NLV+L+G  +E
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 360 GEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
            +  L ++ E M   SL  ++  S  R  L  +        + + + YL  ++    +HR
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 132
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL   NVL+ +D VAK+SDFG+ +   E   T +T ++     + APE   E  FS KSD
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREAAFSTKSD 187
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ EI S  R
Sbjct: 188 VWSFGILLWEIYSFGR 203

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 18/200 (9%)
Query: 300 LGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEE--FKNEIILIAKLQHRNLVRLVGC 356
           LG+G FG V K       +E AVK +++ S +  +      E+ L+ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
             +     ++ EL     L    FD   +R + + +    II  +  G+ Y+H+ +   I
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 416 IHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
           +HRDLKP N+LL   +KD   KI DFG++  F +N K  +    +GT  Y+APE  + G 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRGT 198
Query: 473 FSVKSDVFSFGVIVLEIISG 492
           +  K DV+S GVI+  ++SG
Sbjct: 199 YDEKCDVWSAGVILYILLSG 218

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 292 DGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQH 347
           + F     LG+G F TV     L   +E A+K L ++       +     E  ++++L H
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISKGLLY 406
              V+L  C  + E+         N  L  +I    R++     TC       I   L Y
Sbjct: 97  PFFVKLYFCFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 152
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y++PE
Sbjct: 153 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 209
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISG 492
              E      SD+++ G I+ ++++G
Sbjct: 210 LLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 18/200 (9%)
Query: 300 LGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEE--FKNEIILIAKLQHRNLVRLVGC 356
           LG+G FG V K       +E AVK +++ S +  +      E+ L+ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
             +     ++ EL     L    FD   +R + + +    II  +  G+ Y+H+ +   I
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 416 IHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
           +HRDLKP N+LL   +KD   KI DFG++  F +N K  +    +GT  Y+APE  + G 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRGT 198
Query: 473 FSVKSDVFSFGVIVLEIISG 492
           +  K DV+S GVI+  ++SG
Sbjct: 199 YDEKCDVWSAGVILYILLSG 218

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 18/200 (9%)
Query: 300 LGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEE--FKNEIILIAKLQHRNLVRLVGC 356
           LG+G FG V K       +E AVK +++ S +  +      E+ L+ KL H N+++L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
             +     ++ EL     L    FD   +R + + +    II  +  G+ Y+H+ +   I
Sbjct: 90  LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 416 IHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
           +HRDLKP N+LL   +KD   KI DFG++  F +N K  +    +GT  Y+APE  + G 
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR---IGTAYYIAPE-VLRGT 198
Query: 473 FSVKSDVFSFGVIVLEIISG 492
           +  K DV+S GVI+  ++SG
Sbjct: 199 YDEKCDVWSAGVILYILLSG 218

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 300 LGQGGFGTVYKGVL--PNGKEV--AVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG VY G L   +GK++  AVK L+R +  G + +F  E I++    H N++ L+
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 355 GCGIEGE-EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHED 410
           G  +  E   L++   M +  L  FI     R + +  T  ++IG    ++KG+ +L   
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKFL--- 208
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAPEYA 468
           +  K +HRDL   N +LD+    K++DFG+AR   + +     N         +MA E  
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               F+ KSDV+SFGV++ E+++
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 300 LGQGGFGTVYKGVL--PNGKEV--AVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG VY G L   +GK++  AVK L+R +  G + +F  E I++    H N++ L+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 355 GCGIEGE-EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHED 410
           G  +  E   L++   M +  L  FI     R + +  T  ++IG    ++KG+ +L   
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKFL--- 150
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAPEYA 468
           +  K +HRDL   N +LD+    K++DFG+AR   + +     N         +MA E  
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               F+ KSDV+SFGV++ E+++
Sbjct: 211 QTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 26/276 (9%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            +LG G FG V  G      +VA+K +   S    +EF  E  ++  L H  LV+L G  
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +     +I E M N  L  ++ +   R Q        +   + + + YL      + +H
Sbjct: 73  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLESK---QFLH 127
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAMEGLFS 474
           RDL   N L++   V K+SDFG++R   +++ T++    VG+     +  PE  M   FS
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFS 183
Query: 475 VKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSS 533
            KSD+++FGV++ EI S GK     +        +A   +L++         P L     
Sbjct: 184 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---------PHLASEKV 234
Query: 534 IPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES 569
              +  C H       E P  +  +SN++ ++  ES
Sbjct: 235 YTIMYSCWHEK---ADERPTFKILLSNILDVMDEES 267

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 104/196 (53%), Gaps = 13/196 (6%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE 359
           +G+G FG V  G    G +VAVK +   +    + F  E  ++ +L+H NLV+L+G  +E
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 360 GEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
            +  L ++ E M   SL  ++  S  R  L  +        + + + YL  ++    +HR
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL   NVL+ +D VAK+SDFG+ +   E   T +T ++     + APE   E  FS KSD
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKFSTKSD 368
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ EI S  R
Sbjct: 369 VWSFGILLWEIYSFGR 384

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 300 LGQGGFGTVYKGVL--PNGKEV--AVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG VY G L   +GK++  AVK L+R +  G + +F  E I++    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 355 GCGIEGE-EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHED 410
           G  +  E   L++   M +  L  FI     R + +  T  ++IG    ++KG+ +L   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKFL--- 149
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAPEYA 468
           +  K +HRDL   N +LD+    K++DFG+AR   + +     N         +MA E  
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               F+ KSDV+SFGV++ E+++
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMT 232

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 300 LGQGGFGTVYKGVL--PNGKEV--AVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG VY G L   +GK++  AVK L+R +  G + +F  E I++    H N++ L+
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 355 GCGIEGE-EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHED 410
           G  +  E   L++   M +  L  FI     R + +  T  ++IG    ++KG+ +L   
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKFL--- 147
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAPEYA 468
           +  K +HRDL   N +LD+    K++DFG+AR   + +     N         +MA E  
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 207
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               F+ KSDV+SFGV++ E+++
Sbjct: 208 QTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 300 LGQGGFGTVYKGVL--PNGKEV--AVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG VY G L   +GK++  AVK L+R +  G + +F  E I++    H N++ L+
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 355 GCGIEGE-EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHED 410
           G  +  E   L++   M +  L  FI     R + +  T  ++IG    ++KG+ +L   
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKFL--- 154
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAPEYA 468
           +  K +HRDL   N +LD+    K++DFG+AR   + +     N         +MA E  
Sbjct: 155 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 214
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               F+ KSDV+SFGV++ E+++
Sbjct: 215 QTQKFTTKSDVWSFGVLLWELMT 237

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 26/276 (9%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            +LG G FG V  G      +VA+K +   S    +EF  E  ++  L H  LV+L G  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +     +I E M N  L  ++ +   R Q        +   + + + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLESK---QFLH 123
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAMEGLFS 474
           RDL   N L++   V K+SDFG++R   +++ T++    VG+     +  PE  M   FS
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFS 179
Query: 475 VKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSS 533
            KSD+++FGV++ EI S GK     +        +A   +L++         P L     
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---------PHLASEKV 230
Query: 534 IPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES 569
              +  C H       E P  +  +SN++ ++  ES
Sbjct: 231 YTIMYSCWHEK---ADERPTFKILLSNILDVMDEES 263

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 300 LGQGGFGTVYKGVL--PNGKEV--AVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG VY G L   +GK++  AVK L+R +  G + +F  E I++    H N++ L+
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 355 GCGIEGE-EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHED 410
           G  +  E   L++   M +  L  FI     R + +  T  ++IG    ++KG+ +L   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKFL--- 149
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAPEYA 468
           +  K +HRDL   N +LD+    K++DFG+AR   + +     N         +MA E  
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               F+ KSDV+SFGV++ E+++
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 19/203 (9%)
Query: 300 LGQGGFGTVYKGVL--PNGKEV--AVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG VY G L   +GK++  AVK L+R +  G + +F  E I++    H N++ L+
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 355 GCGIEGE-EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKGLLYLHED 410
           G  +  E   L++   M +  L  FI     R + +  T  ++IG    ++KG+ +L   
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFI-----RNETHNPTVKDLIGFGLQVAKGMKFL--- 150
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAPEYA 468
           +  K +HRDL   N +LD+    K++DFG+AR   + +     N         +MA E  
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               F+ KSDV+SFGV++ E+++
Sbjct: 211 QTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 26/276 (9%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            +LG G FG V  G      +VA+K +   S    +EF  E  ++  L H  LV+L G  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +     +I E M N  L  ++ +   R Q        +   + + + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLESK---QFLH 143
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAMEGLFS 474
           RDL   N L++   V K+SDFG++R   +++ T++    VG+     +  PE  M   FS
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFS 199
Query: 475 VKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSS 533
            KSD+++FGV++ EI S GK     +        +A   +L++         P L     
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---------PHLASEKV 250
Query: 534 IPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES 569
              +  C H       E P  +  +SN++ ++  ES
Sbjct: 251 YTIMYSCWHEK---ADERPTFKILLSNILDVMDEES 283

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/240 (31%), Positives = 117/240 (48%), Gaps = 24/240 (10%)
Query: 300 LGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRL 353
           LG+G FG V    Y     N G++VAVK L  +S    + + K EI ++  L H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 354 VGCGIE--GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            G   E  G    LI E +P+ SL  ++  ++ ++ L     Y +   I KG+ YL   S
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV--QICKGMDYL--GS 132
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK--TANTRRVVGTYGYMAPEYAM 469
           R + +HRDL   NVL++ +   KI DFG+ +    +++  T    R    + Y APE  M
Sbjct: 133 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECLM 190
Query: 470 EGLFSVKSDVFSFGVIVLEII----SGKRNSGFYLT----GHAQTLLAYVWQLWKEGKEM 521
           +  F + SDV+SFGV + E++    S       +L      H Q  +  +    KEGK +
Sbjct: 191 QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL 250

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 26/276 (9%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            +LG G FG V  G      +VA+K +   S    +EF  E  ++  L H  LV+L G  
Sbjct: 21  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 79
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +     +I E M N  L  ++ +   R Q        +   + + + YL      + +H
Sbjct: 80  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLESK---QFLH 134
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAMEGLFS 474
           RDL   N L++   V K+SDFG++R   +++ T++    VG+     +  PE  M   FS
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFS 190
Query: 475 VKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSS 533
            KSD+++FGV++ EI S GK     +        +A   +L++         P L     
Sbjct: 191 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---------PHLASEKV 241
Query: 534 IPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES 569
              +  C H       E P  +  +SN++ ++  ES
Sbjct: 242 YTIMYSCWHEK---ADERPTFKILLSNILDVMDEES 274

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 104/196 (53%), Gaps = 13/196 (6%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE 359
           +G+G FG V  G    G +VAVK +   +    + F  E  ++ +L+H NLV+L+G  +E
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 360 GEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
            +  L ++ E M   SL  ++  S  R  L  +        + + + YL  ++    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 126
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL   NVL+ +D VAK+SDFG+ +   E   T +T ++     + APE   E  FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKFSTKSD 181
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ EI S  R
Sbjct: 182 VWSFGILLWEIYSFGR 197

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/204 (35%), Positives = 111/204 (54%), Gaps = 24/204 (11%)
Query: 300 LGQGGFGTVYKGV-LPNGKEV----AVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRL 353
           LG G FGTVYKG+ +P+G+ V    A+K L    S +  +E  +E  ++A +    + RL
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ----LNWNTCYNIIGGISKGLLYLHE 409
           +G  +    +L + +LMP   L   + ++  RL     LNW  C  I    +KG+ YL E
Sbjct: 85  LGICLTSTVQL-VTQLMPYGCLLDHVRENRGRLGSQDLLNW--CMQI----AKGMSYL-E 136
Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF--CENQKTANTRRVVGTYGYMAPEY 467
           D RL  +HRDL   NVL+      KI+DFG+AR+    E +  A+  +V     +MA E 
Sbjct: 137 DVRL--VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV--PIKWMALES 192
Query: 468 AMEGLFSVKSDVFSFGVIVLEIIS 491
            +   F+ +SDV+S+GV V E+++
Sbjct: 193 ILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 21/201 (10%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAV----KRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +LG G FG VYK      KE +V    K +  KS + LE++  EI ++A   H N+V+L+
Sbjct: 44  ELGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
                     ++ E     ++D  + + ER   L  +    +       L YLH++   K
Sbjct: 101 DAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDN---K 155
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR-RVVGTYGYMAPEYAM---- 469
           IIHRDLK  N+L   D   K++DFG++    +N +    R   +GT  +MAPE  M    
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVS---AKNTRXIQRRDSFIGTPYWMAPEVVMCETS 212
Query: 470 -EGLFSVKSDVFSFGVIVLEI 489
            +  +  K+DV+S G+ ++E+
Sbjct: 213 KDRPYDYKADVWSLGITLIEM 233

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 104/196 (53%), Gaps = 13/196 (6%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE 359
           +G+G FG V  G    G +VAVK +   +    + F  E  ++ +L+H NLV+L+G  +E
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 360 GEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
            +  L ++ E M   SL  ++  S  R  L  +        + + + YL  ++    +HR
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSD 478
           DL   NVL+ +D VAK+SDFG+ +   E   T +T ++     + APE   E  FS KSD
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKKFSTKSD 196
Query: 479 VFSFGVIVLEIISGKR 494
           V+SFG+++ EI S  R
Sbjct: 197 VWSFGILLWEIYSFGR 212

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 21/201 (10%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAV----KRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +LG G FG VYK      KE +V    K +  KS + LE++  EI ++A   H N+V+L+
Sbjct: 44  ELGDGAFGKVYKA---QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 100
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
                     ++ E     ++D  + + ER   L  +    +       L YLH++   K
Sbjct: 101 DAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDN---K 155
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR-RVVGTYGYMAPEYAM---- 469
           IIHRDLK  N+L   D   K++DFG++    +N +    R   +GT  +MAPE  M    
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVS---AKNTRXIQRRDXFIGTPYWMAPEVVMCETS 212
Query: 470 -EGLFSVKSDVFSFGVIVLEI 489
            +  +  K+DV+S G+ ++E+
Sbjct: 213 KDRPYDYKADVWSLGITLIEM 233

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 93/194 (47%), Gaps = 7/194 (3%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            +LG G FG V  G      +VA+K +   S    +EF  E  ++  L H  LV+L G  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +     +I E M N  L  ++ +   R Q        +   + + + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLESK---QFLH 128
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKS 477
           RDL   N L++   V K+SDFG++R   +++ T+ +R       +  PE  M   FS KS
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS-SRGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 478 DVFSFGVIVLEIIS 491
           D+++FGV++ EI S
Sbjct: 188 DIWAFGVLMWEIYS 201

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 120/291 (41%), Gaps = 49/291 (16%)
Query: 300 LGQGGFGTVYKGVLP-----NGKEVAVKRLS-------RKSWQGLEEFKNEIILIAKLQH 347
           LG+G FG V            G+ VAVK L        R  WQ       EI ++  L H
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQ------REIEILRTLYH 70
Query: 348 RNLVRLVGCGIEGEEK--LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
            ++V+  GC  +  EK   L+ E +P  SL     D   R  +           I +G+ 
Sbjct: 71  EHIVKYKGCCEDQGEKSVQLVMEYVPLGSLR----DYLPRHCVGLAQLLLFAQQICEGMA 126
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMA 464
           YLH       IHR L   NVLLD D + KI DFG+A+   E  +    R    +   + A
Sbjct: 127 YLHAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 183
Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIIS------GKRNSGFYLTGHAQTLLAYVWQLWKEG 518
           PE   E  F   SDV+SFGV + E+++              L GH Q  +  +       
Sbjct: 184 PECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVL------- 236
Query: 519 KEMEFVDPLLMKSSSIPQVVRC----IHIGLLCVQEDPAVRPTMSNVVALL 565
                +  LL +   +P+  RC     H+   C + + + RPT  N+V +L
Sbjct: 237 ----RLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPIL 283

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 96/196 (48%), Gaps = 7/196 (3%)
Query: 298 NKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLE-EFKNEIILIAKLQHRNLVRLVG 355
            ++G+G FG V+ G L  +   VAVK         L+ +F  E  ++ +  H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
              + +   ++ EL+       F+     RL++   T   ++G  + G+ YL        
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEYLESKC---C 234
Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSV 475
           IHRDL   N L+ +  V KISDFGM+R   +    A+         + APE    G +S 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 476 KSDVFSFGVIVLEIIS 491
           +SDV+SFG+++ E  S
Sbjct: 295 ESDVWSFGILLWETFS 310

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 21/201 (10%)
Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           +LG G FG VYK      G   A K +  KS + LE++  EI ++A   H  +V+L+G  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRL---QLNWNTCYNIIGGISKGLLYLHEDSRLK 414
               +  ++ E  P  ++D  + + +R L   Q+    C  ++    + L +LH     +
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ-VVCRQML----EALNFLHSK---R 129
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR-RVVGTYGYMAPEYAM---- 469
           IIHRDLK  NVL+  +   +++DFG++    +N KT   R   +GT  +MAPE  M    
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVS---AKNLKTLQKRDSFIGTPYWMAPEVVMCETM 186
Query: 470 -EGLFSVKSDVFSFGVIVLEI 489
            +  +  K+D++S G+ ++E+
Sbjct: 187 KDTPYDYKADIWSLGITLIEM 207

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 21/201 (10%)
Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           +LG G FG VYK      G   A K +  KS + LE++  EI ++A   H  +V+L+G  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRL---QLNWNTCYNIIGGISKGLLYLHEDSRLK 414
               +  ++ E  P  ++D  + + +R L   Q+    C  ++    + L +LH     +
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ-VVCRQML----EALNFLHSK---R 137
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR-RVVGTYGYMAPEYAM---- 469
           IIHRDLK  NVL+  +   +++DFG++    +N KT   R   +GT  +MAPE  M    
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVS---AKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 470 -EGLFSVKSDVFSFGVIVLEI 489
            +  +  K+D++S G+ ++E+
Sbjct: 195 KDTPYDYKADIWSLGITLIEM 215

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 120/291 (41%), Gaps = 49/291 (16%)
Query: 300 LGQGGFGTVYKGVLP-----NGKEVAVKRLS-------RKSWQGLEEFKNEIILIAKLQH 347
           LG+G FG V            G+ VAVK L        R  WQ       EI ++  L H
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQ------REIEILRTLYH 69
Query: 348 RNLVRLVGCGIEGEEK--LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
            ++V+  GC  +  EK   L+ E +P  SL     D   R  +           I +G+ 
Sbjct: 70  EHIVKYKGCCEDQGEKSVQLVMEYVPLGSLR----DYLPRHCVGLAQLLLFAQQICEGMA 125
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMA 464
           YLH       IHR L   NVLLD D + KI DFG+A+   E  +    R    +   + A
Sbjct: 126 YLHAQH---YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 182
Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIIS------GKRNSGFYLTGHAQTLLAYVWQLWKEG 518
           PE   E  F   SDV+SFGV + E+++              L GH Q  +  +       
Sbjct: 183 PECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVL------- 235
Query: 519 KEMEFVDPLLMKSSSIPQVVRC----IHIGLLCVQEDPAVRPTMSNVVALL 565
                +  LL +   +P+  RC     H+   C + + + RPT  N+V +L
Sbjct: 236 ----RLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPIL 282

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V    +E VAVK +  +++    E  K EI + A L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 47/278 (16%)
Query: 300 LGQGGFGTVYKGV-LPNGKE----VAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRL 353
           LG G FGTV+KGV +P G+     V +K +  KS  Q  +   + ++ I  L H ++VRL
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 98
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERR--------LQLNWNTCYNIIGGISKGLL 405
           +G    G    L+ + +P  SL     D  R+        L LNW         I+KG+ 
Sbjct: 99  LGL-CPGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQ------IAKGMY 147
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL E     ++HR+L   NVLL      +++DFG+A +   + K            +MA 
Sbjct: 148 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E    G ++ +SDV+S+GV V E+++      F    +A   LA V  L ++G+ +    
Sbjct: 205 ESIHFGKYTHQSDVWSYGVTVWELMT------FGAEPYAGLRLAEVPDLLEKGERL---- 254
Query: 526 PLLMKSSSIPQV--VRCIHIGLLCVQEDPAVRPTMSNV 561
                  + PQ+  +    + + C   D  +RPT   +
Sbjct: 255 -------AQPQICTIDVYMVMVKCWMIDENIRPTFKEL 285

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 96/196 (48%), Gaps = 7/196 (3%)
Query: 298 NKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLE-EFKNEIILIAKLQHRNLVRLVG 355
            ++G+G FG V+ G L  +   VAVK         L+ +F  E  ++ +  H N+VRL+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
              + +   ++ EL+       F+     RL++   T   ++G  + G+ YL        
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEYLESKC---C 234
Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSV 475
           IHRDL   N L+ +  V KISDFGM+R   +    A+         + APE    G +S 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 476 KSDVFSFGVIVLEIIS 491
           +SDV+SFG+++ E  S
Sbjct: 295 ESDVWSFGILLWETFS 310

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 95/197 (48%), Gaps = 13/197 (6%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            +LG G FG V  G      +VA+K +   S    +EF  E  ++  L H  LV+L G  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +     +I E M N  L  ++ +   R Q        +   + + + YL      + +H
Sbjct: 74  TKQRPIFIITEYMANGCLLNYLREMRHRFQTQ--QLLEMCKDVCEAMEYLESK---QFLH 128
Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAMEGLFS 474
           RDL   N L++   V K+SDFG++R   +++ T++    VG+     +  PE  M   FS
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS----VGSKFPVRWSPPEVLMYSKFS 184
Query: 475 VKSDVFSFGVIVLEIIS 491
            KSD+++FGV++ EI S
Sbjct: 185 SKSDIWAFGVLMWEIYS 201

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 127/278 (45%), Gaps = 47/278 (16%)
Query: 300 LGQGGFGTVYKGV-LPNGKE----VAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRL 353
           LG G FGTV+KGV +P G+     V +K +  KS  Q  +   + ++ I  L H ++VRL
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERR--------LQLNWNTCYNIIGGISKGLL 405
           +G    G    L+ + +P  SL     D  R+        L LNW         I+KG+ 
Sbjct: 81  LGL-CPGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWGVQ------IAKGMY 129
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YL E     ++HR+L   NVLL      +++DFG+A +   + K            +MA 
Sbjct: 130 YLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E    G ++ +SDV+S+GV V E+++      F    +A   LA V  L ++G+ +    
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMT------FGAEPYAGLRLAEVPDLLEKGERL---- 236
Query: 526 PLLMKSSSIPQV--VRCIHIGLLCVQEDPAVRPTMSNV 561
                  + PQ+  +    + + C   D  +RPT   +
Sbjct: 237 -------AQPQICTIDVYMVMVKCWMIDENIRPTFKEL 267

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 106/202 (52%), Gaps = 11/202 (5%)
Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLV 351
           F+   ++G+G FG V+KG+    ++V A+K +   ++   +E+ + EI ++++     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +  G  ++G +  +I E +   S      D  R    +      ++  I KGL YLH + 
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 140
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
           +   IHRD+K +NVLL +    K++DFG+A    + Q   NT   VGT  +MAPE   + 
Sbjct: 141 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 195
Query: 472 LFSVKSDVFSFGVIVLEIISGK 493
            +  K+D++S G+  +E+  G+
Sbjct: 196 AYDSKADIWSLGITAIELAKGE 217

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 292 DGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQH 347
           + F     LG+G F TV     L   +E A+K L ++       +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISKGLLY 406
              V+L     + E+         N  L  +I    R++     TC       I   L Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI----RKIGSFDETCTRFYTAEIVSALEY 147
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y++PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 204
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISG 492
              E   S  SD+++ G I+ ++++G
Sbjct: 205 LLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 127/287 (44%), Gaps = 37/287 (12%)
Query: 300 LGQGGFGTVYKGVLP-----NGKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRL 353
           LG+G FG V            G+ VAVK L      Q    +K EI ++  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 354 VGC-GIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            GC   +GE+ L L+ E +P  SL  ++     R  +           I +G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHSQH 137
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
               IHR+L   NVLLD D + KI DFG+A+   E  +    R    +   + APE   E
Sbjct: 138 ---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 471 GLFSVKSDVFSFGVIVLEIISGKRNSG------FYLTGHAQTLLAYVWQLWKEGKEMEFV 524
             F   SDV+SFGV + E+++   +S         L G AQ  +  +            +
Sbjct: 195 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL-----------RL 243
Query: 525 DPLLMKSSSIPQVVRC----IHIGLLCVQEDPAVRPTMSNVVALLGS 567
             LL +   +P+  +C     H+   C + + + RPT  N++ +L +
Sbjct: 244 TELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKT 290

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 127/287 (44%), Gaps = 37/287 (12%)
Query: 300 LGQGGFGTVYKGVLP-----NGKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRL 353
           LG+G FG V            G+ VAVK L      Q    +K EI ++  L H ++++ 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 354 VGC-GIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            GC   +GE+ L L+ E +P  SL  ++     R  +           I +G+ YLH   
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHAQH 137
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
               IHR+L   NVLLD D + KI DFG+A+   E  +    R    +   + APE   E
Sbjct: 138 ---YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE 194
Query: 471 GLFSVKSDVFSFGVIVLEIISGKRNSG------FYLTGHAQTLLAYVWQLWKEGKEMEFV 524
             F   SDV+SFGV + E+++   +S         L G AQ  +  +            +
Sbjct: 195 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL-----------RL 243
Query: 525 DPLLMKSSSIPQVVRC----IHIGLLCVQEDPAVRPTMSNVVALLGS 567
             LL +   +P+  +C     H+   C + + + RPT  N++ +L +
Sbjct: 244 TELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKT 290

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIA 343
           K   + F     LG+G F TV     L   +E A+K L ++       +     E  +++
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 65
Query: 344 KLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISK 402
           +L H   V+L     + E+         N  L  +I    R++     TC       I  
Sbjct: 66  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVS 121
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
            L YLH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y
Sbjct: 122 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 178
Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           ++PE   E      SD+++ G I+ ++++G
Sbjct: 179 VSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 114/218 (52%), Gaps = 23/218 (10%)
Query: 287 IKAATDGFSDSNK----LGQGGFGTVY--KGVLPNGKEVAVKRLSR---KSWQGLEEFKN 337
           ++ +T  FSD  K    LG+G FG V   K  +  G+E AVK +S+   K     E    
Sbjct: 23  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLR 81
Query: 338 EIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNII 397
           E+ L+ +L H N+++L     +     L+ E+     L   I   +R  +++      II
Sbjct: 82  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARII 138
Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTR 454
             +  G+ Y+H++   KI+HRDLKP N+LL+   KD   +I DFG++  F  ++K  +  
Sbjct: 139 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK- 194
Query: 455 RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
             +GT  Y+APE  + G +  K DV+S GVI+  ++SG
Sbjct: 195 --IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIA 343
           K   + F     LG+G F TV     L   +E A+K L ++       +     E  +++
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 64
Query: 344 KLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISK 402
           +L H   V+L     + E+         N  L  +I    R++     TC       I  
Sbjct: 65  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVS 120
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
            L YLH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y
Sbjct: 121 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 177
Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           ++PE   E      SD+++ G I+ ++++G
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 114/218 (52%), Gaps = 23/218 (10%)
Query: 287 IKAATDGFSDSNK----LGQGGFGTVY--KGVLPNGKEVAVKRLSR---KSWQGLEEFKN 337
           ++ +T  FSD  K    LG+G FG V   K  +  G+E AVK +S+   K     E    
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLR 75
Query: 338 EIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNII 397
           E+ L+ +L H N+++L     +     L+ E+     L   I   +R  +++      II
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARII 132
Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTR 454
             +  G+ Y+H++   KI+HRDLKP N+LL+   KD   +I DFG++  F  ++K  +  
Sbjct: 133 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK- 188
Query: 455 RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
             +GT  Y+APE  + G +  K DV+S GVI+  ++SG
Sbjct: 189 --IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIA 343
           K   + F     LG+G F TV     L   +E A+K L ++       +     E  +++
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 344 KLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISK 402
           +L H   V+L     + E+         N  L  +I    R++     TC       I  
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVS 119
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
            L YLH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y
Sbjct: 120 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 176
Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           ++PE   E      SD+++ G I+ ++++G
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 27/285 (9%)
Query: 292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQ-GLEEFKNEIILIAKLQHRN 349
           D +     +G G    V      P  ++VA+KR++ +  Q  ++E   EI  +++  H N
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRS----LDCFIFDSERRLQ-LNWNTCYNIIGGISKGL 404
           +V      +  +E  L+ +L+   S    +   +   E +   L+ +T   I+  + +GL
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK-TANTRR--VVGTYG 461
            YLH++ +   IHRD+K  N+LL +D   +I+DFG++         T N  R   VGT  
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 186
Query: 462 YMAPEYAMEGL--FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK 519
           +MAPE  ME +  +  K+D++SFG+  +E+ +G   +  Y       +L    Q      
Sbjct: 187 WMAPE-VMEQVRGYDFKADIWSFGITAIELATG---AAPYHKYPPMKVLMLTLQNDPPSL 242
Query: 520 EMEFVDPLLMKS--SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           E    D  ++K    S  +++       LC+Q+DP  RPT + ++
Sbjct: 243 ETGVQDKEMLKKYGKSFRKMIS------LCLQKDPEKRPTAAELL 281

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIA 343
           K   + F     LG+G F TV     L   +E A+K L ++       +     E  +++
Sbjct: 3   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 62
Query: 344 KLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISK 402
           +L H   V+L     + E+         N  L  +I    R++     TC       I  
Sbjct: 63  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVS 118
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
            L YLH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y
Sbjct: 119 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 175
Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           ++PE   E      SD+++ G I+ ++++G
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 112/221 (50%), Gaps = 33/221 (14%)
Query: 300 LGQGGFGTVYK----GVLPNGK--EVAVKRLSRKSWQGLE-EFKNEIILIAKLQHRNLVR 352
           +G+G FG V++    G+LP      VAVK L  ++   ++ +F+ E  L+A+  + N+V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFI-------------FDSERRLQLNWN-----TCY 394
           L+G    G+   L++E M    L+ F+              D   R +++       +C 
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 395 N---IIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCENQKT 450
               I   ++ G+ YL E    K +HRDL   N L+ ++MV KI+DFG++R I+  +   
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
           A+    +    +M PE      ++ +SDV+++GV++ EI S
Sbjct: 232 ADGNDAIPI-RWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 108/217 (49%), Gaps = 23/217 (10%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFK----NEIILIAK 344
           AT  +    ++G G +GTVYK   P+ G  VA+K  S +   G E        E+ L+ +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK--SVRVPNGEEGLPISTVREVALLRR 59
Query: 345 LQ---HRNLVRLVG-CGIEGEEK----LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNI 396
           L+   H N+VRL+  C     ++     L++E + ++ L  ++ D      L   T  ++
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDL 117
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           +    +GL +LH +    I+HRDLKP N+L+      K++DFG+ARI+      A    V
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP---V 171
Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  ++  ++   D++S G I  E+   K
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V    +E VAVK +  +++    E  K EI +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 125/285 (43%), Gaps = 37/285 (12%)
Query: 300 LGQGGFGTVYKGVLP-----NGKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRL 353
           LG+G FG V            G+ VAVK L   +  Q    +K EI ++  L H ++++ 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 354 VGCGIE-GEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            GC  + G   L L+ E +P  SL  ++     R  +           I +G+ YLH   
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHAQH 154
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT-YGYMAPEYAME 470
               IHRDL   NVLLD D + KI DFG+A+   E  +    R    +   + APE   E
Sbjct: 155 ---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKE 211
Query: 471 GLFSVKSDVFSFGVIVLEIISGKRNSG------FYLTGHAQTLLAYVWQLWKEGKEMEFV 524
             F   SDV+SFGV + E+++   +S         L G AQ  +  +            +
Sbjct: 212 YKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL-----------RL 260
Query: 525 DPLLMKSSSIPQVVRC----IHIGLLCVQEDPAVRPTMSNVVALL 565
             LL +   +P+  +C     H+   C + + + RPT  N++ +L
Sbjct: 261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V    +E VAVK +  +++    E  K EI +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V    +E VAVK +  +++    E  K EI +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V    +E VAVK +  +++    E  K EI +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V    +E VAVK +  +++    E  K EI +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V    +E VAVK +  +++    E  K EI +   L H N+V+  G  
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 73  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 125
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 186 PVDVWSCGIVLTAMLAGE 203

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V    +E VAVK +  +++    E  K EI +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 126
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 27/285 (9%)
Query: 292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQ-GLEEFKNEIILIAKLQHRN 349
           D +     +G G    V      P  ++VA+KR++ +  Q  ++E   EI  +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRS----LDCFIFDSERRLQ-LNWNTCYNIIGGISKGL 404
           +V      +  +E  L+ +L+   S    +   +   E +   L+ +T   I+  + +GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK-TANTRR--VVGTYG 461
            YLH++ +   IHRD+K  N+LL +D   +I+DFG++         T N  R   VGT  
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 462 YMAPEYAMEGL--FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK 519
           +MAPE  ME +  +  K+D++SFG+  +E+ +G   +  Y       +L    Q      
Sbjct: 192 WMAPE-VMEQVRGYDFKADIWSFGITAIELATG---AAPYHKYPPMKVLMLTLQNDPPSL 247
Query: 520 EMEFVDPLLMKS--SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           E    D  ++K    S  +++       LC+Q+DP  RPT + ++
Sbjct: 248 ETGVQDKEMLKKYGKSFRKMIS------LCLQKDPEKRPTAAELL 286

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V    +E VAVK +  +++    E  K EI +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 114/218 (52%), Gaps = 23/218 (10%)
Query: 287 IKAATDGFSDSNK----LGQGGFGTVY--KGVLPNGKEVAVKRLSR---KSWQGLEEFKN 337
           ++ +T  FSD  K    LG+G FG V   K  +  G+E AVK +S+   K     E    
Sbjct: 40  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLR 98
Query: 338 EIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNII 397
           E+ L+ +L H N+++L     +     L+ E+     L   I   +R  +++      II
Sbjct: 99  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARII 155
Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTR 454
             +  G+ Y+H++   KI+HRDLKP N+LL+   KD   +I DFG++  F  ++K  +  
Sbjct: 156 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK- 211
Query: 455 RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
             +GT  Y+APE  + G +  K DV+S GVI+  ++SG
Sbjct: 212 --IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V    +E VAVK +  +++    E  K EI +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V    +E VAVK +  +++    E  K EI +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 126
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V    +E VAVK +  +++    E  K EI +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 126
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V    +E VAVK +  +++    E  K EI +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 127
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V    +E VAVK +  +++    E  K EI +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 127
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V    +E VAVK +  +++    E  K EI +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 127
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 292 DGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQH 347
           + F     LG+G F TV     L   +E A+K L ++       +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISKGLLY 406
              V+L     + E+         N  L  +I    R++     TC       I   L Y
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 145
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y++PE
Sbjct: 146 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISG 492
              E      SD+++ G I+ ++++G
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V    +E VAVK +  +++    E  K EI +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V    +E VAVK +  +++    E  K EI +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 187
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 188 PVDVWSCGIVLTAMLAGE 205

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V    +E VAVK +  +++    E  K EI +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 126
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V    +E VAVK +  +++    E  K EI +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 126
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 114/218 (52%), Gaps = 23/218 (10%)
Query: 287 IKAATDGFSDSNK----LGQGGFGTVY--KGVLPNGKEVAVKRLSR---KSWQGLEEFKN 337
           ++ +T  FSD  K    LG+G FG V   K  +  G+E AVK +S+   K     E    
Sbjct: 41  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLR 99
Query: 338 EIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNII 397
           E+ L+ +L H N+++L     +     L+ E+     L   I   +R  +++      II
Sbjct: 100 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARII 156
Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTR 454
             +  G+ Y+H++   KI+HRDLKP N+LL+   KD   +I DFG++  F  ++K  +  
Sbjct: 157 RQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK- 212
Query: 455 RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
             +GT  Y+APE  + G +  K DV+S GVI+  ++SG
Sbjct: 213 --IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 292 DGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQH 347
           + F     LG+G F TV     L   +E A+K L ++       +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISKGLLY 406
              V+L     + E+         N  L  +I    R++     TC       I   L Y
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 145
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y++PE
Sbjct: 146 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISG 492
              E      SD+++ G I+ ++++G
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 292 DGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQH 347
           + F     LG+G F TV     L   +E A+K L ++       +     E  ++++L H
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISKGLLY 406
              V+L     + E+         N  L  +I    R++     TC       I   L Y
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 150
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y++PE
Sbjct: 151 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 207
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISG 492
              E      SD+++ G I+ ++++G
Sbjct: 208 LLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 292 DGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQH 347
           + F     LG+G F TV     L   +E A+K L ++       +     E  ++++L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISKGLLY 406
              V+L     + E+         N  L  +I    R++     TC       I   L Y
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 148
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y++PE
Sbjct: 149 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 205
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISG 492
              E      SD+++ G I+ ++++G
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 292 DGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRKSWQGLEEFK-----NEIILIAKL 345
           + F     LG+G F TV     L   +E A+K L ++    ++E K      E  ++++L
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 89
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISKGL 404
            H   V+L     + E+         N  L  +I    R++     TC       I   L
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSAL 145
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            YLH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y++
Sbjct: 146 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           PE   E      SD+++ G I+ ++++G
Sbjct: 203 PELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 292 DGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQH 347
           + F     LG+G F TV     L   +E A+K L ++       +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISKGLLY 406
              V+L     + E+         N  L  +I    R++     TC       I   L Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 147
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y++PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISG 492
              E      SD+++ G I+ ++++G
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 292 DGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQH 347
           + F     LG+G F TV     L   +E A+K L ++       +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISKGLLY 406
              V+L     + E+         N  L  +I    R++     TC       I   L Y
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 145
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y++PE
Sbjct: 146 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE 202
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISG 492
              E      SD+++ G I+ ++++G
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 292 DGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQH 347
           + F     LG+G F TV     L   +E A+K L ++       +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISKGLLY 406
              V+L     + E+         N  L  +I    R++     TC       I   L Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 147
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y++PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISG 492
              E      SD+++ G I+ ++++G
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 292 DGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQH 347
           + F     LG+G F TV     L   +E A+K L ++       +     E  ++++L H
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISKGLLY 406
              V+L     + E+         N  L  +I    R++     TC       I   L Y
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 129
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y++PE
Sbjct: 130 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 186
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISG 492
              E      SD+++ G I+ ++++G
Sbjct: 187 LLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 292 DGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQH 347
           + F     LG+G F TV     L   +E A+K L ++       +     E  ++++L H
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISKGLLY 406
              V+L     + E+         N  L  +I    R++     TC       I   L Y
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 148
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y++PE
Sbjct: 149 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 205
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISG 492
              E      SD+++ G I+ ++++G
Sbjct: 206 LLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 292 DGFSDSNKLGQGGFGT-VYKGVLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQH 347
           + F     LG+G F T V    L   +E A+K L ++       +     E  ++++L H
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISKGLLY 406
              V+L     + E+         N  L  +I    R++     TC       I   L Y
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 145
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y++PE
Sbjct: 146 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISG 492
              E      SD+++ G I+ ++++G
Sbjct: 203 LLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 292 DGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQH 347
           + F     LG+G F TV     L   +E A+K L ++       +     E  ++++L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISKGLLY 406
              V+L     + E+         N  L  +I    R++     TC       I   L Y
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 144
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y++PE
Sbjct: 145 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 201
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISG 492
              E      SD+++ G I+ ++++G
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/271 (29%), Positives = 122/271 (45%), Gaps = 36/271 (13%)
Query: 299 KLGQGGFGTVYKGVL--PNGKEVAVKRLSRK-----SWQGLEEFKNEIILIAKLQHRNLV 351
           KLG G FG V +G    P+GK V+V     K       + +++F  E+  +  L HRNL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNW--NTCYNIIGGISKGLLYLHE 409
           RL G  +    K+ + EL P  SL     D  R+ Q ++   T       +++G+ YL  
Sbjct: 79  RLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK---TANTRRVVGTYGYMAPE 466
               + IHRDL   N+LL    + KI DFG+ R   +N         R+V   + + APE
Sbjct: 134 K---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--PFAWCAPE 188
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP 526
                 FS  SD + FGV + E+ +  +     L G +Q L     ++ KEG+       
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILH----KIDKEGER------ 237
Query: 527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT 557
            L +    PQ +   ++ + C    P  RPT
Sbjct: 238 -LPRPEDCPQDI--YNVMVQCWAHKPEDRPT 265

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 122/272 (44%), Gaps = 36/272 (13%)
Query: 298 NKLGQGGFGTVYKGVL--PNGK--EVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNL 350
            KLG G FG V +G    P+GK   VAVK L        + +++F  E+  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNW--NTCYNIIGGISKGLLYLH 408
           +RL G  +    K+ + EL P  SL     D  R+ Q ++   T       +++G+ YL 
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK---TANTRRVVGTYGYMAP 465
                + IHRDL   N+LL    + KI DFG+ R   +N         R+V   + + AP
Sbjct: 129 SK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--PFAWCAP 183
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E      FS  SD + FGV + E+ +  +     L G +Q L     ++ KEG+      
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILH----KIDKEGER----- 233
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT 557
             L +    PQ +  + +   C    P  RPT
Sbjct: 234 --LPRPEDCPQDIYNVMVQ--CWAHKPEDRPT 261

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V    +E VAVK +  +++    E  K EI +   L H N+V+  G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 126
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 292 DGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQH 347
           + F     LG+G F TV     L   +E A+K L ++       +     E  ++++L H
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISKGLLY 406
              V+L     + E+         N  L  +I    R++     TC       I   L Y
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 147
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y++PE
Sbjct: 148 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISG 492
              E      SD+++ G I+ ++++G
Sbjct: 205 LLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 13/202 (6%)
Query: 298 NKLGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           ++LG+G FG+V    Y  +  N G  VAVK+L         +F+ EI ++  L    +V+
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 353 LVGC--GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
             G   G    E  L+ E +P+  L  F+     RL  +    Y+    I KG+ YL   
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS--SQICKGMEYL--G 128
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-VGTYGYMAPEYAM 469
           SR + +HRDL   N+L++ +   KI+DFG+A++   ++     R        + APE   
Sbjct: 129 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLS 187
Query: 470 EGLFSVKSDVFSFGVIVLEIIS 491
           + +FS +SDV+SFGV++ E+ +
Sbjct: 188 DNIFSRQSDVWSFGVVLYELFT 209

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 12/206 (5%)
Query: 292 DGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQH 347
           + F     LG+G F TV     L   +E A+K L ++       +     E  ++++L H
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISKGLLY 406
              V+L     + E+         N  L  +I    R++     TC       I   L Y
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEY 144
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y++PE
Sbjct: 145 LHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 201
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISG 492
              E      SD+++ G I+ ++++G
Sbjct: 202 LLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 121/272 (44%), Gaps = 36/272 (13%)
Query: 298 NKLGQGGFGTVYKGVL--PNGKEVAVKRLSRK-----SWQGLEEFKNEIILIAKLQHRNL 350
            KLG G FG V +G    P+GK V+V     K       + +++F  E+  +  L HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNW--NTCYNIIGGISKGLLYLH 408
           +RL G  +    K+ + EL P  SL     D  R+ Q ++   T       +++G+ YL 
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK---TANTRRVVGTYGYMAP 465
                + IHRDL   N+LL    + KI DFG+ R   +N         R+V   + + AP
Sbjct: 139 SK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--PFAWCAP 193
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E      FS  SD + FGV + E+ +  +     L G +Q L     ++ KEG+      
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILH----KIDKEGER----- 243
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT 557
             L +    PQ +  + +   C    P  RPT
Sbjct: 244 --LPRPEDCPQDIYNVMVQ--CWAHKPEDRPT 271

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 122/272 (44%), Gaps = 36/272 (13%)
Query: 298 NKLGQGGFGTVYKGVL--PNGK--EVAVKRLSR---KSWQGLEEFKNEIILIAKLQHRNL 350
            KLG G FG V +G    P+GK   VAVK L        + +++F  E+  +  L HRNL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNW--NTCYNIIGGISKGLLYLH 408
           +RL G  +    K+ + EL P  SL     D  R+ Q ++   T       +++G+ YL 
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 138
Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK---TANTRRVVGTYGYMAP 465
                + IHRDL   N+LL    + KI DFG+ R   +N         R+V   + + AP
Sbjct: 139 SK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV--PFAWCAP 193
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E      FS  SD + FGV + E+ +  +     L G +Q L     ++ KEG+      
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILH----KIDKEGER----- 243
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT 557
             L +    PQ +  + +   C    P  RPT
Sbjct: 244 --LPRPEDCPQDIYNVMVQ--CWAHKPEDRPT 271

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 292 DGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRKSWQGLEEFK-----NEIILIAKL 345
           + F     LG+G F TV     L   +E A+K L ++    ++E K      E  ++++L
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI--IKENKVPYVTRERDVMSRL 89
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISKGL 404
            H   V+L     + E+         N  L  +I    R++     TC       I   L
Sbjct: 90  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSAL 145
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            YLH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y++
Sbjct: 146 EYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 202
Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           PE   E      SD+++ G I+ ++++G
Sbjct: 203 PELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 121/272 (44%), Gaps = 36/272 (13%)
Query: 298 NKLGQGGFGTVYKGVL--PNGKEVAVKRLSRK-----SWQGLEEFKNEIILIAKLQHRNL 350
            KLG G FG V +G    P+GK V+V     K       + +++F  E+  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNW--NTCYNIIGGISKGLLYLH 408
           +RL G  +    K+ + EL P  SL     D  R+ Q ++   T       +++G+ YL 
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK---TANTRRVVGTYGYMAP 465
                + IHRDL   N+LL    + KI DFG+ R   +N         R+V   + + AP
Sbjct: 129 SK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV--PFAWCAP 183
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E      FS  SD + FGV + E+ +  +     L G +Q L     ++ KEG+      
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILH----KIDKEGER----- 233
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT 557
             L +    PQ +  + +   C    P  RPT
Sbjct: 234 --LPRPEDCPQDIYNVMVQ--CWAHKPEDRPT 261

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 122/272 (44%), Gaps = 36/272 (13%)
Query: 298 NKLGQGGFGTVYKGVL--PNGK--EVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNL 350
            KLG G FG V +G    P+GK   VAVK L        + +++F  E+  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNW--NTCYNIIGGISKGLLYLH 408
           +RL G  +    K+ + EL P  SL     D  R+ Q ++   T       +++G+ YL 
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK---TANTRRVVGTYGYMAP 465
                + IHRDL   N+LL    + KI DFG+ R   +N         R+V   + + AP
Sbjct: 129 SK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--PFAWCAP 183
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E      FS  SD + FGV + E+ +  +     L G +Q L     ++ KEG+      
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILH----KIDKEGER----- 233
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT 557
             L +    PQ +  + +   C    P  RPT
Sbjct: 234 --LPRPEDCPQDIYNVMVQ--CWAHKPEDRPT 261

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/272 (29%), Positives = 121/272 (44%), Gaps = 36/272 (13%)
Query: 298 NKLGQGGFGTVYKGVL--PNGKEVAVKRLSRK-----SWQGLEEFKNEIILIAKLQHRNL 350
            KLG G FG V +G    P+GK V+V     K       + +++F  E+  +  L HRNL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNW--NTCYNIIGGISKGLLYLH 408
           +RL G  +    K+ + EL P  SL     D  R+ Q ++   T       +++G+ YL 
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 132
Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK---TANTRRVVGTYGYMAP 465
                + IHRDL   N+LL    + KI DFG+ R   +N         R+V   + + AP
Sbjct: 133 SK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV--PFAWCAP 187
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E      FS  SD + FGV + E+ +  +     L G +Q L     ++ KEG+      
Sbjct: 188 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILH----KIDKEGER----- 237
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT 557
             L +    PQ +  + +   C    P  RPT
Sbjct: 238 --LPRPEDCPQDIYNVMVQ--CWAHKPEDRPT 265

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAV-KRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           LG+G FG   K       EV V K L R   +    F  E+ ++  L+H N+++ +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 359 EGEEKLLIYELMPNRSLDCFI--FDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
           + +    I E +   +L   I   DS    Q  W+   +    I+ G+ YLH    + II
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDS----QYPWSQRVSFAKDIASGMAYLHS---MNII 130
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR------------VVGTYGYMA 464
           HRDL   N L+ ++    ++DFG+AR+  + +      R            VVG   +MA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGKRNS 496
           PE      +  K DVFSFG+++ EII G+ N+
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEII-GRVNA 221

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 117/230 (50%), Gaps = 19/230 (8%)
Query: 299 KLGQGGFGTVYKGVLPNGK---EVAVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLV 354
           +LG G FG+V +GV    K   +VA+K L + + +   EE   E  ++ +L +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           G   + E  +L+ E+     L  F+    +R ++  +    ++  +S G+ YL E +   
Sbjct: 77  GV-CQAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--- 130
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY--GYMAPEYAMEGL 472
            +HRDL   NVLL     AKISDFG+++    +  +  T R  G +   + APE      
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRK 189
Query: 473 FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME 522
           FS +SDV+S+GV + E +S  +    Y       ++A++    ++GK ME
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKP--YKKMKGPEVMAFI----EQGKRME 233

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLV 351
           F+   K+G+G FG V+KG+     K VA+K +   ++   +E+ + EI ++++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +  G  ++  +  +I E +   S      D      L+      I+  I KGL YLH + 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
           +   IHRD+K +NVLL +    K++DFG+A    + Q   NT   VGT  +MAPE   + 
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 179
Query: 472 LFSVKSDVFSFGVIVLEIISGK 493
            +  K+D++S G+  +E+  G+
Sbjct: 180 AYDSKADIWSLGITAIELARGE 201

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 298 NKLGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           ++LG+G FG+V    Y  +  N G  VAVK+L         +F+ EI ++  L    +V+
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 353 LVGCGI-EGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
             G     G + L L+ E +P+  L  F+     RL  +    Y+    I KG+ YL   
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS--SQICKGMEYL--G 131
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-VGTYGYMAPEYAM 469
           SR + +HRDL   N+L++ +   KI+DFG+A++   ++     R        + APE   
Sbjct: 132 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 190
Query: 470 EGLFSVKSDVFSFGVIVLEIIS 491
           + +FS +SDV+SFGV++ E+ +
Sbjct: 191 DNIFSRQSDVWSFGVVLYELFT 212

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 129/291 (44%), Gaps = 45/291 (15%)
Query: 300 LGQGGFGTVYKG------VLPNGKEVAVKRLSRKSWQG-----LEEFKNEIILIAKLQHR 348
           LG+G FG V +            + VAVK L   +        + E K   ILI    H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 91
Query: 349 NLVRLVG-CGIEGEEKLLIYELMPNRSLDCFI------FDSERRLQLNWNTCYNIIG--- 398
           N+V L+G C   G   ++I E     +L  ++      F   + L  ++ T  ++I    
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSF 151
Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG 458
            ++KG+ +L   +  K IHRDL   N+LL +  V KI DFG+AR   ++           
Sbjct: 152 QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS--GKRNSGFYLTGHAQTLLAYVWQLWK 516
              +MAPE   + +++++SDV+SFGV++ EI S       G  +       L       K
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRL-------K 261
Query: 517 EGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS 567
           EG  M   D       + P++ + +   L C   +P+ RPT S +V  LG+
Sbjct: 262 EGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 303

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 104/202 (51%), Gaps = 11/202 (5%)
Query: 294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLV 351
           F+   K+G+G FG V+KG+     K VA+K +   ++   +E+ + EI ++++     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +  G  ++  +  +I E +   S      D      L+      I+  I KGL YLH + 
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 144
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
           +   IHRD+K +NVLL +    K++DFG+A    + Q   NT   VGT  +MAPE   + 
Sbjct: 145 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 199
Query: 472 LFSVKSDVFSFGVIVLEIISGK 493
            +  K+D++S G+  +E+  G+
Sbjct: 200 AYDSKADIWSLGITAIELARGE 221

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/218 (32%), Positives = 112/218 (51%), Gaps = 23/218 (10%)
Query: 287 IKAATDGFSDSNK----LGQGGFGTVY--KGVLPNGKEVAVKRLSR---KSWQGLEEFKN 337
           ++ +T  FSD  K    LG+G FG V   K  +  G+E AVK +S+   K     E    
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLR 75
Query: 338 EIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNII 397
           E+ L+ +L H N+ +L     +     L+ E+     L   I   +R  +++      II
Sbjct: 76  EVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARII 132
Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTR 454
             +  G+ Y H++   KI+HRDLKP N+LL+   KD   +I DFG++  F  ++K  +  
Sbjct: 133 RQVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDK- 188
Query: 455 RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
             +GT  Y+APE  + G +  K DV+S GVI+  ++SG
Sbjct: 189 --IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 117/230 (50%), Gaps = 19/230 (8%)
Query: 299 KLGQGGFGTVYKGVLPNGK---EVAVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLV 354
           +LG G FG+V +GV    K   +VA+K L + + +   EE   E  ++ +L +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           G   + E  +L+ E+     L  F+    +R ++  +    ++  +S G+ YL E +   
Sbjct: 403 GV-CQAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN--- 456
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY--GYMAPEYAMEGL 472
            +HR+L   NVLL     AKISDFG+++    +  +  T R  G +   + APE      
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRK 515
Query: 473 FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME 522
           FS +SDV+S+GV + E +S  +    Y       ++A++    ++GK ME
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKP--YKKMKGPEVMAFI----EQGKRME 559

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 130/289 (44%), Gaps = 40/289 (13%)
Query: 300 LGQGGFGTVYKG-VLPNGKEVAVKRLSRKSWQGL------EEFKNEIILIAKL-QHRNLV 351
           LG G FG V +      GKE AV +++ K  +        E   +E+ +++ L QH N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFI-------FDSERRLQLNWNTCYNIIGGISKGL 404
            L+G    G   L+I E      L  F+        D E    L      +    +++G+
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK---TANTRRVVGTYG 461
            +L   +    IHRD+   NVLL    VAKI DFG+AR    +       N R  V    
Sbjct: 166 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV---K 219
Query: 462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLL-AYVWQLWKEGKE 520
           +MAPE   + +++V+SDV+S+G+++ EI S        L  +   L+ +  ++L K+G +
Sbjct: 220 WMAPESIFDCVYTVQSDVWSYGILLWEIFS------LGLNPYPGILVNSKFYKLVKDGYQ 273
Query: 521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES 569
           M        + +  P+ +  I     C   +P  RPT   + + L  ++
Sbjct: 274 M-------AQPAFAPKNIYSIMQA--CWALEPTHRPTFQQICSFLQEQA 313

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 298 NKLGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           ++LG+G FG+V    Y  +  N G  VAVK+L         +F+ EI ++  L    +V+
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 353 LVGCGI-EGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
             G     G + L L+ E +P+  L  F+     RL  +    Y+    I KG+ YL   
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS--SQICKGMEYL--G 132
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-VGTYGYMAPEYAM 469
           SR + +HRDL   N+L++ +   KI+DFG+A++   ++     R        + APE   
Sbjct: 133 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 191
Query: 470 EGLFSVKSDVFSFGVIVLEIIS 491
           + +FS +SDV+SFGV++ E+ +
Sbjct: 192 DNIFSRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 104/202 (51%), Gaps = 13/202 (6%)
Query: 298 NKLGQGGFGTV----YKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           ++LG+G FG+V    Y  +  N G  VAVK+L         +F+ EI ++  L    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 353 LVGCGI-EGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
             G     G + L L+ E +P+  L  F+     RL  +    Y+    I KG+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS--SQICKGMEYL--G 144
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-VGTYGYMAPEYAM 469
           SR + +HRDL   N+L++ +   KI+DFG+A++   ++     R        + APE   
Sbjct: 145 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 470 EGLFSVKSDVFSFGVIVLEIIS 491
           + +FS +SDV+SFGV++ E+ +
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFT 225

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 109/211 (51%), Gaps = 15/211 (7%)
Query: 287 IKAATDGFSDSNKLGQGGFGTVYKGVLPNGKE-VAVKRLSRKSWQGLEEFKN-----EII 340
           +K+    +   + LG+G F TVYK    N  + VA+K++        ++  N     EI 
Sbjct: 5   VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           L+ +L H N++ L+          L+++ M    L+  I D+   L  +    Y ++   
Sbjct: 65  LLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM--T 121
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
            +GL YLH+     I+HRDLKP+N+LLD++ V K++DFG+A+ F    + A   +VV T 
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYXHQVV-TR 176
Query: 461 GYMAPEYAMEG-LFSVKSDVFSFGVIVLEII 490
            Y APE      ++ V  D+++ G I+ E++
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 299 KLGQGGFGTVY---KGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVG 355
           KLG G +G V      V    + + + R +  S     +   E+ ++  L H N+++L  
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
              +     L+ E      L    FD    R++ N      II  +  G+ YLH+ +   
Sbjct: 104 FFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--- 156
Query: 415 IIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
           I+HRDLKP N+LL   +KD + KI DFG++ +F ENQK    R  +GT  Y+APE  +  
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKER--LGTAYYIAPE-VLRK 212
Query: 472 LFSVKSDVFSFGVIVLEIISG 492
            +  K DV+S GVI+  +++G
Sbjct: 213 KYDEKCDVWSIGVILFILLAG 233

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 130/289 (44%), Gaps = 40/289 (13%)
Query: 300 LGQGGFGTVYKG-VLPNGKEVAVKRLSRKSWQGL------EEFKNEIILIAKL-QHRNLV 351
           LG G FG V +      GKE AV +++ K  +        E   +E+ +++ L QH N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFI-------FDSERRLQLNWNTCYNIIGGISKGL 404
            L+G    G   L+I E      L  F+        D E    L      +    +++G+
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK---TANTRRVVGTYG 461
            +L   +    IHRD+   NVLL    VAKI DFG+AR    +       N R  V    
Sbjct: 174 AFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV---K 227
Query: 462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLL-AYVWQLWKEGKE 520
           +MAPE   + +++V+SDV+S+G+++ EI S        L  +   L+ +  ++L K+G +
Sbjct: 228 WMAPESIFDCVYTVQSDVWSYGILLWEIFS------LGLNPYPGILVNSKFYKLVKDGYQ 281
Query: 521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES 569
           M        + +  P+ +  I     C   +P  RPT   + + L  ++
Sbjct: 282 M-------AQPAFAPKNIYSIMQA--CWALEPTHRPTFQQICSFLQEQA 321

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 23/217 (10%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFK----NEIILIAK 344
           AT  +    ++G G +GTVYK   P+ G  VA+K  S +   G E        E+ L+ +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK--SVRVPNGEEGLPISTVREVALLRR 59
Query: 345 LQ---HRNLVRLVG-CGIEGEEK----LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNI 396
           L+   H N+VRL+  C     ++     L++E + ++ L  ++ D      L   T  ++
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDL 117
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           +    +GL +LH +    I+HRDLKP N+L+      K++DFG+ARI+           V
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDP---V 171
Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  ++  ++   D++S G I  E+   K
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHR 348
           + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 349 NLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL + 
Sbjct: 70  NIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H     +++HRDLKP N+L++ +   K++DFG+AR F    +T  T  VV T  Y APE 
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEI 181
Query: 468 AM-EGLFSVKSDVFSFGVIVLEIISGK 493
            +    +S   D++S G I  E+++ +
Sbjct: 182 LLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 300 LGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+G  G V   V    +E VAVK +  +++    E  K EI +   L H N+V+  G  
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            EG  + L  E      L    FD  E  + +           +  G++YLH    + I 
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGIT 126
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE      F  +
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 477 S-DVFSFGVIVLEIISGK 493
             DV+S G+++  +++G+
Sbjct: 187 PVDVWSCGIVLTAMLAGE 204

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHR 348
           + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 349 NLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL + 
Sbjct: 63  NIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H     +++HRDLKP N+L++ +   K++DFG+AR F    +T  T  VV T  Y APE 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEI 174
Query: 468 AM-EGLFSVKSDVFSFGVIVLEIISGK 493
            +    +S   D++S G I  E+++ +
Sbjct: 175 LLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 23/217 (10%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFK----NEIILIAK 344
           AT  +    ++G G +GTVYK   P+ G  VA+K  S +   G E        E+ L+ +
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK--SVRVPNGEEGLPISTVREVALLRR 59
Query: 345 LQ---HRNLVRLVG-CGIEGEEK----LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNI 396
           L+   H N+VRL+  C     ++     L++E + ++ L  ++ D      L   T  ++
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDL 117
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           +    +GL +LH +    I+HRDLKP N+L+      K++DFG+ARI+           V
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFP---V 171
Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  ++  ++   D++S G I  E+   K
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 127/291 (43%), Gaps = 45/291 (15%)
Query: 300 LGQGGFGTVYKG------VLPNGKEVAVKRLSRKSWQG-----LEEFKNEIILIAKLQHR 348
           LG+G FG V +            + VAVK L   +        + E K   ILI    H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 91
Query: 349 NLVRLVG-CGIEGEEKLLIYELMPNRSLDCFIFDSERR-----------LQLNWNTCYNI 396
           N+V L+G C   G   ++I E     +L  ++                 L L    CY+ 
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSF 151
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
              ++KG+ +L   +  K IHRDL   N+LL +  V KI DFG+AR   ++         
Sbjct: 152 --QVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 206
Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWK 516
                +MAPE   + +++++SDV+SFGV++ EI S     G       +    +  +L K
Sbjct: 207 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRL-K 261
Query: 517 EGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS 567
           EG  M   D       + P++ + +   L C   +P+ RPT S +V  LG+
Sbjct: 262 EGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 303

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHR 348
           + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 349 NLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL + 
Sbjct: 62  NIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H     +++HRDLKP N+L++ +   K++DFG+AR F    +T  T  VV T  Y APE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEI 173
Query: 468 AME-GLFSVKSDVFSFGVIVLEIISGK 493
            +    +S   D++S G I  E+++ +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHR 348
           + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 349 NLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL + 
Sbjct: 63  NIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H     +++HRDLKP N+L++ +   K++DFG+AR F    +T  T  VV T  Y APE 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEI 174
Query: 468 AME-GLFSVKSDVFSFGVIVLEIISGK 493
            +    +S   D++S G I  E+++ +
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHR 348
           + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 349 NLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL + 
Sbjct: 62  NIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H     +++HRDLKP N+L++ +   K++DFG+AR F    +T  T  VV T  Y APE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEI 173
Query: 468 AME-GLFSVKSDVFSFGVIVLEIISGK 493
            +    +S   D++S G I  E+++ +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 110/210 (52%), Gaps = 13/210 (6%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKL 345
            + + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 346 QHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
            H N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL
Sbjct: 61  NHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 117
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            + H     +++HRDLKP N+L++ +   K++DFG+AR F    +T  T  VV T  Y A
Sbjct: 118 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVV-TLWYRA 172
Query: 465 PEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           PE  +    +S   D++S G I  E+++ +
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHR 348
           + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 349 NLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL + 
Sbjct: 70  NIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 126
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H     +++HRDLKP N+L++ +   K++DFG+AR F    +T  T  VV T  Y APE 
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEI 181
Query: 468 AME-GLFSVKSDVFSFGVIVLEIISGK 493
            +    +S   D++S G I  E+++ +
Sbjct: 182 LLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 13/210 (6%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKL 345
            + + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 346 QHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
            H N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL
Sbjct: 63  NHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGL 119
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            + H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y A
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 174
Query: 465 PEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           PE  +    +S   D++S G I  E+++ +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY     N K + A+K L +   +  G+E + + E+ + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     K+IHRD+KP N+LL      KI+DFG +     +++ A    + GT  Y+ P
Sbjct: 123 YCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA----LCGTLDYLPP 175
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           E     +   K D++S GV+  E + GK
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 124/269 (46%), Gaps = 33/269 (12%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSW----QGLEEFKNEIILIAKLQHRNLVRLVG 355
           LG+GGF   ++    + KEV   ++  KS        E+   EI +   L H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
              + +   ++ EL   RSL   +   +RR  L        +  I  G  YLH   R ++
Sbjct: 89  FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 142
Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSV 475
           IHRDLK  N+ L++D+  KI DFG+A     + +   T  + GT  Y+APE   +   S 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 200
Query: 476 KSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIP 535
           + DV+S G I+  ++ GK    F  +   +T L          K+ E+         SIP
Sbjct: 201 EVDVWSIGCIMYTLLVGK--PPFETSCLKETYLRI--------KKNEY---------SIP 241
Query: 536 QVVRCIHIGLL--CVQEDPAVRPTMSNVV 562
           + +  +   L+   +Q DP  RPT++ ++
Sbjct: 242 KHINPVAASLIQKMLQTDPTARPTINELL 270

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHR 348
           + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 349 NLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL + 
Sbjct: 67  NIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 123
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H     +++HRDLKP N+L++ +   K++DFG+AR F    +T  T  VV T  Y APE 
Sbjct: 124 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEI 178
Query: 468 AME-GLFSVKSDVFSFGVIVLEIISGK 493
            +    +S   D++S G I  E+++ +
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 124/269 (46%), Gaps = 33/269 (12%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSW----QGLEEFKNEIILIAKLQHRNLVRLVG 355
           LG+GGF   ++    + KEV   ++  KS        E+   EI +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
              + +   ++ EL   RSL   +   +RR  L        +  I  G  YLH   R ++
Sbjct: 85  FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 138
Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSV 475
           IHRDLK  N+ L++D+  KI DFG+A     + +   T  + GT  Y+APE   +   S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 476 KSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIP 535
           + DV+S G I+  ++ GK    F  +   +T L          K+ E+         SIP
Sbjct: 197 EVDVWSIGCIMYTLLVGK--PPFETSCLKETYLRI--------KKNEY---------SIP 237
Query: 536 QVVRCIHIGLL--CVQEDPAVRPTMSNVV 562
           + +  +   L+   +Q DP  RPT++ ++
Sbjct: 238 KHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 124/269 (46%), Gaps = 33/269 (12%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSW----QGLEEFKNEIILIAKLQHRNLVRLVG 355
           LG+GGF   ++    + KEV   ++  KS        E+   EI +   L H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
              + +   ++ EL   RSL   +   +RR  L        +  I  G  YLH   R ++
Sbjct: 85  FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 138
Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSV 475
           IHRDLK  N+ L++D+  KI DFG+A     + +   T  + GT  Y+APE   +   S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 476 KSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIP 535
           + DV+S G I+  ++ GK    F  +   +T L          K+ E+         SIP
Sbjct: 197 EVDVWSIGCIMYTLLVGK--PPFETSCLKETYLRI--------KKNEY---------SIP 237
Query: 536 QVVRCIHIGLL--CVQEDPAVRPTMSNVV 562
           + +  +   L+   +Q DP  RPT++ ++
Sbjct: 238 KHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHR 348
           + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 349 NLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL + 
Sbjct: 63  NIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H     +++HRDLKP N+L++ +   K++DFG+AR F    +T  T  VV T  Y APE 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEI 174
Query: 468 AME-GLFSVKSDVFSFGVIVLEIISGK 493
            +    +S   D++S G I  E+++ +
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 83/294 (28%), Positives = 129/294 (43%), Gaps = 48/294 (16%)
Query: 300 LGQGGFGTVYK----GVLPNG--KEVAVKRLSRKSWQG-----LEEFKNEIILIAKLQHR 348
           LG+G FG V +    G+      + VAVK L   +        + E K   ILI    H 
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 92
Query: 349 NLVRLVG-CGIEGEEKLLIYELMPNRSLDCFIFDSERR--------------LQLNWNTC 393
           N+V L+G C   G   ++I E     +L  ++                    L L    C
Sbjct: 93  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLIC 152
Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT 453
           Y+    ++KG+ +L   +  K IHRDL   N+LL +  V KI DFG+AR   ++      
Sbjct: 153 YSF--QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
                   +MAPE   + +++++SDV+SFGV++ EI S     G       +    +  +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRR 263
Query: 514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS 567
           L KEG  M   D       + P++ + +   L C   +P+ RPT S +V  LG+
Sbjct: 264 L-KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 307

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 126/270 (46%), Gaps = 35/270 (12%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSW----QGLEEFKNEIILIAKLQHRNLVRLVG 355
           LG+GGF   ++    + KEV   ++  KS        E+   EI +   L H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
              + +   ++ EL   RSL   +   +RR  L        +  I  G  YLH   R ++
Sbjct: 107 FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 160
Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVV-GTYGYMAPEYAMEGLFS 474
           IHRDLK  N+ L++D+  KI DFG+A    + +     ++V+ GT  Y+APE   +   S
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 217
Query: 475 VKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSI 534
            + DV+S G I+  ++ GK    F  +   +T L          K+ E+         SI
Sbjct: 218 FEVDVWSIGCIMYTLLVGK--PPFETSCLKETYLRI--------KKNEY---------SI 258
Query: 535 PQVVRCIHIGLL--CVQEDPAVRPTMSNVV 562
           P+ +  +   L+   +Q DP  RPT++ ++
Sbjct: 259 PKHINPVAASLIQKMLQTDPTARPTINELL 288

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 11/202 (5%)
Query: 294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLV 351
           F+   K+G+G FG V+KG+     K VA+K +   ++   +E+ + EI ++++     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +  G  ++  +  +I E +   S      D      L+      I+  I KGL YLH + 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 139
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
           +   IHRD+K +NVLL +    K++DFG+A    + Q   N    VGT  +MAPE   + 
Sbjct: 140 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQS 194
Query: 472 LFSVKSDVFSFGVIVLEIISGK 493
            +  K+D++S G+  +E+  G+
Sbjct: 195 AYDSKADIWSLGITAIELARGE 216

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 42/292 (14%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGL------EEFKNEIILIAKL-QHRNLV 351
           LG G FG V +      GKE AV +++ K  +        E   +E+ +++ L QH N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            L+G    G   L+I E      L  F+    R L+ +    + I    +     LH  S
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETD--PAFAIANSTASTRDLLHFSS 171
Query: 412 RL----------KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK---TANTRRVVG 458
           ++            IHRD+   NVLL    VAKI DFG+AR    +       N R  V 
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV- 230
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLL-AYVWQLWKE 517
              +MAPE   + +++V+SDV+S+G+++ EI S        L  +   L+ +  ++L K+
Sbjct: 231 --KWMAPESIFDCVYTVQSDVWSYGILLWEIFS------LGLNPYPGILVNSKFYKLVKD 282
Query: 518 GKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES 569
           G +M        + +  P+ +  I     C   +P  RPT   + + L  ++
Sbjct: 283 GYQM-------AQPAFAPKNIYSIMQA--CWALEPTHRPTFQQICSFLQEQA 325

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHR 348
           + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 349 NLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL + 
Sbjct: 63  NIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFC 119
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H     +++HRDLKP N+L++ +   K++DFG+AR F    +T  T  VV T  Y APE 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEI 174
Query: 468 AME-GLFSVKSDVFSFGVIVLEIISGK 493
            +    +S   D++S G I  E+++ +
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 132/293 (45%), Gaps = 44/293 (15%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGL------EEFKNEIILIAKL-QHRNLV 351
           LG G FG V +      GKE AV +++ K  +        E   +E+ +++ L QH N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ-----------LNWNTCYNIIGGI 400
            L+G    G   L+I E      L  F+    R L+           L+     +    +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQV 173
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK---TANTRRVV 457
           ++G+ +L   +    IHRD+   NVLL    VAKI DFG+AR    +       N R  V
Sbjct: 174 AQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 458 GTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLL-AYVWQLWK 516
               +MAPE   + +++V+SDV+S+G+++ EI S        L  +   L+ +  ++L K
Sbjct: 231 ---KWMAPESIFDCVYTVQSDVWSYGILLWEIFS------LGLNPYPGILVNSKFYKLVK 281
Query: 517 EGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES 569
           +G +M        + +  P+ +  I     C   +P  RPT   + + L  ++
Sbjct: 282 DGYQM-------AQPAFAPKNIYSIMQA--CWALEPTHRPTFQQICSFLQEQA 325

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 13/207 (6%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHR 348
           + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 349 NLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL + 
Sbjct: 62  NIVKLLDV-IHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H     +++HRDLKP N+L++ +   K++DFG+AR F    +T  T  VV T  Y APE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEI 173
Query: 468 AME-GLFSVKSDVFSFGVIVLEIISGK 493
            +    +S   D++S G I  E+++ +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 126/270 (46%), Gaps = 35/270 (12%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSW----QGLEEFKNEIILIAKLQHRNLVRLVG 355
           LG+GGF   ++    + KEV   ++  KS        E+   EI +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
              + +   ++ EL   RSL   +   +RR  L        +  I  G  YLH   R ++
Sbjct: 109 FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 162
Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVV-GTYGYMAPEYAMEGLFS 474
           IHRDLK  N+ L++D+  KI DFG+A    + +     ++V+ GT  Y+APE   +   S
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 475 VKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSI 534
            + DV+S G I+  ++ GK    F  +   +T L          K+ E+         SI
Sbjct: 220 FEVDVWSIGCIMYTLLVGK--PPFETSCLKETYLRI--------KKNEY---------SI 260
Query: 535 PQVVRCIHIGLL--CVQEDPAVRPTMSNVV 562
           P+ +  +   L+   +Q DP  RPT++ ++
Sbjct: 261 PKHINPVAASLIQKMLQTDPTARPTINELL 290

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 11/202 (5%)
Query: 294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLV 351
           F+   K+G+G FG V+KG+     K VA+K +   ++   +E+ + EI ++++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +  G  ++  +  +I E +   S      D      L+      I+  I KGL YLH + 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 124
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
           +   IHRD+K +NVLL +    K++DFG+A    + Q   N    VGT  +MAPE   + 
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNX--FVGTPFWMAPEVIKQS 179
Query: 472 LFSVKSDVFSFGVIVLEIISGK 493
            +  K+D++S G+  +E+  G+
Sbjct: 180 AYDSKADIWSLGITAIELARGE 201

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 39/221 (17%)
Query: 300 LGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQ-GLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG+GGFG V++     +    A+KR+   + +   E+   E+  +AKL+H  +VR     
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 358 IE---------GEEKLLIY---ELMPNRSLD------CFIFDSERRLQLNWNTCYNIIGG 399
           +E            K+ +Y   +L    +L       C I + ER      + C +I   
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER------SVCLHIFLQ 126
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT--------A 451
           I++ + +LH      ++HRDLKPSN+    D V K+ DFG+     ++++         A
Sbjct: 127 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 452 NTRRV--VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEII 490
             R    VGT  YM+PE      +S K D+FS G+I+ E++
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 13/210 (6%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKL 345
            + + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 346 QHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
            H N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL
Sbjct: 62  NHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 118
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            + H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y A
Sbjct: 119 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 173
Query: 465 PEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           PE  +    +S   D++S G I  E+++ +
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 129/295 (43%), Gaps = 49/295 (16%)
Query: 300 LGQGGFGTVYK----GVLPNG--KEVAVKRLSRKSWQG-----LEEFKNEIILIAKLQHR 348
           LG+G FG V +    G+      + VAVK L   +        + E K   ILI    H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 91
Query: 349 NLVRLVG-CGIEGEEKLLIYELMPNRSLDCFIFDSERR---------------LQLNWNT 392
           N+V L+G C   G   ++I E     +L  ++                     L L    
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN 452
           CY+    ++KG+ +L   +  K IHRDL   N+LL +  V KI DFG+AR   ++     
Sbjct: 152 CYSF--QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW 512
                    +MAPE   + +++++SDV+SFGV++ EI S     G       +    +  
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCR 262
Query: 513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS 567
           +L KEG  M   D       + P++ + +   L C   +P+ RPT S +V  LG+
Sbjct: 263 RL-KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 307

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 13/210 (6%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKL 345
            + + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 346 QHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
            H N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL
Sbjct: 62  NHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 118
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            + H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y A
Sbjct: 119 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 173
Query: 465 PEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           PE  +    +S   D++S G I  E+++ +
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 32/216 (14%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLV----G 355
           +G+G +G VYKG L + + VAVK  S  + Q     KN I  +  ++H N+ R +     
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKN-IYRVPLMEHDNIARFIVGDER 78
Query: 356 CGIEGE-EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH------ 408
              +G  E LL+ E  PN SL  ++         +W +   +   +++GL YLH      
Sbjct: 79  VTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTRGLAYLHTELPRG 134
Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA------RIFCENQKTANTRRVVGTYGY 462
           +  +  I HRDL   NVL+  D    ISDFG++      R+    ++       VGT  Y
Sbjct: 135 DHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRY 194
Query: 463 MAPEYAMEGLFSVKS--------DVFSFGVIVLEII 490
           MAPE  +EG  +++         D+++ G+I  EI 
Sbjct: 195 MAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 13/210 (6%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKL 345
            + + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L
Sbjct: 4   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 346 QHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
            H N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL
Sbjct: 64  NHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 120
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            + H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y A
Sbjct: 121 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 175
Query: 465 PEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           PE  +    +S   D++S G I  E+++ +
Sbjct: 176 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 13/210 (6%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKL 345
            + + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 346 QHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
            H N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL
Sbjct: 63  NHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 119
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            + H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y A
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 174
Query: 465 PEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           PE  +    +S   D++S G I  E+++ +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 13/210 (6%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKL 345
            + + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 346 QHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
            H N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL
Sbjct: 62  NHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 118
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            + H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y A
Sbjct: 119 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 173
Query: 465 PEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           PE  +    +S   D++S G I  E+++ +
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 13/209 (6%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQ 346
           + + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 347 HRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           H N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL 
Sbjct: 61  HPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 117
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           + H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y AP
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 466 EYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           E  +    +S   D++S G I  E+++ +
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 126/270 (46%), Gaps = 35/270 (12%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSW----QGLEEFKNEIILIAKLQHRNLVRLVG 355
           LG+GGF   ++    + KEV   ++  KS        E+   EI +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
              + +   ++ EL   RSL   +   +RR  L        +  I  G  YLH   R ++
Sbjct: 83  FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLH---RNRV 136
Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVV-GTYGYMAPEYAMEGLFS 474
           IHRDLK  N+ L++D+  KI DFG+A    + +     ++V+ GT  Y+APE   +   S
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLA---TKVEYDGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 475 VKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSI 534
            + DV+S G I+  ++ GK    F  +   +T L          K+ E+         SI
Sbjct: 194 FEVDVWSIGCIMYTLLVGK--PPFETSCLKETYLRI--------KKNEY---------SI 234
Query: 535 PQVVRCIHIGLL--CVQEDPAVRPTMSNVV 562
           P+ +  +   L+   +Q DP  RPT++ ++
Sbjct: 235 PKHINPVAASLIQKMLQTDPTARPTINELL 264

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 13/210 (6%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKL 345
            + + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 346 QHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
            H N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL
Sbjct: 61  NHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 117
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            + H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y A
Sbjct: 118 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 172
Query: 465 PEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           PE  +    +S   D++S G I  E+++ +
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 13/209 (6%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQ 346
           + + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 347 HRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           H N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL 
Sbjct: 61  HPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 117
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           + H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y AP
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 466 EYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           E  +    +S   D++S G I  E+++ +
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 13/210 (6%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKL 345
            + + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 346 QHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
            H N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL
Sbjct: 63  NHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 119
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            + H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y A
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 174
Query: 465 PEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           PE  +    +S   D++S G I  E+++ +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 13/210 (6%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKL 345
            + + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 346 QHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
            H N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL
Sbjct: 61  NHPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 117
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            + H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y A
Sbjct: 118 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 172
Query: 465 PEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           PE  +    +S   D++S G I  E+++ +
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 13/209 (6%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQ 346
           + + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 347 HRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           H N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL 
Sbjct: 61  HPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 117
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           + H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y AP
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 466 EYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           E  +    +S   D++S G I  E+++ +
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 13/207 (6%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHR 348
           + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 349 NLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL + 
Sbjct: 62  NIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y APE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 173
Query: 468 AME-GLFSVKSDVFSFGVIVLEIISGK 493
            +    +S   D++S G I  E+++ +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 13/209 (6%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQ 346
           + + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 347 HRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           H N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL 
Sbjct: 61  HPNIVKLLDV-IHTENKLYLVFEFL-HQDLKDFM-DASALTGIPLPLIKSYLFQLLQGLA 117
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           + H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y AP
Sbjct: 118 FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 466 EYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           E  +    +S   D++S G I  E+++ +
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 129/295 (43%), Gaps = 49/295 (16%)
Query: 300 LGQGGFGTVYK----GVLPNG--KEVAVKRLSRKSWQG-----LEEFKNEIILIAKLQHR 348
           LG+G FG V +    G+      + VAVK L   +        + E K   ILI    H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 82
Query: 349 NLVRLVG-CGIEGEEKLLIYELMPNRSLDCFIFDSERR---------------LQLNWNT 392
           N+V L+G C   G   ++I E     +L  ++                     L L    
Sbjct: 83  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN 452
           CY+    ++KG+ +L   +  K IHRDL   N+LL +  V KI DFG+AR   ++     
Sbjct: 143 CYSF--QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW 512
                    +MAPE   + +++++SDV+SFGV++ EI S     G       +    +  
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCR 253
Query: 513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS 567
           +L KEG  M   D       + P++ + +   L C   +P+ RPT S +V  LG+
Sbjct: 254 RL-KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 298

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 129/295 (43%), Gaps = 49/295 (16%)
Query: 300 LGQGGFGTVYK----GVLPNG--KEVAVKRLSRKSWQG-----LEEFKNEIILIAKLQHR 348
           LG+G FG V +    G+      + VAVK L   +        + E K   ILI    H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 91
Query: 349 NLVRLVG-CGIEGEEKLLIYELMPNRSLDCFIFDSERR---------------LQLNWNT 392
           N+V L+G C   G   ++I E     +L  ++                     L L    
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN 452
           CY+    ++KG+ +L   +  K IHRDL   N+LL +  V KI DFG+AR   ++     
Sbjct: 152 CYSF--QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVR 206
Query: 453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW 512
                    +MAPE   + +++++SDV+SFGV++ EI S     G       +    +  
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCR 262
Query: 513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS 567
           +L KEG  M   D       + P++ + +   L C   +P+ RPT S +V  LG+
Sbjct: 263 RL-KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 307

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 13/207 (6%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHR 348
           + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 349 NLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL + 
Sbjct: 62  NIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y APE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 173
Query: 468 AME-GLFSVKSDVFSFGVIVLEIISGK 493
            +    +S   D++S G I  E+++ +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 22/218 (10%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEF-----KNEIILIA 343
           AT  +    ++G G +GTVYK   P+ G  VA+K +   +  G           E+ L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 344 KLQ---HRNLVRLVG-CGIEGEEK----LLIYELMPNRSLDCFIFDSERRLQLNWNTCYN 395
           +L+   H N+VRL+  C     ++     L++E + ++ L  ++ D      L   T  +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 396 IIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR 455
           ++    +GL +LH +    I+HRDLKP N+L+      K++DFG+ARI+           
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP--- 178
Query: 456 VVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           VV T  Y APE  ++  ++   D++S G I  E+   K
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 129/295 (43%), Gaps = 49/295 (16%)
Query: 300 LGQGGFGTVYK----GVLPNG--KEVAVKRLSRKSWQG-----LEEFKNEIILIAKLQHR 348
           LG+G FG V +    G+      + VAVK L   +        + E K   ILI    H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 82
Query: 349 NLVRLVG-CGIEGEEKLLIYELMPNRSLDCFIFDSERR---------------LQLNWNT 392
           N+V L+G C   G   ++I E     +L  ++                     L L    
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN 452
           CY+    ++KG+ +L   +  K IHRDL   N+LL +  V KI DFG+AR   ++     
Sbjct: 143 CYSF--QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW 512
                    +MAPE   + +++++SDV+SFGV++ EI S     G       +    +  
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCR 253
Query: 513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS 567
           +L KEG  M   D       + P++ + +   L C   +P+ RPT S +V  LG+
Sbjct: 254 RL-KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 298

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 108/209 (51%), Gaps = 13/209 (6%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQ 346
           + + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 347 HRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           H N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL 
Sbjct: 61  HPNIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 117
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           + H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y AP
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 172
Query: 466 EYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           E  +    +S   D++S G I  E+++ +
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 107/207 (51%), Gaps = 13/207 (6%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHR 348
           + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 349 NLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL + 
Sbjct: 64  NIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 120
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y APE 
Sbjct: 121 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAPEI 175
Query: 468 AME-GLFSVKSDVFSFGVIVLEIISGK 493
            +    +S   D++S G I  E+++ +
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 15/211 (7%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKL 345
            + + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 346 QHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIF-DSERRLQLNWNTCYNIIGGISKG 403
            H N+V+L+   I  E KL L++E +   S+D   F D+     +      + +  + +G
Sbjct: 63  NHPNIVKLLDV-IHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           L + H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y 
Sbjct: 119 LAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 173
Query: 464 APEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           APE  +    +S   D++S G I  E+++ +
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 15/211 (7%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKL 345
            + + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 346 QHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIF-DSERRLQLNWNTCYNIIGGISKG 403
            H N+V+L+   I  E KL L++E +   S+D   F D+     +      + +  + +G
Sbjct: 63  NHPNIVKLLDV-IHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQG 118
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           L + H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y 
Sbjct: 119 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 173
Query: 464 APEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           APE  +    +S   D++S G I  E+++ +
Sbjct: 174 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 129/295 (43%), Gaps = 49/295 (16%)
Query: 300 LGQGGFGTVYK----GVLPNG--KEVAVKRLSRKSWQG-----LEEFKNEIILIAKLQHR 348
           LG+G FG V +    G+      + VAVK L   +        + E K   ILI    H 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 93
Query: 349 NLVRLVG-CGIEGEEKLLIYELMPNRSLDCFIFDSERR---------------LQLNWNT 392
           N+V L+G C   G   ++I E     +L  ++                     L L    
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLI 153
Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN 452
           CY+    ++KG+ +L   +  K IHRDL   N+LL +  V KI DFG+AR   ++     
Sbjct: 154 CYSF--QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 208
Query: 453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW 512
                    +MAPE   + +++++SDV+SFGV++ EI S     G       +    +  
Sbjct: 209 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCR 264
Query: 513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS 567
           +L KEG  M   D       + P++ + +   L C   +P+ RPT S +V  LG+
Sbjct: 265 RL-KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 309

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 15/211 (7%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKL 345
            + + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 346 QHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIF-DSERRLQLNWNTCYNIIGGISKG 403
            H N+V+L+   I  E KL L++E +   S+D   F D+     +      + +  + +G
Sbjct: 61  NHPNIVKLLDV-IHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQG 116
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           L + H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y 
Sbjct: 117 LAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 171
Query: 464 APEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           APE  +    +S   D++S G I  E+++ +
Sbjct: 172 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 15/211 (7%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKL 345
            + + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 346 QHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIF-DSERRLQLNWNTCYNIIGGISKG 403
            H N+V+L+   I  E KL L++E +   S+D   F D+     +      + +  + +G
Sbjct: 62  NHPNIVKLLDV-IHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQG 117
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           L + H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y 
Sbjct: 118 LAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYR 172
Query: 464 APEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           APE  +    +S   D++S G I  E+++ +
Sbjct: 173 APEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 127/297 (42%), Gaps = 53/297 (17%)
Query: 300 LGQGGFGTVYK----GVLPNG--KEVAVKRLSRKSWQG-----LEEFKNEIILIAKLQHR 348
           LG+G FG V +    G+      + VAVK L   +        + E K   ILI    H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 91
Query: 349 NLVRLVG-CGIEGEEKLLIYELMPNRSLDCFIFDSERR---------------LQLNWNT 392
           N+V L+G C   G   ++I E     +L  ++                     L L    
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN 452
           CY+    ++KG+ +L   +  K IHRDL   N+LL +  V KI DFG+AR   ++     
Sbjct: 152 CYSF--QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS--GKRNSGFYLTGHAQTLLAY 510
                    +MAPE   + +++++SDV+SFGV++ EI S       G  +       L  
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-- 264
Query: 511 VWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS 567
                KEG  M   D       + P++ + +   L C   +P+ RPT S +V  LG+
Sbjct: 265 -----KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 307

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/299 (27%), Positives = 135/299 (45%), Gaps = 54/299 (18%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGL------EEFKNEIILIAKL-QHRNLV 351
           LG G FG V +      GKE AV +++ K  +        E   +E+ +++ L QH N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERR-----LQLNWNTCYN----------- 395
            L+G    G   L+I E      L  F+    RR     L+ ++N  +N           
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFL----RRKRPPGLEYSYNPSHNPEEQLSSRDLL 169
Query: 396 -IIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK---TA 451
                +++G+ +L   +    IHRD+   NVLL    VAKI DFG+AR    +       
Sbjct: 170 HFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 226
Query: 452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLL-AY 510
           N R  V    +MAPE   + +++V+SDV+S+G+++ EI S        L  +   L+ + 
Sbjct: 227 NARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFS------LGLNPYPGILVNSK 277
Query: 511 VWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES 569
            ++L K+G +M        + +  P+ +  I     C   +P  RPT   + + L  ++
Sbjct: 278 FYKLVKDGYQM-------AQPAFAPKNIYSIMQA--CWALEPTHRPTFQQICSFLQEQA 327

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 291 TDGFSDSNKLGQGGFGTVYK------GVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAK 344
           +D +    +LG+G F  V +      G+    K +  K+LS + +Q LE    E  +  K
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRK 61
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           LQH N+VRL     E     L+++L+    L   I   E   + + + C   I  I + +
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC---IQQILESI 118
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTRRVVGTYG 461
            Y H +    I+HR+LKP N+LL    K    K++DFG+A    E   +       GT G
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPG 172
Query: 462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           Y++PE   +  +S   D+++ GVI+  ++ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG +     +++T     + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 175
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 225
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 226 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 255

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 83/297 (27%), Positives = 127/297 (42%), Gaps = 53/297 (17%)
Query: 300 LGQGGFGTVYK----GVLPNG--KEVAVKRLSRKSWQG-----LEEFKNEIILIAKLQHR 348
           LG+G FG V +    G+      + VAVK L   +        + E K   ILI    H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 82
Query: 349 NLVRLVG-CGIEGEEKLLIYELMPNRSLDCFIFDSERR---------------LQLNWNT 392
           N+V L+G C   G   ++I E     +L  ++                     L L    
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN 452
           CY+    ++KG+ +L   +  K IHRDL   N+LL +  V KI DFG+AR   ++     
Sbjct: 143 CYSF--QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS--GKRNSGFYLTGHAQTLLAY 510
                    +MAPE   + +++++SDV+SFGV++ EI S       G  +       L  
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL-- 255
Query: 511 VWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS 567
                KEG  M   D       + P++ + +   L C   +P+ RPT S +V  LG+
Sbjct: 256 -----KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 298

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 129/295 (43%), Gaps = 49/295 (16%)
Query: 300 LGQGGFGTVYK----GVLPNG--KEVAVKRLSRKSWQG-----LEEFKNEIILIAKLQHR 348
           LG+G FG V +    G+      + VAVK L   +        + E K   ILI    H 
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 82
Query: 349 NLVRLVG-CGIEGEEKLLIYELMPNRSLDCFIFDSERR---------------LQLNWNT 392
           N+V L+G C   G   ++I E     +L  ++                     L L    
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN 452
           CY+    ++KG+ +L   +  K IHRDL   N+LL +  V KI DFG+AR   ++     
Sbjct: 143 CYSF--QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW 512
                    +MAPE   + +++++SDV+SFGV++ EI S     G       +    +  
Sbjct: 198 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCR 253
Query: 513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS 567
           +L KEG  M   D       + P++ + +   L C   +P+ RPT S +V  LG+
Sbjct: 254 RL-KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 298

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 83/295 (28%), Positives = 129/295 (43%), Gaps = 49/295 (16%)
Query: 300 LGQGGFGTVYK----GVLPNG--KEVAVKRLSRKSWQG-----LEEFKNEIILIAKLQHR 348
           LG+G FG V +    G+      + VAVK L   +        + E K   ILI    H 
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 128
Query: 349 NLVRLVG-CGIEGEEKLLIYELMPNRSLDCFIFDSERR---------------LQLNWNT 392
           N+V L+G C   G   ++I E     +L  ++                     L L    
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 188
Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN 452
           CY+    ++KG+ +L   +  K IHRDL   N+LL +  V KI DFG+AR   ++     
Sbjct: 189 CYSF--QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 243
Query: 453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW 512
                    +MAPE   + +++++SDV+SFGV++ EI S     G       +    +  
Sbjct: 244 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCR 299
Query: 513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS 567
           +L KEG  M   D       + P++ + +   L C   +P+ RPT S +V  LG+
Sbjct: 300 RL-KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 344

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 291 TDGFSDSNKLGQGGFGTVYK------GVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAK 344
           +D +    +LG+G F  V +      G+    K +  K+LS + +Q LE    E  +  K
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRK 60
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           LQH N+VRL     E     L+++L+    L   I   E   + + + C   I  I + +
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC---IQQILESI 117
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTRRVVGTYG 461
            Y H +    I+HR+LKP N+LL    K    K++DFG+A    E   +       GT G
Sbjct: 118 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPG 171
Query: 462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           Y++PE   +  +S   D+++ GVI+  ++ G
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG +     +++T     + GT  Y+ P
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 201
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 202 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 251
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 252 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 281

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 108/207 (52%), Gaps = 13/207 (6%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHR 348
           + F    K+G+G +G VYK      G+ VA+   RL  ++         EI L+ +L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 349 NLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL + 
Sbjct: 63  NIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 119
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H     +++HRDLKP N+L++ +   K++DFG+AR F    +T  T  VV T  Y APE 
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEI 174
Query: 468 AME-GLFSVKSDVFSFGVIVLEIISGK 493
            +    +S   D++S G I  E+++ +
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 108/207 (52%), Gaps = 13/207 (6%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHR 348
           + F    K+G+G +G VYK      G+ VA+   RL  ++         EI L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 349 NLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL + 
Sbjct: 62  NIVKLLDV-IHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFC 118
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H     +++HRDLKP N+L++ +   K++DFG+AR F    +T  T  VV T  Y APE 
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEVV-TLWYRAPEI 173
Query: 468 AME-GLFSVKSDVFSFGVIVLEIISGK 493
            +    +S   D++S G I  E+++ +
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG +     +++T     + GT  Y+ P
Sbjct: 122 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 174
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 224
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 225 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 254

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG +     +++T     + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 178
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 228
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 229 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 258

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 83  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG +     +++T     + GT  Y+ P
Sbjct: 140 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 192
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 193 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 242
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 243 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 272

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG +     +++T     + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 180
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 230
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 231 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 260

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 291 TDGFSDSNKLGQGGFGTVYK------GVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAK 344
           +D +    +LG+G F  V +      G+    K +  K+LS + +Q LE    E  +  K
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRK 61
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           LQH N+VRL     E     L+++L+    L   I   E   + + + C   I  I + +
Sbjct: 62  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC---IQQILESI 118
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTRRVVGTYG 461
            Y H +    I+HR+LKP N+LL    K    K++DFG+A    E   +       GT G
Sbjct: 119 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPG 172
Query: 462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           Y++PE   +  +S   D+++ GVI+  ++ G
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG +     +++T     + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----ELCGTLDYLPP 175
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 225
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 226 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 255

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG +     +++ A    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA----LCGTLDYLPP 175
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 225
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 226 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 255

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 14/200 (7%)
Query: 298 NKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLE---EFKNEIILIAKLQHRNLVRL 353
           + LG G FG V  G     G +VAVK L+R+  + L+   + + EI  +   +H ++++L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
                   +  ++ E +    L  +I  + R   L+      +   I  G+ Y H   R 
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCH---RH 135
Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF 473
            ++HRDLKP NVLLD  M AKI+DFG++ +  + +     R   G+  Y APE     L+
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRXSCGSPNYAAPEVISGRLY 192
Query: 474 S-VKSDVFSFGVIVLEIISG 492
           +  + D++S GVI+  ++ G
Sbjct: 193 AGPEVDIWSSGVILYALLCG 212

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG +     +++ A    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA----LCGTLDYLPP 178
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 228
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 229 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 258

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/277 (25%), Positives = 121/277 (43%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG +   C    +  T  + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS---CHAPSSRRT-TLSGTLDYLPP 176
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 226
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 227 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 256

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 129/291 (44%), Gaps = 43/291 (14%)
Query: 300 LGQGGFGTVYKG------VLPNGKEVAVKRLSRKSWQG-----LEEFKNEIILIAKLQHR 348
           LG+G FG V +            + VAVK L   +        + E K   ILI    H 
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELK---ILIHIGHHL 93
Query: 349 NLVRLVG-CGIEGEEKLLIYELMPNRSLDCFIFDSERR--------LQLNWNTCYNIIG- 398
           N+V L+G C   G   ++I E     +L  ++              L  ++ T  ++I  
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXY 153
Query: 399 --GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
              ++KG+ +L   +  K IHRDL   N+LL +  V KI DFG+AR   ++         
Sbjct: 154 SFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWK 516
                +MAPE   + +++++SDV+SFGV++ EI S     G       +    +  +L K
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVKIDEEFCRRL-K 265
Query: 517 EGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS 567
           EG  M   D       + P++ + +   L C   +P+ RPT S +V  LG+
Sbjct: 266 EGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGN 307

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG +     +++T     + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 178
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 228
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 229 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 258

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG +     +++T     + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGTLDYLPP 175
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 225
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 226 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 255

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG +     +++T     + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGTLDYLPP 175
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 225
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 226 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 255

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 108/210 (51%), Gaps = 13/210 (6%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVK--RLSRKSWQGLEEFKNEIILIAKL 345
            + + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 346 QHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
            H N+V+L+   I  E KL L++E + ++ L  F+ D+     +      + +  + +GL
Sbjct: 63  NHPNIVKLLDV-IHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGL 119
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            + H     +++HRDLKP N+L++ +   K++DFG+AR F    +T     V  T  Y A
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRA 174
Query: 465 PEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
           PE  +    +S   D++S G I  E+++ +
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 26/204 (12%)
Query: 300 LGQGGFGTVYKGVLPNGKE----VAVKRLSRKSWQGLE-EFKNEIILIAKLQHRNLVRLV 354
           LG G F  V   +L   K     VA+K +++K+ +G E   +NEI ++ K++H N+V L 
Sbjct: 26  LGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNT---CYNIIGGISKGLLYLHEDS 411
                G    LI +L+    L    FD  R ++  + T      +I  +   + YLH+  
Sbjct: 83  DIYESGGHLYLIMQLVSGGEL----FD--RIVEKGFYTERDASRLIFQVLDAVKYLHD-- 134
Query: 412 RLKIIHRDLKPSNVL---LDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
            L I+HRDLKP N+L   LD+D    ISDFG++++       +      GT GY+APE  
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVL 190
Query: 469 MEGLFSVKSDVFSFGVIVLEIISG 492
            +  +S   D +S GVI   ++ G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 126
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG +     +++T     + GT  Y+ P
Sbjct: 127 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 179
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 229
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 230 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 259

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG +     +++T     + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTX----LCGTLDYLPP 175
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 225
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 226 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 255

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG +     +++T     + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGTLDYLPP 176
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 226
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 227 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 256

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 124/253 (49%), Gaps = 46/253 (18%)
Query: 300 LGQGGFGTVYKGVL-------PNG-KEVAVKRL-SRKSWQGLEEFKNEIILIAKL-QHRN 349
           LG+G FG V            PN   +VAVK L S  + + L +  +E+ ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERR---LQLNWNTCYNIIGGIS----- 401
           ++ L+G   +     +I E     +L  ++    RR   L+ ++N  +N    +S     
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 402 -------KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE---NQKTA 451
                  +G+ YL   +  K IHRDL   NVL+ +D V KI+DFG+AR        +KT 
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTT 210
Query: 452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--HAQTLLA 509
           N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +    + 
Sbjct: 211 NGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEI--------FTLGGSPYPGVPVE 259
Query: 510 YVWQLWKEGKEME 522
            +++L KEG  M+
Sbjct: 260 ELFKLLKEGHRMD 272

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG +     +++T     + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGTLDYLPP 180
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 181 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 230
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 231 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 260

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 291 TDGFSDSNKLGQGGFGTVYK------GVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAK 344
           +D +    +LG+G F  V +      G+    K +  K+LS + +Q LE    E  +  K
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRK 84
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           LQH N+VRL     E     L+++L+    L   I   E   + + + C   I  I + +
Sbjct: 85  LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC---IQQILESI 141
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTRRVVGTYG 461
            Y H +    I+HR+LKP N+LL    K    K++DFG+A    E   +       GT G
Sbjct: 142 AYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPG 195
Query: 462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           Y++PE   +  +S   D+++ GVI+  ++ G
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 111/212 (52%), Gaps = 16/212 (7%)
Query: 288 KAATDGFSDSNKLGQGGFGTVY---KGVLPN-GKEVAVKRLSRKSWQGLEEF--KNEIIL 341
           KA    F     LGQG FG V+   K   P+ G   A+K L + + +  +    K E  +
Sbjct: 24  KADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI 83
Query: 342 IAKLQHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           +A + H  +V+L     + E KL LI + +  R  D F   S+  +    +  +  +  +
Sbjct: 84  LADVNHPFVVKL-HYAFQTEGKLYLILDFL--RGGDLFTRLSKEVMFTEEDVKF-YLAEL 139
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
           + GL +LH    L II+RDLKP N+LLD++   K++DFG+++   +++K A +    GT 
Sbjct: 140 ALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYS--FCGTV 194
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            YMAPE       S  +D +S+GV++ E+++G
Sbjct: 195 EYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG    +  +  ++    + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 177
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 227
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 228 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 257

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 119
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG +     +++T     + GT  Y+ P
Sbjct: 120 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 172
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 222
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 223 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 252

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 121/277 (43%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG +     +++T     + GT  Y+ P
Sbjct: 128 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPP 180
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E         K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 181 EXIEGRXHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 230
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 231 PDFVTEGARDLISRLL-------KHNPSQRPXLREVL 260

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG    +  +  ++    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 178
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 228
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 229 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 258

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG    +  +  ++    + GT  Y+ P
Sbjct: 123 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLCGTLDYLPP 175
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 225
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 226 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 255

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 25/204 (12%)
Query: 300 LGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G  G V   +  VL  G  VAVK+LSR  ++    +    E++L+  + H+N++ L+
Sbjct: 32  IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 89
Query: 355 GCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
                     E ++  L+ ELM + +L C +   E   +      Y ++ GI     +LH
Sbjct: 90  NVFTPQKTLEEFQDVYLVMELM-DANL-CQVIHMELDHERMSYLLYQMLCGIK----HLH 143
Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
                 IIHRDLKPSN+++  D   KI DFG+AR  C N     T  VV  Y Y APE  
Sbjct: 144 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRY-YRAPEVI 197
Query: 469 MEGLFSVKSDVFSFGVIVLEIISG 492
           +   ++   D++S G I+ E++ G
Sbjct: 198 LGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 67  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG    +  +  ++    + GT  Y+ P
Sbjct: 124 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDTLCGTLDYLPP 176
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 226
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 227 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 256

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 123/278 (44%), Gaps = 33/278 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKGL 404
           +H N++RL G   +     LI E  P       ++   ++L + +       I  ++  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQRTATYITELANAL 126
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            Y H     ++IHRD+KP N+LL      KI+DFG +     +++T     + GT  Y+ 
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLP 179
Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV 524
           PE     +   K D++S GV+  E + GK    F    + +T        +K    +EF 
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFT 229
Query: 525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
            P  +   +   + R +       + +P+ RP +  V+
Sbjct: 230 FPDFVTEGARDLISRLL-------KHNPSQRPMLREVL 260

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 18/213 (8%)
Query: 294 FSDSNKLGQGGFGTVYKGVLPNGK----EVAVKRLSRK--SWQGLEEFKNEIILIAKLQH 347
           F+    LG+G FG+V +  L        +VAVK L     +   +EEF  E   + +  H
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 348 RNLVRLVGCGIEGEEK------LLIYELMPNRSLDCFIFDS---ERRLQLNWNTCYNIIG 398
            ++ +LVG  +    K      ++I   M +  L  F+  S   E    L   T    + 
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG 458
            I+ G+ YL   S    IHRDL   N +L +DM   ++DFG++R                
Sbjct: 145 DIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
              ++A E   + L++V SDV++FGV + EI++
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 124/253 (49%), Gaps = 46/253 (18%)
Query: 300 LGQGGFGTVYKGVL-------PNG-KEVAVKRL-SRKSWQGLEEFKNEIILIAKL-QHRN 349
           LG+G FG V            PN   +VAVK L S  + + L +  +E+ ++  + +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERR---LQLNWNTCYNIIGGIS----- 401
           ++ L+G   +     +I E     +L  ++    RR   L+ ++N  +N    +S     
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 402 -------KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE---NQKTA 451
                  +G+ YL   +  K IHRDL   NVL+ +D V KI+DFG+AR        +KT 
Sbjct: 146 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 202
Query: 452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--HAQTLLA 509
           N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +    + 
Sbjct: 203 NGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEI--------FTLGGSPYPGVPVE 251
Query: 510 YVWQLWKEGKEME 522
            +++L KEG  M+
Sbjct: 252 ELFKLLKEGHRMD 264

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 123/251 (49%), Gaps = 42/251 (16%)
Query: 300 LGQGGFGTVYKGVL-------PNG-KEVAVKRL-SRKSWQGLEEFKNEIILIAKL-QHRN 349
           LG+G FG V            PN   +VAVK L S  + + L +  +E+ ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERR-LQLNWNTCYNIIGGIS------- 401
           ++ L+G   +     +I E     +L  ++   E   L+ ++N  +N    +S       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 402 -----KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE---NQKTANT 453
                +G+ YL   +  K IHRDL   NVL+ +D V KI+DFG+AR        +KT N 
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--HAQTLLAYV 511
           R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +    +  +
Sbjct: 213 RLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEI--------FTLGGSPYPGVPVEEL 261
Query: 512 WQLWKEGKEME 522
           ++L KEG  M+
Sbjct: 262 FKLLKEGHRMD 272

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 124/253 (49%), Gaps = 46/253 (18%)
Query: 300 LGQGGFGTVYKGVL-------PNG-KEVAVKRL-SRKSWQGLEEFKNEIILIAKL-QHRN 349
           LG+G FG V            PN   +VAVK L S  + + L +  +E+ ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERR---LQLNWNTCYNIIGGIS----- 401
           ++ L+G   +     +I E     +L  ++    RR   L+ ++N  +N    +S     
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 402 -------KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE---NQKTA 451
                  +G+ YL   +  K IHRDL   NVL+ +D V KI+DFG+AR        +KT 
Sbjct: 154 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 210
Query: 452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--HAQTLLA 509
           N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +    + 
Sbjct: 211 NGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEI--------FTLGGSPYPGVPVE 259
Query: 510 YVWQLWKEGKEME 522
            +++L KEG  M+
Sbjct: 260 ELFKLLKEGHRMD 272

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 124/253 (49%), Gaps = 46/253 (18%)
Query: 300 LGQGGFGTVYKGVL-------PNG-KEVAVKRL-SRKSWQGLEEFKNEIILIAKL-QHRN 349
           LG+G FG V            PN   +VAVK L S  + + L +  +E+ ++  + +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERR---LQLNWNTCYNIIGGIS----- 401
           ++ L+G   +     +I E     +L  ++    RR   L+ ++N  +N    +S     
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 402 -------KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE---NQKTA 451
                  +G+ YL   +  K IHRDL   NVL+ +D V KI+DFG+AR        +KT 
Sbjct: 143 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 199
Query: 452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--HAQTLLA 509
           N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +    + 
Sbjct: 200 NGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEI--------FTLGGSPYPGVPVE 248
Query: 510 YVWQLWKEGKEME 522
            +++L KEG  M+
Sbjct: 249 ELFKLLKEGHRMD 261

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 124/253 (49%), Gaps = 46/253 (18%)
Query: 300 LGQGGFGTVYKGVL-------PNG-KEVAVKRL-SRKSWQGLEEFKNEIILIAKL-QHRN 349
           LG+G FG V            PN   +VAVK L S  + + L +  +E+ ++  + +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERR---LQLNWNTCYNIIGGIS----- 401
           ++ L+G   +     +I E     +L  ++    RR   L+ ++N  +N    +S     
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 402 -------KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE---NQKTA 451
                  +G+ YL   +  K IHRDL   NVL+ +D V KI+DFG+AR        +KT 
Sbjct: 147 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 203
Query: 452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--HAQTLLA 509
           N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +    + 
Sbjct: 204 NGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEI--------FTLGGSPYPGVPVE 252
Query: 510 YVWQLWKEGKEME 522
            +++L KEG  M+
Sbjct: 253 ELFKLLKEGHRMD 265

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 73/224 (32%), Positives = 112/224 (50%), Gaps = 39/224 (17%)
Query: 300 LGQGGFGTVYK----GVLPNGK--EVAVKRLSRKSWQGLEE-FKNEIILIAKL-QHRNLV 351
           LG G FG V      G+   G   +VAVK L  K+     E   +E+ ++ +L  H N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 352 RLVG-CGIEGEEKLLIYE----------LMPNR---SLDCFIFDSERRLQ----LNWNTC 393
            L+G C + G    LI+E          L   R   S D   +++++RL+    LN  T 
Sbjct: 113 NLLGACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 394 YNII---GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK- 449
            +++     ++KG+ +L   S    +HRDL   NVL+    V KI DFG+AR    +   
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 450 --TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
               N R  V    +MAPE   EG++++KSDV+S+G+++ EI S
Sbjct: 229 VVRGNARLPVK---WMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 76/253 (30%), Positives = 124/253 (49%), Gaps = 46/253 (18%)
Query: 300 LGQGGFGTVYKGVL-------PNG-KEVAVKRL-SRKSWQGLEEFKNEIILIAKL-QHRN 349
           LG+G FG V            PN   +VAVK L S  + + L +  +E+ ++  + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERR---LQLNWNTCYNIIGGIS----- 401
           ++ L+G   +     +I E     +L  ++    RR   L+ ++N  +N    +S     
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYL--QARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 402 -------KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE---NQKTA 451
                  +G+ YL   +  K IHRDL   NVL+ +D V KI+DFG+AR        +KT 
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--HAQTLLA 509
           N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +    + 
Sbjct: 252 NGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEI--------FTLGGSPYPGVPVE 300
Query: 510 YVWQLWKEGKEME 522
            +++L KEG  M+
Sbjct: 301 ELFKLLKEGHRMD 313

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 10/207 (4%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEII---LIAKLQH 347
           D F D   LG+GGFG V+   +   GK  A K+L++K  +  + ++  ++   ++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFD-SERRLQLNWNTCYNIIGGISKGLLY 406
           R +V L        +  L+  +M    +   I++  E                I  GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH+ +   II+RDLKP NVLLD D   +ISD G+A      Q    T+   GT G+MAPE
Sbjct: 305 LHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAPE 359
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGK 493
             +   +    D F+ GV + E+I+ +
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 26/204 (12%)
Query: 300 LGQGGFGTVYKGVLPNGKE----VAVKRLSRKSWQGLE-EFKNEIILIAKLQHRNLVRLV 354
           LG G F  V   +L   K     VA+K +++++ +G E   +NEI ++ K++H N+V L 
Sbjct: 26  LGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNT---CYNIIGGISKGLLYLHEDS 411
                G    LI +L+    L    FD  R ++  + T      +I  +   + YLH+  
Sbjct: 83  DIYESGGHLYLIMQLVSGGEL----FD--RIVEKGFYTERDASRLIFQVLDAVKYLHD-- 134
Query: 412 RLKIIHRDLKPSNVL---LDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
            L I+HRDLKP N+L   LD+D    ISDFG++++       +      GT GY+APE  
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVL 190
Query: 469 MEGLFSVKSDVFSFGVIVLEIISG 492
            +  +S   D +S GVI   ++ G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 102/214 (47%), Gaps = 28/214 (13%)
Query: 294 FSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           F +   +G GGFG V+K     +GK   +KR+   +    E+ + E+  +AKL H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVH 68
Query: 353 LVGC--GIEGEEK--------------LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNI 396
             GC  G + + +               +  E     +L+ +I +  R  +L+      +
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALEL 127
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
              I+KG+ Y+H     K+I+RDLKPSN+ L      KI DFG+      + K   ++  
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSK-- 182
Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEII 490
            GT  YM+PE      +  + D+++ G+I+ E++
Sbjct: 183 -GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 122/279 (43%), Gaps = 35/279 (12%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 92  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYM 463
           Y H     ++IHRD+KP N+LL      KI+DFG +          ++RR  + GT  Y+
Sbjct: 149 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS------VHAPSSRRDDLCGTLDYL 199
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF 523
            PE     +   K D++S GV+  E + GK    F    + +T        +K    +EF
Sbjct: 200 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEF 249
Query: 524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
             P  +   +   + R +       + +P+ RP +  V+
Sbjct: 250 TFPDFVTEGARDLISRLL-------KHNPSQRPMLREVL 281

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 122/277 (44%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 68  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI++FG +     +++T     + GT  Y+ P
Sbjct: 125 YCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT----LCGTLDYLPP 177
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 178 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 227
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 228 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 257

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 10/207 (4%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEII---LIAKLQH 347
           D F D   LG+GGFG V+   +   GK  A K+L++K  +  + ++  ++   ++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFD-SERRLQLNWNTCYNIIGGISKGLLY 406
           R +V L        +  L+  +M    +   I++  E                I  GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH+ +   II+RDLKP NVLLD D   +ISD G+A      Q    T+   GT G+MAPE
Sbjct: 305 LHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAPE 359
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGK 493
             +   +    D F+ GV + E+I+ +
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 110/226 (48%), Gaps = 26/226 (11%)
Query: 283 HLAVI-KAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSW--------QGL 332
           H++V  KA  D +  S  LG G  G V         K+VA+K +S++ +           
Sbjct: 6   HMSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPA 65
Query: 333 EEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNT 392
              + EI ++ KL H  ++++     + E+  ++ ELM    L   +  ++R   L   T
Sbjct: 66  LNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR---LKEAT 121
Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQK 449
           C      +   + YLHE+    IIHRDLKP NVLL   ++D + KI+DFG ++I  E   
Sbjct: 122 CKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--- 175
Query: 450 TANTRRVVGTYGYMAPEYAME---GLFSVKSDVFSFGVIVLEIISG 492
           T+  R + GT  Y+APE  +      ++   D +S GVI+   +SG
Sbjct: 176 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 133/304 (43%), Gaps = 57/304 (18%)
Query: 300 LGQGGFGTVYKG-VLPNGKEVAVKRLSRKSWQGL------EEFKNEIILIAKL-QHRNLV 351
           LG G FG V +      GKE AV +++ K  +        E   +E+ +++ L QH N+V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 352 RLVGCGIEGEEKLLIYE----------------------LMPNRSLDCFIFDSERRLQLN 389
            L+G    G   L+I E                      L P +  +    +  R L+L 
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 390 WNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK 449
                +    +++G+ +L   +    IHRD+   NVLL    VAKI DFG+AR    +  
Sbjct: 159 --DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 213
Query: 450 ---TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQT 506
                N R  V    +MAPE   + +++V+SDV+S+G+++ EI S        L  +   
Sbjct: 214 YIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFS------LGLNPYPGI 264
Query: 507 LL-AYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
           L+ +  ++L K+G +M        + +  P+ +  I     C   +P  RPT   + + L
Sbjct: 265 LVNSKFYKLVKDGYQM-------AQPAFAPKNIYSIMQA--CWALEPTHRPTFQQICSFL 315
Query: 566 GSES 569
             ++
Sbjct: 316 QEQA 319

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 10/207 (4%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEII---LIAKLQH 347
           D F D   LG+GGFG V+   +   GK  A K+L++K  +  + ++  ++   ++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFD-SERRLQLNWNTCYNIIGGISKGLLY 406
           R +V L        +  L+  +M    +   I++  E                I  GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH+ +   II+RDLKP NVLLD D   +ISD G+A      Q    T+   GT G+MAPE
Sbjct: 305 LHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAPE 359
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGK 493
             +   +    D F+ GV + E+I+ +
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 26/204 (12%)
Query: 300 LGQGGFGTVYKGVLPNGKE----VAVKRLSRKSWQGLE-EFKNEIILIAKLQHRNLVRLV 354
           LG G F  V   +L   K     VA+K +++++ +G E   +NEI ++ K++H N+V L 
Sbjct: 26  LGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNT---CYNIIGGISKGLLYLHEDS 411
                G    LI +L+    L    FD  R ++  + T      +I  +   + YLH+  
Sbjct: 83  DIYESGGHLYLIMQLVSGGEL----FD--RIVEKGFYTERDASRLIFQVLDAVKYLHD-- 134
Query: 412 RLKIIHRDLKPSNVL---LDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
            L I+HRDLKP N+L   LD+D    ISDFG++++       +      GT GY+APE  
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVL 190
Query: 469 MEGLFSVKSDVFSFGVIVLEIISG 492
            +  +S   D +S GVI   ++ G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIA 343
           K +   F     LG G FG V+      NG+  A+K L ++     + +E   +E ++++
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 344 KLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-ISK 402
            + H  ++R+ G   + ++  +I + +    L    F   R+ Q   N         +  
Sbjct: 62  IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAAEVCL 117
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
            L YLH      II+RDLKP N+LLDK+   KI+DFG A+   +      T  + GT  Y
Sbjct: 118 ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDY 169
Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           +APE      ++   D +SFG+++ E+++G
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 121/277 (43%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI+DFG    +  +  ++    + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRDDLCGTLDYLPP 178
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 228
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 229 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 258

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 10/207 (4%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEII---LIAKLQH 347
           D F D   LG+GGFG V+   +   GK  A K+L++K  +  + ++  ++   ++AK+  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFD-SERRLQLNWNTCYNIIGGISKGLLY 406
           R +V L        +  L+  +M    +   I++  E                I  GL +
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH+ +   II+RDLKP NVLLD D   +ISD G+A      Q    T+   GT G+MAPE
Sbjct: 305 LHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAPE 359
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGK 493
             +   +    D F+ GV + E+I+ +
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 106/230 (46%), Gaps = 31/230 (13%)
Query: 300 LGQGGFGTVYKGVLPNGK----EVAVK--RLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           LG+G FG+V +G L        +VAVK  +L   S + +EEF +E   +    H N++RL
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 354 VGCGIEGEEK-----LLIYELMPNRSLDCFIFDSERRLQ-----LNWNTCYNIIGGISKG 403
           +G  IE   +     ++I   M    L  ++  S  RL+     +   T    +  I+ G
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS--RLETGPKHIPLQTLLKFMVDIALG 159
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           + YL   S    +HRDL   N +L  DM   ++DFG+++           R       ++
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIIS-------GKRNSGFY---LTGH 503
           A E   + +++ KSDV++FGV + EI +       G +N   Y   L GH
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH 266

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 106/197 (53%), Gaps = 11/197 (5%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLS-RKSWQGLEEFK-NEIILIAKLQHRNLVRLVGC 356
           K+G+G +G VYK     G+  A+K++   K  +G+      EI ++ +L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
               +  +L++E + ++ L   +   E  L+    T  + +  +  G+ Y H+    +++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESV--TAKSFLLQLLNGIAYCHDR---RVL 122
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM-EGLFSV 475
           HRDLKP N+L++++   KI+DFG+AR F    +   T  VV T  Y AP+  M    +S 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEVV-TLWYRAPDVLMGSKKYST 180
Query: 476 KSDVFSFGVIVLEIISG 492
             D++S G I  E+++G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 106/197 (53%), Gaps = 11/197 (5%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLS-RKSWQGLEEFK-NEIILIAKLQHRNLVRLVGC 356
           K+G+G +G VYK     G+  A+K++   K  +G+      EI ++ +L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
               +  +L++E + ++ L   +   E  L+    T  + +  +  G+ Y H+    +++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESV--TAKSFLLQLLNGIAYCHDR---RVL 122
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM-EGLFSV 475
           HRDLKP N+L++++   KI+DFG+AR F    +   T  VV T  Y AP+  M    +S 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEVV-TLWYRAPDVLMGSKKYST 180
Query: 476 KSDVFSFGVIVLEIISG 492
             D++S G I  E+++G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 26/204 (12%)
Query: 300 LGQGGFGTVYKGVLPNGKE----VAVKRLSRKSWQGLE-EFKNEIILIAKLQHRNLVRLV 354
           LG G F  V   +L   K     VA+K +++++ +G E   +NEI ++ K++H N+V L 
Sbjct: 26  LGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNT---CYNIIGGISKGLLYLHEDS 411
                G    LI +L+    L    FD  R ++  + T      +I  +   + YLH+  
Sbjct: 83  DIYESGGHLYLIMQLVSGGEL----FD--RIVEKGFYTERDASRLIFQVLDAVKYLHD-- 134
Query: 412 RLKIIHRDLKPSNVL---LDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
            L I+HRDLKP N+L   LD+D    ISDFG++++       +      GT GY+APE  
Sbjct: 135 -LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVL 190
Query: 469 MEGLFSVKSDVFSFGVIVLEIISG 492
            +  +S   D +S GVI   ++ G
Sbjct: 191 AQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 122/277 (44%), Gaps = 31/277 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +H N++RL G   +     LI E  P   L     + ++  + +       I  ++  L 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           Y H     ++IHRD+KP N+LL      KI++FG +     +++T     + GT  Y+ P
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT----LCGTLDYLPP 178
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E     +   K D++S GV+  E + GK    F    + +T        +K    +EF  
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFTF 228
Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
           P  +   +   + R +       + +P+ RP +  V+
Sbjct: 229 PDFVTEGARDLISRLL-------KHNPSQRPMLREVL 258

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLS---RKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +G+G +G V++G    G+ VAVK  S    KSW    E  N ++L    +H N++  +  
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 99
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH-----EDS 411
            +          L+ +      ++D  +   L+  +C  I+  I+ GL +LH        
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 159
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE--NQKTANTRRVVGTYGYMAPEYAM 469
           +  I HRDLK  N+L+ K+    I+D G+A +  +  NQ        VGT  YMAPE   
Sbjct: 160 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 219
Query: 470 EGL----FSV--KSDVFSFGVIVLEI 489
           E +    F    + D+++FG+++ E+
Sbjct: 220 ETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 106/220 (48%), Gaps = 25/220 (11%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSW--------QGLEEFKNE 338
           KA  D +  S  LG G  G V         K+VA+K +S++ +              + E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 339 IILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG 398
           I ++ KL H  ++++     + E+  ++ ELM    L   +  ++R   L   TC     
Sbjct: 66  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFY 121
Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRR 455
            +   + YLHE+    IIHRDLKP NVLL   ++D + KI+DFG ++I  E   T+  R 
Sbjct: 122 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRT 175
Query: 456 VVGTYGYMAPEYAME---GLFSVKSDVFSFGVIVLEIISG 492
           + GT  Y+APE  +      ++   D +S GVI+   +SG
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 106/220 (48%), Gaps = 25/220 (11%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSW--------QGLEEFKNE 338
           KA  D +  S  LG G  G V         K+VA+K +S++ +              + E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 339 IILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG 398
           I ++ KL H  ++++     + E+  ++ ELM    L   +  ++R   L   TC     
Sbjct: 66  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFY 121
Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRR 455
            +   + YLHE+    IIHRDLKP NVLL   ++D + KI+DFG ++I  E   T+  R 
Sbjct: 122 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRT 175
Query: 456 VVGTYGYMAPEYAME---GLFSVKSDVFSFGVIVLEIISG 492
           + GT  Y+APE  +      ++   D +S GVI+   +SG
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 126/290 (43%), Gaps = 46/290 (15%)
Query: 300 LGQGGFGTVYKGVLPNGK------EVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
           LG+G FG V K    + K       VAVK L    S   L +  +E  ++ ++ H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSER---------------------RLQLNWN 391
           L G   +    LLI E     SL  F+ +S +                        L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 392 TCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA 451
              +    IS+G+ YL E   +K++HRDL   N+L+ +    KISDFG++R   E     
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYV 511
              +      +MA E   + +++ +SDV+SFGV++ EI++   N       +       +
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP------YPGIPPERL 261
Query: 512 WQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
           + L K G  ME  D      +   ++ R +   L C +++P  RP  +++
Sbjct: 262 FNLLKTGHRMERPD------NCSEEMYRLM---LQCWKQEPDKRPVFADI 302

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 122/278 (43%), Gaps = 33/278 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKL 345
           A + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKGL 404
           +H N++RL G   +     LI E  P       ++   ++L + +       I  ++  L
Sbjct: 71  RHPNILRLYGYFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQRTATYITELANAL 126
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            Y H     ++IHRD+KP N+LL      KI+DFG    +  +  ++    + GT  Y+ 
Sbjct: 127 SYCHSK---RVIHRDIKPENLLLGSAGELKIADFG----WSVHAPSSRRXXLXGTLDYLP 179
Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV 524
           PE     +   K D++S GV+  E + GK    F    + +T        +K    +EF 
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK--PPFEANTYQET--------YKRISRVEFT 229
Query: 525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
            P  +   +   + R +       + +P+ RP +  V+
Sbjct: 230 FPDFVTEGARDLISRLL-------KHNPSQRPMLREVL 260

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 106/220 (48%), Gaps = 25/220 (11%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSW--------QGLEEFKNE 338
           KA  D +  S  LG G  G V         K+VA+K +S++ +              + E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 339 IILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG 398
           I ++ KL H  ++++     + E+  ++ ELM    L   +  ++R   L   TC     
Sbjct: 66  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFY 121
Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRR 455
            +   + YLHE+    IIHRDLKP NVLL   ++D + KI+DFG ++I  E   T+  R 
Sbjct: 122 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRT 175
Query: 456 VVGTYGYMAPEYAME---GLFSVKSDVFSFGVIVLEIISG 492
           + GT  Y+APE  +      ++   D +S GVI+   +SG
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 106/197 (53%), Gaps = 11/197 (5%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLS-RKSWQGLEEFK-NEIILIAKLQHRNLVRLVGC 356
           K+G+G +G VYK     G+  A+K++   K  +G+      EI ++ +L+H N+V+L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
               +  +L++E + ++ L   +   E  L+    T  + +  +  G+ Y H+    +++
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESV--TAKSFLLQLLNGIAYCHDR---RVL 122
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM-EGLFSV 475
           HRDLKP N+L++++   KI+DFG+AR F    +   T  +V T  Y AP+  M    +S 
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIV-TLWYRAPDVLMGSKKYST 180
Query: 476 KSDVFSFGVIVLEIISG 492
             D++S G I  E+++G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 298 NKLGQGGFGTVYKGVL----PNGKEVAVKRL--SRKSWQGLEEFKNEIILIAKLQHRNLV 351
            K+G+G FG   K +L     +G++  +K +  SR S +  EE + E+ ++A ++H N+V
Sbjct: 30  QKIGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIV 86
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +      E     ++ +      L   I ++++ +    +   +    I   L ++H+  
Sbjct: 87  QYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHDR- 144
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
             KI+HRD+K  N+ L KD   ++ DFG+AR+   N      R  +GT  Y++PE     
Sbjct: 145 --KILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPEICENK 200
Query: 472 LFSVKSDVFSFGVIVLEIISGK 493
            ++ KSD+++ G ++ E+ + K
Sbjct: 201 PYNNKSDIWALGCVLYELCTLK 222

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 107/208 (51%), Gaps = 31/208 (14%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRNLVRLVG 355
           +G G +G+V     + +G ++AVK+LSR  +Q +   K    E+ L+  ++H N++ L+ 
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 117
Query: 356 CGI------EGEEKLLIYELMP---NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLY 406
                    E  +  L+  LM    N  + C         +L  +    +I  I +GL Y
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVKC--------QKLTDDHVQFLIYQILRGLKY 169
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           +H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      V T  Y APE
Sbjct: 170 IHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWYRAPE 221
Query: 467 YAMEGL-FSVKSDVFSFGVIVLEIISGK 493
             +  + +++  D++S G I+ E+++G+
Sbjct: 222 IMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 120/254 (47%), Gaps = 48/254 (18%)
Query: 300 LGQGGFGTVYKGVL-------PNG-KEVAVKRL-SRKSWQGLEEFKNEIILIAKL-QHRN 349
           LG+G FG V            PN   +VAVK L S  + + L +  +E+ ++  + +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG---------- 399
           ++ L+G   +     +I E     +L  ++   + R       CYN              
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYL---QARRPPGLEYCYNPSHNPEEQLSSKDL 137
Query: 400 ------ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE---NQKT 450
                 +++G+ YL   +  K IHRDL   NVL+ +D V KI+DFG+AR        +KT
Sbjct: 138 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--HAQTLL 508
            N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +    +
Sbjct: 195 TNGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEI--------FTLGGSPYPGVPV 243
Query: 509 AYVWQLWKEGKEME 522
             +++L KEG  M+
Sbjct: 244 EELFKLLKEGHRMD 257

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLS---RKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +G+G +G V++G    G+ VAVK  S    KSW    E  N ++L    +H N++  +  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 70
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH-----EDS 411
            +          L+ +      ++D  +   L+  +C  I+  I+ GL +LH        
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE--NQKTANTRRVVGTYGYMAPEYAM 469
           +  I HRDLK  N+L+ K+    I+D G+A +  +  NQ        VGT  YMAPE   
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190
Query: 470 EGL----FSV--KSDVFSFGVIVLEI 489
           E +    F    + D+++FG+++ E+
Sbjct: 191 ETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 106/220 (48%), Gaps = 25/220 (11%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSW--------QGLEEFKNE 338
           KA  D +  S  LG G  G V         K+VA+K +S++ +              + E
Sbjct: 5   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 64
Query: 339 IILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG 398
           I ++ KL H  ++++     + E+  ++ ELM    L   +  ++R   L   TC     
Sbjct: 65  IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFY 120
Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRR 455
            +   + YLHE+    IIHRDLKP NVLL   ++D + KI+DFG ++I  E   T+  R 
Sbjct: 121 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRT 174
Query: 456 VVGTYGYMAPEYAME---GLFSVKSDVFSFGVIVLEIISG 492
           + GT  Y+APE  +      ++   D +S GVI+   +SG
Sbjct: 175 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGCGI 358
           +G G +G VYKG      ++A  ++   +    EE K EI ++ K   HRN+    G  I
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 359 E------GEEKLLIYELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +       ++  L+ E     S+   I +++   L+  W   Y I   I +GL +LH+  
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-IAY-ICREILRGLSHLHQH- 148
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM-- 469
             K+IHRD+K  NVLL ++   K+ DFG++          NT   +GT  +MAPE     
Sbjct: 149 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMAPEVIACD 204
Query: 470 ---EGLFSVKSDVFSFGVIVLEIISG 492
              +  +  KSD++S G+  +E+  G
Sbjct: 205 ENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 21/206 (10%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLS---RKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +G+G +G V++G    G+ VAVK  S    KSW    E  N ++L    +H N++  +  
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRETELYNTVML----RHENILGFIAS 70
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH-----EDS 411
            +          L+ +      ++D  +   L+  +C  I+  I+ GL +LH        
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE--NQKTANTRRVVGTYGYMAPEYAM 469
           +  I HRDLK  N+L+ K+    I+D G+A +  +  NQ        VGT  YMAPE   
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190
Query: 470 EGL----FSV--KSDVFSFGVIVLEI 489
           E +    F    + D+++FG+++ E+
Sbjct: 191 ETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 27/211 (12%)
Query: 299 KLGQGGFGTVYKGVLPNGK-EVAVKRLSRKSWQG-------------LEEFKNEIILIAK 344
           KLG G +G V      NG  E A+K + +  +                EE  NEI L+  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           L H N+++L     + +   L+ E      L   I +   R + +     NI+  I  G+
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGI 159
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKD---MVAKISDFGMARIFCENQKTANTRRVVGTYG 461
            YLH+ +   I+HRD+KP N+LL+     +  KI DFG++  F ++ K    R  +GT  
Sbjct: 160 CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAY 213
Query: 462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           Y+APE  ++  ++ K DV+S GVI+  ++ G
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 120/254 (47%), Gaps = 48/254 (18%)
Query: 300 LGQGGFGTVYKGVL-------PNG-KEVAVKRL-SRKSWQGLEEFKNEIILIAKL-QHRN 349
           LG+G FG V            PN   +VAVK L S  + + L +  +E+ ++  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG---------- 399
           ++ L+G   +     +I E     +L  ++   + R       CYN              
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYL---QARRPPGLEYCYNPSHNPEEQLSSKDL 152
Query: 400 ------ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE---NQKT 450
                 +++G+ YL   +  K IHRDL   NVL+ +D V KI+DFG+AR        +KT
Sbjct: 153 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--HAQTLL 508
            N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +    +
Sbjct: 210 TNGRLPV---KWMAPEALFDRIYTHQSDVWSFGVLLWEI--------FTLGGSPYPGVPV 258
Query: 509 AYVWQLWKEGKEME 522
             +++L KEG  M+
Sbjct: 259 EELFKLLKEGHRMD 272

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           +++G+ +L   S  K IHRDL   N+LL ++ V KI DFG+AR   +N            
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS--GKRNSGFYLTGHAQTLLAYVWQLWKE 517
             +MAPE   + ++S KSDV+S+GV++ EI S  G    G  +     + L       +E
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRL-------RE 317
Query: 518 GKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG 566
           G  M           S P++ +   I L C   DP  RP  + +V  LG
Sbjct: 318 GMRMR------APEYSTPEIYQ---IMLDCWHRDPKERPRFAELVEKLG 357

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 39/226 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           F +   +G GGFG V+K     +GK   ++R+   +    E+ + E+  +AKL H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIVH 69
Query: 353 LVGC--GIE-----GEEKLLIYELMPNRSLD-------CFIFDSE--------------R 384
             GC  G +      ++ L   +  P  S +       C     E              R
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 385 RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF 444
             +L+      +   I+KG+ Y+H     K+IHRDLKPSN+ L      KI DFG+    
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL 186
Query: 445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEII 490
             + K   ++   GT  YM+PE      +  + D+++ G+I+ E++
Sbjct: 187 KNDGKRTRSK---GTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 126/290 (43%), Gaps = 46/290 (15%)
Query: 300 LGQGGFGTVYKGVLPNGK------EVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
           LG+G FG V K    + K       VAVK L    S   L +  +E  ++ ++ H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSER---------------------RLQLNWN 391
           L G   +    LLI E     SL  F+ +S +                        L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 392 TCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA 451
              +    IS+G+ YL E   +K++HRDL   N+L+ +    KISDFG++R   E     
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYV 511
              +      +MA E   + +++ +SDV+SFGV++ EI++   N       +       +
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP------YPGIPPERL 261
Query: 512 WQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
           + L K G  ME  D      +   ++ R +   L C +++P  RP  +++
Sbjct: 262 FNLLKTGHRMERPD------NCSEEMYRLM---LQCWKQEPDKRPVFADI 302

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 104/237 (43%), Gaps = 19/237 (8%)
Query: 283 HLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLE---EFKNE 338
           H+      +D +     LG GG   V+    L + ++VAVK L     +       F+ E
Sbjct: 3   HMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRRE 62
Query: 339 IILIAKLQHRNLVRLVGCG----IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY 394
               A L H  +V +   G      G    ++ E +   +L   +        +      
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAI 119
Query: 395 NIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT-ANT 453
            +I    + L + H++    IIHRD+KP+N+L+      K+ DFG+AR   ++  +   T
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT 176
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAY 510
             V+GT  Y++PE A       +SDV+S G ++ E+++G+       TG +   +AY
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAY 229

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 120/278 (43%), Gaps = 33/278 (11%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE 359
           +G+G FG VY G       + +  + R +   L+ FK E++   + +H N+V  +G  + 
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 360 GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRD 419
                +I  L   R+L   + D+  ++ L+ N    I   I KG+ YLH      I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 420 LKPSNVLLDKDMVAKISDFGM---ARIFCENQKTANTRRVVGTYGYMAPEYAMEGL---- 472
           LK  NV  D   V  I+DFG+   + +    ++    R   G   ++APE   +      
Sbjct: 156 LKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 473 -----FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL 527
                FS  SDVF+ G I  E+ +  R   F      Q   A +WQ+   G  M+   P 
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHA--REWPF----KTQPAEAIIWQM---GTGMK---PN 262
Query: 528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
           L   S I        I L C   +   RPT + ++ +L
Sbjct: 263 L---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 34/231 (14%)
Query: 287 IKAATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKL 345
           ++ A+D F +   LGQG FG V K     + +  A+K++ R + + L    +E++L+A L
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASL 59
Query: 346 QHRNLVRLVGCGIE------------GEEKLLI-YELMPNRSLDCFIFDSERRLQLNWNT 392
            H+ +VR     +E             +  L I  E   NR+L   I      L    + 
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSEN--LNQQRDE 117
Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR--------IF 444
            + +   I + L Y+H      IIHRDLKP N+ +D+    KI DFG+A+        + 
Sbjct: 118 YWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 445 CENQK----TANTRRVVGTYGYMAPE-YAMEGLFSVKSDVFSFGVIVLEII 490
            ++Q     + N    +GT  Y+A E     G ++ K D++S G+I  E+I
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 300 LGQGGFGTVYKGVLP-NGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +G G +G+V   +   +G++VA+K+LSR  +S    +    E++L+  +QH N++ L+  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 357 GIEGEEKLLIYE---LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
                     Y+   +MP    D         L+ +      ++  + KGL Y+H     
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTD---LQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG-- 146
Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL- 472
            ++HRDLKP N+ +++D   KI DFG+AR        A     V T  Y APE  +  + 
Sbjct: 147 -VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILSWMH 200
Query: 473 FSVKSDVFSFGVIVLEIISGK 493
           ++   D++S G I+ E+++GK
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGK 221

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF-------------IFDSERRLQLNWNTCYNI 396
           ++ L+                P RSL+ F             + +  +  +L  +    +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG----Y 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 31/214 (14%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 350 LVRLVGCGI------EGEEKLLIYELMP---NRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           ++ L+          E  +  L+  LM    N  + C         +L  +    +I  I
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--------AKLTDDHVQFLIYQI 130
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
            +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      V T 
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATR 182
Query: 461 GYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
            Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 20/207 (9%)
Query: 299 KLGQGGFGTVYKG--VLPNGKEVAVKRLSRKSWQ---GLEEFKNEIIL--IAKLQHRNLV 351
           ++G+G +G V+K   +   G+ VA+KR+  ++ +    L   +   +L  +   +H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 352 RLVG-CGI---EGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLY 406
           RL   C +   + E KL L++E + ++ L  ++ D      +   T  +++  + +GL +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH     +++HRDLKP N+L+      K++DFG+ARI+       +   VV T  Y APE
Sbjct: 136 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVVTLWYRAPE 189
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGK 493
             ++  ++   D++S G I  E+   K
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 97/205 (47%), Gaps = 14/205 (6%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKLQH 347
           + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
            N++RL G   +     LI E  P   L     + ++  + +       I  ++  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H     ++IHRD+KP N+LL  +   KI+DFG +     +++T     + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTT----LCGTLDYLPPEM 181
Query: 468 AMEGLFSVKSDVFSFGVIVLEIISG 492
               +   K D++S GV+  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 294 FSDSNKLGQGGFGTVYKGVLP----NGKEVAVKRLSRKSWQGLEE-FKNEIILIAKLQHR 348
           F     LG G F  V   VL      GK  AVK + +K+ +G E   +NEI ++ K++H 
Sbjct: 24  FEFKETLGTGAFSEV---VLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHE 80
Query: 349 NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
           N+V L           L+ +L+    L   I +     + + +T   +I  +   + YLH
Sbjct: 81  NIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAST---LIRQVLDAVYYLH 137
Query: 409 EDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
              R+ I+HRDLKP N+L    D++    ISDFG++++     K        GT GY+AP
Sbjct: 138 ---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMSTACGTPGYVAP 191
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E   +  +S   D +S GVI   ++ G
Sbjct: 192 EVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 89  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 137 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 188
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 104/237 (43%), Gaps = 19/237 (8%)
Query: 283 HLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLE---EFKNE 338
           H+      +D +     LG GG   V+    L + ++VAVK L     +       F+ E
Sbjct: 3   HMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRRE 62
Query: 339 IILIAKLQHRNLVRLVGCG----IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY 394
               A L H  +V +   G      G    ++ E +   +L   +        +      
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAI 119
Query: 395 NIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT-ANT 453
            +I    + L + H++    IIHRD+KP+N+++      K+ DFG+AR   ++  +   T
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAY 510
             V+GT  Y++PE A       +SDV+S G ++ E+++G+       TG +   +AY
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAY 229

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 31/214 (14%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 350 LVRLVGCGI------EGEEKLLIYELMP---NRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           ++ L+          E  +  L+  LM    N  + C         +L  +    +I  I
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--------QKLTDDHVQFLIYQI 130
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
            +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      V T 
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATR 182
Query: 461 GYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
            Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 29  YQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 87
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 88  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 136 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG----Y 187
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 102
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 103 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 150
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 151 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 202
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 203 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 101
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 102 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 149
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 150 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 201
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 202 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 20/207 (9%)
Query: 299 KLGQGGFGTVYKG--VLPNGKEVAVKRLSRKSWQ---GLEEFKNEIIL--IAKLQHRNLV 351
           ++G+G +G V+K   +   G+ VA+KR+  ++ +    L   +   +L  +   +H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 352 RLVG-CGI---EGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLY 406
           RL   C +   + E KL L++E + ++ L  ++ D      +   T  +++  + +GL +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH     +++HRDLKP N+L+      K++DFG+ARI+       +   VV T  Y APE
Sbjct: 136 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVVTLWYRAPE 189
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGK 493
             ++  ++   D++S G I  E+   K
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 104/237 (43%), Gaps = 19/237 (8%)
Query: 283 HLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLE---EFKNE 338
           H+      +D +     LG GG   V+    L + ++VAVK L     +       F+ E
Sbjct: 3   HMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRRE 62
Query: 339 IILIAKLQHRNLVRLVGCG----IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY 394
               A L H  +V +   G      G    ++ E +   +L   +        +      
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAI 119
Query: 395 NIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT-ANT 453
            +I    + L + H++    IIHRD+KP+N+++      K+ DFG+AR   ++  +   T
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAY 510
             V+GT  Y++PE A       +SDV+S G ++ E+++G+       TG +   +AY
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPDSVAY 229

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 87
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 88  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 136 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG----Y 187
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 29/215 (13%)
Query: 293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNL 350
            ++D+  +G G FG VY+  L  +G+ VA+K++ +      + FKN E+ ++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 351 VRL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS-------- 401
           VRL       GE+K ++Y    N  LD ++ ++  R+  +++     +  I         
Sbjct: 76  VRLRYFFYSSGEKKDVVYL---NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 402 -KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGT 459
            + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSR 186
Query: 460 YGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           Y Y APE       ++   DV+S G ++ E++ G+
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 39/212 (18%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRNLVRLVG 355
           +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N++ L+ 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLD 98
Query: 356 CGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------IIGGISK 402
                          P RSL+ F  ++     +  + N               +I  I +
Sbjct: 99  V------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 146
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      V T  Y
Sbjct: 147 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATRWY 198
Query: 463 MAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
            APE  +  + ++   D++S G I+ E+++G+
Sbjct: 199 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 20/207 (9%)
Query: 299 KLGQGGFGTVYKG--VLPNGKEVAVKRLSRKSWQ---GLEEFKNEIIL--IAKLQHRNLV 351
           ++G+G +G V+K   +   G+ VA+KR+  ++ +    L   +   +L  +   +H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 352 RLVG-CGI---EGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLY 406
           RL   C +   + E KL L++E + ++ L  ++ D      +   T  +++  + +GL +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH     +++HRDLKP N+L+      K++DFG+ARI+       +   VV T  Y APE
Sbjct: 136 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVVTLWYRAPE 189
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGK 493
             ++  ++   D++S G I  E+   K
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 300 LGQGGFGTVYKGVLP-NGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +G G +G+V   +   +G++VA+K+LSR  +S    +    E++L+  +QH N++ L+  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 357 GIEGEEKLLIYE---LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
                     Y+   +MP    D         ++ +      ++  + KGL Y+H     
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTD---LQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG-- 164
Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL- 472
            ++HRDLKP N+ +++D   KI DFG+AR        A     V T  Y APE  +  + 
Sbjct: 165 -VVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILSWMH 218
Query: 473 FSVKSDVFSFGVIVLEIISGK 493
           ++   D++S G I+ E+++GK
Sbjct: 219 YNQTVDIWSVGCIMAEMLTGK 239

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF-------------IFDSERRLQLNWNTCYNI 396
           ++ L+                P RSL+ F             + +  +  +L  +    +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 115/246 (46%), Gaps = 43/246 (17%)
Query: 266 SLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRL 324
           S++QE      +EL       I    + + + + +G G +G+V        G  VAVK+L
Sbjct: 2   SMSQERPTFYRQELN----KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 57
Query: 325 SRKSWQGLEEFKN---EIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCF--I 379
           SR  +Q +   K    E+ L+  ++H N++ L+                P RSL+ F  +
Sbjct: 58  SR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDV 104
Query: 380 FDSERRLQLNWNTCYN-----------IIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD 428
           +     +  + N               +I  I +GL Y+H      IIHRDLKPSN+ ++
Sbjct: 105 YLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVN 161
Query: 429 KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVL 487
           +D   KI DFG+AR   +++ T      V T  Y APE  +  + ++   D++S G I+ 
Sbjct: 162 EDSELKILDFGLAR-HTDDEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 216
Query: 488 EIISGK 493
           E+++G+
Sbjct: 217 ELLTGR 222

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSW----QGLEEFKNEIILIAKLQHRNLVRLVG 355
           LG+GGF   Y+    + KEV   ++  KS        E+   EI +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
              + +   ++ E+   RSL   +   +RR  +        +    +G+ YLH +   ++
Sbjct: 110 FFEDDDFVYVVLEICRRRSL---LELHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMA-RIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
           IHRDLK  N+ L+ DM  KI DFG+A +I  + ++  +   + GT  Y+APE   +   S
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD---LCGTPNYIAPEVLCKKGHS 220
Query: 475 VKSDVFSFGVIVLEIISGK 493
            + D++S G I+  ++ GK
Sbjct: 221 FEVDIWSLGCILYTLLVGK 239

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 103/227 (45%), Gaps = 32/227 (14%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVLPNGKE----VAVKRL--SRKSWQGLE-EFKNEIILIAK 344
           D F     LG+G FG VY   L   K+    VA+K L  S+   +G+E + + EI + A 
Sbjct: 23  DDFEIGRPLGKGKFGNVY---LAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAH 79
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSL-----DCFIFDSERRLQLNWNTCYNIIGG 399
           L H N++RL     +     LI E  P   L         FD +R           I+  
Sbjct: 80  LHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQR--------TATIMEE 131
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           ++  L+Y H     K+IHRD+KP N+LL      KI+DFG    +  +  +   + + GT
Sbjct: 132 LADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFG----WSVHAPSLRRKTMCGT 184
Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQT 506
             Y+ PE     + + K D++  GV+  E++ G  N  F    H +T
Sbjct: 185 LDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG--NPPFESASHNET 229

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 93
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 94  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 141
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 142 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLAR-HTDDEMTG----Y 193
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 194 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 292 DGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHR-- 348
           D F   ++LG G  G V+K    P+G  +A K +  +    +   +N+II   ++ H   
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI---RNQIIRELQVLHECN 124
Query: 349 --NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS----K 402
              +V   G      E  +  E M   SLD  +  + R  +        I+G +S    K
Sbjct: 125 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGKVSIAVIK 177
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           GL YL E  + KI+HRD+KPSN+L++     K+ DFG++    ++   AN+   VGT  Y
Sbjct: 178 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS--FVGTRSY 231
Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           M+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 232 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 115/246 (46%), Gaps = 43/246 (17%)
Query: 266 SLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRL 324
           S++QE      +EL       I    + + + + +G G +G+V        G  VAVK+L
Sbjct: 2   SMSQERPTFYRQELN----KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 57
Query: 325 SRKSWQGLEEFKN---EIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCF--I 379
           SR  +Q +   K    E+ L+  ++H N++ L+                P RSL+ F  +
Sbjct: 58  SR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDV 104
Query: 380 FDSERRLQLNWNTCYN-----------IIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD 428
           +     +  + N               +I  I +GL Y+H      IIHRDLKPSN+ ++
Sbjct: 105 YLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVN 161
Query: 429 KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVL 487
           +D   KI DFG+AR   +++ T      V T  Y APE  +  + ++   D++S G I+ 
Sbjct: 162 EDCELKILDFGLAR-HTDDEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 216
Query: 488 EIISGK 493
           E+++G+
Sbjct: 217 ELLTGR 222

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSW----QGLEEFKNEIILIAKLQHRNLVRLVG 355
           LG+GGF   Y+    + KEV   ++  KS        E+   EI +   L + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
              + +   ++ E+   RSL   +   +RR  +        +    +G+ YLH +   ++
Sbjct: 94  FFEDDDFVYVVLEICRRRSL---LELHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 147
Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMA-RIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
           IHRDLK  N+ L+ DM  KI DFG+A +I  + ++  +   + GT  Y+APE   +   S
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD---LCGTPNYIAPEVLCKKGHS 204
Query: 475 VKSDVFSFGVIVLEIISGK 493
            + D++S G I+  ++ GK
Sbjct: 205 FEVDIWSLGCILYTLLVGK 223

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 17/207 (8%)
Query: 294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGL--EEFKNEIILIAKLQHRNL 350
           + D   +G G +G V   V    G +VA+K+L R     L  +    E+ L+  ++H N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 351 VRLVGCGIEGE---EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           + L+      E   +    Y +MP    D        +L    +    ++  + KGL Y+
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKL--GEDRIQFLVYQMLKGLRYI 144
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H      IIHRDLKP N+ +++D   KI DFG+AR     Q  +     V T  Y APE 
Sbjct: 145 HAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRWYRAPEV 196
Query: 468 AMEGL-FSVKSDVFSFGVIVLEIISGK 493
            +  + ++   D++S G I+ E+I+GK
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 25/220 (11%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSW--------QGLEEFKNE 338
           KA  D +  S  LG G  G V         K+VA++ +S++ +              + E
Sbjct: 145 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 204
Query: 339 IILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG 398
           I ++ KL H  ++++     + E+  ++ ELM    L   +  ++R   L   TC     
Sbjct: 205 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFY 260
Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRR 455
            +   + YLHE+    IIHRDLKP NVLL   ++D + KI+DFG ++I  E   T+  R 
Sbjct: 261 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRT 314
Query: 456 VVGTYGYMAPEYAME---GLFSVKSDVFSFGVIVLEIISG 492
           + GT  Y+APE  +      ++   D +S GVI+   +SG
Sbjct: 315 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 115/246 (46%), Gaps = 43/246 (17%)
Query: 266 SLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRL 324
           S++QE      +EL       I    + + + + +G G +G+V        G  VAVK+L
Sbjct: 12  SMSQERPTFYRQELN----KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 67
Query: 325 SRKSWQGLEEFKN---EIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCF--I 379
           SR  +Q +   K    E+ L+  ++H N++ L+                P RSL+ F  +
Sbjct: 68  SR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDV 114
Query: 380 FDSERRLQLNWNTCYN-----------IIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD 428
           +     +  + N               +I  I +GL Y+H      IIHRDLKPSN+ ++
Sbjct: 115 YLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVN 171
Query: 429 KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVL 487
           +D   KI DFG+AR   +++ T      V T  Y APE  +  + ++   D++S G I+ 
Sbjct: 172 EDCELKILDFGLAR-HTDDEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 226
Query: 488 EIISGK 493
           E+++G+
Sbjct: 227 ELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 115/246 (46%), Gaps = 43/246 (17%)
Query: 266 SLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRL 324
           S++QE      +EL       I    + + + + +G G +G+V        G  VAVK+L
Sbjct: 12  SMSQERPTFYRQELN----KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 67
Query: 325 SRKSWQGLEEFKN---EIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCF--I 379
           SR  +Q +   K    E+ L+  ++H N++ L+                P RSL+ F  +
Sbjct: 68  SR-PFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDV 114
Query: 380 FDSERRLQLNWNTCYN-----------IIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD 428
           +     +  + N               +I  I +GL Y+H      IIHRDLKPSN+ ++
Sbjct: 115 YLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVN 171
Query: 429 KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVL 487
           +D   KI DFG+AR   +++ T      V T  Y APE  +  + ++   D++S G I+ 
Sbjct: 172 EDCELKILDFGLAR-HTDDEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 226
Query: 488 EIISGK 493
           E+++G+
Sbjct: 227 ELLTGR 232

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 114/232 (49%), Gaps = 27/232 (11%)
Query: 277 EELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLS----RKSWQG 331
           +ELP    A  K     +   + +G+G    V + V    G E AVK +     R S + 
Sbjct: 81  DELP--DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQ 138
Query: 332 LEEFKNEI-----ILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL 386
           LEE +        IL     H +++ L+          L+++LM  R  + F + +E+ +
Sbjct: 139 LEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLM--RKGELFDYLTEK-V 195
Query: 387 QLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE 446
            L+     +I+  + + + +LH ++   I+HRDLKP N+LLD +M  ++SDFG +   C 
Sbjct: 196 ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFS---CH 249
Query: 447 NQKTANTRRVVGTYGYMAPEY---AMEGL---FSVKSDVFSFGVIVLEIISG 492
            +     R + GT GY+APE    +M+     +  + D+++ GVI+  +++G
Sbjct: 250 LEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 106/220 (48%), Gaps = 25/220 (11%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSW--------QGLEEFKNE 338
           KA  D +  S  LG G  G V         K+VA++ +S++ +              + E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 339 IILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG 398
           I ++ KL H  ++++     + E+  ++ ELM    L   +  ++R   L   TC     
Sbjct: 191 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFY 246
Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRR 455
            +   + YLHE+    IIHRDLKP NVLL   ++D + KI+DFG ++I  E   T+  R 
Sbjct: 247 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRT 300
Query: 456 VVGTYGYMAPEYAME---GLFSVKSDVFSFGVIVLEIISG 492
           + GT  Y+APE  +      ++   D +S GVI+   +SG
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSW----QGLEEFKNEIILIAKLQHRNLVRLVG 355
           LG+GGF   Y+    + KEV   ++  KS        E+   EI +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
              + +   ++ E+   RSL   +   +RR  +        +    +G+ YLH +   ++
Sbjct: 110 FFEDDDFVYVVLEICRRRSL---LELHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMA-RIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
           IHRDLK  N+ L+ DM  KI DFG+A +I  + ++    + + GT  Y+APE   +   S
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKTLCGTPNYIAPEVLCKKGHS 220
Query: 475 VKSDVFSFGVIVLEIISGK 493
            + D++S G I+  ++ GK
Sbjct: 221 FEVDIWSLGCILYTLLVGK 239

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 89  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 137 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLAR-HTDDEMTG----Y 188
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 125/290 (43%), Gaps = 46/290 (15%)
Query: 300 LGQGGFGTVYKGVLPNGK------EVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
           LG+G FG V K    + K       VAVK L    S   L +  +E  ++ ++ H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSER---------------------RLQLNWN 391
           L G   +    LLI E     SL  F+ +S +                        L   
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 392 TCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA 451
              +    IS+G+ YL E   + ++HRDL   N+L+ +    KISDFG++R   E     
Sbjct: 151 DLISFAWQISQGMQYLAE---MSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYV 511
              +      +MA E   + +++ +SDV+SFGV++ EI++   N       +       +
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP------YPGIPPERL 261
Query: 512 WQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
           + L K G  ME  D      +   ++ R +   L C +++P  RP  +++
Sbjct: 262 FNLLKTGHRMERPD------NCSEEMYRLM---LQCWKQEPDKRPVFADI 302

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSW----QGLEEFKNEIILIAKLQHRNLVRLVG 355
           LG+GGF   Y+    + KEV   ++  KS        E+   EI +   L + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
              + +   ++ E+   RSL   +   +RR  +        +    +G+ YLH +   ++
Sbjct: 110 FFEDDDFVYVVLEICRRRSL---LELHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RV 163
Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMA-RIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
           IHRDLK  N+ L+ DM  KI DFG+A +I  + ++    + + GT  Y+APE   +   S
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER---KKXLCGTPNYIAPEVLCKKGHS 220
Query: 475 VKSDVFSFGVIVLEIISGK 493
            + D++S G I+  ++ GK
Sbjct: 221 FEVDIWSLGCILYTLLVGK 239

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 84
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 85  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 133 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 184
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 185 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 292 DGFSDSNKLGQGGFGTVYK-----GVLPNGKEVAVKRLSRKSWQGL--EEFKNEIILIAK 344
           D +    +LG G F  V K       L    +   KR ++ S +G+  E+ + E+ ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           +QH N++ L        + +LI EL+    L  F+ + E    L        +  I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGV 127
Query: 405 LYLHEDSRLKIIHRDLKPSNV-LLDKDMVA---KISDFGMARIFCENQKTANTRRVVGTY 460
            YLH    L+I H DLKP N+ LLD+++     KI DFG+A       +  N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE 520
            ++APE        +++D++S GVI   ++SG   +  +L    Q  LA V  +      
Sbjct: 182 AFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGDTKQETLANVSAV-----N 233
Query: 521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSN 560
            EF D     +S++ +      I  L V+ DP  R T+ +
Sbjct: 234 YEFEDEYFSNTSALAKDF----IRRLLVK-DPKKRMTIQD 268

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 87
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 88  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 136 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 187
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 23  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 81
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 82  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 129
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 130 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 181
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 182 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 90  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 138 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 189
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 89  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 137 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 188
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 26  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 84
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 85  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 132
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 133 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 184
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 185 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----X 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 29  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 87
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 88  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 135
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 136 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 187
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 188 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 19/182 (10%)
Query: 386 LQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC 445
           L L    CY+    ++KG+ +L   +  K IHRDL   N+LL +  V KI DFG+AR   
Sbjct: 197 LTLEHLICYSF--QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 251
Query: 446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQ 505
           ++              +MAPE   + +++++SDV+SFGV++ EI S     G       +
Sbjct: 252 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVK 307
Query: 506 TLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
               +  +L KEG  M   D       + P++ + +   L C   +P+ RPT S +V  L
Sbjct: 308 IDEEFCRRL-KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 357
Query: 566 GS 567
           G+
Sbjct: 358 GN 359

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 79
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 80  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 127
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 128 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 179
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 180 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 31/214 (14%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 350 LVRLVGCGI------EGEEKLLIYELMP---NRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           ++ L+          E  +  L+  LM    N  + C         +L  +    +I  I
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--------QKLTDDHVQFLIYQI 130
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
            +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      V T 
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----YVATR 182
Query: 461 GYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
            Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 21  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 79
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 80  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 127
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 128 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 179
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 180 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 43  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 101
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 102 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 149
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 150 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 201
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 202 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 19/182 (10%)
Query: 386 LQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC 445
           L L    CY+    ++KG+ +L   +  K IHRDL   N+LL +  V KI DFG+AR   
Sbjct: 195 LTLEHLICYSF--QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 249
Query: 446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQ 505
           ++              +MAPE   + +++++SDV+SFGV++ EI S     G       +
Sbjct: 250 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVK 305
Query: 506 TLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
               +  +L KEG  M   D       + P++ + +   L C   +P+ RPT S +V  L
Sbjct: 306 IDEEFCRRL-KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 355
Query: 566 GS 567
           G+
Sbjct: 356 GN 357

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 22  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 80
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 81  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 128
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 129 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 180
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 181 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 30  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 89  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 136
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 137 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 188
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 189 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 113/218 (51%), Gaps = 25/218 (11%)
Query: 290 ATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHR 348
             +   D  ++G+G +G+V K V  P+G+ +AVKR+ R +    E+ + ++++   +  R
Sbjct: 20  TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVD--EKEQKQLLMDLDVVMR 76
Query: 349 N-----LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS-- 401
           +     +V+  G      +  +  ELM + S D F         L+      I+G I+  
Sbjct: 77  SSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY--KYVYSVLDDVIPEEILGKITLA 133
Query: 402 --KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
             K L +L E+  LKIIHRD+KPSN+LLD+    K+ DFG++    ++   A TR   G 
Sbjct: 134 TVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS--IAKTRD-AGC 188
Query: 460 YGYMAPEY----AMEGLFSVKSDVFSFGVIVLEIISGK 493
             YMAPE     A    + V+SDV+S G+ + E+ +G+
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 102
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 103 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 150
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 151 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 202
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 203 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 35/210 (16%)
Query: 300 LGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRNLVRL 353
           +G G +G+V   Y   L   ++VAVK+LSR  +Q L   +    E+ L+  L+H N++ L
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 354 V-----GCGIEG-EEKLLIYELMP---NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           +        IE   E  L+  LM    N  + C    S+  +Q        ++  + +GL
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQAL-SDEHVQF-------LVYQLLRGL 136
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            Y+H      IIHRDLKPSNV +++D   +I DFG+AR     Q        V T  Y A
Sbjct: 137 KYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTGYVATRWYRA 188
Query: 465 PEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           PE  +  + ++   D++S G I+ E++ GK
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 105
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 106 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 153
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 154 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 205
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 206 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 292 DGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHR-- 348
           D F   ++LG G  G V+K    P+G  +A K +  +    +   +N+II   ++ H   
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI---RNQIIRELQVLHECN 62
Query: 349 --NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS----K 402
              +V   G      E  +  E M   SLD  +  + R  +        I+G +S    K
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGKVSIAVIK 115
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           GL YL E  + KI+HRD+KPSN+L++     K+ DFG++    ++   AN+   VGT  Y
Sbjct: 116 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS--FVGTRSY 169
Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           M+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 292 DGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHR-- 348
           D F   ++LG G  G V+K    P+G  +A K +  +    +   +N+II   ++ H   
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI---RNQIIRELQVLHECN 62
Query: 349 --NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS----K 402
              +V   G      E  +  E M   SLD  +  + R  +        I+G +S    K
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGKVSIAVIK 115
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           GL YL E  + KI+HRD+KPSN+L++     K+ DFG++    ++   AN+   VGT  Y
Sbjct: 116 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS--FVGTRSY 169
Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           M+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 19/182 (10%)
Query: 386 LQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC 445
           L L    CY+    ++KG+ +L   +  K IHRDL   N+LL +  V KI DFG+AR   
Sbjct: 188 LTLEHLICYSF--QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 242
Query: 446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQ 505
           ++              +MAPE   + +++++SDV+SFGV++ EI S     G       +
Sbjct: 243 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVK 298
Query: 506 TLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
               +  +L KEG  M   D       + P++ + +   L C   +P+ RPT S +V  L
Sbjct: 299 IDEEFCRRL-KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 348
Query: 566 GS 567
           G+
Sbjct: 349 GN 350

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 108/228 (47%), Gaps = 20/228 (8%)
Query: 274 VSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPN------GKEVAVKRLSRK 327
           + +E L F  +A     TD +    +LG+G F  V + V          K +  K+LS +
Sbjct: 13  LGTENLYFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSAR 72
Query: 328 SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ 387
             Q LE    E  +   L+H N+VRL     E     L+++L+    L   I   E   +
Sbjct: 73  DHQKLE---REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSE 129
Query: 388 LNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIF 444
            + + C   I  I + + ++H+     I+HRDLKP N+LL    K    K++DFG+A I 
Sbjct: 130 ADASHC---IHQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLA-IE 182
Query: 445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            + ++ A      GT GY++PE   +  +    D+++ GVI+  ++ G
Sbjct: 183 VQGEQQA-WFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 96/194 (49%), Gaps = 19/194 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRK-----SWQGLEEFKNEIILIAKLQHRNLVRL 353
           LG+G FG V        G++VA+K +++K       QG    + EI  +  L+H ++++L
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 73
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
                  +E +++ E   N   D  +    +R +++          I   + Y H   R 
Sbjct: 74  YDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCH---RH 126
Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF 473
           KI+HRDLKP N+LLD+ +  KI+DFG++ I  +      +    G+  Y APE     L+
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPEVISGKLY 183
Query: 474 S-VKSDVFSFGVIV 486
           +  + DV+S GVI+
Sbjct: 184 AGPEVDVWSCGVIL 197

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNL 350
            ++D+  +G G FG VY+  L  +G+ VA+K    K  QG + FKN E+ ++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQG-KAFKNRELQIMRKLDHCNI 75
Query: 351 VRL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS-------- 401
           VRL       GE+K  +Y    N  LD ++ ++  R+  +++     +  I         
Sbjct: 76  VRLRYFFYSSGEKKDEVYL---NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 402 -KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGT 459
            + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSR 186
Query: 460 YGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           Y Y APE       ++   DV+S G ++ E++ G+
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 292 DGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHR-- 348
           D F   ++LG G  G V+K    P+G  +A K +  +    +   +N+II   ++ H   
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI---RNQIIRELQVLHECN 62
Query: 349 --NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS----K 402
              +V   G      E  +  E M   SLD  +  + R  +        I+G +S    K
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGKVSIAVIK 115
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           GL YL E  + KI+HRD+KPSN+L++     K+ DFG++    ++   AN+   VGT  Y
Sbjct: 116 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS--FVGTRSY 169
Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           M+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNLV 351
           ++D+  +G G FG VY+  L  +G+ VA+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 110
Query: 352 RL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS--------- 401
           RL       GE+K  +Y    N  LD ++ ++  R+  +++     +  I          
Sbjct: 111 RLRYFFYSSGEKKDEVYL---NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGTY 460
           + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   Y
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY 221
Query: 461 GYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
            Y APE       ++   DV+S G ++ E++ G+
Sbjct: 222 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 96/194 (49%), Gaps = 19/194 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRK-----SWQGLEEFKNEIILIAKLQHRNLVRL 353
           LG+G FG V        G++VA+K +++K       QG    + EI  +  L+H ++++L
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 79
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
                  +E +++ E   N   D  +    +R +++          I   + Y H   R 
Sbjct: 80  YDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCH---RH 132
Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF 473
           KI+HRDLKP N+LLD+ +  KI+DFG++ I  +      +    G+  Y APE     L+
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPEVISGKLY 189
Query: 474 S-VKSDVFSFGVIV 486
           +  + DV+S GVI+
Sbjct: 190 AGPEVDVWSCGVIL 203

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 19/182 (10%)
Query: 386 LQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC 445
           L L    CY+    ++KG+ +L   +  K IHRDL   N+LL +  V KI DFG+AR   
Sbjct: 190 LTLEHLICYSF--QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 244
Query: 446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQ 505
           ++              +MAPE   + +++++SDV+SFGV++ EI S     G       +
Sbjct: 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS----LGASPYPGVK 300
Query: 506 TLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
               +  +L KEG  M   D       + P++ + +   L C   +P+ RPT S +V  L
Sbjct: 301 IDEEFCRRL-KEGTRMRAPD------YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 350
Query: 566 GS 567
           G+
Sbjct: 351 GN 352

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNL 350
            ++D+  +G G FG VY+  L  +G+ VA+K    K  QG + FKN E+ ++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQG-KAFKNRELQIMRKLDHCNI 75
Query: 351 VRL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS-------- 401
           VRL       GE+K  +Y    N  LD ++ ++  R+  +++     +  I         
Sbjct: 76  VRLRYFFYSSGEKKDEVYL---NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 402 -KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGT 459
            + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSR 186
Query: 460 YGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           Y Y APE       ++   DV+S G ++ E++ G+
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 96/194 (49%), Gaps = 19/194 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRK-----SWQGLEEFKNEIILIAKLQHRNLVRL 353
           LG+G FG V        G++VA+K +++K       QG    + EI  +  L+H ++++L
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 69
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
                  +E +++ E   N   D  +    +R +++          I   + Y H   R 
Sbjct: 70  YDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCH---RH 122
Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF 473
           KI+HRDLKP N+LLD+ +  KI+DFG++ I  +      +    G+  Y APE     L+
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPEVISGKLY 179
Query: 474 S-VKSDVFSFGVIV 486
           +  + DV+S GVI+
Sbjct: 180 AGPEVDVWSCGVIL 193

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 35  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 93
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 94  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 141
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR   +++ T      
Sbjct: 142 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTG----Y 193
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 194 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQ--GLE-EFKNEIILIAKLQH 347
           + F     LG+G FG VY       K + A+K L +   +  G+E + + E+ + + L+H
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRH 71
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
            N++RL G   +     LI E  P   L     + ++  + +       I  ++  L Y 
Sbjct: 72  PNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYC 128
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H     ++IHRD+KP N+LL  +   KI+DFG    +  +  ++    + GT  Y+ PE 
Sbjct: 129 HSK---RVIHRDIKPENLLLGSNGELKIADFG----WSVHAPSSRRDTLCGTLDYLPPEM 181
Query: 468 AMEGLFSVKSDVFSFGVIVLEIISG 492
               +   K D++S GV+  E + G
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNLV 351
           ++D+  +G G FG VY+  L  +G+ VA+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 112
Query: 352 RL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS--------- 401
           RL       GE+K  +Y    N  LD ++ ++  R+  +++     +  I          
Sbjct: 113 RLRYFFYSSGEKKDEVYL---NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 168
Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGTY 460
           + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   Y
Sbjct: 169 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY 223
Query: 461 GYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
            Y APE       ++   DV+S G ++ E++ G+
Sbjct: 224 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 115/246 (46%), Gaps = 43/246 (17%)
Query: 266 SLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRL 324
           S++QE      +EL       I    + + + + +G G +G+V        G  VAVK+L
Sbjct: 12  SMSQERPTFYRQELN----KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL 67
Query: 325 SRKSWQGLEEFKN---EIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCF--I 379
           S K +Q +   K    E+ L+  ++H N++ L+                P RSL+ F  +
Sbjct: 68  S-KPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDV 114
Query: 380 FDSERRLQLNWNTCYN-----------IIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD 428
           +     +  + N               +I  I +GL Y+H      IIHRDLKPSN+ ++
Sbjct: 115 YLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVN 171
Query: 429 KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVL 487
           +D   KI DFG+AR   +++ T      V T  Y APE  +  + ++   D++S G I+ 
Sbjct: 172 EDCELKILDFGLAR-HTDDEMTG----YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 226
Query: 488 EIISGK 493
           E+++G+
Sbjct: 227 ELLTGR 232

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNLV 351
           ++D+  +G G FG VY+  L  +G+ VA+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 110
Query: 352 RL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS--------- 401
           RL       GE+K  +Y    N  LD ++ ++  R+  +++     +  I          
Sbjct: 111 RLRYFFYSSGEKKDEVYL---NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGTY 460
           + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   Y
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY 221
Query: 461 GYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
            Y APE       ++   DV+S G ++ E++ G+
Sbjct: 222 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  V  N   VA+K++S    Q   +    EI ++ + +H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 140
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 141 HSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 96/194 (49%), Gaps = 19/194 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRK-----SWQGLEEFKNEIILIAKLQHRNLVRL 353
           LG+G FG V        G++VA+K +++K       QG    + EI  +  L+H ++++L
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKL 78
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
                  +E +++ E   N   D  +    +R +++          I   + Y H   R 
Sbjct: 79  YDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCH---RH 131
Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF 473
           KI+HRDLKP N+LLD+ +  KI+DFG++ I  +      +    G+  Y APE     L+
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS---CGSPNYAAPEVISGKLY 188
Query: 474 S-VKSDVFSFGVIV 486
           +  + DV+S GVI+
Sbjct: 189 AGPEVDVWSCGVIL 202

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 121/259 (46%), Gaps = 42/259 (16%)
Query: 292 DGFSDSNKLGQGGFGTVY--------KGVLPNGKEVAVKRLSRKSWQ-GLEEFKNEIILI 342
           D  +    LG+G FG V         K        VAVK L   + +  L +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 343 AKL-QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFI-----------FDSER--RLQL 388
             + +H+N++ L+G   +     +I E     +L  ++           +D  R    Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQM 154
Query: 389 NWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE-- 446
            +    +    +++G+ YL   +  K IHRDL   NVL+ ++ V KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 447 -NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--H 503
             +KT N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +
Sbjct: 212 XXKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSPY 260
Query: 504 AQTLLAYVWQLWKEGKEME 522
               +  +++L KEG  M+
Sbjct: 261 PGIPVEELFKLLKEGHRMD 279

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 104/210 (49%), Gaps = 35/210 (16%)
Query: 300 LGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRNLVRL 353
           +G G +G+V   Y   L   ++VAVK+LSR  +Q L   +    E+ L+  L+H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 354 V-----GCGIEG-EEKLLIYELMP---NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           +        IE   E  L+  LM    N  + C    S+  +Q        ++  + +GL
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQAL-SDEHVQF-------LVYQLLRGL 144
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            Y+H      IIHRDLKPSNV +++D   +I DFG+AR     Q        V T  Y A
Sbjct: 145 KYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRA 196
Query: 465 PEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           PE  +  + ++   D++S G I+ E++ GK
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNLV 351
           ++D+  +G G FG VY+  L  +G+ VA+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 81
Query: 352 RL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS--------- 401
           RL       GE+K  +Y    N  LD ++ ++  R+  +++     +  I          
Sbjct: 82  RLRYFFYSSGEKKDEVYL---NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 137
Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGTY 460
           + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   Y
Sbjct: 138 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY 192
Query: 461 GYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
            Y APE       ++   DV+S G ++ E++ G+
Sbjct: 193 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 102/237 (43%), Gaps = 19/237 (8%)
Query: 283 HLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLE---EFKNE 338
           H+      +D +     LG GG   V+    L   ++VAVK L     +       F+ E
Sbjct: 3   HMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRRE 62
Query: 339 IILIAKLQHRNLVRLVGCG----IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY 394
               A L H  +V +   G      G    ++ E +   +L   +        +      
Sbjct: 63  AQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAI 119
Query: 395 NIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN-QKTANT 453
            +I    + L + H++    IIHRD+KP+N+++      K+ DFG+AR   ++      T
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAY 510
             V+GT  Y++PE A       +SDV+S G ++ E+++G+       TG +   +AY
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAY 229

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  V  N   VA+K++S    Q   +    EI ++ + +H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 140
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 141 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 121/259 (46%), Gaps = 42/259 (16%)
Query: 292 DGFSDSNKLGQGGFGTVY--------KGVLPNGKEVAVKRLSRKSWQ-GLEEFKNEIILI 342
           D  +    LG+G FG V         K        VAVK L   + +  L +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 343 AKL-QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFI-----------FDSER--RLQL 388
             + +H+N++ L+G   +     +I E     +L  ++           +D  R    Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 389 NWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE-- 446
            +    +    +++G+ YL   +  K IHRDL   NVL+ ++ V KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 447 -NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--H 503
             +KT N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +
Sbjct: 212 XXKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSPY 260
Query: 504 AQTLLAYVWQLWKEGKEME 522
               +  +++L KEG  M+
Sbjct: 261 PGIPVEELFKLLKEGHRMD 279

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQH 347
           + +   +G G  G V   Y  +L   + VA+K+LSR  +Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAIL--ERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVNH 82
Query: 348 RNLVRLVGCGI------EGEEKLLIYELMPNRSLDCFI---FDSERRLQLNWNTCYNIIG 398
           +N++ L+          E ++  ++ ELM + +L   I    D ER   L     Y ++ 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYL----LYQMLV 137
Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG 458
           GI     +LH      IIHRDLKPSN+++  D   KI DFG+AR          T  VV 
Sbjct: 138 GIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVT 188
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            Y Y APE  +   +    D++S GVI+ E+I G
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNL 350
            ++D+  +G G FG VY+  L  +G+ VA+K++ +      + FKN E+ ++ KL H N+
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 83
Query: 351 VRL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS-------- 401
           VRL       GE+K  +Y    N  LD ++ ++  R+  +++     +  I         
Sbjct: 84  VRLRYFFYSSGEKKDEVYL---NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 139
Query: 402 -KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGT 459
            + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   
Sbjct: 140 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSR 194
Query: 460 YGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           Y Y APE       ++   DV+S G ++ E++ G+
Sbjct: 195 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 25/211 (11%)
Query: 292 DGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHR-- 348
           D F   ++LG G  G V+K    P+G  +A K +  +    +   +N+II   ++ H   
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI---RNQIIRELQVLHECN 89
Query: 349 --NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS----K 402
              +V   G      E  +  E M   SLD  +  + R           I+G +S    K
Sbjct: 90  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-------IPEQILGKVSIAVIK 142
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           GL YL E  + KI+HRD+KPSN+L++     K+ DFG++    ++   AN+   VGT  Y
Sbjct: 143 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS--FVGTRSY 196
Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           M+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNLV 351
           ++D+  +G G FG VY+  L  +G+ VA+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 104
Query: 352 RL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS--------- 401
           RL       GE+K  +Y    N  LD ++ ++  R+  +++     +  I          
Sbjct: 105 RLRYFFYSSGEKKDEVYL---NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 160
Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGTY 460
           + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   Y
Sbjct: 161 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY 215
Query: 461 GYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
            Y APE       ++   DV+S G ++ E++ G+
Sbjct: 216 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNLV 351
           ++D+  +G G FG VY+  L  +G+ VA+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 114
Query: 352 RL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS--------- 401
           RL       GE+K  +Y    N  LD ++ ++  R+  +++     +  I          
Sbjct: 115 RLRYFFYSSGEKKDEVYL---NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 170
Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGTY 460
           + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   Y
Sbjct: 171 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY 225
Query: 461 GYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
            Y APE       ++   DV+S G ++ E++ G+
Sbjct: 226 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  V  N   VA+K++S    Q   +    EI ++ + +H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 140
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 141 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 109/219 (49%), Gaps = 25/219 (11%)
Query: 284 LAVIKAATDGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEEFKNEIILI 342
           +A+ +   D F   ++LG G  G V+K    P+G  +A K +  +    +   +N+II  
Sbjct: 1   MALGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI---RNQIIRE 57
Query: 343 AKLQHR----NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG 398
            ++ H      +V   G      E  +  E M   SLD  +  + R  +        I+G
Sbjct: 58  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILG 110
Query: 399 GIS----KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR 454
            +S    KGL YL E  + KI+HRD+KPSN+L++     K+ DFG++    +  + AN  
Sbjct: 111 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--EMAN-- 164
Query: 455 RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             VGT  YM+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 165 EFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 292 DGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHR-- 348
           D F   ++LG G  G V+K    P+G  +A K +  +    +   +N+II   ++ H   
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI---RNQIIRELQVLHECN 62
Query: 349 --NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS----K 402
              +V   G      E  +  E M   SLD  +  + R  +        I+G +S    K
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGKVSIAVIK 115
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           GL YL E  + KI+HRD+KPSN+L++     K+ DFG++    ++   AN+   VGT  Y
Sbjct: 116 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS--FVGTRSY 169
Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           M+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 292 DGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHR-- 348
           D F   ++LG G  G V+K    P+G  +A K +  +    +   +N+II   ++ H   
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI---RNQIIRELQVLHECN 62
Query: 349 --NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS----K 402
              +V   G      E  +  E M   SLD  +  + R  +        I+G +S    K
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE-------QILGKVSIAVIK 115
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           GL YL E  + KI+HRD+KPSN+L++     K+ DFG++    ++   AN+   VGT  Y
Sbjct: 116 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS--FVGTRSY 169
Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           M+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR              
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGF 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQH 347
           + +   +G G  G V   Y  +L   + VA+K+LSR  +Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVNH 82
Query: 348 RNLVRLVGCGI------EGEEKLLIYELMPNRSLDCFI---FDSERRLQLNWNTCYNIIG 398
           +N++ L+          E ++  ++ ELM + +L   I    D ER   L     Y ++ 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYL----LYQMLV 137
Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG 458
           GI     +LH      IIHRDLKPSN+++  D   KI DFG+AR          T  VV 
Sbjct: 138 GIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVT 188
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            Y Y APE  +   +    D++S GVI+ E+I G
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR              
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGF 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNL 350
            ++D+  +G G FG VY+  L  +G+ VA+K++ +      + FKN E+ ++ KL H N+
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 94
Query: 351 VRL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS-------- 401
           VRL       GE+K  +Y    N  LD ++ ++  R+  +++     +  I         
Sbjct: 95  VRLRYFFYSSGEKKDEVYL---NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 150
Query: 402 -KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGT 459
            + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   
Sbjct: 151 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSR 205
Query: 460 YGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           Y Y APE       ++   DV+S G ++ E++ G+
Sbjct: 206 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNL 350
            ++D+  +G G FG VY+  L  +G+ VA+K++ +      + FKN E+ ++ KL H N+
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 87
Query: 351 VRL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS-------- 401
           VRL       GE+K  +Y    N  LD ++ ++  R+  +++     +  I         
Sbjct: 88  VRLRYFFYSSGEKKDEVYL---NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 143
Query: 402 -KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGT 459
            + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   
Sbjct: 144 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSR 198
Query: 460 YGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           Y Y APE       ++   DV+S G ++ E++ G+
Sbjct: 199 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  V  N   VA+K++S    Q   +    EI ++ + +H N
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 102
Query: 350 LVRL----VGCGIEG-EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           ++ +        IE  ++  L+  LM     D +     + L  N + CY  +  I +GL
Sbjct: 103 IIGINDIIRAPTIEQMKDVYLVTHLM---GADLYKLLKTQHLS-NDHICY-FLYQILRGL 157
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYM 463
            Y+H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y 
Sbjct: 158 KYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 214
Query: 464 APEYAMEGLFSVKS-DVFSFGVIVLEIISGK 493
           APE  +      KS D++S G I+ E++S +
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 121/259 (46%), Gaps = 42/259 (16%)
Query: 292 DGFSDSNKLGQGGFGTVY--------KGVLPNGKEVAVKRLSRKSWQ-GLEEFKNEIILI 342
           D  +    LG+G FG V         K        VAVK L   + +  L +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 343 AKL-QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFI-----------FDSER--RLQL 388
             + +H+N++ L+G   +     +I E     +L  ++           +D  R    Q+
Sbjct: 95  KMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 389 NWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE-- 446
            +    +    +++G+ YL   +  K IHRDL   NVL+ ++ V KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 447 -NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--H 503
             +KT N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +
Sbjct: 212 YYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSPY 260
Query: 504 AQTLLAYVWQLWKEGKEME 522
               +  +++L KEG  M+
Sbjct: 261 PGIPVEELFKLLKEGHRMD 279

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNL 350
            ++D+  +G G FG VY+  L  +G+ VA+K++ +      + FKN E+ ++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 351 VRL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS-------- 401
           VRL       GE+K  +Y    N  LD ++ ++  R+  +++     +  I         
Sbjct: 76  VRLRYFFYSSGEKKDEVYL---NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 402 -KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGT 459
            + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSR 186
Query: 460 YGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           Y Y APE       ++   DV+S G ++ E++ G+
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 90  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR    ++ T      
Sbjct: 138 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTG----Y 189
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNLV 351
           ++D+  +G G FG VY+  L  +G+ VA+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 88
Query: 352 RL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS--------- 401
           RL       GE+K  +Y    N  LD ++ ++  R+  +++     +  I          
Sbjct: 89  RLRYFFYSSGEKKDEVYL---NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 144
Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGTY 460
           + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   Y
Sbjct: 145 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY 199
Query: 461 GYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
            Y APE       ++   DV+S G ++ E++ G+
Sbjct: 200 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNL 350
            ++D+  +G G FG VY+  L  +G+ VA+K++ +      + FKN E+ ++ KL H N+
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 88
Query: 351 VRL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS-------- 401
           VRL       GE+K  +Y    N  LD ++ ++  R+  +++     +  I         
Sbjct: 89  VRLRYFFYSSGEKKDEVYL---NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 144
Query: 402 -KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGT 459
            + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   
Sbjct: 145 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSR 199
Query: 460 YGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           Y Y APE       ++   DV+S G ++ E++ G+
Sbjct: 200 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 44  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 102
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 103 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 150
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR              
Sbjct: 151 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXGX 202
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 203 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 108/222 (48%), Gaps = 36/222 (16%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQH 347
           KA    F     LGQG FG V+           VK++S    + L  +  +++  A L+ 
Sbjct: 20  KADPSQFELLKVLGQGSFGKVF----------LVKKISGSDARQL--YAMKVLKKATLKV 67
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQL--NWNTCYNIIGGISKGLL 405
           R+ VR      + E  +L+    P      + F +E +L L  ++    ++   +SK ++
Sbjct: 68  RDRVR-----TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM 122
Query: 406 YLHEDSR---------------LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT 450
           +  ED +               L II+RDLKP N+LLD++   K++DFG+++   +++K 
Sbjct: 123 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 182
Query: 451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           A +    GT  YMAPE       +  +D +SFGV++ E+++G
Sbjct: 183 AYS--FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 90  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR    ++ T      
Sbjct: 138 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTG----Y 189
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVK----RLSRKSWQGL--EEFKNEII 340
           +   D +    +LG G F  V K      G E A K    R SR S +G+  EE + E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           ++ ++ H N++ L        + +LI EL+    L  F+   E    L+     + I  I
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQI 124
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNV-LLDKDM---VAKISDFGMARIFCENQKTANTRRV 456
             G+ YLH     KI H DLKP N+ LLDK++     K+ DFG+A    E +     + +
Sbjct: 125 LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNI 178
Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            GT  ++APE        +++D++S GVI   ++SG
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNL 350
            ++D+  +G G FG VY+  L  +G+ VA+K++ +      + FKN E+ ++ KL H N+
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 76
Query: 351 VRL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS-------- 401
           VRL       GE+K  +Y    N  LD ++ ++  R+  +++     +  I         
Sbjct: 77  VRLRYFFYSSGEKKDEVYL---NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 132
Query: 402 -KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGT 459
            + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   
Sbjct: 133 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSR 187
Query: 460 YGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           Y Y APE       ++   DV+S G ++ E++ G+
Sbjct: 188 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNL 350
            ++D+  +G G FG VY+  L  +G+ VA+K++ +      + FKN E+ ++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 351 VRL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS-------- 401
           VRL       GE+K  +Y    N  LD ++ ++  R+  +++     +  I         
Sbjct: 76  VRLRYFFYSSGEKKDEVYL---NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 402 -KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGT 459
            + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSR 186
Query: 460 YGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           Y Y APE       ++   DV+S G ++ E++ G+
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 292 DGFSDSNKLGQGGFGTVYK-----GVLPNGKEVAVKRLSRKSWQGL--EEFKNEIILIAK 344
           D +    +LG G F  V K       L    +   KR ++ S +G+  E+ + E+ ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           +QH N++ L        + +LI EL+    L  F+ + E    L        +  I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGV 127
Query: 405 LYLHEDSRLKIIHRDLKPSNV-LLDKDMVA---KISDFGMARIFCENQKTANTRRVVGTY 460
            YLH    L+I H DLKP N+ LLD+++     KI DFG+A       +  N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE 520
            ++APE        +++D++S GVI   ++SG   +  +L    Q  LA V  +      
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGDTKQETLANVSAV-----N 233
Query: 521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSN 560
            EF D     +S++ +      I  L V+ DP  R T+ +
Sbjct: 234 YEFEDEYFSNTSALAKDF----IRRLLVK-DPKKRMTIQD 268

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 79  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 126
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR              
Sbjct: 127 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMAGF 178
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 41/219 (18%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQH 347
           + +   +G G  G V   Y  VL   + VA+K+LSR  +Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSR-PFQNQTHAKRAYRELVLMKXVNH 82
Query: 348 RNLVRLVGCGI------EGEEKLLIYELMPNRSLDCFI---FDSERRLQLNWNTCYNIIG 398
           +N++ L+          E ++  L+ ELM + +L   I    D ER   L     Y ++ 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYL----LYQMLX 137
Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG 458
           GI     +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++ 
Sbjct: 138 GIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR-------TAGTSFMMT 183
Query: 459 TY----GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
            Y     Y APE  +   +    D++S G I+ E++  K
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  V  N   VA+K++S    Q   +    EI ++ + +H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 140
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 141 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVK----RLSRKSWQGL--EEFKNEII 340
           +   D +    +LG G F  V K      G E A K    R SR S +G+  EE + E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           ++ ++ H N++ L        + +LI EL+    L  F+   E    L+     + I  I
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQI 124
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNV-LLDKDMVA---KISDFGMARIFCENQKTANTRRV 456
             G+ YLH     KI H DLKP N+ LLDK++     K+ DFG+A    E +     + +
Sbjct: 125 LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNI 178
Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            GT  ++APE        +++D++S GVI   ++SG
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 292 DGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVK----RLSRKSWQGL--EEFKNEIILIAK 344
           D +    +LG G F  V K      G E A K    R SR S +G+  EE + E+ ++ +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           + H N++ L        + +LI EL+    L  F+   E    L+     + I  I  G+
Sbjct: 72  VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGV 128
Query: 405 LYLHEDSRLKIIHRDLKPSNV-LLDKDMVA---KISDFGMARIFCENQKTANTRRVVGTY 460
            YLH     KI H DLKP N+ LLDK++     K+ DFG+A    E +     + + GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTP 182
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            ++APE        +++D++S GVI   ++SG
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNLV 351
           ++D+  +G G FG VY+  L  +G+ VA+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 155
Query: 352 RL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS--------- 401
           RL       GE+K  +Y    N  LD ++ ++  R+  +++     +  I          
Sbjct: 156 RLRYFFYSSGEKKDEVYL---NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 211
Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGTY 460
           + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   Y
Sbjct: 212 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY 266
Query: 461 GYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
            Y APE       ++   DV+S G ++ E++ G+
Sbjct: 267 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 90  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 137
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR    ++ T      
Sbjct: 138 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTADEMTG----Y 189
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 29/214 (13%)
Query: 294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNLV 351
           ++D+  +G G FG VY+  L  +G+ VA+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 80
Query: 352 RL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS--------- 401
           RL       GE+K  +Y    N  LD ++ ++  R+  +++     +  I          
Sbjct: 81  RLRYFFYSSGEKKDEVYL---NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 136
Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGTY 460
           + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   Y
Sbjct: 137 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY 191
Query: 461 GYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
            Y APE       ++   DV+S G ++ E++ G+
Sbjct: 192 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  V  N   VA+K++S    Q   +    EI ++ + +H N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 84
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 142
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 143 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVK----RLSRKSWQGL--EEFKNEII 340
           +   D +    +LG G F  V K      G E A K    R SR S +G+  EE + E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           ++ ++ H N++ L        + +LI EL+    L  F+   E    L+     + I  I
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQI 124
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNV-LLDKDM---VAKISDFGMARIFCENQKTANTRRV 456
             G+ YLH     KI H DLKP N+ LLDK++     K+ DFG+A    E +     + +
Sbjct: 125 LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNI 178
Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            GT  ++APE        +++D++S GVI   ++SG
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 121/259 (46%), Gaps = 42/259 (16%)
Query: 292 DGFSDSNKLGQGGFGTVY--------KGVLPNGKEVAVKRLSRKSWQ-GLEEFKNEIILI 342
           D  +    LG+G FG V         K        VAVK L   + +  L +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMM 94
Query: 343 AKL-QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFI-----------FDSER--RLQL 388
             + +H+N++ L+G   +     +I E     +L  ++           +D  R    Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 389 NWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE-- 446
            +    +    +++G+ YL   +  K IHRDL   NVL+ ++ V KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 447 -NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--H 503
             +KT N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +
Sbjct: 212 YYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSPY 260
Query: 504 AQTLLAYVWQLWKEGKEME 522
               +  +++L KEG  M+
Sbjct: 261 PGIPVEELFKLLKEGHRMD 279

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNL 350
            ++D+  +G G FG VY+  L  +G+ VA+K++ +      + FKN E+ ++ KL H N+
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNI 75
Query: 351 VRL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS-------- 401
           VRL       GE+K  +Y    N  LD ++ ++  R+  +++     +  I         
Sbjct: 76  VRLRYFFYSSGEKKDEVYL---NLVLD-YVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 402 -KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGT 459
            + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSR 186
Query: 460 YGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           Y Y APE       ++   DV+S G ++ E++ G+
Sbjct: 187 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 27/206 (13%)
Query: 300 LGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRNLVRL 353
           +G G +G+V   Y   L   ++VAVK+LSR  +Q L   +    E+ L+  L+H N++ L
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSR-PFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 354 V-----GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
           +        IE   ++ +   +    L+  +    +   L+      ++  + +GL Y+H
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIV----KSQALSDEHVQFLVYQLLRGLKYIH 148
Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
                 IIHRDLKPSNV +++D   +I DFG+AR     Q        V T  Y APE  
Sbjct: 149 SAG---IIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIM 200
Query: 469 MEGL-FSVKSDVFSFGVIVLEIISGK 493
           +  + ++   D++S G I+ E++ GK
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 20/212 (9%)
Query: 292 DGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVK----RLSRKSWQGL--EEFKNEIILIAK 344
           D +    +LG G F  V K      G E A K    R SR S +G+  EE + E+ ++ +
Sbjct: 12  DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           + H N++ L        + +LI EL+    L  F+   E    L+     + I  I  G+
Sbjct: 72  VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGV 128
Query: 405 LYLHEDSRLKIIHRDLKPSNV-LLDKDMVA---KISDFGMARIFCENQKTANTRRVVGTY 460
            YLH     KI H DLKP N+ LLDK++     K+ DFG+A    E +     + + GT 
Sbjct: 129 NYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTP 182
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            ++APE        +++D++S GVI   ++SG
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 300 LGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEE--FKNEIILIAKLQHRNLVRLVGC 356
           +G G +G   K     +GK +  K L   S    E+    +E+ L+ +L+H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 357 GIEGEEKLL--IYELMPNRSLDCFIFD-SERRLQLNWNTCYNIIGGISKGLLYLHE--DS 411
            I+     L  + E      L   I   ++ R  L+      ++  ++  L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
              ++HRDLKP+NV LD     K+ DFG+ARI   N  T+  +  VGT  YM+PE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTFVGTPYYMSPEQMNRM 191
Query: 472 LFSVKSDVFSFGVIVLEI 489
            ++ KSD++S G ++ E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 103/237 (43%), Gaps = 19/237 (8%)
Query: 283 HLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLE---EFKNE 338
           H+      +D +     LG GG   V+    L   ++VAVK L     +       F+ E
Sbjct: 3   HMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRRE 62
Query: 339 IILIAKLQHRNLVRLVGCG----IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY 394
               A L H  +V +   G      G    ++ E +   +L   +        +      
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAI 119
Query: 395 NIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT-ANT 453
            +I    + L + H++    IIHRD+KP+N+++      K+ DFG+AR   ++  +   T
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAY 510
             V+GT  Y++PE A       +SDV+S G ++ E+++G+       TG +   +AY
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAY 229

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 121/259 (46%), Gaps = 42/259 (16%)
Query: 292 DGFSDSNKLGQGGFGTVY--------KGVLPNGKEVAVKRLSRKSWQ-GLEEFKNEIILI 342
           D  +    LG+G FG V         K        VAVK L   + +  L +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 343 AKL-QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFI-----------FDSER--RLQL 388
             + +H+N++ L+G   +     +I E     +L  ++           +D  R    Q+
Sbjct: 95  KMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 389 NWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE-- 446
            +    +    +++G+ YL   +  K IHRDL   NVL+ ++ V KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 447 -NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--H 503
             +KT N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +
Sbjct: 212 YYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSPY 260
Query: 504 AQTLLAYVWQLWKEGKEME 522
               +  +++L KEG  M+
Sbjct: 261 PGIPVEELFKLLKEGHRMD 279

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 292 DGFSDSNKLGQGGFGTVYK-----GVLPNGKEVAVKRLSRKSWQGL--EEFKNEIILIAK 344
           D +    +LG G F  V K       L    +   KR ++ S +G+  E+ + E+ ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           +QH N++ L        + +LI EL+    L  F+ + E    L        +  I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGV 127
Query: 405 LYLHEDSRLKIIHRDLKPSNV-LLDKDMVA---KISDFGMARIFCENQKTANTRRVVGTY 460
            YLH    L+I H DLKP N+ LLD+++     KI DFG+A       +  N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE 520
            ++APE        +++D++S GVI   ++SG   +  +L    Q  LA V  +      
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGDTKQETLANVSAV-----N 233
Query: 521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSN 560
            EF D     +S++ +      I  L V+ DP  R T+ +
Sbjct: 234 YEFEDEYFSNTSALAKDF----IRRLLVK-DPKKRMTIQD 268

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 121/259 (46%), Gaps = 42/259 (16%)
Query: 292 DGFSDSNKLGQGGFGTVY--------KGVLPNGKEVAVKRLSRKSWQ-GLEEFKNEIILI 342
           D  +    LG+G FG V         K        VAVK L   + +  L +  +E+ ++
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 343 AKL-QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFI-----------FDSER--RLQL 388
             + +H+N++ L+G   +     +I E     +L  ++           +D  R    Q+
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 389 NWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE-- 446
            +    +    +++G+ YL   +  K IHRDL   NVL+ ++ V KI+DFG+AR      
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 447 -NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--H 503
             +KT N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +
Sbjct: 258 YYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSPY 306
Query: 504 AQTLLAYVWQLWKEGKEME 522
               +  +++L KEG  M+
Sbjct: 307 PGIPVEELFKLLKEGHRMD 325

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI D+G+AR   +++ T      
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLAR-HTDDEMTG----Y 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 20/216 (9%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVK----RLSRKSWQGL--EEFKNEII 340
           +   D +    +LG G F  V K      G E A K    R SR S +G+  EE + E+ 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           ++ ++ H N++ L        + +LI EL+    L  F+   E    L+     + I  I
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQI 124
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNV-LLDKDMVA---KISDFGMARIFCENQKTANTRRV 456
             G+ YLH     KI H DLKP N+ LLDK++     K+ DFG+A    E +     + +
Sbjct: 125 LDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNI 178
Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            GT  ++APE        +++D++S GVI   ++SG
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 106/214 (49%), Gaps = 29/214 (13%)
Query: 294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNLV 351
           ++D+  +G G FG VY+  L  +G+ VA+K    K  QG + FKN E+ ++ KL H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQG-KAFKNRELQIMRKLDHCNIV 76
Query: 352 RL-VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS--------- 401
           RL       GE+K  +Y    N  LD ++  +  R+  +++     +  I          
Sbjct: 77  RLRYFFYSSGEKKDEVYL---NLVLD-YVPATVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGTY 460
           + L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   Y
Sbjct: 133 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXICSRY 187
Query: 461 GYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
            Y APE       ++   DV+S G ++ E++ G+
Sbjct: 188 -YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 292 DGFSDSNKLGQGGFGTVYK-----GVLPNGKEVAVKRLSRKSWQGL--EEFKNEIILIAK 344
           D +    +LG G F  V K       L    +   KR ++ S +G+  E+ + E+ ++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           +QH N++ L        + +LI EL+    L  F+ + E    L        +  I  G+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGV 126
Query: 405 LYLHEDSRLKIIHRDLKPSNV-LLDKDMVA---KISDFGMARIFCENQKTANTRRVVGTY 460
            YLH    L+I H DLKP N+ LLD+++     KI DFG+A       +  N   + GT 
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 180
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            ++APE        +++D++S GVI   ++SG
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQH 347
           KA    F     LGQG FG V+           VK++S    + L   K  ++  A L+ 
Sbjct: 21  KADPSQFELLKVLGQGSFGKVF----------LVKKISGSDARQLYAMK--VLKKATLKV 68
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQL--NWNTCYNIIGGISKGLL 405
           R+ VR      + E  +L+    P      + F +E +L L  ++    ++   +SK ++
Sbjct: 69  RDRVR-----TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM 123
Query: 406 YLHEDSR---------------LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT 450
           +  ED +               L II+RDLKP N+LLD++   K++DFG+++   +++K 
Sbjct: 124 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 183
Query: 451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           A +    GT  YMAPE       +  +D +SFGV++ E+++G
Sbjct: 184 AYS--FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 36/256 (14%)
Query: 292 DGFSDSNKLGQGGFGTVY--------KGVLPNGKEVAVKRLSRKSWQ-GLEEFKNEIILI 342
           D  +    LG+G FG V         K        VAVK L   + +  L +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 343 AKL-QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFI-----------FDSER--RLQL 388
             + +H+N++ L+G   +     +I E     +L  ++           +D  R    Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 389 NWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ 448
            +    +    +++G+ YL   +  K IHRDL   NVL+ ++ V KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--HAQT 506
              NT        +MAPE   + +++ +SDV+SFGV++ EI        F L G  +   
Sbjct: 212 YYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSPYPGI 263
Query: 507 LLAYVWQLWKEGKEME 522
            +  +++L KEG  M+
Sbjct: 264 PVEELFKLLKEGHRMD 279

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  V  N   VA+K++S    Q   +    EI ++ + +H N
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 102
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 103 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 160
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 161 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 292 DGFSDSNKLGQGGFGTVYK-----GVLPNGKEVAVKRLSRKSWQGL--EEFKNEIILIAK 344
           D +    +LG G F  V K       L    +   KR ++ S +G+  E+ + E+ ++ +
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           +QH N++ L        + +LI EL+    L  F+ + E    L        +  I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGV 127
Query: 405 LYLHEDSRLKIIHRDLKPSNV-LLDKDMVA---KISDFGMARIFCENQKTANTRRVVGTY 460
            YLH    L+I H DLKP N+ LLD+++     KI DFG+A       +  N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            ++APE        +++D++S GVI   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF-------------IFDSERRLQLNWNTCYNI 396
           ++ L+                P RSL+ F             + +  +  +L  +    +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+ R   +++ T      
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCR-HTDDEMTG----Y 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 292 DGFSDSNKLGQGGFGTVYK-----GVLPNGKEVAVKRLSRKSWQGL--EEFKNEIILIAK 344
           D +    +LG G F  V K       L    +   KR ++ S +G+  E+ + E+ ++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           +QH N++ L        + +LI EL+    L  F+ + E    L        +  I  G+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGV 126
Query: 405 LYLHEDSRLKIIHRDLKPSNV-LLDKDMVA---KISDFGMARIFCENQKTANTRRVVGTY 460
            YLH    L+I H DLKP N+ LLD+++     KI DFG+A       +  N   + GT 
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 180
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE 520
            ++APE        +++D++S GVI   ++SG   +  +L    Q  LA V  +      
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGDTKQETLANVSAV-----N 232
Query: 521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSN 560
            EF D     +S++ +      I  L V+ DP  R T+ +
Sbjct: 233 YEFEDEYFSNTSALAKDF----IRRLLVK-DPKKRMTIQD 267

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 25/211 (11%)
Query: 292 DGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHR-- 348
           D F   ++LG G  G V+K    P+G  +A K +  +    +   +N+II   ++ H   
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI---RNQIIRELQVLHECN 81
Query: 349 --NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS----K 402
              +V   G      E  +  E M   SLD  +  + R           I+G +S    K
Sbjct: 82  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-------IPEQILGKVSIAVIK 134
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           GL YL E  + KI+HRD+KPSN+L++     K+ DFG++    ++   AN+   VGT  Y
Sbjct: 135 GLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS--FVGTRSY 188
Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           M+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 189 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 292 DGFSDSNKLGQGGFGTVYK-----GVLPNGKEVAVKRLSRKSWQGL--EEFKNEIILIAK 344
           D +    +LG G F  V K       L    +   KR ++ S +G+  E+ + E+ ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           +QH N++ L        + +LI EL+    L  F+ + E    L        +  I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGV 127
Query: 405 LYLHEDSRLKIIHRDLKPSNV-LLDKDMVA---KISDFGMARIFCENQKTANTRRVVGTY 460
            YLH    L+I H DLKP N+ LLD+++     KI DFG+A       +  N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE 520
            ++APE        +++D++S GVI   ++SG   +  +L    Q  LA V  +      
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGDTKQETLANVSAV-----N 233
Query: 521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSN 560
            EF D     +S++ +      I  L V+ DP  R T+ +
Sbjct: 234 YEFEDEYFSNTSALAKDF----IRRLLVK-DPKKRMTIQD 268

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 32/214 (14%)
Query: 300 LGQGGFGTVYKGVLPNGK---EVAVKRLSR-KSWQGLEEFKNEIILIAKL-QHRNLVRLV 354
           +G+G FG V K  +       + A+KR+    S     +F  E+ ++ KL  H N++ L+
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 355 G-CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ--------------LNWNTCYNIIGG 399
           G C   G   L I E  P+ +L  F+  S R L+              L+     +    
Sbjct: 83  GACEHRGYLYLAI-EYAPHGNLLDFLRKS-RVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           +++G+ YL   S+ + IHRDL   N+L+ ++ VAKI+DFG++R      +    ++ +G 
Sbjct: 141 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGR 192
Query: 460 YG--YMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
               +MA E     +++  SDV+S+GV++ EI+S
Sbjct: 193 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 300 LGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEE--FKNEIILIAKLQHRNLVRLVGC 356
           +G G +G   K     +GK +  K L   S    E+    +E+ L+ +L+H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 357 GIEGEEKLL--IYELMPNRSLDCFIFD-SERRLQLNWNTCYNIIGGISKGLLYLHE--DS 411
            I+     L  + E      L   I   ++ R  L+      ++  ++  L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
              ++HRDLKP+NV LD     K+ DFG+ARI   N  T+  +  VGT  YM+PE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKAFVGTPYYMSPEQMNRM 191
Query: 472 LFSVKSDVFSFGVIVLEI 489
            ++ KSD++S G ++ E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/222 (28%), Positives = 107/222 (48%), Gaps = 36/222 (16%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQH 347
           KA    F     LGQG FG V+           VK++S    + L   K  ++  A L+ 
Sbjct: 20  KADPSQFELLKVLGQGSFGKVF----------LVKKISGSDARQLYAMK--VLKKATLKV 67
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQL--NWNTCYNIIGGISKGLL 405
           R+ VR      + E  +L+    P      + F +E +L L  ++    ++   +SK ++
Sbjct: 68  RDRVR-----TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM 122
Query: 406 YLHEDSR---------------LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT 450
           +  ED +               L II+RDLKP N+LLD++   K++DFG+++   +++K 
Sbjct: 123 FTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK 182
Query: 451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           A +    GT  YMAPE       +  +D +SFGV++ E+++G
Sbjct: 183 AYS--FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 292 DGFSDSNKLGQGGFGTVYK-----GVLPNGKEVAVKRLSRKSWQGL--EEFKNEIILIAK 344
           D +    +LG G F  V K       L    +   KR ++ S +G+  E+ + E+ ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           +QH N++ L        + +LI EL+    L  F+ + E    L        +  I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGV 127
Query: 405 LYLHEDSRLKIIHRDLKPSNV-LLDKDMVA---KISDFGMARIFCENQKTANTRRVVGTY 460
            YLH    L+I H DLKP N+ LLD+++     KI DFG+A       +  N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            ++APE        +++D++S GVI   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  V  N   VA+K++S    Q   +    EI ++ + +H N
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 90
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 91  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 148
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 149 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 205
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 206 IMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  V  N   VA+K++S    Q   +    EI ++ + +H N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 140
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 141 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/162 (33%), Positives = 89/162 (54%), Gaps = 19/162 (11%)
Query: 333 EEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWN- 391
           ++FKNE+ +I  +++   +   G     +E  +IYE M N S+  F    E    L+ N 
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKF---DEYFFVLDKNY 144
Query: 392 TCY---NIIGGISKGLL----YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF 444
           TC+    +I  I K +L    Y+H +    I HRD+KPSN+L+DK+   K+SDFG +  +
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESE-Y 201
Query: 445 CENQKTANTRRVVGTYGYMAPE-YAMEGLFS-VKSDVFSFGV 484
             ++K   +R   GTY +M PE ++ E  ++  K D++S G+
Sbjct: 202 MVDKKIKGSR---GTYEFMPPEFFSNESSYNGAKVDIWSLGI 240

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 292 DGFSDSNKLGQGGFGTVYK-----GVLPNGKEVAVKRLSRKSWQGL--EEFKNEIILIAK 344
           D +    +LG G F  V K       L    +   KR ++ S +G+  E+ + E+ ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           +QH N++ L        + +LI EL+    L  F+ + E    L        +  I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGV 127
Query: 405 LYLHEDSRLKIIHRDLKPSNV-LLDKDMVA---KISDFGMARIFCENQKTANTRRVVGTY 460
            YLH    L+I H DLKP N+ LLD+++     KI DFG+A       +  N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE 520
            ++APE        +++D++S GVI   ++SG   +  +L    Q  LA V  +      
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGDTKQETLANVSAV-----N 233
Query: 521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSN 560
            EF D     +S++ +      I  L V+ DP  R T+ +
Sbjct: 234 YEFEDEYFSNTSALAKDF----IRRLLVK-DPKKRMTIQD 268

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 300 LGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEE--FKNEIILIAKLQHRNLVRLVGC 356
           +G+G +G V K    + G+ VA+K+        + +     EI L+ +L+H NLV L+  
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 357 GIEGEEKLLIYELMPNRSLDCF-IFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
             + +   L++E + +  LD   +F +    Q+     + II GI  G  + H      I
Sbjct: 93  CKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI--GFCHSH-----NI 145
Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL-FS 474
           IHRD+KP N+L+ +  V K+ DFG AR      +  +    V T  Y APE  +  + + 
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VATRWYRAPELLVGDVKYG 203
Query: 475 VKSDVFSFGVIVLEIISGK 493
              DV++ G +V E+  G+
Sbjct: 204 KAVDVWAIGCLVTEMFMGE 222

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 298 NKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLE-EFKNEIILIAKLQHRNLVRLVG 355
           +KLG+G + TVYKG        VA+K +  +  +G       E+ L+  L+H N+V L  
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
             I  E+ L L++E + ++ L  ++ D      +N +     +  + +GL Y H   R K
Sbjct: 68  I-IHTEKSLTLVFEYL-DKDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCH---RQK 120
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL-F 473
           ++HRDLKP N+L+++    K++DFG+AR      KT +   V  T  Y  P+  +    +
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTDY 178
Query: 474 SVKSDVFSFGVIVLEIISGK 493
           S + D++  G I  E+ +G+
Sbjct: 179 STQIDMWGVGCIFYEMATGR 198

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 32/214 (14%)
Query: 300 LGQGGFGTVYKGVLPNGK---EVAVKRLSR-KSWQGLEEFKNEIILIAKL-QHRNLVRLV 354
           +G+G FG V K  +       + A+KR+    S     +F  E+ ++ KL  H N++ L+
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 355 G-CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ--------------LNWNTCYNIIGG 399
           G C   G   L I E  P+ +L  F+  S R L+              L+     +    
Sbjct: 93  GACEHRGYLYLAI-EYAPHGNLLDFLRKS-RVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           +++G+ YL   S+ + IHRDL   N+L+ ++ VAKI+DFG++R      +    ++ +G 
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGR 202
Query: 460 Y--GYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
               +MA E     +++  SDV+S+GV++ EI+S
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 292 DGFSDSNKLGQGGFGTVYK-----GVLPNGKEVAVKRLSRKSWQGL--EEFKNEIILIAK 344
           D +    +LG G F  V K       L    +   KR ++ S +G+  E+ + E+ ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           +QH N++ L        + +LI EL+    L  F+ + E    L        +  I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGV 127
Query: 405 LYLHEDSRLKIIHRDLKPSNV-LLDKDMVA---KISDFGMARIFCENQKTANTRRVVGTY 460
            YLH    L+I H DLKP N+ LLD+++     KI DFG+A       +  N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE 520
            ++APE        +++D++S GVI   ++SG   +  +L    Q  LA V  +      
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGDTKQETLANVSAV-----N 233
Query: 521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSN 560
            EF D     +S++ +      I  L V+ DP  R T+ +
Sbjct: 234 YEFEDEYFSNTSALAKDF----IRRLLVK-DPKKRMTIQD 268

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW---QGLE-EFKNEIILIA 343
           K   D F     LG+G FG VY       K +   ++  KS    +G+E + + EI + +
Sbjct: 11  KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 70
Query: 344 KLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKG 403
            L+H N++R+     + +   L+ E  P   L     + ++  + +       +  ++  
Sbjct: 71  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL---YKELQKHGRFDEQRSATFMEELADA 127
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           L Y HE    K+IHRD+KP N+L+      KI+DFG    +  +  +   R + GT  Y+
Sbjct: 128 LHYCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYL 180
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            PE         K D++  GV+  E + G
Sbjct: 181 PPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 107/206 (51%), Gaps = 28/206 (13%)
Query: 299 KLGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNL-----VR 352
           +LG+G +G V K   +P+G+ +AVKR+ R +    E+    +++   +  R +     V 
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQ--KRLLMDLDISMRTVDCPFTVT 114
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS----KGLLYLH 408
             G      +  +  ELM + SLD F    ++ +        +I+G I+    K L +LH
Sbjct: 115 FYGALFREGDVWICMELM-DTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLH 170
Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN-QKTANTRRVVGTYGYMAPEY 467
             S+L +IHRD+KPSNVL++     K+ DFG++    ++  KT +     G   YMAPE 
Sbjct: 171 --SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDA----GCKPYMAPER 224
Query: 468 AMEGL----FSVKSDVFSFGVIVLEI 489
               L    +SVKSD++S G+ ++E+
Sbjct: 225 INPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 297 SNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLE---EFKNEIILIAKLQHRNLVR 352
            + LG G FG V  G     G +VAVK L+R+  + L+   + K EI  +   +H ++++
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
           L        +  ++ E +    L  +I    R  ++     +     I   + Y H   R
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QILSAVDYCH---R 129
Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
             ++HRDLKP NVLLD  M AKI+DFG++ +  + +     R   G+  Y APE     L
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRL 186
Query: 473 FS-VKSDVFSFGVIVLEIISG 492
           ++  + D++S GVI+  ++ G
Sbjct: 187 YAGPEVDIWSCGVILYALLCG 207

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 292 DGFSDSNKLGQGGFGTVYK-----GVLPNGKEVAVKRLSRKSWQGL--EEFKNEIILIAK 344
           D +    +LG G F  V K       L    +   KR ++ S +G+  E+ + E+ ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           +QH N++ L        + +LI EL+    L  F+ + E    L        +  I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGV 127
Query: 405 LYLHEDSRLKIIHRDLKPSNV-LLDKDMVA---KISDFGMARIFCENQKTANTRRVVGTY 460
            YLH    L+I H DLKP N+ LLD+++     KI DFG+A       +  N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE 520
            ++APE        +++D++S GVI   ++SG   +  +L    Q  LA V  +      
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGDTKQETLANVSAV-----N 233
Query: 521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSN 560
            EF D     +S++ +      I  L V+ DP  R T+ +
Sbjct: 234 YEFEDEYFSNTSALAKDF----IRRLLVK-DPKKRMTIQD 268

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 47  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 105
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 106 VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 153
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DFG+AR              
Sbjct: 154 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMXGY 205
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 206 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 127/280 (45%), Gaps = 33/280 (11%)
Query: 292 DGFSDSNKLGQGGFGTVYK-----GVLPNGKEVAVKRLSRKSWQGL--EEFKNEIILIAK 344
           D +    +LG G F  V K       L    +   KR ++ S +G+  E+ + E+ ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           +QH N++ L        + +LI EL+    L  F+ + E    L        +  I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGV 127
Query: 405 LYLHEDSRLKIIHRDLKPSNV-LLDKDMVA---KISDFGMARIFCENQKTANTRRVVGTY 460
            YLH    L+I H DLKP N+ LLD+++     KI DFG+A       +  N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE 520
            ++APE        +++D++S GVI   ++SG   +  +L    Q  LA V  +      
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG---ASPFLGDTKQETLANVSAV-----N 233
Query: 521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSN 560
            EF D     +S++ +      I  L V+ DP  R T+ +
Sbjct: 234 YEFEDEYFSNTSALAKDF----IRRLLVK-DPKKRMTIQD 268

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGLEEFK-NEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  +  N   VA+K++S    Q   +    EI ++ + +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHEN 86
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 144
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  VL   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFI---FDSERRLQLNWNTCYNIIGG 399
           N++ L+          E ++  L+ ELM + +L   I    D ER   L     Y ++ G
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYL----LYQMLCG 138
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I     +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++  
Sbjct: 139 IK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR-------TAGTSFMMTP 184
Query: 460 Y----GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           Y     Y APE  +   +    D++S G I+ E++  K
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 292 DGFSDSNKLGQGGFGTVYK-----GVLPNGKEVAVKRLSRKSWQGL--EEFKNEIILIAK 344
           D +    +LG G F  V K       L    +   KR ++ S +G+  E+ + E+ ++ +
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           +QH N++ L        + +LI EL+    L  F+ + E    L        +  I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGV 127
Query: 405 LYLHEDSRLKIIHRDLKPSNV-LLDKDMVA---KISDFGMARIFCENQKTANTRRVVGTY 460
            YLH    L+I H DLKP N+ LLD+++     KI DFG+A       +  N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            ++APE        +++D++S GVI   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 14/201 (6%)
Query: 297 SNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLE---EFKNEIILIAKLQHRNLVR 352
            + LG G FG V  G     G +VAVK L+R+  + L+   + K EI  +   +H ++++
Sbjct: 16  GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
           L        +  ++ E +    L  +I    R  ++     +     I   + Y H   R
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQ---QILSAVDYCH---R 129
Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
             ++HRDLKP NVLLD  M AKI+DFG++ +  + +     R   G+  Y APE     L
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRDSCGSPNYAAPEVISGRL 186
Query: 473 FS-VKSDVFSFGVIVLEIISG 492
           ++  + D++S GVI+  ++ G
Sbjct: 187 YAGPEVDIWSCGVILYALLCG 207

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  +  N   VA+K++S    Q   +    EI ++ + +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 144
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 20/211 (9%)
Query: 291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVK-----RLSRKSWQGLEEFKNEIILIAK 344
           TD +     +G+G F  V + V L  G E A K     +LS +  Q LE    E  +   
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLE---REARICRL 59
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           L+H N+VRL     E     L+++L+    L   I   E   + + + C   I  I + +
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHC---IQQILEAV 116
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTRRVVGTYG 461
           L+ H+   + ++HRDLKP N+LL    K    K++DFG+A     +Q+        GT G
Sbjct: 117 LHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPG 171
Query: 462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           Y++PE   +  +    D+++ GVI+  ++ G
Sbjct: 172 YLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 121/259 (46%), Gaps = 42/259 (16%)
Query: 292 DGFSDSNKLGQGGFGTVY--------KGVLPNGKEVAVKRLSRKSWQ-GLEEFKNEIILI 342
           D  +    LG+G FG V         K        VAVK L   + +  L +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 343 AKL-QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFI-----------FDSER--RLQL 388
             + +H+N++ L+G   +     +I E     +L  ++           +D  R    Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 389 NWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE-- 446
            +    +    +++G+ YL   +  K IHRDL   NVL+ ++ V +I+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNID 211
Query: 447 -NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--H 503
             +KT N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +
Sbjct: 212 YYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSPY 260
Query: 504 AQTLLAYVWQLWKEGKEME 522
               +  +++L KEG  M+
Sbjct: 261 PGIPVEELFKLLKEGHRMD 279

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  V  N   VA+K++S    Q   +    EI ++   +H N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHEN 84
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 142
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 143 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 102/237 (43%), Gaps = 19/237 (8%)
Query: 283 HLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLE---EFKNE 338
           H+      +D +     LG GG   V+    L   ++VAVK L     +       F+ E
Sbjct: 20  HMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRRE 79
Query: 339 IILIAKLQHRNLVRLVGCG----IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY 394
               A L H  +V +   G      G    ++ E +   +L   +        +      
Sbjct: 80  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAI 136
Query: 395 NIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN-QKTANT 453
            +I    + L + H++    IIHRD+KP+N+++      K+ DFG+AR   ++      T
Sbjct: 137 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 193
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAY 510
             V+GT  Y++PE A       +SDV+S G ++ E+++G+       TG +   +AY
Sbjct: 194 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAY 246

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 14/209 (6%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW---QGLE-EFKNEIILIA 343
           K   D F     LG+G FG VY       K +   ++  KS    +G+E + + EI + +
Sbjct: 10  KFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69
Query: 344 KLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKG 403
            L+H N++R+     + +   L+ E  P   L     + ++  + +       +  ++  
Sbjct: 70  HLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL---YKELQKHGRFDEQRSATFMEELADA 126
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           L Y HE    K+IHRD+KP N+L+      KI+DFG    +  +  +   R + GT  Y+
Sbjct: 127 LHYCHER---KVIHRDIKPENLLMGYKGELKIADFG----WSVHAPSLRRRXMCGTLDYL 179
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            PE         K D++  GV+  E + G
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 107/231 (46%), Gaps = 34/231 (14%)
Query: 287 IKAATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKL 345
           ++ A+D F +   LGQG FG V K     + +  A+K++ R + + L    +E++L+A L
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASL 59
Query: 346 QHRNLVRLVGCGIE------------GEEKLLI-YELMPNRSLDCFIFDSERRLQLNWNT 392
            H+ +VR     +E             +  L I  E   N +L   I      L    + 
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDE 117
Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR--------IF 444
            + +   I + L Y+H      IIHRDLKP N+ +D+    KI DFG+A+        + 
Sbjct: 118 YWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 445 CENQK----TANTRRVVGTYGYMAPE-YAMEGLFSVKSDVFSFGVIVLEII 490
            ++Q     + N    +GT  Y+A E     G ++ K D++S G+I  E+I
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 105/200 (52%), Gaps = 12/200 (6%)
Query: 299 KLGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFK-NEIILIAKLQHRNLVRLVG 355
           K+G+G +GTV+K       E VA+KR+      +G+      EI L+ +L+H+N+VRL  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
                ++  L++E   ++ L  + FDS     L+     + +  + KGL + H  SR  +
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKY-FDSCNG-DLDPEIVKSFLFQLLKGLGFCH--SR-NV 122
Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG-LFS 474
           +HRDLKP N+L++++   K++DFG+AR F    +  +    V T  Y  P+      L+S
Sbjct: 123 LHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE--VVTLWYRPPDVLFGAKLYS 180
Query: 475 VKSDVFSFGVIVLEIISGKR 494
              D++S G I  E+ +  R
Sbjct: 181 TSIDMWSAGCIFAELANAAR 200

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           ++    +G+G +G V   Y  V      VA+K++S    Q   +    EI ++ + +H N
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHV--RKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHEN 102
Query: 350 LVR----LVGCGIEG-EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           ++     L    +E   +  ++ +LM     D +     ++L  N + CY  +  I +GL
Sbjct: 103 VIGIRDILRASTLEAMRDVYIVQDLM---ETDLYKLLKSQQLS-NDHICY-FLYQILRGL 157
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYM 463
            Y+H  +   ++HRDLKPSN+L++     KI DFG+ARI   E+  T      V T  Y 
Sbjct: 158 KYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYR 214
Query: 464 APEYAMEGLFSVKS-DVFSFGVIVLEIISGK 493
           APE  +      KS D++S G I+ E++S +
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 41/219 (18%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQH 347
           + +   +G G  G V   Y  VL   + VA+K+LSR  +Q     K    E++L+  + H
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 75
Query: 348 RNLVRLVGCGI------EGEEKLLIYELMPNRSLDCFI---FDSERRLQLNWNTCYNIIG 398
           +N++ L+          E ++  L+ ELM + +L   I    D ER   L     Y ++ 
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYL----LYQMLX 130
Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG 458
           GI     +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++ 
Sbjct: 131 GIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR-------TAGTSFMMT 176
Query: 459 TY----GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
            Y     Y APE  +   +    D++S G I+ E++  K
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  V  N   VA+K++S    Q   +    EI ++   +H N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHEN 84
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 142
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 143 HSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI DF +AR   +++ T      
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLAR-HTDDEMTG----Y 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 25/211 (11%)
Query: 292 DGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHR-- 348
           D F   ++LG G  G V K    P+G  +A K +  +    +   +N+II   ++ H   
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAI---RNQIIRELQVLHECN 72
Query: 349 --NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS----K 402
              +V   G      E  +  E M   SLD  + +++R           I+G +S    +
Sbjct: 73  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR-------IPEEILGKVSIAVLR 125
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           GL YL E  + +I+HRD+KPSN+L++     K+ DFG++    ++   AN+   VGT  Y
Sbjct: 126 GLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANS--FVGTRSY 179
Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           MAPE      +SV+SD++S G+ ++E+  G+
Sbjct: 180 MAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 121/259 (46%), Gaps = 42/259 (16%)
Query: 292 DGFSDSNKLGQGGFGTVY--------KGVLPNGKEVAVKRLSRKSWQ-GLEEFKNEIILI 342
           D  +    LG+G FG V         K        VAVK L   + +  L +  +E+ ++
Sbjct: 27  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 86
Query: 343 AKL-QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFI-----------FDSER--RLQL 388
             + +H+N++ L+G   +     +I E     +L  ++           +D  R    Q+
Sbjct: 87  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 146
Query: 389 NWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE-- 446
            +    +    +++G+ YL   +  K IHRDL   NVL+ ++ V KI+DFG+AR      
Sbjct: 147 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 203
Query: 447 -NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--H 503
             +KT N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +
Sbjct: 204 YYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSPY 252
Query: 504 AQTLLAYVWQLWKEGKEME 522
               +  +++L KEG  M+
Sbjct: 253 PGIPVEELFKLLKEGHRMD 271

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 41/219 (18%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQH 347
           + +   +G G  G V   Y  VL   + VA+K+LSR  +Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 82
Query: 348 RNLVRLVGCGI------EGEEKLLIYELMPNRSLDCFI---FDSERRLQLNWNTCYNIIG 398
           +N++ L+          E ++  L+ ELM + +L   I    D ER   L     Y ++ 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSYL----LYQMLX 137
Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG 458
           GI     +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++ 
Sbjct: 138 GIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR-------TAGTSFMMT 183
Query: 459 TY----GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
            Y     Y APE  +   +    D++S G I+ E++  K
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 121/259 (46%), Gaps = 42/259 (16%)
Query: 292 DGFSDSNKLGQGGFGTVY--------KGVLPNGKEVAVKRLSRKSWQ-GLEEFKNEIILI 342
           D  +    LG+G FG V         K        VAVK L   + +  L +  +E+ ++
Sbjct: 22  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 81
Query: 343 AKL-QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFI-----------FDSER--RLQL 388
             + +H+N++ L+G   +     +I E     +L  ++           +D  R    Q+
Sbjct: 82  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 141
Query: 389 NWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE-- 446
            +    +    +++G+ YL   +  K IHRDL   NVL+ ++ V KI+DFG+AR      
Sbjct: 142 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNID 198
Query: 447 -NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--H 503
             +KT N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +
Sbjct: 199 YYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSPY 247
Query: 504 AQTLLAYVWQLWKEGKEME 522
               +  +++L KEG  M+
Sbjct: 248 PGIPVEELFKLLKEGHRMD 266

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 25/204 (12%)
Query: 300 LGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +G G  G V   +  VL  G  VAVK+LSR  ++    +    E++L+  + H+N++ L+
Sbjct: 30  IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLL 87
Query: 355 GCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
                     E ++  L+ ELM + +L C +   E   +      Y ++ GI     +LH
Sbjct: 88  NVFTPQKTLEEFQDVYLVMELM-DANL-CQVIHMELDHERMSYLLYQMLCGIK----HLH 141
Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
                 IIHRDLKPSN+++  D   KI DFG+AR    N     T  VV  Y Y APE  
Sbjct: 142 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTN--FMMTPYVVTRY-YRAPEVI 195
Query: 469 MEGLFSVKSDVFSFGVIVLEIISG 492
           +   +    D++S G I+ E++ G
Sbjct: 196 LGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 105/231 (45%), Gaps = 34/231 (14%)
Query: 287 IKAATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKL 345
           ++ A+D F +   LGQG FG V K     + +  A+K++ R + + L    +E+ L+A L
Sbjct: 2   LRYASD-FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASL 59
Query: 346 QHRNLVRLVGCGIE------------GEEKLLI-YELMPNRSLDCFIFDSERRLQLNWNT 392
            H+ +VR     +E             +  L I  E   NR+L   I      L    + 
Sbjct: 60  NHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSEN--LNQQRDE 117
Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR--------IF 444
            + +   I + L Y+H      IIHR+LKP N+ +D+    KI DFG+A+        + 
Sbjct: 118 YWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 445 CENQK----TANTRRVVGTYGYMAPE-YAMEGLFSVKSDVFSFGVIVLEII 490
            ++Q     + N    +GT  Y+A E     G ++ K D +S G+I  E I
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  +  N   VA+K++S    Q   +    EI ++ + +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 144
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 201
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 292 DGFSDSNKLGQGGFGTVYK-----GVLPNGKEVAVKRLSRKSWQGL--EEFKNEIILIAK 344
           D +    +LG G F  V K       L    +   KR ++ S +G+  E+ + E+ ++ +
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           +QH N++ L        + +LI EL+    L  F+ + E    L        +  I  G+
Sbjct: 71  IQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGV 127
Query: 405 LYLHEDSRLKIIHRDLKPSNV-LLDKDMVA---KISDFGMARIFCENQKTANTRRVVGTY 460
            YLH    L+I H DLKP N+ LLD+++     KI DFG+A       +  N   + GT 
Sbjct: 128 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTP 181
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            ++APE        +++D++S GVI   ++SG
Sbjct: 182 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  +  N   VA+K++S    Q   +    EI ++ + +H N
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 87
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 145
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 146 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 202
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 121/259 (46%), Gaps = 42/259 (16%)
Query: 292 DGFSDSNKLGQGGFGTVY--------KGVLPNGKEVAVKRLSRKSWQ-GLEEFKNEIILI 342
           D  +    LG+G FG V         K        VAVK L   + +  L +  +E+ ++
Sbjct: 24  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 83
Query: 343 AKL-QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFI-----------FDSER--RLQL 388
             + +H+N++ L+G   +     +I E     +L  ++           +D  R    Q+
Sbjct: 84  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 143
Query: 389 NWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE-- 446
            +    +    +++G+ YL   +  K IHRDL   NVL+ ++ V KI+DFG+AR      
Sbjct: 144 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 200
Query: 447 -NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--H 503
             +KT N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +
Sbjct: 201 YYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSPY 249
Query: 504 AQTLLAYVWQLWKEGKEME 522
               +  +++L KEG  M+
Sbjct: 250 PGIPVEELFKLLKEGHRMD 268

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  +  N   VA+K++S    Q   +    EI ++ + +H N
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 87
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 145
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 146 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 202
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  +  N   VA+K++S    Q   +    EI ++ + +H N
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 88
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 89  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 146
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 147 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 203
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 204 IMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  +  N   VA+K++S    Q   +    EI ++ + +H N
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 79
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 80  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 137
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 138 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 194
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 195 IMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  +  N   VA+K++S    Q   +    EI ++ + +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 144
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  +  N   VA+K++S    Q   +    EI ++ + +H N
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 80
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 138
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 139 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 196 IMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  +  N   VA+K++S    Q   +    EI ++ + +H N
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 80
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 138
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 139 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 196 IMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  VL   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           N++ L+          E ++  L+ ELM + +L C +   E   +      Y ++ GI  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK- 140
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY-- 460
              +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++  Y  
Sbjct: 141 ---HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR-------TAGTSFMMTPYVV 187
Query: 461 --GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
              Y APE  +   +    D++S G I+ E++  K
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 20/204 (9%)
Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVK-----RLSRKSWQGLEEFKNEIILIAKLQHRNLV 351
            +LG+G F  V + V +  G+E A K     +LS +  Q LE    E  +   L+H N+V
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLE---REARICRLLKHPNIV 84
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           RL     E     LI++L+    L   I   E   + + + C   I  I + +L+ H+  
Sbjct: 85  RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC---IQQILEAVLHCHQ-- 139
Query: 412 RLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
            + ++HRDLKP N+LL    K    K++DFG+A I  E ++ A      GT GY++PE  
Sbjct: 140 -MGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQA-WFGFAGTPGYLSPEVL 196
Query: 469 MEGLFSVKSDVFSFGVIVLEIISG 492
            +  +    D+++ GVI+  ++ G
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVG 220

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 296 DSNKLGQGGFGTVYKG--------------VLPN-GKEVAVKRLSRKSWQGLEEFKNEII 340
           +  +LG G FGTV KG              +L N   + A+K          +E   E  
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK----------DELLAEAN 422
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           ++ +L +  +VR++G   E E  +L+ E+     L+ ++   ++   +       ++  +
Sbjct: 423 VMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQV 478
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF--CENQKTANTRRVVG 458
           S G+ YL E +    +HRDL   NVLL     AKISDFG+++     EN   A T     
Sbjct: 479 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 535
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
              Y APE      FS KSDV+SFGV++ E  S
Sbjct: 536 VKWY-APECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 27/211 (12%)
Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRL---SRKSWQGLEEFK-NEIILIAKLQHRNLVRL 353
            ++G+G +G V+ G    G++VAVK        SW     F+  EI     ++H N++  
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASW-----FRETEIYQTVLMRHENILGF 96
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED--- 410
           +   I+G        L+ +   +  ++D  +   L+  +   +      GL +LH +   
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 411 --SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA----NTRRVVGTYGYMA 464
              +  I HRDLK  N+L+ K+    I+D G+A  F  +        NTR  VGT  YM 
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR--VGTKRYMP 214
Query: 465 PEYAMEGLFS------VKSDVFSFGVIVLEI 489
           PE   E L        + +D++SFG+I+ E+
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 296 DSNKLGQGGFGTVYKG--------------VLPN-GKEVAVKRLSRKSWQGLEEFKNEII 340
           +  +LG G FGTV KG              +L N   + A+K          +E   E  
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK----------DELLAEAN 423
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           ++ +L +  +VR++G   E E  +L+ E+     L+ ++   ++   +       ++  +
Sbjct: 424 VMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQV 479
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF--CENQKTANTRRVVG 458
           S G+ YL E +    +HRDL   NVLL     AKISDFG+++     EN   A T     
Sbjct: 480 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 536
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
              Y APE      FS KSDV+SFGV++ E  S
Sbjct: 537 VKWY-APECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 296 DSNKLGQGGFGTVYKG--------------VLPN-GKEVAVKRLSRKSWQGLEEFKNEII 340
           +  +LG G FGTV KG              +L N   + A+K          +E   E  
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK----------DELLAEAN 78
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           ++ +L +  +VR++G   E E  +L+ E+     L+ ++   ++   +       ++  +
Sbjct: 79  VMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQV 134
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF--CENQKTANTRRVVG 458
           S G+ YL E +    +HRDL   NVLL     AKISDFG+++     EN   A T     
Sbjct: 135 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 191
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
              Y APE      FS KSDV+SFGV++ E  S
Sbjct: 192 VKWY-APECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 296 DSNKLGQGGFGTVYKG--------------VLPN-GKEVAVKRLSRKSWQGLEEFKNEII 340
           +  +LG G FGTV KG              +L N   + A+K          +E   E  
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK----------DELLAEAN 80
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           ++ +L +  +VR++G   E E  +L+ E+     L+ ++   ++   +       ++  +
Sbjct: 81  VMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQV 136
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF--CENQKTANTRRVVG 458
           S G+ YL E +    +HRDL   NVLL     AKISDFG+++     EN   A T     
Sbjct: 137 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 193
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
              Y APE      FS KSDV+SFGV++ E  S
Sbjct: 194 VKWY-APECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 296 DSNKLGQGGFGTVYKG--------------VLPN-GKEVAVKRLSRKSWQGLEEFKNEII 340
           +  +LG G FGTV KG              +L N   + A+K          +E   E  
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK----------DELLAEAN 80
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           ++ +L +  +VR++G   E E  +L+ E+     L+ ++   ++   +       ++  +
Sbjct: 81  VMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQV 136
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF--CENQKTANTRRVVG 458
           S G+ YL E +    +HRDL   NVLL     AKISDFG+++     EN   A T     
Sbjct: 137 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 193
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
              Y APE      FS KSDV+SFGV++ E  S
Sbjct: 194 VKWY-APECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 30/224 (13%)
Query: 290 ATDGFSDSNK----LGQGGFGTVYKGVL-PNGKEVAVK--------RLSRKSWQGLEEFK 336
           +T GF ++ +    LG+G    V + +  P  KE AVK          S +  Q L E  
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 337 -NEIILIAKLQ-HRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY 394
             E+ ++ K+  H N+++L           L+++LM    L  F + +E+ + L+     
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL--FDYLTEK-VTLSEKETR 127
Query: 395 NIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR 454
            I+  + + +  LH   +L I+HRDLKP N+LLD DM  K++DFG +   C+       R
Sbjct: 128 KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLR 181
Query: 455 RVVGTYGYMAPEYAMEGL------FSVKSDVFSFGVIVLEIISG 492
            V GT  Y+APE     +      +  + D++S GVI+  +++G
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 13/207 (6%)
Query: 292 DGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSR-KSWQGLEEFKNEIILIAKLQHRN 349
           D F    KLG G FG V+      +G E  +K +++ +S   +E+ + EI ++  L H N
Sbjct: 22  DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN 81
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ-LNWNTCYNIIGGISKGLLYLH 408
           ++++     +     ++ E      L   I  ++ R + L+      ++  +   L Y H
Sbjct: 82  IIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH 141
Query: 409 EDSRLKIIHRDLKPSNVLLDK---DMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
                 ++H+DLKP N+L          KI DFG+A +F  ++ + N     GT  YMAP
Sbjct: 142 SQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNA---AGTALYMAP 195
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E     + + K D++S GV++  +++G
Sbjct: 196 EVFKRDV-TFKCDIWSAGVVMYFLLTG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 102/214 (47%), Gaps = 33/214 (15%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQH 347
           + +   +G G  G V   Y  +L   + VA+K+LSR  +Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVNH 82
Query: 348 RNLVRLVGCGI------EGEEKLLIYELMPNRSLDCFI---FDSERRLQLNWNTCYNIIG 398
           +N++ L+          E ++  ++ ELM + +L   I    D ER   L     Y ++ 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYL----LYQMLV 137
Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG 458
           GI     +LH      IIHRDLKPSN+++  D   KI DFG+AR          T  VV 
Sbjct: 138 GIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVT 188
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            Y Y APE  +   +    D++S G I+ E+I G
Sbjct: 189 RY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 296 DSNKLGQGGFGTVYKG--------------VLPN-GKEVAVKRLSRKSWQGLEEFKNEII 340
           +  +LG G FGTV KG              +L N   + A+K          +E   E  
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK----------DELLAEAN 64
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           ++ +L +  +VR++G   E E  +L+ E+     L+ ++   ++   +       ++  +
Sbjct: 65  VMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQV 120
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF--CENQKTANTRRVVG 458
           S G+ YL E +    +HRDL   NVLL     AKISDFG+++     EN   A T     
Sbjct: 121 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWP 177
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
              Y APE      FS KSDV+SFGV++ E  S
Sbjct: 178 VKWY-APECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKEV--AVKRLSRKSWQGLEEFKNEIILIAKLQHRNLV 351
           ++  N +G+G +G V K  +  G  +  A K++ +   + ++ FK EI ++  L H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           RL     +  +  L+ EL     L  F     +R+    +    I+  +   + Y H   
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGEL--FERVVHKRV-FRESDAARIMKDVLSAVAYCH--- 123
Query: 412 RLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
           +L + HRDLKP N L      D   K+ DFG+A  F   +     R  VGT  Y++P+  
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF---KPGKMMRTKVGTPYYVSPQ-V 179
Query: 469 MEGLFSVKSDVFSFGVIVLEIISG 492
           +EGL+  + D +S GV++  ++ G
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFK----NEIILIAKLQHRNLVRL 353
           K+GQG FG V+K      G++VA+K++  ++ +  E F      EI ++  L+H N+V L
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNL 82
Query: 354 VG-CGIEGEE----KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
           +  C  +       K  IY +      D     S   ++   +    ++  +  GL Y+H
Sbjct: 83  IEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR---RVVGTYGYMAP 465
              R KI+HRD+K +NVL+ +D V K++DFG+AR F   + +   R   RVV T  Y  P
Sbjct: 143 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRPP 198
Query: 466 EYAM-EGLFSVKSDVFSFGVIVLEI 489
           E  + E  +    D++  G I+ E+
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI  FG+AR   +++ T      
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLAR-HTDDEMTG----Y 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 296 DSNKLGQGGFGTVYKG--------------VLPN-GKEVAVKRLSRKSWQGLEEFKNEII 340
           +  +LG G FGTV KG              +L N   + A+K          +E   E  
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK----------DELLAEAN 60
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           ++ +L +  +VR++G   E E  +L+ E+     L+ ++   ++   +       ++  +
Sbjct: 61  VMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQV 116
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF--CENQKTANTRRVVG 458
           S G+ YL E +    +HRDL   NVLL     AKISDFG+++     EN   A T     
Sbjct: 117 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
              Y APE      FS KSDV+SFGV++ E  S
Sbjct: 174 VKWY-APECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 109/224 (48%), Gaps = 30/224 (13%)
Query: 290 ATDGFSDSNK----LGQGGFGTVYKGVL-PNGKEVAVK--------RLSRKSWQGLEEFK 336
           +T GF ++ +    LG+G    V + +  P  KE AVK          S +  Q L E  
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 337 -NEIILIAKLQ-HRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY 394
             E+ ++ K+  H N+++L           L+++LM    L  F + +E+ + L+     
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL--FDYLTEK-VTLSEKETR 127
Query: 395 NIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR 454
            I+  + + +  LH   +L I+HRDLKP N+LLD DM  K++DFG +   C+       R
Sbjct: 128 KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLR 181
Query: 455 RVVGTYGYMAPEYAMEGL------FSVKSDVFSFGVIVLEIISG 492
            V GT  Y+APE     +      +  + D++S GVI+  +++G
Sbjct: 182 SVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 300 LGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEE--FKNEIILIAKLQHRNLVRLVGC 356
           +G G +G   K     +GK +  K L   S    E+    +E+ L+ +L+H N+VR    
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 357 GIEGEEKLL--IYELMPNRSLDCFIFD-SERRLQLNWNTCYNIIGGISKGLLYLHE--DS 411
            I+     L  + E      L   I   ++ R  L+      ++  ++  L   H   D 
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
              ++HRDLKP+NV LD     K+ DFG+ARI   ++  A  +  VGT  YM+PE     
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA--KEFVGTPYYMSPEQMNRM 191
Query: 472 LFSVKSDVFSFGVIVLEI 489
            ++ KSD++S G ++ E+
Sbjct: 192 SYNEKSDIWSLGCLLYEL 209

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI D G+AR   +++ T      
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLAR-HTDDEMTG----Y 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 16/204 (7%)
Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKEV--AVKRLSRKSWQGLEEFKNEIILIAKLQHRNLV 351
           ++  N +G+G +G V K  +  G  +  A K++ +   + ++ FK EI ++  L H N++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           RL     +  +  L+ EL     L  F     +R+    +    I+  +   + Y H   
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGEL--FERVVHKRV-FRESDAARIMKDVLSAVAYCH--- 140
Query: 412 RLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
           +L + HRDLKP N L      D   K+ DFG+A  F   +     R  VGT  Y++P+  
Sbjct: 141 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF---KPGKMMRTKVGTPYYVSPQ-V 196
Query: 469 MEGLFSVKSDVFSFGVIVLEIISG 492
           +EGL+  + D +S GV++  ++ G
Sbjct: 197 LEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 296 DSNKLGQGGFGTVYKG--------------VLPN-GKEVAVKRLSRKSWQGLEEFKNEII 340
           +  +LG G FGTV KG              +L N   + A+K          +E   E  
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK----------DELLAEAN 58
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           ++ +L +  +VR++G   E E  +L+ E+     L+ ++   ++   +       ++  +
Sbjct: 59  VMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQV 114
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF--CENQKTANTRRVVG 458
           S G+ YL E +    +HRDL   NVLL     AKISDFG+++     EN   A T     
Sbjct: 115 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 171
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
              Y APE      FS KSDV+SFGV++ E  S
Sbjct: 172 VKWY-APECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 120/259 (46%), Gaps = 42/259 (16%)
Query: 292 DGFSDSNKLGQGGFGTVY--------KGVLPNGKEVAVKRLSRKSWQ-GLEEFKNEIILI 342
           D  +    LG+G FG V         K        VAVK L   + +  L +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 343 AKL-QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFI-----------FDSER--RLQL 388
             + +H+N++ L+G   +     +I       +L  ++           +D  R    Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 389 NWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE-- 446
            +    +    +++G+ YL   +  K IHRDL   NVL+ ++ V KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 447 -NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--H 503
             +KT N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +
Sbjct: 212 YYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSPY 260
Query: 504 AQTLLAYVWQLWKEGKEME 522
               +  +++L KEG  M+
Sbjct: 261 PGIPVEELFKLLKEGHRMD 279

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 15/208 (7%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  +  N   VA++++S    Q   +    EI ++ + +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 350 LVRL--VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           ++ +  +      E+   +Y +      D +     + L  N + CY  +  I +GL Y+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS-NDHICY-FLYQILRGLKYI 144
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGYMAPE 466
           H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y APE
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 467 YAMEGLFSVKS-DVFSFGVIVLEIISGK 493
             +      KS D++S G I+ E++S +
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 23/212 (10%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQHRN 349
           +++ + +G+G +G V   Y  +  N   VA+K++S    Q   +    EI ++ + +H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSL--DCFIFDSERRLQL----NWNTCYNIIGGISKG 403
           ++     GI    +    E M +  +  D    D  + L+     N + CY  +  I +G
Sbjct: 87  II-----GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICY-FLYQILRG 140
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF-CENQKTANTRRVVGTYGY 462
           L Y+H  +   ++HRDLKPSN+LL+     KI DFG+AR+   ++  T      V T  Y
Sbjct: 141 LKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 463 MAPEYAMEGLFSVKS-DVFSFGVIVLEIISGK 493
            APE  +      KS D++S G I+ E++S +
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 296 DSNKLGQGGFGTVYKG--------------VLPN-GKEVAVKRLSRKSWQGLEEFKNEII 340
           +  +LG G FGTV KG              +L N   + A+K          +E   E  
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK----------DELLAEAN 70
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           ++ +L +  +VR++G   E E  +L+ E+     L+ ++   ++   +       ++  +
Sbjct: 71  VMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQV 126
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF--CENQKTANTRRVVG 458
           S G+ YL E +    +HRDL   NVLL     AKISDFG+++     EN   A T     
Sbjct: 127 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
              Y APE      FS KSDV+SFGV++ E  S
Sbjct: 184 VKWY-APECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 41/218 (18%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQH 347
           + +   +G G  G V   Y  +L   + VA+K+LSR  +Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSR-PFQNQTHAKRAYRELVLMKVVNH 82
Query: 348 RNLVRLVGCGI------EGEEKLLIYELMPNRSLDCFI---FDSERRLQLNWNTCYNIIG 398
           +N++ L+          E ++  ++ ELM + +L   I    D ER   L     Y ++ 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYL----LYQMLC 137
Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG 458
           GI     +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++ 
Sbjct: 138 GIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR-------TAGTSFMMT 183
Query: 459 TY----GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            Y     Y APE  +   +    D++S G I+ E+I G
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  VL   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           N++ L+          E ++  L+ ELM + +L C +   E   +      Y ++ GI  
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK- 178
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY-- 460
              +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++  Y  
Sbjct: 179 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMTPYVV 225
Query: 461 --GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
              Y APE  +   +    D++S G I+ E++  K
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 296 DSNKLGQGGFGTVYKG--------------VLPN-GKEVAVKRLSRKSWQGLEEFKNEII 340
           +  +LG G FGTV KG              +L N   + A+K          +E   E  
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK----------DELLAEAN 64
Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           ++ +L +  +VR++G   E E  +L+ E+     L+ ++   ++   +       ++  +
Sbjct: 65  VMQQLDNPYIVRMIGI-CEAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQV 120
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF--CENQKTANTRRVVG 458
           S G+ YL E +    +HRDL   NVLL     AKISDFG+++     EN   A T     
Sbjct: 121 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 177
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
              Y APE      FS KSDV+SFGV++ E  S
Sbjct: 178 VKWY-APECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 26/218 (11%)
Query: 287 IKAATDGFSDSNKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSW---QGLEEFKNEIILI 342
           I    + FS    +G+GGFG VY     + GK  A+K L +K     QG     NE I++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 343 AKLQHRN--LVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFD----SERRLQLNWNTCYN 395
           + +   +   +  +       +KL  I +LM    L   +      SE  ++        
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF------- 296
Query: 396 IIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR 455
               I  GL ++H  +R  +++RDLKP+N+LLD+    +ISD G+A  F + +  A+   
Sbjct: 297 YAAEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--- 350
Query: 456 VVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISG 492
            VGT+GYMAPE   +G+ +   +D FS G ++ +++ G
Sbjct: 351 -VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 26/218 (11%)
Query: 287 IKAATDGFSDSNKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSW---QGLEEFKNEIILI 342
           I    + FS    +G+GGFG VY     + GK  A+K L +K     QG     NE I++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 343 AKLQHRN--LVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFD----SERRLQLNWNTCYN 395
           + +   +   +  +       +KL  I +LM    L   +      SE  ++        
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF------- 296
Query: 396 IIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR 455
               I  GL ++H  +R  +++RDLKP+N+LLD+    +ISD G+A  F + +  A+   
Sbjct: 297 YAAEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--- 350
Query: 456 VVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISG 492
            VGT+GYMAPE   +G+ +   +D FS G ++ +++ G
Sbjct: 351 -VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/167 (32%), Positives = 86/167 (51%), Gaps = 14/167 (8%)
Query: 332 LEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL--IYELMPNRSLDCFIFDSERRLQLN 389
           +E+   EI ++ KL H N+V+LV    +  E  L  ++EL+        + +      L+
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP----VMEVPTLKPLS 135
Query: 390 WNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK 449
            +        + KG+ YLH     KIIHRD+KPSN+L+ +D   KI+DFG++  F     
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF--KGS 190
Query: 450 TANTRRVVGTYGYMAPEYAME--GLFSVKS-DVFSFGVIVLEIISGK 493
            A     VGT  +MAPE   E   +FS K+ DV++ GV +   + G+
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI D G+AR   +++ T      
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLAR-HTDDEMTG----Y 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 35/216 (16%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQH 347
           + +   +G G  G V   Y  VL   + VA+K+LSR  +Q     K    E++L+  + H
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 120
Query: 348 RNLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS 401
           +N++ L+          E ++  L+ ELM + +L C +   E   +      Y ++ GI 
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK 178
Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY- 460
               +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++  Y 
Sbjct: 179 ----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMTPYV 224
Query: 461 ---GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
               Y APE  +   +    D++S G I+ E++  K
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  VL   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           N++ L+          E ++  L+ ELM + +L C +   E   +      Y ++ GI  
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK- 134
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY-- 460
              +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++  Y  
Sbjct: 135 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMTPYVV 181
Query: 461 --GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
              Y APE  +   +    D++S G I+ E++  K
Sbjct: 182 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 20/212 (9%)
Query: 292 DGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRK----SWQGL--EEFKNEIILIAK 344
           D +    +LG G F  V K      GKE A K + ++    S +G+  EE + E+ ++ +
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           ++H N++ L        + +LI EL+    L  F+ + E    L  +     +  I  G+
Sbjct: 65  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGV 121
Query: 405 LYLHEDSRLKIIHRDLKPSNV-LLDKDM---VAKISDFGMARIFCENQKTANTRRVVGTY 460
            YLH     +I H DLKP N+ LLDK++     K+ DFG+A       +  N   + GT 
Sbjct: 122 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTP 175
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            ++APE        +++D++S GVI   ++SG
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFK----NEIILIAKLQHRNLVRL 353
           K+GQG FG V+K      G++VA+K++  ++ +  E F      EI ++  L+H N+V L
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNL 82
Query: 354 VG-CGIEGEE----KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
           +  C  +       K  IY +      D     S   ++   +    ++  +  GL Y+H
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR---RVVGTYGYMAP 465
              R KI+HRD+K +NVL+ +D V K++DFG+AR F   + +   R   RVV T  Y  P
Sbjct: 143 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRPP 198
Query: 466 EYAM-EGLFSVKSDVFSFGVIVLEI 489
           E  + E  +    D++  G I+ E+
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 26/218 (11%)
Query: 287 IKAATDGFSDSNKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSW---QGLEEFKNEIILI 342
           I    + FS    +G+GGFG VY     + GK  A+K L +K     QG     NE I++
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 343 AKLQHRN--LVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFD----SERRLQLNWNTCYN 395
           + +   +   +  +       +KL  I +LM    L   +      SE  ++        
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF------- 295
Query: 396 IIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR 455
               I  GL ++H  +R  +++RDLKP+N+LLD+    +ISD G+A  F + +  A+   
Sbjct: 296 YAAEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--- 349
Query: 456 VVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISG 492
            VGT+GYMAPE   +G+ +   +D FS G ++ +++ G
Sbjct: 350 -VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  VL   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           N++ L+          E ++  L+ ELM + +L C +   E   +      Y ++ GI  
Sbjct: 77  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK- 133
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY-- 460
              +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++  Y  
Sbjct: 134 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMTPYVV 180
Query: 461 --GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
              Y APE  +   +    D++S G I+ E++  K
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 26/218 (11%)
Query: 287 IKAATDGFSDSNKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSW---QGLEEFKNEIILI 342
           I    + FS    +G+GGFG VY     + GK  A+K L +K     QG     NE I++
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 343 AKLQHRN--LVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFD----SERRLQLNWNTCYN 395
           + +   +   +  +       +KL  I +LM    L   +      SE  ++        
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF------- 296
Query: 396 IIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR 455
               I  GL ++H  +R  +++RDLKP+N+LLD+    +ISD G+A  F + +  A+   
Sbjct: 297 YAAEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--- 350
Query: 456 VVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISG 492
            VGT+GYMAPE   +G+ +   +D FS G ++ +++ G
Sbjct: 351 -VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVK-----RLSRKSWQGLEEFKNEIILIAK 344
           TD +    +LG+G F  V + + +P G+E A K     +LS +  Q LE    E  +   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE---REARICRL 59
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           L+H N+VRL     E     L+++L+    L   I   E   + + + C   I  I + +
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHC---IQQILESV 116
Query: 405 LYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYG 461
            + H +    I+HRDLKP N+LL    K    K++DFG+A     +Q+        GT G
Sbjct: 117 NHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPG 171
Query: 462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           Y++PE   +  +    D+++ GVI+  ++ G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  VL   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           N++ L+          E ++  L+ ELM + +L C +   E   +      Y ++ GI  
Sbjct: 78  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK- 134
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY-- 460
              +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++  Y  
Sbjct: 135 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMTPYVV 181
Query: 461 --GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
              Y APE  +   +    D++S G I+ E++  K
Sbjct: 182 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 20/212 (9%)
Query: 292 DGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRK----SWQGL--EEFKNEIILIAK 344
           D +    +LG G F  V K      GKE A K + ++    S +G+  EE + E+ ++ +
Sbjct: 12  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 71
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           ++H N++ L        + +LI EL+    L  F+ + E    L  +     +  I  G+
Sbjct: 72  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGV 128
Query: 405 LYLHEDSRLKIIHRDLKPSNV-LLDKDM---VAKISDFGMARIFCENQKTANTRRVVGTY 460
            YLH     +I H DLKP N+ LLDK++     K+ DFG+A       +  N   + GT 
Sbjct: 129 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTP 182
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            ++APE        +++D++S GVI   ++SG
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 107/214 (50%), Gaps = 32/214 (14%)
Query: 300 LGQGGFGTVYKGVLPNGK---EVAVKRLSR-KSWQGLEEFKNEIILIAKL-QHRNLVRLV 354
           +G+G FG V K  +       + A+KR+    S     +F  E+ ++ KL  H N++ L+
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 355 G-CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ--------------LNWNTCYNIIGG 399
           G C   G   L I E  P+ +L  F+  S R L+              L+     +    
Sbjct: 90  GACEHRGYLYLAI-EYAPHGNLLDFLRKS-RVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           +++G+ YL   S+ + IHR+L   N+L+ ++ VAKI+DFG++R      +    ++ +G 
Sbjct: 148 VARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGR 199
Query: 460 Y--GYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS 491
               +MA E     +++  SDV+S+GV++ EI+S
Sbjct: 200 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 109/218 (50%), Gaps = 28/218 (12%)
Query: 287 IKAATDGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL 345
           ++   D      +LG+G +G V K   +P+G+ +AVKR+ R +    E+    +++   +
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI-RATVNSQEQ--KRLLMDLDI 58
Query: 346 QHRNL-----VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
             R +     V   G      +  +  ELM + SLD F    ++ +        +I+G I
Sbjct: 59  SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFY---KQVIDKGQTIPEDILGKI 114
Query: 401 S----KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN-QKTANTRR 455
           +    K L +LH  S+L +IHRD+KPSNVL++     K+ DFG++    ++  K  +   
Sbjct: 115 AVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA-- 170
Query: 456 VVGTYGYMAPEYAMEGL----FSVKSDVFSFGVIVLEI 489
             G   YMAPE     L    +SVKSD++S G+ ++E+
Sbjct: 171 --GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 102/216 (47%), Gaps = 31/216 (14%)
Query: 289 AATDGFSDSNKLGQGGFGTVY----KGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIA 343
           A +D F   ++LG+G    VY    KG   P   +V  K + +K        + EI ++ 
Sbjct: 50  ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI------VRTEIGVLL 103
Query: 344 KLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFD----SERRLQLNWNTCYNIIGG 399
           +L H N+++L        E  L+ EL+    L   I +    SER          + +  
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSER-------DAADAVKQ 156
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDK---DMVAKISDFGMARIFCENQKTANTRRV 456
           I + + YLHE+    I+HRDLKP N+L      D   KI+DFG+++I  E+Q    T  V
Sbjct: 157 ILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKT--V 210
Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            GT GY APE      +  + D++S G+I   ++ G
Sbjct: 211 CGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 20/211 (9%)
Query: 291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVA-----VKRLSRKSWQGLEEFKNEIILIAK 344
           T+ +    +LG+G F  V + V +  G+E A      K+LS +  Q LE    E  +   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRL 66
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           L+H N+VRL     E     LI++L+    L   I   E   + + + C   I  I + +
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC---IQQILEAV 123
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTRRVVGTYG 461
           L+ H+   + ++HR+LKP N+LL    K    K++DFG+A I  E ++ A      GT G
Sbjct: 124 LHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQA-WFGFAGTPG 178
Query: 462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           Y++PE   +  +    D+++ GVI+  ++ G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  VL   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           N++ L+          E ++  L+ ELM + +L C +   E   +      Y ++ GI  
Sbjct: 84  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK- 140
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY-- 460
              +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++  Y  
Sbjct: 141 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMTPYVV 187
Query: 461 --GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
              Y APE  +   +    D++S G I+ E++  K
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  VL   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 82
Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           N++ L+          E ++  L+ ELM + +L C +   E   +      Y ++ GI  
Sbjct: 83  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK- 139
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY-- 460
              +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++  Y  
Sbjct: 140 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMTPYVV 186
Query: 461 --GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
              Y APE  +   +    D++S G I+ E++  K
Sbjct: 187 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 39/218 (17%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRN 349
           + + + +G G +G+V        G  VAVK+LSR  +Q +   K    E+ L+  ++H N
Sbjct: 24  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYN-----------I 396
           ++ L+                P RSL+ F  ++     +  + N               +
Sbjct: 83  VIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL 130
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
           I  I +GL Y+H      IIHRDLKPSN+ +++D   KI D G+AR   +++ T      
Sbjct: 131 IYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLAR-HTDDEMTG----Y 182
Query: 457 VGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           V T  Y APE  +  + ++   D++S G I+ E+++G+
Sbjct: 183 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVK-----RLSRKSWQGLEEFKNEIILIAK 344
           TD +    +LG+G F  V + + +P G+E A K     +LS +  Q LE    E  +   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE---REARICRL 59
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           L+H N+VRL     E     L+++L+    L   I   E   + + + C   I  I + +
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHC---IQQILESV 116
Query: 405 LYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYG 461
            + H +    I+HRDLKP N+LL    K    K++DFG+A     +Q+        GT G
Sbjct: 117 NHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFG--FAGTPG 171
Query: 462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           Y++PE   +  +    D+++ GVI+  ++ G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  VL   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           N++ L+          E ++  L+ ELM + +L C +   E   +      Y ++ GI  
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK- 141
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY-- 460
              +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++  Y  
Sbjct: 142 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMTPYVV 188
Query: 461 --GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
              Y APE  +   +    D++S G I+ E++  K
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 103/216 (47%), Gaps = 35/216 (16%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQH 347
           + +   +G G  G V   Y  VL   + VA+K+LSR  +Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 82
Query: 348 RNLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS 401
           +N++ L+          E ++  L+ ELM + +L C +   E   +      Y ++ GI 
Sbjct: 83  KNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK 140
Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY- 460
               +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++  Y 
Sbjct: 141 ----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMTPYV 186
Query: 461 ---GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
               Y APE  +   +    D++S G I+ E++  K
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 41/218 (18%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQH 347
           + +   +G G  G V   Y  +L   + VA+K+LSR  +Q     K    E++L+  + H
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 82
Query: 348 RNLVRLVGCGI------EGEEKLLIYELMPNRSLDCFI---FDSERRLQLNWNTCYNIIG 398
           +N++ L+          E ++  ++ ELM + +L   I    D ER   L     Y ++ 
Sbjct: 83  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYL----LYQMLC 137
Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG 458
           GI     +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++ 
Sbjct: 138 GIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR-------TAGTSFMMT 183
Query: 459 TY----GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            Y     Y APE  +   +    D++S G I+ E+I G
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  VL   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           N++ L+          E ++  L+ ELM + +L C +   E   +      Y ++ GI  
Sbjct: 85  NIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK- 141
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY-- 460
              +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++  Y  
Sbjct: 142 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMTPYVV 188
Query: 461 --GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
              Y APE  +   +    D++S G I+ E++  K
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 120/259 (46%), Gaps = 42/259 (16%)
Query: 292 DGFSDSNKLGQGGFGTVY--------KGVLPNGKEVAVKRLSRKSWQ-GLEEFKNEIILI 342
           D  +    LG+G FG V         K        VAVK L   + +  L +  +E+ ++
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 343 AKL-QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFI-----------FDSER--RLQL 388
             + +H+N++ L+G   +     +I       +L  ++           +D  R    Q+
Sbjct: 95  KMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 389 NWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE-- 446
            +    +    +++G+ YL   +  K IHRDL   NVL+ ++ V KI+DFG+AR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 447 -NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--H 503
             +KT N R  V    +MAPE   + +++ +SDV+SFGV++ EI        F L G  +
Sbjct: 212 YYKKTTNGRLPV---KWMAPEALFDRVYTHQSDVWSFGVLMWEI--------FTLGGSPY 260
Query: 504 AQTLLAYVWQLWKEGKEME 522
               +  +++L KEG  M+
Sbjct: 261 PGIPVEELFKLLKEGHRMD 279

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 25/210 (11%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  +L   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           N++ L+          E ++  ++ ELM + +L C +   E   +      Y ++ GI  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK- 140
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
              +LH      IIHRDLKPSN+++  D   KI DFG+AR          T  VV  Y Y
Sbjct: 141 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEVVTRY-Y 191
Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            APE  +   +    D++S G I+ E+I G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 20/212 (9%)
Query: 292 DGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRK----SWQGL--EEFKNEIILIAK 344
           D +    +LG G F  V K      GKE A K + ++    S +G+  EE + E+ ++ +
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           ++H N++ L        + +LI EL+    L  F+ + E    L  +     +  I  G+
Sbjct: 86  IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGV 142
Query: 405 LYLHEDSRLKIIHRDLKPSNV-LLDKDM---VAKISDFGMARIFCENQKTANTRRVVGTY 460
            YLH     +I H DLKP N+ LLDK++     K+ DFG+A       +  N   + GT 
Sbjct: 143 HYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTP 196
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            ++APE        +++D++S GVI   ++SG
Sbjct: 197 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 26/210 (12%)
Query: 300 LGQGGFGTVYKGVL-PNGKEVAVK--------RLSRKSWQGLEEFK-NEIILIAKLQ-HR 348
           LG+G    V + +  P  KE AVK          S +  Q L E    E+ ++ K+  H 
Sbjct: 12  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 71
Query: 349 NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
           N+++L           L+++LM    L  F + +E+ + L+      I+  + + +  LH
Sbjct: 72  NIIQLKDTYETNTFFFLVFDLMKKGEL--FDYLTEK-VTLSEKETRKIMRALLEVICALH 128
Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
              +L I+HRDLKP N+LLD DM  K++DFG +   C+       R V GT  Y+APE  
Sbjct: 129 ---KLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLREVCGTPSYLAPEII 182
Query: 469 MEGL------FSVKSDVFSFGVIVLEIISG 492
              +      +  + D++S GVI+  +++G
Sbjct: 183 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 15/213 (7%)
Query: 287 IKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQGLEEFK----NEIIL 341
           IK   + F     LG+G FG V+        +  A+K L +      ++ +     + +L
Sbjct: 13  IKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 72
Query: 342 IAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS 401
               +H  L  +  C  + +E L       N     +   S  +  L+  T Y     I 
Sbjct: 73  SLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAEII 129
Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ-KTANTRRVVGTY 460
            GL +LH      I++RDLK  N+LLDKD   KI+DFGM +   EN    A T    GT 
Sbjct: 130 LGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNEFCGTP 183
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
            Y+APE  +   ++   D +SFGV++ E++ G+
Sbjct: 184 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 39/217 (17%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  +L   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFI---FDSERRLQLNWNTCYNIIGG 399
           N++ L+          E ++  ++ ELM + +L   I    D ER   L     Y ++ G
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSYL----LYQMLCG 138
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I     +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++  
Sbjct: 139 IK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMTP 184
Query: 460 Y----GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           Y     Y APE  +   +    D++S G I+ E+I G
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFK----NEIILIAKLQHRNLVRL 353
           K+GQG FG V+K      G++VA+K++  ++ +  E F      EI ++  L+H N+V L
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNL 82
Query: 354 VG-CGIEGEE----KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
           +  C  +       K  IY +      D     S   ++   +    ++  +  GL Y+H
Sbjct: 83  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR---RVVGTYGYMAP 465
              R KI+HRD+K +NVL+ +D V K++DFG+AR F   + +   R   RVV T  Y  P
Sbjct: 143 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRPP 198
Query: 466 EYAM-EGLFSVKSDVFSFGVIVLEI 489
           E  + E  +    D++  G I+ E+
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 11/204 (5%)
Query: 292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNL 350
           D +    +LG G FG V++      G   A K +        E  + EI  ++ L+H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           V L     +  E ++IYE M    L   + D   ++  +    Y  +  + KGL ++HE+
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY--MRQVCKGLCHMHEN 274
Query: 411 SRLKIIHRDLKPSNVLL--DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
           +    +H DLKP N++    +    K+ DFG+       Q    T    GT  + APE A
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPEVA 328
Query: 469 MEGLFSVKSDVFSFGVIVLEIISG 492
                   +D++S GV+   ++SG
Sbjct: 329 EGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 109/228 (47%), Gaps = 28/228 (12%)
Query: 275 SSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQGLE 333
            +E++ F H  +++A          +G+G FG V      + K++ A+K ++++      
Sbjct: 8   ENEDVNFDHFEILRA----------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERN 57
Query: 334 EFKN---EIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNW 390
           E +N   E+ ++  L+H  LV L     + E+  ++ +L+    L   +   ++ +    
Sbjct: 58  EVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKE 114
Query: 391 NTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC-ENQK 449
            T    I  +   L YL      +IIHRD+KP N+LLD+     I+DF +A +   E Q 
Sbjct: 115 ETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI 171
Query: 450 TANTRRVVGTYGYMAPEY--AMEGL-FSVKSDVFSFGVIVLEIISGKR 494
           T     + GT  YMAPE   + +G  +S   D +S GV   E++ G+R
Sbjct: 172 TT----MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 103/205 (50%), Gaps = 20/205 (9%)
Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFK----NEIILIAKLQHRNLVRL 353
           K+GQG FG V+K      G++VA+K++  ++ +  E F      EI ++  L+H N+V L
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNL 81
Query: 354 VG-CGIEGEE----KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
           +  C  +       K  IY +      D     S   ++   +    ++  +  GL Y+H
Sbjct: 82  IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141
Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR---RVVGTYGYMAP 465
              R KI+HRD+K +NVL+ +D V K++DFG+AR F   + +   R   RVV T  Y  P
Sbjct: 142 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV-TLWYRPP 197
Query: 466 EYAM-EGLFSVKSDVFSFGVIVLEI 489
           E  + E  +    D++  G I+ E+
Sbjct: 198 ELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 300 LGQGGFGTVYKGVL--PNGKEVAVKRLSRKSWQG---LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG V++G+   P    +AV   + K+       E+F  E + + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           G  I      +I EL     L  F+    R+  L+  +       +S  L YL      +
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
            +HRD+   NVL+  +   K+ DFG++R + E+       +      +MAPE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESINFRRFT 190
Query: 475 VKSDVFSFGVIVLEII 490
             SDV+ FGV + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 104/200 (52%), Gaps = 12/200 (6%)
Query: 299 KLGQGGFGTVYKGVLPNGKE-VAVKRLS-RKSWQGLEEFK-NEIILIAKLQHRNLVRLVG 355
           K+G+G +GTV+K       E VA+KR+      +G+      EI L+ +L+H+N+VRL  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
                ++  L++E   ++ L  + FDS     L+     + +  + KGL + H  +   +
Sbjct: 69  VLHSDKKLTLVFEFC-DQDLKKY-FDSCNG-DLDPEIVKSFLFQLLKGLGFCHSRN---V 122
Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG-LFS 474
           +HRDLKP N+L++++   K+++FG+AR F    +  +   V  T  Y  P+      L+S
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV--TLWYRPPDVLFGAKLYS 180
Query: 475 VKSDVFSFGVIVLEIISGKR 494
              D++S G I  E+ +  R
Sbjct: 181 TSIDMWSAGCIFAELANAGR 200

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 11/204 (5%)
Query: 292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNL 350
           D +    +LG G FG V++      G   A K +        E  + EI  ++ L+H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           V L     +  E ++IYE M    L   + D   ++  +    Y  +  + KGL ++HE+
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY--MRQVCKGLCHMHEN 168
Query: 411 SRLKIIHRDLKPSNVLL--DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
           +    +H DLKP N++    +    K+ DFG+       Q    T    GT  + APE A
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPEVA 222
Query: 469 MEGLFSVKSDVFSFGVIVLEIISG 492
                   +D++S GV+   ++SG
Sbjct: 223 EGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  +L   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           N++ L+          E ++  ++ ELM + +L C +   E   +      Y ++ GI  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK- 140
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY-- 460
              +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++  Y  
Sbjct: 141 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMTPYVV 187
Query: 461 --GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
              Y APE  +   +    D++S G I+ E+I G
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  +L   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           N++ L+          E ++  ++ ELM + +L C +   E   +      Y ++ GI  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK- 140
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY-- 460
              +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++  Y  
Sbjct: 141 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMTPYVV 187
Query: 461 --GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
              Y APE  +   +    D++S G I+ E+I G
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  +L   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           N++ L+          E ++  ++ ELM + +L C +   E   +      Y ++ GI  
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK- 141
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY-- 460
              +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++  Y  
Sbjct: 142 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMTPYVV 188
Query: 461 --GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
              Y APE  +   +    D++S G I+ E+I G
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 20/200 (10%)
Query: 300 LGQGGFGTVY--KGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           LG G F  V+  K  L  GK  A+K + +         +NEI ++ K++H N+V L    
Sbjct: 17  LGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 358 IEGEEKLLIYELMPNRSLDCFIFDS--ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
                  L+ +L+    L    FD   ER +    +    +I  +   + YLHE+    I
Sbjct: 76  ESTTHYYLVMQLVSGGEL----FDRILERGVYTEKDASL-VIQQVLSAVKYLHENG---I 127
Query: 416 IHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
           +HRDLKP N+L    +++    I+DFG++++    ++        GT GY+APE   +  
Sbjct: 128 VHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQKP 183
Query: 473 FSVKSDVFSFGVIVLEIISG 492
           +S   D +S GVI   ++ G
Sbjct: 184 YSKAVDCWSIGVITYILLCG 203

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 10/207 (4%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQH 347
           K   + +  +  LG+G FG V++ V  + K+  + +  +         K EI ++   +H
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH 60
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           RN++ L       EE ++I+E +    LD F   +    +LN     + +  + + L +L
Sbjct: 61  RNILHLHESFESMEELVMIFEFISG--LDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 408 HEDSRLKIIHRDLKPSNVLLD--KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           H  +   I H D++P N++    +    KI +FG AR   + +   N R +     Y AP
Sbjct: 119 HSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAP 172
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E     + S  +D++S G +V  ++SG
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSG 199

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 15/213 (7%)
Query: 287 IKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQGLEEFK----NEIIL 341
           IK   + F     LG+G FG V+        +  A+K L +      ++ +     + +L
Sbjct: 12  IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 342 IAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS 401
               +H  L  +  C  + +E L       N     +   S  +  L+  T Y     I 
Sbjct: 72  SLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAEII 128
Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ-KTANTRRVVGTY 460
            GL +LH      I++RDLK  N+LLDKD   KI+DFGM +   EN    A T    GT 
Sbjct: 129 LGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNXFCGTP 182
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
            Y+APE  +   ++   D +SFGV++ E++ G+
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 300 LGQGGFGTVYKGVL--PNGKEVAVKRLSRKSWQG---LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG V++G+   P    +AV   + K+       E+F  E + + +  H ++V+L+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           G  I      +I EL     L  F+    R+  L+  +       +S  L YL      +
Sbjct: 106 GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 159
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
            +HRD+   NVL+  +   K+ DFG++R + E+       +      +MAPE      F+
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 475 VKSDVFSFGVIVLEII 490
             SDV+ FGV + EI+
Sbjct: 219 SASDVWMFGVCMWEIL 234

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 33/214 (15%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  +L   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 85
Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           N++ L+          E ++  ++ ELM + +L C +   E   +      Y ++ GI  
Sbjct: 86  NIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK- 142
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV----VG 458
              +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  +    V 
Sbjct: 143 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMVPFVV 189
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           T  Y APE  +   +    D++S G I+ E+I G
Sbjct: 190 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I  GL  LH   R +I++RDLKP N+LLD     +ISD G+A    E Q        VGT
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGT 348
Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
            GYMAPE      ++   D ++ G ++ E+I+G+
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 300 LGQGGFGTVYK----GVLPNGKEVAVKRLSR----KSWQGLEEFKNEIILIAKLQHRNLV 351
           LG+GG+G V++         GK  A+K L +    ++ +     K E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            L+     G +  LI E +    L       ER      +T    +  IS  L +LH+  
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
              II+RDLKP N++L+     K++DFG+ +    +    +T    GT  YMAPE  M  
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAPEILMRS 196
Query: 472 LFSVKSDVFSFGVIVLEIISG 492
             +   D +S G ++ ++++G
Sbjct: 197 GHNRAVDWWSLGALMYDMLTG 217

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 300 LGQGGFGTVYKGVL--PNGKEVAVKRLSRKSWQG---LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG V++G+   P    +AV   + K+       E+F  E + + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           G  I      +I EL     L  F+    R+  L+  +       +S  L YL      +
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
            +HRD+   NVL+  +   K+ DFG++R + E+       +      +MAPE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 475 VKSDVFSFGVIVLEII 490
             SDV+ FGV + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 300 LGQGGFGTVYKGVL--PNGKEVAVKRLSRKSWQG---LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG V++G+   P    +AV   + K+       E+F  E + + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           G  I      +I EL     L  F+    R+  L+  +       +S  L YL      +
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
            +HRD+   NVL+  +   K+ DFG++R + E+       +      +MAPE      F+
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 475 VKSDVFSFGVIVLEII 490
             SDV+ FGV + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/91 (39%), Positives = 51/91 (56%), Gaps = 6/91 (6%)
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           GL  LH   R +I++RDLKP N+LLD     +ISD G+A    E Q        VGT GY
Sbjct: 298 GLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR---VGTVGY 351
Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           MAPE      ++   D ++ G ++ E+I+G+
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 300 LGQGGFGTVYKGVL--PNGKEVAVKRLSRKSWQG---LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG V++G+   P    +AV   + K+       E+F  E + + +  H ++V+L+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           G  I      +I EL     L  F+    R+  L+  +       +S  L YL      +
Sbjct: 83  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
            +HRD+   NVL+  +   K+ DFG++R + E+       +      +MAPE      F+
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 475 VKSDVFSFGVIVLEII 490
             SDV+ FGV + EI+
Sbjct: 196 SASDVWMFGVCMWEIL 211

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 291 TDGFSDSNKLGQGGFGTVY--KGVLPNGKEVAVKRLSRKSWQGLEE---FKNEIILIAKL 345
           +D +    KLG G +G V   K  L  G E A+K + + S           +E+ ++ +L
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 78
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSL-DCFIFDSERRLQLNWNTCYNIIGGISKGL 404
            H N+++L     +     L+ E+     L D  I     R + +      I+  +  G 
Sbjct: 79  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL----RQKFSEVDAAVIMKQVLSGT 134
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTRRVVGTYG 461
            YLH+ +   I+HRDLKP N+LL+   +D + KI DFG++  F   +     +  +GT  
Sbjct: 135 TYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAY 188
Query: 462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           Y+APE  +   +  K DV+S GVI+  ++ G
Sbjct: 189 YIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 300 LGQGGFGTVYKGVL--PNGKEVAVKRLSRKSWQG---LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG V++G+   P    +AV   + K+       E+F  E + + +  H ++V+L+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           G  I      +I EL     L  F+    R+  L+  +       +S  L YL      +
Sbjct: 80  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 133
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
            +HRD+   NVL+  +   K+ DFG++R + E+       +      +MAPE      F+
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 475 VKSDVFSFGVIVLEII 490
             SDV+ FGV + EI+
Sbjct: 193 SASDVWMFGVCMWEIL 208

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVK-----RLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +G+G F  V + +    G++ AVK     + +       E+ K E  +   L+H ++V L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +          +++E M    L CF  +  ++     +     + +  I + L Y H+++
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL-CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 412 RLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
              IIHRD+KP NVLL   +     K+ DFG+A    E+   A  R  VGT  +MAPE  
Sbjct: 151 ---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGR--VGTPHFMAPEVV 205
Query: 469 MEGLFSVKSDVFSFGVIVLEIISG 492
               +    DV+  GVI+  ++SG
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSG 229

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 300 LGQGGFGTVYKGVL--PNGKEVAVKRLSRKSWQG---LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG V++G+   P    +AV   + K+       E+F  E + + +  H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           G   E     +I EL     L  F+    R+  L+  +       +S  L YL      +
Sbjct: 75  GVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
            +HRD+   NVL+  +   K+ DFG++R + E+       +      +MAPE      F+
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 475 VKSDVFSFGVIVLEII 490
             SDV+ FGV + EI+
Sbjct: 188 SASDVWMFGVCMWEIL 203

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 300 LGQGGFGTVYKGVL--PNGKEVAVKRLSRKSWQG---LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG V++G+   P    +AV   + K+       E+F  E + + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           G   E     +I EL     L  F+    R+  L+  +       +S  L YL      +
Sbjct: 458 GVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
            +HRD+   NVL+  +   K+ DFG++R + E+       +      +MAPE      F+
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 475 VKSDVFSFGVIVLEII 490
             SDV+ FGV + EI+
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 12/196 (6%)
Query: 300 LGQGGFGTVYKGVL--PNGKEVAVKRLSRKSWQG---LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG V++G+   P    +AV   + K+       E+F  E + + +  H ++V+L+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           G  I      +I EL     L  F+    R+  L+  +       +S  L YL      +
Sbjct: 81  GV-ITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 134
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
            +HRD+   NVL+  +   K+ DFG++R + E+       +      +MAPE      F+
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 475 VKSDVFSFGVIVLEII 490
             SDV+ FGV + EI+
Sbjct: 194 SASDVWMFGVCMWEIL 209

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 300 LGQGGFGTVYKGVL--PNGKEVAVKRLSRKSWQG---LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG V++G+   P    +AV   + K+       E+F  E + + +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           G  I      +I EL     L  F+    R+  L+  +       +S  L YL      +
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
            +HRD+   NVL+      K+ DFG++R + E+       +      +MAPE      F+
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 475 VKSDVFSFGVIVLEII 490
             SDV+ FGV + EI+
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 102/236 (43%), Gaps = 29/236 (12%)
Query: 284 LAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGL----------- 332
           +A + A    ++    +  G +G V  GV   G  VA+KR+      G            
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 333 EEFKNEIILIAKLQHRNLVRLVGCGIEGEE----KL-LIYELMPNRSLDCFIFDSERRLQ 387
           +    EI L+    H N++ L    +  EE    KL L+ ELM    L   I D  +R+ 
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHD--QRIV 130
Query: 388 LNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN 447
           ++       +  I  GL  LHE     ++HRDL P N+LL  +    I DF +AR   E+
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---ED 184
Query: 448 QKTANTRRVVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK---RNSGFY 499
              AN    V    Y APE  M+   F+   D++S G ++ E+ + K   R S FY
Sbjct: 185 TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 27/204 (13%)
Query: 300 LGQGGFGTVY--KGVLPNGKEVAVKRLSRKSWQ--GLEEFKNEIILIAKLQHRNLVRLVG 355
           +G+G F  V   + +L  G+EVA+K + +       L++   E+ ++  L H N+V+L  
Sbjct: 20  IGKGNFAKVKLARHIL-TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 78
Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
             IE E+ L LI E      +  ++    R  +    + +     I   + Y H+    +
Sbjct: 79  V-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQYCHQK---R 131
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
           I+HRDLK  N+LLD DM  KI+DFG +  F    K        G+  Y APE     LF 
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT---FCGSPPYAAPE-----LFQ 183
Query: 475 VKS------DVFSFGVIVLEIISG 492
            K       DV+S GVI+  ++SG
Sbjct: 184 GKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 27/204 (13%)
Query: 300 LGQGGFGTVY--KGVLPNGKEVAVKRLSRKSWQG--LEEFKNEIILIAKLQHRNLVRLVG 355
           +G+G F  V   + +L  GKEVAVK + +       L++   E+ ++  L H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
             IE E+ L L+ E      +  ++    R  +      +     I   + Y H+     
Sbjct: 81  V-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQKF--- 133
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
           I+HRDLK  N+LLD DM  KI+DFG +  F    K        G+  Y APE     LF 
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPE-----LFQ 185
Query: 475 VKS------DVFSFGVIVLEIISG 492
            K       DV+S GVI+  ++SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 27/204 (13%)
Query: 300 LGQGGFGTVY--KGVLPNGKEVAVKRLSRKSWQG--LEEFKNEIILIAKLQHRNLVRLVG 355
           +G+G F  V   + +L  GKEVAVK + +       L++   E+ ++  L H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
             IE E+ L L+ E      +  ++    R  +      +     I   + Y H+     
Sbjct: 81  V-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQKF--- 133
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
           I+HRDLK  N+LLD DM  KI+DFG +  F    K        G+  Y APE     LF 
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPE-----LFQ 185
Query: 475 VKS------DVFSFGVIVLEIISG 492
            K       DV+S GVI+  ++SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 104/216 (48%), Gaps = 17/216 (7%)
Query: 284 LAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLE---EFKNEI 339
           +A+ K     +     LG+G FG V         ++VA+K +SR+  +  +     + EI
Sbjct: 1   MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 340 ILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYN-IIG 398
             +  L+H ++++L        + +++ E       D +I + +R  +      +  II 
Sbjct: 61  SYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFD-YIVEKKRMTEDEGRRFFQQIIC 119
Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG 458
            I     Y H   R KI+HRDLKP N+LLD ++  KI+DFG++ I  +      +    G
Sbjct: 120 AIE----YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS---CG 169
Query: 459 TYGYMAPEYAMEGLFS-VKSDVFSFGVIVLEIISGK 493
           +  Y APE     L++  + DV+S G+++  ++ G+
Sbjct: 170 SPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 102/236 (43%), Gaps = 29/236 (12%)
Query: 284 LAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGL----------- 332
           +A + A    ++    +  G +G V  GV   G  VA+KR+      G            
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 333 EEFKNEIILIAKLQHRNLVRLVGCGIEGEE----KL-LIYELMPNRSLDCFIFDSERRLQ 387
           +    EI L+    H N++ L    +  EE    KL L+ ELM    L   I D  +R+ 
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHD--QRIV 130
Query: 388 LNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN 447
           ++       +  I  GL  LHE     ++HRDL P N+LL  +    I DF +AR   E+
Sbjct: 131 ISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---ED 184
Query: 448 QKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGK---RNSGFY 499
              AN    V    Y APE  M+   F+   D++S G ++ E+ + K   R S FY
Sbjct: 185 TADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 300 LGQGGFGTVYK----GVLPNGKEVAVKRLSR----KSWQGLEEFKNEIILIAKLQHRNLV 351
           LG+GG+G V++         GK  A+K L +    ++ +     K E  ++ +++H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            L+     G +  LI E +    L       ER      +T    +  IS  L +LH+  
Sbjct: 85  DLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYLAEISMALGHLHQKG 141
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
              II+RDLKP N++L+     K++DFG+ +    +     T    GT  YMAPE  M  
Sbjct: 142 ---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THXFCGTIEYMAPEILMRS 196
Query: 472 LFSVKSDVFSFGVIVLEIISG 492
             +   D +S G ++ ++++G
Sbjct: 197 GHNRAVDWWSLGALMYDMLTG 217

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLS-RKSWQGLEEFK-NEIILIAKL 345
            + D +    KLG+G +G VYK +     + VA+KR+      +G+      E+ L+ +L
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL 90
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           QHRN++ L           LI+E   N        + +  +++  +  Y +I G++    
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN---- 146
Query: 406 YLHEDSRLKIIHRDLKPSNVLL-----DKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
           + H  SR + +HRDLKP N+LL      +  V KI DFG+AR F    +   T  ++ T 
Sbjct: 147 FCH--SR-RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-THEII-TL 201
Query: 461 GYMAPEYAMEGL-FSVKSDVFSFGVIVLEII 490
            Y  PE  +    +S   D++S   I  E++
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 27/204 (13%)
Query: 300 LGQGGFGTVY--KGVLPNGKEVAVKRLSRKSWQ--GLEEFKNEIILIAKLQHRNLVRLVG 355
           +G+G F  V   + VL  G+EVAVK + +       L++   E+ ++  L H N+V+L  
Sbjct: 23  IGKGNFAKVKLARHVL-TGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
             IE E+ L L+ E      +  ++    R  +      +     I   + Y H+     
Sbjct: 82  V-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQKY--- 134
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
           I+HRDLK  N+LLD DM  KI+DFG +  F    K        G+  Y APE     LF 
Sbjct: 135 IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGSPPYAAPE-----LFQ 186
Query: 475 VKS------DVFSFGVIVLEIISG 492
            K       DV+S GVI+  ++SG
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 291 TDGFSDSNKLGQGGFGTVY--KGVLPNGKEVAVKRLSRKSWQGLEE---FKNEIILIAKL 345
           +D +    KLG G +G V   K  L  G E A+K + + S           +E+ ++ +L
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSL-DCFIFDSERRLQLNWNTCYNIIGGISKGL 404
            H N+++L     +     L+ E+     L D  I     R + +      I+  +  G 
Sbjct: 62  DHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIIL----RQKFSEVDAAVIMKQVLSGT 117
Query: 405 LYLHEDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTRRVVGTYG 461
            YLH+ +   I+HRDLKP N+LL+   +D + KI DFG++  F   +     +  +GT  
Sbjct: 118 TYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF---EVGGKMKERLGTAY 171
Query: 462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           Y+APE  +   +  K DV+S GVI+  ++ G
Sbjct: 172 YIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/108 (32%), Positives = 56/108 (51%), Gaps = 13/108 (12%)
Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT-- 450
           C +I   I++ + +LH      ++HRDLKPSN+    D V K+ DFG+     ++++   
Sbjct: 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222
Query: 451 --------ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEII 490
                   A     VGT  YM+PE      +S K D+FS G+I+ E++
Sbjct: 223 VLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 27/204 (13%)
Query: 300 LGQGGFGTVY--KGVLPNGKEVAVKRLSRKSWQ--GLEEFKNEIILIAKLQHRNLVRLVG 355
           +G+G F  V   + +L  G+EVA+K + +       L++   E+ ++  L H N+V+L  
Sbjct: 23  IGKGNFAKVKLARHIL-TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFE 81
Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
             IE E+ L LI E      +  ++    R  +    + +     I   + Y H+    +
Sbjct: 82  V-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFR---QIVSAVQYCHQK---R 134
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
           I+HRDLK  N+LLD DM  KI+DFG +  F    K        G   Y APE     LF 
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA---FCGAPPYAAPE-----LFQ 186
Query: 475 VKS------DVFSFGVIVLEIISG 492
            K       DV+S GVI+  ++SG
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +G+G +G V++G L +G+ VAVK  S +   SW    E  N ++L    +H N++  +  
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTVLL----RHDNILGFIAS 70
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED-----S 411
            +          L+ +      ++D  +R  L  +    +    + GL +LH +      
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQG 130
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ---KTANTRRVVGTYGYMAPEYA 468
           +  I HRD K  NVL+  ++   I+D G+A +  +        N  R VGT  YMAPE  
Sbjct: 131 KPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPR-VGTKRYMAPEVL 189
Query: 469 MEGLFS------VKSDVFSFGVIVLEI 489
            E + +        +D+++FG+++ EI
Sbjct: 190 DEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)
Query: 300 LGQGGFGTVYKGVL--PNGKEVAVKRLSRKSWQG---LEEFKNEIILIAKLQHRNLVRLV 354
           +G+G FG V++G+   P    +AV   + K+       E+F  E + + +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           G   E     +I EL     L  F+    R+  L+  +       +S  L YL      +
Sbjct: 458 GVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
            +HRD+   NVL+      K+ DFG++R + E+       +      +MAPE      F+
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 475 VKSDVFSFGVIVLEII 490
             SDV+ FGV + EI+
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 97/221 (43%), Gaps = 34/221 (15%)
Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLS---RKSWQGLEEFKNEIILIAKLQHRNLVRLV 354
           KLG+G +G V+K +    G+ VAVK++    + S      F+  +IL     H N+V L+
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 355 GC--GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
                    +  L+++ M    L   I  +           Y +I    K + YLH    
Sbjct: 76  NVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVVYQLI----KVIKYLHSGG- 129
Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT------------------- 453
             ++HRD+KPSN+LL+ +   K++DFG++R F   ++  N                    
Sbjct: 130 --LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 454 RRVVGTYGYMAPEYAMEGLFSVKS-DVFSFGVIVLEIISGK 493
              V T  Y APE  +      K  D++S G I+ EI+ GK
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 27/204 (13%)
Query: 300 LGQGGFGTVY--KGVLPNGKEVAVKRLSRKSWQG--LEEFKNEIILIAKLQHRNLVRLVG 355
           +G+G F  V   + +L  GKEVAV+ + +       L++   E+ ++  L H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
             IE E+ L L+ E      +  ++    R  +      +     I   + Y H+     
Sbjct: 81  V-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQKF--- 133
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
           I+HRDLK  N+LLD DM  KI+DFG +  F    K        G+  Y APE     LF 
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDE---FCGSPPYAAPE-----LFQ 185
Query: 475 VKS------DVFSFGVIVLEIISG 492
            K       DV+S GVI+  ++SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 27/204 (13%)
Query: 300 LGQGGFGTVY--KGVLPNGKEVAVKRLSRKSWQG--LEEFKNEIILIAKLQHRNLVRLVG 355
           +G+G F  V   + +L  GKEVAV+ + +       L++   E+ ++  L H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
             IE E+ L L+ E      +  ++    R  +      +     I   + Y H+     
Sbjct: 81  V-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQKF--- 133
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
           I+HRDLK  N+LLD DM  KI+DFG +  F    K        G+  Y APE     LF 
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPE-----LFQ 185
Query: 475 VKS------DVFSFGVIVLEIISG 492
            K       DV+S GVI+  ++SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  +L   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           N++ L+          E ++  ++ ELM + +L C +   E   +      Y ++ GI  
Sbjct: 78  NIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK- 134
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY-- 460
              +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++  Y  
Sbjct: 135 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMTPYVV 181
Query: 461 --GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
              Y APE  +   +    D++S G I+ E++  K
Sbjct: 182 TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  +L   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           N++ L+          E ++  ++ ELM + +L C +   E   +      Y ++ GI  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK- 140
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV----VG 458
              +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  +    V 
Sbjct: 141 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMEPEVV 187
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           T  Y APE  +   +    D++S G I+ E++  K
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  +L   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 88
Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           N++ L+          E ++  ++ ELM + +L C +   E   +      Y ++ GI  
Sbjct: 89  NIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK- 145
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY-- 460
              +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  ++  Y  
Sbjct: 146 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMTPYVV 192
Query: 461 --GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
              Y APE  +   +    D++S G I+ E++  K
Sbjct: 193 TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 27/204 (13%)
Query: 300 LGQGGFGTVY--KGVLPNGKEVAVKRLSRKSWQG--LEEFKNEIILIAKLQHRNLVRLVG 355
           +G+G F  V   + +L  GKEVAVK + +       L++   E+ ++  L H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 80
Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
             IE E+ L L+ E      +  ++    R  +      +     I   + Y H+     
Sbjct: 81  V-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR---QIVSAVQYCHQKF--- 133
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
           I+HRDLK  N+LLD DM  KI+DFG +  F    K        G   Y APE     LF 
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPE-----LFQ 185
Query: 475 VKS------DVFSFGVIVLEIISG 492
            K       DV+S GVI+  ++SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 34/222 (15%)
Query: 294 FSDSNKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           + D   LG GG G V+  V  +  K VA+K++     Q ++    EI +I +L H N+V+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 353 L--------------VGCGIEGEEKLLIYELMPNRSLDCF----IFDSERRLQLNWNTCY 394
           +              VG   E     ++ E M     +      + +   RL +     Y
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFM-----Y 127
Query: 395 NIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD-KDMVAKISDFGMARIFCEN-QKTAN 452
            ++    +GL Y+H  +   ++HRDLKP+N+ ++ +D+V KI DFG+ARI   +     +
Sbjct: 128 QLL----RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 453 TRRVVGTYGYMAPEYAMEGLFSVKS-DVFSFGVIVLEIISGK 493
               + T  Y +P   +      K+ D+++ G I  E+++GK
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 101/202 (50%), Gaps = 25/202 (12%)
Query: 299 KLGQGGFGTVYKGVLPNGK------EVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           ++G+G F TVYKG+           E+  ++L++   Q    FK E   +  LQH N+VR
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIVR 89
Query: 353 LVG---CGIEGEE-KLLIYELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYL 407
                   ++G++  +L+ EL  + +L  ++   +  ++++  + C  I+    KGL +L
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQIL----KGLQFL 145
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           H  +   IIHRDLK  N+ +       KI D G+A +    ++ +  + V+GT  + APE
Sbjct: 146 HTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFXAPE 200
Query: 467 YAMEGLFSVKSDVFSFGVIVLE 488
              E  +    DV++FG   LE
Sbjct: 201 -XYEEKYDESVDVYAFGXCXLE 221

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 89/210 (42%), Gaps = 13/210 (6%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRKSWQGLEEFK----NEIILI 342
           +   D F     LG+G FG V    V   G   AVK L +      ++ +     + IL 
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 343 AKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
               H  L +L  C    +    + E +    L  F     RR        Y     I  
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL-MFHIQKSRRFDEARARFY--AAEIIS 135
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
            L++LH+     II+RDLK  NVLLD +   K++DFGM +    N  T  T    GT  Y
Sbjct: 136 ALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDY 190
Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           +APE   E L+    D ++ GV++ E++ G
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 103/215 (47%), Gaps = 33/215 (15%)
Query: 294 FSDSNKLGQGGFGTV---YKGVLPNGKEVAVKRLSR--KSWQGLEEFKNEIILIAKLQHR 348
           + +   +G G  G V   Y  +L   + VA+K+LSR  ++    +    E++L+  + H+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 349 NLVRLVGCGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           N++ L+          E ++  ++ ELM + +L C +   E   +      Y ++ GI  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQMLCGIK- 140
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV----VG 458
              +LH      IIHRDLKPSN+++  D   KI DFG+AR       TA T  +    V 
Sbjct: 141 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-------TAGTSFMMEPEVV 187
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           T  Y APE  +   +    D++S G I+ E++  K
Sbjct: 188 TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 33/207 (15%)
Query: 300 LGQGGFGTVY--KGVLPNGKEVAVKRLSRKSWQG--LEEFKNEIILIAKLQHRNLVRLVG 355
           +G+G F  V   + +L  GKEVAVK + +       L++   E+ ++  L H N+V+L  
Sbjct: 15  IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFE 73
Query: 356 CGIEGEEKLLIYELMPNRS----LDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
             IE E+ L  Y +M   S     D  +     + +        I+  +     Y H+  
Sbjct: 74  V-IETEKTL--YLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ----YCHQKF 126
Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
              I+HRDLK  N+LLD DM  KI+DFG +  F    K        G+  Y APE     
Sbjct: 127 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPE----- 175
Query: 472 LFSVKS------DVFSFGVIVLEIISG 492
           LF  K       DV+S GVI+  ++SG
Sbjct: 176 LFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLS---RKSWQGLEEFKN-EIILIAKLQHRNLVRLVG 355
           +G+G FG V++G    G+EVAVK  S    +SW     F+  EI     L+H N++  + 
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-----FREAEIYQTVMLRHENILGFIA 103
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED----- 410
              +         L+ +      +FD   R  +       +    + GL +LH +     
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT--RRVVGTYGYMAPEYA 468
            +  I HRDLK  N+L+ K+    I+D G+A        T +      VGT  YMAPE  
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 223
Query: 469 -----MEGLFSVK-SDVFSFGVIVLEI 489
                M+   S K +D+++ G++  EI
Sbjct: 224 DDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLS---RKSWQGLEEFKN-EIILIAKLQHRNLVRLVG 355
           +G+G FG V++G    G+EVAVK  S    +SW     F+  EI     L+H N++  + 
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-----FREAEIYQTVMLRHENILGFIA 90
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED----- 410
              +         L+ +      +FD   R  +       +    + GL +LH +     
Sbjct: 91  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT--RRVVGTYGYMAPEYA 468
            +  I HRDLK  N+L+ K+    I+D G+A        T +      VGT  YMAPE  
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 210
Query: 469 -----MEGLFSVK-SDVFSFGVIVLEI 489
                M+   S K +D+++ G++  EI
Sbjct: 211 DDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLS---RKSWQGLEEFKN-EIILIAKLQHRNLVRLVG 355
           +G+G FG V++G    G+EVAVK  S    +SW     F+  EI     L+H N++  + 
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-----FREAEIYQTVMLRHENILGFIA 65
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED----- 410
              +         L+ +      +FD   R  +       +    + GL +LH +     
Sbjct: 66  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT--RRVVGTYGYMAPEY- 467
            +  I HRDLK  N+L+ K+    I+D G+A        T +      VGT  YMAPE  
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 185
Query: 468 ----AMEGLFSVK-SDVFSFGVIVLEI 489
                M+   S K +D+++ G++  EI
Sbjct: 186 DDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 116/261 (44%), Gaps = 40/261 (15%)
Query: 258 ELAGPISVSLTQEGDLVSSEELPFVHLAVIKAAT--------DGFSDSNKLGQGGFGTVY 309
           E  GP+          V+++     +LA++KA +        D +     +G G +G V 
Sbjct: 18  EPPGPVKAEPAHTAASVAAK-----NLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVS 72
Query: 310 KGVLP-NGKEVAVKRLSR------------KSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
                  G++VA+K++              +  + L+ FK++ I+  K    +++R    
Sbjct: 73  SARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK----DILRPTVP 128
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
             E +   ++ +LM    L   I  S+    L        +  + +GL Y+H     ++I
Sbjct: 129 YGEFKSVYVVLDLM-ESDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHS---AQVI 181
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN--TRRVVGTYGYMAPEYAME-GLF 473
           HRDLKPSN+L++++   KI DFGMAR  C +           V T  Y APE  +    +
Sbjct: 182 HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEY 241
Query: 474 SVKSDVFSFGVIVLEIISGKR 494
           +   D++S G I  E+++ ++
Sbjct: 242 TQAIDLWSVGCIFGEMLARRQ 262

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLS---RKSWQGLEEFKN-EIILIAKLQHRNLVRLVG 355
           +G+G FG V++G    G+EVAVK  S    +SW     F+  EI     L+H N++  + 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-----FREAEIYQTVMLRHENILGFIA 64
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED----- 410
              +         L+ +      +FD   R  +       +    + GL +LH +     
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT--RRVVGTYGYMAPEYA 468
            +  I HRDLK  N+L+ K+    I+D G+A        T +      VGT  YMAPE  
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 469 -----MEGLFSVK-SDVFSFGVIVLEI 489
                M+   S K +D+++ G++  EI
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLS---RKSWQGLEEFKN-EIILIAKLQHRNLVRLVG 355
           +G+G FG V++G    G+EVAVK  S    +SW     F+  EI     L+H N++  + 
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-----FREAEIYQTVMLRHENILGFIA 70
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED----- 410
              +         L+ +      +FD   R  +       +    + GL +LH +     
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT--RRVVGTYGYMAPEY- 467
            +  I HRDLK  N+L+ K+    I+D G+A        T +      VGT  YMAPE  
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 190
Query: 468 ----AMEGLFSVK-SDVFSFGVIVLEI 489
                M+   S K +D+++ G++  EI
Sbjct: 191 DDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLS---RKSWQGLEEFKN-EIILIAKLQHRNLVRLVG 355
           +G+G FG V++G    G+EVAVK  S    +SW     F+  EI     L+H N++  + 
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW-----FREAEIYQTVMLRHENILGFIA 67
Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED----- 410
              +         L+ +      +FD   R  +       +    + GL +LH +     
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT--RRVVGTYGYMAPEY- 467
            +  I HRDLK  N+L+ K+    I+D G+A        T +      VGT  YMAPE  
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 187
Query: 468 ----AMEGLFSVK-SDVFSFGVIVLEI 489
                M+   S K +D+++ G++  EI
Sbjct: 188 DDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 55/94 (58%), Gaps = 5/94 (5%)
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           IS GL +LH   +  II+RDLK  NV+LD +   KI+DFGM +    +  T  TR   GT
Sbjct: 129 ISIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVT--TREFCGT 183
Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y+APE      +    D +++GV++ E+++G+
Sbjct: 184 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFK---NEIILIAK 344
           A  D F     +G G FG V     +  G   A+K L ++    L++ +   NE  ++  
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           +    LV+L     +     ++ E MP   +    F   RR+ + +          I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+L+D+    K++DFG A+     +    T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFK---NEIILIAK 344
           A  D F     +G G FG V     +  G   A+K L ++    L++ +   NE  ++  
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           +    LV+L     +     ++ E MP   +    F   RR+ + +          I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+L+D+    K++DFG A+     +    T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 117/261 (44%), Gaps = 40/261 (15%)
Query: 258 ELAGPISVSLTQEGDLVSSEELPFVHLAVIKAAT--------DGFSDSNKLGQGGFGTVY 309
           E  GP+          V+++     +LA++KA +        D +     +G G +G V 
Sbjct: 17  EPPGPVKAEPAHTAASVAAK-----NLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVS 71
Query: 310 KGVLP-NGKEVAVKRL------------SRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
                  G++VA+K++            + +  + L+ FK++ I+  K    +++R    
Sbjct: 72  SARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK----DILRPTVP 127
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
             E +   ++ +LM    L   I  S+    L        +  + +GL Y+H     ++I
Sbjct: 128 YGEFKSVYVVLDLM-ESDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHS---AQVI 180
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN--TRRVVGTYGYMAPEYAME-GLF 473
           HRDLKPSN+L++++   KI DFGMAR  C +           V T  Y APE  +    +
Sbjct: 181 HRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEY 240
Query: 474 SVKSDVFSFGVIVLEIISGKR 494
           +   D++S G I  E+++ ++
Sbjct: 241 TQAIDLWSVGCIFGEMLARRQ 261

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 110/237 (46%), Gaps = 22/237 (9%)
Query: 285 AVIKAATDGFSDSNKLGQGGFGT-VYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIA 343
           +V+      F   + LG G  GT VY+G+  N ++VAVKR+  + +   +  +   +L  
Sbjct: 17  SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDN-RDVAVKRILPECFSFAD--REVQLLRE 73
Query: 344 KLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISK 402
             +H N++R      + + + +  EL    +L  ++   +   L L   T   ++   + 
Sbjct: 74  SDEHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPIT---LLQQTTS 129
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDK-----DMVAKISDFGMARIFCENQKTANTRR-V 456
           GL +LH    L I+HRDLKP N+L+        + A ISDFG+ +     + + + R  V
Sbjct: 130 GLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186
Query: 457 VGTYGYMAPEYAMEGLF---SVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLA 509
            GT G++APE   E      +   D+FS G +   +IS G    G  L   A  LL 
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLG 243

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 297 SNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLV 354
           S  LG+G +  V   V L NGKE AVK + +++         E+  + + Q ++N++ L+
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
               +     L++E +   S+   I   +++   N      ++  ++  L +LH      
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHI---QKQKHFNEREASRVVRDVAAALDFLHTKG--- 131
Query: 415 IIHRDLKPSNVLL---DKDMVAKISDFGMARIF-----CENQKTANTRRVVGTYGYMAPE 466
           I HRDLKP N+L    +K    KI DF +         C    T       G+  YMAPE
Sbjct: 132 IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPE 191
Query: 467 YA-----MEGLFSVKSDVFSFGVIVLEIISG 492
                      +  + D++S GV++  ++SG
Sbjct: 192 VVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFK---NEIILIAK 344
           A  D F     LG G FG V     +  G   A+K L ++    L+E +   NE  ++  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQA 97
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           +    LV+L     +     ++ E  P   +    F   RR+ + +          I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+++D+    K++DFG+A+     +    T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLCGTPEYL 205
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 57/99 (57%), Gaps = 10/99 (10%)
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I K L YL E  +  +IHRD+KPSN+LLD+    K+ DFG++    +++      R  G 
Sbjct: 133 IVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD---RSAGC 187
Query: 460 YGYMAPEY-----AMEGLFSVKSDVFSFGVIVLEIISGK 493
             YMAPE        +  + +++DV+S G+ ++E+ +G+
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 293 GFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNLV 351
            +++   +G G FG V++  L    EVA+K++ +      + FKN E+ ++  ++H N+V
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVV 95
Query: 352 RLVGC----GIEGEEKL--LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
            L       G + +E    L+ E +P          ++ +  +        +  + + L 
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
           Y+H    + I HRD+KP N+LLD    V K+ DFG A+I    +   N   +   Y Y A
Sbjct: 156 YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSXICSRY-YRA 209
Query: 465 PEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           PE       ++   D++S G ++ E++ G+
Sbjct: 210 PELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 90/172 (52%), Gaps = 25/172 (14%)
Query: 285 AVIK--AATDGFSDSNKLGQGGFGTVYKGVLPNG-KEVAVKRLSRKSWQGLEEFKN---E 338
           A+IK     D +   + +G+G +G VY     N  K VA+K+++R  ++ L + K    E
Sbjct: 19  AIIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNR-MFEDLIDCKRILRE 77
Query: 339 IILIAKLQHRNLVRLVGCGI-----EGEEKLLIYELMPNRSLDCF---IFDSERRLQLNW 390
           I ++ +L+   ++RL    I     + +E  ++ E+  +     F   IF +E+ ++   
Sbjct: 78  ITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVK--- 134
Query: 391 NTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR 442
              YN++ G      ++HE     IIHRDLKP+N LL++D   KI DFG+AR
Sbjct: 135 TILYNLLLGEK----FIHESG---IIHRDLKPANCLLNQDCSVKICDFGLAR 179

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 92/204 (45%), Gaps = 27/204 (13%)
Query: 300 LGQGGFGTVY--KGVLPNGKEVAVKRLSRKSWQG--LEEFKNEIILIAKLQHRNLVRLVG 355
           +G+G F  V   + +L  GKEVAVK + +       L++   E+ +   L H N+V+L  
Sbjct: 22  IGKGNFAKVKLARHIL-TGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFE 80
Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
             IE E+ L L+ E      +  ++    R  +      +     I   + Y H+     
Sbjct: 81  V-IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR---QIVSAVQYCHQKF--- 133
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
           I+HRDLK  N+LLD D   KI+DFG +  F    K        G   Y APE     LF 
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPE-----LFQ 185
Query: 475 VKS------DVFSFGVIVLEIISG 492
            K       DV+S GVI+  ++SG
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 15/169 (8%)
Query: 331 GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCF-----IFDSERR 385
           G    K EI L+ +L+H+N+++LV   +  EEK  +Y +M      C      + DS   
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDV-LYNEEKQKMYMVMEY----CVCGMQEMLDSVPE 103
Query: 386 LQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC 445
            +      +     +  GL YLH      I+H+D+KP N+LL      KIS  G+A    
Sbjct: 104 KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALH 160
Query: 446 ENQKTANTRRVVGTYGYMAPEYA--MEGLFSVKSDVFSFGVIVLEIISG 492
                   R   G+  +  PE A  ++     K D++S GV +  I +G
Sbjct: 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 26/213 (12%)
Query: 291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN 349
            D      +LG+G +G V K   +P+G+  AVKR+ R +    E+    ++    +  R 
Sbjct: 33  ADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRI-RATVNSQEQ--KRLLXDLDISXRT 89
Query: 350 L-----VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS--- 401
           +     V   G      +  +  EL  + SLD F    ++ +        +I+G I+   
Sbjct: 90  VDCPFTVTFYGALFREGDVWICXELX-DTSLDKFY---KQVIDKGQTIPEDILGKIAVSI 145
Query: 402 -KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
            K L +LH  S+L +IHRD+KPSNVL++     K  DFG++    ++          G  
Sbjct: 146 VKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDD---VAKDIDAGCK 200
Query: 461 GYMAPEYAMEGL----FSVKSDVFSFGVIVLEI 489
            Y APE     L    +SVKSD++S G+  +E+
Sbjct: 201 PYXAPERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFK---NEIILIAK 344
           A  D F     LG G FG V     +  G   A+K L ++    L+E +   NE  ++  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQA 97
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           +    LV+L     +     ++ E  P   +    F   RR+ + +          I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+++D+    +++DFG+A+     +    T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWXLCGTPEYL 205
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 130/290 (44%), Gaps = 47/290 (16%)
Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKEV-AVK--RLSRKSWQGLEEFKNEIILIAKLQHRN- 349
           +S   ++G GG   V++ VL   K++ A+K   L     Q L+ ++NEI  + KLQ  + 
Sbjct: 14  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 72
Query: 350 -LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL-YL 407
            ++RL    I  +    IY +M   ++D   +  +++    W           K +L  +
Sbjct: 73  KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWER-----KSYWKNMLEAV 124
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H   +  I+H DLKP+N L+   M+ K+ DFG+A     +  +      VGT  YM PE 
Sbjct: 125 HTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE- 182
Query: 468 AMEGLFSVKS------------DVFSFGVIVLEIISGKRNSGFYLTGHAQTL--LAYVWQ 513
           A++ + S +             DV+S G I+  +  GK       T   Q +  ++ +  
Sbjct: 183 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK-------TPFQQIINQISKLHA 235
Query: 514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA 563
           +     E+EF D   +    +  V++C      C++ DP  R ++  ++A
Sbjct: 236 IIDPNHEIEFPD---IPEKDLQDVLKC------CLKRDPKQRISIPELLA 276

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 93/200 (46%), Gaps = 17/200 (8%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEF--KNEIILIAKLQHRNLVRLVGC 356
           +LG G FG V++ V      V V +     +  L+++  KNEI ++ +L H  L+ L   
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFD--SERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
             +  E +LI E +    L    FD  +    +++     N +    +GL ++HE S   
Sbjct: 117 FEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS--- 169
Query: 415 IIHRDLKPSNVLLD--KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
           I+H D+KP N++ +  K    KI DFG+A     ++    T     T  + APE      
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT---TATAEFAAPEIVDREP 226
Query: 473 FSVKSDVFSFGVIVLEIISG 492
               +D+++ GV+   ++SG
Sbjct: 227 VGFYTDMWAIGVLGYVLLSG 246

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 77/315 (24%), Positives = 125/315 (39%), Gaps = 42/315 (13%)
Query: 274 VSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYK----GVLPN--GKEVAVKRLSRK 327
           +   +LP+ H    +   +  S    LG G FG V +    G++ +     VAVK L   
Sbjct: 7   IDPTQLPYDH--KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 64
Query: 328 S-WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYEL--------MPNRSLDC 377
           +     E   +E+ +++ L  H N+V L+G    G   L+I E            R  D 
Sbjct: 65  AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124
Query: 378 FIFDSERRLQLNWNTCYNIIGG-------ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD 430
           FI        +  +     +         ++KG+ +L   +    IHRDL   N+LL   
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHG 181
Query: 431 MVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEII 490
            + KI DFG+AR    +              +MAPE     +++ +SDV+S+G+ + E+ 
Sbjct: 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 491 SGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQE 550
           S    S  Y       + +  +++ KEG  M       +     P       I   C   
Sbjct: 242 S--LGSSPY---PGMPVDSKFYKMIKEGFRM-------LSPEHAP--AEMYDIMKTCWDA 287
Query: 551 DPAVRPTMSNVVALL 565
           DP  RPT   +V L+
Sbjct: 288 DPLKRPTFKQIVQLI 302

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFK---NEIILIAK 344
           A  D F     LG G FG V     +  G   A+K L ++    L++ +   NE  ++  
Sbjct: 24  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 83
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           +    LV+L     +     ++ E +P   +    F   RR+ + +          I   
Sbjct: 84  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 139
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+
Sbjct: 140 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYL 191
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 192 APEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 109/234 (46%), Gaps = 46/234 (19%)
Query: 292 DGFSDSNKLGQGGFGTVYKGVLPNG-KEVAVKRLSRKSWQGLEEFKN---EIILIAKLQH 347
           D +   + +G+G +G VY     N  K VA+K+++R  ++ L + K    EI ++ +L+ 
Sbjct: 26  DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-MFEDLIDCKRILREITILNRLKS 84
Query: 348 RNLVRLVGCGIEGE-----EKLLIYELMPNRSLDCF---IFDSERRLQLNWNTCYNIIGG 399
             ++RL    I  +     E  ++ E+  +     F   IF +E  ++      YN++ G
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIK---TILYNLLLG 141
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF--------------- 444
            +    ++HE     IIHRDLKP+N LL++D   K+ DFG+AR                 
Sbjct: 142 EN----FIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 445 ------CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKS-DVFSFGVIVLEIIS 491
                  +N K   T  VV T  Y APE  +      KS D++S G I  E+++
Sbjct: 195 EEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFK---NEIILIAK 344
           A  D F     +G G FG V     +  G   A+K L ++    L++ +   NE  ++  
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           +    LV+L     +     ++ E +P   +    F   RR+ + +          I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+L+D+    K++DFG A+     +    T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 130/290 (44%), Gaps = 47/290 (16%)
Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKEV-AVK--RLSRKSWQGLEEFKNEIILIAKLQHRN- 349
           +S   ++G GG   V++ VL   K++ A+K   L     Q L+ ++NEI  + KLQ  + 
Sbjct: 58  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 350 -LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL-YL 407
            ++RL    I  +    IY +M   ++D   +  +++    W           K +L  +
Sbjct: 117 KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWER-----KSYWKNMLEAV 168
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H   +  I+H DLKP+N L+   M+ K+ DFG+A     +  +      VGT  YM PE 
Sbjct: 169 HTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE- 226
Query: 468 AMEGLFSVKS------------DVFSFGVIVLEIISGKRNSGFYLTGHAQTL--LAYVWQ 513
           A++ + S +             DV+S G I+  +  GK       T   Q +  ++ +  
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK-------TPFQQIINQISKLHA 279
Query: 514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA 563
           +     E+EF D   +    +  V++C      C++ DP  R ++  ++A
Sbjct: 280 IIDPNHEIEFPD---IPEKDLQDVLKC------CLKRDPKQRISIPELLA 320

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 77/315 (24%), Positives = 125/315 (39%), Gaps = 42/315 (13%)
Query: 274 VSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYK----GVLPN--GKEVAVKRLSRK 327
           +   +LP+ H    +   +  S    LG G FG V +    G++ +     VAVK L   
Sbjct: 30  IDPTQLPYDH--KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 87
Query: 328 S-WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYEL--------MPNRSLDC 377
           +     E   +E+ +++ L  H N+V L+G    G   L+I E            R  D 
Sbjct: 88  AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 147
Query: 378 FIFDSERRLQLNWNTCYNIIGG-------ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD 430
           FI        +  +     +         ++KG+ +L   +    IHRDL   N+LL   
Sbjct: 148 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHG 204
Query: 431 MVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEII 490
            + KI DFG+AR    +              +MAPE     +++ +SDV+S+G+ + E+ 
Sbjct: 205 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 491 SGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQE 550
           S    S  Y       + +  +++ KEG  M       +     P       I   C   
Sbjct: 265 S--LGSSPY---PGMPVDSKFYKMIKEGFRM-------LSPEHAP--AEMYDIMKTCWDA 310
Query: 551 DPAVRPTMSNVVALL 565
           DP  RPT   +V L+
Sbjct: 311 DPLKRPTFKQIVQLI 325

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFK---NEIILIAK 344
           A  D F     LG G FG V     +  G   A+K L ++    L++ +   NE  ++  
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           +    LV+L     +     ++ E +P   +    F   RR+ + +          I   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 206
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFK---NEIILIAK 344
           A  D F     LG G FG V     +  G   A+K L ++    L++ +   NE  ++  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           +    LV+L     +     ++ E +P   +    F   RR+ + +          I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFK---NEIILIAK 344
           A  D F     LG G FG V     +  G   A+K L ++    L++ +   NE  ++  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           +    LV+L     +     ++ E +P   +    F   RR+ + +          I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFK---NEIILIAK 344
           A  D F     LG G FG V     +  G   A+K L ++    L++ +   NE  ++  
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           +    LV+L     +     ++ E +P   +    F   RR+ + +          I   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYL 206
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 77/315 (24%), Positives = 125/315 (39%), Gaps = 42/315 (13%)
Query: 274 VSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYK----GVLPN--GKEVAVKRLSRK 327
           +   +LP+ H    +   +  S    LG G FG V +    G++ +     VAVK L   
Sbjct: 30  IDPTQLPYDH--KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 87
Query: 328 S-WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYEL--------MPNRSLDC 377
           +     E   +E+ +++ L  H N+V L+G    G   L+I E            R  D 
Sbjct: 88  AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 147
Query: 378 FIFDSERRLQLNWNTCYNIIGG-------ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD 430
           FI        +  +     +         ++KG+ +L   +    IHRDL   N+LL   
Sbjct: 148 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHG 204
Query: 431 MVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEII 490
            + KI DFG+AR    +              +MAPE     +++ +SDV+S+G+ + E+ 
Sbjct: 205 RITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 264
Query: 491 SGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQE 550
           S    S  Y       + +  +++ KEG  M       +     P       I   C   
Sbjct: 265 S--LGSSPY---PGMPVDSKFYKMIKEGFRM-------LSPEHAP--AEMYDIMKTCWDA 310
Query: 551 DPAVRPTMSNVVALL 565
           DP  RPT   +V L+
Sbjct: 311 DPLKRPTFKQIVQLI 325

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 130/290 (44%), Gaps = 47/290 (16%)
Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKEV-AVK--RLSRKSWQGLEEFKNEIILIAKLQHRN- 349
           +S   ++G GG   V++ VL   K++ A+K   L     Q L+ ++NEI  + KLQ  + 
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 350 -LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL-YL 407
            ++RL    I  +    IY +M   ++D   +  +++    W           K +L  +
Sbjct: 89  KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWER-----KSYWKNMLEAV 140
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H   +  I+H DLKP+N L+   M+ K+ DFG+A     +  +      VGT  YM PE 
Sbjct: 141 HTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE- 198
Query: 468 AMEGLFSVKS------------DVFSFGVIVLEIISGKRNSGFYLTGHAQTL--LAYVWQ 513
           A++ + S +             DV+S G I+  +  GK       T   Q +  ++ +  
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK-------TPFQQIINQISKLHA 251
Query: 514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA 563
           +     E+EF D   +    +  V++C      C++ DP  R ++  ++A
Sbjct: 252 IIDPNHEIEFPD---IPEKDLQDVLKC------CLKRDPKQRISIPELLA 292

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 130/290 (44%), Gaps = 47/290 (16%)
Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKEV-AVK--RLSRKSWQGLEEFKNEIILIAKLQHRN- 349
           +S   ++G GG   V++ VL   K++ A+K   L     Q L+ ++NEI  + KLQ  + 
Sbjct: 10  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 68
Query: 350 -LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL-YL 407
            ++RL    I  +    IY +M   ++D   +  +++    W           K +L  +
Sbjct: 69  KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWER-----KSYWKNMLEAV 120
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H   +  I+H DLKP+N L+   M+ K+ DFG+A     +  +      VGT  YM PE 
Sbjct: 121 HTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE- 178
Query: 468 AMEGLFSVKS------------DVFSFGVIVLEIISGKRNSGFYLTGHAQTL--LAYVWQ 513
           A++ + S +             DV+S G I+  +  GK       T   Q +  ++ +  
Sbjct: 179 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK-------TPFQQIINQISKLHA 231
Query: 514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA 563
           +     E+EF D   +    +  V++C      C++ DP  R ++  ++A
Sbjct: 232 IIDPNHEIEFPD---IPEKDLQDVLKC------CLKRDPKQRISIPELLA 272

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 77/315 (24%), Positives = 125/315 (39%), Gaps = 42/315 (13%)
Query: 274 VSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYK----GVLPN--GKEVAVKRLSRK 327
           +   +LP+ H    +   +  S    LG G FG V +    G++ +     VAVK L   
Sbjct: 25  IDPTQLPYDH--KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 82
Query: 328 S-WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYEL--------MPNRSLDC 377
           +     E   +E+ +++ L  H N+V L+G    G   L+I E            R  D 
Sbjct: 83  AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 142
Query: 378 FIFDSERRLQLNWNTCYNIIGG-------ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD 430
           FI        +  +     +         ++KG+ +L   +    IHRDL   N+LL   
Sbjct: 143 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHG 199
Query: 431 MVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEII 490
            + KI DFG+AR    +              +MAPE     +++ +SDV+S+G+ + E+ 
Sbjct: 200 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 259
Query: 491 SGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQE 550
           S    S  Y       + +  +++ KEG  M       +     P       I   C   
Sbjct: 260 S--LGSSPY---PGMPVDSKFYKMIKEGFRM-------LSPEHAP--AEMYDIMKTCWDA 305
Query: 551 DPAVRPTMSNVVALL 565
           DP  RPT   +V L+
Sbjct: 306 DPLKRPTFKQIVQLI 320

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 94/209 (44%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFK---NEIILIAK 344
           A  D F     LG G FG V     +  G   A+K L ++    L++ +   NE  ++  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           +    LV+L     +     ++ E +P   +    F   RR+ + +          I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFK---NEIILIAK 344
           A  D F     LG G FG V     +  G   A+K L ++    L++ +   NE  ++  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           +    LV+L     +     ++ E  P   +    F   RR+ + +          I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+++D+    K++DFG A+     +    T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 103/209 (49%), Gaps = 17/209 (8%)
Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFK-NEIILIAKLQHRNLVRLVGCG 357
           K+G+G +G VYK    +GK+     L +    G+      EI L+ +L+H N++ L    
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 358 IEGEEK--LLIYELMPNRSLDCFIFD-----SERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +   ++   L+++   +       F      +++ +QL      +++  I  G+ YLH +
Sbjct: 88  LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 147
Query: 411 SRLKIIHRDLKPSNVLL----DKDMVAKISDFGMARIFCENQKT-ANTRRVVGTYGYMAP 465
               ++HRDLKP+N+L+     +    KI+D G AR+F    K  A+   VV T+ Y AP
Sbjct: 148 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 204
Query: 466 EYAMEGLFSVKS-DVFSFGVIVLEIISGK 493
           E  +      K+ D+++ G I  E+++ +
Sbjct: 205 ELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 81/160 (50%), Gaps = 12/160 (7%)
Query: 379 IFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDF 438
           +F  +R+ +L           IS  L YLHE     II+RDLK  NVLLD +   K++D+
Sbjct: 141 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 197
Query: 439 GMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGF 498
           GM +       T +T    GT  Y+APE      +    D ++ GV++ E+++G+  S F
Sbjct: 198 GMCKEGLRPGDTTST--FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR--SPF 253
Query: 499 YLTGHA----QTLLAYVWQLWKEGKEMEFVDPLLMKSSSI 534
            + G +    Q    Y++Q+  E K++     L +K++S+
Sbjct: 254 DIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKAASV 292

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 77/315 (24%), Positives = 125/315 (39%), Gaps = 42/315 (13%)
Query: 274 VSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYK----GVLPN--GKEVAVKRLSRK 327
           +   +LP+ H    +   +  S    LG G FG V +    G++ +     VAVK L   
Sbjct: 23  IDPTQLPYDH--KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS 80
Query: 328 S-WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYEL--------MPNRSLDC 377
           +     E   +E+ +++ L  H N+V L+G    G   L+I E            R  D 
Sbjct: 81  AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 140
Query: 378 FIFDSERRLQLNWNTCYNIIGG-------ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD 430
           FI        +  +     +         ++KG+ +L   +    IHRDL   N+LL   
Sbjct: 141 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHG 197
Query: 431 MVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEII 490
            + KI DFG+AR    +              +MAPE     +++ +SDV+S+G+ + E+ 
Sbjct: 198 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 257
Query: 491 SGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQE 550
           S    S  Y       + +  +++ KEG  M       +     P       I   C   
Sbjct: 258 S--LGSSPY---PGMPVDSKFYKMIKEGFRM-------LSPEHAP--AEMYDIMKTCWDA 303
Query: 551 DPAVRPTMSNVVALL 565
           DP  RPT   +V L+
Sbjct: 304 DPLKRPTFKQIVQLI 318

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 26/221 (11%)
Query: 286 VIKAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLS--RKSWQGLEEFKNEIILI 342
           ++   +  F   + LG+G +G V      P G+ VA+K++    K    L   + EI ++
Sbjct: 5   IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKIL 63
Query: 343 AKLQHRNLVRLVGCGIEGE-----EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNII 397
              +H N++ +             E  +I ELM          D  R +     +  +I 
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT--------DLHRVISTQMLSDDHIQ 115
Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--------K 449
             I + L  +       +IHRDLKPSN+L++ +   K+ DFG+ARI  E+         +
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 450 TANTRRVVGTYGYMAPEYAM-EGLFSVKSDVFSFGVIVLEI 489
            +     V T  Y APE  +    +S   DV+S G I+ E+
Sbjct: 176 QSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 26/221 (11%)
Query: 286 VIKAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLS--RKSWQGLEEFKNEIILI 342
           ++   +  F   + LG+G +G V      P G+ VA+K++    K    L   + EI ++
Sbjct: 5   IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKIL 63
Query: 343 AKLQHRNLVRLVGCGIEGE-----EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNII 397
              +H N++ +             E  +I ELM          D  R +     +  +I 
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT--------DLHRVISTQMLSDDHIQ 115
Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--------K 449
             I + L  +       +IHRDLKPSN+L++ +   K+ DFG+ARI  E+         +
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 450 TANTRRVVGTYGYMAPEYAM-EGLFSVKSDVFSFGVIVLEI 489
            +     V T  Y APE  +    +S   DV+S G I+ E+
Sbjct: 176 QSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 130/290 (44%), Gaps = 47/290 (16%)
Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKEV-AVK--RLSRKSWQGLEEFKNEIILIAKLQHRN- 349
           +S   ++G GG   V++ VL   K++ A+K   L     Q L+ ++NEI  + KLQ  + 
Sbjct: 11  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 350 -LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL-YL 407
            ++RL    I  +    IY +M   ++D   +  +++    W           K +L  +
Sbjct: 70  KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWER-----KSYWKNMLEAV 121
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H   +  I+H DLKP+N L+   M+ K+ DFG+A     +  +      VGT  YM PE 
Sbjct: 122 HTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE- 179
Query: 468 AMEGLFSVKS------------DVFSFGVIVLEIISGKRNSGFYLTGHAQTL--LAYVWQ 513
           A++ + S +             DV+S G I+  +  GK       T   Q +  ++ +  
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK-------TPFQQIINQISKLHA 232
Query: 514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA 563
           +     E+EF D   +    +  V++C      C++ DP  R ++  ++A
Sbjct: 233 IIDPNHEIEFPD---IPEKDLQDVLKC------CLKRDPKQRISIPELLA 273

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 128/285 (44%), Gaps = 47/285 (16%)
Query: 299 KLGQGGFGTVYKGVLPNGKEV-AVK--RLSRKSWQGLEEFKNEIILIAKLQHRN--LVRL 353
           ++G GG   V++ VL   K++ A+K   L     Q L+ ++NEI  + KLQ  +  ++RL
Sbjct: 63  QIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL-YLHEDSR 412
               I  +    IY +M   ++D   +  +++    W           K +L  +H   +
Sbjct: 122 YDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWER-----KSYWKNMLEAVHTIHQ 173
Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
             I+H DLKP+N L+   M+ K+ DFG+A     +  +      VGT  YM PE A++ +
Sbjct: 174 HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE-AIKDM 231
Query: 473 FSVKS------------DVFSFGVIVLEIISGKRNSGFYLTGHAQTL--LAYVWQLWKEG 518
            S +             DV+S G I+  +  GK       T   Q +  ++ +  +    
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK-------TPFQQIINQISKLHAIIDPN 284
Query: 519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA 563
            E+EF D   +    +  V++C      C++ DP  R ++  ++A
Sbjct: 285 HEIEFPD---IPEKDLQDVLKC------CLKRDPKQRISIPELLA 320

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 292 DGFSDSNKLGQGGFGTVYK-GVLPNGKEVAVKR-LSRKSWQGLEEFK-NEIILIAKLQHR 348
           + +    K+G+G +G V+K      G+ VA+K+ L  +    +++    EI ++ +L+H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 349 NLVRLVGCGIEGEEKLLIYELMPN---RSLDCFIFDSERRL--QLNWNTCYNIIGGISKG 403
           NLV L+          L++E   +     LD +       L   + W T         + 
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTL--------QA 114
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           + + H+ +    IHRD+KP N+L+ K  V K+ DFG AR+        +    V T  Y 
Sbjct: 115 VNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYR 169
Query: 464 APEYAM-EGLFSVKSDVFSFGVIVLEIISG 492
           +PE  + +  +    DV++ G +  E++SG
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFK---NEIILIAK 344
           A  D F     LG G FG V     +  G   A+K L ++    L++ +   NE  ++  
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           +    LV+L     +     ++ E +P   +    F   RR+ +            I   
Sbjct: 99  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVLT 154
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+
Sbjct: 155 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 206
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFK---NEIILIAK 344
           A  D F     LG G FG V     +  G   A+K L ++    L++ +   NE  ++  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           +    LV+L     +     ++ E +P   +    F   RR+ +            I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVLT 153
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFK---NEIILIAK 344
           A  D F     LG G FG V     +  G   A+K L ++    L++ +   NE  ++  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           +    LV+L     +     ++ E  P   +    F   RR+ +            I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFYAAQIVLT 153
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+++D+    K++DFG A+     +    T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFK---NEIILIAK 344
           A  D F     LG G FG V     +  G   A+K L ++    L++ +   NE  ++  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           +    LV+L     +     ++ E +P   +    F   RR+ +            I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQIVLT 153
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 96/221 (43%), Gaps = 26/221 (11%)
Query: 286 VIKAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLS--RKSWQGLEEFKNEIILI 342
           ++   +  F   + LG+G +G V      P G+ VA+K++    K    L   + EI ++
Sbjct: 5   IVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKIL 63
Query: 343 AKLQHRNLVRLVGCGIEGE-----EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNII 397
              +H N++ +             E  +I ELM          D  R +     +  +I 
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT--------DLHRVISTQMLSDDHIQ 115
Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--------K 449
             I + L  +       +IHRDLKPSN+L++ +   K+ DFG+ARI  E+         +
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 450 TANTRRVVGTYGYMAPEYAM-EGLFSVKSDVFSFGVIVLEI 489
            +     V T  Y APE  +    +S   DV+S G I+ E+
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 300 LGQGGFGTVYKG-VLPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKL----QHR 348
           LG+GGFGTV+ G  L +  +VA+K + R    G     +      E+ L+ K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 349 NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSER-RLQLNWNTCYNIIGGISKGLLYL 407
            ++RL+    E +E  ++    P  + D F + +E+  L    + C+   G +   + + 
Sbjct: 99  GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCF--FGQVVAAIQHC 155
Query: 408 HEDSRLKIIHRDLKPSNVLLD-KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           H      ++HRD+K  N+L+D +   AK+ DFG   +  +   T       GT  Y  PE
Sbjct: 156 HSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD----GTRVYSPPE 208
Query: 467 Y-AMEGLFSVKSDVFSFGVIVLEIISG 492
           + +     ++ + V+S G+++ +++ G
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVK-----RLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +G+G F  V + +    G++ AVK     + +       E+ K E  +   L+H ++V L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +          +++E M    L CF  +  ++     +     + +  I + L Y H+++
Sbjct: 92  LETYSSDGMLYMVFEFMDGADL-CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150
Query: 412 RLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
              IIHRD+KP  VLL   +     K+  FG+A    E+   A  R  VGT  +MAPE  
Sbjct: 151 ---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPEVV 205
Query: 469 MEGLFSVKSDVFSFGVIVLEIISG 492
               +    DV+  GVI+  ++SG
Sbjct: 206 KREPYGKPVDVWGCGVILFILLSG 229

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 73/290 (25%), Positives = 129/290 (44%), Gaps = 47/290 (16%)
Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKEV-AVK--RLSRKSWQGLEEFKNEIILIAKLQHRN- 349
           +S   ++G GG   V++ VL   K++ A+K   L     Q L+ ++NEI  + KLQ  + 
Sbjct: 30  YSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88
Query: 350 -LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL-YL 407
            ++RL    I  +    IY +M   ++D   +  +++    W           K +L  +
Sbjct: 89  KIIRLYDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWER-----KSYWKNMLEAV 140
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H   +  I+H DLKP+N L+   M+ K+ DFG+A     +         VGT  YM PE 
Sbjct: 141 HTIHQHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPE- 198
Query: 468 AMEGLFSVKS------------DVFSFGVIVLEIISGKRNSGFYLTGHAQTL--LAYVWQ 513
           A++ + S +             DV+S G I+  +  GK       T   Q +  ++ +  
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK-------TPFQQIINQISKLHA 251
Query: 514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA 563
           +     E+EF D   +    +  V++C      C++ DP  R ++  ++A
Sbjct: 252 IIDPNHEIEFPD---IPEKDLQDVLKC------CLKRDPKQRISIPELLA 292

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVK-----RLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +G+G F  V + +    G++ AVK     + +       E+ K E  +   L+H ++V L
Sbjct: 34  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 93
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCF--IFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +          +++E M    L CF  +  ++     +     + +  I + L Y H+++
Sbjct: 94  LETYSSDGMLYMVFEFMDGADL-CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 152
Query: 412 RLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
              IIHRD+KP  VLL   +     K+  FG+A    E+   A  R  VGT  +MAPE  
Sbjct: 153 ---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGTPHFMAPEVV 207
Query: 469 MEGLFSVKSDVFSFGVIVLEIISG 492
               +    DV+  GVI+  ++SG
Sbjct: 208 KREPYGKPVDVWGCGVILFILLSG 231

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLPNGKEV----AVKRLSRKSWQGLEEFK---NEIIL 341
           A  D F     LG G FG V   +L   KE     A+K L ++    L++ +   NE  +
Sbjct: 31  AHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 87
Query: 342 IAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGI 400
           +  +    LV+L     +     ++ E +P   +    F   RR+ + +          I
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQI 143
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
                YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT 
Sbjct: 144 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 195
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            Y+APE  +   ++   D ++ GV++ E+ +G
Sbjct: 196 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 37/210 (17%)
Query: 300 LGQGGFGTVYKGVLPNGKEV--AVKRLSRKSWQGLEEFKNEI----ILIAKLQHRNLVRL 353
           +G+G FG V        +EV  AVK L +K+    +E K+ +    +L+  ++H  LV L
Sbjct: 46  IGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 354 VGCGIEGEEKL-----------LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
                +  +KL           L Y L   R   CF+   E R +            I+ 
Sbjct: 105 -HFSFQTADKLYFVLDYINGGELFYHLQRER---CFL---EPRARF-------YAAEIAS 150
Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
            L YLH    L I++RDLKP N+LLD      ++DFG+ +   E+  T +T    GT  Y
Sbjct: 151 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEY 205
Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           +APE   +  +    D +  G ++ E++ G
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 35/215 (16%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCG 357
           L +GGF  VY+   + +G+E A+KRL     +       E+  + KL  H N+V+     
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 358 IEGEEK--------LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
             G+E+        LL+ EL   + ++ F+   E R  L+ +T   I     + + ++H 
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVE-FLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA---------------RIFCENQKTANTR 454
             +  IIHRDLK  N+LL      K+ DFG A               R   E + T NT 
Sbjct: 155 Q-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT- 212
Query: 455 RVVGTYGYMAPEYA-MEGLFSV--KSDVFSFGVIV 486
               T  Y  PE   +   F +  K D+++ G I+
Sbjct: 213 ----TPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLPNGKEV----AVKRLSRKSWQGLEEFK---NEIIL 341
           A  D F     LG G FG V   +L   KE     A+K L ++    L++ +   NE  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 342 IAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGI 400
           +  +    LV+L     +     ++ E +P   +    F   RR+ + +          I
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQI 151
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
                YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT 
Sbjct: 152 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 203
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            Y+APE  +   ++   D ++ GV++ E+ +G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLPNGKEV----AVKRLSRKSWQGLEEFK---NEIIL 341
           A  D F     LG G FG V   +L   KE     A+K L ++    L++ +   NE  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 342 IAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGI 400
           +  +    LV+L     +     ++ E +P   +    F   RR+ + +          I
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQI 151
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
                YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT 
Sbjct: 152 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 203
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            Y+APE  +   ++   D ++ GV++ E+ +G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFK---NEIILIAK 344
           A  D F     LG G FG V     +  G   A+K L ++    L++ +   NE  ++  
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           +    LV+L     +     ++ E  P   +    F   RR+ + +          I   
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+++D+    +++DFG A+     +    T  + GT  Y+
Sbjct: 154 FEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 205
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLPNGKEV----AVKRLSRKSWQGLEEFK---NEIIL 341
           A  D F     LG G FG V   +L   KE     A+K L ++    L++ +   NE  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 342 IAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGI 400
           +  +    LV+L     +     ++ E  P   +    F   RR+ + +          I
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQI 151
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
                YLH    L +I+RDLKP N+++D+    K++DFG A+     +    T  + GT 
Sbjct: 152 VLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTP 203
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            Y+APE  +   ++   D ++ GV++ E+ +G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLPNGKEV----AVKRLSRKSWQGLEEFK---NEIIL 341
           A  D F     LG G FG V   +L   KE     A+K L ++    L++ +   NE  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 342 IAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGI 400
           +  +    LV+L     +     ++ E +P   +    F   RR+ + +          I
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQI 150
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
                YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT 
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            Y+APE  +   ++   D ++ GV++ E+ +G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLPNGKEV----AVKRLSRKSWQGLEEFK---NEIIL 341
           A  D F     LG G FG V   +L   KE     A+K L ++    L++ +   NE  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 342 IAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGI 400
           +  +    LV+L     +     ++ E +P   +    F   RR+ + +          I
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQI 151
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
                YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT 
Sbjct: 152 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 203
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            Y+APE  +   ++   D ++ GV++ E+ +G
Sbjct: 204 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLPNGKEV----AVKRLSRKSWQGLEEFK---NEIIL 341
           A  D F     LG G FG V   +L   KE     A+K L ++    L++ +   NE  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 342 IAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGI 400
           +  +    LV+L     +     ++ E +P   +    F   RR+ + +          I
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQI 150
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
                YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT 
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            Y+APE  +   ++   D ++ GV++ E+ +G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 84/323 (26%), Positives = 132/323 (40%), Gaps = 54/323 (16%)
Query: 278 ELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKE-VAVKRLSRKSWQGLEEFK 336
           ++P +H       +D +     +G G FG          KE VAVK + R +    E  +
Sbjct: 12  DMPIMH------DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID-ENVQ 64
Query: 337 NEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNI 396
            EII    L+H N+VR     +      +I E      L   I ++ R    + +     
Sbjct: 65  REIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR---FSEDEARFF 121
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVA--KISDFGMARIFCENQKTANTR 454
              +  G+ Y H    ++I HRDLK  N LLD       KI DFG ++    + +  +T 
Sbjct: 122 FQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 177
Query: 455 RVVGTYGYMAPEYAMEGLFSVK-SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
             VGT  Y+APE  +   +  K +DV+S GV +  ++ G                AY ++
Sbjct: 178 --VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG----------------AYPFE 219
Query: 514 LWKEGKEM-EFVDPLLMKSSSIPQVVR----CIHIGLLCVQEDPAVRPT----------M 558
             +E ++  + +  +L    SIP  +R    C H+       DPA R +          +
Sbjct: 220 DPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFL 279
Query: 559 SNVVALLGSES---IALSEPRQP 578
            N+ A L +ES       EP QP
Sbjct: 280 KNLPADLMNESNTGSQFQEPEQP 302

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 103/228 (45%), Gaps = 43/228 (18%)
Query: 300 LGQGGFGTV-YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-----QHRNLVRL 353
           LG G  GTV ++G    G+ VAVKR+       L +F +  ++  KL      H N++R 
Sbjct: 41  LGYGSSGTVVFQGSF-QGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRY 92
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFI-----FDSERRLQLNWNTCYNIIGGISKGLLYLH 408
             C    +  L I   + N +L   +      D   +LQ  +N   +++  I+ G+ +LH
Sbjct: 93  Y-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHLH 150
Query: 409 EDSRLKIIHRDLKPSNVLL--------DKDMVAK-----ISDFGMARIFCENQKT--ANT 453
               LKIIHRDLKP N+L+        D+   A+     ISDFG+ +     Q     N 
Sbjct: 151 S---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 454 RRVVGTYGYMAPEYAMEGL---FSVKSDVFSFGVIVLEIIS-GKRNSG 497
               GT G+ APE   E      +   D+FS G +   I+S GK   G
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 255

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLPNGKEV----AVKRLSRKSWQGLEEFK---NEIIL 341
           A  D F     LG G FG V   +L   KE     A+K L ++    L++ +   NE  +
Sbjct: 59  AHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 115
Query: 342 IAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGI 400
           +  +    LV+L     +     ++ E +P   +    F   RR+ + +          I
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQI 171
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
                YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT 
Sbjct: 172 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 223
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            Y+APE  +   ++   D ++ GV++ E+ +G
Sbjct: 224 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLPNGKEV----AVKRLSRKSWQGLEEFK---NEIIL 341
           A  D F     LG G FG V   +L   KE     A+K L ++    L++ +   NE  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 342 IAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGI 400
           +  +    LV+L     +     ++ E +P   +    F   RR+ + +          I
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQI 150
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
                YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT 
Sbjct: 151 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 202
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            Y+APE  +   ++   D ++ GV++ E+ +G
Sbjct: 203 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 103/228 (45%), Gaps = 43/228 (18%)
Query: 300 LGQGGFGTV-YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-----QHRNLVRL 353
           LG G  GTV ++G    G+ VAVKR+       L +F +  ++  KL      H N++R 
Sbjct: 41  LGYGSSGTVVFQGSF-QGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRY 92
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFI-----FDSERRLQLNWNTCYNIIGGISKGLLYLH 408
             C    +  L I   + N +L   +      D   +LQ  +N   +++  I+ G+ +LH
Sbjct: 93  Y-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHLH 150
Query: 409 EDSRLKIIHRDLKPSNVLL--------DKDMVAK-----ISDFGMARIFCENQKT--ANT 453
               LKIIHRDLKP N+L+        D+   A+     ISDFG+ +     Q     N 
Sbjct: 151 S---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 207
Query: 454 RRVVGTYGYMAPEYAMEGL---FSVKSDVFSFGVIVLEIIS-GKRNSG 497
               GT G+ APE   E      +   D+FS G +   I+S GK   G
Sbjct: 208 NNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 255

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 289 AATDGFSDSNKLGQGGFGTVYKGVLPNGKEV----AVKRLSRKSWQGLEEFK---NEIIL 341
           A  D F     LG G FG V   +L   KE     A+K L ++    L++ +   NE  +
Sbjct: 31  AHLDQFERIKTLGTGSFGRV---MLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 87
Query: 342 IAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGI 400
           +  +    LV+L     +     ++ E +P   +    F   RR+ +            I
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFYAAQI 143
Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
                YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT 
Sbjct: 144 VLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTP 195
Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            Y+APE  +   ++   D ++ GV++ E+ +G
Sbjct: 196 EYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 68/277 (24%), Positives = 117/277 (42%), Gaps = 36/277 (12%)
Query: 294 FSDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL----QHR 348
           F   ++LG G +G V+K     +G+  AVKR S   ++G ++   ++  +       QH 
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 349 NLVRLVGCGIEGEEKLLIYELM-PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
             VRL     EG    L  EL  P+    C  + +       W    + +      L +L
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTL----LALAHL 173
Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H      ++H D+KP+N+ L      K+ DFG   +  E           G   YMAPE 
Sbjct: 174 HSQG---LVHLDVKPANIFLGPRGRCKLGDFG---LLVELGTAGAGEVQEGDPRYMAPEL 227
Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL 527
            ++G +   +DVFS G+ +LE+     N      G         WQ  ++G    ++ P 
Sbjct: 228 -LQGSYGTAADVFSLGLTILEVAC---NMELPHGGEG-------WQQLRQG----YLPPE 272
Query: 528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL 564
              ++ +   +R + +  + ++ DP +R T   ++AL
Sbjct: 273 F--TAGLSSELRSVLV--MMLEPDPKLRATAEALLAL 305

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFK---NEIILIAK 344
           A  D F     LG G FG V     +  G   A+K L ++    L++ +   NE  ++  
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           +    L +L     +     ++ E  P   +    F   RR+ + +          I   
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+++D+    K++DFG A+     +    T  + GT  Y+
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYL 206
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 104/232 (44%), Gaps = 47/232 (20%)
Query: 300 LGQGGFGTV-YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-----QHRNLVRL 353
           LG G  GTV ++G    G+ VAVKR+       L +F +  ++  KL      H N++R 
Sbjct: 23  LGYGSSGTVVFQGSF-QGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFI-----FDSERRLQLNWNTCYNIIGGISKGLLYLH 408
             C    +  L I   + N +L   +      D   +LQ  +N   +++  I+ G+ +LH
Sbjct: 75  Y-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHLH 132
Query: 409 EDSRLKIIHRDLKPSNVLL--------DKDMVAK-----ISDFGMARIFCENQKT--ANT 453
               LKIIHRDLKP N+L+        D+   A+     ISDFG+ +     Q +   N 
Sbjct: 133 S---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 454 RRVVGTYGYMAPEYAMEG-------LFSVKSDVFSFGVIVLEIIS-GKRNSG 497
               GT G+ APE   E          +   D+FS G +   I+S GK   G
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFK---NEIILIAK 344
           A  D F     LG G FG V     +  G   A+K L ++    L++ +   NE  ++  
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           +    L +L     +     ++ E  P   +    F   RR+ + +          I   
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+++D+    K++DFG A+     +    T  + GT  Y+
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYL 206
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I   L YLH  S   +++RDLK  N++LDKD   KI+DFG+ +   ++  T  T    GT
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGT 312
Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 379 IFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDF 438
           +F  +R+ +L           IS  L YLHE     II+RDLK  NVLLD +   K++D+
Sbjct: 98  MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 154
Query: 439 GMARIFCENQKTANTRRVV-GTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSG 497
           GM +   E  +  +T     GT  Y+APE      +    D ++ GV++ E+++G+  S 
Sbjct: 155 GMCK---EGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR--SP 209
Query: 498 FYLTGHA----QTLLAYVWQLWKEGKEMEFVDPLLMKSSSI 534
           F + G +    Q    Y++Q+  E K++     L +K++S+
Sbjct: 210 FDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKAASV 249

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 379 IFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDF 438
           +F  +R+ +L           IS  L YLHE     II+RDLK  NVLLD +   K++D+
Sbjct: 94  MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 150
Query: 439 GMARIFCENQKTANTRRVV-GTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSG 497
           GM +   E  +  +T     GT  Y+APE      +    D ++ GV++ E+++G+  S 
Sbjct: 151 GMCK---EGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR--SP 205
Query: 498 FYLTGHA----QTLLAYVWQLWKEGKEMEFVDPLLMKSSSI 534
           F + G +    Q    Y++Q+  E K++     L +K++S+
Sbjct: 206 FDIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSLSVKAASV 245

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I   L YLH  S   +++RDLK  N++LDKD   KI+DFG+ +   ++  T  T    GT
Sbjct: 260 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGT 315
Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 316 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 119/256 (46%), Gaps = 35/256 (13%)
Query: 297 SNKLGQGGFGTVYKGVLPN-GKEVAVKRLS--RKSWQGLEEFKNEIILI--AKLQHRNLV 351
           S +LG+G F  V + +  + G+E A K L   R+      E  +EI ++  AK   R ++
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR-VI 92
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            L        E +LI E      +       E    ++ N    +I  I +G+ YLH+++
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCL-PELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 412 RLKIIHRDLKPSNVLLDK-----DMVAKISDFGMARIF---CENQKTANTRRVVGTYGYM 463
              I+H DLKP N+LL       D+  KI DFGM+R     CE       R ++GT  Y+
Sbjct: 152 ---IVHLDLKPQNILLSSIYPLGDI--KIVDFGMSRKIGHACE------LREIMGTPEYL 200
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIIS------GKRNSGFYLTGHAQTLLAYVWQLWKE 517
           APE       +  +D+++ G+I   +++      G+ N   YL   +Q  + Y  + +  
Sbjct: 201 APEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI-SQVNVDYSEETFSS 259
Query: 518 GKEM--EFVDPLLMKS 531
             ++  +F+  LL+K+
Sbjct: 260 VSQLATDFIQSLLVKN 275

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN-QKTANTRRVVG 458
           I+ GL +L       II+RDLK  NV+LD +   KI+DFGM +   EN      T+   G
Sbjct: 451 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCG 504
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           T  Y+APE      +    D ++FGV++ E+++G+
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 28/213 (13%)
Query: 291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN 349
           TDG+     +G G +    + +      E AVK + +      EE +   IL+   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFI----FDSERRLQLNWNTCYNIIGGISKGLL 405
           ++ L     +G+   ++ ELM    L   I    F SER           ++  I+K + 
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSERE-------ASAVLFTITKTVE 130
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDM----VAKISDFGMARIFCENQKTANTRRVVGTY- 460
           YLH      ++HRDLKPSN+L   +       +I DFG    F +  +  N   +   Y 
Sbjct: 131 YLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFG----FAKQLRAENGLLMTPCYT 183
Query: 461 -GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
             ++APE      +    D++S GV++  +++G
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKS-----W---QGLEEFKNEIILIAK 344
           +S  + LG G FG V+  V     KEV VK + ++      W     L +   EI ++++
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           ++H N+++++    E +    +        LD F F  +R  +L+      I   +   +
Sbjct: 86  VEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAF-IDRHPRLDEPLASYIFRQLVSAV 143
Query: 405 LYLHEDSRLK-IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
            YL    RLK IIHRD+K  N+++ +D   K+ DFG A  + E  K   T    GT  Y 
Sbjct: 144 GYL----RLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA-YLERGKLFYT--FCGTIEYC 196
Query: 464 APEYAMEGLF-SVKSDVFSFGVIVLEII 490
           APE  M   +   + +++S GV +  ++
Sbjct: 197 APEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 298 NKLGQGGFGTV--YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVG 355
            KLG+GGF  V   +G L +G   A+KR+     Q  EE + E  +     H N++RLV 
Sbjct: 35  QKLGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 356 -CGIEGEEKLLIYELMPNRSLDCFIFDSER-RLQLNWNTCYNIIG---GISKGLLYLHED 410
            C  E   K   + L+P         + ER + + N+ T   I+    GI +GL  +H  
Sbjct: 94  YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153
Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFG---MARIFCENQKTANTRRVVG----TYGYM 463
                 HRDLKP+N+LL  +    + D G    A I  E  + A T +       T  Y 
Sbjct: 154 G---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210
Query: 464 APEYAMEGLFSVKS--------DVFSFGVIVLEIISGK 493
           APE     LFSV+S        DV+S G ++  ++ G+
Sbjct: 211 APE-----LFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 12/160 (7%)
Query: 379 IFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDF 438
           +F  +R+ +L           IS  L YLHE     II+RDLK  NVLLD +   K++D+
Sbjct: 109 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 165
Query: 439 GMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGF 498
           GM +       T  T    GT  Y+APE      +    D ++ GV++ E+++G+  S F
Sbjct: 166 GMCKEGLRPGDT--TSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR--SPF 221
Query: 499 YLTGHA----QTLLAYVWQLWKEGKEMEFVDPLLMKSSSI 534
            + G +    Q    Y++Q+  E K++     + +K++S+
Sbjct: 222 DIVGSSDNPDQNTEDYLFQVILE-KQIRIPRSMSVKAASV 260

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH    L +I+RDLKP N+L+D+    K++DFG A+     +    T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/200 (29%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 299 KLGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEEFK-NEIILIAKLQHRNLVRLVGC 356
           +LG+G FG V++      G + AVK++       LE F+  E++  A L    +V L G 
Sbjct: 79  RLGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGA 132
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
             EG    +  EL+   SL   I   ++   L  +     +G   +GL YLH     +I+
Sbjct: 133 VREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RIL 186
Query: 417 HRDLKPSNVLLDKDMV-AKISDFGMARIFCEN---QKTANTRRVVGTYGYMAPEYAMEGL 472
           H D+K  NVLL  D   A + DFG A     +   +       + GT  +MAPE  M   
Sbjct: 187 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 246
Query: 473 FSVKSDVFSFGVIVLEIISG 492
              K D++S   ++L +++G
Sbjct: 247 CDAKVDIWSSCCMMLHMLNG 266

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 11/206 (5%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQH 347
           A  D F     LG G FG V     +  G   A+K L ++    L++ ++ +     LQ 
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKGLLY 406
            N   LV      ++   +Y +M   +    +F   RR+ + +          I     Y
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYMVMEYVA-GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+APE
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPE 208
Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISG 492
             +   ++   D ++ GV++ E+ +G
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTVY-KGVLPNGKEVAVKRLSRKSWQGLEEFK---NEIILIAK 344
           A  D F     LG G FG V     +  G   A+K L ++    L++ +   NE  ++  
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           +    L +L     +     ++ E  P   +    F   RR+ +            I   
Sbjct: 99  VNFPFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFYAAQIVLT 154
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+++D+    K++DFG A+     +    T  + GT  Y+
Sbjct: 155 FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYL 206
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 102/228 (44%), Gaps = 30/228 (13%)
Query: 289 AATDGFS---------DSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNE 338
            +TD FS           + LG+G    V   + L   +E AVK + ++          E
Sbjct: 1   GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE 60
Query: 339 IILIAKLQ-HRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNII 397
           + ++ + Q HRN++ L+    E +   L++E M   S+   I    +R   N      ++
Sbjct: 61  VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI---HKRRHFNELEASVVV 117
Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK-DMVA--KISDFGMARIF-----CENQK 449
             ++  L +LH      I HRDLKP N+L +  + V+  KI DFG+         C    
Sbjct: 118 QDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPIS 174
Query: 450 TANTRRVVGTYGYMAPE----YAMEG-LFSVKSDVFSFGVIVLEIISG 492
           T       G+  YMAPE    ++ E  ++  + D++S GVI+  ++SG
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 7/95 (7%)
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN-QKTANTRRVVG 458
           I+ GL +L       II+RDLK  NV+LD +   KI+DFGM +   EN      T+   G
Sbjct: 130 IAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCG 183
Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           T  Y+APE      +    D ++FGV++ E+++G+
Sbjct: 184 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 125/307 (40%), Gaps = 61/307 (19%)
Query: 299 KLGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEEFK-NEIILIAKLQHRNLVRLVGC 356
           +LG+G FG V++      G + AVK++       LE F+  E++  A L    +V L G 
Sbjct: 81  RLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVPLYGA 134
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
             EG    +  EL+   SL   +   + +  L  +     +G   +GL YLH  SR +I+
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLV---KEQGCLPEDRALYYLGQALEGLEYLH--SR-RIL 188
Query: 417 HRDLKPSNVLLDKDMV-AKISDFGMARIFCEN---QKTANTRRVVGTYGYMAPEYAMEGL 472
           H D+K  NVLL  D   A + DFG A     +   +       + GT  +MAPE  +   
Sbjct: 189 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS 248
Query: 473 FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSS 532
              K DV+S   ++L +++G                 + W  +       F  PL +K +
Sbjct: 249 CDAKVDVWSSCCMMLHMLNG----------------CHPWTQF-------FRGPLCLKIA 285
Query: 533 SIPQVVR-----CIHIGLLCVQEDPAVRPTMSNVVALLGSE-SIALS------------- 573
           S P  VR     C  +    +QE     P      A LG + + AL              
Sbjct: 286 SEPPPVREIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNRALQQVGGLKSPWRGEY 345
Query: 574 -EPRQPP 579
            EPR PP
Sbjct: 346 KEPRHPP 352

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 117/281 (41%), Gaps = 46/281 (16%)
Query: 299 KLGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEEFK-NEIILIAKLQHRNLVRLVGC 356
           +LG+G FG V++      G + AVK++       LE F+  E++  A L    +V L G 
Sbjct: 100 RLGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACAGLTSPRIVPLYGA 153
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
             EG    +  EL+   SL   +   + +  L  +     +G   +GL YLH  SR +I+
Sbjct: 154 VREGPWVNIFMELLEGGSLGQLV---KEQGCLPEDRALYYLGQALEGLEYLH--SR-RIL 207
Query: 417 HRDLKPSNVLLDKDMV-AKISDFGMARIFCEN---QKTANTRRVVGTYGYMAPEYAMEGL 472
           H D+K  NVLL  D   A + DFG A     +   +       + GT  +MAPE  +   
Sbjct: 208 HGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS 267
Query: 473 FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSS 532
              K DV+S   ++L +++G                 + W  +       F  PL +K +
Sbjct: 268 CDAKVDVWSSCCMMLHMLNG----------------CHPWTQF-------FRGPLCLKIA 304
Query: 533 SIPQVVR-----CIHIGLLCVQEDPAVRPTMSNVVALLGSE 568
           S P  VR     C  +    +QE     P      A LG +
Sbjct: 305 SEPPPVREIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGK 345

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/285 (24%), Positives = 127/285 (44%), Gaps = 47/285 (16%)
Query: 299 KLGQGGFGTVYKGVLPNGKEV-AVK--RLSRKSWQGLEEFKNEIILIAKLQHRN--LVRL 353
           ++G GG   V++ VL   K++ A+K   L     Q L+ ++NEI  + KLQ  +  ++RL
Sbjct: 63  QIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL-YLHEDSR 412
               I  +    IY +M   ++D   +  +++    W           K +L  +H   +
Sbjct: 122 YDYEITDQ---YIYMVMECGNIDLNSWLKKKKSIDPWER-----KSYWKNMLEAVHTIHQ 173
Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
             I+H DLKP+N L+   M+ K+ DFG+A     +  +      VG   YM PE A++ +
Sbjct: 174 HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE-AIKDM 231
Query: 473 FSVKS------------DVFSFGVIVLEIISGKRNSGFYLTGHAQTL--LAYVWQLWKEG 518
            S +             DV+S G I+  +  GK       T   Q +  ++ +  +    
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK-------TPFQQIINQISKLHAIIDPN 284
Query: 519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA 563
            E+EF D   +    +  V++C      C++ DP  R ++  ++A
Sbjct: 285 HEIEFPD---IPEKDLQDVLKC------CLKRDPKQRISIPELLA 320

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 22/212 (10%)
Query: 297 SNKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRLV 354
           S+ LGQG    V++G     G   A+K  +  S+ + ++    E  ++ KL H+N+V+L 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 355 GCGIEG--EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
               E     K+LI E  P  SL   + +      L  +    ++  +  G+ +L E+  
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132
Query: 413 LKIIHRDLKPSNVLL----DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
             I+HR++KP N++     D   V K++DFG AR   ++++  +   + GT  Y+ P+  
Sbjct: 133 --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHPDMY 187
Query: 469 MEGL--------FSVKSDVFSFGVIVLEIISG 492
              +        +    D++S GV      +G
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLAGTPEYLAP 207
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 103/232 (44%), Gaps = 47/232 (20%)
Query: 300 LGQGGFGTV-YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-----QHRNLVRL 353
           LG G  GTV ++G    G+ VAVKR+       L +F +  ++  KL      H N++R 
Sbjct: 23  LGYGSSGTVVFQGSF-QGRPVAVKRM-------LIDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFI-----FDSERRLQLNWNTCYNIIGGISKGLLYLH 408
             C    +  L I   + N +L   +      D   +LQ  +N   +++  I+ G+ +LH
Sbjct: 75  Y-CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHLH 132
Query: 409 EDSRLKIIHRDLKPSNVLL--------DKDMVAK-----ISDFGMARIFCENQKT--ANT 453
               LKIIHRDLKP N+L+        D+   A+     ISDFG+ +     Q     N 
Sbjct: 133 S---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNL 189
Query: 454 RRVVGTYGYMAPEYAMEG-------LFSVKSDVFSFGVIVLEIIS-GKRNSG 497
               GT G+ APE   E          +   D+FS G +   I+S GK   G
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGTPEYLAP 207
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 294 FSDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEEFK-NEIILIAKLQHRNLV 351
            +   ++G+G FG V++      G + AVK++       LE F+  E++  A L    +V
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 113
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            L G   EG    +  EL+   SL   I   ++   L  +     +G   +GL YLH   
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR- 169
Query: 412 RLKIIHRDLKPSNVLLDKDMV-AKISDFGMARIFCEN---QKTANTRRVVGTYGYMAPEY 467
             +I+H D+K  NVLL  D   A + DFG A     +   +       + GT  +MAPE 
Sbjct: 170 --RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
Query: 468 AMEGLFSVKSDVFSFGVIVLEIISG 492
            M      K D++S   ++L +++G
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 294 FSDSNKLGQGGFGTVYK-GVLPNGKEVAVKRLSRKSWQGLEEFK-NEIILIAKLQHRNLV 351
            +   ++G+G FG V++      G + AVK++       LE F+  E++  A L    +V
Sbjct: 76  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 129
Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            L G   EG    +  EL+   SL   I   ++   L  +     +G   +GL YLH   
Sbjct: 130 PLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR- 185
Query: 412 RLKIIHRDLKPSNVLLDKDMV-AKISDFGMARIFCEN---QKTANTRRVVGTYGYMAPEY 467
             +I+H D+K  NVLL  D   A + DFG A     +   +       + GT  +MAPE 
Sbjct: 186 --RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 243
Query: 468 AMEGLFSVKSDVFSFGVIVLEIISG 492
            M      K D++S   ++L +++G
Sbjct: 244 VMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+AP
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 228
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN 349
           +DG+     +G G +    + V      E AVK + +      EE +   IL+   QH N
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIE---ILLRYGQHPN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFI----FDSERRLQLNWNTCYNIIGGISKGLL 405
           ++ L     +G+   L+ ELM    L   I    F SER      +T       I K + 
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHT-------IGKTVE 135
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDM----VAKISDFGMARIFCENQKTANTRRVVGTY- 460
           YLH      ++HRDLKPSN+L   +       +I DFG    F +  +  N   +   Y 
Sbjct: 136 YLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFG----FAKQLRAENGLLMTPCYT 188
Query: 461 -GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
             ++APE      +    D++S G+++  +++G
Sbjct: 189 ANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 208
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+AP
Sbjct: 151 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 202
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 203 EIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN 349
           +DG+     +G G +    + V      E AVK + +      EE +   IL+   QH N
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIE---ILLRYGQHPN 82
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFI----FDSERRLQLNWNTCYNIIGGISKGLL 405
           ++ L     +G+   L+ ELM    L   I    F SER      +T       I K + 
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHT-------IGKTVE 135
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDM----VAKISDFGMARIFCENQKTANTRRVVGTY- 460
           YLH      ++HRDLKPSN+L   +       +I DFG    F +  +  N   +   Y 
Sbjct: 136 YLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFG----FAKQLRAENGLLMTPCYT 188
Query: 461 -GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
             ++APE      +    D++S G+++  +++G
Sbjct: 189 ANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I   L YLH  S   +++RDLK  N++LDKD   KI+DFG+ +   ++   A  +   GT
Sbjct: 119 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCGT 174
Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 175 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 289 AATDGFSDSNKLGQGGFGTV----YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAK 344
           A  D F     LG G FG V    +K    +G   A+K L ++    L++ ++ +     
Sbjct: 25  AQLDQFDRIKTLGTGSFGRVMLVKHK---ESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 81
Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL-QLNWNTCYNIIGGISKG 403
           LQ  N   LV      ++   +Y +M   +    +F   RR+ + +          I   
Sbjct: 82  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVA-GGEMFSHLRRIGRFSEPHARFYAAQIVLT 140
Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
             YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+
Sbjct: 141 FEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYL 192
Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           APE  +   ++   D ++ GV++ E+ +G
Sbjct: 193 APEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I   L YLH  S   +++RDLK  N++LDKD   KI+DFG+ +   ++   A  +   GT
Sbjct: 117 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCGT 172
Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 173 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/261 (22%), Positives = 116/261 (44%), Gaps = 27/261 (10%)
Query: 300 LGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEE-----FKNEIILIAKLQHRNLVRLV 354
           +G+G FG V    L N  +V   ++  K W+ L+      F+ E  ++     + +  L 
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNK-WEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
               +     L+ +      L   +   E RL       Y     +++ ++ +    +L 
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY-----LAEMVIAIDSVHQLH 195
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE--YAME-- 470
            +HRD+KP N+L+D +   +++DFG      E+  T  +   VGT  Y++PE   AME  
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQSSVAVGTPDYISPEILQAMEGG 254
Query: 471 -GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
            G +  + D +S GV + E++ G+  + FY    A++L+    ++    +  +F   +  
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGE--TPFY----AESLVETYGKIMNHKERFQFPTQVTD 308
Query: 530 KSSSIPQVVRCIHIGLLCVQE 550
            S +   ++R     L+C +E
Sbjct: 309 VSENAKDLIR----RLICSRE 325

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I   L YLH  S   +++RDLK  N++LDKD   KI+DFG+ +   ++   A  +   GT
Sbjct: 118 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKXFCGT 173
Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 174 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 26/214 (12%)
Query: 297 SNKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRLV 354
           S+ LGQG    V++G     G   A+K  +  S+ + ++    E  ++ KL H+N+V+L 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 355 GCGIEGE----EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
              IE E     K+LI E  P  SL   + +      L  +    ++  +  G+ +L E+
Sbjct: 74  A--IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131
Query: 411 SRLKIIHRDLKPSNVLL----DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
               I+HR++KP N++     D   V K++DFG AR   ++++      + GT  Y+ P+
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX---LYGTEEYLHPD 185
Query: 467 YAMEGL--------FSVKSDVFSFGVIVLEIISG 492
                +        +    D++S GV      +G
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+AP
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTPEYLAP 228
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 300 LGQGGFGTVYKGVLPNGKEV-AVKRLSRKSWQGLEEFKNEIILIAKL--QHRNLVRLVGC 356
           LG+G F    K V     +  AVK +S++    +E    + I   KL   H N+V+L   
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEV 74
Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
             +     L+ EL+    L   I   +++   +      I+  +   + ++H+   + ++
Sbjct: 75  FHDQLHTFLVMELLNGGELFERI---KKKKHFSETEASYIMRKLVSAVSHMHD---VGVV 128
Query: 417 HRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF 473
           HRDLKP N+L    + ++  KI DFG AR+   + +   T     T  Y APE   +  +
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQNGY 186
Query: 474 SVKSDVFSFGVIVLEIISGK 493
               D++S GVI+  ++SG+
Sbjct: 187 DESCDLWSLGVILYTMLSGQ 206

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E  +   ++   D ++ GV++ ++ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH    L +I+RDLKP N+++D+    +++DFG A+     +    T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 101/228 (44%), Gaps = 30/228 (13%)
Query: 289 AATDGFS---------DSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNE 338
            +TD FS           + LG+G    V   + L   +E AVK + ++          E
Sbjct: 1   GSTDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFRE 60
Query: 339 IILIAKLQ-HRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNII 397
           + ++ + Q HRN++ L+    E +   L++E M   S+   I    +R   N      ++
Sbjct: 61  VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHI---HKRRHFNELEASVVV 117
Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK-DMVA--KISDFGMARIF-----CENQK 449
             ++  L +LH      I HRDLKP N+L +  + V+  KI DF +         C    
Sbjct: 118 QDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 450 TANTRRVVGTYGYMAPE----YAMEG-LFSVKSDVFSFGVIVLEIISG 492
           T       G+  YMAPE    ++ E  ++  + D++S GVI+  ++SG
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 24/211 (11%)
Query: 291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN 349
           TDG+     +G G +    + +      E AVK + +      EE +   IL+   QH N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIE---ILLRYGQHPN 77
Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFI----FDSERRLQLNWNTCYNIIGGISKGLL 405
           ++ L     +G+   ++ EL     L   I    F SER           ++  I+K + 
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASA-------VLFTITKTVE 130
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDM----VAKISDFGMARIFCENQKTANTRRVVGTYG 461
           YLH      ++HRDLKPSN+L   +       +I DFG A+          T     T  
Sbjct: 131 YLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTP--CYTAN 185
Query: 462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           ++APE      +    D++S GV++   ++G
Sbjct: 186 FVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I   L YLH  SR  +++RD+K  N++LDKD   KI+DFG+ +    +  T  T    GT
Sbjct: 117 IVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGT 171
Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 172 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I   L YLH  SR  +++RD+K  N++LDKD   KI+DFG+ +    +  T  T    GT
Sbjct: 114 IVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGT 168
Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I   L YLH  SR  +++RD+K  N++LDKD   KI+DFG+ +    +  T  T    GT
Sbjct: 114 IVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGT 168
Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 96/221 (43%), Gaps = 24/221 (10%)
Query: 278 ELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKE-VAVKRLSRKSWQGLEEFK 336
           +LP +H       +D +     +G G FG           E VAVK + R   +  E  K
Sbjct: 11  DLPIMH------DSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGE-KIDENVK 63
Query: 337 NEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNI 396
            EII    L+H N+VR     +      ++ E      L   I ++ R    + +     
Sbjct: 64  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFF 120
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVA--KISDFGMAR--IFCENQKTAN 452
              +  G+ Y H    +++ HRDLK  N LLD       KI+DFG ++  +     K+A 
Sbjct: 121 FQQLISGVSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA- 176
Query: 453 TRRVVGTYGYMAPEYAMEGLFSVK-SDVFSFGVIVLEIISG 492
               VGT  Y+APE  ++  +  K +DV+S GV +  ++ G
Sbjct: 177 ----VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAP 207
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
              +   ++   D ++ GV++ E+ +G
Sbjct: 208 AIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 18/216 (8%)
Query: 288 KAATDGFSDSNKLGQGGFGTVYK----GVLPNGKEVAVKRLSR----KSWQGLEEFKNEI 339
           K   + F     LG G +G V+          GK  A+K L +    +  +  E  + E 
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 340 ILIAKLQHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG 398
            ++  ++    +  +    + E KL LI + +    L   +   ER      +     +G
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVG 166
Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG 458
            I   L +LH   +L II+RD+K  N+LLD +    ++DFG+++ F  ++ T       G
Sbjct: 167 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCG 222
Query: 459 TYGYMAPEYAMEGL--FSVKSDVFSFGVIVLEIISG 492
           T  YMAP+    G        D +S GV++ E+++G
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I   L YLH  SR  +++RD+K  N++LDKD   KI+DFG+ +    +   A  +   GT
Sbjct: 114 IVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGT 168
Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 60/112 (53%), Gaps = 8/112 (7%)
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I + +L +    +L  +HRD+KP NVLLD +   +++DFG   +   +  T  +   VGT
Sbjct: 181 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGT 239
Query: 460 YGYMAPEY--AME---GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQT 506
             Y++PE   AME   G +  + D +S GV + E++ G+  + FY     +T
Sbjct: 240 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVET 289

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 95/219 (43%), Gaps = 20/219 (9%)
Query: 278 ELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKE-VAVKRLSRKSWQGLEEFK 336
           +LP +H       +D +     +G G FG           E VAVK + R   +  E  K
Sbjct: 10  DLPIMH------DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE-KIDENVK 62
Query: 337 NEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNI 396
            EII    L+H N+VR     +      ++ E      L   I ++ R    + +     
Sbjct: 63  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDEARFF 119
Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVA--KISDFGMARIFCENQKTANTR 454
              +  G+ Y H    +++ HRDLK  N LLD       KI DFG ++    + +  +T 
Sbjct: 120 FQQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 175
Query: 455 RVVGTYGYMAPEYAMEGLFSVK-SDVFSFGVIVLEIISG 492
             VGT  Y+APE  ++  +  K +DV+S GV +  ++ G
Sbjct: 176 --VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I   L YLH  SR  +++RD+K  N++LDKD   KI+DFG+ +    +   A  +   GT
Sbjct: 119 IVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGT 173
Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 174 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 60/112 (53%), Gaps = 8/112 (7%)
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I + +L +    +L  +HRD+KP NVLLD +   +++DFG   +   +  T  +   VGT
Sbjct: 197 IGEMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSC-LKMNDDGTVQSSVAVGT 255
Query: 460 YGYMAPEY--AME---GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQT 506
             Y++PE   AME   G +  + D +S GV + E++ G+  + FY     +T
Sbjct: 256 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE--TPFYAESLVET 305

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I   L YLH  SR  +++RD+K  N++LDKD   KI+DFG+ +    +   A  +   GT
Sbjct: 114 IVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGT 168
Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I   L YLH  SR  +++RD+K  N++LDKD   KI+DFG+ +    +   A  +   GT
Sbjct: 114 IVSALEYLH--SR-DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGT 168
Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y+APE   +  +    D +  GV++ E++ G+
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQH--RNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 161
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 162 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 215
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQH--RNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 160
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 161 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 214
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQH--RNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 161
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 162 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 215
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQH--RNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 147
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 148 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 201
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQH--RNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 91  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 147
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 148 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 201
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQH--RNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 160
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 161 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 214
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQH--RNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 161
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 162 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 215
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQ--HRNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNX 129
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 182
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQH--RNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 105 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 161
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 162 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 215
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQH--RNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 160
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 161 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 214
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQ--HRNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 175
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 176 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 229
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQH--RNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 148
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 149 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 202
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQH--RNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 104 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 160
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 161 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 214
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 70/149 (46%), Gaps = 15/149 (10%)
Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           C  + ++ L ++ E MP   L   +  S   +   W   Y      ++ +L L     + 
Sbjct: 142 CAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYT-----AEVVLALDAIHSMG 194
Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY----AME 470
           +IHRD+KP N+LLDK    K++DFG      E     +    VGT  Y++PE       +
Sbjct: 195 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET-GMVHCDTAVGTPDYISPEVLKSQGGD 253
Query: 471 GLFSVKSDVFSFGVIVLEIISGKRNSGFY 499
           G +  + D +S GV + E++ G  ++ FY
Sbjct: 254 GYYGRECDWWSVGVFLFEMLVG--DTPFY 280

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQH--RNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 119 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 175
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 176 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 229
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQH--RNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 148
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 149 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 202
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH    L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT   +AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEALAP 207
Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISG 492
           E  +   ++   D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQH--RNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 92  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 148
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 149 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 202
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQH--RNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 111 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 167
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 168 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 221
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQ--HRNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH-- 132
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 133 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 187
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQ--HRNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 76  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 132
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 133 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 186
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQ--HRNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 133
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 134 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 187
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQH--RNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 124 IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 180
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 181 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 234
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 235 YHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQ--HRNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 128
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 182
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQ--HRNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 77  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH-- 132
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 133 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 187
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQ--HRNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 75  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 131
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 132 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 185
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 25/76 (32%), Positives = 42/76 (55%), Gaps = 1/76 (1%)
Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+KP N+L+  D  A + DFG+A     ++K       VGT  Y APE   E   + +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASA-TTDEKLTQLGNTVGTLYYXAPERFSESHATYR 215
Query: 477 SDVFSFGVIVLEIISG 492
           +D+++   ++ E ++G
Sbjct: 216 ADIYALTCVLYECLTG 231

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQ--HRNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 72  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHN- 128
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 182
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN------EIILIAKLQ--HRNL 350
           LG GGFG+VY G+ + +   VA+K + +       E  N      E++L+ K+      +
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL+      +  +LI E  P    D F F +ER   L      +    + + + + H  
Sbjct: 99  IRLLDWFERPDSFVLILE-RPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH-- 154
Query: 411 SRLKIIHRDLKPSNVLLDKDMVA-KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
               ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+  
Sbjct: 155 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYSPPEWIR 209
Query: 470 EGLFSVKS-DVFSFGVIVLEIISG 492
              +  +S  V+S G+++ +++ G
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMVCG 233
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	611
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-142
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-140
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-121
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-92
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-77
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-62
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-61
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-61
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-59
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-59
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-59
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-57
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-55
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-54
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-52
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-51
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	9e-46
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-45
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-44
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-43
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-43
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-43
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-43
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-43
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-43
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-42
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-42
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-42
3pls_A	298	Macrophage-stimulating protein receptor; protein k	4e-42
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-42
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-42
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-42
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-42
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-42
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-42
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-41
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-41
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-41
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-41
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-41
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	3e-41
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-41
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-41
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-41
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	9e-41
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	9e-41
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-41
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-40
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-40
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-40
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-40
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-40
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-40
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-40
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-40
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-40
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-40
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-40
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-40
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-40
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	7e-40
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-40
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-40
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-40
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-39
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-39
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-39
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-39
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-39
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-39
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-39
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-39
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-38
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-38
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-38
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-38
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-38
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-37
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-37
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-37
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-37
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-37
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-37
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-36
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-36
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-35
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-34
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-34
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	9e-34
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-33
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-33
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-33
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-33
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-33
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-32
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-32
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-32
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-32
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-32
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	9e-32
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-31
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-31
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-31
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	9e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-31
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-30
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-30
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-30
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-30
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-30
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-30
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-30
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-30
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-30
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-30
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-30
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-30
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	7e-30
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-30
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-29
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-29
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-29
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-29
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-29
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	7e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-28
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-28
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-28
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-28
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-28
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-28
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-28
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-28
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-28
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-27
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-27
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-27
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-26
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-26
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-26
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-26
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-26
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-26
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-26
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-26
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-25
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-25
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	6e-25
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	2e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-24
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-24
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-24
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-24
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-24
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-24
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-24
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-23
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-23
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-23
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-22
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-22
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-21
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-21
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-21
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-21
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-21
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-21
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-21
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-09
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-20
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-20
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-20
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-19
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-19
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-19
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-19
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	6e-19
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-19
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-18
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-18
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-18
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-18
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-15
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	6e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-14
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-14
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-13
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-07
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-07

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  413 bits (1064), Expect = e-142
 Identities = 106/301 (35%), Positives = 160/301 (53%), Gaps = 21/301 (6%)

Query: 284 LAVIKAATDGFSD------SNKLGQGGFGTVYKGVLPNGKEVAVKRLS----RKSWQGLE 333
              +K  T+ F +       NK+G+GGFG VYKG + N   VAVK+L+      + +  +
Sbjct: 17  FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75

Query: 334 EFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTC 393
           +F  EI ++AK QH NLV L+G   +G++  L+Y  MPN SL   +   +    L+W+  
Sbjct: 76  QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135

Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT 453
             I  G + G+ +LHE+     IHRD+K +N+LLD+   AKISDFG+AR   +  +T  T
Sbjct: 136 CKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192

Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
            R+VGT  YMAPE  + G  + KSD++SFGV++LEII+G            Q LL    +
Sbjct: 193 SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDE--HREPQLLLDIKEE 249

Query: 514 LWKEGKEME-FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIAL 572
           +  E K +E ++D  +   +    V     +   C+ E    RP +  V  LL  + +  
Sbjct: 250 IEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL--QEMTA 306

Query: 573 S 573
           S
Sbjct: 307 S 307

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  409 bits (1054), Expect = e-140
 Identities = 122/310 (39%), Positives = 173/310 (55%), Gaps = 13/310 (4%)

Query: 274 VSSEELPFVHLAV--------IKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLS 325
           V +EE P VHL          ++ A+D FS+ N LG+GGFG VYKG L +G  VAVKRL 
Sbjct: 4   VPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLK 63

Query: 326 RKSWQGLE-EFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSER 384
            +  QG E +F+ E+ +I+   HRNL+RL G  +   E+LL+Y  M N S+   + +   
Sbjct: 64  EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 123

Query: 385 -RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI 443
            +  L+W     I  G ++GL YLH+    KIIHRD+K +N+LLD++  A + DFG+A++
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183

Query: 444 FCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRN--SGFYLT 501
                    T  V GT G++APEY   G  S K+DVF +GV++LE+I+G+R         
Sbjct: 184 MDYKDTHVTT-AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242

Query: 502 GHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
                LL +V  L KE K    VD  L  +    +V + I + LLC Q  P  RP MS V
Sbjct: 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

Query: 562 VALLGSESIA 571
           V +L  + +A
Sbjct: 303 VRMLEGDGLA 312

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  359 bits (925), Expect = e-121
 Identities = 98/283 (34%), Positives = 157/283 (55%), Gaps = 4/283 (1%)

Query: 284 LAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIA 343
           L  ++ AT+ F     +G G FG VYKGVL +G +VA+KR + +S QG+EEF+ EI  ++
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90

Query: 344 KLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSER-RLQLNWNTCYNIIGGISK 402
             +H +LV L+G   E  E +LIY+ M N +L   ++ S+   + ++W     I  G ++
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           GL YLH  +   IIHRD+K  N+LLD++ V KI+DFG+++   E  +T  +  V GT GY
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGY 207

Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME 522
           + PEY ++G  + KSDV+SFGV++ E++  +      L      L  +  +    G+  +
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267

Query: 523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
            VDP L        + +     + C+      RP+M +V+  L
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  286 bits (733), Expect = 3e-92
 Identities = 68/304 (22%), Positives = 120/304 (39%), Gaps = 28/304 (9%)

Query: 284 LAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIA 343
              +   +          +G FG V+K      + VAVK    +  Q   + + E+  + 
Sbjct: 16  TENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQS-WQNEYEVYSLP 73

Query: 344 KLQHRNLVRLVGCGIEGE----EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG 399
            ++H N+++ +G    G     +  LI       SL  F+    +   ++WN   +I   
Sbjct: 74  GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIAET 129

Query: 400 ISKGLLYLHED-------SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN 452
           +++GL YLHED        +  I HRD+K  NVLL  ++ A I+DFG+A  F   +   +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

Query: 453 TRRVVGTYGYMAPEYAMEGL-----FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTL 507
           T   VGT  YMAPE     +       ++ D+++ G+++ E+ S    +   +  +    
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249

Query: 508 LAYVWQLWKEGKEMEFV-----DPLLMKSSSIPQVVRCI-HIGLLCVQEDPAVRPTMSNV 561
              + Q        E V      P+L         +  +      C   D   R +   V
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309

Query: 562 VALL 565
              +
Sbjct: 310 GERI 313

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  248 bits (634), Expect = 2e-77
 Identities = 68/326 (20%), Positives = 119/326 (36%), Gaps = 45/326 (13%)

Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNE--IILIAKLQH 347
             D       +G+G +G VYKG L + + VAVK  S   +   + F NE  I  +  ++H
Sbjct: 11  DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFS---FANRQNFINEKNIYRVPLMEH 66

Query: 348 RNLVRLVGCGIEGE-----EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
            N+ R +            E LL+ E  PN SL  ++         +W +   +   +++
Sbjct: 67  DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL----SLHTSDWVSSCRLAHSVTR 122

Query: 403 GLLYLHED------SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF------CENQKT 450
           GL YLH +       +  I HRDL   NVL+  D    ISDFG++            ++ 
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182

Query: 451 ANTRRVVGTYGYMAPEYAMEGL-------FSVKSDVFSFGVIVLEIISGKRNSGFYLTGH 503
                 VGT  YMAPE     +          + D+++ G+I  EI     +        
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG-ESV 241

Query: 504 AQTLLAYVWQLWKEGKEMEFVDPLLMKSS--SIPQVVRCIHIGLL--------CVQEDPA 553
            +  +A+  ++       +    +  +      P+  +   + +         C  +D  
Sbjct: 242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAE 301

Query: 554 VRPTMSNVVALLGSESIALSEPRQPP 579
            R T       +    +     +   
Sbjct: 302 ARLTAQXAEERMAELMMIWERNKSVS 327

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  208 bits (531), Expect = 1e-62
 Identities = 76/284 (26%), Positives = 133/284 (46%), Gaps = 25/284 (8%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQG--LEEFKNEIILIAKLQHRNLVRLVG 355
            K+G G FGTV++    +G +VAVK L  + +    + EF  E+ ++ +L+H N+V  +G
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
              +     ++ E +   SL   +  S  R QL+     ++   ++KG+ YLH      I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160

Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSV 475
           +HR+LK  N+L+DK    K+ DFG++R+      ++ +    GT  +MAPE   +   + 
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKS--AAGTPEWMAPEVLRDEPSNE 218

Query: 476 KSDVFSFGVIVLEIISGKR-NSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSI 534
           KSDV+SFGVI+ E+ + ++                 V  +  + K +E          ++
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNL-------NPAQVVAAVGFKCKRLEI-------PRNL 264

Query: 535 PQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQP 578
              V    I   C   +P  RP+ + ++ LL    +  S    P
Sbjct: 265 NPQVA--AIIEGCWTNEPWKRPSFATIMDLL--RPLIKSAVPPP 304

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  204 bits (520), Expect = 6e-61
 Identities = 73/288 (25%), Positives = 124/288 (43%), Gaps = 37/288 (12%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
             +G+G FG V K      K+VA+K++  +S    + F  E+  ++++ H N+V+L G  
Sbjct: 14  EVVGRGAFGVVCKAKW-RAKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
           +      L+ E     SL   +  +E           +     S+G+ YLH      +IH
Sbjct: 71  LN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128

Query: 418 RDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           RDLKP N+LL     V KI DFG A    +   T N     G+  +MAPE      +S K
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-DIQTHMTNNK----GSAAWMAPEVFEGSNYSEK 183

Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
            DVFS+G+I+ E+I+ +                   + + E     F     + + + P 
Sbjct: 184 CDVFSWGIILWEVITRR-------------------KPFDEIGGPAFRIMWAVHNGTRPP 224

Query: 537 VVRCIHIGLL-----CVQEDPAVRPTMSNVVALLGSESIALSEPRQPP 579
           +++ +   +      C  +DP+ RP+M  +V ++    +    P    
Sbjct: 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIM--THLMRYFPGADE 270

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  203 bits (519), Expect = 7e-61
 Identities = 70/295 (23%), Positives = 116/295 (39%), Gaps = 32/295 (10%)

Query: 298 NKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
             LG+G FG   K      G+ + +K L R   +    F  E+ ++  L+H N+++ +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
             + +    I E +   +L   I   +   Q  W+   +    I+ G+ YLH    + II
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHS---MNII 130

Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR------------VVGTYGYMA 464
           HRDL   N L+ ++    ++DFG+AR+  + +      R            VVG   +MA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV 524
           PE      +  K DVFSFG+++ EII        YL       L       +   +    
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-----RGFLDRY-- 243

Query: 525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPP 579
                   + P       I + C   DP  RP+   +   L +  + L+      
Sbjct: 244 -----CPPNCPPSFF--PITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  197 bits (504), Expect = 4e-59
 Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 38/281 (13%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRL----SRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
             +G GGFG VY+     G EVAVK           Q +E  + E  L A L+H N++ L
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
            G  ++     L+ E      L+  +       ++  +   N    I++G+ YLH+++ +
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 414 KIIHRDLKPSNVLLDK--------DMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
            IIHRDLK SN+L+ +        + + KI+DFG+AR +    K +      G Y +MAP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA----GAYAWMAP 183

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKR-NSGFYLTGHAQTLLAYVWQLWKEGKEMEFV 524
           E     +FS  SDV+S+GV++ E+++G+    G          LA  + +      +   
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI-------DGLAVAYGVAMNKLALPI- 235

Query: 525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
                  S+ P+      +   C   DP  RP+ +N++  L
Sbjct: 236 ------PSTCPEPFA--KLMEDCWNPDPHSRPSFTNILDQL 268

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  197 bits (504), Expect = 6e-59
 Identities = 69/283 (24%), Positives = 133/283 (46%), Gaps = 38/283 (13%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG-------LEEFKNEIILIAKLQHRN 349
            ++G+GGFG V+KG  + +   VA+K L     +G        +EF+ E+ +++ L H N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
           +V+L G         ++ E +P   L   + D  +   + W+    ++  I+ G+ Y+  
Sbjct: 85  IVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQ- 139

Query: 410 DSRLKIIHRDLKPSNVLLDK-----DMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
           +    I+HRDL+  N+ L        + AK++DFG+++         +   ++G + +MA
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQWMA 194

Query: 465 PE--YAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME 522
           PE   A E  ++ K+D +SF +I+  I++G+     +   ++   + ++  + +EG    
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEG---PF-DEYSYGKIKFINMIREEGLRPT 250

Query: 523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
                       P  +R  ++  LC   DP  RP  S +V  L
Sbjct: 251 I-------PEDCPPRLR--NVIELCWSGDPKKRPHFSYIVKEL 284

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  193 bits (493), Expect = 2e-57
 Identities = 70/273 (25%), Positives = 131/273 (47%), Gaps = 24/273 (8%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQG--LEEFKNEIILIAKLQHRNLVRLVG 355
            ++G G FGTVYKG   +G +VAVK L+  +     L+ FKNE+ ++ K +H N++  +G
Sbjct: 30  QRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
                 +  ++ +     SL   +  SE   +       +I    ++G+ YLH      I
Sbjct: 88  Y-STAPQLAIVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLH---AKSI 141

Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE---YAMEGL 472
           IHRDLK +N+ L +D   KI DFG+A        +    ++ G+  +MAPE         
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201

Query: 473 FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSS 532
           +S +SDV++FG+++ E+++G+     Y   +       +  + +     +    L    S
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLP---Y--SNINNRDQIIEMVGRGSLSPD----LSKVRS 252

Query: 533 SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
           + P+ ++   +   C+++    RP+   ++A +
Sbjct: 253 NCPKRMK--RLMAECLKKKRDERPSFPRILAEI 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  190 bits (485), Expect = 7e-56
 Identities = 76/302 (25%), Positives = 126/302 (41%), Gaps = 46/302 (15%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQG--LEEFKNEIILIAKLQHRNLVRLVG 355
             +G+G FG VY G   +G EVA++ +  +      L+ FK E++   + +H N+V  +G
Sbjct: 39  ELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
             +      +I  L   R+L   +   + ++ L+ N    I   I KG+ YLH      I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151

Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFC---ENQKTANTRRVVGTYGYMAPE------ 466
           +H+DLK  NV  D   V  I+DFG+  I       ++    R   G   ++APE      
Sbjct: 152 LHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 467 ---YAMEGLFSVKSDVFSFGVIVLEIISGK---RNSGFYLTGHAQTLLAYVWQLWKEGKE 520
                 +  FS  SDVF+ G I  E+ + +   +          Q   A +WQ+    K 
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT---------QPAEAIIWQMGTGMK- 260

Query: 521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPF 580
                P L +     ++   +   L C   +   RPT + ++ +L  E +     R+   
Sbjct: 261 -----PNLSQIGMGKEISDIL---LFCWAFEQEERPTFTKLMDML--EKLP-KRNRRLSH 309

Query: 581 PV 582
           P 
Sbjct: 310 PG 311

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  188 bits (479), Expect = 2e-55
 Identities = 57/283 (20%), Positives = 109/283 (38%), Gaps = 48/283 (16%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQG--LEEFKNEIILIAKLQHRNLVRLVG 355
            KL +   G ++KG    G ++ VK L  + W      +F  E   +    H N++ ++G
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 356 CGIEGEEKLL--IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
                       I   MP  SL   + +      ++ +        +++G+ +LH     
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARGMAFLH-TLEP 132

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG-- 471
            I    L   +V++D+DM A+IS   +   F   Q             ++APE A++   
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSF---QSPGRM----YAPAWVAPE-ALQKKP 184

Query: 472 --LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
                  +D++SF V++ E+++ +                     + +   ME    + +
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE-------------------VPFADLSNMEIGMKVAL 225

Query: 530 KSS--SIPQVVRCIHIGL-----LCVQEDPAVRPTMSNVVALL 565
           +    +IP     I   +     +C+ EDPA RP    +V +L
Sbjct: 226 EGLRPTIP---PGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  186 bits (474), Expect = 5e-54
 Identities = 68/297 (22%), Positives = 115/297 (38%), Gaps = 42/297 (14%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNE--IILIAKLQHRNLVRLVG 355
            ++G+G +G V+ G    G++VAVK            +  E  I     ++H N++  + 
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIA 98

Query: 356 CGIEGEEK----LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED- 410
             I+G        LI +   N SL    +D  +   L+  +   +      GL +LH + 
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 411 ----SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF--CENQKTANTRRVVGTYGYMA 464
                +  I HRDLK  N+L+ K+    I+D G+A  F    N+        VGT  YM 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 465 PEYAMEGLFSV-------KSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKE 517
           PE  ++   +         +D++SFG+I+ E+     + G       +  L Y   +  +
Sbjct: 215 PE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG----IVEEYQLPYHDLVPSD 269

Query: 518 GKEMEFVDPLLMKSS--SIPQVVRCIHIGLL-------CVQEDPAVRPTMSNVVALL 565
               +  + + +K    S P                  C   +PA R T   V   L
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  183 bits (467), Expect = 2e-53
 Identities = 62/298 (20%), Positives = 118/298 (39%), Gaps = 44/298 (14%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNE--IILIAKLQHRNLVRLVG 355
             +G+G +G V++G    G+ VAVK  S    +  + +  E  +     L+H N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 356 CGIEGEEK----LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED- 410
             +          LI       SL    +D  +   L+  +C  I+  I+ GL +LH + 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 411 ----SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMA 464
                +  I HRDLK  N+L+ K+    I+D G+A +  ++    +      VGT  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 465 PE------YAMEGLFSVKSDVFSFGVIVLEIISGKRNSG---------FYLTGHAQTLLA 509
           PE               + D+++FG+++ E+     ++G         + +  +  +   
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245

Query: 510 YVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLL--CVQEDPAVRPTMSNVVALL 565
               +  + +      P    S      +      L+  C  ++P+ R T   +   L
Sbjct: 246 MRKVVCVDQQRPNI--PNRWFSDPTLTSLA----KLMKECWYQNPSARLTALRIKKTL 297

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  179 bits (456), Expect = 2e-51
 Identities = 65/297 (21%), Positives = 112/297 (37%), Gaps = 42/297 (14%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNE--IILIAKLQHRNLVRLVG 355
             +G+G FG V++G    G+EVAVK  S    +    +  E  I     L+H N++  + 
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 103

Query: 356 CGIEGEEK----LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED- 410
              +         L+ +   + SL    FD   R  +       +    + GL +LH + 
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 411 ----SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF--CENQKTANTRRVVGTYGYMA 464
                +  I HRDLK  N+L+ K+    I+D G+A       +         VGT  YMA
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219

Query: 465 PEYAMEGLFSV-------KSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKE 517
           PE  ++   ++       ++D+++ G++  EI       G     H    L Y   +  +
Sbjct: 220 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG----IHEDYQLPYYDLVPSD 274

Query: 518 GKEMEFVDPLLMKSS--SIPQVVRCIHIGLL-------CVQEDPAVRPTMSNVVALL 565
               E    +  +    +IP   +      +       C   + A R T   +   L
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  163 bits (415), Expect = 9e-46
 Identities = 76/307 (24%), Positives = 125/307 (40%), Gaps = 51/307 (16%)

Query: 298 NKLGQGGFGTVYKGVLPNGKE-----VAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLV 351
             LG+G FG V         +     VAVK L +    Q    +K EI ++  L H +++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 352 RLVGCGIEGEEK--LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
           +  GC  +       L+ E +P  SL  ++     R  +           I +G+ YLH 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA 152

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG-----YMA 464
                 IHRDL   NVLLD D + KI DFG+A+   E  +       V   G     + A
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWYA 205

Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAY-------VWQLWK 516
           PE   E  F   SDV+SFGV + E+++    +            +A        + +L +
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265

Query: 517 EGKEMEFVDPLLMKSSSIPQVVRC---IH-IGLLCVQEDPAVRPTMSNVVALLGSESIAL 572
            G+ +             P+  +C   ++ +   C + + + RPT  N++ +L  +++  
Sbjct: 266 RGERL-------------PRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL--KTVHE 310

Query: 573 SEPRQPP 579
               Q P
Sbjct: 311 KYQGQAP 317

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  164 bits (417), Expect = 2e-45
 Identities = 73/276 (26%), Positives = 116/276 (42%), Gaps = 36/276 (13%)

Query: 299 KLGQGGFGTVYKGVL-PNGKEVAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           ++G+G FG V+ G L  +   VAVK            +F  E  ++ +  H N+VRL+G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
             + +   ++ EL+       F+     RL++   T   ++G  + G+ YL        I
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVK--TLLQMVGDAAAGMEYLES---KCCI 235

Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   N L+ +  V KISDFGM+R   +    A+         + APE    G +S +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295

Query: 477 SDVFSFGVIVLEIIS-------GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
           SDV+SFG+++ E  S          N         Q    +V    ++G  +    P L 
Sbjct: 296 SDVWSFGILLWETFSLGASPYPNLSN---------QQTREFV----EKGGRLPC--PELC 340

Query: 530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
                P  V    +   C   +P  RP+ S +   L
Sbjct: 341 -----PDAVF--RLMEQCWAYEPGQRPSFSTIYQEL 369

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  159 bits (405), Expect = 1e-44
 Identities = 70/293 (23%), Positives = 121/293 (41%), Gaps = 47/293 (16%)

Query: 298 NKLGQGGFGTVYKGVLP-----NGKEVAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLV 351
             LG+G FG V            G++VAVK L        + + K EI ++  L H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 352 RLVG-CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
           +  G C  +G   + LI E +P+ SL  ++  ++ ++ L           I KG+ YL  
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLK--QQLKYAVQICKGMDYLGS 144

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG-----YMA 464
               + +HRDL   NVL++ +   KI DFG+ +    +++    +            + A
Sbjct: 145 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK----DDRDSPVFWYA 197

Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAY-------VWQLWK 516
           PE  M+  F + SDV+SFGV + E+++    +S             +       +    K
Sbjct: 198 PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257

Query: 517 EGKEMEFVDPLLMKSSSIPQVVRC---IH-IGLLCVQEDPAVRPTMSNVVALL 565
           EGK +             P    C   ++ +   C +  P+ R +  N++   
Sbjct: 258 EGKRL-------------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  158 bits (401), Expect = 1e-43
 Identities = 78/315 (24%), Positives = 128/315 (40%), Gaps = 49/315 (15%)

Query: 298 NKLGQGGFGTVYKGVLP-----NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           ++LG+G FG+V            G  VAVK+L         +F+ EI ++  L    +V+
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 353 LVG-CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
             G     G + L L+ E +P+  L  F+     RL  +          I KG+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGMEYLGS- 145

Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG-----YMAP 465
              + +HRDL   N+L++ +   KI+DFG+A++   ++       VV   G     + AP
Sbjct: 146 --RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVREPGQSPIFWYAP 199

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS--------GKRNSGFYLTGHAQTLLAYVWQLWKE 517
           E   + +FS +SDV+SFGV++ E+ +                        L+ + +L +E
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259

Query: 518 GKEMEFVDPLLMKSSSIPQVVRC---IH-IGLLCVQEDPAVRPTMSNVVALLG---SESI 570
           G+ +             P    C   +H +  LC    P  RP+ S +   L    S S 
Sbjct: 260 GQRL-------------PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306

Query: 571 ALSEPRQPPFPVGRT 585
                     P G+ 
Sbjct: 307 GCETHAFTAHPEGKH 321

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  157 bits (398), Expect = 1e-43
 Identities = 68/288 (23%), Positives = 114/288 (39%), Gaps = 47/288 (16%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVG 355
            LG+GGFG V++     +    A+K  RL  +     E+   E+  +AKL+H  +VR   
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA-REKVMREVKALAKLEHPGIVRYFN 70

Query: 356 CGIEGEE---------KLLIY---ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKG 403
             +E            K+ +Y   +L    +L  ++       +   + C +I   I++ 
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV------- 456
           + +LH      ++HRDLKPSN+    D V K+ DFG+     ++++              
Sbjct: 131 VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187

Query: 457 ---VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
              VGT  YM+PE      +S K D+FS G+I+ E++       F      Q        
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL-----YPFS----TQMERVRTLT 238

Query: 514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
             +  K   F      K      +V+        +   P  RP   N+
Sbjct: 239 DVRNLK---FPPLFTQKYPCEYVMVQ------DMLSPSPMERPEAINI 277

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  156 bits (396), Expect = 2e-43
 Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 39/289 (13%)

Query: 298 NKLGQGGFGTVYKGVLP-----NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
            +LG+G FG+V            G+ VAVK+L   + + L +F+ EI ++  LQH N+V+
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 353 LVGCGIEGEEK--LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
             G       +   LI E +P  SL  ++   + R+             I KG+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICKGMEYLGT- 132

Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG-----YMAP 465
              + IHRDL   N+L++ +   KI DFG+ ++  ++++    +      G     + AP
Sbjct: 133 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK----EPGESPIFWYAP 186

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAY---------VWQLWK 516
           E   E  FSV SDV+SFGV++ E+ +    S        + +            + +L K
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246

Query: 517 EGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
               +        +    P  +    I   C   +   RP+  ++   +
Sbjct: 247 NNGRLP-------RPDGCPDEIY--MIMTECWNNNVNQRPSFRDLALRV 286

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  157 bits (398), Expect = 2e-43
 Identities = 71/289 (24%), Positives = 121/289 (41%), Gaps = 39/289 (13%)

Query: 298 NKLGQGGFGTVYKGVLP-----NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
            +LG+G FG+V            G+ VAVK+L   + + L +F+ EI ++  LQH N+V+
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 353 LVGCGIEGEEK--LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
             G       +   LI E +P  SL  ++   + R+             I KG+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI--KLLQYTSQICKGMEYLGT- 163

Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG-----YMAP 465
              + IHRDL   N+L++ +   KI DFG+ ++  ++++       V   G     + AP
Sbjct: 164 --KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAP 217

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAY---------VWQLWK 516
           E   E  FSV SDV+SFGV++ E+ +    S        + +            + +L K
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277

Query: 517 EGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
               +        +    P  +    I   C   +   RP+  ++   +
Sbjct: 278 NNGRLP-------RPDGCPDEIY--MIMTECWNNNVNQRPSFRDLALRV 317

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  155 bits (395), Expect = 2e-43
 Identities = 57/197 (28%), Positives = 95/197 (48%), Gaps = 13/197 (6%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            +LG G FG V  G      +VA+K + ++     +EF  E  ++  L H  LV+L G  
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +     +I E M N  L  ++   E R +        +   + + + YL      + +H
Sbjct: 89  TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLH 143

Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAMEGLFS 474
           RDL   N L++   V K+SDFG++R   +++ T++     G+     +  PE  M   FS
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV----GSKFPVRWSPPEVLMYSKFS 199

Query: 475 VKSDVFSFGVIVLEIIS 491
            KSD+++FGV++ EI S
Sbjct: 200 SKSDIWAFGVLMWEIYS 216

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  155 bits (394), Expect = 2e-43
 Identities = 63/197 (31%), Positives = 99/197 (50%), Gaps = 13/197 (6%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FG V+ G   N  +VA+K + R+     E+F  E  ++ KL H  LV+L G  
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
           +E     L+ E M +  L  ++            T   +   + +G+ YL       +IH
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAE--TLLGMCLDVCEGMAYL---EEACVIH 127

Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAMEGLFS 474
           RDL   N L+ ++ V K+SDFGM R   ++Q T++T    GT     + +PE      +S
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFSFSRYS 183

Query: 475 VKSDVFSFGVIVLEIIS 491
            KSDV+SFGV++ E+ S
Sbjct: 184 SKSDVWSFGVLMWEVFS 200

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  154 bits (392), Expect = 1e-42
 Identities = 73/310 (23%), Positives = 130/310 (41%), Gaps = 65/310 (20%)

Query: 298 NKLGQGGFGTVYKGVLPNGKE------VAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLV 351
            +LG+G FG V+     N         VAVK L   +    ++F+ E  L+  LQH ++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCF-------------IFDSERRLQLNWNTCYNIIG 398
           +  G   +G+  ++++E M +  L+ F                 + + +L  +   +I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ---KTANTR- 454
            I+ G++YL   +    +HRDL   N L+  +++ KI DFGM+R            +T  
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197

Query: 455 --RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-------GKRNSGFYLTGHAQ 505
             R      +M PE  M   F+ +SDV+SFGVI+ EI +          N          
Sbjct: 198 PIR------WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---------T 242

Query: 506 TLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
            ++  +     +G+ +E       +    P+ V    + L C Q +P  R  +  +  +L
Sbjct: 243 EVIECI----TQGRVLE-------RPRVCPKEVY--DVMLGCWQREPQQRLNIKEIYKIL 289

Query: 566 GSESIALSEP 575
              ++  + P
Sbjct: 290 --HALGKATP 297

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  153 bits (389), Expect = 1e-42
 Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 13/196 (6%)

Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
           +LG G FG V  G      +VAVK + ++     +EF  E   + KL H  LV+  G   
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR 418
           +     ++ E + N  L  ++        L  +    +   + +G+ +L      + IHR
Sbjct: 74  KEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHR 128

Query: 419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAMEGLFSV 475
           DL   N L+D+D+  K+SDFGM R   ++Q  ++     GT     + APE      +S 
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHYFKYSS 184

Query: 476 KSDVFSFGVIVLEIIS 491
           KSDV++FG+++ E+ S
Sbjct: 185 KSDVWAFGILMWEVFS 200

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  153 bits (390), Expect = 3e-42
 Identities = 78/293 (26%), Positives = 126/293 (43%), Gaps = 50/293 (17%)

Query: 298 NKLGQGGFGTVYKGVLPNGKE------VAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLV 351
            +LG+G FG V+     N         VAVK L   S    ++F+ E  L+  LQH+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCF------------IFDSERRLQLNWNTCYNIIGG 399
           R  G   EG   L+++E M +  L+ F              +      L       +   
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ---KTANTR-- 454
           ++ G++YL   + L  +HRDL   N L+ + +V KI DFGM+R             T   
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223

Query: 455 -RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVW 512
            R      +M PE  +   F+ +SDV+SFGV++ EI + GK+    +        +  + 
Sbjct: 224 IR------WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP---WYQLSNTEAIDCI- 273

Query: 513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
               +G+E+E       +  + P  V    I   C Q +P  R ++ +V A L
Sbjct: 274 ---TQGRELE-------RPRACPPEVY--AIMRGCWQREPQQRHSIKDVHARL 314

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  152 bits (387), Expect = 4e-42
 Identities = 70/277 (25%), Positives = 121/277 (43%), Gaps = 30/277 (10%)

Query: 298 NKLGQGGFGTVYKGVLPNGKE----VAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
             +G+G FG VY G   +  +     A+K LSR    Q +E F  E +L+  L H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 353 LVG-CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           L+G          ++   M +  L  FI   +R   +      +    +++G+ YL   +
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVK--DLISFGLQVARGMEYL---A 141

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY--GYMAPEYAM 469
             K +HRDL   N +LD+    K++DFG+AR   + +  +  +         + A E   
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201

Query: 470 EGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL 528
              F+ KSDV+SFGV++ E+++ G      Y       L  ++     +G+ +       
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPP---YRHIDPFDLTHFL----AQGRRLP------ 248

Query: 529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
            +    P  +    +   C + DPAVRPT   +V  +
Sbjct: 249 -QPEYCPDSLY--QVMQQCWEADPAVRPTFRVLVGEV 282

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  152 bits (386), Expect = 4e-42
 Identities = 66/197 (33%), Positives = 105/197 (53%), Gaps = 13/197 (6%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            +LG G FG V+ G      +VAVK L ++     + F  E  L+ +LQH+ LVRL    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV- 76

Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
           +  E   +I E M N SL  F+       +L  N   ++   I++G+ ++        IH
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFI---EERNYIH 132

Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAMEGLFS 474
           RDL+ +N+L+   +  KI+DFG+AR+  +N+ TA      G      + APE    G F+
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE----GAKFPIKWTAPEAINYGTFT 188

Query: 475 VKSDVFSFGVIVLEIIS 491
           +KSDV+SFG+++ EI++
Sbjct: 189 IKSDVWSFGILLTEIVT 205

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  153 bits (389), Expect = 5e-42
 Identities = 62/209 (29%), Positives = 114/209 (54%), Gaps = 23/209 (11%)

Query: 299 KLGQGGFGTVYKGVL--PNGKE---VAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLVR 352
            +G G FG VYKG+L   +GK+   VA+K L +  + +   +F  E  ++ +  H N++R
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
           L G   + +  ++I E M N +LD F+ + +    +       ++ GI+ G+ YL   + 
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL--QLVGMLRGIAAGMKYL---AN 165

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG------YMAPE 466
           +  +HRDL   N+L++ ++V K+SDFG++R+  ++ +   T       G      + APE
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIRWTAPE 220

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIIS-GKR 494
                 F+  SDV+SFG+++ E+++ G+R
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGER 249

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  153 bits (388), Expect = 6e-42
 Identities = 65/209 (31%), Positives = 108/209 (51%), Gaps = 22/209 (10%)

Query: 298 NKLGQGGFGTVYKGVL--PNGKE--VAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLVR 352
             +G G  G V  G L  P  ++  VA+K L +  + +   +F +E  ++ +  H N++R
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
           L G    G   +++ E M N SLD F+   + +  +       ++ G+  G+ YL   S 
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM--QLVGMLRGVGAGMRYL---SD 169

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG------YMAPE 466
           L  +HRDL   NVL+D ++V K+SDFG++R+  ++   A T       G      + APE
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT-----GGKIPIRWTAPE 224

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIIS-GKR 494
                 FS  SDV+SFGV++ E+++ G+R
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  153 bits (388), Expect = 6e-42
 Identities = 62/211 (29%), Positives = 104/211 (49%), Gaps = 27/211 (12%)

Query: 298 NKLGQGGFGTVYKGVLPNGKE-----VAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLV 351
             LG G FGTVYKG+     E     VA+K L    S +  +E  +E  ++A + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLN--WNTCYNIIGGISKGLLYLHE 409
           RL+G         LI +LMP   L  ++ + +  +      N C      I+KG+ YL  
Sbjct: 81  RLLGI-CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV----QIAKGMNYL-- 133

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG-----YMA 464
               +++HRDL   NVL+      KI+DFG+A++    +K  +        G     +MA
Sbjct: 134 -EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMA 187

Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIIS-GKR 494
            E  +  +++ +SDV+S+GV V E+++ G +
Sbjct: 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSK 218

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  152 bits (385), Expect = 7e-42
 Identities = 62/198 (31%), Positives = 103/198 (52%), Gaps = 13/198 (6%)

Query: 298 NKLGQGGFGTVYKGVLPNGK-EVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           +KLG G +G VY+GV       VAVK L ++    +EEF  E  ++ +++H NLV+L+G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   +I E M   +L  ++     R +++      +   IS  + YL    +   I
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL---EKKNFI 133

Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAMEGLF 473
           HRDL   N L+ ++ + K++DFG++R+   +  TA+     G      + APE      F
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA----GAKFPIKWTAPESLAYNKF 189

Query: 474 SVKSDVFSFGVIVLEIIS 491
           S+KSDV++FGV++ EI +
Sbjct: 190 SIKSDVWAFGVLLWEIAT 207

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  156 bits (397), Expect = 9e-42
 Identities = 78/328 (23%), Positives = 138/328 (42%), Gaps = 48/328 (14%)

Query: 249 KRSQRGLLHELAGPISVSLTQEGDLVSSE----ELPFVHLAVIKAATDGFSDSNKLGQGG 304
                GL+  L  P           VS      E+    + +            KLG G 
Sbjct: 183 STVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKH----------KLGGGQ 232

Query: 305 FGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEK 363
           +G VY+GV       VAVK L ++    +EEF  E  ++ +++H NLV+L+G        
Sbjct: 233 YGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291

Query: 364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPS 423
            +I E M   +L  ++     R +++      +   IS  + YL    +   IHR+L   
Sbjct: 292 YIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAAR 347

Query: 424 NVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFG 483
           N L+ ++ + K++DFG++R+   +  TA+         + APE      FS+KSDV++FG
Sbjct: 348 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFG 406

Query: 484 VIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF----VDPL--LMKSSSIPQV 537
           V++ EI +   +    +          V++L ++   ME      + +  LM++      
Sbjct: 407 VLLWEIATYGMSPYPGIDLSQ------VYELLEKDYRMERPEGCPEKVYELMRA------ 454

Query: 538 VRCIHIGLLCVQEDPAVRPTMSNVVALL 565
                    C Q +P+ RP+ + +    
Sbjct: 455 ---------CWQWNPSDRPSFAEIHQAF 473

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  155 bits (393), Expect = 1e-41
 Identities = 88/322 (27%), Positives = 139/322 (43%), Gaps = 41/322 (12%)

Query: 249 KRSQRGLLHELAGPISVSLTQEGDLVSSE-ELPFVHLAVIKAATDGFSDSNKLGQGGFGT 307
            +   GL H L      S  Q   L     E+P   L +            KLGQG FG 
Sbjct: 150 SKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEV----------KLGQGCFGE 199

Query: 308 VYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY 367
           V+ G       VA+K L +      E F  E  ++ KL+H  LV+L    +  E   ++ 
Sbjct: 200 VWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVT 257

Query: 368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL 427
           E M   SL  F    E    L      ++   I+ G+ Y+    R+  +HRDL+ +N+L+
Sbjct: 258 EYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILV 313

Query: 428 DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVL 487
            +++V K++DFG+AR+  +N+ TA          + APE A+ G F++KSDV+SFG+++ 
Sbjct: 314 GENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLT 372

Query: 488 EIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRC---IH-I 543
           E+ +  R     +          V    + G  M             P    C   +H +
Sbjct: 373 ELTTKGRVPYPGMVNRE------VLDQVERGYRMP-----------CPP--ECPESLHDL 413

Query: 544 GLLCVQEDPAVRPTMSNVVALL 565
              C +++P  RPT   + A L
Sbjct: 414 MCQCWRKEPEERPTFEYLQAFL 435

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  156 bits (397), Expect = 1e-41
 Identities = 88/322 (27%), Positives = 139/322 (43%), Gaps = 41/322 (12%)

Query: 249 KRSQRGLLHELAGPISVSLTQEGDLVSSE-ELPFVHLAVIKAATDGFSDSNKLGQGGFGT 307
            +   GL H L      S  Q   L     E+P   L +            KLGQG FG 
Sbjct: 233 SKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEV----------KLGQGCFGE 282

Query: 308 VYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY 367
           V+ G       VA+K L +      E F  E  ++ KL+H  LV+L    +  E   ++ 
Sbjct: 283 VWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEEPIYIVT 340

Query: 368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL 427
           E M   SL  F    E    L      ++   I+ G+ Y+    R+  +HRDL+ +N+L+
Sbjct: 341 EYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILV 396

Query: 428 DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVL 487
            +++V K++DFG+AR+  +N+ TA          + APE A+ G F++KSDV+SFG+++ 
Sbjct: 397 GENLVCKVADFGLARLIEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLT 455

Query: 488 EIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRC---IH-I 543
           E+ +  R     +          V    + G  M             P    C   +H +
Sbjct: 456 ELTTKGRVPYPGMVNRE------VLDQVERGYRMP-----------CPP--ECPESLHDL 496

Query: 544 GLLCVQEDPAVRPTMSNVVALL 565
              C +++P  RPT   + A L
Sbjct: 497 MCQCWRKEPEERPTFEYLQAFL 518

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  152 bits (387), Expect = 2e-41
 Identities = 64/206 (31%), Positives = 110/206 (53%), Gaps = 16/206 (7%)

Query: 298 NKLGQGGFGTVYKGVL--PNGKE--VAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLVR 352
             +G G FG V  G L  P+ KE  VA+K L    + +   +F  E  ++ +  H N++R
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
           L G   + +  +++ E M N SLD F+   +   Q        ++ GI+ G+ YL   S 
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYL---SD 165

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAM 469
           +  +HRDL   N+L++ ++V K+SDFG+ R+  ++ + A T R  G      + +PE   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAIA 223

Query: 470 EGLFSVKSDVFSFGVIVLEIIS-GKR 494
              F+  SDV+S+G+++ E++S G+R
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGER 249

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  150 bits (381), Expect = 2e-41
 Identities = 64/204 (31%), Positives = 92/204 (45%), Gaps = 20/204 (9%)

Query: 299 KLGQGGFGTVYKGVL--PNGKE--VAVKRL---SRKSWQGLEEFKNEIILIAKLQHRNLV 351
           KLG G FG V +G    P+GK   VAVK L        + +++F  E+  +  L HRNL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 352 RLVG-CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           RL G          ++ EL P  SL   +   +    L   T       +++G+ YL E 
Sbjct: 85  RLYGVV--LTPPMKMVTELAPLGSLLDRLRKHQGHFLLG--TLSRYAVQVAEGMGYL-ES 139

Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEY 467
            R   IHRDL   N+LL    + KI DFG+ R   +N      +        + + APE 
Sbjct: 140 KRF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPES 195

Query: 468 AMEGLFSVKSDVFSFGVIVLEIIS 491
                FS  SD + FGV + E+ +
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFT 219

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  150 bits (381), Expect = 2e-41
 Identities = 71/237 (29%), Positives = 109/237 (45%), Gaps = 20/237 (8%)

Query: 264 SVSLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVK 322
           S+  T+EGD  S                D   D   LG+G +G VY G  L N   +A+K
Sbjct: 1   SMRSTEEGDCESDLLEYDYEY-------DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIK 53

Query: 323 RLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY-ELMPNRSLDCFIFD 381
            +  +  +  +    EI L   L+H+N+V+ +G        + I+ E +P  SL   +  
Sbjct: 54  EIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS-FSENGFIKIFMEQVPGGSLSALLRS 112

Query: 382 SERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD-KDMVAKISDFGM 440
               L+ N  T       I +GL YLH++   +I+HRD+K  NVL++    V KISDFG 
Sbjct: 113 KWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGT 169

Query: 441 ARIFCENQKTANTRRVVGTYGYMAPE---YAMEGLFSVKSDVFSFGVIVLEIISGKR 494
           ++          T    GT  YMAPE       G +   +D++S G  ++E+ +GK 
Sbjct: 170 SKRLAGINPCTET--FTGTLQYMAPEIIDKGPRG-YGKAADIWSLGCTIIEMATGKP 223

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  150 bits (381), Expect = 3e-41
 Identities = 72/281 (25%), Positives = 121/281 (43%), Gaps = 38/281 (13%)

Query: 298 NKLGQGGFGTVYKGVL--PNGKE--VAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVR 352
             +G+G FG VY G L   +GK+   AVK L+R      + +F  E I++    H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 353 LVGCGIEGEEKLL-IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           L+G  +  E   L +   M +  L  FI +      +           ++KG+ YL    
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK--DLIGFGLQVAKGMKYLAS-- 146

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG------YMAP 465
             K +HRDL   N +LD+    K++DFG+AR   +         V    G      +MA 
Sbjct: 147 -KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK----EYYSVHNKTGAKLPVKWMAL 201

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV 524
           E      F+ KSDV+SFGV++ E+++ G      Y   +   +  Y+     +G+ +   
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP---YPDVNTFDITVYL----LQGRRLL-- 252

Query: 525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
                +    P  +    + L C      +RP+ S +V+ +
Sbjct: 253 -----QPEYCPDPLY--EVMLKCWHPKAEMRPSFSELVSRI 286

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  150 bits (380), Expect = 3e-41
 Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 22/207 (10%)

Query: 299 KLGQGGFGTVYKGVLPNGKE---VAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +LG G FG+V +GV    K+   VA+K L         EE   E  ++ +L +  +VRL+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           G   + E  +L+ E+     L  F+    +R ++  +    ++  +S G+ YL       
Sbjct: 77  GV-CQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 130

Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG------YMAPEYA 468
            +HRDL   NVLL     AKISDFG+++    +      R             + APE  
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWYAPECI 185

Query: 469 MEGLFSVKSDVFSFGVIVLEIIS-GKR 494
               FS +SDV+S+GV + E +S G++
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQK 212

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  154 bits (391), Expect = 4e-41
 Identities = 74/246 (30%), Positives = 120/246 (48%), Gaps = 23/246 (9%)

Query: 249 KRSQRGLLHELAGPISVSLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTV 308
           K+   GL  +L+ P   S  Q+     + E+P   L + K          KLG G FG V
Sbjct: 155 KKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEK----------KLGAGQFGEV 204

Query: 309 YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE 368
           +        +VAVK + +     +E F  E  ++  LQH  LV+L    +  E   +I E
Sbjct: 205 WMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV-VTKEPIYIITE 262

Query: 369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD 428
            M   SL  F+   E   +       +    I++G+ ++    +   IHRDL+ +N+L+ 
Sbjct: 263 FMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFI---EQRNYIHRDLRAANILVS 318

Query: 429 KDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAMEGLFSVKSDVFSFGVI 485
             +V KI+DFG+AR+  +N+ TA      G      + APE    G F++KSDV+SFG++
Sbjct: 319 ASLVCKIADFGLARVIEDNEYTARE----GAKFPIKWTAPEAINFGSFTIKSDVWSFGIL 374

Query: 486 VLEIIS 491
           ++EI++
Sbjct: 375 LMEIVT 380

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  150 bits (380), Expect = 7e-41
 Identities = 83/319 (26%), Positives = 143/319 (44%), Gaps = 66/319 (20%)

Query: 298 NKLGQGGFGTVYKGVLPNGKE------VAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNL 350
            +LGQG FG VY+GV     +      VA+K ++   S +   EF NE  ++ +    ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCF-------IFDSERRLQLNWNTCYNIIGGISKG 403
           VRL+G   +G+  L+I ELM    L  +       + ++      + +    + G I+ G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCEN--QKTANTR---RVV 457
           + YL+     K +HRDL   N ++ +D   KI DFGM R I+  +  +K        R  
Sbjct: 151 MAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 205

Query: 458 GTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-------GKRNSGFYLTGHAQTLLAY 510
               +M+PE   +G+F+  SDV+SFGV++ EI +       G  N         + +L +
Sbjct: 206 ----WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---------EQVLRF 252

Query: 511 VWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL----- 565
           V     EG  ++       K  + P ++    +  +C Q +P +RP+   +++ +     
Sbjct: 253 V----MEGGLLD-------KPDNCPDMLF--ELMRMCWQYNPKMRPSFLEIISSIKEEME 299

Query: 566 ---GSESIALSEPRQPPFP 581
                 S   SE  + P P
Sbjct: 300 PGFREVSFYYSEENKLPEP 318

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  149 bits (377), Expect = 9e-41
 Identities = 68/267 (25%), Positives = 123/267 (46%), Gaps = 31/267 (11%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVG 355
           ++G+G F TVYKG+      EVA    +  + +    + FK E  ++  LQH N+VR   
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 356 C---GIEGEEKLLIY-ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
                ++G++ +++  ELM + +L  ++   +R   +      +    I KGL +LH  +
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149

Query: 412 RLKIIHRDLKPSNVLLD-KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAME 470
              IIHRDLK  N+ +       KI D G+A +    ++ +  + V+GT  +MAPE   E
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEMYEE 204

Query: 471 GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK 530
             +    DV++FG+ +LE+ + +     Y             Q+++         P    
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYP---YSECQNAA------QIYRRVTSGV--KPASFD 252

Query: 531 SSSIPQVVRCIHIGLLCVQEDPAVRPT 557
             +IP+V   I     C++++   R +
Sbjct: 253 KVAIPEVKEIIE---GCIRQNKDERYS 276

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  148 bits (376), Expect = 9e-41
 Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 24/204 (11%)

Query: 299 KLGQGGFGTVYKGVL--PNGKE--VAVKRLSR-KSWQGLEEFKNEIILIAKLQHRNLVRL 353
            LG+G FG VY+GV     G++  VAVK   +  +    E+F +E +++  L H ++V+L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 354 VG-CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
           +G    E E   +I EL P   L  ++  ++  L++   T       I K + YL     
Sbjct: 79  IGII--EEEPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSLQICKAMAYL---ES 131

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR-----RVVGTYGYMAPEY 467
           +  +HRD+   N+L+      K+ DFG++R   +      +      +      +M+PE 
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK------WMSPES 185

Query: 468 AMEGLFSVKSDVFSFGVIVLEIIS 491
                F+  SDV+ F V + EI+S
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILS 209

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  153 bits (388), Expect = 9e-41
 Identities = 70/247 (28%), Positives = 109/247 (44%), Gaps = 26/247 (10%)

Query: 249 KRSQRGLLHELAGPISVSLTQEGDLVSSE---ELPFVHLAVIKAATDGFSDSNKLGQGGF 305
                GL   L  P  +  T             L    L +++           +G+G F
Sbjct: 157 TTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQ----------TIGKGEF 206

Query: 306 GTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL- 364
           G V  G    G +VAVK +  K+    + F  E  ++ +L+H NLV+L+G  +E +  L 
Sbjct: 207 GDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263

Query: 365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSN 424
           ++ E M   SL  ++    R   L  +        + + + YL        +HRDL   N
Sbjct: 264 IVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARN 319

Query: 425 VLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGV 484
           VL+ +D VAK+SDFG+ +    +      +  V    + APE   E  FS KSDV+SFG+
Sbjct: 320 VLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGI 374

Query: 485 IVLEIIS 491
           ++ EI S
Sbjct: 375 LLWEIYS 381

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  148 bits (376), Expect = 1e-40
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 26/213 (12%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
             +G GGFG V+K     +GK   +KR+   +    E+ + E+  +AKL H N+V   GC
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGC 72

Query: 357 GIEGEEKLLIYELMPNRSLDCFIF---------------DSERRLQLNWNTCYNIIGGIS 401
               +          +RS    +F               +  R  +L+      +   I+
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQIT 132

Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG 461
           KG+ Y+H     K+I+RDLKPSN+ L      KI DFG+       +      R  GT  
Sbjct: 133 KGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTRSKGTLR 186

Query: 462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKR 494
           YM+PE      +  + D+++ G+I+ E++    
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  149 bits (378), Expect = 2e-40
 Identities = 72/287 (25%), Positives = 123/287 (42%), Gaps = 41/287 (14%)

Query: 298 NKLGQGGFGTVYKGVLPNGKE----VAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLV 351
             LG+G FG+V +  L         VAVK L     +   +EEF  E   + +  H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 352 RLVGCGIEGEEK------LLIYELMPNRSLDCFIFDS---ERRLQLNWNTCYNIIGGISK 402
           +LVG  +    K      ++I   M +  L  F+  S   E    L   T    +  I+ 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCEN--QKTANTRRVVGT 459
           G+ YL   S    IHRDL   N +L +DM   ++DFG++R I+  +  ++   ++  V  
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV-- 203

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEG 518
             ++A E   + L++V SDV++FGV + EI++ G+     Y       +  Y+      G
Sbjct: 204 -KWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP---YAGIENAEIYNYL----IGG 255

Query: 519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
             ++       +     + V    +   C   DP  RP+ + +   L
Sbjct: 256 NRLK-------QPPECMEEVY--DLMYQCWSADPKQRPSFTCLRMEL 293

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  147 bits (374), Expect = 2e-40
 Identities = 64/198 (32%), Positives = 98/198 (49%), Gaps = 19/198 (9%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
             +G+G FG V  G    G +VAVK +  K+    + F  E  ++ +L+H NLV+L+G  
Sbjct: 27  QTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 358 IEGEEKLLI-YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
           +E +  L I  E M   SL  ++  S  R  L  +        + + + YL        +
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNFV 139

Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR---RVVGTYGYMAPEYAMEGLF 473
           HRDL   NVL+ +D VAK+SDFG+ +    +      +   +      + APE   E  F
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLPVK------WTAPEALREKKF 191

Query: 474 SVKSDVFSFGVIVLEIIS 491
           S KSDV+SFG+++ EI S
Sbjct: 192 STKSDVWSFGILLWEIYS 209

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  148 bits (375), Expect = 2e-40
 Identities = 77/295 (26%), Positives = 126/295 (42%), Gaps = 52/295 (17%)

Query: 298 NKLGQGGFGTVYKGVLPNGKE------VAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNL 350
            +LG+  FG VYKG L           VA+K L  K      EEF++E +L A+LQH N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCF-------------IFDSERRLQLNWNTCYNII 397
           V L+G   + +   +I+    +  L  F               D   +  L      +++
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN---QKTANTR 454
             I+ G+ YL   S   ++H+DL   NVL+   +  KISD G+ R        +   N+ 
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191

Query: 455 ---RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAY 510
              R      +MAPE  M G FS+ SD++S+GV++ E+ S G +    Y     Q ++  
Sbjct: 192 LPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP---YCGYSNQDVVEM 242

Query: 511 VWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
           +    +  + +             P  V    + + C  E P+ RP   ++ + L
Sbjct: 243 I----RNRQVLP-------CPDDCPAWVY--ALMIECWNEFPSRRPRFKDIHSRL 284

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  150 bits (380), Expect = 2e-40
 Identities = 73/307 (23%), Positives = 132/307 (42%), Gaps = 42/307 (13%)

Query: 274 VSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVL--PNGKE--VAVKRLSRK-S 328
           ++ E +  V   VI  ++     +  +G+G FG VY G L   +GK+   AVK L+R   
Sbjct: 71  LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 130

Query: 329 WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL-IYELMPNRSLDCFIFDSERRLQ 387
              + +F  E I++    H N++ L+G  +  E   L +   M +  L  FI +      
Sbjct: 131 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT 190

Query: 388 LNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN 447
           +           ++KG+ +L   +  K +HRDL   N +LD+    K++DFG+AR   + 
Sbjct: 191 VK--DLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245

Query: 448 -----QKTANTR---RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGF 498
                      +   +      +MA E      F+ KSDV+SFGV++ E+++ G      
Sbjct: 246 EFDSVHNKTGAKLPVK------WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--- 296

Query: 499 YLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTM 558
           Y   +   +  Y+     +G+ +        +    P  +    + L C      +RP+ 
Sbjct: 297 YPDVNTFDITVYL----LQGRRLL-------QPEYCPDPLY--EVMLKCWHPKAEMRPSF 343

Query: 559 SNVVALL 565
           S +V+ +
Sbjct: 344 SELVSRI 350

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  149 bits (378), Expect = 2e-40
 Identities = 50/199 (25%), Positives = 99/199 (49%), Gaps = 9/199 (4%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVG 355
           K+G+G FG         +G++  +K   +SR S +  EE + E+ ++A ++H N+V+   
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
              E     ++ +      L   I ++++ +    +   +    I   L ++H+    KI
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHDR---KI 146

Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSV 475
           +HRD+K  N+ L KD   ++ DFG+AR+     + A     +GT  Y++PE      ++ 
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEICENKPYNN 204

Query: 476 KSDVFSFGVIVLEIISGKR 494
           KSD+++ G ++ E+ + K 
Sbjct: 205 KSDIWALGCVLYELCTLKH 223

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  148 bits (376), Expect = 2e-40
 Identities = 70/292 (23%), Positives = 121/292 (41%), Gaps = 52/292 (17%)

Query: 298 NKLGQGGFGTVYKGVLPNGKE----VAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLV 351
             LG+G FG+V +G L         VAVK +     S + +EEF +E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 352 RLVGCGIEGE-----EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIG---GISKG 403
           RL+G  IE       + ++I   M    L  ++  S             ++     I+ G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCEN--QKTANTRRVVGTY 460
           + YL   S    +HRDL   N +L  DM   ++DFG+++ I+  +  ++    +  V   
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV--- 213

Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-------GKRNSGFYLTGHAQTLLAYVWQ 513
            ++A E   + +++ KSDV++FGV + EI +       G +N           +  Y+  
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN---------HEMYDYL-- 262

Query: 514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
               G  ++       +       +    I   C + DP  RPT S +   L
Sbjct: 263 --LHGHRLK-------QPEDCLDELY--EIMYSCWRTDPLDRPTFSVLRLQL 303

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  148 bits (376), Expect = 3e-40
 Identities = 84/294 (28%), Positives = 123/294 (41%), Gaps = 56/294 (19%)

Query: 298 NKLGQGGFGTVYKGVLPNGK------EVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNL 350
             LG G FG VY+G +          +VAVK L    S Q   +F  E ++I+K  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFI----FDSERRLQLNWNTCYNIIGGISKGLLY 406
           VR +G  ++   + ++ ELM    L  F+        +   L      ++   I+ G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 407 LHEDSRLKIIHRDLKPSNVLLDK---DMVAKISDFGMARIFCENQKTANTRRVVGTYGY- 462
           L        IHRD+   N LL       VAKI DFGMAR   +  + +  R+  G     
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---DIYRASYYRK--GGCAML 207

Query: 463 ----MAPEYAMEGLFSVKSDVFSFGVIVLEIIS-------GKRNSGFYLTGHAQTLLAYV 511
               M PE  MEG+F+ K+D +SFGV++ EI S        K N         Q +L +V
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---------QEVLEFV 258

Query: 512 WQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
                 G  M+          + P  V    I   C Q  P  RP  + ++  +
Sbjct: 259 ----TSGGRMD-------PPKNCPGPVY--RIMTQCWQHQPEDRPNFAIILERI 299

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  148 bits (375), Expect = 3e-40
 Identities = 50/211 (23%), Positives = 96/211 (45%), Gaps = 23/211 (10%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNL--VRL 353
            ++G GG   V++ +    +  A+K ++ +    Q L+ ++NEI  + KLQ  +   +RL
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
                  ++ + +     N  L+ ++   +++  ++     +    + + +  +H+    
Sbjct: 94  YDY-EITDQYIYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 146

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE------- 466
            I+H DLKP+N L+   M+ K+ DFG+A     +  +      VGT  YM PE       
Sbjct: 147 GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205

Query: 467 ----YAMEGLFSVKSDVFSFGVIVLEIISGK 493
                  +   S KSDV+S G I+  +  GK
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  149 bits (377), Expect = 4e-40
 Identities = 84/288 (29%), Positives = 123/288 (42%), Gaps = 44/288 (15%)

Query: 298 NKLGQGGFGTVYKGVLPNGK------EVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNL 350
             LG G FG VY+G +          +VAVK L    S Q   +F  E ++I+K  H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFI----FDSERRLQLNWNTCYNIIGGISKGLLY 406
           VR +G  ++   + ++ ELM    L  F+        +   L      ++   I+ G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 407 LHEDSRLKIIHRDLKPSNVLLDK---DMVAKISDFGMARIFCENQKTANTRRVVGTYGY- 462
           L        IHRD+   N LL       VAKI DFGMAR   +  +    R+  G     
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR---DIYRAGYYRK--GGCAML 248

Query: 463 ----MAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKE 517
               M PE  MEG+F+ K+D +SFGV++ EI S G      Y +   Q +L +V      
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---YPSKSNQEVLEFV----TS 301

Query: 518 GKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
           G  M+          + P  V    I   C Q  P  RP  + ++  +
Sbjct: 302 GGRMD-------PPKNCPGPVY--RIMTQCWQHQPEDRPNFAIILERI 340

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  146 bits (371), Expect = 6e-40
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 22/203 (10%)

Query: 299 KLGQGGFGTVYKGVL--PNGKE--VAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
            +G+G FG V++G+   P      VA+K   +  S    E+F  E + + +  H ++V+L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
           +G  I      +I EL     L  F+   +  L L   +       +S  L YL      
Sbjct: 82  IGV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYL---ESK 135

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR-----RVVGTYGYMAPEYA 468
           + +HRD+   NVL+  +   K+ DFG++R   ++     ++     +      +MAPE  
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK------WMAPESI 189

Query: 469 MEGLFSVKSDVFSFGVIVLEIIS 491
               F+  SDV+ FGV + EI+ 
Sbjct: 190 NFRRFTSASDVWMFGVCMWEILM 212

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  153 bits (388), Expect = 6e-40
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 15/200 (7%)

Query: 299 KLGQGGFGTVYKGVLPNGKE---VAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLVRLV 354
           +LG G FG+V +GV    K+   VA+K L         EE   E  ++ +L +  +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           G   + E  +L+ E+     L  F+    +R ++  +    ++  +S G+ YL       
Sbjct: 403 GV-CQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL---EEKN 456

Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT---YGYMAPEYAMEG 471
            +HR+L   NVLL     AKISDFG+++    +      R          + APE     
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAGKWPLKWYAPECINFR 514

Query: 472 LFSVKSDVFSFGVIVLEIIS 491
            FS +SDV+S+GV + E +S
Sbjct: 515 KFSSRSDVWSYGVTMWEALS 534

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  146 bits (371), Expect = 6e-40
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 26/209 (12%)

Query: 299 KLGQGGFGTVYKGVLPNGK---EVAVKRL--SRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
           +LG G FGTV KG     K    VAVK L          +E   E  ++ +L +  +VR+
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 354 VG-CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
           +G C  E E  +L+ E+     L+ ++  +     +       ++  +S G+ YL     
Sbjct: 84  IGIC--EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYL---EE 135

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG------YMAPE 466
              +HRDL   NVLL     AKISDFG+++    ++     +             + APE
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYAPE 190

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIIS-GKR 494
                 FS KSDV+SFGV++ E  S G++
Sbjct: 191 CINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  148 bits (375), Expect = 7e-40
 Identities = 50/211 (23%), Positives = 96/211 (45%), Gaps = 23/211 (10%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNL--VRL 353
            ++G GG   V++ +    +  A+K ++ +    Q L+ ++NEI  + KLQ  +   +RL
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
                  ++ + +     N  L+ ++   +++  ++     +    + + +  +H+    
Sbjct: 75  YDY-EITDQYIYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 127

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE------- 466
            I+H DLKP+N L+   M+ K+ DFG+A     +  +      VGT  YM PE       
Sbjct: 128 GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 467 ----YAMEGLFSVKSDVFSFGVIVLEIISGK 493
                  +   S KSDV+S G I+  +  GK
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  147 bits (372), Expect = 7e-40
 Identities = 73/297 (24%), Positives = 113/297 (38%), Gaps = 52/297 (17%)

Query: 298 NKLGQGGFGTVYKGVLPNGKE------VAVKRLSRK-SWQGLEEFKNEIILIAKL-QHRN 349
             LG G FG V +       +      VAVK L         E   +E+ +++ L  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG---------- 399
           +V L+G    G   L+I E      L  F+         +  +   +             
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 400 -----ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN---QKTA 451
                ++KG+ +L   +    IHRDL   N+LL    + KI DFG+AR    +       
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFY--LTGHAQTLL 508
           N R  V    +MAPE     +++ +SDV+S+G+ + E+ S G      Y  +   ++   
Sbjct: 206 NARLPV---KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP---YPGMPVDSK-FY 258

Query: 509 AYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
             +    KEG  M             P  +    I   C   DP  RPT   +V L+
Sbjct: 259 KMI----KEGFRML-------SPEHAPAEMY--DIMKTCWDADPLKRPTFKQIVQLI 302

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  147 bits (373), Expect = 9e-40
 Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 22/205 (10%)

Query: 298 NKLGQGGFGTVYKGVLPNGKE-----VAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLV 351
             LG G FGTVYKG+     E     VA+K L    S +  +E  +E  ++A + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           RL+G         LI +LMP   L  ++   E +  +      N    I+KG+ YL    
Sbjct: 81  RLLGI-CLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL---E 134

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG-----YMAPE 466
             +++HRDL   NVL+      KI+DFG+A++    +K  +        G     +MA E
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKWMALE 189

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIIS 491
             +  +++ +SDV+S+GV V E+++
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMT 214

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  146 bits (371), Expect = 9e-40
 Identities = 73/271 (26%), Positives = 130/271 (47%), Gaps = 29/271 (10%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRL---SRKSWQGLEEFKNEIILIAKLQHRNLVRLV 354
           K+G+G F  VY+   L +G  VA+K++        +   +   EI L+ +L H N+++  
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 355 GCGIEGEEKLLIY-ELMPNRSLDCFI-FDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
              IE + +L I  EL     L   I    +++  +   T +     +   L ++H    
Sbjct: 99  ASFIE-DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-- 155

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
            +++HRD+KP+NV +    V K+ D G+ R F      A++  +VGT  YM+PE   E  
Sbjct: 156 -RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHENG 212

Query: 473 FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK-- 530
           ++ KSD++S G ++ E+ + +    FY  G    L +    L K+ ++ ++  PL     
Sbjct: 213 YNFKSDIWSLGCLLYEMAALQS--PFY--GDKMNLYS----LCKKIEQCDY-PPLPSDHY 263

Query: 531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
           S  + Q+V       +C+  DP  RP ++ V
Sbjct: 264 SEELRQLVN------MCINPDPEKRPDVTYV 288

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  147 bits (373), Expect = 1e-39
 Identities = 72/304 (23%), Positives = 125/304 (41%), Gaps = 67/304 (22%)

Query: 298 NKLGQGGFGTVYKGVLPNGKE--------VAVKRLSRK-SWQGLEEFKNEIILIAKL-QH 347
             LG+G FG V         +        VAVK L    + + L +  +E+ ++  + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-------- 399
           +N++ L+G   +     +I E     +L  ++                +           
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 400 -----ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCEN--QKTA 451
                +++G+ YL   +  K IHRDL   NVL+ ++ V KI+DFG+AR I   +  +KT 
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217

Query: 452 NTR---RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-------GKRNSGFYLT 501
           N R   +      +MAPE   + +++ +SDV+SFGV++ EI +       G         
Sbjct: 218 NGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------ 265

Query: 502 GHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
              + L   +    KEG  M+       K ++    +    +   C    P+ RPT   +
Sbjct: 266 ---EELFKLL----KEGHRMD-------KPANCTNELY--MMMRDCWHAVPSQRPTFKQL 309

Query: 562 VALL 565
           V  L
Sbjct: 310 VEDL 313

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  148 bits (376), Expect = 1e-39
 Identities = 49/211 (23%), Positives = 95/211 (45%), Gaps = 23/211 (10%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNL--VRL 353
            ++G GG   V++ +    +  A+K ++ +    Q L+ ++NEI  + KLQ  +   +RL
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
                  ++ + +     N  L+ ++   +++  ++     +    + + +  +H+    
Sbjct: 122 YDY-EITDQYIYMVMECGNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 174

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE------- 466
            I+H DLKP+N L+   M+ K+ DFG+A     +  +      VG   YM PE       
Sbjct: 175 GIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSS 233

Query: 467 ----YAMEGLFSVKSDVFSFGVIVLEIISGK 493
                  +   S KSDV+S G I+  +  GK
Sbjct: 234 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  147 bits (372), Expect = 1e-39
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 22/205 (10%)

Query: 298 NKLGQGGFGTVYKGVLPNGKE-----VAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLV 351
             LG G FGTV+KGV     E     V +K +  +   Q  +   + ++ I  L H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           RL+G    G    L+ + +P  SL   +      L        N    I+KG+ YL    
Sbjct: 79  RLLGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQ--LLLNWGVQIAKGMYYL---E 132

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG-----YMAPE 466
              ++HR+L   NVLL      +++DFG+A +   + K                 +MA E
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIKWMALE 187

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIIS 491
               G ++ +SDV+S+GV V E+++
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMT 212

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  146 bits (371), Expect = 1e-39
 Identities = 82/347 (23%), Positives = 146/347 (42%), Gaps = 83/347 (23%)

Query: 261 GPISVSLTQEGDLVSSE-ELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKE- 318
           GP+S+S+     L   + E P  +L + K           LG+G FG V K    + K  
Sbjct: 1   GPLSLSVDAFKILEDPKWEFPRKNLVLGK----------TLGEGEFGKVVKATAFHLKGR 50

Query: 319 -----VAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPN 372
                VAVK L    S   L +  +E  ++ ++ H ++++L G   +    LLI E    
Sbjct: 51  AGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKY 110

Query: 373 RSLDCFIFDSERRLQLNWNTCYNIIGG---------------------ISKGLLYLHEDS 411
            SL  F+ +S +       +  +                         IS+G+ YL   +
Sbjct: 111 GSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---A 167

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCEN--QKTANTR---RVVGTYGYMAP 465
            +K++HRDL   N+L+ +    KISDFG++R ++ E+   K +  R   +      +MA 
Sbjct: 168 EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVK------WMAI 221

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIIS-------GKRNSGFYLTGHAQTLLAYVWQLWKEG 518
           E   + +++ +SDV+SFGV++ EI++       G            + L   +    K G
Sbjct: 222 ESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP---------ERLFNLL----KTG 268

Query: 519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
             ME       +  +  + +    + L C +++P  RP  +++   L
Sbjct: 269 HRME-------RPDNCSEEMY--RLMLQCWKQEPDKRPVFADISKDL 306

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  147 bits (374), Expect = 1e-39
 Identities = 84/384 (21%), Positives = 148/384 (38%), Gaps = 80/384 (20%)

Query: 218 VNENCNLRFQLSLFYNASTRIALTYPTSTDEKRSQRGLLHELAGPISVSLTQEGDLVSSE 277
           + +   LR Q+++   +S+ +    P      R        +   +S     E       
Sbjct: 20  LTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKW--- 76

Query: 278 ELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKE--------VAVKRLSRK-S 328
           E P   L + K           LG+G FG V         +        VAVK L    +
Sbjct: 77  EFPRDKLTLGK----------PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT 126

Query: 329 WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ 387
            + L +  +E+ ++  + +H+N++ L+G   +     +I E     +L  ++        
Sbjct: 127 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGM 186

Query: 388 LNWNTCYNIIGG-------------ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAK 434
                   +                +++G+ YL   +  K IHRDL   NVL+ ++ V K
Sbjct: 187 EYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMK 243

Query: 435 ISDFGMAR-IFCEN--QKTANTR---RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLE 488
           I+DFG+AR I   +  +KT N R   +      +MAPE   + +++ +SDV+SFGV++ E
Sbjct: 244 IADFGLARDINNIDYYKKTTNGRLPVK------WMAPEALFDRVYTHQSDVWSFGVLMWE 297

Query: 489 IIS-------GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCI 541
           I +       G            + L   +    KEG  M+       K ++    +   
Sbjct: 298 IFTLGGSPYPGIPV---------EELFKLL----KEGHRMD-------KPANCTNELY-- 335

Query: 542 HIGLLCVQEDPAVRPTMSNVVALL 565
            +   C    P+ RPT   +V  L
Sbjct: 336 MMMRDCWHAVPSQRPTFKQLVEDL 359

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  146 bits (370), Expect = 2e-39
 Identities = 71/300 (23%), Positives = 119/300 (39%), Gaps = 59/300 (19%)

Query: 298 NKLGQGGFGTVYKGVLPNGKE------VAVKRLSRK-SWQGLEEFKNEIILIAKL-QHRN 349
             LG+G FG V +       +      VAVK L    +        +E+ ++  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 350 LVRLVG-CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG--------- 399
           +V L+G C   G   ++I E     +L  ++               ++            
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 400 ----ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN---QKTAN 452
               ++KG+ +L   +  K IHRDL   N+LL +  V KI DFG+AR   ++    +  +
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209

Query: 453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-------GKRNSGFYLTGHAQ 505
            R  +    +MAPE   + +++++SDV+SFGV++ EI S       G       +    +
Sbjct: 210 ARLPL---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEE 259

Query: 506 TLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
                  +  KEG  M                +      L C   +P+ RPT S +V  L
Sbjct: 260 -----FCRRLKEGTRMR-------APDYTTPEMY--QTMLDCWHGEPSQRPTFSELVEHL 305

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  145 bits (367), Expect = 2e-39
 Identities = 47/215 (21%), Positives = 88/215 (40%), Gaps = 38/215 (17%)

Query: 299 KLGQGGFGTVYKGVL--------PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNL 350
            LGQG F  ++KGV          +  EV +K L +      E F     +++KL H++L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           V   G  + G+E +L+ E +   SLD ++  ++  + + W     +   ++  + +L   
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL--EVAKQLAAAMHFL--- 129

Query: 411 SRLKIIHRDLKPSNVLLDKD--------MVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
               +IH ++   N+LL ++           K+SD G++                     
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------ILQ 178

Query: 463 -----MAPEYAMEG-LFSVKSDVFSFGVIVLEIIS 491
                + PE        ++ +D +SFG  + EI S
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  145 bits (369), Expect = 3e-39
 Identities = 72/290 (24%), Positives = 120/290 (41%), Gaps = 47/290 (16%)

Query: 298 NKLGQGGFGTVYKGVLPNGKE---VAVKRL-SRKSWQGLEEFKNEIILIAKL-QHRNLVR 352
           + +G+G FG V K  +         A+KR+    S     +F  E+ ++ KL  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG------------- 399
           L+G         L  E  P+ +L  F+  S            N                 
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR---RV 456
           +++G+ YL   S+ + IHRDL   N+L+ ++ VAKI+DFG++R      K    R   R 
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR- 206

Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLW 515
                +MA E     +++  SDV+S+GV++ EI+S G      Y       L   +    
Sbjct: 207 -----WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP---YCGMTCAELYEKL---- 254

Query: 516 KEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
            +G  +E       K  +    V    +   C +E P  RP+ + ++  L
Sbjct: 255 PQGYRLE-------KPLNCDDEVY--DLMRQCWREKPYERPSFAQILVSL 295

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  144 bits (366), Expect = 1e-38
 Identities = 78/292 (26%), Positives = 123/292 (42%), Gaps = 44/292 (15%)

Query: 298 NKLGQGGFGTVYKGVL------PNGKEVAVKRL-SRKSWQGLEEFKNEIILIAKL-QHRN 349
             LG G FG V +             +VAVK L S       E   +E+ +++ L QH N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYN-----------IIG 398
           +V L+G    G   L+I E      L  F+    R L+ +                    
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 399 GISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCEN--QKTANTRR 455
            +++G+ +L   +    IHRD+   NVLL    VAKI DFG+AR I  ++      N R 
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228

Query: 456 VVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQL 514
            V    +MAPE   + +++V+SDV+S+G+++ EI S G   + +            V   
Sbjct: 229 PV---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL--NPYPGILVNSKFYKLV--- 280

Query: 515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG 566
            K+G +M        + +  P+ +    I   C   +P  RPT   + + L 
Sbjct: 281 -KDGYQMA-------QPAFAPKNIY--SIMQACWALEPTHRPTFQQICSFLQ 322

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  144 bits (365), Expect = 2e-38
 Identities = 74/309 (23%), Positives = 130/309 (42%), Gaps = 72/309 (23%)

Query: 298 NKLGQGGFGTVYKGVLPNGKE------VAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNL 350
             +G+G FG V++   P          VAVK L  + S     +F+ E  L+A+  + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCF---------------------IFDSERRLQLN 389
           V+L+G    G+   L++E M    L+ F                        S     L+
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 390 WNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCEN- 447
                 I   ++ G+ YL   S  K +HRDL   N L+ ++MV KI+DFG++R I+  + 
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229

Query: 448 -QKTANTR---RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-------GKRNS 496
            +   N     R      +M PE      ++ +SDV+++GV++ EI S       G  + 
Sbjct: 230 YKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH- 282

Query: 497 GFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRP 556
                   + ++ YV    ++G  +           + P  +   ++  LC  + PA RP
Sbjct: 283 --------EEVIYYV----RDGNILA-------CPENCPLELY--NLMRLCWSKLPADRP 321

Query: 557 TMSNVVALL 565
           +  ++  +L
Sbjct: 322 SFCSIHRIL 330

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  145 bits (367), Expect = 2e-38
 Identities = 73/304 (24%), Positives = 123/304 (40%), Gaps = 67/304 (22%)

Query: 298 NKLGQGGFGTVYKGVLPNGK--------EVAVKRLSRK-SWQGLEEFKNEIILIAKL-QH 347
             LG+G FG V                 +VAVK L    + + L +  +E+ ++  + +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG-------- 399
           +N++ L+G   +     +I E     +L  ++               +            
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 400 -----ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN---QKTA 451
                +++G+ YL   +  K IHRDL   NVL+ +D V KI+DFG+AR        +KT 
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251

Query: 452 NTR---RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-------GKRNSGFYLT 501
           N R   +      +MAPE   + +++ +SDV+SFGV++ EI +       G         
Sbjct: 252 NGRLPVK------WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------ 299

Query: 502 GHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
              + L   +    KEG  M+       K S+    +    +   C    P+ RPT   +
Sbjct: 300 ---EELFKLL----KEGHRMD-------KPSNCTNELY--MMMRDCWHAVPSQRPTFKQL 343

Query: 562 VALL 565
           V  L
Sbjct: 344 VEDL 347

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  142 bits (359), Expect = 2e-38
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 10/204 (4%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVG 355
            +G G +G   K     +GK +  K       +    +   +E+ L+ +L+H N+VR   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 356 CGIEGEEKLL--IYELMPNRSLDCFI-FDSERRLQLNWNTCYNIIGGISKGLLYLHE--D 410
             I+     L  + E      L   I   ++ R  L+      ++  ++  L   H   D
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAME 470
               ++HRDLKP+NV LD     K+ DFG+ARI   +   A T   VGT  YM+PE    
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYMSPEQMNR 190

Query: 471 GLFSVKSDVFSFGVIVLEIISGKR 494
             ++ KSD++S G ++ E+ +   
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMP 214

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  142 bits (361), Expect = 5e-38
 Identities = 64/268 (23%), Positives = 108/268 (40%), Gaps = 21/268 (7%)

Query: 234 ASTRIALTYPTSTDEKRSQRGLLHELAGPISVSLTQEGDLVSSEELPFVHLAVIKAATDG 293
            S  ++     S                 +         ++ +E+L  V     +     
Sbjct: 1   GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEY-REEVHW 59

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFK-NEIILIAKLQHRNLV 351
            +   ++G+G FG V++      G + AVK++       LE F+  E++  A L    +V
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIV 113

Query: 352 RLVGCGIEGEEKLLIY-ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
            L G   EG   + I+ EL+   SL   I   ++   L  +     +G   +GL YLH  
Sbjct: 114 PLYGAVREGP-WVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR 169

Query: 411 SRLKIIHRDLKPSNVLLDKD-MVAKISDFGMARIFCENQKTANTRR---VVGTYGYMAPE 466
              +I+H D+K  NVLL  D   A + DFG A     +    +      + GT  +MAPE
Sbjct: 170 ---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGKR 494
             M      K D++S   ++L +++G  
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCH 254

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  142 bits (359), Expect = 1e-37
 Identities = 71/303 (23%), Positives = 116/303 (38%), Gaps = 59/303 (19%)

Query: 298 NKLGQGGFGTVYKGVLPNGKE------VAVKRLSRK-SWQGLEEFKNEIILIAKL-QHRN 349
             LG G FG V         +      VAVK L  K      E   +E+ ++ +L  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG---------- 399
           +V L+G         LI+E      L  ++     +   +     N              
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 400 ----------ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCEN- 447
                     ++KG+ +L        +HRDL   NVL+    V KI DFG+AR I  ++ 
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227

Query: 448 -QKTANTR---RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTG 502
                N R   +      +MAPE   EG++++KSDV+S+G+++ EI S G   + +    
Sbjct: 228 YVVRGNARLPVK------WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV--NPYPGIP 279

Query: 503 HAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
                   +    + G +M+       +     + +    I   C   D   RP+  N+ 
Sbjct: 280 VDANFYKLI----QNGFKMD-------QPFYATEEIY--IIMQSCWAFDSRKRPSFPNLT 326

Query: 563 ALL 565
           + L
Sbjct: 327 SFL 329

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  140 bits (355), Expect = 1e-37
 Identities = 64/265 (24%), Positives = 104/265 (39%), Gaps = 36/265 (13%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEE---FKNEIILIAKL-QHRNLVRL 353
           +LG G +G V+K     +G+  AVKR S   ++G ++      E+    K+ QH   VRL
Sbjct: 64  RLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
                EG    L  EL    SL            L     +  +      L +LH     
Sbjct: 123 EQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLHS---Q 176

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF 473
            ++H D+KP+N+ L      K+ DFG+                 G   YMAPE  ++G +
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEV--QEGDPRYMAPE-LLQGSY 232

Query: 474 SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK-SS 532
              +DVFS G+ +LE+                  L +  + W++ ++           SS
Sbjct: 233 GTAADVFSLGLTILEVACNME-------------LPHGGEGWQQLRQGYLPPEFTAGLSS 279

Query: 533 SIPQVVRCIHIGLLCVQEDPAVRPT 557
            +  V+       + ++ DP +R T
Sbjct: 280 ELRSVLV------MMLEPDPKLRAT 298

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  140 bits (355), Expect = 2e-37
 Identities = 50/219 (22%), Positives = 92/219 (42%), Gaps = 24/219 (10%)

Query: 292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG-LEEFKNEIILIAKLQHRN 349
             +  S+ LGQG    V++G     G   A+K  +  S+   ++    E  ++ KL H+N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 350 LVRLVGCGIEGEEKLLIY---ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLY 406
           +V+L     E           E  P  SL   + +      L  +    ++  +  G+ +
Sbjct: 69  IVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 407 LHEDSRLKIIHRDLKPSNVLL----DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           L E     I+HR++KP N++     D   V K++DFG AR   ++++   +  + GT  Y
Sbjct: 128 LRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS--LYGTEEY 181

Query: 463 MAPE--------YAMEGLFSVKSDVFSFGVIVLEIISGK 493
           + P+           +  +    D++S GV      +G 
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  139 bits (353), Expect = 2e-37
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 29/219 (13%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            LGQG FG V K     + +  A+K++ R + + L    +E++L+A L H+ +VR     
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71

Query: 358 IEGEEKLLIYELMPNRSLDCFI---------FD--SERRLQLNWNTCYNIIGGISKGLLY 406
           +E    +     +  +S              +D      L    +  + +   I + L Y
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSY 131

Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR----------- 455
           +H      IIHRDLKP N+ +D+    KI DFG+A+    +                   
Sbjct: 132 IHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188

Query: 456 -VVGTYGYMAPE-YAMEGLFSVKSDVFSFGVIVLEIISG 492
             +GT  Y+A E     G ++ K D++S G+I  E+I  
Sbjct: 189 SAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  146 bits (369), Expect = 3e-37
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 12/198 (6%)

Query: 299 KLGQGGFGTVYKGVL--PNGKE--VAVKRL-SRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
            +G+G FG V++G+   P      VA+K   +  S    E+F  E + + +  H ++V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
           +G  I      +I EL     L  F+    R+  L+  +       +S  L YL      
Sbjct: 457 IGV-ITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL---ESK 510

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF 473
           + +HRD+   NVL+  +   K+ DFG++R   ++     ++  +    +MAPE      F
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRF 569

Query: 474 SVKSDVFSFGVIVLEIIS 491
           +  SDV+ FGV + EI+ 
Sbjct: 570 TSASDVWMFGVCMWEILM 587

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  142 bits (359), Expect = 5e-37
 Identities = 53/210 (25%), Positives = 94/210 (44%), Gaps = 21/210 (10%)

Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEI-ILIAKLQHRNLVR 352
           F   + LG G  GT+    + + ++VAVKR+  +          E+ +L    +H N++R
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIR 82

Query: 353 LVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
                 +  +   +  EL    +L  ++   ++           ++   + GL +LH   
Sbjct: 83  YFCT-EKDRQFQYIAIELCAA-TLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHS-- 136

Query: 412 RLKIIHRDLKPSNVLL-----DKDMVAKISDFGMARIFCENQKTANTRR-VVGTYGYMAP 465
            L I+HRDLKP N+L+        + A ISDFG+ +     + + + R  V GT G++AP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 466 EY---AMEGLFSVKSDVFSFGVIVLEIISG 492
           E      +   +   D+FS G +   +IS 
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  139 bits (352), Expect = 2e-36
 Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 24/212 (11%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEE-FKNEIILIAKLQHRNLVRLVGC 356
            LGQG    V++G     G   A+K  +  S+    +    E  ++ KL H+N+V+L   
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 357 GIEGEEKLLIY---ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
             E           E  P  SL   + +      L  +    ++  +  G+ +L E    
Sbjct: 76  -EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131

Query: 414 KIIHRDLKPSNVLL----DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE--- 466
            I+HR++KP N++     D   V K++DFG AR   ++++   +  + GT  Y+ P+   
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVS--LYGTEEYLHPDMYE 188

Query: 467 -----YAMEGLFSVKSDVFSFGVIVLEIISGK 493
                   +  +    D++S GV      +G 
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  137 bits (346), Expect = 4e-36
 Identities = 66/306 (21%), Positives = 117/306 (38%), Gaps = 47/306 (15%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           KLG+GGF  V     L +G   A+KR+     Q  EE + E  +     H N++RLV   
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 358 IE----GEEKLLIYELMPNRSLDCFIFDSERRLQLNW----NTCYNIIGGISKGLLYLHE 409
           +       E  L+       +L   I   ER          +    ++ GI +GL  +H 
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEI---ERLKDKGNFLTEDQILWLLLGICRGLEAIHA 152

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVV-------GTYGY 462
                  HRDLKP+N+LL  +    + D G     C + + +     +        T  Y
Sbjct: 153 ---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209

Query: 463 MAPE------YAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWK 516
            APE      + +      ++DV+S G ++  ++ G+    + +       +A       
Sbjct: 210 RAPELFSVQSHCVID---ERTDVWSLGCVLYAMMFGE--GPYDMVFQKGDSVAL-----A 259

Query: 517 EGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPR 576
              ++         SS++ Q++         +  DP  RP +  +++ L  E++    P 
Sbjct: 260 VQNQLSIPQSPRH-SSALWQLLNS------MMTVDPHQRPHIPLLLSQL--EALQPPAPG 310

Query: 577 QPPFPV 582
           Q    +
Sbjct: 311 QHTTQI 316

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  139 bits (352), Expect = 4e-36
 Identities = 60/223 (26%), Positives = 88/223 (39%), Gaps = 36/223 (16%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEI-ILIAKLQHRNLVRLVGC 356
             LG G  GTV       G+ VAVKR+        +    EI +L     H N++R   C
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYY-C 76

Query: 357 GIEGEEKL-LIYELMPNRSLDCFI----FDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
               +  L +  EL    +L   +       E           +++  I+ G+ +LH   
Sbjct: 77  SETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-- 133

Query: 412 RLKIIHRDLKPSNVLLD-------------KDMVAKISDFGMARIFCENQKTANTRR--V 456
            LKIIHRDLKP N+L+              +++   ISDFG+ +     Q +  T     
Sbjct: 134 -LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192

Query: 457 VGTYGYMAPEYAMEGLFSV-------KSDVFSFGVIVLEIISG 492
            GT G+ APE   E              D+FS G +   I+S 
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  139 bits (351), Expect = 6e-35
 Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 19/208 (9%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEE-FKNEIILIAKLQHRNLVRLVGC 356
           +LG GGFG V + +    G++VA+K+  ++      E +  EI ++ KL H N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 357 GIEGEEKL-------LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
             +G +KL       L  E      L  ++   E    L       ++  IS  L YLHE
Sbjct: 81  -PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139

Query: 410 DSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
               +IIHRDLKP N++L    + ++ KI D G A+   + +        VGT  Y+APE
Sbjct: 140 ---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTEF--VGTLQYLAPE 193

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGKR 494
              +  ++V  D +SFG +  E I+G R
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFR 221

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  130 bits (329), Expect = 4e-34
 Identities = 56/290 (19%), Positives = 108/290 (37%), Gaps = 65/290 (22%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKR--LSRKSWQGLEEFKNEIILIAKL-QHRNLVRLV 354
           K+G G FG+V+K V   +G   A+KR           +    E+   A L QH ++VR  
Sbjct: 18  KIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77

Query: 355 GCGIEGEEKLLIY-ELMPNRSLDCFIFDSERRLQ-LNWNTCYNIIGGISKGLLYLHEDSR 412
               E +  +LI  E     SL   I ++ R +         +++  + +GL Y+H    
Sbjct: 78  SAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM-- 134

Query: 413 LKIIHRDLKPSNVLLDKD-------------------MVAKISDFGMARIFCENQKTANT 453
             ++H D+KPSN+ + +                    ++ KI D G         + ++ 
Sbjct: 135 -SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT------RISSP 187

Query: 454 RRVVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW 512
           +   G   ++A E   E      K+D+F+  + V+     +                   
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE------------------- 228

Query: 513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGL-----LCVQEDPAVRPT 557
            L + G +        ++   +P++ + +         + +  DP  RP+
Sbjct: 229 PLPRNGDQW-----HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPS 273

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  130 bits (328), Expect = 7e-34
 Identities = 56/201 (27%), Positives = 105/201 (52%), Gaps = 10/201 (4%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           ++   K+GQG  GTVY  + +  G+EVA+++++ +     E   NEI+++ + ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
            +   + G+E  ++ E +   SL   +  +E  +         +     + L +LH +  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAA--VCRECLQALEFLHSN-- 135

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
            ++IHRD+K  N+LL  D   K++DFG        Q   +T  +VGT  +MAPE      
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 192

Query: 473 FSVKSDVFSFGVIVLEIISGK 493
           +  K D++S G++ +E+I G+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGE 213

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  131 bits (331), Expect = 9e-34
 Identities = 60/221 (27%), Positives = 103/221 (46%), Gaps = 11/221 (4%)

Query: 275 SSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGL 332
             E        V +   D F   ++LG G  G V+K    P+G  +A K +  +      
Sbjct: 16  RLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIR 75

Query: 333 EEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNT 392
            +   E+ ++ +     +V   G      E  +  E M   SLD  +   ++  ++    
Sbjct: 76  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQI 132

Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN 452
              +   + KGL YL E    KI+HRD+KPSN+L++     K+ DFG++    ++   AN
Sbjct: 133 LGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--AN 188

Query: 453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           +   VGT  YM+PE      +SV+SD++S G+ ++E+  G+
Sbjct: 189 S--FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  129 bits (326), Expect = 2e-33
 Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 14/203 (6%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
                K+G+G  G V       +G++VAVK +  +  Q  E   NE++++   QH N+V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
           +    + GEE  ++ E +   +L     D   +++LN      +   + + L YLH    
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ-- 160

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPEYAME 470
             +IHRD+K  ++LL  D   K+SDFG    FC        +R  +VGT  +MAPE    
Sbjct: 161 -GVIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGTPYWMAPEVISR 215

Query: 471 GLFSVKSDVFSFGVIVLEIISGK 493
            L++ + D++S G++V+E++ G+
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGE 238

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  128 bits (324), Expect = 2e-33
 Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 17/203 (8%)

Query: 299 KLGQGGFGTVYKG---VLPNGKEVAVKRLSRKSWQG----LEEFKNEIILIAKLQHRNLV 351
           KLG GG  TVY     +L    +VA+K +     +     L+ F+ E+   ++L H+N+V
Sbjct: 18  KLGGGGMSTVYLAEDTIL--NIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNIV 74

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            ++    E +   L+ E +   +L  +I   E    L+ +T  N    I  G+ + H   
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAH--- 128

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
            ++I+HRD+KP N+L+D +   KI DFG+A+   E   T  T  V+GT  Y +PE A   
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGE 187

Query: 472 LFSVKSDVFSFGVIVLEIISGKR 494
                +D++S G+++ E++ G+ 
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEP 210

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  128 bits (324), Expect = 3e-33
 Identities = 61/202 (30%), Positives = 104/202 (51%), Gaps = 11/202 (5%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLV 351
           F+   K+G+G FG V+KG+     K VA+K +  +  +  +E+ + EI ++++     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +  G  ++  +  +I E +   S      D      L+      I+  I KGL YLH + 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSE- 138

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
             K IHRD+K +NVLL +    K++DFG+A    + Q   NT   VGT  +MAPE   + 
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 194

Query: 472 LFSVKSDVFSFGVIVLEIISGK 493
            +  K+D++S G+  +E+  G+
Sbjct: 195 AYDSKADIWSLGITAIELARGE 216

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  128 bits (323), Expect = 5e-33
 Identities = 70/242 (28%), Positives = 114/242 (47%), Gaps = 29/242 (11%)

Query: 265 VSLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKR 323
           +S+   G L  S E  +          +   D  ++G+G +G+V K V  P+G+ +AVKR
Sbjct: 1   MSIESSGKLKISPEQHW------DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKR 54

Query: 324 LSRKSWQGLEEFK---NEI-ILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFI 379
           +        +E K    ++ +++       +V+  G      +  +  ELM + S D F 
Sbjct: 55  IRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY 111

Query: 380 FDSERRLQLNWNTCYNIIGGIS----KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKI 435
                 L         I+G I+    K L +L E+  LKIIHRD+KPSN+LLD+    K+
Sbjct: 112 KYVYSVLDDVIPE--EILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKL 167

Query: 436 SDFGMARIFCENQKTANTRRVVGTYGYMAPE----YAMEGLFSVKSDVFSFGVIVLEIIS 491
            DFG++    +   +    R  G   YMAPE     A    + V+SDV+S G+ + E+ +
Sbjct: 168 CDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELAT 224

Query: 492 GK 493
           G+
Sbjct: 225 GR 226

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  127 bits (320), Expect = 8e-33
 Identities = 54/206 (26%), Positives = 101/206 (49%), Gaps = 13/206 (6%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           +    +LG G FG VYK      G   A K +  KS + LE++  EI ++A   H  +V+
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
           L+G      +  ++ E  P  ++D  + + +R L         +   + + L +LH    
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV--VCRQMLEALNFLHSK-- 136

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE-----Y 467
            +IIHRDLK  NVL+  +   +++DFG++    +  +  ++   +GT  +MAPE      
Sbjct: 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCET 193

Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGK 493
             +  +  K+D++S G+ ++E+   +
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIE 219

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  126 bits (320), Expect = 8e-33
 Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 20/202 (9%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQ--GLEE-FKNEIILIAKLQHRNLVRLVG 355
           LG+GGF   ++       +  A K + +         E    EI +   L H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
              E  + + ++ EL   RSL     +  +RR  L        +  I  G  YLH   R 
Sbjct: 83  F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLH---RN 134

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVV--GTYGYMAPEYAMEG 471
           ++IHRDLK  N+ L++D+  KI DFG+A       +    R+ V  GT  Y+APE   + 
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV----EYDGERKKVLCGTPNYIAPEVLSKK 190

Query: 472 LFSVKSDVFSFGVIVLEIISGK 493
             S + DV+S G I+  ++ GK
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGK 212

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  127 bits (320), Expect = 2e-32
 Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 20/202 (9%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQ--GLEE-FKNEIILIAKLQHRNLVRLVG 355
           LG+GGF   ++       +  A K + +         E    EI +   L H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
              E  + + ++ EL   RSL     +  +RR  L        +  I  G  YLH   R 
Sbjct: 109 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARYYLRQIVLGCQYLH---RN 160

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVV--GTYGYMAPEYAMEG 471
           ++IHRDLK  N+ L++D+  KI DFG+A       +    R+ V  GT  Y+APE   + 
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV----EYDGERKKVLCGTPNYIAPEVLSKK 216

Query: 472 LFSVKSDVFSFGVIVLEIISGK 493
             S + DV+S G I+  ++ GK
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGK 238

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  124 bits (315), Expect = 3e-32
 Identities = 58/201 (28%), Positives = 106/201 (52%), Gaps = 17/201 (8%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQ--GLEE-FKNEIILIAKLQHRNLVRLVG 355
           LG+G F  VY+   +  G EVA+K + +K+    G+ +  +NE+ +  +L+H +++ L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
              E    + L+ E+  N  ++ ++ +  +    + N   + +  I  G+LYLH      
Sbjct: 79  Y-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPF--SENEARHFMHQIITGMLYLH---SHG 132

Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPEYAMEGL 472
           I+HRDL  SN+LL ++M  KI+DFG+A       K  + +   + GT  Y++PE A    
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQL----KMPHEKHYTLCGTPNYISPEIATRSA 188

Query: 473 FSVKSDVFSFGVIVLEIISGK 493
             ++SDV+S G +   ++ G+
Sbjct: 189 HGLESDVWSLGCMFYTLLIGR 209

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  127 bits (320), Expect = 3e-32
 Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 33/206 (16%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVK-----RLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
            +G+G F  V + +    G++ AVK     + +       E+ K E  +   L+H ++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 353 LVGCGIEGEEKL-LIYELMP---------NRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           L+      +  L +++E M           R+   F++ SE           + +  I +
Sbjct: 91  LLET-YSSDGMLYMVFEFMDGADLCFEIVKRADAGFVY-SEA-------VASHYMRQILE 141

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
            L Y H+     IIHRD+KP  VLL   +     K+  FG+A    E+   A  R  VGT
Sbjct: 142 ALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR--VGT 196

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVI 485
             +MAPE      +    DV+  GVI
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVI 222

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  125 bits (315), Expect = 3e-32
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 30/218 (13%)

Query: 292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFK---NEI-ILIAKLQ 346
           D      +LG+G +G V K   +P+G+ +AVKR+        +E K    ++ I +  + 
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTVD 64

Query: 347 HRNLVRLVGCGIEGEEKLLIYELMPNRSLDCF---IFDSERRLQLNWNTCYNIIGGIS-- 401
               V   G      +  +  ELM + SLD F   + D  + +        +I+G I+  
Sbjct: 65  CPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIP------EDILGKIAVS 117

Query: 402 --KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
             K L +LH  S+L +IHRD+KPSNVL++     K+ DFG++     +    +     G 
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDI--DAGC 172

Query: 460 YGYMAPE----YAMEGLFSVKSDVFSFGVIVLEIISGK 493
             YMAPE       +  +SVKSD++S G+ ++E+   +
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  125 bits (315), Expect = 6e-32
 Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 10/201 (4%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           F    KLG+G +G+VYK +    G+ VA+K++  +    L+E   EI ++ +    ++V+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVK 88

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
             G   +  +  ++ E     S+   I    + L  +      I+    KGL YLH    
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE--IATILQSTLKGLEYLHFM-- 144

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
            + IHRD+K  N+LL+ +  AK++DFG+A    +     NT  V+GT  +MAPE   E  
Sbjct: 145 -RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQEIG 201

Query: 473 FSVKSDVFSFGVIVLEIISGK 493
           ++  +D++S G+  +E+  GK
Sbjct: 202 YNCVADIWSLGITAIEMAEGK 222

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  127 bits (322), Expect = 9e-32
 Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 38/228 (16%)

Query: 286 VIKAATDGFSD----SNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG--LEEFKNE 338
            I +     S+      KLG G +G V          E A+K + + S       +   E
Sbjct: 27  FITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEE 86

Query: 339 IILIAKLQHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFD--------SERRLQLN 389
           + ++  L H N+++L     E +    L+ E      L    FD        +E      
Sbjct: 87  VAVLKLLDHPNIMKLYDF-FEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEV----- 136

Query: 390 WNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCE 446
                 II  +  G+ YLH+     I+HRDLKP N+LL   +KD + KI DFG++ +F  
Sbjct: 137 --DAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191

Query: 447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKR 494
            +K    +  +GT  Y+APE  +   +  K DV+S GVI+  +++G  
Sbjct: 192 QKK---MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP 235

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  127 bits (320), Expect = 2e-31
 Identities = 71/227 (31%), Positives = 109/227 (48%), Gaps = 39/227 (17%)

Query: 286 VIKAATDGFSD----SNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG---LEEFKN 337
            ++ +T  FSD       LG+G FG V        G+E AVK +S++  +     E    
Sbjct: 16  FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75

Query: 338 EIILIAKLQHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFD--------SERRLQL 388
           E+ L+ +L H N+++L     E +    L+ E+     L    FD        SE     
Sbjct: 76  EVQLLKQLDHPNIMKLYEF-FEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEV---- 126

Query: 389 NWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFC 445
                  II  +  G+ Y+H+    KI+HRDLKP N+LL    KD   +I DFG++  F 
Sbjct: 127 ---DAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180

Query: 446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
            ++K    +  +GT  Y+APE  + G +  K DV+S GVI+  ++SG
Sbjct: 181 ASKK---MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  122 bits (309), Expect = 2e-31
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 14/213 (6%)

Query: 292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQ-GLEEFKNEIILIAKLQHRN 349
           D +     +G G    V      P  ++VA+KR++ +  Q  ++E   EI  +++  H N
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTC-YNIIGGIS----KGL 404
           +V      +  +E  L+ +L+   S+   I     + +        + I  I     +GL
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGM-ARIFCENQKTANTRR--VVGTYG 461
            YLH++     IHRD+K  N+LL +D   +I+DFG+ A +      T N  R   VGT  
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 462 YMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
           +MAPE   +   +  K+D++SFG+  +E+ +G 
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  125 bits (317), Expect = 5e-31
 Identities = 68/210 (32%), Positives = 101/210 (48%), Gaps = 34/210 (16%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG--LEEFKNEIILIAKLQHRNLVRLV 354
             LG+G FG V K       +E AVK +++ S +         E+ L+ KL H N+++L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 355 GCGIEGEEKL-LIYELMPNRSLDCFIFD--------SERRLQLNWNTCYNIIGGISKGLL 405
              +E      ++ EL     L    FD        SE            II  +  G+ 
Sbjct: 88  EI-LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHD-------AARIIKQVFSGIT 135

Query: 406 YLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           Y+H+     I+HRDLKP N+LL   +KD   KI DFG++  F +N K    +  +GT  Y
Sbjct: 136 YMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYY 189

Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISG 492
           +APE  + G +  K DV+S GVI+  ++SG
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  122 bits (309), Expect = 5e-31
 Identities = 65/308 (21%), Positives = 115/308 (37%), Gaps = 48/308 (15%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGC 356
            L +GGF  VY+   + +G+E A+KRL     +       E+  + KL  H N+V+    
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 357 GI-------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
                     G+ + L+   +    L  F+   E R  L+ +T   I     + + ++H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH- 153

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR----------VVGT 459
             +  IIHRDLK  N+LL      K+ DFG A         + + +             T
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213

Query: 460 YGYMAPEYAMEGLFS-----VKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL 514
             Y  PE  +  L+S      K D+++ G I+  +   +    F      + +       
Sbjct: 214 PMYRTPE--IIDLYSNFPIGEKQDIWALGCILYLLCFRQ--HPFEDGAKLRIVNG----- 264

Query: 515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSE 574
                  ++  P      +         +    +Q +P  R +++ VV  L  + IA + 
Sbjct: 265 -------KYSIPPHDTQYT-----VFHSLIRAMLQVNPEERLSIAEVVHQL--QEIAAAR 310

Query: 575 PRQPPFPV 582
              P  P+
Sbjct: 311 NVNPKSPI 318

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  121 bits (306), Expect = 9e-31
 Identities = 49/203 (24%), Positives = 85/203 (41%), Gaps = 17/203 (8%)

Query: 299 KLGQGGFGTVYKG---VLPNGKEVAVKRLSRKSWQG----LEEFKNEIILIAKLQHRNLV 351
            +G+GG G VY+    V    + VA+K +  ++           + E     +LQ  ++V
Sbjct: 41  LVGRGGMGDVYEAEDTVR--ERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHVV 97

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            +   G    +  +   L+    L   +    R+  L       I+  I   L   H   
Sbjct: 98  PIHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA- 153

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
                HRD+KP N+L+  D  A + DFG+A    + + T      VGT  YMAPE   E 
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LGNTVGTLYYMAPERFSES 210

Query: 472 LFSVKSDVFSFGVIVLEIISGKR 494
             + ++D+++   ++ E ++G  
Sbjct: 211 HATYRADIYALTCVLYECLTGSP 233

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  121 bits (306), Expect = 9e-31
 Identities = 52/208 (25%), Positives = 88/208 (42%), Gaps = 21/208 (10%)

Query: 299 KLGQGGFGTVYKG---VLPNGKEVAVKRLSRKSWQG----LEEFKNEIILIAKLQHRNLV 351
            LG GG   V+          ++VAVK L R            F+ E    A L H  +V
Sbjct: 19  ILGFGGMSEVHLARDLRD--HRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 352 RLVGCGIEGEEKLLIY----ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
            +   G        +     E +   +L   +        +       +I    + L + 
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFS 132

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT-ANTRRVVGTYGYMAPE 466
           H   +  IIHRD+KP+N+++      K+ DFG+AR   ++  +   T  V+GT  Y++PE
Sbjct: 133 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGKR 494
            A       +SDV+S G ++ E+++G+ 
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEP 217

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  122 bits (309), Expect = 1e-30
 Identities = 67/259 (25%), Positives = 113/259 (43%), Gaps = 29/259 (11%)

Query: 243 PTSTDEKRSQRGLLHELAGPISVSLTQEGDL---VSSEELPFVHLAVIKAATDGFSD--- 296
             S   +  +     +L   + V   +   L   + +   PF H  ++ A     +    
Sbjct: 32  SRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDH-RIVTAKQGAVNSFYT 90

Query: 297 ---SNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
              +  LG G FG V+K      G ++A K +  +  +  EE KNEI ++ +L H NL++
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 353 LVGCGIEGEEKL-LIYELMPNRSLDCFIFDS--ERRLQLNWNTCYNIIGGISKGLLYLHE 409
           L     E +  + L+ E +    L    FD   +    L        +  I +G+ ++H+
Sbjct: 151 LYDA-FESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205

Query: 410 DSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
              + I+H DLKP N+L    D   + KI DFG+AR +   +K    +   GT  ++APE
Sbjct: 206 ---MYILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREK---LKVNFGTPEFLAPE 258

Query: 467 YAMEGLFSVKSDVFSFGVI 485
                  S  +D++S GVI
Sbjct: 259 VVNYDFVSFPTDMWSVGVI 277

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  122 bits (309), Expect = 1e-30
 Identities = 49/193 (25%), Positives = 85/193 (44%), Gaps = 17/193 (8%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           +LG G FG V++ V    G+    K ++          KNEI ++ +L H  L+ L    
Sbjct: 58  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA- 116

Query: 358 IEGEEKL-LIYELMPNRSLDCFIFD--SERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
            E + ++ LI E +    L    FD  +    +++     N +    +GL ++HE     
Sbjct: 117 FEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HS 169

Query: 415 IIHRDLKPSNVLL--DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
           I+H D+KP N++    K    KI DFG+A     ++     +    T  + APE      
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREP 226

Query: 473 FSVKSDVFSFGVI 485
               +D+++ GV+
Sbjct: 227 VGFYTDMWAIGVL 239

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  120 bits (304), Expect = 1e-30
 Identities = 55/201 (27%), Positives = 88/201 (43%), Gaps = 32/201 (15%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            LG G F  V+       GK  A+K + +         +NEI ++ K++H N+V L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI- 74

Query: 358 IEGEEKL-LIYELMPNRSLDCFIFD--------SERRLQLNWNTCYNIIGGISKGLLYLH 408
            E      L+ +L+    L    FD        +E+           +I  +   + YLH
Sbjct: 75  YESTTHYYLVMQLVSGGEL----FDRILERGVYTEKD-------ASLVIQQVLSAVKYLH 123

Query: 409 EDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           E     I+HRDLKP N+L    +++    I+DFG++++     +        GT GY+AP
Sbjct: 124 E---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME----QNGIMSTACGTPGYVAP 176

Query: 466 EYAMEGLFSVKSDVFSFGVIV 486
           E   +  +S   D +S GVI 
Sbjct: 177 EVLAQKPYSKAVDCWSIGVIT 197

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  122 bits (307), Expect = 2e-30
 Identities = 64/274 (23%), Positives = 111/274 (40%), Gaps = 47/274 (17%)

Query: 241 TYPTSTDEKRSQRGLLHELAGPISVSLTQEGDLVSSEELPFVHLAVIKAATDGFSD---- 296
            +  S  +  SQ   L   A  ++ +  +  + +  + +         AA   F      
Sbjct: 39  AFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDP 98

Query: 297 SNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG--------LEEFKNEI-ILIAKLQ 346
            + +G+G    V + V    G E AVK +   + +          E  + E  IL     
Sbjct: 99  KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158

Query: 347 HRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFD--------SERRLQLNWNTCYNII 397
           H +++ L+    E    + L+++LM    L    FD        SE+          +I+
Sbjct: 159 HPHIITLIDS-YESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKE-------TRSIM 206

Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVV 457
             + + + +LH      I+HRDLKP N+LLD +M  ++SDFG +      +K    R + 
Sbjct: 207 RSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELC 260

Query: 458 GTYGYMAPE------YAMEGLFSVKSDVFSFGVI 485
           GT GY+APE            +  + D+++ GVI
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  122 bits (308), Expect = 2e-30
 Identities = 54/309 (17%), Positives = 99/309 (32%), Gaps = 47/309 (15%)

Query: 291 TDGFSDSNKLGQG--GFGTVYKGV-LPNGKEVAVKR--LSRKSWQGLEEFKNEIILIAKL 345
              +     +G+G     TV      P G+ V V+R  L   S + +   + E+ +    
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSL-DCFIFDSERRLQLNWNTCYNIIGGISKGL 404
            H N+V      I   E  ++   M   S  D  +  +     +N      I+ G+ K L
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYILQGVLKAL 141

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV-----VGT 459
            Y+H       +HR +K S++L+  D    +S          + +            V  
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198

Query: 460 YGYMAPEYAMEGL--FSVKSDVFSFGVIVLEIISGK----------------RNSGFYLT 501
             +++PE   + L  +  KSD++S G+   E+ +G                   +   L 
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258

Query: 502 GHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGL-------------LCV 548
             +      +            +   L  S+  P                        C+
Sbjct: 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL 318

Query: 549 QEDPAVRPT 557
           Q +P  RP+
Sbjct: 319 QRNPDARPS 327

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  119 bits (302), Expect = 2e-30
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 33/202 (16%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG--LEEFKNEIILIAKLQHRNLVRLVG 355
           +LG+G F  V + V    G E A K ++ K       ++ + E  +  KLQH N+VRL  
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72

Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFD--------SERRLQLNWNTCYNIIGGISKGLLY 406
             I+ E    L+++L+    L    F+        SE           + I  I + + Y
Sbjct: 73  S-IQEESFHYLVFDLVTGGEL----FEDIVAREFYSEAD-------ASHCIQQILESIAY 120

Query: 407 LHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
            H      I+HR+LKP N+LL    K    K++DFG+A    +++         GT GY+
Sbjct: 121 CHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGTPGYL 174

Query: 464 APEYAMEGLFSVKSDVFSFGVI 485
           +PE   +  +S   D+++ GVI
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVI 196

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  120 bits (302), Expect = 2e-30
 Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 34/202 (16%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG--LEEFKNEIILIAKLQHRNLVRLVG 355
            LG+G FG V K       +E AVK +++ S +         E+ L+ KL H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFD--------SERRLQLNWNTCYNIIGGISKGLLY 406
             +E      ++ EL     L    FD        SE            II  +  G+ Y
Sbjct: 89  I-LEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEH-------DAARIIKQVFSGITY 136

Query: 407 LHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           +H+     I+HRDLKP N+LL   +KD   KI DFG++  F +N K    +  +GT  Y+
Sbjct: 137 MHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYI 190

Query: 464 APEYAMEGLFSVKSDVFSFGVI 485
           APE  + G +  K DV+S GVI
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVI 211

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  120 bits (303), Expect = 2e-30
 Identities = 60/247 (24%), Positives = 104/247 (42%), Gaps = 35/247 (14%)

Query: 261 GPISVSLTQEGDLVSSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEV 319
           G    S  Q G L    +         +A  +   +  ++G G  G V+K      G  +
Sbjct: 1   GSSGSSGKQTGYLTIGGQ-------RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVI 53

Query: 320 AVKRLSRKSWQGLEEFKN---EI-ILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSL 375
           AVK++ R      EE K    ++ +++       +V+  G  I   +  +  ELM     
Sbjct: 54  AVKQMRRSG--NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCA 110

Query: 376 DCFIFDSERRLQLNWNTCYNIIGGIS----KGLLYLHEDSRLKIIHRDLKPSNVLLDKDM 431
           +      +  +         I+G ++    K L YL E     +IHRD+KPSN+LLD+  
Sbjct: 111 EKLKKRMQGPIPER------ILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERG 162

Query: 432 VAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE-----YAMEGLFSVKSDVFSFGVIV 486
             K+ DFG++             R  G   YMAPE        +  + +++DV+S G+ +
Sbjct: 163 QIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISL 219

Query: 487 LEIISGK 493
           +E+ +G+
Sbjct: 220 VELATGQ 226

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  120 bits (303), Expect = 3e-30
 Identities = 43/204 (21%), Positives = 81/204 (39%), Gaps = 31/204 (15%)

Query: 368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL 427
           +L    +L  ++             C +I   I++ + +LH      ++HRDLKPSN+  
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFF 197

Query: 428 DKDMVAKISDFGMARIFCENQKTANTR----------RVVGTYGYMAPEYAMEGLFSVKS 477
             D V K+ DFG+     ++++                 VGT  YM+PE      +S K 
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257

Query: 478 DVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQV 537
           D+FS G+I+ E++          T   +       ++  + + ++F      K      +
Sbjct: 258 DIFSLGLILFELLYSFS------TQMERV------RIITDVRNLKFPLLFTQKYPQEHMM 305

Query: 538 VRCIHIGLLCVQEDPAVRPTMSNV 561
           V+        +   P  RP  +++
Sbjct: 306 VQ------DMLSPSPTERPEATDI 323

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  121 bits (305), Expect = 3e-30
 Identities = 33/293 (11%), Positives = 66/293 (22%), Gaps = 51/293 (17%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRL---SRKSWQGLEEFKNEIILIAKLQHRNLVRL-- 353
           L  G    V+    +   ++ A+K     +  S   LE         A+L   +      
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 354 ---------------------VGCGIEGEEKLLIYELMP------NRSLDCFIFDSERRL 386
                                +  G +         LMP              F    R 
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 387 QLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE 446
                  + +   + +    L       ++H    P N+ +  D    + D         
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246

Query: 447 NQKTANTRRVVGTYGYMAPEYAM--EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHA 504
                          Y   E+       F+   + +  G+ +  +            G  
Sbjct: 247 RGPA-----SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF-----LPFGLV 296

Query: 505 QTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT 557
              +   W+     +            + +P  V+ +    L    D   R  
Sbjct: 297 TPGIKGSWKR-PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNF--DRRRRLL 346

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  120 bits (303), Expect = 3e-30
 Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 41/210 (19%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEE--------FKNEIILIAKLQHRN 349
            LG G  G V         K+VA+K +S++ +              + EI ++ KL H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFD--------SERRLQLNWNTCYNIIGGIS 401
           ++++     + E+  ++ ELM    L    FD         E        TC      + 
Sbjct: 77  IIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEA-------TCKLYFYQML 124

Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVG 458
             + YLHE     IIHRDLKP NVLL   ++D + KI+DFG ++I  E       R + G
Sbjct: 125 LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCG 178

Query: 459 TYGYMAPE---YAMEGLFSVKSDVFSFGVI 485
           T  Y+APE         ++   D +S GVI
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  121 bits (305), Expect = 3e-30
 Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 37/219 (16%)

Query: 286 VIKAATDGFSDS----NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG--LEEFKNE 338
            +  A+  FSD+     +LG+G F  V + V    G E A K ++ K       ++ + E
Sbjct: 19  FMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLERE 78

Query: 339 IILIAKLQHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFD--------SERRLQLN 389
             +  KLQH N+VRL    I+ E    L+++L+    L    F+        SE      
Sbjct: 79  ARICRKLQHPNIVRLHDS-IQEESFHYLVFDLVTGGEL----FEDIVAREFYSEAD---- 129

Query: 390 WNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCE 446
                + I  I + + Y H      I+HR+LKP N+LL    K    K++DFG+A    +
Sbjct: 130 ---ASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183

Query: 447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVI 485
           ++         GT GY++PE   +  +S   D+++ GVI
Sbjct: 184 SEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVI 219

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  122 bits (307), Expect = 4e-30
 Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 41/211 (19%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEE--------FKNEIILIAKLQHRN 349
            LG G  G V         K+VA++ +S++ +              + EI ++ KL H  
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFD--------SERRLQLNWNTCYNIIGGIS 401
           ++++     + E+  ++ ELM    L    FD         E        TC      + 
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEA-------TCKLYFYQML 249

Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVG 458
             + YLHE     IIHRDLKP NVLL   ++D + KI+DFG ++I  E       R + G
Sbjct: 250 LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCG 303

Query: 459 TYGYMAPE---YAMEGLFSVKSDVFSFGVIV 486
           T  Y+APE         ++   D +S GVI+
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  118 bits (299), Expect = 4e-30
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 32/200 (16%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            +G+G +G V   V        A K++ +   + ++ FK EI ++  L H N++RL    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET- 74

Query: 358 IEGEEKL-LIYELMPNRSLDCFIFD--------SERRLQLNWNTCYNIIGGISKGLLYLH 408
            E    + L+ EL     L    F+         E           +++  ++    Y H
Sbjct: 75  FEDNTDIYLVMELCTGGEL----FERVVHKRVFRESDAA---RIMKDVLSAVA----YCH 123

Query: 409 EDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           +   L + HRDLKP N L      D   K+ DFG+A  F   +     R  VGT  Y++P
Sbjct: 124 K---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSP 177

Query: 466 EYAMEGLFSVKSDVFSFGVI 485
           +  +EGL+  + D +S GV+
Sbjct: 178 Q-VLEGLYGPECDEWSAGVM 196

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  120 bits (303), Expect = 4e-30
 Identities = 54/221 (24%), Positives = 96/221 (43%), Gaps = 35/221 (15%)

Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRK-----------------SWQGLEEFKNEIIL 341
            L QG F  +      + K  A+K+  +                       ++FKNE+ +
Sbjct: 38  TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 342 IAKLQHRNLVRLVGCGIEGEEKL-LIYELMPNRSL-----DCFIFDSERRLQLNWNTCYN 395
           I  +++   +   G  I   +++ +IYE M N S+       F+ D      +       
Sbjct: 97  ITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155

Query: 396 IIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ-KTANTR 454
           II  +     Y+H  +   I HRD+KPSN+L+DK+   K+SDFG +    + + K +   
Sbjct: 156 IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS--- 210

Query: 455 RVVGTYGYMAPE-YAMEGLFS-VKSDVFSFGVIVLEIISGK 493
              GTY +M PE ++ E  ++  K D++S G+ +  +    
Sbjct: 211 --RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  121 bits (306), Expect = 7e-30
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 32/202 (15%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEE--FKNEIILIAKLQHRNLVRLVG 355
           +LG+G F  V + V +  G+E A   ++ K     +    + E  +   L+H N+VRL  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFD--------SERRLQLNWNTCYNIIGGISKGLLY 406
             I  E    LI++L+    L    F+        SE           + I  I + +L+
Sbjct: 78  S-ISEEGHHYLIFDLVTGGEL----FEDIVAREYYSEAD-------ASHCIQQILEAVLH 125

Query: 407 LHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
            H+   + ++HR+LKP N+LL    K    K++DFG+A      Q+        GT GY+
Sbjct: 126 CHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYL 180

Query: 464 APEYAMEGLFSVKSDVFSFGVI 485
           +PE   +  +    D+++ GVI
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVI 202

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  118 bits (298), Expect = 7e-30
 Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 48/228 (21%)

Query: 288 KAATDGFSD----SNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGL---------E 333
             +T GF +       LG+G    V + +  P  KE AVK +                 E
Sbjct: 9   SHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE 68

Query: 334 EFKNEI-ILIAKLQHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFD--------SE 383
               E+ IL     H N+++L     E      L+++LM    L    FD        SE
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDT-YETNTFFFLVFDLMKKGEL----FDYLTEKVTLSE 123

Query: 384 RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI 443
           +           I+  + + +  LH+   L I+HRDLKP N+LLD DM  K++DFG +  
Sbjct: 124 KE-------TRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173

Query: 444 FCENQKTANTRRVVGTYGYMAPE------YAMEGLFSVKSDVFSFGVI 485
               +K    R V GT  Y+APE            +  + D++S GVI
Sbjct: 174 LDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  118 bits (298), Expect = 1e-29
 Identities = 48/193 (24%), Positives = 83/193 (43%), Gaps = 18/193 (9%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            LG+G FG V++ V   + K    K +  K        K EI ++   +HRN++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHES- 69

Query: 358 IEGEEKL-LIYELMPNRSLDCFIFD--SERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
            E  E+L +I+E +    +    F+  +    +LN     + +  + + L +LH      
Sbjct: 70  FESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFLHS---HN 122

Query: 415 IIHRDLKPSNVLL--DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
           I H D++P N++    +    KI +FG AR           R +     Y APE     +
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDV 179

Query: 473 FSVKSDVFSFGVI 485
            S  +D++S G +
Sbjct: 180 VSTATDMWSLGTL 192

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  116 bits (294), Expect = 2e-29
 Identities = 52/194 (26%), Positives = 90/194 (46%), Gaps = 15/194 (7%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLS-RKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
           KLG G FG V+      +G E  +K ++  +S   +E+ + EI ++  L H N++++   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 357 GIEGEEKL-LIYELMPNRSL-DCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
             E    + ++ E      L +  +    R   L+      ++  +   L Y H      
Sbjct: 89  -FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QH 144

Query: 415 IIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
           ++H+DLKP N+L          KI DFG+A +F  ++ + N     GT  YMAPE   + 
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAGTALYMAPE-VFKR 200

Query: 472 LFSVKSDVFSFGVI 485
             + K D++S GV+
Sbjct: 201 DVTFKCDIWSAGVV 214

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  121 bits (306), Expect = 2e-29
 Identities = 59/256 (23%), Positives = 104/256 (40%), Gaps = 22/256 (8%)

Query: 243 PTSTDEKRSQRGLLHELAGPISV---SLTQEGDLVSSEELPFVHLAVIKAATDGFSD--- 296
               DE++ +RG   +  G I     +++   D    +     +   ++   D   D   
Sbjct: 101 LIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYD 160

Query: 297 -SNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLV 354
              +LG G FG V++      G   A K +        E  + EI  ++ L+H  LV L 
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 220

Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFD--SERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
               +  E ++IYE M    L    F+  ++   +++ +     +  + KGL ++HE   
Sbjct: 221 DAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE--- 273

Query: 413 LKIIHRDLKPSNVLL--DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAME 470
              +H DLKP N++    +    K+ DFG+       Q     +   GT  + APE A  
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEG 330

Query: 471 GLFSVKSDVFSFGVIV 486
                 +D++S GV+ 
Sbjct: 331 KPVGYYTDMWSVGVLS 346

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  118 bits (298), Expect = 3e-29
 Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 38/207 (18%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG------LEEFKNEIILIAKLQHRNLV 351
           +LG G F  V K      G E A K + ++  +        EE + E+ ++ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 352 RLVGCGIEGEEKL-LIYELMPNRSLDCFIFD--------SERRLQLNWNTCYNIIGGISK 402
            L     E    + LI EL+    L    FD        SE           + I  I  
Sbjct: 79  TLHDV-YENRTDVVLILELVSGGEL----FDFLAQKESLSEEE-------ATSFIKQILD 126

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLL----DKDMVAKISDFGMARIFCENQKTANTRRVVG 458
           G+ YLH     KI H DLKP N++L          K+ DFG+A    +  +    + + G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180

Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVI 485
           T  ++APE        +++D++S GVI
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVI 207

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  118 bits (297), Expect = 3e-29
 Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 19/207 (9%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLS---RKSWQGLEEFKNEIILIAKLQHRN 349
           FSD  ++G G FG VY    + N + VA+K++S   ++S +  ++   E+  + KL+H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
            ++  GC +      L+ E     + D        +  L       +  G  +GL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE--- 466
                +IHRD+K  N+LL +  + K+ DFG           AN+   VGT  +MAPE   
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFG----SASIMAPANS--FVGTPYWMAPEVIL 223

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGK 493
              EG +  K DV+S G+  +E+   K
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERK 250

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  120 bits (303), Expect = 3e-29
 Identities = 63/239 (26%), Positives = 101/239 (42%), Gaps = 49/239 (20%)

Query: 286 VIKAATDGFSD----SNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG--------- 331
            ++       +      KLG G +G V          E A+K + +  +           
Sbjct: 26  YVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKN 85

Query: 332 ----LEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFD----- 381
                EE  NEI L+  L H N+++L     E ++   L+ E      L    F+     
Sbjct: 86  IEKFHEEIYNEISLLKSLDHPNIIKLFDV-FEDKKYFYLVTEFYEGGEL----FEQIINR 140

Query: 382 ---SERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKI 435
               E           NI+  I  G+ YLH+     I+HRD+KP N+LL   +  +  KI
Sbjct: 141 HKFDEC-------DAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKI 190

Query: 436 SDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKR 494
            DFG++  F ++ K    R  +GT  Y+APE  ++  ++ K DV+S GVI+  ++ G  
Sbjct: 191 VDFGLSSFFSKDYK---LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  116 bits (293), Expect = 6e-29
 Identities = 56/207 (27%), Positives = 88/207 (42%), Gaps = 38/207 (18%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG------LEEFKNEIILIAKLQHRNLV 351
           +LG G F  V K      G E A K + ++  +        EE + E+ ++ ++ H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 352 RLVGCGIEGEEKL-LIYELMPNRSLDCFIFD--------SERRLQLNWNTCYNIIGGISK 402
            L     E    + LI EL+    L    FD        SE           + I  I  
Sbjct: 79  TLHDV-YENRTDVVLILELVSGGEL----FDFLAQKESLSEEE-------ATSFIKQILD 126

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLL----DKDMVAKISDFGMARIFCENQKTANTRRVVG 458
           G+ YLH     KI H DLKP N++L          K+ DFG+A    +  +    + + G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFG 180

Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVI 485
           T  ++APE        +++D++S GVI
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVI 207

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  116 bits (292), Expect = 7e-29
 Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 22/214 (10%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLV 351
           F     +G G +G VYKG  +  G+  A+K +        EE K EI ++ K   HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84

Query: 352 RLVGC-----GIEGEEKL-LIYELMPNRSL-DCFIFDSERRLQLNWNTCYNIIGGISKGL 404
              G          +++L L+ E     S+ D         L+  W     I   I +GL
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 142

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            +LH+    K+IHRD+K  NVLL ++   K+ DFG++          NT   +GT  +MA
Sbjct: 143 SHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT--FIGTPYWMA 197

Query: 465 PE-----YAMEGLFSVKSDVFSFGVIVLEIISGK 493
           PE        +  +  KSD++S G+  +E+  G 
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  117 bits (295), Expect = 1e-28
 Identities = 43/347 (12%), Positives = 91/347 (26%), Gaps = 73/347 (21%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLS---RKSWQGLEEFKNEIILIAKLQ--------- 346
           LGQ       +      G+   V       R     +++ K E++ +  L+         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 347 -------------HRNLVRLVGCGIEGEEK--LLIYELMPNRSLDCFIF------DSERR 385
                             +++   ++  +   L  + L P    +   F       S   
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 386 LQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC 445
             L  +    +   + + L  LH      ++H  L+P +++LD+     ++ F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 446 ENQKTANTRRVVGTYGYMAPE-----YAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYL 500
            +  +    R        A            L +   D ++ G+ +  I           
Sbjct: 263 ASAVSP-IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI----------W 311

Query: 501 TGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSN 560
                           +   +   + +     +IPQ VR +  G L  +     R     
Sbjct: 312 CADL---------PNTDDAALGGSEWIFRSCKNIPQPVRALLEGFL--RYPKEDRLLPLQ 360

Query: 561 VV---------ALLGSESIALSEPRQPPFPVGRTIVLAEQPSTKDPS 598
            +           L +         +P    G       QP     +
Sbjct: 361 AMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGAA 407

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  114 bits (288), Expect = 1e-28
 Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 22/204 (10%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQ--GLEE-FKNEIILIAKLQHRNLVRL 353
             LG+G FG VY      +   +A+K L +   +  G+E   + E+ + + L+H N++RL
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 354 VGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQ-LNWNTCYNIIGGISKGLLYLHEDS 411
            G       ++ LI E  P  ++    +   ++L   +       I  ++  L Y H   
Sbjct: 75  YGY-FHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCH--- 126

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPEYAM 469
             ++IHRD+KP N+LL      KI+DFG +          ++RR  + GT  Y+ PE   
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSV------HAPSSRRTDLCGTLDYLPPEMIE 180

Query: 470 EGLFSVKSDVFSFGVIVLEIISGK 493
             +   K D++S GV+  E + GK
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGK 204

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  120 bits (302), Expect = 1e-28
 Identities = 41/205 (20%), Positives = 83/205 (40%), Gaps = 26/205 (12%)

Query: 299 KLGQGGFGTVYKG---VLPNGKEVAVKRLSRKSWQGLEE-FKNEIILIAKLQHRNLVRLV 354
            +  GG G +Y      + NG+ V +K L        +     E   +A++ H ++V++ 
Sbjct: 87  CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 355 GCGIEGEEKL-----LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
                 +        ++ E +  +SL        +  +L        +  I   L YLH 
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLLEILPALSYLH- 199

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
              + +++ DLKP N++L ++ + K+ D G         +  +   + GT G+ APE   
Sbjct: 200 --SIGLVYNDLKPENIMLTEEQL-KLIDLGAVS------RINSFGYLYGTPGFQAPEIVR 250

Query: 470 EGLFSVKSDVFSFGVIVLEIISGKR 494
            G  +V +D+++ G  +  +     
Sbjct: 251 TGP-TVATDIYTVGRTLAALTLDLP 274

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  115 bits (291), Expect = 1e-28
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 38/207 (18%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG------LEEFKNEIILIAKLQHRNLV 351
           +LG G F  V K      G + A K + ++  +        E+ + E+ ++ ++QH N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 352 RLVGCGIEGEEKL-LIYELMPNRSLDCFIFD--------SERRLQLNWNTCYNIIGGISK 402
            L     E +  + LI EL+    L    FD        +E             +  I  
Sbjct: 78  TLHEV-YENKTDVILILELVAGGEL----FDFLAEKESLTEEE-------ATEFLKQILN 125

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLL----DKDMVAKISDFGMARIFCENQKTANTRRVVG 458
           G+ YLH    L+I H DLKP N++L          KI DFG+A       +    + + G
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFG 179

Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVI 485
           T  ++APE        +++D++S GVI
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVI 206

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  115 bits (290), Expect = 2e-28
 Identities = 57/269 (21%), Positives = 96/269 (35%), Gaps = 54/269 (20%)

Query: 275 SSEELPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVK-----RLSRKS 328
           S  E  +     +      +     +GQG +G V   +        A+K     ++ + +
Sbjct: 9   SGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQIN 68

Query: 329 WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL-LIYELM----------------- 370
            + +E  K E+ L+ KL H N+ RL     E E+ + L+ EL                  
Sbjct: 69  PKDVERIKTEVRLMKKLHHPNIARLYEV-YEDEQYICLVMELCHGGHLLDKLNVFIDDST 127

Query: 371 --------------PNRSLDCFIFDSERRLQLNWNTCYN------IIGGISKGLLYLHED 410
                              +  I  S    + + +          I+  I   L YLH  
Sbjct: 128 GKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN- 186

Query: 411 SRLKIIHRDLKPSNVLL--DKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPE 466
               I HRD+KP N L   +K    K+ DFG+++ F +             GT  ++APE
Sbjct: 187 --QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244

Query: 467 --YAMEGLFSVKSDVFSFGVIVLEIISGK 493
                   +  K D +S GV++  ++ G 
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  114 bits (287), Expect = 2e-28
 Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 38/207 (18%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG------LEEFKNEIILIAKLQHRNLV 351
           +LG G F  V K      GKE A K + ++           EE + E+ ++ +++H N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 352 RLVGCGIEGEEKL-LIYELMPNRSLDCFIFD--------SERRLQLNWNTCYNIIGGISK 402
            L     E +  + LI EL+    L    FD        +E             +  I  
Sbjct: 72  TLHDI-FENKTDVVLILELVSGGEL----FDFLAEKESLTEDE-------ATQFLKQILD 119

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLL----DKDMVAKISDFGMARIFCENQKTANTRRVVG 458
           G+ YLH     +I H DLKP N++L      +   K+ DFG+A       +    + + G
Sbjct: 120 GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFG 173

Query: 459 TYGYMAPEYAMEGLFSVKSDVFSFGVI 485
           T  ++APE        +++D++S GVI
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVI 200

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  114 bits (288), Expect = 2e-28
 Identities = 50/210 (23%), Positives = 85/210 (40%), Gaps = 39/210 (18%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCG 357
           LG+G    V   + L   +E AVK + ++          E+ ++ + Q HRN++ L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF- 79

Query: 358 IEGEEKL-LIYELMPNRSLDCFIFD--------SERRLQLNWNTCYNIIGGISKGLLYLH 408
            E E++  L++E M   S+              +E            ++  ++  L +LH
Sbjct: 80  FEEEDRFYLVFEKMRGGSI----LSHIHKRRHFNELE-------ASVVVQDVASALDFLH 128

Query: 409 EDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRR-----VVGTY 460
                 I HRDLKP N+L    ++    KI DF +      N   +           G+ 
Sbjct: 129 N---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185

Query: 461 GYMAPE-----YAMEGLFSVKSDVFSFGVI 485
            YMAPE          ++  + D++S GVI
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  116 bits (291), Expect = 2e-28
 Identities = 40/310 (12%), Positives = 84/310 (27%), Gaps = 79/310 (25%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLS---RKSWQGLEEFKNEIILIAKLQ--------- 346
           LGQ       +      G+   V       R     +++ K E++ +  L+         
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 347 ----------------HRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSE------R 384
                            + ++R+          L  + L P    +   F          
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDE-RDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 385 RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF 444
              L  +    +   + + L  LH      ++H  L+P +++LD+     ++ F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254

Query: 445 CENQKTANTRRVVGTYGYMAPEY-----------AMEGLFSVKSDVFSFGVIVLEIISGK 493
               +         + G+  PE                L +   D ++ G+++  I    
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

Query: 494 RNSGFYLTGHAQTLLAYVWQL-WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDP 552
                               L   +   +   + +     +IPQ VR +  G L      
Sbjct: 311 --------------------LPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRY--PK 348

Query: 553 AVRPTMSNVV 562
             R      +
Sbjct: 349 EDRLLPLQAM 358

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  114 bits (288), Expect = 4e-28
 Identities = 53/217 (24%), Positives = 84/217 (38%), Gaps = 36/217 (16%)

Query: 286 VIKAATDGFSD----SNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEII 340
            +   +  F+D       +G G +    + +      E AVK + +      EE     I
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEI 68

Query: 341 LIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFD--------SERRLQLNWNT 392
           L+   QH N++ L     +G+   ++ ELM    L     D        SER        
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFFSERE------- 117

Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL----DKDMVAKISDFGMARIFCENQ 448
              ++  I+K + YLH      ++HRDLKPSN+L           +I DFG A+      
Sbjct: 118 ASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174

Query: 449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVI 485
               T     T  ++APE      +    D++S GV+
Sbjct: 175 GLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVL 209

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  114 bits (288), Expect = 4e-28
 Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 33/200 (16%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           +LG+G    VY+       K  A+K L +      +  + EI ++ +L H N+++L    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEI- 116

Query: 358 IEGEEKL-LIYELMPNRSLDCFIFD--------SERRLQLNWNTCYNIIGGISKGLLYLH 408
            E   ++ L+ EL+    L    FD        SER          + +  I + + YLH
Sbjct: 117 FETPTEISLVLELVTGGEL----FDRIVEKGYYSER-------DAADAVKQILEAVAYLH 165

Query: 409 EDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           E     I+HRDLKP N+L      D   KI+DFG+++I          + V GT GY AP
Sbjct: 166 E---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAP 219

Query: 466 EYAMEGLFSVKSDVFSFGVI 485
           E      +  + D++S G+I
Sbjct: 220 EILRGCAYGPEVDMWSVGII 239

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  113 bits (286), Expect = 5e-28
 Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 32/200 (16%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGC 356
            LG+G F    K V   + +  AVK +S++        + EI  +   + H N+V+L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74

Query: 357 GIEGEEKLLIYELMPNRSLDCFIFD--------SERRLQLNWNTCYNIIGGISKGLLYLH 408
             +     L+ EL+    L    F+        SE            I+  +   + ++H
Sbjct: 75  FHDQLHTFLVMELLNGGEL----FERIKKKKHFSETE-------ASYIMRKLVSAVSHMH 123

Query: 409 EDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           +   + ++HRDLKP N+L    + ++  KI DFG AR+   + +   T     T  Y AP
Sbjct: 124 D---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAP 178

Query: 466 EYAMEGLFSVKSDVFSFGVI 485
           E   +  +    D++S GVI
Sbjct: 179 ELLNQNGYDESCDLWSLGVI 198

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  114 bits (287), Expect = 1e-27
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 34/216 (15%)

Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNLVR 352
           +++   +G G FG V++  L    EVA+K++ +      + FKN E+ ++  ++H N+V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVD 96

Query: 353 LVGC-----GIEGEEKL-LIYELMP---NRSLDCFIFDSERRLQLNWNTCYNIIGGISKG 403
           L          + E  L L+ E +P    R+   +   ++ +  +        +  + + 
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHY---AKLKQTMPMLLIKLYMYQLLRS 153

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           L Y+H    + I HRD+KP N+LLD    V K+ DFG A+I    +   N   +   Y Y
Sbjct: 154 LAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSYICSRY-Y 207

Query: 463 MAPEYAMEGLF-----SVKSDVFSFGVIVLEIISGK 493
            APE     +F     +   D++S G ++ E++ G+
Sbjct: 208 RAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  113 bits (284), Expect = 1e-27
 Identities = 40/262 (15%), Positives = 81/262 (30%), Gaps = 26/262 (9%)

Query: 252 QRGLLHELAGPISVSLTQEGDLVSSEELPFVHLAV-IKAATDGFSDSNKLGQGGFGTVYK 310
              LL  L+ P+S   +         +LP +      +  +      + LG+G F  VY+
Sbjct: 27  IFKLLSGLSKPVS---SYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYE 83

Query: 311 GV------LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL 364
                     N ++  +K     +          +  +        ++     +     +
Sbjct: 84  ATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSV 143

Query: 365 LIYELMPNRSLDCFI--FDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKP 422
           L+ EL    +L   I  + +     +      +    +   +  +H+    +IIH D+KP
Sbjct: 144 LVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKP 200

Query: 423 SNVLL-----------DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
            N +L           D      + D G +       K         T G+   E     
Sbjct: 201 DNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK 260

Query: 472 LFSVKSDVFSFGVIVLEIISGK 493
            ++ + D F     V  ++ G 
Sbjct: 261 PWNYQIDYFGVAATVYCMLFGT 282

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  111 bits (281), Expect = 3e-27
 Identities = 52/204 (25%), Positives = 85/204 (41%), Gaps = 34/204 (16%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHR-NLVRLV 354
           +LG+G F  V + +    G+E A K  +  R+      E  +EI ++   +    ++ L 
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95

Query: 355 GCGIEGEEKL-LIYELMP---------NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
               E   ++ LI E                +     SE            +I  I +G+
Sbjct: 96  EV-YENTSEIILILEYAAGGEIFSLCLPELAEMV---SEND-------VIRLIKQILEGV 144

Query: 405 LYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYG 461
            YLH+     I+H DLKP N+LL         KI DFGM+R      +    R ++GT  
Sbjct: 145 YYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPE 198

Query: 462 YMAPEYAMEGLFSVKSDVFSFGVI 485
           Y+APE       +  +D+++ G+I
Sbjct: 199 YLAPEILNYDPITTATDMWNIGII 222

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  109 bits (276), Expect = 1e-26
 Identities = 67/210 (31%), Positives = 106/210 (50%), Gaps = 33/210 (15%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKN--------EIILIAKLQHRN 349
            K+G+G +G VYK     G+ VA+KR+       L+            EI L+ +L H N
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLKELHHPN 80

Query: 350 LVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
           +V L+   I  E  L L++E M    L   + +++  LQ +    Y  +  + +G+ + H
Sbjct: 81  IVSLIDV-IHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIY--LYQLLRGVAHCH 136

Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
           +    +I+HRDLKP N+L++ D   K++DFG+AR F    ++  T  VV T  Y AP+  
Sbjct: 137 QH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS-YTHEVV-TLWYRAPDV- 190

Query: 469 MEGLFSVKS-----DVFSFGVIVLEIISGK 493
              L   K      D++S G I  E+I+GK
Sbjct: 191 ---LMGSKKYSTSVDIWSIGCIFAEMITGK 217

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  112 bits (281), Expect = 1e-26
 Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 39/219 (17%)

Query: 294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNLV 351
           ++D+  +G G FG VY+  L  +G+ VA+K++ +      + FKN E+ ++ KL H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 110

Query: 352 RLVGCGIEGEEKL------LIYELMP---NRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           RL        EK       L+ + +P    R    +   S  +  L        +  + +
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY---SRAKQTLPVIYVKLYMYQLFR 167

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQKTANTRRVVGTYG 461
            L Y+H      I HRD+KP N+LLD D  V K+ DFG A+     +   N   +   Y 
Sbjct: 168 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYICSRY- 221

Query: 462 YMAPE-------YAMEGLFSVKSDVFSFGVIVLEIISGK 493
           Y APE       Y      +   DV+S G ++ E++ G+
Sbjct: 222 YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  110 bits (277), Expect = 1e-26
 Identities = 52/206 (25%), Positives = 83/206 (40%), Gaps = 36/206 (17%)

Query: 296 DSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEI-ILIAKLQHRNLVRL 353
               LG G  G V +      G++ A+K L         + + E+          ++V +
Sbjct: 33  SKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCI 87

Query: 354 VGC---GIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYN------IIGGISKG 403
           +        G+  L +I E M    L    F    R+Q   +  +       I+  I   
Sbjct: 88  LDVYENMHHGKRCLLIIMECMEGGEL----FS---RIQERGDQAFTEREAAEIMRDIGTA 140

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQ-KTANTRRVVGT 459
           + +LH      I HRD+KP N+L    +KD V K++DFG A+   +N  +T        T
Sbjct: 141 IQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT-----PCYT 192

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVI 485
             Y+APE      +    D++S GVI
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVI 218

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  111 bits (279), Expect = 1e-26
 Identities = 48/202 (23%), Positives = 82/202 (40%), Gaps = 33/202 (16%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEI-ILIAKLQHRNLVRLVGC 356
            LG G  G V +       ++ A+K L         + + E+ +     Q  ++VR+V  
Sbjct: 69  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 123

Query: 357 ---GIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCY------NIIGGISKGLLY 406
                 G + L ++ E +    L    F    R+Q   +  +       I+  I + + Y
Sbjct: 124 YENLYAGRKCLLIVMECLDGGEL----FS---RIQDRGDQAFTEREASEIMKSIGEAIQY 176

Query: 407 LHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           LH    + I HRD+KP N+L      + + K++DFG A+    +           T  Y+
Sbjct: 177 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYV 230

Query: 464 APEYAMEGLFSVKSDVFSFGVI 485
           APE      +    D++S GVI
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVI 252

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  109 bits (274), Expect = 2e-26
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 24/208 (11%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSR----KSWQGLEEFKNEIILIAKLQHRNLVRL- 353
           LG+G +G V + +        AVK L +    +   G    K EI L+ +L+H+N+++L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 354 -VGCGIEGEEKLLIY---ELMPNRSLDCFIFDSERRLQLNWNTCY--NIIGGISKGLLYL 407
            V   +  EEK  +Y   E       +      E+R  +     Y   +I G+     YL
Sbjct: 73  DV---LYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE----YL 125

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H      I+H+D+KP N+LL      KIS  G+A            R   G+  +  PE 
Sbjct: 126 H---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182

Query: 468 AM-EGLFS-VKSDVFSFGVIVLEIISGK 493
           A     FS  K D++S GV +  I +G 
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  108 bits (272), Expect = 3e-26
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 51/223 (22%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRK--------------------------SWQGL 332
           +G+G +G V       +    A+K LS+K                              +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 333 EEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY---ELMPNRSLDCFIFDSERRLQLN 389
           E+   EI ++ KL H N+V+LV   ++   +  +Y   EL+    +     +      L+
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135

Query: 390 WNTCYN----IIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC 445
            +        +I GI     YLH     KIIHRD+KPSN+L+ +D   KI+DFG++  F 
Sbjct: 136 EDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 446 ENQKTANTRRVVGTYGYMAPE--YAMEGLFS-VKSDVFSFGVI 485
            +    +    VGT  +MAPE       +FS    DV++ GV 
Sbjct: 189 GSDALLSN--TVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  107 bits (269), Expect = 5e-26
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 33/210 (15%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKN--------EIILIAKLQHRN 349
            K+G+G +G VYK     G+  A+K++       LE+           EI ++ +L+H N
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILKELKHSN 61

Query: 350 LVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
           +V+L    I  +++L L++E +    L   +   E  L+      +  +  +  G+ Y H
Sbjct: 62  IVKLYDV-IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSF--LLQLLNGIAYCH 117

Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
           +    +++HRDLKP N+L++++   KI+DFG+AR F    +   T  +V T  Y AP+  
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTHEIV-TLWYRAPDV- 171

Query: 469 MEGLFSVKS-----DVFSFGVIVLEIISGK 493
              L   K      D++S G I  E+++G 
Sbjct: 172 ---LMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  107 bits (269), Expect = 6e-26
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 34/212 (16%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN--------EIILIAKLQHR 348
            K+G+G +GTV+K       + VA+KR+       L++           EI L+ +L+H+
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLLKELKHK 61

Query: 349 NLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           N+VRL    +  ++KL L++E      L  +       L       +  +  + KGL + 
Sbjct: 62  NIVRLHDV-LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSF--LFQLLKGLGFC 117

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H      ++HRDLKP N+L++++   K+++FG+AR F    +   +  VV T  Y  P+ 
Sbjct: 118 HSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVV-TLWYRPPDV 172

Query: 468 AMEGLFSVKS-----DVFSFGVIVLEIISGKR 494
               LF  K      D++S G I  E+ +  R
Sbjct: 173 ----LFGAKLYSTSIDMWSAGCIFAELANAGR 200

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  105 bits (265), Expect = 1e-25
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 18/200 (9%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQ--GLEE-FKNEIILIAKLQHRNLVRLVG 355
           LG+G FG VY      N   +A+K L +   +  G+E   + EI + + L+H N++R+  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQ-LNWNTCYNIIGGISKGLLYLHEDSRL 413
                 +++ L+ E  P   L    +   ++    +       +  ++  L Y H     
Sbjct: 82  Y-FHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHYCH---ER 133

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF 473
           K+IHRD+KP N+L+      KI+DFG + +   + +   T  + GT  Y+ PE       
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRR-RT--MCGTLDYLPPEMIEGKTH 189

Query: 474 SVKSDVFSFGVIVLEIISGK 493
             K D++  GV+  E + G 
Sbjct: 190 DEKVDLWCAGVLCYEFLVGM 209

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  107 bits (269), Expect = 2e-25
 Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 31/211 (14%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN--------EIILIAKLQHR 348
           + LG+G F TVYK       + VA+K++         E K+        EI L+ +L H 
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLLQELSHP 72

Query: 349 NLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           N++ L+      +  + L+++ M    L+  I D+   L  +    Y  +    +GL YL
Sbjct: 73  NIIGLLDA-FGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAY--MLMTLQGLEYL 128

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H+     I+HRDLKP+N+LLD++ V K++DFG+A+ F    +   T +VV T  Y APE 
Sbjct: 129 HQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YTHQVV-TRWYRAPEL 183

Query: 468 AMEGLF-----SVKSDVFSFGVIVLEIISGK 493
               LF      V  D+++ G I+ E++   
Sbjct: 184 ----LFGARMYGVGVDMWAVGCILAELLLRV 210

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  105 bits (265), Expect = 2e-25
 Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 34/211 (16%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN--------EIILIAKLQHR 348
            K+G+G +G V+K      G+ VA+K+          E           EI ++ +L+H 
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRMLKQLKHP 62

Query: 349 NLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           NLV L+      + +L L++E   + ++   +     +  +  +   +I     + + + 
Sbjct: 63  NLVNLLEV-FRRKRRLHLVFEYC-DHTVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFC 118

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H   +   IHRD+KP N+L+ K  V K+ DFG AR+            V  T  Y +PE 
Sbjct: 119 H---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY-YDDEVA-TRWYRSPEL 173

Query: 468 AMEGLFSVKS-----DVFSFGVIVLEIISGK 493
               L          DV++ G +  E++SG 
Sbjct: 174 ----LVGDTQYGPPVDVWAIGCVFAELLSGV 200

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  106 bits (268), Expect = 2e-25
 Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 43/227 (18%)

Query: 291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKR-LSRKSWQGLEEFKN----EIILIAK 344
            D F      GQG FGTV  G     G  VA+K+ +          F+N     +  +A 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR------FRNRELQIMQDLAV 75

Query: 345 LQHRNLVRL------VGCGIEGEEKL-LIYELMP---NRSLDCFIFDSERRLQLNWNTCY 394
           L H N+V+L      +G     +  L ++ E +P   +R    +     R++        
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY---YRRQVAPPPILIK 132

Query: 395 NIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK-DMVAKISDFGMARIFCENQKTANT 453
             +  + + +  LH  S + + HRD+KP NVL+++ D   K+ DFG A+    ++   N 
Sbjct: 133 VFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE--PNV 189

Query: 454 RRVVGTYGYMAPE-------YAMEGLFSVKSDVFSFGVIVLEIISGK 493
             +   Y Y APE       Y      +   D++S G I  E++ G+
Sbjct: 190 AYICSRY-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  104 bits (261), Expect = 1e-24
 Identities = 72/278 (25%), Positives = 115/278 (41%), Gaps = 74/278 (26%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRL--V 354
           +G+G F  V     +  G+EVA+K + +   +   L++   E+ ++  L H N+V+L  V
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 355 GCGIEGEEKL-LIYELMPNRSLDCFIFD---SERRLQLNWNTCY--NIIGGISKGLLYLH 408
              IE E+ L LI E      +    FD   +  R++          I+  +     Y H
Sbjct: 83  ---IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ----YCH 131

Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAPE 466
              + +I+HRDLK  N+LLD DM  KI+DFG +  F               G   Y APE
Sbjct: 132 ---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-----CGAPPYAAPE 183

Query: 467 YAMEGLFS------VKSDVFSFGVI--VL-----------------EIISGKRNSGFYLT 501
                LF        + DV+S GVI   L                  ++ GK    FY++
Sbjct: 184 -----LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMS 238

Query: 502 GHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVR 539
              + LL          K    ++P  +K  ++ Q+++
Sbjct: 239 TDCENLL----------KRFLVLNP--IKRGTLEQIMK 264

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  104 bits (261), Expect = 1e-24
 Identities = 58/214 (27%), Positives = 106/214 (49%), Gaps = 32/214 (14%)

Query: 298 NKLGQGGFGTVYKG--VLPNGKEVAVKRLSRKSWQGLEEFKN--------EIILIAKLQ- 346
            ++G+G +G V+K   +   G+ VA+KR+       ++  +         E+ ++  L+ 
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAVLRHLET 70

Query: 347 --HRNLVRL----VGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG 399
             H N+VRL         + E KL L++E + ++ L  ++ D      +   T  +++  
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQ 128

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           + +GL +LH     +++HRDLKP N+L+      K++DFG+ARI+        T  VV T
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVV-T 182

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
             Y APE  ++  ++   D++S G I  E+   K
Sbjct: 183 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  104 bits (261), Expect = 1e-24
 Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 34/211 (16%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVK--RLSRKSWQGLEEFKN----EIILIAKLQHRNL 350
             +G+G +G V K      G+ VA+K    S       +  K     EI L+ +L+H NL
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKLLKQLRHENL 86

Query: 351 VRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
           V L+    + +++  L++E + + ++   +        L++      +  I  G+ + H 
Sbjct: 87  VNLLEV-CKKKKRWYLVFEFV-DHTILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCHS 142

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE--- 466
                IIHRD+KP N+L+ +  V K+ DFG AR      +      V  T  Y APE   
Sbjct: 143 H---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YDDEVA-TRWYRAPELLV 197

Query: 467 ----YAMEGLFSVKSDVFSFGVIVLEIISGK 493
               Y      +V  DV++ G +V E+  G+
Sbjct: 198 GDVKYGK----AV--DVWAIGCLVTEMFMGE 222

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  102 bits (257), Expect = 1e-24
 Identities = 59/195 (30%), Positives = 85/195 (43%), Gaps = 21/195 (10%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEE-FKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V     + VAVK +  K      E  K EI +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73

Query: 358 IEGEEKL-LIYELMPNRSLDCFIFD---SERRLQLNWNTCY--NIIGGISKGLLYLHEDS 411
                   L  E      L    FD    +  +       +   ++ G+     YLH   
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
            + I HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 472 LFS-VKSDVFSFGVI 485
            F     DV+S G++
Sbjct: 183 EFHAEPVDVWSCGIV 197

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  103 bits (259), Expect = 2e-24
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 34/216 (15%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN-----------EIILIAKL 345
            ++G G +GTVYK     +G  VA+K +       +                E+ L+ +L
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVR------VPNGGGGGGGLPISTVREVALLRRL 68

Query: 346 Q---HRNLVRL----VGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNII 397
           +   H N+VRL         + E K+ L++E + ++ L  ++ D      L   T  +++
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLM 126

Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVV 457
               +GL +LH +    I+HRDLKP N+L+      K++DFG+ARI+        T  VV
Sbjct: 127 RQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL--TPVVV 181

Query: 458 GTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
            T  Y APE  ++  ++   D++S G I  E+   K
Sbjct: 182 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  103 bits (259), Expect = 2e-24
 Identities = 53/264 (20%), Positives = 101/264 (38%), Gaps = 45/264 (17%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVK-----RLSRKSW---QGLEEFKNEIILIAKLQHRNL 350
           LG G FG V+  V     KEV VK     ++    W     L +   EI ++++++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHE 409
           ++++    E +       +M        +F   +R  +L+      I   +   + YL  
Sbjct: 92  IKVLDI-FENQGF--FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLR- 147

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE-YA 468
                IIHRD+K  N+++ +D   K+ DFG A      +         GT  Y APE   
Sbjct: 148 --LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLM 202

Query: 469 MEGLFSVKSDVFSFGVI--VL-----------EIISGKRNSGFYLTGHAQTLLAYVWQLW 515
                  + +++S GV    L           E +    +  + ++    +L+       
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLV------- 255

Query: 516 KEGKEMEFVDPLLMKSSSIPQVVR 539
                +    P   + +++ ++V 
Sbjct: 256 ---SGLLQPVP--ERRTTLEKLVT 274

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  102 bits (257), Expect = 4e-24
 Identities = 59/195 (30%), Positives = 85/195 (43%), Gaps = 21/195 (10%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEE-FKNEIILIAKLQHRNLVRLVGCG 357
           LG+G +G V   V     + VAVK +  K      E  K EI +   L H N+V+  G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH- 73

Query: 358 IEGEEKL-LIYELMPNRSLDCFIFD---SERRLQLNWNTCY--NIIGGISKGLLYLHEDS 411
                   L  E      L    FD    +  +       +   ++ G+     YLH   
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLH--- 122

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
            + I HRD+KP N+LLD+    KISDFG+A +F  N +     ++ GT  Y+APE     
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 182

Query: 472 LFS-VKSDVFSFGVI 485
            F     DV+S G++
Sbjct: 183 EFHAEPVDVWSCGIV 197

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  102 bits (257), Expect = 6e-24
 Identities = 58/238 (24%), Positives = 97/238 (40%), Gaps = 64/238 (26%)

Query: 292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN--------EIILI 342
             +    K+GQG FG V+K      G++VA+K++       +E  K         EI ++
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70

Query: 343 AKLQHRNLVRLVG-------CGIEGEEKL-LIYELM----------PNRSLD-----CFI 379
             L+H N+V L+             +  + L+++                         +
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM 130

Query: 380 FDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFG 439
                   L              GL Y+H +   KI+HRD+K +NVL+ +D V K++DFG
Sbjct: 131 ------QMLL------------NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169

Query: 440 MARIFCENQKTAN---TRRVVGTYGYMAPEYAM-EGLFSVKSDVFSFGVIVLEIISGK 493
           +AR F   + +     T RVV T  Y  PE  + E  +    D++  G I+ E+ +  
Sbjct: 170 LARAFSLAKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  101 bits (253), Expect = 1e-23
 Identities = 75/212 (35%), Positives = 107/212 (50%), Gaps = 32/212 (15%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN-----EIILIAKLQHRNLV 351
            KLG G + TVYKG+    G  VA+K +   S    EE        EI L+ +L+H N+V
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDS----EEGTPSTAIREISLMKELKHENIV 66

Query: 352 RLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS----KGLLY 406
           RL    I  E KL L++E M N  L  ++ DS            N++        +GL +
Sbjct: 67  RLYDV-IHTENKLTLVFEFMDN-DLKKYM-DSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
            HE+   KI+HRDLKP N+L++K    K+ DFG+AR F     T  +  VV T  Y AP+
Sbjct: 124 CHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT-FSSEVV-TLWYRAPD 178

Query: 467 YAMEGLFSVKS-----DVFSFGVIVLEIISGK 493
                L   ++     D++S G I+ E+I+GK
Sbjct: 179 V----LMGSRTYSTSIDIWSCGCILAEMITGK 206

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  101 bits (253), Expect = 1e-23
 Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 29/214 (13%)

Query: 292 DGFSDSNKLGQGGFGTVYKG-VLPNGKEVAVKRLSRKSWQGLEEFKN-----EIILIAKL 345
           + +   +KLG+G + TVYKG        VA+K +  +     EE        E+ L+  L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH----EEGAPCTAIREVSLLKDL 57

Query: 346 QHRNLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           +H N+V L    I  E+ L L++E + ++ L  ++ D    + ++    +  +  + +GL
Sbjct: 58  KHANIVTLHDI-IHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLF--LFQLLRGL 113

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            Y H     K++HRDLKP N+L+++    K++DFG+AR      KT     VV T  Y  
Sbjct: 114 AYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-YDNEVV-TLWYRP 168

Query: 465 PEYAMEGLF-----SVKSDVFSFGVIVLEIISGK 493
           P+     L      S + D++  G I  E+ +G+
Sbjct: 169 PDI----LLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  101 bits (253), Expect = 1e-23
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 40/216 (18%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN--------EIILIAKLQHR 348
            KLG+G +G VYK +     + VA+KR+       LE  +         E+ L+ +LQHR
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLLKELQHR 93

Query: 349 NLVRLVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           N++ L    I    +L LI+E      L  ++ D    + +     +  +  +  G+ + 
Sbjct: 94  NIIELKSV-IHHNHRLHLIFEYA-ENDLKKYM-DKNPDVSMRVIKSF--LYQLINGVNFC 148

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVA-----KISDFGMARIFCENQKTANTRRVVGTYGY 462
           H     + +HRDLKP N+LL     +     KI DFG+AR F    +   T  ++ T  Y
Sbjct: 149 HSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ-FTHEII-TLWY 203

Query: 463 MAPEYAMEGLFSVKS-----DVFSFGVIVLEIISGK 493
             PE     L   +      D++S   I  E++   
Sbjct: 204 RPPEI----LLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  102 bits (255), Expect = 5e-23
 Identities = 68/211 (32%), Positives = 95/211 (45%), Gaps = 34/211 (16%)

Query: 300 LGQGGFGTVY----KGVLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVR 352
           LG+GGFG V+    K     GK  A K+L++K     +G +    E  ++AK+  R +V 
Sbjct: 193 LGRGGFGEVFACQMKA---TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249

Query: 353 LVGCGIEGEEKL-LIYELMP---------NRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           L     E +  L L+  +M          N   D   F  E R        Y     I  
Sbjct: 250 LAYA-FETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF-QEPRAIF-----Y--TAQIVS 300

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           GL +LH+     II+RDLKP NVLLD D   +ISD G+A      Q         GT G+
Sbjct: 301 GLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGTPGF 355

Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           MAPE  +   +    D F+ GV + E+I+ +
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 99.9 bits (249), Expect = 3e-22
 Identities = 82/298 (27%), Positives = 118/298 (39%), Gaps = 59/298 (19%)

Query: 300 LGQGGFGTVY----KGVLPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVR 352
           LG+GGFG V     +     GK  A K+L +K     +G     NE  ++ K+  R +V 
Sbjct: 192 LGKGGFGEVCACQVRA---TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248

Query: 353 LVGCGIEGEEKL-LIYELMP---------NRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           L     E ++ L L+  LM          +     F    E R        Y     I  
Sbjct: 249 LAYA-YETKDALCLVLTLMNGGDLKFHIYHMGQAGF---PEARAVF-----Y--AAEICC 297

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGY 462
           GL  LH     +I++RDLKP N+LLD     +ISD G+A    E Q     R  VGT GY
Sbjct: 298 GLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI-KGR--VGTVGY 351

Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME 522
           MAPE      ++   D ++ G ++ E+I+G+  S F                 +E + + 
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQ--SPFQQRKKKIK--------REEVERLV 401

Query: 523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPF 580
              P    S       R +   LL   +DPA R         LG    +  E ++ P 
Sbjct: 402 KEVPEEY-SERFSPQARSLCSQLL--CKDPAER---------LGCRGGSAREVKEHPL 447

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 95.4 bits (238), Expect = 5e-22
 Identities = 61/201 (30%), Positives = 95/201 (47%), Gaps = 34/201 (16%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSR---KSWQGLEEFKNEIILIAKLQHRNLVRL-- 353
           LG G FG V  G     G +VAVK L+R   +S   + + K EI  +   +H ++++L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 354 VGCGIEGEEKL-LIYELMPNRSLDCFIFD---SERRLQLNWNTCY--NIIGGISKGLLYL 407
           V   I       ++ E +    L    FD      R++          I+  +     Y 
Sbjct: 79  V---ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD----YC 127

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAP 465
           H   R  ++HRDLKP NVLLD  M AKI+DFG++ +  + +  +T+      G+  Y AP
Sbjct: 128 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-----CGSPNYAAP 179

Query: 466 EYAMEGLFS-VKSDVFSFGVI 485
           E     L++  + D++S GVI
Sbjct: 180 EVISGRLYAGPEVDIWSCGVI 200

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 95.5 bits (238), Expect = 9e-22
 Identities = 55/237 (23%), Positives = 95/237 (40%), Gaps = 41/237 (17%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRK---SWQ---GLEEFKNEIILIAKLQHR--NL 350
           LG GGFG+VY G+ + +   VA+K + +     W           E++L+ K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 351 VRL--VGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           +RL       E  +   LI E  P    D F F +ER   L      +    + + + + 
Sbjct: 111 IRLLDW---FERPDSFVLILER-PEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHC 165

Query: 408 HEDSRLKIIHRDLKPSNVLLDKD-MVAKISDFGMARIFCENQ-KTANTRRVVGTYGYMAP 465
           H      ++HRD+K  N+L+D +    K+ DFG   +  +            GT  Y  P
Sbjct: 166 H---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF-----DGTRVYSPP 217

Query: 466 EYAMEGLFS-VKSDVFSFGVI--VL-----------EIISGKRNSGFYLTGHAQTLL 508
           E+     +    + V+S G++   +           EII G+      ++   Q L+
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI 274

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 98.8 bits (246), Expect = 9e-22
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 24/205 (11%)

Query: 300 LGQGGFGTVYKG-VLPNGKEVAVKRLSRK---SWQGLEEFKNE-IIL--IAKLQHRNLVR 352
           +G+GGFG VY       GK  A+K L +K     QG     NE I+L  ++      +V 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 353 LVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +        +KL  I +LM    L  +               Y     I  GL ++H   
Sbjct: 257 MSYA-FHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEADMRFY--AAEIILGLEHMHN-- 310

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
              +++RDLKP+N+LLD+    +ISD G+A  F + +   +    VGT+GYMAPE   +G
Sbjct: 311 -RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHAS--VGTHGYMAPEVLQKG 365

Query: 472 L---FSVKSDVFSFGVIVLEIISGK 493
           +    S   D FS G ++ +++ G 
Sbjct: 366 VAYDSSA--DWFSLGCMLFKLLRGH 388

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 96.8 bits (241), Expect = 2e-21
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 44/206 (21%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSR---KSWQGLEEFKNEIILIAKLQHRNLVRL-- 353
           LG G FG V  G     G +VAVK L+R   +S   + + + EI  +   +H ++++L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 354 VGCGIEGEEKL-LIYELMPNRSLDCFIFD---SERRLQLN--WNTCYNIIGGISKGLLYL 407
           V   I     + ++ E +    L    FD      RL           I+ G+     Y 
Sbjct: 84  V---ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVD----YC 132

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTYGYMAP 465
           H   R  ++HRDLKP NVLLD  M AKI+DFG++ +  + +  +T+      G+  Y AP
Sbjct: 133 H---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS-----CGSPNYAAP 184

Query: 466 E------YAMEGLFSVKSDVFSFGVI 485
           E      YA       + D++S GVI
Sbjct: 185 EVISGRLYA-----GPEVDIWSSGVI 205

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 55/211 (26%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGL---EEFKNEIILIAKLQHRNLVRLVG 355
           LG+G FG V         ++VA+K +SR+  +        + EI  +  L+H ++++L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74

Query: 356 CGIEGEEKLLIYELMPNRSLDCFI--------FD---SERRLQLNWNTCY--NIIGGISK 402
                      Y+++   +    +        FD    ++R+  +    +   II  I  
Sbjct: 75  -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE- 122

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ--KTANTRRVVGTY 460
              Y H   R KI+HRDLKP N+LLD ++  KI+DFG++ I  +    KT+      G+ 
Sbjct: 123 ---YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS-----CGSP 171

Query: 461 GYMAPE------YAMEGLFSVKSDVFSFGVI 485
            Y APE      YA       + DV+S G++
Sbjct: 172 NYAAPEVINGKLYA-----GPEVDVWSCGIV 197

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 96.5 bits (240), Expect = 2e-21
 Identities = 66/270 (24%), Positives = 113/270 (41%), Gaps = 40/270 (14%)

Query: 243 PTSTDEKRSQRGLLHELAGPISVSLTQEGDLVSSEELPFVHLAVIKAA---TDGFSDSNK 299
           PT   +    +G   ++               S  +  F  + V  +       + +   
Sbjct: 12  PTLDVKIAFCQGFDKQVDVSYIAKHYNMS--KSKVDNQFYSVEVGDSTFTVLKRYQNLKP 69

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---------EIILIAKLQHRN 349
           +G G  G V         + VA+K+LSR        F+N         E++L+  + H+N
Sbjct: 70  IGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKN 122

Query: 350 LVRLV------GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKG 403
           ++ L+          E ++  L+ ELM   +L   I     +++L+      ++  +  G
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVI-----QMELDHERMSYLLYQMLCG 176

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           + +LH      IIHRDLKPSN+++  D   KI DFG+AR    +     T  VV T  Y 
Sbjct: 177 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVV-TRYYR 230

Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           APE  +   +    D++S G I+ E++  K
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 95.2 bits (237), Expect = 2e-21
 Identities = 51/244 (20%), Positives = 95/244 (38%), Gaps = 57/244 (23%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN-EIILIAKLQHRNLV 351
           +S    LG G FG V +   + +GK  A+K++ +        +KN E+ ++  L H N++
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHVNII 63

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWN-------------------T 392
           +LV       ++       P+        ++                            T
Sbjct: 64  KLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDT 123

Query: 393 CYNIIGGISK-------------------GLLYLHEDSRLKIIHRDLKPSNVLLD-KDMV 432
            + ++    +                    + ++H    L I HRD+KP N+L++ KD  
Sbjct: 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNT 180

Query: 433 AKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY---AMEGLFSVKSDVFSFGVIVLEI 489
            K+ DFG A+    ++   +   +   + Y APE    A E  ++   D++S G +  E+
Sbjct: 181 LKLCDFGSAKKLIPSE--PSVAYICSRF-YRAPELMLGATE--YTPSIDLWSIGCVFGEL 235

Query: 490 ISGK 493
           I GK
Sbjct: 236 ILGK 239

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 95.6 bits (238), Expect = 2e-21
 Identities = 55/217 (25%), Positives = 102/217 (47%), Gaps = 33/217 (15%)

Query: 299 KLGQGGFGTVYKGV---LPNGKEVAVKRLSRKSWQGLEEFK-NEIILIAKLQHRNLVRLV 354
           K+G+G +G VYK       + K+ A+K++      G+      EI L+ +L+H N++ L 
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSACREIALLRELKHPNVISLQ 84

Query: 355 G-CGIEGEEKL-LIYELMPN---RSLDCF--IFDSERRLQLNWNTCYNIIGGISKGLLYL 407
                  + K+ L+++   +     +        +++ +QL      +++  I  G+ YL
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDM----VAKISDFGMARIFCENQK--TANTRRVVGTYG 461
           H +    ++HRDLKP+N+L+  +       KI+D G AR+F    K        VV T+ 
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200

Query: 462 YMAPEYAMEGLFSVKS-----DVFSFGVIVLEIISGK 493
           Y APE     L   +      D+++ G I  E+++ +
Sbjct: 201 YRAPEL----LLGARHYTKAIDIWAIGCIFAELLTSE 233

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 57/220 (25%), Positives = 87/220 (39%), Gaps = 26/220 (11%)

Query: 291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEE--FKN---------EI 339
              ++    +  G +G V  GV   G  VA+KR+      G       +         EI
Sbjct: 21  QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 340 ILIAKLQHRNLVRLVGCGI-----EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY 394
            L+    H N++ L    +        +  L+ ELM    L   I D    +    +  Y
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVIS-PQHIQY 138

Query: 395 NIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR 454
             +  I  GL  LHE     ++HRDL P N+LL  +    I DF +AR    +     T 
Sbjct: 139 -FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANK--TH 192

Query: 455 RVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
            V     Y APE  M+   F+   D++S G ++ E+ + K
Sbjct: 193 YVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 93.8 bits (234), Expect = 3e-21
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 32/209 (15%)

Query: 300 LGQGGFGTVY----KGVLPNGKEVAVKRLSRKSWQGLEEF---KNEIILIAKLQHRNLVR 352
           LG+G F TV            +E A+K L ++      +      E  ++++L H   V+
Sbjct: 38  LGEGSFSTVVLARELA---TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94

Query: 353 LVGCGIEGEEKL-LIYELMPN-------RSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           L     + +EKL        N       R +  F    E   +      Y     I   L
Sbjct: 95  LYFT-FQDDEKLYFGLSYAKNGELLKYIRKIGSF---DETCTRF-----Y--TAEIVSAL 143

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            YLH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y++
Sbjct: 144 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200

Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           PE   E      SD+++ G I+ ++++G 
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGL 229

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 30/210 (14%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSR---KSWQGLEEFKN---EIILIAKL----QHR 348
           LG+GGFGTV+ G  L +  +VA+K + R     W  L +      E+ L+ K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 349 NLVRL--VGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
            ++RL       E +E   L+ E  P  + D F + +E+   L         G +   + 
Sbjct: 99  GVIRLLDW---FETQEGFMLVLER-PLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQ 153

Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQ-KTANTRRVVGTYGYM 463
           + H      ++HRD+K  N+L+D     AK+ DFG   +  +            GT  Y 
Sbjct: 154 HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF-----DGTRVYS 205

Query: 464 APEYAMEGLFS-VKSDVFSFGVIVLEIISG 492
            PE+     +  + + V+S G+++ +++ G
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCG 235

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 94.4 bits (235), Expect = 5e-21
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 35/216 (16%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---------EIILIA 343
           + +   +G G  G V         + VA+K+LSR        F+N         E++L+ 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELVLMK 79

Query: 344 KLQHRNLVRLV------GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNII 397
            + H+N++ L+          E ++  ++ ELM   +L   I     +++L+      ++
Sbjct: 80  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI-----QMELDHERMSYLL 133

Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVV 457
             +  G+ +LH      IIHRDLKPSN+++  D   KI DFG+AR    +         V
Sbjct: 134 YQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---V 187

Query: 458 GTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
            T  Y APE  +   +    D++S G I+ E+I G 
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 92.7 bits (230), Expect = 2e-20
 Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 39/179 (21%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ---KTANTRRV 456
           ++KG+ +L   +  K IHRDL   N+LL +  V KI DFG+AR   ++    +  + R  
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258

Query: 457 VGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-G-------KRNSGFYLTGHAQTLL 508
           +    +MAPE   + +++++SDV+SFGV++ EI S G       K +  F          
Sbjct: 259 L---KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC--------- 306

Query: 509 AYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS 567
               +  KEG  M                +      L C   +P+ RPT S +V  LG+
Sbjct: 307 ----RRLKEGTRMR-------APDYTTPEMY--QTMLDCWHGEPSQRPTFSELVEHLGN 352

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 33/160 (20%), Positives = 56/160 (35%), Gaps = 19/160 (11%)

Query: 298 NKLGQGGFGTVYKGVL------PNGKEVAVKRLSRK-SWQGLEEFKNEI-ILIAKLQHRN 349
             LG+G FG V +            + VAVK L    +        +E+ ILI    H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 350 LVRLVG-CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
           +V L+G C   G   ++I E     +L  ++           +     +   +KG  +  
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137

Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ 448
               +  I  DLK     +     +  S F   +   + +
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 91.3 bits (227), Expect = 4e-20
 Identities = 61/214 (28%), Positives = 84/214 (39%), Gaps = 62/214 (28%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEE-FKNEIILIAKLQHRNLVRL--VG 355
           +G G FG           + VAVK + R     ++E  + EII    L+H N+VR   V 
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERG--AAIDENVQREIINHRSLRHPNIVRFKEV- 84

Query: 356 CGIEGEEKL-LIYELMPNRSLDCFIFD--------SE---RRL--QLNWNTCYNIIGGIS 401
             I     L +I E      L    ++        SE   R    Q        ++ G+S
Sbjct: 85  --ILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQ--------LLSGVS 130

Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVA--KISDFGMARIFCENQ--KTANTRRVV 457
               Y H    ++I HRDLK  N LLD       KI DFG ++    +   K+      V
Sbjct: 131 ----YCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----V 178

Query: 458 GTYGYMAPE------YAMEGLFSVKSDVFSFGVI 485
           GT  Y+APE      Y         +DV+S GV 
Sbjct: 179 GTPAYIAPEVLLRQEYD-----GKIADVWSCGVT 207

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 91.2 bits (227), Expect = 4e-20
 Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 38/220 (17%)

Query: 291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---------EII 340
              +     +G G +G+V   +   +G++VA+K+LSR        F++         E++
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75

Query: 341 LIAKLQHRNLVRLV------GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY 394
           L+  +QH N++ L+             +  L+   M    L   +      L+ +     
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM-----GLKFSEEKIQ 129

Query: 395 NIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR 454
            ++  + KGL Y+H      ++HRDLKP N+ +++D   KI DFG+AR   + + T    
Sbjct: 130 YLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA-DAEMTGY-- 183

Query: 455 RVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
             V T  Y APE  +    ++   D++S G I+ E+++GK
Sbjct: 184 --VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 90.8 bits (226), Expect = 6e-20
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 49/225 (21%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---------EIILIA 343
           +++ + +G+G +G V       N   VA+K++S         F++         EI ++ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIKILL 80

Query: 344 KLQHRNLVRLVGC----GIEGEEKL-LIYELMP---NRSLDCFIFDSERRLQLNWNTCYN 395
           + +H N++ +        IE  + + ++ +LM     + L      ++         CY 
Sbjct: 81  RFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDH-------ICY- 132

Query: 396 IIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN--T 453
            +  I +GL Y+H  +   ++HRDLKPSN+LL+     KI DFG+AR+   +       T
Sbjct: 133 FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189

Query: 454 RRVVGTYGYMAPEYAMEGLFSVKS-----DVFSFGVIVLEIISGK 493
             V  T  Y APE     + + K      D++S G I+ E++S +
Sbjct: 190 EYVA-TRWYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 90.3 bits (224), Expect = 2e-19
 Identities = 40/190 (21%), Positives = 83/190 (43%), Gaps = 35/190 (18%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---------EIILIAKLQHR 348
            +G G +G V +       + VA+K++ R        F++         EI ++ +L H 
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIAILNRLNHD 112

Query: 349 NLVRLV----GCGIEGEEKL-LIYELMP---NRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           ++V+++       +E  ++L ++ E+      +     ++ +E  ++      YN++   
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKT---LLYNLL--- 166

Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
             G+ Y+H      I+HRDLKP+N L+++D   K+ DFG+AR     +   +   +    
Sbjct: 167 -VGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222

Query: 461 GYMAPEYAME 470
             M       
Sbjct: 223 DDMNLVTFPH 232

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 55/228 (24%), Positives = 99/228 (43%), Gaps = 46/228 (20%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---------EIILIA 343
           + D   LG GG G V+  V     K VA+K++            +         EI +I 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIKIIR 63

Query: 344 KLQHRNLVRLV----------GCGIEGEEKL----LIYELMPNRSLDCFIFDSERRLQLN 389
           +L H N+V++              +    +L    ++ E M    L   +     +  L 
Sbjct: 64  RLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVL----EQGPLL 118

Query: 390 WNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD-KDMVAKISDFGMARIFCENQ 448
                  +  + +GL Y+H  +   ++HRDLKP+N+ ++ +D+V KI DFG+ARI   + 
Sbjct: 119 EEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175

Query: 449 KTAN--TRRVVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGK 493
                 +  +V T  Y +P   +    ++   D+++ G I  E+++GK
Sbjct: 176 SHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 38/158 (24%), Positives = 66/158 (41%), Gaps = 30/158 (18%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEI-ILIAKLQHRNLVRLVGC 356
            LG G  G V +       ++ A+K L         + + E+ +     Q  ++VR+V  
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79

Query: 357 ---GIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCY------NIIGGISKGLLY 406
                 G + L ++ E +    L    F    R+Q   +  +       I+  I + + Y
Sbjct: 80  YENLYAGRKCLLIVMECLDGGEL----FS---RIQDRGDQAFTEREASEIMKSIGEAIQY 132

Query: 407 LHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMA 441
           LH    + I HRD+KP N+L      + + K++DFG A
Sbjct: 133 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 88.1 bits (219), Expect = 5e-19
 Identities = 55/243 (22%), Positives = 91/243 (37%), Gaps = 72/243 (29%)

Query: 291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---------EII 340
           +  F   + LG+G +G V      P G+ VA+K++          F           EI 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61

Query: 341 LIAKLQHRNLVRLV-----GCGIEGEEKLLIYELMP--------NRSLD----CFIFDSE 383
           ++   +H N++ +             E  +I ELM          + L      +     
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI--- 118

Query: 384 RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI 443
                     Y  +    + +  LH  +   +IHRDLKPSN+L++ +   K+ DFG+ARI
Sbjct: 119 ----------YQTL----RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161

Query: 444 FCENQKTANTRRV--------VGTYGYMAPEYAMEGLFSVKS-----DVFSFGVIVLEII 490
             E+    +            V T  Y APE     + +        DV+S G I+ E+ 
Sbjct: 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEV----MLTSAKYSRAMDVWSCGCILAELF 217

Query: 491 SGK 493
             +
Sbjct: 218 LRR 220

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 87.8 bits (218), Expect = 6e-19
 Identities = 59/217 (27%), Positives = 101/217 (46%), Gaps = 37/217 (17%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---------EIILIA 343
           + D   +G G +G V   V    G +VA+K+L R        F++         E+ L+ 
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELRLLK 79

Query: 344 KLQHRNLVRLV------GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNII 397
            ++H N++ L+          +  +  L+   M    L   +    +  +L  +    ++
Sbjct: 80  HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM----KHEKLGEDRIQFLV 134

Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVV 457
             + KGL Y+H      IIHRDLKP N+ +++D   KI DFG+AR   +++ T      V
Sbjct: 135 YQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA-DSEMTGY----V 186

Query: 458 GTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
            T  Y APE  +    ++   D++S G I+ E+I+GK
Sbjct: 187 VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 86.9 bits (216), Expect = 9e-19
 Identities = 52/220 (23%), Positives = 93/220 (42%), Gaps = 41/220 (18%)

Query: 291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HR 348
            D +    KLG+G +  V++ + + N ++V VK L     +   + K EI ++  L+   
Sbjct: 35  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91

Query: 349 NLVRL---VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ-LNWNTCYNIIGGISKGL 404
           N++ L   V   +     L+   +           D ++  Q L        +  I K L
Sbjct: 92  NIITLADIVKDPVSRTPALVFEHVNNT--------DFKQLYQTLTDYDIRFYMYEILKAL 143

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLD-KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
            Y H  S   I+HRD+KP NV++D +    ++ D+G+A  +   Q+     RV   Y + 
Sbjct: 144 DYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRY-FK 197

Query: 464 APE---------YAMEGLFSVKSDVFSFGVIVLEIISGKR 494
            PE         Y++        D++S G ++  +I  K 
Sbjct: 198 GPELLVDYQMYDYSL--------DMWSLGCMLASMIFRKE 229

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 86.0 bits (213), Expect = 1e-18
 Identities = 32/299 (10%), Positives = 79/299 (26%), Gaps = 56/299 (18%)

Query: 299 KLGQGGFGTVYKG---VLPNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVR 352
             G       ++     L   ++VA+  +  +       L+E  +  + ++++    + R
Sbjct: 38  FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSR 412
           ++         L++ E +   SL       +             +  ++      H   R
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVG--AIRAMQSLAAAADAAH---R 147

Query: 413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL 472
             +      PS V +  D    ++                          M         
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYP----------------------ATMPDA------ 179

Query: 473 FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSS 532
            + + D+   G  +  ++  +        G    L         +  E   +D       
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWP--LPEAGVRSGLAPAERDTAGQPIEPADIDR------ 230

Query: 533 SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFPVGRTIVLAEQ 591
            IP  +  +    +  Q D  +R   S ++ L+   +                +  A +
Sbjct: 231 DIPFQISAVAARSV--QGDGGIRSA-STLLNLMQQATAVADRTEVLGPIDEAPVSAAPR 286

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 86.6 bits (215), Expect = 2e-18
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 42/215 (19%)

Query: 300 LGQGGFGTVY----KGVLPNGKEVAVKRLSRKSWQGLEEFKN---EIILIAKLQHRNLVR 352
           +G+G FG V            K  A+K ++++      E +N   E+ ++  L+H  LV 
Sbjct: 23  IGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN 79

Query: 353 LVGCGIEGEEKL-LIYELMPN-------RSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           L     + EE + ++ +L+         +    F    E  ++L     +  I  +   L
Sbjct: 80  LWYS-FQDEEDMFMVVDLLLGGDLRYHLQQNVHF---KEETVKL-----F--ICELVMAL 128

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            YL      +IIHRD+KP N+LLD+     I+DF +A +     +   T  + GT  YMA
Sbjct: 129 DYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI-TT--MAGTKPYMA 182

Query: 465 PE--YAMEGL---FSVKSDVFSFGVIVLEIISGKR 494
           PE   + +G    F+V  D +S GV   E++ G+R
Sbjct: 183 PEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGRR 215

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 87.1 bits (216), Expect = 2e-18
 Identities = 54/251 (21%), Positives = 103/251 (41%), Gaps = 56/251 (22%)

Query: 291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---------EII 340
            D +   + +G+G +G VY        K VA+K+++R        F++         EI 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR-------MFEDLIDCKRILREIT 77

Query: 341 LIAKLQHRNLVRLV-----GCGIEGEEKLLIYELMP---NRSLDCFIFDSERRLQLNWNT 392
           ++ +L+   ++RL         ++ +E  ++ E+      +     IF +E  ++     
Sbjct: 78  ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKT---I 134

Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN 452
            YN++     G  ++HE     IIHRDLKP+N LL++D   K+ DFG+AR     + T  
Sbjct: 135 LYNLL----LGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187

Query: 453 TRRVVGTYGYMAP---------EY-------AMEGLFSVKS-----DVFSFGVIVLEIIS 491
              +                   +       A E +   ++     D++S G I  E+++
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

Query: 492 GKRNSGFYLTG 502
             ++     T 
Sbjct: 248 MLQSHINDPTN 258

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 84.7 bits (210), Expect = 7e-18
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 37/220 (16%)

Query: 291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---------EII 340
            + + + + +G G +G+V        G  VAVK+LSR        F++         E+ 
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80

Query: 341 LIAKLQHRNLVRLV------GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCY 394
           L+  ++H N++ L+          E  +  L+  LM    L+  +    +  +L  +   
Sbjct: 81  LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIV----KCQKLTDDHVQ 135

Query: 395 NIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR 454
            +I  I +GL Y+H  S   IIHRDLKPSN+ +++D   KI DFG+AR    ++ T    
Sbjct: 136 FLIYQILRGLKYIH--SA-DIIHRDLKPSNLAVNEDCELKILDFGLARH-TADEMTGY-- 189

Query: 455 RVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGK 493
             V T  Y APE  +    ++   D++S G I+ E+++G+
Sbjct: 190 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 81.3 bits (201), Expect = 1e-16
 Identities = 59/245 (24%), Positives = 101/245 (41%), Gaps = 72/245 (29%)

Query: 294 FSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKN---------EIILIA 343
           +    KLG+G +G V+K +    G+ VAVK++          F+N         EI+++ 
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIMILT 63

Query: 344 KLQ-HRNLVRLVGCGI--EGEEKLLIYELMP--------NRSLD----CFIFDSERRLQL 388
           +L  H N+V L+         +  L+++ M            L+     ++         
Sbjct: 64  ELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVV-------- 115

Query: 389 NWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ 448
                Y +I    K + YLH  S   ++HRD+KPSN+LL+ +   K++DFG++R F   +
Sbjct: 116 -----YQLI----KVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163

Query: 449 KTANTRRVVGTYGYMAP--------EY-------AMEGLFSVKS-----DVFSFGVIVLE 488
           +  N   +                 +Y       A E L          D++S G I+ E
Sbjct: 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGE 223

Query: 489 IISGK 493
           I+ GK
Sbjct: 224 ILCGK 228

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 80.2 bits (198), Expect = 4e-16
 Identities = 50/221 (22%), Positives = 95/221 (42%), Gaps = 27/221 (12%)

Query: 300 LGQGGFGTVY----KGVLPNGKEVAVKRLSRKSWQGLEE---FKNEIILIAKLQHRNLVR 352
           +G+G FG V     K      K  A+K L++       E   F+ E  ++     + +  
Sbjct: 82  IGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138

Query: 353 LVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           L     + +  L L+ +      L   +   E RL       Y  +  +   +  +H+  
Sbjct: 139 LHYA-FQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY--LAEMVIAIDSVHQ-- 193

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMA-RIFCENQKTANTRRVVGTYGYMAPE---- 466
            L  +HRD+KP N+L+D +   +++DFG   ++  +    ++    VGT  Y++PE    
Sbjct: 194 -LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV--AVGTPDYISPEILQA 250

Query: 467 -YAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQT 506
               +G +  + D +S GV + E++ G+  + FY     +T
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGE--TPFYAESLVET 289

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 77.6 bits (192), Expect = 1e-15
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 35/215 (16%)

Query: 300 LGQGGFGTV----YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEI----ILIAKLQHRNLV 351
           LG+G FG V    +K      +  A+K L +      ++ +  +    +L    +H  L 
Sbjct: 25  LGKGSFGKVFLAEFKK---TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81

Query: 352 RLVGCGIEGEEKL---LIY----ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
            +     + +E L   + Y    +LM       +   S  +  L+  T Y     I  GL
Sbjct: 82  HMFCT-FQTKENLFFVMEYLNGGDLM-------YHIQSCHKFDLSRATFY--AAEIILGL 131

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            +LH      I++RDLK  N+LLDKD   KI+DFGM +         NT    GT  Y+A
Sbjct: 132 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIA 186

Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFY 499
           PE  +   ++   D +SFGV++ E++ G+  S F+
Sbjct: 187 PEILLGQKYNHSVDWWSFGVLLYEMLIGQ--SPFH 219

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 38/220 (17%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ----------- 346
           KLG G F TV+    + N   VA+K + R      E  ++EI L+ ++            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 347 HRNLVRLVGC----GIEGEEKLLIYELMPNRSLDCFIFDSERR---LQLNWNTCYNIIGG 399
             ++++L+      G  G   ++++E++   +L   I   E R   L         ++  
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLL-- 141

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLD------KDMVAKISDFGMARIFCENQKTANT 453
              GL Y+H   R  IIH D+KP NVL++        +  KI+D G A  + +   T   
Sbjct: 142 --LGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-CWYDEHYT--- 193

Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
              + T  Y +PE  +   +   +D++S   ++ E+I+G 
Sbjct: 194 -NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 47/209 (22%), Positives = 84/209 (40%), Gaps = 27/209 (12%)

Query: 300 LGQGGFGTVY----KGVLPNGKEVAVKRLSRKSWQGLEE---FKNEIILIAKLQHRNLVR 352
           +G+G F  V     K     G+  A+K +++       E   F+ E  ++     R + +
Sbjct: 69  IGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125

Query: 353 LVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           L     + E  L L+ E      L   +     R+       Y  +  I   +  +H   
Sbjct: 126 LH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY--LAEIVMAIDSVHR-- 180

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMA-RIFCENQKTANTRRVVGTYGYMAPE---- 466
            L  +HRD+KP N+LLD+    +++DFG   ++  +    +     VGT  Y++PE    
Sbjct: 181 -LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV--AVGTPDYLSPEILQA 237

Query: 467 ---YAMEGLFSVKSDVFSFGVIVLEIISG 492
                  G +  + D ++ GV   E+  G
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYG 266

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 76.8 bits (190), Expect = 2e-15
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 38/212 (17%)

Query: 300 LGQGGFGTVY---KGVLPNGKEV-AVKRLSRKSWQGLEEFKNEI-------ILIAKLQHR 348
           LGQG FG V+   K    + +++ A+K L + +   L+  ++ +       IL  ++ H 
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKAT---LKV-RDRVRTKMERDIL-VEVNHP 86

Query: 349 NLVRLVGCGIEGEEKL---LIY----ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGIS 401
            +V+L     + E KL   L +    +L             E          Y  +  ++
Sbjct: 87  FIVKLHYA-FQTEGKLYLILDFLRGGDLF-------TRLSKEVMFTEEDVKFY--LAELA 136

Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYG 461
             L +LH    L II+RDLKP N+LLD++   K++DFG+++   +++K A +    GT  
Sbjct: 137 LALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVE 191

Query: 462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           YMAPE       +  +D +SFGV++ E+++G 
Sbjct: 192 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 76.4 bits (189), Expect = 2e-15
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 38/213 (17%)

Query: 300 LGQGGFGTVY---KGVLPNGKEV-AVKRLSRKSWQGLEEFKNEI--------ILIAKLQH 347
           LG+GG+G V+   K    N  ++ A+K L +     +     +         IL  +++H
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAM---IVRNAKDTAHTKAERNIL-EEVKH 80

Query: 348 RNLVRLVGCGIEGEEKL---LIY----ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
             +V L+    +   KL   L Y    EL           + E     +    Y  +  I
Sbjct: 81  PFIVDLIYA-FQTGGKLYLILEYLSGGELF-------MQLEREGIFMEDTACFY--LAEI 130

Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
           S  L +LH+     II+RDLKP N++L+     K++DFG+ +    +    +T    GT 
Sbjct: 131 SMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTI 185

Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
            YMAPE  M    +   D +S G ++ ++++G 
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 76.3 bits (188), Expect = 5e-15
 Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 28/220 (12%)

Query: 300 LGQGGFGTVY----KGVLPNGKEVAVKRLSRKSWQGLEE---FKNEIILIAKLQHRNLVR 352
           +G+G FG V     K      K  A+K LS+       +   F  E  ++A      +V+
Sbjct: 77  IGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 133

Query: 353 LVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           L     + +  L ++ E MP   L      S   +   W   Y     +   L  +H   
Sbjct: 134 LFYA-FQDDRYLYMVMEYMPGGDL--VNLMSNYDVPEKWARFY--TAEVVLALDAIHS-- 186

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMA-RIFCENQKTANTRRVVGTYGYMAPE---- 466
            +  IHRD+KP N+LLDK    K++DFG   ++  E     +T   VGT  Y++PE    
Sbjct: 187 -MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT--AVGTPDYISPEVLKS 243

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQT 506
              +G +  + D +S GV + E++ G   + FY      T
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGD--TPFYADSLVGT 281

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 75.8 bits (187), Expect = 6e-15
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 35/215 (16%)

Query: 300 LGQGGFGTVY----KGVLPNGKEVAVKRLSRKSWQGLEEFKNEI----ILIAKLQHRNLV 351
           +G+G FG V     K         AVK L +K+    +E K+ +    +L+  ++H  LV
Sbjct: 46  IGKGSFGKVLLARHKA---EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 352 RLVGCGIEGEEKL---LIY----ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
            L     +  +KL   L Y    EL        +    ER         Y     I+  L
Sbjct: 103 GLHFS-FQTADKLYFVLDYINGGELF-------YHLQRERCFLEPRARFY--AAEIASAL 152

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            YLH    L I++RDLKP N+LLD      ++DFG+ +   E+  T +T    GT  Y+A
Sbjct: 153 GYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLA 207

Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFY 499
           PE   +  +    D +  G ++ E++ G     FY
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGL--PPFY 240

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 75.3 bits (186), Expect = 6e-15
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 33/209 (15%)

Query: 300 LGQGGFGTVY----KGVLPNGKEVAVKRLSRKSWQGLEEFKNEI----ILIAKLQHRNLV 351
           +G+G +  V     K      +  A+K + ++     E+         +      H  LV
Sbjct: 17  IGRGSYAKVLLVRLKK---TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73

Query: 352 RLVGCGIEGEEKL---LIY----ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
            L  C  + E +L   + Y    +LM       F    +R+L       Y     IS  L
Sbjct: 74  GLHSC-FQTESRLFFVIEYVNGGDLM-------FHMQRQRKLPEEHARFY--SAEISLAL 123

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            YLHE     II+RDLK  NVLLD +   K++D+GM +       T +T    GT  Y+A
Sbjct: 124 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIA 178

Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           PE      +    D ++ GV++ E+++G+
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 33/209 (15%)

Query: 300 LGQGGFGTVY----KGVLPNGKEVAVKRLSRKSWQGLEEFKNEI----ILIAKLQHRNLV 351
           +G+G +  V     K      +  A++ + ++     E+         +      H  LV
Sbjct: 60  IGRGSYAKVLLVRLKK---TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116

Query: 352 RLVGCGIEGEEKL---LIY----ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
            L  C  + E +L   + Y    +LM       F    +R+L       Y     IS  L
Sbjct: 117 GLHSC-FQTESRLFFVIEYVNGGDLM-------FHMQRQRKLPEEHARFY--SAEISLAL 166

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            YLHE     II+RDLK  NVLLD +   K++D+GM +       T +T    GT  Y+A
Sbjct: 167 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIA 221

Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           PE      +    D ++ GV++ E+++G+
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 74.6 bits (184), Expect = 1e-14
 Identities = 61/213 (28%), Positives = 89/213 (41%), Gaps = 41/213 (19%)

Query: 300 LGQGGFGTVY----KGVLPNGKEVAVKRLSRKSWQGLEEFKNEI--------ILIAKLQH 347
           LG+G FG V     K     G   AVK L +          +++        IL     H
Sbjct: 31  LGKGSFGKVMLARVKE---TGDLYAVKVLKKDVILQ----DDDVECTMTEKRILSLARNH 83

Query: 348 RNLVRLVGCGIEGEEKL---LIY----ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
             L +L  C  +  ++L   + +    +LM       F     RR        Y     I
Sbjct: 84  PFLTQLFCC-FQTPDRLFFVMEFVNGGDLM-------FHIQKSRRFDEARARFY--AAEI 133

Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
              L++LH+     II+RDLK  NVLLD +   K++DFGM +    N  T  T    GT 
Sbjct: 134 ISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTP 188

Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
            Y+APE   E L+    D ++ GV++ E++ G 
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 7/100 (7%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I   L YLH      +++RD+K  N++LDKD   KI+DFG+ +    +  T  T    GT
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGT 168

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFY 499
             Y+APE   +  +    D +  GV++ E++ G+    FY
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFY 206

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 6/100 (6%)

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I   L YLH  S   +++RDLK  N++LDKD   KI+DFG+ +   ++  T  T    GT
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGT 312

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFY 499
             Y+APE   +  +    D +  GV++ E++ G+    FY
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFY 350

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 56/213 (26%), Positives = 90/213 (42%), Gaps = 41/213 (19%)

Query: 300 LGQGGFGTV----YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEI--------ILIAKLQH 347
           LG+G FG V     KG     +  AVK L +          +++        +L    + 
Sbjct: 28  LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQ----DDDVECTMVEKRVLALPGKP 80

Query: 348 RNLVRLVGCGIEGEEKL---LIY----ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
             L +L  C  +  ++L   + Y    +LM       +      R +      Y     I
Sbjct: 81  PFLTQLHSC-FQTMDRLYFVMEYVNGGDLM-------YHIQQVGRFKEPHAVFY--AAEI 130

Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
           + GL +L       II+RDLK  NV+LD +   KI+DFGM +    +  T  T    GT 
Sbjct: 131 AIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTP 185

Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
            Y+APE      +    D ++FGV++ E+++G+
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 75.1 bits (184), Expect = 3e-14
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 35/215 (16%)

Query: 300 LGQGGFGTV----YKGVLPNGKEVAVKRLSRKSWQGLEEFKNEI----ILIAKLQHRNLV 351
           LG+G FG V     KG     +  AVK L +      ++ +  +    +L    +   L 
Sbjct: 349 LGKGSFGKVMLSERKG---TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405

Query: 352 RLVGCGIEGEEKL---LIY----ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           +L  C  +  ++L   + Y    +LM       +      R +      Y     I+ GL
Sbjct: 406 QLHSC-FQTMDRLYFVMEYVNGGDLM-------YHIQQVGRFKEPHAVFY--AAEIAIGL 455

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            +L       II+RDLK  NV+LD +   KI+DFGM +    +  T  T    GT  Y+A
Sbjct: 456 FFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIA 510

Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFY 499
           PE      +    D ++FGV++ E+++G+  + F 
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQ--APFE 543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 72.6 bits (177), Expect = 5e-14
 Identities = 34/219 (15%), Positives = 63/219 (28%), Gaps = 57/219 (26%)

Query: 290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRL--------SRKSWQGLEEFKNEIIL 341
            T+      K+G+G FG V++ +  +   VA+K +        +    +  EE   EII+
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 342 IAKLQ---------HRNLVRLVGC----GIEGEEKLLIYELMPNRSLDCFIFDSERRLQ- 387
             +L              + L       G      L  ++   +            +   
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 388 ---------------------LNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVL 426
                                 +  T  +I+  ++  L        L+  HRDL   NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194

Query: 427 LDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           L K  + K+      +              + + G    
Sbjct: 195 LKKTSLKKLHYTLNGKSST-----------IPSCGLQVS 222

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 44/175 (25%), Positives = 76/175 (43%), Gaps = 18/175 (10%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQH-RNLVRLVGC 356
           K+G G FG +Y G  +  G+EVA+K    K+     +   E  +   +Q    +  +  C
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWC 73

Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
           G EG+  +++ EL+   SL+       R+  L   T   +   +   + Y+H  +    I
Sbjct: 74  GAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLK--TVLLLADQMISRIEYIHSKN---FI 127

Query: 417 HRDLKPSNVLLDKDMVAK---ISDFGMARIFCENQK-----TANTRRVVGTYGYM 463
           HRD+KP N L+          I DFG+A+ + + +          + + GT  Y 
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 72.7 bits (179), Expect = 6e-14
 Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 40/228 (17%)

Query: 300 LGQGGFGTVY---KGVLPNGKEV-AVKRLSRKS----WQGLEEFKNE-IILIAKLQHRNL 350
           LG G +G V+   K    +  ++ A+K L + +     +  E  + E  +L    Q   L
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 351 VRLVGCGIEGEEKL---LIY----ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKG 403
           V L     + E KL   L Y    EL               R   +    Y  +G I   
Sbjct: 122 VTLHYA-FQTETKLHLILDYINGGELF-------THLSQRERFTEHEVQIY--VGEIVLA 171

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ-KTANTRRVVGTYGY 462
           L +LH+   L II+RD+K  N+LLD +    ++DFG+++ F  ++ + A      GT  Y
Sbjct: 172 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD--FCGTIEY 226

Query: 463 MAPEYAMEGL----FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQT 506
           MAP+    G      +V  D +S GV++ E+++G   S F + G   +
Sbjct: 227 MAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA--SPFTVDGEKNS 270

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 50/201 (24%), Positives = 86/201 (42%), Gaps = 23/201 (11%)

Query: 300 LGQGGFGTVY----KGVLPNGKEVAVKRLSRKSWQGLEEF---KNEIILIAKLQHRNLVR 352
           LG G FG V     K    +G   A+K L ++    L++     NE  ++  +    LV+
Sbjct: 49  LGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105

Query: 353 LVGCGIEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           L     +    L ++ E +    +         R        Y     I     YLH   
Sbjct: 106 LEFS-FKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARFY--AAQIVLTFEYLHS-- 159

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
            L +I+RDLKP N+L+D+    +++DFG A+     +    T  + GT   +APE  +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWT--LCGTPEALAPEIILSK 213

Query: 472 LFSVKSDVFSFGVIVLEIISG 492
            ++   D ++ GV++ E+ +G
Sbjct: 214 GYNKAVDWWALGVLIYEMAAG 234

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 70.8 bits (173), Expect = 4e-13
 Identities = 45/176 (25%), Positives = 78/176 (44%), Gaps = 20/176 (11%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLV-RLVGC 356
           K+G G FG +Y G  +   +EVA+K  + K+     +   E  +   LQ    +  +   
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWF 71

Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
           G+EG+  +L+ +L+   SL+       R+L L   T   +   +   + ++H  S    +
Sbjct: 72  GVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKS---FL 125

Query: 417 HRDLKPSNVLLDKDMVAK---ISDFGMARIFCENQKT------ANTRRVVGTYGYM 463
           HRD+KP N L+     A    I DFG+A+ +  +  T         + + GT  Y 
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR-DTSTHQHIPYRENKNLTGTARYA 180

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 68.7 bits (169), Expect = 8e-13
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 47/213 (22%)

Query: 300 LGQGGFGTVY----KGVLPNGKEVAVKRLSRKSWQGLEEF---KNEIILIAKLQHRNLVR 352
           LG G FG V+    +    NG+  A+K L ++    L++     +E ++++ + H  ++R
Sbjct: 14  LGTGSFGRVHLIRSRH---NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70

Query: 353 LVGCGIEGEEKL-LIYELMPNRSL-----DCFIFDSER-RLQLNWNTCYNIIGGISKGLL 405
           + G   +  +++ +I + +    L         F +   +        Y     +   L 
Sbjct: 71  MWGT-FQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-------Y--AAEVCLALE 120

Query: 406 YLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           YLH      II+RDLKP N+LLDK+   KI+DFG A+          T  + GT  Y+AP
Sbjct: 121 YLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK---YVPDVTYT--LCGTPDYIAP 172

Query: 466 E------YAMEGLFSVKSDVFSFGVIVLEIISG 492
           E      Y      S+  D +SFG+++ E+++G
Sbjct: 173 EVVSTKPYNK----SI--DWWSFGILIYEMLAG 199

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 27/174 (15%), Positives = 68/174 (39%), Gaps = 27/174 (15%)

Query: 298 NKLGQGGFGTVYKGV---------LPNGKEVAVKRLSRKSWQGLEEF-------KNEIIL 341
           +   +   G +Y+            P  ++ ++K  ++      E+          ++  
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107

Query: 342 IAKLQHRNLV---RLVGCGI-EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNII 397
             KL    L+     +G G+ + + + L+   +  RSL     D   +  L+  +   + 
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSERSVLQVA 165

Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKI--SDFGMARIFCENQK 449
             +   L +LHE+     +H ++   N+ +D +  +++  + +G A  +C + K
Sbjct: 166 CRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 40/177 (22%), Positives = 70/177 (39%), Gaps = 20/177 (11%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           K+G G FG +  G  L   + VA+K    KS       +             + ++   G
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG-SGDGIPQVYYFG 74

Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
             G+   ++ EL+   SL+      +R   L   T   I   +   + Y+H  +   +I+
Sbjct: 75  PCGKYNAMVLELL-GPSLEDLFDLCDRTFSLK--TVLMIAIQLISRMEYVHSKN---LIY 128

Query: 418 RDLKPSNVLLDKDMVAK-----ISDFGMARIFCENQKT------ANTRRVVGTYGYM 463
           RD+KP N L+ +          I DF +A+ +  + +T         + + GT  YM
Sbjct: 129 RDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI-DPETKKHIPYREHKSLTGTARYM 184

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 36/174 (20%), Positives = 64/174 (36%), Gaps = 29/174 (16%)

Query: 299 KLGQGGFGTVYKGVLPNGK------EVAVKRLSRKSWQGLEEFK-----------NEIIL 341
            +GQGGFG +Y   + + +         VK     +     E K            + I 
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 342 IAKLQHRNLVRLVGCGIEGEEKL----LIYELMPNRSLDCFIFDSERRLQLNWNTCYNII 397
             KL++  + +  G G+  +       +I +      L      + +R      T   + 
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSR--KTVLQLS 158

Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKI--SDFGMARIFCENQK 449
             I   L Y+HE      +H D+K SN+LL+     ++   D+G+A  +C    
Sbjct: 159 LRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 42/179 (23%), Positives = 81/179 (45%), Gaps = 24/179 (13%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVG 355
           ++G+G FG +++G  L N ++VA+K   R+S   Q  +E++   +L        +  +  
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGC---TGIPNVYY 73

Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
            G EG   +L+ +L+   SL+  +    R+  +   T       +   +  +HE S   +
Sbjct: 74  FGQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSVK--TVAMAAKQMLARVQSIHEKS---L 127

Query: 416 IHRDLKPSNVLLDKDMVAK-----ISDFGMARIFCENQKT------ANTRRVVGTYGYM 463
           ++RD+KP N L+ +          + DFGM + +  +  T         + + GT  YM
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR-DPVTKQHIPYREKKNLSGTARYM 185

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 66.3 bits (162), Expect = 9e-12
 Identities = 50/207 (24%), Positives = 92/207 (44%), Gaps = 28/207 (13%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRL-SRKSW--QGLEEFKNEIILIAKLQHR------N 349
           +G+G FG V K       + VA+K + + K +  Q  EE    I ++  L+ +      N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNTMN 160

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ-LNWNTCYNIIGGISKGLLYLH 408
           ++ ++          + +EL+   S++ +    + + Q  +          I + L  LH
Sbjct: 161 VIHMLENFTFRNHICMTFELL---SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217

Query: 409 EDSRLKIIHRDLKPSNVLL--DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
              + +IIH DLKP N+LL        K+ DFG +   C   +   T   + +  Y APE
Sbjct: 218 ---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYT--YIQSRFYRAPE 269

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGK 493
             +   + +  D++S G I+ E+++G 
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGY 296

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 49/209 (23%), Positives = 92/209 (44%), Gaps = 26/209 (12%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRL-SRKSW--QGLEEFKNEIILIAKLQHR----- 348
           + +G+G FG V K       + VA+K + ++K++  Q       E+ L+  +        
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMK 115

Query: 349 -NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ-LNWNTCYNIIGGISKGLLY 406
             +V L    +      L++E++   S + +        + ++ N        +   LL+
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML---SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172

Query: 407 LHEDSRLKIIHRDLKPSNVLL--DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
           L     L IIH DLKP N+LL   K    KI DFG +   C+  +       + +  Y +
Sbjct: 173 LA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIYQ--YIQSRFYRS 226

Query: 465 PEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           PE  +   + +  D++S G I++E+ +G+
Sbjct: 227 PEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 33/172 (19%), Positives = 66/172 (38%), Gaps = 28/172 (16%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVA---VKRLSRKSWQGLEEFKNEIIL-----------IA 343
           K+G GGFG +Y        ++ A   VK   +++     E K    +             
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 344 KLQHRNLVRLVGCGI----EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGG 399
           +L +  +    G G+        + ++ E +    L   I       + +  T   +   
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ-KISGQNGTFKKS--TVLQLGIR 159

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKI--SDFGMARIFCENQK 449
           +   L Y+HE+     +H D+K +N+LL      ++  +D+G++  +C N  
Sbjct: 160 MLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 63.4 bits (154), Expect = 8e-11
 Identities = 52/258 (20%), Positives = 96/258 (37%), Gaps = 72/258 (27%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ--------HRN 349
           KLG G F TV+    +   K VA+K + + +    E   +EI L+  ++           
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 350 LVRLVGC----GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLL 405
           +V+L+      G+ G    +++E++    L  +I  S  +  L       II  + +GL 
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQG-LPLPCVKKIIQQVLQGLD 160

Query: 406 YLHEDSRLKIIHRDLKPSNVLL-------------------------------------- 427
           YLH  ++ +IIH D+KP N+LL                                      
Sbjct: 161 YLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 428 -----------DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
                       + +  KI+D G A    ++         + T  Y + E  +   ++  
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSLEVLIGSGYNTP 273

Query: 477 SDVFSFGVIVLEIISGKR 494
           +D++S   +  E+ +G  
Sbjct: 274 ADIWSTACMAFELATGDY 291

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 55.6 bits (133), Expect = 3e-08
 Identities = 80/599 (13%), Positives = 153/599 (25%), Gaps = 178/599 (29%)

Query: 75  DVNRTVCQNCLENARHEILKNCKTAEEA---IIWYELCQIQYS-YRKFLVMVYAGQY--- 127
           D+ +++    L     + +   K A      + W  L   Q    +KF+  V    Y   
Sbjct: 40  DMPKSI----LSKEEIDHIIMSKDAVSGTLRLFWT-LLSKQEEMVQKFVEEVLRINYKFL 94

Query: 128 AEKWNNQWKSVSNPAR-FIEVLTYLMTNLSIEASSDPAMFAVGEVKFPK-----RK---- 177
                 + +  S   R +IE    L          D  +FA   V   +     R+    
Sbjct: 95  MSPIKTEQRQPSMMTRMYIEQRDRLYN--------DNQVFAKYNVSRLQPYLKLRQALLE 146

Query: 178 -------TIYG--------LV-QCTRDINSRDCNDC----LTGALGDLKACCGAREAGII 217
                   I G        +          +   D     L      LK C       ++
Sbjct: 147 LRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLN-----LKNCN--SPETVL 199

Query: 218 VNENCNLRFQLSLFYNASTRIALTYPTSTDEKRSQ-RGLLHELAGPIS-VSLTQEGDLVS 275
                 L +Q+   + + +  +          +++ R LL         + L      V 
Sbjct: 200 EMLQ-KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVL----LNVQ 254

Query: 276 SEELPFVHLAVIKA---------ATDGFSDSNKLGQGGFGTVYKGVLPNG--KEVAVKRL 324
           + +          A          T     ++ L       +           +     L
Sbjct: 255 NAK-------AWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL 307

Query: 325 SRKSWQGLEEFKNE--------IILIAKLQHRNLVRL-----VGCGIEGEEKLL------ 365
            +      ++   E        + +IA+     L        V C     +KL       
Sbjct: 308 LKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC-----DKLTTIIESS 362

Query: 366 IYELMPN--RSL--DCFIFD-----SERRLQLNW------------NTCYN---IIGGIS 401
           +  L P   R +     +F          L L W            N  +    +     
Sbjct: 363 LNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPK 422

Query: 402 KGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISD-FGMARIFCENQKTANTRRVVGTY 460
           +  + +        I+ +LK   +  +  +   I D + + + F  +            Y
Sbjct: 423 ESTISIPS------IYLELKV-KLENEYALHRSIVDHYNIPKTFDSDDLIPPYLD---QY 472

Query: 461 -----GYMAPEYAMEGLFSVKSDV---FSFGVIVLEIISGK-RNSGFYLTGHAQTLLAYV 511
                G+           ++   V   F F       +  K R+          ++L  +
Sbjct: 473 FYSHIGHHLKNIEHPERMTLFRMVFLDFRF-------LEQKIRHDSTAWNASG-SILNTL 524

Query: 512 WQLWKEGKEMEFVDPL-----------LMKSSSIPQVVRC-----IHIGLLCVQEDPAV 554
            QL      +   DP            L K      ++       + I L+   ED A+
Sbjct: 525 QQLKFYKPYICDNDPKYERLVNAILDFLPKIE--ENLICSKYTDLLRIALM--AEDEAI 579

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 57/232 (24%), Positives = 92/232 (39%), Gaps = 54/232 (23%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRL-SRKSW--QGLEEFKNEIILIAKLQHR-----N 349
           K+G G FG V     + N K  AVK + + K +      E      ++ K+Q+      N
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNNN 97

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERR---LQLNWNTCYNIIGGISKGLLY 406
           +V+  G  +  +   LI+E +   SL   I  +      ++     C  I+    K L Y
Sbjct: 98  IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEIL----KALNY 152

Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVA-------------------------KISDFGMA 441
           L +   + + H DLKP N+LLD                              K+ DFG A
Sbjct: 153 LRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209

Query: 442 RIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
                      +  ++ T  Y APE  +   + V SD++SFG ++ E+ +G 
Sbjct: 210 ---TFKSDYHGS--IINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 47/228 (20%), Positives = 87/228 (38%), Gaps = 50/228 (21%)

Query: 299 KLGQGGFGTVYKGV--LPNGKEVAVKRL-SRKSW--QGLEEFKNEIILIAKLQHR----- 348
            LG+G FG V + +       +VA+K + +   +      E    I ++ K++ +     
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKENK 81

Query: 349 -NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERR---LQLNWNTCYNIIGGISKGL 404
              V +           + +EL+  ++   F+ ++  +   L    +  Y +       L
Sbjct: 82  FLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLC----HAL 136

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVA-------------------KISDFGMARIFC 445
            +LHE    ++ H DLKP N+L                          +++DFG A    
Sbjct: 137 RFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA---T 190

Query: 446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
            + +   T  +V T  Y  PE  +E  ++   DV+S G I+ E   G 
Sbjct: 191 FDHEHHTT--IVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGF 236

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 54/228 (23%), Positives = 87/228 (38%), Gaps = 50/228 (21%)

Query: 299 KLGQGGFGTVYKGV--LPNGKEVAVKRL-SRKSW--QGLEEFKNEIILIAKLQHR----- 348
            LG+G FG V + +     G+ VAVK + +   +      E +   +L   L        
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ---VL-EHLNTTDPNST 76

Query: 349 -NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERR---LQLNWNTCYNIIGGISKGL 404
              V+++          +++EL+   S   FI ++      L       Y I     K +
Sbjct: 77  FRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQIC----KSV 131

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVA-------------------KISDFGMARIFC 445
            +LH     K+ H DLKP N+L  +                       K+ DFG A    
Sbjct: 132 NFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA---T 185

Query: 446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
            + +  +T  +V T  Y APE  +   +S   DV+S G I++E   G 
Sbjct: 186 YDDEHHST--LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	611
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.89
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.88
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.79
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.69
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.4
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.22
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.05
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.0
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.66
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.51
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.48
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.47
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.37
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.32
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.11
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.01
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.89
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.88
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.62
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.57
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.49
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.43
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.39
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.31
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.3
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.24
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.09
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.08
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.9
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.73
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.02
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.36
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	82.49
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	81.69

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.7e-53  Score=433.82  Aligned_cols=258  Identities=26%  Similarity=0.431  Sum_probs=213.1

Q ss_pred             CCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      ++|.+.++||+|+||+||+|++.      +++.||||+++.......++|.+|+++|++++|||||++++++.+++..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            57889999999999999999853      477899999988777778889999999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhch----------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEE
Q 007239          366 IYELMPNRSLDCFIFDSE----------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKI  435 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl  435 (611)
                      |||||++|+|.++|....          ....++|.+++.|+.||++||.|||+++   ||||||||+||||++++++||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999996432          2346999999999999999999999986   999999999999999999999


Q ss_pred             eccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHH
Q 007239          436 SDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQL  514 (611)
Q Consensus       436 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~  514 (611)
                      +|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||....   ...+...    
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~~----  242 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---NNEVIEC----  242 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC---HHHHHHH----
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHH----
Confidence            99999987655444333445679999999999999999999999999999999998 899975322   2222222    


Q ss_pred             HhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       515 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      +..+...+.         +.....++.+|+.+||+.||++|||+++|+++|++.
T Consensus       243 i~~~~~~~~---------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          243 ITQGRVLQR---------PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             HHHTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCCCCC---------CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            222322111         111224577899999999999999999999999753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.4e-53  Score=429.00  Aligned_cols=264  Identities=24%  Similarity=0.382  Sum_probs=203.5

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      +++++.++||+|+||+||+|++++  .||||+++..  ..+..+.|.+|+.++++++|||||++++++.+ +..+|||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy  112 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW  112 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence            578889999999999999999753  5999998643  34556789999999999999999999998754 568999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      |++|+|.+++...  ...+++.++..|+.||++||.|||+++   ||||||||+||||++++++||+|||+|+.......
T Consensus       113 ~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          113 CEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             CSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             CCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            9999999998542  346999999999999999999999986   99999999999999999999999999987654444


Q ss_pred             ccccccccccCCCCCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          450 TANTRRVVGTYGYMAPEYAME---GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      .......+||+.|||||++.+   +.|+.++|||||||+||||+||+.||.....  ...+    ......+....    
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--~~~~----~~~~~~~~~~p----  257 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN--RDQI----IFMVGRGYASP----  257 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHH----HHHHHTTCCCC----
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--HHHH----HHHHhcCCCCC----
Confidence            444556789999999999864   4699999999999999999999999853221  1111    11222221111    


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCCCCCCC
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSE  574 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~  574 (611)
                      .+. .........+.+|+.+||+.||++|||+.||++.|+...-++|.
T Consensus       258 ~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk  304 (307)
T 3omv_A          258 DLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK  304 (307)
T ss_dssp             CST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred             Ccc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence            110 01112234577899999999999999999999998765444443

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.9e-53  Score=435.19  Aligned_cols=258  Identities=28%  Similarity=0.412  Sum_probs=205.5

Q ss_pred             CCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      ++|.+.++||+|+||+||+|++.      +++.||||+++.......++|.+|+++|++++|||||++++++.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56888899999999999999853      478899999988777778899999999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhch------------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCE
Q 007239          366 IYELMPNRSLDCFIFDSE------------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVA  433 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~------------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~  433 (611)
                      |||||++|+|.+++....            ....++|.+++.|+.||++||.|||+++   ||||||||+||||++++++
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            999999999999986532            2346999999999999999999999986   9999999999999999999


Q ss_pred             EEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHH
Q 007239          434 KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVW  512 (611)
Q Consensus       434 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~  512 (611)
                      ||+|||+++...............||+.|||||++.+..++.++|||||||+||||+| |+.||....   ...+...  
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~---~~~~~~~--  272 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS---NTEAIDC--  272 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC---HHHHHHH--
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC---HHHHHHH--
Confidence            9999999997655444444455789999999999999999999999999999999999 899975322   2222222  


Q ss_pred             HHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       513 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                        +..+...+.     .    .....++.+|+.+||+.||++|||++||+++|+..
T Consensus       273 --i~~g~~~~~-----p----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l  317 (329)
T 4aoj_A          273 --ITQGRELER-----P----RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL  317 (329)
T ss_dssp             --HHHTCCCCC-----C----TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred             --HHcCCCCCC-----c----ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence              222222111     1    11224577899999999999999999999999764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.6e-53  Score=435.87  Aligned_cols=257  Identities=28%  Similarity=0.413  Sum_probs=211.5

Q ss_pred             CCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  364 (611)
                      .++++.++||+|+||+||+|++.      +++.||||+++... ....++|.+|+.++++++|||||++++++.+.+..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            45677899999999999999862      46789999997543 334678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhHhhhch-------------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC
Q 007239          365 LIYELMPNRSLDCFIFDSE-------------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM  431 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~  431 (611)
                      ||||||++|+|.++|....             ....++|.+++.|+.||++||.|||+++   ||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            9999999999999995422             2346899999999999999999999986   99999999999999999


Q ss_pred             CEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHH
Q 007239          432 VAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAY  510 (611)
Q Consensus       432 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~  510 (611)
                      ++||+|||+++...............||+.|||||++.++.|+.++|||||||+||||+| |+.||....   ...+.. 
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~---~~~~~~-  258 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS---NQDVVE-  258 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC---HHHHHH-
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC---HHHHHH-
Confidence            999999999997755544444556789999999999999999999999999999999998 888975332   222222 


Q ss_pred             HHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          511 VWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       511 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                         .+..+.....         +.....++.+|+.+||+.||++|||++||++.|++
T Consensus       259 ---~i~~~~~~~~---------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          259 ---MIRNRQVLPC---------PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             ---HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             ---HHHcCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence               2233322211         11223457789999999999999999999999975

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.2e-53  Score=431.24  Aligned_cols=248  Identities=24%  Similarity=0.316  Sum_probs=209.2

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++++.||+|+||+||+++. .+|+.||||++.+..   ....+.+.+|+++|++++|||||++++++.+++.+|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999995 579999999997542   234678999999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||++||+|.+++.   +.+.+++..++.++.||+.||.|||+++   |+||||||+||||+.++++||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            9999999999983   4567999999999999999999999997   999999999999999999999999999987655


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                      .........+||+.|||||++.+..|+.++||||+||++|||++|+.||...   ....+...+    ..+.. +     
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i----~~~~~-~-----  252 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEGLIFAKI----IKLEY-D-----  252 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH----HHTCC-C-----
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHH----HcCCC-C-----
Confidence            5444556689999999999999999999999999999999999999998432   222222222    12211 1     


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV  562 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  562 (611)
                      +...    ...++.+|+.+||+.||++|||++|++
T Consensus       253 ~p~~----~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          253 FPEK----FFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             CCTT----CCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             CCcc----cCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            1111    123567899999999999999999863

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3e-52  Score=431.03  Aligned_cols=250  Identities=21%  Similarity=0.340  Sum_probs=201.8

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ++|+++++||+|+||+||++++ .+|+.||||++.+.  .....+.+.+|+.+|++|+|||||++++++.+++..|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            6899999999999999999995 57999999999754  33456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |++||+|.++|.. .+...+++.+++.|+.||+.||.|||+++   ||||||||+||||+.+|++||+|||+|+.+....
T Consensus       104 y~~gg~L~~~i~~-~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINA-QKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHH-cCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9999999999854 23456799999999999999999999997   9999999999999999999999999998764322


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                        ......+||+.|||||++.+..|+.++|||||||++|||++|+.||...   ....+   ..+... +....     +
T Consensus       180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~---~~~i~~-~~~~~-----~  245 (350)
T 4b9d_A          180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG---SMKNL---VLKIIS-GSFPP-----V  245 (350)
T ss_dssp             --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHH---HHHHHH-TCCCC-----C
T ss_pred             --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHH---HHHHHc-CCCCC-----C
Confidence              1233568999999999999999999999999999999999999998532   12222   222222 22111     1


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..    ....++.+|+.+||+.||++|||++|+++
T Consensus       246 ~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          246 SL----HYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             Cc----cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11    12245778999999999999999999986

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.8e-52  Score=428.80  Aligned_cols=249  Identities=24%  Similarity=0.352  Sum_probs=207.8

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      +.|++.++||+|+||+||+|++ .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+||||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            5699999999999999999996 479999999997665556677899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      +||+|.+++..    ..+++.++..++.||+.||.|||+++   ||||||||+||||+.+|++||+|||+|+.+..... 
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-  225 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  225 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence            99999998842    46999999999999999999999997   99999999999999999999999999997654332 


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                       .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...   ....+...+    ..+....     +. 
T Consensus       226 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i----~~~~~~~-----~~-  291 (346)
T 4fih_A          226 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMI----RDNLPPR-----LK-  291 (346)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHH----HHSSCCC-----CS-
T ss_pred             -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHH----HcCCCCC-----CC-
Confidence             234579999999999999999999999999999999999999998432   222222222    2211111     10 


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       .......++.+|+.+||+.||++|||++|+++
T Consensus       292 -~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          292 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             01112245779999999999999999999886

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.1e-51  Score=425.03  Aligned_cols=252  Identities=25%  Similarity=0.300  Sum_probs=203.3

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      .+.|++.++||+|+||+||+|++ .+|+.||||+++....     ..+|+.+++.++|||||++++++.+++.+||||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            45788999999999999999995 4799999999976532     24799999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC-CEEEeccccceecccCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCENQ  448 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGla~~~~~~~  448 (611)
                      ++||+|.+++.   +.+.+++.++..++.||+.||.|||+++   ||||||||+||||+.+| ++||+|||+|+.+....
T Consensus       132 ~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIK---QMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            99999999994   4467999999999999999999999986   99999999999999987 69999999999875433


Q ss_pred             Ccc---ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          449 KTA---NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       449 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ...   .....+||+.|||||++.+..|+.++|||||||++|||++|++||.......   +...+   ........   
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i---~~~~~~~~---  276 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCLKI---ASEPPPIR---  276 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHHHH---HHSCCGGG---
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHH---HcCCCCch---
Confidence            211   2234689999999999999999999999999999999999999985433222   11111   11111100   


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                       .+..    .....+.+|+.+||+.||++|||+.|+++.|..
T Consensus       277 -~~~~----~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          277 -EIPP----SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             -GSCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -hcCc----cCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence             1111    112456789999999999999999999988854

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=6.7e-51  Score=430.47  Aligned_cols=250  Identities=24%  Similarity=0.343  Sum_probs=208.5

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      .+.|++.++||+|+||.||+|++ .+|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+.+||||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            35799999999999999999996 47999999999876666667789999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      |+||+|.+++.    ...+++.++..++.||+.||.|||+++   ||||||||+||||+.+|++||+|||+|+.+.....
T Consensus       230 ~~gG~L~~~i~----~~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~  302 (423)
T 4fie_A          230 LEGGALTDIVT----HTRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP  302 (423)
T ss_dssp             CTTEEHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred             CCCCcHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence            99999999883    345999999999999999999999997   99999999999999999999999999997644332


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                        .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...   ....+...    +..+....     +.
T Consensus       303 --~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~----i~~~~~~~-----~~  368 (423)
T 4fie_A          303 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKM----IRDNLPPR-----LK  368 (423)
T ss_dssp             --CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHH----HHHSCCCC-----CS
T ss_pred             --cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHH----HHcCCCCC-----Cc
Confidence              234578999999999999999999999999999999999999998432   22222221    22221111     11


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..  .....++.+|+.+||+.||++|||+.|+++
T Consensus       369 ~~--~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          369 NL--HKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CT--TSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cc--ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            10  111235778999999999999999999986

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.6e-50  Score=409.30  Aligned_cols=247  Identities=27%  Similarity=0.391  Sum_probs=197.6

Q ss_pred             CCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee----CCeEEEE
Q 007239          294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE----GEEKLLI  366 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~lv  366 (611)
                      |++.++||+|+||+||+|++ .+++.||+|++...  .....+.|.+|+.++++++|||||++++++.+    .+.++||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            36778899999999999996 46889999998654  33446789999999999999999999999875    3568999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec-CCCCEEEeccccceecc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD-KDMVAKISDFGMARIFC  445 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~-~~~~~kl~DFGla~~~~  445 (611)
                      |||+++|+|.+++.   +...+++..+..|+.||+.||.|||+++ .+||||||||+||||+ .++.+||+|||+|+...
T Consensus       108 mEy~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          108 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            99999999999994   4567999999999999999999999874 3599999999999998 47999999999997532


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      .    ......+||+.|||||++.+ .|+.++|||||||++|||++|+.||.....  ...    +......+......+
T Consensus       184 ~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~--~~~----~~~~i~~~~~~~~~~  252 (290)
T 3fpq_A          184 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQ----IYRRVTSGVKPASFD  252 (290)
T ss_dssp             T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHH----HHHHHTTTCCCGGGG
T ss_pred             C----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc--HHH----HHHHHHcCCCCCCCC
Confidence            2    22345789999999998864 699999999999999999999999843221  111    222222222211111


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..    .    ..++.+|+.+||+.||++|||++|+++
T Consensus       253 ~~----~----~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          253 KV----A----IPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GC----C----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cc----C----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11    1    134678999999999999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=6.3e-51  Score=408.66  Aligned_cols=246  Identities=24%  Similarity=0.359  Sum_probs=189.8

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++.+.||+|+||+||+++. .+|+.||+|++.+..   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            46899999999999999999995 579999999997542   23356799999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+ +|+|.+++.   +...+++.++..++.||+.||+|||+++   |+||||||+|||++.++++||+|||+|+....
T Consensus        92 mEy~-~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           92 IEYA-GNELFDYIV---QRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             EECC-CEEHHHHHH---HSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             EeCC-CCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            9999 578888884   4467999999999999999999999997   99999999999999999999999999987543


Q ss_pred             CCCccccccccccCCCCCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLF-SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ..   .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||...   ....+..    .+..+...    
T Consensus       165 ~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---~~~~~~~----~i~~~~~~----  230 (275)
T 3hyh_A          165 GN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---SIPVLFK----NISNGVYT----  230 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHH----HHHHTCCC----
T ss_pred             CC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC---CHHHHHH----HHHcCCCC----
Confidence            32   2335689999999999998876 58999999999999999999998432   2222222    22222110    


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                        +...    ...++.+|+.+||+.||++|||++|+++
T Consensus       231 --~p~~----~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          231 --LPKF----LSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             --CCTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --CCCC----CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              1111    1235678999999999999999999987

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.2e-50  Score=421.87  Aligned_cols=267  Identities=26%  Similarity=0.380  Sum_probs=214.7

Q ss_pred             CHHHHHHhhCCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCC-CCeeeEE
Q 007239          283 HLAVIKAATDGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQH-RNLVRLV  354 (611)
Q Consensus       283 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h-~niv~l~  354 (611)
                      +....+...++|++.+.||+|+||+||+|.+.      .++.||||++.... ....+.|.+|+.+|.+++| ||||+++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            33444455688999999999999999999853      24679999997653 3345779999999999975 8999999


Q ss_pred             EeEeeC-CeEEEEEEecCCCChhhHhhhchh-------------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCC
Q 007239          355 GCGIEG-EEKLLIYELMPNRSLDCFIFDSER-------------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDL  420 (611)
Q Consensus       355 ~~~~~~-~~~~lv~E~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDi  420 (611)
                      ++|.+. +.+++|||||++|+|.++|.....             ...+++.++..++.||++||.|||+++   ||||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDL  211 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  211 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCcc
Confidence            998764 568999999999999999965322             345899999999999999999999986   999999


Q ss_pred             CCCcEEecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCC
Q 007239          421 KPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFY  499 (611)
Q Consensus       421 kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~  499 (611)
                      ||+|||+++++.+||+|||+|+.+.............||+.|||||++.++.|+.++|||||||+||||+| |+.||...
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999997755544444556789999999999999999999999999999999998 89998543


Q ss_pred             CCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          500 LTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       500 ~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ...  ..    +...+..+...+..     .    ....++.+++..||+.||++|||++||++.|++
T Consensus       292 ~~~--~~----~~~~i~~g~~~~~p-----~----~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          292 KID--EE----FCRRLKEGTRMRAP-----D----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             CCS--HH----HHHHHHHTCCCCCC-----T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHH--HH----HHHHHHcCCCCCCC-----c----cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            221  11    22223333222211     1    112457789999999999999999999999864

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5e-50  Score=410.47  Aligned_cols=266  Identities=23%  Similarity=0.289  Sum_probs=199.8

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC----eEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE----EKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----~~~lv~  367 (611)
                      ++|.+.++||+|+||+||+|++ +|+.||||++...... ...+..|+..+.+++|||||++++++.+++    .++|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4688889999999999999998 5899999999755422 223345666667899999999999998654    579999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcC-----CCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS-----RLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~-----~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      ||+++|+|.+++..    ..++|+.+.+++.|+++||.|||++.     ..+||||||||+||||+.++++||+|||+++
T Consensus        81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            99999999999843    45899999999999999999999861     2359999999999999999999999999998


Q ss_pred             ecccCCCcc--ccccccccCCCCCccccccC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCch--------hh
Q 007239          443 IFCENQKTA--NTRRVVGTYGYMAPEYAMEG------LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHA--------QT  506 (611)
Q Consensus       443 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~--------~~  506 (611)
                      .........  .....+||+.|||||++.+.      .++.|+|||||||+||||+||++|++.......        ..
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            775433221  23346899999999998764      467899999999999999999887653322110        00


Q ss_pred             HHHHHHHHHhcCccccccccccCCC-CCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          507 LLAYVWQLWKEGKEMEFVDPLLMKS-SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       507 l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      .............    +++.+... ...+....+.+|+.+||+.||++|||+.||+++|+.
T Consensus       237 ~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  294 (303)
T 3hmm_A          237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            1111222221111    12222111 122445567899999999999999999999999964

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.3e-51  Score=415.43  Aligned_cols=247  Identities=23%  Similarity=0.292  Sum_probs=195.3

Q ss_pred             CCCCcccccCccCceEEEEEEc----CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL----PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      ++|++.+.||+|+||+||+++.    .+++.||+|++++..  .....++.+|+.++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5799999999999999999985    247889999987542  2233468899999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||++||+|.+++.   +.+.+++.++..++.||+.||.|||+++   |+||||||+|||++.+|++||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLS---KEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            999999999999984   4567999999999999999999999997   9999999999999999999999999998654


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ....  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...   ....+...+   . .+.. .   
T Consensus       178 ~~~~--~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i---~-~~~~-~---  244 (304)
T 3ubd_A          178 DHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK---DRKETMTMI---L-KAKL-G---  244 (304)
T ss_dssp             ---C--CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH---H-HCCC-C---
T ss_pred             CCCc--cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc---CHHHHHHHH---H-cCCC-C---
Confidence            3322  233578999999999999999999999999999999999999998532   222222222   1 1111 0   


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT-----MSNVVA  563 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  563 (611)
                        ....    ...++.+|+.+||+.||++|||     ++|+++
T Consensus       245 --~p~~----~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          245 --MPQF----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             --CCTT----SCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             --CCCc----CCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence              1111    1235778999999999999998     467664

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.5e-49  Score=401.74  Aligned_cols=251  Identities=24%  Similarity=0.359  Sum_probs=189.7

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC--------
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE--------  361 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~--------  361 (611)
                      ++|++.+.||+|+||+||+|++ .+|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4699999999999999999995 478999999987543 334577999999999999999999999987544        


Q ss_pred             ----eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEec
Q 007239          362 ----EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISD  437 (611)
Q Consensus       362 ----~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~D  437 (611)
                          .+|+||||+++|+|.+++.........++..++.++.||++||.|||+++   |+||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                36999999999999999965544455677789999999999999999997   99999999999999999999999


Q ss_pred             cccceecccCCCcc----------ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhH
Q 007239          438 FGMARIFCENQKTA----------NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTL  507 (611)
Q Consensus       438 FGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l  507 (611)
                      ||+|+.+.......          .....+||+.|||||++.+..|+.++|||||||++|||++   ||..     ....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~-----~~~~  233 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-----QMER  233 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS-----HHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC-----ccHH
Confidence            99998775433211          1234589999999999999999999999999999999996   5421     1111


Q ss_pred             HHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          508 LAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       508 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ... .............         ......+.+|+.+||+.||++|||+.|+++
T Consensus       234 ~~~-~~~~~~~~~p~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          234 VRT-LTDVRNLKFPPLF---------TQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HHH-HHHHHTTCCCHHH---------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHH-HHHHhcCCCCCCC---------cccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111 1112222211110         112234568999999999999999999987

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.9e-47  Score=400.18  Aligned_cols=263  Identities=21%  Similarity=0.306  Sum_probs=202.1

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEee------CC
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIE------GE  361 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~------~~  361 (611)
                      .++|++++.||+|+||+||+|++ .+|+.||||+++...  ....+.+.+|+.+|+.++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            36799999999999999999995 579999999997542  3345678899999999999999999998764      36


Q ss_pred             eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccc
Q 007239          362 EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA  441 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  441 (611)
                      .+||||||++ |+|.+++.   ....+++.++..++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|
T Consensus       133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence            7899999996 57888884   4457999999999999999999999997   999999999999999999999999999


Q ss_pred             eecccCC--CccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC
Q 007239          442 RIFCENQ--KTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG  518 (611)
Q Consensus       442 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  518 (611)
                      +.+....  ........+||+.|||||++.+. .++.++||||+||++|||++|++||...   .....+..+.......
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~---~~~~~l~~I~~~~g~p  282 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGK---NYVHQLQLIMMVLGTP  282 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCS---SHHHHHHHHHHHHCCC
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCC---CHHHHHHHHHHhcCCC
Confidence            8764322  12233457999999999998875 5699999999999999999999998532   2223333333322211


Q ss_pred             ccccccc----------cccC--CCCCHH-----HHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          519 KEMEFVD----------PLLM--KSSSIP-----QVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       519 ~~~~~~d----------~~l~--~~~~~~-----~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .......          ..+.  ...+..     ...++++|+.+||+.||++|||+.|+++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1100000          0000  001111     1235779999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.6e-46  Score=391.50  Aligned_cols=198  Identities=23%  Similarity=0.343  Sum_probs=170.6

Q ss_pred             HhhCCCCcccccCccCceEEEEEEcC----CCcEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeE
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVLP----NGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~  363 (611)
                      ...++|++.++||+|+||+||+|+.+    .++.||+|++.+..  ...++.+|+++|+.+ +||||+++++++.+.+..
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            45688999999999999999999842    46789999987653  345688999999998 599999999999999999


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC-CCEEEeccccce
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD-MVAKISDFGMAR  442 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~-~~~kl~DFGla~  442 (611)
                      ++||||+++++|.+++      ..+++.++..++.||+.||.|||++|   |+||||||+|||++.+ +.+||+|||+|+
T Consensus        96 ~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           96 VIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            9999999999999987      24899999999999999999999997   9999999999999877 799999999998


Q ss_pred             ecccCCCc--------------------------cccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCC
Q 007239          443 IFCENQKT--------------------------ANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRN  495 (611)
Q Consensus       443 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p  495 (611)
                      ........                          ......+||+.|+|||++.+. .++.++||||+||++|||++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            65432211                          112245799999999999876 589999999999999999999999


Q ss_pred             CC
Q 007239          496 SG  497 (611)
Q Consensus       496 ~~  497 (611)
                      |.
T Consensus       247 f~  248 (361)
T 4f9c_A          247 FY  248 (361)
T ss_dssp             SS
T ss_pred             CC
Confidence            74

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.1e-45  Score=381.89  Aligned_cols=277  Identities=35%  Similarity=0.578  Sum_probs=241.9

Q ss_pred             HHhhCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          288 KAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       288 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ...+++|++.+.||+|+||.||+|++.+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  114 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY  114 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEE
T ss_pred             HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            34678999999999999999999998889999999998776667788999999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhch-hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          368 ELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      ||+++++|.+++.... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999999985432 2235899999999999999999999987   99999999999999999999999999987644


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ...........||+.|+|||++.++.++.++||||||+++|||++|+.||.............+.......+.....+++
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP  271 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred             ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence            33333334457999999999999999999999999999999999999998766665555666666666667777777777


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      .+...........+.+++.+||+.||++|||+.||++.|+.
T Consensus       272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  312 (321)
T 2qkw_B          272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY  312 (321)
T ss_dssp             SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            77777777888899999999999999999999999999974

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.3e-45  Score=405.18  Aligned_cols=249  Identities=26%  Similarity=0.292  Sum_probs=199.1

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHH---HHHHHHhcCCCCeeeEEEeEeeCCeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKN---EIILIAKLQHRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~---E~~il~~l~h~niv~l~~~~~~~~~~  363 (611)
                      .++|++.+.||+|+||+||+++. .+|+.||||++.+...   .....+.+   ++.+++.++|||||+++++|.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            46899999999999999999995 5799999999975321   12233334   45667778899999999999999999


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      |+||||++||+|.++|.   +.+.+++..++.++.||+.||.|||+++   ||||||||+||||+.+|++||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~---~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence            99999999999999994   4567999999999999999999999997   99999999999999999999999999987


Q ss_pred             cccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          444 FCENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       444 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      +....    ....+||+.|||||++.. ..|+.++|||||||+||||++|++||..........+...+   .. ... .
T Consensus       342 ~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i---~~-~~~-~  412 (689)
T 3v5w_A          342 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LT-MAV-E  412 (689)
T ss_dssp             CSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH---HH-CCC-C
T ss_pred             cCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh---cC-CCC-C
Confidence            64432    335689999999999975 57999999999999999999999998543332222222111   11 111 0


Q ss_pred             ccccccCCCCCHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 007239          523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT-----MSNVVA  563 (611)
Q Consensus       523 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  563 (611)
                           ...    ....++.+|+.+||+.||.+|++     ++||++
T Consensus       413 -----~p~----~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          413 -----LPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             -----CCT----TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             -----CCc----cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                 111    11235678999999999999998     577664

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=6.8e-45  Score=403.21  Aligned_cols=252  Identities=24%  Similarity=0.314  Sum_probs=208.7

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      .++|++.+.||+|+||+||+++. .+|+.||+|++........+.+.+|+.+|+.++||||+++++++.+...++|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            47899999999999999999995 57999999999877766778899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC--CCEEEeccccceecccC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD--MVAKISDFGMARIFCEN  447 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~--~~~kl~DFGla~~~~~~  447 (611)
                      |+||+|.+++.+  +...+++.++..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+++.+...
T Consensus       236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999998843  3356899999999999999999999997   9999999999999854  89999999999987543


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                      .   .....+||+.|||||++.+..|+.++|||||||++|||++|+.||....   ...+...    +..... .+.+..
T Consensus       311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~---~~~~~~~----i~~~~~-~~~~~~  379 (573)
T 3uto_A          311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRN----VKSCDW-NMDDSA  379 (573)
T ss_dssp             S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHH----HHTTCC-CCCSGG
T ss_pred             C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHH----HHhCCC-CCCccc
Confidence            2   2335689999999999999999999999999999999999999985322   1122211    122111 001111


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      . ..    ...++.+|+.+||+.||++|||+.|+++
T Consensus       380 ~-~~----~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          380 F-SG----ISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             G-TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             c-cC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0 11    1235679999999999999999999997

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5e-45  Score=377.66  Aligned_cols=289  Identities=40%  Similarity=0.618  Sum_probs=242.5

Q ss_pred             CCccCHHHHHHhhCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChh-hHHHHHHHHHHHHhcCCCCeeeEEEeE
Q 007239          279 LPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQ-GLEEFKNEIILIAKLQHRNLVRLVGCG  357 (611)
Q Consensus       279 ~~~~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~~~~  357 (611)
                      ...+....+....++|++.+.||+|+||.||++...+++.||+|++...... ....+.+|+.+++.++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            3446778888999999999999999999999999888999999998765322 233689999999999999999999999


Q ss_pred             eeCCeEEEEEEecCCCChhhHhhhch-hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEe
Q 007239          358 IEGEEKLLIYELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKIS  436 (611)
Q Consensus       358 ~~~~~~~lv~E~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~  436 (611)
                      ...+..++||||+++++|.+++.... ....+++..++.++.||+.||.|||++...+|+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~  176 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG  176 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence            99999999999999999999986533 33459999999999999999999999822239999999999999999999999


Q ss_pred             ccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--CCchhhHHHHHHHH
Q 007239          437 DFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYL--TGHAQTLLAYVWQL  514 (611)
Q Consensus       437 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~--~~~~~~l~~~~~~~  514 (611)
                      |||+++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....  ......+..+....
T Consensus       177 Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          177 DFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             cCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            99999876433322 2334569999999999999999999999999999999999999985321  22333455555555


Q ss_pred             HhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       515 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ........+.+..+...........+.+++.+||+.||++|||++||+++|+..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            666667777777777778888889999999999999999999999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.1e-42  Score=355.63  Aligned_cols=250  Identities=24%  Similarity=0.377  Sum_probs=207.2

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      .++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46899999999999999999995 57899999999776656677899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++..    ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            999999998843    35899999999999999999999997   99999999999999999999999999987654332


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                        ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ..   ........... ...     
T Consensus       172 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~---~~~~~~~~~~~-~~~-----  237 (297)
T 3fxz_A          172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LR---ALYLIATNGTP-ELQ-----  237 (297)
T ss_dssp             --CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HH---HHHHHHHHCSC-CCS-----
T ss_pred             --ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HH---HHHHHHhCCCC-CCC-----
Confidence              23346899999999999999999999999999999999999999843221   11   11111111111 100     


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                        .+......+.+++.+||+.||++|||++|+++
T Consensus       238 --~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          238 --NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             --CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence              01112245678999999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=361.27  Aligned_cols=257  Identities=26%  Similarity=0.418  Sum_probs=210.3

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      .++|.+.+.||+|+||.||++.+ .+++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            36799999999999999999996 46899999999877777788899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++...  ...+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            9999999998542  356899999999999999999999997   99999999999999999999999999987644332


Q ss_pred             ccc------------cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchh---hHHHHHHHH
Q 007239          450 TAN------------TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQ---TLLAYVWQL  514 (611)
Q Consensus       450 ~~~------------~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~---~l~~~~~~~  514 (611)
                      ...            .....||+.|+|||++.+..++.++||||||+++|||++|..|+.........   ......   
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~---  240 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL---  240 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH---
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc---
Confidence            111            11457999999999999999999999999999999999999987543332211   111111   


Q ss_pred             HhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCC
Q 007239          515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES  569 (611)
Q Consensus       515 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  569 (611)
                       .         ......    ....+.+++.+||+.||++|||+.++++.|+...
T Consensus       241 -~---------~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~  281 (310)
T 3s95_A          241 -D---------RYCPPN----CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLR  281 (310)
T ss_dssp             -H---------HTCCTT----CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -c---------ccCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             0         000011    1124678999999999999999999999997643

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.7e-42  Score=352.89  Aligned_cols=282  Identities=36%  Similarity=0.548  Sum_probs=227.8

Q ss_pred             CCccCHHHHHHhhCCCCcc------cccCccCceEEEEEEcCCCcEEEEEEeccc----ChhhHHHHHHHHHHHHhcCCC
Q 007239          279 LPFVHLAVIKAATDGFSDS------NKLGQGGFGTVYKGVLPNGKEVAVKRLSRK----SWQGLEEFKNEIILIAKLQHR  348 (611)
Q Consensus       279 ~~~~~~~~~~~~~~~y~~~------~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~il~~l~h~  348 (611)
                      .+.+.+..+..++++|...      +.||+|+||.||+|.. +++.||+|++...    .....+.+.+|+.++++++||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            3457788888888888877      8999999999999997 6889999998653    223467899999999999999


Q ss_pred             CeeeEEEeEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec
Q 007239          349 NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD  428 (611)
Q Consensus       349 niv~l~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~  428 (611)
                      ||+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||.|||+++   |+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence            999999999999999999999999999999866555567999999999999999999999997   99999999999999


Q ss_pred             CCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHH
Q 007239          429 KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLL  508 (611)
Q Consensus       429 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~  508 (611)
                      .++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|+|++|+.||........  +.
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~  244 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LL  244 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TT
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HH
Confidence            999999999999987654433333345679999999998764 588999999999999999999999865433221  11


Q ss_pred             HHHHHHHh-cCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          509 AYVWQLWK-EGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       509 ~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ........ .......++..+ ..........+.+++..||+.||++|||+++|++.|+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          245 DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            11111111 112233334333 234556667888999999999999999999999999753

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=8.5e-43  Score=358.52  Aligned_cols=259  Identities=29%  Similarity=0.427  Sum_probs=202.4

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.+.||+|+||.||++.+ +++.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  114 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE  114 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence            46899999999999999999987 68889999987553  3445778999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++++|.+++........+++..++.++.||+.||.|||+++ .+|+||||||+|||++.++.+||+|||+++......
T Consensus       115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~  193 (309)
T 3p86_A          115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF  193 (309)
T ss_dssp             CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC---------
T ss_pred             cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccc
Confidence            9999999999976554556999999999999999999999873 239999999999999999999999999998643322


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                        .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....   ......+   .......+     +
T Consensus       194 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~---~~~~~~~~-----~  260 (309)
T 3p86_A          194 --LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAV---GFKCKRLE-----I  260 (309)
T ss_dssp             ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHH---HHSCCCCC-----C
T ss_pred             --cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH---HhcCCCCC-----C
Confidence              122346799999999999999999999999999999999999999853321   1111111   11111111     1


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      .    .....++.+|+.+||+.||++|||+.++++.|+..
T Consensus       261 ~----~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~  296 (309)
T 3p86_A          261 P----RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL  296 (309)
T ss_dssp             C----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1    11223577899999999999999999999999864

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8e-43  Score=367.90  Aligned_cols=258  Identities=26%  Similarity=0.394  Sum_probs=210.1

Q ss_pred             hCCCCcccccCccCceEEEEEEc--------CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeC
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL--------PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEG  360 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~  360 (611)
                      .++|++.+.||+|+||.||++.+        .++..||+|+++... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            47899999999999999999984        235679999997653 34567899999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhhHhhhchh-------------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe
Q 007239          361 EEKLLIYELMPNRSLDCFIFDSER-------------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL  427 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll  427 (611)
                      +..++||||+++++|.+++.....             ...+++..++.++.||++||.|||+++   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999864321             235899999999999999999999997   9999999999999


Q ss_pred             cCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhh
Q 007239          428 DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQT  506 (611)
Q Consensus       428 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~  506 (611)
                      +.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||.....   ..
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~---~~  313 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---EE  313 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GG
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH---HH
Confidence            9999999999999987655443333344567889999999999999999999999999999999 9988754322   22


Q ss_pred             HHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          507 LLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       507 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      +...    ...+....         .+.....++.+++.+||+.||++||++.|+++.|+.
T Consensus       314 ~~~~----~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~  361 (370)
T 2psq_A          314 LFKL----LKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  361 (370)
T ss_dssp             HHHH----HHTTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHH----HhcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            2221    22222111         111122457789999999999999999999999974

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.1e-43  Score=362.50  Aligned_cols=248  Identities=25%  Similarity=0.348  Sum_probs=205.5

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      .++|++.+.||+|+||.||++++ .+|+.||+|++...  .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            56899999999999999999996 58999999998754  3345677899999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++.....
T Consensus        94 e~~~~~~L~~~l~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            9999999999984   3456999999999999999999999997   999999999999999999999999999866433


Q ss_pred             CCccccccccccCCCCCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFS-VKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      .   .....+||+.|+|||++.+..+. .++||||||+++|+|++|+.||....   ...+...+   . .+...     
T Consensus       168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i---~-~~~~~-----  232 (328)
T 3fe3_A          168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN---LKELRERV---L-RGKYR-----  232 (328)
T ss_dssp             C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH---H-HCCCC-----
T ss_pred             C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC---HHHHHHHH---H-hCCCC-----
Confidence            2   23356899999999999988875 89999999999999999999985322   11222211   1 11110     


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                       +    +......+.+|+.+||+.||++|||++|+++.
T Consensus       233 -~----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          233 -I----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             -C----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             -C----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             0    11122356789999999999999999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2e-43  Score=365.34  Aligned_cols=265  Identities=24%  Similarity=0.328  Sum_probs=207.2

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC----eEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE----EKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----~~~lv  366 (611)
                      .++|++.+.||+|+||.||+|++. ++.||+|++..... ......+|+.++++++||||+++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            468999999999999999999975 78999999976543 3445667999999999999999999998744    47999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhc----------CCCceEecCCCCCcEEecCCCCEEEe
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED----------SRLKIIHRDLKPSNVLLDKDMVAKIS  436 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~----------~~~~iiHrDikp~NIll~~~~~~kl~  436 (611)
                      |||+++++|.+++..    ..+++..++.++.||+.||.|||+.          +   |+||||||+|||++.++.+||+
T Consensus       101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence            999999999999843    3589999999999999999999987          6   9999999999999999999999


Q ss_pred             ccccceecccCCCccccccccccCCCCCccccccC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHH---
Q 007239          437 DFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG-----LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLL---  508 (611)
Q Consensus       437 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~---  508 (611)
                      |||+++.+.............||+.|+|||++.+.     .++.++||||||+++|||++|+.||............   
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            99999887655444444456899999999999863     4567899999999999999999998654332111111   


Q ss_pred             ------HHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          509 ------AYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       509 ------~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                            ...............+....   ........+.+|+.+||+.||++|||+.||++.|+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  315 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ  315 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ccCCchhhhhhhhhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                  11111111111111111111   122344568899999999999999999999999974

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.8e-42  Score=358.34  Aligned_cols=254  Identities=28%  Similarity=0.382  Sum_probs=204.3

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.+.||+|+||.||++++. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999999964 789999999865432 234668899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999883   3456999999999999999999999987   9999999999999999999999999998765444


Q ss_pred             CccccccccccCCCCCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLF-SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                      .........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......... .     ..+......  ..+ 
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~-----~~~~~~~~~--~~~-  230 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-Y-----SDWKEKKTY--LNP-  230 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-H-----HHHHTTCTT--STT-
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-H-----HHHhccccc--CCc-
Confidence            3333445789999999999988775 78999999999999999999998644332211 1     111111110  000 


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                           .......+.+|+.+||+.||++|||+.|+++.
T Consensus       231 -----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          231 -----WKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             -----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -----cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                 01122456789999999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.6e-41  Score=350.92  Aligned_cols=247  Identities=25%  Similarity=0.378  Sum_probs=204.7

Q ss_pred             CCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          294 FSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||+++
T Consensus        47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  126 (321)
T 2c30_A           47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG  126 (321)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred             hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence            777889999999999999965 7999999999877666778899999999999999999999999999999999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      ++|.+++..    ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++........  .
T Consensus       127 ~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~  197 (321)
T 2c30_A          127 GALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K  197 (321)
T ss_dssp             CBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred             CCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--c
Confidence            999998742    45899999999999999999999987   99999999999999999999999999987644322  2


Q ss_pred             cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCC
Q 007239          453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSS  532 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~  532 (611)
                      .....||+.|+|||++.+..++.++||||||+++|||++|+.||....   ......    .+.......+.     .  
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~---~~~~~~----~~~~~~~~~~~-----~--  263 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS---PVQAMK----RLRDSPPPKLK-----N--  263 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHH----HHHHSSCCCCT-----T--
T ss_pred             cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHH----HHhcCCCCCcC-----c--
Confidence            234689999999999999999999999999999999999999974321   111111    11111111110     0  


Q ss_pred             CHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          533 SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       533 ~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .......+.+++.+||+.||++|||+.++++
T Consensus       264 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          264 SHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1112235778999999999999999999987

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=349.32  Aligned_cols=272  Identities=22%  Similarity=0.267  Sum_probs=213.3

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC--eEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE--EKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~--~~~lv  366 (611)
                      .++|++.+.||+|+||.||++++. +++.||+|++.... ....+.+.+|+.++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            367999999999999999999964 58999999997543 334677889999999999999999999988765  77999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe----cCCCCEEEeccccce
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL----DKDMVAKISDFGMAR  442 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll----~~~~~~kl~DFGla~  442 (611)
                      |||+++++|.+++........+++..++.++.||+.||.|||+++   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976555555999999999999999999999997   9999999999999    788889999999998


Q ss_pred             ecccCCCccccccccccCCCCCccccc--------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc-hhhHHHHHHH
Q 007239          443 IFCENQKTANTRRVVGTYGYMAPEYAM--------EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGH-AQTLLAYVWQ  513 (611)
Q Consensus       443 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~-~~~l~~~~~~  513 (611)
                      .......   .....||+.|+|||++.        +..++.++||||||+++|||++|+.||....... ...+...+..
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             ECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            7644332   22457999999999986        5778999999999999999999999985433322 1222222211


Q ss_pred             HHhcCcccccc---------ccc--cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          514 LWKEGKEMEFV---------DPL--LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       514 ~~~~~~~~~~~---------d~~--l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      .........+.         ...  ............+.+++..||+.||++|||++|+++..+..
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            11111000000         001  11123345556778999999999999999999999988754

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.7e-42  Score=359.16  Aligned_cols=252  Identities=25%  Similarity=0.309  Sum_probs=204.7

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChh------hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQ------GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  362 (611)
                      ..++|++.+.||+|+||.||+++.. +|+.||+|++.+....      ..+.+.+|+.++++++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            3578999999999999999999964 6899999999765322      35789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC----CEEEecc
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM----VAKISDF  438 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~----~~kl~DF  438 (611)
                      .++||||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++    .+||+||
T Consensus        90 ~~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF  163 (361)
T 2yab_A           90 VVLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (361)
T ss_dssp             EEEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence            999999999999999984   3456999999999999999999999997   99999999999998777    7999999


Q ss_pred             ccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC
Q 007239          439 GMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG  518 (611)
Q Consensus       439 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  518 (611)
                      |+++......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||....   ...+...    +...
T Consensus       164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~---~~~~~~~----i~~~  233 (361)
T 2yab_A          164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLAN----ITAV  233 (361)
T ss_dssp             SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHH----HHTT
T ss_pred             CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH----HHhc
Confidence            9998764432   2234679999999999999999999999999999999999999974321   1112111    1111


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       519 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ... + +......    ....+.+|+..||+.||++|||+.|+++
T Consensus       234 ~~~-~-~~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          234 SYD-F-DEEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CCC-C-CHHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCC-C-CchhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            110 0 0000001    1235678999999999999999999985

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.5e-43  Score=358.51  Aligned_cols=264  Identities=26%  Similarity=0.376  Sum_probs=205.8

Q ss_pred             hCCCCcccccCccCceEEEEEEc-----CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC--CeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-----PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG--EEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~  363 (611)
                      .++|++.+.||+|+||.||++++     .+++.||+|++........+.+.+|+.++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46899999999999999999983     36889999999877777778899999999999999999999998653  558


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            9999999999999998543  335899999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCCCc-cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC---------chhhHHHHHHH
Q 007239          444 FCENQKT-ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG---------HAQTLLAYVWQ  513 (611)
Q Consensus       444 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~---------~~~~l~~~~~~  513 (611)
                      ....... .......+++.|+|||.+.+..++.++||||||+++|||++|..|+......         ...........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            6443322 1222345778899999999999999999999999999999999887432110         11111112222


Q ss_pred             HHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       514 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ....+....         .+.....++.+++..||+.||++|||+.|++++|+..
T Consensus       244 ~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          244 LLKNNGRLP---------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHTTCCCC---------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhccCcCC---------CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            222221111         1112234677899999999999999999999999754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=359.43  Aligned_cols=257  Identities=28%  Similarity=0.443  Sum_probs=205.7

Q ss_pred             hCCCCcccccCccCceEEEEEEcC----CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP----NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|+++.. .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            467999999999999999999963    3456999999765 34456779999999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999843  2346999999999999999999999997   9999999999999999999999999998765


Q ss_pred             cCCCcc-ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          446 ENQKTA-NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       446 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      ...... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||....   ...+..    ....+.... 
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~---~~~~~~----~~~~~~~~~-  274 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT---NRDVIS----SVEEGYRLP-  274 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC---HHHHHH----HHHTTCCCC-
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC---HHHHHH----HHHcCCCCC-
Confidence            432221 2223456788999999999999999999999999999999 999974322   111221    122221111 


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                              .+......+.+|+..||+.||++|||+.+|+++|+..
T Consensus       275 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l  311 (325)
T 3kul_A          275 --------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL  311 (325)
T ss_dssp             --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                    1112224577899999999999999999999999754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.6e-42  Score=355.47  Aligned_cols=249  Identities=21%  Similarity=0.257  Sum_probs=204.5

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++.+.||+|+||.||+++.. +|+.||+|++++.   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            468999999999999999999964 7899999999754   223466789999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|..++.   +...+++..++.++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            99999999998884   3456899999999999999999999997   99999999999999999999999999986432


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ..  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...   ....+...+   .. ...      
T Consensus       158 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i---~~-~~~------  222 (337)
T 1o6l_A          158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELI---LM-EEI------  222 (337)
T ss_dssp             TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH---HH-CCC------
T ss_pred             CC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC---CHHHHHHHH---Hc-CCC------
Confidence            22  2234568999999999999999999999999999999999999997432   122222211   11 111      


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCC-----CHHHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVAL  564 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~  564 (611)
                      .+..    ....++.+|+.+||+.||++||     +++||++.
T Consensus       223 ~~p~----~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          223 RFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCCC----CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            0111    1224567899999999999999     89998763

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.3e-41  Score=344.67  Aligned_cols=262  Identities=22%  Similarity=0.294  Sum_probs=202.4

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ++|++.+.||+|+||+||++... +++.||+|++....  ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999964 68999999987543  2335778899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |++++.+..+.   .....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCCCHHHHHH---hCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            99874444433   23456999999999999999999999997   9999999999999999999999999998764332


Q ss_pred             CccccccccccCCCCCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc-
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP-  526 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~-  526 (611)
                      .  ......||+.|+|||++.+.. ++.++||||||+++|||++|+.|+.  ...........+.+.........+... 
T Consensus       156 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~--~~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF--PGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC--CCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             c--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCc--CCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence            2  223457899999999998766 8999999999999999999988852  222333333333333322211111000 


Q ss_pred             --------------ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          527 --------------LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       527 --------------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                                    .............+.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                          0000001112345678999999999999999999986

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.4e-41  Score=344.02  Aligned_cols=259  Identities=25%  Similarity=0.358  Sum_probs=204.4

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++.+.||+|+||.||++++ .+++.||+|++...   .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            46899999999999999999995 47899999998543   334457889999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        90 ~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            99999999999983   4456999999999999999999999997   99999999999999999999999999986643


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....      ........... .... ..
T Consensus       164 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~-~~~~-~~  234 (294)
T 4eqm_A          164 TSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA------VSIAIKHIQDS-VPNV-TT  234 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH------HHHHHHHHSSC-CCCH-HH
T ss_pred             ccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhhcc-CCCc-ch
Confidence            322 223346799999999999999999999999999999999999999853221      11111222221 1111 01


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCC-CHHHHHHHhcCC
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRP-TMSNVVALLGSE  568 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~  568 (611)
                      ....    .....+.+++.+||+.||++|| +++++.+.|.+.
T Consensus       235 ~~~~----~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          235 DVRK----DIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             HSCT----TSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             hccc----CCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence            1111    1123567899999999999998 999999999764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=7.2e-42  Score=351.91  Aligned_cols=263  Identities=25%  Similarity=0.342  Sum_probs=202.8

Q ss_pred             hhCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ..++|++.++||+|+||.||++.+.+++.||+|++.....  .....+.+|+.++++++||||+++++++.+....++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            3478999999999999999999988899999999875432  23467889999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++ +|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        99 e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           99 EFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             ECCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             cCCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            99986 67676643  3345899999999999999999999997   999999999999999999999999999876433


Q ss_pred             CCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc-
Q 007239          448 QKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD-  525 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d-  525 (611)
                      ..  ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.......   ....+...........+.. 
T Consensus       173 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          173 VR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD---QLPKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             CC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT---HHHHHHHHHCCCCTTTSGGG
T ss_pred             cc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHHCCCChHHhhhh
Confidence            22  2234578999999999876 568999999999999999999999986443332   2222222222211111000 


Q ss_pred             --------ccc--CCCCCHH-----HHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          526 --------PLL--MKSSSIP-----QVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       526 --------~~l--~~~~~~~-----~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                              ...  .......     ...++.+|+.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                    000  0001111     1235779999999999999999999987

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.2e-42  Score=362.62  Aligned_cols=268  Identities=26%  Similarity=0.377  Sum_probs=212.8

Q ss_pred             cCHHHHHHhhCCCCcccccCccCceEEEEEEc------CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeE
Q 007239          282 VHLAVIKAATDGFSDSNKLGQGGFGTVYKGVL------PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKL-QHRNLVRL  353 (611)
Q Consensus       282 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l  353 (611)
                      +.....+...++|++.+.||+|+||.||++.+      .+++.||+|++.... ....+.+.+|+.+++++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            44455556678999999999999999999973      346789999997643 33456799999999999 79999999


Q ss_pred             EEeEeeCCe-EEEEEEecCCCChhhHhhhchh------------------------------------------------
Q 007239          354 VGCGIEGEE-KLLIYELMPNRSLDCFIFDSER------------------------------------------------  384 (611)
Q Consensus       354 ~~~~~~~~~-~~lv~E~~~~~sL~~~l~~~~~------------------------------------------------  384 (611)
                      ++++.+.+. .++||||+++++|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999887554 8999999999999999865332                                                


Q ss_pred             ---------------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          385 ---------------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       385 ---------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                                     ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           122899999999999999999999997   99999999999999999999999999987654443


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                      ........||+.|+|||++.+..++.++||||||+++|||++ |+.||.......  .    .......+......    
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~----~~~~~~~~~~~~~~----  318 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E----FCRRLKEGTRMRAP----  318 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--H----HHHHHHHTCCCCCC----
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--H----HHHHHHcCCCCCCC----
Confidence            333445678999999999999999999999999999999998 999975432221  1    11222222211111    


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                           .....++.+++..||+.||++|||+.||++.|+.
T Consensus       319 -----~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  352 (359)
T 3vhe_A          319 -----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  352 (359)
T ss_dssp             -----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence                 1112357789999999999999999999999974

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=8.6e-43  Score=368.66  Aligned_cols=256  Identities=27%  Similarity=0.385  Sum_probs=206.7

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.+.||+|+||.||+|.+. +++.||+|+++... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            367899999999999999999975 78999999987543 2334578899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       193 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          193 LVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             CCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            9999999999853  2345899999999999999999999997   9999999999999999999999999998654332


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                      .........+++.|+|||.+..+.++.++||||||+++|||++ |..|+.....   ....    .....+.....    
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~~----~~~~~~~~~~~----  336 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQTR----EFVEKGGRLPC----  336 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHHH----HHHHTTCCCCC----
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHH----HHHHcCCCCCC----
Confidence            2222222346778999999999999999999999999999998 8888753321   1111    22222221111    


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                           +......+.+|+.+||+.||++|||+++|++.|+.
T Consensus       337 -----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  371 (377)
T 3cbl_A          337 -----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS  371 (377)
T ss_dssp             -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence                 11112356789999999999999999999999974

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.4e-42  Score=359.76  Aligned_cols=255  Identities=26%  Similarity=0.426  Sum_probs=198.7

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCc----EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGK----EVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  364 (611)
                      .++|++.+.||+|+||.||+|++. +++    +||+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            367999999999999999999953 444    3588887543 3345678999999999999999999999988754 78


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +|+||+.+++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++..
T Consensus        93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            999999999999998542  356899999999999999999999996   999999999999999999999999999877


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      .............||+.|+|||++.+..++.++||||||+++|||++ |+.||......   .+...    ...+.... 
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~----~~~~~~~~-  239 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSI----LEKGERLP-  239 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH----HHTTCCCC-
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---HHHHH----HHcCCCCC-
Confidence            55444444444567889999999999999999999999999999999 99998543322   22211    11221111 


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                              .......++.+++.+||+.||++||++.++++.|+.
T Consensus       240 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~  275 (327)
T 3poz_A          240 --------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  275 (327)
T ss_dssp             --------CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred             --------CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence                    111223457789999999999999999999999854

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-42  Score=347.96  Aligned_cols=253  Identities=28%  Similarity=0.415  Sum_probs=207.2

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      ++|++.+.||+|+||.||++.+.+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   88 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence            57999999999999999999988889999999976542 34678999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +++|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+||+++.++.+||+|||+++........ 
T Consensus        89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-  162 (269)
T 4hcu_A           89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  162 (269)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH-
T ss_pred             CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc-
Confidence            9999999853  3346899999999999999999999997   999999999999999999999999999865433211 


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                      ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||....   ...+..    ....+...  .   .  
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~---~~~~~~----~~~~~~~~--~---~--  228 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVE----DISTGFRL--Y---K--  228 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHH----HHHTTCCC--C---C--
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC---HHHHHH----HHhcCccC--C---C--
Confidence            2223467888999999999999999999999999999999 888874322   111111    12221110  0   0  


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                        +......+.+++..||+.||++|||+.++++.|+.
T Consensus       229 --~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  263 (269)
T 4hcu_A          229 --PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE  263 (269)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence              11112457789999999999999999999999974

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.4e-41  Score=360.27  Aligned_cols=251  Identities=23%  Similarity=0.303  Sum_probs=199.4

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~  364 (611)
                      ..++|++.+.||+|+||+||+++.. +++.||+|++++..   ....+.+.+|..++.++ +||||+++++++.+.+..+
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            3568999999999999999999964 67889999997653   22345678899999887 7999999999999999999


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +||||+++|+|..++.   +...+++..++.++.||+.||.|||+++   |+||||||+||||+.++++||+|||+++..
T Consensus       130 lV~E~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~  203 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  203 (396)
T ss_dssp             EEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEcCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence            9999999999998884   3456999999999999999999999997   999999999999999999999999999853


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc--hhhHHHHHHHHHhcCcccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGH--AQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~  522 (611)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .........+.+.....  
T Consensus       204 ~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--  279 (396)
T 4dc2_A          204 LRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--  279 (396)
T ss_dssp             CCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--
T ss_pred             ccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--
Confidence            2222  22345789999999999999999999999999999999999999985432211  11111222222222211  


Q ss_pred             ccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCH
Q 007239          523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTM  558 (611)
Q Consensus       523 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  558 (611)
                          .+.    .....++.+|+..||+.||++||++
T Consensus       280 ----~~p----~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          280 ----RIP----RSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             ----CCC----TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             ----CCC----CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                011    1122356789999999999999995

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.3e-42  Score=355.09  Aligned_cols=252  Identities=24%  Similarity=0.363  Sum_probs=200.3

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC-------
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE-------  361 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-------  361 (611)
                      .++|++.+.||+|+||.||++++. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467999999999999999999965 79999999997543 335678999999999999999999999986543       


Q ss_pred             --------------------------------------------------eEEEEEEecCCCChhhHhhhchhhccCCHH
Q 007239          362 --------------------------------------------------EKLLIYELMPNRSLDCFIFDSERRLQLNWN  391 (611)
Q Consensus       362 --------------------------------------------------~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~  391 (611)
                                                                        ..++||||+++++|.+++..........+.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              279999999999999999776666667788


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc----------cccccccccCC
Q 007239          392 TCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT----------ANTRRVVGTYG  461 (611)
Q Consensus       392 ~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~  461 (611)
                      .++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999997   999999999999999999999999999877543221          11234579999


Q ss_pred             CCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHH
Q 007239          462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCI  541 (611)
Q Consensus       462 y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  541 (611)
                      |+|||++.+..++.++||||||+++|||++|..|+.        .... .............         ......++.
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~-~~~~~~~~~~~~~---------~~~~~~~~~  303 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVR-IITDVRNLKFPLL---------FTQKYPQEH  303 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHH-HHHHHHTTCCCHH---------HHHHCHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHH-HHHHhhccCCCcc---------cccCChhHH
Confidence            999999999999999999999999999999876521        1111 1111112111110         112224567


Q ss_pred             HHhhccccCCCCCCCCHHHHHH
Q 007239          542 HIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       542 ~li~~cl~~dP~~RPt~~evl~  563 (611)
                      +++.+||+.||++|||+.|+++
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCCCCcCCCHHHHhh
Confidence            8999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.7e-42  Score=345.00  Aligned_cols=256  Identities=27%  Similarity=0.399  Sum_probs=208.8

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      .++|++.+.||+|+||.||++.+.++..||+|++..... ..+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            468999999999999999999988888999999976543 3467899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            999999998542  345899999999999999999999997   999999999999999999999999999876443322


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                      . .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.....   .....   . ...+...  ..+   
T Consensus       161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~---~-~~~~~~~--~~~---  227 (268)
T 3sxs_A          161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---SEVVL---K-VSQGHRL--YRP---  227 (268)
T ss_dssp             E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHH---H-HHTTCCC--CCC---
T ss_pred             c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh---HHHHH---H-HHcCCCC--CCC---
Confidence            1 223456778999999999899999999999999999999 9988743321   11111   1 1111110  001   


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCC
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES  569 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  569 (611)
                          ......+.+++..||+.||++|||+.++++.|+...
T Consensus       228 ----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          228 ----HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             ----TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             ----CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                011235778999999999999999999999998653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.8e-41  Score=349.33  Aligned_cols=258  Identities=19%  Similarity=0.224  Sum_probs=208.1

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++.....  .+.+.+|+.+++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46899999999999999999995 5789999999875432  24688999999999 89999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCC-----EEEecccccee
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV-----AKISDFGMARI  443 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~-----~kl~DFGla~~  443 (611)
                      |+ +++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999998542  356999999999999999999999997   999999999999998887     99999999997


Q ss_pred             cccCCCcc-----ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC
Q 007239          444 FCENQKTA-----NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG  518 (611)
Q Consensus       444 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  518 (611)
                      +.......     ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+.......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            64433221     1235689999999999999999999999999999999999999986554433333222222111111


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       519 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                      ..     ..+...  .+   ++.+++..||+.||.+||++++|++.|+
T Consensus       240 ~~-----~~~~~~--~p---~~~~li~~~l~~~p~~RP~~~~l~~~l~  277 (330)
T 2izr_A          240 PI-----EVLCEN--FP---EMATYLRYVRRLDFFEKPDYDYLRKLFT  277 (330)
T ss_dssp             CH-----HHHTTT--CH---HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             CH-----HHHhcc--Ch---HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence            10     001111  11   6778999999999999999999999885

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-42  Score=354.03  Aligned_cols=253  Identities=23%  Similarity=0.305  Sum_probs=205.1

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ..++|++.+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            3578999999999999999999964 68889999987554 345678999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC--CCCEEEeccccceeccc
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK--DMVAKISDFGMARIFCE  446 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~--~~~~kl~DFGla~~~~~  446 (611)
                      |+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.  ++.+||+|||+++.+..
T Consensus        82 ~~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~  156 (321)
T 1tki_A           82 FISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             eCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence            9999999998843  2346899999999999999999999997   999999999999987  78999999999987644


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ..   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....   ...+...+    ..+... + ..
T Consensus       157 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i----~~~~~~-~-~~  224 (321)
T 1tki_A          157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIENI----MNAEYT-F-DE  224 (321)
T ss_dssp             TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHH----HHTCCC-C-CH
T ss_pred             CC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC---HHHHHHHH----HcCCCC-C-Ch
Confidence            32   2234679999999999999889999999999999999999999974322   11122111    111110 0 00


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ....    ....++.+++.+||+.||++|||+.|+++.
T Consensus       225 ~~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          225 EAFK----EISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             hhhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0000    112357799999999999999999999983

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.5e-42  Score=364.42  Aligned_cols=256  Identities=28%  Similarity=0.468  Sum_probs=195.5

Q ss_pred             hCCCCcccccCccCceEEEEEEcC----CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP----NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      .++|++.+.||+|+||.||+|++.    ++..||+|+++.. .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357999999999999999999864    5678999999764 33456789999999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+++++|.+++..  ....+++.+++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            9999999999999853  2346899999999999999999999986   9999999999999999999999999998764


Q ss_pred             cCCCcc-ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          446 ENQKTA-NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       446 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      ...... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||....   ...+..    ....+...  
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~---~~~~~~----~i~~~~~~--  269 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS---NQDVIK----AVDEGYRL--  269 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC---HHHHHH----HHHTTEEC--
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC---HHHHHH----HHHcCCCC--
Confidence            432211 1222345788999999999999999999999999999998 999974322   112221    12222110  


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                             .........+.+++.+||+.||++||++++|+++|+.
T Consensus       270 -------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~  306 (373)
T 2qol_A          270 -------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK  306 (373)
T ss_dssp             -------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHH
Confidence                   1111223467789999999999999999999999964

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6.6e-42  Score=358.20  Aligned_cols=249  Identities=24%  Similarity=0.321  Sum_probs=198.8

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~  364 (611)
                      ..++|++.+.||+|+||.||+++. .+++.||+|++++.   .....+.+.+|..+++.+ +||||+++++++.+.+..+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            357899999999999999999995 46899999999754   223456788999999988 6999999999999999999


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +||||+++++|..++.   ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++++||+|||+++..
T Consensus       101 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~  174 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQ---KSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG  174 (353)
T ss_dssp             EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence            9999999999999884   3456999999999999999999999997   999999999999999999999999999854


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ....  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....   ...+...+    ..+..    
T Consensus       175 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~---~~~~~~~i----~~~~~----  241 (353)
T 3txo_A          175 ICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAI----LNDEV----  241 (353)
T ss_dssp             CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH----HHCCC----
T ss_pred             ccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC---HHHHHHHH----HcCCC----
Confidence            3222  22345689999999999999999999999999999999999999985322   22222221    11111    


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCH------HHHHH
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTM------SNVVA  563 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~------~evl~  563 (611)
                        ..    +......+.+++..||+.||++||++      +++++
T Consensus       242 --~~----p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 --VY----PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             --CC----CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             --CC----CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence              00    11122356789999999999999998      67765

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2e-42  Score=364.44  Aligned_cols=258  Identities=31%  Similarity=0.447  Sum_probs=207.8

Q ss_pred             hCCCCcccccCccCceEEEEEEcC------CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  363 (611)
                      .++|++.+.||+|+||.||+|.+.      +++.||+|++... .......+.+|+.++++++||||+++++++......
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467999999999999999999942      4678999998654 344556789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhHhhhch----hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC---CEEEe
Q 007239          364 LLIYELMPNRSLDCFIFDSE----RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM---VAKIS  436 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~---~~kl~  436 (611)
                      ++||||+++++|.+++....    ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999986432    1245899999999999999999999997   99999999999999555   59999


Q ss_pred             ccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHH
Q 007239          437 DFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLW  515 (611)
Q Consensus       437 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  515 (611)
                      |||+++...............||+.|+|||++.+..++.++||||||+++|||++ |..||....   ...+..    ..
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~---~~~~~~----~i  299 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLE----FV  299 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHH----HH
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHH----HH
Confidence            9999986644433333445678999999999999999999999999999999998 888874322   112222    12


Q ss_pred             hcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          516 KEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       516 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ..+.....         .......+.+|+.+||+.||++|||+.+|++.|+.
T Consensus       300 ~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          300 TSGGRMDP---------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HcCCCCCC---------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            22221111         11112357789999999999999999999999964

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.1e-41  Score=356.53  Aligned_cols=254  Identities=24%  Similarity=0.295  Sum_probs=203.4

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-----hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-----WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  364 (611)
                      .++|++.+.||+|+||.||+++. .+++.||+|++....     ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            35799999999999999999995 478999999986432     124678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhHhhhch-hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCC---EEEecccc
Q 007239          365 LIYELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV---AKISDFGM  440 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~---~kl~DFGl  440 (611)
                      +||||+++++|.+.+.... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999988775432 2345899999999999999999999997   999999999999986654   99999999


Q ss_pred             ceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc
Q 007239          441 ARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE  520 (611)
Q Consensus       441 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  520 (611)
                      ++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...    ...+.    ..+..+..
T Consensus       180 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~----~~i~~~~~  249 (351)
T 3c0i_A          180 AIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLF----EGIIKGKY  249 (351)
T ss_dssp             CEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS----HHHHH----HHHHHTCC
T ss_pred             eeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc----HHHHH----HHHHcCCC
Confidence            987654322  223457999999999999999999999999999999999999998532    11111    11111111


Q ss_pred             ccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       521 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..  .+.....    ...++.+|+.+||+.||++|||+.++++
T Consensus       250 ~~--~~~~~~~----~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          250 KM--NPRQWSH----ISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             CC--CHHHHTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CC--Ccccccc----CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00  0000000    1235778999999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.1e-41  Score=362.28  Aligned_cols=277  Identities=16%  Similarity=0.182  Sum_probs=212.2

Q ss_pred             HHHhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe
Q 007239          287 IKAATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       287 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  362 (611)
                      +....++|++.++||+|+||+||++++. +++.||+|++.+...   .....+.+|+.++..++||||+++++++.+.+.
T Consensus        69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  148 (437)
T 4aw2_A           69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN  148 (437)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence            3345689999999999999999999965 578899999975321   122348899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .++||||+++|+|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++++||+|||+++
T Consensus       149 ~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~  223 (437)
T 4aw2_A          149 LYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL  223 (437)
T ss_dssp             EEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhh
Confidence            99999999999999998542  356999999999999999999999987   9999999999999999999999999998


Q ss_pred             ecccCCCccccccccccCCCCCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhc
Q 007239          443 IFCENQKTANTRRVVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKE  517 (611)
Q Consensus       443 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  517 (611)
                      ........ .....+||+.|+|||++.     .+.++.++|||||||++|||++|+.||....   .......+......
T Consensus       224 ~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~  299 (437)
T 4aw2_A          224 KLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHKER  299 (437)
T ss_dssp             ECCTTSCE-ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTHHHH
T ss_pred             hcccCCCc-ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC---hhHHHHhhhhcccc
Confidence            76443322 223468999999999987     5678999999999999999999999985322   22222222111111


Q ss_pred             CccccccccccCCCCCHHHHHHHHHHhhccccCCCCC--CCCHHHHHHH--hcCCCCCCCCCCCCCCc
Q 007239          518 GKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAV--RPTMSNVVAL--LGSESIALSEPRQPPFP  581 (611)
Q Consensus       518 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~--L~~~~~~l~~~~~p~~~  581 (611)
                      .....     ...    ....++.+|+.+||+.+|++  ||+++|+++.  +....+.......|||.
T Consensus       300 ~~~p~-----~~~----~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~~~~~p~~  358 (437)
T 4aw2_A          300 FQFPT-----QVT----DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYI  358 (437)
T ss_dssp             CCCCS-----SCC----CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGGGSCCSCC
T ss_pred             ccCCc-----ccc----cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHhhCCCCCC
Confidence            11110     000    11235678899999998888  9999999873  45544443333344443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.5e-42  Score=353.09  Aligned_cols=258  Identities=28%  Similarity=0.408  Sum_probs=210.5

Q ss_pred             hCCCCcccccCccCceEEEEEEc------CCCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL------PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  363 (611)
                      .++|.+.+.||+|+||.||++..      .+++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            46899999999999999999985      24578999999754 344567889999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhHhhhchh---------------------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCC
Q 007239          364 LLIYELMPNRSLDCFIFDSER---------------------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKP  422 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp  422 (611)
                      ++||||+++++|.+++.....                     ...+++..++.++.||++||.|||+++   |+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccch
Confidence            999999999999999865332                     234899999999999999999999997   99999999


Q ss_pred             CcEEecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 007239          423 SNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLT  501 (611)
Q Consensus       423 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~  501 (611)
                      +|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987755443333344567889999999999999999999999999999999 9998754332


Q ss_pred             CchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          502 GHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       502 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                         ..+..    ....+.....         .......+.+++.+||+.||++||++.++++.|+.
T Consensus       259 ---~~~~~----~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~  308 (314)
T 2ivs_A          259 ---ERLFN----LLKTGHRMER---------PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK  308 (314)
T ss_dssp             ---GGHHH----HHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---HHHHH----HhhcCCcCCC---------CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence               22222    2222221111         11122457789999999999999999999999974

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-41  Score=355.79  Aligned_cols=260  Identities=27%  Similarity=0.380  Sum_probs=211.6

Q ss_pred             hCCCCcccccCccCceEEEEEEcC--------CCcEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeC
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP--------NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEG  360 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~  360 (611)
                      .++|.+.+.||+|+||.||++++.        .+..||+|++.... ......+.+|+++++++ +||||+++++++...
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            478999999999999999999842        34579999997653 34457899999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhhHhhhchh-------------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe
Q 007239          361 EEKLLIYELMPNRSLDCFIFDSER-------------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL  427 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll  427 (611)
                      +..++||||+++++|.+++.....             ...+++..++.++.||+.||.|||+++   |+||||||+||||
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence            999999999999999999864321             235899999999999999999999997   9999999999999


Q ss_pred             cCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhh
Q 007239          428 DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQT  506 (611)
Q Consensus       428 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~  506 (611)
                      +.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.|+....   ...
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~---~~~  301 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---VEE  301 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHH
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC---HHH
Confidence            9999999999999987654443333444578899999999999999999999999999999999 998874322   111


Q ss_pred             HHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCC
Q 007239          507 LLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES  569 (611)
Q Consensus       507 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  569 (611)
                          +...+..+.....         +.....++.+|+.+||+.||++|||++||++.|++..
T Consensus       302 ----~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          302 ----LFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             ----HHHHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----HHHHHHcCCCCCC---------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                2222233222111         1112245778999999999999999999999997653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.3e-41  Score=353.52  Aligned_cols=248  Identities=22%  Similarity=0.305  Sum_probs=201.1

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      ..++|++.+.||+|+||.||++.+ .+++.||+|++....   ......+.+|+.+++.++||||+++++++...+..++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            357899999999999999999995 678999999987532   1224578999999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+ +|+|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus        87 v~E~~-~g~l~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           87 VIEYA-GGELFDYIV---EKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             EECCC-CEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EEECC-CCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            99999 678888774   3456999999999999999999999997   9999999999999999999999999998664


Q ss_pred             cCCCccccccccccCCCCCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLF-SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ....   ....+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........               ...+.
T Consensus       160 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---------------~~~i~  221 (336)
T 3h4j_B          160 DGNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---------------FKKVN  221 (336)
T ss_dssp             TSBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------------BCCCC
T ss_pred             CCcc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------------HHHHH
Confidence            4322   234579999999999988776 7899999999999999999999853221110               00000


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ....  ..+......+.+|+.+||+.||++|||++|+++.
T Consensus       222 ~~~~--~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          222 SCVY--VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             SSCC--CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             cCCC--CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            0000  0111122456789999999999999999999863

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.7e-41  Score=341.73  Aligned_cols=261  Identities=17%  Similarity=0.238  Sum_probs=210.8

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.+.||+|+||.||++.. .+++.||+|++....  ..+.+.+|+.+++.+ +|+|++++++++......++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46799999999999999999995 578999999986543  234678899999999 69999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCC-----EEEecccccee
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV-----AKISDFGMARI  443 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~-----~kl~DFGla~~  443 (611)
                      |+ +++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.     +||+|||+++.
T Consensus        87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 99999998532  345899999999999999999999986   999999999999987776     99999999987


Q ss_pred             cccCCCc-----cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC
Q 007239          444 FCENQKT-----ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG  518 (611)
Q Consensus       444 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  518 (611)
                      .......     .......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            7543322     12335679999999999999999999999999999999999999987654444333333332222211


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       519 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ...+..     ..    ....+.+++.+||+.||++||++++|++.|+..
T Consensus       241 ~~~~~~-----~~----~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          241 PLRELC-----AG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             CHHHHT-----TT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             cHHHHH-----hh----CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            111111     11    124577899999999999999999999999754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-41  Score=352.55  Aligned_cols=263  Identities=25%  Similarity=0.402  Sum_probs=212.0

Q ss_pred             HHhhCCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC
Q 007239          288 KAATDGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG  360 (611)
Q Consensus       288 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~  360 (611)
                      ....++|++.+.||+|+||.||++.+.      +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            345688999999999999999999963      34789999997653 34467799999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhHhhhchh---------------------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecC
Q 007239          361 EEKLLIYELMPNRSLDCFIFDSER---------------------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRD  419 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrD  419 (611)
                      +..++||||+++++|.+++.....                     ...+++.+++.++.||++||.|||+++   |+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            999999999999999999865221                     256899999999999999999999997   99999


Q ss_pred             CCCCcEEecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 007239          420 LKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGF  498 (611)
Q Consensus       420 ikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~  498 (611)
                      |||+|||++.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999987654433333344678999999999999999999999999999999999 9888743


Q ss_pred             CCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCC
Q 007239          499 YLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES  569 (611)
Q Consensus       499 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  569 (611)
                      ..   ...+.    .....+.....     ..    ....++.+++.+||+.||++||++.+|++.|+...
T Consensus       280 ~~---~~~~~----~~~~~~~~~~~-----~~----~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~  334 (343)
T 1luf_A          280 MA---HEEVI----YYVRDGNILAC-----PE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  334 (343)
T ss_dssp             SC---HHHHH----HHHHTTCCCCC-----CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CC---hHHHH----HHHhCCCcCCC-----CC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence            21   11111    22222222111     11    12235778999999999999999999999998653

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.7e-42  Score=347.24  Aligned_cols=254  Identities=26%  Similarity=0.381  Sum_probs=204.8

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      .++|++.+.||+|+||.||++.+.+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            468999999999999999999988888999999986543 3467899999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++........
T Consensus       102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  176 (283)
T 3gen_A          102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  176 (283)
T ss_dssp             TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred             CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence            999999998542  346999999999999999999999997   999999999999999999999999999865432211


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                       ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.....   .....    ....+...     .. 
T Consensus       177 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~---~~~~~----~~~~~~~~-----~~-  242 (283)
T 3gen_A          177 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAE----HIAQGLRL-----YR-  242 (283)
T ss_dssp             -STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHH----HHHTTCCC-----CC-
T ss_pred             -cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---hHHHH----HHhcccCC-----CC-
Confidence             1223457788999999999999999999999999999998 9999753321   11111    11221110     00 


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                         +......+.+++.+||+.||++|||+.++++.|..
T Consensus       243 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  277 (283)
T 3gen_A          243 ---PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  277 (283)
T ss_dssp             ---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence               01112457789999999999999999999999964

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.2e-41  Score=343.00  Aligned_cols=261  Identities=24%  Similarity=0.330  Sum_probs=200.0

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      ++|++.+.||+|+||.||++...+++.||+|++.....  .....+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57999999999999999999988899999999875432  2346788999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++ +|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            986 88887743  2356899999999999999999999997   99999999999999999999999999986543221


Q ss_pred             ccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc------
Q 007239          450 TANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME------  522 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~------  522 (611)
                        ......||+.|+|||++.+. .++.++||||||+++|||++|+.||....   .......+.+.........      
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS---EADQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             --ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHHCCCChhhchhhhc
Confidence              12235789999999998764 58999999999999999999999975332   2222223322222211110      


Q ss_pred             --ccccccCC-------CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          523 --FVDPLLMK-------SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       523 --~~d~~l~~-------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                        ..++....       ........++.+|+.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              01111100       000112345678999999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1e-41  Score=350.62  Aligned_cols=258  Identities=23%  Similarity=0.317  Sum_probs=195.3

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe---
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE---  362 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~---  362 (611)
                      ..++|++.+.||+|+||.||++++ .+++.||+|++....   ......+.+|+.++++++||||+++++++.....   
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            347899999999999999999995 578999999997643   3345678999999999999999999999876543   


Q ss_pred             -EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccc
Q 007239          363 -KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA  441 (611)
Q Consensus       363 -~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  441 (611)
                       .++||||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a  163 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA  163 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred             ccEEEEecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence             499999999999999984   3456999999999999999999999997   999999999999999999999999999


Q ss_pred             eecccCCCc-cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc
Q 007239          442 RIFCENQKT-ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE  520 (611)
Q Consensus       442 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  520 (611)
                      +.+...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....      ....++.......
T Consensus       164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~------~~~~~~~~~~~~~  237 (311)
T 3ork_A          164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPI  237 (311)
T ss_dssp             ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCC
T ss_pred             ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHhcCCCC
Confidence            876443222 223346799999999999999999999999999999999999999743221      1222222222211


Q ss_pred             ccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHH-HHhc
Q 007239          521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV-ALLG  566 (611)
Q Consensus       521 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl-~~L~  566 (611)
                      ...   ....    ....++.+++.+||+.||++||+..+++ ..|.
T Consensus       238 ~~~---~~~~----~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  277 (311)
T 3ork_A          238 PPS---ARHE----GLSADLDAVVLKALAKNPENRYQTAAEMRADLV  277 (311)
T ss_dssp             CHH---HHST----TCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             Ccc---cccC----CCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence            100   0000    1123577899999999999999665544 4443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.6e-41  Score=355.94  Aligned_cols=250  Identities=23%  Similarity=0.339  Sum_probs=204.5

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++.+.||+|+||.||++.. .+++.||+|++.+..   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            36799999999999999999995 468899999986542   23457788999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+.+++|..++.   ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus        94 ~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQ---QNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHH---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            99999999999984   3456999999999999999999999997   99999999999999999999999999987643


Q ss_pred             CCCccccccccccCCCCCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAME---GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      ..   .....+||+.|+|||++..   ..++.++|||||||++|||++|+.||..........+...+    .....   
T Consensus       168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~----~~~~~---  237 (384)
T 4fr4_A          168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF----ETTVV---  237 (384)
T ss_dssp             TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH----HHCCC---
T ss_pred             CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH----hhccc---
Confidence            32   2335689999999999874   45899999999999999999999998654443333222221    11110   


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCC-HHHHHH
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT-MSNVVA  563 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~  563 (611)
                             ..+......+.+|+..||+.||++||+ +++|++
T Consensus       238 -------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          238 -------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                   001112245778999999999999998 777765

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-42  Score=356.42  Aligned_cols=262  Identities=27%  Similarity=0.405  Sum_probs=208.9

Q ss_pred             hhCCCCcccccCccCceEEEEEEc------CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCC
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL------PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGE  361 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~  361 (611)
                      ..++|++.+.||+|+||.||++.+      .+++.||+|++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            347899999999999999999995      245689999997542 23457789999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCChhhHhhhchh--------------------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCC
Q 007239          362 EKLLIYELMPNRSLDCFIFDSER--------------------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLK  421 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDik  421 (611)
                      ..++||||+++++|.+++.....                    ...+++..++.++.||+.||.|||+++   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            99999999999999999865322                    134799999999999999999999997   9999999


Q ss_pred             CCcEEecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 007239          422 PSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYL  500 (611)
Q Consensus       422 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~  500 (611)
                      |+|||++.++.+||+|||++................||+.|+|||.+.++.++.++||||||+++|+|++ |..||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987755443333445678899999999999999999999999999999998 999975433


Q ss_pred             CCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCC
Q 007239          501 TGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES  569 (611)
Q Consensus       501 ~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  569 (611)
                      ...  ..    ......+....         .+.....++.+|+.+||+.||++|||+.+|++.|+...
T Consensus       280 ~~~--~~----~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  333 (344)
T 1rjb_A          280 VDA--NF----YKLIQNGFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL  333 (344)
T ss_dssp             CSH--HH----HHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             cHH--HH----HHHHhcCCCCC---------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            211  11    12222221111         01112245778999999999999999999999997643

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=349.38  Aligned_cols=251  Identities=26%  Similarity=0.343  Sum_probs=203.7

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChh------hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQ------GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  363 (611)
                      .++|++.+.||+|+||.||++... +++.||+|++......      ..+.+.+|+.+++.++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            457999999999999999999964 6899999998754321      367899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC----CEEEeccc
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM----VAKISDFG  439 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~----~~kl~DFG  439 (611)
                      ++||||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999999984   3456899999999999999999999987   99999999999999887    89999999


Q ss_pred             cceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCc
Q 007239          440 MARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK  519 (611)
Q Consensus       440 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  519 (611)
                      +++.......   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....   .......+    ....
T Consensus       164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~~----~~~~  233 (326)
T 2y0a_A          164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANV----SAVN  233 (326)
T ss_dssp             TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHH----HHTC
T ss_pred             CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHH----HhcC
Confidence            9987643322   234579999999999999999999999999999999999999974321   11111111    1111


Q ss_pred             cccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          520 EMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       520 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      . ....... .    .....+.+|+.+||+.||++|||+.|+++
T Consensus       234 ~-~~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          234 Y-EFEDEYF-S----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             C-CCCHHHH-T----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             C-CcCcccc-c----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0 0000000 0    01235678999999999999999999997

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.9e-41  Score=343.25  Aligned_cols=261  Identities=24%  Similarity=0.342  Sum_probs=201.0

Q ss_pred             hhCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHh--cCCCCeeeEEEeEee----CCeE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAK--LQHRNLVRLVGCGIE----GEEK  363 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~h~niv~l~~~~~~----~~~~  363 (611)
                      ..++|++.+.||+|+||.||+|.+ +++.||+|++....   ...+.+|.+++..  ++||||+++++++..    ....
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            357899999999999999999998 68899999987543   3456667777776  789999999998654    3468


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHh--------hcCCCceEecCCCCCcEEecCCCCEEE
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH--------EDSRLKIIHRDLKPSNVLLDKDMVAKI  435 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH--------~~~~~~iiHrDikp~NIll~~~~~~kl  435 (611)
                      ++||||+++++|.+++.    ...+++..++.++.||+.||.|||        +.+   |+||||||+|||++.++.+||
T Consensus        82 ~lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             EEEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred             EEehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence            99999999999999983    346899999999999999999999        665   999999999999999999999


Q ss_pred             eccccceecccCCCcc--ccccccccCCCCCccccccC------CCCchhhHHHHHHHHHHHHhC----------CCCCC
Q 007239          436 SDFGMARIFCENQKTA--NTRRVVGTYGYMAPEYAMEG------LFSVKSDVFSFGVIVLEIISG----------KRNSG  497 (611)
Q Consensus       436 ~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~k~DvwSlGvll~elltG----------~~p~~  497 (611)
                      +|||+++.........  ......||+.|+|||++.+.      .++.++||||||+++|||++|          +.||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            9999998764433221  12335799999999999876      455799999999999999999          67764


Q ss_pred             CCCCCchhhHHHHHHHHHhc-CccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          498 FYLTGHAQTLLAYVWQLWKE-GKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       498 ~~~~~~~~~l~~~~~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ........  .......... .........    .........+.+|+.+||+.||++|||+.+|++.|++
T Consensus       235 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          235 DVVPNDPS--FEDMRKVVCVDQQRPNIPNR----WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             TTSCSSCC--HHHHHHHHTTSCCCCCCCGG----GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             ccCCCCcc--hhhhhHHHhccCCCCCCChh----hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            33222211  1111111111 111111111    1122455678899999999999999999999999974

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=5.4e-41  Score=350.36  Aligned_cols=250  Identities=24%  Similarity=0.318  Sum_probs=200.1

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc---ChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK---SWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~l  365 (611)
                      .++|++.+.||+|+||.||+++.. +++.||+|++.+.   .....+.+.+|..+++++ +||||+++++++.+.+..++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            367999999999999999999964 6889999999764   233456788999999988 79999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+++++|.+++.   +...+++..++.++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++...
T Consensus        88 v~e~~~gg~L~~~l~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            999999999999884   3456999999999999999999999997   9999999999999999999999999998542


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCch--hhHHHHHHHHHhcCccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHA--QTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~  523 (611)
                      ...  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........  ........+.+..... . 
T Consensus       162 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-~-  237 (345)
T 3a8x_A          162 RPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-R-  237 (345)
T ss_dssp             CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-C-
T ss_pred             CCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-C-
Confidence            222  123356899999999999999999999999999999999999999854322111  1111122222222211 0 


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCH
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTM  558 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  558 (611)
                          +..    ....++.+|+.+||+.||++||++
T Consensus       238 ----~p~----~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          238 ----IPR----SLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             ----CCT----TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             ----CCC----CCCHHHHHHHHHHhcCCHhHCCCC
Confidence                111    122456789999999999999995

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=354.88  Aligned_cols=252  Identities=24%  Similarity=0.357  Sum_probs=196.5

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCC--CCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQH--RNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h--~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++.+.||+|+||.||++...+++.||+|++...  .....+.+.+|+.++++++|  |||+++++++......++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            4679999999999999999999888999999998754  33456789999999999986  9999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      || +.+++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++ ++.+||+|||+++.+..
T Consensus        88 ~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 56789999984   3456899999999999999999999997   99999999999997 67899999999987755


Q ss_pred             CCCccccccccccCCCCCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHH
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAME-----------GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLW  515 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~  515 (611)
                      ...........||+.|+|||++.+           ..++.++||||||+++|||++|+.||.....     .........
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~  234 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAII  234 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHHHHH
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHHHHh
Confidence            443333445689999999999865           6789999999999999999999999853221     111111212


Q ss_pred             hcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          516 KEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       516 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ......+         .+.....++.+|+..||+.||++|||+.|+++.
T Consensus       235 ~~~~~~~---------~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          235 DPNHEIE---------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             CTTSCCC---------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCcccC---------CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            1111111         111112356789999999999999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.8e-42  Score=353.19  Aligned_cols=259  Identities=26%  Similarity=0.426  Sum_probs=192.0

Q ss_pred             hCCCCcccccCccCceEEEEEEcCC-Cc---EEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeE-
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPN-GK---EVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEK-  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~-~~---~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~-  363 (611)
                      .++|++.+.||+|+||.||++.+.. ++   .||+|++...  .....+.+.+|+.++++++||||+++++++...... 
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            4689999999999999999999653 32   7999998764  334567899999999999999999999999877655 


Q ss_pred             -----EEEEEecCCCChhhHhhhchh---hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEE
Q 007239          364 -----LLIYELMPNRSLDCFIFDSER---RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKI  435 (611)
Q Consensus       364 -----~lv~E~~~~~sL~~~l~~~~~---~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl  435 (611)
                           ++||||+++++|.+++.....   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl  178 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV  178 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence                 999999999999999854322   225899999999999999999999997   999999999999999999999


Q ss_pred             eccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHH
Q 007239          436 SDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQL  514 (611)
Q Consensus       436 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~  514 (611)
                      +|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||......   .+...    
T Consensus       179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~----  251 (323)
T 3qup_A          179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYNY----  251 (323)
T ss_dssp             CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH----
T ss_pred             eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHHH----
Confidence            99999987654443333334567889999999999999999999999999999999 88887543221   22221    


Q ss_pred             HhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       515 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ...+.....         .......+.+++.+||+.||++|||+.++++.|+..
T Consensus       252 ~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  296 (323)
T 3qup_A          252 LIGGNRLKQ---------PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI  296 (323)
T ss_dssp             HHTTCCCCC---------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhcCCCCCC---------CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            111111110         111224577999999999999999999999999753

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=365.65  Aligned_cols=254  Identities=25%  Similarity=0.302  Sum_probs=204.0

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ..++|++.+.||+|+||.||++.. .+|+.+|+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            457899999999999999999995 578999999987654  23456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec---CCCCEEEecccccee
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARI  443 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~---~~~~~kl~DFGla~~  443 (611)
                      |||+++++|.+.+.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||++..
T Consensus        89 ~E~~~gg~L~~~i~---~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIV---AREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            99999999998884   3456999999999999999999999997   99999999999998   567899999999987


Q ss_pred             cccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          444 FCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       444 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      ......  ......||+.|+|||++.+..++.++||||||+++|+|++|++||...   ....+..    .+..+... +
T Consensus       163 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~---~~~~~~~----~i~~~~~~-~  232 (444)
T 3soa_A          163 VEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE---DQHRLYQ----QIKAGAYD-F  232 (444)
T ss_dssp             CCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHH----HHHHTCCC-C
T ss_pred             ecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc---cHHHHHH----HHHhCCCC-C
Confidence            644322  223468999999999999999999999999999999999999997432   1222222    12222111 1


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ..+..     .....++.+|+..||+.||++|||+.|+++.
T Consensus       233 ~~~~~-----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          233 PSPEW-----DTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             CTTTT-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             Ccccc-----ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11100     0112356789999999999999999999973

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.6e-41  Score=348.89  Aligned_cols=259  Identities=28%  Similarity=0.411  Sum_probs=210.0

Q ss_pred             hCCCCcccccCccCceEEEEEEc------CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL------PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~  362 (611)
                      .++|++.+.||+|+||.||++.+      .+++.||+|++.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            46899999999999999999984      356789999997653 34467899999999999 89999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchh---------------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe
Q 007239          363 KLLIYELMPNRSLDCFIFDSER---------------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL  427 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll  427 (611)
                      .++||||+++++|.+++.....               ...+++..++.++.||++||.|||+++   |+||||||+|||+
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence            9999999999999999865322               225899999999999999999999997   9999999999999


Q ss_pred             cCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhh
Q 007239          428 DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQT  506 (611)
Q Consensus       428 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~  506 (611)
                      +.++.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|+|++ |+.||.......  .
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~  256 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS--K  256 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--H
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--H
Confidence            9999999999999987755443333334567889999999999999999999999999999999 998875433221  1


Q ss_pred             HHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          507 LLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       507 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ..    .........     ..    .......+.+++.+||+.||++|||+.+++++|+.
T Consensus       257 ~~----~~~~~~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  304 (313)
T 1t46_A          257 FY----KMIKEGFRM-----LS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (313)
T ss_dssp             HH----HHHHHTCCC-----CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HH----HHhccCCCC-----CC----cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence            11    111221110     00    11122457789999999999999999999999975

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.7e-41  Score=356.69  Aligned_cols=253  Identities=26%  Similarity=0.350  Sum_probs=204.4

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ..++|++.+.||+|+||.||+++. .+++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            356899999999999999999996 468999999997543  34457789999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC---CEEEecccccee
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM---VAKISDFGMARI  443 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~---~~kl~DFGla~~  443 (611)
                      |||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++   .+||+|||++..
T Consensus       107 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHT---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            99999999998884   3456899999999999999999999997   99999999999998654   599999999987


Q ss_pred             cccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          444 FCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       444 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      ......   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...   ....+..    .+..+... .
T Consensus       181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~---~~~~~~~----~i~~~~~~-~  249 (362)
T 2bdw_A          181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYA----QIKAGAYD-Y  249 (362)
T ss_dssp             CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHH----HHHHTCCC-C
T ss_pred             ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC---CHHHHHH----HHHhCCCC-C
Confidence            643322   23468999999999999999999999999999999999999997432   1122222    12222111 0


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ..+..     .....++.+|+.+||+.||++|||+.++++.
T Consensus       250 ~~~~~-----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          250 PSPEW-----DTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CTTGG-----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             Ccccc-----cCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000     1112457789999999999999999999864

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=8.2e-41  Score=336.41  Aligned_cols=253  Identities=30%  Similarity=0.458  Sum_probs=195.2

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccCh----hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW----QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++.+.||+|+||.||++.+. ++.||+|++.....    ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            468999999999999999999974 88999999875432    2356789999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC--------CCCEEEecc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK--------DMVAKISDF  438 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~--------~~~~kl~DF  438 (611)
                      |||+++++|.+++.    ...+++..++.++.||+.||.|||+++..+|+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999998873    346899999999999999999999986445899999999999986        778999999


Q ss_pred             ccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC
Q 007239          439 GMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG  518 (611)
Q Consensus       439 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  518 (611)
                      |++........    ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....      ...........
T Consensus       161 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~~~  230 (271)
T 3dtc_A          161 GLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAYGVAMNK  230 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH------HHHHHHHHTSC
T ss_pred             Ccccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHhhhcCC
Confidence            99986543322    235799999999999999999999999999999999999999753221      11111111111


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       519 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ....         .+......+.+++.+||+.||++|||+.|+++.|++
T Consensus       231 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          231 LALP---------IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             CCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCCC---------CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            1111         111122457789999999999999999999999975

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-41  Score=345.48  Aligned_cols=245  Identities=23%  Similarity=0.315  Sum_probs=203.0

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++.+.||+|+||.||+++. .+|+.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            46899999999999999999996 478999999997542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLR---KSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHH---HTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            99999999999984   3456899999999999999999999986   99999999999999999999999999987533


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      .     ....+||+.|+|||++.+..++.++||||||+++|||++|+.||....   ......   ..... .. .    
T Consensus       159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~---~i~~~-~~-~----  221 (318)
T 1fot_A          159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN---TMKTYE---KILNA-EL-R----  221 (318)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHH---HHHHC-CC-C----
T ss_pred             c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHH---HHHhC-CC-C----
Confidence            2     234689999999999999999999999999999999999999974321   111111   11111 11 0    


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVA  563 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  563 (611)
                       ...    ....++.+++.+||+.||++||     +++++++
T Consensus       222 -~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          222 -FPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             -CCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCC----CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence             111    1124567899999999999999     8888884

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.6e-41  Score=350.14  Aligned_cols=270  Identities=25%  Similarity=0.352  Sum_probs=210.8

Q ss_pred             hCCCCcccccCccCceEEEEEEc-----CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEe--eCCeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-----PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI--EGEEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~--~~~~~  363 (611)
                      .++|++.+.||+|+||.||++++     .+++.||+|++........+.+.+|+.++++++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            36799999999999999999983     368899999998877777788999999999999999999999886  45678


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            9999999999999998542  345899999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCCCcc-ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC--------chhhHHHHHHHH
Q 007239          444 FCENQKTA-NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--------HAQTLLAYVWQL  514 (611)
Q Consensus       444 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~--------~~~~l~~~~~~~  514 (611)
                      ........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.|+......        ............
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            64433221 223356888899999999999999999999999999999999986432111        000011111222


Q ss_pred             HhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCCCCCCC
Q 007239          515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSE  574 (611)
Q Consensus       515 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~  574 (611)
                      ...+...         .........+.+|+.+||+.||++|||++++++.|+........
T Consensus       257 ~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  307 (327)
T 3lxl_A          257 LEEGQRL---------PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG  307 (327)
T ss_dssp             HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred             hhcccCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence            2222111         11122234577899999999999999999999999866443333

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=340.04  Aligned_cols=249  Identities=26%  Similarity=0.329  Sum_probs=195.2

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh--------------------------hhHHHHHHHHHHHH
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW--------------------------QGLEEFKNEIILIA  343 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~il~  343 (611)
                      .++|++.+.||+|+||.||+++. .+++.||+|++.....                          ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            47899999999999999999995 4688999999875431                          12356889999999


Q ss_pred             hcCCCCeeeEEEeEee--CCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCC
Q 007239          344 KLQHRNLVRLVGCGIE--GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLK  421 (611)
Q Consensus       344 ~l~h~niv~l~~~~~~--~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDik  421 (611)
                      +++||||+++++++.+  ....++||||+++++|.+++    ....+++..++.++.||++||.|||+++   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999986  56889999999999998765    2346899999999999999999999997   9999999


Q ss_pred             CCcEEecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCC
Q 007239          422 PSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL---FSVKSDVFSFGVIVLEIISGKRNSGF  498 (611)
Q Consensus       422 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~k~DvwSlGvll~elltG~~p~~~  498 (611)
                      |+|||++.++.+||+|||+++.+.....  ......||+.|+|||.+.+..   ++.++||||||+++|+|++|+.||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999987644322  123457999999999998765   47899999999999999999999743


Q ss_pred             CCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          499 YLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       499 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..   ...+.    ........ ....       .......+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~---~~~~~----~~~~~~~~-~~~~-------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ER---IMCLH----SKIKSQAL-EFPD-------QPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SS---HHHHH----HHHHHCCC-CCCS-------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cc---HHHHH----HHHhcccC-CCCC-------ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            21   11111    11111111 0000       0111235778999999999999999999875

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-41  Score=354.91  Aligned_cols=253  Identities=23%  Similarity=0.270  Sum_probs=206.4

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            46899999999999999999996 47889999999877666667899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC--CCCEEEeccccceecccC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK--DMVAKISDFGMARIFCEN  447 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~--~~~~kl~DFGla~~~~~~  447 (611)
                      +++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.  ++.+||+|||+++.....
T Consensus       130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999998843  2346899999999999999999999997   999999999999974  578999999999876443


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                      ..   .....||+.|+|||++.+..++.++||||||+++|||++|+.||....   .......+    ......  .+..
T Consensus       205 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~i----~~~~~~--~~~~  272 (387)
T 1kob_A          205 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNV----KRCDWE--FDED  272 (387)
T ss_dssp             SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHH----HHCCCC--CCSS
T ss_pred             cc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC---HHHHHHHH----HhCCCC--CCcc
Confidence            22   234579999999999999999999999999999999999999975322   11111111    111110  0111


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ..    .....++.+|+.+||+.||++|||+.|+++.
T Consensus       273 ~~----~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          273 AF----SSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             TT----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cc----ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            11    1122457799999999999999999999974

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.2e-42  Score=369.67  Aligned_cols=256  Identities=28%  Similarity=0.430  Sum_probs=208.4

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      .++|++.+.||+|+||.||+|.+++++.||||+++... ...+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus       187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~  264 (454)
T 1qcf_A          187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM  264 (454)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred             hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence            46799999999999999999999888999999998654 35678999999999999999999999986 66789999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++|+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++........
T Consensus       265 ~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~  340 (454)
T 1qcf_A          265 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT  340 (454)
T ss_dssp             TTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence            999999998543 2346899999999999999999999996   999999999999999999999999999876432211


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                       ......+|+.|+|||++..+.++.++||||||+++|||++ |+.||....   ...+...+    ..+....       
T Consensus       341 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~---~~~~~~~i----~~~~~~~-------  405 (454)
T 1qcf_A          341 -AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS---NPEVIRAL----ERGYRMP-------  405 (454)
T ss_dssp             -TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHHH----HHTCCCC-------
T ss_pred             -ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC---HHHHHHHH----HcCCCCC-------
Confidence             1223456788999999999999999999999999999999 999975322   12222221    2221111       


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCC
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES  569 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  569 (611)
                        .+.....++.+|+.+||+.||++|||+++|+++|+...
T Consensus       406 --~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          406 --RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             --CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence              01112245778999999999999999999999998753

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.2e-41  Score=344.25  Aligned_cols=263  Identities=26%  Similarity=0.394  Sum_probs=202.2

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      ++|++.+.||+|+||.||++.+. ++.||+|++...  ...+.+.+|+.++++++||||+++++++.  +..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence            57899999999999999999974 788999998654  34578899999999999999999999876  34799999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCC-EEEeccccceecccCCCc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV-AKISDFGMARIFCENQKT  450 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~-~kl~DFGla~~~~~~~~~  450 (611)
                      +++|.+++........+++..++.++.||++||.|||+.+..+|+||||||+|||++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999966554456889999999999999999999932224999999999999998886 799999999765322   


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                        .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......    ....+... .+.....     ..
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~-~~~~~~~-----~~  227 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMWAVH-NGTRPPL-----IK  227 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHHHHH-TTCCCCC-----BT
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHHHHh-cCCCCCc-----cc
Confidence              123469999999999999999999999999999999999999985432221    11122211 2211111     11


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCCCCCCCCCCC
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQP  578 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~~~~p  578 (611)
                      .    ....+.+++.+||+.||++|||++++++.|+.....++.+..|
T Consensus       228 ~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~  271 (307)
T 2eva_A          228 N----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP  271 (307)
T ss_dssp             T----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred             c----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence            1    1235678999999999999999999999997654444444433

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.6e-40  Score=342.71  Aligned_cols=264  Identities=28%  Similarity=0.373  Sum_probs=189.7

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            46899999999999999999996 4689999999875432 234678899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhch---hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          369 LMPNRSLDCFIFDSE---RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      |++ ++|.+++....   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 48888875422   1235899999999999999999999987   9999999999999999999999999998764


Q ss_pred             cCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc---
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM---  521 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~---  521 (611)
                      ....  ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.....   ......+..........   
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND---EEQLKLIFDIMGTPNESLWP  234 (317)
T ss_dssp             SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCTTTCG
T ss_pred             CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHHhCCCChhHhh
Confidence            3322  1234578999999999876 4689999999999999999999999853322   22222222222111000   


Q ss_pred             c-----ccccccCC------------CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          522 E-----FVDPLLMK------------SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       522 ~-----~~d~~l~~------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .     ...+.+..            ........++.+|+.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0     00000000            000011235789999999999999999999885

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.2e-41  Score=368.54  Aligned_cols=259  Identities=28%  Similarity=0.432  Sum_probs=204.4

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      .++|++.++||+|+||.||+|.+.++..||||+++... ...+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~  260 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  260 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence            46789999999999999999998888889999998654 345789999999999999999999999876 6789999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++........
T Consensus       261 ~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  336 (452)
T 1fmk_A          261 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  336 (452)
T ss_dssp             TTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             cCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence            999999998542 2345899999999999999999999986   999999999999999999999999999876433221


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                       ......+++.|+|||.+..+.++.++||||||+++|||++ |+.|+....   ...+..    ....+....       
T Consensus       337 -~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~---~~~~~~----~i~~~~~~~-------  401 (452)
T 1fmk_A          337 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLD----QVERGYRMP-------  401 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHH----HHHTTCCCC-------
T ss_pred             -cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCC---HHHHHH----HHHcCCCCC-------
Confidence             2223457889999999999999999999999999999999 888874322   111221    122221111       


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCCCCC
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIAL  572 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l  572 (611)
                        .+......+.+|+.+||+.||++|||+++|++.|+......
T Consensus       402 --~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          402 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             --CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence              11122345778999999999999999999999998765433

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2e-41  Score=353.28  Aligned_cols=250  Identities=24%  Similarity=0.303  Sum_probs=202.7

Q ss_pred             HHhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCe
Q 007239          288 KAATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       288 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~  362 (611)
                      ....++|++.+.||+|+||.||+++.. +++.||+|++++..   ....+.+.+|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345689999999999999999999964 68899999997642   23456788899999887 89999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .++||||+++|+|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++
T Consensus        93 ~~lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            999999999999999984   3456999999999999999999999997   9999999999999999999999999998


Q ss_pred             ecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          443 IFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       443 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      ......  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||....   ...+...    +.....  
T Consensus       167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~----i~~~~~--  235 (345)
T 1xjd_A          167 ENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHS----IRMDNP--  235 (345)
T ss_dssp             CCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH----HHHCCC--
T ss_pred             hcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC---HHHHHHH----HHhCCC--
Confidence            543222  22345789999999999999999999999999999999999999975321   2222221    111111  


Q ss_pred             ccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHH-HHH
Q 007239          523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMS-NVV  562 (611)
Q Consensus       523 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl  562 (611)
                          .....    ...++.+|+.+||+.||++||++. +|+
T Consensus       236 ----~~p~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          236 ----FYPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             ----CCCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             ----CCCcc----cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                11111    124567899999999999999997 665

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-41  Score=358.76  Aligned_cols=276  Identities=18%  Similarity=0.207  Sum_probs=211.2

Q ss_pred             HHHhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe
Q 007239          287 IKAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       287 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  362 (611)
                      .+...++|++.+.||+|+||+||+++. .+|+.||+|++.+...   ...+.+.+|..++..++||||+++++++.+.+.
T Consensus        56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  135 (412)
T 2vd5_A           56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY  135 (412)
T ss_dssp             HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            334568999999999999999999996 4789999999975321   223457899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .++||||+++|+|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++
T Consensus       136 ~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~  210 (412)
T 2vd5_A          136 LYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCL  210 (412)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhhe
Confidence            99999999999999998432  236899999999999999999999987   9999999999999999999999999998


Q ss_pred             ecccCCCccccccccccCCCCCccccc-------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHH
Q 007239          443 IFCENQKTANTRRVVGTYGYMAPEYAM-------EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLW  515 (611)
Q Consensus       443 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~  515 (611)
                      ....... ......+||+.|+|||++.       .+.++.++|||||||++|||++|+.||....   .......+....
T Consensus       211 ~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~~  286 (412)
T 2vd5_A          211 KLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS---TAETYGKIVHYK  286 (412)
T ss_dssp             ECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTHH
T ss_pred             eccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC---HHHHHHHHHhcc
Confidence            7644322 1223468999999999987       3568999999999999999999999984322   222222221110


Q ss_pred             hcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCC---CCHHHHHHH--hcCCCCCCCCCCCCCCc
Q 007239          516 KEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVR---PTMSNVVAL--LGSESIALSEPRQPPFP  581 (611)
Q Consensus       516 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R---Pt~~evl~~--L~~~~~~l~~~~~p~~~  581 (611)
                      .....     +....    ....++.+|+.+||+ +|++|   |+++|+++.  +....+.......|||.
T Consensus       287 ~~~~~-----p~~~~----~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~~~~p~~  347 (412)
T 2vd5_A          287 EHLSL-----PLVDE----GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFT  347 (412)
T ss_dssp             HHCCC-----C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTTSCCSCC
T ss_pred             cCcCC-----Ccccc----CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCC
Confidence            00000     11111    112356789999999 99998   689998763  44444443344445554

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.1e-41  Score=343.44  Aligned_cols=263  Identities=26%  Similarity=0.385  Sum_probs=205.9

Q ss_pred             hCCCCcccccCccCceEEEEEEc-----CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC--Ce
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-----PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG--EE  362 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~  362 (611)
                      .++|++.+.||+|+||.||++++     .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            35689999999999999999983     368899999997543 33467899999999999999999999999876  66


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .++||||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus       100 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            8999999999999999853  2345899999999999999999999997   9999999999999999999999999998


Q ss_pred             ecccCCCc-cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------CCchhhHHHHHHH
Q 007239          443 IFCENQKT-ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYL--------TGHAQTLLAYVWQ  513 (611)
Q Consensus       443 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~--------~~~~~~l~~~~~~  513 (611)
                      ........ .......||..|+|||.+.+..++.++||||||+++|+|++|..|+....        .............
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            76543321 22334568889999999999999999999999999999999998753211        1111111122222


Q ss_pred             HHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       514 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ....+....         .+......+.+|+.+||+.||++|||+.+++++|++
T Consensus       255 ~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          255 TLKEGKRLP---------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHHTTCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhccCCCC---------CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            222222111         111222457799999999999999999999999964

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.2e-41  Score=358.11  Aligned_cols=251  Identities=24%  Similarity=0.367  Sum_probs=196.6

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcC--CCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQ--HRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~--h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++.+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++++++  ||||+++++++...+..++||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            469999999999999999999878999999998654  3445678999999999997  599999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      | +.+++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++ ++.+||+|||+++.+...
T Consensus       136 E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~  207 (390)
T 2zmd_A          136 E-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  207 (390)
T ss_dssp             E-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred             e-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence            9 578899999843   346899999999999999999999986   99999999999995 589999999999877544


Q ss_pred             CCccccccccccCCCCCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHh
Q 007239          448 QKTANTRRVVGTYGYMAPEYAME-----------GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWK  516 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~  516 (611)
                      ..........||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....     ..........
T Consensus       208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~~~~~  282 (390)
T 2zmd_A          208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLHAIID  282 (390)
T ss_dssp             ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHC
T ss_pred             CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHHHHhC
Confidence            43333345689999999999865           4689999999999999999999999853221     1111212121


Q ss_pred             cCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          517 EGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       517 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ......+     ..    .....+.+|+.+||+.||++|||+.|+++.
T Consensus       283 ~~~~~~~-----~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          283 PNHEIEF-----PD----IPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             TTSCCCC-----CC----CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccCCC-----Cc----cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            1111110     01    112357789999999999999999999864

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=346.73  Aligned_cols=267  Identities=17%  Similarity=0.194  Sum_probs=200.6

Q ss_pred             hCCCCcccccCccCceEEEEEEcC----CCcEEEEEEecccChh-----------hHHHHHHHHHHHHhcCCCCeeeEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP----NGKEVAVKRLSRKSWQ-----------GLEEFKNEIILIAKLQHRNLVRLVG  355 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~il~~l~h~niv~l~~  355 (611)
                      .++|++.+.||+|+||.||+|.+.    ++..+|+|++......           ....+.+|+.+++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367999999999999999999964    5778999998765321           1123667889999999999999999


Q ss_pred             eEee----CCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC
Q 007239          356 CGIE----GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM  431 (611)
Q Consensus       356 ~~~~----~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~  431 (611)
                      ++..    ....++||||+ +++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9988    78899999999 9999999843   337999999999999999999999996   99999999999999887


Q ss_pred             --CEEEeccccceecccCCCcc-----ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCch
Q 007239          432 --VAKISDFGMARIFCENQKTA-----NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHA  504 (611)
Q Consensus       432 --~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~  504 (611)
                        .+||+|||+++.+.......     ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... 
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-  267 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP-  267 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence              99999999998764432211     1234579999999999999999999999999999999999999985322211 


Q ss_pred             hhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCCC
Q 007239          505 QTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESI  570 (611)
Q Consensus       505 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  570 (611)
                      . ............. ...+......   .....++.+++..||+.||++||++++|++.|+....
T Consensus       268 ~-~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          268 V-AVQTAKTNLLDEL-PQSVLKWAPS---GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             H-HHHHHHHHHHHTT-THHHHHHSCT---TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             H-HHHHHHHhhcccc-cHHHHhhccc---cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            1 1111111111111 1111111110   0122357789999999999999999999999997654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.7e-41  Score=353.17  Aligned_cols=253  Identities=25%  Similarity=0.285  Sum_probs=194.0

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      .++|++.+.||+|+||.||+++.. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            468999999999999999999964 789999999976442 236688999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCC--EEEeccccceecccC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV--AKISDFGMARIFCEN  447 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~--~kl~DFGla~~~~~~  447 (611)
                      +++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~---~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERIC---NAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            99999999884   3456999999999999999999999987   999999999999987765  999999999743222


Q ss_pred             CCccccccccccCCCCCccccccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVK-SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      .   ......||+.|+|||++.+..++.+ +||||||+++|+|++|+.||.......  ...............      
T Consensus       172 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~~~~------  240 (361)
T 3uc3_A          172 S---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSVKYS------  240 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTTCCC------
T ss_pred             C---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcCCCC------
Confidence            2   2234579999999999988888665 999999999999999999985433221  122222221111110      


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                       ...  .......+.+|+.+||+.||++|||+.|+++.
T Consensus       241 -~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          241 -IPD--DIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             -CCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             -CCC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence             000  01112456789999999999999999999874

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=8.9e-41  Score=349.34  Aligned_cols=245  Identities=22%  Similarity=0.253  Sum_probs=203.4

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++.+.||+|+||.||+++.. +|+.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            468999999999999999999964 78999999987542   23457789999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++.   +...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~e~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence            99999999999984   3456999999999999999999999997   99999999999999999999999999987643


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      .     ....+||+.|+|||++.+..++.++||||||+++|||++|+.||...   ....+..    .+..+.. .    
T Consensus       194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~----~i~~~~~-~----  256 (350)
T 1rdq_E          194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYE----KIVSGKV-R----  256 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHH----HHHHCCC-C----
T ss_pred             C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC---CHHHHHH----HHHcCCC-C----
Confidence            2     23468999999999999999999999999999999999999997532   1112221    1222211 0    


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT-----MSNVVA  563 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  563 (611)
                       +..    .....+.+++.+||+.||++||+     +++|++
T Consensus       257 -~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          257 -FPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -CCT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCC----CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence             111    11245778999999999999998     788875

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.7e-41  Score=355.16  Aligned_cols=205  Identities=20%  Similarity=0.251  Sum_probs=177.5

Q ss_pred             hCCCCcccccCcc--CceEEEEEEcC-CCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          291 TDGFSDSNKLGQG--GFGTVYKGVLP-NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       291 ~~~y~~~~~lg~G--~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      .++|++.+.||+|  +||.||+++.. +++.||+|++....  ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4689999999999  99999999964 79999999997543  3445778899999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+++++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus       104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999998543 2245899999999999999999999997   9999999999999999999999999987653


Q ss_pred             cCCC-----ccccccccccCCCCCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 007239          446 ENQK-----TANTRRVVGTYGYMAPEYAME--GLFSVKSDVFSFGVIVLEIISGKRNSGFY  499 (611)
Q Consensus       446 ~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvll~elltG~~p~~~~  499 (611)
                      ....     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||...
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~  240 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM  240 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC
Confidence            2211     111223478999999999987  67999999999999999999999998543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.4e-40  Score=344.75  Aligned_cols=248  Identities=25%  Similarity=0.289  Sum_probs=193.2

Q ss_pred             hCCCCcccccCccCceEEEEEEc----CCCcEEEEEEecccC----hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL----PNGKEVAVKRLSRKS----WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  362 (611)
                      .++|++.+.||+|+||.||+++.    .+++.||+|++++..    ......+.+|+.+++.++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46899999999999999999996    478999999997642    2334567899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .++||||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLE---REGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            999999999999999884   3456899999999999999999999997   9999999999999999999999999997


Q ss_pred             ecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          443 IFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       443 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      .......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||....   .......+   ... ..  
T Consensus       170 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i---~~~-~~--  238 (327)
T 3a62_A          170 ESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN---RKKTIDKI---LKC-KL--  238 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHH---HHT-CC--
T ss_pred             ccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC---HHHHHHHH---HhC-CC--
Confidence            6432221  2234679999999999999999999999999999999999999985322   11222211   111 11  


Q ss_pred             ccccccCCCCCHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 007239          523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVA  563 (611)
Q Consensus       523 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  563 (611)
                          .+.    ......+.+++.+||+.||++||     ++.++++
T Consensus       239 ----~~p----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          239 ----NLP----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ----CCC----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ----CCC----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                011    11124567899999999999999     7778876

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.7e-41  Score=346.88  Aligned_cols=250  Identities=23%  Similarity=0.263  Sum_probs=179.3

Q ss_pred             ccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEEEEecCCCC
Q 007239          297 SNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLIYELMPNRS  374 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~E~~~~~s  374 (611)
                      .+.||+|+||.||++++ .+++.||+|++...   ....+.+|+.+++.+. ||||+++++++.+....++||||+++++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            37899999999999996 46899999999654   3456789999999998 9999999999999999999999999999


Q ss_pred             hhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC---CEEEeccccceecccCCCcc
Q 007239          375 LDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM---VAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       375 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~---~~kl~DFGla~~~~~~~~~~  451 (611)
                      |.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++   .+||+|||+++.......  
T Consensus        93 L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--  164 (325)
T 3kn6_A           93 LFERIK---KKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--  164 (325)
T ss_dssp             HHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--
Confidence            999984   3456999999999999999999999997   99999999999998765   899999999986543322  


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKS  531 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  531 (611)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..................+..+.... ....    
T Consensus       165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~-~~~~----  239 (325)
T 3kn6_A          165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF-EGEA----  239 (325)
T ss_dssp             -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC-CSHH----
T ss_pred             cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC-Cccc----
Confidence            22345789999999999999999999999999999999999999864433211111112222222222110 0000    


Q ss_pred             CCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          532 SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       532 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       ......++.+|+.+||+.||++|||++++++
T Consensus       240 -~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          240 -WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             -HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             -ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence             0011245779999999999999999999884

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.4e-40  Score=338.44  Aligned_cols=259  Identities=26%  Similarity=0.431  Sum_probs=194.2

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.++||+|+||.||++++..  .+|+|+++..  .....+.+.+|+.++++++||||++++++. .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            4689999999999999999998643  5999998754  334567899999999999999999999964 5667899999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A          100 WCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             ecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence            99999999988532  356899999999999999999999997   9999999999999999999999999998665433


Q ss_pred             CccccccccccCCCCCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAM---EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      .........||+.|+|||.+.   +..++.++||||||+++|+|++|+.||.....  ...+..    ....+.....+.
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~----~~~~~~~~~~~~  248 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIE----MVGRGSLSPDLS  248 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHHH----HHHHTSCCCCTT
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHHH----HhcccccCcchh
Confidence            333344567999999999986   66789999999999999999999999853322  112222    222222211111


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ..     ......++.+|+..||+.||++|||+.+++++|+..
T Consensus       249 ~~-----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l  286 (289)
T 3og7_A          249 KV-----RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL  286 (289)
T ss_dssp             SS-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             hc-----cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            11     111224677899999999999999999999999764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1e-40  Score=349.04  Aligned_cols=249  Identities=23%  Similarity=0.268  Sum_probs=202.2

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~  364 (611)
                      ..++|++.+.||+|+||.||+++.. +++.||+|++++..   ....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            4578999999999999999999965 57889999997542   23456788999999988 7999999999999999999


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +||||+++|+|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++..
T Consensus        98 lv~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            9999999999999984   3456999999999999999999999997   999999999999999999999999999854


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ....  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...   ....+...+    ..... .  
T Consensus       172 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i----~~~~~-~--  239 (353)
T 2i0e_A          172 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSI----MEHNV-A--  239 (353)
T ss_dssp             CCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH----HHCCC-C--
T ss_pred             ccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC---CHHHHHHHH----HhCCC-C--
Confidence            3222  2234568999999999999999999999999999999999999997532   222222211    11111 0  


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT-----MSNVVA  563 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  563 (611)
                         .    +.....++.+|+.+||+.||++||+     ++++++
T Consensus       240 ---~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          240 ---Y----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             ---C----CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             ---C----CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence               1    1112245778999999999999995     466664

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.9e-41  Score=370.96  Aligned_cols=256  Identities=26%  Similarity=0.400  Sum_probs=209.5

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      .++|++.+.||+|+||.||+|++. +++.||||+++... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            467899999999999999999975 48899999997654 3467899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       298 ~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          298 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             cCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            9999999998542 2345899999999999999999999996   99999999999999999999999999987643322


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                      . ......+++.|+|||++..+.++.++||||||+++|||++ |+.|+.....   ..+...    ...+....      
T Consensus       374 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~---~~~~~~----~~~~~~~~------  439 (495)
T 1opk_A          374 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYEL----LEKDYRME------  439 (495)
T ss_dssp             E-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHH----HHTTCCCC------
T ss_pred             e-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHH----HHcCCCCC------
Confidence            1 2223456788999999999999999999999999999999 8888754322   122221    22221111      


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                         .+.....++.+|+.+||+.||++|||+.+|+++|+..
T Consensus       440 ---~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          440 ---RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ---CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence               1111224577899999999999999999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.6e-40  Score=347.04  Aligned_cols=246  Identities=26%  Similarity=0.306  Sum_probs=196.2

Q ss_pred             ccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCCCCh
Q 007239          297 SNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSL  375 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~~sL  375 (611)
                      .+.||+|+||.||++.. .+|+.||+|++........+.+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            57899999999999995 57899999999887766778899999999999999999999999999999999999999999


Q ss_pred             hhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe--cCCCCEEEeccccceecccCCCcccc
Q 007239          376 DCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL--DKDMVAKISDFGMARIFCENQKTANT  453 (611)
Q Consensus       376 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll--~~~~~~kl~DFGla~~~~~~~~~~~~  453 (611)
                      .+++..  ....+++..++.++.||++||.|||+++   |+||||||+|||+  +.++.+||+|||+++.+.....   .
T Consensus       174 ~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~  245 (373)
T 2x4f_A          174 FDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---L  245 (373)
T ss_dssp             HHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---C
T ss_pred             HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---c
Confidence            888853  2346899999999999999999999997   9999999999999  5678999999999987644332   2


Q ss_pred             ccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCC
Q 007239          454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSS  533 (611)
Q Consensus       454 ~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~  533 (611)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.||....   .......+   .... . .+..... .   
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i---~~~~-~-~~~~~~~-~---  313 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN---DAETLNNI---LACR-W-DLEDEEF-Q---  313 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHH---HHTC-C-CSCSGGG-T---
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH---Hhcc-C-CCChhhh-c---
Confidence            23579999999999999999999999999999999999999974322   11111111   1111 1 0001100 1   


Q ss_pred             HHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          534 IPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       534 ~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       ....++.+|+.+||+.||++|||+.|+++
T Consensus       314 -~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          314 -DISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             -TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             11245779999999999999999999997

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.1e-41  Score=352.64  Aligned_cols=256  Identities=27%  Similarity=0.398  Sum_probs=201.3

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCc----EEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGK----EVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  364 (611)
                      .++|++.+.||+|+||.||+|++. +++    +|++|.+.... ......+.+|+.+++.++||||+++++++. .+..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            367999999999999999999953 444    37888775432 233456788999999999999999999886 56789


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +||||+++++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++..
T Consensus        91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence            999999999999988543  356899999999999999999999997   999999999999999999999999999987


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      .............||+.|+|||.+.++.++.++||||||+++|+|++ |+.||......   .+..    ....+.....
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~----~~~~~~~~~~  238 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---EVPD----LLEKGERLAQ  238 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---HHHH----HHHTTCBCCC
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---HHHH----HHHcCCCCCC
Confidence            55544444445678889999999999999999999999999999999 99998543322   1111    1222211111


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      .. .        ....+.+++.+||+.||++||++.++++.|+..
T Consensus       239 ~~-~--------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~  274 (325)
T 3kex_A          239 PQ-I--------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRM  274 (325)
T ss_dssp             CT-T--------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred             CC-c--------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            00 0        112356888899999999999999999999653

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-40  Score=344.89  Aligned_cols=261  Identities=21%  Similarity=0.241  Sum_probs=202.1

Q ss_pred             HHHhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc-----ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC
Q 007239          287 IKAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK-----SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG  360 (611)
Q Consensus       287 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~  360 (611)
                      +....++|++.+.||+|+||.||+++. .+++.||+|++...     .....+.+.+|+.++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            345678899999999999999999996 56889999998654     234567899999999999999999999999999


Q ss_pred             CeEEEEEEecCCCChhhHhhhch-------------------------------------hhccCCHHHHHHHHHHHHHH
Q 007239          361 EEKLLIYELMPNRSLDCFIFDSE-------------------------------------RRLQLNWNTCYNIIGGISKG  403 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qi~~~  403 (611)
                      +..++||||+++++|.+++....                                     ....+++..++.++.||+.|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            99999999999999999884210                                     02234677889999999999


Q ss_pred             HHHHhhcCCCceEecCCCCCcEEecCCC--CEEEeccccceecccCCCcc--ccccccccCCCCCcccccc--CCCCchh
Q 007239          404 LLYLHEDSRLKIIHRDLKPSNVLLDKDM--VAKISDFGMARIFCENQKTA--NTRRVVGTYGYMAPEYAME--GLFSVKS  477 (611)
Q Consensus       404 l~yLH~~~~~~iiHrDikp~NIll~~~~--~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~k~  477 (611)
                      |.|||+++   |+||||||+|||++.++  .+||+|||+++.+.......  ......||+.|+|||++.+  ..++.++
T Consensus       181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999997   99999999999998776  89999999998764322211  2334679999999999875  6789999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCC
Q 007239          478 DVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT  557 (611)
Q Consensus       478 DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt  557 (611)
                      ||||||+++|||++|+.||.....   .   ..............  .+..     ......+.+|+..||+.||++||+
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~---~---~~~~~~~~~~~~~~--~~~~-----~~~~~~~~~li~~~l~~~p~~Rps  324 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVND---A---DTISQVLNKKLCFE--NPNY-----NVLSPLARDLLSNLLNRNVDERFD  324 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSH---H---HHHHHHHHCCCCTT--SGGG-----GGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCCh---H---HHHHHHHhcccccC--Cccc-----ccCCHHHHHHHHHHcCCChhHCCC
Confidence            999999999999999999743321   1   11222222221111  0100     011245778999999999999999


Q ss_pred             HHHHHH
Q 007239          558 MSNVVA  563 (611)
Q Consensus       558 ~~evl~  563 (611)
                      +.++++
T Consensus       325 ~~~~l~  330 (345)
T 3hko_A          325 AMRALQ  330 (345)
T ss_dssp             HHHHHH
T ss_pred             HHHHhc
Confidence            999987

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1e-40  Score=361.90  Aligned_cols=251  Identities=26%  Similarity=0.383  Sum_probs=206.0

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|.+.+.||+|+||.||+|++. +|+.||+|++.....   ...+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            468999999999999999999964 799999999975422   2356789999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++....
T Consensus        95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            99999999999984   3456999999999999999999999986   99999999999999999999999999987644


Q ss_pred             CCCccccccccccCCCCCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLF-SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ..   .....+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....   ...+..    .+..+...    
T Consensus       169 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~----~i~~~~~~----  234 (476)
T 2y94_A          169 GE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH---VPTLFK----KICDGIFY----  234 (476)
T ss_dssp             TC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS---SHHHHH----HHHTTCCC----
T ss_pred             cc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC---HHHHHH----HHhcCCcC----
Confidence            32   2234689999999999988775 789999999999999999999985322   112221    12222110    


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH--HhcC
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA--LLGS  567 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~  567 (611)
                        ...    ....++.+|+.+||+.||++|||++|+++  .+..
T Consensus       235 --~p~----~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          235 --TPQ----YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             --CCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             --CCc----cCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence              001    11235678999999999999999999997  4543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=4.1e-41  Score=346.26  Aligned_cols=245  Identities=25%  Similarity=0.287  Sum_probs=191.9

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC--hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++.++||+|+||+||+|++. +++.||||++....  ......+..|+..+.++ +||||+++++++.+.+..++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            367999999999999999999965 79999999986532  23344555666666555 899999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+ +++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus       136 ~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 66888877432  346999999999999999999999986   99999999999999999999999999987643


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ...   .....||+.|+|||++.+ .++.++||||||+++|||++|..++...          ..+..+..+.....+. 
T Consensus       210 ~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~~~~~~-  274 (311)
T 3p1a_A          210 AGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYLPPEFT-  274 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCCCHHHH-
T ss_pred             CCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCCCcccc-
Confidence            322   234579999999998875 7899999999999999999997664211          0112222221111000 


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                         .    ....++.+++.+||+.||++|||++|+++
T Consensus       275 ---~----~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          275 ---A----GLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ---T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---c----CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence               1    11245778999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.1e-40  Score=350.77  Aligned_cols=266  Identities=18%  Similarity=0.207  Sum_probs=203.5

Q ss_pred             hCCCCcccccCccCceEEEEEEcCC------CcEEEEEEecccChhhH-----------HHHHHHHHHHHhcCCCCeeeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPN------GKEVAVKRLSRKSWQGL-----------EEFKNEIILIAKLQHRNLVRL  353 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~il~~l~h~niv~l  353 (611)
                      .++|++.+.||+|+||.||+|.+..      ++.||+|++........           ..+.+|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4689999999999999999999654      47899999876542211           123456667778889999999


Q ss_pred             EEeEeeC----CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec-
Q 007239          354 VGCGIEG----EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD-  428 (611)
Q Consensus       354 ~~~~~~~----~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~-  428 (611)
                      ++++...    ...++||||+ +++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence            9998765    4589999999 9999999854  2356999999999999999999999997   99999999999999 


Q ss_pred             -CCCCEEEeccccceecccCCCcc-----ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 007239          429 -KDMVAKISDFGMARIFCENQKTA-----NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG  502 (611)
Q Consensus       429 -~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~  502 (611)
                       .++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             88999999999998765432221     113456999999999999999999999999999999999999998643222


Q ss_pred             chhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          503 HAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       503 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                        ............ ....++++..+.....   ..++.+++..||+.||++||++++|+++|+..
T Consensus       268 --~~~~~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          268 --PKYVRDSKIRYR-ENIASLMDKCFPAANA---PGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             --HHHHHHHHHHHH-HCHHHHHHHHSCTTCC---CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             --HHHHHHHHHHhh-hhHHHHHHHhcccccC---HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence              122222222121 1233333333321111   23567888899999999999999999999643

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=348.06  Aligned_cols=251  Identities=25%  Similarity=0.318  Sum_probs=188.6

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ..++|++.+.||+|+||.||++++. +++.||+|++....  ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4578999999999999999999965 68899999997653  34568899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC---CCCEEEeccccceecc
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK---DMVAKISDFGMARIFC  445 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFGla~~~~  445 (611)
                      |+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||+++...
T Consensus       129 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIV---EKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHT---TCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            999999999884   3456899999999999999999999997   999999999999975   8899999999998654


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ...   ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....  ...+.    ..+..... ....
T Consensus       203 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~----~~i~~~~~-~~~~  272 (349)
T 2w4o_A          203 HQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG--DQFMF----RRILNCEY-YFIS  272 (349)
T ss_dssp             -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC--HHHHH----HHHHTTCC-CCCT
T ss_pred             ccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc--cHHHH----HHHHhCCC-ccCC
Confidence            322   22346799999999999999999999999999999999999999743221  11111    11222111 1111


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      +.     .......+.+|+.+||+.||++|||+.++++
T Consensus       273 ~~-----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          273 PW-----WDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ch-----hhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11     1112245779999999999999999999987

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.6e-41  Score=348.99  Aligned_cols=260  Identities=28%  Similarity=0.466  Sum_probs=210.0

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  362 (611)
                      ..++|++.+.||+|+||.||+|++.      +++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  102 (322)
T 1p4o_A           23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP  102 (322)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred             hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence            4578999999999999999999853      36789999997543 3445678999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchhh-------ccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEE
Q 007239          363 KLLIYELMPNRSLDCFIFDSERR-------LQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKI  435 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~-------~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl  435 (611)
                      .++||||+++++|.+++......       ..+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||
T Consensus       103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl  179 (322)
T 1p4o_A          103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI  179 (322)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred             cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEE
Confidence            99999999999999998653221       45789999999999999999999997   999999999999999999999


Q ss_pred             eccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHH
Q 007239          436 SDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQL  514 (611)
Q Consensus       436 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~  514 (611)
                      +|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |+.|+....   ...+.    ..
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~----~~  252 (322)
T 1p4o_A          180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---NEQVL----RF  252 (322)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---HHHHH----HH
T ss_pred             CcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC---HHHHH----HH
Confidence            99999987654433333334567899999999999999999999999999999999 788864321   11111    12


Q ss_pred             HhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       515 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ...+.....         .......+.+++.+||+.||++|||+.|+++.|+..
T Consensus       253 ~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~  297 (322)
T 1p4o_A          253 VMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  297 (322)
T ss_dssp             HHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence            222221111         111224577899999999999999999999999864

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.3e-41  Score=357.72  Aligned_cols=257  Identities=20%  Similarity=0.214  Sum_probs=204.1

Q ss_pred             HHHhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe
Q 007239          287 IKAATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       287 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  362 (611)
                      ++...++|++.+.||+|+||+||+++.. +++.||+|++.+...   ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            3345678999999999999999999964 688999999865321   123457899999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .++||||+++|+|.+++..    ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++
T Consensus       144 ~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence            9999999999999998842    35899999999999999999999997   9999999999999999999999999998


Q ss_pred             ecccCCCccccccccccCCCCCccccccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC
Q 007239          443 IFCENQKTANTRRVVGTYGYMAPEYAMEGL----FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG  518 (611)
Q Consensus       443 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  518 (611)
                      ....... ......+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...   ........+.......
T Consensus       217 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~  292 (410)
T 3v8s_A          217 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD---SLVGTYSKIMNHKNSL  292 (410)
T ss_dssp             ECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTHHHHC
T ss_pred             eeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC---ChhhHHHHHHhccccc
Confidence            7643321 1233568999999999998765    789999999999999999999998532   2222222221110000


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHhhccccCCCCC--CCCHHHHHHH
Q 007239          519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAV--RPTMSNVVAL  564 (611)
Q Consensus       519 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~--RPt~~evl~~  564 (611)
                         .+.+       ......++.+|+.+||+.+|++  ||+++||++.
T Consensus       293 ---~~p~-------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          293 ---TFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             ---CCCT-------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             ---cCCC-------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence               0000       0011235678899999999999  9999999975

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7e-41  Score=344.82  Aligned_cols=261  Identities=23%  Similarity=0.298  Sum_probs=199.2

Q ss_pred             hCCCCcc-cccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEEE
Q 007239          291 TDGFSDS-NKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       291 ~~~y~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      .+.|++. +.||+|+||.||++.. .+++.||+|++........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3578885 7899999999999995 47899999999876656678899999999985 6999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCC---EEEeccccceec
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV---AKISDFGMARIF  444 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~---~kl~DFGla~~~  444 (611)
                      ||+++++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.   +||+|||++...
T Consensus        91 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           91 EKMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            99999999999843   456899999999999999999999996   999999999999998776   999999999865


Q ss_pred             ccCCC-----ccccccccccCCCCCcccccc-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchh--------h
Q 007239          445 CENQK-----TANTRRVVGTYGYMAPEYAME-----GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQ--------T  506 (611)
Q Consensus       445 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~--------~  506 (611)
                      .....     ........||+.|+|||++..     ..++.++||||||+++|||++|+.||......+..        .
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            32211     111223569999999999875     56889999999999999999999998654322100        0


Q ss_pred             HHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          507 LLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       507 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ........+..+... +..... .    .....+.+|+.+||+.||++|||+.|+++
T Consensus       245 ~~~~~~~~i~~~~~~-~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          245 CQNMLFESIQEGKYE-FPDKDW-A----HISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHHCCCC-CCHHHH-T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHhccCcc-cCchhc-c----cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            011122222222110 000000 0    01235779999999999999999999997

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.9e-41  Score=337.04  Aligned_cols=251  Identities=22%  Similarity=0.303  Sum_probs=204.0

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ..++|++.+.||+|+||.||+++.. ++..+|+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            4568999999999999999999964 578899999987666667889999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe---cCCCCEEEeccccceecc
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFC  445 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGla~~~~  445 (611)
                      |+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+||++   +.++.+||+|||++..+.
T Consensus        87 ~~~~~~L~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           87 LCTGGELFERVV---HKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ccCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            999999998884   3456899999999999999999999997   9999999999999   788999999999998764


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ....   .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||.....   .....    .+..+.... ..
T Consensus       161 ~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~----~~~~~~~~~-~~  228 (277)
T 3f3z_A          161 PGKM---MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTD---SEVML----KIREGTFTF-PE  228 (277)
T ss_dssp             TTSC---BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH----HHHHCCCCC-CH
T ss_pred             Cccc---hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCH---HHHHH----HHHhCCCCC-Cc
Confidence            4332   234579999999998865 489999999999999999999999753221   11111    111211100 00


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ... .    .....+.+++..||+.||++|||+.++++
T Consensus       229 ~~~-~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          229 KDW-L----NVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHH-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hhh-h----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000 0    11245778999999999999999999985

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4.7e-41  Score=348.85  Aligned_cols=260  Identities=28%  Similarity=0.414  Sum_probs=209.0

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CC-----cEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCC
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NG-----KEVAVKRLSRKS-WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGE  361 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~-----~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~  361 (611)
                      ..++|++.+.||+|+||.||++.+. .+     +.||+|.+.... ....+.+.+|+.+++.+ +||||+++++++...+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            4578999999999999999999953 22     479999997653 34567799999999999 8999999999999999


Q ss_pred             eEEEEEEecCCCChhhHhhhchh-----------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC
Q 007239          362 EKLLIYELMPNRSLDCFIFDSER-----------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD  430 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~-----------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~  430 (611)
                      ..++||||+++++|.+++.....           ...+++..++.++.||+.||.|||+++   |+||||||+|||++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence            99999999999999999865332           245799999999999999999999997   9999999999999999


Q ss_pred             CCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHH
Q 007239          431 MVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLA  509 (611)
Q Consensus       431 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~  509 (611)
                      +.+||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||++ |..||.......  ... 
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~-  277 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS--KFY-  277 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH--HHH-
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH--HHH-
Confidence            9999999999987654443333334567889999999999999999999999999999998 888875332211  111 


Q ss_pred             HHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          510 YVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       510 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                         .....+....     .    +......+.+++..||+.||++|||+.+|++.|+.
T Consensus       278 ---~~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  323 (333)
T 2i1m_A          278 ---KLVKDGYQMA-----Q----PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE  323 (333)
T ss_dssp             ---HHHHHTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---HHHhcCCCCC-----C----CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence               1122221110     0    01112457789999999999999999999999964

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.9e-41  Score=349.85  Aligned_cols=259  Identities=27%  Similarity=0.395  Sum_probs=207.9

Q ss_pred             hCCCCcccccCccCceEEEEEEc--------CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeC
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL--------PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEG  360 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~  360 (611)
                      .++|++.+.||+|+||.||++.+        .+++.||+|++.... ......+.+|+.+++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            47899999999999999999985        246789999997653 34567889999999999 899999999999999


Q ss_pred             CeEEEEEEecCCCChhhHhhhchh-------------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe
Q 007239          361 EEKLLIYELMPNRSLDCFIFDSER-------------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL  427 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll  427 (611)
                      +..++||||+++++|.+++.....             ...+++..++.++.||+.||.|||+++   |+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence            999999999999999999864321             234899999999999999999999997   9999999999999


Q ss_pred             cCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhh
Q 007239          428 DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQT  506 (611)
Q Consensus       428 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~  506 (611)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|||++ |+.||....   ...
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~  267 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP---VEE  267 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC---HHH
Confidence            9999999999999987654433333334567889999999999999999999999999999999 998874322   112


Q ss_pred             HHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          507 LLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       507 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      +..    ....+....     .    .......+.+++.+||+.||++|||+.++++.|++.
T Consensus       268 ~~~----~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          268 LFK----LLKEGHRMD-----K----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             HHH----HHHHTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH----HHhcCCCCC-----C----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            221    122221111     1    111224577899999999999999999999999753

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.7e-40  Score=337.24  Aligned_cols=262  Identities=22%  Similarity=0.281  Sum_probs=197.9

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      .++|++.+.||+|+||.||++.+. +|+.||+|++.....  ...+.+.+|+.++++++||||+++++++...+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            468999999999999999999964 689999999865432  23567889999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++......
T Consensus        82 e~~~~~~l~~~~~---~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           82 EYCDHTVLHELDR---YQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             ECCSEEHHHHHHH---TSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EeCCCchHHHHHh---hhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            9999999988873   3456899999999999999999999997   999999999999999999999999999876433


Q ss_pred             CCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH-----------H
Q 007239          448 QKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL-----------W  515 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~-----------~  515 (611)
                      ..  ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.......   ....+...           +
T Consensus       156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  230 (311)
T 4agu_A          156 SD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD---QLYLIRKTLGDLIPRHQQVF  230 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHHHH
T ss_pred             cc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhccccccccccc
Confidence            22  1234578999999999876 678999999999999999999999985433222   11111111           1


Q ss_pred             hcCccccccc-cccCCCCC-----HHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          516 KEGKEMEFVD-PLLMKSSS-----IPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       516 ~~~~~~~~~d-~~l~~~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .......... +.......     ......+.+|+..||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            1111000000 00000000     011234778999999999999999999986

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=9.4e-41  Score=361.25  Aligned_cols=249  Identities=29%  Similarity=0.394  Sum_probs=202.7

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC-eEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE-EKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~-~~~lv~E~  369 (611)
                      .++|++.+.||+|+||.||+|.+. ++.||||+++...  ..+.+.+|+.++++++||||+++++++...+ ..++||||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            467899999999999999999984 7899999997654  4567999999999999999999999987665 78999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++... ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus       269 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  343 (450)
T 1k9a_A          269 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  343 (450)
T ss_dssp             CTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-
Confidence            9999999998542 2234799999999999999999999996   9999999999999999999999999998543221 


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                          ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......   .+...    ...+....      
T Consensus       344 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~---~~~~~----i~~~~~~~------  406 (450)
T 1k9a_A          344 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPR----VEKGYKMD------  406 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT---THHHH----HHTTCCCC------
T ss_pred             ----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHcCCCCC------
Confidence                12367889999999999999999999999999999998 99998543322   12221    22221111      


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                         .+......+.+|+..||+.||++|||+.++++.|+.
T Consensus       407 ---~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~  442 (450)
T 1k9a_A          407 ---APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH  442 (450)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence               111122457789999999999999999999999964

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.6e-40  Score=337.51  Aligned_cols=250  Identities=24%  Similarity=0.374  Sum_probs=202.3

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CC-------cEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NG-------KEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  362 (611)
                      .++|++.+.||+|+||.||++++. ++       +.||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            467999999999999999999954 33       5799999987766777889999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCC--------EE
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV--------AK  434 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~--------~k  434 (611)
                      .++||||+++++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999998542  334899999999999999999999997   999999999999998887        99


Q ss_pred             EeccccceecccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHH
Q 007239          435 ISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ  513 (611)
Q Consensus       435 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~  513 (611)
                      |+|||++.....      .....||+.|+|||++.+ ..++.++||||||+++|||++|..|+....  ......    .
T Consensus       162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~--~~~~~~----~  229 (289)
T 4fvq_A          162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL--DSQRKL----Q  229 (289)
T ss_dssp             ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTS--CHHHHH----H
T ss_pred             eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcccc--chHHHH----H
Confidence            999999865422      123568999999999987 779999999999999999999665532111  111111    1


Q ss_pred             HHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       514 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      .......  . ....        ..++.+++..||+.||++|||++++++.|++.
T Consensus       230 ~~~~~~~--~-~~~~--------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l  273 (289)
T 4fvq_A          230 FYEDRHQ--L-PAPK--------AAELANLINNCMDYEPDHRPSFRAIIRDLNSL  273 (289)
T ss_dssp             HHHTTCC--C-CCCS--------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTC
T ss_pred             HhhccCC--C-CCCC--------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            1111110  0 0000        12366888999999999999999999999865

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=343.54  Aligned_cols=262  Identities=22%  Similarity=0.263  Sum_probs=204.7

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee----CCeEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE----GEEKLL  365 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~l  365 (611)
                      .++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|+.+++.++||||+++++++..    ....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            36799999999999999999996 5789999999977766777889999999999999999999999873    347899


Q ss_pred             EEEecCCCChhhHhhhch-hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          366 IYELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      ||||+++++|.+++.... ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            999999999999885422 3456899999999999999999999996   999999999999999999999999998765


Q ss_pred             ccCCCcc-------ccccccccCCCCCccccccCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH
Q 007239          445 CENQKTA-------NTRRVVGTYGYMAPEYAMEGL---FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL  514 (611)
Q Consensus       445 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~  514 (611)
                      .......       ......||+.|+|||.+....   ++.++||||||+++|+|++|+.||........ .+..    .
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~----~  259 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL----A  259 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH----H
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH----H
Confidence            3221110       112346799999999987654   68899999999999999999999742111110 1111    1


Q ss_pred             HhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCC
Q 007239          515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES  569 (611)
Q Consensus       515 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  569 (611)
                      ......         ..........+.+++.+||+.||++|||+.++++.|+...
T Consensus       260 ~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          260 VQNQLS---------IPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HHCC-----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             hhccCC---------CCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            111100         0001112245778999999999999999999999998654

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.7e-41  Score=350.55  Aligned_cols=258  Identities=24%  Similarity=0.254  Sum_probs=190.0

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEe--------eC
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGI--------EG  360 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~--------~~  360 (611)
                      ..+|++.+.||+|+||.||++++ .+++.||+|++..........+.+|+.+++++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            35799999999999999999995 478999999997777677788999999999996 999999999984        34


Q ss_pred             CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccc
Q 007239          361 EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGM  440 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  440 (611)
                      ...++||||++ |+|.+++........+++..++.++.||+.||.|||+++ .+|+||||||+|||++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCcc
Confidence            45899999996 688888865555667999999999999999999999873 2499999999999999999999999999


Q ss_pred             ceecccCCCcc----------ccccccccCCCCCcccc---ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhH
Q 007239          441 ARIFCENQKTA----------NTRRVVGTYGYMAPEYA---MEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTL  507 (611)
Q Consensus       441 a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l  507 (611)
                      ++.........          ......||+.|+|||++   .+..++.++||||||+++|+|++|+.||......     
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----  259 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-----  259 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-----
Confidence            98764432211          11135699999999998   5677899999999999999999999997422110     


Q ss_pred             HHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCC
Q 007239          508 LAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES  569 (611)
Q Consensus       508 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  569 (611)
                       ...    ..         .............+.+|+..||+.||++|||+.|+++.|....
T Consensus       260 -~~~----~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~  307 (337)
T 3ll6_A          260 -RIV----NG---------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA  307 (337)
T ss_dssp             --------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -Hhh----cC---------cccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence             000    00         0000000111123668889999999999999999999997653

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2e-40  Score=334.31  Aligned_cols=253  Identities=28%  Similarity=0.391  Sum_probs=205.5

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467999999999999999999964 78999999987543 3446788999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++++|.+++.   ....+++..++.++.||+.||.|||+++   ++||||||+||+++.++.+||+|||++..+....
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            999999999883   3456899999999999999999999997   9999999999999999999999999998765443


Q ss_pred             CccccccccccCCCCCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLF-SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                      .........||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||......... .     ..+......  ... 
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~-----~~~~~~~~~--~~~-  230 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-Y-----SDWKEKKTY--LNP-  230 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-H-----HHHHTTCTT--STT-
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-H-----HHhhhcccc--cCc-
Confidence            3333345679999999999987765 78999999999999999999998644332211 1     111211110  000 


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                           .......+.+++..||+.||++|||++|+++
T Consensus       231 -----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          231 -----WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                 0111235678999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.3e-40  Score=347.07  Aligned_cols=252  Identities=23%  Similarity=0.297  Sum_probs=201.0

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ..++|++.+.||+|+||.||+++.. +++.||+|++.+....    ..+|++++.++ +||||+++++++.+.+..++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3567999999999999999999964 6889999999765432    35788888888 6999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC----CCEEEecccccee
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD----MVAKISDFGMARI  443 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~----~~~kl~DFGla~~  443 (611)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||+..+    +.+||+|||+++.
T Consensus        96 E~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            99999999998843   456899999999999999999999997   9999999999998433    3599999999987


Q ss_pred             cccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          444 FCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       444 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      ......  .....+||+.|+|||++.+..++.++||||||+++|||++|+.||..........+...    +..+.... 
T Consensus       170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~----i~~~~~~~-  242 (342)
T 2qr7_A          170 LRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR----IGSGKFSL-  242 (342)
T ss_dssp             CBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH----HHHCCCCC-
T ss_pred             CcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH----HccCCccc-
Confidence            644322  22346899999999999888899999999999999999999999865433333333222    22222110 


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                           ...........+.+|+.+||+.||++|||+.++++
T Consensus       243 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          243 -----SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             -----CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 00011112245678999999999999999999986

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.2e-40  Score=335.07  Aligned_cols=254  Identities=28%  Similarity=0.495  Sum_probs=200.7

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhh-------HHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQG-------LEEFKNEIILIAKLQHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  362 (611)
                      .++|++.+.||+|+||.||++++ .+++.||+|++.......       .+.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            46899999999999999999996 578999999986543221       267899999999999999999999986655 


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCC-----EEEec
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV-----AKISD  437 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~-----~kl~D  437 (611)
                       ++||||+++++|.+++..  ....+++..++.++.||+.||.|||+++ .+|+||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             799999999999888754  3346899999999999999999999873 23999999999999988776     99999


Q ss_pred             cccceecccCCCccccccccccCCCCCccccc--cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHH
Q 007239          438 FGMARIFCENQKTANTRRVVGTYGYMAPEYAM--EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLW  515 (611)
Q Consensus       438 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~  515 (611)
                      ||+++....     ......||+.|+|||.+.  ...++.++||||||+++|||++|+.||.........    ......
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~  243 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK----FINMIR  243 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----HHHHHH
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----HHHHHh
Confidence            999975422     223467999999999984  456789999999999999999999998644332211    111111


Q ss_pred             hcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          516 KEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       516 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ..+...     .+.    ......+.+++..||+.||++|||++++++.|++
T Consensus       244 ~~~~~~-----~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          244 EEGLRP-----TIP----EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HSCCCC-----CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             ccCCCC-----CCC----cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            111111     111    1122457789999999999999999999999975

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.6e-41  Score=345.26  Aligned_cols=268  Identities=26%  Similarity=0.381  Sum_probs=212.0

Q ss_pred             cCHHHHHHhhCCCCcccccCccCceEEEEEEc------CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeE
Q 007239          282 VHLAVIKAATDGFSDSNKLGQGGFGTVYKGVL------PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKL-QHRNLVRL  353 (611)
Q Consensus       282 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l  353 (611)
                      ..........++|++.+.||+|+||.||++.+      .+++.||+|++.... ......+.+|+.+++++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            33444445568999999999999999999983      356889999997653 33456789999999999 69999999


Q ss_pred             EEeEeeCC-eEEEEEEecCCCChhhHhhhchh-------------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecC
Q 007239          354 VGCGIEGE-EKLLIYELMPNRSLDCFIFDSER-------------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRD  419 (611)
Q Consensus       354 ~~~~~~~~-~~~lv~E~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrD  419 (611)
                      ++++...+ ..++||||+++++|.+++.....             ...+++..++.++.||+.||.|||+++   |+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence            99987654 58999999999999999865332             123789999999999999999999997   99999


Q ss_pred             CCCCcEEecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCC
Q 007239          420 LKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGF  498 (611)
Q Consensus       420 ikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~  498 (611)
                      |||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |+.||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987654433333345678899999999999999999999999999999998 9988754


Q ss_pred             CCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          499 YLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       499 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ....  ..+    ......+.....     .    .....++.+++.+||+.||++|||+.+|++.|+.
T Consensus       254 ~~~~--~~~----~~~~~~~~~~~~-----~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  307 (316)
T 2xir_A          254 VKID--EEF----CRRLKEGTRMRA-----P----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  307 (316)
T ss_dssp             CCCS--HHH----HHHHHHTCCCCC-----C----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cchh--HHH----HHHhccCccCCC-----C----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            3221  111    112222221111     1    1112357789999999999999999999999964

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.3e-41  Score=340.88  Aligned_cols=255  Identities=30%  Similarity=0.453  Sum_probs=206.4

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      .++|++.+.||+|+||.||++...+++.||+|++.... ...+.+.+|+++++.++||||+++++++. .+..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence            36799999999999999999998888899999997654 34578999999999999999999999876 45689999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++.........
T Consensus        90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence            999999998542 2336899999999999999999999997   999999999999999999999999999876443221


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                       ......+++.|+|||.+.++.++.++||||||+++|||++ |+.||....   ...+..    ....+....     . 
T Consensus       166 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~---~~~~~~----~~~~~~~~~-----~-  231 (279)
T 1qpc_A          166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT---NPEVIQ----NLERGYRMV-----R-  231 (279)
T ss_dssp             -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHHH----HHHTTCCCC-----C-
T ss_pred             -cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC---HHHHHH----HHhcccCCC-----C-
Confidence             2223467889999999998999999999999999999999 888874322   111211    122221110     1 


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                         ......++.+++..||+.||++|||++++++.|+..
T Consensus       232 ---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          232 ---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence               111224577899999999999999999999999754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.3e-41  Score=347.19  Aligned_cols=259  Identities=28%  Similarity=0.396  Sum_probs=203.9

Q ss_pred             CCcccccCccCceEEEEEEc-----CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC--CeEEE
Q 007239          294 FSDSNKLGQGGFGTVYKGVL-----PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG--EEKLL  365 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~l  365 (611)
                      |++.+.||+|+||.||++.+     .+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            49999999999999998864     267889999997653 34467799999999999999999999999874  67899


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+++++|.+++..    ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus       113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            9999999999999843    34899999999999999999999997   9999999999999999999999999998775


Q ss_pred             cCCCc-cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC--------chhhHHHHHHHHHh
Q 007239          446 ENQKT-ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG--------HAQTLLAYVWQLWK  516 (611)
Q Consensus       446 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~--------~~~~l~~~~~~~~~  516 (611)
                      ..... .......||+.|+|||.+.+..++.++||||||+++|+|++|+.|+......        ..............
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            43321 1223456888899999999999999999999999999999999987432111        00000111112222


Q ss_pred             cCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          517 EGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       517 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      .+..         ..........+.+|+.+||+.||++|||++++++.|+..
T Consensus       266 ~~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          266 RGER---------LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccC---------CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            2211         111122234678999999999999999999999999754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.1e-41  Score=340.13  Aligned_cols=254  Identities=24%  Similarity=0.360  Sum_probs=193.3

Q ss_pred             hCCCCcccccCccCceEEEEEEcC----CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP----NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|++... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            468999999999999999999963    2457999998754 3344677999999999999999999999974 567899


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        93 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           93 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence            9999999999999853  2346899999999999999999999997   9999999999999999999999999998764


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ..... ......+|+.|+|||.+....++.++||||||+++|||++ |..||.....   ..+...+    ..+....  
T Consensus       168 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~---~~~~~~i----~~~~~~~--  237 (281)
T 1mp8_A          168 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRI----ENGERLP--  237 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHH----HTTCCCC--
T ss_pred             ccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH---HHHHHHH----HcCCCCC--
Confidence            43221 1223457889999999999999999999999999999996 8888754322   1222211    1211111  


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                         +    .......+.+++.+||+.||++|||+.++++.|+.
T Consensus       238 ---~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  273 (281)
T 1mp8_A          238 ---M----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  273 (281)
T ss_dssp             ---C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---C----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence               1    11122457789999999999999999999999964

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.4e-41  Score=338.23  Aligned_cols=253  Identities=28%  Similarity=0.403  Sum_probs=206.7

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      ++|++.+.||+|+||.||++.+.+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   86 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME   86 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence            57899999999999999999988888999999986543 34678999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +++|.+++..  ....+++..++.++.||+.||.|||+++   ++||||||+||+++.++.+||+|||++........ .
T Consensus        87 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~  160 (267)
T 3t9t_A           87 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-T  160 (267)
T ss_dssp             TCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-H
T ss_pred             CCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccc-c
Confidence            9999999853  2346899999999999999999999997   99999999999999999999999999986533221 1


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                      ......|++.|+|||.+.+..++.++||||||+++|+|++ |+.||....   .....    ..+..+....     .  
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~----~~i~~~~~~~-----~--  226 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVV----EDISTGFRLY-----K--  226 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHH----HHHHTTCCCC-----C--
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC---HHHHH----HHHhcCCcCC-----C--
Confidence            1223467889999999999999999999999999999999 888874321   11111    1122221100     0  


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                        +......+.+++.+||+.||++||+++++++.|+.
T Consensus       227 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  261 (267)
T 3t9t_A          227 --PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE  261 (267)
T ss_dssp             --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence              11112456789999999999999999999999974

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.5e-39  Score=329.53  Aligned_cols=251  Identities=26%  Similarity=0.348  Sum_probs=203.2

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      .++|++.+.||+|+||.||++.+ .+++.||+|++...  .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            57899999999999999999995 46899999998654  3344577899999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCC---EEEeccccceec
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV---AKISDFGMARIF  444 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~---~kl~DFGla~~~  444 (611)
                      ||+++++|.+.+.   ....+++..++.++.||+.||.|||+++   |+||||||+||+++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIV---AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            9999999988874   3456899999999999999999999997   999999999999986655   999999999876


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      .....   .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||....   .......    ...+... ..
T Consensus       159 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~----~~~~~~~-~~  227 (284)
T 3kk8_A          159 NDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQ----IKAGAYD-YP  227 (284)
T ss_dssp             CSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH----HHHTCCC-CC
T ss_pred             ccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc---hhHHHHH----HHhcccc-CC
Confidence            43322   234579999999999999999999999999999999999999974321   1112211    1111111 00


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .+..     ......+.+++..||+.||++|||+.|+++
T Consensus       228 ~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          228 SPEW-----DTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             TTTT-----TTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             chhh-----cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0000     111235678999999999999999999987

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.9e-40  Score=337.46  Aligned_cols=264  Identities=25%  Similarity=0.340  Sum_probs=199.3

Q ss_pred             HhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh-----hhHHHHHHHHHHHHhcC---CCCeeeEEEeEee
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW-----QGLEEFKNEIILIAKLQ---HRNLVRLVGCGIE  359 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~---h~niv~l~~~~~~  359 (611)
                      ...++|++.+.||+|+||+||++++ .+++.||+|++.....     .....+.+|+.+++.++   ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            3467999999999999999999995 5789999999874321     12345677888877775   9999999999987


Q ss_pred             CC-----eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEE
Q 007239          360 GE-----EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAK  434 (611)
Q Consensus       360 ~~-----~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~k  434 (611)
                      ..     ..++||||+.+ +|.+++.... ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CCSSSEEEEEEEEECCCC-BHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred             cCCCCceeEEEEehhhhc-CHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence            65     57999999984 9988885432 234899999999999999999999997   99999999999999999999


Q ss_pred             EeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH
Q 007239          435 ISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL  514 (611)
Q Consensus       435 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~  514 (611)
                      |+|||+++......   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....   .......+...
T Consensus       161 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~i~~~  234 (308)
T 3g33_A          161 LADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS---EADQLGKIFDL  234 (308)
T ss_dssp             ECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS---HHHHHHHHHHH
T ss_pred             EeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHH
Confidence            99999998654322   2234689999999999999999999999999999999999999975322   22233333332


Q ss_pred             HhcCccccccc------cccCC--CCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          515 WKEGKEMEFVD------PLLMK--SSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       515 ~~~~~~~~~~d------~~l~~--~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ........+..      .....  ....     .....+.+|+.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            22211111100      00000  0001     11245678999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=351.59  Aligned_cols=269  Identities=22%  Similarity=0.285  Sum_probs=211.4

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC--eEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE--EKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~--~~~lv  366 (611)
                      .++|++.+.||+|+||.||+|++. +++.||+|++.... ....+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            367999999999999999999964 58999999997543 334677889999999999999999999988765  77999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe----cCCCCEEEeccccce
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL----DKDMVAKISDFGMAR  442 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll----~~~~~~kl~DFGla~  442 (611)
                      |||+++++|.+++........+++..++.++.||+.||.|||+++   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999976555555999999999999999999999997   9999999999999    778889999999998


Q ss_pred             ecccCCCccccccccccCCCCCcccccc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH
Q 007239          443 IFCENQKTANTRRVVGTYGYMAPEYAME--------GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL  514 (611)
Q Consensus       443 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~  514 (611)
                      .......   .....||+.|+|||++.+        ..++.++||||||+++|||++|+.||.........  .......
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~  239 (396)
T 4eut_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKI  239 (396)
T ss_dssp             ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHH
T ss_pred             EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHH
Confidence            7644322   224579999999999875        56788999999999999999999998543332211  1222222


Q ss_pred             HhcCccccc--c----------cccc--CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          515 WKEGKEMEF--V----------DPLL--MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       515 ~~~~~~~~~--~----------d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ........+  +          ...+  ...........+.+++..||+.||++||++.++++.|..
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~  306 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence            222111000  0          0011  112234555677899999999999999999999998854

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5.8e-41  Score=340.61  Aligned_cols=256  Identities=26%  Similarity=0.407  Sum_probs=209.4

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ..++|++.+.||+|+||.||++.+. +++.||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            3578999999999999999999965 58889999997654 346788999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            99999999998542 3356899999999999999999999997   9999999999999999999999999998764333


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                      . .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..|+......   .+...+    .......     
T Consensus       166 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~----~~~~~~~-----  232 (288)
T 3kfa_A          166 Y-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELL----EKDYRME-----  232 (288)
T ss_dssp             S-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHH----HTTCCCC-----
T ss_pred             c-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----hccCCCC-----
Confidence            2 22234567889999999999999999999999999999999 88887543222   222211    1111111     


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                          .+......+.+++..||+.||++|||+.+++++|+.
T Consensus       233 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~  268 (288)
T 3kfa_A          233 ----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET  268 (288)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence                111122457789999999999999999999999864

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.3e-40  Score=334.81  Aligned_cols=248  Identities=24%  Similarity=0.318  Sum_probs=200.0

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      ..++|++.+.||+|+||.||++.. .+++.||+|++....   ......+.+|+.++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            357899999999999999999995 467889999986542   2235678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus        87 v~e~~~~~~l~~~l~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~  160 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP  160 (279)
T ss_dssp             EECCCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred             EEecCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence            999999999999884   3456899999999999999999999986   9999999999999999999999999986543


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ...    .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||....   .......    ......     
T Consensus       161 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~----~~~~~~-----  224 (279)
T 3fdn_A          161 SSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKR----ISRVEF-----  224 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHH----HHHTCC-----
T ss_pred             ccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc---HHHHHHH----HHhCCC-----
Confidence            222    234579999999999999999999999999999999999999975321   1111111    111110     


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                       ..    +......+.+|+..||+.||++|||++|+++.
T Consensus       225 -~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          225 -TF----PDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             -CC----CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             -CC----CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             01    11112356789999999999999999999974

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-40  Score=353.98  Aligned_cols=265  Identities=23%  Similarity=0.318  Sum_probs=192.8

Q ss_pred             HhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCC--e
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGE--E  362 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~--~  362 (611)
                      ...++|++.+.||+|+||.||++.+ .+|+.||+|++...  .......+.+|+.+++.+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            4568999999999999999999995 57899999998643  3345667889999999998 999999999997544  7


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .++||||++ ++|..++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999998 488887732    46899999999999999999999997   9999999999999999999999999998


Q ss_pred             ecccCCC-------------------ccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC
Q 007239          443 IFCENQK-------------------TANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG  502 (611)
Q Consensus       443 ~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~  502 (611)
                      .+.....                   .......+||+.|+|||++.+ ..++.++|||||||++|||++|++||....  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--  235 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS--  235 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC--
Confidence            7633111                   112234689999999999986 678999999999999999999999985432  


Q ss_pred             chhhHHHHHHHHHhcCcccccc---------------------ccccCCC------------CCHHHHHHHHHHhhcccc
Q 007239          503 HAQTLLAYVWQLWKEGKEMEFV---------------------DPLLMKS------------SSIPQVVRCIHIGLLCVQ  549 (611)
Q Consensus       503 ~~~~l~~~~~~~~~~~~~~~~~---------------------d~~l~~~------------~~~~~~~~l~~li~~cl~  549 (611)
                       .......+...........+.                     .......            .......++.+|+.+||+
T Consensus       236 -~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~  314 (388)
T 3oz6_A          236 -TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ  314 (388)
T ss_dssp             -HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred             -HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence             222222222211111100000                     0000000            000112357799999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 007239          550 EDPAVRPTMSNVVAL  564 (611)
Q Consensus       550 ~dP~~RPt~~evl~~  564 (611)
                      .||++|||++|+++.
T Consensus       315 ~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          315 FNPNKRISANDALKH  329 (388)
T ss_dssp             SSGGGSCCHHHHTTS
T ss_pred             cCcccCCCHHHHhCC
Confidence            999999999999875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.4e-40  Score=350.59  Aligned_cols=252  Identities=21%  Similarity=0.244  Sum_probs=194.4

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh---hhHHHHHHHHHH-HHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW---QGLEEFKNEIIL-IAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~i-l~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      .++|++.+.||+|+||.||+++.. +++.||+|++.+...   .....+.+|..+ ++.++||||+++++++.+.+..++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            468999999999999999999964 688999999976532   234456677776 577899999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+++++|.+++.   +...+++..++.++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQ---RERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            999999999999884   3456899999999999999999999997   9999999999999999999999999998643


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ...  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||...   ....+...+   .. ... .   
T Consensus       191 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i---~~-~~~-~---  257 (373)
T 2r5t_A          191 EHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---NTAEMYDNI---LN-KPL-Q---  257 (373)
T ss_dssp             CCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS---BHHHHHHHH---HH-SCC-C---
T ss_pred             cCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC---CHHHHHHHH---Hh-ccc-C---
Confidence            222  2234578999999999999999999999999999999999999998432   122222211   11 111 0   


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                        +...    ....+.+|+..||+.||++||++.+.++.+.+
T Consensus       258 --~~~~----~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~  293 (373)
T 2r5t_A          258 --LKPN----ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKS  293 (373)
T ss_dssp             --CCSS----SCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHT
T ss_pred             --CCCC----CCHHHHHHHHHHcccCHHhCCCCCCCHHHHhC
Confidence              1111    12356789999999999999998654444433

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=345.70  Aligned_cols=244  Identities=23%  Similarity=0.313  Sum_probs=201.5

Q ss_pred             HhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh--------hhHHHHHHHHHHHHhcCCCCeeeEEEeEee
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW--------QGLEEFKNEIILIAKLQHRNLVRLVGCGIE  359 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~niv~l~~~~~~  359 (611)
                      ...++|++.+.||+|+||.||++++ .+++.||+|++.....        .....+.+|+.++++++||||+++++++.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            3467899999999999999999995 5788999999876431        123457789999999999999999999999


Q ss_pred             CCeEEEEEEecCCC-ChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecc
Q 007239          360 GEEKLLIYELMPNR-SLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDF  438 (611)
Q Consensus       360 ~~~~~lv~E~~~~~-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  438 (611)
                      .+..++||||+.+| +|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus       101 ~~~~~lv~e~~~~g~~l~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          101 QGFFQLVMEKHGSGLDLFAFID---RHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SSEEEEEEECCTTSCBHHHHHH---TCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             CCEEEEEEEeCCCCccHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence            99999999999776 9988883   3456999999999999999999999997   999999999999999999999999


Q ss_pred             ccceecccCCCccccccccccCCCCCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhc
Q 007239          439 GMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF-SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKE  517 (611)
Q Consensus       439 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  517 (611)
                      |+++.......   .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.....                
T Consensus       175 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------  235 (335)
T 3dls_A          175 GSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------  235 (335)
T ss_dssp             TTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------------
T ss_pred             ccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------------
Confidence            99987644322   234679999999999988876 8899999999999999999999742111                


Q ss_pred             CccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          518 GKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       518 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                           ..........  ....++.+|+..||+.||++|||++++++.
T Consensus       236 -----~~~~~~~~~~--~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 -----TVEAAIHPPY--LVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----GTTTCCCCSS--CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----HHhhccCCCc--ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 0111111111  112357789999999999999999999984

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.1e-39  Score=332.35  Aligned_cols=262  Identities=20%  Similarity=0.260  Sum_probs=202.7

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEe-EeeCCeEEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC-GIEGEEKLLIY  367 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~-~~~~~~~~lv~  367 (611)
                      ..++|++.+.||+|+||.||+++. .+++.||+|++.....  ...+.+|+.+++.++|++++..+.. +......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999995 5788999998765432  2357889999999998876665554 46778889999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe---cCCCCEEEeccccceec
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIF  444 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGla~~~  444 (611)
                      ||+ +++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 9999998853  2345899999999999999999999997   9999999999999   78899999999999877


Q ss_pred             ccCCCcc-----ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCc
Q 007239          445 CENQKTA-----NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK  519 (611)
Q Consensus       445 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  519 (611)
                      .......     ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||..............+........
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            5443211     22346899999999999999999999999999999999999999876544433333333222211111


Q ss_pred             cccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          520 EMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       520 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ...     +....    ..++.+++..||+.||++|||+++|++.|+..
T Consensus       239 ~~~-----~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          239 IEV-----LCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HHH-----HTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             hhh-----hhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            100     00111    13577899999999999999999999999653

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.9e-40  Score=332.67  Aligned_cols=252  Identities=23%  Similarity=0.341  Sum_probs=197.9

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|.+.+.||+|+||.||++.. .+++.+|+|++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            46799999999999999999995 468899999987643 3356789999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhc-hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe---cCCCCEEEeccccceec
Q 007239          369 LMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIF  444 (611)
Q Consensus       369 ~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGla~~~  444 (611)
                      |+++++|.+++... .....+++..++.++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||++..+
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999888553 23467999999999999999999999997   9999999999999   45688999999999866


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      .....   .....||+.|+|||.+. +.++.++||||||+++|||++|+.||.....   ..+..   ........... 
T Consensus       178 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~~~~~---~~~~~~~~~~~-  246 (285)
T 3is5_A          178 KSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---EEVQQ---KATYKEPNYAV-  246 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHH---HHHHCCCCCCC-
T ss_pred             CCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---HHHHh---hhccCCccccc-
Confidence            43322   23457999999999875 5789999999999999999999999753221   11111   11111111000 


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                         ....    ...++.+++.+||+.||++|||+.|+++
T Consensus       247 ---~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          247 ---ECRP----LTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -----CC----CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ---ccCc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               0000    1235678999999999999999999985

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=8.1e-41  Score=361.54  Aligned_cols=248  Identities=22%  Similarity=0.259  Sum_probs=193.8

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++.+.||+|+||.||++.. .+|+.||+|++...   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            46799999999999999999995 57899999999754   233456678899999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhh-cCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE-DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      |||+++++|.+++.   ....+++..+..++.||+.||.|||+ ++   |+||||||+||||+.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLS---RERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            99999999998884   34568999999999999999999998 76   9999999999999999999999999998543


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ...  ......+||+.|+|||++.+..++.++||||||+++|||++|+.||....   ...+...+   .....  .   
T Consensus       301 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i---~~~~~--~---  367 (446)
T 4ejn_A          301 KDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELI---LMEEI--R---  367 (446)
T ss_dssp             C-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH---HHCCC--C---
T ss_pred             CCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHH---HhCCC--C---
Confidence            222  12334689999999999999999999999999999999999999974322   12222211   11111  0   


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVA  563 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  563 (611)
                        ...    ....++.+|+..||+.||++||     +++|+++
T Consensus       368 --~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          368 --FPR----TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             --CCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --CCc----cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence              111    1124567899999999999999     9999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.4e-41  Score=347.93  Aligned_cols=256  Identities=26%  Similarity=0.416  Sum_probs=197.2

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCc----EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGK----EVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  364 (611)
                      .++|++.+.||+|+||.||+|.+. +++    +|++|.+... .....+.+.+|+.+++.++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            368999999999999999999953 444    3577777543 3345678999999999999999999999988654 78


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +|+||+.+++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            999999999999998542  346899999999999999999999997   999999999999999999999999999877


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      .............||+.|+|||.+.+..++.++||||||+++|||++ |+.||......   .+...    ...+.... 
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~----~~~~~~~~-  239 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSI----LEKGERLP-  239 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHH----HHTTCCCC-
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHH----HHcCCCCC-
Confidence            55444333444567889999999999999999999999999999999 99998543322   22221    11211111 


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                              .......++.+++.+||+.||++||++.|+++.|+..
T Consensus       240 --------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  276 (327)
T 3lzb_A          240 --------QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             --------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                    1111223577899999999999999999999999754

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.3e-40  Score=340.06  Aligned_cols=252  Identities=24%  Similarity=0.309  Sum_probs=204.3

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChh------hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQ------GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~  362 (611)
                      ..++|++.+.||+|+||.||++... +|+.||+|++......      ..+.+.+|+.++++++||||+++++++.+...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            3467999999999999999999964 6899999998754321      36789999999999999999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC----CEEEecc
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM----VAKISDF  438 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~----~~kl~DF  438 (611)
                      .++||||+++++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++    .+||+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence            9999999999999999843   456899999999999999999999997   99999999999999888    7999999


Q ss_pred             ccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC
Q 007239          439 GMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG  518 (611)
Q Consensus       439 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  518 (611)
                      |++........   .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||....   ......    .+...
T Consensus       164 g~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~----~i~~~  233 (321)
T 2a2a_A          164 GLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLA----NITSV  233 (321)
T ss_dssp             TTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHH----HHHTT
T ss_pred             ccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC---HHHHHH----HHHhc
Confidence            99987644322   234579999999999999999999999999999999999999974321   111111    11111


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       519 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .. . .++.....    ....+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~-~-~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          234 SY-D-FDEEFFSH----TSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             CC-C-CCHHHHTT----CCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             cc-c-cChhhhcc----cCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11 0 00000011    1235678999999999999999999997

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.5e-41  Score=352.32  Aligned_cols=266  Identities=26%  Similarity=0.275  Sum_probs=204.8

Q ss_pred             HHHHHHhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcC-----CCCeeeEEEeE
Q 007239          284 LAVIKAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-----HRNLVRLVGCG  357 (611)
Q Consensus       284 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----h~niv~l~~~~  357 (611)
                      +.......++|++.++||+|+||.||++++ .+++.||+|++... ......+..|+.+++.++     ||||+++++++
T Consensus        27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~  105 (360)
T 3llt_A           27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF  105 (360)
T ss_dssp             CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred             eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence            333344568999999999999999999996 57889999998743 234566788999999997     99999999999


Q ss_pred             eeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC--------
Q 007239          358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK--------  429 (611)
Q Consensus       358 ~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~--------  429 (611)
                      ...+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.        
T Consensus       106 ~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~  180 (360)
T 3llt_A          106 MYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLI  180 (360)
T ss_dssp             EETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEE
T ss_pred             eECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccccccc
Confidence            9999999999999 89999988543 2235899999999999999999999997   999999999999975        


Q ss_pred             -----------------CCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhC
Q 007239          430 -----------------DMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISG  492 (611)
Q Consensus       430 -----------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG  492 (611)
                                       ++.+||+|||+++......     ....||+.|+|||++.+..++.++||||||+++|+|++|
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  255 (360)
T 3llt_A          181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG  255 (360)
T ss_dssp             EEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred             chhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHC
Confidence                             7899999999998643322     245799999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCchhhHHHHHHHHHhcC-----------cccccccc-----ccCC-CCCHHH---------------HHHH
Q 007239          493 KRNSGFYLTGHAQTLLAYVWQLWKEG-----------KEMEFVDP-----LLMK-SSSIPQ---------------VVRC  540 (611)
Q Consensus       493 ~~p~~~~~~~~~~~l~~~~~~~~~~~-----------~~~~~~d~-----~l~~-~~~~~~---------------~~~l  540 (611)
                      +.||.....   ......+.......           .....++.     .... ......               ...+
T Consensus       256 ~~pf~~~~~---~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          256 SLLFRTHEH---MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             SCSCCCSSH---HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             CCCCCCCcH---HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            999854322   12222221111100           00000000     0000 000000               1356


Q ss_pred             HHHhhccccCCCCCCCCHHHHHH
Q 007239          541 IHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       541 ~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .+|+.+||+.||++|||++|+++
T Consensus       333 ~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHhcCChhhCCCHHHHhc
Confidence            79999999999999999999985

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=335.69  Aligned_cols=250  Identities=26%  Similarity=0.412  Sum_probs=182.9

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      ..++|++.+.||+|+||.||+++. .+++.||+|++.....   ...+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            457899999999999999999996 5789999999865421   235678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+++++|.+++..  ....+++..++.++.||++||.|||+++   ++||||||+||+++.++.+||+|||++....
T Consensus        89 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EEECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            9999999999998853  2356899999999999999999999996   9999999999999999999999999998764


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      .....  .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||........   .       ......   +
T Consensus       164 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~-------~~~~~~---~  228 (278)
T 3cok_A          164 MPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT---L-------NKVVLA---D  228 (278)
T ss_dssp             ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CCSS---C
T ss_pred             CCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH---H-------HHHhhc---c
Confidence            32221  2235799999999999999999999999999999999999999754322110   0       000000   0


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ...    +.....++.+++.+||+.||++|||++++++
T Consensus       229 ~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          229 YEM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cCC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            011    1112245678999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2e-39  Score=330.42  Aligned_cols=262  Identities=20%  Similarity=0.260  Sum_probs=206.4

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEe-EeeCCeEEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC-GIEGEEKLLIY  367 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~-~~~~~~~~lv~  367 (611)
                      ..++|++.+.||+|+||.||+++. .+++.||+|++.....  .+.+.+|+.+++.++|++++..+.. .......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            357899999999999999999995 6789999999875543  2468899999999998876655554 46677889999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe---cCCCCEEEeccccceec
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIF  444 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGla~~~  444 (611)
                      ||+ +++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Eec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            999 8999999853  2346999999999999999999999997   9999999999999   48899999999999876


Q ss_pred             ccCCCcc-----ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCc
Q 007239          445 CENQKTA-----NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK  519 (611)
Q Consensus       445 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  519 (611)
                      .......     ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..............+........
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            5443211     12346799999999999999999999999999999999999999876544333333333222111111


Q ss_pred             cccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          520 EMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       520 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ...     +....    ..++.+++.+||+.||++|||+++|++.|+..
T Consensus       239 ~~~-----~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          239 IEV-----LCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             HHH-----HTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             hHH-----HHhhC----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            100     11111    13577899999999999999999999999754

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.4e-39  Score=334.21  Aligned_cols=260  Identities=23%  Similarity=0.357  Sum_probs=198.1

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++.+.||+|+||.||++.. .+|+.||+|++...   .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            46799999999999999999995 57899999998753   334567789999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhch-hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          367 YELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      |||+++++|.+++.... ....+++..++.++.||+.||.|||+++   ++||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999999885432 3456899999999999999999999997   9999999999999999999999999998654


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ....  ......|++.|+|||.+.+..++.++||||||+++|+|++|+.||......    ..... .............
T Consensus       188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~~~~~~~~~~~~  260 (310)
T 2wqm_A          188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLC-KKIEQCDYPPLPS  260 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHH-HHHHTTCSCCCCT
T ss_pred             CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHH-HHhhcccCCCCcc
Confidence            3322  122457899999999999999999999999999999999999997432211    11111 1122222111110


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                              .....++.+++.+||+.||++|||+++|++.|+..
T Consensus       261 --------~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l  295 (310)
T 2wqm_A          261 --------DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM  295 (310)
T ss_dssp             --------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                    11123577899999999999999999999999764

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5.5e-40  Score=332.36  Aligned_cols=248  Identities=26%  Similarity=0.394  Sum_probs=203.3

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee---------
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE---------  359 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~---------  359 (611)
                      ..++|++.+.||+|+||.||++.+. +++.||+|++....    +.+.+|+.++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4567999999999999999999965 78999999997654    356789999999999999999998854         


Q ss_pred             -------CCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCC
Q 007239          360 -------GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV  432 (611)
Q Consensus       360 -------~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~  432 (611)
                             ....++||||+++++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                   45579999999999999998542 2356899999999999999999999996   999999999999999999


Q ss_pred             EEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHH
Q 007239          433 AKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW  512 (611)
Q Consensus       433 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~  512 (611)
                      +||+|||++........   .....||+.|+|||.+.+..++.++||||||+++|+|++|..|+..         ....+
T Consensus       161 ~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---------~~~~~  228 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---------TSKFF  228 (284)
T ss_dssp             EEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---------HHHHH
T ss_pred             EEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---------HHHHH
Confidence            99999999987654322   2235799999999999999999999999999999999999987421         11112


Q ss_pred             HHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCC
Q 007239          513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES  569 (611)
Q Consensus       513 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  569 (611)
                      .....+..        ....    ...+.+++.+||+.||++|||+.|+++.|....
T Consensus       229 ~~~~~~~~--------~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          229 TDLRDGII--------SDIF----DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             HHHHTTCC--------CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             HHhhcccc--------cccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            22222211        1111    134678899999999999999999999997543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=5.7e-40  Score=356.07  Aligned_cols=259  Identities=24%  Similarity=0.273  Sum_probs=194.9

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC------C
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG------E  361 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~  361 (611)
                      .++|++.+.||+|+||+||++++ .+++.||||++...  .....+++.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            57899999999999999999995 46889999999754  344567889999999999999999999998654      4


Q ss_pred             eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccc
Q 007239          362 EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA  441 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  441 (611)
                      ..++||||++++ |.+.+.     ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            679999999875 444442     24899999999999999999999997   999999999999999999999999999


Q ss_pred             eecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc-
Q 007239          442 RIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE-  520 (611)
Q Consensus       442 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-  520 (611)
                      +......   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....   ......+.+....... 
T Consensus       212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~---~~~~~~i~~~lg~p~~~  285 (464)
T 3ttj_A          212 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPCPE  285 (464)
T ss_dssp             -----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCSCCHH
T ss_pred             eecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCCHH
Confidence            8764322   23346899999999999999999999999999999999999999854321   2222222221111000 


Q ss_pred             ------------------------ccccccccC-CCCC--HHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          521 ------------------------MEFVDPLLM-KSSS--IPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       521 ------------------------~~~~d~~l~-~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                                              .......+. ....  .....++.+|+.+||+.||++|||++|+++.
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                                    000000000 0000  0113467899999999999999999999873

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.1e-40  Score=342.44  Aligned_cols=263  Identities=23%  Similarity=0.329  Sum_probs=193.6

Q ss_pred             HhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChh--hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQ--GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      ...++|++.+.||+|+||.||+++. .+++.||+|++......  ..+.+.+|+.++++++||||+++++++...+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            4567899999999999999999995 57889999999754322  24567899999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec-----CCCCEEEecccc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD-----KDMVAKISDFGM  440 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~-----~~~~~kl~DFGl  440 (611)
                      ||||+++ +|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++     .++.+||+|||+
T Consensus       111 v~e~~~~-~L~~~~~---~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~  183 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMD---KNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL  183 (329)
T ss_dssp             EEECCSE-EHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred             EEecCCC-CHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence            9999985 8888884   3345899999999999999999999997   99999999999994     455699999999


Q ss_pred             ceecccCCCccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCc
Q 007239          441 ARIFCENQKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK  519 (611)
Q Consensus       441 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  519 (611)
                      ++.+.....  ......||+.|+|||++.+. .++.++||||||+++|||++|+.||....   .......+........
T Consensus       184 a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~~~~~~~~~~  258 (329)
T 3gbz_A          184 ARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS---EIDQLFKIFEVLGLPD  258 (329)
T ss_dssp             HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHHHCCCC
T ss_pred             ccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC---HHHHHHHHHHHhCCCc
Confidence            987643322  22345789999999999874 48999999999999999999999975322   2222222222211111


Q ss_pred             ccccc--------ccccC--CCCCHH------HHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          520 EMEFV--------DPLLM--KSSSIP------QVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       520 ~~~~~--------d~~l~--~~~~~~------~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ...+.        .....  ......      ...++.+|+.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            10000        00000  000111      1245679999999999999999999987

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.2e-39  Score=334.87  Aligned_cols=258  Identities=22%  Similarity=0.245  Sum_probs=197.3

Q ss_pred             HhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  364 (611)
                      ...++|++.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.++++++||||+++++++...+..+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  110 (309)
T 2h34_A           31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLY  110 (309)
T ss_dssp             ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEE
Confidence            34578999999999999999999964 78899999987543   233577899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +||||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus       111 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          111 VDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EEEECCCCEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEEEecCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            9999999999999984   3456899999999999999999999997   999999999999999999999999999866


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc-ccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE-MEF  523 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-~~~  523 (611)
                      ...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....   .    ........... ...
T Consensus       185 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~----~~~~~~~~~~~~~~~  256 (309)
T 2h34_A          185 TDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---S----VMGAHINQAIPRPST  256 (309)
T ss_dssp             -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---H----HHHHHHHSCCCCGGG
T ss_pred             cccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---H----HHHHHhccCCCCccc
Confidence            433221 22345799999999999999999999999999999999999999753211   1    11122222111 111


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCC-CHHHHHHHhcCC
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRP-TMSNVVALLGSE  568 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~~  568 (611)
                      ..+    .    ....+.+++.+||+.||++|| +++++++.|...
T Consensus       257 ~~~----~----~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~  294 (309)
T 2h34_A          257 VRP----G----IPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAA  294 (309)
T ss_dssp             TST----T----CCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred             cCC----C----CCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence            111    1    112467889999999999999 999999999764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6.1e-41  Score=344.89  Aligned_cols=260  Identities=26%  Similarity=0.396  Sum_probs=196.3

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC----CCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC--
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP----NGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE--  361 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~--  361 (611)
                      ..++|.+.+.||+|+||.||+|.+.    +++.||+|++...  .....+.+.+|+.++++++||||+++++++....  
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            4578999999999999999999853    3458999998754  3345677999999999999999999999987655  


Q ss_pred             ---eEEEEEEecCCCChhhHhhhc---hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEE
Q 007239          362 ---EKLLIYELMPNRSLDCFIFDS---ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKI  435 (611)
Q Consensus       362 ---~~~lv~E~~~~~sL~~~l~~~---~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl  435 (611)
                         ..++||||+++++|.+++...   .....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence               349999999999999988532   23456999999999999999999999986   999999999999999999999


Q ss_pred             eccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHH
Q 007239          436 SDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQL  514 (611)
Q Consensus       436 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~  514 (611)
                      +|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....   ..+...    
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~----  261 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN---HEMYDY----  261 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHH----
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHHHH----
Confidence            99999987654433333334567889999999999999999999999999999999 8888753322   122221    


Q ss_pred             HhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       515 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ...+.....         .......+.+++.+||+.||++|||++++++.|+..
T Consensus       262 ~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          262 LLHGHRLKQ---------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             HHTTCCCCC---------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCCCCC---------CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            112211111         111224577899999999999999999999999754

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.3e-41  Score=370.75  Aligned_cols=257  Identities=28%  Similarity=0.434  Sum_probs=208.0

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      .++|++.++||+|+||.||+|.+.++..||||+++... ...+.|.+|+.++++++||||+++++++.+ +..++||||+
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~  343 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM  343 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence            46789999999999999999998888889999998654 345789999999999999999999999866 6789999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++++|.+++... ....+++.+++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++....... 
T Consensus       344 ~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-  418 (535)
T 2h8h_A          344 SKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-  418 (535)
T ss_dssp             TTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-
T ss_pred             cCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-
Confidence            999999998542 2345899999999999999999999986   99999999999999999999999999986543221 


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                      .......++..|+|||.+..+.++.++||||||++||||++ |+.||....   ...+..    ....+....       
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~---~~~~~~----~i~~~~~~~-------  484 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV---NREVLD----QVERGYRMP-------  484 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC---HHHHHH----HHHTTCCCC-------
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHH----HHHcCCCCC-------
Confidence            11223457788999999999999999999999999999999 888874322   111222    222221111       


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCCC
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESI  570 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~  570 (611)
                        ........+.+|+.+||+.||++|||+++|+++|+....
T Consensus       485 --~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          485 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             --CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence              011122457789999999999999999999999987543

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.9e-40  Score=345.92  Aligned_cols=251  Identities=16%  Similarity=0.132  Sum_probs=203.0

Q ss_pred             hhCCCCcccccCccCceEEEEEE------cCCCcEEEEEEecccChhhHHHHHHHHHHHHhcC---CCCeeeEEEeEeeC
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGV------LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ---HRNLVRLVGCGIEG  360 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~  360 (611)
                      ..++|.+.+.||+|+||.||+|+      ..+++.||+|++....   ..++.+|+.+++.++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            35789999999999999999994      3468899999997654   346777888888887   99999999999999


Q ss_pred             CeEEEEEEecCCCChhhHhhhch--hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC---------
Q 007239          361 EEKLLIYELMPNRSLDCFIFDSE--RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK---------  429 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~~~--~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~---------  429 (611)
                      +..++||||+++|+|.+++....  ....+++..++.++.||++||.|||+++   |+||||||+||||+.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence            99999999999999999986432  3456999999999999999999999986   999999999999988         


Q ss_pred             --CCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhH
Q 007239          430 --DMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTL  507 (611)
Q Consensus       430 --~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l  507 (611)
                        ++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.......    
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----  292 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----  292 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc----
Confidence              89999999999987654333334455789999999999999999999999999999999999999973221110    


Q ss_pred             HHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCC-CCHHHHHHHhcC
Q 007239          508 LAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVR-PTMSNVVALLGS  567 (611)
Q Consensus       508 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~R-Pt~~evl~~L~~  567 (611)
                                    ..+...+.....   ...+.+++..||+.+|.+| |++.++.+.|+.
T Consensus       293 --------------~~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          293 --------------CKPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             --------------EEECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             --------------eeechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence                          111122222222   2345577888999999999 688888877753

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.9e-41  Score=346.59  Aligned_cols=260  Identities=23%  Similarity=0.333  Sum_probs=194.6

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhh-HHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      ++|++.+.||+|+||.||++... +++.||+|++....... ...+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999964 78999999987543221 12456799999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++ +|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           82 LDK-DLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             CSE-EHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             ccc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            985 787777432  345899999999999999999999997   99999999999999999999999999986543222


Q ss_pred             ccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          450 TANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                        ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....   .......+.+.........+ ...+
T Consensus       156 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~-~~~~  229 (324)
T 3mtl_A          156 --TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST---VEEQLHFIFRILGTPTEETW-PGIL  229 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTS-TTGG
T ss_pred             --ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHHHhCCCChHhc-hhhh
Confidence              2234578999999999876 568999999999999999999999985432   22333333332222111111 0000


Q ss_pred             C----------C--CCC-----HHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          529 M----------K--SSS-----IPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       529 ~----------~--~~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .          .  ...     .....++.+|+.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            0          0  000     011235679999999999999999999987

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=331.90  Aligned_cols=253  Identities=28%  Similarity=0.400  Sum_probs=199.5

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      ++|.....||+|+||.||+|.+ .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            4455667999999999999995 578899999998776666788999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC-CCCEEEeccccceecccCCC
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK-DMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGla~~~~~~~~  449 (611)
                      ++++|.+++........+++..++.++.||+.||.|||+++   |+||||||+||+++. ++.+||+|||++........
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~  178 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP  178 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence            99999999865444456778999999999999999999987   999999999999987 89999999999987643221


Q ss_pred             ccccccccccCCCCCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGL--FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                        ......||+.|+|||++.+..  ++.++||||||+++|+|++|+.||.......  .   ..........     .+.
T Consensus       179 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~---~~~~~~~~~~-----~~~  246 (295)
T 2clq_A          179 --CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ--A---AMFKVGMFKV-----HPE  246 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH--H---HHHHHHHHCC-----CCC
T ss_pred             --cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh--H---HHHhhccccc-----ccc
Confidence              123457999999999997654  8899999999999999999999974322111  1   1111101111     111


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      +..    ....++.+++.+||+.||++||++.++++
T Consensus       247 ~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          247 IPE----SMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCT----TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111    12245678999999999999999999985

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-39  Score=337.39  Aligned_cols=271  Identities=25%  Similarity=0.336  Sum_probs=201.9

Q ss_pred             HHHHHHhhCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhc--CCCCeeeEEEeEeeC-
Q 007239          284 LAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL--QHRNLVRLVGCGIEG-  360 (611)
Q Consensus       284 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l--~h~niv~l~~~~~~~-  360 (611)
                      ........++|++.+.||+|+||.||+|.+. ++.||+|++....   ...+.+|.+++..+  +||||+++++++... 
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            4444556789999999999999999999975 8999999986543   33455566666554  899999999999887 


Q ss_pred             ---CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcC-----CCceEecCCCCCcEEecCCCC
Q 007239          361 ---EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS-----RLKIIHRDLKPSNVLLDKDMV  432 (611)
Q Consensus       361 ---~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~-----~~~iiHrDikp~NIll~~~~~  432 (611)
                         ...++||||+++++|.+++..    ..+++..++.++.||+.||.|||+++     ..+|+||||||+|||++.++.
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~  180 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT  180 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             CCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence               789999999999999999832    35899999999999999999999870     113999999999999999999


Q ss_pred             EEEeccccceecccCCCcc--ccccccccCCCCCccccccCCCCch------hhHHHHHHHHHHHHhC----------CC
Q 007239          433 AKISDFGMARIFCENQKTA--NTRRVVGTYGYMAPEYAMEGLFSVK------SDVFSFGVIVLEIISG----------KR  494 (611)
Q Consensus       433 ~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k------~DvwSlGvll~elltG----------~~  494 (611)
                      +||+|||+++.+.......  ......||+.|+|||++.+.....+      +||||||+++|||++|          +.
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            9999999998764433221  1224579999999999987766654      9999999999999999          55


Q ss_pred             CCCCCCCCchhhHHHHHHHHHhcCccccccccccCCC-CCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          495 NSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKS-SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       495 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      |+.........  .............    .+..... .......++.+|+.+||+.||++|||+.+|++.|+..
T Consensus       261 p~~~~~~~~~~--~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  329 (337)
T 3mdy_A          261 PYHDLVPSDPS--YEDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM  329 (337)
T ss_dssp             TTTTTSCSSCC--HHHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             cHhhhcCCCCc--hhhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence            54332222111  1111111111111    1111110 1124456788999999999999999999999999753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.8e-39  Score=345.78  Aligned_cols=253  Identities=22%  Similarity=0.260  Sum_probs=191.3

Q ss_pred             hhCCCCcc-cccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHH-hcCCCCeeeEEEeEee----CCe
Q 007239          290 ATDGFSDS-NKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIA-KLQHRNLVRLVGCGIE----GEE  362 (611)
Q Consensus       290 ~~~~y~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~-~l~h~niv~l~~~~~~----~~~  362 (611)
                      ..++|.+. +.||+|+||+||++.+ .+++.||||++...     ..+.+|+.++. ..+||||+++++++..    ...
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            34567776 6899999999999996 46899999998632     35678888874 4579999999999876    567


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC---CCCEEEeccc
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK---DMVAKISDFG  439 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFG  439 (611)
                      .++||||+++|+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecc
Confidence            89999999999999998542 2345899999999999999999999986   999999999999987   7899999999


Q ss_pred             cceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCch-hhHHHHHHHHHhcC
Q 007239          440 MARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHA-QTLLAYVWQLWKEG  518 (611)
Q Consensus       440 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~  518 (611)
                      +++......   .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+    ..+
T Consensus       210 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~  282 (400)
T 1nxk_A          210 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMG  282 (400)
T ss_dssp             TCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHT
T ss_pred             cccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcC
Confidence            998654322   22346899999999999999999999999999999999999999854332211 1111111    111


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       519 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      .. .+..+..     .....++.+|+..||+.||++|||+.|+++.
T Consensus       283 ~~-~~~~~~~-----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          283 QY-EFPNPEW-----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             CC-CCCTTTT-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             cc-cCCCccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11 0000000     1122457789999999999999999999974

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-40  Score=336.31  Aligned_cols=255  Identities=27%  Similarity=0.390  Sum_probs=205.2

Q ss_pred             CCCCccc-ccCccCceEEEEEEcC---CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          292 DGFSDSN-KLGQGGFGTVYKGVLP---NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       292 ~~y~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ++|.+.+ .||+|+||.||+|++.   +++.||+|++... .....+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4566666 9999999999999853   5778999999764 334567899999999999999999999998 56678999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            999999999999853  3345899999999999999999999997   99999999999999999999999999987644


Q ss_pred             CCCc-cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          447 NQKT-ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       447 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      .... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||.....   ..+.    .....+....  
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~----~~i~~~~~~~--  233 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVM----AFIEQGKRME--  233 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHH----HHHHTTCCCC--
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH---HHHH----HHHhcCCcCC--
Confidence            3321 11223457889999999998899999999999999999998 9999754322   1122    1122222111  


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                         .    +.....++.+++..||+.||++||++.++++.|+..
T Consensus       234 ---~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          234 ---C----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             ---C----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---C----CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               1    111224677899999999999999999999999764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-40  Score=339.26  Aligned_cols=256  Identities=27%  Similarity=0.374  Sum_probs=201.6

Q ss_pred             CCCcccccCccCceEEEEEEcC-C---CcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeE-EEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP-N---GKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEK-LLI  366 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~-~lv  366 (611)
                      .|...+.||+|+||.||+|.+. +   +..+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4667799999999999999852 2   3379999987543 34567899999999999999999999999876655 999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+.+++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999999854  2456899999999999999999999997   99999999999999999999999999986543


Q ss_pred             CC--CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          447 NQ--KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       447 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ..  .........+|+.|+|||.+.+..++.++||||||+++|+|++|..|+...  .....+...+    ..+....  
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~--~~~~~~~~~~----~~~~~~~--  248 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH--IDPFDLTHFL----AQGRRLP--  248 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT--SCGGGHHHHH----HTTCCCC--
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc--CCHHHHHHHh----hcCCCCC--
Confidence            32  112233457889999999999999999999999999999999966654221  1222222222    1111111  


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                             .+......+.+++.+||+.||++|||+++++++|+..
T Consensus       249 -------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          249 -------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             -------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                   0111123577899999999999999999999999764

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.8e-41  Score=347.98  Aligned_cols=263  Identities=26%  Similarity=0.377  Sum_probs=207.3

Q ss_pred             hCCCCcccccCccCceEEEEEEc-----CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC--eE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-----PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE--EK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~--~~  363 (611)
                      .++|++.+.||+|+||.||++.+     .+++.||+|++........+.+.+|+.++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            46799999999999999999983     368899999998776667788999999999999999999999886544  78


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ++||||+++++|.+++...  ...+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus       120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            9999999999999998542  345899999999999999999999987   99999999999999999999999999987


Q ss_pred             cccCCCcc-ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---------CchhhHHHHHHH
Q 007239          444 FCENQKTA-NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLT---------GHAQTLLAYVWQ  513 (611)
Q Consensus       444 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~---------~~~~~l~~~~~~  513 (611)
                      ........ ......++..|+|||.+.+..++.++||||||+++|||++|..|+.....         .........+..
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            65433211 12234577889999999999999999999999999999999988642210         000111111222


Q ss_pred             HHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       514 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ....+....         .......++.+++.+||+.||++|||+.+|++.|+.
T Consensus       275 ~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~  319 (326)
T 2w1i_A          275 LLKNNGRLP---------RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  319 (326)
T ss_dssp             HHHTTCCCC---------CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             HhhcCCCCC---------CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            222221111         111123457789999999999999999999999975

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.6e-40  Score=344.74  Aligned_cols=198  Identities=27%  Similarity=0.382  Sum_probs=175.3

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.+.||+|+||.||++.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            467999999999999999999964 7899999998765 33446778999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhc-CCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED-SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      |+++++|.+++.   ....+++..+..++.||+.||.|||++ +   |+||||||+|||++.++.+||+|||++......
T Consensus       112 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999999984   345689999999999999999999985 6   999999999999999999999999999765332


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGF  498 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~  498 (611)
                      .    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus       186 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          186 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             C--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred             c----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            2    2245799999999999999999999999999999999999999854

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.4e-40  Score=344.26  Aligned_cols=264  Identities=23%  Similarity=0.322  Sum_probs=200.1

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEeEee--------
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVGCGIE--------  359 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~--------  359 (611)
                      .++|++.+.||+|+||.||+++. .+|+.||+|++.....  .....+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            46899999999999999999996 5789999999865432  234567899999999999999999999887        


Q ss_pred             CCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccc
Q 007239          360 GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFG  439 (611)
Q Consensus       360 ~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  439 (611)
                      .+..++||||+++ +|...+..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence            4468999999986 66565533  2345899999999999999999999997   9999999999999999999999999


Q ss_pred             cceecccCCC--ccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHh
Q 007239          440 MARIFCENQK--TANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWK  516 (611)
Q Consensus       440 la~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~  516 (611)
                      +++.+.....  ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||....   .......+.....
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~  246 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT---EQHQLALISQLCG  246 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhC
Confidence            9987643222  122334678999999999876 458999999999999999999999975432   2223333322221


Q ss_pred             cCccc---c-----cccc---ccCCCCCHHH-------HHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          517 EGKEM---E-----FVDP---LLMKSSSIPQ-------VVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       517 ~~~~~---~-----~~d~---~l~~~~~~~~-------~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .....   .     ..+.   ..........       ...+.+|+.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            11100   0     0000   0001111111       124678999999999999999999997

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.7e-39  Score=338.08  Aligned_cols=269  Identities=23%  Similarity=0.317  Sum_probs=208.7

Q ss_pred             cCHHHHHHhhCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHh--cCCCCeeeEEEeEee
Q 007239          282 VHLAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAK--LQHRNLVRLVGCGIE  359 (611)
Q Consensus       282 ~~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~h~niv~l~~~~~~  359 (611)
                      .++.......++|++.+.||+|+||.||++++ +++.||+|++....   ...+.+|.+++..  ++||||+++++++..
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            44555566778999999999999999999998 58999999996543   4567889999887  789999999999987


Q ss_pred             CC----eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHh--------hcCCCceEecCCCCCcEEe
Q 007239          360 GE----EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH--------EDSRLKIIHRDLKPSNVLL  427 (611)
Q Consensus       360 ~~----~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH--------~~~~~~iiHrDikp~NIll  427 (611)
                      ..    ..++||||+++++|.+++..    ..+++..++.++.||+.||.|||        +.+   |+||||||+|||+
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll  180 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV  180 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence            76    78999999999999999843    35899999999999999999999        664   9999999999999


Q ss_pred             cCCCCEEEeccccceecccCCCcc--ccccccccCCCCCccccccCC------CCchhhHHHHHHHHHHHHhC-------
Q 007239          428 DKDMVAKISDFGMARIFCENQKTA--NTRRVVGTYGYMAPEYAMEGL------FSVKSDVFSFGVIVLEIISG-------  492 (611)
Q Consensus       428 ~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~k~DvwSlGvll~elltG-------  492 (611)
                      +.++.+||+|||++..........  ......||+.|+|||++.+..      ++.++||||||+++|||++|       
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            999999999999998765433221  223457999999999987753      34789999999999999999       


Q ss_pred             ---CCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCC-CCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          493 ---KRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKS-SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       493 ---~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                         +.||........ .. ............    .+.+... ........+.+|+.+||+.||++|||+.+|++.|+.
T Consensus       261 ~~~~~p~~~~~~~~~-~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~  333 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDP-SV-EEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  333 (342)
T ss_dssp             CCCCCTTTTTSCSSC-CH-HHHHHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cccccCccccCcCcc-cH-HHHHHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence               566543322111 11 111122222111    1111110 123455678899999999999999999999999975

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.3e-40  Score=332.74  Aligned_cols=246  Identities=24%  Similarity=0.341  Sum_probs=198.6

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc--ChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK--SWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~l  365 (611)
                      ..++|++.+.||+|+||.||++++. +++.||+|++...  .......+.+|+.++..+ +||||+++++++.+.+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3467999999999999999999964 7899999998754  233456788999999999 89999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchh-hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC--------------
Q 007239          366 IYELMPNRSLDCFIFDSER-RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD--------------  430 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~--------------  430 (611)
                      ||||+++++|.+++..... ...+++..++.++.||+.||.|||+++   |+||||||+|||++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999865332 256899999999999999999999997   9999999999999844              


Q ss_pred             -----CCEEEeccccceecccCCCccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCch
Q 007239          431 -----MVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHA  504 (611)
Q Consensus       431 -----~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~  504 (611)
                           ..+||+|||++.......      ...||+.|+|||.+.+. .++.++||||||+++|+|++|.+++...     
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----  234 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG-----  234 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-----
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-----
Confidence                 479999999998764322      23589999999999876 5678999999999999999998764211     


Q ss_pred             hhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          505 QTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       505 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       .    .+.....+....     +...    ....+.+++.+||+.||++|||+.++++
T Consensus       235 -~----~~~~~~~~~~~~-----~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          235 -D----QWHEIRQGRLPR-----IPQV----LSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -H----HHHHHHTTCCCC-----CSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -h----HHHHHHcCCCCC-----CCcc----cCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence             1    112222222211     1111    1235678999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=5.7e-40  Score=361.25  Aligned_cols=253  Identities=29%  Similarity=0.362  Sum_probs=205.2

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++.+.||+|+||.||+++. .+|+.||+|++.+..   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            46799999999999999999996 479999999997542   23456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++|+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++++||+|||+++....
T Consensus       263 mEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            9999999999988543 2345899999999999999999999997   99999999999999999999999999987644


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ...   ....+||+.|+|||++.+..++.++|||||||++|||++|+.||..........   .+.+....... .    
T Consensus       339 ~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~---~i~~~i~~~~~-~----  407 (576)
T 2acx_A          339 GQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVKEVPE-E----  407 (576)
T ss_dssp             TCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH---HHHHHHHHCCC-C----
T ss_pred             Ccc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH---HHHHHhhcccc-c----
Confidence            322   234589999999999999999999999999999999999999986443222111   11111111111 0    


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVA  563 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  563 (611)
                       .    +.....++.+|+.+||+.||++||     +++||++
T Consensus       408 -~----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          408 -Y----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             -C----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             -C----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence             1    111224577899999999999999     7788875

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.1e-40  Score=342.89  Aligned_cols=247  Identities=27%  Similarity=0.399  Sum_probs=198.6

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .+.|++.+.||+|+||.||+|+. .+++.||+|++....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            35599999999999999999995 578999999987542   23356789999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+. |+|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       133 ~e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99998 577776642  3456899999999999999999999997   99999999999999999999999999986532


Q ss_pred             CCCccccccccccCCCCCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAM---EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      .      ....||+.|+|||++.   .+.++.++||||||+++|||++|+.||.....      ............ ...
T Consensus       207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~------~~~~~~~~~~~~-~~~  273 (348)
T 1u5q_A          207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------MSALYHIAQNES-PAL  273 (348)
T ss_dssp             B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC-CCC
T ss_pred             C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHHhcCC-CCC
Confidence            2      2357999999999985   56789999999999999999999999743211      111222222211 111


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      .    ...    ....+.+++.+||+.||++|||++++++.
T Consensus       274 ~----~~~----~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          274 Q----SGH----WSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             C----CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             C----CCC----CCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            1    111    12346789999999999999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.6e-40  Score=332.89  Aligned_cols=249  Identities=26%  Similarity=0.325  Sum_probs=204.5

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|.+.+.||+|+||.||++... +++.+|+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467999999999999999999964 6888999998654   234567789999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++.   ....+++..++.++.||++||.|||+++   ++||||||+||+++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            99999999999873   3456899999999999999999999997   99999999999999999999999999987643


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ...  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....   .   ... ........      
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~---~~~-~~~~~~~~------  232 (294)
T 2rku_A          168 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---K---ETY-LRIKKNEY------  232 (294)
T ss_dssp             TTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---H---HHH-HHHHTTCC------
T ss_pred             Ccc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---H---HHH-HHHhhccC------
Confidence            222  22345799999999999999999999999999999999999999753221   1   111 11111111      


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      .+..    .....+.+++.+||+.||++|||++++++.
T Consensus       233 ~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          233 SIPK----HINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             CCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CCcc----ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0111    112356789999999999999999999973

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.2e-40  Score=357.21  Aligned_cols=195  Identities=25%  Similarity=0.415  Sum_probs=154.7

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC-----Ce
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG-----EE  362 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~  362 (611)
                      .++|++.+.||+|+||+||++++. +++.||||++...  .....+++.+|+.+|++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            368999999999999999999954 7899999998653  334567889999999999999999999998443     57


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .++||||+. ++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++
T Consensus       132 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCCS-EEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeccc-cchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            899999985 68888873   3456999999999999999999999997   9999999999999999999999999998


Q ss_pred             ecccCCCc-------------------------cccccccccCCCCCcccc-ccCCCCchhhHHHHHHHHHHHHhC
Q 007239          443 IFCENQKT-------------------------ANTRRVVGTYGYMAPEYA-MEGLFSVKSDVFSFGVIVLEIISG  492 (611)
Q Consensus       443 ~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~DvwSlGvll~elltG  492 (611)
                      ........                         ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            76432211                         122346789999999976 466799999999999999999994

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-39  Score=340.06  Aligned_cols=267  Identities=25%  Similarity=0.334  Sum_probs=198.2

Q ss_pred             HHhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhh-----HHHHHHHHHHHHhcCCCCeeeEEEeEeeCC
Q 007239          288 KAATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQG-----LEEFKNEIILIAKLQHRNLVRLVGCGIEGE  361 (611)
Q Consensus       288 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~  361 (611)
                      ....++|++.+.||+|+||.||++++. +|+.||+|++.......     ...+.+|+.+++.++||||+++++++...+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344678999999999999999999964 68999999987532211     246789999999999999999999999999


Q ss_pred             eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccc
Q 007239          362 EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA  441 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  441 (611)
                      ..++||||+++ +|..++..  ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA  159 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred             ceEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence            99999999987 78777743  2346889999999999999999999997   999999999999999999999999999


Q ss_pred             eecccCCCccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc
Q 007239          442 RIFCENQKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE  520 (611)
Q Consensus       442 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  520 (611)
                      +.+.....  ......||+.|+|||++.+. .++.++||||||+++|||++|.+|+...   ........+.........
T Consensus       160 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~---~~~~~~~~i~~~~~~~~~  234 (346)
T 1ua2_A          160 KSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD---SDLDQLTRIFETLGTPTE  234 (346)
T ss_dssp             STTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCT
T ss_pred             eeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC---CHHHHHHHHHHHcCCCCh
Confidence            87643322  22345799999999998764 5899999999999999999999887432   222233333332222211


Q ss_pred             ccccc------cccC---CCCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHHHh
Q 007239          521 MEFVD------PLLM---KSSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVALL  565 (611)
Q Consensus       521 ~~~~d------~~l~---~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~L  565 (611)
                      ..+.+      ....   ...+.     .....+.+|+.+||+.||++|||+.|+++.-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence            11111      0000   00111     1124678999999999999999999999753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=9.9e-40  Score=339.55  Aligned_cols=248  Identities=26%  Similarity=0.340  Sum_probs=204.2

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|.+.+.||+|+||.||++.+. +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            468999999999999999999964 6889999998754   234567789999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++.   ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus       120 ~e~~~~~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHK---RRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            99999999999873   3456899999999999999999999997   99999999999999999999999999987643


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ...  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....   ...   ... ......      
T Consensus       194 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~---~~~-~~~~~~------  258 (335)
T 2owb_A          194 DGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL---KET---YLR-IKKNEY------  258 (335)
T ss_dssp             TTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH---HHH---HHH-HHHTCC------
T ss_pred             Ccc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH---HHH---HHH-HhcCCC------
Confidence            322  22346799999999999999999999999999999999999999753221   111   111 111111      


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .+...    ....+.+|+.+||+.||++|||++|+++
T Consensus       259 ~~~~~----~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          259 SIPKH----INPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             CCCTT----SCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCCcc----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            01111    1235678999999999999999999997

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.6e-40  Score=334.87  Aligned_cols=254  Identities=26%  Similarity=0.384  Sum_probs=200.6

Q ss_pred             hCCCCcccccCccCceEEEEEEcCC----CcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPN----GKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      .++|++.+.||+|+||.||+|++.+    +..||+|++... .....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence            4689999999999999999998532    346999998765 33456789999999999999999999999765 45689


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++....
T Consensus        90 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            9999999999999853  2345899999999999999999999997   9999999999999999999999999998764


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ..... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......   .....+    ..+..... 
T Consensus       165 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~---~~~~~~----~~~~~~~~-  235 (281)
T 3cc6_A          165 DEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK---DVIGVL----EKGDRLPK-  235 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG---GHHHHH----HHTCCCCC-
T ss_pred             ccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH---HHHHHH----hcCCCCCC-
Confidence            43221 1223467889999999999999999999999999999998 99997533222   222211    11111110 


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                              .......+.+++.+||+.||++|||+.|+++.|+.
T Consensus       236 --------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  270 (281)
T 3cc6_A          236 --------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD  270 (281)
T ss_dssp             --------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence                    01112357789999999999999999999999964

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.7e-40  Score=331.48  Aligned_cols=246  Identities=22%  Similarity=0.273  Sum_probs=202.3

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++.+.||+|+||.||++... +++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            468999999999999999999964 67889999986542   22356789999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++..   ...+++..++.++.||++||.|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            999999999998843   356899999999999999999999986   99999999999999999999999999976533


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ..    .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....   ....    ........      
T Consensus       167 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~----~~~~~~~~------  229 (284)
T 2vgo_A          167 LR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH---TETH----RRIVNVDL------  229 (284)
T ss_dssp             SC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH---HHHH----HHHHTTCC------
T ss_pred             cc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH---hHHH----HHHhcccc------
Confidence            22    2345799999999999999999999999999999999999999753221   1111    11111111      


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ....    .....+.+++.+||+.||++||+++++++
T Consensus       230 ~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          230 KFPP----FLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCC----cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            1111    11235678999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.7e-39  Score=349.71  Aligned_cols=199  Identities=28%  Similarity=0.442  Sum_probs=167.3

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC-----Ce
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG-----EE  362 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~  362 (611)
                      .++|++.+.||+|+||.||++++ .+++.||||++...  .....+.+.+|+.+++.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            47899999999999999999995 46889999999753  334567889999999999999999999998776     57


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .++||||+++ +|.+++.   ....+++..++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++
T Consensus       105 ~~lv~e~~~~-~L~~~~~---~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIADS-DLKKLFK---TPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCSE-EHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCCc-CHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            8999999874 8988883   3456999999999999999999999997   9999999999999999999999999999


Q ss_pred             ecccCCCc--------------------cccccccccCCCCCcccc-ccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007239          443 IFCENQKT--------------------ANTRRVVGTYGYMAPEYA-MEGLFSVKSDVFSFGVIVLEIISGKRNS  496 (611)
Q Consensus       443 ~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~k~DvwSlGvll~elltG~~p~  496 (611)
                      ........                    ......+||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            76443221                    123457899999999986 5667999999999999999999865554

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.1e-39  Score=327.69  Aligned_cols=253  Identities=21%  Similarity=0.294  Sum_probs=202.3

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC--CeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG--EEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~--~~~~lv  366 (611)
                      .++|++.+.||+|+||.||+|++. ++.||+|++....  ....+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            367999999999999999999984 8899999987643  34467799999999999999999999999877  788999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++... ....+++..++.++.||+.||.|||+++ ..++||||||+||+++.++.++|.|||++.... 
T Consensus        88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-  164 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-  164 (271)
T ss_dssp             EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred             ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence            9999999999998542 2235899999999999999999999873 249999999999999999999999998875421 


Q ss_pred             CCCccccccccccCCCCCccccccCCCC---chhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFS---VKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                            .....||+.|+|||.+.+..++   .++||||||+++|||++|+.||.....      ..........+.... 
T Consensus       165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~-  231 (271)
T 3kmu_A          165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN------MEIGMKVALEGLRPT-  231 (271)
T ss_dssp             ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH------HHHHHHHHHSCCCCC-
T ss_pred             ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh------HHHHHHHHhcCCCCC-
Confidence                  1234789999999999876544   489999999999999999999753221      111122222222111 


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                          +..    .....+.+++..||+.||++|||++++++.|+..
T Consensus       232 ----~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          232 ----IPP----GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             ----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence                111    1223577899999999999999999999999753

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.2e-39  Score=338.35  Aligned_cols=263  Identities=24%  Similarity=0.353  Sum_probs=199.2

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      .++|++.+.||+|+||.||+++.. +++.||+|++.....  ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            468999999999999999999964 689999999865432  33566889999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       104 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999988763   3345899999999999999999999997   999999999999999999999999999865433


Q ss_pred             CCccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHH----------HHHHh
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYV----------WQLWK  516 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~----------~~~~~  516 (611)
                      ..  ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||......  ..+....          +..+.
T Consensus       178 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  253 (331)
T 4aaa_A          178 GE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI--DQLYHIMMCLGNLIPRHQELFN  253 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCSCCHHHHHHHH
T ss_pred             cc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCChhhhhHhh
Confidence            22  22345799999999999875 7899999999999999999999997543221  1111111          11111


Q ss_pred             cCc-cccccccccCCCCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          517 EGK-EMEFVDPLLMKSSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       517 ~~~-~~~~~d~~l~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ... ......+.+......     .....+.+|+.+||+.||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            111 111111111111111     12346789999999999999999999886

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.3e-39  Score=342.77  Aligned_cols=259  Identities=24%  Similarity=0.378  Sum_probs=206.0

Q ss_pred             CHHHHHHhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh--------hhHHHHHHHHHHHHhc-CCCCeee
Q 007239          283 HLAVIKAATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW--------QGLEEFKNEIILIAKL-QHRNLVR  352 (611)
Q Consensus       283 ~~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l-~h~niv~  352 (611)
                      .........++|++.+.||+|+||.||++++. +|+.||||++.....        ...+.+.+|+.+++++ +||||++
T Consensus        85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~  164 (365)
T 2y7j_A           85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT  164 (365)
T ss_dssp             HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            34444556678999999999999999999964 799999999875431        1245678999999999 7999999


Q ss_pred             EEEeEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCC
Q 007239          353 LVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV  432 (611)
Q Consensus       353 l~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~  432 (611)
                      +++++......++||||+++++|.+++.   ....+++..+..++.||+.||.|||+.|   |+||||||+|||++.++.
T Consensus       165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          165 LIDSYESSSFMFLVFDLMRKGELFDYLT---EKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             EEEEEEBSSEEEEEECCCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred             EEEEEeeCCEEEEEEEeCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence            9999999999999999999999999984   3456999999999999999999999997   999999999999999999


Q ss_pred             EEEeccccceecccCCCccccccccccCCCCCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhh
Q 007239          433 AKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAME------GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQT  506 (611)
Q Consensus       433 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~  506 (611)
                      +||+|||++..+.....   .....||+.|+|||++.+      ..++.++||||||+++|+|++|+.||....   ...
T Consensus       239 ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~  312 (365)
T 2y7j_A          239 IRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QIL  312 (365)
T ss_dssp             EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHH
T ss_pred             EEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHH
Confidence            99999999987654322   234689999999999863      358899999999999999999999974321   111


Q ss_pred             HHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          507 LLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       507 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ....    +..+... ...+.. .    .....+.+++.+||+.||++|||+.++++
T Consensus       313 ~~~~----i~~~~~~-~~~~~~-~----~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          313 MLRM----IMEGQYQ-FSSPEW-D----DRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHH----HHHTCCC-CCHHHH-S----SSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHH----HHhCCCC-CCCccc-c----cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1111    1111110 000000 0    01235778999999999999999999987

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.7e-40  Score=341.67  Aligned_cols=265  Identities=26%  Similarity=0.336  Sum_probs=194.5

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHH--HHhcCCCCeeeEEEeEee-----CCeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIIL--IAKLQHRNLVRLVGCGIE-----GEEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~i--l~~l~h~niv~l~~~~~~-----~~~~  363 (611)
                      .++|++.+.||+|+||.||+|+. +++.||+|++....   ...+..|.++  +..++||||+++++.+..     ....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            47899999999999999999987 68899999997543   2344445544  445899999999985432     3367


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhc---------CCCceEecCCCCCcEEecCCCCEE
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED---------SRLKIIHRDLKPSNVLLDKDMVAK  434 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~---------~~~~iiHrDikp~NIll~~~~~~k  434 (611)
                      ++||||+++++|.+++..    ...++..++.++.||++||.|||++         +   |+||||||+|||++.++.+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence            899999999999999833    3458899999999999999999988         6   99999999999999999999


Q ss_pred             EeccccceecccCCC------ccccccccccCCCCCcccccc-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Q 007239          435 ISDFGMARIFCENQK------TANTRRVVGTYGYMAPEYAME-------GLFSVKSDVFSFGVIVLEIISGKRNSGFYLT  501 (611)
Q Consensus       435 l~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwSlGvll~elltG~~p~~~~~~  501 (611)
                      |+|||+++.+.....      ........||+.|+|||++.+       ..++.++||||||+++|||++|..|+.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            999999987643321      112224579999999999986       4567799999999999999999776532221


Q ss_pred             Cch-hhH----------HHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          502 GHA-QTL----------LAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       502 ~~~-~~l----------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ... ...          ................+....  ........++.+|+.+||+.||++|||+.|+++.|+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            110 000          001111111111111111111  11223445688999999999999999999999999764

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-40  Score=344.70  Aligned_cols=255  Identities=22%  Similarity=0.266  Sum_probs=202.4

Q ss_pred             hCCCCcccccCccCceEEEEEEc----CCCcEEEEEEecccC----hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCC
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL----PNGKEVAVKRLSRKS----WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGE  361 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~  361 (611)
                      .++|++.+.||+|+||.||+++.    .+++.||+|+++...    ....+.+.+|+.+++++ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46899999999999999999996    378999999987532    22345677899999999 5999999999999999


Q ss_pred             eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccc
Q 007239          362 EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA  441 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  441 (611)
                      ..++||||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            9999999999999999984   3456899999999999999999999986   999999999999999999999999999


Q ss_pred             eecccCCCccccccccccCCCCCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCc
Q 007239          442 RIFCENQKTANTRRVVGTYGYMAPEYAME--GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK  519 (611)
Q Consensus       442 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  519 (611)
                      +.+..... .......||+.|+|||++.+  ..++.++||||||+++|||++|+.||........  .............
T Consensus       207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~  283 (355)
T 1vzo_A          207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSEP  283 (355)
T ss_dssp             EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHCCC
T ss_pred             eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhccCC
Confidence            87643322 22334679999999999986  3478999999999999999999999864333222  1111111111110


Q ss_pred             cccccccccCCCCCHHHHHHHHHHhhccccCCCCCCC-----CHHHHHHHh
Q 007239          520 EMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVALL  565 (611)
Q Consensus       520 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~~L  565 (611)
                             ..    +......+.+|+.+||+.||++||     +++|+++..
T Consensus       284 -------~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          284 -------PY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             -------CC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             -------CC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                   01    111223567899999999999999     999998765

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=9e-40  Score=334.84  Aligned_cols=251  Identities=26%  Similarity=0.335  Sum_probs=201.8

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ..++|.+.+.||+|+||.||++... +|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            4568999999999999999999964 789999999986655555678999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe---cCCCCEEEeccccceecc
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFC  445 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGla~~~~  445 (611)
                      |+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+||++   +.++.+||+|||++....
T Consensus        87 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~  160 (304)
T 2jam_A           87 LVSGGELFDRIL---ERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ  160 (304)
T ss_dssp             CCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred             cCCCccHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence            999999999884   3456899999999999999999999997   9999999999999   788999999999997543


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ..    ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....   ...+..    .+..+.. ....
T Consensus       161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~----~i~~~~~-~~~~  228 (304)
T 2jam_A          161 NG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET---ESKLFE----KIKEGYY-EFES  228 (304)
T ss_dssp             CB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHH----HHHHCCC-CCCT
T ss_pred             CC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHH----HHHcCCC-CCCc
Confidence            22    2234579999999999999999999999999999999999999974321   112222    1222211 0000


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      + .    .......+.+++.+||+.||++|||+.++++
T Consensus       229 ~-~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          229 P-F----WDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             T-T----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             c-c----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0 1    1112245778999999999999999999987

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.1e-39  Score=335.85  Aligned_cols=256  Identities=20%  Similarity=0.283  Sum_probs=200.0

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEee--CCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIE--GEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~--~~~~~lv  366 (611)
                      .++|++.+.||+|+||.||+++. .+++.||+|++....   .+.+.+|+.++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            36799999999999999999995 578999999997543   467899999999998 9999999999987  6678999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC-CEEEeccccceecc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFC  445 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGla~~~~  445 (611)
                      |||+++++|.+++.      .+++..++.++.||+.||.|||+++   |+||||||+|||++.++ .+||+|||+++...
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999988872      3889999999999999999999997   99999999999999777 89999999998764


Q ss_pred             cCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH---------H
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL---------W  515 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~---------~  515 (611)
                      ....   .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.....  ...........         +
T Consensus       183 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~--~~~~l~~~~~~~~~~~~~~~~  257 (330)
T 3nsz_A          183 PGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVRIAKVLGTEDLYDYI  257 (330)
T ss_dssp             TTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS--HHHHHHHHHHHHCHHHHHHHH
T ss_pred             CCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc--hHHHHHHHHHhcCCchhhhHH
Confidence            4332   234578999999999887 6789999999999999999999999743222  11111111111         1


Q ss_pred             hcCc--------------cccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          516 KEGK--------------EMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       516 ~~~~--------------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ....              ...................++.+|+..||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            1000              00011111111111123356789999999999999999999997

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-40  Score=342.81  Aligned_cols=255  Identities=26%  Similarity=0.463  Sum_probs=198.4

Q ss_pred             CCCCcccccCccCceEEEEEEcCC-----CcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPN-----GKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      ++|++.+.||+|+||.||+|.+..     +..||+|++.... ......+.+|+.++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            578889999999999999998542     2459999997643 3345678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            9999999999999853  2356899999999999999999999997   9999999999999999999999999998764


Q ss_pred             cCCCcc-ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          446 ENQKTA-NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       446 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      ...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....   ...+.    ..+..+.... 
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~---~~~~~----~~~~~~~~~~-  270 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS---NHEVM----KAINDGFRLP-  270 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHH----HHHHTTCCCC-
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC---HHHHH----HHHHCCCcCC-
Confidence            432211 1222356788999999999999999999999999999999 999874322   11111    2222221111 


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                              ........+.+++.+||+.||++||++.++++.|+.
T Consensus       271 --------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  306 (333)
T 1mqb_A          271 --------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK  306 (333)
T ss_dssp             --------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             --------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                    011122457789999999999999999999999964

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.7e-40  Score=343.91  Aligned_cols=258  Identities=31%  Similarity=0.460  Sum_probs=202.1

Q ss_pred             hCCCCcccccCccCceEEEEEEc------CCCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL------PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  363 (611)
                      .++|++.+.||+|+||.||++++      .+++.||+|++... .......+.+|+.++++++||||+++++++......
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46899999999999999999984      25778999999754 334566789999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhHhhhchh----hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC---CCCEEEe
Q 007239          364 LLIYELMPNRSLDCFIFDSER----RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK---DMVAKIS  436 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl~  436 (611)
                      ++||||+++++|.+++.....    ...+++..++.++.||+.||.|||+++   |+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999865321    245899999999999999999999997   999999999999984   4469999


Q ss_pred             ccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHH
Q 007239          437 DFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLW  515 (611)
Q Consensus       437 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  515 (611)
                      |||++................||+.|+|||.+.+..++.++||||||+++|+|++ |+.||....   ...+.    ...
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~----~~~  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVL----EFV  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHH----HHH
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC---HHHHH----HHH
Confidence            9999986544433333344578999999999999999999999999999999998 888874322   11122    112


Q ss_pred             hcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          516 KEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       516 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ..+.....         .......+.+++.+||+.||++||++.+|++.|..
T Consensus       259 ~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  301 (327)
T 2yfx_A          259 TSGGRMDP---------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  301 (327)
T ss_dssp             HTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hcCCCCCC---------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            22211110         11112357789999999999999999999999964

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.3e-39  Score=329.86  Aligned_cols=251  Identities=25%  Similarity=0.322  Sum_probs=200.5

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh------hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW------QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  363 (611)
                      .++|++.+.||+|+||.||++... +++.||+|++.....      ...+.+.+|+.++++++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            357999999999999999999965 689999999875422      1367899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC----CEEEeccc
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM----VAKISDFG  439 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~----~~kl~DFG  439 (611)
                      ++||||+++++|.+++.   ....+++..++.++.||+.||.|||+++   ++||||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLA---EKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            99999999999999984   3456899999999999999999999987   99999999999998877    89999999


Q ss_pred             cceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCc
Q 007239          440 MARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK  519 (611)
Q Consensus       440 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  519 (611)
                      ++........   .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||....   .....    ..+....
T Consensus       158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~----~~~~~~~  227 (283)
T 3bhy_A          158 IAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET---KQETL----TNISAVN  227 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHH----HHHHTTC
T ss_pred             cceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc---hHHHH----HHhHhcc
Confidence            9987643322   234579999999999999999999999999999999999999974322   11111    1111111


Q ss_pred             cccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          520 EMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       520 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..  .......    .....+.+++.+||+.||++|||+.++++
T Consensus       228 ~~--~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          228 YD--FDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CC--CCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cC--Ccchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            10  0000000    11235678999999999999999999997

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.5e-39  Score=348.49  Aligned_cols=254  Identities=28%  Similarity=0.369  Sum_probs=192.3

Q ss_pred             HHhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh--------hhHHHHHHHHHHHHhcCCCCeeeEEEeEe
Q 007239          288 KAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW--------QGLEEFKNEIILIAKLQHRNLVRLVGCGI  358 (611)
Q Consensus       288 ~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~niv~l~~~~~  358 (611)
                      ....++|.+.+.||+|+||.||+|.. .+++.||+|++.+...        .....+.+|+.++++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            34578999999999999999999995 4689999999875421        12235789999999999999999999975


Q ss_pred             eCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC---CEEE
Q 007239          359 EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM---VAKI  435 (611)
Q Consensus       359 ~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~---~~kl  435 (611)
                       .+..++||||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++   .+||
T Consensus       211 -~~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          211 -AEDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             -SSEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             -cCceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence             556899999999999998884   3456999999999999999999999987   99999999999997544   5999


Q ss_pred             eccccceecccCCCccccccccccCCCCCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHH
Q 007239          436 SDFGMARIFCENQKTANTRRVVGTYGYMAPEYAME---GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW  512 (611)
Q Consensus       436 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~  512 (611)
                      +|||+++......   ......||+.|+|||++..   ..++.++||||||+++|+|++|+.||.......  .+...  
T Consensus       284 ~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~--  356 (419)
T 3i6u_A          284 TDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ--  356 (419)
T ss_dssp             CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHH--
T ss_pred             eecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHH--
Confidence            9999998764322   2334689999999999863   678899999999999999999999985432221  12211  


Q ss_pred             HHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       513 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                        +..+.... ... ...    .....+.+|+.+||+.||++|||+.|+++
T Consensus       357 --i~~~~~~~-~~~-~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          357 --ITSGKYNF-IPE-VWA----EVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             --HHTTCCCC-CHH-HHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --HhcCCCCC-Cch-hhc----ccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence              11111110 000 000    11235778999999999999999999987

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.5e-40  Score=336.71  Aligned_cols=257  Identities=25%  Similarity=0.371  Sum_probs=199.8

Q ss_pred             hCCCCcccccCccCceEEEEEEcCC----CcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeE-eeCCeEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPN----GKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCG-IEGEEKL  364 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~-~~~~~~~  364 (611)
                      ..+|++.+.||+|+||.||+|.+.+    ...+|+|.+... .....+.+.+|+.++++++||||+++++++ ..++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3568899999999999999999532    235899998754 334567899999999999999999999985 4556789


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +||||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||+++..
T Consensus       104 ~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             EEEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             EEEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence            99999999999999853  3456899999999999999999999997   999999999999999999999999999876


Q ss_pred             ccCCCc--cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCchhhHHHHHHHHHhcCccc
Q 007239          445 CENQKT--ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK-RNSGFYLTGHAQTLLAYVWQLWKEGKEM  521 (611)
Q Consensus       445 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~  521 (611)
                      ......  .......||+.|+|||.+.+..++.++||||||+++|+|++|. +|+.....   .......    ..+...
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---~~~~~~~----~~~~~~  251 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT---FDITVYL----LQGRRL  251 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT---TTHHHHH----HTTCCC
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH---HHHHHHH----hcCCCC
Confidence            433221  1223456788999999999999999999999999999999955 45432221   1222111    111110


Q ss_pred             cccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          522 EFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       522 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      .     ....    ....+.+++.+||+.||++|||+++++++|++.
T Consensus       252 ~-----~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          252 L-----QPEY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             C-----CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C-----CCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0     0011    123577899999999999999999999999754

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.3e-40  Score=343.39  Aligned_cols=262  Identities=15%  Similarity=0.197  Sum_probs=203.4

Q ss_pred             hCCCCcccccCccCceEEEEEEcCC---------CcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeee---------
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPN---------GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR---------  352 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~---------  352 (611)
                      .++|++.+.||+|+||.||++++..         ++.||+|++...     +.+.+|+.++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999999653         788999998754     35789999999999999887         


Q ss_pred             ------EEEeEee-CCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcE
Q 007239          353 ------LVGCGIE-GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNV  425 (611)
Q Consensus       353 ------l~~~~~~-~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NI  425 (611)
                            +++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  5667665 67889999999 99999999543 2367999999999999999999999997   99999999999


Q ss_pred             EecCCC--CEEEeccccceecccCCCcc-----ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 007239          426 LLDKDM--VAKISDFGMARIFCENQKTA-----NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGF  498 (611)
Q Consensus       426 ll~~~~--~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~  498 (611)
                      |++.++  .+||+|||+++.+.......     ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  99999999998765432211     12345899999999999999999999999999999999999999864


Q ss_pred             CCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          499 YLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       499 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ..... ..+...... +... ...+.+.....   .....++.+|+.+||+.||++||++++|+++|+..
T Consensus       271 ~~~~~-~~~~~~~~~-~~~~-~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          271 CLPNT-EDIMKQKQK-FVDK-PGPFVGPCGHW---IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             GTTCH-HHHHHHHHH-HHHS-CCCEECTTSCE---ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CCcCH-HHHHHHHHh-ccCC-hhhhhhhcccc---CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            43221 222222211 1111 11122111110   01124577899999999999999999999999653

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.7e-39  Score=356.46  Aligned_cols=249  Identities=28%  Similarity=0.362  Sum_probs=202.5

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++.+.||+|+||.||+++. .+|+.||+|++.+...   .....+.+|+.++++++||||+++++++......++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            46799999999999999999996 4699999999975422   3456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhch-hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          367 YELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      |||+++++|..++.... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.+|++||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999886432 2456999999999999999999999997   9999999999999999999999999998764


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCC-chhhHHHHHHHHHhcCcccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTG-HAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+..   . ...... .  
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~---~-i~~~~~-~--  411 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ---R-VLEQAV-T--  411 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH---H-HHHCCC-C--
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH---H-Hhhccc-C--
Confidence            4332  223468999999999999999999999999999999999999998643321 1111211   1 111111 0  


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCH
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTM  558 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  558 (611)
                             .+......+.+|+..||+.||++||++
T Consensus       412 -------~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          412 -------YPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             -------CCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             -------CCcccCHHHHHHHHHhccCCHhHCCCC
Confidence                   011122456789999999999999976

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-39  Score=340.75  Aligned_cols=260  Identities=27%  Similarity=0.319  Sum_probs=195.9

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC------
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE------  361 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------  361 (611)
                      .++|++.+.||+|+||.||++++ .+|+.||+|++...  .....+++.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            36899999999999999999996 57999999998653  3334567899999999999999999999987653      


Q ss_pred             eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccc
Q 007239          362 EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA  441 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  441 (611)
                      ..++||||+ +++|.+++..    ..+++..+..++.||++||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            469999999 7899988743    46899999999999999999999997   999999999999999999999999999


Q ss_pred             eecccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc
Q 007239          442 RIFCENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE  520 (611)
Q Consensus       442 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  520 (611)
                      +.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....   ......+........ 
T Consensus       176 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~~~-  246 (367)
T 1cm8_A          176 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTGTPP-  246 (367)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCC-
T ss_pred             cccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhcCCCC-
Confidence            875332     234578999999999887 6799999999999999999999999853322   122222211111100 


Q ss_pred             cccc-------------------ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH--HhcCC
Q 007239          521 MEFV-------------------DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA--LLGSE  568 (611)
Q Consensus       521 ~~~~-------------------d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~  568 (611)
                      .+++                   ...+. .........+.+|+.+||+.||++|||++|+++  .++..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence            0000                   00000 000111245778999999999999999999998  45544

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3e-40  Score=336.22  Aligned_cols=255  Identities=28%  Similarity=0.363  Sum_probs=202.0

Q ss_pred             hCCCCccc-ccCccCceEEEEEEc---CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE
Q 007239          291 TDGFSDSN-KLGQGGFGTVYKGVL---PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       291 ~~~y~~~~-~lg~G~fg~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  364 (611)
                      .++|.+.+ .||+|+||.||++.+   ..++.||+|++....  ....+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            35788888 999999999999963   346889999997543  23357899999999999999999999998 667889


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +||||+++++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            99999999999999843   345899999999999999999999997   999999999999999999999999999876


Q ss_pred             ccCCCcc-ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          445 CENQKTA-NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       445 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      ....... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.....   ..+    ......+....
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~----~~~~~~~~~~~  240 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEV----TAMLEKGERMG  240 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHH----HHHHHTTCCCC
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHH----HHHHHcCCCCC
Confidence            4433221 1222356788999999999899999999999999999999 9999753221   111    12222222111


Q ss_pred             ccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       523 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      .         +......+.+++..||+.||++||++.+|++.|+..
T Consensus       241 ~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          241 C---------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             C---------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             C---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1         111224577899999999999999999999999753

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.1e-39  Score=338.17  Aligned_cols=259  Identities=22%  Similarity=0.295  Sum_probs=202.6

Q ss_pred             HHHHhhCCCCcc-cccCccCceEEEEEEcC-CCcEEEEEEecccC--hhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeC
Q 007239          286 VIKAATDGFSDS-NKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEG  360 (611)
Q Consensus       286 ~~~~~~~~y~~~-~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~  360 (611)
                      ..+...++|.+. +.||+|+||.||+++.. +++.||+|++....  ......+.+|+.+++.+. ||||+++++++.+.
T Consensus        22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~  101 (327)
T 3lm5_A           22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT  101 (327)
T ss_dssp             CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence            345556778887 89999999999999964 68999999987543  234678899999999996 69999999999999


Q ss_pred             CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC---CCCEEEec
Q 007239          361 EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK---DMVAKISD  437 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl~D  437 (611)
                      +..++||||+++++|.+++.. .....+++..++.++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~D  177 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLP-ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVD  177 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSS-CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECC
T ss_pred             CeEEEEEEecCCCcHHHHHHH-hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEee
Confidence            999999999999999998843 22356899999999999999999999997   999999999999987   78999999


Q ss_pred             cccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhc
Q 007239          438 FGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKE  517 (611)
Q Consensus       438 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  517 (611)
                      ||+++.......   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.....   ......+.   ..
T Consensus       178 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~---~~  248 (327)
T 3lm5_A          178 FGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---QETYLNIS---QV  248 (327)
T ss_dssp             GGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH---HT
T ss_pred             CccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHH---hc
Confidence            999987643322   2345799999999999999999999999999999999999999743221   11111111   11


Q ss_pred             CccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          518 GKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       518 ~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                       .. ....     .........+.+++.+||+.||++|||++++++.
T Consensus       249 -~~-~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          249 -NV-DYSE-----ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             -CC-CCCT-----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             -cc-ccCc-----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence             10 0000     0011122456789999999999999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=8.9e-39  Score=327.25  Aligned_cols=253  Identities=23%  Similarity=0.258  Sum_probs=198.3

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC----hhhHHHHHHHHHHHHhcCCCCeeeEEEeEe--eCCe
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS----WQGLEEFKNEIILIAKLQHRNLVRLVGCGI--EGEE  362 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h~niv~l~~~~~--~~~~  362 (611)
                      ..++|++.+.||+|+||.||++.. .+++.||+|++....    ....+.+.+|+.++++++||||+++++++.  +...
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            357899999999999999999996 468899999997542    234578999999999999999999999984  4567


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .++||||++++ |.+++.. .....+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++.
T Consensus        83 ~~lv~e~~~~~-l~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~  157 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDS-VPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE  157 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHH-STTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEehhccCC-HHHHHHh-CcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence            89999999987 6666543 23456899999999999999999999997   9999999999999999999999999998


Q ss_pred             ecccCCCccccccccccCCCCCccccccCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc
Q 007239          443 IFCENQKTANTRRVVGTYGYMAPEYAMEGL--FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE  520 (611)
Q Consensus       443 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  520 (611)
                      ...............||+.|+|||++.+..  ++.++||||||+++|||++|+.||....   ...+.    ..+..+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~----~~i~~~~~  230 (305)
T 2wtk_C          158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IYKLF----ENIGKGSY  230 (305)
T ss_dssp             ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHH----HHHHHCCC
T ss_pred             ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HHHHH----HHHhcCCC
Confidence            765433333334567999999999987654  3789999999999999999999975321   11111    11222211


Q ss_pred             ccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       521 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                            .+..    .....+.+++.+||+.||++|||++++++.
T Consensus       231 ------~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          231 ------AIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ------CCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ------CCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                  0111    112356789999999999999999999964

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=5.7e-39  Score=348.82  Aligned_cols=260  Identities=20%  Similarity=0.278  Sum_probs=207.0

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCC-CCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQH-RNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.++||+|+||.||++++ .+++.||||++.....  ...+.+|+++++.++| +++..+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            47899999999999999999995 5789999998865432  2357899999999987 566667777778889999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe---cCCCCEEEeccccceecc
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFC  445 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGla~~~~  445 (611)
                      |+ +++|.+++...  ...+++..++.|+.||+.||.|||+++   |+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999998532  346999999999999999999999997   9999999999999   688999999999999875


Q ss_pred             cCCCcc-----ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc
Q 007239          446 ENQKTA-----NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE  520 (611)
Q Consensus       446 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  520 (611)
                      ......     ......||+.|+|||++.+..++.++||||||++||||++|+.||..............+.........
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            443221     123568999999999999999999999999999999999999998765544433333333222211111


Q ss_pred             ccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       521 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ..+..     ..    ..++.+|+..||+.+|++||++.+|+++|+.
T Consensus       238 ~~l~~-----~~----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~  275 (483)
T 3sv0_A          238 EALCR-----GY----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRD  275 (483)
T ss_dssp             HHHHT-----TS----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             HHHhc-----CC----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            11111     11    2357789999999999999999999998854

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.7e-39  Score=331.06  Aligned_cols=249  Identities=26%  Similarity=0.401  Sum_probs=205.1

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .+.|++.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            46799999999999999999995 578999999987543 3456789999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++++|.+++.    ...+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++.......
T Consensus       101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            999999999883    246899999999999999999999997   9999999999999999999999999998764433


Q ss_pred             CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                      .  ......||+.|+|||++.+..++.++||||||+++|+|++|+.|+....   .......    .......     .+
T Consensus       174 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~----~~~~~~~-----~~  239 (303)
T 3a7i_A          174 I--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH---PMKVLFL----IPKNNPP-----TL  239 (303)
T ss_dssp             C--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHH----HHHSCCC-----CC
T ss_pred             c--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC---HHHHHHH----hhcCCCC-----CC
Confidence            2  2234579999999999999999999999999999999999999975322   1111111    1111111     11


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ....    ...+.+++..||+.||++|||+.++++.
T Consensus       240 ~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          240 EGNY----SKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             CSSC----CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             cccc----CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            1111    2356789999999999999999999874

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.7e-40  Score=351.16  Aligned_cols=242  Identities=13%  Similarity=0.113  Sum_probs=188.0

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc---ChhhHHHHHHHHH---HHHhcCCCCeeeEE-------Ee
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK---SWQGLEEFKNEII---LIAKLQHRNLVRLV-------GC  356 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~---il~~l~h~niv~l~-------~~  356 (611)
                      .++|++.+.||+|+||.||+|++ .+|+.||||++...   .....+.+.+|+.   +++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46799999999999999999996 57999999998743   3345678899994   55556799999998       66


Q ss_pred             EeeCC-----------------eEEEEEEecCCCChhhHhhhchh----hccCCHHHHHHHHHHHHHHHHHHhhcCCCce
Q 007239          357 GIEGE-----------------EKLLIYELMPNRSLDCFIFDSER----RLQLNWNTCYNIIGGISKGLLYLHEDSRLKI  415 (611)
Q Consensus       357 ~~~~~-----------------~~~lv~E~~~~~sL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~i  415 (611)
                      +...+                 ..++||||+ +|+|.+++.....    ...+++..++.++.||+.||.|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            55543                 278999999 5799999854321    122335888899999999999999997   9


Q ss_pred             EecCCCCCcEEecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccC-----------CCCchhhHHHHHH
Q 007239          416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG-----------LFSVKSDVFSFGV  484 (611)
Q Consensus       416 iHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~k~DvwSlGv  484 (611)
                      +||||||+||||+.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986322     2234578 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          485 IVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       485 ll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ++|||++|+.||.......               ....+.. .. ..    ...++.+|+.+||+.||++|||+.++++
T Consensus       302 il~elltg~~Pf~~~~~~~---------------~~~~~~~-~~-~~----~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALG---------------GSEWIFR-SC-KN----IPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------C---------------CSGGGGS-SC-CC----CCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCccccccc---------------chhhhhh-hc-cC----CCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999999999974322111               0001111 00 11    1245778999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4e-40  Score=332.90  Aligned_cols=249  Identities=28%  Similarity=0.385  Sum_probs=195.7

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC-CeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG-EEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-~~~~lv~E~  369 (611)
                      .++|++.+.||+|+||.||++.+ .|+.||+|++....  ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            46899999999999999999987 48899999997553  456789999999999999999999987554 478999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++++|.+++... ....+++..++.++.||+.||.|||+++   ++||||||+||+++.++.+||+|||++....... 
T Consensus        97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            9999999998542 2334899999999999999999999997   9999999999999999999999999998653321 


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                          ....+++.|+|||.+.+..++.++||||||+++|+|++ |+.|+.....   ..+..    ....+...     ..
T Consensus       172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~----~~~~~~~~-----~~  235 (278)
T 1byg_A          172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVP----RVEKGYKM-----DA  235 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHH----HHTTTCCC-----CC
T ss_pred             ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH----HHhcCCCC-----CC
Confidence                23467889999999999999999999999999999998 9998754322   12221    11221111     11


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                          .......+.+++..||+.||++|||+.++++.|+.
T Consensus       236 ----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  270 (278)
T 1byg_A          236 ----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  270 (278)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence                11122457789999999999999999999999964

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.4e-40  Score=336.31  Aligned_cols=261  Identities=26%  Similarity=0.407  Sum_probs=186.2

Q ss_pred             HhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ...++|++.+.||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            3457899999999999999999995 478899999986543 23456788999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhc-----hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccc
Q 007239          367 YELMPNRSLDCFIFDS-----ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA  441 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~-----~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  441 (611)
                      |||+++++|.+++...     .....+++..++.++.||+.||.|||+++   ++||||||+||+++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence            9999999999988542     12355899999999999999999999997   999999999999999999999999999


Q ss_pred             eecccCCC---ccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhc
Q 007239          442 RIFCENQK---TANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKE  517 (611)
Q Consensus       442 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  517 (611)
                      ........   ........||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.......   ....   ....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~---~~~~  242 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---VLML---TLQN  242 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---HHHH---HHTS
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---HHHH---Hhcc
Confidence            76543221   111234579999999999876 568999999999999999999999985433221   1111   1111


Q ss_pred             Cccccc----cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          518 GKEMEF----VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       518 ~~~~~~----~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       .....    .+......    ....+.+++.+||+.||++|||+.++++
T Consensus       243 -~~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          243 -DPPSLETGVQDKEMLKK----YGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             -SCCCTTC-----CCCCC----CCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -CCCccccccccchhhhh----hhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence             11111    11111111    1235678999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.8e-39  Score=331.97  Aligned_cols=253  Identities=23%  Similarity=0.384  Sum_probs=198.7

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ..++|++.+.||+|+||.||++.+. +++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3478999999999999999999965 688999999987766677889999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++++|.+++..  ....+++..++.++.||+.||.|||+++   ++||||||+||+++.++.+||+|||++.......
T Consensus        97 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             CCTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             eCCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            9999999988743  2345899999999999999999999997   9999999999999999999999999986432211


Q ss_pred             CccccccccccCCCCCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      .  ......||+.|+|||++.     ...++.++||||||+++|+|++|+.|+.....      ............ ...
T Consensus       172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~-~~~  242 (302)
T 2j7t_A          172 Q--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSDP-PTL  242 (302)
T ss_dssp             H--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHHHSCC-CCC
T ss_pred             c--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH------HHHHHHHhccCC-ccc
Confidence            1  122357999999999983     67789999999999999999999999753321      111112122211 111


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..       .......+.+++.+||+.||++|||+.++++
T Consensus       243 ~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 LT-------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             SS-------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             CC-------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            10       1111245778999999999999999999875

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=8.7e-39  Score=325.14  Aligned_cols=249  Identities=26%  Similarity=0.373  Sum_probs=197.8

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee----CCeEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE----GEEKL  364 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~  364 (611)
                      +.|++.+.||+|+||.||+|.+ .++..||+|++...  .....+.+.+|+.+++.++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            4588889999999999999995 46888999998754  33456778999999999999999999998875    45689


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec-CCCCEEEecccccee
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD-KDMVAKISDFGMARI  443 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~-~~~~~kl~DFGla~~  443 (611)
                      +||||+++++|.+++.   ....+++..++.++.||+.||.|||+++ .+|+||||||+|||++ .++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHH---HccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            9999999999999984   3456899999999999999999999873 2499999999999997 789999999999975


Q ss_pred             cccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          444 FCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       444 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      ....    ......||+.|+|||.+. +.++.++||||||+++|+|++|+.||.....  ...    .......+.....
T Consensus       182 ~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~----~~~~~~~~~~~~~  250 (290)
T 1t4h_A          182 KRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQ----IYRRVTSGVKPAS  250 (290)
T ss_dssp             CCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHH----HHHHHTTTCCCGG
T ss_pred             cccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHH----HHHHHhccCCccc
Confidence            4322    223457999999999876 5689999999999999999999999753222  111    1111222211111


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .+..        ...++.+++..||+.||++|||++++++
T Consensus       251 ~~~~--------~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          251 FDKV--------AIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGGC--------CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCC--------CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            1111        1135778999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.3e-39  Score=329.03  Aligned_cols=258  Identities=24%  Similarity=0.308  Sum_probs=203.4

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEee--CCeEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIE--GEEKLL  365 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~l  365 (611)
                      .++|++.+.||+|+||.||++... +++.||+|++....  ....+.+.+|+.++++++||||+++++++..  ....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999999964 78999999997543  3446779999999999999999999998754  568899


Q ss_pred             EEEecCCCChhhHhhhch-hhccCCHHHHHHHHHHHHHHHHHHhhcC--CCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          366 IYELMPNRSLDCFIFDSE-RRLQLNWNTCYNIIGGISKGLLYLHEDS--RLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~l~yLH~~~--~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      ||||+++++|.+++.... ....+++..++.++.||+.||.|||+++  ..+|+||||||+||+++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999986532 2345899999999999999999999974  1239999999999999999999999999998


Q ss_pred             ecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          443 IFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       443 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      .......  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....   ...+.    ..+..+....
T Consensus       165 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~----~~i~~~~~~~  235 (279)
T 2w5a_A          165 ILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELA----GKIREGKFRR  235 (279)
T ss_dssp             HC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH----HHHHHTCCCC
T ss_pred             eeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC---HHHHH----HHHhhccccc
Confidence            6543221  1224578999999999999999999999999999999999999975332   11222    2222222211


Q ss_pred             ccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       523 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                           +..    ....++.+++.+||+.||++||+++||++.+.
T Consensus       236 -----~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          236 -----IPY----RYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             -----CCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             -----CCc----ccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence                 111    12245778999999999999999999998764

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=2.7e-39  Score=326.16  Aligned_cols=248  Identities=26%  Similarity=0.383  Sum_probs=195.3

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++.+.||+|+||.||++.+. +++.||+|++....   ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            478999999999999999999965 78999999986542   23456789999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++.   ....+++..++.++.||+.||.|||+++   ++|+||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYIC---KHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            99999999999984   3456899999999999999999999997   99999999999999999999999999987543


Q ss_pred             CCCccccccccccCCCCCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLF-SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ...   .....||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||....   ...+.    +....+..     
T Consensus       164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~----~~~~~~~~-----  228 (276)
T 2h6d_A          164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLF----KKIRGGVF-----  228 (276)
T ss_dssp             ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH----HHHHHCCC-----
T ss_pred             Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHH----HHhhcCcc-----
Confidence            321   223578999999999988765 689999999999999999999974321   11111    11222211     


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                       .+...    ....+.+++.+||+.||++|||++++++.
T Consensus       229 -~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 -YIPEY----LNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -CCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -cCchh----cCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             01111    12356789999999999999999999973

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.6e-40  Score=340.03  Aligned_cols=255  Identities=25%  Similarity=0.399  Sum_probs=200.7

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcE--EEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKE--VAVKRLSRK-SWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ++|++.+.||+|+||.||++++. +++.  +++|.+... .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            68999999999999999999964 5664  499988753 233456789999999999 899999999999999999999


Q ss_pred             EEecCCCChhhHhhhch-------------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCE
Q 007239          367 YELMPNRSLDCFIFDSE-------------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVA  433 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~  433 (611)
                      |||+++++|.+++....             ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999985432             2246899999999999999999999997   9999999999999999999


Q ss_pred             EEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHH
Q 007239          434 KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVW  512 (611)
Q Consensus       434 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~  512 (611)
                      ||+|||+++......   ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....   ..    ..
T Consensus       182 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~----~~  251 (327)
T 1fvr_A          182 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AE----LY  251 (327)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HH----HH
T ss_pred             EEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---HH----HH
Confidence            999999997432211   1223467889999999999899999999999999999998 9999743221   11    11


Q ss_pred             HHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       513 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      .....+....         .......++.+|+.+||+.||++|||++++++.|+..
T Consensus       252 ~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          252 EKLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             HHGGGTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhhcCCCCC---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1222221111         1111224577899999999999999999999999753

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.1e-39  Score=366.72  Aligned_cols=249  Identities=23%  Similarity=0.263  Sum_probs=203.2

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~  364 (611)
                      ..++|++.+.||+|+||.||+++.. +++.||||++++..   ....+.+.+|..++..+ +||+|+++++++.+.+.++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4578999999999999999999964 68899999997542   23456788899999988 6999999999999999999


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +||||+++|+|..++.   ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++++||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQ---QVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            9999999999999984   3456999999999999999999999997   999999999999999999999999999864


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ....  ......+||+.|+|||++.+..++.++||||||++||||++|+.||...   ....+...    +..... .  
T Consensus       493 ~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~----i~~~~~-~--  560 (674)
T 3pfq_A          493 IWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQS----IMEHNV-A--  560 (674)
T ss_dssp             CCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHH----HHSSCC-C--
T ss_pred             ccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC---CHHHHHHH----HHhCCC-C--
Confidence            3322  2234578999999999999999999999999999999999999998532   22222221    222111 0  


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCH-----HHHHH
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTM-----SNVVA  563 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~-----~evl~  563 (611)
                         .    +.....++.+|+..||+.||++||++     +||++
T Consensus       561 ---~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          561 ---Y----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             ---C----CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             ---C----CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence               1    11123457789999999999999997     66664

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4e-39  Score=342.09  Aligned_cols=262  Identities=23%  Similarity=0.259  Sum_probs=201.8

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcC--------CCCeeeEEEeEe---
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ--------HRNLVRLVGCGI---  358 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--------h~niv~l~~~~~---  358 (611)
                      .++|++.++||+|+||.||+++. .+++.||+|++... ....+.+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            47899999999999999999995 56889999999754 344577899999999996        788999999987   


Q ss_pred             -eCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhc-CCCceEecCCCCCcEEecCCC-----
Q 007239          359 -EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED-SRLKIIHRDLKPSNVLLDKDM-----  431 (611)
Q Consensus       359 -~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDikp~NIll~~~~-----  431 (611)
                       .....++||||+. ++|.+.+... ....+++..++.++.||+.||.|||++ +   |+||||||+||||+.++     
T Consensus       115 ~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVLG-HHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEeccC-ccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence             5568899999995 4555555332 234689999999999999999999998 6   99999999999999775     


Q ss_pred             --------------------------------------------CEEEeccccceecccCCCccccccccccCCCCCccc
Q 007239          432 --------------------------------------------VAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY  467 (611)
Q Consensus       432 --------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~  467 (611)
                                                                  .+||+|||+++.....     .....||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence                                                        8999999999876432     223579999999999


Q ss_pred             cccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchh---hHHHHHHHHHhcCc---------cccccccc-----c--
Q 007239          468 AMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQ---TLLAYVWQLWKEGK---------EMEFVDPL-----L--  528 (611)
Q Consensus       468 ~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~---~l~~~~~~~~~~~~---------~~~~~d~~-----l--  528 (611)
                      +.+..++.++|||||||++|||++|+.||.........   .....+.+......         ..++....     +  
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            99999999999999999999999999998654433221   12222222111100         00000000     0  


Q ss_pred             ------------CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          529 ------------MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       529 ------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                                  ...........+.+|+.+||+.||++|||+.|+++
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                        01223455667889999999999999999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.2e-40  Score=367.52  Aligned_cols=254  Identities=26%  Similarity=0.375  Sum_probs=198.9

Q ss_pred             CCCccc-ccCccCceEEEEEEcC---CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          293 GFSDSN-KLGQGGFGTVYKGVLP---NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       293 ~y~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++.+.+ .||+|+||.||+|.+.   ++..||||+++... ....+.+.+|+.++++++||||+++++++.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344444 7999999999999853   46679999997643 3456889999999999999999999999876 5689999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus       415 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          415 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             ECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             EeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            99999999999853  2456899999999999999999999986   999999999999999999999999999876433


Q ss_pred             CCcc-ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          448 QKTA-NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       448 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      .... ......+|+.|+|||++.++.++.++|||||||++|||++ |+.||.....   ..+.    ..+..+.....  
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~----~~i~~~~~~~~--  560 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVM----AFIEQGKRMEC--  560 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS---HHHH----HHHHTTCCCCC--
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHH----HHHHcCCCCCC--
Confidence            2211 1122346789999999999999999999999999999998 9999854332   1122    22223322111  


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                             +.....++.+|+..||+.||++||++.+|++.|+..
T Consensus       561 -------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          561 -------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             -------CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                   111234677899999999999999999999999753

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.3e-40  Score=345.89  Aligned_cols=255  Identities=26%  Similarity=0.403  Sum_probs=191.3

Q ss_pred             CCCcccccCccCceEEEEEEcC--CC--cEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEe-eCCeEEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVLP--NG--KEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGI-EGEEKLLI  366 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~-~~~~~~lv  366 (611)
                      .|++.+.||+|+||.||+|.+.  ++  ..||+|.+... .....+.+.+|+.++++++||||+++++++. ..+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4777899999999999999853  32  35899998654 3345678999999999999999999999865 45678999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999999999843  3345889999999999999999999997   99999999999999999999999999986643


Q ss_pred             CCCcc--ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          447 NQKTA--NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       447 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      .....  ......+|+.|+|||.+.+..++.++||||||+++|||++ |.+||......   .+...+    ..+.... 
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~---~~~~~~----~~~~~~~-  316 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF---DITVYL----LQGRRLL-  316 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS---CHHHHH----HTTCCCC-
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH---HHHHHH----HcCCCCC-
Confidence            32211  1223467889999999999999999999999999999999 56666433222   222211    1221110 


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                       .   ..    .....+.+++.+||+.||++|||++++++.|+..
T Consensus       317 -~---p~----~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          317 -Q---PE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             -C---CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -C---CC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             0   01    1123577899999999999999999999999764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8.1e-39  Score=349.67  Aligned_cols=252  Identities=27%  Similarity=0.346  Sum_probs=201.3

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ..++|++.+.||+|+||+||+++.. +++.||+|++...  .......+.+|+.++++++||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            4468999999999999999999964 7899999998643  223467889999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec---CCCCEEEecccccee
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARI  443 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~---~~~~~kl~DFGla~~  443 (611)
                      |||+++++|.+.+.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||+++.
T Consensus       100 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEII---KRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            99999999998884   3456999999999999999999999997   99999999999995   456899999999986


Q ss_pred             cccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          444 FCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       444 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      +....   ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||....   ...+...    +..+.....
T Consensus       174 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~----i~~~~~~~~  242 (486)
T 3mwu_A          174 FQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKR----VETGKYAFD  242 (486)
T ss_dssp             BCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH----HHHTCCCSC
T ss_pred             CCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH----HHhCCCCCC
Confidence            54332   2234579999999999875 59999999999999999999999974321   1122221    122211100


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ... .     ......+.+|+..||+.||++|||+.++++.
T Consensus       243 ~~~-~-----~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          243 LPQ-W-----RTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             SGG-G-----GGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             Ccc-c-----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000 0     1112357799999999999999999999974

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=9.3e-39  Score=349.85  Aligned_cols=250  Identities=28%  Similarity=0.386  Sum_probs=197.1

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      .++|++.+.||+|+||.||+++.. +++.||+|++....  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457999999999999999999964 78899999987543  233567899999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC---CCEEEeccccceec
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD---MVAKISDFGMARIF  444 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~---~~~kl~DFGla~~~  444 (611)
                      ||+++++|.+.+.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++..   +.+||+|||++..+
T Consensus       116 e~~~~g~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEII---HRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            9999999988884   3456999999999999999999999997   9999999999999764   55999999999876


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      .....   .....||+.|+|||++. +.++.++|||||||++|+|++|+.||....   ...+...    +..+... +.
T Consensus       190 ~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~----i~~~~~~-~~  257 (494)
T 3lij_A          190 ENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT---DQEILRK----VEKGKYT-FD  257 (494)
T ss_dssp             BTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH----HHHTCCC-CC
T ss_pred             CCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH----HHhCCCC-CC
Confidence            54322   23457999999999876 569999999999999999999999985322   1222221    2222111 00


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .+.. .    .....+.+|+.+||+.||++|||+.++++
T Consensus       258 ~~~~-~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          258 SPEW-K----NVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             SGGG-T----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhc-c----cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            1111 1    11235678999999999999999999985

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4e-39  Score=353.66  Aligned_cols=251  Identities=28%  Similarity=0.377  Sum_probs=199.5

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccCh-------------hhHHHHHHHHHHHHhcCCCCeeeEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW-------------QGLEEFKNEIILIAKLQHRNLVRLVG  355 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~il~~l~h~niv~l~~  355 (611)
                      ..++|++.++||+|+||+||++... +++.||+|++.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999964 688999999875431             23567899999999999999999999


Q ss_pred             eEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC---C
Q 007239          356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM---V  432 (611)
Q Consensus       356 ~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~---~  432 (611)
                      ++.+....++||||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQII---NRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            9999999999999999999998884   3456999999999999999999999997   99999999999998776   6


Q ss_pred             EEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHH
Q 007239          433 AKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW  512 (611)
Q Consensus       433 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~  512 (611)
                      +||+|||++..+.....   .....||+.|+|||++. +.++.++||||||+++|+|++|+.||....   ...+...  
T Consensus       188 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~--  258 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN---DQDIIKK--  258 (504)
T ss_dssp             EEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH--
T ss_pred             EEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH--
Confidence            99999999987654322   23457999999999886 568999999999999999999999985322   1222221  


Q ss_pred             HHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       513 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                        +..+........  ...    ...++.+|+.+||+.||++|||++|+++
T Consensus       259 --i~~~~~~~~~~~--~~~----~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          259 --VEKGKYYFDFND--WKN----ISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             --HHHCCCCCCHHH--HTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --HHcCCCCCCccc--cCC----CCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence              122211100000  000    1235778999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=327.73  Aligned_cols=252  Identities=26%  Similarity=0.388  Sum_probs=199.2

Q ss_pred             HhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ...++|++.+.||+|+||.||++.+. +|+.||+|++....  ..+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            34578999999999999999999964 68999999997643  3467899999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus       104 e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            99999999998842  3456899999999999999999999987   999999999999999999999999999876443


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                      ..  ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.....      ........ ......+..  
T Consensus       179 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~-~~~~~~~~~--  247 (314)
T 3com_A          179 MA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP------MRAIFMIP-TNPPPTFRK--  247 (314)
T ss_dssp             BS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH------HHHHHHHH-HSCCCCCSS--
T ss_pred             cc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHHh-cCCCcccCC--
Confidence            22  22345799999999999999999999999999999999999999753221      11111111 111111110  


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                           .......+.+++.+||+.||++|||+.++++
T Consensus       248 -----~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          248 -----PELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             -----GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -----cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                 1111245778999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.1e-39  Score=346.74  Aligned_cols=261  Identities=20%  Similarity=0.298  Sum_probs=196.1

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe------EE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE------KL  364 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~------~~  364 (611)
                      ..+|++.+.||+|+||.||++++..+..+|+|++......    ..+|+.+++.++||||+++++++.....      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            3579999999999999999999877777999988654322    2479999999999999999999865443      78


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec-CCCCEEEecccccee
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD-KDMVAKISDFGMARI  443 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~-~~~~~kl~DFGla~~  443 (611)
                      +||||++++.+............+++..++.++.||++||.|||+++   |+||||||+|||++ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999998655544433344567999999999999999999999997   99999999999999 799999999999987


Q ss_pred             cccCCCccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc-
Q 007239          444 FCENQKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM-  521 (611)
Q Consensus       444 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~-  521 (611)
                      .......   ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.....   ......+.+........ 
T Consensus       192 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~p~~~~  265 (394)
T 4e7w_A          192 LIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESG---IDQLVEIIKVLGTPSREQ  265 (394)
T ss_dssp             CCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCHHH
T ss_pred             ccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHHH
Confidence            6443322   245789999999998765 589999999999999999999999854321   12222222211111000 


Q ss_pred             ------cccccccC--CCCCH------HHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          522 ------EFVDPLLM--KSSSI------PQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       522 ------~~~d~~l~--~~~~~------~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                            ......+.  .....      ....++.+|+.+||+.||++|||+.|+++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                  00000000  00011      122467899999999999999999999874

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=8.1e-39  Score=326.44  Aligned_cols=253  Identities=25%  Similarity=0.313  Sum_probs=202.8

Q ss_pred             HhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---------hhhHHHHHHHHHHHHhcC-CCCeeeEEEeE
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---------WQGLEEFKNEIILIAKLQ-HRNLVRLVGCG  357 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~il~~l~-h~niv~l~~~~  357 (611)
                      ...++|++.+.||+|+||.||++... +++.||+|++....         ....+.+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34578999999999999999999964 68899999987543         123456889999999996 99999999999


Q ss_pred             eeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEec
Q 007239          358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISD  437 (611)
Q Consensus       358 ~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~D  437 (611)
                      ......++||||+++++|.+++.   ....+++..++.++.||+.||.|||+++   ++||||||+||+++.++.+||+|
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence            99999999999999999999984   3456899999999999999999999997   99999999999999999999999


Q ss_pred             cccceecccCCCccccccccccCCCCCccccc------cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHH
Q 007239          438 FGMARIFCENQKTANTRRVVGTYGYMAPEYAM------EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYV  511 (611)
Q Consensus       438 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~  511 (611)
                      ||++........   .....||+.|+|||++.      ...++.++||||||+++|+|++|+.||....   ......  
T Consensus       168 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~--  239 (298)
T 1phk_A          168 FGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLR--  239 (298)
T ss_dssp             CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH--
T ss_pred             ccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc---HHHHHH--
Confidence            999987643322   23457999999999885      4568899999999999999999999974321   111111  


Q ss_pred             HHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          512 WQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       512 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                        ....+.... ..+     ........+.+++.+||+.||++|||+.++++
T Consensus       240 --~~~~~~~~~-~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          240 --MIMSGNYQF-GSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             --HHHHTCCCC-CTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --HHhcCCccc-Ccc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence              111111110 000     01122345779999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=6.6e-40  Score=368.30  Aligned_cols=247  Identities=28%  Similarity=0.377  Sum_probs=195.4

Q ss_pred             cccCccCceEEEEEEc---CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVL---PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      ++||+|+||.||+|.+   ..++.||||+++...  ....+.+.+|+.++++++||||+++++++. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            4799999999999964   346789999997643  334678999999999999999999999986 4568999999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc-c
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT-A  451 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~-~  451 (611)
                      ++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus       454 g~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            99999994   3456899999999999999999999997   999999999999999999999999999876443321 1


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                      ......||+.|+|||++.+..++.++||||||+++|||++ |+.||.....   ..+    ...+..+.....       
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~----~~~i~~~~~~~~-------  593 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEV----TAMLEKGERMGC-------  593 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHH----HHHHHTTCCCCC-------
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHH----HHHHHcCCCCCC-------
Confidence            2223457889999999999999999999999999999998 9999753221   111    222222222111       


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                        +.....++.+|+..||+.||++||++.+|+++|+.
T Consensus       594 --p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          594 --PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             --CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence              11122467789999999999999999999999974

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=9.5e-40  Score=331.83  Aligned_cols=252  Identities=26%  Similarity=0.343  Sum_probs=186.9

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      .++|++.+.||+|+||.||++.. .+++.||+|++.....  .....+.++...++.++||||+++++++.+.+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            47899999999999999999995 5789999999975422  22334455566688899999999999999999999999


Q ss_pred             EecCCCChhhHhhhc-hhhccCCHHHHHHHHHHHHHHHHHHhhc-CCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          368 ELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHED-SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       368 E~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||+++ +|.+++... .....+++..++.++.||+.||.|||++ +   |+||||||+||+++.++.+||+|||+++...
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99985 887776432 3346799999999999999999999997 7   9999999999999999999999999998764


Q ss_pred             cCCCccccccccccCCCCCcccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYA----MEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM  521 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  521 (611)
                      ....   .....||+.|+|||.+    .+..++.++||||||+++|+|++|+.||......     ............. 
T Consensus       162 ~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~-  232 (290)
T 3fme_A          162 DDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEPSP-  232 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSCCC-
T ss_pred             cccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccCCC-
Confidence            4322   2234799999999996    5667899999999999999999999998532211     1112222222211 


Q ss_pred             cccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          522 EFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       522 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ....        .....++.+++.+||+.||++|||+.|+++
T Consensus       233 ~~~~--------~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          233 QLPA--------DKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             CCCT--------TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             Cccc--------ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            1100        111235778999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.4e-39  Score=340.86  Aligned_cols=257  Identities=26%  Similarity=0.353  Sum_probs=184.1

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC------C
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG------E  361 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~  361 (611)
                      .++|++.+.||+|+||.||+|.+ .+|+.||+|++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            36899999999999999999995 57899999998653  334567788999999999999999999998654      5


Q ss_pred             eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccc
Q 007239          362 EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA  441 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  441 (611)
                      ..++|+|++ +++|.+++..    ..+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 6788888732    46999999999999999999999987   999999999999999999999999999


Q ss_pred             eecccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc
Q 007239          442 RIFCENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE  520 (611)
Q Consensus       442 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  520 (611)
                      +.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.....   ......+.+...... 
T Consensus       180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~l~~i~~~~g~p~-  250 (367)
T 2fst_X          180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH---IDQLKLILRLVGTPG-  250 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCC-
T ss_pred             cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCC-
Confidence            865322     234679999999999887 6789999999999999999999999854322   222222222211110 


Q ss_pred             cccccc-----------ccC--CCCCHH-----HHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          521 MEFVDP-----------LLM--KSSSIP-----QVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       521 ~~~~d~-----------~l~--~~~~~~-----~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      .+.+..           .+.  ......     ....+.+|+.+||+.||++|||+.|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            000000           000  011111     12356799999999999999999999873

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.6e-39  Score=342.86  Aligned_cols=253  Identities=13%  Similarity=0.074  Sum_probs=181.0

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHHHHHHHHhc--CCCCeeeEE-------EeEe
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKL--QHRNLVRLV-------GCGI  358 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l--~h~niv~l~-------~~~~  358 (611)
                      .+|++.+.||+|+||.||+|++ .+++.||+|++.....   ...+.+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            4588999999999999999995 4789999999987542   3456678886655555  599988865       4443


Q ss_pred             eC-----------------CeEEEEEEecCCCChhhHhhhchhhccCCHHHH------HHHHHHHHHHHHHHhhcCCCce
Q 007239          359 EG-----------------EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTC------YNIIGGISKGLLYLHEDSRLKI  415 (611)
Q Consensus       359 ~~-----------------~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~------~~i~~qi~~~l~yLH~~~~~~i  415 (611)
                      ..                 ...++||||++ ++|.+++....  ..+.+..+      +.++.||+.||.|||+++   |
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i  215 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG---L  215 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence            32                 34799999999 89999986532  23455555      678899999999999997   9


Q ss_pred             EecCCCCCcEEecCCCCEEEeccccceecccCCCccccccccccCCCCCcccccc--CCCCchhhHHHHHHHHHHHHhCC
Q 007239          416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAME--GLFSVKSDVFSFGVIVLEIISGK  493 (611)
Q Consensus       416 iHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvll~elltG~  493 (611)
                      +||||||+||||+.++.+||+|||+++......     ....+|+.|+|||++.+  ..++.++||||||+++|||++|+
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            999999999999999999999999998653221     13467799999999987  67999999999999999999999


Q ss_pred             CCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          494 RNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       494 ~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .||..........        +........................+.+|+.+||+.||++|||+.++++
T Consensus       291 ~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          291 LPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9986443221110        0000000000111111111122346778999999999999999999974

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.3e-39  Score=333.18  Aligned_cols=252  Identities=24%  Similarity=0.367  Sum_probs=194.9

Q ss_pred             hhCCCCcccccCccCceEEEEEEcCCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcC--CCCeeeEEEeEeeCCeEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQ--HRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~--h~niv~l~~~~~~~~~~~l  365 (611)
                      ..++|++.+.||+|+||.||++...+++.||+|++...  .....+.+.+|+.++++++  ||||+++++++...+..++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            34679999999999999999999888999999998654  3345678999999999997  5999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||| +.+++|.+++.   ....+++..++.++.||++||.|||+++   |+||||||+|||+++ +.+||+|||+++...
T Consensus       106 v~e-~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          106 VME-CGNIDLNSWLK---KKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ  177 (313)
T ss_dssp             EEC-CCSEEHHHHHH---HCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred             EEe-cCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence            999 66889999984   3456899999999999999999999996   999999999999964 899999999998765


Q ss_pred             cCCCccccccccccCCCCCcccccc-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAME-----------GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL  514 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~  514 (611)
                      ............||+.|+|||.+.+           ..++.++||||||+++|+|++|+.||......     .......
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~~~  252 (313)
T 3cek_A          178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAI  252 (313)
T ss_dssp             ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHH
T ss_pred             CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHHHHHH
Confidence            4433333345679999999999875           47889999999999999999999997532211     1111111


Q ss_pred             HhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       515 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ........+     ..    ....++.+++.+||+.||++||++.|+++
T Consensus       253 ~~~~~~~~~-----~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          253 IDPNHEIEF-----PD----IPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             HCTTSCCCC-----CC----CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HhcccccCC-----cc----cchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            211111111     11    11245778999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.3e-39  Score=326.49  Aligned_cols=257  Identities=28%  Similarity=0.383  Sum_probs=195.3

Q ss_pred             hCCCCcccccCccCceEEEEEEcC--CCc--EEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP--NGK--EVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  363 (611)
                      .++|++.+.||+|+||.||++++.  +++  .||+|+++..   .....+.+.+|+.++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            367999999999999999999853  333  6899998754   2345678999999999999999999999987655 8


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||.|||+++   ++||||||+||+++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            9999999999999988542  356899999999999999999999997   99999999999999999999999999987


Q ss_pred             cccCCCcc-ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccc
Q 007239          444 FCENQKTA-NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEM  521 (611)
Q Consensus       444 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  521 (611)
                      ........ ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||....   ...+.   ..........
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~---~~~~~~~~~~  244 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQIL---HKIDKEGERL  244 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHH---HHHHTSCCCC
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC---HHHHH---HHHHccCCCC
Confidence            64433221 2233567889999999999889999999999999999999 999874322   11111   1111221111


Q ss_pred             cccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          522 EFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       522 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      .         .......++.+++.+||+.||++|||+.++++.|...
T Consensus       245 ~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  282 (291)
T 1u46_A          245 P---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  282 (291)
T ss_dssp             C---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C---------CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence            1         0111224577899999999999999999999999754

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.6e-39  Score=351.46  Aligned_cols=250  Identities=27%  Similarity=0.362  Sum_probs=202.7

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++.+.||+|+||.||++... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467999999999999999999964 78999999986542   34567899999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe---cCCCCEEEecccccee
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARI  443 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGla~~  443 (611)
                      |||+.+++|.+.+.   ....+++..++.++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++.
T Consensus       105 ~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEII---SRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHH---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999998884   3456899999999999999999999997   9999999999999   5678999999999987


Q ss_pred             cccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          444 FCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       444 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      +....   ......||+.|+|||++.+ .++.++||||||+++|+|++|++||....   ...+...    +..+.....
T Consensus       179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~----i~~~~~~~~  247 (484)
T 3nyv_A          179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN---EYDILKK----VEKGKYTFE  247 (484)
T ss_dssp             BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH----HHHCCCCCC
T ss_pred             ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC---HHHHHHH----HHcCCCCCC
Confidence            64332   2234579999999998865 68999999999999999999999985322   1222221    122211100


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      . +..     ......+.+|+.+||+.||++|||+.|+++
T Consensus       248 ~-~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          248 L-PQW-----KKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             S-GGG-----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C-ccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            0 000     111245778999999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.8e-39  Score=339.59  Aligned_cols=268  Identities=24%  Similarity=0.284  Sum_probs=197.4

Q ss_pred             HHHHHHhhCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccCh-----------hhHHHHHHHHHHHHhcCCCCeee
Q 007239          284 LAVIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW-----------QGLEEFKNEIILIAKLQHRNLVR  352 (611)
Q Consensus       284 ~~~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~il~~l~h~niv~  352 (611)
                      ...+....++|++.+.||+|+||.||++...+|+.||+|++.....           ...+.+.+|+.++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            4556778899999999999999999999988899999999864321           22478899999999999999999


Q ss_pred             EEEeEee-----CCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe
Q 007239          353 LVGCGIE-----GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL  427 (611)
Q Consensus       353 l~~~~~~-----~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll  427 (611)
                      +++++..     ....++||||++ ++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL  167 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence            9999854     336899999998 477777643  3446899999999999999999999997   9999999999999


Q ss_pred             cCCCCEEEeccccceecccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhh
Q 007239          428 DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQT  506 (611)
Q Consensus       428 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~  506 (611)
                      +.++.+||+|||+++......   ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....   ...
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~  241 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST---FYN  241 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHH
T ss_pred             cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC---HHH
Confidence            999999999999997543322   2234578999999999887 678999999999999999999999975322   122


Q ss_pred             HHHHHHHHHhcCccc-----------cccccccCCC--CC-----HHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          507 LLAYVWQLWKEGKEM-----------EFVDPLLMKS--SS-----IPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       507 l~~~~~~~~~~~~~~-----------~~~d~~l~~~--~~-----~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ....+..........           ..+...+...  ..     ......+.+|+..||+.||++|||+.|+++
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            222222211111110           0000000000  00     011235778999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.1e-38  Score=333.52  Aligned_cols=268  Identities=25%  Similarity=0.300  Sum_probs=200.9

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC-----Ce
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG-----EE  362 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~  362 (611)
                      ..++|++.+.||+|+||.||++.+. +|+.||+|++.... ......+.+|+.++++++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            3478999999999999999999964 68899999997543 33456788999999999999999999987654     67


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .++||||++ ++|.+++..    ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        89 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR  160 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence            899999998 588887732    46899999999999999999999997   9999999999999999999999999998


Q ss_pred             ecccCCCcc--------ccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHH
Q 007239          443 IFCENQKTA--------NTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ  513 (611)
Q Consensus       443 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~  513 (611)
                      .........        ......||+.|+|||++.. ..++.++||||||+++|+|++|+.||.....   ......+..
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~~~~~~~~~  237 (353)
T 2b9h_A          161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY---RHQLLLIFG  237 (353)
T ss_dssp             ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHH
T ss_pred             ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHH
Confidence            764332111        1223578999999998765 7789999999999999999999999854321   112222222


Q ss_pred             HHhcCcccccc------------ccccC-CCCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHH--HhcCC
Q 007239          514 LWKEGKEMEFV------------DPLLM-KSSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVA--LLGSE  568 (611)
Q Consensus       514 ~~~~~~~~~~~------------d~~l~-~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~  568 (611)
                      ...........            ..... .....     ....++.+|+.+||+.||++|||+.|+++  .|...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY  312 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence            21111100000            00000 00000     11245679999999999999999999997  45443

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.1e-39  Score=343.03  Aligned_cols=268  Identities=24%  Similarity=0.354  Sum_probs=184.7

Q ss_pred             hCCCCc-ccccCccCceEEEEEEcC---CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee--CCeEE
Q 007239          291 TDGFSD-SNKLGQGGFGTVYKGVLP---NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE--GEEKL  364 (611)
Q Consensus       291 ~~~y~~-~~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~  364 (611)
                      .+.|++ +++||+|+||.||++++.   +++.||+|++.....  ...+.+|+.++++++||||+++++++..  ....+
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            345666 568999999999999954   578899999975532  3467899999999999999999999954  67899


Q ss_pred             EEEEecCCCChhhHhhhch------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe----cCCCCEE
Q 007239          365 LIYELMPNRSLDCFIFDSE------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL----DKDMVAK  434 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll----~~~~~~k  434 (611)
                      +||||+++ +|.+++....      ....+++..++.++.||+.||.|||+++   |+||||||+||||    +.++.+|
T Consensus        97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence            99999975 6766664322      1224899999999999999999999997   9999999999999    6788999


Q ss_pred             EeccccceecccCCCc-cccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCC------chhh
Q 007239          435 ISDFGMARIFCENQKT-ANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTG------HAQT  506 (611)
Q Consensus       435 l~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~------~~~~  506 (611)
                      |+|||+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|++||......      ....
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            9999999876433211 223346899999999999874 5899999999999999999999998543321      1112


Q ss_pred             HHHHHHHHHhcCcccccccc---------------ccCCCCCH---------HHHHHHHHHhhccccCCCCCCCCHHHHH
Q 007239          507 LLAYVWQLWKEGKEMEFVDP---------------LLMKSSSI---------PQVVRCIHIGLLCVQEDPAVRPTMSNVV  562 (611)
Q Consensus       507 l~~~~~~~~~~~~~~~~~d~---------------~l~~~~~~---------~~~~~l~~li~~cl~~dP~~RPt~~evl  562 (611)
                      .+..+...+.......+.+-               ........         .....+.+|+.+||+.||++|||++|++
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            22222222221111100000               00000000         0023567899999999999999999999


Q ss_pred             HH
Q 007239          563 AL  564 (611)
Q Consensus       563 ~~  564 (611)
                      +.
T Consensus       333 ~h  334 (405)
T 3rgf_A          333 QD  334 (405)
T ss_dssp             TS
T ss_pred             cC
Confidence            73

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.2e-38  Score=341.76  Aligned_cols=258  Identities=24%  Similarity=0.319  Sum_probs=192.5

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC------CeEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG------EEKL  364 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~~~~  364 (611)
                      .+|++.+.||+|+||.||++++. +|+.||||++.....    ...+|+++++.++||||+++++++...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46999999999999999999964 689999999865432    234799999999999999999988542      2367


Q ss_pred             EEEEecCCCChhhHhhh-chhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC-CCEEEeccccce
Q 007239          365 LIYELMPNRSLDCFIFD-SERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD-MVAKISDFGMAR  442 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~-~~~kl~DFGla~  442 (611)
                      +||||+++ +|.+++.. ......+++..++.++.||++||.|||+++   |+||||||+||||+.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999987 55555432 233567999999999999999999999986   9999999999999965 578999999998


Q ss_pred             ecccCCCccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC---
Q 007239          443 IFCENQKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG---  518 (611)
Q Consensus       443 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---  518 (611)
                      .+.....   .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.....  ...+.. +.+.....   
T Consensus       206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~l~~-i~~~lg~p~~~  279 (420)
T 1j1b_A          206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVE-IIKVLGTPTRE  279 (420)
T ss_dssp             ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHH-HHHHHCSCCHH
T ss_pred             hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHH-HHHHhCCCCHH
Confidence            7643322   2235789999999998765 799999999999999999999999754321  112222 22211111   


Q ss_pred             -------ccccccccccCCC-----CCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          519 -------KEMEFVDPLLMKS-----SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       519 -------~~~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                             ...++..+.+...     .......++.+|+.+||+.||++|||+.|+++
T Consensus       280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                   1111111111100     00111246789999999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=327.25  Aligned_cols=262  Identities=22%  Similarity=0.296  Sum_probs=193.5

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEe-----------
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI-----------  358 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~-----------  358 (611)
                      .++|++.+.||+|+||.||++... +++.||+|++........+.+.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            468999999999999999999965 58999999998777677788999999999999999999999873           


Q ss_pred             ---eCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec-CCCCEE
Q 007239          359 ---EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD-KDMVAK  434 (611)
Q Consensus       359 ---~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~-~~~~~k  434 (611)
                         +....++||||++ ++|.+++.    ...+++..++.++.||+.||.|||+++   |+||||||+|||++ .++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               4467899999998 58988873    246899999999999999999999997   99999999999997 567999


Q ss_pred             EeccccceecccCCC-ccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHH
Q 007239          435 ISDFGMARIFCENQK-TANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVW  512 (611)
Q Consensus       435 l~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~  512 (611)
                      |+|||+++....... ........||+.|+|||.+.. ..++.++||||||+++|||++|+.||.....   ......+.
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~~~  238 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE---LEQMQLIL  238 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHH
Confidence            999999987643221 112234567999999998875 6789999999999999999999999853321   11111111


Q ss_pred             HHHhcC----------ccccccccccC-CCCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          513 QLWKEG----------KEMEFVDPLLM-KSSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       513 ~~~~~~----------~~~~~~d~~l~-~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ......          .....+..... .....     ....++.+++.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            110000          00000000000 00011     11245789999999999999999999987

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=9.9e-39  Score=334.92  Aligned_cols=269  Identities=21%  Similarity=0.243  Sum_probs=190.5

Q ss_pred             HHHHhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe--
Q 007239          286 VIKAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE--  362 (611)
Q Consensus       286 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~--  362 (611)
                      ......++|++.+.||+|+||.||++++ .+++.||+|++.... .....+.+|+..++.++||||+++++++.....  
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            4556778999999999999999999996 468999999986543 223456788888999999999999999876443  


Q ss_pred             -----EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHh--hcCCCceEecCCCCCcEEecC-CCCEE
Q 007239          363 -----KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH--EDSRLKIIHRDLKPSNVLLDK-DMVAK  434 (611)
Q Consensus       363 -----~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH--~~~~~~iiHrDikp~NIll~~-~~~~k  434 (611)
                           .++||||++++.+..+.........+++..++.++.||+.||.|||  +++   |+||||||+|||++. ++.+|
T Consensus        96 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             TTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEE
T ss_pred             ccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEE
Confidence                 7899999987543333222244567899999999999999999999  776   999999999999996 89999


Q ss_pred             EeccccceecccCCCccccccccccCCCCCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHH
Q 007239          435 ISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ  513 (611)
Q Consensus       435 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~  513 (611)
                      |+|||+++.......   .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||....   .......+.+
T Consensus       173 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~~~~  246 (360)
T 3e3p_A          173 LCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN---SAGQLHEIVR  246 (360)
T ss_dssp             ECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHH
T ss_pred             EeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC---hHHHHHHHHH
Confidence            999999987654332   22457899999999987654 8999999999999999999999975432   2222222221


Q ss_pred             HHhcCc------------ccccccc------ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          514 LWKEGK------------EMEFVDP------LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       514 ~~~~~~------------~~~~~d~------~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ......            .....+.      .............+.+|+.+||+.||++|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            111100            0000000      00011111234568899999999999999999999863

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=9e-39  Score=330.25  Aligned_cols=253  Identities=28%  Similarity=0.370  Sum_probs=195.9

Q ss_pred             HhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh--------hhHHHHHHHHHHHHhcCCCCeeeEEEeEee
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW--------QGLEEFKNEIILIAKLQHRNLVRLVGCGIE  359 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~niv~l~~~~~~  359 (611)
                      ...++|++.+.||+|+||.||+++. .+++.||+|++.....        .....+.+|+.++++++||||+++++++..
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   86 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA   86 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence            3457899999999999999999996 4688999999865421        123457899999999999999999999876


Q ss_pred             CCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCC---EEEe
Q 007239          360 GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV---AKIS  436 (611)
Q Consensus       360 ~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~---~kl~  436 (611)
                      .. .++||||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.   +||+
T Consensus        87 ~~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           87 ED-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             SS-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             Cc-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence            54 899999999999998884   3456899999999999999999999997   999999999999987664   9999


Q ss_pred             ccccceecccCCCccccccccccCCCCCccccc---cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHH
Q 007239          437 DFGMARIFCENQKTANTRRVVGTYGYMAPEYAM---EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ  513 (611)
Q Consensus       437 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~  513 (611)
                      |||+++......   ......||+.|+|||++.   ...++.++||||||+++|+|++|+.||.......  .+...+  
T Consensus       160 Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~--  232 (322)
T 2ycf_A          160 DFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQI--  232 (322)
T ss_dssp             CCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHH--
T ss_pred             cCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHH--
Confidence            999998764322   123457999999999874   5678999999999999999999999985433221  122211  


Q ss_pred             HHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       514 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                        ..+.... . +....    .....+.+++.+||+.||++||++.++++
T Consensus       233 --~~~~~~~-~-~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          233 --TSGKYNF-I-PEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             --HHTCCCC-C-HHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --HhCcccc-C-chhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence              1111100 0 00000    11245778999999999999999999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.3e-38  Score=333.08  Aligned_cols=262  Identities=21%  Similarity=0.294  Sum_probs=200.4

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC-----CeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG-----EEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~~  363 (611)
                      .++|++.+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            36899999999999999999995 478889999997543 33457789999999999999999999998755     468


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ++||||+++ +|.+++.    ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~~-~L~~~l~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLK----TQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCSE-EHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccCc-CHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            999999985 8888773    245899999999999999999999997   99999999999999999999999999987


Q ss_pred             cccCCCcc-ccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc
Q 007239          444 FCENQKTA-NTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM  521 (611)
Q Consensus       444 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  521 (611)
                      ........ ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......   .....+..........
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~  254 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL---DQLNHILGILGSPSQE  254 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG---GHHHHHHHHHCSCCHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH---HHHHHHHHHhCCCCHH
Confidence            65433221 2234689999999998764 45899999999999999999999998543322   2222222211111100


Q ss_pred             cc-----------ccccc-CCCCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          522 EF-----------VDPLL-MKSSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       522 ~~-----------~d~~l-~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .+           ..... ......     ....++.+|+.+||+.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          255 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00           00000 000000     11235779999999999999999999997

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.5e-39  Score=334.69  Aligned_cols=258  Identities=24%  Similarity=0.346  Sum_probs=203.7

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhh-----------------HHHHHHHHHHHHhcCCCCeeeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQG-----------------LEEFKNEIILIAKLQHRNLVRL  353 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~il~~l~h~niv~l  353 (611)
                      .++|++.+.||+|+||.||++.. +++.||+|++.......                 .+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            47899999999999999999999 89999999987542211                 2789999999999999999999


Q ss_pred             EEeEeeCCeEEEEEEecCCCChhhH------hhhchhhccCCHHHHHHHHHHHHHHHHHHhh-cCCCceEecCCCCCcEE
Q 007239          354 VGCGIEGEEKLLIYELMPNRSLDCF------IFDSERRLQLNWNTCYNIIGGISKGLLYLHE-DSRLKIIHRDLKPSNVL  426 (611)
Q Consensus       354 ~~~~~~~~~~~lv~E~~~~~sL~~~------l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDikp~NIl  426 (611)
                      ++++.+.+..++||||+++++|.++      +.. .....+++..++.++.||+.||.|||+ ++   |+||||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999988      422 224679999999999999999999998 76   999999999999


Q ss_pred             ecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCCCCCch
Q 007239          427 LDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG-LFSV-KSDVFSFGVIVLEIISGKRNSGFYLTGHA  504 (611)
Q Consensus       427 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-k~DvwSlGvll~elltG~~p~~~~~~~~~  504 (611)
                      ++.++.+||+|||++......    ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||......  
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--  258 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--  258 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS--
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH--
Confidence            999999999999999876433    22345799999999999887 6666 999999999999999999998543321  


Q ss_pred             hhHHHHHHHHHhcCcccccc------ccccCC---CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          505 QTLLAYVWQLWKEGKEMEFV------DPLLMK---SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       505 ~~l~~~~~~~~~~~~~~~~~------d~~l~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..+.    ..+..+......      .+....   .........+.+|+.+||+.||++|||+.|+++
T Consensus       259 ~~~~----~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          259 VELF----NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHH----HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHH----HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111    122222111000      000000   000112346779999999999999999999987

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=9.9e-39  Score=343.19  Aligned_cols=199  Identities=23%  Similarity=0.292  Sum_probs=171.6

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhc------CCCCeeeEEEeEeeCCe
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL------QHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l------~h~niv~l~~~~~~~~~  362 (611)
                      ...+|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.+++.+      .|+||+++++++.....
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            356899999999999999999985 468899999997543 3456778899998888      46799999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCC--EEEecccc
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV--AKISDFGM  440 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~--~kl~DFGl  440 (611)
                      .++||||+. ++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.  +||+|||+
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence            999999997 5888887542 2345899999999999999999999997   999999999999999887  99999999


Q ss_pred             ceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 007239          441 ARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFY  499 (611)
Q Consensus       441 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~  499 (611)
                      ++.....     .....||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus       249 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          249 SCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             CEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            9764322     22458999999999999999999999999999999999999997543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.3e-39  Score=339.75  Aligned_cols=261  Identities=23%  Similarity=0.287  Sum_probs=195.2

Q ss_pred             HhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC-------
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG-------  360 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-------  360 (611)
                      ...++|++.+.||+|+||.||+++. .+|+.||+|++.....    ...+|+.+++.++||||+++++++...       
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~   79 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP   79 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence            4567899999999999999999995 5789999999875432    234799999999999999999998543       


Q ss_pred             -------------------------------CeEEEEEEecCCCChhhHhhhc-hhhccCCHHHHHHHHHHHHHHHHHHh
Q 007239          361 -------------------------------EEKLLIYELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLH  408 (611)
Q Consensus       361 -------------------------------~~~~lv~E~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH  408 (611)
                                                     ...++||||+++ +|.+.+... .....+++..++.++.||++||.|||
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH  158 (383)
T 3eb0_A           80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH  158 (383)
T ss_dssp             ------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence                                           348899999985 777776542 33467999999999999999999999


Q ss_pred             hcCCCceEecCCCCCcEEec-CCCCEEEeccccceecccCCCccccccccccCCCCCccccccC-CCCchhhHHHHHHHH
Q 007239          409 EDSRLKIIHRDLKPSNVLLD-KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIV  486 (611)
Q Consensus       409 ~~~~~~iiHrDikp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll  486 (611)
                      +++   |+||||||+|||++ .++.+||+|||+++.......   .....||+.|+|||.+.+. .++.++||||+|+++
T Consensus       159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            987   99999999999998 688999999999987644332   2245789999999998875 489999999999999


Q ss_pred             HHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc----------ccccccccCCC-----CCHHHHHHHHHHhhccccCC
Q 007239          487 LEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE----------MEFVDPLLMKS-----SSIPQVVRCIHIGLLCVQED  551 (611)
Q Consensus       487 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~----------~~~~d~~l~~~-----~~~~~~~~l~~li~~cl~~d  551 (611)
                      |||++|+.||....   .......+.+.......          .+..-+.+...     .+......+.+|+.+||+.|
T Consensus       233 ~ell~g~~pf~~~~---~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          233 GELILGKPLFSGET---SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHSSCSSCCSS---HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHhCCCCCCCCC---hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            99999999985432   22222222221111110          00000111000     01112235779999999999


Q ss_pred             CCCCCCHHHHHH
Q 007239          552 PAVRPTMSNVVA  563 (611)
Q Consensus       552 P~~RPt~~evl~  563 (611)
                      |++|||+.|+++
T Consensus       310 P~~R~t~~e~l~  321 (383)
T 3eb0_A          310 PDLRINPYEAMA  321 (383)
T ss_dssp             GGGSCCHHHHHT
T ss_pred             hhhCCCHHHHhc
Confidence            999999999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=7.4e-39  Score=337.76  Aligned_cols=259  Identities=23%  Similarity=0.270  Sum_probs=190.9

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC------
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE------  361 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------  361 (611)
                      .++|++.+.||+|+||.||++.. .+++.||+|++...  .....+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            46899999999999999999995 46889999998753  3344567889999999999999999999987654      


Q ss_pred             eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccc
Q 007239          362 EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA  441 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  441 (611)
                      ..++||||+++ +|.+.+.     ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            78999999986 6766662     34899999999999999999999997   999999999999999999999999999


Q ss_pred             eecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH-------
Q 007239          442 RIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL-------  514 (611)
Q Consensus       442 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~-------  514 (611)
                      +......   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....   ......+.+.       
T Consensus       175 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~~  248 (371)
T 2xrw_A          175 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTPCPE  248 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHC-CCCCCHH
T ss_pred             ccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCHH
Confidence            8654322   22345799999999999999999999999999999999999999854321   1111111100       


Q ss_pred             ------------HhcCc------cccccccccCCCC---CHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          515 ------------WKEGK------EMEFVDPLLMKSS---SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       515 ------------~~~~~------~~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                                  .....      ..+..........   .......+.+|+.+||+.||++|||++|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                        00000      0000000000000   01124567899999999999999999999873

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=8.8e-39  Score=331.66  Aligned_cols=259  Identities=25%  Similarity=0.312  Sum_probs=201.7

Q ss_pred             hCCCCcccccCccCceEEEEEEc--CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCC------eeeEEEeEeeCCe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL--PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN------LVRLVGCGIEGEE  362 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n------iv~l~~~~~~~~~  362 (611)
                      .++|++.+.||+|+||.||++.+  .+++.||+|++.... ...+.+.+|+.+++.++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999985  368899999987542 44577889999999997654      9999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC-------------
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK-------------  429 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~-------------  429 (611)
                      .++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 88998888542 2246899999999999999999999997   999999999999987             


Q ss_pred             ------CCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 007239          430 ------DMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGH  503 (611)
Q Consensus       430 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~  503 (611)
                            ++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             ccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                  678999999999864332     224579999999999999999999999999999999999999986433221


Q ss_pred             hhhHHHHHHHHHhcCc--------ccccc---------------------cccc-CCCCCHHHHHHHHHHhhccccCCCC
Q 007239          504 AQTLLAYVWQLWKEGK--------EMEFV---------------------DPLL-MKSSSIPQVVRCIHIGLLCVQEDPA  553 (611)
Q Consensus       504 ~~~l~~~~~~~~~~~~--------~~~~~---------------------d~~l-~~~~~~~~~~~l~~li~~cl~~dP~  553 (611)
                         ....+........        .....                     .+.. ..........++.+|+.+||+.||+
T Consensus       242 ---~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  318 (339)
T 1z57_A          242 ---HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA  318 (339)
T ss_dssp             ---HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             ---HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence               1221211111000        00000                     0000 0011223456788999999999999


Q ss_pred             CCCCHHHHHH
Q 007239          554 VRPTMSNVVA  563 (611)
Q Consensus       554 ~RPt~~evl~  563 (611)
                      +|||+.|+++
T Consensus       319 ~Rpt~~ell~  328 (339)
T 1z57_A          319 KRITLREALK  328 (339)
T ss_dssp             TSCCHHHHTT
T ss_pred             cccCHHHHhc
Confidence            9999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.9e-39  Score=334.37  Aligned_cols=268  Identities=27%  Similarity=0.374  Sum_probs=198.1

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.+.||+|+||.||+|.+..  .+|+|++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e  109 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS  109 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence            5789999999999999999999753  49999987542  2234567889999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++ ++.+||+|||+++......
T Consensus       110 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~  183 (319)
T 2y4i_B          110 LCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ  183 (319)
T ss_dssp             CCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred             cccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence            9999999999853  2346899999999999999999999997   99999999999998 6899999999987653211


Q ss_pred             ---CccccccccccCCCCCcccccc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHh
Q 007239          449 ---KTANTRRVVGTYGYMAPEYAME---------GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWK  516 (611)
Q Consensus       449 ---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~  516 (611)
                         .........||+.|+|||.+..         ..++.++||||||+++|||++|+.||....   ..   ...+. ..
T Consensus       184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~---~~~~~-~~  256 (319)
T 2y4i_B          184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP---AE---AIIWQ-MG  256 (319)
T ss_dssp             ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC---HH---HHHHH-HH
T ss_pred             ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HH---HHHHH-hc
Confidence               1122234569999999999874         457899999999999999999999975322   11   11122 22


Q ss_pred             cCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCCCCCCCCCCCCCc
Q 007239          517 EGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFP  581 (611)
Q Consensus       517 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~l~~~~~p~~~  581 (611)
                      .+.........        ...++.+++..||+.||++|||+.+++++|+...........|..+
T Consensus       257 ~~~~~~~~~~~--------~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~  313 (319)
T 2y4i_B          257 TGMKPNLSQIG--------MGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHF  313 (319)
T ss_dssp             TTCCCCCCCSS--------CCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------------
T ss_pred             cCCCCCCCcCC--------CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccc
Confidence            22211111111        1124678999999999999999999999999876555444444433

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.8e-38  Score=325.82  Aligned_cols=253  Identities=25%  Similarity=0.372  Sum_probs=195.5

Q ss_pred             HhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEee------C
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIE------G  360 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~------~  360 (611)
                      ...++|++.+.||+|+||.||+|.+ .+++.||+|++.... ...+.+.+|+.+++++ +||||+++++++..      .
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   99 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   99 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence            3467899999999999999999996 578999999987543 3346789999999999 79999999999987      4


Q ss_pred             CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccc
Q 007239          361 EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGM  440 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  440 (611)
                      ...++||||+++++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~  175 (326)
T 2x7f_A          100 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  175 (326)
T ss_dssp             CEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcC
Confidence            6889999999999999998543 2356899999999999999999999997   99999999999999999999999999


Q ss_pred             ceecccCCCccccccccccCCCCCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHH
Q 007239          441 ARIFCENQKTANTRRVVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLW  515 (611)
Q Consensus       441 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~  515 (611)
                      +........  ......||+.|+|||++.     +..++.++||||||+++|+|++|+.||.....   .   .......
T Consensus       176 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~---~~~~~~~  247 (326)
T 2x7f_A          176 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---M---RALFLIP  247 (326)
T ss_dssp             TC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---H---HHHHHHH
T ss_pred             ceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---H---HHHHHhh
Confidence            986543221  123457999999999987     56789999999999999999999999743221   1   1111111


Q ss_pred             hcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          516 KEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       516 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .. .......    ..    ....+.+++.+||+.||++||++.++++
T Consensus       248 ~~-~~~~~~~----~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          248 RN-PAPRLKS----KK----WSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HS-CCCCCSC----SC----SCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cC-ccccCCc----cc----cCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            11 1111111    11    1235678999999999999999999987

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.9e-38  Score=323.83  Aligned_cols=252  Identities=25%  Similarity=0.382  Sum_probs=191.6

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee----------
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE----------  359 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~----------  359 (611)
                      .++|++.+.||+|+||.||+++. .+++.||+|++... ....+.+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            46799999999999999999995 47899999998653 3456788999999999999999999998765          


Q ss_pred             ---CCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEe
Q 007239          360 ---GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKIS  436 (611)
Q Consensus       360 ---~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~  436 (611)
                         ....++||||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence               4567999999999999999854  2345788999999999999999999997   9999999999999999999999


Q ss_pred             ccccceecccCCC------------ccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 007239          437 DFGMARIFCENQK------------TANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGH  503 (611)
Q Consensus       437 DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~  503 (611)
                      |||++........            ........||+.|+|||++.+. .++.++||||||+++|+|++   |+..  .  
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~--~--  231 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST--G--  231 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS--H--
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC--c--
Confidence            9999986543210            1122345799999999999864 78999999999999999998   3211  1  


Q ss_pred             hhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          504 AQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       504 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       ..... ....+.....      .............+.+++.+||+.||++|||+.++++
T Consensus       232 -~~~~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          232 -MERVN-ILKKLRSVSI------EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             -HHHHH-HHHHHHSTTC------CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -hhHHH-HHHhcccccc------ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence             11111 1111222111      1111122223345678999999999999999999997

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.3e-38  Score=326.19  Aligned_cols=263  Identities=23%  Similarity=0.326  Sum_probs=199.4

Q ss_pred             hhCCCCcccccCccCceEEEEEEc--CCCcEEEEEEecccCh--hhHHHHHHHHHHHHhc---CCCCeeeEEEeEe----
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL--PNGKEVAVKRLSRKSW--QGLEEFKNEIILIAKL---QHRNLVRLVGCGI----  358 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~h~niv~l~~~~~----  358 (611)
                      ..++|++.+.||+|+||.||++.+  .+++.||+|++.....  .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            357899999999999999999996  4678899999865422  1223566788877776   8999999999987    


Q ss_pred             -eCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEec
Q 007239          359 -EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISD  437 (611)
Q Consensus       359 -~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~D  437 (611)
                       .....++||||++ ++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             5567899999998 5998888542 2335899999999999999999999997   99999999999999999999999


Q ss_pred             cccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhc
Q 007239          438 FGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKE  517 (611)
Q Consensus       438 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  517 (611)
                      ||+++......   ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....   .......+......
T Consensus       164 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~  237 (326)
T 1blx_A          164 FGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS---DVDQLGKILDVIGL  237 (326)
T ss_dssp             CCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCC
T ss_pred             CcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHHHcCC
Confidence            99998654322   2234578999999999999999999999999999999999999975332   22222222222211


Q ss_pred             Cccccccc------cccC-------CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          518 GKEMEFVD------PLLM-------KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       518 ~~~~~~~d------~~l~-------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .....+..      ....       ..........+.+|+.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11111000      0000       0000112245678999999999999999999995

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.2e-37  Score=329.82  Aligned_cols=201  Identities=25%  Similarity=0.344  Sum_probs=170.8

Q ss_pred             HhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcC-CC-----CeeeEEEeEeeCC
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HR-----NLVRLVGCGIEGE  361 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~-----niv~l~~~~~~~~  361 (611)
                      ...++|++.+.||+|+||.||+|+.. +++.||||++.... .....+.+|+.+++.++ |+     +|+++++++...+
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            34678999999999999999999954 68889999997542 34567788999999886 55     4999999999999


Q ss_pred             eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec--CCCCEEEeccc
Q 007239          362 EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD--KDMVAKISDFG  439 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~--~~~~~kl~DFG  439 (611)
                      ..++||||+++ +|.+++... ....+++..++.++.||+.||.|||++ ..+|+||||||+|||++  .++.+||+|||
T Consensus       130 ~~~lv~e~~~~-~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG  206 (382)
T 2vx3_A          130 HLCLVFEMLSY-NLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG  206 (382)
T ss_dssp             EEEEEEECCCC-BHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCT
T ss_pred             ceEEEEecCCC-CHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEecc
Confidence            99999999975 898888543 224589999999999999999999953 12599999999999994  57889999999


Q ss_pred             cceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 007239          440 MARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGF  498 (611)
Q Consensus       440 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~  498 (611)
                      +++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       207 ~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          207 SSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             TCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             Cceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence            99876432     2245799999999999999999999999999999999999999853

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9.4e-38  Score=317.12  Aligned_cols=253  Identities=27%  Similarity=0.347  Sum_probs=202.0

Q ss_pred             HHhhCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE
Q 007239          288 KAATDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       288 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  364 (611)
                      ....++|++.+.||+|+||.||++... +++.||+|++....  ....+.+.+|+.++++++||||+++++++......+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            445678999999999999999999964 78999999986542  345678999999999999999999999999999999


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC---CCEEEeccccc
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD---MVAKISDFGMA  441 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~---~~~kl~DFGla  441 (611)
                      +||||+++++|.+++..   ...+++..++.++.||+.||.|||+++   ++||||||+||+++.+   +.+||+|||++
T Consensus        98 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~  171 (287)
T 2wei_A           98 IVGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS  171 (287)
T ss_dssp             EEECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred             EEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence            99999999999888843   346899999999999999999999997   9999999999999754   47999999999


Q ss_pred             eecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc
Q 007239          442 RIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM  521 (611)
Q Consensus       442 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  521 (611)
                      ........   .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||....   ...+.    ..+..+...
T Consensus       172 ~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~----~~~~~~~~~  240 (287)
T 2wei_A          172 TCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDIL----KRVETGKYA  240 (287)
T ss_dssp             GTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH----HHHHHCCCC
T ss_pred             eeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC---HHHHH----HHHHcCCCC
Confidence            86543322   223468999999998865 58999999999999999999999974322   11111    122222211


Q ss_pred             cccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          522 EFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       522 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .... .. .    ....++.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~-~~-~----~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          241 FDLP-QW-R----TISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CCSG-GG-T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCch-hh-h----hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            1000 00 0    11235778999999999999999999997

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.1e-38  Score=328.14  Aligned_cols=255  Identities=26%  Similarity=0.364  Sum_probs=177.6

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-hhhHHHHHHHHH-HHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGLEEFKNEII-LIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~-il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      .++|++.+.||+|+||.||++.. .+++.||+|++.... .....++.+|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            36899999999999999999996 478999999997653 233445666666 777889999999999999999999999


Q ss_pred             EecCCCChhhHhhhc--hhhccCCHHHHHHHHHHHHHHHHHHhhc-CCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          368 ELMPNRSLDCFIFDS--ERRLQLNWNTCYNIIGGISKGLLYLHED-SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       368 E~~~~~sL~~~l~~~--~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      ||+++ +|.+++...  .....+++..+..++.|++.||.|||++ +   |+||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99986 777766431  1245689999999999999999999998 7   999999999999999999999999999876


Q ss_pred             ccCCCccccccccccCCCCCcccc----ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYA----MEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE  520 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  520 (611)
                      .....   .....||+.|+|||++    .+..++.++||||||+++|+|++|+.||.......     ..    ...  .
T Consensus       177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~----~~~--~  242 (327)
T 3aln_A          177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQ----LTQ--V  242 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------CC--C
T ss_pred             ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HH----HHH--H
Confidence            43322   2234799999999998    46678999999999999999999999985322110     00    000  0


Q ss_pred             ccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       521 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .....+.+...........+.+|+.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            0000011111111112345778999999999999999999976

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.1e-37  Score=328.36  Aligned_cols=262  Identities=22%  Similarity=0.265  Sum_probs=199.4

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcC-----------CCCeeeEEEeEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-----------HRNLVRLVGCGI  358 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----------h~niv~l~~~~~  358 (611)
                      .++|++.+.||+|+||.||++.. .+++.||+|++.... ...+.+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            36899999999999999999995 578899999997543 34567889999999887           889999999988


Q ss_pred             eCC----eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhc-CCCceEecCCCCCcEEec-----
Q 007239          359 EGE----EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED-SRLKIIHRDLKPSNVLLD-----  428 (611)
Q Consensus       359 ~~~----~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDikp~NIll~-----  428 (611)
                      ..+    ..++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ +   |+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            654    789999999 88999988542 234589999999999999999999997 7   99999999999994     


Q ss_pred             -CCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCch---
Q 007239          429 -KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHA---  504 (611)
Q Consensus       429 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~---  504 (611)
                       ..+.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||........   
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             4458999999999876432     2235799999999999999999999999999999999999999864432211   


Q ss_pred             hhHHHHHHHHHhcCc------------------ccccccc--------c--cCCCCCHHHHHHHHHHhhccccCCCCCCC
Q 007239          505 QTLLAYVWQLWKEGK------------------EMEFVDP--------L--LMKSSSIPQVVRCIHIGLLCVQEDPAVRP  556 (611)
Q Consensus       505 ~~l~~~~~~~~~~~~------------------~~~~~d~--------~--l~~~~~~~~~~~l~~li~~cl~~dP~~RP  556 (611)
                      ......+........                  ....+..        .  -....+.....++.+|+.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            111111211111100                  0000000        0  00122345566788999999999999999


Q ss_pred             CHHHHHH
Q 007239          557 TMSNVVA  563 (611)
Q Consensus       557 t~~evl~  563 (611)
                      |+.|+++
T Consensus       327 t~~ell~  333 (373)
T 1q8y_A          327 DAGGLVN  333 (373)
T ss_dssp             CHHHHHT
T ss_pred             CHHHHhh
Confidence            9999987

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-38  Score=325.19  Aligned_cols=244  Identities=23%  Similarity=0.378  Sum_probs=190.5

Q ss_pred             HHhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChh------hHHHHHHHHHHHHhc----CCCCeeeEEEe
Q 007239          288 KAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQ------GLEEFKNEIILIAKL----QHRNLVRLVGC  356 (611)
Q Consensus       288 ~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l----~h~niv~l~~~  356 (611)
                      +...++|++.+.||+|+||.||++.. .+++.||+|++......      ....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            34567899999999999999999995 57889999999755322      223456799999999    89999999999


Q ss_pred             EeeCCeEEEEEEe-cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec-CCCCEE
Q 007239          357 GIEGEEKLLIYEL-MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD-KDMVAK  434 (611)
Q Consensus       357 ~~~~~~~~lv~E~-~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~-~~~~~k  434 (611)
                      +...+..++|||+ +.+++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+||+++ .++.+|
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence            9999999999999 789999999843   456999999999999999999999997   99999999999999 889999


Q ss_pred             EeccccceecccCCCccccccccccCCCCCccccccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHH
Q 007239          435 ISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS-VKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ  513 (611)
Q Consensus       435 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~  513 (611)
                      |+|||++.......    .....||+.|+|||++.+..+. .++||||||+++|+|++|+.||....        .    
T Consensus       181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~----  244 (312)
T 2iwi_A          181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------E----  244 (312)
T ss_dssp             ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H----
T ss_pred             EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------H----
Confidence            99999998764432    2345799999999999877764 58999999999999999999974210        0    


Q ss_pred             HHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       514 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      ..... .      .+.    .....++.+++.+||+.||++|||++|+++.
T Consensus       245 ~~~~~-~------~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          245 ILEAE-L------HFP----AHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             HHHTC-C------CCC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             Hhhhc-c------CCc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            01110 0      011    1122356789999999999999999999983

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=6.3e-38  Score=330.62  Aligned_cols=256  Identities=24%  Similarity=0.334  Sum_probs=194.6

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeE----
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEK----  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~----  363 (611)
                      .++|.+.+.||+|+||.||++++ .+|+.||+|++...  .....+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            46899999999999999999995 47899999999764  333457789999999999999999999999877655    


Q ss_pred             --EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccc
Q 007239          364 --LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA  441 (611)
Q Consensus       364 --~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  441 (611)
                        ++||||+. ++|.+++.     ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999998 57776662     34899999999999999999999997   999999999999999999999999999


Q ss_pred             eecccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc
Q 007239          442 RIFCENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE  520 (611)
Q Consensus       442 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  520 (611)
                      +.....     .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||....   .......+....... .
T Consensus       192 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~~~-~  262 (371)
T 4exu_A          192 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD---YLDQLTQILKVTGVP-G  262 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCC-C
T ss_pred             cccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHHHhCCC-c
Confidence            865332     224578999999999887 688999999999999999999999985332   111222221111110 0


Q ss_pred             cccccc-----------ccC--CCCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          521 MEFVDP-----------LLM--KSSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       521 ~~~~d~-----------~l~--~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      .+....           .+.  .....     .....+.+|+.+||+.||++|||+.|+++.
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            000000           000  00000     112467799999999999999999999863

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.9e-38  Score=327.67  Aligned_cols=243  Identities=22%  Similarity=0.365  Sum_probs=198.1

Q ss_pred             HHhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChh------hHHHHHHHHHHHHhcC--CCCeeeEEEeEe
Q 007239          288 KAATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQ------GLEEFKNEIILIAKLQ--HRNLVRLVGCGI  358 (611)
Q Consensus       288 ~~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~--h~niv~l~~~~~  358 (611)
                      +...++|++.+.||+|+||.||+|+. .+++.||+|++......      ....+.+|+.++++++  |+||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            34567899999999999999999995 57889999998754321      2245678999999997  599999999999


Q ss_pred             eCCeEEEEEEecCC-CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec-CCCCEEEe
Q 007239          359 EGEEKLLIYELMPN-RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD-KDMVAKIS  436 (611)
Q Consensus       359 ~~~~~~lv~E~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~-~~~~~kl~  436 (611)
                      ..+..++|||++.+ ++|.+++.   ....+++..++.++.||++||.|||+++   |+||||||+|||++ +++.+||+
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence            99999999999986 89999884   3456899999999999999999999987   99999999999999 78999999


Q ss_pred             ccccceecccCCCccccccccccCCCCCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHH
Q 007239          437 DFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF-SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLW  515 (611)
Q Consensus       437 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~  515 (611)
                      |||+++......    .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....            ...
T Consensus       193 Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------~~~  256 (320)
T 3a99_A          193 DFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EII  256 (320)
T ss_dssp             CCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHH
T ss_pred             eCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------hhh
Confidence            999998764332    223579999999999987776 688999999999999999999974211            001


Q ss_pred             hcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          516 KEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       516 ~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ....       .....    ...++.+|+.+||+.||++|||+++|++
T Consensus       257 ~~~~-------~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          257 RGQV-------FFRQR----VSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HCCC-------CCSSC----CCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccc-------ccccc----CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1110       01111    1235778999999999999999999987

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.2e-37  Score=322.16  Aligned_cols=259  Identities=22%  Similarity=0.275  Sum_probs=198.0

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CC-cEEEEEEecccChhhHHHHHHHHHHHHhcCCCC------eeeEEEeEeeCCe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NG-KEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN------LVRLVGCGIEGEE  362 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n------iv~l~~~~~~~~~  362 (611)
                      .++|++.+.||+|+||.||++... ++ +.||+|+++.. ....+.+.+|+.++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            478999999999999999999963 44 68999999754 244567889999999998765      8999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe---------------
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL---------------  427 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll---------------  427 (611)
                      .++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            99999999 55665665332 2246899999999999999999999986   9999999999999               


Q ss_pred             ----cCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCc
Q 007239          428 ----DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGH  503 (611)
Q Consensus       428 ----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~  503 (611)
                          +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... 
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-  245 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR-  245 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-
T ss_pred             cccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-
Confidence                66889999999999864322     22457999999999999999999999999999999999999998543221 


Q ss_pred             hhhHHHHHHHHHhcCc--------ccc-cccccc---------------------CCCCCHHHHHHHHHHhhccccCCCC
Q 007239          504 AQTLLAYVWQLWKEGK--------EME-FVDPLL---------------------MKSSSIPQVVRCIHIGLLCVQEDPA  553 (611)
Q Consensus       504 ~~~l~~~~~~~~~~~~--------~~~-~~d~~l---------------------~~~~~~~~~~~l~~li~~cl~~dP~  553 (611)
                        .....+........        ... ......                     ...........+.+|+.+||+.||+
T Consensus       246 --~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~  323 (355)
T 2eu9_A          246 --EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA  323 (355)
T ss_dssp             --HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred             --HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence              11222211111000        000 000000                     0011123345788999999999999


Q ss_pred             CCCCHHHHHH
Q 007239          554 VRPTMSNVVA  563 (611)
Q Consensus       554 ~RPt~~evl~  563 (611)
                      +|||+.|+++
T Consensus       324 ~Rpt~~e~l~  333 (355)
T 2eu9_A          324 QRITLAEALL  333 (355)
T ss_dssp             TSCCHHHHTT
T ss_pred             hCcCHHHHhc
Confidence            9999999984

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1e-37  Score=335.95  Aligned_cols=253  Identities=25%  Similarity=0.294  Sum_probs=186.7

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      +.|...+.||+|+||+||.+...+|+.||||++....   .+.+.+|+.+++++ +||||+++++++.+.+..++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            4566678899999999987666689999999986543   35678999999886 7999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhc----cCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC-------------CCE
Q 007239          371 PNRSLDCFIFDSERRL----QLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD-------------MVA  433 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~----~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~-------------~~~  433 (611)
                      + ++|.+++.......    ..++..++.++.||+.||.|||+++   |+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 59999985432211    1234456789999999999999987   9999999999999754             489


Q ss_pred             EEeccccceecccCCCcc--ccccccccCCCCCcccccc-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCc
Q 007239          434 KISDFGMARIFCENQKTA--NTRRVVGTYGYMAPEYAME-------GLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGH  503 (611)
Q Consensus       434 kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~  503 (611)
                      ||+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            999999999875433221  1234679999999999975       678999999999999999999 898875322111


Q ss_pred             hhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          504 AQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       504 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                          ..    ........    +.+..........++.+|+.+||+.||++|||+.+|++
T Consensus       248 ----~~----i~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 ----SN----IIRGIFSL----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ----HH----HHHTCCCC----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----HH----HhcCCCCc----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                11    11111110    01111123344567889999999999999999999985

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.8e-38  Score=329.12  Aligned_cols=255  Identities=23%  Similarity=0.296  Sum_probs=194.0

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe-----
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE-----  362 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-----  362 (611)
                      .++|.+.+.||+|+||.||+|++ .+|+.||+|++...  .....+.+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            36799999999999999999996 47899999999754  23345678999999999999999999999987654     


Q ss_pred             -EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccc
Q 007239          363 -KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA  441 (611)
Q Consensus       363 -~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  441 (611)
                       .++||||++ ++|.+++.     ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999998 47777662     24899999999999999999999997   999999999999999999999999999


Q ss_pred             eecccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCc-
Q 007239          442 RIFCENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK-  519 (611)
Q Consensus       442 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-  519 (611)
                      +.....     .....||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.....   ......+........ 
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~~~  245 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVTGVPGT  245 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH---HHHHHHHHHHHCBCCH
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCCCH
Confidence            865322     224578999999999887 6789999999999999999999999853321   122222211111000 


Q ss_pred             -----------------cccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          520 -----------------EMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       520 -----------------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                                       ........+ ..........+.+|+.+||+.||++|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          246 EFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                             000000000 0001122346778999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.4e-37  Score=323.41  Aligned_cols=253  Identities=22%  Similarity=0.235  Sum_probs=172.1

Q ss_pred             hhCCCCccc-ccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee----CCeE
Q 007239          290 ATDGFSDSN-KLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE----GEEK  363 (611)
Q Consensus       290 ~~~~y~~~~-~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~  363 (611)
                      ..++|.+.+ .||+|+||.||++.+. +++.||+|++....    ....+....++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            357899865 6999999999999965 78999999986532    222233344677789999999999876    4558


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC---CCCEEEecccc
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK---DMVAKISDFGM  440 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFGl  440 (611)
                      ++||||+++++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            9999999999999998543 2246899999999999999999999997   999999999999976   45599999999


Q ss_pred             ceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc
Q 007239          441 ARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE  520 (611)
Q Consensus       441 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  520 (611)
                      ++......    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||........   .............
T Consensus       178 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~  250 (336)
T 3fhr_A          178 AKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI---SPGMKRRIRLGQY  250 (336)
T ss_dssp             CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             ceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh---hhhHHHhhhcccc
Confidence            98654322    2345789999999999888999999999999999999999999853322111   0000000000000


Q ss_pred             ccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       521 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       .     ...........++.+|+..||+.||++|||++|+++
T Consensus       251 -~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          251 -G-----FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             -C-----CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -c-----cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             0     000000112345778999999999999999999998

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.8e-38  Score=356.40  Aligned_cols=255  Identities=24%  Similarity=0.355  Sum_probs=200.7

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC----CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP----NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  364 (611)
                      ..++|++.+.||+|+||.||+|.+.    .+..||+|++... .....+.+.+|+.++++++||||+++++++. .+..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            4578999999999999999999863    2457999998754 3344578999999999999999999999985 46689


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +||||+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       467 lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             EEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             EEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            99999999999999853  2345899999999999999999999997   999999999999999999999999999876


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      ...... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||....   ...+...    +..+.... 
T Consensus       542 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~---~~~~~~~----i~~~~~~~-  612 (656)
T 2j0j_A          542 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK---NNDVIGR----IENGERLP-  612 (656)
T ss_dssp             CC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHH----HHHTCCCC-
T ss_pred             CCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC---HHHHHHH----HHcCCCCC-
Confidence            433221 2223467889999999999999999999999999999997 888874322   1222221    12221111 


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                          +    +......+.+++.+||+.||++|||+.+|++.|+.
T Consensus       613 ----~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~  648 (656)
T 2j0j_A          613 ----M----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  648 (656)
T ss_dssp             ----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----C----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                1    11122457789999999999999999999999964

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.1e-37  Score=315.93  Aligned_cols=251  Identities=23%  Similarity=0.344  Sum_probs=178.6

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChh-h-HHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQ-G-LEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      .++|++.+.||+|+||.||++.+. +|+.||+|++...... . ...+.++..+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467999999999999999999964 7899999999765322 2 234455556788889999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhc-CCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED-SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      ||+ ++.+..+..  .....+++..++.++.||++||.|||++ +   |+||||||+||+++.++.+||+|||++.....
T Consensus       104 e~~-~~~~~~l~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKK--RMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHH--HhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 445554442  2245689999999999999999999985 6   99999999999999999999999999976543


Q ss_pred             CCCccccccccccCCCCCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM  521 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  521 (611)
                      ...   .....||+.|+|||++.     ...++.++||||||+++|+|++|+.||.....  ....   ........ ..
T Consensus       178 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~---~~~~~~~~-~~  248 (318)
T 2dyl_A          178 DKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEV---LTKVLQEE-PP  248 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHH---HHHHHHSC-CC
T ss_pred             Ccc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHH---HHHHhccC-CC
Confidence            322   22457999999999984     56788999999999999999999999753221  1111   11212221 11


Q ss_pred             cccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          522 EFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       522 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .     +...  .....++.+++.+||+.||++||++.++++
T Consensus       249 ~-----~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          249 L-----LPGH--MGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             C-----CCSS--SCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             C-----CCcc--CCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            1     1100  011235678999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-37  Score=331.96  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=185.1

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      .+|.+.+.||+|+||+||.....+++.||||++......   .+.+|+.+++++ +||||+++++++.+....++||||+
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~  100 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC  100 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence            468899999999999976555557899999999764432   356899999999 7999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC-----CCCEEEeccccceecc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK-----DMVAKISDFGMARIFC  445 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~-----~~~~kl~DFGla~~~~  445 (611)
                      . ++|.+++....  ..+.+..++.++.||+.||.|||+++   |+||||||+|||++.     ...+||+|||+++...
T Consensus       101 ~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A          101 A-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             S-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             C-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            7 48988885432  33555667899999999999999997   999999999999943     3368899999998765


Q ss_pred             cCCCc-cccccccccCCCCCccccc---cCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcc
Q 007239          446 ENQKT-ANTRRVVGTYGYMAPEYAM---EGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKE  520 (611)
Q Consensus       446 ~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~  520 (611)
                      ..... .......||+.|+|||++.   ...++.++|||||||++|||++ |..||+.....    ...   . ......
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~----~~~---~-~~~~~~  246 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR----QAN---I-LLGACS  246 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH----HHH---H-HTTCCC
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH----HHH---H-HhccCC
Confidence            43221 2233467999999999997   4667889999999999999999 88887432211    111   1 111111


Q ss_pred             ccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       521 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ...    .  .........+.+|+.+||+.||++|||+.+|++
T Consensus       247 ~~~----~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          247 LDC----L--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CTT----S--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccc----c--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            111    1  111223345678999999999999999999984

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.7e-37  Score=345.08  Aligned_cols=261  Identities=26%  Similarity=0.323  Sum_probs=196.9

Q ss_pred             HhhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee------C
Q 007239          289 AATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE------G  360 (611)
Q Consensus       289 ~~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~------~  360 (611)
                      ...++|++.+.||+|+||.||++.+ .+|+.||+|++... .....+.+.+|+.++++++||||+++++++..      .
T Consensus        11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            3457899999999999999999996 46899999998764 34456779999999999999999999998765      6


Q ss_pred             CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCC---EEEec
Q 007239          361 EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMV---AKISD  437 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~---~kl~D  437 (611)
                      +..++||||+++++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.   +||+|
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcc
Confidence            778999999999999999966554456899999999999999999999987   999999999999997765   99999


Q ss_pred             cccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhc
Q 007239          438 FGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKE  517 (611)
Q Consensus       438 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  517 (611)
                      ||++........   .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||......     ..+.......
T Consensus       168 FG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~  239 (676)
T 3qa8_A          168 LGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREK  239 (676)
T ss_dssp             CCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC--
T ss_pred             cccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcc
Confidence            999987644332   23468999999999999999999999999999999999999998432110     0000000000


Q ss_pred             C----cccccc------cccc--CCCCCHHHHHHHHHHhhccccCCCCCCCCHHH
Q 007239          518 G----KEMEFV------DPLL--MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSN  560 (611)
Q Consensus       518 ~----~~~~~~------d~~l--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e  560 (611)
                      .    ...+..      ...+  ...........+.+++..||+.||++|||+.+
T Consensus       240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence            0    000000      0000  11223334567889999999999999999966

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-36  Score=345.93  Aligned_cols=237  Identities=20%  Similarity=0.269  Sum_probs=190.6

Q ss_pred             hCCCCcccccCccCceEEEEEEcC--CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCe-----
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP--NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEE-----  362 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~-----  362 (611)
                      .++|++.+.||+|+||.||++++.  +++.||||++... .......+.+|+.++++++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            478999999999999999999964  6899999998654 33455678999999999999999999999987665     


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .++||||+++++|.+++..     .+++.+++.++.||+.||.|||+++   |+||||||+|||++.+ .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence            7999999999999887632     6899999999999999999999997   9999999999999885 99999999998


Q ss_pred             ecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          443 IFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       443 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      .....      ....||+.|+|||++.++. +.++||||||+++|+|++|.+|+......                    
T Consensus       230 ~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------------------  282 (681)
T 2pzi_A          230 RINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD--------------------  282 (681)
T ss_dssp             ETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS--------------------
T ss_pred             hcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc--------------------
Confidence            76432      3457999999999987765 89999999999999999998875321110                    


Q ss_pred             ccccccCCCCCHHHHHHHHHHhhccccCCCCCCCC-HHHHHHHhc
Q 007239          523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT-MSNVVALLG  566 (611)
Q Consensus       523 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-~~evl~~L~  566 (611)
                         ..............+.+|+.+||+.||++||+ ++++...|.
T Consensus       283 ---~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          283 ---GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             ---SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ---cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence               00000001112245778999999999999994 666665553

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.8e-36  Score=305.45  Aligned_cols=228  Identities=11%  Similarity=0.033  Sum_probs=179.8

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++.+.||+|+||.||++++. +++.||+|++....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367999999999999999999964 58999999997653   23457889999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++..    . ....++.+++.||+.||.|||+++   |+||||||+|||++.++.+||+++|       
T Consensus       110 ~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------  174 (286)
T ss_dssp             EECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred             EEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence            999999999999832    1 355678899999999999999997   9999999999999999999997443       


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                                     |++|       ++.++||||||+++|||++|+.||..........            .....+..
T Consensus       175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~~~  220 (286)
T 3uqc_A          175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTAG  220 (286)
T ss_dssp             ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------ECCBCTTS
T ss_pred             ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------HHHHHhcc
Confidence                           3333       6899999999999999999999985433211000            00000000


Q ss_pred             ccCC--CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          527 LLMK--SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       527 ~l~~--~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ....  ........++.+++.+||+.||++| |+.|+++.|...
T Consensus       221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~  263 (286)
T 3uqc_A          221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA  263 (286)
T ss_dssp             CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred             CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence            0000  0000112357789999999999999 999999999764

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.5e-36  Score=321.74  Aligned_cols=240  Identities=14%  Similarity=0.131  Sum_probs=177.4

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCC-CCee---------e-----
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQH-RNLV---------R-----  352 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h-~niv---------~-----  352 (611)
                      ..|+..+.||+|+||+||+|++ .+|+.||||++....   ....+.+.+|+.+++.++| +|..         .     
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            4578889999999999999994 579999999987432   2236789999999999987 3211         1     


Q ss_pred             -------EEEeEee-----CCeEEEEEEecCCCChhhHhhh----chhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceE
Q 007239          353 -------LVGCGIE-----GEEKLLIYELMPNRSLDCFIFD----SERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII  416 (611)
Q Consensus       353 -------l~~~~~~-----~~~~~lv~E~~~~~sL~~~l~~----~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~ii  416 (611)
                             +...+..     ....+++|+++ +++|.+++..    ......+++..++.++.||++||.|||+++   |+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ii  233 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LV  233 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence                   1111111     12356677765 5789888742    122445788899999999999999999997   99


Q ss_pred             ecCCCCCcEEecCCCCEEEeccccceecccCCCccccccccccCCCCCcccc----------ccCCCCchhhHHHHHHHH
Q 007239          417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA----------MEGLFSVKSDVFSFGVIV  486 (611)
Q Consensus       417 HrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~k~DvwSlGvll  486 (611)
                      ||||||+||||+.++.+||+|||+++.....     .....| +.|+|||++          ....++.++|||||||++
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            9999999999999999999999999865433     334578 999999999          555688999999999999


Q ss_pred             HHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 007239          487 LEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV  562 (611)
Q Consensus       487 ~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  562 (611)
                      |||++|+.||.......                   .....+......  ...+.+|+..||+.||++||++.+++
T Consensus       308 ~elltg~~Pf~~~~~~~-------------------~~~~~~~~~~~~--~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALG-------------------GSEWIFRSCKNI--PQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHSSCCCCTTGGGS-------------------CSGGGGSSCCCC--CHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHCCCCCCCcchhh-------------------hHHHHHhhcccC--CHHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999985332111                   111111111111  14577899999999999999976664

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.9e-35  Score=298.45  Aligned_cols=227  Identities=21%  Similarity=0.246  Sum_probs=176.8

Q ss_pred             hCCCCcc-cccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHH-HhcCCCCeeeEEEeEee----CCeE
Q 007239          291 TDGFSDS-NKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILI-AKLQHRNLVRLVGCGIE----GEEK  363 (611)
Q Consensus       291 ~~~y~~~-~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il-~~l~h~niv~l~~~~~~----~~~~  363 (611)
                      .++|.+. +.||+|+||.||++.. .+++.||+|++...     ..+.+|+.++ +.++||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            4667777 7799999999999996 57899999998642     3567889888 56689999999999887    6788


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC---CCCEEEecccc
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK---DMVAKISDFGM  440 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFGl  440 (611)
                      ++||||+++++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            9999999999999998542 2346899999999999999999999997   999999999999998   78999999999


Q ss_pred             ceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc
Q 007239          441 ARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE  520 (611)
Q Consensus       441 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  520 (611)
                      +....                        +..++.++||||||+++|||++|+.||........           .....
T Consensus       167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~  211 (299)
T 3m2w_A          167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMK  211 (299)
T ss_dssp             CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSC
T ss_pred             ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHH
Confidence            87432                        23467899999999999999999999843221110           00000


Q ss_pred             ccccccccCCCCCH----HHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          521 MEFVDPLLMKSSSI----PQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       521 ~~~~d~~l~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ........  ....    ....++.+++..||+.||++|||+.|+++
T Consensus       212 ~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          212 TRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             CSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            00000000  1111    11346778999999999999999999997

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.8e-36  Score=313.53  Aligned_cols=241  Identities=17%  Similarity=0.151  Sum_probs=182.8

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccC--------hhhHHHHHHHHHHHHhcC---------CCCeeeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKS--------WQGLEEFKNEIILIAKLQ---------HRNLVRL  353 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~il~~l~---------h~niv~l  353 (611)
                      .++|++.+.||+|+||+||+|++ +|+.||||++....        ....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46799999999999999999998 68999999997543        223478899999999986         7777777


Q ss_pred             EEeEe------------------------------eCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHH
Q 007239          354 VGCGI------------------------------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKG  403 (611)
Q Consensus       354 ~~~~~------------------------------~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~  403 (611)
                      ++++.                              ..+..++||||+++|++.+.+.+    ..+++..++.++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            76542                              26789999999999976666522    458999999999999999


Q ss_pred             HHHHh-hcCCCceEecCCCCCcEEecCCC--------------------CEEEeccccceecccCCCccccccccccCCC
Q 007239          404 LLYLH-EDSRLKIIHRDLKPSNVLLDKDM--------------------VAKISDFGMARIFCENQKTANTRRVVGTYGY  462 (611)
Q Consensus       404 l~yLH-~~~~~~iiHrDikp~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  462 (611)
                      |.||| +++   |+||||||+||||+.++                    .+||+|||+++.....       ...||+.|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence            99999 886   99999999999999887                    8999999999876432       34899999


Q ss_pred             CCccccccCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCCCchhhHHHHHH-HHHhcCccccccccccCCCCCHHHHHHH
Q 007239          463 MAPEYAMEGLFSVKSDVFSFGVI-VLEIISGKRNSGFYLTGHAQTLLAYVW-QLWKEGKEMEFVDPLLMKSSSIPQVVRC  540 (611)
Q Consensus       463 ~aPE~~~~~~~~~k~DvwSlGvl-l~elltG~~p~~~~~~~~~~~l~~~~~-~~~~~~~~~~~~d~~l~~~~~~~~~~~l  540 (611)
                      +|||++.+.. +.++||||+|++ .+++++|..|+..      ........ .........    .............++
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~------~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~s~~~  312 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN------VLWLHYLTDKMLKQMTFK----TKCNTPAMKQIKRKI  312 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH------HHHHHHHHHHHHHTCCCS----SCCCSHHHHHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc------hhhhhHHHHhhhhhhccC----cccchhhhhhcCHHH
Confidence            9999998766 899999998777 7788889888521      00001111 111111110    000001112344578


Q ss_pred             HHHhhccccCCCCCCCCHHHHH
Q 007239          541 IHIGLLCVQEDPAVRPTMSNVV  562 (611)
Q Consensus       541 ~~li~~cl~~dP~~RPt~~evl  562 (611)
                      .+|+.+||+.|     |++|++
T Consensus       313 ~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          313 QEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHhccC-----CHHHHH
Confidence            89999999976     999988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=3.8e-30  Score=284.96  Aligned_cols=185  Identities=18%  Similarity=0.175  Sum_probs=130.6

Q ss_pred             ccCccCceEEEEEE-cCCCcEEEEEEecccC----------hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEE
Q 007239          299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKS----------WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       299 ~lg~G~fg~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++.|++|.+..++ .-.|+.+++|.+.+..          ....++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            45667777666555 3358889999986542          22356799999999999 599999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||++|++|.++|.   +.+.++..   +|+.||+.||.|||++|   ||||||||+||||+.+|++||+|||+|+....
T Consensus       321 MEyv~G~~L~d~i~---~~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLA---AGEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHH---TTCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHH---hCCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            99999999999994   34556654   58999999999999997   99999999999999999999999999987644


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRN  495 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p  495 (611)
                      ...  .....+||++|||||++.+ .+..++|+||+|+++++|.++..+
T Consensus       392 ~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          392 DCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             --C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            332  2345789999999999875 467789999999998887665443

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.93  E-value=1.2e-26  Score=197.57  Aligned_cols=101  Identities=28%  Similarity=0.542  Sum_probs=91.4

Q ss_pred             CCcCCCCCCCccCCCChhHHHHHHHHHHHHhcc-cC--CceeeeeCC-CCCeEEEEEEcCCCCCccchHHHHHHHHHHHH
Q 007239           18 NPLDIACSNTSYAPNSPFESSLKLLLESIATNT-SQ--GFYNLSIGD-DPNRVFGRALCRGDVNRTVCQNCLENARHEIL   93 (611)
Q Consensus        18 ~~~~~~C~~~~~~~~s~~~~nl~~l~~~l~~~~-~~--~f~~~~~g~-~~~~vyg~~~C~~d~~~~~C~~C~~~a~~~~~   93 (611)
                      ..+++.|++++|+++++|++||+.||++|++++ ..  +|++...|. ++++|||++|||||+++++|..||+.|+.++.
T Consensus         4 ~~v~~~Cn~~~~t~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~   83 (108)
T 3a2e_A            4 AFVSSACNTQKIPSGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIF   83 (108)
T ss_dssp             CEEEEEECSSBCCTTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHH
T ss_pred             ceeeeecCCCccCCCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHH
Confidence            446778999999999999999999999999988 33  456666554 56899999999999999999999999999999


Q ss_pred             HhCCCcceeeEEcCccEEEecCccc
Q 007239           94 KNCKTAEEAIIWYELCQIQYSYRKF  118 (611)
Q Consensus        94 ~~C~~~~~a~~~~~~C~~ry~~~~f  118 (611)
                      +.||++++|+||++.|++|||+++|
T Consensus        84 ~~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           84 SICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             HHTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HHCCCCceEEEECCCEEEEEeCCcC
Confidence            9999999999999999999999998

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=1e-26  Score=256.06  Aligned_cols=185  Identities=17%  Similarity=0.191  Sum_probs=144.4

Q ss_pred             CcccccCccCceEEEEEEcCCCcEEEEEEecccChh--------hHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          295 SDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQ--------GLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       295 ~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ...+.||+|+||.||++.. .++.+++|+.......        ..+++.+|++++++++||||+++..++...+..++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            3467899999999999965 5788999986543211        234589999999999999999655555577788999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++++|.+++..           +..++.||+++|.|||+++   |+||||||+|||++.  ++||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999843           4689999999999999997   999999999999998  999999999998754


Q ss_pred             CCCcc-----ccccccccCCCCCcccccc--CCCCchhhHHHHHHHHHHHHhCCCCC
Q 007239          447 NQKTA-----NTRRVVGTYGYMAPEYAME--GLFSVKSDVFSFGVIVLEIISGKRNS  496 (611)
Q Consensus       447 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~k~DvwSlGvll~elltG~~p~  496 (611)
                      .....     ......||+.|||||++..  ..|+.++|+|+..+-.++.+.++.++
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            32211     1235789999999999987  56888899999999888888776553

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=1.4e-23  Score=212.02  Aligned_cols=149  Identities=18%  Similarity=0.090  Sum_probs=120.1

Q ss_pred             HHhhCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccCh------------------hhHHHHHHHHHHHHhcCCCC
Q 007239          288 KAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW------------------QGLEEFKNEIILIAKLQHRN  349 (611)
Q Consensus       288 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~il~~l~h~n  349 (611)
                      ......|.+.+.||+|+||.||+|.+.+|+.||+|+++....                  .....+.+|+.++++++|  
T Consensus        86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~--  163 (282)
T 1zar_A           86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG--  163 (282)
T ss_dssp             HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT--
T ss_pred             HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC--
Confidence            334556778899999999999999997799999999864321                  134668999999999994  


Q ss_pred             eeeEEEeEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC
Q 007239          350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK  429 (611)
Q Consensus       350 iv~l~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~  429 (611)
                       +++.+++. .+..++||||+++++|.+ +.         ......++.||+.||.|||+.+   |+||||||+|||++ 
T Consensus       164 -~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~---------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-  227 (282)
T 1zar_A          164 -LAVPKVYA-WEGNAVLMELIDAKELYR-VR---------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-  227 (282)
T ss_dssp             -SSSCCEEE-EETTEEEEECCCCEEGGG-CC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-
T ss_pred             -CCcCeEEe-ccceEEEEEecCCCcHHH-cc---------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-
Confidence             55555443 356699999999999987 41         1234579999999999999987   99999999999999 


Q ss_pred             CCCEEEeccccceecccCCCccccccccccCCCCCccccc
Q 007239          430 DMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM  469 (611)
Q Consensus       430 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~  469 (611)
                      ++.+||+|||+++.               +..++|||++.
T Consensus       228 ~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          228 EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence            99999999999863               34578999874

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.89  E-value=2.3e-23  Score=177.13  Aligned_cols=104  Identities=16%  Similarity=0.312  Sum_probs=92.2

Q ss_pred             ccceecCCCCccCCChhHHHHHHHHHHHHHHHHhcCCCccceeeeeccCCccceEEEEeeecCCCCCchhhHHHHHHhhh
Q 007239          126 QYAEKWNNQWKSVSNPARFIEVLTYLMTNLSIEASSDPAMFAVGEVKFPKRKTIYGLVQCTRDINSRDCNDCLTGALGDL  205 (611)
Q Consensus       126 ~~~~~~~~~~~~~~~~~~f~~~~~~ll~~l~~~a~~~~~~fa~~~~~~~~~~~~yglaqC~~dls~~~C~~CL~~a~~~~  205 (611)
                      .....| +..+++ +.+.|+.+|+.||+.|+.+|+.++.+|+++..+..+.++||||+||+||+++.+|..||..++.++
T Consensus         5 ~v~~~C-n~~~~t-~~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~   82 (108)
T 3a2e_A            5 FVSSAC-NTQKIP-SGSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRI   82 (108)
T ss_dssp             EEEEEE-CSSBCC-TTCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTH
T ss_pred             eeeeec-CCCccC-CCChHHHHHHHHHHHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHH
Confidence            345678 555544 568899999999999999998877778887766556679999999999999999999999999999


Q ss_pred             hhhcCCCcceEEEcccccceeeccee
Q 007239          206 KACCGAREAGIIVNENCNLRFQLSLF  231 (611)
Q Consensus       206 ~~~c~~~~~~~v~~~~C~lry~~~~f  231 (611)
                      +++|++++||+||+++|+||||+++|
T Consensus        83 ~~~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           83 FSICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             HHHTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HHHCCCCceEEEECCCEEEEEeCCcC
Confidence            99999999999999999999999998

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.79  E-value=1.6e-19  Score=179.88  Aligned_cols=136  Identities=16%  Similarity=0.153  Sum_probs=106.7

Q ss_pred             CCcccccCccCceEEEEEEc-CCCcE--EEEEEecccChh------------------------hHHHHHHHHHHHHhcC
Q 007239          294 FSDSNKLGQGGFGTVYKGVL-PNGKE--VAVKRLSRKSWQ------------------------GLEEFKNEIILIAKLQ  346 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~il~~l~  346 (611)
                      |.+.+.||+|+||.||+|.+ .+|+.  ||||+++.....                        ....+.+|+.++..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67889999999999999997 68888  999987543111                        1236789999999999


Q ss_pred             CCCe--eeEEEeEeeCCeEEEEEEecCC-C----ChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHh-hcCCCceEec
Q 007239          347 HRNL--VRLVGCGIEGEEKLLIYELMPN-R----SLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH-EDSRLKIIHR  418 (611)
Q Consensus       347 h~ni--v~l~~~~~~~~~~~lv~E~~~~-~----sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH-~~~~~~iiHr  418 (611)
                      |+++  ..++..    ...++||||+.+ |    +|.++...      .++..+..++.||+.+|.||| +.+   |+||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr  195 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA  195 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence            8764  444432    356899999942 3    56554321      235567889999999999999 886   9999


Q ss_pred             CCCCCcEEecCCCCEEEeccccceec
Q 007239          419 DLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       419 Dikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      ||||+|||++.  .++|+|||++...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.69  E-value=1.2e-17  Score=173.59  Aligned_cols=134  Identities=13%  Similarity=0.166  Sum_probs=99.9

Q ss_pred             CCcccccCccCceEEEEEEcCCCcEEEEEEecccCh--------------hhHH--------HHHHHHHHHHhcCCCCee
Q 007239          294 FSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW--------------QGLE--------EFKNEIILIAKLQHRNLV  351 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~il~~l~h~niv  351 (611)
                      |++.+.||+|++|.||+|...+|+.||||+++....              ....        ....|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            899999999999999999998999999998753210              0011        123466677777554432


Q ss_pred             --eEEEeEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC
Q 007239          352 --RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK  429 (611)
Q Consensus       352 --~l~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~  429 (611)
                        ..++.    ...+|||||++|+.|..+.         .......++.||+.+|.+||+.|   ||||||||.|||+++
T Consensus       177 vp~p~~~----~~~~LVME~i~G~~L~~l~---------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~  240 (397)
T 4gyi_A          177 VPEPIAQ----SRHTIVMSLVDALPMRQVS---------SVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIRE  240 (397)
T ss_dssp             CCCEEEE----ETTEEEEECCSCEEGGGCC---------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEE
T ss_pred             CCeeeec----cCceEEEEecCCccHhhhc---------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeC
Confidence              22222    2347999999998886543         12244678899999999999987   999999999999987


Q ss_pred             CC----------CEEEecccccee
Q 007239          430 DM----------VAKISDFGMARI  443 (611)
Q Consensus       430 ~~----------~~kl~DFGla~~  443 (611)
                      ++          .+.|+||+-+..
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCcccccccccceEEEEeCCccc
Confidence            76          389999997764

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.40  E-value=1.6e-12  Score=129.12  Aligned_cols=146  Identities=14%  Similarity=0.067  Sum_probs=115.8

Q ss_pred             HHhhCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEE
Q 007239          288 KAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       288 ~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv  366 (611)
                      ....+.|++...++.|+.+.||++... ++.+++|+...........+.+|+.+++.+. +..+.+++++....+..++|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            455678999999999999999998864 6889999987532222346889999999995 67788899999888899999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhc------------------------------------
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED------------------------------------  410 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------------------------------------  410 (611)
                      |||++|.+|.+.+.        +......++.+++++|..||+.                                    
T Consensus        89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            99999999876531        1223346788999999999981                                    


Q ss_pred             --------------------CCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          411 --------------------SRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       411 --------------------~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                                          ....++|+|++|.|||++++..+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                01348999999999999876667799999875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.22  E-value=1.9e-11  Score=120.77  Aligned_cols=139  Identities=15%  Similarity=0.153  Sum_probs=102.7

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--eeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN--LVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~~~~~~~~~~lv~E  368 (611)
                      ..++.+....+.|..+.||++...+|+.+++|+.....   ...+.+|+.+++.+.+.+  +.+++.+....+..++|||
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            34455544444666799999987778889999976542   245788999999997544  4568888887788999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS-------------------------------------  411 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~-------------------------------------  411 (611)
                      |++|.+|.  . ..     .+   ...++.++++.|..||+..                                     
T Consensus        96 ~i~G~~l~--~-~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           96 EVPGQDLL--S-SH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             CCSSEETT--T-SC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             ecCCcccC--c-Cc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            99998884  2 11     11   1256777788888888642                                     


Q ss_pred             ------------------CCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          412 ------------------RLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       412 ------------------~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                                        ...++|+|++|.|||+++++.+.|+||+.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                              11299999999999998876678999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.05  E-value=6.9e-10  Score=115.50  Aligned_cols=142  Identities=13%  Similarity=0.188  Sum_probs=106.7

Q ss_pred             cccccCccCceEEEEEEcCCCcEEEEEEec--ccC-hhhHHHHHHHHHHHHhcCC--CCeeeEEEeEeeC---CeEEEEE
Q 007239          296 DSNKLGQGGFGTVYKGVLPNGKEVAVKRLS--RKS-WQGLEEFKNEIILIAKLQH--RNLVRLVGCGIEG---EEKLLIY  367 (611)
Q Consensus       296 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~il~~l~h--~niv~l~~~~~~~---~~~~lv~  367 (611)
                      ..+.|+.|.++.||+.... ++.+++|+..  ... ......+.+|+.+++.+.+  ..+.+++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4568999999999998875 4678899876  332 1224567889999999974  4578888887766   4579999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS------------------------------------  411 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~------------------------------------  411 (611)
                      ||++|..+.+..     ...++..+...++.++++.|..||+..                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998874322     123677788889999999999999731                                    


Q ss_pred             -------------------CCceEecCCCCCcEEecCCCC--EEEecccccee
Q 007239          412 -------------------RLKIIHRDLKPSNVLLDKDMV--AKISDFGMARI  443 (611)
Q Consensus       412 -------------------~~~iiHrDikp~NIll~~~~~--~kl~DFGla~~  443 (611)
                                         ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               246999999999999997753  69999999874

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.00  E-value=6.2e-10  Score=113.07  Aligned_cols=182  Identities=18%  Similarity=0.217  Sum_probs=121.7

Q ss_pred             ccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcC-CCC--eeeEEEeEeeCC---eEEEEEEec
Q 007239          297 SNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRN--LVRLVGCGIEGE---EKLLIYELM  370 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~n--iv~l~~~~~~~~---~~~lv~E~~  370 (611)
                      .+.++.|....||+..    +.+++|+....  .....+.+|..+++.+. +..  +.+++......+   ..|+|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999863    56899986533  34567899999999884 332  344554433333   348899999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhc----------------------------------------
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED----------------------------------------  410 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~----------------------------------------  410 (611)
                      +|..|.....     ..++..+...++.++++.|..||+.                                        
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9998865432     2366777778888888888888861                                        


Q ss_pred             ---------------CCCceEecCCCCCcEEecC--CCCEEEeccccceecccCCCccccccccccCCC---CCcccccc
Q 007239          411 ---------------SRLKIIHRDLKPSNVLLDK--DMVAKISDFGMARIFCENQKTANTRRVVGTYGY---MAPEYAME  470 (611)
Q Consensus       411 ---------------~~~~iiHrDikp~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~  470 (611)
                                     ....++|+|++|.||++++  ...+.|+||+.+..-.... ..     .....+   ..|+....
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl-----~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DF-----ISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HH-----HTTCCTTTSCCHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HH-----HHHHhhccccCHHHHHH
Confidence                           1135899999999999998  4568899999987532110 00     000111   22322110


Q ss_pred             -----CCC---------CchhhHHHHHHHHHHHHhCCCC
Q 007239          471 -----GLF---------SVKSDVFSFGVIVLEIISGKRN  495 (611)
Q Consensus       471 -----~~~---------~~k~DvwSlGvll~elltG~~p  495 (611)
                           +..         ....+.|+++.++|.+.+|..+
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~  286 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMD  286 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHH
Confidence                 111         1236899999999999999866

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.48  E-value=1.4e-06  Score=88.25  Aligned_cols=136  Identities=21%  Similarity=0.179  Sum_probs=92.5

Q ss_pred             ccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCC---CeeeEEEeEe-eCCeEEEEEEecCC
Q 007239          297 SNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHR---NLVRLVGCGI-EGEEKLLIYELMPN  372 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~---niv~l~~~~~-~~~~~~lv~E~~~~  372 (611)
                      .+.++.|....||+.    ++.+++|+...  ......+.+|..+|+.+.+.   .+.+++.+.. ..+..++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            356788888899987    56789998532  23456789999999999753   2556666653 34567899999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhc------------------------------------------
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED------------------------------------------  410 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~------------------------------------------  410 (611)
                      ..+.....     ..++..+...++.++.+.|..||+.                                          
T Consensus        98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            88865321     1123333444444444444444432                                          


Q ss_pred             ---------------CCCceEecCCCCCcEEecC---CCC-EEEecccccee
Q 007239          411 ---------------SRLKIIHRDLKPSNVLLDK---DMV-AKISDFGMARI  443 (611)
Q Consensus       411 ---------------~~~~iiHrDikp~NIll~~---~~~-~kl~DFGla~~  443 (611)
                                     ....++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           2235799999999999987   455 48999998864

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.47  E-value=2e-06  Score=85.21  Aligned_cols=142  Identities=18%  Similarity=0.193  Sum_probs=99.4

Q ss_pred             hCCCCcccccCccCce-EEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEEE
Q 007239          291 TDGFSDSNKLGQGGFG-TVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ...|+.. .+..|..+ .||+.... ++..+++|+-...   ....+.+|..+|+.+. +--+.+++.++.+.+..++||
T Consensus        24 l~g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvm   99 (272)
T 4gkh_A           24 LYGYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLT   99 (272)
T ss_dssp             HTTCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             ccCCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEE
Confidence            3344432 34455554 68988754 5677999986543   3456788999999886 333677888888889999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhc-------------------------------------
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED-------------------------------------  410 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-------------------------------------  410 (611)
                      |+++|.++.+....       .......+..++++.|..||..                                     
T Consensus       100 e~l~G~~~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (272)
T 4gkh_A          100 TAIPGKTAFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN  172 (272)
T ss_dssp             ECCCSEEHHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred             EeeCCccccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence            99999888665421       1122334566666666666631                                     


Q ss_pred             ------------------CCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          411 ------------------SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       411 ------------------~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                                        ....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                              111379999999999999887778999998853

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.32  E-value=9.3e-07  Score=91.49  Aligned_cols=80  Identities=5%  Similarity=-0.024  Sum_probs=56.2

Q ss_pred             cccc-CccCceEEEEEEcC-------CCcEEEEEEecccC---hhhHHHHHHHHHHHHhcC-C--CCeeeEEEeEeeC--
Q 007239          297 SNKL-GQGGFGTVYKGVLP-------NGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQ-H--RNLVRLVGCGIEG--  360 (611)
Q Consensus       297 ~~~l-g~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-h--~niv~l~~~~~~~--  360 (611)
                      .+.| +.|....+|+....       +++.+++|+.....   ......+.+|+.+++.+. +  -.+.+++.+..+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3567 88889999998754       26789999865432   111245778999998886 3  2466777776554  


Q ss_pred             -CeEEEEEEecCCCChh
Q 007239          361 -EEKLLIYELMPNRSLD  376 (611)
Q Consensus       361 -~~~~lv~E~~~~~sL~  376 (611)
                       +..++||||++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3568999999987764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.11  E-value=1.4e-05  Score=81.77  Aligned_cols=140  Identities=16%  Similarity=0.183  Sum_probs=80.4

Q ss_pred             cccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCC--CCeeeEEE------eEeeCCeEEEEEEe
Q 007239          298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQH--RNLVRLVG------CGIEGEEKLLIYEL  369 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h--~niv~l~~------~~~~~~~~~lv~E~  369 (611)
                      +.|+.|..+.||+....+| .+++|+....    ...+..|..+++.|..  -.+.+++.      +....+..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677899999887554 5999998752    2344456666666541  12333332      12346678999999


Q ss_pred             cCCCChh-----------hH---hhhchhhc-----------cCCHHH-------------------------------H
Q 007239          370 MPNRSLD-----------CF---IFDSERRL-----------QLNWNT-------------------------------C  393 (611)
Q Consensus       370 ~~~~sL~-----------~~---l~~~~~~~-----------~l~~~~-------------------------------~  393 (611)
                      ++|..+.           ..   ++......           ...|..                               .
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542           00   11100000           012211                               0


Q ss_pred             HHHHHHHHHHHHHHhh--------c--CCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          394 YNIIGGISKGLLYLHE--------D--SRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       394 ~~i~~qi~~~l~yLH~--------~--~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      ..+..++.+++.+|++        .  ....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            1111223445666653        1  23469999999999999888899999999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.01  E-value=1.6e-05  Score=83.53  Aligned_cols=75  Identities=11%  Similarity=0.168  Sum_probs=50.8

Q ss_pred             ccccCccCceEEEEEEcC-CCcEEEEEEecccCh-------hhHHHHHHHHHHHHhcCC--CC-eeeEEEeEeeCCeEEE
Q 007239          297 SNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW-------QGLEEFKNEIILIAKLQH--RN-LVRLVGCGIEGEEKLL  365 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~il~~l~h--~n-iv~l~~~~~~~~~~~l  365 (611)
                      .+.||.|..+.||++... +++.+++|.......       ...+++..|.++++.+..  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467999999999999854 568899998653211       123466789999988753  33 4455543  4455689


Q ss_pred             EEEecCCC
Q 007239          366 IYELMPNR  373 (611)
Q Consensus       366 v~E~~~~~  373 (611)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999874

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.89  E-value=0.00011  Score=74.41  Aligned_cols=139  Identities=19%  Similarity=0.150  Sum_probs=92.5

Q ss_pred             cccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcC---CCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          296 DSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ---HRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       296 ~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      ..+.|+.|....+|+... +++.+++|+....   ....+..|...|+.|.   ...+.+++.+....+..++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            346799999999999886 4678999987643   3567889999999885   25678888888777889999999999


Q ss_pred             CChhh--------H---hhhchh---hc----------------cCCHHHHH---HHH----------------HHHHHH
Q 007239          373 RSLDC--------F---IFDSER---RL----------------QLNWNTCY---NII----------------GGISKG  403 (611)
Q Consensus       373 ~sL~~--------~---l~~~~~---~~----------------~l~~~~~~---~i~----------------~qi~~~  403 (611)
                      ..+..        .   ++....   .+                .-+|...+   ++.                .++++-
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            86521        1   111110   00                11343321   011                112211


Q ss_pred             -HHHHhh-cCCCceEecCCCCCcEEecCCCCEEEeccc
Q 007239          404 -LLYLHE-DSRLKIIHRDLKPSNVLLDKDMVAKISDFG  439 (611)
Q Consensus       404 -l~yLH~-~~~~~iiHrDikp~NIll~~~~~~kl~DFG  439 (611)
                       ...|.. .....++|+|+.+.|++++.++ +.|+||.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             223432 2245799999999999999887 8999984

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.88  E-value=7.5e-05  Score=74.63  Aligned_cols=80  Identities=18%  Similarity=0.206  Sum_probs=59.4

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCC---CeeeEEEeEeeCCeEEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHR---NLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~---niv~l~~~~~~~~~~~lv~E  368 (611)
                      ......+.+|.|..+.||+....+|+.|++|+...........|..|...|+.|...   -+.+++.+    +..++|||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e   90 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME   90 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence            345556789999999999999999999999987655444445678899999988522   24455554    23478999


Q ss_pred             ecCCCCh
Q 007239          369 LMPNRSL  375 (611)
Q Consensus       369 ~~~~~sL  375 (611)
                      |++++..
T Consensus        91 ~l~~~~~   97 (288)
T 3f7w_A           91 WVDERPP   97 (288)
T ss_dssp             CCCCCCC
T ss_pred             eecccCC
Confidence            9987654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.62  E-value=0.00025  Score=74.95  Aligned_cols=77  Identities=13%  Similarity=0.113  Sum_probs=47.3

Q ss_pred             CceEecCCCCCcEEecCCCCEEEeccccceecccCCCccccccccc--cCCCCCccccccC---CCCchhhHHHHHHHHH
Q 007239          413 LKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVG--TYGYMAPEYAMEG---LFSVKSDVFSFGVIVL  487 (611)
Q Consensus       413 ~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~k~DvwSlGvll~  487 (611)
                      ..++|+|+++.|||++.++ ++|+||+.+..-.... ..  .....  ...|++|+.....   .-....++......+|
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dl--a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DI--GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HH--HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HH--HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            4699999999999998876 9999999887532111 00  00111  1245666554311   1122355667888888


Q ss_pred             HHHhCC
Q 007239          488 EIISGK  493 (611)
Q Consensus       488 elltG~  493 (611)
                      +.+.++
T Consensus       308 ~~y~~~  313 (420)
T 2pyw_A          308 NLFNKR  313 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            877653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.57  E-value=0.00023  Score=72.08  Aligned_cols=156  Identities=12%  Similarity=0.124  Sum_probs=85.7

Q ss_pred             HHHHHHhhCCCCc-----ccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--eeeEEEe
Q 007239          284 LAVIKAATDGFSD-----SNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN--LVRLVGC  356 (611)
Q Consensus       284 ~~~~~~~~~~y~~-----~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~~  356 (611)
                      ...+.....+|.+     .+.|+.|....+|+....+| .+++|+.....  ..+.+..|..+++.+...+  +.+++..
T Consensus         9 ~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~   85 (322)
T 2ppq_A            9 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPR   85 (322)
T ss_dssp             HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred             HHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCC
Confidence            3344444455554     24567788899999887555 68899887531  1234567888887775322  2333321


Q ss_pred             ------EeeCCeEEEEEEecCCCChhh----H----------hhhchhh---c---c---CCHHHHHH------------
Q 007239          357 ------GIEGEEKLLIYELMPNRSLDC----F----------IFDSERR---L---Q---LNWNTCYN------------  395 (611)
Q Consensus       357 ------~~~~~~~~lv~E~~~~~sL~~----~----------l~~~~~~---~---~---l~~~~~~~------------  395 (611)
                            ....+..+++|+|++|..+..    .          ++.....   .   .   ..|...+.            
T Consensus        86 ~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~  165 (322)
T 2ppq_A           86 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG  165 (322)
T ss_dssp             TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred             CCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhh
Confidence                  123456789999999865421    0          1110000   0   0   01211000            


Q ss_pred             HHHHHHHHHHHHhhc----CCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          396 IIGGISKGLLYLHED----SRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       396 i~~qi~~~l~yLH~~----~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      +...+.+.+..++..    ....++|+|+++.|||+++++.+.|+||+.+.
T Consensus       166 l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          166 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            001133445555431    12358999999999999987666899998875

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.49  E-value=0.00042  Score=71.98  Aligned_cols=141  Identities=19%  Similarity=0.238  Sum_probs=84.6

Q ss_pred             cccCccCceEEEEEEcC--------CCcEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEEEE
Q 007239          298 NKLGQGGFGTVYKGVLP--------NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      +.|..|-...+|+....        +++.+++|+.... ......+.+|..+++.|. +.-..++++.+.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            46777888899998864        3578999986432 234556778999998886 3333566666543    29999


Q ss_pred             ecCCCChhhH-h----------------hhc-hh-hccCC--HHHHHHHHHHHHH-------------------HHHHHh
Q 007239          369 LMPNRSLDCF-I----------------FDS-ER-RLQLN--WNTCYNIIGGISK-------------------GLLYLH  408 (611)
Q Consensus       369 ~~~~~sL~~~-l----------------~~~-~~-~~~l~--~~~~~~i~~qi~~-------------------~l~yLH  408 (611)
                      |++|..|..- +                +.. .. .....  +.++.++..++-.                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9998765321 0                000 00 01111  3455555544422                   123332


Q ss_pred             ----hc-CCCceEecCCCCCcEEecCC----CCEEEecccccee
Q 007239          409 ----ED-SRLKIIHRDLKPSNVLLDKD----MVAKISDFGMARI  443 (611)
Q Consensus       409 ----~~-~~~~iiHrDikp~NIll~~~----~~~kl~DFGla~~  443 (611)
                          .. ....++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                22 23468999999999999876    7899999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.43  E-value=0.00041  Score=73.48  Aligned_cols=73  Identities=18%  Similarity=0.221  Sum_probs=51.0

Q ss_pred             ccccCccCceEEEEEEcCC--------CcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCe-eeEEEeEeeCCeEEEEE
Q 007239          297 SNKLGQGGFGTVYKGVLPN--------GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNL-VRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lv~  367 (611)
                      .+.|+.|-...+|++...+        ++.+++|+.....  ..+.+.+|..+++.|...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4568888889999998643        5789999885421  12456689999998863333 566665532    3899


Q ss_pred             EecCCCCh
Q 007239          368 ELMPNRSL  375 (611)
Q Consensus       368 E~~~~~sL  375 (611)
                      ||++|..|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99987554

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.39  E-value=0.00049  Score=69.10  Aligned_cols=72  Identities=6%  Similarity=0.094  Sum_probs=46.9

Q ss_pred             ccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCe-eeEEEeEeeCCeEEEEEEec-CCCC
Q 007239          297 SNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNL-VRLVGCGIEGEEKLLIYELM-PNRS  374 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lv~E~~-~~~s  374 (611)
                      .+.|+.|....+|+.     +.+++|+........ ....+|..+++.+...++ .+++..  +.+.-++++||+ ++..
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            678999999999998     568999876532111 123568888888763333 455544  334457899999 7655


Q ss_pred             hh
Q 007239          375 LD  376 (611)
Q Consensus       375 L~  376 (611)
                      +.
T Consensus        95 l~   96 (301)
T 3dxq_A           95 MS   96 (301)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.31  E-value=0.00084  Score=71.57  Aligned_cols=74  Identities=14%  Similarity=0.019  Sum_probs=49.1

Q ss_pred             ccccCccCceEEEEEEcCC-CcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCe-eeEEEeEeeCCeEEEEEEecCCCC
Q 007239          297 SNKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNL-VRLVGCGIEGEEKLLIYELMPNRS  374 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~~~~~~~~~~~lv~E~~~~~s  374 (611)
                      .+.|+.|-...+|+....+ ++.+++|+........+ ...+|..+++.|...++ .++++.+.  +  .+||||++|..
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            4568888889999998754 57899998754321111 12589999999975544 56777653  2  35999999865


Q ss_pred             h
Q 007239          375 L  375 (611)
Q Consensus       375 L  375 (611)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            5

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.30  E-value=0.0013  Score=66.54  Aligned_cols=142  Identities=15%  Similarity=0.141  Sum_probs=82.2

Q ss_pred             cccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCC--eeeEEEe-----EeeCCeEEEEEEec
Q 007239          298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN--LVRLVGC-----GIEGEEKLLIYELM  370 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~~~-----~~~~~~~~lv~E~~  370 (611)
                      ..|+ |....||+....+|+.+++|+..... ...+.+..|..+++.+....  +.+++..     ....+..+++||++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            3466 77889999877677789999986432 13456777888888875322  3344432     12345668899999


Q ss_pred             CCCChhh-----H---------hhhchh------hccCCHHHH----------------------HHHHHHHHHHHHHHh
Q 007239          371 PNRSLDC-----F---------IFDSER------RLQLNWNTC----------------------YNIIGGISKGLLYLH  408 (611)
Q Consensus       371 ~~~sL~~-----~---------l~~~~~------~~~l~~~~~----------------------~~i~~qi~~~l~yLH  408 (611)
                      +|..+..     .         ++....      ...+++...                      ...+.+++..+.-+-
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            9865421     0         111000      011121110                      111122222222221


Q ss_pred             h-cCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          409 E-DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       409 ~-~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      . .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            1 1234589999999999999 4 899999988753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.24  E-value=0.0024  Score=64.84  Aligned_cols=141  Identities=14%  Similarity=0.120  Sum_probs=73.5

Q ss_pred             cccCccCceE-EEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCC--CeeeEEEeEeeCCeEEEEEEecCCCC
Q 007239          298 NKLGQGGFGT-VYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHR--NLVRLVGCGIEGEEKLLIYELMPNRS  374 (611)
Q Consensus       298 ~~lg~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~--niv~l~~~~~~~~~~~lv~E~~~~~s  374 (611)
                      +.|+.|.... +|+....+++.+++|.......   +.+..|+.+++.+...  .+.+++.+....  -+++||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence            4566665554 6677654477788886544321   2345677777777522  245566653322  378999998776


Q ss_pred             hhhHhhhchh-----------------------hccCCHHHHH-------HH-------------HHHHHHHHHHHh---
Q 007239          375 LDCFIFDSER-----------------------RLQLNWNTCY-------NI-------------IGGISKGLLYLH---  408 (611)
Q Consensus       375 L~~~l~~~~~-----------------------~~~l~~~~~~-------~i-------------~~qi~~~l~yLH---  408 (611)
                      +.+.+.....                       ...++.....       .+             ...+.+.+..|.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            6544321100                       0011111100       00             001111222221   


Q ss_pred             hcCCCceEecCCCCCcEEecCC----CCEEEecccccee
Q 007239          409 EDSRLKIIHRDLKPSNVLLDKD----MVAKISDFGMARI  443 (611)
Q Consensus       409 ~~~~~~iiHrDikp~NIll~~~----~~~kl~DFGla~~  443 (611)
                      ......++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1123469999999999999875    6899999998874

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.09  E-value=0.00093  Score=69.14  Aligned_cols=74  Identities=12%  Similarity=0.043  Sum_probs=45.8

Q ss_pred             ccccCccCceEEEEEEcCC---------CcEEEEEEecccChhhHHHHHHHHHHHHhcCCCC-eeeEEEeEeeCCeEEEE
Q 007239          297 SNKLGQGGFGTVYKGVLPN---------GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN-LVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~l~~~~~~~~~~~lv  366 (611)
                      .+.|+.|....+|+....+         ++.+++|+...... .......|..+++.+...+ ..++++..  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            3567888888999988643         26899998754321 1112467888888886333 34666543  2  3689


Q ss_pred             EEecCCCCh
Q 007239          367 YELMPNRSL  375 (611)
Q Consensus       367 ~E~~~~~sL  375 (611)
                      |||++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999998654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.08  E-value=0.0022  Score=65.51  Aligned_cols=68  Identities=10%  Similarity=0.062  Sum_probs=44.7

Q ss_pred             CccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCC---CCeeeEEEe------EeeCCeEEEEEEecC
Q 007239          301 GQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQH---RNLVRLVGC------GIEGEEKLLIYELMP  371 (611)
Q Consensus       301 g~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h---~niv~l~~~------~~~~~~~~lv~E~~~  371 (611)
                      |.|....||+....+| .+++|+......      ..|+.+++.|..   |.+.+++..      ....+..+++|||++
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~  104 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH  104 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence            3344688999987667 899998765432      356666666642   224444432      233567899999999


Q ss_pred             CCCh
Q 007239          372 NRSL  375 (611)
Q Consensus       372 ~~sL  375 (611)
                      |..+
T Consensus       105 G~~~  108 (339)
T 3i1a_A          105 APNG  108 (339)
T ss_dssp             CCBT
T ss_pred             CCcC
Confidence            8766

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.73  E-value=0.0081  Score=56.42  Aligned_cols=103  Identities=12%  Similarity=0.061  Sum_probs=66.3

Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCccc
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN  452 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  452 (611)
                      -+|.++|.  ....+++++++|.++.|.+..|.-+-.+. .+ ..+=+.|..|++..+|+|.+.+ ..+.          
T Consensus        33 vSL~eIL~--~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILR--LYNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHH--HHTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHH--HcCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----------
Confidence            37888874  34568999999999999999987762211 11 1222446899999999988864 1110          


Q ss_pred             cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCC
Q 007239          453 TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRN  495 (611)
Q Consensus       453 ~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p  495 (611)
                          .....+.|||... ...+.+.=|||||+++|.-+--..|
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                1122456888653 3456889999999999999875443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.02  E-value=0.032  Score=58.60  Aligned_cols=141  Identities=13%  Similarity=0.122  Sum_probs=85.3

Q ss_pred             ccccCccCceEEEEEEcCC--------CcEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEEE
Q 007239          297 SNKLGQGGFGTVYKGVLPN--------GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~  367 (611)
                      .+.|..|-...+|+....+        ++.+++|+....... .-...+|..+++.+. +.-..++++.+.    -++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            4567778889999998653        578999987543211 122367888888886 333445555332    27899


Q ss_pred             EecCCCChhh--H--------h-------hhchh----------hccCCHHHHHHHHHHHH-------------------
Q 007239          368 ELMPNRSLDC--F--------I-------FDSER----------RLQLNWNTCYNIIGGIS-------------------  401 (611)
Q Consensus       368 E~~~~~sL~~--~--------l-------~~~~~----------~~~l~~~~~~~i~~qi~-------------------  401 (611)
                      ||++|..|..  +        +       +....          ..+.-+.++.++..++-                   
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            9999976421  0        0       00000          01112444444443321                   


Q ss_pred             HHHHHHh---------------------hcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          402 KGLLYLH---------------------EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       402 ~~l~yLH---------------------~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ..+.+|.                     ......++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            1223322                     111345899999999999 8888999999998874

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.36  E-value=0.18  Score=52.42  Aligned_cols=30  Identities=23%  Similarity=0.366  Sum_probs=25.4

Q ss_pred             ceEecCCCCCcEEe------cCCCCEEEecccccee
Q 007239          414 KIIHRDLKPSNVLL------DKDMVAKISDFGMARI  443 (611)
Q Consensus       414 ~iiHrDikp~NIll------~~~~~~kl~DFGla~~  443 (611)
                      -++|+|+.+.|||+      +++..++++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            35799999999999      4567899999998864

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=82.49  E-value=2.2  Score=39.81  Aligned_cols=115  Identities=11%  Similarity=0.087  Sum_probs=77.4

Q ss_pred             CCCCeeeEEEeEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcE
Q 007239          346 QHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNV  425 (611)
Q Consensus       346 ~h~niv~l~~~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NI  425 (611)
                      .||++++. .+-...+.+.+.++.-++  ...+    ..-..++....++++..|+....+++.     -+|--|.|+||
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f----~~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDN--HTPF----DNIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTT--SEEG----GGGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcc--cCCH----HHHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence            47888866 455566666666655432  2222    123457888899999999988866654     47888999999


Q ss_pred             EecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007239          426 LLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNS  496 (611)
Q Consensus       426 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~  496 (611)
                      +++.++.+++.-.|+-..                   ++|.     .++...=.-.+=+++..+++++..|
T Consensus       111 ~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             EECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             EEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            999999999987665432                   2222     1222233446778888999998775

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=81.69  E-value=4  Score=38.19  Aligned_cols=113  Identities=8%  Similarity=0.075  Sum_probs=74.5

Q ss_pred             CCCCeeeEEEeEeeCCeEEEEEEecCCC-ChhhHhhhchhhccCCHHHHHHHHHHHHHHHH-HHhhcCCCceEecCCCCC
Q 007239          346 QHRNLVRLVGCGIEGEEKLLIYELMPNR-SLDCFIFDSERRLQLNWNTCYNIIGGISKGLL-YLHEDSRLKIIHRDLKPS  423 (611)
Q Consensus       346 ~h~niv~l~~~~~~~~~~~lv~E~~~~~-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~-yLH~~~~~~iiHrDikp~  423 (611)
                      .||.+  -..+-.+++.+.+.++.-+++ ++. -+      ..++....++++..|+.... +++.     -+|--|.|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            47877  333446667777777765332 222 22      34788889999999888777 5554     578889999


Q ss_pred             cEEecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCC
Q 007239          424 NVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNS  496 (611)
Q Consensus       424 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~  496 (611)
                      ||+++.++.++|.-.|+-.                   -++|.-     .+..-=.-++=+++..++.++..|
T Consensus       114 NL~f~~~~~p~i~hRGi~~-------------------~lpP~e-----~~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKE-------------------SLPPDE-----WDDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             GEEECTTCCEEESCCEETT-------------------TBSSCS-----CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             eEEEeCCCcEEEEEcCCcc-------------------cCCCCC-----CCHHHHHHHHHHHHHHHHcCCCCH
Confidence            9999999999998766532                   233331     122222335677888888887654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	611
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-72
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-68
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-66
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-65
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-63
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-63
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-63
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-62
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-62
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-62
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-61
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-61
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-61
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-61
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-60
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-60
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-60
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-60
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-60
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-59
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-57
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-57
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-56
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	8e-56
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-54
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-53
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-52
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-49
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-47
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-47
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-46
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-46
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-45
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-45
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-44
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-44
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-44
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-44
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-43
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-43
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-41
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-41
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-41
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	4e-40
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-39
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-38
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-36
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-32
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-31
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-26

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  231 bits (590), Expect = 3e-72
 Identities = 68/282 (24%), Positives = 134/282 (47%), Gaps = 22/282 (7%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            ++G G FGTVYKG       V +  ++  + Q L+ FKNE+ ++ K +H N++  +G  
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73

Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
              +   ++ +     SL   +   E +         +I    ++G+ YLH      IIH
Sbjct: 74  TAPQ-LAIVTQWCEGSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLHAK---SIIH 127

Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM---EGLFS 474
           RDLK +N+ L +D+  KI DFG+A +      +    ++ G+  +MAPE      +  +S
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187

Query: 475 VKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSI 534
            +SDV++FG+++ E+++G+    +    +   +      +   G     +  +    S+ 
Sbjct: 188 FQSDVYAFGIVLYELMTGQLP--YSNINNRDQI----IFMVGRGYLSPDLSKV---RSNC 238

Query: 535 PQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPR 576
           P+ ++   +   C+++    RP    ++A +  E +A S P+
Sbjct: 239 PKAMK--RLMAECLKKKRDERPLFPQILASI--ELLARSLPK 276

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (565), Expect = 1e-68
 Identities = 82/274 (29%), Positives = 132/274 (48%), Gaps = 22/274 (8%)

Query: 292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLV 351
           +      +LG G FG V+ G      +VAVK L ++     + F  E  L+ +LQH+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           RL     + E   +I E M N SL  F+      ++L  N   ++   I++G+ ++ E  
Sbjct: 72  RLYAVVTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEE-- 127

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
               IHRDL+ +N+L+   +  KI+DFG+AR+  +N+ TA          + APE    G
Sbjct: 128 -RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYG 185

Query: 472 LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKS 531
            F++KSDV+SFG+++ EI++  R     +T         V Q  + G  M   D      
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------VIQNLERGYRMVRPD------ 233

Query: 532 SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
            + P+      +  LC +E P  RPT   + ++L
Sbjct: 234 -NCPE--ELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 9e-66
 Identities = 76/287 (26%), Positives = 128/287 (44%), Gaps = 22/287 (7%)

Query: 292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLV 351
           +      KLGQG FG V+ G       VA+K L +      E F  E  ++ KL+H  LV
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 75

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
           +L    +  E   ++ E M   SL  F+     +         ++   I+ G+ Y+    
Sbjct: 76  QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE--- 130

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
           R+  +HRDL+ +N+L+ +++V K++DFG+AR+  +N+ TA          + APE A+ G
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYG 189

Query: 472 LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKS 531
            F++KSDV+SFG+++ E+ +  R     +          V    + G  M          
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVERGYRMPC-------P 236

Query: 532 SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQP 578
              P+      +   C +++P  RPT   + A L     +     QP
Sbjct: 237 PECPE--SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 2e-65
 Identities = 72/272 (26%), Positives = 118/272 (43%), Gaps = 22/272 (8%)

Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRL 353
            +   ++G G FG V+ G   N  +VA+K + R+     E+F  E  ++ KL H  LV+L
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 65

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
            G  +E     L++E M +  L  ++    +R      T   +   + +G+ YL E    
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLR--TQRGLFAAETLLGMCLDVCEGMAYLEE---A 120

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF 473
            +IHRDL   N L+ ++ V K+SDFGM R   ++Q T ++        + +PE      +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRY 179

Query: 474 SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSS 533
           S KSDV+SFGV++ E+ S  +      +            +           P L  +  
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNS--------EVVEDISTGFRLYKPRLAST-- 229

Query: 534 IPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
                    I   C +E P  RP  S ++  L
Sbjct: 230 -----HVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 4e-63
 Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 11/207 (5%)

Query: 290 ATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGL-EEFKNEIILIAKLQH 347
             D F   ++LG G  G V+K    P+G  +A K +  +    +  +   E+ ++ +   
Sbjct: 4   KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63

Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
             +V   G      E  +  E M   SLD  +  + R   +       +   + KGL YL
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYL 120

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
               + KI+HRD+KPSN+L++     K+ DFG++    ++         VGT  YM+PE 
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPER 174

Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGKR 494
                +SV+SD++S G+ ++E+  G+ 
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRY 201

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 6e-63
 Identities = 64/268 (23%), Positives = 109/268 (40%), Gaps = 22/268 (8%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            +LG G FG V  G      +VA+K +   S    +EF  E  ++  L H  LV+L G  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +     +I E M N  L  ++ +   R          +   + + + YL      + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESK---QFLH 123

Query: 418 RDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKS 477
           RDL   N L++   V K+SDFG++R   +++ T++         +  PE  M   FS KS
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKFSSKS 182

Query: 478 DVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQV 537
           D+++FGV++ EI S  +      T           +   +G  +              + 
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRLYR-------PHLASE- 228

Query: 538 VRCIHIGLLCVQEDPAVRPTMSNVVALL 565
            +   I   C  E    RPT   +++ +
Sbjct: 229 -KVYTIMYSCWHEKADERPTFKILLSNI 255

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 7e-63
 Identities = 61/289 (21%), Positives = 113/289 (39%), Gaps = 28/289 (9%)

Query: 299 KLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGI 358
            +G+G FG V++G    G+EVAVK  S +  +     + EI     L+H N++  +    
Sbjct: 10  SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADN 67

Query: 359 EGEEKL----LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED---- 410
           +         L+ +   + SL  ++     R  +       +    + GL +LH +    
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 411 -SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR--RVVGTYGYMAPEY 467
             +  I HRDLK  N+L+ K+    I+D G+A        T +      VGT  YMAPE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 468 AMEGL------FSVKSDVFSFGVIVLEIISGKRNSGFYLTG----HAQTLLAYVWQLWKE 517
             + +         ++D+++ G++  EI       G +       +         +  ++
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243

Query: 518 GKEMEFVDPLLMKSSSIPQVVRCIH-IGLLCVQEDPAVRPTMSNVVALL 565
               + + P +       + +R +  I   C   + A R T   +   L
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  206 bits (526), Expect = 1e-62
 Identities = 72/275 (26%), Positives = 132/275 (48%), Gaps = 22/275 (8%)

Query: 292 DGFSDSNKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNL 350
              +  +KLG G +G VY+GV       VAVK L   + + +EEF  E  ++ +++H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75

Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           V+L+G         +I E M   +L  ++ +  R+ +++      +   IS  + YL   
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLE-- 132

Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAME 470
            +   IHRDL   N L+ ++ + K++DFG++R+   +  TA+         + APE    
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190

Query: 471 GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK 530
             FS+KSDV++FGV++ EI +         + +    L+ V++L ++   ME  +     
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGM------SPYPGIDLSQVYELLEKDYRMERPE----- 239

Query: 531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
               P+  +   +   C Q +P+ RP+ + +    
Sbjct: 240 --GCPE--KVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 1e-62
 Identities = 75/269 (27%), Positives = 118/269 (43%), Gaps = 28/269 (10%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
             +G+G FG V  G    G +VAVK +   +    + F  E  ++ +L+H NLV+L+G  
Sbjct: 13  QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 358 IEGEEKL-LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
           +E +  L ++ E M   SL  ++    R + L  +        + + + YL        +
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLE---GNNFV 125

Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRDL   NVL+ +D VAK+SDFG+ +     Q T           + APE   E  FS K
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALREKKFSTK 180

Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
           SDV+SFG+++ EI S  R     +          V    ++G +M+  D         P 
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMDAPD-------GCPP 227

Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
                 +   C   D A+RP+   +   L
Sbjct: 228 --AVYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 1e-62
 Identities = 71/285 (24%), Positives = 119/285 (41%), Gaps = 26/285 (9%)

Query: 299 KLGQGGFGTVYKGVL---PNGKEVAVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLVRLV 354
           +LG G FG+V +GV        +VA+K L + + +   EE   E  ++ +L +  +VRL+
Sbjct: 16  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75

Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
           G   + E  +L+ E+     L  F+    +R ++  +    ++  +S G+ YL       
Sbjct: 76  GV-CQAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLE---EKN 129

Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR-VVGTYGYMAPEYAMEGLF 473
            +HRDL   NVLL     AKISDFG+++    +      R        + APE      F
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189

Query: 474 SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSS 533
           S +SDV+S+GV + E +S  +     + G        V    ++GK ME           
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRMECPP-------E 236

Query: 534 IPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQP 578
            P       +   C       RP    V   + +   +L+   + 
Sbjct: 237 CPP--ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 1e-61
 Identities = 72/276 (26%), Positives = 117/276 (42%), Gaps = 28/276 (10%)

Query: 296 DSNKLGQGGFGTVYKGVLPN---GKEVAVKRLSRKSWQG--LEEFKNEIILIAKLQHRNL 350
           +  +LG G FGTV KG        K VAVK L  ++      +E   E  ++ +L +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           VR++G   E E  +L+ E+     L+ ++  +     +       ++  +S G+ YL   
Sbjct: 71  VRMIGI-CEAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE-- 124

Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR-RVVGTYGYMAPEYAM 469
                +HRDL   NVLL     AKISDFG+++    ++     +        + APE   
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 470 EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
              FS KSDV+SFGV++ E  S  +     + G        V  + ++G+ M        
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE------VTAMLEKGERMGC------ 231

Query: 530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
             +  P+      +  LC   D   RP  + V   L
Sbjct: 232 -PAGCPR--EMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  202 bits (515), Expect = 5e-61
 Identities = 70/302 (23%), Positives = 123/302 (40%), Gaps = 46/302 (15%)

Query: 292 DGFSDSNKLGQGGFGTVYKGVLPN------GKEVAVKRLSRK-SWQGLEEFKNEIILIAK 344
           +       +G+G FG V++   P          VAVK L  + S     +F+ E  L+A+
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRL------------------ 386
             + N+V+L+G    G+   L++E M    L+ F+                         
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 387 ---QLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI 443
               L+      I   ++ G+ YL E    K +HRDL   N L+ ++MV KI+DFG++R 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 444 FCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGH 503
                             +M PE      ++ +SDV+++GV++ EI S      +Y   H
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP-YYGMAH 248

Query: 504 AQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA 563
            +     V    ++G  +   +       + P      ++  LC  + PA RP+  ++  
Sbjct: 249 EE-----VIYYVRDGNILACPE-------NCPL--ELYNLMRLCWSKLPADRPSFCSIHR 294

Query: 564 LL 565
           +L
Sbjct: 295 IL 296

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 6e-61
 Identities = 70/298 (23%), Positives = 113/298 (37%), Gaps = 45/298 (15%)

Query: 299 KLGQGGFGTVYKGVLPN------GKEVAVKRLSRKSWQG-LEEFKNEIILIAKL-QHRNL 350
            LG G FG V               +VAVK L  K+     E   +E+ ++ +L  H N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ--------------------LNW 390
           V L+G         LI+E      L  ++     +                      L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 391 NTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT 450
                    ++KG+ +L        +HRDL   NVL+    V KI DFG+AR    +   
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAY 510
                      +MAPE   EG++++KSDV+S+G+++ EI S               + A 
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-----NPYPGIPVDAN 275

Query: 511 VWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE 568
            ++L + G +M+             +      I   C   D   RP+  N+ + LG +
Sbjct: 276 FYKLIQNGFKMDQ-------PFYATE--EIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 324

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  202 bits (515), Expect = 7e-61
 Identities = 73/279 (26%), Positives = 119/279 (42%), Gaps = 34/279 (12%)

Query: 291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG---LEEFKNEIILIAKLQ 346
              FSD  ++G G FG VY    + N + VA+K++S    Q     ++   E+  + KL+
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 347 HRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLY 406
           H N ++  GC +      L+ E     + D        +  L       +  G  +GL Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130

Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH      +IHRD+K  N+LL +  + K+ DFG A I             VGT  +MAPE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPE 181

Query: 467 YAM---EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF 523
             +   EG +  K DV+S G+  +E+   K         +A + L ++ Q          
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKP---PLFNMNAMSALYHIAQN--------- 229

Query: 524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
            +   ++S    +  R  +    C+Q+ P  RPT   ++
Sbjct: 230 -ESPALQSGHWSEYFR--NFVDSCLQKIPQDRPTSEVLL 265

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  202 bits (514), Expect = 9e-61
 Identities = 69/296 (23%), Positives = 124/296 (41%), Gaps = 37/296 (12%)

Query: 287 IKAATDGFSDS---------NKLGQGGFGTVYKGVLPNGKE----VAVKRLSRK-SWQGL 332
              A   F+             +G G FG V  G L    +    VA+K L    + +  
Sbjct: 12  PNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQR 71

Query: 333 EEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNT 392
            +F +E  ++ +  H N++ L G   +    ++I E M N SLD F+  ++ +       
Sbjct: 72  RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF--TVIQ 129

Query: 393 CYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTAN 452
              ++ GI+ G+ YL     +  +HRDL   N+L++ ++V K+SDFG++R   ++     
Sbjct: 130 LVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 186

Query: 453 TRRVVG---TYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLA 509
               +G      + APE      F+  SDV+S+G+++ E++S       Y     Q ++ 
Sbjct: 187 YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMTNQDVIN 244

Query: 510 YVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
            + Q ++    M+                    + L C Q+D   RP    +V  L
Sbjct: 245 AIEQDYRLPPPMDCPS-------------ALHQLMLDCWQKDRNHRPKFGQIVNTL 287

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 2e-60
 Identities = 68/279 (24%), Positives = 128/279 (45%), Gaps = 27/279 (9%)

Query: 294 FSDSNKLGQGGFGTVYKGVLPNGKE-----VAVKRLSRKSWQG-LEEFKNEIILIAKLQH 347
            +    +G G FG VYKG+L          VA+K L     +    +F  E  ++ +  H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
            N++RL G   + +  ++I E M N +     F  E+  + +      ++ GI+ G+ YL
Sbjct: 69  HNIIRLEGVISKYKPMMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR-RVVGTYGYMAPE 466
                +  +HRDL   N+L++ ++V K+SDFG++R+  ++ +   T         + APE
Sbjct: 127 A---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP 526
                 F+  SDV+SFG+++ E+++      + L+ H       V +   +G  +     
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------VMKAINDGFRLPT--- 234

Query: 527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
                   P       + + C Q++ A RP  +++V++L
Sbjct: 235 ----PMDCPS--AIYQLMMQCWQQERARRPKFADIVSIL 267

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 2e-60
 Identities = 65/277 (23%), Positives = 117/277 (42%), Gaps = 28/277 (10%)

Query: 297 SNKLGQGGFGTVYKGVLPNGK----EVAVKRLSRKSWQG-LEEFKNEIILIAKLQHRNLV 351
           +  +G+G FG VY G L +        AVK L+R +  G + +F  E I++    H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 352 RLVGCGIEGEEK-LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
            L+G  +  E   L++   M +  L  FI +      +     + +          +   
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK-----GMKFL 146

Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPEYA 468
           +  K +HRDL   N +LD+    K++DFG+AR   + +  +   +        +MA E  
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 206

Query: 469 MEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL 528
               F+ KSDV+SFGV++ E+++       Y   +   +  Y+ Q              L
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVYLLQ-----------GRRL 253

Query: 529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
           ++    P       + L C      +RP+ S +V+ +
Sbjct: 254 LQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELVSRI 288

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 3e-60
 Identities = 70/273 (25%), Positives = 122/273 (44%), Gaps = 31/273 (11%)

Query: 298 NKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLV 354
            ++G+G F TVYKG+      EVA   L  +  +    + FK E  ++  LQH N+VR  
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 355 GCGIEGEEK----LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
                  +     +L+ ELM + +L  ++    R   +      +    I KGL +LH  
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 411 SRLKIIHRDLKPSNVLL-DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
           +   IIHRDLK  N+ +       KI D G+A +     + +  + V+GT  +MAPE   
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEM-Y 185

Query: 470 EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
           E  +    DV++FG+ +LE+ + +    +    +A  +   V            V P   
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRV---------TSGVKPASF 234

Query: 530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
              +IP+V   I     C++++   R ++ +++
Sbjct: 235 DKVAIPEVKEII---EGCIRQNKDERYSIKDLL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 3e-60
 Identities = 68/270 (25%), Positives = 115/270 (42%), Gaps = 27/270 (10%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
            +LG G FG VYK          A K +  KS + LE++  EI ++A   H N+V+L+  
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
                   ++ E     ++D  + + ER   L  +    +       L YLH+    KII
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVVCKQTLDALNYLHD---NKII 132

Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM-----EG 471
           HRDLK  N+L   D   K++DFG++       +  ++   +GT  +MAPE  M     + 
Sbjct: 133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDR 190

Query: 472 LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKS 531
            +  K+DV+S G+ ++E+   +     +     + LL          K  +   P L + 
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEP--PHHELNPMRVLL----------KIAKSEPPTLAQP 238

Query: 532 SSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
           S              C++++   R T S +
Sbjct: 239 SRWSS--NFKDFLKKCLEKNVDARWTTSQL 266

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 4e-60
 Identities = 75/286 (26%), Positives = 125/286 (43%), Gaps = 32/286 (11%)

Query: 279 LPFVHLAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRK-SWQGLEEFK 336
           +PFV         + +     LG+G +G V   V     + VAVK +  K +    E  K
Sbjct: 1   VPFV---------EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK 51

Query: 337 NEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNI 396
            EI +   L H N+V+  G   EG  + L  E      L   I   E  + +        
Sbjct: 52  KEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI---EPDIGMPEPDAQRF 108

Query: 397 IGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRV 456
              +  G++YLH    + I HRD+KP N+LLD+    KISDFG+A +F  N +     ++
Sbjct: 109 FHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 165

Query: 457 VGTYGYMAPEYAMEGLF-SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLW 515
            GT  Y+APE      F +   DV+S G+++  +++G+            +     +  W
Sbjct: 166 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDW 219

Query: 516 KEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
           KE K   +++P     S+   ++         + E+P+ R T+ ++
Sbjct: 220 KEKK--TYLNPWKKIDSAPLALLHK------ILVENPSARITIPDI 257

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 1e-59
 Identities = 70/291 (24%), Positives = 111/291 (38%), Gaps = 40/291 (13%)

Query: 298 NKLGQGGFGTVYKGVL------PNGKEVAVKRLSRKSWQG-LEEFKNEIILIAKL-QHRN 349
             LG G FG V +              VAVK L   +     E   +E+ +++ L  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFD---------------SERRLQLNWNTCY 394
           +V L+G    G   L+I E      L  F+                  +  L L+     
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 395 NIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR 454
           +    ++KG+ +L        IHRDL   N+LL    + KI DFG+AR    +       
Sbjct: 149 SFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 455 RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL 514
                  +MAPE     +++ +SDV+S+G+ + E+ S   +    +   ++      +++
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-----FYKM 260

Query: 515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
            KEG  M             P       I   C   DP  RPT   +V L+
Sbjct: 261 IKEGFRMLS-------PEHAPA--EMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 1e-57
 Identities = 79/327 (24%), Positives = 139/327 (42%), Gaps = 34/327 (10%)

Query: 284 LAVIKAATDGFSDSNKLGQGGFGTVYKGV-LPNGKE----VAVKRLSR-KSWQGLEEFKN 337
           L ++K     F     LG G FGTVYKG+ +P G++    VA+K L    S +  +E  +
Sbjct: 3   LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60

Query: 338 EIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNII 397
           E  ++A + + ++ RL+G  +      LI +LMP   L  ++   E +  +      N  
Sbjct: 61  EAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVR--EHKDNIGSQYLLNWC 117

Query: 398 GGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVV 457
             I+KG+ YL      +++HRDL   NVL+      KI+DFG+A++    +K  +     
Sbjct: 118 VQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174

Query: 458 GTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKE 517
               +MA E  +  +++ +SDV+S+GV V E+++       Y    A  + + +    ++
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK--PYDGIPASEISSIL----EK 228

Query: 518 GKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQ 577
           G+ +                +    I + C   D   RP    ++       +A    R 
Sbjct: 229 GERLPQPPIC---------TIDVYMIMVKCWMIDADSRPKFRELIIEF--SKMARDPQRY 277

Query: 578 PPFPVGRTIVLAEQPSTKDPSVCHDLT 604
                   + L   PS  D +    L 
Sbjct: 278 LVIQGDERMHL---PSPTDSNFYRALM 301

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 1e-57
 Identities = 64/273 (23%), Positives = 110/273 (40%), Gaps = 26/273 (9%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLV 354
             +G G +G   K     +GK +  K L   S      +   +E+ L+ +L+H N+VR  
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 355 GCGIEGEEKLL--IYELMPNRSLDCFIFDSERRLQ-LNWNTCYNIIGGISKGLLYLHE-- 409
              I+     L  + E      L   I    +  Q L+      ++  ++  L   H   
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
           D    ++HRDLKP+NV LD     K+ DFG+ARI   +   A     VGT  YM+PE   
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYMSPEQMN 187

Query: 470 EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
              ++ KSD++S G ++ E+ +      F      +     +    +EGK          
Sbjct: 188 RMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKE-----LAGKIREGKFRRIPYRY-- 238

Query: 530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV 562
            S  + +++         +      RP++  ++
Sbjct: 239 -SDELNEIITR------MLNLKDYHRPSVEEIL 264

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (490), Expect = 3e-57
 Identities = 77/301 (25%), Positives = 134/301 (44%), Gaps = 34/301 (11%)

Query: 294 FSDSNKLGQGGFGTVYKGVLPN------GKEVAVKRLSR-KSWQGLEEFKNEIILIAKLQ 346
            + S +LGQG FG VY+GV            VA+K ++   S +   EF NE  ++ +  
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 347 HRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQ-------LNWNTCYNIIGG 399
             ++VRL+G   +G+  L+I ELM    L  ++      +         + +    + G 
Sbjct: 82  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141

Query: 400 ISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGT 459
           I+ G+ YL+ +   K +HRDL   N ++ +D   KI DFGM R   E        + +  
Sbjct: 142 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 460 YGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK 519
             +M+PE   +G+F+  SDV+SFGV++ EI +        L+         V +   EG 
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------VLRFVMEGG 252

Query: 520 EMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPP 579
            ++  D       + P       +  +C Q +P +RP+   +++ +  +       R+  
Sbjct: 253 LLDKPD-------NCPD--MLFELMRMCWQYNPKMRPSFLEIISSI--KEEMEPGFREVS 301

Query: 580 F 580
           F
Sbjct: 302 F 302

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 4e-57
 Identities = 72/276 (26%), Positives = 111/276 (40%), Gaps = 28/276 (10%)

Query: 298 NKLGQGGFGTVYKGVLP----NGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNL 350
            KLG G FG V +G           VAVK L        + +++F  E+  +  L HRNL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED 410
           +RL G  +    K+ + EL P  SL   +   +    L           +++G+ YL   
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGT--LSRYAVQVAEGMGYLES- 129

Query: 411 SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT-ANTRRVVGTYGYMAPEYAM 469
              + IHRDL   N+LL    + KI DFG+ R   +N             + + APE   
Sbjct: 130 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187

Query: 470 EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
              FS  SD + FGV + E+ +  +     L G        + ++ KEG+ +   +    
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-----LHKIDKEGERLPRPE---- 238

Query: 530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
                PQ     ++ + C    P  RPT   +   L
Sbjct: 239 ---DCPQ--DIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 1e-56
 Identities = 60/277 (21%), Positives = 108/277 (38%), Gaps = 35/277 (12%)

Query: 292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQH 347
           + F     LG+G FG VY      +   +A+K L +          + + E+ + + L+H
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
            N++RL G   +     LI E  P  ++   +    +    +       I  ++  L Y 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H     ++IHRD+KP N+LL      KI+DFG +     ++       + GT  Y+ PE 
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175

Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL 527
               +   K D++S GV+  E + GK                     ++     E    +
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKP-------------------PFEANTYQETYKRI 216

Query: 528 LMKSSSIPQVV--RCIHIGLLCVQEDPAVRPTMSNVV 562
                + P  V      +    ++ +P+ RP +  V+
Sbjct: 217 SRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 3e-56
 Identities = 64/292 (21%), Positives = 120/292 (41%), Gaps = 39/292 (13%)

Query: 292 DGFSDSNKLGQGGFGTVYKGVLPNG---KEVAVKRLSR-KSWQGLEEFKNEIILIAKL-Q 346
           +     + +G+G FG V K  +       + A+KR+    S     +F  E+ ++ KL  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 347 HRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFI-------------FDSERRLQLNWNTC 393
           H N++ L+G         L  E  P+ +L  F+               +     L+    
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 394 YNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANT 453
            +    +++G+ YL +    + IHRDL   N+L+ ++ VAKI+DFG++R      K    
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---K 183

Query: 454 RRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ 513
                   +MA E     +++  SDV+S+GV++ EI+S        +T         +++
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYE 237

Query: 514 LWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
              +G  +E          +         +   C +E P  RP+ + ++  L
Sbjct: 238 KLPQGYRLEK-------PLNCDD--EVYDLMRQCWREKPYERPSFAQILVSL 280

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 8e-56
 Identities = 67/286 (23%), Positives = 128/286 (44%), Gaps = 27/286 (9%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGC 356
            K+GQG  GTVY  + +  G+EVA+++++ +     E   NEI+++ + ++ N+V  +  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
            + G+E  ++ E +   SL   + ++     ++      +     + L +LH     ++I
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS---NQVI 138

Query: 417 HRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVK 476
           HRD+K  N+LL  D   K++DFG        Q   +T  +VGT  +MAPE      +  K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPK 196

Query: 477 SDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQ 536
            D++S G++ +E+I G+    +      + L      L       E  +P       +  
Sbjct: 197 VDIWSLGIMAIEMIEGEPP--YLNENPLRAL-----YLIATNGTPELQNP-----EKLSA 244

Query: 537 VVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALSEPRQPPFPV 582
           + R       C+  D   R +      LL  + + +++P     P+
Sbjct: 245 IFR--DFLNRCLDMDVEKRGSAK---ELLQHQFLKIAKPLSSLTPL 285

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 2e-54
 Identities = 73/292 (25%), Positives = 115/292 (39%), Gaps = 39/292 (13%)

Query: 298 NKLGQGGFGTVYKGV------LPNGKEVAVKRLSRKSWQG-LEEFKNEI-ILIAKLQHRN 349
             LG+G FG V +            + VAVK L   +         +E+ ILI    H N
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 350 LVRLVGCGIEGEEKLLI-YELMPNRSLDCFIF-------------DSERRLQLNWNTCYN 395
           +V L+G   +    L++  E     +L  ++              +   +  L       
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 396 IIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR 455
               ++KG+ +L      K IHRDL   N+LL +  V KI DFG+AR   ++        
Sbjct: 139 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195

Query: 456 VVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLW 515
                 +MAPE   + +++++SDV+SFGV++ EI      S          +     +  
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF-----SLGASPYPGVKIDEEFCRRL 250

Query: 516 KEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS 567
           KEG  M   D    +              L C   +P+ RPT S +V  LG+
Sbjct: 251 KEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLGN 293

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 1e-53
 Identities = 64/280 (22%), Positives = 106/280 (37%), Gaps = 31/280 (11%)

Query: 288 KAATDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRK---SWQGLEEFKNEIILIA 343
           K   + F     LG+G F TV     L   +E A+K L ++       +     E  +++
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 344 KLQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKG 403
           +L H   V+L     + E+         N  L  +I         +          I   
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSA 120

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
           L YLH      IIHRDLKP N+LL++DM  +I+DFG A++     K A     VGT  Y+
Sbjct: 121 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177

Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF 523
           +PE   E      SD+++ G I+ ++++G                      ++ G E   
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLP-------------------PFRAGNEYLI 218

Query: 524 VDPLLMKSSSIPQVV--RCIHIGLLCVQEDPAVRPTMSNV 561
              ++      P+    +   +    +  D   R     +
Sbjct: 219 FQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-52
 Identities = 72/299 (24%), Positives = 124/299 (41%), Gaps = 42/299 (14%)

Query: 298 NKLGQGGFGTVYKGVLP--------NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKL-QH 347
             LG+G FG V                 +VAVK L    + + L +  +E+ ++  + +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIF-------------DSERRLQLNWNTCY 394
           +N++ L+G   +     +I E     +L  ++                    QL+     
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 395 NIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR 454
           +    +++G+ YL      K IHRDL   NVL+ +D V KI+DFG+AR          T 
Sbjct: 139 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 455 RVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL 514
                  +MAPE   + +++ +SDV+SFGV++ EI +   +    +          +++L
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKL 249

Query: 515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIALS 573
            KEG  M+         S+         +   C    P+ RPT   +V  L    +AL+
Sbjct: 250 LKEGHRMDK-------PSNCTN--ELYMMMRDCWHAVPSQRPTFKQLVEDL-DRIVALT 298

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 4e-52
 Identities = 62/272 (22%), Positives = 112/272 (41%), Gaps = 27/272 (9%)

Query: 299 KLGQGGFGTVYKGVLPNGKE----VAVKRLSRKSWQGL-EEFKNEIILIAKLQHRNLVRL 353
            +G+G FG V++G+  + +     VA+K     +   + E+F  E + + +  H ++V+L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
           +G   E     +I EL     L  F+   +  L  +  +       +S  L YL      
Sbjct: 74  IGVITENP-VWIIMELCTLGELRSFLQVRKYSL--DLASLILYAYQLSTALAYLES---K 127

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF 473
           + +HRD+   NVL+  +   K+ DFG++R + E+       +      +MAPE      F
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRF 186

Query: 474 SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSS 533
           +  SDV+ FGV + EI+         +  +       V    + G+ +           +
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLPMPP-------N 233

Query: 534 IPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
            P       +   C   DP+ RP  + + A L
Sbjct: 234 CPP--TLYSLMTKCWAYDPSRRPRFTELKAQL 263

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  180 bits (458), Expect = 4e-52
 Identities = 63/266 (23%), Positives = 99/266 (37%), Gaps = 24/266 (9%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           +LG G FG V++      G   A K +        E  + EI  ++ L+H  LV L    
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +  E ++IYE M    L   + D   +  ++ +     +  + KGL ++HE      +H
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHE---NNYVH 147

Query: 418 RDLKPSNVLL--DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSV 475
            DLKP N++    +    K+ DFG+       Q    T    GT  + APE A       
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPEVAEGKPVGY 204

Query: 476 KSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIP 535
            +D++S GV+   ++SG     F      +TL       W         D      S   
Sbjct: 205 YTDMWSVGVLSYILLSGLSP--FGGENDDETLRNVKSCDWN------MDDSAFSGISE-- 254

Query: 536 QVVRCIHIGLLCVQEDPAVRPTMSNV 561
                       +  DP  R T+   
Sbjct: 255 ---DGKDFIRKLLLADPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  172 bits (436), Expect = 6e-49
 Identities = 62/266 (23%), Positives = 106/266 (39%), Gaps = 24/266 (9%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           +LG G FG V++ V    G+    K ++          KNEI ++ +L H  L+ L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
            +  E +LI E +    L   I  +    +++     N +    +GL ++HE     I+H
Sbjct: 96  EDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVH 150

Query: 418 RDLKPSNVLLD--KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSV 475
            D+KP N++ +  K    KI DFG+A     ++    T     T  + APE         
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT---TATAEFAAPEIVDREPVGF 207

Query: 476 KSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIP 535
            +D+++ GV+   ++SG     F      +TL       W      EF +      S   
Sbjct: 208 YTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDW------EFDEDAFSSVSP-- 257

Query: 536 QVVRCIHIGLLCVQEDPAVRPTMSNV 561
                       +Q++P  R T+ + 
Sbjct: 258 ---EAKDFIKNLLQKEPRKRLTVHDA 280

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  166 bits (420), Expect = 2e-47
 Identities = 59/277 (21%), Positives = 105/277 (37%), Gaps = 27/277 (9%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVG-C 356
           K+G G FG +Y G  +  G+EVA+K    K+     +   E  +   +Q    +  +  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
           G EG+  +++ EL+     D F F S +    +  T   +   +   + Y+H       I
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS---KNFI 125

Query: 417 HRDLKPSNVL---LDKDMVAKISDFGMARIFCENQKTAN-----TRRVVGTYGYMAPEYA 468
           HRD+KP N L     K  +  I DFG+A+ + + +   +      + + GT  Y +    
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 469 MEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL 528
           +    S + D+ S G +++    G                A   Q ++   E +   P+ 
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLP-------WQGLKAATKRQKYERISEKKMSTPIE 238

Query: 529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
           +     P           C       +P  S +  L 
Sbjct: 239 VLCKGYPSEFA--TYLNFCRSLRFDDKPDYSYLRQLF 273

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 7e-47
 Identities = 58/291 (19%), Positives = 112/291 (38%), Gaps = 25/291 (8%)

Query: 291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG-LEEFKNEIILIAKLQHR 348
              +++ + +G+G +G V       N   VA+K++S    Q   +    EI ++ + +H 
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 349 NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
           N++ +         + +    +    +   ++   +   L+ +     +  I +GL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTR-RVVGTYGYMAPEY 467
                 ++HRDLKPSN+LL+     KI DFG+AR+   +          V T  Y APE 
Sbjct: 127 S---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 468 AMEGLFSVKS-DVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP 526
            +      KS D++S G I+ E++S +    F    +   L   +  L    +E      
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPI--FPGKHYLDQLNHILGILGSPSQEDLNCII 241

Query: 527 LLMKSSSIPQVVRCIHIGLL----------------CVQEDPAVRPTMSNV 561
            L   + +  +     +                    +  +P  R  +   
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  165 bits (418), Expect = 2e-46
 Identities = 66/280 (23%), Positives = 109/280 (38%), Gaps = 32/280 (11%)

Query: 292 DGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQ- 346
           + FS    +G+GGFG VY       GK  A+K L +K     QG     NE I+++ +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 347 --HRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
                +V +       ++   I +LM    L   +    +    +          I  GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGL 120

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMA 464
            ++H      +++RDLKP+N+LLD+    +ISD G+A  F + +        VGT+GYMA
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173

Query: 465 PEYAMEGL-FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF 523
           PE   +G+ +   +D FS G ++ +++ G     F               L    +  + 
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDRMTLTMAVELPDS 231

Query: 524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA 563
             P                +    +Q D   R       A
Sbjct: 232 FSP------------ELRSLLEGLLQRDVNRRLGCLGRGA 259

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  163 bits (414), Expect = 3e-46
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 15/201 (7%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRL 353
             LG G FG V+      NG+  A+K L ++     + +E   +E ++++ + H  ++R+
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 354 VGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
            G   + ++  +I + +    L   +  S+R            +       L L      
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLALEYLHSK 123

Query: 414 KIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF 473
            II+RDLKP N+LLDK+   KI+DFG A+   +   T     + GT  Y+APE      +
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIAPEVVSTKPY 178

Query: 474 SVKSDVFSFGVIVLEIISGKR 494
           +   D +SFG+++ E+++G  
Sbjct: 179 NKSIDWWSFGILIYEMLAGYT 199

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 5e-46
 Identities = 59/266 (22%), Positives = 106/266 (39%), Gaps = 25/266 (9%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
            LG+G FG V++ V   + K    K +  K        K EI ++   +HRN++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESF 70

Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIH 417
              EE ++I+E +    +   I  +    +LN     + +  + + L +LH      I H
Sbjct: 71  ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125

Query: 418 RDLKPSNVLLD--KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSV 475
            D++P N++    +    KI +FG AR     +   N R +     Y APE     + S 
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYAPEVHQHDVVST 182

Query: 476 KSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIP 535
            +D++S G +V  ++SG      +L    Q ++  +        E  F +    + S   
Sbjct: 183 ATDMWSLGTLVYVLLSGIN---PFLAETNQQIIENIMN-----AEYTFDEEAFKEISI-- 232

Query: 536 QVVRCIHIGLLCVQEDPAVRPTMSNV 561
                +      + ++   R T S  
Sbjct: 233 ---EAMDFVDRLLVKERKSRMTASEA 255

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  160 bits (406), Expect = 1e-45
 Identities = 60/276 (21%), Positives = 108/276 (39%), Gaps = 28/276 (10%)

Query: 291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSR---KSWQGLEEFKNEIILIAKLQ 346
           +D +     LG GG   V+    L   ++VAVK L     +       F+ E    A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 347 HRNLVRLVGCGIE----GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISK 402
           H  +V +   G      G    ++ E +   +L   +        +       +I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 403 GLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT-ANTRRVVGTYG 461
            L + H+     IIHRD+KP+N+++      K+ DFG+AR   ++  +   T  V+GT  
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 462 YMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM 521
           Y++PE A       +SDV+S G ++ E+++G+    F           +V +        
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVAYQHVREDPI----- 232

Query: 522 EFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT 557
               P   +   +        + L  + ++P  R  
Sbjct: 233 ----PPSARHEGLSA--DLDAVVLKALAKNPENRYQ 262

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  161 bits (408), Expect = 2e-45
 Identities = 73/276 (26%), Positives = 112/276 (40%), Gaps = 27/276 (9%)

Query: 291 TDGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEE-FKNEIILIAKLQHR 348
            D +   + LG G F  V         K VA+K +++K+ +G E   +NEI ++ K++H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 349 NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
           N+V L      G    LI +L+    L   I     +          +I  +   + YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124

Query: 409 EDSRLKIIHRDLKPSNVLL---DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           +     I+HRDLKP N+L    D+D    ISDFG++++              GT GY+AP
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAP 178

Query: 466 EYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           E   +  +S   D +S GVI   ++ G     FY    A+     +        E EF  
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPP--FYDENDAKLFEQILKA------EYEFDS 230

Query: 526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
           P     S               +++DP  R T    
Sbjct: 231 PYWDDISD-----SAKDFIRHLMEKDPEKRFTCEQA 261

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  159 bits (404), Expect = 3e-45
 Identities = 65/287 (22%), Positives = 112/287 (39%), Gaps = 39/287 (13%)

Query: 292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGL---------EEFKNEIIL 341
           + +     LG+G    V + +  P  KE AVK +                 E    E+ +
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 342 IAKLQ-HRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGI 400
           + K+  H N+++L           L+++LM    L  ++     ++ L+      I+  +
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119

Query: 401 SKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTY 460
            + +  LH+   L I+HRDLKP N+LLD DM  K++DFG +      +K    R V GT 
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173

Query: 461 GYMAPEYAMEGL------FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL 514
            Y+APE     +      +  + D++S GVI+  +++G     F+       L   +   
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--FWHRKQMLMLRMIMS-- 229

Query: 515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
                  +F  P     S          +    +   P  R T    
Sbjct: 230 ----GNYQFGSPEWDDYSD-----TVKDLVSRFLVVQPQKRYTAEEA 267

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  159 bits (403), Expect = 4e-45
 Identities = 67/279 (24%), Positives = 117/279 (41%), Gaps = 23/279 (8%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVG 355
            K+G+G +G VYK     G+  A+K  RL ++          EI ++ +L+H N+V+L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKI 415
                +  +L++E +                 L   T  + +  +  G+ Y H+    ++
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD---RRV 121

Query: 416 IHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM-EGLFS 474
           +HRDLKP N+L++++   KI+DFG+AR F    +       + T  Y AP+  M    +S
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE--IVTLWYRAPDVLMGSKKYS 179

Query: 475 VKSDVFSFGVIVLEIISGK-----RNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM 529
              D++S G I  E+++G       +    L    + L     + W    E+   DP   
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239

Query: 530 KSSSIPQVVRCIHIG-----LL--CVQEDPAVRPTMSNV 561
               +P       +      LL   ++ DP  R T    
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  158 bits (401), Expect = 1e-44
 Identities = 48/279 (17%), Positives = 99/279 (35%), Gaps = 29/279 (10%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN-LVRLVGC 356
           ++G+G FG +++G  L N ++VA+K   R+S     + ++E      L     +  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 357 GIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKII 416
           G EG   +L+ +L+                + +  T       +   +  +HE     ++
Sbjct: 70  GQEGLHNVLVIDLLGP---SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLV 123

Query: 417 HRDLKPSNVLLDKDMV-----AKISDFGMARIFCENQKTAN-----TRRVVGTYGYMAPE 466
           +RD+KP N L+ +          + DFGM + + +     +      + + GT  YM+  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP 526
             +    S + D+ + G + +  + G                A   Q ++   E +   P
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA-------ATNKQKYERIGEKKQSTP 236

Query: 527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALL 565
           L    +  P+                   P    +  L 
Sbjct: 237 LRELCAGFPEEFY--KYMHYARNLAFDATPDYDYLQGLF 273

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 4e-44
 Identities = 62/274 (22%), Positives = 102/274 (37%), Gaps = 34/274 (12%)

Query: 292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRK---SWQGLEEFKNEI-ILIAKLQ 346
           + F     LG+G FG V+        +  A+K L +        +E    E  +L    +
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 347 HRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLY 406
           H  L  +       E    + E +    L   I    +    + +        I  GL +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118

Query: 407 LHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE 466
           LH      I++RDLK  N+LLDKD   KI+DFGM +         NT    GT  Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173

Query: 467 YAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP 526
             +   ++   D +SFGV++ E++ G+                     +    E E    
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQS-------------------PFHGQDEEELFHS 214

Query: 527 LLMKSSSIPQVV--RCIHIGLLCVQEDPAVRPTM 558
           + M +   P+ +      + +     +P  R  +
Sbjct: 215 IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGV 248

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 5e-44
 Identities = 68/282 (24%), Positives = 119/282 (42%), Gaps = 26/282 (9%)

Query: 298 NKLGQGGFGTVYKGVLPN-GKEVAVKRLSRKSWQGLEE-----FKNEIILIAKLQHRNLV 351
           + LG+G F TVYK    N  + VA+K++        ++        EI L+ +L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 352 RLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
            L+          L+++ M            +  L L  +     +    +GL YLH+  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAME- 470
              I+HRDLKP+N+LLD++ V K++DFG+A+ F    +    +  V T  Y APE     
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ--VVTRWYRAPELLFGA 175

Query: 471 GLFSVKSDVFSFGVIVLEIISGK-----RNSGFYLTGHAQTLLAYVWQLWKEGKEM-EFV 524
            ++ V  D+++ G I+ E++         +    LT   +TL     + W +   + ++V
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 525 DPLLMKSSSIPQVVRCIHIGLL-----CVQEDPAVRPTMSNV 561
                    +  +       LL         +P  R T +  
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 5e-44
 Identities = 68/286 (23%), Positives = 117/286 (40%), Gaps = 23/286 (8%)

Query: 292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVK--RLSRKSWQGLEEFKNEIILIAKLQHR 348
           + F    K+G+G +G VYK      G+ VA+K  RL  ++         EI L+ +L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 349 NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
           N+V+L+       +  L++E +          D+     +      + +  + +GL + H
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPE-Y 467
                +++HRDLKP N+L++ +   K++DFG+AR F    +T      V T  Y APE  
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE--VVTLWYRAPEIL 174

Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGK-----RNSGFYLTGHAQTLLAYVWQLWKEGKEME 522
                +S   D++S G I  E+++ +      +    L    +TL      +W     M 
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 523 FVDPLLMKSSSIPQVVRCIHIG-----LL--CVQEDPAVRPTMSNV 561
              P   K +          +      LL   +  DP  R +    
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 1e-43
 Identities = 61/284 (21%), Positives = 113/284 (39%), Gaps = 26/284 (9%)

Query: 298 NKLGQGGFGTVYKG--VLPNGKEVAVKRLSRKSWQG--LEEFKNEIILIAKL---QHRNL 350
            ++G+G +G V+K   +   G+ VA+KR+  ++ +         E+ ++  L   +H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 351 VRLVGCGIEGEEKLLIYELMPNRSLDC---FIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
           VRL                +    +D       D      +   T  +++  + +GL +L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H     +++HRDLKP N+L+      K++DFG+ARI+           VV T  Y APE 
Sbjct: 133 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVTLWYRAPEV 186

Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGKR-----NSGFYLTGHAQTLLAYVWQLWKEGKEME 522
            ++  ++   D++S G I  E+   K      +    L      +     + W     + 
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246

Query: 523 FVDPLLMKSSSIPQVVRCIHIGLL-----CVQEDPAVRPTMSNV 561
                   +  I + V  I          C+  +PA R +  + 
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 2e-43
 Identities = 66/289 (22%), Positives = 112/289 (38%), Gaps = 35/289 (12%)

Query: 294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVR 352
           ++D+  +G G FG VY+  L  +G+ VA+K++ +           E+ ++ KL H N+VR
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVR 77

Query: 353 LVGCGIEGEEK------LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLY 406
           L        EK       L+ + +P          S  +  L        +  + + L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 407 LHEDSRLKIIHRDLKPSNVLLDKD-MVAKISDFGMARIFCENQKTANTRRVVGTYGYMAP 465
           +H      I HRD+KP N+LLD D  V K+ DFG A+     +   +    + +  Y AP
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRAP 191

Query: 466 EYAMEGL-FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV 524
           E       ++   DV+S G ++ E++ G+    F        L+  +  L    +E    
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPI--FPGDSGVDQLVEIIKVLGTPTREQIRE 249

Query: 525 DPLLMKSSSIPQVVR--------------CIHIGLLCVQEDPAVRPTMS 559
                     PQ+                 I +    ++  P  R T  
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 2e-41
 Identities = 67/281 (23%), Positives = 115/281 (40%), Gaps = 33/281 (11%)

Query: 292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG------LEEFKNEIILIAK 344
           D +    +LG G F  V K      G + A K + ++  +        E+ + E+ ++ +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 345 LQHRNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGL 404
           +QH N++ L        + +LI EL+    L  F+ + E    L        +  I   L
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQI---L 123

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDKDMVA----KISDFGMARIFCENQKTANTRRVVGTY 460
             ++    L+I H DLKP N++L    V     KI DFG+A       +    + + GT 
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180

Query: 461 GYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE 520
            ++APE        +++D++S GVI   ++SG      +L    Q  LA V  +      
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS---PFLGDTKQETLANVSAV-----N 232

Query: 521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
            EF D     +S+              + +DP  R T+ + 
Sbjct: 233 YEFEDEYFSNTSA-----LAKDFIRRLLVKDPKKRMTIQDS 268

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 3e-41
 Identities = 57/271 (21%), Positives = 105/271 (38%), Gaps = 30/271 (11%)

Query: 300 LGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGCG 357
           LG G  G V +       ++ A+K L         + + E+ L  +  Q  ++VR+V   
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVY 74

Query: 358 IEGEEK----LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
                     L++ E +    L   I D   +          I+  I + + YLH    +
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS---I 130

Query: 414 KIIHRDLKPSNVLLDK---DMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAME 470
            I HRD+KP N+L      + + K++DFG A+    +           T  Y+APE    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187

Query: 471 GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK 530
             +    D++S GVI+  ++ G      + + H   +   +    + G+  EF +P   +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYP---PFYSNHGLAISPGMKTRIRMGQ-YEFPNPEWSE 243

Query: 531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
            S          +    ++ +P  R T++  
Sbjct: 244 VSE-----EVKMLIRNLLKTEPTQRMTITEF 269

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 8e-41
 Identities = 53/274 (19%), Positives = 103/274 (37%), Gaps = 43/274 (15%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEE------FKNEIILIAKLQ--HRN 349
            LG GGFG+VY G+ + +   VA+K + +       E         E++L+ K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 350 LVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
           ++RL+      +  +LI E                R  L      +    + + + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128

Query: 410 DSRLKIIHRDLKPSNVLLDKD-MVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
                ++HRD+K  N+L+D +    K+ DFG   +  +   T       GT  Y  PE+ 
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT----DFDGTRVYSPPEWI 181

Query: 469 M-EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL 527
                    + V+S G+++ +++ G                      ++  +E+  +   
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDI-------------------PFEHDEEI--IRGQ 220

Query: 528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNV 561
           +     +     C H+   C+   P+ RPT   +
Sbjct: 221 VFFRQRVSS--ECQHLIRWCLALRPSDRPTFEEI 252

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 4e-40
 Identities = 60/282 (21%), Positives = 117/282 (41%), Gaps = 27/282 (9%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLV 354
            K+G+G +GTV+K       + VA+KR+               EI L+ +L+H+N+VRL 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 355 GCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
                 ++  L++E         F   +      +     + +  + KGL + H      
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCH---SRN 121

Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFS 474
           ++HRDLKP N+L++++   K+++FG+AR F    +   +  VV  +           L+S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKLYS 180

Query: 475 VKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD--------- 525
              D++S G I  E+ +  R    +        L  +++L     E ++           
Sbjct: 181 TSIDMWSAGCIFAELANAGRP--LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 526 -PLLMKSSSIPQVVRCIHIGLL-----CVQEDPAVRPTMSNV 561
            P+   ++S+  VV  ++          ++ +P  R +    
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 4e-40
 Identities = 66/290 (22%), Positives = 117/290 (40%), Gaps = 29/290 (10%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQG--LEEFKNEIILIAKLQHRNLVRLV 354
            K+GQG FG V+K      G++VA+K++  ++ +         EI ++  L+H N+V L+
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 355 GCGIE-----GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
                        K  IY +      D     S   ++   +    ++  +   L  L+ 
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML---LNGLYY 132

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRR--VVGTYGYMAPEY 467
             R KI+HRD+K +NVL+ +D V K++DFG+AR F   + +   R    V T  Y  PE 
Sbjct: 133 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192

Query: 468 AM-EGLFSVKSDVFSFGVIVLEIISGK-----RNSGFYLTGHAQTLLAYVWQLWKEGKEM 521
            + E  +    D++  G I+ E+ +             L   +Q   +   ++W      
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252

Query: 522 EFVDPLLMKSSSIPQVVRCIHIGLL----------CVQEDPAVRPTMSNV 561
           E  + L +      +V   +   +            +  DPA R    + 
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 1e-39
 Identities = 55/278 (19%), Positives = 99/278 (35%), Gaps = 33/278 (11%)

Query: 292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQH 347
           + F     LG+G FG V        G+  A+K L ++   +   +     E  ++   +H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
             L  L       +    + E      L   +    R               I   L YL
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H      +++RD+K  N++LDKD   KI+DFG+ +    +  T   +   GT  Y+APE 
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEV 176

Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL 527
             +  +    D +  GV++ E++ G+                     +         + +
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRL-------------------PFYNQDHERLFELI 217

Query: 528 LMKSSSIPQVV--RCIHIGLLCVQEDPAVRPTMSNVVA 563
           LM+    P+ +      +    +++DP  R       A
Sbjct: 218 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  141 bits (357), Expect = 6e-38
 Identities = 49/207 (23%), Positives = 87/207 (42%), Gaps = 15/207 (7%)

Query: 292 DGFSDSNKLGQGGFGTVYKGV-LPNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQH 347
           D F     LG G FG V       +G   A+K L ++     + +E   NE  ++  +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 348 RNLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYL 407
             LV+L     +     ++ E +    +   +    R  + +          I     YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157

Query: 408 HEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEY 467
           H    L +I+RDLKP N+L+D+    +++DFG A+       T     + GT   +APE 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209

Query: 468 AMEGLFSVKSDVFSFGVIVLEIISGKR 494
            +   ++   D ++ GV++ E+ +G  
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYP 236

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (347), Expect = 1e-36
 Identities = 64/282 (22%), Positives = 112/282 (39%), Gaps = 27/282 (9%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVG 355
            +G G +G V   V    G +VA+K+L R   S    +    E+ L+  ++H N++ L+ 
Sbjct: 25  PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84

Query: 356 CGIEGEEKLLIYELMPNRSL-DCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLK 414
                E      +           +    +  +L  +    ++  + KGL Y+H      
Sbjct: 85  VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AG 141

Query: 415 IIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGL-F 473
           IIHRDLKP N+ +++D   KI DFG+AR              V T  Y APE  +  + +
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG-----YVVTRWYRAPEVILNWMRY 196

Query: 474 SVKSDVFSFGVIVLEIISGKR--------NSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD 525
           +   D++S G I+ E+I+GK         +    +     T  A   Q  +  +   ++ 
Sbjct: 197 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256

Query: 526 PLL-MKSSSIPQVVRCIH---IGLL--CVQEDPAVRPTMSNV 561
            L  ++      ++       + LL   +  D   R T    
Sbjct: 257 GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 3e-34
 Identities = 61/277 (22%), Positives = 110/277 (39%), Gaps = 31/277 (11%)

Query: 298 NKLGQGGFGTVYKGVL----PNGKEVAVKRLSRKSW----QGLEEFKNEIILIAKLQHR- 348
             LG G +G V+          GK  A+K L + +     +  E  + E  ++  ++   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 349 NLVRLVGCGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLH 408
            LV L        +  LI + +    L   +    +R +   +     +G I   L +LH
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHL---SQRERFTEHEVQIYVGEIVLALEHLH 146

Query: 409 EDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYA 468
           +   L II+RD+K  N+LLD +    ++DFG+++ F  ++         GT  YMAP+  
Sbjct: 147 K---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIV 202

Query: 469 MEGL--FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP 526
             G        D +S GV++ E+++G     F + G   +      ++ +   + E   P
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVDGEKNSQ----AEISRRILKSEPPYP 256

Query: 527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA 563
                  +  + + +   LL    DP  R       A
Sbjct: 257 -----QEMSALAKDLIQRLLMK--DPKKRLGCGPRDA 286

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 4e-33
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 21/204 (10%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVG 355
            +G G  G V         + VA+K+LSR   +    +    E++L+  + H+N++ L+ 
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 356 CGI------EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE 409
                    E ++  L+ ELM              +++L+      ++  +  G+ +LH 
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHS 137

Query: 410 DSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAM 469
                IIHRDLKPSN+++  D   KI DFG+AR    +         V T  Y APE  +
Sbjct: 138 A---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVIL 191

Query: 470 EGLFSVKSDVFSFGVIVLEIISGK 493
              +    D++S G I+ E++  K
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHK 215

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  126 bits (316), Expect = 1e-32
 Identities = 46/203 (22%), Positives = 91/203 (44%), Gaps = 21/203 (10%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVG 355
            KLG+G +  V++ + + N ++V VK L        ++ K EI ++  L+   N++ L  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLAD 97

Query: 356 CGIEGEEKL--LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRL 413
              +   +   L++E + N          +    L        +  I K L Y H    +
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCHS---M 148

Query: 414 KIIHRDLKPSNVLLD-KDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAME-G 471
            I+HRD+KP NV++D +    ++ D+G+A  +   Q+       V +  +  PE  ++  
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQ 205

Query: 472 LFSVKSDVFSFGVIVLEIISGKR 494
           ++    D++S G ++  +I  K 
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKE 228

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  122 bits (306), Expect = 4e-31
 Identities = 47/210 (22%), Positives = 82/210 (39%), Gaps = 18/210 (8%)

Query: 299 KLGQGGFGTVYKGV-LPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCG 357
           KLG G F TV+    + N   VA+K + R      E  ++EI L+ ++   +  +    G
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 358 IEGEEKLLIYELMPNRSLDCFIFDSE-------------RRLQLNWNTCYNIIGGISKGL 404
                KLL +      +    +   E                 +       I   +  GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 405 LYLHEDSRLKIIHRDLKPSNVLLDK-DMVAKISDFGMARIFCENQKTANTRRVVGTYGYM 463
            Y+H   R  IIH D+KP NVL++  D    +    +A +        +    + T  Y 
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 464 APEYAMEGLFSVKSDVFSFGVIVLEIISGK 493
           +PE  +   +   +D++S   ++ E+I+G 
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 8e-31
 Identities = 70/285 (24%), Positives = 116/285 (40%), Gaps = 35/285 (12%)

Query: 298 NKLGQGGFGTVYKGV-LPNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLV 354
           + +G G +G+V        G  VAVK+LSR   S    +    E+ L+  ++H N++ L+
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 355 GCGIEGE---EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS 411
                     E   +Y +      D       ++L    +    +I  I +GL Y+H   
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHVQFLIYQILRGLKYIHS-- 139

Query: 412 RLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEG 471
              IIHRDLKPSN+ +++D   KI DFG+AR   +            T  Y APE  +  
Sbjct: 140 -ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEIMLNW 193

Query: 472 L-FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME-------- 522
           + ++   D++S G I+ E+++G+    F  T H   L   +  +   G E+         
Sbjct: 194 MHYNQTVDIWSVGCIMAELLTGRTL--FPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 523 ---FVDPLLMKSSSIPQVVRCIH---IGLL--CVQEDPAVRPTMS 559
                    M   +   V    +   + LL   +  D   R T +
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score =  103 bits (257), Expect = 5e-26
 Identities = 38/206 (18%), Positives = 69/206 (33%), Gaps = 35/206 (16%)

Query: 298 NKLGQGGFGTVYKGVLPNGKEVAVK--RLSRKS--------WQGLEEFKNEIILIAKLQH 347
             +G+G    V+        E  VK  ++   S          G   F    I  A+ + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 348 RNLVRLVGCGI----EGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKG 403
           R L +L G  +      E   ++ EL+  + L                    ++  I + 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV----------RVENPDEVLDMILEE 115

Query: 404 LLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR-IFCENQKTANTRRVVGTYGY 462
           +   +      I+H DL   NVL+ ++ +  I DF  +  +  E  +    R V     Y
Sbjct: 116 VAKFYHR---GIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEGWREILERDVRNIITY 171

Query: 463 MAPEYAMEGLFSVKSDVFSFGVIVLE 488
            +  Y        + D+ S    +L+
Sbjct: 172 FSRTY------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	611
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.72
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.04
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.7
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.05
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.98
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.63

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-52  Score=413.64  Aligned_cols=253  Identities=27%  Similarity=0.375  Sum_probs=204.8

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.+.||+|+||+||+|++ .+|+.||+|++.... .+..+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            36799999999999999999996 478999999987553 2345678999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++|+|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||+++++++||+|||+|+.+....
T Consensus        84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            999999999983   4457999999999999999999999986   9999999999999999999999999999876554


Q ss_pred             CccccccccccCCCCCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGLF-SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                      ........+||+.|||||++.+..+ +.++|||||||++|||++|+.||.........  ..   . +........    
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~~---~-~~~~~~~~~----  227 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YS---D-WKEKKTYLN----  227 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--HH---H-HHTTCTTST----
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--HH---H-HhcCCCCCC----
Confidence            4444556789999999999988876 57899999999999999999998543322211  11   1 111111100    


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                          .......++.+|+.+||+.||++|||++|+++
T Consensus       228 ----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         228 ----PWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                00111245678999999999999999999865

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-50  Score=407.11  Aligned_cols=249  Identities=24%  Similarity=0.377  Sum_probs=207.1

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      ++|++.++||+|+||+||+|+. .+|+.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            5799999999999999999995 579999999998766566788999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++|+|.+++.+    ..+++.+++.++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++.+..... 
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-  171 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence            99999987632    45999999999999999999999997   99999999999999999999999999997644332 


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                       .....+||+.|+|||++.++.++.++|||||||++|||++|+.||....   ..   .........+.. .+.      
T Consensus       172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~---~~---~~~~~~~~~~~~-~~~------  237 (293)
T d1yhwa1         172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN---PL---RALYLIATNGTP-ELQ------  237 (293)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HH---HHHHHHHHHCSC-CCS------
T ss_pred             -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC---HH---HHHHHHHhCCCC-CCC------
Confidence             2335689999999999999999999999999999999999999984321   11   112222222211 100      


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       .+......+.+|+.+||+.||++|||+.|+++
T Consensus       238 -~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         238 -NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             01112245778999999999999999999875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=406.21  Aligned_cols=260  Identities=25%  Similarity=0.401  Sum_probs=201.3

Q ss_pred             hCCCCcccccCccCceEEEEEEcCCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.+.||+|+||+||+|+++  ..||||+++..  ..+..+.|.+|+.++++++||||+++++++. .+..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence            367999999999999999999874  36999998654  3455788999999999999999999999865 456899999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+++|+|.+++...  ...+++..+..++.||++||.|||+++   ||||||||+||||+.++++||+|||+++......
T Consensus        84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            99999999998532  346999999999999999999999986   9999999999999999999999999998775544


Q ss_pred             CccccccccccCCCCCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          449 KTANTRRVVGTYGYMAPEYAME---GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      .........||+.|||||++.+   +.++.++|||||||++|||++|+.||.....  ...+...    ...+.....+.
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--~~~~~~~----~~~~~~~p~~~  232 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFM----VGRGYLSPDLS  232 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHH----HHHTSCCCCGG
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--HHHHHHH----HhcCCCCCcch
Confidence            4444556789999999999864   4589999999999999999999999753221  1112211    22221111111


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCC
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSES  569 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~  569 (611)
                      . ..    .....++.+|+.+||+.||++|||++||++.|+...
T Consensus       233 ~-~~----~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~  271 (276)
T d1uwha_         233 K-VR----SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA  271 (276)
T ss_dssp             G-SC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             h-cc----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            1 11    111245778999999999999999999999997543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-50  Score=401.37  Aligned_cols=246  Identities=24%  Similarity=0.322  Sum_probs=205.0

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++.+.||+|+||+||+|++ .+++.||+|++.+..   ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence            36799999999999999999996 478999999986532   23457789999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++|+|.+++.   +...+++..++.++.||++||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 mEy~~~g~L~~~l~---~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          85 LEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             EeecCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence            99999999999984   4456999999999999999999999986   99999999999999999999999999986543


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ..    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...   ....+..    .+.....      
T Consensus       159 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~----~i~~~~~------  221 (263)
T d2j4za1         159 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYK----RISRVEF------  221 (263)
T ss_dssp             CC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHH----HHHTTCC------
T ss_pred             Cc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC---CHHHHHH----HHHcCCC------
Confidence            22    23468999999999999999999999999999999999999998432   1222222    1222211      


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .+..    ....++.+|+.+||+.||++|||++|+++
T Consensus       222 ~~p~----~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 TFPD----FVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            0111    11245678999999999999999999986

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-50  Score=400.67  Aligned_cols=254  Identities=28%  Similarity=0.425  Sum_probs=198.3

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      ++|++.+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++||||+++++++...+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            5788999999999999999999888899999997644 345789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +|+|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+||||++++++||+|||+++........ 
T Consensus        84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-  157 (263)
T d1sm2a_          84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-  157 (263)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCce-
Confidence            9999998753  3356899999999999999999999986   999999999999999999999999999876543322 


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKS  531 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  531 (611)
                      ......||+.|+|||++.++.++.++|||||||++|||+++..|+..  ......+...+    ..+...  ..+     
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~--~~~~~~~~~~i----~~~~~~--~~p-----  224 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE--NRSNSEVVEDI----STGFRL--YKP-----  224 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC--SCCHHHHHHHH----HHTCCC--CCC-----
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC--CCCHHHHHHHH----HhcCCC--CCc-----
Confidence            22345799999999999999999999999999999999996554321  11222222222    222111  111     


Q ss_pred             CCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          532 SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       532 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                        .....++.+|+.+||+.||++|||++||++.|+.
T Consensus       225 --~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~  258 (263)
T d1sm2a_         225 --RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE  258 (263)
T ss_dssp             --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence              1112457789999999999999999999999974

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=408.11  Aligned_cols=248  Identities=24%  Similarity=0.310  Sum_probs=202.5

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.+..   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5799999999999999999996 578999999987532   234577999999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++|+|.+++   ...+.+++..++.++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++.+...
T Consensus        88 Ey~~gg~L~~~~---~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHH---HHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhh---hccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            999999999987   34567999999999999999999999996   999999999999999999999999999987654


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                      .........+||+.|+|||++.+..++.++|||||||++|||++|+.||...   ....+...    +..... .     
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~----i~~~~~-~-----  228 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQK----IIKLEY-D-----  228 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHH----HHTTCC-C-----
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc---CHHHHHHH----HHcCCC-C-----
Confidence            4444445578999999999999999999999999999999999999998532   12222221    122211 1     


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVV  562 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl  562 (611)
                      +...    ...++.+|+.+||+.||++|||++|++
T Consensus       229 ~p~~----~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         229 FPEK----FFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             CCTT----CCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             CCcc----CCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence            1111    123577899999999999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-50  Score=402.35  Aligned_cols=254  Identities=30%  Similarity=0.452  Sum_probs=206.0

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      ++|++.+.||+|+||+||+|++++++.||||+++... ...+.|.+|+.++++++||||+++++++.+ +..++||||++
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~   90 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYME   90 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCC
Confidence            5789999999999999999999888899999997654 345789999999999999999999998754 56799999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +|+|.+++... ....+++..+++++.||++||.|||+++   |+||||||+||||++++.+||+|||+++....... .
T Consensus        91 ~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~  165 (272)
T d1qpca_          91 NGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-T  165 (272)
T ss_dssp             TCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-E
T ss_pred             CCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc-c
Confidence            99999887543 3346899999999999999999999986   99999999999999999999999999998754332 2


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKS  531 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  531 (611)
                      ......||+.|+|||++.++.++.++|||||||++|||+||..|+...  .....+.    +.+..+....     ... 
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~--~~~~~~~----~~i~~~~~~~-----~p~-  233 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG--MTNPEVI----QNLERGYRMV-----RPD-  233 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHH----HHHHTTCCCC-----CCT-
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC--CCHHHHH----HHHHhcCCCC-----Ccc-
Confidence            233467999999999999999999999999999999999976654221  1122222    2222222111     111 


Q ss_pred             CCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          532 SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       532 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                         ....++.+|+.+||+.||++|||+++|+++|+.
T Consensus       234 ---~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         234 ---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             ---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence               122357789999999999999999999998863

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-50  Score=401.57  Aligned_cols=254  Identities=24%  Similarity=0.330  Sum_probs=195.0

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEee--CCeEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIE--GEEKLLI  366 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--~~~~~lv  366 (611)
                      ++|++.+.||+|+||+||+|+. .+|+.||+|++....  ....+.+.+|++++++++||||+++++++.+  ...+++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            6799999999999999999995 578999999987553  3345678999999999999999999999865  4568999


Q ss_pred             EEecCCCChhhHhhhc-hhhccCCHHHHHHHHHHHHHHHHHHhhcC--CCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          367 YELMPNRSLDCFIFDS-ERRLQLNWNTCYNIIGGISKGLLYLHEDS--RLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~l~yLH~~~--~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      |||+++|+|.+++... .....+++..++.++.||+.||.|||+++  ..+|+||||||+||||+.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998653 23467999999999999999999999864  23599999999999999999999999999987


Q ss_pred             cccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc
Q 007239          444 FCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF  523 (611)
Q Consensus       444 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  523 (611)
                      +.....  ......||+.|||||++.+..++.++|||||||++|||++|++||...   ....+..    .+..+....+
T Consensus       164 ~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~---~~~~~~~----~i~~~~~~~~  234 (269)
T d2java1         164 LNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAG----KIREGKFRRI  234 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHH----HHHHTCCCCC
T ss_pred             cccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC---CHHHHHH----HHHcCCCCCC
Confidence            644322  233578999999999999999999999999999999999999998532   2222222    2222322211


Q ss_pred             cccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          524 VDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       524 ~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                           ...    ...++.+|+.+||+.||++|||++|+++
T Consensus       235 -----~~~----~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         235 -----PYR----YSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -----CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----Ccc----cCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                 111    1235778999999999999999999975

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-50  Score=402.47  Aligned_cols=251  Identities=25%  Similarity=0.340  Sum_probs=206.0

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEec
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELM  370 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~  370 (611)
                      +.|++.+.||+|+||+||+|++ .+++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            5789999999999999999996 578999999998776677788999999999999999999999999999999999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++|+|.+++.+  ....+++.++..++.||+.||.|||+++   |+||||||+|||++.++++||+|||+++....... 
T Consensus        92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-  165 (288)
T d2jfla1          92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  165 (288)
T ss_dssp             TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred             CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence            99999998743  2346999999999999999999999997   99999999999999999999999999986533221 


Q ss_pred             cccccccccCCCCCccccc-----cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          451 ANTRRVVGTYGYMAPEYAM-----EGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~-----~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                       ......||+.|+|||++.     +..|+.++|||||||++|||++|+.||.....   ......+   .... ...+..
T Consensus       166 -~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~---~~~~~~i---~~~~-~~~~~~  237 (288)
T d2jfla1         166 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP---MRVLLKI---AKSE-PPTLAQ  237 (288)
T ss_dssp             -HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG---GGHHHHH---HHSC-CCCCSS
T ss_pred             -cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH---HHHHHHH---HcCC-CCCCCc
Confidence             223468999999999984     45689999999999999999999999853322   2222211   1111 111100


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                             +.....++.+|+.+||+.||++|||++|+++
T Consensus       238 -------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         238 -------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -------cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   1112246778999999999999999999976

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-50  Score=412.01  Aligned_cols=199  Identities=28%  Similarity=0.385  Sum_probs=177.2

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.++||+|+||+||+|++ .+|+.||+|+++... ....+++.+|+.+|++++||||+++++++.+.+..++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            47899999999999999999995 578999999997653 3345778999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhc-CCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED-SRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      |+++|+|.+++.   +...+++..++.++.||+.||.|||++ +   |+||||||+||||+.++++||+|||+|+.+...
T Consensus        85 y~~gg~L~~~l~---~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          85 HMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             CCTTEEHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            999999999984   445699999999999999999999974 5   999999999999999999999999999876432


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFY  499 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~  499 (611)
                      .    ....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...
T Consensus       159 ~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         159 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             T----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCC
T ss_pred             c----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            2    23468999999999999999999999999999999999999998543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.6e-50  Score=406.88  Aligned_cols=257  Identities=26%  Similarity=0.395  Sum_probs=210.1

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      .++|++.++||+|+||+||+|++. +++.||||+++... ...++|.+|+.+|++++||||+++++++.+.+..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            357899999999999999999964 68899999987554 3467899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +++|+|.+++... ....+++..++.++.||++||.|||+++   |+||||||+||||+.++++||+|||+++.......
T Consensus        95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            9999999998543 3356899999999999999999999986   99999999999999999999999999987644332


Q ss_pred             ccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          450 TANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                      . ......||+.|+|||++.++.++.++|||||||++|||++|+.|+...  .....+    .+....+...+.      
T Consensus       171 ~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~--~~~~~~----~~~i~~~~~~~~------  237 (287)
T d1opja_         171 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG--IDLSQV----YELLEKDYRMER------  237 (287)
T ss_dssp             E-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT--CCHHHH----HHHHHTTCCCCC------
T ss_pred             e-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc--chHHHH----HHHHhcCCCCCC------
Confidence            2 223356899999999999999999999999999999999987764221  122222    222233221111      


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                         +.....++.+|+..||+.||++|||++||++.|+..
T Consensus       238 ---~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         238 ---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             ---CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               111224577999999999999999999999999753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-49  Score=394.40  Aligned_cols=252  Identities=26%  Similarity=0.390  Sum_probs=209.8

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      ++|++.++||+|+||+||+|++++++.||||+++.... ..+.|.+|+.++++++||||+++++++.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            58999999999999999999998888999999986543 45789999999999999999999999999999999999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +|+|..++..  ....+++..+++++.||++||.|||+++   |+||||||+|||+++++.+||+|||+++........ 
T Consensus        83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-  156 (258)
T d1k2pa_          83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-  156 (258)
T ss_dssp             TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred             CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCce-
Confidence            9999988743  3456899999999999999999999986   999999999999999999999999999876544332 


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                      ......||+.|+|||.+.++.++.|+|||||||++|||+| |+.||....   ...+..    .+..+....  .+    
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~---~~~~~~----~i~~~~~~~--~p----  223 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT---NSETAE----HIAQGLRLY--RP----  223 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC---HHHHHH----HHHTTCCCC--CC----
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC---HHHHHH----HHHhCCCCC--Cc----
Confidence            2334679999999999999999999999999999999998 788875332   122222    222222111  11    


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                         .....++.+|+.+||+.||++|||+++|++.|.
T Consensus       224 ---~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         224 ---HLASEKVYTIMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             ---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ---ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence               111245779999999999999999999999885

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.8e-50  Score=405.80  Aligned_cols=255  Identities=26%  Similarity=0.419  Sum_probs=195.4

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CC---cEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NG---KEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ++|++.+.||+|+||+||+|++. ++   ..||||++... .....+.|.+|+.+|++++|||||++++++.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            56888899999999999999964 33   25889988654 344567899999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++|+|.+++..  ....+++.+++.++.||++||.|||+++   |+||||||+||||+.++++||+|||+++.+..
T Consensus       106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999998753  2346899999999999999999999986   99999999999999999999999999987654


Q ss_pred             CCCccc---cccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          447 NQKTAN---TRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       447 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      ......   .....||+.|||||++.++.++.++|||||||++|||+| |++||....   ...+...    ...+....
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~---~~~~~~~----i~~~~~~~  253 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT---NQDVINA----IEQDYRLP  253 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHH----HHTTCCCC
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC---HHHHHHH----HHcCCCCC
Confidence            332221   223468999999999999999999999999999999998 888874322   2222222    22221111


Q ss_pred             ccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       523 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                               .+.....++.+|+.+||+.||++|||+.||++.|+.
T Consensus       254 ---------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~  289 (299)
T d1jpaa_         254 ---------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK  289 (299)
T ss_dssp             ---------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ---------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                     111223457789999999999999999999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=399.15  Aligned_cols=258  Identities=28%  Similarity=0.422  Sum_probs=203.3

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecC
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMP  371 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~  371 (611)
                      ++|++.+.||+|+||+||+|+++++++||||+++... ...+.|.+|+.++++++|||||++++++.+ +..++||||++
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            5799999999999999999999888899999997554 345789999999999999999999999854 56899999999


Q ss_pred             CCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCcc
Q 007239          372 NRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKTA  451 (611)
Q Consensus       372 ~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  451 (611)
                      +|+|..++... ....+++.+++.++.||+.||.|||+++   |+||||||+||||+.++++||+|||+++........ 
T Consensus        95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-  169 (285)
T d1fmka3          95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-  169 (285)
T ss_dssp             TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce-
Confidence            99999887543 3346999999999999999999999986   999999999999999999999999999876443322 


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKS  531 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~  531 (611)
                      ......||+.|+|||++..+.++.++||||||+++|||++|+.|+....  ....+...    +..+...+     .   
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~--~~~~~~~~----i~~~~~~~-----~---  235 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM--VNREVLDQ----VERGYRMP-----C---  235 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC--CHHHHHHH----HHTTCCCC-----C---
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC--CHHHHHHH----HHhcCCCC-----C---
Confidence            2334679999999999999999999999999999999999776643222  12222222    22221111     1   


Q ss_pred             CCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCCCCC
Q 007239          532 SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSESIA  571 (611)
Q Consensus       532 ~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~~~~  571 (611)
                       +.....++.+|+.+||+.||++|||+++|+++|+.....
T Consensus       236 -~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         236 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence             111224577999999999999999999999999875443

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=408.29  Aligned_cols=258  Identities=28%  Similarity=0.408  Sum_probs=206.2

Q ss_pred             hCCCCcccccCccCceEEEEEEcCC-C-----cEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPN-G-----KEVAVKRLSRK-SWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~  362 (611)
                      .++|++.+.||+|+||+||+|++.. +     .+||+|++... .......+.+|+.++.++ +|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3679999999999999999998532 2     36999998654 333456789999999998 89999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchh--------------------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCC
Q 007239          363 KLLIYELMPNRSLDCFIFDSER--------------------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKP  422 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp  422 (611)
                      .++||||+++|+|.+++.....                    ...+++..++.++.||++||.|||+++   ||||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            9999999999999999864321                    245899999999999999999999986   99999999


Q ss_pred             CcEEecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCC
Q 007239          423 SNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLT  501 (611)
Q Consensus       423 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~  501 (611)
                      +|||++.++++||+|||+|+...............||+.|||||++.++.++.++|||||||++|||++ |+.||.....
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987755544444445678999999999999999999999999999999998 8998753322


Q ss_pred             CchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhc
Q 007239          502 GHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLG  566 (611)
Q Consensus       502 ~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~  566 (611)
                      .  ..+.    +....+...+         .+.....++.+|+.+||+.||++|||++||+++|.
T Consensus       273 ~--~~~~----~~~~~~~~~~---------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 D--ANFY----KLIQNGFKMD---------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             S--HHHH----HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             H--HHHH----HHHhcCCCCC---------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            1  1122    2222222111         11112245779999999999999999999999995

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=388.97  Aligned_cols=247  Identities=27%  Similarity=0.390  Sum_probs=196.8

Q ss_pred             CCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee----CCeEEEE
Q 007239          294 FSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE----GEEKLLI  366 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~----~~~~~lv  366 (611)
                      |++.++||+|+||+||+|++ .+++.||+|++...  .....+.+.+|++++++++||||+++++++.+    ....++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            36677899999999999996 46889999998754  33446779999999999999999999999865    3567999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec-CCCCEEEeccccceecc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD-KDMVAKISDFGMARIFC  445 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~-~~~~~kl~DFGla~~~~  445 (611)
                      |||+++|+|.+++.   +...+++..++.++.||++||.|||+++ .+|+||||||+|||++ +++.+||+|||+++...
T Consensus        91 mE~~~~g~L~~~l~---~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCcHHHHHh---ccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            99999999999984   4457999999999999999999999873 3499999999999996 57899999999997542


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVD  525 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d  525 (611)
                      ..    .....+||+.|||||++.+ +++.++|||||||++|||++|+.||....  ....    +.+....+.....++
T Consensus       167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~--~~~~----~~~~i~~~~~~~~~~  235 (270)
T d1t4ha_         167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQ----IYRRVTSGVKPASFD  235 (270)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHH----HHHHHTTTCCCGGGG
T ss_pred             CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc--cHHH----HHHHHHcCCCCcccC
Confidence            22    2335689999999998865 69999999999999999999999985322  1111    122222222211111


Q ss_pred             cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          526 PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       526 ~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..        ...++.+|+.+||+.||++|||++|+++
T Consensus       236 ~~--------~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         236 KV--------AIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             GC--------CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cc--------CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            11        1234678999999999999999999986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6e-48  Score=399.76  Aligned_cols=253  Identities=25%  Similarity=0.310  Sum_probs=208.6

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46899999999999999999995 57899999999877766778899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec--CCCCEEEeccccceecccC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD--KDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~--~~~~~kl~DFGla~~~~~~  447 (611)
                      +++|+|.+++.+  ....+++..++.++.||+.||.|||+++   |+||||||+|||++  .++.+||+|||+++.+...
T Consensus       105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            999999998843  3346999999999999999999999997   99999999999995  4678999999999876443


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                      ..   .....||+.|||||++.+..++.++|||||||++|||++|+.||...   ....+...+    ...... . ...
T Consensus       180 ~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i----~~~~~~-~-~~~  247 (350)
T d1koaa2         180 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNV----KSCDWN-M-DDS  247 (350)
T ss_dssp             SC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH----HHTCCC-S-CCG
T ss_pred             cc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHH----HhCCCC-C-Ccc
Confidence            32   33468999999999999999999999999999999999999998432   222222221    111110 0 000


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      .    ......++.+|+.+||+.||++|||++|+++.
T Consensus       248 ~----~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         248 A----FSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             G----GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             c----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0    01112357789999999999999999999984

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-48  Score=398.73  Aligned_cols=252  Identities=26%  Similarity=0.288  Sum_probs=189.6

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh-hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW-QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ..+.|++.+.||+|+||+||+|+. .+++.||||++.+... .....+.+|+.++++++||||+++++++.+++..++||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            346799999999999999999996 4789999999976542 23456889999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec---CCCCEEEeccccceec
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIF  444 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~---~~~~~kl~DFGla~~~  444 (611)
                      ||++||+|.+++.   ....+++.++..++.||+.||.|||+++   |+||||||+|||+.   +++.+||+|||+++..
T Consensus        87 E~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          87 QLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             eccCCCcHHHhhh---cccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            9999999999984   3456999999999999999999999997   99999999999994   5789999999999865


Q ss_pred             ccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      .....   ....+||+.|||||++.+..++.++|||||||++|||++|+.||....   ...+...    +..+... . 
T Consensus       161 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~----i~~~~~~-~-  228 (307)
T d1a06a_         161 DPGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN---DAKLFEQ----ILKAEYE-F-  228 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHH----HHTTCCC-C-
T ss_pred             cCCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC---HHHHHHH----HhccCCC-C-
Confidence            43322   234689999999999999999999999999999999999999984321   1112211    1111110 0 


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..    ........++.+|+.+||+.||++|||++|+++
T Consensus       229 ~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         229 DS----PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             CT----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CC----ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            00    011112245779999999999999999999997

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=394.72  Aligned_cols=256  Identities=26%  Similarity=0.455  Sum_probs=198.5

Q ss_pred             CCCCcccccCccCceEEEEEEcCCC-----cEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNG-----KEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      +.|++.+.||+|+||+||+|.++..     ..||||++.... .....+|.+|+.++++++|||||++++++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4688899999999999999996432     369999987543 3345678999999999999999999999999999999


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+.++++.+++..  ....+++.++..++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus        87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999887743  3356999999999999999999999986   9999999999999999999999999998764


Q ss_pred             cCCCc-cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          446 ENQKT-ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       446 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ..... .......||+.|+|||++.++.++.++|||||||++|||++|..|+....  ....+.    +.+..+....  
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~--~~~~~~----~~i~~~~~~~--  233 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVM----KAINDGFRLP--  233 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHH----HHHHTTCCCC--
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC--CHHHHH----HHHhccCCCC--
Confidence            43222 22334578999999999999999999999999999999999766643221  122222    2223322111  


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                             .+.....++.+|+.+||+.||++|||+.||+++|+.
T Consensus       234 -------~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~  269 (283)
T d1mqba_         234 -------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK  269 (283)
T ss_dssp             -------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -------CchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence                   111223457799999999999999999999999964

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-49  Score=396.38  Aligned_cols=254  Identities=27%  Similarity=0.389  Sum_probs=205.1

Q ss_pred             CCCCccc-ccCccCceEEEEEEcC---CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          292 DGFSDSN-KLGQGGFGTVYKGVLP---NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       292 ~~y~~~~-~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ++|.+.+ +||+|+||+||+|++.   ++..||||+++... ....++|.+|+++|++++||||+++++++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4566777 4999999999999853   35579999997643 3456789999999999999999999999864 568999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++|+|.+++..  .+..+++..+..++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.+..
T Consensus        87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            999999999998743  3356899999999999999999999986   99999999999999999999999999998754


Q ss_pred             CCCc-cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          447 NQKT-ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       447 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      .... .......||+.|+|||++.++.++.++|||||||++|||++ |+.||.....   ..+.    ..+..+...+..
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~---~~~~----~~i~~~~~~~~p  234 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVM----AFIEQGKRMECP  234 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT---HHHH----HHHHTTCCCCCC
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH---HHHH----HHHHcCCCCCCC
Confidence            3322 22234578999999999999999999999999999999998 8999854322   1222    223333322211


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                               .....++.+|+.+||+.||++|||+.+|++.|+.
T Consensus       235 ---------~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         235 ---------PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             ---------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---------CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                     1122457789999999999999999999999864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-49  Score=395.02  Aligned_cols=247  Identities=28%  Similarity=0.382  Sum_probs=196.6

Q ss_pred             cccCccCceEEEEEEcC---CCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEecCC
Q 007239          298 NKLGQGGFGTVYKGVLP---NGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYELMPN  372 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~~~~  372 (611)
                      ++||+|+||+||+|.+.   .++.||||+++...  ....++|.+|+.++++++||||+++++++.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            47999999999999853   35689999986542  3345789999999999999999999999864 567899999999


Q ss_pred             CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc-c
Q 007239          373 RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT-A  451 (611)
Q Consensus       373 ~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~-~  451 (611)
                      |+|.+++.   +...+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus        92 g~L~~~l~---~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHH---HCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHh---hccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            99999984   3456999999999999999999999986   999999999999999999999999999876543322 2


Q ss_pred             ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccCC
Q 007239          452 NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMK  530 (611)
Q Consensus       452 ~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~  530 (611)
                      ......||+.|+|||.+.++.++.++|||||||++|||++ |+.||....   ...+.    ..+..+...+.       
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~---~~~~~----~~i~~~~~~~~-------  231 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK---GSEVT----AMLEKGERMGC-------  231 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC---HHHHH----HHHHTTCCCCC-------
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC---HHHHH----HHHHcCCCCCC-------
Confidence            2334579999999999999999999999999999999998 899975322   12222    22233322111       


Q ss_pred             CCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          531 SSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       531 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                        +.....++.+|+.+||+.||++|||+++|+++|+.
T Consensus       232 --p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         232 --PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             --CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence              11122457789999999999999999999998863

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-48  Score=395.96  Aligned_cols=245  Identities=27%  Similarity=0.411  Sum_probs=200.2

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      +.|+..+.||+|+||+||+|++ .+++.||||++.....   ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            3599999999999999999995 5788999999875532   34567899999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+++|+|..++   .....+++.+++.++.||+.||.|||+++   |+||||||+||||+.++++||+|||+++.... 
T Consensus        95 E~~~~g~l~~~~---~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHH---HHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            999999997666   33456999999999999999999999997   99999999999999999999999999986432 


Q ss_pred             CCccccccccccCCCCCcccccc---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAME---GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                           .....||+.|||||++.+   +.|+.++|||||||++|||++|+.||....   .   ........... ...+.
T Consensus       168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~---~---~~~~~~i~~~~-~~~~~  235 (309)
T d1u5ra_         168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---A---MSALYHIAQNE-SPALQ  235 (309)
T ss_dssp             -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---H---HHHHHHHHHSC-CCCCS
T ss_pred             -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC---H---HHHHHHHHhCC-CCCCC
Confidence                 224689999999999864   568999999999999999999999974221   1   11122222221 11111


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .    .    .....+.+|+.+||+.||++|||++|+++
T Consensus       236 ~----~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         236 S----G----HWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             C----T----TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C----C----CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1    1    11235778999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7e-48  Score=399.56  Aligned_cols=256  Identities=24%  Similarity=0.278  Sum_probs=209.5

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      .++|++.+.||+|+||+||+|+. .+|+.||||+++.........+.+|+.+|++++||||+++++++.+++..++||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46799999999999999999995 57999999999877666677889999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec--CCCCEEEeccccceecccC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD--KDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~--~~~~~kl~DFGla~~~~~~  447 (611)
                      +++|+|.+++..  ....+++.+++.++.||+.||.|||+++   |+||||||+||||+  .++.+||+|||+++.+...
T Consensus       108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            999999887643  3346999999999999999999999987   99999999999997  6789999999999987543


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                      .   ......||+.|+|||++.+..++.++|||||||++|||++|+.||....   ...+...+    ..+... + ...
T Consensus       183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i----~~~~~~-~-~~~  250 (352)
T d1koba_         183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNV----KRCDWE-F-DED  250 (352)
T ss_dssp             S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHH----HHCCCC-C-CSS
T ss_pred             C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHH----HhCCCC-C-Ccc
Confidence            3   2334689999999999999999999999999999999999999984321   12222211    111110 0 000


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH--hcC
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL--LGS  567 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~  567 (611)
                      .    ......++.+|+.+||+.||++|||+.|+++.  |..
T Consensus       251 ~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~  288 (352)
T d1koba_         251 A----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG  288 (352)
T ss_dssp             T----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred             c----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            1    11122456799999999999999999999873  544

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-48  Score=390.05  Aligned_cols=251  Identities=25%  Similarity=0.322  Sum_probs=204.4

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh------hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW------QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~  363 (611)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++.+...      ...+.+.+|+.+|++++||||+++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46799999999999999999996 5799999999865322      2367899999999999999999999999999999


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC----CEEEeccc
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM----VAKISDFG  439 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~----~~kl~DFG  439 (611)
                      ++||||+++|+|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~---~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhc---cccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            99999999999999984   3457999999999999999999999996   99999999999998776    59999999


Q ss_pred             cceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCc
Q 007239          440 MARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGK  519 (611)
Q Consensus       440 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  519 (611)
                      +++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||....   ......    .+....
T Consensus       163 ~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~----~i~~~~  232 (293)
T d1jksa_         163 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLA----NVSAVN  232 (293)
T ss_dssp             TCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH----HHHTTC
T ss_pred             hhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC---HHHHHH----HHHhcC
Confidence            9987644332   234579999999999999999999999999999999999999975321   111111    112211


Q ss_pred             cccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          520 EMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       520 ~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .. ..... ..    .....+.+|+.+||+.||++|||++|+++
T Consensus       233 ~~-~~~~~-~~----~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 YE-FEDEY-FS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CC-CCHHH-HT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CC-CCchh-cC----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            10 00000 00    11235678999999999999999999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=392.54  Aligned_cols=248  Identities=21%  Similarity=0.253  Sum_probs=205.7

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++++.||+|+||.||+++. .+|+.||+|++++..   ....+.+.+|+.+|++++||||+++++++.+.+.+++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            46899999999999999999995 579999999997542   23467889999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++|+|.+++   .+...+++..++.++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+|+....
T Consensus        84 ~ey~~gg~L~~~~---~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHH---HHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhh---hcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            9999999999988   44567899999999999999999999997   99999999999999999999999999986543


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ...  .....+||+.|+|||++.+..|+.++|||||||++|||++|++||....   ...+..    .+..+.. .    
T Consensus       158 ~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~~----~i~~~~~-~----  223 (337)
T d1o6la_         158 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFE----LILMEEI-R----  223 (337)
T ss_dssp             TTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH----HHHHCCC-C----
T ss_pred             CCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC---HHHHHH----HHhcCCC-C----
Confidence            222  2345789999999999999999999999999999999999999975322   222222    1222211 1    


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT-----MSNVVA  563 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  563 (611)
                       ....    ...++.+|+..||+.||++||+     ++|+++
T Consensus       224 -~p~~----~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         224 -FPRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -CCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -CCcc----CCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence             1111    1235678999999999999995     778775

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7e-48  Score=392.23  Aligned_cols=263  Identities=24%  Similarity=0.389  Sum_probs=211.1

Q ss_pred             HHHhhCCCCcccccCccCceEEEEEEcC------CCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEee
Q 007239          287 IKAATDGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIE  359 (611)
Q Consensus       287 ~~~~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~  359 (611)
                      ++...++|++.+.||+|+||+||+|++.      +++.||||++.... .+..++|.+|+.++++++||||+++++++..
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3345678999999999999999999853      45789999997653 3345779999999999999999999999999


Q ss_pred             CCeEEEEEEecCCCChhhHhhhch---------------------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEec
Q 007239          360 GEEKLLIYELMPNRSLDCFIFDSE---------------------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHR  418 (611)
Q Consensus       360 ~~~~~lv~E~~~~~sL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHr  418 (611)
                      .+..++||||+++|+|.+++....                     ....+++..++.++.||+.||+|||+++   ||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEee
Confidence            999999999999999999985321                     1234889999999999999999999986   9999


Q ss_pred             CCCCCcEEecCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCC-CCC
Q 007239          419 DLKPSNVLLDKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKR-NSG  497 (611)
Q Consensus       419 Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~-p~~  497 (611)
                      ||||+||||+.++++||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|.. |+.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            9999999999999999999999987655544444455789999999999999999999999999999999999964 543


Q ss_pred             CCCCCchhhHHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          498 FYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       498 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      ..   ....+..    ....+...+..     .    ....++.+|+.+||+.||++|||+.||+++|+..
T Consensus       245 ~~---~~~e~~~----~v~~~~~~~~p-----~----~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         245 GM---AHEEVIY----YVRDGNILACP-----E----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TS---CHHHHHH----HHHTTCCCCCC-----T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CC---CHHHHHH----HHHcCCCCCCC-----c----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            22   2222222    23333322211     1    1123577999999999999999999999999753

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9.3e-47  Score=379.40  Aligned_cols=258  Identities=23%  Similarity=0.310  Sum_probs=200.5

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC----e
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE----E  362 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----~  362 (611)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++++..   ......+.+|+.+++.++||||+++++++....    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            47899999999999999999995 579999999997543   334567999999999999999999999987654    4


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .|+||||++|++|.+++   ...+.+++.+++.++.||+.||.|||+++   |+||||||+|||++.++.++|+|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~---~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHH---HHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhh---cccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            79999999999999887   34557999999999999999999999986   9999999999999999999999999998


Q ss_pred             ecccCC-CccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc
Q 007239          443 IFCENQ-KTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM  521 (611)
Q Consensus       443 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  521 (611)
                      ...... ........+||+.|+|||++.+..++.++|||||||++|||++|+.||....      ......+........
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~------~~~~~~~~~~~~~~~  233 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS------PVSVAYQHVREDPIP  233 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS------HHHHHHHHHHCCCCC
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC------HHHHHHHHHhcCCCC
Confidence            654322 2223345689999999999999999999999999999999999999985321      122223333332221


Q ss_pred             cccccccCCCCCHHHHHHHHHHhhccccCCCCCCC-CHHHHHHHhcC
Q 007239          522 EFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRP-TMSNVVALLGS  567 (611)
Q Consensus       522 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~evl~~L~~  567 (611)
                      ..   .....    ...++.+++.+||+.||++|| |++++++.|.+
T Consensus       234 ~~---~~~~~----~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         234 PS---ARHEG----LSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             GG---GTSSS----CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             Cc---hhccC----CCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            10   11111    124577899999999999999 89999888753

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=393.04  Aligned_cols=254  Identities=26%  Similarity=0.431  Sum_probs=199.3

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCc----EEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGK----EVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      .+|++.+.||+|+||+||+|.+. +|+    +||+|+++.. ..+..+++.+|+.++++++||||+++++++.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            46999999999999999999964 444    6899988653 344567899999999999999999999998764 5678


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ++||+.+++|.+++..  ....+++..+++++.||++||.|||+++   |+||||||+||||+.++++||+|||+++...
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8999999999888753  3456899999999999999999999986   9999999999999999999999999999876


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      ............||+.|+|||++.++.++.++|||||||++|||+| |++||.....   ..+...+    ..+....  
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~---~~~~~~i----~~~~~~~--  233 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSIL----EKGERLP--  233 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG---GGHHHHH----HHTCCCC--
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH---HHHHHHH----HcCCCCC--
Confidence            5554444445679999999999999999999999999999999998 7777653322   2222222    2222111  


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                             .+.....++.+|+.+||+.||++|||+.||++.|..
T Consensus       234 -------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~  269 (317)
T d1xkka_         234 -------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  269 (317)
T ss_dssp             -------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence                   111122457789999999999999999999998753

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=383.26  Aligned_cols=261  Identities=24%  Similarity=0.302  Sum_probs=198.6

Q ss_pred             cccccCccCceEEEEEEc-CCCcEEEEEEecccChhh-----HHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          296 DSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQG-----LEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       296 ~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      .+++||+|+||+||+|++ .+|+.||||+++......     ...+.+|+.++++++||||+++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            357899999999999996 468999999987543221     24688999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +.++++..++   .....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            9998777665   34456899999999999999999999997   99999999999999999999999999987644332


Q ss_pred             ccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc-
Q 007239          450 TANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL-  527 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~-  527 (611)
                      .  ....+||+.|+|||++..+ .++.++|||||||++|||++|++||...   ...+....+.+.........+.+.. 
T Consensus       156 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~---~~~~~l~~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         156 A--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD---SDLDQLTRIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             C--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             c--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCC---CHHHHHHHHHHhcCCCChhhccchhc
Confidence            2  2346899999999998754 5799999999999999999999987432   2223333333332221111111100 


Q ss_pred             ------cC--CCCCHH-----HHHHHHHHhhccccCCCCCCCCHHHHHH--HhcC
Q 007239          528 ------LM--KSSSIP-----QVVRCIHIGLLCVQEDPAVRPTMSNVVA--LLGS  567 (611)
Q Consensus       528 ------l~--~~~~~~-----~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~  567 (611)
                            ..  ...+..     ...++++|+.+||+.||++|||++|+++  .|++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~  285 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  285 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence                  00  011111     1246789999999999999999999987  4543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.6e-47  Score=389.78  Aligned_cols=245  Identities=23%  Similarity=0.321  Sum_probs=203.5

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++++.   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence            35799999999999999999996 57999999999753   223467899999999999999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||++||+|..++   .....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus        83 mE~~~gg~l~~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          83 MDYIEGGELFSLL---RKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             ECCCCSCBHHHHH---HHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eeecCCccccccc---cccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence            9999999998888   44556899999999999999999999986   99999999999999999999999999987643


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      .     ....+||+.|||||++.+..++.++|||||||++|||++|+.||...   ....+..   + +..+.. .    
T Consensus       157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~---~-i~~~~~-~----  219 (316)
T d1fota_         157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYE---K-ILNAEL-R----  219 (316)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHH---H-HHHCCC-C----
T ss_pred             c-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc---CHHHHHH---H-HHcCCC-C----
Confidence            2     23468999999999999999999999999999999999999998532   1112221   1 111111 0    


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVA  563 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  563 (611)
                       ...    ....++.+++.+||+.||.+||     |++++++
T Consensus       220 -~p~----~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         220 -FPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             -CCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCC----CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence             111    1123567899999999999996     8999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-47  Score=385.35  Aligned_cols=260  Identities=27%  Similarity=0.391  Sum_probs=198.3

Q ss_pred             hhCCCCcccccCccCceEEEEEEcC------CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeC-
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEG-  360 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~-  360 (611)
                      ..++|++.++||+|+||.||+|.+.      +++.||||+++.. .....+.+.+|..++.++ +|+||+++++++... 
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            3478999999999999999999852      3468999998754 334456788888888877 589999999987654 


Q ss_pred             CeEEEEEEecCCCChhhHhhhchh-------------hccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe
Q 007239          361 EEKLLIYELMPNRSLDCFIFDSER-------------RLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL  427 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll  427 (611)
                      ...++||||+++|+|.+++.....             ...+++.+++.++.||++||.|||+++   |+||||||+||||
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl  167 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL  167 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeE
Confidence            568999999999999999864322             345899999999999999999999986   9999999999999


Q ss_pred             cCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCCCchhh
Q 007239          428 DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKR-NSGFYLTGHAQT  506 (611)
Q Consensus       428 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~-p~~~~~~~~~~~  506 (611)
                      ++++++||+|||+++...............||+.|+|||++.++.++.++|||||||++|||++|.. ||.....  ...
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~--~~~  245 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DEE  245 (299)
T ss_dssp             CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC--SHH
T ss_pred             CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH--HHH
Confidence            9999999999999987655544444556789999999999999999999999999999999999754 5532221  111


Q ss_pred             HHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          507 LLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       507 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      +    ...+..+...+..+         ....++.+++.+||+.||++|||++||+++|++
T Consensus       246 ~----~~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         246 F----CRRLKEGTRMRAPD---------YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             H----HHHHHHTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             H----HHHHhcCCCCCCCc---------cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            2    22223332222111         112357789999999999999999999999964

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-47  Score=380.17  Aligned_cols=248  Identities=28%  Similarity=0.403  Sum_probs=195.4

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee-CCeEEEEEEec
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE-GEEKLLIYELM  370 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~~lv~E~~  370 (611)
                      ++|++.+.||+|+||.||+|++ .|++||||+++...  ..+.+.+|++++++++||||+++++++.+ .+..++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            5688999999999999999998 47889999997543  45779999999999999999999998865 45689999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++|+|.+++... ....+++..+++++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---  156 (262)
T d1byga_          84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  156 (262)
T ss_dssp             TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence            999999998543 3345899999999999999999999986   999999999999999999999999999865332   


Q ss_pred             cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCccccccccccC
Q 007239          451 ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLLM  529 (611)
Q Consensus       451 ~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~  529 (611)
                        .....+|+.|+|||++.++.+++++||||||+++|||++ |+.|+...   ....+...+    ..+...++     .
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~---~~~~~~~~i----~~~~~~~~-----~  222 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRV----EKGYKMDA-----P  222 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS---CGGGHHHHH----TTTCCCCC-----C
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC---CHHHHHHHH----HcCCCCCC-----C
Confidence              223568999999999999999999999999999999998 67665432   222232222    22222221     1


Q ss_pred             CCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          530 KSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       530 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      .    ....++.+|+.+||+.||++|||+.+|+++|+.
T Consensus       223 ~----~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         223 D----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             c----cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            1    112456789999999999999999999999964

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.4e-46  Score=374.33  Aligned_cols=250  Identities=25%  Similarity=0.333  Sum_probs=203.2

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh---------hhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeC
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---------QGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEG  360 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~  360 (611)
                      ++|++.+.||+|+||+||+++. .+|+.||||++.+...         ...+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6899999999999999999995 5789999999875432         12346889999999997 99999999999999


Q ss_pred             CeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccc
Q 007239          361 EEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGM  440 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  440 (611)
                      +..++||||+++|+|.+++.   ..+.+++.+++.++.||++||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~---~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            99999999999999999994   4557999999999999999999999987   99999999999999999999999999


Q ss_pred             ceecccCCCccccccccccCCCCCcccccc------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH
Q 007239          441 ARIFCENQKTANTRRVVGTYGYMAPEYAME------GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL  514 (611)
Q Consensus       441 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~  514 (611)
                      ++.+.....   .....||+.|+|||++.+      ..++.++||||+||++|||++|+.||....   .....    +.
T Consensus       157 a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~~~----~~  226 (277)
T d1phka_         157 SCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLML----RM  226 (277)
T ss_dssp             CEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH----HH
T ss_pred             eeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HHHHH----HH
Confidence            998754332   234689999999999863      357889999999999999999999985322   12222    11


Q ss_pred             HhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          515 WKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       515 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      +..+... ..     .........++.+|+.+||+.||++|||++||++
T Consensus       227 i~~~~~~-~~-----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         227 IMSGNYQ-FG-----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHTCCC-CC-----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHhCCCC-CC-----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            2222111 00     0011122246789999999999999999999875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-47  Score=381.96  Aligned_cols=254  Identities=24%  Similarity=0.359  Sum_probs=194.4

Q ss_pred             hCCCCcccccCccCceEEEEEEcCC----CcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLPN----GKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~l  365 (611)
                      .++|++.+.||+|+||+||+|++..    +..||+|.++.. .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3679999999999999999998642    356899988654 3344677999999999999999999999985 567899


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecc
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFC  445 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  445 (611)
                      ||||+++|+|.+++..  ....+++..++.++.||++||.|||+++   |+||||||+||+++.++.+||+|||+++.+.
T Consensus        85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            9999999999988743  3456899999999999999999999996   9999999999999999999999999998764


Q ss_pred             cCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccccc
Q 007239          446 ENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV  524 (611)
Q Consensus       446 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  524 (611)
                      .... .......||+.|+|||++.++.++.++|||||||++|||++ |.+|+.....   ..+...+    ..+..... 
T Consensus       160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~~~~~i----~~~~~~~~-  230 (273)
T d1mp8a_         160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRI----ENGERLPM-  230 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHH----HTTCCCCC-
T ss_pred             CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH---HHHHHHH----HcCCCCCC-
Confidence            3332 22334678999999999999999999999999999999998 7888754322   2222222    22222111 


Q ss_pred             ccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          525 DPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       525 d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                          ..    ....++.+|+..||+.||++|||++||++.|++
T Consensus       231 ----~~----~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         231 ----PP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             ----CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CC----CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                11    112457789999999999999999999999864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=376.84  Aligned_cols=255  Identities=27%  Similarity=0.383  Sum_probs=195.0

Q ss_pred             CCCCcccccCccCceEEEEEEcC--CC--cEEEEEEeccc---ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP--NG--KEVAVKRLSRK---SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  364 (611)
                      ++|++.+.||+|+||.||+|++.  ++  .+||||++.+.   ..+..++|.+|+.++++++||||+++++++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56999999999999999999853  23  36899998654   33446789999999999999999999999965 5678


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      +||||++++++.+.+..  ....+++..++.++.||++||.|||+++   |+||||||+||||+.++.+||+|||+++.+
T Consensus        87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            99999999999988753  3456999999999999999999999986   999999999999999999999999999987


Q ss_pred             ccCCCcc-ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          445 CENQKTA-NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       445 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      ....... ......|++.|+|||.+.+..++.++||||||+++|||++ |+.||...   .....   .....+.+...+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~---~~~~~---~~~i~~~~~~~~  235 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQI---LHKIDKEGERLP  235 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHH---HHHHHTSCCCCC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc---CHHHH---HHHHHhCCCCCC
Confidence            5443322 2334568889999999999999999999999999999998 89887422   22222   222223322211


Q ss_pred             ccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       523 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ..     .    .....+.+|+.+||+.||++|||+.||++.|..
T Consensus       236 ~~-----~----~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         236 RP-----E----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             CC-----T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             Cc-----c----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence            11     1    112357789999999999999999999999863

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-47  Score=386.19  Aligned_cols=260  Identities=27%  Similarity=0.396  Sum_probs=209.8

Q ss_pred             hCCCCcccccCccCceEEEEEEc------CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCe
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL------PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEE  362 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~  362 (611)
                      .++|++.++||+|+||.||+|++      .+++.||||+++... ......+.+|+.+++++ +||||+++++++.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            46899999999999999999984      346789999997643 34556789999999999 69999999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhch---------------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe
Q 007239          363 KLLIYELMPNRSLDCFIFDSE---------------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL  427 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~---------------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll  427 (611)
                      .++||||+++|+|.+++....               ....+++..+..++.||++||.|||+++   ++||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            999999999999999986432               2345899999999999999999999997   9999999999999


Q ss_pred             cCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhH
Q 007239          428 DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTL  507 (611)
Q Consensus       428 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l  507 (611)
                      +.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||++++.|+....... .. 
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-~~-  256 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SK-  256 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HH-
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-HH-
Confidence            9999999999999998765544444556789999999999999999999999999999999999554432222111 11 


Q ss_pred             HHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          508 LAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       508 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                         +++....+....         .+.....++.+|+.+||+.||++|||+++|+++|++
T Consensus       257 ---~~~~i~~~~~~~---------~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         257 ---FYKMIKEGFRML---------SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             ---HHHHHHHTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---HHHHHhcCCCCC---------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence               222222222111         111122457899999999999999999999999974

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=380.79  Aligned_cols=258  Identities=27%  Similarity=0.385  Sum_probs=206.9

Q ss_pred             hCCCCcccccCccCceEEEEEEcC--------CCcEEEEEEecccCh-hhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeC
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP--------NGKEVAVKRLSRKSW-QGLEEFKNEIILIAKL-QHRNLVRLVGCGIEG  360 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~  360 (611)
                      .++|++++.||+|+||.||+|+..        ++..||||++++... ....++.+|...+.++ +||||+++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            368999999999999999999842        234799999976543 4467889999999888 799999999999999


Q ss_pred             CeEEEEEEecCCCChhhHhhhch-------------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEe
Q 007239          361 EEKLLIYELMPNRSLDCFIFDSE-------------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLL  427 (611)
Q Consensus       361 ~~~~lv~E~~~~~sL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll  427 (611)
                      +..++||||+++|+|.+++....             ....+++..++.++.||+.||+|||+++   ||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            99999999999999999985432             1245899999999999999999999996   9999999999999


Q ss_pred             cCCCCEEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCCCchhh
Q 007239          428 DKDMVAKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIIS-GKRNSGFYLTGHAQT  506 (611)
Q Consensus       428 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~ellt-G~~p~~~~~~~~~~~  506 (611)
                      +.++.+||+|||+++...............||+.|+|||.+.++.|+.++||||||+++|||++ |++||....   .. 
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~---~~-  244 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---VE-  244 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HH-
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC---HH-
Confidence            9999999999999998766555555566789999999999999999999999999999999998 677764221   11 


Q ss_pred             HHHHHHHHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          507 LLAYVWQLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       507 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                         .+++.+..+...+..     .    ....++.+|+.+||+.||++|||+.||+++|++
T Consensus       245 ---~~~~~i~~~~~~~~p-----~----~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~  293 (299)
T d1fgka_         245 ---ELFKLLKEGHRMDKP-----S----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  293 (299)
T ss_dssp             ---HHHHHHHTTCCCCCC-----S----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---HHHHHHHcCCCCCCC-----c----cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence               222333333322211     1    112357799999999999999999999999975

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-47  Score=387.17  Aligned_cols=252  Identities=23%  Similarity=0.300  Sum_probs=204.5

Q ss_pred             hhCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          290 ATDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       290 ~~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ..++|++.+.||+|+||+||+|++ .+++.||+|+++.... ....+.+|+++|+.++||||+++++++.+.+..|+|||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            457899999999999999999996 4788999999987653 34568899999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCC--CCEEEeccccceeccc
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKD--MVAKISDFGMARIFCE  446 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~--~~~kl~DFGla~~~~~  446 (611)
                      |++|++|.+++..  ....+++.+++.++.||+.||.|||+++   |+||||||+|||++.+  ..+||+|||+++....
T Consensus        82 ~~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          82 FISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             cCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            9999999999843  2346899999999999999999999987   9999999999999854  5899999999987643


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ..   ......||+.|+|||.+.+..++.++||||+||++|+|++|+.||....   ...+...+   ......  +...
T Consensus       157 ~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~---~~~~~~~i---~~~~~~--~~~~  225 (321)
T d1tkia_         157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIENI---MNAEYT--FDEE  225 (321)
T ss_dssp             TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHH---HHTCCC--CCHH
T ss_pred             CC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC---HHHHHHHH---HhCCCC--CChh
Confidence            32   2334679999999999999999999999999999999999999985322   22222221   111110  0000


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                       ....    ...++.+|+.+||+.||++|||++|+++
T Consensus       226 -~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         226 -AFKE----ISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -HHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -hccC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0000    1235679999999999999999999997

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.6e-46  Score=388.63  Aligned_cols=249  Identities=26%  Similarity=0.297  Sum_probs=198.1

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh---hhHHHHHH---HHHHHHhcCCCCeeeEEEeEeeCCeE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW---QGLEEFKN---EIILIAKLQHRNLVRLVGCGIEGEEK  363 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~---E~~il~~l~h~niv~l~~~~~~~~~~  363 (611)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++.+...   .....+.+   |+.+++.++||||+++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            36899999999999999999996 4799999999864321   12233444   46677777899999999999999999


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecccccee
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ++||||+++|+|.+++.   +...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.
T Consensus        83 ~ivmE~~~gg~L~~~l~---~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEEECCCCSCBHHHHHH---HHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHH---hcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence            99999999999999984   4566899999999999999999999997   99999999999999999999999999987


Q ss_pred             cccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          444 FCENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       444 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      +....    .....||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+.    +..... ...
T Consensus       157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~~~~-~~~  227 (364)
T d1omwa3         157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLTM-AVE  227 (364)
T ss_dssp             CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HHSSSC-CCC
T ss_pred             cCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhcccC-CCC
Confidence            65432    234689999999999975 56899999999999999999999998654333221111    111111 000


Q ss_pred             ccccccCCCCCHHHHHHHHHHhhccccCCCCCCCC-----HHHHHH
Q 007239          523 FVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPT-----MSNVVA  563 (611)
Q Consensus       523 ~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~evl~  563 (611)
                           ...    ....++.+|+.+||+.||++|||     ++|+++
T Consensus       228 -----~~~----~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         228 -----LPD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             -----CCS----SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             -----CCC----CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                 111    11235778999999999999999     678875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.1e-46  Score=387.04  Aligned_cols=244  Identities=22%  Similarity=0.258  Sum_probs=203.7

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~  367 (611)
                      ++|++++.||+|+||+||+|++ .+|+.||||++.+..   ....+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            6899999999999999999996 579999999986532   234677899999999999999999999999999999999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccC
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCEN  447 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  447 (611)
                      ||+.+|+|..++.   +...+++..++.++.||+.||.|||+++   ||||||||+||||+.++++||+|||+++.+...
T Consensus       121 e~~~~g~l~~~l~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHH---HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            9999999999883   4457999999999999999999999986   999999999999999999999999999876432


Q ss_pred             CCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccccccc
Q 007239          448 QKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPL  527 (611)
Q Consensus       448 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~  527 (611)
                           .....||+.|||||++.+..++.++|||||||++|||++|+.||...   ....+...+   . .+...      
T Consensus       195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i---~-~~~~~------  256 (350)
T d1rdqe_         195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKI---V-SGKVR------  256 (350)
T ss_dssp             -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHH---H-HCCCC------
T ss_pred             -----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc---CHHHHHHHH---h-cCCCC------
Confidence                 23468999999999999999999999999999999999999998432   222222211   1 11110      


Q ss_pred             cCCCCCHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 007239          528 LMKSSSIPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVA  563 (611)
Q Consensus       528 l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  563 (611)
                      ...    ....++.+|+.+||+.||.+|+     |++++++
T Consensus       257 ~p~----~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         257 FPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCc----cCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            011    1123577899999999999994     8999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=385.61  Aligned_cols=247  Identities=23%  Similarity=0.310  Sum_probs=201.4

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC---hhhHHHHHHHHHHHH-hcCCCCeeeEEEeEeeCCeEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS---WQGLEEFKNEIILIA-KLQHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~-~l~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ++|++.+.||+|+||+||+|+. .+++.||||++++..   ....+.+.+|..++. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            6899999999999999999996 478999999997542   234556777777765 68999999999999999999999


Q ss_pred             EEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceeccc
Q 007239          367 YELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCE  446 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  446 (611)
                      |||+++|+|.+++.   ....+++.+++.++.||+.||.|||+++   |+||||||+|||+++++++||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~---~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHH---HHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            99999999999984   4556899999999999999999999997   99999999999999999999999999986543


Q ss_pred             CCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccc
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDP  526 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~  526 (611)
                      ...  ......||+.|+|||++.++.++.++|||||||++|||++|+.||...   ....+..    ....+..      
T Consensus       156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~----~i~~~~~------  220 (320)
T d1xjda_         156 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEELFH----SIRMDNP------  220 (320)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHH----HHHHCCC------
T ss_pred             ccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC---CHHHHHH----HHHcCCC------
Confidence            322  233468999999999999999999999999999999999999998532   2222222    1222211      


Q ss_pred             ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHH-HHHH
Q 007239          527 LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMS-NVVA  563 (611)
Q Consensus       527 ~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-evl~  563 (611)
                      .....    ...++.+|+.+||+.||++||++. ++++
T Consensus       221 ~~p~~----~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 FYPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CCCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCCcc----CCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            11111    123577899999999999999996 6754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-46  Score=384.51  Aligned_cols=255  Identities=26%  Similarity=0.383  Sum_probs=201.3

Q ss_pred             CCCCcccccCccCceEEEEEEcC-CCc--EEEEEEeccc-ChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEeeCCeEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP-NGK--EVAVKRLSRK-SWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIEGEEKLLI  366 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~lv  366 (611)
                      ++|++.+.||+|+||+||+|++. +|.  .||||++... ..+..+.+.+|+++|+++ +||||+++++++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            68999999999999999999964 444  4778887543 334556799999999999 699999999999999999999


Q ss_pred             EEecCCCChhhHhhhc-------------hhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCE
Q 007239          367 YELMPNRSLDCFIFDS-------------ERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVA  433 (611)
Q Consensus       367 ~E~~~~~sL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~  433 (611)
                      |||+++|+|.+++...             .....+++..++.++.||++||.|||+++   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999998643             23456899999999999999999999986   9999999999999999999


Q ss_pred             EEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCCCchhhHHHHHH
Q 007239          434 KISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKR-NSGFYLTGHAQTLLAYVW  512 (611)
Q Consensus       434 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~-p~~~~~~~~~~~l~~~~~  512 (611)
                      ||+|||+++.......   .....||+.|+|||.+.++.++.++|||||||++|||++|.. |+..   .....+..   
T Consensus       167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~---~~~~~~~~---  237 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG---MTCAELYE---  237 (309)
T ss_dssp             EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT---CCHHHHHH---
T ss_pred             EEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC---CCHHHHHH---
Confidence            9999999986543222   224578999999999999999999999999999999999765 4422   12222222   


Q ss_pred             HHHhcCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          513 QLWKEGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       513 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                       ....+...+         .+.....++.+|+.+||+.||++|||++||++.|++.
T Consensus       238 -~i~~~~~~~---------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         238 -KLPQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             -HGGGTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHhcCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence             222221111         1111224677999999999999999999999998753

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=383.81  Aligned_cols=258  Identities=28%  Similarity=0.459  Sum_probs=210.2

Q ss_pred             CCCCcccccCccCceEEEEEEcC------CCcEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLP------NGKEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  364 (611)
                      ++|++.++||+|+||+||+|.+.      +++.||||+++.. ..+....|.+|+.++++++||||+++++++...+..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            68899999999999999999863      3578999999754 3344567899999999999999999999999999999


Q ss_pred             EEEEecCCCChhhHhhhch-------hhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEec
Q 007239          365 LIYELMPNRSLDCFIFDSE-------RRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISD  437 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~D  437 (611)
                      +||||+++|+|.+++....       ....+++..+.+++.||++||.|||+++   |+||||||+|||++.++++||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence            9999999999999886432       1234689999999999999999999986   99999999999999999999999


Q ss_pred             cccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCCCchhhHHHHHHHHHh
Q 007239          438 FGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGK-RNSGFYLTGHAQTLLAYVWQLWK  516 (611)
Q Consensus       438 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~-~p~~~~~~~~~~~l~~~~~~~~~  516 (611)
                      ||+++...............||+.|+|||.+.++.++.++||||||+++|||++|. +|+..   ........    ...
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~---~~~~~~~~----~i~  249 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSNEQVLR----FVM  249 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT---SCHHHHHH----HHH
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC---CCHHHHHH----HHH
Confidence            99999776555444455567999999999999999999999999999999999986 55422   12222222    222


Q ss_pred             cCccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          517 EGKEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       517 ~~~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                      .+......+         .....+.+|+.+||+.||++|||+++|+++|++.
T Consensus       250 ~~~~~~~p~---------~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         250 EGGLLDKPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             TTCCCCCCT---------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             hCCCCCCcc---------cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            322211111         1124578999999999999999999999999764

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-45  Score=373.23  Aligned_cols=263  Identities=23%  Similarity=0.330  Sum_probs=200.2

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ++|++.+.||+|+||+||+|++ .+|+.||||+++....  ...+++.+|+.++++++||||+++++++.+....++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            6899999999999999999995 5799999999965432  235688999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      |+.++.+.....  .....+++..++.++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            998765544332  23456999999999999999999999987   9999999999999999999999999998764333


Q ss_pred             CccccccccccCCCCCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc---
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV---  524 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~---  524 (611)
                      .  ......||+.|+|||.+.... ++.++||||+||++|+|++|+.||...   ........+.............   
T Consensus       157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~  231 (298)
T d1gz8a_         157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD---SEIDQLFRIFRTLGTPDEVVWPGVT  231 (298)
T ss_dssp             B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             c--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCC---CHHHHHHHHHHhcCCCchhhccccc
Confidence            2  233458999999999877665 578999999999999999999998532   2222222222221111100000   


Q ss_pred             -----ccccCC--CCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          525 -----DPLLMK--SSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       525 -----d~~l~~--~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                           ......  ....     ....++.+|+.+||+.||++|||++|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                 000000  0000     112467889999999999999999999973

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-45  Score=375.69  Aligned_cols=266  Identities=23%  Similarity=0.286  Sum_probs=198.5

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC----eEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE----EKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----~~~lv~  367 (611)
                      ++|.+.++||+|+||.||+|++ +|+.||||+++..... ......|+..+..++||||+++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            5678889999999999999997 6889999999754322 122334555556789999999999987654    679999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcC-----CCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDS-----RLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~-----~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      ||+++|+|.+++..    ..++|..+++++.|++.||.|||+..     ..+|+||||||+||||+.++++||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999943    35899999999999999999999731     2369999999999999999999999999999


Q ss_pred             ecccCCCcc--ccccccccCCCCCccccccCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCCCch--------hh
Q 007239          443 IFCENQKTA--NTRRVVGTYGYMAPEYAMEGL------FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHA--------QT  506 (611)
Q Consensus       443 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~k~DvwSlGvll~elltG~~p~~~~~~~~~--------~~  506 (611)
                      .........  ......||+.|+|||++.+..      ++.|+|||||||+||||++|..|++.......        ..
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            875443222  234578999999999987643      57799999999999999999887643222110        01


Q ss_pred             HHHHHHHHHhcCccccccccccCCCC-CHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          507 LLAYVWQLWKEGKEMEFVDPLLMKSS-SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       507 l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ...........+..    ++.+.... ..+....+.+|+.+||+.||++|||+.||++.|+.
T Consensus       237 ~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~  294 (303)
T d1vjya_         237 SVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            11122222222111    11111111 22344568899999999999999999999999964

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-46  Score=381.20  Aligned_cols=252  Identities=21%  Similarity=0.225  Sum_probs=196.2

Q ss_pred             hCCCCccc-ccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhc-CCCCeeeEEEeEee----CCeE
Q 007239          291 TDGFSDSN-KLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKL-QHRNLVRLVGCGIE----GEEK  363 (611)
Q Consensus       291 ~~~y~~~~-~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~~~~~~----~~~~  363 (611)
                      .++|++.+ .||+|+||+||+|++ .+++.||||+++..     ..+.+|+.++.++ +||||++++++|.+    ...+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46898875 599999999999995 57899999998643     4567899987655 79999999999875    4678


Q ss_pred             EEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC---CCCEEEecccc
Q 007239          364 LLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK---DMVAKISDFGM  440 (611)
Q Consensus       364 ~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFGl  440 (611)
                      |+||||++||+|.+++... ....+++.+++.++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            9999999999999998542 2246999999999999999999999997   999999999999975   56799999999


Q ss_pred             ceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc
Q 007239          441 ARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE  520 (611)
Q Consensus       441 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  520 (611)
                      ++.......   .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||........   ...+......+. 
T Consensus       161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~-  233 (335)
T d2ozaa1         161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQ-  233 (335)
T ss_dssp             CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS-
T ss_pred             eeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCC-
Confidence            987654332   2346899999999999999999999999999999999999999853322111   110100000000 


Q ss_pred             ccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       521 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                           .............++.+|+.+||+.||++|||+.|+++
T Consensus       234 -----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         234 -----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             -----SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -----CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                 00000000112346789999999999999999999988

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-46  Score=377.62  Aligned_cols=252  Identities=26%  Similarity=0.425  Sum_probs=199.7

Q ss_pred             ccccCccCceEEEEEEcCC--C--cEEEEEEeccc-ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee-CCeEEEEEEec
Q 007239          297 SNKLGQGGFGTVYKGVLPN--G--KEVAVKRLSRK-SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE-GEEKLLIYELM  370 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~~--~--~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~-~~~~~lv~E~~  370 (611)
                      .++||+|+||+||+|++.+  +  ..||||+++.. .....++|.+|++++++++||||+++++++.. +...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            5789999999999999643  2  25899998753 45566889999999999999999999999875 46889999999


Q ss_pred             CCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCCc
Q 007239          371 PNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQKT  450 (611)
Q Consensus       371 ~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  450 (611)
                      ++++|.+++..  ....+++..++.++.||++||.|||+.+   |+||||||+||||++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999998853  3445788899999999999999999986   999999999999999999999999999876544322


Q ss_pred             c--ccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccccccc
Q 007239          451 A--NTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFVDPLL  528 (611)
Q Consensus       451 ~--~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l  528 (611)
                      .  ......||+.|+|||.+..+.++.++||||||+++|||++|+.|+.....  ...+...    ...+....  .+  
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~----i~~g~~~~--~p--  256 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVY----LLQGRRLL--QP--  256 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH----HHTTCCCC--CC--
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHH----HHcCCCCC--Cc--
Confidence            2  22335789999999999999999999999999999999998877643221  1111221    22222211  11  


Q ss_pred             CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcCC
Q 007239          529 MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGSE  568 (611)
Q Consensus       529 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~~  568 (611)
                       .    ....++.+|+.+||+.||++||++.||++.|++.
T Consensus       257 -~----~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         257 -E----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             -T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -c----cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             1    1123577899999999999999999999999764

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.2e-45  Score=369.94  Aligned_cols=261  Identities=23%  Similarity=0.328  Sum_probs=201.0

Q ss_pred             CCCCcccccCccCceEEEEEEcCCCcEEEEEEecccCh--hhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEEe
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW--QGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E~  369 (611)
                      ++|++.++||+|+||+||+|++++|+.||||++.....  ...+++.+|+.+|++++||||+++++++...+..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            68999999999999999999998999999999976532  2357899999999999999999999999999999999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCCC
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQK  449 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  449 (611)
                      +.++.+..+.   .....+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            9988777665   33466999999999999999999999986   99999999999999999999999999987643322


Q ss_pred             ccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccccc----
Q 007239          450 TANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEFV----  524 (611)
Q Consensus       450 ~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~~----  524 (611)
                        ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||....   .......+.............    
T Consensus       156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS---EADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             --ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC---HHHHHHHHHHhhCCCChhhccchhh
Confidence              23345799999999998764 56899999999999999999999974322   222222222222111111000    


Q ss_pred             ----ccccC--CC-----CCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          525 ----DPLLM--KS-----SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       525 ----d~~l~--~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                          +....  ..     ........+.+|+.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                00000  00     00111235779999999999999999999984

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=369.88  Aligned_cols=240  Identities=22%  Similarity=0.366  Sum_probs=194.8

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChh------hHHHHHHHHHHHHhcC--CCCeeeEEEeEeeCC
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQ------GLEEFKNEIILIAKLQ--HRNLVRLVGCGIEGE  361 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~--h~niv~l~~~~~~~~  361 (611)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.+....      ...++.+|+.++++++  ||||+++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            36899999999999999999995 57899999998753211      1234678999999997  899999999999999


Q ss_pred             eEEEEEEecCC-CChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC-CCCEEEeccc
Q 007239          362 EKLLIYELMPN-RSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK-DMVAKISDFG  439 (611)
Q Consensus       362 ~~~lv~E~~~~-~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFG  439 (611)
                      ..++||||+.+ +++.+++   .....+++.+++.++.||++||.|||+++   |+||||||+|||++. ++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~---~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHH---HHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHH---hccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence            99999999986 5676766   34567999999999999999999999997   999999999999985 4799999999


Q ss_pred             cceecccCCCccccccccccCCCCCccccccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC
Q 007239          440 MARIFCENQKTANTRRVVGTYGYMAPEYAMEGLF-SVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG  518 (611)
Q Consensus       440 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  518 (611)
                      +++......    .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....     .       .....
T Consensus       157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~-------i~~~~  220 (273)
T d1xwsa_         157 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----E-------IIRGQ  220 (273)
T ss_dssp             TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----H-------HHHCC
T ss_pred             cceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----H-------Hhhcc
Confidence            998653322    234689999999999987765 577999999999999999999984211     0       11111


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       519 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .       ......    ..++.+|+.+||+.||++|||++|+++
T Consensus       221 ~-------~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 V-------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             C-------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             c-------CCCCCC----CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            0       011111    245778999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=366.64  Aligned_cols=262  Identities=23%  Similarity=0.302  Sum_probs=196.6

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CC-CcEEEEEEecccCh--hhHHHHHHHHHHHHhc---CCCCeeeEEEeEee----
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PN-GKEVAVKRLSRKSW--QGLEEFKNEIILIAKL---QHRNLVRLVGCGIE----  359 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~-~~~vavK~~~~~~~--~~~~~~~~E~~il~~l---~h~niv~l~~~~~~----  359 (611)
                      .++|+++++||+|+||+||+|++ .+ ++.||||+++....  .....+.+|+.+++.|   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999996 34 56799999865422  1233466788877766   79999999999853    


Q ss_pred             -CCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEecc
Q 007239          360 -GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDF  438 (611)
Q Consensus       360 -~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  438 (611)
                       ....+++|||++++.+.....  .....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             346799999999987754442  34456899999999999999999999996   999999999999999999999999


Q ss_pred             ccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC
Q 007239          439 GMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG  518 (611)
Q Consensus       439 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  518 (611)
                      |+++......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||....   .......+.+.....
T Consensus       161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~~  234 (305)
T d1blxa_         161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS---DVDQLGKILDVIGLP  234 (305)
T ss_dssp             CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCC
T ss_pred             hhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC---HHHHHHHHHHhhCCC
Confidence            9998653322   2345689999999999999999999999999999999999999985332   222222222222111


Q ss_pred             ccccccc------cccC--CC-----CCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          519 KEMEFVD------PLLM--KS-----SSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       519 ~~~~~~d------~~l~--~~-----~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ....+..      ....  ..     ........+.+|+.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            1110000      0000  00     00111235678999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-44  Score=366.66  Aligned_cols=264  Identities=22%  Similarity=0.310  Sum_probs=197.6

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee--------
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE--------  359 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~--------  359 (611)
                      .++|++.++||+|+||+||+|++ .+|+.||||++...  ......++.+|+.+|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            47899999999999999999996 57999999998654  22345678999999999999999999998754        


Q ss_pred             CCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccc
Q 007239          360 GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFG  439 (611)
Q Consensus       360 ~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  439 (611)
                      ....++||||+.++.+....   .....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg  162 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  162 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence            34679999999988776554   34456899999999999999999999987   9999999999999999999999999


Q ss_pred             cceecccCCCc--cccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHh
Q 007239          440 MARIFCENQKT--ANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWK  516 (611)
Q Consensus       440 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~  516 (611)
                      +++.+......  ......+||+.|+|||++.+. .++.++||||+||++|||++|+.||...   ........+.+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~---~~~~~~~~i~~~~~  239 (318)
T d3blha1         163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN---TEQHQLALISQLCG  239 (318)
T ss_dssp             TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHHHC
T ss_pred             eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC---CHHHHHHHHHHhcC
Confidence            99876543322  122345799999999998765 6899999999999999999999997432   22222222222221


Q ss_pred             cCccc---cc--------cccccCCCCCHHH-------HHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          517 EGKEM---EF--------VDPLLMKSSSIPQ-------VVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       517 ~~~~~---~~--------~d~~l~~~~~~~~-------~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .....   ..        +............       ...+++|+.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            11100   00        0001111111111       124578999999999999999999996

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-44  Score=370.08  Aligned_cols=258  Identities=24%  Similarity=0.283  Sum_probs=193.9

Q ss_pred             CCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC------CeEEE
Q 007239          293 GFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG------EEKLL  365 (611)
Q Consensus       293 ~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~------~~~~l  365 (611)
                      +|+..++||+|+||+||+|++ .+|+.||||++.....    .+.+|+.+|++++||||+++++++...      ..+++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            588899999999999999996 4799999999976542    235799999999999999999998543      34789


Q ss_pred             EEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC-CEEEeccccceec
Q 007239          366 IYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIF  444 (611)
Q Consensus       366 v~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGla~~~  444 (611)
                      ||||++++.+..+.........+++.+++.++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987765555433345567999999999999999999999986   99999999999999775 8999999999876


Q ss_pred             ccCCCccccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHH---------
Q 007239          445 CENQKTANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQL---------  514 (611)
Q Consensus       445 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~---------  514 (611)
                      .....   .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.....   ......+.+.         
T Consensus       174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~---~~~l~~i~~~~g~~~~~~~  247 (350)
T d1q5ka_         174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG---VDQLVEIIKVLGTPTREQI  247 (350)
T ss_dssp             CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH---HHHHHHHHHHHCCCCHHHH
T ss_pred             cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH---HHHHHHHHHHhCCChHHhh
Confidence            44332   224589999999998875 5689999999999999999999999853322   1111111111         


Q ss_pred             --HhcCcccccccc----ccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          515 --WKEGKEMEFVDP----LLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       515 --~~~~~~~~~~d~----~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                        ............    ............++.+|+.+||+.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              111000000000    0000001112235778999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=367.27  Aligned_cols=264  Identities=20%  Similarity=0.273  Sum_probs=197.0

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC-hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC----eEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS-WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE----EKL  364 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~----~~~  364 (611)
                      .++|+++++||+|+||+||+|+. .+|+.||||++.+.. ....+.+.+|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            46799999999999999999995 589999999997543 344667899999999999999999999987653    235


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceec
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIF  444 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  444 (611)
                      ++++++.+++|.+++..    ..+++..++.++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+++..
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            55667789999999842    36999999999999999999999997   999999999999999999999999999876


Q ss_pred             ccCCCc-cccccccccCCCCCcccccc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcccc
Q 007239          445 CENQKT-ANTRRVVGTYGYMAPEYAME-GLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEME  522 (611)
Q Consensus       445 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  522 (611)
                      ...... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||.....   .+................
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~  236 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY---LDQLNHILGILGSPSQED  236 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHHHCSCCHHH
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH---HHHHHHHhhhccCCChhh
Confidence            443322 22345679999999999854 5678999999999999999999999853322   111111111111110000


Q ss_pred             c------------cccccCCCCCHHH-----HHHHHHHhhccccCCCCCCCCHHHHHHH
Q 007239          523 F------------VDPLLMKSSSIPQ-----VVRCIHIGLLCVQEDPAVRPTMSNVVAL  564 (611)
Q Consensus       523 ~------------~d~~l~~~~~~~~-----~~~l~~li~~cl~~dP~~RPt~~evl~~  564 (611)
                      .            .........+...     ..++++|+.+||+.||++|||++|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0            0000000111111     1357899999999999999999999974

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.3e-43  Score=354.85  Aligned_cols=259  Identities=21%  Similarity=0.280  Sum_probs=196.1

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCC-eeeEEEeEeeCCeEEEEEEe
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRN-LVRLVGCGIEGEEKLLIYEL  369 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~l~~~~~~~~~~~lv~E~  369 (611)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++.....  .+++.+|+++++.++|+| |+.+..++.+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            5799999999999999999995 5789999999876532  245788999999998766 55566677888899999999


Q ss_pred             cCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEec---CCCCEEEeccccceeccc
Q 007239          370 MPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLD---KDMVAKISDFGMARIFCE  446 (611)
Q Consensus       370 ~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~---~~~~~kl~DFGla~~~~~  446 (611)
                      +.+ +|...+.  .....+++..+..++.||+.||+|||+++   |+||||||+|||++   .+..+||+|||+++.+..
T Consensus        85 ~~~-~l~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 LGP-SLEDLFN--FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             CCC-BHHHHHH--HTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             cCC-chhhhhh--hccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            955 5555443  23356899999999999999999999997   99999999999985   455799999999998754


Q ss_pred             CCCc-----cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc
Q 007239          447 NQKT-----ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM  521 (611)
Q Consensus       447 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  521 (611)
                      ....     .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........................
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  238 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence            3322     12345689999999999999999999999999999999999999986544333222221111111111111


Q ss_pred             cccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          522 EFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       522 ~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      .     +....    ..++.+++..||+.||++||+++++.+.|+.
T Consensus       239 ~-----~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         239 V-----LCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             H-----HTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             H-----hccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            1     11111    1346788899999999999999999888864

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-43  Score=352.84  Aligned_cols=262  Identities=23%  Similarity=0.303  Sum_probs=204.9

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCCeEEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      ++|+++++||+|+||+||+|++ .+++.||||+++...  .....++.+|+.+++.++||||+++++++.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5899999999999999999995 578899999986543  3346789999999999999999999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccceecccCC
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMARIFCENQ  448 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  448 (611)
                      ++.+++|..++.   ..+.+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999999888773   4456899999999999999999999986   9999999999999999999999999998765433


Q ss_pred             CccccccccccCCCCCccccccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccccc----
Q 007239          449 KTANTRRVVGTYGYMAPEYAMEGL-FSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEMEF----  523 (611)
Q Consensus       449 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~----  523 (611)
                      ..  .....+++.|+|||.+.... ++.++|||||||++|||++|+.|+..  ..........+............    
T Consensus       156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP--GNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC--CSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             cc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC--CCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            22  22346788999999987665 68999999999999999999998632  22233333333333222111100    


Q ss_pred             --ccc----cc-----CCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          524 --VDP----LL-----MKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       524 --~d~----~l-----~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                        .+.    ..     ...........+.+|+.+||+.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              000    00     00001112235678999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-42  Score=359.85  Aligned_cols=261  Identities=26%  Similarity=0.307  Sum_probs=193.0

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeCC------
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIEGE------  361 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~------  361 (611)
                      .++|++.++||+|+||+||+|++ .+|+.||||+++..  .....+.+.+|+.+|+.++||||+++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            36899999999999999999995 57999999999754  3334567899999999999999999999997654      


Q ss_pred             eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccc
Q 007239          362 EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA  441 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  441 (611)
                      ..++||||+ +.+|..++    ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+|++|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLM----KHEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHH----HhccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            569999999 55666665    2356999999999999999999999997   999999999999999999999999999


Q ss_pred             eecccCCCccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC--
Q 007239          442 RIFCENQKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG--  518 (611)
Q Consensus       442 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--  518 (611)
                      +.....     .....||+.|+|||++.+. .++.++||||+||++|||++|+.||.....   ..............  
T Consensus       169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~---~~~~~~~~~~~~~~~~  240 (346)
T d1cm8a_         169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH---LDQLKEIMKVTGTPPA  240 (346)
T ss_dssp             EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCH
T ss_pred             eccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh---HHHHHHHHhccCCCcH
Confidence            875432     2346799999999998764 568999999999999999999999753321   11111111110000  


Q ss_pred             ------c----------cccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHH--hcCC
Q 007239          519 ------K----------EMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVAL--LGSE  568 (611)
Q Consensus       519 ------~----------~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~--L~~~  568 (611)
                            .          ..+.....+. .........+++|+.+||+.||++|||++|+++.  |+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         241 EFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence                  0          0000000000 0000112346789999999999999999999984  5543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.4e-42  Score=349.75  Aligned_cols=260  Identities=17%  Similarity=0.235  Sum_probs=205.2

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcCC-CCeeeEEEeEeeCCeEEEEEE
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQH-RNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~~~lv~E  368 (611)
                      .++|++.++||+|+||+||+|++ .+|+.||||++.....  ...+.+|+++++.++| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            36899999999999999999995 4789999999865432  2457889999999985 899999999999999999999


Q ss_pred             ecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecC-----CCCEEEecccccee
Q 007239          369 LMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDK-----DMVAKISDFGMARI  443 (611)
Q Consensus       369 ~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~-----~~~~kl~DFGla~~  443 (611)
                      |+ +++|.+++..  ....+++..+..++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+++.
T Consensus        82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            98 6788888743  2346899999999999999999999997   999999999999964     57899999999998


Q ss_pred             cccCCCc-----cccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcC
Q 007239          444 FCENQKT-----ANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEG  518 (611)
Q Consensus       444 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  518 (611)
                      +......     .......||+.|||||.+.+..++.++||||||+++|||++|+.||..............+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            7543221     12335689999999999999999999999999999999999999986554444333332222221111


Q ss_pred             ccccccccccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHHHhcC
Q 007239          519 KEMEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVALLGS  567 (611)
Q Consensus       519 ~~~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~~L~~  567 (611)
                      ...++     ....    ..++.+++..|++.+|++||+++.+.+.|..
T Consensus       236 ~~~~l-----~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         236 PLREL-----CAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             CHHHH-----TTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             ChHHh-----cCCC----CHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            11111     1111    1356788889999999999999988887753

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.6e-42  Score=357.08  Aligned_cols=255  Identities=20%  Similarity=0.278  Sum_probs=196.3

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeC--CeEEEEE
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEG--EEKLLIY  367 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~--~~~~lv~  367 (611)
                      ++|+++++||+|+||+||+|+. .+|+.||||+++...   .+++.+|+.+|++++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            6799999999999999999996 578999999997543   457889999999996 99999999998743  5689999


Q ss_pred             EecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCC-CEEEeccccceeccc
Q 007239          368 ELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDM-VAKISDFGMARIFCE  446 (611)
Q Consensus       368 E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGla~~~~~  446 (611)
                      ||+++++|..+.      ..+++..++.++.||+.||.|||+++   |+||||||+||||+.++ .+||+|||+++....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999987654      35899999999999999999999997   99999999999998655 699999999987654


Q ss_pred             CCCccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHH---------HHh
Q 007239          447 NQKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ---------LWK  516 (611)
Q Consensus       447 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~---------~~~  516 (611)
                      ...   .....||+.|+|||.+.+. .++.++||||+|+++|||++|+.||.........  ...+..         ...
T Consensus       183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~--~~~i~~~~g~~~~~~~~~  257 (328)
T d3bqca1         183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIAKVLGTEDLYDYID  257 (328)
T ss_dssp             TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHHHHHCHHHHHHHHH
T ss_pred             CCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH--HHHHHHHHCCchhhhhhh
Confidence            332   2345799999999998765 4799999999999999999999997543332111  111110         000


Q ss_pred             cC--ccccccc------------cccCCCCCHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          517 EG--KEMEFVD------------PLLMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       517 ~~--~~~~~~d------------~~l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      ..  .......            .............++++|+.+||+.||++|||++|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         258 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00  0000000            00111111112245789999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-42  Score=356.34  Aligned_cols=252  Identities=22%  Similarity=0.276  Sum_probs=200.2

Q ss_pred             CCCCcccccCccCceEEEEEEc----CCCcEEEEEEecccC----hhhHHHHHHHHHHHHhcCC-CCeeeEEEeEeeCCe
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL----PNGKEVAVKRLSRKS----WQGLEEFKNEIILIAKLQH-RNLVRLVGCGIEGEE  362 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h-~niv~l~~~~~~~~~  362 (611)
                      ++|++.+.||+|+||+||+|+.    .+|+.||||++.+..    ....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999984    257899999986532    2334668899999999987 899999999999999


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .+++|||+.+++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~---~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHH---HHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHH---hcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999983   4456788999999999999999999986   9999999999999999999999999998


Q ss_pred             ecccCCCccccccccccCCCCCccccccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCcc
Q 007239          443 IFCENQKTANTRRVVGTYGYMAPEYAMEG--LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKE  520 (611)
Q Consensus       443 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  520 (611)
                      .+...... ......|++.|++||.+.+.  .++.++|||||||+||||++|+.||.........   ..+.+.......
T Consensus       178 ~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~~i~~~~~~~~~  253 (322)
T d1vzoa_         178 EFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRILKSEP  253 (322)
T ss_dssp             ECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHHHHCCC
T ss_pred             hhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcccCCC
Confidence            76443322 23346899999999999764  4788999999999999999999998544332221   112111111111


Q ss_pred             ccccccccCCCCCHHHHHHHHHHhhccccCCCCCCC-----CHHHHHH
Q 007239          521 MEFVDPLLMKSSSIPQVVRCIHIGLLCVQEDPAVRP-----TMSNVVA  563 (611)
Q Consensus       521 ~~~~d~~l~~~~~~~~~~~l~~li~~cl~~dP~~RP-----t~~evl~  563 (611)
                            .+    +.....++.+|+.+||+.||++||     |++|+++
T Consensus       254 ------~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         254 ------PY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ------CC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ------CC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                  01    111234677899999999999999     4788886

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-41  Score=354.73  Aligned_cols=258  Identities=23%  Similarity=0.276  Sum_probs=189.2

Q ss_pred             hCCCCcccccCccCceEEEEEEcC-CCcEEEEEEeccc--ChhhHHHHHHHHHHHHhcCCCCeeeEEEeEee------CC
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK--SWQGLEEFKNEIILIAKLQHRNLVRLVGCGIE------GE  361 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~------~~  361 (611)
                      .++|++.++||+|+||+||+|++. +|+.||||++...  ......++.+|+.++++++||||+++++++..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            368999999999999999999964 6999999999754  33445678999999999999999999999863      36


Q ss_pred             eEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccc
Q 007239          362 EKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMA  441 (611)
Q Consensus       362 ~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  441 (611)
                      ..|+||||+.++.+..+.      ..+++..++.++.||+.||.|||++|   |+||||||+|||++.++.+|++|||++
T Consensus        96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             eeEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence            889999999876654432      35899999999999999999999997   999999999999999999999999999


Q ss_pred             eecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHH--------
Q 007239          442 RIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQ--------  513 (611)
Q Consensus       442 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~--------  513 (611)
                      +......   ......||+.|+|||++.+..++.++||||+||++|||++|+.||.....   ......+..        
T Consensus       167 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~---~~~~~~i~~~~~~~~~~  240 (355)
T d2b1pa1         167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY---IDQWNKVIEQLGTPCPE  240 (355)
T ss_dssp             -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCCHH
T ss_pred             hcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH---HHHHHHHHHhccCCCHH
Confidence            8654433   23346799999999999999999999999999999999999999753221   111111110        


Q ss_pred             HH-----------hcCc------cccccccccCCCC---CHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 007239          514 LW-----------KEGK------EMEFVDPLLMKSS---SIPQVVRCIHIGLLCVQEDPAVRPTMSNVVA  563 (611)
Q Consensus       514 ~~-----------~~~~------~~~~~d~~l~~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~evl~  563 (611)
                      .+           ....      .............   .......+++|+.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00           0000      0000101111111   1123446789999999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-42  Score=355.25  Aligned_cols=274  Identities=24%  Similarity=0.325  Sum_probs=201.0

Q ss_pred             hCCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccC--hhhHHHHHHHHHHHHhcCCCCeeeEEEeEeeC-----Ce
Q 007239          291 TDGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKS--WQGLEEFKNEIILIAKLQHRNLVRLVGCGIEG-----EE  362 (611)
Q Consensus       291 ~~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~-----~~  362 (611)
                      .++|++.++||+|+||+||+|++ .+|+.||||++++..  ....+++.+|+.+|++++||||+++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            36899999999999999999995 579999999997543  34456789999999999999999999998643     34


Q ss_pred             EEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          363 KLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       363 ~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .+++|+|+.+++|.+++..    ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            5677888899999998832    35999999999999999999999997   9999999999999999999999999997


Q ss_pred             ecccCCCccccccccccCCCCCccccccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhHHHHHHHHHhcCccc
Q 007239          443 IFCENQKTANTRRVVGTYGYMAPEYAMEG-LFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTLLAYVWQLWKEGKEM  521 (611)
Q Consensus       443 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  521 (611)
                      .....     .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||....   .......+........ .
T Consensus       170 ~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~---~~~~~~~i~~~~~~~~-~  240 (348)
T d2gfsa1         170 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD---HIDQLKLILRLVGTPG-A  240 (348)
T ss_dssp             CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHHHCCCC-H
T ss_pred             ccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHHhcCCCC-h
Confidence            64322     2345799999999987765 46899999999999999999999985332   1112222211111100 0


Q ss_pred             ccc------------cccc-CCCCCH-----HHHHHHHHHhhccccCCCCCCCCHHHHHH--HhcCCCCCCCCCCCCCC
Q 007239          522 EFV------------DPLL-MKSSSI-----PQVVRCIHIGLLCVQEDPAVRPTMSNVVA--LLGSESIALSEPRQPPF  580 (611)
Q Consensus       522 ~~~------------d~~l-~~~~~~-----~~~~~l~~li~~cl~~dP~~RPt~~evl~--~L~~~~~~l~~~~~p~~  580 (611)
                      +..            .... ......     .....+++|+.+||+.||++|||++|+++  .|........+|..+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~~~~~~~~~  319 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY  319 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTTSCCCCCCC
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCccCCCCCCC
Confidence            000            0000 000011     11235678999999999999999999997  56544333334443433

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.9e-37  Score=319.55  Aligned_cols=263  Identities=21%  Similarity=0.213  Sum_probs=192.5

Q ss_pred             CCCCcccccCccCceEEEEEEc-CCCcEEEEEEecccChhhHHHHHHHHHHHHhcC-----------CCCeeeEEEeEee
Q 007239          292 DGFSDSNKLGQGGFGTVYKGVL-PNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-----------HRNLVRLVGCGIE  359 (611)
Q Consensus       292 ~~y~~~~~lg~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----------h~niv~l~~~~~~  359 (611)
                      ++|+++++||+|+||+||+|+. .+|+.||||++++.. ...+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            3599999999999999999996 579999999997653 23467788999998886           4789999988754


Q ss_pred             --CCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhh-cCCCceEecCCCCCcEEecCCCC----
Q 007239          360 --GEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHE-DSRLKIIHRDLKPSNVLLDKDMV----  432 (611)
Q Consensus       360 --~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~-~~~~~iiHrDikp~NIll~~~~~----  432 (611)
                        ....+++|++..................+++..+..++.||+.||+|||+ .   +|+||||||+||||+.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccccc
Confidence              35667777777665544444344555678999999999999999999998 5   4999999999999986653    


Q ss_pred             --EEEeccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCCchhhH---
Q 007239          433 --AKISDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIVLEIISGKRNSGFYLTGHAQTL---  507 (611)
Q Consensus       433 --~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll~elltG~~p~~~~~~~~~~~l---  507 (611)
                        +|++|||.+.......     ....||+.|+|||++....++.++||||+||++++|++|+.||...........   
T Consensus       169 ~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              9999999998653322     245799999999999999999999999999999999999999854332211111   


Q ss_pred             HHHHHHHHhc--------C-c---------cccccccc----------cCCCCCHHHHHHHHHHhhccccCCCCCCCCHH
Q 007239          508 LAYVWQLWKE--------G-K---------EMEFVDPL----------LMKSSSIPQVVRCIHIGLLCVQEDPAVRPTMS  559 (611)
Q Consensus       508 ~~~~~~~~~~--------~-~---------~~~~~d~~----------l~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~  559 (611)
                      .......+..        . .         ....+...          ...........++++|+.+||+.||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            1111111100        0 0         00000000          01122344566789999999999999999999


Q ss_pred             HHHH
Q 007239          560 NVVA  563 (611)
Q Consensus       560 evl~  563 (611)
                      |+++
T Consensus       324 e~L~  327 (362)
T d1q8ya_         324 GLVN  327 (362)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9987

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=4.8e-24  Score=200.50  Aligned_cols=170  Identities=18%  Similarity=0.134  Sum_probs=121.9

Q ss_pred             CCcccccCccCceEEEEEEcCCCcEEEEEEecccCh------------------hhHHHHHHHHHHHHhcCCCCeeeEEE
Q 007239          294 FSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSW------------------QGLEEFKNEIILIAKLQHRNLVRLVG  355 (611)
Q Consensus       294 y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~il~~l~h~niv~l~~  355 (611)
                      +.++++||+|+||+||+|+..+|++||||+++....                  .......+|...+.++.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            346789999999999999988899999998753211                  01233456889999999999998876


Q ss_pred             eEeeCCeEEEEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhcCCCceEecCCCCCcEEecCCCCEEE
Q 007239          356 CGIEGEEKLLIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHEDSRLKIIHRDLKPSNVLLDKDMVAKI  435 (611)
Q Consensus       356 ~~~~~~~~~lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~~~~~iiHrDikp~NIll~~~~~~kl  435 (611)
                      +.    ..+++|||+++..+..          ++...+..++.|++++|.|||+++   |+||||||+|||++++ .++|
T Consensus        82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred             ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence            53    2379999999865432          445566789999999999999997   9999999999999965 5899


Q ss_pred             eccccceecccCCCccccccccccCCCCCccccccCCCCchhhHHHHHHHH
Q 007239          436 SDFGMARIFCENQKTANTRRVVGTYGYMAPEYAMEGLFSVKSDVFSFGVIV  486 (611)
Q Consensus       436 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k~DvwSlGvll  486 (611)
                      +|||+|.....+.......+.+..    -.| ...+.|+.++|+||+.--+
T Consensus       144 iDFG~a~~~~~~~~~~~l~rd~~~----~~~-~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         144 IDFPQSVEVGEEGWREILERDVRN----IIT-YFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCCTTCEETTSTTHHHHHHHHHHH----HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred             EECCCcccCCCCCcHHHHHHHHHH----HHH-HHcCCCCCcccHHHHHHHH
Confidence            999999765322211000000000    001 1235678889999976544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.72  E-value=4.7e-08  Score=94.23  Aligned_cols=148  Identities=15%  Similarity=0.077  Sum_probs=103.8

Q ss_pred             HHHHhhCCCCcccccCccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEE
Q 007239          286 VIKAATDGFSDSNKLGQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKL  364 (611)
Q Consensus       286 ~~~~~~~~y~~~~~lg~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~  364 (611)
                      +++...+.|+..+..+.++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.+...++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            4556667888877766666678999865 56678899887654444556788999988875 333667788888888999


Q ss_pred             EEEEecCCCChhhHhhhchhhccCCHHHHHHHHHHHHHHHHHHhhc----------------------------------
Q 007239          365 LIYELMPNRSLDCFIFDSERRLQLNWNTCYNIIGGISKGLLYLHED----------------------------------  410 (611)
Q Consensus       365 lv~E~~~~~sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~l~yLH~~----------------------------------  410 (611)
                      +||++++|..+......        ......++.++++.+..||+.                                  
T Consensus        87 lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          87 LLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            99999999887554311        111223444555555555531                                  


Q ss_pred             ----------------------CCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          411 ----------------------SRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       411 ----------------------~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                                            ....++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                  11237999999999999987777899999875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.04  E-value=1.1e-05  Score=76.51  Aligned_cols=75  Identities=15%  Similarity=0.123  Sum_probs=55.2

Q ss_pred             ccCccC-ceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCC--CeeeEEEeEeeCCeEEEEEEecCCCCh
Q 007239          299 KLGQGG-FGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHR--NLVRLVGCGIEGEEKLLIYELMPNRSL  375 (611)
Q Consensus       299 ~lg~G~-fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~--niv~l~~~~~~~~~~~lv~E~~~~~sL  375 (611)
                      .+..|. .+.||+...+++..+++|.......   ..+..|...++.+...  .+.+++.+..+.+..++|||+++|..+
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            344554 3679999887888899998765542   3467788888877533  356678887888889999999998766


Q ss_pred             h
Q 007239          376 D  376 (611)
Q Consensus       376 ~  376 (611)
                      .
T Consensus        94 ~   94 (255)
T d1nd4a_          94 L   94 (255)
T ss_dssp             T
T ss_pred             c
Confidence            4

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.70  E-value=7.4e-05  Score=75.76  Aligned_cols=77  Identities=12%  Similarity=0.163  Sum_probs=50.5

Q ss_pred             ccccCccCceEEEEEEcC-CCcEEEEEEeccc-------ChhhHHHHHHHHHHHHhcC-C--CCeeeEEEeEeeCCeEEE
Q 007239          297 SNKLGQGGFGTVYKGVLP-NGKEVAVKRLSRK-------SWQGLEEFKNEIILIAKLQ-H--RNLVRLVGCGIEGEEKLL  365 (611)
Q Consensus       297 ~~~lg~G~fg~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~E~~il~~l~-h--~niv~l~~~~~~~~~~~l  365 (611)
                      .+.||.|....||+.... +++.+++|.-...       -....++...|.+.|+.+. +  ..+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            357899999999999865 4678999975431       1112345667888887764 2  335556544  4556689


Q ss_pred             EEEecCCCCh
Q 007239          366 IYELMPNRSL  375 (611)
Q Consensus       366 v~E~~~~~sL  375 (611)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.05  E-value=0.00087  Score=67.59  Aligned_cols=72  Identities=15%  Similarity=0.163  Sum_probs=50.2

Q ss_pred             cccCccCceEEEEEEcCC--------CcEEEEEEecccChhhHHHHHHHHHHHHhcC-CCCeeeEEEeEeeCCeEEEEEE
Q 007239          298 NKLGQGGFGTVYKGVLPN--------GKEVAVKRLSRKSWQGLEEFKNEIILIAKLQ-HRNLVRLVGCGIEGEEKLLIYE  368 (611)
Q Consensus       298 ~~lg~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~lv~E  368 (611)
                      +.|+.|-.-.+|++..++        .+.|++++....  .......+|..+++.+. +.-..++++++.+    .+|+|
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            578888889999988543        356777776532  22334568999999886 4334577777643    68999


Q ss_pred             ecCCCCh
Q 007239          369 LMPNRSL  375 (611)
Q Consensus       369 ~~~~~sL  375 (611)
                      |++|..+
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9988655

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.98  E-value=0.0021  Score=62.80  Aligned_cols=135  Identities=14%  Similarity=0.136  Sum_probs=78.8

Q ss_pred             eEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCe--eeEE-----EeEeeCCeEEEEEEecCCCChhh-
Q 007239          306 GTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNL--VRLV-----GCGIEGEEKLLIYELMPNRSLDC-  377 (611)
Q Consensus       306 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni--v~l~-----~~~~~~~~~~lv~E~~~~~sL~~-  377 (611)
                      -.||++...+|+.+++|+.++.. ...+++..|...+..|...++  +..+     ..+...+..+.++++++|..+.. 
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            57999999899999999987543 235677889988888863222  1111     12344567789999998754421 


Q ss_pred             ----H------h---hh------chhhccCCHH----------------------HHHHHHHHHHHHHHHH-hhcCCCce
Q 007239          378 ----F------I---FD------SERRLQLNWN----------------------TCYNIIGGISKGLLYL-HEDSRLKI  415 (611)
Q Consensus       378 ----~------l---~~------~~~~~~l~~~----------------------~~~~i~~qi~~~l~yL-H~~~~~~i  415 (611)
                          +      +   +.      ...+..+++.                      .....+.++...+.-+ .+.....+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                0      0   00      0001111111                      1122223333332222 12223458


Q ss_pred             EecCCCCCcEEecCCCCEEEecccccee
Q 007239          416 IHRDLKPSNVLLDKDMVAKISDFGMARI  443 (611)
Q Consensus       416 iHrDikp~NIll~~~~~~kl~DFGla~~  443 (611)
                      ||+|+.+.|||++++  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999743  45899998763

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.63  E-value=0.015  Score=56.01  Aligned_cols=157  Identities=13%  Similarity=0.027  Sum_probs=84.1

Q ss_pred             CHHHHHHhhCCCCccccc-----CccCceEEEEEEcCCCcEEEEEEecccChhhHHHHHHHHHHHHhcCCCCe-----ee
Q 007239          283 HLAVIKAATDGFSDSNKL-----GQGGFGTVYKGVLPNGKEVAVKRLSRKSWQGLEEFKNEIILIAKLQHRNL-----VR  352 (611)
Q Consensus       283 ~~~~~~~~~~~y~~~~~l-----g~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-----v~  352 (611)
                      ...+++....+|.+++..     ..|---+.|+...++| ++++|+.....  ..+++..|+.++..|...++     +.
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~   80 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP   80 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence            445666777788775543     3555677899887665 49999986532  22345567777777753222     11


Q ss_pred             EE---EeEeeCCeEEEEEEecCCCChhhHh--------------hh------------------------chhhccCCHH
Q 007239          353 LV---GCGIEGEEKLLIYELMPNRSLDCFI--------------FD------------------------SERRLQLNWN  391 (611)
Q Consensus       353 l~---~~~~~~~~~~lv~E~~~~~sL~~~l--------------~~------------------------~~~~~~l~~~  391 (611)
                      ..   .+.........++.++.+.......              +.                        ..........
T Consensus        81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (316)
T d2ppqa1          81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  160 (316)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence            10   0122344556677777664332110              00                        0000000111


Q ss_pred             HHHHHHHHHHHHHHHHhhc-CCCceEecCCCCCcEEecCCCCEEEeccccce
Q 007239          392 TCYNIIGGISKGLLYLHED-SRLKIIHRDLKPSNVLLDKDMVAKISDFGMAR  442 (611)
Q Consensus       392 ~~~~i~~qi~~~l~yLH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  442 (611)
                      .....+..+...+.-.+.. -+..+||+|+.++||+++++...-|+||+.+.
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            1222233333333333322 13359999999999999988877899999886